>12e8_2M (L) [b.1.1 - b.1.1] IGG1-KAPPA 2E8 FAB (LIGHT CHAIN)
DIVMTQSQKFMSTSVGDRVSITCKASQNVGTAVAWYQQKPGQSPKLMIYSASNRYTGVPD
RFTGSGSGTDFTLTISNMQSEDLADYFCQQYSSYPLTFGAGTKLELKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSATDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>12e8_2P (H) [b.1.1 - b.1.1] IGG1-KAPPA 2E8 FAB (HEAVY CHAIN)
EVQLQQSGAEVVRSGASVKLSCTASGFNIKDYYIHWVKQRPEKGLEWIGWIDPEIGDTEY
VPKFQGKATMTADTSSNTAYLQLSSLTSEDTAVYYCNAGHDYDRGRFPYWGQGTLVTVSA
AKTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSD
LYTLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKIVPRD
//
>15c8L [b.1.1 - b.1.1] IGG 5C8 FAB (LIGHT CHAIN)
DIVLTQSPAIMSASLGERVTMTCTASSSVSSSNLHWYQQKPGSSPKLWIYSTSNLASGVP
ARFSGSGSGTSYSLTISSMEAEDAATYYCHQYHRSPYTFGGGTKLEIKRADAAPTVSIFP
PSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTL
TLTKDEYERHNSYTCEATHKTSTSPIVKSFNRN
//
>15c8H [b.1.1 - b.1.1] IGG 5C8 FAB (HEAVY CHAIN)
EVQLQQSGAELVKPGASVKLSCTASGFNIKDTYMHWVKQKPEQGLEWIAQIDPANGNTKY
DPKFQGKATITADTSSNTAYLHLSSLTSEDSAVYYCAADPPYYGHGDYWGQGTTLTVSSA
KTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDL
YTLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKIV
//
>1a02N [b.2.5 - b.1.18] NUCLEAR FACTOR OF ACTIVATED T CELLS
WPLSSQSGSYELRIEVQPKPHHRAHYETEGSRGAVKAPTGGHPVVQLHGYMENKPLGLQI
FIGTADERILKPHAFYQVHRITGKTVTTTSYEKIVGNTKVLEIPLEPKNNMRATIDCAGI
LKLRNADIELRKGETDIGRKNTRVRLVFRVHIPESSGRIVSLQTASNPIECSQRSAHELP
MVERQDTDSCLVYGGQQMILTGQNFTSESKVVFTEKTTDGQQIWEMEATVDKDKSQPNML
FVEIPEYRNKHIRTPVKVNFYVINGKRKRSQPQHFTYHPV
//
>1a02F [h.1.3] AP-1 FRAGMENT FOS
RRIRRERNKMAAAKSRNRRRELTDTLQAETDQLEDEKSALQTEIANLLKEKEK
//
>1a02J [h.1.3] AP-1 FRAGMENT JUN
RKRMRNRIAASKSRKRKLERIARLEEKVKTLKAQNSELASTANMLREQVAQL
//
>1a0hA [g.14.1 - b.47.1] MEIZOTHROMBIN
SPLLETCVPDRGREYRGRLAVTTHGSRCLAWSSEQAKALSKDQDFNPAVPLAENFCRNPD
GDEEGAWCYVADQPGDFEYCDLNYCEEPVDGDLGDRLGEDPDPDAAIEGRTSEDHFQPFF
NEKTFGAGEADCGLRPLFEKKQVQDQTEKELFESYIEGR
//
>1a0hB [b.47.1] MEIZOTHROMBIN
IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLL
VRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCL
PDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKASTRIR
ITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFY
THVFRLKKWIQKVIDRLGS
//
>1a0qL [b.1.1 - b.1.1] 29G11 FAB (LIGHT CHAIN)
IELTQSPSSLSASLGGKVTITCKASQDIKKYIGWYQHKPGKQPRLLIHYTSTLLPGIPSR
FRGSGSGRDYSFSISNLEPEDIATYYCLQYYNLRTFGGGTKLEIKRADAAPTVSIFPPSS
EQLTSGGASVVCFLNNFYSKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLTLT
KDEYERHNSYTCEATHKTSTSPIVKSFNRNE
//
>1a0qH [b.1.1 - b.1.1] 29G11 FAB (HEAVY CHAIN)
VQLQESDAELVKPGASVKISCKASGYTFTDHVIHWVKQKPEQGLEWIGYISPGNGDIKYN
EKFKGKATLTADKSSSTAYMQLNSLTSEDSAVYLCKRGYYVDYWGQGTTLTVSSAKTTPP
SVYPLAPSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTLSSSVTVPSS
TWPSETVTCNVAHPASSTKVDKKIE
//
>1a0rB [b.69.4] TRANSDUCIN (BETA SUBUNIT)
SELDQLRQEAEQLKNQIRDARKACADATLSQITNNIDPVGRIQMRTRRTLRGHLAKIYAM
HWGTDSRLLLSASQDGKLIIWDSYTTNKVHAIPLRSSWVMTCAYAPSGNYVACGGLDNIC
SIYNLKTREGNVRVSRELAGHTGYLSCCRFLDDNQIVTSSGDTTCALWDIETGQQTTTFT
GHTGDVMSLSLAPDTRLFVSGACDASAKLWDVREGMCRQTFTGHESDINAICFFPNGNAF
ATGSDDATCRLFDLRADQELMTYSHDNIICGITSVSFSKSGRLLLAGYDDFNCNVWDALK
ADRAGVLAGHDNRVSCLGVTDDGMAVATGSWDSFLKIWN
//
>1a0rP [c.47.1] PHOSDUCIN
FEGQASHTGPKGVINDWRKFKLESEFSRKMSVQEYELIHKDKEDENCLRKYRRQCMQDMH
QKLSFGPRYGFVYELESGEQFLETIEKEQKITTIVVHIYEDGIKGCDALNSSLICLAAEY
PMVKFCKIKASNTGAGDRFSSDVLPTLLVYKGGELLSNFISVTEQLAEEFFTGDVESFLN
EYGLLPEK
//
>1a14B (H) [b.1.1] NC10 FV (HEAVY CHAIN)
QVQLQQSGAELVKPGASVRMSCKASGYTFTNYNMYWVKQSPGQGLEWIGIFYPGNGDTSY
NQKFKDKATLTADKSSNTAYMQLSSLTSEDSAVYYCARSGGSYRYDGGFDYWGQGTTVTV
//
>1a14C (L) [b.1.1] NC10 FV (LIGHT CHAIN)
DIELTQTTSSLSASLGDRVTISCRASQDISNYLNWYQQNPDGTVKLLIYYTSNLHSEVPS
RFSGSGSGTDYSLTISNLEQEDIATYFCQQDFTLPFTFGGGTAA
//
>1a1yI [x.x.x]
KTEWPELVGKSVEEAKKVILQDKPEAQIIVLPVGTIVTMEYRIDRVRLFVDKLDNIAEVP
RVG
//
>1a1yE [x.x.x]
AQTVPYGIPLIKADKVQAQGFKGANVKVAVLDTGIQASHPDLNVVGGASFVAGEAYNTDG
NGHGTHVAGTVAALDNTTGVLGVAPSVSLYAVKVLNSSGSGSYSGIVSGIEWATTNGMDV
INMSLGGASGSTAMKQAVDNAYARGVVVVAAAGNSGSSGNTNTIGYPAKYDSVIAVGAVD
SNSNRASFSSVGAELEVMAPGAGVYSTYPTNTYATLNGTSMASPHVAGAAALILSKHPNL
SASQVRNRLSSTATYLGSSFYYGKGLINVEAAAQ
//
>1a2kA [d.17.4] NUCLEAR TRANSPORT FACTOR 2
KPIWEQIGSSFIQHYYQLFDNDRTQLGAIYIDASCLTWEGQQFQGKAAIVEKLSSLPFQK
IQHSITAQDHQPTPDSCIISMVVGQLKADEDPIMGFHQMFLLKNINDAWVCTNDMFRLAL
HNFG
//
>1a2kD [c.37.1] RAN
QVQFKLVLVGDGGTGKTTFVKRHLTGEFEKKYVATLGVEVHPLVFHTNRGPIKFNVWDTA
GQEKFGGLRDGYYIQAQCAIIMFDVTSRVTYKNVPNWHRDLVRVCENIPIVLCGNKVDIK
DRKVKAKSIVFHRKNLQYYDISAKSNYNFEKPFLWLARKLIGDPNLEFVAMPALAPPEVV
MDPALAAQYEHDLEVAQ
//
>1a2xA [a.39.1] TROPONIN C
DQQAEARSYLSEEMIAEFKAAFDMFDADGGGDISVKELGTVMRMLGQTPTKEELDAIIEE
VDEDGSGTIDFEEFLVMMVRQMKEDAKGKSEEELAECFRIFDRNADGYIDAEELAEIFRA
SGEHVTDEEIESLMKDGDKNNDGRIDFDEFLKMMEGVQ
//
>1a2xB [j.22.1] TROPONIN I
EEKRNRAITARRQHLKSVMLQIAATELEKEE
//
>1a3lL [b.1.1 - b.1.1] IMMUNOGLOBULIN FAB 13G5 (LIGHT CHAIN)
DIVLTQAAFSNPVTLGASASISCRSSKSLLNSNGIIHMYWYLQKPGQSPQLLIYQMSKLA
SGAPDRFSGSGSGTDFTLRISRVEAEDVGVYYCAQNLELPYTFGGGTKLEIKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDTKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRN
//
>1a3lH [b.1.1 - b.1.1] IMMUNOGLOBULIN FAB 13G5 (HEAVY CHAIN)
EVQLEESGPELVRPGTSVKISCKASGYTFTNYWLGWVKQRPGHGFEWIGDIYPGGVYTTN
NEKFRGKAILTADTSSSTAYMQLSSLTSEDSAVYFCARAGGYYTGGDYWGQGTSVTVSSA
KTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDL
YTLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKIVP
//
>1a4k_1L [b.1.1 - b.1.1] ANTIBODY FAB
ELVMTQTPLSLPVSLGDQASISCRSSQSLLHSNGNTYLHWYLQKPGQSPKLLIYKVSNRF
SGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQVTHVPPTFGGGTKLEIKRTVAAPSV
FIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSL
SSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRG
//
>1a4k_1H [b.1.1 - b.1.1] ANTIBODY FAB
QVQLLESGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLKWMGWINTYTGEPTY
ADDFKGRFAFSLETSASTAYLQINNLKNEDTATYFCVQAERLRRTFDYWGAGTTVTVSSA
STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG
LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKV
//
>1a4yA [c.10.1] RIBONUCLEASE INHIBITOR
SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL
NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS
DNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNND
INEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD
VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGA
RLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVREL
CQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES
VRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS
//
>1a4yB [d.5.1] ANGIOGENIN
QDNSRYTHFLTQHYDAKPQGRDDRYCESIMRRRGLTSPCKDINTFIHGNKRSIKAICENK
NGNPHRENLRISKSSFQVTTCKLHGGSPWPPCQYRATAGFRNVVVACENGLPVHLDQSIF
RRP
//
>1a5fL [b.1.1 - b.1.1] MONOCLONAL ANTI-E-SELECTIN 7A9 ANTIBODY (LIGHT
DIVMTQSPSSLTVTTGEKVTMTCKSSQSLLNSGAQKNYLTWYQQKPGQSPKLLIYWASTR
ESGVPDRFTGSGSGTDFTLSISGVQAEDLAVYYCQNNYNYPLTFGAGTKLELKRADAAPT
VSIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYS
MSSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1a5fH [b.1.1 - b.1.1] MONOCLONAL ANTI-E-SELECTIN 7A9 ANTIBODY (HEAVY
EVALQQSGAELVKPGASVKLSCAASGFTIKDAYMHWVKQKPEQGLEWIGRIDSGSSNTNY
DPTFKGKATITADDSSNTAYLQMSSLTSEDTAVYYCARVYAMDYWGQGTSVTVSSAKTTP
PSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTLS
SSVSVPTSTETVTCNVAHAPSSTKVDKKIVPR
//
>1a6aA [d.19.1 - b.1.1] HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR
HVIIQAEFYLNPDQSGEFMFDFDGDEIFHVDMAKKETVWRLEEFGRFASFEAQGALANIA
VDKANLEIMTKRSNYTPITNVPPEVTVLTNSPVELREPNVLICFIDKFTPPVVNVTWLRN
GKPVTTGVSETVFLPREDHLFRKFHYLPFLPSTEDVYDCRVEHWGLDEPLLKHWEF
//
>1a6aB [d.19.1 - b.1.1] HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR-1
PRFLEYSTSECHFFNGTERVRYLDRYFHNQEENVRFDSDVGEFRAVTELGRPDAEYWNSQ
KDLLEQKRGRVDNYCRHNYGVVESFTVQRRVHPKVTVYPSKTQPLQHHNLLVCSVSGFYP
GSIEVRWFRNGQEEKTGVVSTGLIHNGDWTFQTLVMLETVPRSGEVYTCQVEHPSVTSPL
TVEWRAR
//
>1a6t_2C (A) [b.1.1 - b.1.1] IGG1 FAB1-IA FAB (LIGHT CHAIN)
QSVLSQSPAILSASPGEKVIMTCSPSSSVSYMQWYQQKPGSSPKPWIYSTSNLASGVPGR
FSGGGSGTSFSLTISGVEAEDAATYYCQQYSSHPLTFGGGTKLELKRADAAPTVSIFPPS
SEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLTL
TKDEYERHNSYTCEATHKTSTSPIVKSFNR
//
>1a6t_2D (B) [b.1.1 - b.1.1] IGG1 FAB1-IA FAB (HEAVY CHAIN)
EVQLQQSGPDLVKPGASVKISCKASGYSFSTYYMHWVKQSHGKSLEWIGRVDPDNGGTSF
NQKFKGKAILTVDKSSSTAYMELGSLTSEDSAVYYCARRDDYYFDFWGQGTSLTVSSAKT
TPPSVYPLAPVCGGTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSGLYT
LSSSVTVTSSTWPSQTITCNVAHPASSTKVDKKIEPR
//
>1a6v_2M [b.1.1] B1-8 FV (LIGHT CHAIN)
QAVVTQESALTTSPGETVTLTCRSSTGAVTTSNYANWVQEKPDHLFTGLIGGTNNRAPGV
PARFSGSLIGNKAALTITGAQTEDEAIYFCALWYSNHWVFGGGTKLTVL
//
>1a6v_2I [b.1.1] B1-8 FV (HEAVY CHAIN)
QVQLQQPGAELVKPGASVKLSCKASGYTFTSYWMHWVKQRPGRGLEWIGRIDPNSGGTKY
NEKFKSKATLTVDKPSSTAYMQLSSLTSEDSAVYYCARYDYYGSSYFDYWGQGTTVTVS
//
>1a9n_1B [d.58.7] SPLICEOSOMAL U2B''
IRPNHTIYINNMNDKIKKEELKRSLYALFSQFGHVVDIVALKTMKMRGQAFVIFKELGSS
TNALRQLQGFPFYGKPMRIQYAKTDSDIISKMRG
//
>1a9n_1A [c.10.2] U2A'
VKLTAELIEQAAQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDGFP
LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCIL
RNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLKERQEAEKMFK
//
>1a9wA [a.1.1] HEMOGLOBIN (ALPHA CHAIN)
VLSPADKTNVKAAWGKVGAHAGEYGAEALERMFLSFPTTKTYFPHFDLSHGSAQVKGHGK
KVADALTNAVAHVDDMPNALSALSDLHAHKLRVDPVNFKLLSHCLLVTLAAHLPAEFTPA
VHASLDKFLASVSTVLTSKYR
//
>1a9wE [a.1.1] HEMOGLOBIN (BETA CHAIN)
VHFTAEEKAAVTSLWSKMNVEEAGGEALGRLLVVYPWTQRFFDSFGNLSSPSAILGNPKV
KAHGKKVLTSFGDAIKNMDNLKPAFAKLSELHCDKLHVDPENFKLLGNVMVIILATHFGK
EFTPEVQAAWQKLVSAVAIALAHKY
//
>1abiH [b.47.1] ALPHA-THROMBIN (LARGE SUBUNIT)
IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL
VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL
PDRETAASLLQAGYKGRVTGWGNLKETGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFC
AGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLK
KWIQKVIDQFGE
//
>1abiI [x.x.x]
FPxGGGGGNGDFEEIPEEYL
//
>1abrA [d.165.1] ABRIN-A
EDRPIKFSTEGATSQSYKQFIEALRERLRGGLIHDIPVLPDPTTLQERNRYITVELSNSD
TESIEVGIDVTNAYVVAYRAGTQSYFLRDAPSSASDYLFTGTDQHSLPFYGTYGDLERWA
HQSRQQIPLGLQALTHGISFFRSGGNDNEEKARTLIVIIQMVAEAARFRYISNRVRVSIQ
TGTAFQPDAAMISLENNWDNLSRGVQESVQDTFPNQVTLTNIRNEPVIVDSLSHPTVAVL
ALMLFVCNPPN
//
>1abrB [b.42.2 - b.42.2] ABRIN-A
IVEKSKICSSRYEPTVRIGGRDGMCVDVYDNGYHNGNRIIMWKCKDRLEENQLWTLKSDK
TIRSNGKCLTTYGYAPGSYVMIYDCTSAVAEATYWEIWDNGTIINPKSALVLSAESSSMG
GTLTVQTNEYLMRQGWRTGNNTSPFVTSISGYSDLCMQAQGSNVWMADCDSNKKEQQWAL
YTDGSIRSVQNTNNCLTSKDHKQGSTILLMGCSNGWASQRWVFKNDGSIYSLYDDMVMDV
KGSDPSLKQIILWPYTGKPNQIWLTLF
//
>1abwA [a.1.1 - a.1.1] HEMOGLOBIN-BASED BLOOD SUBSTITUTE
MLSPADKTNVKAAWGKVGAHAGEYGAEALERMFLSFPTTKTYFPHFDLSHGSAQVKGHGK
KVADALTNAVAHVDDMPNALSALSDLHAHKLRVDPVNFKLLSHCLLVTLAAHLPAEFTPA
VHASLDKFLASVSTVLTSKYRGVLSPADKTNVKAAWGKVGAHAGEYGAEALERMFLSFPT
TKTYFPHFDLSHGSAQVKGHGKKVADALTNAVAHVDDMPNALSALSDLHAHKLRVDPVNF
KLLSHCLLVTLAAHLPAEFTPAVHASLDKFLASVSTVLTSKYR
//
>1abwD (B) [a.1.1] HEMOGLOBIN-BASED BLOOD SUBSTITUTE
MHLTPEEKSAVTALWGKVNVDEVGGEALGRLLVVYPWTQRFFESFGDLSTPDAVMGNPKV
KAHGKKVLGAFSDGLAHLDNLKGTFATLSELHCDKLHVDPENFRLLGKVLVCVLAHHFGK
EFTPPVQAAYQKVVAGVANALAHKYH
//
>1acbE [x.x.x]
IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGS
SSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTT
CVTTGWGLTRYANTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVSSCMGDSGG
PLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN
//
>1acbI [d.40.1] EGLIN C
KSFPEVVGKTVDQAREYFTLHYPQYDVYFLPEGSPVTLDLRYNRVRVFYNPGTNVVNHVP
HVG
//
>1acyL [b.1.1 - b.1.1] IGG1-KAPPA 59.1 FAB (LIGHT CHAIN)
DIVMTQSPASLVVSLGQRATISCRASESVDSYGKSFMHWYQQKPGQPPKVLIYIASNLES
GVPARFSGSGSRTDFTLTIDPVEADDAATYYCQQNNEDPPTFGAGTKLEMRRADAAPTVS
IFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMS
STLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNR
//
>1acyH [b.1.1 - b.1.1] IGG1-KAPPA 59.1 FAB (HEAVY CHAIN)
QVKLQESGPAVIKPSQSLSLTCIVSGFSITRTNYCWHWIRQAPGKGLEWMGRICYEGSIY
YSPSIKSRSTISRDTSLNKFFIQLISVTNEDTAMYYCSRENHMYETYFDVWGQGTTVTVS
SAKTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQS
DLYTLSSSVTVPSSPRPSETVTCNVAHPASSTKVDKKIVPR
//
>1ad0_1A [b.1.1 - b.1.1] ANTIBODY A5B7 (LIGHT CHAIN)
QTVLTQSPSSLSVSVGDRVTITCRASSSVTYIHWYQQKPGLAPKSLIYATSNLASGVPSR
FSGSGSGTDYTFTISSLQPEDIATYYCQHWSSKPPTFGQGTKVEVKRTVAAPSVFIFPPS
DEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTL
SKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
//
>1ad0_1B [b.1.1 - b.1.1] ANTIBODY A5B7 (HEAVY CHAIN)
EVQLLESGGGLVQPGGSLRLSCATSGFTFTDYYMNWVRQAPGKGLEWLGFIGNKANGYTT
EYSASVKGRFTISRDKSKSTLYLQMNTLQAEDSAIYYCTRDRGLRFYFDYWGQGTLVTVS
SASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQS
SGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVE
//
>1ad9_2A (L) [b.1.1 - b.1.1] IGG CTM01 FAB (LIGHT CHAIN)
DIQMTQSPSTLSASVGDRVTITCRSSKSLLHSNGDTFLYWFQQKPGKAPKLLMYRMSNLA
SGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCMQHLEYPFTFGQGTKVEVKRTVAAPSV
FIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSL
SSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
//
>1ad9_2B (H) [b.1.1 - b.1.1] IGG CTM01 FAB (HEAVY CHAIN)
EIQLVQSGAEVKKPGSSVKVSCKASGYTFTDYYINWMRQAPGQGLEWIGWIDPGSGNTKY
NEKFKGRATLTVDTSTNTAYMELSSLRSEDTAFYFCAREKTTYYYAMDYWGQGTLVTVSS
ASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSS
GLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVE
//
>1adqA [b.1.1 - b.1.1] IGG4 REA FC
PSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPQVQFNWYVDGVQVHNAKTKPREQQFN
STYRVVSVLTVLHQNWLDGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEE
MTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRW
QEGNVFSCSVMHEALHNHYTQKSLSL
//
>1adqH [b.1.1 - b.1.1] IGM-LAMBDA RF-AN FAB (HEAVY CHAIN)
EVQLVESGGGLVQPGRSLRLSCVTSGFTFDDYAMHWVRQSPGKGLEWVSGISWNTGTIIY
ADSVKGRFIISRDNAKNSLYLQMNSLRVEDTALYYCAKTRSYVVAAEYYFHYWGQGILVT
VSSGSASAPTLFPLVSCENSNPSSTVAVGCLAQDFLPDSITFSWKYKNNSDISSTRGFPS
VLRGGKYAATSQVLLPSKDVMQGTNEHVVCKVQHPNGNKEKDVPL
//
>1adqC (L) [b.1.1 - b.1.1] IGM-LAMBDA RF-AN FAB (LIGHT CHAIN)
YVLTQPPSVSVAPGQTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDSDRPPGIPERF
SGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDHAVFGGGTKLTVLGQPKAAPSVTLFP
PSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTTPSKQSNNKYAASSYLS
LTPEQWKSHKSYSCQVTHEGSTVEKTVAPTECS
//
>1adqD (H) [b.1.1 - b.1.1] IGM-LAMBDA RF-AN FAB (HEAVY CHAIN)
EVQLVESGGGLVQPGRSLRLSCVTSGFTFDDYAMHWVRQSPGKGLEWVSGISWNTGTIIY
ADSVKGRFIISRDNAKNSLYLQMNSLRVEDTALYYCAKTRSYVVAAEYYFHYWGQGILVT
VSSGSASAPTLFPLVSCENSNPSSTVAVGCLAQDFLPDSITFSWKYKNNSDISSTRGFPS
VLRGGKYAATSQVLLPSKDVMQGTNEHVVCKVQHPNGNKEKDVPL
//
>1ae6L [b.1.1 - b.1.1] IGG CTM01 FAB (LIGHT CHAIN)
DIVMTQAAPSVPVTPGESLSISCRSSKSLLHSNGDTFLYWFLQRPGQSPQLLIYRMSNLA
SGVPDRFSGSGSGTAFTLRVSRVEAEDVGVYYCMQHLEYPFTFGAGTKLELKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1ae6H [b.1.1 - b.1.1] IGG CTM01 FAB (HEAVY CHAIN)
QIQLQQSGPELVKPGASVKISCKASGYTFTDYYINWMKQKPGQGLEWIGWIDPGSGNTKY
NEKFKGKATLTVDTSSSTAYMQLSSLTSEDTAVYFCAREKTTYYYAMDYWGQGTSVTVSA
AKTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSD
LYTLSSSVTVPSSPRPSETVTCNVAHPASSTKVDKKIV
//
>1afvA [a.73.1] HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 CAPSID
PIVQNLQGQMVHQAISPRTLNAWVKVVEEKAFSPEVIPMFSALSEGATPQDLNTMLNTVG
GHQAAMQMLKETINEEAAEWDRLHPVHAGPIAPGQMREPRGSDIAGTTSTLQEQIGWMTH
NPPIPVGEIYKRWIILGLNKIVRMYSPTSIL
//
>1afvL [b.1.1 - b.1.1] ANTIBODY FAB25.3 FRAGMENT (LIGHT CHAIN)
DIVLTQSPASLAVSLGQRATISCRASESVDNYGISFMNWFQQKPGQPPKLLIYAASNLGS
GVPARFSGSGSGTDFSLNIHPMEEEDTAMYFCQQSKEVPLTFGAGTKVELKRADAAPTVS
IFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMS
STLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNE
//
>1afvH [b.1.1 - b.1.1] ANTIBODY FAB25.3 FRAGMENT (HEAVY CHAIN)
QVQLQQPGSVLVRPGASVKLSCKASGYTFTSSWIHWAKQRPGQGLEWIGEIHPNSGNTNY
NEKFKGKATLTVDTSSSTAYVDLSSLTSEDSAVYYCARWRYGSPYYFDYWGQGTTLTVSS
AKTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSD
LYTLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKIVPK
//
>1agr_1A [c.37.1 - a.66.1] GUANINE NUCLEOTIDE-BINDING PROTEIN G(I)
LSAEDKAAVERSKMIDRNLREDGEKAAREVKLLLLGAGESGKSTIVKQMKIIHEAGYSEE
ECKQYKAVVYSNTIQSIIAIIRAMGRLKIDFGDAARADDARQLFVLAGAAEEGFMTAELA
GVIKRLWKDSGVQACFNRSREYQLNDSAAYYLNDLDRIAQPNYIPTQQDVLRTRVKTTGI
VETHFTFKDLHFKMFDVGGQRSERKKWIHCFEGVTAIIFCVALSDYDLVLAEDEEMNRMH
ESMKLFDSICNNKWFTDTSIILFLNKKDLFEEKIKKSPLTICYPEYAGSNTYEEAAAYIQ
CQFEDLNKRKDTKEIYTHFTCATDTKNVQFVFDAVTDVIIKNNLKDCGL
//
>1agr_1E [a.91.1] RGS4
VSQEEVKKWAESLENLINHECGLAAFKAFLKSEYSEENIDFWISCEEYKKIKSPSKLSPK
AKKIYNEFISVQATKEVNLDSCTREETSRNMLEPTITCFDEAQKKIFNLMEKDSYRRFLK
SRFYLDLT
//
>1ahw_1A [b.1.1 - b.1.1] IMMUNOGLOBULIN FAB 5G9 (LIGHT CHAIN)
DIKMTQSPSSMYASLGERVTITCKASQDIRKYLNWYQQKPWKSPKTLIYYATSLADGVPS
RFSGSGSGQDYSLTISSLESDDTATYYCLQHGESPYTFGGGTKLEINRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1ahw_1B [b.1.1 - b.1.1] IMMUNOGLOBULIN FAB 5G9 (HEAVY CHAIN)
EIQLQQSGAELVRPGALVKLSCKASGFNIKDYYMHWVKQRPEQGLEWIGLIDPENGNTIY
DPKFQGKASITADTSSNTAYLQLSSLTSEDTAVYYCARDNSYYFDYWGQGTTLTVSSAKT
TPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYT
LSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKI
//
>1ahw_2D (A) [b.1.1 - b.1.1] IMMUNOGLOBULIN FAB 5G9 (LIGHT CHAIN)
DIKMTQSPSSMYASLGERVTITCKASQDIRKYLNWYQQKPWKSPKTLIYYATSLADGVPS
RFSGSGSGQDYSLTISSLESDDTATYYCLQHGESPYTFGGGTKLEINRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1ahw_2E (B) [b.1.1 - b.1.1] IMMUNOGLOBULIN FAB 5G9 (HEAVY CHAIN)
EIQLQQSGAELVRPGALVKLSCKASGFNIKDYYMHWVKQRPEQGLEWIGLIDPENGNTIY
DPKFQGKASITADTSSNTAYLQLSSLTSEDTAVYYCARDNSYYFDYWGQGTTLTVSSAKT
TPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYT
LSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKI
//
>1ahw_2F (C) [b.1.2 - b.1.2] TISSUE FACTOR
TNTVAAYNLTWKSTNFKTILEWEPKPVNQVYTVQISTKSGDWKSKCFYTTDTECDLTDEI
VKDVKQTYLARVFSYPAGNEPLYENSPEFTPYLETNLGQPTIQSFEQVGTKVNVTVEDER
TLVRRNNTFLSLRDVFGKDLIYTLYYWKSSSSGKKTAKTNTNEFLIDVDKGENYCFSVQA
VIPSRTVNRKSTDSPVECMG
//
>1aig_1L [f.26.1] PHOTOSYNTHETIC REACTION CENTER (L SUBUNIT)
ALLSFERKYRVPGGTLVGGNLFDFWVGPFYVGFFGVATFFFAALGIILIAWSAVLQGTWN
PQLISVYPPALEYGLGGAPLAKGGLWQIITICATGAFVSWALREVEICRKLGIGYHIPFA
FAFAILAYLTLVLFRPVMMGAWGYAFPYGIWTHLDWVSNTGYTYGNFHYNPAHMIAISFF
FTNALALALHGALVLSAANPEKGKEMRTPDHEDTFFRDLVGYSIGTLGIHRLGLLLSLSA
VFFSALCMIITGTIWFDQWVDWWQWWVKLPWWANIPGGING
//
>1aig_1M [f.26.1] PHOTOSYNTHETIC REACTION CENTER (M SUBUNIT)
YQNIFSQVQVRGPADLGMTEDVNLANRSGVGPFSTLLGWFGNAQLGPIYLGSLGVLSLFS
GLMWFFTIGIWFWYQAGWNPAVFLRDLFFFSLEPPAPEYGLSFAAPLKEGGLWLIASFFM
FVAVWSWWGRTYLRAQALGMGKHTAWAFLSAIWLWMVLGFIRPILMGSWSEAVPYGIFSH
LDWTNNFSLVHGNLFYNPFHGLSIAFLYGSALLFAMHGATILAVSRFGGERELEQIADRG
TAAERAALFWRWTMGFNATMEGIHRWAIWMAVLVTLTGGIGILLSGTVVDNWYVWGQNH
//
>1aij_1M [f.26.1] PHOTOSYNTHETIC REACTION CENTER (M SUBUNIT)
AEYQNIFSQVQVRGPADLGMTEDVNLANRSGVGPFSTLLGWFGNAQLGPIYLGSLGVLSL
FSGLMWFFTIGIWFWYQAGWNPAVFLRDLFFFSLEPPAPEYGLSFAAPLKEGGLWLIASF
FMFVAVWSWWGRTYLRAQALGMGKHTAWAFLSAIWLWMVLGFIRPILMGSWSEAVPYGIF
SHLDWTNNFSLVHGNLFYNPFHGLSIAFLYGSALLFAMHGATILAVSRFGGERELEQIAD
RGTAAERAALFWRWTMGFNATMEGIHRWAIWMAVLVTLTGGIGILLSGTVVDNWYVWGQN
H
//
>1aij_1H [f.23.10 - b.41.1] PHOTOSYNTHETIC REACTION CENTER (H SUBUNIT)
DLASLAIYSFWIFLAGLIYYLQTENMREGYPLENEDGTPAANQGPFPLPKPKTFILPHGR
GTLTVPGPESEDRPIALARTAVSEGFPHAPTGDPMKDGVGPASWVARRDLPELDGHGHNK
IKPMKAAAGFHVSAGKNPIGLPVRGCDLEIAGKVVDIWVDIPEQMARFLEVELKDGSTRL
LPMQMVKVQSNRVHVNALSSDLFAGIPTIKSPTEVTLLEEDKICGYVAGGLMYAAPKRKS
VVAAML
//
>1aikA (N) [h.3.2] HIV-1 GP41 GLYCOPROTEIN
SGIVQQQNNLLRAIEAQQHLLQLTVWGIKQLQARIL
//
>1aikB (C) [h.3.2] HIV-1 GP41 GLYCOPROTEIN
WMEWDREINNYTSLIHSLIEESQNQQEKNEQELL
//
>1aip_1B (A) [c.37.1 - b.43.3 - b.44.1] ELONGATION FACTOR TU
KPHVNVGTIGHVDHGKTTLTAALTYVTAAENPTAHVEYETAKRHYSHVDCPGHADYIKNM
ITGAAQMDGAILVVSAADGPMPQTREHILLARQVGVPYIVVFMNKVDMVDDPELLDLVEM
EVRDLLNQYEFPGDEVPVIRGSALLALEQMHRNPKTRRGENEWVDKIWELLDAIDEYIPT
PVRDVDKPFLMPVEDVFTITGRGTVATGRIERGKVKVGDEVEIVGLAPETRRTVVTGVEM
HRKTLQEGIAGDNVGVLLRGVSREEVERGQVLAKPGSITPHTKFEASVYVLKKEEGGRHT
GFFSGYRPQFYFRTTDVTGVVQLPPGVEMVMPGDNVTFTVELIKPVALEEGLRFAIREGG
RTVGAGVVTKILE
//
>1aip_1D (C) [a.5.2 - d.43.1] ELONGATION FACTOR TS
SQMELIKKLREATGAGMMDVKRALEDAGWDEEKAVQLLRERGAMKAAKKADREAREGIIG
HYIHHNQRVGVLVELNCETDFVARNELFQNLAKDLAMHIAMMNPRYVSAEEIPAEELEKE
RQIYIQAALNEGKPQQIAEKIAEGRLKKYLEEVVLLEQPFVKDDKVKVKELIQQAIAKIG
ENIVVRRFCRFELGA
//
>1aj7L [b.1.1 - b.1.1] IMMUNOGLOBULIN 48G7 FAB (LIGHT CHAIN)
DIQMTQSPSSLSASLGERVSLTCRASQEISGYLSWLQQKPDGTIKRLIYAASTLDSGVPK
RFSGSRSGSDYSLTISSLESEDFADYYCLQYASYPRTFGGGTKVEIKRTVAAPSVFIFPP
SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT
LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
//
>1aj7H [b.1.1 - b.1.1] IMMUNOGLOBULIN 48G7 FAB (HEAVY CHAIN)
QVQLQQSGAELVKPGASVKLSCTASGFNIKDTYMHWVKQRPEQGLEWIGRIDPANGNTKY
DPKFQGKATITADTSSNTAYLQLSSLTSEDTAVYYCASYYGIYWGQGTTLTVSSASTKGP
SVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLS
SVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC
//
>1ak4_2C [a.73.1] HIV-1 CAPSID
PIVQNLQGQMVHQAISPRTLNAWVKVVEEKAFSPEVIPMFSALSEGATPQDLNTMLNTVG
GHQAAMQMLKETINEEAAEWDRLHPVHAGPIAPGQMREPRGSDIAGTTSTLQEQIGWMTH
NPPIPVGEIYKRWIILGLNKIVRMY
//
>1ak4_2B [b.62.1] CYCLOPHILIN A
NPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMC
QGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWL
DGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE
//
>1akhA [a.4.1] PROTEIN (MATING-TYPE PROTEIN A-1)
ISPQARAFLEEVFRRKQSLNSKEKEEVAKKCGITPLQVRVWFINKRMRS
//
>1akhB [a.4.1] PROTEIN (MATING-TYPE PROTEIN ALPHA-2)
TKPYRGHRFTKENVRILESWFAKNIENPYLDTKGLENLMKNTSLSRIQIKNWVSNRRRKE
KTITIAPELADLLSGEPL
//
>1akjA [d.19.1 - b.1.1] MHC CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-
GSHSMRYFFTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGPEYW
DGETRKVKAHSQTHRVDLGTLRGYYNQSEAGSHTVQRMYGCDVGSDWRFLRGYHQYAYDG
KDYIALKEDLRSWTAADMAAQTTKHKWEAAHVAEQLRAYLEGTCVEWLRRYLENGKETLQ
RTDAPKTHMTHHAVSDHEATLRCWALSFYPAEITLTWQRDGEDQTQDTELVETRPAGDGT
FQKWAAVVVPSGQEQRYTCHVQHEGLPKPLTLRWEP
//
>1akjD [b.1.1] T-CELL CORECEPTOR CD8
SQFRVSPLDRTWNLGETVELKCQVLLSNPTSGCSWLFQPRGAAASPTFLLYLSQNKPKAA
EGLDTQRFSGKRLGDTFVLTLSDFRRENEGYYFCSALSNSIMYFSHFVPVFLPA
//
>1aksA [b.47.1] ALPHA TRYPSIN
IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYKSRIQVRLGEHNIDVLEG
NEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSCAAAGTECLISG
WGNTK
//
>1aksB [b.47.1] ALPHA TRYPSIN
SSGSSYPSLLQCLKAPVLSNSSCKSSYPGQITGNMICVGFLQGGKDSCQGDSGGPVVCNG
QLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIAAN
//
>1al0_3F [b.121.5] CAPSID PROTEIN GPF
QTGAERMPHDLSHLGFLAGQIGRLITISTTPVIAGDSFEMDAVGALRLSPLRRGLAIDST
VDIFTFYVPHRHVYGEQWIKFMKDGVNATPLPTVNTTGYIDHAAFLGTINPDTNKIPKHL
FQGYLNIYNNYFKAPWMPDRTEANPNELNQDDARYGFRCCHLKNIWTAPLPPETELSRQM
TTSTTSIDIMGLQAAYANLHTDQERDYFMQRYRDVISSFGGKTSYDADNRPLLVMRSNLW
ASGYDVDGTDQTSLGQFSGRVQQTYKHSVPRFFVPEHGTMFTLALVRFPPTATKEIQYLN
AKGALTYTDIAGDPVLYGNLPPREISMKDVFRSGDSSKKFKIAEGQWYRYAPSYVSPAYH
LLEGFPFIQEPPSGDLQERVLIRHHDYDQCFQSVQLLQWNSQVKFNVTVYRNLPTTRD
//
>1al0_3B [x.x.x] SCAFFOLDING PROTEIN GPB
MEQLTKNQGATCDDKSAQIYARFDKNDWRIQPAEFYRFHDAEVNTFGYF
//
>1al0_3d (B) [x.x.x] SCAFFOLDING PROTEIN GPB
EQSVRFQTALASIKLIQASAVLDLTEDDFDFLTSNKVWIATDRSRARRCVEACVYGTLDF
VGYPRFPAPVEFIAAVIAYYVHPVNIQTACLIMEGAEFTENIINGVERPVKAAELFAFTL
RVRAGNTDVLTDAEENVRQKLRA
//
>1al0_3b (F) [b.121.5] CAPSID PROTEIN GPF
QTGAERMPHDLSHLGFLAGQIGRLITISTTPVIAGDSFEMDAVGALRLSPLRRGLAIDST
VDIFTFYVPHRHVYGEQWIKFMKDGVNATPLPTVNTTGYIDHAAFLGTINPDTNKIPKHL
FQGYLNIYNNYFKAPWMPDRTEANPNELNQDDARYGFRCCHLKNIWTAPLPPETELSRQM
TTSTTSIDIMGLQAAYANLHTDQERDYFMQRYRDVISSFGGKTSYDADNRPLLVMRSNLW
ASGYDVDGTDQTSLGQFSGRVQQTYKHSVPRFFVPEHGTMFTLALVRFPPTATKEIQYLN
AKGALTYTDIAGDPVLYGNLPPREISMKDVFRSGDSSKKFKIAEGQWYRYAPSYVSPAYH
LLEGFPFIQEPPSGDLQERVLIRHHDYDQCFQSVQLLQWNSQVKFNVTVYRNLPTTRD
//
>1al0_3d (B) [x.x.x] SCAFFOLDING PROTEIN GPB
MEQLTKNQGATCDDKSAQIYARFDKNDWRIQPAEFYRFHDAEVNTFGYF
//
>1al2_23 [b.121.4] P1/MAHONEY POLIOVIRUS
GLPVMNTPGSNQYLTADNFQSPCALPEFDVTPPIDIPGEVKNMMELAEIDTMIPFDLSAT
KKNTMEMYRVRLSDKPHTDDPILCLSLSPASDPRLSHTMLGEILNYYTHWAGSLKFTFLF
CGSMMATGKLLVSYAPPGADPPKKRKEAMLGTHVIWDIGLQSSCTMVVPWISNTTYRQTI
DDSFTEGGYISVFYQTRIVVPLSTPREMDILGFVSACNDFSVRLLRDTTHIEQKA
//
>1al2_24 [b.121.4] P1/MAHONEY POLIOVIRUS
GAQVSSQKVGAHESTINYTTINYYRDSASNAASKQDFSQDPSKFTEPIKDVLIKTAPMLN
//
>1al2_32 (3) [b.121.4] P1/MAHONEY POLIOVIRUS
EACGYSDRVLQLTLGNSTITTQEAANSVVAYGRWPEYLRDSEANPVDQPTEPDVAACRFY
TLDTVSWTKESRGWWWKLPDALRDMGLFGQNMYYHYLGRSGYTVHVQCNASKFHQGALGV
FAVPEMCLAGDSNTTTMHTSYQNANPGEKGGTFTGTFTPDNNQTSPARRFCPVDYLLGNG
TLLGNAFVFPHQIINLRTNNCATLVLPYVNSLSIDSMVKHNNWGIAILPLAPLNFASESS
PEIPITLTIAPMCCEFNGLRNITLPRLQ
//
>1al2_32 (3) [b.121.4] P1/MAHONEY POLIOVIRUS
GLPVMNTPGSNQYLTADNFQSPCALPEFDVTPPIDIPGEVKNMMELAEIDTMIPFDLSAT
KKNTMEMYRVRLSDKPHTDDPILCLSLSPASDPRLSHTMLGEILNYYTHWAGSLKFTFLF
CGSMMATGKLLVSYAPPGADPPKKRKEAMLGTHVIWDIGLQSSCTMVVPWISNTTYRQTI
DDSFTEGGYISVFYQTRIVVPLSTPREMDILGFVSACNDFSVRLLRDTTHIEQKA
//
>1al2_3A (4) [b.121.4] P1/MAHONEY POLIOVIRUS
GAQVSSQKVGAHESTINYTTINYYRDSASNAASKQDFSQDPSKFTEPIKDVLIKTAPMLN
//
>1allA [a.1.1] ALLOPHYCOCYANIN
SIVTKSIVNADAEARYLSPGELDRIKSFVTSGERRVRIAETMTGARERIIKQAGDQLFGK
RPDVVSPGGNAYGADMTATCLRDLDYYLRLITYGIVAGDVTPIEEIGVVGVREMYKSLGT
PIEAIAEGVRAMKSVATSLLSGADAAEAGSYFDYLIGAMS
//
>1allB [x.x.x]
MQDAITSVINSSDVQGKYLDASAIQKLKAYFATGELRVRAATTISANAANIVKEAVAKSL
LYSDVTRPGGNMYTTRRYAACIRDLDYYLRYATYAMLAGDPSILDERVLNGLKETYNSLG
VPIGATVQAIQAMKEVTAGLVGGGAGKEMGIYFDYICSGLS
//
>1ao7A [d.19.1 - b.1.1] HLA-A 0201
GSHSMRYFFTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGPEYW
DGETRKVKAHSQTHRVDLGTLRGYYNQSEAGSHTVQRMYGCDVGSDWRFLRGYHQYAYDG
KDYIALKEDLRSWTAADMAAQTTKHKWEAAHVAEQLRAYLEGTCVEWLRRYLENGKETLQ
RTDAPKTHMTHHAVSDHEATLRCWALSFYPAEITLTWQRDGEDQTQDTELVETRPAGDGT
FQKWAAVVVPSGQEQRYTCHVQHEGLPKPLTLRW
//
>1ao7D [b.1.1] T CELL RECEPTOR ALPHA
KEVEQNSGPLSVPEGAIASLNCTYSDRGSQSFFWYRQYSGKSPELIMSIYSNGDKEDGRF
TAQLNKASQYVSLLIRDSQPSDSATYLCAVTTDSWGKLQFGAGTQVVVTPDIQNP
//
>1ao7E [b.1.1 - b.1.1] T CELL RECEPTOR BETA
GVTQTPKFQVLKTGQSMTLQCAQDMNHEYMSWYRQDPGMGLRLIHYSVGAGITDQGEVPN
GYNVSRSTTEDFPLRLLSAAPSQTSVYFCASRPGLAGGRPEQYFGPGTRLTVTEDLKNVF
PPEVAVFLVCLATGFYPDHVELSWWVNGKEVHSGVSTDPQPLYALSSRLRVSATFWQNPR
NHFRCQVQFYGLAKPVTQIVSAEAWGRAD
//
>1apzC (A) [d.153.1] ASPARTYLGLUCOSAMINIDASE
SPLPLVVNTWPFKNATEAAWRALASGGSALDAVESGCAMCEREQCDGSVGFGGSPDELGE
TTLDAMIMDGTTMDVGAVGDLRRIKNAIGVARKVLEHTTHTLLVGESATTFAQSMGFINE
DLSTSASQALHSDWLARNCQPNYWRNVIPDPSKYCGPYKPP
//
>1apzD (B) [d.153.1] ASPARTYLGLUCOSAMINIDASE
TIGMVVIHKTGHIAAGTSTNGIKFKIHGRVGDSPIPGAGAYADDTAGAAAATGNGDILMR
FLPSYQAVEYMRRGEDPTIACQKVISRIQKHFPEFFGAVICANVTGSYGAACNKLSTFTQ
FSFMVYNSEKNQPTEEKVDCI
//
>1aqkL [b.1.1 - b.1.1] FAB B7-15A2
xNVLTQPPSVSGAPGQRVTISCTGSNSNIGAGFTVHWYQHLPGTAPKLLIFANTNRPSGV
PDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSARFGGGTRLTVLGQPKAAPSVT
LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVNAGVETTKPSKQSNNKYAASS
YLSLTPEQWKSHKSYSCQVTHEGSTVEKTVAPAECS
//
>1aqkH [b.1.1 - b.1.1] FAB B7-15A2
xVQLVESGGGVVQPGRSLRLSCAASGFTFNNYAIHWVRQAPGKGLEWVAFISYDGSKNYY
ADSVKGRFTISRDNSKNTLFLQMNSLRPEDTAIYYCARVLFQQLVLYAPFDIWGQGTMVT
VSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPQPVTVSWNSGALTSGVHTFPAVL
QSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC
//
>1ar1B [f.17.2 - b.6.1] CYTOCHROME C OXIDASE
QDVLGDLPVIGKPVNGGMNFQPASSPLAHDQQWLDHFVLYIITAVTIFVCLLLLICIVRF
NRRANPVPARFTHNTPIEVIWTLVPVLILVAIGAFSLPILFRSQEMPNDPDLVIKAIGHQ
WYWSYEYPNDGVAFDALMLEKEALADAGYSEDEYLLATDNPVVVPVGKKVLVQVTATDVI
HAWTIPAFAVKQDAVPGRIAQLWFSVDQEGVYFGQCSELCGINHAYMPIVVKAVSQEKYE
AWLAGAKEEFAA
//
>1ar1C [b.1.1] ANTIBODY FV FRAGMENT
EVKLQESGGDLVQPGGSLKLSCAASGFTFSSYTMSWVRQTPEKRLEWVASINNGGGRTYY
PDTVKGRFTISRDNAKNTLYLQMSSLKSEDTAMYYCVRHEYYYAMDYWGQGTTVTVSS
//
>1ar1D [b.1.1] ANTIBODY FV FRAGMENT
DIELTQTPVSLSASVGETVTITCRASENIYSYLAWYQQKQGKSPQFLVYNAKTLGEGVPS
RFSGSGSGTQFSLKINSLLPEDFGSYYCQHHYGTPPLTFGGGTKLEIK
//
>1ar6_2t (3) [b.121.4] P1/MAHONEY POLIOVIRUS
GLPVMNTPGSNQYLTADNFQSPCALPEFDVTPPIDIPGEVKNMMELAEIDTMIPFDLSAT
KKNTMEMYRVRLSDKPHTDDPILCLSLSPASDPRLSHTMLGEILNYYTHWAGSLKFTFLF
CGSMMATGKLLVSYAPPGADPPKKRKEAMLGTHVIWDIGLQSSCTMVVPWISNTTYRQTI
DDSFTEGGYISVFYQTRIVVPLSTPREMDILGFVSACNDFSVRLLRDTTHIEQKAAATSR
DALPNTEASGPTHSKEIPALTAVETGATNPLVPSDTVQTRHVVQHRSRSESSIESFFARG
ACVTIMTVDNSASTTNKDKLFAVWKITYKDTVQLRRKLEFFTYSRFDMELTFVVTANFTE
TNNGHALNQVYQIMYIPPGAPVPEKWDDYTWQTSSNPSIFYTYGTAPARISVPYVGISNA
YSHFYDGFSKVPLKDQSAALGDSLYGAASLNDFGILAVRVVNDHNPTKVTSKIRVYLKPK
HIRVWCPRPPRAVAYYGPGVDYKDGTLTPLSTKDLTTY
//
>1ar6_2u (4) [b.121.4] P1/MAHONEY POLIOVIRUS
GAQVSSQKVGAHESTINYTTINYYRDSASNAASKQDFSQDPSKFTEPIKDVLIKTAPMLN
//
>1ar6_2u (4) [b.121.4] P1/MAHONEY POLIOVIRUS
EACGYSDRVLQLTLGNSTITTQEAANSVVAYGRWPEYLRDSEANPVDQPTEPDVAACRFY
TLDTVSWTKESRGWWWKLPDALRDMGLFGQNMYYHYLGRSGYTVHVQCNASKFHQGALGV
FAVPEMCLAGDSNTTTMHTSYQNANPGEKGGTFTGTFTPDNNQTSPARRFCPVDYLLGNG
TLLGNAFVFPHQIINLRTNNCATLVLPYVNSLSIDSMVKHNNWGIAILPLAPLNFASESS
PEIPITLTIAPMCCEFNGLRNITLPRLQ
//
>1ar7_21 [b.121.4] P1/MAHONEY POLIOVIRUS
AATSRDALPNTEASGPTHSKEIPALTAVETGATNPLVPSDTVQTRHVVQHRSRSESSIES
FFARGACVTIMTVDNSASTTNKDKLFAVWKITYKDTVQLRRKLEFFTYSRFDMELTFVVT
ANFTETNNGHALNQVYQIMYVPPGAPVPEKWDDYTWQTSSNPSIFYTYGTAPARISVPYV
GISNAYSHFYDGFSKVPLKDQSAALGDSLYGAASLNDFGILAVRVVNDHNPTKVTSKIRV
YLKPKHIRVWCPRPPRAVAYYGPGVDYKDGTLTPLSTKDLTTY
//
>1ar7_23 [b.121.4] P1/MAHONEY POLIOVIRUS
GLPVMNTPGSNQYLTADNFQSPCALPEFDVTPPIDIPGEVKNMMELAEIDTMIPFDLSAT
KKNTMEMYRVRLSDKPHTDDPILCLSLSPASDPRLSHTMLGEILNYYTHWAGSLKFTFLF
CGSMMATGKLLVSYAPPGADPPKKRKEAMLGTHVIWDIGLQSSCTMVVPWISNTTYRQTI
DDSFTEGGYISVFYQTRIVVPLSTPREMDILGFVSACNDFSVRLLRDTTHIEQKA
//
>1ar7_2t (3) [b.121.4] P1/MAHONEY POLIOVIRUS
GLPVMNTPGSNQYLTADNFQSPCALPEFDVTPPIDIPGEVKNMMELAEIDTMIPFDLSAT
KKNTMEMYRVRLSDKPHTDDPILCLSLSPASDPRLSHTMLGEILNYYTHWAGSLKFTFLF
CGSMMATGKLLVSYAPPGADPPKKRKEAMLGTHVIWDIGLQSSCTMVVPWISNTTYRQTI
DDSFTEGGYISVFYQTRIVVPLSTPREMDILGFVSACNDFSVRLLRDTTHIEQKAAATSR
DALPNTEASGPTHSKEIPALTAVETGATNPLVPSDTVQTRHVVQHRSRSESSIESFFARG
ACVTIMTVDNSASTTNKDKLFAVWKITYKDTVQLRRKLEFFTYSRFDMELTFVVTANFTE
TNNGHALNQVYQIMYVPPGAPVPEKWDDYTWQTSSNPSIFYTYGTAPARISVPYVGISNA
YSHFYDGFSKVPLKDQSAALGDSLYGAASLNDFGILAVRVVNDHNPTKVTSKIRVYLKPK
HIRVWCPRPPRAVAYYGPGVDYKDGTLTPLSTKDLTTY
//
>1ar7_2v (3) [b.121.4] P1/MAHONEY POLIOVIRUS
GLPVMNTPGSNQYLTADNFQSPCALPEFDVTPPIDIPGEVKNMMELAEIDTMIPFDLSAT
KKNTMEMYRVRLSDKPHTDDPILCLSLSPASDPRLSHTMLGEILNYYTHWAGSLKFTFLF
CGSMMATGKLLVSYAPPGADPPKKRKEAMLGTHVIWDIGLQSSCTMVVPWISNTTYRQTI
DDSFTEGGYISVFYQTRIVVPLSTPREMDILGFVSACNDFSVRLLRDTTHIEQKA
//
>1ar7_2w (4) [b.121.4] P1/MAHONEY POLIOVIRUS
GAQVSSQKVGAHESTINYTTINYYRDSASNAASKQDFSQDPSKFTEPIKDVLIKTAPMLN
//
>1ar7_32 (3) [b.121.4] P1/MAHONEY POLIOVIRUS
EACGYSDRVLQLTLGNSTITTQEAANSVVAYGRWPEYLRDSEANPVDQPTEPDVAACRFY
TLDTVSWTKESRGWWWKLPDALRDMGLFGQNMYYHYLGRSGYTVHVQCNASKFHQGALGV
FAVPEMCLAGDSNTTTMYTSYQNANPGEKGGTFTGTFTPDNNQTSPARRFCPVDYLLGNG
TLLGNAFVFPHQIINLRTNNCATLVLPYVNSLSIDSMVKHNNWGIAILPLAPLNFASESS
PEIPITLTIAPMCCEFNGLRNITLPRLQ
//
>1ar7_30 (1) [b.121.4] P1/MAHONEY POLIOVIRUS
AATSRDALPNTEASGPTHSKEIPALTAVETGATNPLVPSDTVQTRHVVQHRSRSESSIES
FFARGACVTIMTVDNSASTTNKDKLFAVWKITYKDTVQLRRKLEFFTYSRFDMELTFVVT
ANFTETNNGHALNQVYQIMYVPPGAPVPEKWDDYTWQTSSNPSIFYTYGTAPARISVPYV
GISNAYSHFYDGFSKVPLKDQSAALGDSLYGAASLNDFGILAVRVVNDHNPTKVTSKIRV
YLKPKHIRVWCPRPPRAVAYYGPGVDYKDGTLTPLSTKDLTTY
//
>1ar7_32 (3) [b.121.4] P1/MAHONEY POLIOVIRUS
GLPVMNTPGSNQYLTADNFQSPCALPEFDVTPPIDIPGEVKNMMELAEIDTMIPFDLSAT
KKNTMEMYRVRLSDKPHTDDPILCLSLSPASDPRLSHTMLGEILNYYTHWAGSLKFTFLF
CGSMMATGKLLVSYAPPGADPPKKRKEAMLGTHVIWDIGLQSSCTMVVPWISNTTYRQTI
DDSFTEGGYISVFYQTRIVVPLSTPREMDILGFVSACNDFSVRLLRDTTHIEQKA
//
>1aroA (L) [d.118.1] T7 LYSOZYME
RVQFKQRESTDAIFVHCSATKPSQNVGVREIRQWHKEQGWLDVGYHFIIKRDGTVEAGRD
EMAVGSHAKGYNHNSIGVCLVGGIDDKGKFDANFTPAQMQSLRSLLVTLLAKYEGAVLRA
HHEVAPKACPSFDLKRWWEKNELVTSDRG
//
>1aroB (P) [e.8.1] T7 RNA POLYMERASE
KNDFSDIELAAIPFNTLADHYGERLAREQLALEHESYEMGEARFRKMFERQLLITTLLPK
MIARINDWFEEVKAKRGKRPTAFQFLQEIKPEAVAYITIKTTLACLTSADNTTVQAVASA
IGRAIEDEARFGRIRDLEAKHFKFMQVVEADMLSKGLLGGEAWSSWHKEDSIHVGVRCIE
MLIESTGMVSLHRQSETIELAPEYAEAIATRAGALAGISPMFQPCVVPPKPWTGITGGGY
WANGRRPLALVRTHSKKALMRYEDVYMPEVYKAINIAQNTAWKINKKVLAVANVITKVYR
KDKARKSRRISLEFMLEQANKFANHKAIWFPYNMDWRGRVYAVSMFNPQGNDMTKGLLTL
AKGKPIGKEGYYWLKIHGANCAGVDKVPFPERIKFIEENHENIMACAKSPLENTWWAEQD
SPFCFLAFCFEYAGVQHHGLSYNCSLPLAFDGSCSGIQHFSAMLRDEVGGRAVNLLPSET
VQDIYGIVAKKVNEILQADAINGTKALAGQWLAYGVTRSVTKRSVMTLAYGSKEFGFRQQ
VLEDTIQPAIDSGKGLMFTQPNQAAGYMAKLIWESVSVTVVAAVEAMNWLKSAAKLLAAE
VKDKKTGEILRKRSAVHWVTPDGFPVWQEYKKPIQTRLNLMFLGQFRLQPTINTNKDSEI
DAHKQESGIAPNFVHSQDGSHLRKTVVWAHEKYGIESFALIHDSFGTIPADAANLFKAVR
ETMVDTYESSDVLADFYDQFADQLHESQLDKMPALPAKGNLNLRDILES
//
>1asj_2k (2) [b.121.4] P1/MAHONEY POLIOVIRUS
EACGYSDRVLQLTLGNSTITTQEAANSVVAYGRWPEYLRDSEANPVDQPTEPDVAACRFY
TLDTVSWTKESRGWWWKLPDALRDMGLFGQNMYYHYLGRSGYTVHVQCNASKFHQGALGV
FAVPEMCLAGDSNTTTMHTSYQNANPGEKGGTFTGTFTPDNNQTSPARRFCPVDYLLGNG
TLLGNAFVFPHQIINLRTNNCATLVLPYVNSLSIDSMVKHNNWGIAILPLAPLNFASESS
PEIPITLTIAPMCCEFNGLRNITLPRLQ
//
>1asj_2l (3) [b.121.4] P1/MAHONEY POLIOVIRUS
GLPVMNTPGSNQYLTADNFQSPCALPEFDVTPPIDIPGEVKNMMELAEIDTMIPFDLSAT
KKNTMEMYRVRLSDKPHTDDPILCLSLSPASDPRLSHTMLGEILNYYTHWAGSLKFTFLF
CGSMMATGKLLVSYAPPGADPPKKRKEAMLGTHVIWDIGLQSSCTMVVPWISNTTYRQTI
DDSFTEGGYISVFYQTRIVVPLSTPREMDILGFVSACNDFSVRLLRDTTHIEQKA
//
>1atnA [x.x.x]
DEDETTALVCDNGSGLVKAGFAGDDAPRAVFPSIVGRPRHQGVMVGMGQKDSYVGDEAQS
KRGILTLKYPIEHGIITNWDDMEKIWHHTFYNELRVAPEEHPTLLTEAPLNPKANREKMT
QIMFETFNVPAMYVAIQAVLSLYASGRTTGIVLDSGDGVTHNVPIYEGYALPHAIMRLDL
AGRDLTDYLMKILTERGYSFVTTAEREIVRDIKEKLCYVALDFENEMATAASSSSLEKSY
ELPDGQVITIGNERFRCPETLFQPSFIGMESAGIHETTYNSIMKCDIDIRKDLYANNVMS
GGTTMYPGIADRMQKEITALAPSTMKIKIIAPPERKYSVWIGGSILASLSTFQQMWITKQ
EYDEAGPSIVHR
//
>1atnD [d.151.1] DEOXYRIBONUCLEASE I
LKIAAFNIRTFGETKMSNATLASYIVRIVRRYDIVLIQEVRDSHLVAVGKLLDYLNQDDP
NTYHYVVSEPLGRNSYKERYLFLFRPNKVSVLDTYQYDDGCCGNDSFSREPAVVKFSSHS
TKVKEFAIVALHSAPSDAVAEINSLYDVYLDVQQKWHLNDVMLMGDFNADCSYVTSSQWS
SIRLRTSSTFQWLIPDSADTTATSTNCAYDRIVVAGSLLQSSVVPGSAAPFDFQAAYGLS
NEMALAISDHYPVEVTLT
//
>1auiA [d.159.1] SERINE/THREONINE PHOSPHATASE 2B
TDRVVKAVPFPPSHRLTAKEVFDNDGKPRVDILKAHLMKEGRLEESVALRIITEGASILR
QEKNLLDIDAPVTVCGDIHGQFFDLMKLFEVGGSPANTRYLFLGDYVDRGYFSIECVLYL
WALKILYPKTLFLLRGNHECRHLTEYFTFKQECKIKYSERVYDACMDAFDCLPLAALMNQ
QFLCVHGGLSPEINTLDDIRKLDRFKEPPAYGPMCDILWSDPLEDFGNEKTQEHFTHNTV
RGCSYFYSYPAVCEFLQHNNLLSILRAHEAQDAGYRMYRKSQTTGFPSLITIFSAPNYLD
VYNNKAAVLKYENNVMNIRQFNCSPHPYWLPNFMDVFTWSLPFVGEKVTEMLVNVLNICS
SFEEAKGLDRINERMPPR
//
>1auiB [a.39.1] SERINE/THREONINE PHOSPHATASE 2B
SYPLEMCSHFDADEIKRLGKRFKKLDLDNSGSLSVEEFMSLPELQQNPLVQRVIDIFDTD
GNGEVDFKEFIEGVSQFSVKGDKEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLK
DTQLQQIVDKTIINADKDGDGRISFEEFCAVVGGLDIHKKMVVDV
//
>1autC [b.47.1] ACTIVATED PROTEIN C
LIDGKMTRRGDSPWQVVLLDSKKKLACGAVLIHPSWVLTAAHCMDESKKLLVRLGEYDLR
RWEKWELDLDIKEVFVHPNYSKSTTDNDIALLHLAQPATLSQTIVPICLPDSGLAERELN
QAGQETLVTGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNECSEVMSNMVSENMLCAGIL
GDRQDACEGDSGGPMVASFHGTWFLVGLVSWGEGCGLLHNYGVYTKVSRYLDWIHGHIR
//
>1autL [g.3.11 - g.3.11] ACTIVATED PROTEIN C
QCLVLPLEHPCASLCCGHGTCIxGIGSFSCDCRSGWEGRFCQREVSFLNCSLDNGGCTHY
CLEEVGWRRCSCAPGYKLGDDLLQCHPAVKFPCGRPW
//
>1ava_1A [c.1.8 - b.71.1] BARLEY ALPHA-AMYLASE 2(CV MENUET)
QVLFQGFNWESWKHNGGWYNFLMGKVDDIAAAGITHVWLPPASQSVAEQGYMPGRLYDLD
ASKYGNKAQLKSLIGALHGKGVKAIADIVINHRTAEHKDGRGIYCIFEGGTPDARLDWGP
HMICRDDRPYADGTGNPDTGADFGAAPDIDHLNLRVQKELVEWLNWLKADIGFDGWRFDF
AKGYSADVAKIYIDRSEPSFAVAEIWTSLAYGGDGKPNLNQDQHRQELVNWVDKVGGKGP
ATTFDFTTKGILNVAVEGELWRLRGTDGKAPGMIGWWPAKAVTFVDNHDTGSTQHMWPFP
SDRVMQGYAYILTHPGTPCIFYDHFFDWGLKEEIDRLVSVRTRHGIHNESKLQIIEADAD
LYLAEIDGKVIVKLGPRYDVGNLIPGGFKVAAHGNDYAVWEKI
//
>1ava_1C [b.42.4] BARLEY ALPHA-AMYLASE/SUBTILISIN INHIBITOR
ADPPPVHDTDGHELRADANYYVLSANRAHGGGLTMAPGHGRHCPLFVSQDPNGQHDGFPV
RITPYGVAPSDKIIRLSTDVRISFRAYTTCLQSTEWHIDSELAAGRRHVITGPVKDPSPS
GRENAFRIEKYSGAEVHEYKLMSCGDWCQDLGVFRDLKGGAWFLGATEPYHVVVFKKAPP
A
//
>1avf_1P [b.50.1] GASTRICSIN
AVVKVPLKKFKSIRETMKEKG
//
>1avf_1A [b.50.1] GASTRICSIN
VTYEPMAYMDAAYFGEISIGTPPQNFLVLFDTGSSNLWVPSVYCQSQACTSHSRFNPSES
STYSTNGQTFSLQSGSLTGFFGYDTLTVQSIQVPNQEFGLSENEPGTNFVYAQFDGIMGL
AYPALSVDEATTAMQGMVQEGALTSPVFSVYLSGGAVVFGGVDSSLYTGQIYWAPVTQEL
YWQIGIEEFLIGGQASGWCSEGCQAIVDTGTSLLTVPQQYMSALLQATGAQEDEYGQFLV
NCNSIQNLPSLTFIINGVEFPLPPSSYILSNNGYCTVGVEPTYLSSQNGQPLWILGDVFL
RSYYSVYDLGNNRVGFATAA
//
>1avgH [b.47.1] THROMBIN
IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLL
VRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCL
PDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKASTRIR
ITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFY
THVFRLKKWIQKVIDRLGS
//
>1avgI [b.60.1] TRIABIN
AEGDDCSIEKAMGDFKPEEFFNGTWYLAHGPGVTSPAVCQKFTTSGSKGFTQIVEIGYNK
FESNVKFQCNQVDNKNGEQYSFKCKSSDNTEFEADFTFISVSYDNFALVCRSITFTSQPK
EDRYLVFERTKSDTDPDAKEIC
//
>1avoA [a.24.8] 11S REGULATOR
LRVQPEAQAKVDVFREDLCTKTENLLGSYFPKKISELDAFLKEPALNEANLSNLKAPLDI
//
>1avoB [a.24.8] 11S REGULATOR
AVNCNEKIVVLLQRLKPEIKDVIEQLNLVTTWLQLQIPRIEDGNNFGVAVQEKVFELMTS
LHTKLEGFHTQISKYFSERGDAVTKAAKQPHVGDYRQLVHELDEAEYRDIRLMVMEIRNA
YAVLYDIILKNFEKLKKPRG
//
>1avwA [b.47.1] TRYPSIN
IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYKSRIQVRLGEHNIDVLEG
NEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSCAAAGTECLISG
WGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSYPGQITGNMICVGFLEGGKDSCQGDSGGP
VVCNGQLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIAAN
//
>1avwB [b.42.4] TRYPSIN INHIBITOR
DFVLDNEGNPLENGGTYYILSDITAFGGIRAAPTGNERCPLTVVQSRNELDKGIGTIISS
PYRIRFIAEGHPLSLKFDSFAVIMLCVGIPTEWSVVEDLPEGPAVKIGENKDAMDGWFRL
ERVSEFNNYKLVFCPQDKCGDIGISIDHDDGTRRLVVSKNKPLVVQFQKLD
//
>1awcA [a.4.5] PROTEIN (GA BINDING PROTEIN ALPHA)
IQLWQFLLELLTDKDARDCISWVGDEGEFKLNQPELVAQKWGQRKNKPTMNYEKLSRALR
YYYDGDMICKVQGKRFVYKFVCDLKTLIGYSAAELNRLVIECEQKKLARM
//
>1awcB [d.211.1] PROTEIN (GA BINDING PROTEIN BETA 1)
DLGKKLLEAARAGQDDEVRILMANGAPFTTDWLGTSPLHLAAQYGHFSTTEVLLRAGVSR
DARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLI
KYGADVHTQSKFCKTAFDISIDNGNEDLAEILQ
//
>1axiA [a.26.1] GROWTH HORMONE
TIPLSRLFDNAMLRAHRLHQLAFDTYQEFEEAYIPKEQKYSFLQNPSLCFSESIPTPSNR
EETQQKSNLELLRISLLLIQSWLEPVQFLRSVFANSLVYGASDSNVYDLLKDLEERIQTL
MGRLTGQIFKQTYSKFDTALLKNYGLLYCFRRDMTYVATYLRIVQCRSVEGSCGF
//
>1axiB [b.1.2 - b.1.2] GROWTH HORMONE RECEPTOR
EPKFTKCRSPERETFSCHWTDEGPIQLFYTRRNEWKECPDYVSAGENSCYFNSSFTSIAI
PYCIKLTSNGGTVDEKCFSVDEIVQPDPPIALNWTLLNVSLTGIHADIQVRWEAPRNADI
QKGWMVLEYELQYKEVNETKWKMMDPILTTSVPVYSLKVDKEYEVRVRSKQRNSGNYGEF
SEVLYVTLPQM
//
>1axtL [b.1.1 - b.1.1] IMMUNOGLOBULIN IGG2A
ELVMTQTPLSLPVSLGDQASISCRSSQSLVHSYGNTFLNWYLQKSGQSPKLLIYKVSNRF
SGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQGTHVPYTFGGGTKLEIKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNR
//
>1axtH [b.1.1 - b.1.1] IMMUNOGLOBULIN IGG2A
EVKLEESGGGLVQPGGSMKLSCVVSGLTFSRFWMSWVRQSPEKGLEWVAEIRLKSDNYAT
HYAESVKGKFTISRDDSKSRLYLQMNSLRTEDTGIYYCKIYFYSFSYWGQGTLVTVSAAK
TTAPSVYPLAPVCGDTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDLY
TLSSSVTVTSSTWPSQSITCNVAHPASSTKVDKKIEPR
//
>1ay7A [d.1.1] GUANYL-SPECIFIC RIBONUCLEASE SA
DVSGTVCLSALPPEATDTLNLIASDGPFPYSQDGVVFQNRESVLPTQSYGYYHEYTVITP
GARTRGTRRIITGEATQEDYYTGDHYATFSLIDQTC
//
>1ay7B [c.9.1] BARSTAR
KKAVINGEQIRSISDLHQTLKKELALPEYYGENLDALWDCLTGWVEYPLVLEWRQFEQSK
QLTENGAESVLQVFREAKAEGCDITIILS
//
>1aym_21 [b.121.4] HUMAN RHINOVIRUS 16 COAT PROTEIN
NPVERYVDEVLNEVLVVPNINQSHPTTSNAAPVLDAAETGHTNKIQPEDTIETRYVQSSQ
TLDEMSVESFLGRSGCIHESVLDIVDNYNDQSFTKWNINLQEMAQIRRKFEMFTYARFDS
EITMVPSVAAKDGHIGHIVMQYMYVPPGAPIPTTRDDYAWQSGTNASVFWQHGQPFPRFS
LPFLSIASAYYMFYDGYDGDTYKSRYGTVVTNDMGTLCSRIVTSEQLHKVKVVTRIYHKA
KHTKAWCPRPPRAVQYSHTHTTNYKLSSEVHNDVAIRPRTNLTTV
//
>1aym_22 [b.121.4] HUMAN RHINOVIRUS 16 COAT PROTEIN
SDRIIQITRGDSTITSQDVANAVVGYGVWPHYLTPQDATAIDKPTQPDTSSNRFYTLDSK
MWNSTSKGWWWKLPDALKDMGIFGENMFYHFLGRSGYTVHVQCNASKFHQGTLLVVMIPE
HQLATVNKGNVNAGYKYTHPGEAGREVGTQVENEKQPSDDNWLNFDGTLLGNLLIFPHQF
INLRSNNSATLIVPYVNAVPMDSMVRHNNWSLVIIPVCQLQSNNISNIVPITVSISPMCA
EFSGARAKTVVQ
//
>1aym_4o (1) [b.121.4] HUMAN RHINOVIRUS 16 COAT PROTEIN
NPVERYVDEVLNEVLVVPNINQSHPTTSNAAPVLDAAETGHTNKIQPEDTIETRYVQSSQ
TLDEMSVESFLGRSGCIHESVLDIVDNYNDQSFTKWNINLQEMAQIRRKFEMFTYARFDS
EITMVPSVAAKDGHIGHIVMQYMYVPPGAPIPTTRDDYAWQSGTNASVFWQHGQPFPRFS
LPFLSIASAYYMFYDGYDGDTYKSRYGTVVTNDMGTLCSRIVTSEQLHKVKVVTRIYHKA
KHTKAWCPRPPRAVQYSHTHTTNYKLSSEVHNDVAIRPRTNLTTV
//
>1aym_4a (4) [b.121.4] HUMAN RHINOVIRUS 16 COAT PROTEIN
NPVERYVDEVLNEVLVVPNINQSHPTTSNAAPVLDAAETGHTNKIQPEDTIETRYVQSSQ
TLDEMSVESFLGRSGCIHESVLDIVDNYNDQSFTKWNINLQEMAQIRRKFEMFTYARFDS
EITMVPSVAAKDGHIGHIVMQYMYVPPGAPIPTTRDDYAWQSGTNASVFWQHGQPFPRFS
LPFLSIASAYYMFYDGYDGDTYKSRYGTVVTNDMGTLCSRIVTSEQLHKVKVVTRIYHKA
KHTKAWCPRPPRAVQYSHTHTTNYKLSSEVHNDVAIRPRTNLTTVSDRIIQITRGDSTIT
SQDVANAVVGYGVWPHYLTPQDATAIDKPTQPDTSSNRFYTLDSKMWNSTSKGWWWKLPD
ALKDMGIFGENMFYHFLGRSGYTVHVQCNASKFHQGTLLVVMIPEHQLATVNKGNVNAGY
KYTHPGEAGREVGTQVENEKQPSDDNWLNFDGTLLGNLLIFPHQFINLRSNNSATLIVPY
VNAVPMDSMVRHNNWSLVIIPVCQLQSNNISNIVPITVSISPMCAEFSGARAKTVVQGLP
VYVTPGSGQFMTTDDMQSPCALPWYHPTKEIFIPGEVKNLIEMCQVDTLIPINSTQSNIG
NVSMYTVTLSPQTKLAEEIFAIKVDIASHPLATTLIGEIASYFTHWTGSLRFSFMFCGTA
NTTLKVLLAYTPPGIGKPRSRKEAMLGTHVVWDVGLQSTVSLVVPWISASQYRFTTPDTY
SSAGYITCWYQTNFVVPPNTPNTAEMLCFVSGCKDFCLRMARDTDLHKQTGPITQGAQVS
RQSLNYFNINYFKDAASSGASRLDNPVERYVDEVLNEVLVVPNINQSHPTTSNAAPVLDA
AETGHTNKIQPEDTIETRYVQSSQTLDEMSVESFLGRSGCIHESVLDIVDNYNDQSFTKW
NINLQEMAQIRRKFEMFTYARFDSEITMVPSVAAKDGHIGHIVMQYMYVPPGAPIPTTRD
DYAWQSGTNASVFWQHGQPFPRFSLPFLSIASAYYMFYDGYDGDTYKSRYGTVVTNDMGT
LCSRIVTSEQLHKVKVVTRIYHKAKHTKAWCPRPPRAVQYSHTHTTNYKLSSEVHNDVAI
RPRTNLTTVSDRIIQITRGDSTITSQDVANAVVGYGVWPHYLTPQDATAIDKPTQPDTSS
NRFYTLDSKMWNSTSKGWWWKLPDALKDMGIFGENMFYHFLGRSGYTVHVQCNASKFHQG
TLLVVMIPEHQLATVNKGNVNAGYKYTHPGEAGREVGTQVENEKQPSDDNWLNFDGTLLG
NLLIFPHQFINLRSNNSATLIVPYVNAVPMDSMVRHNNWSLVIIPVCQLQSNNISNIVPI
TVSISPMCAEFSGARAKTVVQGLPVYVTPGSGQFMTTDDMQSPCALPWYHPTKEIFIPGE
VKNLIEMCQVDTLIPINSTQSNIGNVSMYTVTLSPQTKLAEEIFAIKVDIASHPLATTLI
GEIASYFTHWTGSLRFSFMFCGTANTTLKVLLAYTPPGIGKPRSRKEAMLGTHVVWDVGL
QSTVSLVVPWISASQYRFTTPDTYSSAGYITCWYQTNFVVPPNTPNTAEMLCFVSGCKDF
CLRMARDTDLHKQTGPITQGAQVSRQSLNYFNINYFKDAASSGASRLD
//
>1ayn_23 [b.121.4] HUMAN RHINOVIRUS 16 COAT PROTEIN
GLPVYVTPGSGQFMTTDDMQSPCALPWYHPTKEIFIPGEVKNLIEMCQVDTLIPINSTQS
NIGNVSMYTVTLSPQTKLAEEIFAIKVDIASHPLATTLIGEIASYFTHWTGSLRFSFMFC
GTANTTLKVLLAYTPPGIGKPRSRKEAMLGTHVVWDVGLQSTVSLVVPWISASQYRFTTP
DTYSSAGYITCWYQTNFVVPPNTPNTAEMLCFVSGCKDFCLRMARDTDLHKQTGPITQ
//
>1ayn_24 [b.121.4] HUMAN RHINOVIRUS 16 COAT PROTEIN
GAQVSRQSLNYFNINYFKDAASSGASRLD
//
>1ayyA [d.153.1] GLYCOSYLASPARAGINASE
TNKPIVLSTWNFGLHANVEAWKVLSKGGKALDAVEKGVRLVEDDPTERSVGYGGRPDRDG
RVTLDACIMDENYNIGSVACMEHIKNPISVARAVMEKTPHVMLVGDGALEFALSQGFKKE
NLLTAESEKEWKEWLKTS
//
>1ayyB [d.153.1] GLYCOSYLASPARAGINASE
TIGMIALDAQGNLSGACTTSGMAYKMHGRVGDSPIIGAGLFVDNEIGAATATGHGEEVIR
TVGTHLVVELMNQGRTPQQACKEAVERIVKIVNRRGKNLKDIQVGFIALNKKGEYGAYCI
QDGFNFAVHDQKGNRLETPGFAL
//
>1azz_1A [b.47.1] COLLAGENASE
IVGGVEAVPNSWPHQAALFIDDMYFCGGSLISPEWILTAAHCMDGAGFVDVVLGAHNIRE
DEATQVTIQSTDFTVHENYNSFVISNDIAVIRLPVPVTLTAAIATVGLPSTDVGVGTVVT
PTGWGLPSDSALGISDVLRQVDVPIMSNADCDAVYGIVTDGNICIDSTGGKGTCNGDSGG
PLNYNGLTYGITSFGAAAGCEAGYPDAFTRVTYFLDWIQTQTGITP
//
>1azz_1C [b.16.1] ECOTIN
PLEKIAPYPQAEKGMKRQVIQLTPQEDESTLKVELLIGQTLEVDCNLHRLGGKLENKTLE
GWGYDYYVFDKVSSPVSTMMACPDGKKEKKFVTAYLGDAGMLRYNSKLPIVVYTPDNVDV
KYRVWKAEEKIDNAVVR
//
>1b0nA [a.35.1 - a.34.1] PROTEIN (SINR PROTEIN)
MIGQRIKQYRKEKGYSLSELAEKAGVAKSYLSSIERNLQTNPSIQFLEKVSAVLDVSVHT
LLDEKHETLDSEWEKLVRDAMTSGVSKKQFREFLDYQKWRKSQ
//
>1b0nB [a.34.1] PROTEIN (SINI PROTEIN)
FELDQEWVELMVEAKEANISPEEIRKYLLLN
//
>1b27_3B (A) [d.1.1] PROTEIN (BARNASE)
AQVINTFDGVADYLQTYHKLPDNYITKSEAQALGWVASKGNLADVAPGKSIGGDIFSNRE
GKLPGKSGRTWREADINYTSGFRNSDRILYSSDWLIYKTTDHYQTFTKI
//
>1b27_3E [c.9.1] PROTEIN (BARSTAR)
KKAVINGEQIRSISDLHQTLKKELALPEYYGENLDALWDALTGWVEYPLVLEWRQGAESV
LQVFREAKAEGADITIIL
//
>1b2u_1B (A) [d.1.1] PROTEIN (BARNASE)
AQVINTFDGVADYLQTYHKLPDNYITASEAQALGWVASKGNLADVAPGKSIGGDIFSNRE
GKLPGKSGRTWREADINYTSGFRNSDRILYSSDWLIYKTTDHYQTFTKIR
//
>1b2u_1E [c.9.1] PROTEIN (BARSTAR)
KKAVINGEQIRSISDLHQTLKKELALPEYYGENLAALWDCLTGWVEYPLVLEWRQFGAES
VLQVFREAKAEGCDITIILS
//
>1b2wL [b.1.1 - b.1.1] PROTEIN (ANTIBODY (LIGHT CHAIN))
DIQMTQSPSTLSASVGDRVTITCKASENVDTYVSWYQQKPGKAPKLLIYGASNRYTGVPS
RFSGSGSGTDFTLTISSLQPDDFATYYCGQSYNYPFTFGQGTKVEVKRTVAAPSVFIFPP
SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT
LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
//
>1b2wH [b.1.1 - b.1.1] PROTEIN (ANTIBODY (HEAVY CHAIN))
xVQLVQSGGGVVQPGRSLKLSCLASGYIFTSSWINWVKQRPGRGLEWIGRIDPSDGEVHY
NQDFKDRFTISRDKSKNTLYLQMNSLRPEDTAVYYCARGFLPWFADWGQGTLVTVSSAST
KGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLY
SLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC
//
>1b33_1F (B) [a.1.1] ALLOPHYCOCYANIN, BETA CHAIN
MQDAITAVINSSDVQGKYLDTAALEKLKSYFSTGELRVRAATTIAANAAAIVKEAVAKSL
LYSDITRPGGxMYTTRRYAACIRDLDYYLRYATYAMLAGDPSILDERVLNGLKETYNSLG
VPISATVQAIQAMKEVTASLVGPDAGKEMGVYFDYICSGLS
//
>1b33_1N [d.30.1] PHYCOBILISOME 7.8 KD LINKER POLYPEPTIDE
GRLFKITACVPSQTRIRTQRELQNTYFTKLVPYENWFREQQRIQKMGGKIVKVELATGKQ
GINTGLA
//
>1b33_1D (B) [a.1.1] ALLOPHYCOCYANIN, BETA CHAIN
MQDAITAVINSSDVQGKYLDTAALEKLKSYFSTGELRVRAATTIAANAAAIVKEAVAKSL
LYSDITRPGGxMYTTRRYAACIRDLDYYLRYATYAMLAGDPSILDERVLNGLKETYNSLG
VPISATVQAIQAMKEVTASLVGPDAGKEMGVYFDYICSGLS
//
>1b33_1E (A) [a.1.1] ALLOPHYCOCYANIN, ALPHA CHAIN
SIVTKSIVNADAEARYLSPGELDRIKSFVSSGEKRLRIAQILTDNRERIVKQAGDQLFQK
RPDVVSPGGNAYGQEMTATCLRDLDYYLRLITYGIVAGDVTPIEEIGIVGVREMYKSLGT
PIDAVAAGVSAMKNVASSILSAEDAAEAGAYFDYVAGALA
//
>1b33_2L (A) [a.1.1] ALLOPHYCOCYANIN, ALPHA CHAIN
SIVTKSIVNADAEARYLSPGELDRIKSFVSSGEKRLRIAQILTDNRERIVKQAGDQLFQK
RPDVVSPGGNAYGQEMTATCLRDLDYYLRLITYGIVAGDVTPIEEIGIVGVREMYKSLGT
PIDAVAAGVSAMKNVASSILSAEDAAEAGAYFDYVAGALA
//
>1b33_2O (N) [d.30.1] PHYCOBILISOME 7.8 KD LINKER POLYPEPTIDE
GRLFKITACVPSQTRIRTQRELQNTYFTKLVPYENWFREQQRIQKMGGKIVKVELATGKQ
GINTGLA
//
>1b34A [b.38.1] PROTEIN (SMALL NUCLEAR RIBONUCLEOPROTEIN SM D1)
KLVRFLMKLSHETVTIELKNGTQVHGTITGVDVSMNTHLKAVKMTLKNREPVQLETLSIR
GNNIRYFILPDSLPLDTLLV
//
>1b34B [b.38.1] PROTEIN (SMALL NUCLEAR RIBONUCLEOPROTEIN SM D2)
TGPLSVLTQSVKNNTQVLINCRNNKKLLGRVKAFDRHCNMVLENVKEMDRYISKMFLRGD
SVIVVLRNPLIAGK
//
>1b35_2A [b.121.4] PROTEIN (CRICKET PARALYSIS VIRUS, VP1)
VMGEDQQIPRNEAQHGVHPISIDTHRISNNWSPQAMCIGEKVVSIRQLIKRFGIFGDANT
LQADGSSFVVAPFTVTSPTKTLTSTRNYTQFDYYYYLYAFWRGSMRIKMVAETQDGTGTP
RKKTNFTWFVRMFNSLQDSFNSLISTSSSAVTTTVLPSGTINMGPSTQVIDPTVEGLIEV
EVPYYNISHITPAVTIDDGTPSMEDYLKGHSPPCLLTFSPRDSISATNHIITASFMRALG
DDFSFMYLLGVPPLVNVARA
//
>1b35_2C [b.121.4] PROTEIN (CRICKET PARALYSIS VIRUS, VP3)
SKPTVQGKIGECKLRGQGRMANFDGMDMSHKMALSSTNEIETNEGLAGTSLDVMDLSRVL
SIPNYWDRFTWKTSDVINTVLWDNYVSPFKVKPYSATITDRFRCTHMGKVANAFTYWRGS
MVYTFKFVKTQYHSGRLRISFIPYYYNTTISTGTPDVSRTQKIVVDLRTSTAVSFTVPYI
GSRPWLYCIRPESSWLSKDNTDGALMYNCVSGIVRVEVLNQLVAAQNVFSEIDVICEVNG
GPDLEFAGPTCPRYVPYAGDFTLADTRKIEAERTQEYSNNED
//
>1b35_2f (C) [b.121.4] PROTEIN (CRICKET PARALYSIS VIRUS, VP3)
VMGEDQQIPRNEAQHGVHPISIDTHRISNNWSPQAMCIGEKVVSIRQLIKRFGIFGDANT
LQADGSSFVVAPFTVTSPTKTLTSTRNYTQFDYYYYLYAFWRGSMRIKMVAETQDGTGTP
RKKTNFTWFVRMFNSLQDSFNSLISTSSSAVTTTVLPSGTINMGPSTQVIDPTVEGLIEV
EVPYYNISHITPAVTIDDGTPSMEDYLKGHSPPCLLTFSPRDSISATNHIITASFMRALG
DDFSFMYLLGVPPLVNVARA
//
>1b35_2n (D) [b.121.4] PROTEIN (CRICKET PARALYSIS VIRUS, VP4)
AASELKQLETNNSPSTALGQISEGLTTLSHIPVLGNIFSTPAWISAKAADLAKLFGF
//
>1b35_2e (B) [b.121.4] PROTEIN (CRICKET PARALYSIS VIRUS, VP2)
ENSHIENEDKRLTSEQKEIVHFVSEGVTPSTTALPDIVNLSTNYLDKNTREDRIHSIKDF
LSRPIIIATNLWSVSDPVEKQLYTANFPEVLISNAMYQDKLKGFVGLRATLVVKVQVNSQ
PFQQGRLMLQYIPYAQYMPNRVTLINETLQGRSGCPRTDLELSVGTEVEMRIPYVSPHLY
YNLITGQGSFGSIYVVVYSQLHDQVSGTGSIEYTVWAHLEDVDVQYPTGANIFTGNEAYI
KGTSRYDAAQKAHAA
//
>1b35_2f (C) [b.121.4] PROTEIN (CRICKET PARALYSIS VIRUS, VP3)
SKPTVQGKIGECKLRGQGRMANFDGMDMSHKMALSSTNEIETNEGLAGTSLDVMDLSRVL
SIPNYWDRFTWKTSDVINTVLWDNYVSPFKVKPYSATITDRFRCTHMGKVANAFTYWRGS
MVYTFKFVKTQYHSGRLRISFIPYYYNTTISTGTPDVSRTQKIVVDLRTSTAVSFTVPYI
GSRPWLYCIRPESSWLSKDNTDGALMYNCVSGIVRVEVLNQLVAAQNVFSEIDVICEVNG
GPDLEFAGPTCPRYVPYAGDFTLADTRKIEAERTQEYSNNED
//
>1b35_2v (D) [b.121.4] PROTEIN (CRICKET PARALYSIS VIRUS, VP4)
AASELKQLETNNSPSTALGQISEGLTTLSHIPVLGNIFSTPAWISAKAADLAKLFGF
//
>1b35_2a (D) [b.121.4] PROTEIN (CRICKET PARALYSIS VIRUS, VP4)
VMGEDQQIPRNEAQHGVHPISIDTHRISNNWSPQAMCIGEKVVSIRQLIKRFGIFGDANT
LQADGSSFVVAPFTVTSPTKTLTSTRNYTQFDYYYYLYAFWRGSMRIKMVAETQDGTGTP
RKKTNFTWFVRMFNSLQDSFNSLISTSSSAVTTTVLPSGTINMGPSTQVIDPTVEGLIEV
EVPYYNISHITPAVTIDDGTPSMEDYLKGHSPPCLLTFSPRDSISATNHIITASFMRALG
DDFSFMYLLGVPPLVNVARAENSHIENEDKRLTSEQKEIVHFVSEGVTPSTTALPDIVNL
STNYLDKNTREDRIHSIKDFLSRPIIIATNLWSVSDPVEKQLYTANFPEVLISNAMYQDK
LKGFVGLRATLVVKVQVNSQPFQQGRLMLQYIPYAQYMPNRVTLINETLQGRSGCPRTDL
ELSVGTEVEMRIPYVSPHLYYNLITGQGSFGSIYVVVYSQLHDQVSGTGSIEYTVWAHLE
DVDVQYPTGANIFTGNEAYIKGTSRYDAAQKAHAASKPTVQGKIGECKLRGQGRMANFDG
MDMSHKMALSSTNEIETNEGLAGTSLDVMDLSRVLSIPNYWDRFTWKTSDVINTVLWDNY
VSPFKVKPYSATITDRFRCTHMGKVANAFTYWRGSMVYTFKFVKTQYHSGRLRISFIPYY
YNTTISTGTPDVSRTQKIVVDLRTSTAVSFTVPYIGSRPWLYCIRPESSWLSKDNTDGAL
MYNCVSGIVRVEVLNQLVAAQNVFSEIDVICEVNGGPDLEFAGPTCPRYVPYAGDFTLAD
TRKIEAERTQEYSNNEDAASELKQLETNNSPSTALGQISEGLTTLSHIPVLGNIFSTPAW
ISAKAADLAKLFGF
//
>1b35_2a (D) [b.121.4] PROTEIN (CRICKET PARALYSIS VIRUS, VP4)
VMGEDQQIPRNEAQHGVHPISIDTHRISNNWSPQAMCIGEKVVSIRQLIKRFGIFGDANT
LQADGSSFVVAPFTVTSPTKTLTSTRNYTQFDYYYYLYAFWRGSMRIKMVAETQDGTGTP
RKKTNFTWFVRMFNSLQDSFNSLISTSSSAVTTTVLPSGTINMGPSTQVIDPTVEGLIEV
EVPYYNISHITPAVTIDDGTPSMEDYLKGHSPPCLLTFSPRDSISATNHIITASFMRALG
DDFSFMYLLGVPPLVNVARAENSHIENEDKRLTSEQKEIVHFVSEGVTPSTTALPDIVNL
STNYLDKNTREDRIHSIKDFLSRPIIIATNLWSVSDPVEKQLYTANFPEVLISNAMYQDK
LKGFVGLRATLVVKVQVNSQPFQQGRLMLQYIPYAQYMPNRVTLINETLQGRSGCPRTDL
ELSVGTEVEMRIPYVSPHLYYNLITGQGSFGSIYVVVYSQLHDQVSGTGSIEYTVWAHLE
DVDVQYPTGANIFTGNEAYIKGTSRYDAAQKAHAASKPTVQGKIGECKLRGQGRMANFDG
MDMSHKMALSSTNEIETNEGLAGTSLDVMDLSRVLSIPNYWDRFTWKTSDVINTVLWDNY
VSPFKVKPYSATITDRFRCTHMGKVANAFTYWRGSMVYTFKFVKTQYHSGRLRISFIPYY
YNTTISTGTPDVSRTQKIVVDLRTSTAVSFTVPYIGSRPWLYCIRPESSWLSKDNTDGAL
MYNCVSGIVRVEVLNQLVAAQNVFSEIDVICEVNGGPDLEFAGPTCPRYVPYAGDFTLAD
TRKIEAERTQEYSNNEDAASELKQLETNNSPSTALGQISEGLTTLSHIPVLGNIFSTPAW
ISAKAADLAKLFGF
//
>1b35_2a (D) [b.121.4] PROTEIN (CRICKET PARALYSIS VIRUS, VP4)
VMGEDQQIPRNEAQHGVHPISIDTHRISNNWSPQAMCIGEKVVSIRQLIKRFGIFGDANT
LQADGSSFVVAPFTVTSPTKTLTSTRNYTQFDYYYYLYAFWRGSMRIKMVAETQDGTGTP
RKKTNFTWFVRMFNSLQDSFNSLISTSSSAVTTTVLPSGTINMGPSTQVIDPTVEGLIEV
EVPYYNISHITPAVTIDDGTPSMEDYLKGHSPPCLLTFSPRDSISATNHIITASFMRALG
DDFSFMYLLGVPPLVNVARAENSHIENEDKRLTSEQKEIVHFVSEGVTPSTTALPDIVNL
STNYLDKNTREDRIHSIKDFLSRPIIIATNLWSVSDPVEKQLYTANFPEVLISNAMYQDK
LKGFVGLRATLVVKVQVNSQPFQQGRLMLQYIPYAQYMPNRVTLINETLQGRSGCPRTDL
ELSVGTEVEMRIPYVSPHLYYNLITGQGSFGSIYVVVYSQLHDQVSGTGSIEYTVWAHLE
DVDVQYPTGANIFTGNEAYIKGTSRYDAAQKAHAASKPTVQGKIGECKLRGQGRMANFDG
MDMSHKMALSSTNEIETNEGLAGTSLDVMDLSRVLSIPNYWDRFTWKTSDVINTVLWDNY
VSPFKVKPYSATITDRFRCTHMGKVANAFTYWRGSMVYTFKFVKTQYHSGRLRISFIPYY
YNTTISTGTPDVSRTQKIVVDLRTSTAVSFTVPYIGSRPWLYCIRPESSWLSKDNTDGAL
MYNCVSGIVRVEVLNQLVAAQNVFSEIDVICEVNGGPDLEFAGPTCPRYVPYAGDFTLAD
TRKIEAERTQEYSNNEDAASELKQLETNNSPSTALGQISEGLTTLSHIPVLGNIFSTPAW
ISAKAADLAKLFGF
//
>1b4jL [b.1.1 - b.1.1] ANTIBODY
NIVMTQSPKSMYVSIGERVTLSCKASENVDTYVSWYQQKPEQSPKLLIYGASNRYTGVPD
RFTGSGSATDFTLTISSVQAEDLADYHCGQSYNYPFTFGSGTKLEIKRTVAAPSVFIFPP
SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT
LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
//
>1b4jH [b.1.1 - b.1.1] ANTIBODY
xVQLQQPGADLVMPGAPVKLSCLASGYIFTSSWINWVKQRPGRGLEWIGRIDPSDGEVHY
NQDFKDKATLTVDKSSSTAYIQLNSLTSEDSAVYYCARGFLPWFADWGQGTLVTVSAAST
KGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLY
SLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC
//
>1b4uA [a.88.1] PROTOCATECHUATE 4,5-DIOXYGENASE
IDVHAYLAEFDDIPGTRVFTAQRARKGYNLNQFAMSLMKAENRERFKADESAYLDEWNLT
PAAKAAVLARDYNAMIDEGGNVYFLSKLFSTDGKSFQFAAGSMTGMTQEEYAQMMIDGGR
SPAGVRSIKGGY
//
>1b4uB [c.56.6] PROTOCATECHUATE 4,5-DIOXYGENASE
ARVTTGITSSHIPALGAAIQTGTSDNDYWGPVFKGYQPIRDWIKQPGNMPDVVILVYNDH
ASAFDMNIIPTFAIGCAETFKPADEGWGPRPVPDVKGHPDLAWHIAQSLILDEFDMTIMN
QMDVDHGCTVPLSMIFGEPEEWPCKVIPFPVNVVTYPPPSGKRCFALGDSIRAAVESFPE
DLNVHVWGTGGMSHQLQGPRAGLINKEFDLNFIDKLISDPEELSKMPHIQYLRESGSEGV
ELVMWLIMRGALPEKVRDLYTFYHIPASNTALGAMILQPEETAGTPLEPRKVMSGHSL
//
>1b5fC [b.50.1] PROTEIN (CARDOSIN A)
SAVVALTNDRDTSYFGEIGIGTPPQKFTVIFDTGSSVLWVPSSKCINSKACRAHSMYESS
DSSTYKENGTFGAIIYGTGSITGFFSQDSVTIGDLVVKEQDFIEATDEADNVFLHRLFDG
ILGLSFQTISVPVWYNMLNQGLVKERRFSFWLNRNVDEEEGGELVFGGLDPNHFRGDHTY
VPVTYQYYWQFGIGDVLIGDKSTGFCAPGCQAFADSGTSLLSGPTAIVTQINHAIGAN
//
>1b5fD (B) [b.50.1] PROTEIN (CARDOSIN A)
EELQVDCNTLSSMPNVSFTIGGKKFGLTPEQYILKVGKGEATQCISGFTAMDATLLGPLW
ILGDVFMRPYHTVFDYGNLLVGFAEAA
//
>1b6c_1A [d.26.1] FK506-BINDING PROTEIN
GVQVETISPGDGRTFPKRGQTCVVHYTGMLEDGKKFDSSRDRNKPFKFMLGKQEVIRGWE
EGVAQMSVGQRAKLTISPDYAYGATGHPGIIPPHATLVFDVELLKLE
//
>1b6c_1B [d.144.1] TGF-B SUPERFAMILY RECEPTOR TYPE I
TTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIF
SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR
YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL
AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR
CSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMREC
WYANGAARLTALRIKKTLSQLSQQEG
//
>1b72A [a.4.1] PROTEIN (HOMEOBOX PROTEIN HOX-B1)
ARTFDWMKVLRTNFTTRQLTELEKEFHFNKYLSRARRVEIAATLELNETQVKIWFQNRRM
KQKKRERE
//
>1b72B [a.4.1] PROTEIN (PBX1)
RKRRNFNKQATEILNEYFYSHLSNPYPSEEAKEELAKKCGITVSQVSNWFGNKRIRYKKN
IGKFQEEANIYAA
//
>1b8dA [a.1.1] PROTEIN (RHODOPHYTAN PHYCOERYTHRIN (ALPHA CHAIN)
MKSVITTTISAADAAGRFPSSSDLESIQGNIQRAAARLEAAQKLSGNHEAVVKEAGDACF
AKYSYLKNAGEAGDSPEKINKCYRDIDHYMRLINYSLVVGGTGPVDEWGIAGSREVYRAL
NLPGSAYIAAFTFTRDRLCVPRDMSSQAGVEFTSALDYVINSLC
//
>1b8dB [a.1.1] PROTEIN (RHODOPHYTAN PHYCOERYTHRIN (BETA CHAIN))
MLDAFSRVVVTSDAKAAYVGGSDLQSLKSFINDGNKRLDAVNYIVSNASCIVSDAVSGMI
CENPGLIAPGGxCYTNRRMAACLRDGEIILRYVSYALLAGDSSVLDDRCLNGLKETYIAL
GVPTASSSRAVSIMKATATAFITNTASGRKVEVAAGDCQALQAEAASYFDKVGSSID
//
>1b8iA [a.4.1] PROTEIN (ULTRABITHORAX HOMEOTIC PROTEIN IV)
FYPWMARQTYTRYQTLELEKEFHTNHYLTRRRRIEMAHALSLTERQIKIWFQNRRMKLKK
EI
//
>1b8iB [a.4.1] PROTEIN (HOMEOBOX PROTEIN EXTRADENTICLE)
RRNFSKQASEILNEYFYSHLSNPYPSEEAKEELARKCGITVSQVSNWFGNKRIRYKKN
//
>1b9yA [b.69.4] PROTEIN (TRANSDUCIN)
MSELDQLRQEAEQLKNQIRDARKACADATLSQITNNIDPVGRIQMRTRRTLRGHLAKIYA
MHWGTDSRLLLSASQDGKLIIWDSYTTNKVHAIPLRSSWVMTCAYAPSGNYVACGGLDNI
CSIYNLKTREGNVRVSRELAGHTGYLSCCRFLDDNQIVTSSGDTTCALWDIETGQQTTTF
TGHTGDVMSLSLAPDTRLFVSGACDASAKLWDVREGMCRQTFTGHESDINAICFFPNGNA
FATGSDDATCRLFDLRADQELMTYSHDNIICGITSVSFSKSGRLLLAGYDDFNCNVWDAL
KADRAGVLAGHDNRVSCLGVTDDGMAVATGSWDSFLKIWN
//
>1b9yB [a.137.3] PROTEIN (TRANSDUCIN)
MPVINIEDLTEKDKLKMEVDQLKKEVTLERMLVSKCCEEFRDYVEERSGEDPLVKGIPED
KNPFKELK
//
>1b9yC [c.47.1] PROTEIN (PHOSDUCIN)
EGQATHTGPKGVINDWRKFKLESEGCLRKYRRQCMQDMHQKLSFGPRYGFVYELETGEQF
LETIEKEQKVTTIVVNIYEDGVRGCDALNSSLECLAAEYPMVKFCKIRASNTGAGDRFSS
DVLPTLLVYKGGELISNFISVAEQFAEDFFAADVESFLNEYGLLPER
//
>1bafL [b.1.1 - b.1.1] IGG1-KAPPA AN02 FAB (LIGHT CHAIN)
QIVLTQSPAIMSASPGEKVTMTCSASSSVYYMYWYQQKPGSSPRLLIYDTSNLASGVPVR
FSGSGSGTSYSLTISRMEAEDAATYYCQQWSSYPPITFGVGTKLELKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1bafH [b.1.1 - b.1.1] IGG1-KAPPA AN02 FAB (HEAVY CHAIN)
DVQLQESGPGLVKPSQSQSLTCTVTGYSITSDYAWNWIRQFPGNKLEWMGYMSYSGSTRY
NPSLRSRISITRDTSKNQFFLQLKSVTTEDTATYFCARGWPLAYWGQGTQVSVSEAKTTP
PSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTLS
SSVTVPSSPRPSETVTCNVAHPASSTKVDKKIVPRDC
//
>1bbdL [b.1.1 - b.1.1] IGG2A-KAPPA 8F5 FAB (LIGHT CHAIN)
DIVMTQSPSSLTVTTGEKVTMTCKSSQSLLNSRTQKNYLTWYQQKPGQSPKLLIYWASTR
ESGVPDRFTGSGSGTDFTLSISGVQAEDLAVYYCQNNYNYPLTFGAGTKLELKRADAAPT
VSIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYS
MSSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNE
//
>1bbdH [b.1.1 - b.1.1] IGG2A-KAPPA 8F5 FAB (HEAVY CHAIN)
EVQLQQSGAELVRPGASVKLSCTTSGFNIKDIYIHWVKQRPEQGLEWIGRLDPANGYTKY
DPKFQGKATITVDTSSNTAYLHLSSLTSEDTAVYYCDGYYSYYDMDYWGPGTSVTVSSAK
TTAPSVYPLAPVCSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDLYTLSSS
VTVTSSTWPSQSITCNVAHPASSTKVDKKIEPR
//
>1bbj_1H [b.1.1 - b.1.1] IGG4-KAPPA B72.3 FAB (HEAVY CHAIN)
xVQLQQSDAELVKPGASVKISCKASGYTFTDHAIHWAKQKPEQGLEWIGYISPGNDDIKY
NEKFKGKATLTADKSSSTAYMQLNSLTSEDSAVYFCKRSYYGHWGQGTTLTVSSASTKGP
SVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLS
SVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRV
//
>1bbj_1L [b.1.1 - b.1.1] IGG4-KAPPA B72.3 FAB (LIGHT CHAIN)
DIQMTQSPASLSVSVGETVTITCRASENIYSNLAWYQQKQGKSPQLLVYAATNLADGVPS
RFSGSGSGTQYSLKINSLQSEDFGSYYCQHFWGTPYTFGGGTRLEIKRADAAPTVFIFPP
SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT
LSKADYEKHKVYACEVTHQGLSSPVTKSFNR
//
>1bbr_2J (L) [b.47.1] EPSILON-THROMBIN
TFGAGEADCGLRPLFEKKQVQDQTEKELFESYIEGR
//
>1bbr_2K [b.47.1] EPSILON-THROMBIN
IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLL
VRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCL
PDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKASTRIR
ITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFY
THVFRLKKWIQKVIDRLGS
//
>1bbr_3M (L) [b.47.1] EPSILON-THROMBIN
TFGAGEADCGLRPLFEKKQVQDQTEKELFESYIEGR
//
>1bbr_3N (K) [b.47.1] EPSILON-THROMBIN
IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLL
VRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCL
PDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKASTRIR
ITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFY
THVFRLKKWIQKVIDRLGS
//
>1bbt_21 [b.121.4] FOOT-AND-MOUTH DISEASE VIRUS (SUBUNIT VP1)
TTSAGESADPVTTTVENYGGETQIQRRQHTDVSFIMDRFVKVTPQNQINILDLMQVPSHT
LVGGLLRASTYYFSDLEIAVKHEGDLTWVPNGAPEKALDNTTNPTAYHKAPLTRLALPYT
APHRVLATVYNGECRTLPTSFNYGAIKATRVTELLYRMKRAETYCPRPLLAIHPTEARHK
QKIVAP
//
>1bbt_24 [b.121.4] FOOT-AND-MOUTH DISEASE VIRUS (SUBUNIT VP4)
SGNTGSIINNYYMQQYQNSMDTQLGNDWFSKLASSAFSGLFGALLA
//
>1bbt_24 [b.121.4] FOOT-AND-MOUTH DISEASE VIRUS (SUBUNIT VP4)
SGNTGSIINNYYMQQYQNSMDTQLGNDWFSKLASSAFSGLFGALLA
//
>1bccA [d.185.1 - d.185.1] UBIQUINOL CYTOCHROME C OXIDOREDUCTASE
YAQALQSVPETQVSQLDNGVRVASEQSSQPTCTVGVWIDAGSRYESEKNNGAGYFLEHLA
FKGTKNRPQNALEKEVESMGAHLNAYSSREHTAYYIKALSKDVPKAVELLADIVQNCSLE
DSQIEKERDVIVRELQENDTSMREVVFNYLHATAFQGTGLAQSVEGPSENIRKLSRADLT
EYLSTHYTAPRMVLAAAGGVEHQQLLELAQKHFGGVPFTYDDDAVPTLSKCRFTGSQIRH
REDGLPLAHVAIAVEGPGWAHPDLVALQVANAIIGHYDRTYGGGLHSSSPLASIAVTNKL
CQSFQTFSICYSETGLFGFYFVCDRMSIDDMMFVLQGQWMRLCTSISESEVLRGKNFLRN
ALVSHLDGTTPVCEDIGRELLTYGRRIPLEEWEERLAEVDARMVREVCSKYIYDQCPAVA
GPGPIEQLPDYNRIRSGMFWLR
//
>1bccC [f.21.1 - f.32.1] UBIQUINOL CYTOCHROME C OXIDOREDUCTASE
APNIRKSHPLLKMINNSLIDLPAPSNISAWWNFGSLLAVCLMTQILTGLLLAMHYTADTS
LAFSSVAHTCRNVQYGWLIRNLHANGASFFFICIFLHIGRGLYYGSYLYKETWNTGVILL
LTLMATAFVGYVLPWGQMSFWGATVITNLFSAIPYIGHTLVEWAWGGFSVDNPTLTRFFA
LHFLLPFAIAGITIIHLTFLHESGSNNPLGISSDSDKIPFHPYYSFKDILGLTLMLTPFL
TLALFSPNLLGDPENFTPANPLVTPPHIKPEWYFLFAYAILRSIPNKLGGVLALAASVLI
LFLIPFLHKSKQRTMTFRPLSQTLFWLLVANLLILTWIGSQPVEHPFIIIGQMASLSYFT
ILLILFPTIGTLENKMLNY
//
>1bccD [a.3.1 - f.23.11] UBIQUINOL CYTOCHROME C OXIDOREDUCTASE
SDLELHPPSYPWSHRGPLSSLDHTSIRRGFQVYKQVCSSCHSMDYVAYRHLVGVCYTEDE
AKALAEEVEVQDGPNEDGEMFMRPGKLSDYFPKPYPNPEAARAANNGALPPDLSYIVRAR
HGGEDYVFSLLTGYCEPPTGVSVREGLYFNPYFPGQAIGMAPPIYNDVLEFDDGTPATMS
QVAKDVCTFLRWAAEPEHDHRKRMGLKMLLMMGLLVPLVYYMKRHKWSVLKSRKLAYRPP
K
//
>1bccE [f.23.12 - b.33.1] UBIQUINOL CYTOCHROME C OXIDOREDUCTASE
SHTDIKVPNFSDYRRPPDDYSTKSSRESDPSRKGFSYLVTAVTTLGVAYAAKNVVTQFVS
SMSASADVLAMSKIEIKLSDIPEGKNMAFKWRGKPLFVRHRTKKEIDQEAAVEVSQLRDP
QHDLERVKKPEWVILIGVCTHLGCVPIANAGDFGGYYCPCHGSHYDASGRIRKGPAPLNL
EVPSYEFTSDDMVIVG
//
>1bccF [f.27.1] UBIQUINOL CYTOCHROME C OXIDOREDUCTASE
SRWLEGIRKWYYNAAGFNKYGLMRDDTIYENDDVKEAIRRLPENLYDDRMFRIKRALDLN
MRQQILPKEQWTKYEEDVPYLEPYLKEVIRERKEREEWDK
//
>1bccG [f.23.13] UBIQUINOL CYTOCHROME C OXIDOREDUCTASE
RQFGHLTRVRHLITYSLSPFEQRPFPHYFSKGVPNVWRRLRACILRVAPPFLAFYLLYTW
GTQEFEKSKRKNPAAYVN
//
>1bcp_1A [d.166.1] PERTUSSIS TOXIN
DPPATVYRYDSRPPEDVFQNGFTAWGNNDNVLEHLTGRSCQVGSSNSAFVSTSSSRRYTE
VYLEHRMQEAVEAERAGRGTGHFIGYIYEVRADNNFYGAASSYFEYVDTYGDNAGRILAG
ALATYQSEYLAHRRIPPENIRRVTRVYHNGITGETTTTEYSNARYVSQQTRANPNPYTSR
RSVASIVGTLVRMAPVVGACMARQAESSEEAMVLVYYESIAYSF
//
>1bcp_1B [d.169.1 - b.40.2] PERTUSSIS TOXIN
PGIVIPPQEQITQHGSPYGRCANKTRALTVAELRGSGDLQEYLRHVTRGWSIFALYDGTY
LGGEYGGVIKDGTPGGAFDLKTTFCIMTTRNTGQPATDHYYSNVTATRLLSSTNSRLCAV
FVRSGQPVIGACTSPYDGKYWSMYSRLRKMLYLIYVAGISVRVHVSKEEQYYDYEDATFE
TYALTGISICNPGSSLC
//
>1bcp_1E (D) [b.40.2] PERTUSSIS TOXIN
DVPYVLVKTNMVVTSVAMKPYEVTPTRMLVCGIAAKLGAAASSPDAHVPFCFGKDLKRPG
SSPMEVMLRAVFMQQRPLRMFLGPKQLTFEGKPALELIRMVECSGKQDCP
//
>1bcp_1F [b.40.2] PERTUSSIS TOXIN
LPTHLYKNFTVQELALKLKGKNQEFCLTAFMSGRSLVRACLSDAGHEHDTWFDTMLGFAI
SAYALKSRIALTVEDSPYPGTPGDLLELQICPLNGYCE
//
>1bcp_2G (A) [d.166.1] PERTUSSIS TOXIN
DPPATVYRYDSRPPEDVFQNGFTAWGNNDNVLEHLTGRSCQVGSSNSAFVSTSSSRRYTE
VYLEHRMQEAVEAERAGRGTGHFIGYIYEVRADNNFYGAASSYFEYVDTYGDNAGRILAG
ALATYQSEYLAHRRIPPENIRRVTRVYHNGITGETTTTEYSNARYVSQQTRANPNPYTSR
RSVASIVGTLVRMAPVVGACMARQAESSEEAMVLVYYESIAYSF
//
>1bcp_2K (D) [b.40.2] PERTUSSIS TOXIN
DVPYVLVKTNMVVTSVAMKPYEVTPTRMLVCGIAAKLGAAASSPDAHVPFCFGKDLKRPG
SSPMEVMLRAVFMQQRPLRMFLGPKQLTFEGKPALELIRMVECSGKQDCP
//
>1bcsA [c.69.1] SERINE CARBOXYPEPTIDASE II
HAADRIARLPGQPAVDFDMYSGYITVDEGAGRSLFYLLQEAPEDAQPAPLVLWLNGGPGC
SSVAYGASEELGAFRVKPRGAGLVLNEYRWNKVANVLFLDSPAGVGFSYTNTSSDIYTSG
DNRTAHDSYAFLAKWFERFPHYKYRDFYIAGESYAGHYVPELSQLVHRSKNPVINLKGFM
VGNGLIDDYHDYVGTFEFWWNHGIVSDDTYRRLKEACLHDSFIHPSPACDAATDVATAEQ
GNIDMYSLYTPVCNI
//
>1bcsB [c.69.1] SERINE CARBOXYPEPTIDASE II
SYDPCTERYSTAYYNRRDVQMALHANVTGAMNYTWATCSDTINTHWHDAPRSMLPIYREL
IAAGLRIWVFSGDTDAVVPLTATRYSIGALGLPTTTSWYPWYDDQEVGGWSQVYKGLTLV
SVRGAGHEVPLHRPRQALVLFQYFLQGKPMPGQ
//
>1bd2A [d.19.1 - b.1.1] HLA-A 0201
GSHSMRYFFTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGPEYW
DGETRKVKAHSQTHRVDLGTLRGYYNQSEAGSHTVQRMYGCDVGSDWRFLRGYHQYAYDG
KDYIALKEDLRSWTAADMAAQTTKHKWEAAHVAEQLRAYLEGTCVEWLRRYLENGKETLQ
RTDAPKTHMTHHAVSDHEATLRCWALSFYPAEITLTWQRDGEDQTQDTELVETRPAGDGT
FQKWAAVVVPSGQEQRYTCHVQHEGLPKPLTLRWE
//
>1bd2D [x.x.x]
QQVKQNSPSLSVQEGRISILNCDYTNSMFDYFLWYKKYPAEGPTFLISISSIKDKNADGR
FTVFLNKSAKHLSLHIVPSQPGDSAVYFCAAMEGAQKLVFGQGTRLTINPNIQNPDPAVY
QLRDSKSVCLFTDFDSQTNVSQSKDSDVYITDKTVLDMDFKSNSAVAWSNKSDFACANAF
NNSIIPEDTF
//
>1bd2E [b.1.1 - b.1.1] T CELL RECEPTOR BETA
GVTQTPKFQVLKTGQSMTLQCAQDMNHEYMSWYRQDPGMGLRLIHYSVGAGITDQGEVPN
GYNVSRSTTEDFPLRLLSAAPSQTSVYFCASSYPGGGFYEQYFGPGTRLTVTEDLKNVFP
PEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVSTDPQPLKEQPA
LNDSRYALSSRLRVSATFWQDPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGR
AD
//
>1be3A [d.185.1 - d.185.1] CYTOCHROME BC1 COMPLEX
TATYAQALQSVPETQVSQLDNGLRVASEQSSQPTCTVGVWIDAGSRYESEKNNGAGYFVE
HLAFKGTKNRPGNALEKEVESMGAHLNAYSTREHTAYYIKALSKDLPKAVELLADIVQNC
SLEDSQIEKERDVILQELQENDTSMRDVVFNYLHATAFQGTPLAQSVEGPSENVRKLSRA
DLTEYLSRHYKAPRMVLAAAGGLEHRQLLDLAQKHFSGLSGTYDEDAVPTLSPCRFTGSQ
ICHREDGLPLAHVAIAVEGPGWAHPDNVALQVANAIIGHYDCTYGGGAHLSSPLASIAAT
NKLCQSFQTFNICYADTGLLGAHFVCDHMSIDDMMFVLQGQWMRLCTSATESEVLRGKNL
LRNALVSHLDGTTPVCEDIGRSLLTYGRRIPLAEWESRIAEVDARVVREVCSKYFYDQCP
AVAGFGPIEQLPDYNRIRSGMFWLRF
//
>1be3C [f.21.1 - f.32.1] CYTOCHROME BC1 COMPLEX
MTNIRKSHPLMKIVNNAFIDLPAPSNISSWWNFGSLLGICLILQILTGLFLAMHYTSDTT
TAFSSVTHICRDVNYGWIIRYMHANGASMFFICLYMHVGRGLYYGSYTFLETWNIGVILL
LTVMATAFMGYVLPWGQMSFWGATVITNLLSAIPYIGTNLVEWIWGGFSVDKATLTRFFA
FHFILPFIIMAIAMVHLLFLHETGSNNPTGISSDVDKIPFHPYYTIKDILGALLLILALM
LLVLFAPDLLGDPDNYTPANPLNTPPHIKPEWYFLFAYAILRSIPNKLGGVLALAFSILI
LALIPLLHTSKQRSMMFRPLSQCLFWALVADLLTLTWIGGQPVEHPYITIGQLASVLYFL
LILVLMPTAGTIENKLLKW
//
>1be3G [f.23.13] CYTOCHROME BC1 COMPLEX
GRQFGHLTRVRHVITYSLSPFEQRAFPHYFSKGIPNVLRRTRACILRVAPPFVAFYLVYT
WGTQEFEKSKRKNPAAYENDR
//
>1be3J [f.23.14] CYTOCHROME BC1 COMPLEX
VAPTLTARLYSLLFRRTSTFALTIVVGALFFERAFDQGADAIYEHINEGKLWKHIKHKYE
NK
//
>1be3K [f.23.15] CYTOCHROME BC1 COMPLEX
RNWVPTAQLWGAVGAVGLVSAT
//
>1be3F [f.27.1] CYTOCHROME BC1 COMPLEX
AVSASSRWLEGIRKWYYNAAGFNKLGLMRDDTIHENDDVKEAIRRLPENLYDDRVFRIKR
ALDLSMRQQILPKEQWTKYEEDKSYLEPYLKEVIRERKEREEWAKK
//
>1bev_21 [b.121.4] BOVINE ENTEROVIRUS COAT PROTEINS VP1 TO VP4
QAAGALVAGTSTSTHSVATDSTPALQAAETGATSTARDESMIETRTIVPTHGIHETSVES
FFGRSSLVGMPLLATGTSITHWRIDFREFVQLRAKMSWFTYMRFDVEFTIIATSSTGQNV
TTEQHTTYQVMYVPPGAPVPSNQDSFQWQSGCNPSVFADTDGPPAQFSVPFMSSANAYST
VYDGYARFMDTDPDRYGILPSNFLGFMYFRTLEDAAHQVRFRIYAKIKHTSCWIPRAPRQ
APYKKRYNLVFSGDSDRICSNRASLTSY
//
>1bev_22 [b.121.4] BOVINE ENTEROVIRUS COAT PROTEINS VP1 TO VP4
EACGYSDRVAQLTLGNSTITTQEAANICVAYGCWPAKLSDTDATSVDKPTEPGVSADRFY
TLRSKPWQADSKGWYWKLPDALNNTGMFGQNAQFHYLYRGGWAVHVQCNATKFHQGTLLV
LAIPEHQIATQEQPAFDRTMPGSEGGTFQEPFWLEDGTSLGNSLIYPHQWINLRTNNSAT
LILPYVNAIPMDSAIRHSNWTLAIIPVAPLKYAAETTPLVPITVTIAPMETEYNGLRRAI
ASNQ
//
>1bev_23 [b.121.4] BOVINE ENTEROVIRUS COAT PROTEINS VP1 TO VP4
GLPTKPGPGSYQFMTTDEDCSPCILPDFQPTPEIFIPGKVNNLLEIAQVESILEANNREG
VEGVERYVIPVSVQDALDAQIYALRLELGGSGPLSSSLLGTLAKHYTQWSGSVEITCMFT
GTFMTTGKVLLAYTPPGGDMPRNREEAMLGTHVIWDFGLQSSITLVIPWISASHFRGVSN
DDVLNYQYYAAGHVTIWYQTNMVIPPGFPNTAGIIMMIAAQPNFSFRIQKDREDMTQTAI
LQ
//
>1bev_24 [b.121.4] BOVINE ENTEROVIRUS COAT PROTEINS VP1 TO VP4
STINYNNINYYSHAASAAQNKQDFTQDPSKFTQPIADVIK
//
>1bev_2C (3) [b.121.4] BOVINE ENTEROVIRUS COAT PROTEINS VP1 TO VP4
EACGYSDRVAQLTLGNSTITTQEAANICVAYGCWPAKLSDTDATSVDKPTEPGVSADRFY
TLRSKPWQADSKGWYWKLPDALNNTGMFGQNAQFHYLYRGGWAVHVQCNATKFHQGTLLV
LAIPEHQIATQEQPAFDRTMPGSEGGTFQEPFWLEDGTSLGNSLIYPHQWINLRTNNSAT
LILPYVNAIPMDSAIRHSNWTLAIIPVAPLKYAAETTPLVPITVTIAPMETEYNGLRRAI
ASNQ
//
>1bev_2J (4) [b.121.4] BOVINE ENTEROVIRUS COAT PROTEINS VP1 TO VP4
STINYNNINYYSHAASAAQNKQDFTQDPSKFTQPIADVIK
//
>1bev_2M (2) [b.121.4] BOVINE ENTEROVIRUS COAT PROTEINS VP1 TO VP4
EACGYSDRVAQLTLGNSTITTQEAANICVAYGCWPAKLSDTDATSVDKPTEPGVSADRFY
TLRSKPWQADSKGWYWKLPDALNNTGMFGQNAQFHYLYRGGWAVHVQCNATKFHQGTLLV
LAIPEHQIATQEQPAFDRTMPGSEGGTFQEPFWLEDGTSLGNSLIYPHQWINLRTNNSAT
LILPYVNAIPMDSAIRHSNWTLAIIPVAPLKYAAETTPLVPITVTIAPMETEYNGLRRAI
ASNQ
//
>1bev_2a (4) [b.121.4] BOVINE ENTEROVIRUS COAT PROTEINS VP1 TO VP4
QAAGALVAGTSTSTHSVATDSTPALQAAETGATSTARDESMIETRTIVPTHGIHETSVES
FFGRSSLVGMPLLATGTSITHWRIDFREFVQLRAKMSWFTYMRFDVEFTIIATSSTGQNV
TTEQHTTYQVMYVPPGAPVPSNQDSFQWQSGCNPSVFADTDGPPAQFSVPFMSSANAYST
VYDGYARFMDTDPDRYGILPSNFLGFMYFRTLEDAAHQVRFRIYAKIKHTSCWIPRAPRQ
APYKKRYNLVFSGDSDRICSNRASLTSY
//
>1bev_2J (4) [b.121.4] BOVINE ENTEROVIRUS COAT PROTEINS VP1 TO VP4
GLPTKPGPGSYQFMTTDEDCSPCILPDFQPTPEIFIPGKVNNLLEIAQVESILEANNREG
VEGVERYVIPVSVQDALDAQIYALRLELGGSGPLSSSLLGTLAKHYTQWSGSVEITCMFT
GTFMTTGKVLLAYTPPGGDMPRNREEAMLGTHVIWDFGLQSSITLVIPWISASHFRGVSN
DDVLNYQYYAAGHVTIWYQTNMVIPPGFPNTAGIIMMIAAQPNFSFRIQKDREDMTQTAI
LQ
//
>1bev_2M (2) [b.121.4] BOVINE ENTEROVIRUS COAT PROTEINS VP1 TO VP4
QAAGALVAGTSTSTHSVATDSTPALQAAETGATSTARDESMIETRTIVPTHGIHETSVES
FFGRSSLVGMPLLATGTSITHWRIDFREFVQLRAKMSWFTYMRFDVEFTIIATSSTGQNV
TTEQHTTYQVMYVPPGAPVPSNQDSFQWQSGCNPSVFADTDGPPAQFSVPFMSSANAYST
VYDGYARFMDTDPDRYGILPSNFLGFMYFRTLEDAAHQVRFRIYAKIKHTSCWIPRAPRQ
APYKKRYNLVFSGDSDRICSNRASLTSY
//
>1bev_2A (1) [b.121.4] BOVINE ENTEROVIRUS COAT PROTEINS VP1 TO VP4
QAAGALVAGTSTSTHSVATDSTPALQAAETGATSTARDESMIETRTIVPTHGIHETSVES
FFGRSSLVGMPLLATGTSITHWRIDFREFVQLRAKMSWFTYMRFDVEFTIIATSSTGQNV
TTEQHTTYQVMYVPPGAPVPSNQDSFQWQSGCNPSVFADTDGPPAQFSVPFMSSANAYST
VYDGYARFMDTDPDRYGILPSNFLGFMYFRTLEDAAHQVRFRIYAKIKHTSCWIPRAPRQ
APYKKRYNLVFSGDSDRICSNRASLTSY
//
>1bev_2C (3) [b.121.4] BOVINE ENTEROVIRUS COAT PROTEINS VP1 TO VP4
GLPTKPGPGSYQFMTTDEDCSPCILPDFQPTPEIFIPGKVNNLLEIAQVESILEANNREG
VEGVERYVIPVSVQDALDAQIYALRLELGGSGPLSSSLLGTLAKHYTQWSGSVEITCMFT
GTFMTTGKVLLAYTPPGGDMPRNREEAMLGTHVIWDFGLQSSITLVIPWISASHFRGVSN
DDVLNYQYYAAGHVTIWYQTNMVIPPGFPNTAGIIMMIAAQPNFSFRIQKDREDMTQTAI
LQ
//
>1bev_2a (4) [b.121.4] BOVINE ENTEROVIRUS COAT PROTEINS VP1 TO VP4
QAAGALVAGTSTSTHSVATDSTPALQAAETGATSTARDESMIETRTIVPTHGIHETSVES
FFGRSSLVGMPLLATGTSITHWRIDFREFVQLRAKMSWFTYMRFDVEFTIIATSSTGQNV
TTEQHTTYQVMYVPPGAPVPSNQDSFQWQSGCNPSVFADTDGPPAQFSVPFMSSANAYST
VYDGYARFMDTDPDRYGILPSNFLGFMYFRTLEDAAHQVRFRIYAKIKHTSCWIPRAPRQ
APYKKRYNLVFSGDSDRICSNRASLTSYEACGYSDRVAQLTLGNSTITTQEAANICVAYG
CWPAKLSDTDATSVDKPTEPGVSADRFYTLRSKPWQADSKGWYWKLPDALNNTGMFGQNA
QFHYLYRGGWAVHVQCNATKFHQGTLLVLAIPEHQIATQEQPAFDRTMPGSEGGTFQEPF
WLEDGTSLGNSLIYPHQWINLRTNNSATLILPYVNAIPMDSAIRHSNWTLAIIPVAPLKY
AAETTPLVPITVTIAPMETEYNGLRRAIASNQGLPTKPGPGSYQFMTTDEDCSPCILPDF
QPTPEIFIPGKVNNLLEIAQVESILEANNREGVEGVERYVIPVSVQDALDAQIYALRLEL
GGSGPLSSSLLGTLAKHYTQWSGSVEITCMFTGTFMTTGKVLLAYTPPGGDMPRNREEAM
LGTHVIWDFGLQSSITLVIPWISASHFRGVSNDDVLNYQYYAAGHVTIWYQTNMVIPPGF
PNTAGIIMMIAAQPNFSFRIQKDREDMTQTAILQSTINYNNINYYSHAASAAQNKQDFTQ
DPSKFTQPIADVIK
//
>1bfo_1A [b.1.1 - b.1.1] CAMPATH-1G ANTIBODY
DIKMTQSPSFLSASVGDRVTLNCKASQNIDKYLNWYQQKLGESPKLLIYNTNNLQTGIPS
RFSGSGSGTDFTLTISSLQPEDVATYFCLQHISRPRTFGTGTKLELKRANAAPTVSIFPP
STEQLATGGASVVCLMNKFYPRDISVKWKIDGTERNGVLNSVTDQDSADSTYSMSSTLSL
TKADYQSHNLYTCQVVHKTSSSPVVAKNFNRNEC
//
>1bfo_1B [b.1.1 - b.1.1] CAMPATH-1G ANTIBODY
EVKLLESGGGLVQPGGSMRLSCAGSGFTFTDFYMNWIRQPAGKAPEWLGFIRDKAKGYTT
EYNPSVKGRFTISRDNTQNMLYLQMNTLRAEDTATYYCAREGHTAAPFDYWGQGVMVTVS
SAQTTAPSVYPLAPGCGDTTSSTVTLGCLVKGYFPEPVTVTWNSGALSSDVHTFPAVLQS
GLYTLTSSVTSSTWPSQTVTCNVAHPASSTKVDKKV
//
>1bgs_1A [d.1.1] BARNASE
AQVINTFDGVADYLQTYHKLPDNYITKSEAQALGWVASKGNLADVAPGKSIGGDIFSNRE
GKLPGKSGRTWREADINYTSGFRNSDRILYSSDWLIYKTTDHYQTFTKIR
//
>1bgs_1E [c.9.1] BARSTAR
KKAVINGEQIRSISDLHQTLKKELALPEYYGENLDALWDALTGWVEYPLVLEWRQFEQSK
QLTENGAESVLQVFREAKAEGADITIILS
//
>1bgxT [c.120.1 - a.60.7 - c.55.3 - e.8.1] TAQ DNA POLYMERASE
MRGMLPLFEPKGRVLLVDGHHLAYRTFHALKGLTTSRGEPVQAVYGFAKSLLKALKEDGD
AVIVVFDAKAPSFRHEAYGGYKAGRAPTPEDFPRQLALIKELVDLLGLARLEVPGYEADD
VLASLAKKAEKEGYEVRILTADKDLYQLLSDRIHVLHPEGYLITPAWLWEKYGLRPDQWA
DYRALTGDESDNLPGVKGIGEKTARKLLEEWGSLEALLKNLDRLKPAIREKILAHMDDLK
LSWDLAKVRTDLPLEVDFAKRREPDRERLRAFLERLEFGSLLHEFGLLESPKALEEAPWP
PPEGAFVGFVLSRKEPMWADLLALAAARGGRVHRAPEPYKALRDLKEARGLLAKDLSVLA
LREGLGLPPGDDPMLLAYLLDPSNTTPEGVARRYGGEWTEEAGERAALSERLFANLWGRL
EGEERLLWLYREVERPLSAVLAHMEATGVRLDVAYLRALSLEVAEEIARLEAEVFRLAGH
PFNLNSRDQLERVLFDELGLPAIGKTEKTGKRSTSAAVLEALREAHPIVEKILQYRELTK
LKSTYIDPLPDLIHPRTGRLHTRFNQTATATGRLSSSDPNLQNIPVRTPLGQRIRRAFIA
EEGWLLVALDYSQIELRVLAHLSGDENLIRVFQEGRDIHTETASWMFGVPREAVDPLMRR
AAKTINFGVLYGMSAHRLSQELAIPYEEAQAFIERYFQSFPKVRAWIEKTLEEGRRRGYV
ETLFGRRRYVPDLEARVKSVREAAERMAFNMPVQGTAADLMKLAMVKLFPRLEEMGARML
LQVHDELVLEAAEAVARLAKEVMEGVYPLAVPLEVEVGIGEDWLSAKE
//
>1bgxL [b.1.1 - b.1.1] TP7 MAB
DIQMTQSPAIMSASPGEKVTMTCSASSSVSYMYWYQQKPGSSPRLLIYDSTNLASGVPVR
FSGSGSGTSYSLTISRMEAEDAATYYCQQWSTYPLTFGAGTKLELKRADAAPTVSIFPPS
SEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLTL
TKDEYERHNSYTCEATHKTSTSPIVKSFNR
//
>1bgxH [b.1.1 - b.1.1] TP7 MAB
QESGPGLVKPYQSLSLSCTVTGYSITSDYAWNWIRQFPGNKLEWMGYITYSGTTDYNPSL
KSRISITRDTSKNQFFLQLNSVTTEDTATYYCARYYYGYWYFDVWGQGTTLTVSSAKTTA
PSVYPLAPVSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDLYTLSSSVTVT
SSTWPSQSITCNVAHPASSTKVDKKIEPR
//
>1bgyA [d.185.1 - d.185.1] CYTOCHROME BC1 COMPLEX
TATYAQALQSVPETQVSQLDNGLRVASEQSSQPTCTVGVWIDAGSRYESEKNNGAGYFVE
HLAFKGTKNRPGNALEKEVESMGAHLNAYSTREHTAYYIKALSKDLPKAVELLADIVQNC
SLEDSQIEKERDVILQELQENDTSMRDVVFNYLHATAFQGTPLAQSVEGPSENVRKLSRA
DLTEYLSRHYKAPRMVLAAAGGLEHRQLLDLAQKHFSGLSGTYDEDAVPTLSPCRFTGSQ
ICHREDGLPLAHVAIAVEGPGWAHPDNVALQVANAIIGHYDCTYGGGAHLSSPLASIAAT
NKLCQSFQTFNICYADTGLLGAHFVCDHMSIDDMMFVLQGQWMRLCTSATESEVLRGKNL
LRNALVSHLDGTTPVCEDIGRSLLTYGRRIPLAEWESRIAEVDARVVREVCSKYFYDQCP
AVAGFGPIEQLPDYNRIRSGMFWLRF
//
>1bgyB [d.185.1 - d.185.1] CYTOCHROME BC1 COMPLEX
PQDLEFTRLPNGLVIASLENYAPASRIGLFIKAGSRYENSNNLGTSHLLRLASSLTTKGA
SSFKITRGIEAVGGKLSVTSTRENMAYTVECLRDDVDILMEFLLNVTTAPEFRRWEVAAL
QPQLRIDKAVALQNPQAHVIENLHAAAYRNALANSLYCPDYRIGKVTPVELHDYVQNHFT
SARMALIGLGVSHPVLKQVAEQFLNIRGGLGLSGAKAKYHGGEIREQNGDSLVHAALVAE
SAAIGSAEANAFSVLQHVLGAGPHVKRGSNATSSLYQAVAKGVHQPFDVSAFNASYSDSG
LFGFYTISQAASAGDVIKAAYNQVKTIAQGNLSNPDVQAAKNKLKAGYLMSVESSEGFLD
EVGSQALAAGSYTPPSTVLQQIDAVADADVINAAKKFVSGRKSMAASGNLGHTPFIDEL
//
>1bgyC [f.21.1 - f.32.1] CYTOCHROME BC1 COMPLEX
MTNIRKSHPLMKIVNNAFIDLPAPSNISSWWNFGSLLGICLILQILTGLFLAMHYTSDTT
TAFSSVTHICRDVNYGWIIRYMHANGASMFFICLYMHVGRGLYYGSYTFLETWNIGVILL
LTVMATAFMGYVLPWGQMSFWGATVITNLLSAIPYIGTNLVEWIWGGFSVDKATLTRFFA
FHFILPFIIMAIAMVHLLFLHETGSNNPTGISSDVDKIPFHPYYTIKDILGALLLILALM
LLVLFAPDLLGDPDNYTPANPLNTPPHIKPEWYFLFAYAILRSIPNKLGGVLALAFSILI
LALIPLLHTSKQRSMMFRPLSQCLFWALVADLLTLTWIGGQPVEHPYITIGQLASVLYFL
LILVLMPTAGTIENKLLKW
//
>1bgyD [a.3.1 - f.23.11] CYTOCHROME BC1 COMPLEX
SDLELHPPSYPWSHRGLLSSLDHTSIRRGFQVYKQVCSSCHSMDYVAYRHLVGVCYTEDE
AKALAEEVEVQDGPNEDGEMFMRPGKLSDYFPKPYPNPEAARAANNGALPPDLSYIVRAR
HGGEDYVFSLLTGYCEPPTGVSLREGLYFNPYFPGQAIGMAPPIYNEVLEFDDGTPATMS
QVAKDVCTFLRWAAEPEHDHRKRMGLKMLLMMGLLLPLVYAMKRHKWSVLKSRKLAYRPP
K
//
>1bgyE [f.23.12] CYTOCHROME BC1 COMPLEX
SHTDIKVPDFSDYRRPEVLDSTKSSKESSEARKGFSYLVTATTTVGVAYAAKNVVSQFVS
SMSASADVLAMSKIE
//
>1bgyG [f.23.13] CYTOCHROME BC1 COMPLEX
GRQFGHLTRVRHVITYSLSPFEQRAFPHYFSKGIPNVLRRTRACILRVAPPFVAFYLVYT
WGTQEFEKSKRKNPAAYENDR
//
>1bgyI [x.x.x] CYTOCHROME BC1 COMPLEX
KRSVLCRESLRGQAAGRPLVASVSLNVPASVRY
//
>1bgyJ [f.23.14] CYTOCHROME BC1 COMPLEX
VAPTLTARLYSLLFRRTSTFALTIVVGALFFERAFDQGADAIYEHINEGKLWKHIKHKYE
NK
//
>1bgyM (A) [d.185.1 - d.185.1] CYTOCHROME BC1 COMPLEX
TATYAQALQSVPETQVSQLDNGLRVASEQSSQPTCTVGVWIDAGSRYESEKNNGAGYFVE
HLAFKGTKNRPGNALEKEVESMGAHLNAYSTREHTAYYIKALSKDLPKAVELLADIVQNC
SLEDSQIEKERDVILQELQENDTSMRDVVFNYLHATAFQGTPLAQSVEGPSENVRKLSRA
DLTEYLSRHYKAPRMVLAAAGGLEHRQLLDLAQKHFSGLSGTYDEDAVPTLSPCRFTGSQ
ICHREDGLPLAHVAIAVEGPGWAHPDNVALQVANAIIGHYDCTYGGGAHLSSPLASIAAT
NKLCQSFQTFNICYADTGLLGAHFVCDHMSIDDMMFVLQGQWMRLCTSATESEVLRGKNL
LRNALVSHLDGTTPVCEDIGRSLLTYGRRIPLAEWESRIAEVDARVVREVCSKYFYDQCP
AVAGFGPIEQLPDYNRIRSGMFWLRF
//
>1bgyS (G) [f.23.13] CYTOCHROME BC1 COMPLEX
GRQFGHLTRVRHVITYSLSPFEQRAFPHYFSKGIPNVLRRTRACILRVAPPFVAFYLVYT
WGTQEFEKSKRKNPAAYENDR
//
>1bh8A [a.22.1] TAFII18
LFSKELRCMMYGFGDDQNPYTESVDILEDLVIEFITEMTHKAMSI
//
>1bh8B [a.22.1] TAFII28
FSEEQLNRYEMYRRSAFPKAAIKRLIQSITGTSVSQNVVIAMSGISKVFVGEVVEEALDV
CEKWGEMPPLQPKHMREAVRRLKSKGQIP
//
>1bhxA [b.47.1] ALPHA THROMBIN
SGEADCGLRPLFEKKSLEDKTERELLESYI
//
>1bhxB [b.47.1] ALPHA THROMBIN
IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL
VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL
PDRETAASLLQAGYKGRVTGWGNLKET
//
>1bhxF [b.47.1] ALPHA THROMBIN
GQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSP
FNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE
//
>1bi7A [d.144.1] CYCLIN-DEPENDENT KINASE 6
DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQEHPNVVRLFDVCTVSRTDRET
KLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNIL
VTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM
FRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDEL
GKDLLLKCLTFNPAKRISAYSALSHPYFQ
//
>1bi7B [d.211.1] MULTIPLE TUMOR SUPPRESSOR
EPSADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMMMGSARVAELLLLHGAE
PNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDAWGRLPVDLAEELGHRDVARY
LRAAA
//
>1bi8A [d.144.1] CYCLIN-DEPENDENT KINASE 6
QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQEHPNVVRLFDVCTVSRTKLTLV
FEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG
QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP
LFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLL
LKCLTFNPAKRISAYSALSHPYFQ
//
>1bi8B [d.211.1] CYCLIN-DEPENDENT KINASE INHIBITOR
VRAGDRLSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMMFGSTAIALELLKQGA
SPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGHTAVVSF
LAAESDLHRRDARGLTPLELALQRGAQDLVDILQG
//
>1bj1H [b.1.1 - b.1.1] FAB FRAGMENT
EVQLVESGGGLVQPGGSLRLSCAASGYTFTNYGMNWVRQAPGKGLEWVGWINTYTGEPTY
AADFKRRFTFSLDTSKSTAYLQMNSLRAEDTAVYYCAKYPHYYGSSHWYFDVWGQGTLVT
VSSASTKGPSVFPLAPSGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLY
SLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK
//
>1bj1W (V) [g.17.1] VASCULAR ENDOTHELIAL GROWTH FACTOR
VVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEE
SNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPK
//
>1blnA [b.1.1 - b.1.1] PROTEIN (MONOCLONAL ANTIBODY MRK-16 (LIGHT
DVLMTQTPVSLSVSLGDQASISCRSSQSIVHSTGNTYLEWYLQKPGQSPKLLIYKISNRF
SGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCFQASHAPRTFGGGTKLEIKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATSPIVKSFNRNE
//
>1blnB [b.1.1 - b.1.1] PROTEIN (MONOCLONAL ANTIBODY MRK-16 (HEAVY
EVILVESGGGLVKPGGSLKLSCAASGFTFSSYTMSWVRQTPEKRLEWVATISSGGGNTYY
PDSVKGRFTISRDNAKNNLYLQMSSLRSEDTALYYCARYYRYEAWFASWGQGTLVTVSAA
KTTAPSVYPLAPVCGDTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDL
YTLSSSVTVTSSTWPSQSITCNVAHPASSTKVDKKIE
//
>1blwC [x.x.x]
LICDSRVLERYLLEAKEAEKITTGCAEHCSLNEKITVPDTKVNFYAWKRMEVGQQAVEVW
QGLALLSEAVLRGQALLVNSSQPWEPLQLHVDKAVSGLRSLTTLLRALGATITADTFRKL
FRVYSNFLRGKLKLYTGEACR
//
>1blwB [x.x.x]
SSSAFESKAALLAARGPEELLCFTERLEDLVCFWEEAASAGVGPGNYSFSYQLEDEPWKL
CRLHQAPTARGAVRFWCSLPTADTSSFVPLELRVTAASGAPRYHRVIHINEVVLLDAPVG
LVARLADESGHVVLRWLPPPETPMTSHIRYEVDVSAGNGAGSVQRVEILEGRTECVLSNL
RGRTRYTFAVRARMAEPSFGGFWSEWSEPVSLLT
//
>1blxA [d.144.1] CYCLIN-DEPENDENT KINASE 6
GLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV
LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD
MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW
YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP
RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE
RCKEN
//
>1blxB [d.211.1] P19INK4D
VCVGDRLSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMMFGSPAVALELLKQGA
SPNVQDASGTSPVHDAARTGFLDTLKVLVEHGADVNALDSTGSLPIHLAIREGHSSVVSF
LAPESDLHHRDASGLTPLELARQRGAQNLMDILQGHMMIP
//
>1bmlD (C) [d.15.5 - d.15.5 - d.15.5] STREPTOKINASE
SVNNSQLVVSVAGTVEGTNQDISLKFFEIDLTSRPHKLEKADLLKAIQEQLIANVHSNDD
YFEVIDFASDATITDRNGKVYFADKDGSVTLPTQPVQEFLLSGHVRVRPYKEKPIQNQAK
SVDVEYTVQFTPLNPDDDTKLLKTLAIGDTITSQELLAQAQSILNKTHPGYTIYERDSSI
VTHDNDIFRTILPMDQEFTYHVKNREQAEINNTDLISEKYYVLKKGEKPYDPFDRSHLKL
FTIKYVDVNTNELLKSEQLLTASERNLDFRDLYDPRDKAKLLYNNLDAFGIMDYTLTGKV
EDNHDDTNRIITVYMGKR
//
>1bmlB (A) [b.47.1] PLASMIN
AAPSFDCGKPQVEPKKCPGRVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTA
AHCLEKSPRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLEPTRKDIALLKLSSPAVITDK
VIPACLPSPNYVVADRTECFITGWGETQGTFGAGLLKEAQLPVIENKVCNRYEFLNGRVQ
STELCAGHLAGGTDSCQGDAGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFV
TWIEGVMRNN
//
>1bp3A [x.x.x]
FPTIPLSRLFDNAMLRAHRLHQLAFDTYQEFEEAYIPKEQKYSFLQNPQTSLCFSESIPT
PSNREETQQKSNLELLRISLLLIQSWLEPVQFLRSVFANSLVYGASDSNVYDLLKDLEAR
IQTLMGRLEDGAPRTGQIFAATYSKFDTDDALLKNYGLLYCFRKDMDKVETFLRIVQCRS
VEGSCG
//
>1bp3B [x.x.x]
APPGKPEIFKCRSPNKETFTCWWRPGTDGTNYSLTYHREGETLMHECPDYITGGPNSCHF
GKQYTSMWRTYIMMVNATNSSFSDELYVDVTYIVQPDPPLALAVEVKQPEDRKPYLWIKW
SPPTLIDLKTGWFTLLYEIRLKPEKAAEWEIHFAGQQTEFKILSLHPGQAYLVQVRCKPD
HGYWSAWSPATFIQIPS
//
>1bplA [c.1.8] ALPHA-1,4-GLUCAN-4-GLUCANOHYDROLASE
LNGTLMQYFEWYMPNDGQHWKRLQNDSAYLAEHGITAVWIPPAYKGTSQADVGYGAYDLY
DLGEFHQKGTVRTKYGTKGELQSAIKSLHSRDINVYGDVVINHKGGADATEDVTAVEVDP
ADRNRVISGEHLIKAWTHFHFPGRGSTYSDFKWHWYHFDGTDWDESRKLNRIYKFQGKA
//
>1bplB [c.1.8 - b.71.1] ALPHA-1,4-GLUCAN-4-GLUCANOHYDROLASE
YDYLMYADIDYDHPDVAAEIKRWGTWYANELQLDGFRLDAVKHIKFSFLRDWVNHVREKT
GKEMFTVAEYWQNDLGALENYLNKTNFNHSVFDVPLHYQFHAASTQGGGYDMRKLLNSTV
VSKHPLKAVTFVDNHDTQPGQSLESTVQTWFKPLAYAFILTRESGYPQVFYGDMYGTKGD
SQREIPALKHKIEPILKARKQYAYGAQHDYFDHHDIVGWTREGDSSVANSGLAALITDGP
GGAKRMYVGRQNAGETWHDITGNRSEPVVINSEGWGEFHVNGGSVSIYVQ
//
>1bqh_1A [d.19.1 - b.1.1] PROTEIN (H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN)
GPHSLRYFVTAVSRPGLGEPRYMEVGYVDDTEFVRFDSDAENPRYEPRARWMEQEGPEYW
ERETQKAKGNEQSFRVDLRTLLGYYNQSKGGSHTIQVISGCEVGSDGRLLRGYQQYAYDG
CDYIALNEDLKTWTAADMAALITKHKWEQAGEAERLRAYLEGTCVEWLRRYLKNGNATLL
RTDSPKAHVTHHSRPEDKVTLRCWALGFYPADITLTWQLNGEELIQDMELVETRPAGDGT
FQKWASVVVPLGKEQYYTCHVYHQGLPEPLTLRW
//
>1bqh_1B [b.1.1] PROTEIN (BETA-2-MICROGLOBULIN )
IQKTPQIQVYSRHPPENGKPNILNCYVTQFHPPHIEIQMLKNGKKIPKVEMSDMSFSKDW
SFYILAHTEFTPTETDTYACRVKHDSMAEPKTVYWDRDM
//
>1bqh_1H [b.1.1] PROTEIN (CD8A OR LYT2 OR LYT-2)
KPQAPELRIFPKKMDAELGQKVDLVCEVLGSVSQGCSWLFQNSSSKLPQPTFVVYMASSH
NKITWDEKLNSSKLFSAMRDTNNKYVLTLNKFSKENEGYYFCSVISNSVMYFSSVVPVLQ
KVSSA
//
>1bqqT [b.40.3] METALLOPROTEINASE INHIBITOR 2
CSCSPVHPQQAFCNADIVIRAKAVNKKEVDSGNDIYGNPIKRIQYEIKQIKMFKGPDQDI
EFIYTAPAAAVCGVSLDIGGKKEYLIAGKAEGNGNMHITLCDFIVPWDTLSATQKKSLNH
RYQMGCECKITRCPMIPCYISSPDECLWMDWVTEKNINGHQAKFFACIKRSDGSCAWYRG
AAPP
//
>1bqqM [d.92.1] MEMBRANE-TYPE MATRIX METALLOPROTEINASE
IQGLKWQHNEITFCIQNYTPKVGEYATYEAIRKAFRVWESATPLRFREVPYAYIREGHEK
QADIMIFFAEGFHGDSTPFDGEGGFLAHAYFPGPNIGGDTHFDSAEPWTVRNEDLNGNDI
FLVAVHELGHALGLEHSSDPSAIMAPFYQWMDTENFVLPDDDRRGIQQLYGGES
//
>1br1_1A [c.37.1 - b.34.3] MYOSIN
AQKPLSDDEKFLFVDKNFVNNPLAQADWSAKKLVWVPSEKHGFEAASIKEEKGDEVTVEL
QENGKKVTLSKDDIQKMNPPKFSKVEDMAELTCLNEASVLHNLRERYFSGLIYTYSGLFC
VVINPYKQLPIYSEKIIDMYKGKKRHEMPPHIYAIADTAYRSMLQDREDQSILCTGESGA
GKTENTKKVIQYLAVVASSHKGKQGPSFSYGELEKQLLQANPILEAFGNAKTVKNDNSSR
FGKFIRINFDVTGYIVGANIETYLLEKSRAIRQAKDERTFHIFYYLIAGASEQMRNDLLL
EGFNNYTFLSNGHVPIPAQQDDEMFQETLEAMTIMGFTEEEQTSILRVVSSVLQLGNIVF
KKERNTDQASMPDNTAAQKVCHLMGINVTDFTRSILTPRIKVGRDVVQKAQTKEQADFAI
EALAKAKFERLFRWILTRVNKALDASFLGILDIAGFEIFEINSFEQLCINYTNEKLQQLF
NHTMFILEQEEYQREGIEWNFIDFGLDLQPCIELIERPTNPPGVLALLDEECWFPKATDT
SFVEKLIQEQGNHAKFQKSKQLKDKTEFCILHYAGKVTYNASAWLTKNMDPLNDNVTSLL
NQSSDKFVADLWKDVDRIVGLFRTVGQLYKEQLTKLMTTLRNTNPNFVRCIIPNHEKRAG
KLDAHLVLEQLRCNGVLEGIRICRQGFPNRIVFQEFRQRYEILAANAIPKGFMDGKQACI
LMIKALELDPNLYRIGQSKIFFRTGVLAHLEEERDLKITDVIIAFQAQCRGYLARKAFAK
RQQQLGS
//
>1br1_1B [a.39.1] MYOSIN
FSEEQTAEFKEAFQLFDRTGDGKILYSQCGDVMRALGQNPTNAEVMKVLGNPKSDEMNLK
TLKFEQFLPMMQTIAKNKDQGCFEDYVEGLRVFDKEGNGTVMGAEIRHVLVTLGEKMTEE
EVEQLVAGHEDSNGCINYEELVRMVLSG
//
>1brbA (E) [b.47.1] TRYPSIN
IVGGYTCQENSVPYQVSLNSGYHFCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLEG
NEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLISG
WGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKGSCQGDSGGP
VVCNGELQGIVSWGYGCALPDNPDVYTKVCNYVDWIQDTIAAN
//
>1brbB (I) [g.8.1] PANCREATIC TRYPSIN INHIBITOR
AGEPPYTGPCKARIIRYFYNAKAGLCQTFVYGGCRAKRNNFKSAEDCMRTA
//
>1brcA (I) [g.8.1] AMYLOID BETA-PROTEIN PRECURSOR INHIBITOR DOMAIN
VREVCSEQAETGPCRAMISRWYFDVTEGKCAPFFYGGCGGNRNNFDTEEYCMAVCG
//
>1brcB (E) [b.47.1] TRYPSIN
IVGGYTCQENSVPYQVSLNSGYHFCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLEG
NEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLISG
WGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKGSCQGDSGGP
VVCNGELQGIVSWGYGCALPDNPDVYTKVCNYVDWIQDTIAAN
//
>1bth_1H [b.47.1] THROMBIN
IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL
VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL
PDRETAASLLQAGYKGRVTGWGNLKETWTTNVGKGQPSVLQVVNLPIVERPVCKDSTRIR
ITDNMFCAGYKPDEGKRGDACQGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFY
THVFRLKKWIQKVI
//
>1bth_1P [g.8.1] BOVINE PANCREATIC TRYPSIN INHIBITOR
RPDFCLEPPYTGPCKARIIRYFYNAKAGLCQTFVYGGCRAKRNNFKSAEDCMRTCGGA
//
>1buhA [d.144.1] PROTEIN (CDK2 HUMAN)
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTTAIREISLLKELNHPNIVKLL
DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD
LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW
SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD
FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP
//
>1buhB [d.97.1] PROTEIN (CKSHS1 HUMAN)
QIYYSDKYDDEEFEYRHVMLPKDIAKLVPKTHLMSESEWRNLGVQQSQGWVHYMIHEPEP
HILLFRRPLP
//
>1buiA [b.47.1] PROTEIN (PLASMIN)
PSFDCGKPQVEPKKCPGVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHC
LEKSPRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLEPTRKDIALLKLSSPAVITDKVIP
ACLPSPNYVVADRTECFITGWGETQGTFGAGLLKEAQLPVIENKVCNRYEFLNGRVQSTE
LCAGHLAGGTDSCQGDSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWI
EGVMRNN
//
>1buiC [d.15.5] PROTEIN (STAPHYLOKINASE SAK-C-PHI-C)
ASYFEPTGPYLMVNVTGVDSKGNELLSPHYVEFPIKPGTTLTKEKIEYYVEWALDATAYK
EFRVVELDPSAKIEVTYYDKNKKKEETKSFPITEKGFVVPDLSEHIKNPGFNLITKVVIE
KK
//
>1bunA [a.133.1] BETA2-BUNGAROTOXIN
NLINFMEMIRYTIPCEKTWGEYADYGCYCGAGGSGRPIDALDRCCYVHDNCYGDAEKKHK
CNPKTQSYSYKLTKRTIICYGAAGTCARIVCDCDRTAALCFGNSEYIEGHKNIDTARFCQ
//
>1bunB [g.8.1] BETA2-BUNGAROTOXIN
RKRHPDCDKPPDTKICQTVVRAFYYKPSAKRCVQFRYGGCNGNGNHFKSDHLCRCECLEY
R
//
>1burD [x.x.x]
EFKAGVKDYKLTYYTPEYETLDTDILAAFRVSPQPGVPPEEAGAAVAAESSTGTWTTVWT
DGLTNLDRYKGRCYHIEPVAGEENQYICYVAYPLDLFEEGSVTNMFTSIVGNVFGFKALR
ALRLEDLRIPVAYVKTFQGPPHGIQVERDKLNKYGRPLLGCTIKPKLGLSAKNYGRAVYE
CLRGGLDFTxDDENVNSQPFMRWRDRFLFCAEALYKAQAETGEIKGHYLNATAGTCEDMM
KRAVFARELGVPIVMHDYLTGGFTANTTLSHYCRDNGLLLHIHRAMHAVIDRQKNHGMHF
RVLAKALRLSGGDHIHSGTVVGKLEGERDITLGFVDLLRDDYTEKDRSRGIYFTQSWVST
PGVLPVASGGIHVWHMPALTEIFGDDSVLQFGGGTLGHPWGNAPGAVANRVALEACVQAR
NEGRDLAREGNTIIREATKWSPELAAACEVWKEIKFEFPAMDTV
//
>1burV [x.x.x]
MQVWPILGMKKYETLSYLPPLTTEQLLAEVNYLLVNNWIPCLEFEVKDGFVYREHHKSPG
YYDGRYWTMWKLPMFGCTDPAQVLNELEECKKAYPDAFIRIIGFDNKRQVQCISFIAYKP
AGY
//
>1bvk_1A [b.1.1] HULYS11
DIQMTQSPSSLSASVGDRVTITCRASGNIHNYLAWYQQKPGKAPKLLIYYTTTLADGVPS
RFSGSGSGTDYTFTISSLQPEDIATYYCQHFWSTPRTFGQGTKVEIKR
//
>1bvk_1B [b.1.1] HULYS11
QVQLQESGPGLVRPSQTLSLTCTVSGFSLTGYGVNWVRQPPGRGLEWIGMIWGDGNTDYN
SALKSRVTMLKDTSKNQFSLRLSSVTAADTAVYYCARERDYRLDYWGQGSLVTVSS
//
>1bvk_1C [d.2.1] LYSOZYME
KVFGRCELAAAMKRHGLDNYRGYSLGNWVCAAKFESNFNTQATNRNTDGSTDYGILQINS
RWWCNDGRTPGSRNLCNIPCSALLSSDITASVNCAKKIVSDGNGMNAWVAWRNRCKGTDV
QAWIRGCRL
//
>1bvl_2C (A) [b.1.1] HULYS11
QVQLQESGPGLVRPSQTLSLTCTVSGFSLTGYGVNWVRQPPGRGLEWIGMIWGDGNTDYN
SALKSRVTMLKDTSKNQFSLRLSSVTAADTAVYYCARERDYRLDYWGQGSLVTVSS
//
>1bvl_2D (B) [b.1.1] HULYS11
DIQMTQSPSSLSASVGDRVTITCRASGNIHNYLAWYQQKPGKAPKLLIYYTTTLADGVPS
RFSGSGSGTDYTFTISSLQPEDIATYYCQHFWSTPRTFGQGTKVEIKR
//
>1bvnA (T) [b.5.1] PROTEIN (TENDAMISTAT)
VSEPAPSCVTLYQSWRYSQADNGCAETVTVKVVYEDDTEGLCYAVAPGQITTVGDGYIGS
HGHARYLARCL
//
>1bvnB (P) [c.1.8 - b.71.1] PROTEIN (ALPHA-AMYLASE)
QYAPQTQSGRTDIVHLFEWRWVDIALECERYLGPKGFGGVQVSPPNENVVVTNPSRPWWE
RYQPVSYKLCTRSGNENEFRDMVTRCNNVGVRIYVDAVINHMCGSGAAAGTGTTCGSYCN
PGSREFPAVPYSAWDFNDGKCKTASGGIESYNDPYQVRDCQLVGLLDLALEKDYVRSMIA
DYLNKLIDIGVAGFRLDASKHMWPGDIKAVLDKLHNLNTNWFPAGSRPFIFQEVIDLGGE
AISSSEYFGNGRVTEFKYGAKLGTVVRKWSGEKMSYLKNWGEGWGFMPSDRALVFVDNHD
NQRGHGAGGSSILTFWDARLYKVAVGFMLAHPYGFTRVMSSYRWARNFVNGEDVNDWIGP
PNNNGVIKEVTINADTTCGNDWVCEHRWREIRNMVWFRNVVDGQPFANWWDNGSNQVAFG
RGNRGFIVFNNDDWQLSSTLQTGLPGGTYCNVISGDKVGNSCTGIKVYVSSDGTAQFSIS
NSAQDPFIAIHAESKL
//
>1bvyA [a.104.1] PROTEIN (CYTOCHROME P450 BM-3)
LNTDKPVQALMKIADELGEIFKFEAPGRVTRYLSSQRLIKEACDESRFDKNLSQALKFVR
DFAGDGLFTSWTHEKNWKKAHNILLPSFSQQAMKGYHAMMVDIAVQLVQKWERLNADEHI
EVPEDMTRLTLDTIGLCGFNYRFNSFYRDQPHPFITSMVRALDEAMNKLQRANPDDPAYD
ENKRQFQEDIKVMNDLVDKIIADRKASGEQSDDLLTHMLNGKDPETGEPLDDENIRYQII
TFLIAGHETTSGLLSFALYFLVKNPHVLQKAAEEAARVLVDPVPSYKQVKQLKYVGMVLN
EALRLWPTAPAFSLYAKEDTVLGGEYPLEKGDELMVLIPQLHRDKTIWGDDVEEFRPERF
ENPSAIPQHAFKPFGNGQRACIGQQFALHEATLVLGMMLKHFDFEDHTNYELDIKETLTL
KPEGFVVKAKSKKIPLGGI
//
>1bvyF [c.23.5] PROTEIN (CYTOCHROME P450 BM-3)
NTPLLVLYGSNMGTAEGTARDLADIAMSKGFAPQVATLDSHAGNLPREGAVLIVTASYNG
HPPDNAKQFVDWLDQASADEVKGVRYSVFGCGDKNWATTYQKVPAFIDETLAAKGAENIA
DRGEADASDDFEGTYEEWREHMWSDVAAYFNL
//
>1bwvA [d.58.9 - c.1.14] PROTEIN (RIBULOSE BISPHOSPHATE CARBOXYLASE)
RIKNSRYESGVIPYAKMGYWNPDYQVKDTDVLALFRVTPQPGVDPIEAAAAVAGESSTAT
WTVVWTDLLTAADLYRAKAYKVDQVPNNPEQYFAYIAYELDLFEEGSIANLTASIIGNVF
GFKAVKALRLEDMRLPLAYLKTFQGPATGVILERERLDKFGRPLLGCTTKPKLGLSGKNY
GRVVYEALKGGLDFVxDDENINSQPFMRWRERYLFTMEAVNKASAATGEVKGHYLNVTAA
TMEEMYARANFAKELGSVIIMIDLVIGYTAIQTMAKWARDNDMILHLHRAGNSTYSRQKN
HGMNFRVICKWMRMAGVDHIHAGTVVGKLEGDPIITRGFYKTLLLPKLERNLQEGLFFDM
EWASLRKVMPVASGGIHAGQMHQLIHYLGEDVVLQFGGGTIGHPDGIQAGATANRVALEA
MILARNENRDYLTEGPEILREAAKTCGALRTALDLWKDITFNYTSTDTSDFV
//
>1bwvS [d.73.1] PROTEIN (RIBULOSE BISPHOSPHATE CARBOXYLASE)
VRITQGTFSFLPDLTDEQIKKQIDYMISKKLAIGIEYTNDIHPRNAYWEIWGLPLFDVTD
PAAVLFEINACRKARSNFYIKVVGFSSVRGIESTIISFIVNRPKHEPGFNLMRQEDKSRS
IKYTIHSYESYKPEDERY
//
>1bx2A [x.x.x]
AEEHVIIQAEFYLNPDQSGEFMFDFDGDEIFHVDAAAAETVWRLAEFGRFASFEAQGALA
NIAVDKANLEIMTKRSAYTPITNVPPEVTVLTNSPVELAAPNVLICFIDKFTPPVVNVTW
LRNGKPVTTGVSETVFLPREDHLFRKFHYLPFLPSTEDVYDCRVEHWGLDEPLLKHWEFD
//
>1bx2B [x.x.x]
TRPRFLWQPKRECHFFNGTARVRFLDRYFYNQAESVRFDSDVGEFRAVTALGRPDAAYWN
SQADILAQARAAVDTYCRHNYGVVESFTVQRRVQPKVTVYPSKTQALQHHNLLVCSVSGF
YPGSIEVRWFLNGQEEKAGMVSTGLIQNGDWTFQTLVMLETVPRSGEVYTCQVEHPSVTS
PLTVEWAARSE
//
>1bxnA [d.58.9 - c.1.14] PROTEIN (RIBULOSE BISPHOSPHATE CARBOXYLASE LARGE
YKMGYWDGDYVPKDTDLLALFRITPQDGVDPVEAAAAVAGESSTATWTVVWTDRLTACDM
YRAKAYRVDPVPNNPEQFFCYVAYDLSLFEEGSIANLTASIIGNVFSFKPIKAARLEDMR
FPVAYVKTFAGPSTGIIVERERLDKFGRPLLGATTKPKLGLSGRNYGRVVYEGLKGGLDF
MKDDENINSQPFMHWRDRFLFVMDAVNKASAATGEVKGSYLNVTAGTMEEMYRRAEFAKS
LGSVIIMVDLIVGWTCIQSMSNWCRQNDMILHLHRAGHGTYTRQKNHGVSFRVIAKWLRL
AGVDHMHTGTAVGKLEGDPLTVQGYYNVCRDAYTQTDLTRGLFFDQDWASLRKVMPVASG
GIHAGQMHQLIHLFGDDVVLQFGGGTIGHPQGIQAGATANRVALEAMVLARNEGRDILNE
GPEILRDAARWCGPLRAALDTWGDI
//
>1bxnI [d.73.1] PROTEIN (RIBULOSE BISPHOSPHATE CARBOXYLASE SMALL
MRITQGTFSFLPELTDEQITKQLEYCLNQGWAVGLEYTDDPHPRNTYWEMFGLPMFDLRD
AAGILMEINNARNTFPNHYIRVTAFDSTHTVESVVMSFIVNRPADEPGFRLVRQEEPGRT
LRYSIESYA
//
>1bz7A [b.1.1 - b.1.1] PROTEIN (ANTIBODY R24 (LIGHT CHAIN))
DIQMTQITSSLSVSLGDRVIISCRASQDIGNFLNWYQQKPDGSLKLLIYYTSRLQSGVPS
RFSGWGSGTDYSLTISNLEEEDIATFFCQQGKTLPYTFGGGTKLEIKRTVAAPSVFIFPP
SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT
LSKADYEKHKVYACEVTHQGLSSPVT
//
>1bz7B [b.1.1 - b.1.1] PROTEIN (ANTIBODY R24 (HEAVY CHAIN))
DVQLVESGGGLVQPGGSRKLSCAASGFTFSNFGMHWVRQAPEKGLEWVAYISSGGSSINY
ADTVKGRFTISRDNPKNTLFLQMTSLRSEDTAIYYCTRGGTGTRSLYYFDYWGQGATLIV
SSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQ
SGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDK
//
>1bzxA (I) [g.8.1] PROTEIN (BOVINE PANCREATIC TRYPSIN INHIBITOR)
RPDFCLEPPYTGPCKARIIRYFYNAKAGLCQTFVYGGCRAKRNNFKSAEDCMRTCGGA
//
>1bzxB (E) [b.47.1] PROTEIN (TRYPSIN)
IVGGYECKPYSQPHQVSLNSGYHFCGGSLVNENWVVSAAHCYKSRVEVRLGEHNIKVTEG
SEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPTSCAPAGTMCTVSG
WGNTMSSTADSNKLQCLNIPILSYSDCNNSYPGMITNAMFCAGYLEGGKDSCQGDSGGPV
VCNGELQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTSTMASY
//
>1c12A [b.1.1 - b.1.1] PROTEIN (ANTIBODY FRAGMENT FAB)
DIELTQSPSSMSVSLGDTVSITCHASQGISSNIGWLQQKPGKSFKGLIYHGTNLEDGVPS
RFSGSGSGADYSLTISSLESEDFADYYCVQYVQFPFTFGSGTKLEIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEA
//
>1c12B [b.1.1 - b.1.1] PROTEIN (ANTIBODY FRAGMENT FAB)
QVQLQESGPGLVKPSQSLSLTCTVTGYSITSDYAWNWIRQFPGNKLEWMGYISYSGSTSY
SPSLKSRISLTRDTSKNQFFLQLNSVTTEDTATYYCVTSLTWLLRRKRSYWGQGTTVTVS
SASTKGPSVYPLAPGSKAAASMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSD
LYTLSSSVTVPSSPRPSETVTCNVAHPASSTKVDKKIVPE
//
>1c1eA (H) [b.1.1 - b.1.1] CATALYTIC ANTIBODY 1E9 (HEAVY CHAIN)
QIQLVQSGPELKKPGETVKISCKASGYMFTNYGMNWVKQAPGKALKLMGWINPYTGESTF
ADDFKGRFAFFLETSATTAYLQINNLKNEDMATYFCARGTTIVRAMDYWGQGTSLTVSSA
KTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDL
YTLSSSVTVPSSPRPSETVTCNVAHPASSTKVDKKIVPR
//
>1c1eB (L) [b.1.1 - b.1.1] CATALYTIC ANTIBODY 1E9 (LIGHT CHAIN)
ELVMTQTPLSLPVSLGDQASISCRSSQSLVHSNGNTYLHWYLQKPGQSPKFLIYKVSNRF
SGVPDRFGGSGSGTDFILKISRVEAEDLGVYFCFQSTHFFPTFGGGTKLEIKSADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNR
//
>1c3a_1A [d.169.1] FLAVOCETIN-A: ALPHA SUBUNIT
DFDCIPGWSAYDRYCYQAFSKPKNWEDAESFCEEGVKTSHLVSIESSGEGDFVAQLVAEK
IKTSFQYVWIGLRIQNKEQQCRSEWSDASSVNYENLVKQFSKKCYALKKGTELRTWFNVY
CGTENPEVCKYTPEC
//
>1c3a_1B [d.169.1] FLAVOCETIN-A: BETA SUBUNIT
GFCCPLGWSSYDEHCYQVFQQKMNWEDAEKFCTQQHKGSHLVSFHSSEEVDFVTSKTFPI
LKYDFVWIGLSNVWNECTKEWSDGTKLDYKAWSGGSDCIVSKTTDNQWLSMDCSSKYYVV
CKFQA
//
>1c3o_2C (A) [c.30.1 - d.142.1 - a.92.1 - c.30.1 - d.142.1 - c.24.1] CARBAMOYL PHOSPHATE SYNTHETASE: LARGE SUBUNIT
MPKRTDIKSILILGAGPIVIGQACEFDYSGAQACKALREEGYRVILVNSNPATIMTDPEM
ADATYIEPIHWEVVRKIIEKERPDAVLPTMGGQTALNCALELERQGVLEEFGVTMIGATA
DAIDKAEDRRRFDVAMKKIGLETARSGIAHTMEEALAVAADVGFPCIIRPSFTMGGSGGG
IAYNREEFEEICARGLDLSPTKELLIDESLIGWKEYEMEVVRDKNDNCIIVCSIENFDAM
GIHTGDSITVAPAQTLTDKEYQIMRNASMAVLREIGVETGGSNVQFAVNPKNGRLIVIEM
NPRVSRSSALASKATGFPIAKVAAKLAVGYTLDELMNDITGGRTPASFEPSIDYVVTKIP
RFNFEKFAGANDRLTTQMKSVGEVMAIGRTQQESLQKALRGLEVGATGFDPKVSLDDPEA
LTKIRRELKDAGADRIWYIADAFRAGLSVDGVFNLTNIDRWFLVQIEELVRLEEKVAEVG
ITGLNADFLRQLKRKGFADARLAKLAGVREAEIRKLRDQYDLHPVYKRVDTCAAEFATDT
AYMYSTYEEECEANPSTDREKIMVLGGGPNRIGQGIEFDYCCVHASLALREDGYETIMVN
CNPETVSTDYDTSDRLYFEPVTLEDVLEIVRIEKPKGVIVQYGGQTPLKLARALEAAGVP
VIGTSPDAIDRAEDRERFQHAVERLKLKQPANATVTAIEMAVEKAKEIGYPLVVRPAMEI
VYDEADLRRYFQTAVLLDHFLDDAVEVDVDAICDGEMVLIGGIMEHIEQAGVHSGDSACS
LPAYTLSQEIQDVMRQQVQKLAFELQVRGLMNVQFAVKNNEVYLIEVNPRAARTVPFVSK
ATGVPLAKVAARVMAGKSLAEQGVTKEVIPPYYSVKEVVLPFNKFPGVDPLLGPEMRSTG
EVMGVGRTFAEAFAKAQLGSNSTMKKHGRALLSVREGDKERVVDLAAKLLKQGFELDATH
GTAIVLGEAGINPRLVNKVHEGRPHIQDRIKNGEYTYIINTTSGRRAIEDSRVIRRSALQ
YKVHYDTTLNGGFATAMALNADATEKVISVQEMHAQIK
//
>1c3o_2D (B) [c.8.3 - c.23.16] CARBAMOYL PHOSPHATE SYNTHETASE: SMALL SUBUNIT
IKSALLVLEDGTQFHGRAIGATGSAVGEVVFNTSMTGYQEILTDPSYSRQIVTLTYPHIG
NVGTNDADEESSQVHAQGLVIRDLPLIASNFRNTEDLSSYLKRHNIVAIADIDTRKLTRL
LREKGAQNGCIIAGDNPDAALALEKARAFPGLNGMDLAKEVTTAEAYSWTQGSWTLTGGL
PEAKKEDELPFHVVAYDFGAKRNILRMLVDRGCRLTIVPAQTSAEDVLKMNPDGIFLSNG
PGDPAPCDYAITAIQKFLETDIPVFGISLGHQLLALASGAKTVKMKFGHHGGNHPVKDVE
KNVVMITAQNHGFAVDEATLPANLRVTHKSLFDGTLQGIHRTDKPAFSFQGHPEASPGPH
DAAPLFDHFIELIEQYRKT
//
>1c40B [a.1.1] PROTEIN (HEMOGLOBIN (BETA CHAIN))
VHWSAEEKQLITGLWGKVNVADCGAEALARLLIVYPWTQRFFSSFGNLSSPTAILGNPMV
RAHGKKVLTSFGDAVKNLDNIKNTFAQLSELHCDKLHVDPENFRLLGDILIIVLAAHFAK
EFTPDCQAAWQKLVRVVAHALARKYH
//
>1c40A [a.1.1] PROTEIN (HEMOGLOBIN (ALPHA CHAIN))
VLSAADKTNVKGVFSKISGHAEEYGAETLERMFTAYPQTKTYFPHFDLQHGSAQIKAHGK
KVVAALVEAVNHIDDIAGALSKLSNLHAQKLRVDPVNFKFLGHCFLVVVAIHHPSALTAE
VHASLDKFLCAVGTVLTAKYR
//
>1c4zA [d.148.1] UBIQUITIN-PROTEIN LIGASE E3A
NPYLRLKVRRDHIIDDALVRLEMIAMENPADLKKQLYVEFEGEQGVDEGGVSKEFFQLVV
EEIFNPDIGMFTYDESTKLFWFNPSSFETEGQFTLIGIVLGLAIYNNCILDVHFPMVVYR
KLMGKKGTFRDLGDSHPVLYQSLKDLLEYEGNVEDDMMITFQISQTDLFGNPMMYDLKEN
GDKIPITNENRKEFVNLYSDYILNKSVEKQFKAFRRGFHMVTNESPLKYLFRPEEIELLI
CGSRNLDFQALEETTEYDGGYTRDSVLIREFWEIVHSFTDEQKRLFLQFTTGTDRAPVGG
LGKLKMIIAKNGPDTERLPTSHTCFNVLLLPEYSSKEKLKERLLKAITYA
//
>1c4zD [d.20.1] UBIQUITIN CONJUGATING ENZYME E2
SRRLMKELEEIRKCGMKNFRNIQVDEANLLTWQGLIVPDNPPYDKGAFRIEINFPAEYPF
KPPKITFKTKIYHPNIDEKGQVCLPVISAENWKPATKTDQVIQSLIALVNDPQPEHPLRA
DLAEEYSKDRKKFCKNAEEFTKKY
//
>1c5cL [b.1.1 - b.1.1] CHIMERIC DECARBOXYLASE ANTIBODY 21D8
EIQLTQSPSSLSASLGERVSLTCRTSQEISGYLSWLQQKPDGTIKRLIYDATKLDSGAPK
RFSGSRSGSDYSLTISSLESEDFADYYCLQYASFPRTFGGGTKLEIKRTVAAPSVFIFPP
SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT
LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
//
>1c5cH [b.1.1 - b.1.1] CHIMERIC DECARBOXYLASE ANTIBODY 21D8
QVQLLEPGTELVKPGASVKLSCRASGYSFTSYWMHWVKQRPGQGLEWIGLIDPSNGRTNF
NDKFKSRATLTVDTSSSTAYMQLSSLTSEDSAVYYCVRIAYWGQGTLVTVSSASTKGPSV
FPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSV
VTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC
//
>1c5d_1L [b.1.1 - b.1.1] MONOCLONAL ANTIBODY AGAINST THE MAIN IMMUNOGENIC
DIQMTQSPPSLSASLGDKVTITCQASQDINKYIAWYQQKPGKAPRQLIRYTSILVLGTPS
RFSGSGSGRDFSFSISNVASEDIASYYCLQYGNLYTFGAGTKLEIKRADAAPTVSIFPPS
TEQLATGGASVVCLMNNFYPRDISVKWKIDGTERRDGVLDSVTDQDSKDSTYSMSSTLSL
TKADYESHNLYTCEVVHKTSSSPVVKSFNRNEC
//
>1c5d_1H [b.1.1 - b.1.1] MONOCLONAL ANTIBODY AGAINST THE MAIN IMMUNOGENIC
EVKLLESGPGLVQPSQTLSLTCTVSGFPLTTNGVSWVRQPPGKGLEWIAAISSGGSPYYN
SALKSRLSINRDTSKSQVFLKMNSLQTEDTAIYFCTREDGWNYFDYWGPGTMVTVSSAQT
TAPSVYPLAPGCGDTTSSTVTLGCLVKGYFPEPVTVTWNSGALSSDVHTFPAVLQSGLYT
LTSSVTSSTWPSQTVTCNVAHPASSTKVDKKLER
//
>1c5mA (F) [g.3.11] PROTEIN (COAGULATION FACTOR X)
LCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLER
//
>1c5mB (D) [b.47.1] PROTEIN (COAGULATION FACTOR X)
IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTE
QEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLM
TQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDA
CQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKA
K
//
>1c5oL [b.47.1] PROTEIN (HUMAN ALPHA THROMBIN)
TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR
//
>1c5oH [b.47.1] PROTEIN (HUMAN ALPHA THROMBIN)
IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL
VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL
PDRETAASLLQAGYKGRVTGWGNLKETGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFC
AGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLK
KWIQKVIDQFGE
//
>1c6vA [c.55.3] PROTEIN (SIV INTEGRASE)
NSDLGTWQMDCTHLEGKIVIVAVHVASGFIEAEVIPQETGRQTALFLLKLAGRWPITHLH
TDNGANFASQEVKMVAWWAGIEHTFGEAMNHHLKNQIDRIREQANSVETIVLMAVHCMNH
KRRGGIGDMTPAERLINMITTEQEIQFQ
//
>1c6vX [b.34.7] PROTEIN (SIU89134)
KNSKFKNFRVYYREGRDQLWKGPGELLWKGEGAVLLKVGTDIKVVPRRKAKIIKD
//
>1c8m_21 [b.121.4] HUMAN RHINOVIRUS 16 COAT PROTEIN
NPVERYVDEVLNEVLVVPNINQSHPTTSNAAPVLDAAETGHTNKIQPEDTIETRYVQSSQ
TLDEMSVESFLGRSGCIHESVLDIVDNYNDQSFTKWNINLQEMAQIRRKFEMFTYARFDS
EITMVPSVAAKDGHIGHIVMQYMYVPPGAPIPTTRDDYAWQSGTNASVFWQHGQPFPRFS
LPFLSIASAYYMFYDGYDGDTYKSRYGTVVTNDMGTLCSRIVTSEQLHKVKVVTRIYHKA
KHTKAWCPRPPRAVQYSHTHTTNYKLSSEVHNDVAIRPRTNLTTV
//
>1c8m_22 [b.121.4] HUMAN RHINOVIRUS 16 COAT PROTEIN
SDRIIQITRGDSTITSQDVANAVVGYGVWPHYLTPQDATAIDKPTQPDTSSNRFYTLDSK
MWNSTSKGWWWKLPDALKDMGIFGENMFYHFLGRSGYTVHVQCNASKFHQGTLLVVMIPE
HQLATVNKGNVNAGYKYTHPGEAGREVGTQVENEKQPSDDNWLNFDGTLLGNLLIFPHQF
INLRSNNSATLIVPYVNAVPMDSMVRHNNWSLVIIPVCQLQSNNISNIVPITVSISPMCA
EFSGARAKTVVQ
//
>1c8m_23 [b.121.4] HUMAN RHINOVIRUS 16 COAT PROTEIN
GLPVYVTPGSGQFMTTDDMQSPCALPWYHPTKEIFIPGEVKNLIEMCQVDTLIPINSTQS
NIGNVSMYTVTLSPQTKLAEEIFAIKVDIASHPLATTLIGEIASYFTHWTGSLRFSFMFC
GTANTTLKVLLAYTPPGIGKPRSRKEAMLGTHVVWDVGLQSTVSLVVPWISASQYRFTTP
DTYSSAGYITCWYQTNFVVPPNTPNTAEMLCFVSGCKDFCLRMARDTDLHKQTGPITQ
//
>1c8oA [e.1.1] ICE INHIBITOR
MDIFREIASSMKGENVFISPPSISSVLTILYYGANGSTAEQLSKYVEKEADKNKDDISFK
SMNKVYGRYSAVFKDSFLRKIGDNFQTVDFTDSRTVDAINKSVDIFTEGKINPLLDEPLS
PDTSLLAISAVYFKAKWLMPFEKEFTSDYPFYVSPTEMVDVSMMSMYGEAFNHASVKESF
GNFSIIELPYVGDTSMVVILPDNIDGLESIEQNLTDTNFKKWSDSMDAMFIDVHIPKFKV
TGSYNLVDALVKLGLTEVFGSTGDYSNMSNSDVSVDAMIHKTYIDVNEEYTEAAAATSAL
//
>1c8oB [e.1.1] ICE INHIBITOR
NEFSADHPFIYVIRHVDGKILFVGRYSSPTTN
//
>1c9b_2E (A) [a.74.1 - a.74.1] GENERAL TRANSCRIPTION FACTOR IIB
SDRAMMNAFKEITTMADRINLPRNIVDRTNNLFKQVYEQKSLKGRANDAIASACLYIACR
QEGVPRTFKEICAVSRISKKEIGRCFKLILKALETSVDLITTGDFMSRFCSNLCLPKQVQ
MAATHIARKAVELDLVPGRSPISVAAAAIYMASQASAEKRTQKEIGDIAGVADVTIRQSY
RLIYPRAPDLFPTDFKFDTPVDKLPQL
//
>1c9b_2F (B) [d.129.1 - d.129.1] TATA BOX BINDING PROTEIN
GSGIVPQLQNIVSTVNLGCKLDLKTIALRARNAEYNPKRFAAVIMRIREPRTTALIFSSG
KMVCTGAKSEEQSRLAARKYARVVQKLGFPAKFLDFKIQNMVGSCDVKFPIRLEGLVLTH
QQFSSYEPELFPGLIYRMIKPRIVLLIFVSGKVVLTGAKVRAEIYEAFENIYPILKGFRK
//
>1c9pA [x.x.x]
IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYKSRIQVRLGEHNIDVLEG
NEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLxSRVATVSLPRSCAAAGTECLISG
WGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSYPGQITGNMICVGFLEGGKDSCQGDSGGP
VVCNGQLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIAAN
//
>1c9pB [g.3.15] BDELLASTASIN
CGPVTCSGAQMCEVDKCVCSDLHCKVKCEHGFKKDDNGCEYACICADAPQ
//
>1c9rA [x.x.x]
PISPIETVPVKLAPGMDGPKVKQWPLTAEAIAALVAICTAMEAEGKISKIGPENPYNTPV
FAIKKAAAAAAAALVDFRELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPL
DEDFRKYTAFTIPSIANATPGIRYQYNVLPQGWKGSPAIFQSSMTKILEPFKKQNPDIVI
YQYIDDLYVGSDLEIGQHATKIAELRQHLLAWGLTTPDKKHAAEPPFLWMGYELHPDAWT
VAPAALAAAASAAVNDIQKLVGKLNWASQIYPGIAVRALSAAAAGTKAAAEAAAATAAAA
LALAAAREALAAPVHGVYYDPSKDLIAEIQAQGQGQWTYQIYQEPFKNLKTGKYARMRGA
HTNDVKQLTEAVQKITTESIVIWGKTPKFKLPIQKETWETWWTEYWQATWIPEWEFVNTP
PLVKLWYQLEKEPIVGAETFYVDGAANAATKLGKAGYVTNKGRQKVVPLTNTTNQKTELQ
AIYLALQDSGLEVNIVTDSQYALGIIQAQPDKSESELVNQIIEALIKKEAVYLAWVPAHA
GIGGNAAVDALVSAGIAA
//
>1c9rB [x.x.x]
PISPIETVPVKLAPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPV
FAIKKKDSTKWRKLVDFRELNKRTQDFWEAALGIPHPAGLKKKKSVTVLDVGDAYFSVPL
DEDFRKYTAFTIPSINNETPGIRYQYNVLPQGWKGSPAIFQSSMTKILEPFKAQNPDIVI
YQYIDDLYVGSDLEIGQHRTKIEELRQHLLRWGLTTPDKKHQKEPPFLWMGYELHPDKWA
AAAAAAAAAAAATVNDIQKLVGKLNWAAQIYPGIAAAALSAALAGTKALTAAAPLTAAAA
LELAANRAAAAAAAAGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMRGA
HTNDVKQLTEAVQKITTESIVIWGKTPKFKLPIQKETWETWWTEYWQATWIPEWEFVNTP
PLVALWYALE
//
>1c9rH [x.x.x]
QITLKESGPGIVQPSQPFRLTCTFSGFSLSTSGIGVTWIRQPSGKGLEWLATIWWDDDNR
YNPSLKSRLTVSKDTSNNQAFLNMMTVETADTAIYYCAQSAITSVTDSAMDHWGQGTSVT
VSSAATTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVL
QSDLYTLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKI
//
>1c9rI [x.x.x]
QITLKESGPGIVQPSQPFRLTCTFSGFSLSTSGIGVTWIRQPSGKGLEWLATIWWDDDNR
YNPSLKSRLTVSKDTSNNQAFLNMMTVETADTAIYYCAQSAITSVTDSAMDHWGQGTSVT
VSSAATTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVL
QSDLYTLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKI
//
>1c9t_2J (G) [g.3.15] BDELLASTASIN
TTPCGPVTCSGAQMCEVDKCVCSDLHCKVKCEHGFKKDDNGCEYACICADAPQ
//
>1c9t_2D (A) [b.47.1] TRYPSIN
IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEG
NEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISG
WGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGP
VVCSGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN
//
>1ca0_1B [b.47.1] BOVINE CHYMOTRYPSIN
IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGS
SSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTT
CVTTGWGLTRY
//
>1ca0_1C [b.47.1] BOVINE CHYMOTRYPSIN
ANTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVSSCMGDSGGPLVCKKNGAWT
LVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN
//
>1ca0_1D [g.8.1] PROTEASE INHIBITOR DOMAIN OF ALZHEIMER'S AMYLOID
EVCSEQAETGPCRAMISRWYFDVTEGKCAPFFYGGCGGNRNNFDTEEYCMAVCG
//
>1ca0_2I (D) [g.8.1] PROTEASE INHIBITOR DOMAIN OF ALZHEIMER'S AMYLOID
EVCSEQAETGPCRAMISRWYFDVTEGKCAPFFYGGCGGNRNNFDTEEYCMAVCG
//
>1ca0_2G (B) [b.47.1] BOVINE CHYMOTRYPSIN
IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGS
SSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTT
CVTTGWGLTRY
//
>1cauA [b.82.1] CANAVALIN
AQNNPYLFRSNKFLTLFKNQHGSLRLLQRFNEDTEKLENLRDYRVLEYCSKPNTLLLPHH
SDSDLLVLVLEGQAILVLVNPDGRDTYKLDQGDAIKIQAGTPFYLINPDNNQNLRILKFA
ITFRRPGTVEDFFLSSTKRLPSYLSAFSKNFLEASYDSPYDEIEQTLLQEEQEGVIVKMP
K
//
>1cauC (B) [b.82.1] CANAVALIN
TLSSQDKPFNLRSRDPIYSNNYGKLYEITPEKNSQLRDLDILLNCLQMNEGALFVPHYNS
RATVILVANEGRAEVELVGLEQQQQQGLESMQLRRYAATLSEGDIIVIPSSFPVALKAAS
DLNMVGIGVNAENNERNFLAGHKENVIRQIPRQVSDLTFPGSGEEVEELLENQKESYFVD
GQPR
//
>1cb7_1A [c.23.6] PROTEIN (GLUTAMATE MUTASE)
MEKKTIVLGVIGSDCHAVGNKILDHAFTNAGFNVVNIGVLSPQELFIKAAIETKADAILV
SSLYGQGEIDCKGLRQKCDEAGLEGILLYVGGNIVVGKQHWPDVEKRFKDMGYDRVYAPG
TPPEVGIADLKKDLNIE
//
>1cb7_1B [c.1.19] PROTEIN (GLUTAMATE MUTASE)
MELKNKKWTDEEFHKQREEVLQQWPTGKEVDLQEAVDYLKKIPAEKNFAEKLVLAKKKGI
TMAQPRAGVALLDEHIELLRYLQDEGGADFLPSTIDAYTRQNRYDECENGIKESEKAGRS
LLNGFPGVNFGVKGCRKVLEAVNLPLQARHGTPDSRLLAEIIHAGGWTSNEGGGISYNVP
YAKNVTIEKSLLDWQYCDRLVGFYEEQGVHINREPFGPLTGTLVPPSMSNAVGITEALLA
AEQGVKNITVGYGECGNMIQDIAALRCLEEQTNEYLKAYGYNDVFVTTVFHQWMGGFPQD
ESKAFGVIVTATTIAALAGATKVIVKTPHEAIGIPTKEANAAGIKATKMALNMLEGQRMP
MSKELETEMAVIKAETKCILDKMFELGKGDLAIGTVKAFETGVMDIPFGPSKYNAGKMMP
VRDNLGCVRYLEFGNVPFTEEIKNYNRERLQERAKFEGRDVSFQMVIDDIFAVGKGRLIG
RPE
//
>1cbw_1B [b.47.1] BOVINE CHYMOTRYPSIN
IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGS
SSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTT
CVTTGWGLTRY
//
>1cbw_1C [b.47.1] BOVINE CHYMOTRYPSIN
ANTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVSSCMGDSGGPLVCKKNGAWT
LVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN
//
>1cbw_1D [g.8.1] BPTI
RPDFCLEPPYTGPCKARIIRYFYNAKAGLCQTFVYGGCRAKRNNFKSAEDCMRTCGGA
//
>1cbw_2G (B) [b.47.1] BOVINE CHYMOTRYPSIN
IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGS
SSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTT
CVTTGWGLTRY
//
>1cbw_2H (C) [b.47.1] BOVINE CHYMOTRYPSIN
ANTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVSSCMGDSGGPLVCKKNGAWT
LVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN
//
>1cbw_2I (D) [g.8.1] BPTI
RPDFCLEPPYTGPCKARIIRYFYNAKAGLCQTFVYGGCRAKRNNFKSAEDCMRTCGGA
//
>1cc0A [c.37.1] TRANSFORMING PROTEIN RHOA
IRKKLVIVGDGACGKTCLLIVNSKDQFPEVYVPTVFENYVADIEVDGKQVELALWDTAGQ
EDYDRLRPLSYPDTDVILMCFSIDSPDSLENIPEKWTPEVKHFCPNVPIILVGNKKDLRN
DEHTRRELAKMKQEPVKPEEGRDMANRIGAFGYMECSAKTKDGVREVFEMATRAALQ
//
>1cc0E [b.1.18] RHO GDP DISSOCIATION INHIBITOR ALPHA
PNVVVTGLTLVCSSAPGPLELDLTGDLESFKKQSFVLKEGVEYRIKISFRVNREIVSGMK
YIQHTYRKGVKIDKTDYMVGSYGPRAEEYEFLTPVEEAPKGMLARGSYSIKSRFTDDDKT
DHLSWEWNLTIKKDWK
//
>1cc1S [e.19.1] HYDROGENASE (SMALL SUBUNIT)
KKAPVIWVQGQGCTGCSVSLLNAVHPRIKEILLDVISLEFHPTVMASEGEMALAHMYEIA
EKFNGNFFLLVEGAIPTAKEGRYCIVGEAKAHHHEVTMMELIRDLAPKSLATVAVGTCSA
YGGIPAAEGNVTGSKSVRDFFADEKIEKLLVNVPGCPPHPDWMVGTLVAAWSHVLNPTEH
PLPELDDDGRPLLFFGDNIHENCPYLDKYDNSEFAETFTKPGCKAELGCKGPSTYADCAK
RRWNNGINWCVENAVCIGCVEPDFPDGKSPFYVAE
//
>1cc1L [e.18.1] HYDROGENASE (LARGE SUBUNIT)
VKISIDPLTRVEGHLKIEVEVKDGKVVDAKCSGGMFRGFEQILRGRDPRDSSQIVQRICG
VCPTAHCTASVMAQDDAFGVKVTTNGRITRNLIFGANYLQSHILHFYHLAALDYVKGPDV
SPFVPRYANADLLTDRIKDGAKADATNTYGLNQYLKALEIRRICHEMVAMFGGRMPHVQG
MVVGGATEIPTADKVAEYAARFKEVQKFVIEEYLPLIYTLGSVYTDLFETGIGWKNVIAF
GVFPEDDDYKTFLLKPGVYIDGKDEEFDSKLVKEYVGHSFFDHSAPGGLHYSVGETNPNP
DKPGAYSFVKAPRYKDKPCEVGPLARMWVQNPELSPVGQKLLKELYGIEAKKFRDLGDKA
FSIMGRHVLRAEETWLTAVAVEKWLKQVQPGAETYVKSEIPDAAEGTGFTEAPRGALLHY
LKIKDKKIENYQIVSATLWNANPRDDMGQRGPIEEALIGVPVPDIKNPVNVGRLVRSYDP
cLGCAVH
//
>1cd3_3F [b.121.5] PROTEIN (CAPSID PROTEIN GPF)
SNIQTGAERMPHDLSHLGFLAGQIGRLITISTTPVIAGDSFEMDAVGALRLSPLRRGLAI
DSTVDIFTFYVPHRHVYGEQWIKFMKDGVNATPLPTVNTTGYIDHAAFLGTINPDTNKIP
KHLFQGYLNIYNNYFKAPWMPDRTEANPNELNQDDARFGFRCCHLKNIWTAPLPPETELS
RQMTTSTTSIDIMGLQAAYANLHTDQERDYFMQRYRDVISSFGGKTSYDADNRPLLVMRS
NLWASGYDVDGTDQTSLGQFSGRVQQTYKHSVPRFFVPEHGTMFTLALVRFPPTATKEIQ
YLNAKGALTYTDIAGDPVLYGNLPPREISMKDVFRSGDSSKKFKIAEGQWYRYAPSYVSP
AYHLLEGFPFIQEPPSGDLQERVLIRHHDYDQCFQSVQLLQWNSQVKFNVTVYRNLPTTR
DSIMTS
//
>1cd3_3B [x.x.x] PROTEIN (SCAFFOLDING PROTEIN GPB)
MEQLTKNQRKKRDEIEAGKSYCSRRFGGATCDDKSAQIYARFDKNDWRIQPAEFYRFHDA
EVNTFGYF
//
>1cd3_3s (1) [a.84.1] PROTEIN (SCAFFOLDING PROTEIN GPD)
EQSVRFQTALASIKLIQASAVLDLTEDDFDFLTSNKVWIATDRSRARRCVEACVYGTLDF
VGYPRFPAPVEFIAAVIAYYVHPVNIQTACLIMEGAEFTENIINGVERPVKAAELFAFTL
RVRAGNTDVLTDAEENVRQKLRA
//
>1cd3_3Q (F) [b.121.5] PROTEIN (CAPSID PROTEIN GPF)
SNIQTGAERMPHDLSHLGFLAGQIGRLITISTTPVIAGDSFEMDAVGALRLSPLRRGLAI
DSTVDIFTFYVPHRHVYGEQWIKFMKDGVNATPLPTVNTTGYIDHAAFLGTINPDTNKIP
KHLFQGYLNIYNNYFKAPWMPDRTEANPNELNQDDARFGFRCCHLKNIWTAPLPPETELS
RQMTTSTTSIDIMGLQAAYANLHTDQERDYFMQRYRDVISSFGGKTSYDADNRPLLVMRS
NLWASGYDVDGTDQTSLGQFSGRVQQTYKHSVPRFFVPEHGTMFTLALVRFPPTATKEIQ
YLNAKGALTYTDIAGDPVLYGNLPPREISMKDVFRSGDSSKKFKIAEGQWYRYAPSYVSP
AYHLLEGFPFIQEPPSGDLQERVLIRHHDYDQCFQSVQLLQWNSQVKFNVTVYRNLPTTR
DSIMTS
//
>1cd3_39 (G) [b.121.5] PROTEIN (SPIKE PROTEIN GPG)
MFQTFISRHNSNFFSDKLVLTSVTPASSAPVLQTPKATSSTLYFDSLTVNAGNGGFLHCI
QMDTSVNAANQVVSVGADIAFDADPKFFACLVRFESSSVPTTLPTAYDVYPLNGRHDGGY
YTVKDCVTIDVLPRTPGNNVYVGFMVWSNFTATKCRGLVSLNQVIKEIICLQPLK
//
>1cd3_3Q (F) [b.121.5] PROTEIN (CAPSID PROTEIN GPF)
EQSVRFQTALASIKLIQASAVLDLTEDDFDFLTSNKVWIATDRSRARRCVEACVYGTLDF
VGYPRFPAPVEFIAAVIAYYVHPVNIQTACLIMEGAEFTENIINGVERPVKAAELFAFTL
RVRAGNTDVLTDAEENVRQKLRA
//
>1cd3_3a (B) [x.x.x] PROTEIN (SCAFFOLDING PROTEIN GPB)
EQSVRFQTALASIKLIQASAVLDLTEDDFDFLTSNKVWIATDRSRARRCVEACVYGTLDF
VGYPRFPAPVEFIAAVIAYYVHPVNIQTACLIMEGAEFTENIINGVERPVKAAELFAFTL
RVRAGNTDVLTDAEENVRQKLRAEQSVRFQTALASIKLIQASAVLDLTEDDFDFLTSNKV
WIATDRSRARRCVEACVYGTLDFVGYPRFPAPVEFIAAVIAYYVHPVNIQTACLIMEGAE
FTENIINGVERPVKAAELFAFTLRVRAGNTDVLTDAEETEQSVRFQTALASIKLIQASAV
LDLTEDDFDFLTSNKVWIATDRSRARRCVEACVYGTLDFVGYPRFPAPVEFIAAVIAYYV
HPVNIQTACLIMEGAEFTENIINGVERPVKAAELFAFTLRVRAGNTDVLTDAEENVRQQS
VRFQTALASIKLIQASAVLDLTEDDFDFLTSNKVWIATDRSRARRCVEACVYGTLDFVGY
PRFPAPVEFIAAVIAYYVHPVNIQTACLIMEGAEFTENIINGVERPVKAAELFAFTLRVR
AGNTDVLTDAEENVRQKLRAEGVMSNIQTGAERMPHDLSHLGFLAGQIGRLITISTTPVI
AGDSFEMDAVGALRLSPLRRGLAIDSTVDIFTFYVPHRHVYGEQWIKFMKDGVNATPLPT
VNTTGYIDHAAFLGTINPDTNKIPKHLFQGYLNIYNNYFKAPWMPDRTEANPNELNQDDA
RFGFRCCHLKNIWTAPLPPETELSRQMTTSTTSIDIMGLQAAYANLHTDQERDYFMQRYR
DVISSFGGKTSYDADNRPLLVMRSNLWASGYDVDGTDQTSLGQFSGRVQQTYKHSVPRFF
VPEHGTMFTLALVRFPPTATKEIQYLNAKGALTYTDIAGDPVLYGNLPPREISMKDVFRS
GDSSKKFKIAEGQWYRYAPSYVSPAYHLLEGFPFIQEPPSGDLQERVLIRHHDYDQCFQS
VQLLQWNSQVKFNVTVYRNLPTTRDSIMTSMFQTFISRHNSNFFSDKLVLTSVTPASSAP
VLQTPKATSSTLYFDSLTVNAGNGGFLHCIQMDTSVNAANQVVSVGADIAFDADPKFFAC
LVRFESSSVPTTLPTAYDVYPLNGRHDGGYYTVKDCVTIDVLPRTPGNNVYVGFMVWSNF
TATKCRGLVSLNQVIKEIICLQPLKMEQLTKNQRKKRDEIEAGKSYCSRRFGGATCDDKS
AQIYARFDKNDWRIQPAEFYRFHDAEVNTFGYF
//
>1cd3_4T (4) [a.84.1] PROTEIN (SCAFFOLDING PROTEIN GPD)
QSVRFQTALASIKLIQASAVLDLTEDDFDFLTSNKVWIATDRSRARRCVEACVYGTLDFV
GYPRFPAPVEFIAAVIAYYVHPVNIQTACLIMEGAEFTENIINGVERPVKAAELFAFTLR
VRAGNTDVLTDAEENVRQKLRAEGVM
//
>1cd3_4V (G) [b.121.5] PROTEIN (SPIKE PROTEIN GPG)
MFQTFISRHNSNFFSDKLVLTSVTPASSAPVLQTPKATSSTLYFDSLTVNAGNGGFLHCI
QMDTSVNAANQVVSVGADIAFDADPKFFACLVRFESSSVPTTLPTAYDVYPLNGRHDGGY
YTVKDCVTIDVLPRTPGNNVYVGFMVWSNFTATKCRGLVSLNQVIKEIICLQPLK
//
>1cd3_4a (B) [x.x.x] PROTEIN (SCAFFOLDING PROTEIN GPB)
EQSVRFQTALASIKLIQASAVLDLTEDDFDFLTSNKVWIATDRSRARRCVEACVYGTLDF
VGYPRFPAPVEFIAAVIAYYVHPVNIQTACLIMEGAEFTENIINGVERPVKAAELFAFTL
RVRAGNTDVLTDAEENVRQKLRAEQSVRFQTALASIKLIQASAVLDLTEDDFDFLTSNKV
WIATDRSRARRCVEACVYGTLDFVGYPRFPAPVEFIAAVIAYYVHPVNIQTACLIMEGAE
FTENIINGVERPVKAAELFAFTLRVRAGNTDVLTDAEETEQSVRFQTALASIKLIQASAV
LDLTEDDFDFLTSNKVWIATDRSRARRCVEACVYGTLDFVGYPRFPAPVEFIAAVIAYYV
HPVNIQTACLIMEGAEFTENIINGVERPVKAAELFAFTLRVRAGNTDVLTDAEENVRQQS
VRFQTALASIKLIQASAVLDLTEDDFDFLTSNKVWIATDRSRARRCVEACVYGTLDFVGY
PRFPAPVEFIAAVIAYYVHPVNIQTACLIMEGAEFTENIINGVERPVKAAELFAFTLRVR
AGNTDVLTDAEENVRQKLRAEGVMSNIQTGAERMPHDLSHLGFLAGQIGRLITISTTPVI
AGDSFEMDAVGALRLSPLRRGLAIDSTVDIFTFYVPHRHVYGEQWIKFMKDGVNATPLPT
VNTTGYIDHAAFLGTINPDTNKIPKHLFQGYLNIYNNYFKAPWMPDRTEANPNELNQDDA
RFGFRCCHLKNIWTAPLPPETELSRQMTTSTTSIDIMGLQAAYANLHTDQERDYFMQRYR
DVISSFGGKTSYDADNRPLLVMRSNLWASGYDVDGTDQTSLGQFSGRVQQTYKHSVPRFF
VPEHGTMFTLALVRFPPTATKEIQYLNAKGALTYTDIAGDPVLYGNLPPREISMKDVFRS
GDSSKKFKIAEGQWYRYAPSYVSPAYHLLEGFPFIQEPPSGDLQERVLIRHHDYDQCFQS
VQLLQWNSQVKFNVTVYRNLPTTRDSIMTSMFQTFISRHNSNFFSDKLVLTSVTPASSAP
VLQTPKATSSTLYFDSLTVNAGNGGFLHCIQMDTSVNAANQVVSVGADIAFDADPKFFAC
LVRFESSSVPTTLPTAYDVYPLNGRHDGGYYTVKDCVTIDVLPRTPGNNVYVGFMVWSNF
TATKCRGLVSLNQVIKEIICLQPLKMEQLTKNQRKKRDEIEAGKSYCSRRFGGATCDDKS
AQIYARFDKNDWRIQPAEFYRFHDAEVNTFGYF
//
>1cdl_3C (A) [a.39.1] CALMODULIN
TEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTID
FPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEM
IREADIDGDGQVNYEEFVQMMT
//
>1cdl_3G [x.x.x] CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE TYPE
ARRKWQKTGHAVRAIGRLSS
//
>1ce1L [b.1.1 - b.1.1] PROTEIN (CAMPATH-1H:LIGHT CHAIN)
DIQMTQSPSSLSASVGDRVTITCKASQNIDKYLNWYQQKPGKAPKLLIYNTNNLQTGVPS
RFSGSGSGTDFTFTISSLQPEDIATYYCLQHISRPRTFGQGTKVEIKRTVAAPSVFIFPP
SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT
LSKADYEKHKVYACEVTHQGLSSPVTKSFNR
//
>1ce1H [b.1.1 - b.1.1] PROTEIN (CAMPATH-1H:HEAVY CHAIN)
QVQLQESGPGLVRPSQTLSLTCTVSGFTFTDFYMNWVRQPPGRGLEWIGFIRDKAKGYTT
EYNPSVKGRVTMLVDTSKNQFSLRLSSVTAADTAVYYCAREGHTAAPFDYWGQGSLVTVS
SASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQS
SGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVE
//
>1ce7A [d.165.1] PROTEIN (RIBOSOME-INACTIVATING PROTEIN TYPE II)
YERGDLDVTAQTTGAGYFSFITLLRDYVSSGSFSNAIPLLSQSGGGGEAGRFVLVELTNS
GGDGITVAIDVTNLYVVAYQAGSQSYFLSGPGGRHGFTGTTRSSLPFNGSYPDLEQYGGQ
RKQIPLGIDQLIQSVTALKFPGSTRTGARSILILIQMISEAARFNPILWRARQYINSGAS
FLPDVYMLELETSWGQQSTQVQHSTDGVFNNPIALADPGGGVTLTNVRDVIASLAIMLFV
C
//
>1ce7B [b.42.2 - b.42.2] PROTEIN (RIBOSOME-INACTIVATING PROTEIN TYPE II)
CSASEPTVRIVGRNGMNVDVRDDDFHDGNQIQLWPSKSNNDPNQLWTIKRDGTIRSNGSC
LTTYGYTAGVYVMIFDCATAVGEATVWQIWGNGTIINPRSNLVLAASSGIKGTTLTVQTL
DYTLGQGWLAGNDTAPREVTIYGFNDLCMESGGGSVTVETCSSGKADKWALYGDGSIRPE
QNQAQCLTSGGDSVAGVNIVSCSGAASGQRWVFTNEGAILNLKNGLAMDVANPGGGRIII
YPATGKPNQMWLPVF
//
>1cf7A [a.4.5] PROTEIN (TRANSCRIPTION FACTOR E2F-4)
SRHEKSLGLLTTKFVSLLQEAKDGVLDLKLAADTLAVRQKRRIYDITNVLEGIGLIEKKS
KNSIQWK
//
>1cf7B [a.4.5] PROTEIN (TRANSCRIPTION FACTOR DP-2)
GKGLRHFSMKVCEKVQRKGTTSYNEVADELVSEFTNSNNHLAADSAYDQKNIRRRVYDAL
NVLMAMNIISKEKKEIKWIGLP
//
>1cf8A (H) [b.1.1 - b.1.1] PROTEIN (CATALYTIC ANTIBODY 19A4 (HEAVY CHAIN))
DVQLQESGPGLVKPSQSLSLTCTVTGYSITSGYAWNWIRQFPGNKLEWMGYIRYSGDTRY
NPSLKSRISITRDTSKNQFFLQLNSVTTEDTATYYCAIGYGNSDYWGQGTLVTVSAAKTT
PPSVYPLAPGCGDTTGSSVTLGCLVKGYFPESVTVTWNSGSLSSSVHAFPALLQSDLYTM
SSSVTVPSSTWPSQTVTCSVAHPASSTTVDKKLEPKDC
//
>1cf8B (L) [b.1.1 - b.1.1] PROTEIN (CATALYTIC ANTIBODY 19A4 (LIGHT CHAIN))
DIVLTQSPTIMSVSPGEKVTLTCSASSSVSSNYVYWYQQKPGSSPKVWIYSTSNLASGVP
ARFSGSGSGTSYSLTISSMEAEDAASYFCLQWSSFPYTFGGGTKLELKRADVAPTVSIFP
PSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTL
TLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1cftA [b.1.1 - b.1.1] PROTEIN (IGG2A KAPPA ANTIBODY CB41 (LIGHT CHAIN)
DIKMTQSPSSMYTSLGERVTITCKASQDINSFLTWFLQKPGKSPKTLIYRANRLMIGVPS
RFSGSGSGQTYSLTISSLEYEDMGIYYCLQYDDFPLTFGAGTKLDLKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKEINVKWKIDGSERQNGVLDSWTEQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1cftB [b.1.1 - b.1.1] PROTEIN (IGG2A KAPPA ANTIBODY CB41 (HEAVY CHAIN)
QDQLQQSGAELVRPGASVKLSCKALGYIFTDYEIHWVKQTPVHGLEWIGGIHPGSSGTAY
NQKFKGKATLTADKSSTTAFMELSSLTSEDSAVYYCTRKDYWGQGTLVTVSAAKTTAPSV
YPLVPVCGGTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPALLQSGLYTLSSSV
TVTSNTWPSQTITCNVAHPASSTKVDKKIEPRV
//
>1cfvL [b.1.1] MONOCLONAL ANTIBODY FV4155
DIELTQSPPSLPVSLGDQVSISCRSSQSLVSNNRRNYLHWYLQKPGQSPKLVIYKVSNRF
SGVPDRFSGSGSGTDFTLKISRVAAEDLGLYFCSQSSHVPLTFGSGTKLEIKR
//
>1cfvH [b.1.1] MONOCLONAL ANTIBODY FV4155
QVQLQESGGGLVNLGGSMTLSCVASGFTFNTYYMSWVRQTPEKTLELVAAINSDGEPIYY
PDTLKGRVTISRDNAKKTLYLQMSSLNFEDTALYYCARLNYAVYGMDYWGQGTTVTVSS
//
>1cg5A [a.1.1] PROTEIN (HEMOGLOBIN)
VLSSQNKKAIEELGNLIKANAEAWGADALARLFELHPQTKTYFSKFSGFEACNEQVKKHG
KRVMNALADATHHLDNLHLHLEDLARKHGENLLVDPHNFHLFADCIVVTLAVNLQAFTPV
THCAVDKFLELVAYELSSCYR
//
>1cg5B [a.1.1] PROTEIN (HEMOGLOBIN)
VKLSEDQEHYIKGVWKDVDHKQITAKALERVFVVYPWTTRLFSKLQGLFSANDIGVQQHA
DKVQRALGEAIDDLKKVEINFQNLSGKHQEIGVDTQNFKLLGQTFMVELALHYKKTFRPK
EHAAAYKFFRLVAEALSSNYH
//
>1cgiE [b.47.1] ALPHA-CHYMOTRYPSINOGEN
CGVPAIQPVLSGLSRIVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGV
TTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSA
VCLPSASDDFAAGTTCVTTGWGLTRYTNANTPDRLQQASLPLLSNTNCKKYWGTKIKDAM
ICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQ
TLAAN
//
>1cgiI [g.68.1] PANCREATIC SECRETORY TRYPSIN INHIBITOR (KAZAL
DSLGREAKCYNELNGCTYEYRPVCGTDGDTYPNECVLCFENRKRQTSILIQKSGPC
//
>1ci6A [h.1.3] TRANSCRIPTION FACTOR ATF-4
EQNKTAATRYRQKKRAEQEALTGECKELEKKNEALKERADSLAKEIQYLKDLIEEV
//
>1ci6B [h.1.3] TRANSCRIPTION FACTOR C/EBP BETA
SRDKAKMRNLETQHKVLELTAENERLQKKVEQLSRELSTLRNLFKQL
//
>1cic_1A [b.1.1 - b.1.1] PROTEIN (IG HEAVY CHAIN V REGIONS)
DIVMTQSHKFMSTSVGDRVSITCKASQDVRIAVAWYQQKPGQSPKLLIYWASTRHTGVPD
RFTGSGSGTDFTLTISNVQSEDLADYFCQHCGSYPFTFGSGTKLEIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLDSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1cic_1B [b.1.1 - b.1.1] PROTEIN (IG HEAVY CHAIN V REGIONS)
QVQLQQPGSELVRPGASVKLSCKASGYTFTNYWMHWVKQRPGQGLEWIGNIYPGSGDSNY
DEKFKSKATLTVDTSSSTAYMQLSGLTSEDSAVYYCARGLAFYFDHWGQGTTLTVSSALT
TPPSVYPLAPGCGDTTGSSVTLGCLVKGYFPEPVTVTWNSGSLSSSVHTFPALLQSGLYT
MSSSVTVPSSTWPSETVTCSVAHPASSTTVDKKLEPS
//
>1cl7L [b.1.1 - b.1.1] PROTEIN (IGG1 ANTIBODY 1696 (LIGHT CHAIN))
DVLMTQTPLYLPVSLGDQASISCRSSQTIVHNNGNTYLEWYLQKPGQSPQLLIYKVSNRF
SGVPDRFSGSGSGTDFTLKISRVEAEDLGIYYCFQGSHFPPTFGGGTKLEIKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNR
//
>1cl7H [b.1.1 - b.1.1] PROTEIN (IGG1 ANTIBODY 1696 (VARIABLE HEAVY
QIQLQQSGPELKKPGETVKISCKATNYAFTDYSMHWVKQAPGGDLKYVGWINTETDEPTF
ADDFKGRFAFSLDTSTSTAFLQINNLKNEDTATYFCVRDRHDYGEIFTYWGQGTTVTVSS
AKTTPPSVYPLAPGS
//
>1cl7I [b.1.1] PROTEIN (IGG1 ANTIBODY 1696 (CONSTANT HEAVY
SMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTLSSSVTVPSSPRPSETV
TCNVAHPASSTKVDKKIVPRDC
//
>1cloL [b.1.1 - b.1.1] A5B7 MONOCLONAL ANTIBODY
QTVLSQSPAILSASPGEKVTMTCRASSSVTYIHWYQQKPGSSPKSWIYATSNLASGVPAR
FSGSGSGTSYSLTISRVEAEDAATYYCQHWSSKPPTFGGGTKLEIKRADAAPTVSIFPPS
SEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLTL
TKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1cloH [b.1.1 - b.1.1] A5B7 MONOCLONAL ANTIBODY
EVKLVESGGGLVQPGGSLRLSCATSGFTFTDYYMNWVRQPPGKALEWLGFIGNKANGYTT
EYSASVKGRFTISRDKSQSILYLQMNTLRAEDSATYYCTRDRGLRFYFDYWGQGTTLTVS
SAKTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQS
DLYTLSSSVTVPSSPRPSETVTCNVAHPASSTKVDKKIVPRD
//
>1clvA [c.1.8 - b.71.1] PROTEIN (ALPHA-AMYLASE)
xKDANFASGRNSIVHLFEWKWNDIADECERFLQPQGFGGVQISPPNEYLVADGRPWWERY
QPVSYIINTRSGDESAFTDMTRRCNDAGVRIYVDAVINHMTGMNGVGTSGSSADHDGMNY
PAVPYGSGDFHSPCEVNNYQDADNVRNCELVGLRDLNQGSDYVRGVLIDYMNHMIDLGVA
GFRVDAAKHMSPGDLSVIFSGLKNLNTDYGFADGARPFIYQEVIDLGGEAISKNEYTGFG
CVLEFQFGVSLGNAFQGGNQLKNLANWGPEWGLLEGLDAVVFVDNHDNQRTGGSQILTYK
NPKPYKMAIAFMLAHPYGTTRIMSSFDFTDNDQGPPQDGSGNLISPGINDDNTCSNGYVC
EHRWRQVYGMVGFRNAVEGTQVENWWSNDDNQIAFSRGSQGFVAFTNGGDLNQNLNTGLP
AGTYCDVISGELSGGSCTGKSVTVGDNGSADISLGSAEDDGVLAIHVNAKL
//
>1clvI [g.3.2] PROTEIN (ALPHA-AMYLASE INHIBITOR)
CIPKWNRCGPKMDGVPCCEPYTCTSDYYGNCS
//
>1clyL [b.1.1 - b.1.1] IGG FAB (HUMAN IGG1, KAPPA)
LMTQIPVSLPVSLGDQASISCRSSQIIVHNNGNTYLEWYLQKPGQSPQLLIYKVSNRFSG
VPDRFSGSGSGTDFTLKISRVEAEDLGVYYCFQGSHVPFTFGSGTKLEIKRTVAAPSVFI
FPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSS
TLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
//
>1clyH [b.1.1 - b.1.1] IGG FAB (HUMAN IGG1, KAPPA)
EVNLVESGGGLVQPGGSLKVSCVTSGFTFSDYYMYWVRQTPEKRLEWVAYISQGGDITDY
PDTVKGRFTISRDNAKNSLYLQMSRLKSEDTAMYYCARGLDDGAWFAYWGQGTLVTVSVA
STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPQPVTVSWNSGALTSGVHTFPAVLQSSG
LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEP
//
>1clzL [b.1.1 - b.1.1] IGG FAB (IGG3, KAPPA)
DVLMTQIPVSLPVSLGDQASISCRSSQIIVHNNGNTYLEWYLQKPGQSPQLLIYKVSNRF
SGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCFQGSHVPFTFGSGTKLEIKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1clzH [b.1.1 - b.1.1] IGG FAB (IGG3, KAPPA)
EVNLVESGGGLVQPGGSLKVSCVTSGFTFSDYYMYWVRQTPEKRLEWVAYISQGGDITDY
PDTVKGRFTISRDNAKNSLYLQMSRLKSEDTAMYYCARGLDDGAWFAYWGQGTLVTVSVT
TTAPSVYPLVPGCSDTSGSSVTLGCLVKGYFPEPVTVKWNYGALSSGVRTVSSVLQSGFY
SLSSLVTVPSSTWPSQTVICNVAHPASKTELIKRIEPR
//
>1cmx_1A [d.3.1] PROTEIN (UBIQUITIN YUH1-UBAL)
RAVVPIESNPEVFTNFAHKLGLKNEWAYFDIYSLTEPELLAFLPRPVKAIVLLFPINDVI
WFKQSVKNACGLYAILHSLSNNQSLLEPGSDLDNFLKSQSDTSSSKNRFDDVTTDQFVLN
VIKENVQTFSTGQSEAPEATADTNLHYITYVEENGGIFELDGRNLSGPLYLGKSDPTATD
LIEQELVRVRVASYMENANEEDVLNFAMLGLGPN
//
>1cmx_1B [d.15.1] PROTEIN (UBIQUITIN YUH1-UBAL)
MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYN
IQKESTLHLVLRLRGx
//
>1cn3E (A) [b.121.6] COAT PROTEIN VP1
MEVLDLVTGPDSVTEIEAFLNPRMGQPPTPESLTEGGQYYGWSRGINLATSDTEDSPGNN
TLPTWSMAKLQLPMLNEDLTCDTLQMWEAVSVKTEVVGSGSLLDVHGFNKPTDTVNTKGI
STPVEGSQYHVFAVGGEPLDLQGLVTDARTKYKEEGVVTIKTITKKDMVNKDQVLNPISK
AKLDKDGMYPVEIWHPDPAKNENTRYFGNYTGGTTTPPVLQFTNTLTTVLLDENGVGPLC
KGEGLYLSCVDIMGWRVTRNYDVHHWRGLPRYFKITLRKRWVK
//
>1cn3F [x.x.x] FRAGMENT OF COAT PROTEIN VP2
GGGGGGGGAASHQRVTPDWMLPLILGLYG
//
>1cn4C [a.26.1] PROTEIN (ERYTHROPOIETIN)
PPRLICDSRVLERYLLEAKEAEKITTGCAEHCSLNEKITVPDTKVNFYAWKRMEVGQQAV
EVWQGLALLSEAVLRGQALLVKSSQPWEPLQLHVDKAVSGLRSLTTLLRALGAQKEAISP
PDRTITADTFRKLFRVYSNFLRGKLKLYTGEACR
//
>1cn4B [b.1.2 - b.1.2] PROTEIN (ERYTHROPOIETIN RECEPTOR)
DPKFESKAALLAARGPEELLCFTERLEDLVCFWEEAASAGVGPGQYSFSYQLEDEPWKLC
RLHQAPTARGAVRFWCSLPTADTSSFVPLELRVTAASGAPRYHRVIHINEVVLLDAPVGL
VARLADESGHVVLRWLPPPETPMTSHIRYEVDVSAGQGAGSVQRVEILEGRTECVLSNLR
GRTRYTFAVRARMAEPSFGGFWSEWSEPVSLLTPSDLD
//
>1co7A (E) [b.47.1] TRYPSIN II
IVGGYTCQENSVPYQVSLNSGYHFCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLEG
NEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNAHVATVALPSSCAPAGTQCLISG
WGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDSGGP
VVCNGELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAAN
//
>1co7B (I) [g.8.1] BOVINE PANCREATIC TRYPSIN INHIBITOR
PYTGPCKARIIRYFYNLCQTFVYGGCRAKRNNFKSAEDCMR
//
>1cov_21 [b.121.4] COXSACKIEVIRUS COAT PROTEIN
RVADTVGTGPTNSEAIPALTAAETGHTSQVVPSDTMQTRHVKNYHSRSESTIENFLCRSA
CVYFTEYENSGAKRYAEWVITPRQAAQLRRKLEFFTYVRFDLELTFVITSTQQPSTTQNQ
DAQILTHQIMYVPPGGPVPDKVDSYVWQTSTNPSVFWTEGNAPPRMSVPFLSIGNAYSNF
YDGWSEFSRNGVYGINTLNNMGTLYARHVNAGSTGPIKSTIRIYFKPKHVKAWIPRPPRL
CQYEKAKNVNFQPSGVTTTRQSITTMTNT
//
>1cov_22 [b.121.4] COXSACKIEVIRUS COAT PROTEIN
GYSDRVRSITLGNSTITTQECANVVVGYGVWPDYLKDSEATAEDQPTQPDVATCRFYTLD
SVQWQKTSPGWWWKLPDALSNLGLFGQNMQYHYLGRTGYTIHVQCNASKFHQGCLLVVCV
PEAEMGCATLNNTPSSAELLGGDTAKEFADKPVASGSNKLVQRVVYNAGMGVGVGNLTIF
PHQWINLRTNNSATIVMPYTNSVPMDNMFRHNNVTLMVIPFVPLDYCPGSTTYVPITVTI
APMCAEYNGLRLAGHQ
//
>1cov_23 [b.121.4] COXSACKIEVIRUS COAT PROTEIN
GLPTMNTPGSCQFLTSDDFQSPSAMPQYDVTPEMRIPGEVKNLMEIAEVDSVVPVQNVGE
KVNSMEAYQIPVRSNEGSGTQVFGFPLQPGYSSVFSRTLLGEILNYYTHWSGSIKLTFMF
CGSAMATGKFLLAYSPPGAGAPTKRVDAMLGTHVVWDVGLQSSCVLCIPWISQTHYRYVA
SDEYTAGGFITCWYQTNIVVPADAQSSCYIMCFVSACNDFSVRLLKDTPFISQENFFQ
//
>1cov_24 [b.121.4] COXSACKIEVIRUS COAT PROTEIN
GAQVSTQKTGIHYTNINYYKDAASNSANRQDFTQDPSKFTEPVKDIMIKSLPALN
//
>1cov_2a (4) [b.121.4] COXSACKIEVIRUS COAT PROTEIN
RVADTVGTGPTNSEAIPALTAAETGHTSQVVPSDTMQTRHVKNYHSRSESTIENFLCRSA
CVYFTEYENSGAKRYAEWVITPRQAAQLRRKLEFFTYVRFDLELTFVITSTQQPSTTQNQ
DAQILTHQIMYVPPGGPVPDKVDSYVWQTSTNPSVFWTEGNAPPRMSVPFLSIGNAYSNF
YDGWSEFSRNGVYGINTLNNMGTLYARHVNAGSTGPIKSTIRIYFKPKHVKAWIPRPPRL
CQYEKAKNVNFQPSGVTTTRQSITTMTNT
//
>1cov_2l (1) [b.121.4] COXSACKIEVIRUS COAT PROTEIN
RVADTVGTGPTNSEAIPALTAAETGHTSQVVPSDTMQTRHVKNYHSRSESTIENFLCRSA
CVYFTEYENSGAKRYAEWVITPRQAAQLRRKLEFFTYVRFDLELTFVITSTQQPSTTQNQ
DAQILTHQIMYVPPGGPVPDKVDSYVWQTSTNPSVFWTEGNAPPRMSVPFLSIGNAYSNF
YDGWSEFSRNGVYGINTLNNMGTLYARHVNAGSTGPIKSTIRIYFKPKHVKAWIPRPPRL
CQYEKAKNVNFQPSGVTTTRQSITTMTNT
//
>1cov_2a (4) [b.121.4] COXSACKIEVIRUS COAT PROTEIN
RVADTVGTGPTNSEAIPALTAAETGHTSQVVPSDTMQTRHVKNYHSRSESTIENFLCRSA
CVYFTEYENSGAKRYAEWVITPRQAAQLRRKLEFFTYVRFDLELTFVITSTQQPSTTQNQ
DAQILTHQIMYVPPGGPVPDKVDSYVWQTSTNPSVFWTEGNAPPRMSVPFLSIGNAYSNF
YDGWSEFSRNGVYGINTLNNMGTLYARHVNAGSTGPIKSTIRIYFKPKHVKAWIPRPPRL
CQYEKAKNVNFQPSGVTTTRQSITTMTNTGYSDRVRSITLGNSTITTQECANVVVGYGVW
PDYLKDSEATAEDQPTQPDVATCRFYTLDSVQWQKTSPGWWWKLPDALSNLGLFGQNMQY
HYLGRTGYTIHVQCNASKFHQGCLLVVCVPEAEMGCATLNNTPSSAELLGGDTAKEFADK
PVASGSNKLVQRVVYNAGMGVGVGNLTIFPHQWINLRTNNSATIVMPYTNSVPMDNMFRH
NNVTLMVIPFVPLDYCPGSTTYVPITVTIAPMCAEYNGLRLAGHQGLPTMNTPGSCQFLT
SDDFQSPSAMPQYDVTPEMRIPGEVKNLMEIAEVDSVVPVQNVGEKVNSMEAYQIPVRSN
EGSGTQVFGFPLQPGYSSVFSRTLLGEILNYYTHWSGSIKLTFMFCGSAMATGKFLLAYS
PPGAGAPTKRVDAMLGTHVVWDVGLQSSCVLCIPWISQTHYRYVASDEYTAGGFITCWYQ
TNIVVPADAQSSCYIMCFVSACNDFSVRLLKDTPFISQENFFQGAQVSTQKTGIHYTNIN
YYKDAASNSANRQDFTQDPSKFTEPVKDIMIKSLPALNRVADTVGTGPTNSEAIPALTAA
ETGHTSQVVPSDTMQTRHVKNYHSRSESTIENFLCRSACVYFTEYENSGAKRYAEWVITP
RQAAQLRRKLEFFTYVRFDLELTFVITSTQQPSTTQNQDAQILTHQIMYVPPGGPVPDKV
DSYVWQTSTNPSVFWTEGNAPPRMSVPFLSIGNAYSNFYDGWSEFSRNGVYGINTLNNMG
TLYARHVNAGSTGPIKSTIRIYFKPKHVKAWIPRPPRLCQYEKAKNVNFQPSGVTTTRQS
ITTMTNTGYSDRVRSITLGNSTITTQECANVVVGYGVWPDYLKDSEATAEDQPTQPDVAT
CRFYTLDSVQWQKTSPGWWWKLPDALSNLGLFGQNMQYHYLGRTGYTIHVQCNASKFHQG
CLLVVCVPEAEMGCATLNNTPSSAELLGGDTAKEFADKPVASGSNKLVQRVVYNAGMGVG
VGNLTIFPHQWINLRTNNSATIVMPYTNSVPMDNMFRHNNVTLMVIPFVPLDYCPGSTTY
VPITVTIAPMCAEYNGLRLAGHQGLPTMNTPGSCQFLTSDDFQSPSAMPQYDVTPEMRIP
GEVKNLMEIAEVDSVVPVQNVGEKVNSMEAYQIPVRSNEGSGTQVFGFPLQPGYSSVFSR
TLLGEILNYYTHWSGSIKLTFMFCGSAMATGKFLLAYSPPGAGAPTKRVDAMLGTHVVWD
VGLQSSCVLCIPWISQTHYRYVASDEYTAGGFITCWYQTNIVVPADAQSSCYIMCFVSAC
NDFSVRLLKDTPFISQENFFQGAQVSTQKTGIHYTNINYYKDAASNSANRQDFTQDPSKF
TEPVKDIMIKSLPALN
//
>1cov_2a (4) [b.121.4] COXSACKIEVIRUS COAT PROTEIN
RVADTVGTGPTNSEAIPALTAAETGHTSQVVPSDTMQTRHVKNYHSRSESTIENFLCRSA
CVYFTEYENSGAKRYAEWVITPRQAAQLRRKLEFFTYVRFDLELTFVITSTQQPSTTQNQ
DAQILTHQIMYVPPGGPVPDKVDSYVWQTSTNPSVFWTEGNAPPRMSVPFLSIGNAYSNF
YDGWSEFSRNGVYGINTLNNMGTLYARHVNAGSTGPIKSTIRIYFKPKHVKAWIPRPPRL
CQYEKAKNVNFQPSGVTTTRQSITTMTNTGYSDRVRSITLGNSTITTQECANVVVGYGVW
PDYLKDSEATAEDQPTQPDVATCRFYTLDSVQWQKTSPGWWWKLPDALSNLGLFGQNMQY
HYLGRTGYTIHVQCNASKFHQGCLLVVCVPEAEMGCATLNNTPSSAELLGGDTAKEFADK
PVASGSNKLVQRVVYNAGMGVGVGNLTIFPHQWINLRTNNSATIVMPYTNSVPMDNMFRH
NNVTLMVIPFVPLDYCPGSTTYVPITVTIAPMCAEYNGLRLAGHQGLPTMNTPGSCQFLT
SDDFQSPSAMPQYDVTPEMRIPGEVKNLMEIAEVDSVVPVQNVGEKVNSMEAYQIPVRSN
EGSGTQVFGFPLQPGYSSVFSRTLLGEILNYYTHWSGSIKLTFMFCGSAMATGKFLLAYS
PPGAGAPTKRVDAMLGTHVVWDVGLQSSCVLCIPWISQTHYRYVASDEYTAGGFITCWYQ
TNIVVPADAQSSCYIMCFVSACNDFSVRLLKDTPFISQENFFQGAQVSTQKTGIHYTNIN
YYKDAASNSANRQDFTQDPSKFTEPVKDIMIKSLPALN
//
>1cp9A [d.153.1] PENICILLIN AMIDOHYDROLASE
xSTQIKIERDNYGVPHIYANDTYSLFYGYGYAVAQDRLFQMEMAKRSTQGTVSEVFGKDY
ISFDKEIRNNYWPDSIHKQINQLPSQEQDILRGYADGMNAWIKQINTKPDDLMPKQFIDY
DFLPSQWTSFDVAMIMVGTLANRFSDMNSEIDNLALLTALKDKYGEQLGVEFFNQINWLN
NPNAPTTISSEEFTYSD
//
>1cp9B [d.153.1] PENICILLIN AMIDOHYDROLASE
SNVWLVGKTKASGAKAILLNGPQFGWFNPAYTYGIGLHGAGFNIVGNTPFAYPAILFGHN
GHVSWGSTAGFGDGVDIFAEQVSPEDPNSYLHQGQWKKMLSRQETLNVKGEQPITFEIYR
TVHGNVVKRDKTTHTAYSKARAWDGKELTSLMAWVKQGQAQNWQQWLDQAQNQALTINWY
YADKDGNIGYVHTGHYPDRQINHDPRLPVSGTGEWDWKGIQPFANNPKVYNPKSGYIANW
NNSPAKNYPASDLFAFLWGSADRVKEIDNRIEAYDKLTADDMWAILQQTSRVDLNHRLFT
PFLTQATQGLPSNDNSVKLVSMLQQWDGINQLSSDGKHYIHPGSAILDIWLKEMLKATLG
QTVPAPFDKWYLASGYETTQEGPTGSLNISTGAKLLYESLLEDKSPISQSIDLFSGQPQN
DVIRKTLNTTYQKMIEKYGDNPANWQTPATALTFRENNFFGIPQALPQENFHQNEYHNRG
TENDLIVFTEEGVSAWDVVAPGQSGFISPQGKPSPHYQDQLSLYQQFGKKPLWLNSEDVA
PYIESTETLIIER
//
>1cpcA [a.1.1] C-PHYCOCYANIN (ALPHA SUBUNIT)
MKTPLTEAVAAADSQGRFLSSTEIQTAFGRFRQASASLAAAKALTEKASSLASGAANAVY
SKFPYTTSQNGPNFASTQTGKDKCVRDIGYYLRMVTYCLVVGGTGPLDDYLIGGIAEINR
TFDLSPSWYVEALKYIKANHGLSGDPAVEANSYIDYAINALS
//
>1cpcB [a.1.1] C-PHYCOCYANIN (BETA  SUBUNIT)
MLDAFAKVVSQADARGEYLSGSQIDALSALVADGNKRMDVVNRITGNSSTIVANAARSLF
AEQPQLIAPGGNAYTSRRMAACLRDMEIILRYVTYAIFAGDASVLDDRCLNGLKETYLAL
GTPGSSVAVGVQKMKDAALAIAGDTNGITRGDCASLMAEVASYFDKAASAVA
//
>1cq4A [d.40.1] PROTEIN (SERINE PROTEINASE INHIBITOR 2)
KTEWPELVGKSVEEAKKVILQDKPEAQIIVLPVGTIV
//
>1cq4B [d.40.1] PROTEIN (SERINE PROTEINASE INHIBITOR 2)
YRIDRVRLFVDKLDNIAQVPRVG
//
>1cqt_1A [a.35.1 - a.4.1] POU DOMAIN, CLASS 2, TRANSCRIPTION FACTOR 1
EPSDLEELEQFAKTFKQRRIKLGFTQGDVGLAMGKLYGNDFSQTTISRFEALNLSFKNMC
KLKPLLEKWLNDAERKKRTSIETNIRVALEKSFLENQKPTSEEITMIADQLNMEKEVIRV
WFCNRRQKEKRINP
//
>1cqt_1I [x.x.x] POU DOMAIN, CLASS 2, ASSOCIATING FACTOR 1
ARPYQGVRVKEPVKELLRRKRG
//
>1cr9L [b.1.1 - b.1.1] FAB ANTIBODY LIGHT CHAIN
DVVMTQTPLSLSVTIGQPASISCKSSQSLLDSDGKTYLIWVFQRPGQSPKRLIFLVSKRD
SGVPDRFTGSGSGTDFTLKISRVEAEDVGVYYCWQGTHFPHTVGGGTKLEIARADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1cr9H [b.1.1 - b.1.1] FAB ANTIBODY HEAVY CHAIN
KVKLQQSGAELVRSGASVKLSCTASGFNIKDYYIQWVKQRPEQGLEWIGWIDPENGNSEY
APRFQGKATMTADTLSNTAYLQLSSLTSEDTAVYYCNADLHDYWGQGTTLTVSSAKTTAP
SVYPLAPVCGDTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDLYTLSS
SVTVTSSTWPSQSITCNVAHPASSTKVDKKIEPRVTS
//
>1cseE [c.41.1] SUBTILISIN CARLSBERG
AQTVPYGIPLIKADKVQAQGFKGANVKVAVLDTGIQASHPDLNVVGGASFVAGEAYNTDG
NGHGTHVAGTVAALDNTTGVLGVAPSVSLYAVKVLNSSGSGSYSGIVSGIEWATTNGMDV
INMSLGGASGSTAMKQAVDNAYARGVVVVAAAGNSGNSGSTNTIGYPAKYDSVIAVGAVD
SNSNRASFSSVGAELEVMAPGAGVYSTYPTNTYATLNGTSMASPHVAGAAALILSKHPNL
SASQVRNRLSSTATYLGSSFYYGKGLINVEAAAQ
//
>1cseI [d.40.1] EGLIN C
KSFPEVVGKTVDQAREYFTLHYPQYNVYFLPEGSPVTLDLRYNRVRVFYNPGTNVVNHVP
HVG
//
>1ct8_2C (A) [b.1.1 - b.1.1] 7C8 FAB FRAGMENT SHORT CHAIN
ELVMTQTPATLSVTPGDSVSLSCRASQSVSNKLHWYQQKSHESPRLLIKFASQSIPGIPS
RFSGSGSGSDFTLSINSVETEDFGIYFCHQTHGRPLTFGAGTKLELKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1ct8_2D (B) [b.1.1 - b.1.1] 7C8 FAB FRAGMENT LONG CHAIN
QVKLLESGAVLVKPGASVKLSCKTSGFTFSSSYINWLKQKPGQSLEWIAWIYAGSGGTVY
NQHFTDKARLTVDTSSSTAYMQFSSLTTEDSAIYYCARYRYDEGFAYWGQGTLVTVSAAK
TTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLY
TLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKIVPRDC
//
>1culA [d.58.29] TYPE V ADENYLYL CYCLASE
MMFHKIYIQKHDNVSILFADIEGFTSLASQCTAQELVMTLNELFARFDKLAAENHCLRIK
ILGDCYYCVSGLPEARADHAHCCVEMGMDMIEAISLVREMTGVNVNMRVGIHSGRVHCGV
LGLRKWQFDVWSNDVTLANHMEAGGKAGRIHITKATLSYLNGDYEVEPGCGGERNAYLKE
HSIETFLIL
//
>1culB [d.58.29] TYPE II ADENYLYL CYCLASE
YHQSYDCVCVMFASIPDFKEFYTESDVNKEGLECLRLLNEIIADFDDLLSKPKFSGVEKI
KTIGSTYMAATGLSAERQYMHIGTMVEFAYALVGKLDAINKHSFNDFKLRVGINHGPVIA
GVIGAQKPQYDIWGNTVNVASRMDSTGVLDKIQVTEETSLILQTLGYTCTCRGIINVKGK
GDLKTYFVNT
//
>1cvs_1A [b.42.1] FIBROBLAST GROWTH FACTOR 2
HFKDPKRLYCKNGGFFLRIHPDGRVDGVREKSDPHIKLQLQAEERGVVSIKGVSANRYLA
MKEDGRLLASKSVTDECFFFERLESNNYNTYRSRKYTSWYVALKRTGQYKLGSKTGPGQK
AILFLPMSA
//
>1cvs_1C [b.1.1 - b.1.1] FIBROBLAST GROWTH FACTOR RECEPTOR 1
MPVAPYWTSPEKMEKKLHAVPAAKTVKFKCPSSGTPQPTLRWLKNGKEFKPDHRIGGYKV
RYATWSIIMDSVVPSDKGNYTCIVENEYGSINHTYQLDVVERSPHRPILQAGLPANKTVA
LGSNVEFMCKVYSDPQPHIQWLKHIEVNGSKIGPDNLPYVQILKTAGVNTTDKEMEVLHL
RNVSFEDAGEYTCLAGNSIGLSHHSAWLTVL
//
>1cwp_2e (B) [b.121.4] COAT PROTEIN
KAIKAWTGYSVSKWTASCAAAEAKVTSAITISLPNELSSERNKQLKVGRVLLWLGLLPSV
SGTVKSCVTETQTTAAASFQVALAVADNSKDVVAAMYPEAFKGITLEQLAADLTIYLYSS
AALTEGDVIVHLEVEHVRPTFDDSFTPVYVVQPVIVEPIASGQGKAIKAWTGYSVSKWTA
SCAAAEAKVTSAITISLPNELSSERNKQLKVGRVLLWLGLLPSVSGTVKSCVTETQTTAA
ASFQVALAVADNSKDVVAAMYPEAFKGITLEQLAADLTIYLYSSAALTEGDVIVHLEVEH
VRPTFDDSFTPVY
//
>1cwp_2a (A) [b.121.4] COAT PROTEIN
KAIKAWTGYSVSKWTASCAAAEAKVTSAITISLPNELSSERNKQLKVGRVLLWLGLLPSV
SGTVKSCVTETQTTAAASFQVALAVADNSKDVVAAMYPEAFKGITLEQLAADLTIYLYSS
AALTEGDVIVHLEVEHVRPTFDDSFTPVY
//
>1cxzA [c.37.1] PROTEIN (HIS-TAGGED TRANSFORMING PROTEIN RHOA(0-
SMAAIRKKLVIVGDVACGKTCLLIVFSKDQFPEVYVPTVFENYVADIEVDGKQVELALWD
TAGQEDYDRLRPLSYPDTDVILMCFSIDSPDSLENIPEKWTPEVKHFCPNVPIILVGNKK
DLRNDEHTRRELAKMKQEPVKPEEGRDMANRIGAFGYMECSAKTKDGVREVFEMATRAAL
QA
//
>1cxzB [a.2.6] PROTEIN (PKN)
WSLLEQLGLAGADLAAPGVQQQLELERERLRREIRKELKLKEGAENLRRATTDLGRSLGP
VELLLRGSSRRLDLLHQQLQELHAHV
//
>1cz8H [b.1.1 - b.1.1] HEAVY CHAIN OF NEUTRALIZING ANTIBODY
EVQLVESGGGLVQPGGSLRLSCAASGYDFTHYGMNWVRQAPGKGLEWVGWINTYTGEPTY
AADFKRRFTFSLDTSKSTAYLQMNSLRAEDTAVYYCAKYPYYYGTSHWYFDVWGQGTLVT
VSSASTKGPSVFPLAPSGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLY
SLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK
//
>1cz8L [b.1.1 - b.1.1] LIGHT CHAIN OF NEUTRALIZING ANTIBODY
DIQLTQSPSSLSASVGDRVTITCSASQDISNYLNWYQQKPGKAPKVLIYFTSSLHSGVPS
RFSGSGSGTDFTLTISSLQPEDFATYYCQQYSTVPWTFGQGTKVEIKRTVAAPSVFIFPP
SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT
LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGE
//
>1d0gR [g.24.1 - g.24.1 - g.24.1] DEATH RECEPTOR-5
SSPSEGLCPPGHHISEDGRDCISCKYGQDYSTHWNDLLFCLRCTRCDSGEVELSPCTTTR
NTVCQCEEGTFREEDSPEMCRKCRTGCPRGMVKVGDCTPWSDIECVHK
//
>1d0gD (A) [b.22.1] APOPTOSIS-2 LIGAND
PQRVAAHITGTRGEKALGRKINSWESSRSGHSFLSNLHLRNGELVIHEKGFYYIYSQTYF
RFQEEIKENTKNDKQMVQYIYKYTSYPDPILLMKSARNSCWSKDAEYGLYSIYQGGIFEL
KENDRIFVSVTNEHLIDMDHEASFFGAFLVG
//
>1d2z_2C [a.77.1] DEATH DOMAIN OF PELLE
GSHMSHLDNTMAIRLLPLPVRAQLCAHLDALDVWQQLATAVKLYPDQVEQISSQKQRGRS
ASNEFLNIWGGQYNHTVQTLFALFKKLKLHNAMRLIKDYVSEDLHKYI
//
>1d2z_2D [a.77.1] DEATH DOMAIN OF TUBE
LSSKYSRNTELRRVEDNDIYRLAKILDENSCWRKLMSIIPKGMDVQACSGAGCLNFPAEI
KKGFKYTAQDVFQIDEAANRLPPDQSKSQMMIDEWKTSGKLNERPTVGVLLQLLVQAELF
SAADFVALDFLNESTPARPVDGPGALISLELLE
//
>1d3b_1E [b.38.1] PROTEIN (SMALL NUCLEAR RIBONUCLEOPROTEIN SM D3)
SIGVPIKVLHEAEGHIVTCETNTGEVYRGKLIEAEDNMNCQMSNITVTYRDGRVAQLEQV
YIRGCKIRFLILPD
//
>1d3b_1D [b.38.1] PROTEIN (SMALL NUCLEAR RIBONUCLEOPROTEIN
TVGKSSKMLQHIDYRMRCILQDGRIFIGTFKAFDKHMNLILCDCDEFRKIKPKNSKQAER
EEKRVLGLVLLRGENLVSMTVEGPPP
//
>1d3uA [d.129.1 - d.129.1] TATA-BINDING PROTEIN
MVDMSKVKLRIENIVASVDLFAQLDLEKVLDLCPNSKYNPEEFPGIICHLDDPKVALLIF
SSGKLVVTGAKSVQDIERAVAKLAQKLKSIGVKFKRAPQIDVQNMVFSGDIGREFNLDVV
ALTLPNCEYEPEQFPGVIYRVKEPKSVILLFSSGKIVCSGAKSEADAWEAVRKLLRELDK
Y
//
>1d3uB [a.74.1 - a.74.1] TRANSCRIPTION INITIATION FACTOR IIB
MVSDAAERNLAFALSELDRITAQLKLPRHVEEEAARLYREAVRKGLIRGRSIESVMAACV
YAACRLLKVPRTLDEIADIARVDKKEIGRSYRFIARNLNLTPKKLFVKPTDYVNKFADEL
GLSEKVRRRAIEILDEAYKRGLTSGKSPAGLVAAALYIASLLEGEKRTQREVAEVARVTE
VTVRNRYKELVEKLKIKVPIA
//
>1d4m_21 [b.121.4] PROTEIN (COXSACKIEVIRUS A9)
GDVEEAIERAVVHVADTMRSGPSNSASVPALTAVETGHTSQVTPSDTMQTRHVKNYHSRS
ESTVENFLGRSACVYMEEYKTTDNDVNKKFVAWPINTKQMVQMRRKLEMFTYLRFDMEVT
FVITSRQDPGTTLAQDMPVLTHQIMYVPPGGPIPAKVDDYAWQTSTNPSIFWTEGNAPAR
MSIPFISIGNAYSNFYDGWSNFDQRGSYGYNTLNNLGHIYVRHVSGSSPHPITSTIRVYF
KPKHTRAWVPRPPRLCQYKKAFSVDFTPTPITDTRKDINTVTTV
//
>1d4m_22 [b.121.4] PROTEIN (COXSACKIEVIRUS A9)
SDRVRSITLGNSTITTQECANVVVGYGRWPTYLRDDEATAEDQPTQPDVATCRFYTLDSI
KWEKGSVGWWWKFPEALSDMGLFGQNMQYHYLGRAGYTIHVQCNASKFHQGCLLVVCVPE
AEMGGAVVGQAFSATAMANGDKAYEFTSATQSDQTKVQTAIHNAGMGVGVGNLTIYPHQW
INLRTNNSATIVMPYINSVPMDNMFRHYNFTLMVIPFVKLDYADTASTYVPITVTVAPMC
AEYNGLRLAQAQ
//
>1d4m_23 [b.121.4] PROTEIN (COXSACKIEVIRUS A9)
GLPTMNTPGSTQFLTSDDFQSPCALPQFDVTPSMNIPGEVKNLMEIAEVDSVVPVNNVQD
TTDQMEMFRIPVTINAPLQQQVFGLRLQPGLDSVFKHTLLGEILNYYAHWSGSMKLTFVF
CGSAMATGKFLIAYSPPGANPPKTRKDAMLGTHIIWDIGLQSSCVLCVPWISQTHYRLVQ
QDEYTSAGYVTCWYQTGMIVPPGTPNSSSIMCFASACNDFSVRMLRDTPFISQDNKLQ
//
>1d4m_24 [b.121.4] PROTEIN (COXSACKIEVIRUS A9)
GAQVSTQKTGAHETSIIHYTNINYYKDAASNSANRQDFTQDPSKFTEPVKDVMIKSLPAL
N
//
>1d4m_2G (1) [b.121.4] PROTEIN (COXSACKIEVIRUS A9)
GDVEEAIERAVVHVADTMRSGPSNSASVPALTAVETGHTSQVTPSDTMQTRHVKNYHSRS
ESTVENFLGRSACVYMEEYKTTDNDVNKKFVAWPINTKQMVQMRRKLEMFTYLRFDMEVT
FVITSRQDPGTTLAQDMPVLTHQIMYVPPGGPIPAKVDDYAWQTSTNPSIFWTEGNAPAR
MSIPFISIGNAYSNFYDGWSNFDQRGSYGYNTLNNLGHIYVRHVSGSSPHPITSTIRVYF
KPKHTRAWVPRPPRLCQYKKAFSVDFTPTPITDTRKDINTVTTV
//
>1d4m_2I (3) [b.121.4] PROTEIN (COXSACKIEVIRUS A9)
GLPTMNTPGSTQFLTSDDFQSPCALPQFDVTPSMNIPGEVKNLMEIAEVDSVVPVNNVQD
TTDQMEMFRIPVTINAPLQQQVFGLRLQPGLDSVFKHTLLGEILNYYAHWSGSMKLTFVF
CGSAMATGKFLIAYSPPGANPPKTRKDAMLGTHIIWDIGLQSSCVLCVPWISQTHYRLVQ
QDEYTSAGYVTCWYQTGMIVPPGTPNSSSIMCFASACNDFSVRMLRDTPFISQDNKLQ
//
>1d4m_29 (2) [b.121.4] PROTEIN (COXSACKIEVIRUS A9)
SDRVRSITLGNSTITTQECANVVVGYGRWPTYLRDDEATAEDQPTQPDVATCRFYTLDSI
KWEKGSVGWWWKFPEALSDMGLFGQNMQYHYLGRAGYTIHVQCNASKFHQGCLLVVCVPE
AEMGGAVVGQAFSATAMANGDKAYEFTSATQSDQTKVQTAIHNAGMGVGVGNLTIYPHQW
INLRTNNSATIVMPYINSVPMDNMFRHYNFTLMVIPFVKLDYADTASTYVPITVTVAPMC
AEYNGLRLAQAQ
//
>1d4m_23 [b.121.4] PROTEIN (COXSACKIEVIRUS A9)
GLPTMNTPGSTQFLTSDDFQSPCALPQFDVTPSMNIPGEVKNLMEIAEVDSVVPVNNVQD
TTDQMEMFRIPVTINAPLQQQVFGLRLQPGLDSVFKHTLLGEILNYYAHWSGSMKLTFVF
CGSAMATGKFLIAYSPPGANPPKTRKDAMLGTHIIWDIGLQSSCVLCVPWISQTHYRLVQ
QDEYTSAGYVTCWYQTGMIVPPGTPNSSSIMCFASACNDFSVRMLRDTPFISQDNKLQ
//
>1d4m_24 [b.121.4] PROTEIN (COXSACKIEVIRUS A9)
GAQVSTQKTGAHETSIIHYTNINYYKDAASNSANRQDFTQDPSKFTEPVKDVMIKSLPAL
N
//
>1d4m_2I (3) [b.121.4] PROTEIN (COXSACKIEVIRUS A9)
SDRVRSITLGNSTITTQECANVVVGYGRWPTYLRDDEATAEDQPTQPDVATCRFYTLDSI
KWEKGSVGWWWKFPEALSDMGLFGQNMQYHYLGRAGYTIHVQCNASKFHQGCLLVVCVPE
AEMGGAVVGQAFSATAMANGDKAYEFTSATQSDQTKVQTAIHNAGMGVGVGNLTIYPHQW
INLRTNNSATIVMPYINSVPMDNMFRHYNFTLMVIPFVKLDYADTASTYVPITVTVAPMC
AEYNGLRLAQAQ
//
>1d4vA [g.24.1 - g.24.1 - g.24.1] DEATH RECEPTOR 5
PQQKRSSPSEGLCPPGHHISEDGRDCISCKYGQDYSTHWNDLLFCLRCTRCDSGEVELSP
CTTTRNTVCQCEEGTFREEDSPEMCRKCRTGCPRGMVKVGDCTPWSDIECVHKESGD
//
>1d4vE (B) [b.22.1] TNF-RELATED APOPTOSIS INDUCING LIGAND
PQRVAAHITGTRGRSNTLSSPNSKNEKALGRKINSWESSRSGHSFLSNLHLRNGELVIHE
KGFYYIYSQTYFRFQEEIKENTKNDKQMVQYIYKYTSYPDPILLMKSARNSCWSKDAEYG
LYSIYQGGIFELKENDRIFVSVTNEHLIDMDHEASFFGAFLVG
//
>1d4xA [c.55.1 - c.55.1] C. ELEGANS ACTIN 1/3
EVAALVVDNGSGMCKAGFAGDDAPRAVFPSIVGRPRHQGVGQKDSYVGDEAQSKRGILTL
KYPIEHGIVTNWDDMEKIWHHTFYNELRVAPEEHPVLLTEAPLNPKANREKMTQIMFETF
NTPAMYVAIQAVLSLYASGRTTGVVLDSGDGVTHTVPIYEGYALPHAILRLDLAGRDLTD
YLMKILTERGYSFTTTAEREIVRDIKEKLCYVALDFEQEMATAASSSSLEKSYELPDGQV
ITVGNERFRCPEAMFQPSFLGMESAGIHETSYNSIMKCDIDIRKDLYANTVLSGGTTMYP
GIADRMQKEITALAPSTMKIKIIAPPERKYSVWIGGSILASLSTFQQMWISKQEYDESGP
SIVHRKCF
//
>1d4xG [d.109.1] GELSOLIN
VEHPEFLKAGKEPGLQIWRVEKFDLVPVPTNLYGDFFTGDAYVILKTVQLRNGNLQYDLH
YWLGNECSQDESGAAAIFTVQLDDYLNGRAVQHREVQGFESATFLGYFKSGLKYKKGGVA
SGFK
//
>1d5b_2L (A) [b.1.1 - b.1.1] CHIMERIC OXY-COPE CATALYTIC ANTIBODY AZ-28
DIKMTQSPSSMYASLGERVTITCKASQDINSYLNWFQQKPGKSPKTLIYRTNRLVDGVPS
RFSGSGSGQDYSLTISSLEYEDMGIYYCLQYDEFPYTFGSGTKLEIKRTVAAPSVFIFPP
SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT
LSKADYEKHKVYACEVTHQGLSSPVTKSFNR
//
>1d5b_2H (B) [b.1.1 - b.1.1] CHIMERIC OXY-COPE CATALYTIC ANTIBODY AZ-28
QVQLQQSGAELMKPGASVKISCKATGYTFSSFWIEWVKQRPGHGLEWIGEILPGSGGTHY
NEKFKGKATFTADKSSNTAYMQLSSLTSEDSAVYYCARGHSYYFYDGDYWGQGTSVTVSS
ASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSS
GLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK
//
>1d5mA [d.19.1 - b.1.1] HLA CLASS II HISTOCOMPATIBILITY ANTIGEN
EHVIIQAEFYLNPDQSGEFMFDFDGDEIFHVDMAKKETVWRLEEFGRFASFEAQGALANI
AVDKANLEIMTKRSNYTPITNVPPEVTVLTNSPVELREPNVLICFIDKFTPPVVNVTWLR
NGKPVTTGVSETVFLPREDHLFRKFHYLPFLPSTEDVYDCRVEHWGLDEPLLKHWEFD
//
>1d5mC [b.40.2 - d.15.6] ENTEROTOXIN TYPE B
SQPDPKPDELHKSSKFTGLMENMKVLYDDNHVSAINVKSIDQFLYFDLIYSIKDTKLGNY
DNVRVEFKNKDLADKYKDKYVDVFGANYYYQCYFSKKKRKTCMYGGVTEHNGNQLDKYRS
ITVRVFEDGKNLLSFDVQTNKKKVTAQELDYLTRHYLVKNKKLYEFNNSPYETGYIKFIE
NENSFWYDMMPAPGDKFDQSKYLMMYNDNKMVDSKDVKIEVYLTTK
//
>1d5sA [e.1.1] P1-ARG ANTITRYPSIN
HPTFNKITPNLAEFAFSLYRQLAHQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEG
LNFNLTEIPEAQIHEGFQELLRTLNQPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYH
SEAFTVNFGDTEEAKKQINDYVEKGTQGKIVDLVKELDRDTVFALVNYIFFKGKWERPFE
VKDTEEEDFHVDQVTTVKVPMMKRLGMFNIQHCKKLSSWVLLMKYLGNATAIFFLPDEGK
LQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSNGADLS
GVTEEAPLKLSKAVHKAVLTIDEKGTEAAGAMFL
//
>1d5sB [e.1.1] P1-ARG ANTITRYPSIN
EAIPRSIPPEVKFNKPFVFLMIEQNTKSPLFMGKVVNPTQK
//
>1d6rA [b.47.1] TRYPSINOGEN
IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEG
NEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISG
WGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGP
VVCSGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN
//
>1d6rI [g.3.13] BOWMAN-BIRK PROTEINASE INHIBITOR PRECURSOR
KPCCDQCACTKSNPPQCRCSDMRLNSCHSACKSCICALSYPAQCFCVDITDFCYEPCK
//
>1d9k_2E (A) [b.1.1] T-CELL RECEPTOR D10 (ALPHA CHAIN)
QVRQSPQSLTVWEGETTILNCSYEDSTFDYFPWYRQFPGKSPALLIAISLVSNKKEDGRF
TIFFNKREKKLSLHITDSQPGDSATYFCAATGSFNKLTFGAGTRLAVSPY
//
>1d9k_2F (B) [b.1.1] T-CELL RECEPTOR D10 (BETA CHAIN)
AVTQSPRNKVAVTGGKVTLSCNQTNNHNNMYWYRQDTGHGLRLIHYSYGAGSTEKGDIPD
GYKASRPSQENFSLILELATPSQTSVYFCASGGQGRAEQFFGPGTRLTVLGS
//
>1d9k_2H (D) [d.19.1 - b.1.1] MHC I-AK B CHAIN (BETA CHAIN)
GSERHFVHQFQPFCYFTNGTQRIRLVIRYIYNREEYVRFDSDVGEYRAVTELGRPDAEYW
NKQYLERTRAELDTVCRHNYEKTETPTSLRRLEQPSVVISLSRTEALNHHNTLVCSVTDF
YPAKIKVRWFRNGQEETVGVSSTQLIRNGDWTFQVLVMLEMTPRRGEVYTCHVEHPSLKS
PITVEWRA
//
>1danH [x.x.x]
IVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHD
LSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERT
LAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGY
SDGKSDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMR
SEPRPGVLLRAPFP
//
>1danL [g.32.1 - g.3.11 - g.3.11] BLOOD COAGULATION FACTOR VIIA
ANAFLxxLRPGSLxRxCKxxQCSFxxARxIFKDAxRTKLFWISYSDGDQCASSPCQNGGS
CKDQLQSYICFCLPAFEGRNCETHKDDQLICVNENGGCEQYCSDHTGTKRSCRCHEGYSL
LADGVSCTPTVEYPCGKIPILE
//
>1danT [b.1.2] SOLUBLE TISSUE FACTOR
TVAAYNLTWKSTNFKTILEWEPKPVNQVYTVQISTKSGDWKSKCFYTTDTECDLTDEIVK
DVKQTYLARVFSYPA
//
>1danU [b.1.2 - b.1.2] SOLUBLE TISSUE FACTOR
EPLYENSPEFTPYLETNLGQPTIQSFEQVGTKVNVTVEDERTLVRRNNTFLSLRDVFGKD
LIYTLYYWSGKKTAKTNTNEFLIDVDKGENYCFSVQAVIPSRTVNRKSTDSPVECM
//
>1dbmL [b.1.1 - b.1.1] IGG1-KAPPA DB3 FAB (LIGHT CHAIN)
DVVMTQIPLSLPVNLGDQASISCRSSQSLIHSNGNTYLHWYLQKPGQSPKLLMYKVSNRF
YGVPDRFSGSGSGTDFTLKISRVEAEDLGIYFCSQSSHVPPTFGGGTKLEIKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNR
//
>1dbmH [b.1.1 - b.1.1] IGG1-KAPPA DB3 FAB (HEAVY CHAIN)
QIQLVQSGPELKKPGETVKISCKASGYAFTNYGVNWVKEAPGKELKWMGWINIYTGEPTY
VDDFKGRFAFSLETSASTAYLEINNLKNEDTATYFCTRGDYVNWYFDVWGAGTTVTVSSA
KTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDL
YTLSSSVTVPSSPRPSETVTCNVAHPASSTKVDKKIVPR
//
>1dce_1A [a.118.6 - b.7.4 - c.10.2] PROTEIN (RAB GERANYLGERANYLTRANSFERASE ALPHA
xHGRLKVKTSEEQAEAKRLEREQKLKLYQSATQAVFQKRQAGELDESVLELTSQILGANP
DFATLWNCRREVLQHLETEKSPEESAALVKAELGFLESCLRVNPKSYGTWHHRCWLLSRL
PEPNWARELELCARFLEADERNFHCWDYRRFVAAQAAVAPAEELAFTDSLITRNFSNYSS
WHYRSCLLPQLHPQPDSGPQGRLPENVLLKELELVQNAFFTDPNDQSAWFYHRWLLGRAE
PHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVW
LCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEK
STVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAA
YLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCHLEQLLLVTHLDLSHNRLRALPP
ALAALRCLEVLQASDNALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNL
QGNSLCQEEGIQERLAEMLPSVSSILT
//
>1dce_1B [a.102.4] PROTEIN (RAB GERANYLGERANYLTRANSFERASE BETA
TQQKDVTIKSDAPDTLLLEKHADYIASYGSKKDDYEYCMSEYLRMSGVYWGLTVMDLMGQ
LHRMNKEEILVFIKSCQHECGGVSASIGHDPHLLYTLSAVQILTLYDSIHVINVDKVVAY
VQSLQKEDGSFAGDIWGEIDTRFSFCAVATLALLGKLDAINVEKAIEFVLSCMNFDGGFG
CRPGSESHAGQIYCCTGFLAITSQLHQVNSDLLGWWLCERQLPSGGLNGRPEKLPDVCYS
WWVLASLKIIGRLHWIDREKLRSFILACQDEETGGFADRPGDMVDPFHTLFGIAGLSLLG
EEQIKPVSPVFCMPEEVLQRVNVQPELVS
//
>1dd4B (A) [a.108.1 - d.45.1] 50S RIBOSOMAL PROTEIN L7/L12
MTIDEIIEAIEKLTVSELAELVKKLEDKFGVTAAAPVAVAAAPVAGAAAGAAQEEKTEFD
VVLKSFGQNKIQVIKVVREITGLGLKEAKDLVEKAGSPDAVIKSGVSKEEAEEIKKKLEE
AGAEVELK
//
>1dd4D [a.108.1] 50S RIBOSOMAL PROTEIN L7/L12
MTIDEIIEAIEKLTVSELAELVKKLEDKFGVTAAAPVAVA
//
>1de4_1A [d.19.1 - b.1.1] HEMOCHROMATOSIS PROTEIN
RSHSLHYLFMGASEQDLGLSLFEALGYVDDQLFVFYDHESRRVEPRTPWVSSRISSQMWL
QLSQSLKGWDHMFTVDFWTIMENHNHSKESHTLQVILGCEMQEDNSTEGYWKYGYDGQDH
LEFCPDTLDWRAAEPRAWPTKLEWERHKIRARQNRAYLERDCPAQLQQLLELGRGVLDQQ
VPPLVKVTHHVTSSVTTLRCRALNYYPQNITMKWLKDKQPMDAKEFEPKDVLPNGDGTYQ
GWITLAVPPGEEQRYTCQVEHPGLDQPLIVIW
//
>1de4_1C [c.56.5 - c.8.4 - a.48.2] TRANSFERRIN RECEPTOR
LYWDDLKRKLSEKLDSTDFTSTIKLLNENSYVPREAGSQKDENLALYVENQFREFKLSKV
WRDQHFVKIQVKDSAQNSVIIVDKNGRLVYLVENPGGYVAYSKAATVTGKLVHANFGTKK
DFEDLYTPVNGSIVIVRAGKITFAEKVANAESLNAIGVLIYMDQTKFPIVNAELSFFGHA
HLGTGDPYTPGFPSFNHTQFPPSRSSGLPNIPVQTISRAAAEKLFGNMEGDCPSDWKTDS
TCRMVTSESKNVKLTVSNVLKEIKILNIFGVIKGFVEPDHYVVVGAQRDAWGPGAAKSGV
GTALLLKLAQMFSDMVLKDGFQPSRSIIFASWSAGDFGSVGATEWLEGYLSSLHLKAFTY
INLDKAVLGTSNFKVSASPLLYTLIEKTMQNVKHPVTGQFLYQDSNWASKVEKLTLDNAA
FPFLAYSGIPAVSFCFCEDTDYPYLGTTMDTYKELIERIPELNKVARAAAEVAGQFVIKL
THDVELNLDYERYNSQLLSFVRDLNQYRADIKEMGLSLQWLYSARGDFFRATSRLTTDFG
NAEKTDRFVMKKLNDRVMRVEYHFLSPYVSPKESPFRHVFWGSGSHTLPALLENLKLRKQ
NNGAFNETLFRNQLALATWTIQGAANALSGDVWDI
//
>1de4_1D (A) [d.19.1 - b.1.1] HEMOCHROMATOSIS PROTEIN
RSHSLHYLFMGASEQDLGLSLFEALGYVDDQLFVFYDHESRRVEPRTPWVSSRISSQMWL
QLSQSLKGWDHMFTVDFWTIMENHNHSKESHTLQVILGCEMQEDNSTEGYWKYGYDGQDH
LEFCPDTLDWRAAEPRAWPTKLEWERHKIRARQNRAYLERDCPAQLQQLLELGRGVLDQQ
VPPLVKVTHHVTSSVTTLRCRALNYYPQNITMKWLKDKQPMDAKEFEPKDVLPNGDGTYQ
GWITLAVPPGEEQRYTCQVEHPGLDQPLIVIW
//
>1de4_1E (B) [b.1.1] BETA-2-MICROGLOBULIN
IQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDW
SFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM
//
>1dee_2C (A) [b.1.1 - b.1.1] IGM RF 2A2
DIQMTQSPSSLSASVGDRVTITCRTSQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPS
RFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSAPRTFGQGTKVEIKRTVAAPSVFIFPP
SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT
LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
//
>1dee_2D (B) [b.1.1 - b.1.1] IGM RF 2A2
QVQLVESGGGVVQPGKSLRLSCAASGFTFSGYGMHWVRQAPGKGLEWVALISYDESNKYY
ADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKVKFYDPTAPNDYWGQGTLVTVS
SGSASAPTLFPLVSCENSNPSSTVAVGCLAQDFLPDSITFSWKYKNNSDISSTRGFPSVL
RGGKYAATSQVLLPSKDVAQGTNEHVVCKVQHPNGNKEKDVPL
//
>1dee_2G [a.8.1] IMMUNOGLOBULIN G BINDING PROTEIN A
DQQSAFYEILNMPNLNEAQRNGFIQSLKDDPSQSTNVLGEAKKLNESQAPK
//
>1dev_2C [b.26.1] MAD (MOTHERS AGAINST DECAPENTAPLEGIC,
LDLQPVTYSEPAFWCSIAYYELNQRVGETFHASQPSLTVDGFTDPSNSERFCLGLLSNVN
RNATVEMTRRHIGRGVRLYYIGGEVFAECLSDSAIFVQSPNCNQRYGWHPATVCKIPPGC
NLKIFNNQEFAALLAQSVNQGFEAVYQLTRMCTIRMSFVKGWGRQTVTSTPCWIELHLNG
PLQWLDKVLTQM
//
>1dev_2D [j.64.1] SMAD ANCHOR FOR RECEPTOR ACTIVATION
SQSPNPNNPAEYCSTIPPLQQAQASGALSSPPPTVMVPV
//
>1df0A [d.3.1 - b.14.1 - a.39.1] M-CALPAIN
AGIAMKLAKDREAAEGLGSHERAIKYLNQDYETLRNECLEAGALFQDPSFPALPSSLGFK
ELGPYSSKTRGIEWKRPTEICADPQFIIGGATRTDICQGALGDSWLLAAIASLTLNEEIL
ARVVPLDQSFQENYAGIFHFQFWQYGEWVEVVVDDRLPTKDGELLFVHSAEGSEFWSALL
EKAYAKINGCYEALSGGATTEGFEDFTGGIAEWYELRKPPPNLFKIIQKALEKGSLLGCS
IDIGHAYSVTGAEEVQKLIRIRNPWGQGEFWMSFSDFLRHYSRLEICNLTPDTLTCDSYK
KWKLTKMDGNWRRGSTAGGCRNYPNTFWMNPQYLIKLEEEDEDDEDGRGCTFLVGLIQKH
RRRQRKMGEDMHTIGFGIYEVSKNFFLTERSDTFINLREVLNRFKLPPGEYVLVPSTFEP
HKNGDFCIRVFSEKKADYQTVDDEIEANIEEIANEEDIGDGFRRLFAQLAGEDAEISAFE
LQTILRRVLAKKSDGFSIETCKIMVDMLDEDGSGKLGLKEFYILWTKIQKYQKIYREIDV
DRSGTMNSYEMRKALEEAGFKLPCQLHQVIVARFADDELIIDFDNFVRCLVRLEILFKIF
KQLDPENTGTIQLDLISWLSFSVL
//
>1df0B [a.39.1] CALPAIN
NESEEERQFRKLFVQLAGDDMEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMD
SDTTGKLGFEEFKYLWNNIKKWQGIYKRFDTDRSGTIGSNELPGAFEAAGFHLNQHIYSM
IIRRYSDETGNMDFDNFISCLVRLDAMFRAFRSLDKNGTGQIQVNIQEWLQLTMYS
//
>1df9C [g.3.13] BOWMAN-BIRK TYPE TRYPSIN INHIBITOR
SHDEPSESSEPCCDSCDCTKSIPPQCHCANIRLNSCHSACKSCICTRSMPGKCRCLDTDD
FCYKPCESMDK
//
>1df9B (A) [b.47.1] NONSTRUCTURAL PROTEIN 1
WDVPSPPPVGKAELEDGAYRIKQKGILGYSQIGAGVYKEGTFHTMWHVTRGAVLMHKGKR
IEPSWADVKKDLVSCGGGWKLEGEWKEGEEVQVLALEPGKNPRAVQTKPGLFKTNAGTIG
AVSLDFSPGTSGSPIIDKKGKVVGIYGNGVVTRSGAYVSAIAQTEKSIEDNPEIEDD
//
>1dfbL [b.1.1 - b.1.1] IGG1-KAPPA 3D6 FAB (LIGHT CHAIN)
DIQMTQSPSTLSASVGDRVTITCRASQSISRWLAWYQQKPGKVPKLLIYKASSLESGVPS
RFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYSFGPGTKVDIKRTVAAPSVFIFPPSD
EQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLS
KADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
//
>1dfbH [b.1.1 - b.1.1] IGG1-KAPPA 3D6 FAB (HEAVY CHAIN)
EVQLVESGGGLVQPGRSLRLSCAASGFTFNDYAMHWVRQAPGKGLEWVSGISWDSSSIGY
ADSVKGRFTISRDNAKNSLYLQMNSLRAEDMALYYCVKGRDYYDSGGYFTVAFDIWGQGT
MVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFP
AVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC
//
>1dfjE [d.5.1] RIBONUCLEASE A
KETAAAKFERQHMDSSTSAASSSNYCNQMMKSRNLTKDRCKPVNTFVHESLADVQAVCSQ
KNVACKNGQTNCYQSYSTMSITDCRETGSSKYPNCAYKTTQANKHIIVACEGNPYVPVHF
DASV
//
>1dfjI [c.10.1] RIBONUCLEASE INHIBITOR
MNLDIHCEQLSDARWTELLPLLQQYEVVRLDDCGLTEEHCKDIGSALRANPSLTELCLRT
NELGDAGVHLVLQGLQSPTCKIQKLSLQNCSLTEAGCGVLPSTLRSLPTLRELHLSDNPL
GDAGLRLLCEGLLDPQCHLEKLQLEYCRLTAASCEPLASVLRATRALKELTVSNNDIGEA
GARVLGQGLADSACQLETLRLENCGLTPANCKDLCGIVASQASLRELDLGSNGLGDAGIA
ELCPGLLSPASRLKTLWLWECDITASGCRDLCRVLQAKETLKELSLAGNKLGDEGARLLC
ESLLQPGCQLESLWVKSCSLTAACCQHVSLMLTQNKHLLELQLSSNKLGDSGIQELCQAL
SQPGTTLRVLCLGDCEVTNSGCSSLASLLLANRSLRELDLSNNCVGDPGVLQLLGSLEQP
GCALEQLVLYDTYWTEEVEDRLQALEGSKPGLRVIS
//
>1dfkA [c.37.1 - b.34.3] MYOSIN HEAD
SDPDFQYLAVDFDGKKNCWVPDEKEGFASAEIQSSKGDEITVKIVADSSTRTVKKDDIQS
MNPPKFEKLEDMANMTYLNEASVLYNLRSRYTSGLIYTYSGLFCIAVNPYRRLPIYTDSV
IAKYRGKRKTEIPPHLFSVADNAYQNMVTDRENQSCLITGESGAGKTENTKKVIMYLAKV
EDQIIQANPVLEAYGRFGKFIRIHFGPTGKIAGADIETYLLEKSRVTYQQSAIPELNDVM
LVTPDSGLYSFINQGCLTVDNIDDVEEFKLCDEAFDILGFTKEEKQSMFKCTASILHMGE
MKFKAESDGTAEAEKVAFLCGINAGDLLKALLKPKMNQVVNSVGALAKSLYDRMFNWLVR
RVNKTLDTKAKRNYYIGVLDIAGFEIFDFNSFEQLCINYTNERLQQFFNHHMFILEQEEY
KKEGIAWEFIDFGMDLQMCIDLIEKPMGILSILEEECMFPKADDKSFQDKLYQNHMGKNR
MFTKPGKPNQGPAHFELHHYAGNVPYSITGWLEKNKDPINENVVALLGASKEPLVAELFK
ATISAVHRESLNKLMKNLYSTHPHFVRCIIPNELKQPGLVDAELVLHQLQCNGVLEGIRI
CRKGFPSRLIYSEFKQRYSILAPNAIPGKTVSEKILAGLQMDPAEYRLGTTKVFFKAGVL
GNLEEMRDERLSKIISMFQAHIRGYLIRKAYKKLQDQRIGLSVIQRNIRKWLVLRNWQWW
KLYSKVKP
//
>1dfkZ [a.39.1] MYOSIN HEAD
LSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAVGGTHKMGEKS
LPFEEFLPAYEGLMDCEQGTFADYMEAFKTFDREGQGFISGAELRHVLTALGERLSDEDV
DEIIKLTDLQEDLEGNVKYEDFVKKVMAGPYP
//
>1dgrA [b.82.1] CANAVALIN
NNPYLFRSNKFLTLFKNQHGSLRLLQRFNEDTEKLENLRDYRVLEYCSKPNTLLLPHHSD
SDLLVLVLEGQAILVLVNPDGRDTYKLDQGDAIKIQAGTPFYLINPDNNQNLRILKFAIT
FRRPGTVEDFFLSSTKRLPSYLSAFSKNFLEASYDSPYDEIEQTLLQEEQEGVIVKMP
//
>1dgrV [b.82.1] CANAVALIN
DKPFNLRSRDPIYSNNYGKLYEITPEKNSQLRDLDILLNCLQMNEGALFVPHYNSRATVI
LVANEGRAEVELVGLE
//
>1dgrW (Y) [b.82.1] CANAVALIN
MQLRRYAATLSEGDIIVIPSSFPVALKAASDLNMVGIGVNAENNERNFLAGHKENVIRQI
PRQVSDLTFPGSGEEVEELLENQKESYFVDGQP
//
>1dgwA [b.82.1] CANAVALIN
NNPYLFRSNKFLTLFKNQHGSLRLLQRFNEDTEKLENLRDYRVLEYCSKPNTLLLPHHSD
SDLLVLVLEGQAILVLVNPDGRDTYKLDQGDAIKIQAGTPFYLINPDNNQNLRILKFAIT
FRRPGTVEDFFLSSTKRLPSYLSAFSKNFLEASYDSPYDEIEQTLLQEEQEGVIVKMP
//
>1dgwX [b.82.1] CANAVALIN
DKPFNLRSRDPIYSNNYGKLYEITPEKNSQLRDLDILLNCLQMNEGALFVPHYNSRATVI
LVANEGRAEVELVGLE
//
>1dhkA [c.1.8 - b.71.1] PORCINE PANCREATIC ALPHA-AMYLASE
xYAPQTQSGRTSIVHLFEWRWVDIALECERYLGPKGFGGVQVSPPNENVVVTNPSRPWWE
RYQPVSYKLCTRSGNENEFRDMVTRCNNVGVRIYVDAVINHMCGSGAAAGTGTTCGSYCN
PGSREFPAVPYSAWDFNDGKCKTASGGIESYNDPYQVRDCQLVGLLDLALEKDYVRSMIA
DYLNKLIDIGVAGFRIDASKHMWPGDIKAVLDKLHNLNTNWFPAGSRPFIFQEVIDLGGE
AIQSSEYFGNGRVTEFKYGAKLGTVVRKWSGEKMSYLKNWGEGWGFMPSDRALVFVDNHD
NQRGHGAGGASILTFWDARLYKVAVGFMLAHPYGFTRVMSSYRWARNFVNGEDVNDWIGP
PNNNGVIKEVTINADTTCGNDWVCEHRWREIRNMVWFRNVVDGQPFANWWDNGSNQVAFG
RGNRGFIVFNNDDWQLSSTLQTGLPGGTYCDVISGDKVGNSCTGIKVYVSSDGTAQFSIS
NSAEDPFIAIHAESKL
//
>1dhkB [b.29.1] BEAN LECTIN-LIKE INHIBITOR
ATETSFIIDAFNKTNLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIRDSTTGNVA
SFDTNFTMNIRTHRSAVGLDFVLVPVDTVTVEFDTFLSRISIDVNNNDIKSVPWDVHDYD
GQNAEVRITYNSSTKVFSVSLSNPSTGKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWS
YETHDVLSWSFSSKF
//
>1diiA [d.145.1 - d.58.32] P-CRESOL METHYLHYDROXYLASE
AVLPKGVTQGEFNKAVQKFRALLGDDNVLVESDQLVPYNKIMMPVENAAHAPSAAVTATT
VEQVQGVVKICNEHKIPIWTISTGRNFGYGSAAPVQRGQVILDLKKMNKIIKIDPEMCYA
LVEPGVTFGQMYDYIQENNLPVMLSFSAPSAIAGPVGNTMDRGVGYTPYGEHFMMQCGME
VVLANGDVYRTGMGGVPGSNTWQIFKWGYGPTLDGMFTQANYGICTKMGFWLMPKPPVFK
PFEVIFEDEADIVEIVDALRPLRMSNTIPNSVVIASTLWEAGSAHLTRAQYTTEPGHTPD
SVIKQMQKDTGMGAWNLYAALYGTQEQVDVNWKIVTDVFKKLGKGRIVTQEEAGDTQPFK
YRAQLMSGVPNLQEFGLYNWRGGGGSMWFAPVSEARGSECKKQAAMAKRVLHKYGLDYVA
EFIVAPRDMHHVIDVLYDRTNPEETKRADACFNELLDEFEKEGYAVYRVNTRFQDRVAQS
YGPVKRKLEHAIKRAVDPNNILAPGRSGIDLNNDF
//
>1diiC [a.3.1] P-CRESOL METHYLHYDROXYLASE
SQWGSGKNLYDKVCGHCHKPEVGVGPVLEGRGLPEAYIKDIVRNGFRAMPAFPASYVDDE
SLTQVAEYLSSLP
//
>1dioL (A) [c.1.19] PROTEIN (DIOL DEHYDRATASE)
MRSKRFEALAKRPVNQDGFVKEWIEEGFIAMESPNDPKPSIKIVNGAVTELDGKPVSDFD
LIDHFIARYGINLNRAEEVMAMDSVKLANMLCDPNVKRSEIVPLTTAMTPAKIVEVVSHM
NVVEMMMAMQKMRARRTPSQQAHVTNVKDNPVQIAADAAEGAWRGFDEQETTVAVARYAP
FNAIALLVGSQVGRPGVLTQCSLEEATELKLGMLGHTCYAETISVYGTEPVFTDGDDTPW
SKGFLASSYASRGLKMRFTSGSGSEVQMGYAEGKSMLYLEARCIYITKAAGVQGLQNGSV
SCIGVPSAVPSGIRAVLAENLICSSLDLECASSNDQTFTHSDMRRTARLLMQFLPGTDFI
SSGYSAVPNYDNMFAGSNEDAEDFDDYNVIQRDLKVDGGLRPVREEDVIAIRNKAARALQ
AVFAGMGLPPITDEEVEAATYAHGSKDMPERNIVEDIKFAQEIINKNRNGLEVVKALAQG
GFTDVAQDMLNIQKAKLTGDYLHTSAIIVGDGQVLSAVNDVNDYAGPATGYRLQGERWEE
IKNIPGALDPN
//
>1dioE (B) [c.51.3] PROTEIN (DIOL DEHYDRATASE)
GFLTEVGEARQGTQQDEVIIAVGPAFGLAQTVNIVGIPHKSILREVIAGIEEEGIKARVI
RCFKSSDVAFVAVEGNRLSGSGISIGIQSKGTTVIHQQGLPPLSNLELFPQAPLLTLETY
RQIGKNAARYAKRESPQPVPTLNDQMARPKYQAKSAILHIKETKYVVTGKNPQELRVAL
//
>1djsA [b.1.1 - b.1.1] PROTEIN (FIBROBLAST GROWTH FACTOR RECEPTOR 2)
TLEPEGAPYWTNTEKmEKRLHAVPAANTVKFRCPAGGNPmPTmRWLKNGKEFKQEHRIGG
YKVRNQHWSLImESVVPSDKGNYTCVVENEYGSINHTYHLDVVERSPHRPILQAGLPANA
STVVGGDVEFVCKVYSDAQPHIQWIKHVEKPYLKVLKAAGVNTTDKEIEVLYIRNVTFED
AGEYTCLAGNSIGISFHSAWLTVLPA
//
>1djsB [b.42.1] PROTEIN (FIBROBLAST GROWTH FACTOR 1)
GNYKKPKLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYL
AmDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLKKNGSCKRGPRTHY
GQKAILFLPLPVSSD
//
>1dkfA [a.123.1] PROTEIN (RETINOID X RECEPTOR-ALPHA)
SANEDMPVEKILEAELAVEPPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVIL
LRAGWNELLIASASHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLTELVSKMRDM
QMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYASLEAYCKHKYPEQPGRFAKLLL
RLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLEA
//
>1dkfB [a.123.1] PROTEIN (RETINOIC ACID RECEPTOR-ALPHA)
PEVGELIEKVRKAHQETFPALCQLGKYTTSEQRVSLDIDLWDKFSELSTKCIIKTVEFAK
QLPGFTTLTIADQITLLKAACLDILILRICTRYTPEQDTMTFSDGLTLNRTQMHNAGFGP
LTDLVFAFANQLLPLEMDDAETGLLSAICLICGDRQDLEQPDRVDMLQEPLLEALKVYVR
KRRPSRPHMFPKMLMKITDLRSISAKGAERVITLKMEIPGSMPPLIQEMLEN
//
>1dkgA [h.1.9 - b.73.1] NUCLEOTIDE EXCHANGE FACTOR GRPE
AEQVDPRDEKVANLEAQLAEAQTRERDGILRVKAEMENLRRRTELDIEKAHKFALEKFIN
ELLPVIDSLDRALEVAMSAMVEDIELTLKSMLDVVRKFGVEVIAETNVPLDPNVHQAIAM
VESDDVAPGNVLGIMQKGYTLNGRTIRAAMVTVAKAKA
//
>1dkgD [c.55.1 - c.55.1] MOLECULAR CHAPERONE DNAK
KIIGIDLGTTNSCVAIMDGTTPRVLENAEGDRTTPSIIAYTQDGETLVGQPAKRQAVTNP
QNTLFAIKRLIGRRFQDEEVQRDVSIMPFKIIAADNGDAWVEVKGQKMAPPQISAEVLKK
MKKTAEDYLGEPVTEAVITVPAYFNDAQRQATKDAGRIAGLEVKRIINEPTAAALAYGLD
KTGNRTIAVYDLGGGTFDISIIEIDEKTFEVLATNGDTHLGGEDFDSRLINYLVEEFKKD
QGIDLRNDPLAMQRLKEAAEKAKIELSSAQQTDVNLPYITADATGPKHMNIKVTRAKLES
LVEDLVNRSIELLKVALQDAGLSVSDIDDVILVGGQTRMPMVQKKVAEFFGKEPRKDVNP
DEAVAIGAAVQGGVLT
//
>1dl7L [b.1.1] PROTEIN (ANTIBODY M3C65 (LIGHT CHAIN))
QAVVTQESALTTSPGETVTLTCRSSTGAVTTSNYANWVQEKPDHLFTGLIGGTKHRTPGA
PARFSGSLIGDKAALTITGAQTEDEAIYFCALWYSNHWVFGGGTKLTVL
//
>1dl7H [b.1.1] PROTEIN (ANTIBODY M3C65 (HEAVY CHAIN))
QVQLKESGPGLVAPSQSLSITCTVSGFSLTGYGVNWVRQPPGKGLEWLGMIWGDGSTDYN
SALKSRLNISKDKSKSQVFLRMYSLQTDDTARYYCARDYGPYWGQGTLVTVS
//
>1dlfL [b.1.1] ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S)
DVVMTQTPLSLPVSLGNQASISCRSSQSLVHSNGNTYLHWYLQKPGQSPKLLIYKVSNRF
SGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQSTHVPFTFGSGTKLEIKR
//
>1dlfH [b.1.1] ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S)
EVKLEESGGGLVQPGGSMKLSCATSGFTFSDAWMDWVRQSPEKGLEWVAEIRNKANNHAT
YYAESVKGRFTISRDDSKRRVYLQMNTLRAEDTGIYYCTGIYYHYPWFAYWGQGTLVTVS
//
>1dml_1A [d.131.1 - d.131.1] DNA POLYMERASE PROCESSIVITY FACTOR
APCQVVLQGAELNGILQAFAPLRTSLLDSLLVMGDRGILIHNTIFGEQVFLPLEHSQFSR
YRWRGPTAAFLSLVDQKRSLLSVFRANQYPDLRRVELAITGQAPFRTLVQRIWTTTSDGE
AVELASETLMKRELTSFVVLVPQGTPDVQLRLTRPQLTKVLNATGADSATPTTFELGVNG
KFSVFTTSTCVTFAAREEGNAKTVYGENTHRTFSVVVDDCSMRAVLRRLQVGGGTLKFFL
TTPVPSLCVTATGPNAVSAVFLLKPQK
//
>1dml_1B [x.x.x] DNA POLYMERASE
DDVAARLRAAGFGAVGAGATAEETRRMLHRAFDTLA
//
>1dn0_1A [b.1.1 - b.1.1] IGM-KAPPA COLD AGGLUTININ (LIGHT CHAIN)
EIVLTQSPATLSLSPGERATLSCGASQSVSSNYLAWYQQKPGQAPRLLIYDASSRATGIP
DRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPLTFGGGTKVEIKRTVAAPSVFIFP
PSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTL
TLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
//
>1dn0_1B [b.1.1 - b.1.1] IGM-KAPPA COLD AGGLUTININ (HEAVY CHAIN)
EVQLQQWGAGLLKPSETLSLTCAVYGGSFSDYYWSWIRQPPGKGLEWIGEINHSGSTNYN
PSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARPPHDTSGHYWNYWGQGTLVTVSS
GSASAPTLFPLVSCTSSVAVGCLAQDFLPDSITFSWKYKNNSDISSTRGFPSVLRGGKYA
ATSQVLLPSKDVTDEHVVCKVQHPNGNKEKNVPLPV
//
>1dnuC [a.93.1] MYELOPEROXIDASE
VNCETSCVQQPPCFPLKIPPNDPRIKNQADCIPFFRSxPACPGSNITIRNQINALTSFVD
ASMVYGSEEPLARNLRNMSNQLGLLAVNQRFQDNGRALLPFDNLHDDPCLLTNRSARIPC
FLAGDTRSSEMPELTSMHTLLLREHNRLATELKSLNPRWDGERLYQEARKIVGAMVQIIT
YRDYLPLVLGPTAMRKYLPTYRSYNDSVDPRIANVFTNAFRYGHTLIQPFMFRLDNRYQP
MEPNPRVPLSRVFFASWRVVLEGGIDPILRGLMATPAKLNRQNQIAVDEIRERLFEQVMR
IGLDLPALNMQRSRDHGLPGYNAWRRFCGLPQPETVGQLGTVLRNLKLARKLMEQYGTPN
NIDIWMGGVSEPLKRKGRVGPLLACIIGTQFRKLRDGDRFWWENEGVFSMQQRQALAQIS
LPRIICDNTGITTVSKNNIFMSNSYPRDFVNCSTLPALNLASWREA
//
>1dnuA [a.93.1] MYELOPEROXIDASE
CPEQDKYRTITGMCNNRRSPTLGASNRAFVRWLPAEYEDGFSLPYGWTPGVKRNGFPVAL
ARAVSNEIVRFPTDQLTPDQERSLMFMQWGQLLDHDLDFTPEPA
//
>1doaA [c.37.1] PROTEIN (GTP-BINDING PROTEIN)
GSHMQTIKCVVVGDGAVGKTCLLISYTTNKFPSEYVPTVFDNYAVTVMIGGEPYTLGLFD
TAGQEDYDRLRPLSYPQTDVFLVCFSVVSPSSFENVKEKWVPEITHHCPKTPFLLVGTQI
DLRDDPSTIEKLAKNKQKPITPETAEKLARDLKAVKYVECSALTQKGLKNVFDEAILAAL
EPPEPKKSRRx
//
>1doaB [b.1.18] PROTEIN (GDP-DISSOCIATION INHIBITOR 1)
EPTAEQLAQIAAENEEDEHSVNYKPPAQKSIQEIQELDKDDESLRKYKEALLGRVAVSAD
PNVPNVVVTRLTLVCSTAPGPLELDLTGDLESFKKQSFVLKEGVEYRIKISFRVNREIVS
GMKYIQHTYRKGVKIDKTDYMVGSYGPRAEEYEFLTPMEEAPKGMLARGSYNIKSRFTDD
DRTDHLSWEWNLTIKKEWKD
//
>1dowA [a.24.9] ALPHA-CATENIN
KAHVLAASVEQATENFLEKGDKIAKESQFLKEELVVAVEDVRKQGDLmKSAAGEFADDPC
SSVKRGNmVRAARALLSAVTRLLILADmADVYKLLVQLKVVEDGILKLRNAGNEQDLGIQ
YKALKPEVDKLNImAAKRQQELKDVGNRDQmAAARGILQKNVPILYTASQACLQHPDVAA
YKANRDLIYKQLQQAVTGISNAAQA
//
>1dowB [x.x.x] BETA-CATENIN
HPTNVQRLAEPSQmLKHAVVNLINYQDDAELA
//
>1dp5A [b.50.1] PROTEINASE A
GGHDVPLTNYLNAQYYTDITLGTPPQNFKVILDTGSSNLWVPSNECGSLACFLHSKYDHE
ASSSYKANGTEFAIQYGTGSLEGYISQDTLSIGDLTIPKQDFAEATSEPGLTFAFGKFDG
ILGLGYDTISVDKVVPPFYNAIQQDLLDEKRFAFYLGDTSKDTENGGEATFGGIDESKFK
GDITWLPVRRKAYWEVKFEGIGLGDEYAELESHGAAIDTGTSLITLPSGLAEMINAEIGA
KKGWTGQYTLDCNTRDNLPDLIFNFNGYNFTIGPYDYTLEVSGSCISAITPMDFPEPVGP
LAIVGDAFLRKYYSIYDLGNNAVGLAKAI
//
>1dp5B [a.137.7] PROTEINASE INHIBITOR IA3
NTDQQKVSEIFQSSKEKLQGDAKVVSDAFMM
//
>1dqdL [b.1.1 - b.1.1] FAB HGR-2 F6
DIVLSQSPAIMSASPGEKVTITCSASSSVSYMHWFQQKPGTSPKLCIYTTSNLASGVPAR
FSGSGSGTSYSLTISRMEAEDAATYYCQQRSTYPPTFGSGTKLEIKRADAAPTVSIFPPS
SEQLTSGGASVVCFLNNFYPRDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLTL
TKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1dqdH [b.1.1 - b.1.1] FAB HGR-2 F6
EVQLQESGPSLVKPSQTLSLTCSVTGDSITSGYWNWIRKFPGNKLEYMGYISYSGSTYYN
PSLKSRLSITRDTSRNQYYLQLKSVTPEDTATYYCASPPGYYGSGPYAMDYWGQGTSVTV
SSAKTTPPSVYPLAPGSAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQS
DLYTLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKISP
//
>1dqjA [b.1.1 - b.1.1] ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN)
DIVLTQSPATLSVTPGDSVSLSCRASQSISNNLHWYQQKSHESPRLLIKYASQSISGIPS
RFSGSGSGTDFTLSINSVETEDFGMYFCQQSNSWPYTFGGGTKLEIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1dqjB [b.1.1 - b.1.1] ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN)
EVQLQESGPSLVKPSQTLSLTCSVTGDSVTSDYWSWIRKFPGNKLEYMGYISYSGSTYYH
PSLKSRISITRDTSKNQYYLQLNSVTTEDTATYYCASWGGDVWGAGTTVTVSSAKTTAPS
VYPLAPVCGDTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDLYTLSSS
VTVTSSTWPSQSITCNVAHPASSTKVDKKI
//
>1dqjC [d.2.1] LYSOZYME
KVFGRCELAAAMKRHGLDNYRGYSLGNWVCAAKFESNFNTQATNRNTDGSTDYGILQINS
RWWCNDGRTPGSRNLCNIPCSALLSSDITASVNCAKKIVSDGNGMNAWVAWRNRCKGTDV
QAWIRGCRL
//
>1dqlL [b.1.1] IGM MEZ IMMUNOGLOBULIN
DIQMTQSPSSLSASVGDRVTITCRASQDIRNDLGWYQQKPGKAPKKLIYAASSLQSGVPS
RFSGSGSGTDFTLTISSLQPEDFATYYCLQQNSNWTFGQGTKVDIK
//
>1dqlH [b.1.1] IGM MEZ IMMUNOGLOBULIN
xVQLVESGGGLVQPGGSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISSDGGNKYY
TDSVKGRFTISRNDSKNTLYLQMNSLRTEDTAVFYCARGNPPYSSGWGGGDYWGQGTMVT
VSS
//
>1ds2E [b.47.1] PROTEINASE B (SGPB)
ISGGDAIYSSTGRCSLGFNVRSGSTYYFLTAGHCTDGATTWWANSARTTVLGTTSGSSFP
NNDYGIVRYTNTTIPKDGTVGGQDITSAANATVGMAVTRRGSTTGTHSGSVTALNATVNY
GGGDVVYGMIRTNVCAEPGDSGGPLYSGTRAIGLTSGGSGNCSSGGTTFFQPVTEALVAY
GVSVY
//
>1ds2I [g.68.1] OVOMUCOID
EYRPLCGSDNKTYGNKCNFCNAVVESNGTLTLSHFGKC
//
>1ds6A [c.37.1] RAS-RELATED C3 BOTULINUM TOXIN SUBSTRATE 2
MQAIKCVVVGDGAVGKTCLLISYTTNAFPGEYIPTVFDNYSANVMVDSKPVNLGLWDTAG
QEDYDRLRPLSYPQTDVFLICFSLVSPASYENVRAKWFPEVRHHCPSTPIILVGTKLDLR
DDKDTIEKLKEKKLAPITYPQGLALAKEIDSVKYLECSALTQRGLKTVFDEAIRAVLCPQ
P
//
>1ds6B [b.1.18] RHO GDP-DISSOCIATION INHIBITOR 2
GNYKPPPQKSLKELQEMDKDDESLIKYKKTLLGDGPVVTDPKAPNVVVTRLTLVCESAPG
PITMDLTGDLEALKKETIVLKEGSEYRVKIHFKVNRDIVSGLKYVQHTYRTGVKVDKATF
MVGSYGPRPEEYEFLTPVEEAPKGMLARGTYHNKSFFTDDDKQDHLSWEWNLSIKKEWG
//
>1dsfL [b.1.1] ANTICANCER ANTIBODY B1
DVVMTQTPLSLPVSLGDQASISCRSSQNLVHSDGKTYLHWFLQKPGQSPTLLIYKVSNRF
SGVPDRFSGSGSGTDFILKISRVEAEDLGVYFCSQSTHVPLTFGCGTKLELK
//
>1dsfH [b.1.1] ANTICANCER ANTIBODY B1
QLVESGGGLVKPGGSLKLSCAASGFIFSDNYMYWVRQTPEKCLEWVATISDGGTYIDYSD
SVKGRFTISRDNAKNNLYLQMSSLRSEDTGMYYCGRSPIYYDYAPFTYWGQGTLVTVSA
//
>1dtdA [c.56.5] CARBOXYPEPTIDASE A2
FNFGAYHTLEEISQEMDNLVAEHPGLVSKVNIGSSFENRPMNVLKFSTGGDKPAIWLDAG
IHAREWVTQATALWTANKIVSDYGKDPSITSILDALDIFLLPVTNPDGYVFSQTKNRMWR
KTRSKVSAGSLCVGVDPNRNWDAGFGGPGASSNPCSDSYHGPSANSEVEVKSIVDFIKSH
GKVKAFIILHSYSQLLMFPYGYKCTKLDDFDELSEVAQKAAQSLSRLHGTKYKVGPICSV
IYQASGGSIDWSYDYGIKYSFAFELRDTGRYGFLLPARQILPTAEETWLGLKAIMEHVRD
HPY
//
>1dtdB [g.30.1] METALLOCARBOXYPEPTIDASE INHIBITOR
DESFLCYQPDQVCCFICRGAAPLPSEGECNPHPTAPWCREGAVEWVPYSTGQCRTTCIPY
V
//
>1du3_1F (D) [b.22.1] TNF-RELATED APOPTOSIS INDUCING LIGAND
QRVAAHITGTRGRSNTALGRKINSWESSRSGHSFLSNLHLRNGELVIHEKGFYYIYSQTY
FRFQEEIKENTKNDKQMVQYIYKYTSYPDPILLMKSARNSCWSKDAEYGLYSIYQGGIFE
LKENDRIFVSVTNEHLIDMDHEASFFGAFLVG
//
>1du3_1C (A) [g.24.1 - g.24.1 - g.24.1] DEATH RECEPTOR 5
SSPSEGLCPPGHHISEDGRDCISCKYGQDYSTHWNDLLFCLRCTRCDSGEVELSPCTTTR
NTVCQCEEGTFREEDSPEMCRKDCTPWSDI
//
>1dvfB [b.1.1] FV D1.3
QVQLQESGPGLVAPSQSLSITCTVSGFSLTGYGVNWVRQPPGKGLEWLGMIWGDGNTDYN
SALKSRLSISKDNSKSQVFLKMNSLHTDDTARYYCARERDYRLDYWGQGTTLTVSS
//
>1dvfD [b.1.1] FV E5.2
QVQLQQSGTELVKSGASVKLSCTASGFNIKDTHMNWVKQRPEQGLEWIGRIDPANGNIQY
DPKFRGKATITADTSSNTAYLQLSLTSEDTAVYYCATKVIYYQGRGAMDYWGQGTTLTVS
//
>1dvfC [b.1.1] FV E5.2
DIQLTQSPSSLSASLGDRVTISCRASQDISNYLNWYQQKPDGTVKLLIYYTSRLHSGVPS
RFSGSGSGTDYSLTISNLEQEDIATYFCQQGNTLPWTFGGGTKLEIK
//
>1dx5_1M [b.47.1] THROMBIN HEAVY CHAIN
IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFIENDLL
VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL
PDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIR
ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFY
THVFRLKKWIQKVIDQFGE
//
>1dx5_1I [g.3.11 - g.3.11 - g.3.11] THROMBOMODULIN
VEPVDPCFRANCEYQCQPLDQTSYLCVCAEGFAPIPHEPHRCQMFCNQTACPADCDPNTQ
ASCECPEGYILDDGFICTDIDECENGGFCSGVCHNLPGTFECICGPDSALAGQIGTDC
//
>1dzbA [b.1.1 - b.1.1] SCFV FRAGMENT 1F9
QVKLQQSGAELVKPGASVKLSCTASGFNIKDTYMHWVKQRPEQGLEWIGRIDPANGNTKY
DPKFQGKATITADTSSNTAYLQLSSLTSEDTAVYYCARWDWYFDVWGQGTTVTVSSDIEL
TQSPSSMYTSLGERVTITCKASQDINSYLRWFQQKPGKSPKTLIYYATSLADGVPSRFSG
SGSGQDYSLTISSLESDDTTTYYCLQHGESPYTFGGGTKLEI
//
>1dzbX [d.2.1] TURKEY EGG-WHITE LYSOZYME C
KVYGRCELAAAMKRLGLDNYRGYSLGNWVCAAKFESNFNTHATNRNTDGSTDYGILQINS
RWWCNDGRTPGSKNLCNIPCSALLSSDITASVNCAKKIASGGNGMNAWVAWRNRCKGTDV
HAWIRGCRL
//
>1dziA [c.62.1] INTEGRIN
ALIDVVVVCDESNSIYPWDAVKNFLEKFVQGLDIGPTKTQVGLIQYANNPRVVFNLNTYK
TKEEMIVATSQTSQYGGDLTNTFGAIQYARKYAYSAASGGRRSATKVMVVVTDGESHDGS
MLKAVIDQCNHDNILRFGIAVLGYLNRNALDTKNLIKEIKAIASIPTERYFFNVSDEAAL
LEKAG
//
>1dziC (B) [k.3.1] COLLAGEN
GPxGPxGFxGERGPxGPxGPx
//
>1e0fF [b.47.1] THROMBIN
IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFIENDLL
VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL
PDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIR
ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFY
THVFRLKKWIQKVIDQFGE
//
>1e0fK (I) [g.3.15] HAEMADIN
IRFGMGKVPCPDGEVGYTCDCGEKICLYGQSCNDGQCSGDPKPSSEFEEFEIDEEEK
//
>1e1hC (A) [d.92.1] BOTULINUM NEUROTOXIN TYPE A LIGHT CHAIN
MAYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQ
VPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTEL
KVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIR
FSPDFTFGFEESLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAY
//
>1e1hD [d.92.1] BOTULINUM NEUROTOXIN TYPE A LIGHT CHAIN
YEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASL
QYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFD
KAVFRINIVPDENYTIKDGFNLKANLSTNFNGQNTEINSRNFTRL
//
>1e3aB [d.153.1] PENICILLIN AMIDASE BETA SUBUNIT
PTGSNMWVIGKSKAQDAKAIMVNGPQFGWYAPAYTYGIGLHGAGYDVTGNTPFAYPGLVF
GHNGVISWGSTAGFGDDVDIFAERLSAEKPGYYLHNGKWVKMLSREETITVKNGQAETFT
VWRTVHGNILQTDQTTQTAYAKSRAWDGKEVASLLAWTHQMKAKNWQEWTQQAAKQALTI
NWYYADVNGNIGYVHTGAYPDRQSGHDPRLPVPGTGKWDWKGLLPFEMNPKVYNPQSGYI
ANWNNSPQKDYPASDLFAFLWGGADRVTEIDRLLEQKPRLTADQAWDVIRQTSRQDLNLR
LFLPTLQAATSGLTQSDPRRQLVETLTRWDGINLLNDDGKTWQQPGSAILNVWLTSMLKR
TVVAAVPMPFDKWYSASGYETTQDGPTGSLNISVGAKILYEAVQGDKSPIPQAVDLFAGK
PQQEVVLAALEDTWETLSKRYGNNVSNWKTPAMALTFRANNFFGVPQAAAEETRHQAEYQ
NRGTENDMIVFSPTTSDRPVLAWDVVAPGQSGFIAPDGTVDKHYEDQLKMYENFGRKSLW
LTKQDVEAHKESQEVLHVQR
//
>1e3aA [d.153.1] PENICILLIN AMIDASE ALPHA SUBUNIT
SSSEIKIVRDEYGMPHIYANDTWHLFYGYGYVVAQDRLFQMEMARRSTQGTVAEVLGKDF
VKFDKDIRRNYWPDAIRAQIAALSPEDMSILQGYADGMNAWIDKVNTNPETLLPKQFNTF
GFTPKRWEPFDVAMIFVGTMANRFSDSTSEIDNLALLTALKDKYGVSQGMAVFNQLKWLV
NPSAPTTIAVQESNYPLKFNQQNSQTAALLPRYDLPAPMLDRPAKGADGALLALAAGKNR
ETIAAQFAQGGANGLAGY
//
>1e3d_1B [e.18.1] [NIFE] HYDROGENASE LARGE SUBUNIT
TPRSNYTGPIVVDPLTRIEGHLRIEVEVEGGVIKEARSCATLFRGIETILKGRDPRDAQH
FTQRTCGVCTYTHALASTRCLEDAINKPIPANATYIRNLVLGNQFMHDHLVHFYHLHALD
FVDVTSALLADPAKAAKLANSISPRKATTEEFAAVQAKLKTFVASGQLGPFTNAYFLGGH
EGYYMDPEANLVCTAHYLQALRAQVEVAKGMAVFGAKNPHTQFTVAGGVTCYEALTPERI
KQFRELYVKARAFIEEVYIPDLLLVASYYKDWGKIGGTNNFMAFGEFPAPGGERDLNSRW
YKPGVIYDRKVGSVQPFDPSKIEEHVRHSWYEGKARAPFEGETNPHFTFMGDTDKYSWNK
APRYDGHAVETGPLAQMLVAYGHNHKTIKPTIDAVLGKLNLGPEALFSTLGRTAARGIQT
LVIAQQMENWLNEYENNIVKDKQIVEDYAVPTSARGVGFADVSRGGLSHWMTIEDGKIDN
FQLVVPTTWNLGPRDDKGVPSAAEAALVGTPVADPKRPVEILRTIHSFDPCIACSTH
//
>1e3d_1A [e.19.1] [NIFE] HYDROGENASE SMALL SUBUNIT
SRPSVVYLHAAECTGCSEALLRTYQPFIDTLILDTISLDYHETIMAAAGEAAEEALQAAV
NGPDGFICLVEGAIPTGMDNKYGYIAGHTMYDICKNILPKAKAVVSIGTCACYGGIQAAK
PNPTAAKGINDCYADLGVKAINVPGCPPNPLNMVGTLVAFLKGQKIELDEVGRPVMFFGQ
SVHDLCERRKHFDAGEFAPSFNSEEARKGWCLYDVGCKGPETYNNCPKVLFNETNWPVAA
GHPCIGCSEPNFWDDMTPFYQN
//
>1e44B [b.101.1] COLICIN E3
GFKDYGHDYHPAPKTENIKGLGDLKPGIPKTPKQNGGGKRKRWTGDKGRKIYEWDSQHGE
LEGYRASDGQHLGSFDPKTGNQLKGPDPKRNIKKYL
//
>1e44A [d.26.2] IMMUNITY PROTEIN
GLKLDLTWFDKSTEDFKGEEYSKDFGDDGSVMESLGVPFKDNVNNGCFDVIAEWVPLLQP
YFNHQIDISDNEYFVSFDYRDGDW
//
>1e4kB (A) [b.1.1 - b.1.1] FC FRAGMENT OF HUMAN IGG1
CPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPQVKFNWYVDGVQVHNAK
TKPREQQYNSTYRVVSVLTVLHQNWLDGKEYKCKVSNKALPAPIEKTISKAKGQPREPQV
YTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYS
KLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLS
//
>1e4kC [b.1.1 - b.1.1] LOW AFFINITY IMMUNOGLOBULIN GAMMA FC RECEPTOR
DLPKAVVFLEPQWYSVLEKDSVTLKCQGAYSPEDNSTQWFHNESLISSQASSYFIDAATV
NDSGEYRCQTNLSTLSDPVQLEVHIGWLLLQAPRWVFKEEDPIHLRCHSWKNTALHKVTY
LQNGKDRKYFHHNSDFHIPKATLKDSGSYFCRGLVGSKNVSSETVNITITQG
//
>1e4x_1L [b.1.1 - b.1.1] TAB2
DIQMTQTPSSLSASLGDRVTISCRASQDISHYLNWFQQKPDGTVKLLIYYTSTLHSGVPS
RFSGSGSGTDYSLTISNLEEEDIAFYFCQQGGALPFTFGSGTKLAIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLDSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1e4x_1H [b.1.1 - b.1.1] TAB2
QVQLQQPGAELVKPGASVKLSCKASGFTFTNYWMHWVKQRPGQGLEWIGEILPSNGRTNY
NEKFKTKATLTVDKSSNTAYMQLSSLTSEDSAVYYCARSPSDYWGQGTTLTVSSAKTTAP
SVYPLAPVCGDTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDLYTLSS
SVTVTSSTWPSQSITCNVAHPASSTKVDKKIEPRVP
//
>1e57_2a (C) [b.121.4] PHYSALIS MOTTLE VIRUS
KQASIPAPGSILSQPNTEQSPAIVLPFQFEATTFGTAETAAQVSLQTADPITKLTAPYRH
AQIVECKAILTPTDLAVSNPLTVYLAWVPANSPATPTQILRVYGGQSFVLGGAISAAKTI
EVPLNLDSVNRMLKDSVTYTDTPKLLAYSRAPTNPSKIPTASIQISGRIRLSKPMLIANV
VKVKQASIPAPGSILSQPNTEQSPAIVLPFQFEATTFGTAETAAQVSLQTADPITKLTAP
YRHAQIVECKAILTPTDLAVSNPLTVYLAWVPANSPATPTQILRVYGGQSFVLGGAISAA
KTIEVPLNLDSVNRMLKDSVTYTDTPKLLAYSRAPTNPSKIPTASIQISGRIRLSKPMLI
AN
//
>1e57_2b (C) [b.121.4] PHYSALIS MOTTLE VIRUS
SPAIVLPFQFEATTFGTAETAAQVSLQTADPITKLTAPYRHAQIVECKAILTPTDLAVSN
PLTVYLAWVPANSPATPTQILRVYGGQSFVLGGAISAAKTIEVPLNLDSVNRMLKDSVTY
TDTPKLLAYSRAPTNPSKIPTASIQISGRIRLSKPMLIAN
//
>1e57_2b (C) [b.121.4] PHYSALIS MOTTLE VIRUS
KQASIPAPGSILSQPNTEQSPAIVLPFQFEATTFGTAETAAQVSLQTADPITKLTAPYRH
AQIVECKAILTPTDLAVSNPLTVYLAWVPANSPATPTQILRVYGGQSFVLGGAISAAKTI
EVPLNLDSVNRMLKDSVTYTDTPKLLAYSRAPTNPSKIPTASIQISGRIRLSKPMLIAN
//
>1e6jH [b.1.1 - b.1.1] IMMUNOGLOBULIN
EVQLQQSGAELARPGASVKMSCKASGYTFTSYTMHWVKQRPGQGLEWIGYINPSSGYSNY
NQKFKDKATLTADKSSSTAYMQLSSLTSEDSAVYYCSRPVVRLGYNFDYWGQGSTLTVSS
AKTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSD
LYTLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKIV
//
>1e6jL [b.1.1 - b.1.1] IMMUNOGLOBULIN
EIVLTQSPAITAASLGQKVTITCSASSSVSYMHWYQQKSGTSPKPWIYEISKLASGVPAR
FSGSGSGTSYSLTISSMEAEDAAIYYCQQWNYPFTFGSGTKLEIKRADAAPTVSIFPPSS
EQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLTLT
KDEYERHNSYTCEATHKTSTSPIVKSFNR
//
>1e6jP [a.73.1 - a.28.3] CAPSID PROTEIN P24
VHQAISPRTLNAWVKVVEEKAFSPEVIPMFSALSEGATPQDLNTMLNTVGGHQAAMQMLK
ETINEEAAEWDRVHPVHAGPIAPGQMREPRGSDIAGTTSTLQEQIGWMTNNPPIPVGEIY
KRWIILGLNKIVRMYSPTSILDIRQGPKEPFRDYVDRFYKTLRAEQASQEVKNWMTETLL
VQNANPDCKTILKALGPAATLEEMMTACQ
//
>1e6vA [d.58.31 - a.89.1] METHYL-COENZYME M REDUCTASE I ALPHA SUBUNIT
LFMKALKEKFEESPEEKYTKFYIFGGWKQSERKKEFKEWADKIVEERGVPHYNPDIGVPL
GQRKLMSYQVSGTDVFVEGDDLTFVNNAAMQQMWDDIRRTVIVGMDTAHRVLERRLGKEV
TPETINEYMETLNHALPGGAVVQEHMVEIHPGLTWDCYAKIITGDLELADEIDDKFLIDI
EKLFPEEQAEQLIKAIGNRTYQVCRMPTIVGHVCDGATMYRWAAMQIAMSFICAYKIAAG
EAAVSDFAFASKHAEVINMGEMLPARRARGENEPGGVPFGVLADCVQTMRKYPDDPAKVA
LEVIAAGAMLYDQIWLGSYMSGGVGFTQYATAVYPDNILDDYVYYGLEYVEDKYGIAEAE
PSMDVVKDVATEVTLYGLEQYERYPAAMETHFGGSQRAAVCAAAAGCSTAFATGHAQAGL
NGWYLSQILHKEGQGRLGFYGYALQDQCGAANSLSVRSDEGLPLELRGPNYPNYAMNVGH
LGEYAGIVQAAHAARGDAFCVHPVIKVAFADENLVFDFTEPRKEFAKGALREFEPAGERD
LIVPA
//
>1e6vC [d.58.31] METHYL-COENZYME M REDUCTASE I GAMMA SUBUNIT
FYYPGETDVAENRRKYMNPNYELKKLREIPDEDIVRLMGHREPGEEYPSVHPPLEEMEEP
ECPIRELVEPTEGAKAGDRIRYIQFTDSVYFAPIHPYIRARMYMWRYRGVDTGSLSGRQI
IEVRERDLEKIAKELLETEIFDPARSGVRGATVHGHALRLDENGLMLHALRRYRLNEETG
EVEYVKDQVGIELDEPIPVGAPADEDDLKERTTIYRIDGTPYREDEELLQVVQRIHELRT
LAGYRPEE
//
>1e6vB [d.58.31 - a.89.1] METHYL-COENZYME M REDUCTASE I BETA SUBUNIT
DTVDLYDDRGNCVAEEVPIEVLSPMRNEAIQSIVNDIKRTVAVDLEGIENALQNATVGGK
GMKIPGREMDVDIVDNAEAIADEIEKMIRVYQDDDTNVEPMYDGKRLLVQLPSERVKVMA
DPYSGTLQAGMAVVHAIIDVCEVDMWDANMVKAAVFGRYPQTIDYFGGNVASMLDVPMKQ
EGVGYALRNIMVNHIVAATRKNTMQAVCLAATLQQTAMFEMGDALGPFERLHLLGYAYQG
LNADNMVYDIVKKHGKEGTVGTVVREVVERALEDGVIEVKEELPSFKVYKANDMDLWNAY
AAAGLVAAVMVNQGAARAAQGVSATILYYNDLLEYETGLPGVDFGRAEGTAVGFSFFSHS
IYGGGGPGIFHGNHIVTRHSKGFAIPPVAAAMALDAGTQMFSPEVTSKLIGDVFGEIDEF
REPMKYITEAAAEEAK
//
>1e6vE (B) [d.58.31 - a.89.1] METHYL-COENZYME M REDUCTASE I BETA SUBUNIT
DTVDLYDDRGNCVAEEVPIEVLSPMRNEAIQSIVNDIKRTVAVDLEGIENALQNATVGGK
GMKIPGREMDVDIVDNAEAIADEIEKMIRVYQDDDTNVEPMYDGKRLLVQLPSERVKVMA
DPYSGTLQAGMAVVHAIIDVCEVDMWDANMVKAAVFGRYPQTIDYFGGNVASMLDVPMKQ
EGVGYALRNIMVNHIVAATRKNTMQAVCLAATLQQTAMFEMGDALGPFERLHLLGYAYQG
LNADNMVYDIVKKHGKEGTVGTVVREVVERALEDGVIEVKEELPSFKVYKANDMDLWNAY
AAAGLVAAVMVNQGAARAAQGVSATILYYNDLLEYETGLPGVDFGRAEGTAVGFSFFSHS
IYGGGGPGIFHGNHIVTRHSKGFAIPPVAAAMALDAGTQMFSPEVTSKLIGDVFGEIDEF
REPMKYITEAAAEEAK
//
>1e6yA [x.x.x]
AADIFSKFKKDMEVKFAQEFGSNKQTGGDITDKTAKFLRLGPEQDPRKVEMIKAGKEIAE
KRGIAFYNPMMHSGAPLGQRAITPYTISGTDIVCEPDDLHYVNNAAMQQMWDDIRRTCIV
GLDMAHETLEKRLGKEVTPETINHYLEVLNHAMPGAAVVQEMMVETHPALVDDCYVKVFT
GDDALADEIDKQFLIDINKEFSEEQAAQIKASIGKTSWQAIHIPTIVSRTTDGAQTSRWA
AMQIGMSFISAYAMCAGEAAVADLSFAAKxAALVSMGEMLPARxARGPNEPGGLSFGHLS
DIVQTSRVSEDPAKIALEVVGAGCMLYDQIWLGSYMSGGVGFTQYATAAYTDDILDNNTY
YDVDYINDKYNGAATVGKDNKVKASLEVVKDIATESTLYGIETYEKFPTALEDHFGGSQR
ATVLAAAAGVACSLATGNANAGLSGWYLSMYLHKEAWGRLGFFFDLQDQxGATNVLSYQG
DEGLPDELRGPNYPNYAMNVGHQGGYAGIAQAAHSGRGDAFTVNPLLKVCFADDLLPFNF
AEPRREFGRGAIREFVPAGERSLVIPA
//
>1e6yB [d.58.31 - a.89.1] METHYL-COENZYME M REDUCTASE I BETA SUBUNIT
SDTVDIYDDRGKLLESNVDIMSLAPTRNAAIQSIIMDTKRSVAVNLAGIQGALASGKMGG
KGRQILGRGLNYDIVGNADAIAENVKKLVQVDEGDDTNVIKVKGGKSLLIQSPKSRIIAG
ADFMSATTVGAAAVTQTIMDMFGTDPYDAPIVKSAVWGSYPQTMDLMGGQVQGILSIPQN
NEGLGFSLRNIMANHVAAISNRNAMNASALSSIYEQSGIFEMGGAVGMFERHQLLGLAYQ
GLNANNLLYDIVKENGKDGTIGTVIESVVRRAIEAGIISVDKTAPSGYNFYKANDVPKWN
ACAAVGTLAATLVNCGAGRAAQNVSSTLLYFNDILEKETGLPGCDYGKVEGTAVGFSFFS
HSIYGGGGPGVFNGNHVVTRHSRGFAIPCVCAAVALDAGTQMFSIESTSGLIGDVFGAIP
EFREPIKAVAGV
//
>1e6yC [d.58.31] METHYL-COENZYME M REDUCTASE I GAMMA SUBUNIT
AYERQYYPGATSVAANRRKHMSGKLEKLREISDEDLTAVLGHRAPGSDYPSTHPPLAEMG
EPAxSTRENVAATPGAAAGDRVRYIQFADSMYNAPATPYFRSYFAAINFRGVDPGTLSGR
QIVEARERDMEQCAKVQMETEITDHALAGVRGATVHGHSVRLQEDGVMFDMLDRRRLENG
TIIMDKDQVAIPLDRKVDLGKPMSSEEAAKRTTIYRVDNVAFRDDAEVVEWVHRIFDQRT
KFGFQPK
//
>1e6yE [d.58.31 - a.89.1] METHYL-COENZYME M REDUCTASE I BETA SUBUNIT
SDTVDIYDDRGKLLESNVDIMSLAPTRNAAIQSIIMDTKRSVAVNLAGIQGALASGKMGG
KGRQILGRGLNYDIVGNADAIAENVKKLVQVDEGDDTNVIKVKGGKSLLIQSPKSRIIAG
ADFMSATTVGAAAVTQTIMDMFGTDPYDAPIVKSAVWGSYPQTMDLMGGQVQGILSIPQN
NEGLGFSLRNIMANHVAAISNRNAMNASALSSIYEQSGIFEMGGAVGMFERHQLLGLAYQ
GLNANNLLYDIVKENGKDGTIGTVIESVVRRAIEAGIISVDKTAPSGYNFYKANDVPKWN
ACAAVGTLAATLVNCGAGRAAQNVSSTLLYFNDILEKETGLPGCDYGKVEGTAVGFSFFS
HSIYGGGGPGVFNGNHVVTRHSRGFAIPCVCAAVALDAGTQMFSIESTSGLIGDVFGAIP
EFREPIKAVAGVL
//
>1e79A [b.49.1 - c.37.1 - a.69.1] ATP SYNTHASE ALPHA CHAIN HEART ISOFORM
ADTSVDLEETGRVLSIGDGIARVHGLRNVQAEEMVEFSSGLKGMSLNLEPDNVGVVVFGN
DKLIKEGDIVKRTGAIVDVPVGEELLGRVVDALGNAIDGKGPIGSKARRRVGLKAPGIIP
RISVREPMQTGIKAVDSLVPIGRGQRELIIGDRQTGKTSIAIDTIINQKRFNDGTDEKKK
LYCIYVAIGQKRSTVAQLVKRLTDADAMKYTIVVSATASDAAPLQYLAPYSGCSMGEYFR
DNGKHALIIYDDLSKQAVAYRQMSLLLRRPPGREAYPGDVFYLHSRLLERAAKMNDAFGG
GSLTALPVIETQAGDVSAYIPTNVISITDGQIFLETELFYKGIRPAINVGLSVSRVGSAA
QTRAMKQVAGTMKLELAQYREVAAFAQFGSDLDAATQQLLSRGVRLTELLKQGQYSPMAI
EEQVAVIYAGVRGYLDKLEPSKITKFENAFLSHVISQHQALLGKIRTDGKISEESDAKLK
EIVTNFLAGFEA
//
>1e79D [b.49.1 - c.37.1 - a.69.1] ATP SYNTHASE BETA CHAIN
TTGRIVAVIGAVVDVQFDEGLPPILNALEVQGRETRLVLEVAQHLGESTVRTIAMDGTEG
LVRGQKVLDSGAPIRIPVGPETLGRIMNVIGEPIDERGPIKTKQFAAIHAEAPEFVEMSV
EQEILVTGIKVVDLLAPYAKGGKIGLFGGAGVGKTVLIMELINNVAKAHGGYSVFAGVGE
RTREGNDLYHxMIESGVINLKDATSKVALVYGQMNEPPGARARVALTGLTVAEYFRDQEG
QDVLLFIDNIFRFTQAGSEVSALLGRIPSAVGYQPTLATDMGTMQERITTTKKGSITSVQ
AIYVPADDLTDPAPATTFAHLDATTVLSRAIAELGIYPAVDPLDSTSRIMDPNIVGSEHY
DVARGVQKILQDYKSLQDIIAILGMDELSEEDKLTVSRARKIQRFLSQPFQVAEVFTGHL
GKLVPLKETIKGFQQILAGEYDHLPEQAFYMVGPIEEAVAKADKLAE
//
>1e79H [b.93.1 - a.2.10] ATP SYNTHASE DELTA CHAIN
QMSFTFASPTQVFFNSANVRQVDVPTQTGAFGILAAHVPTLQVLRPGLVVVHAEDGTTSK
YFVSSGSVTVNADSSVQLLAEEAVTLDMLDLGAAKANLEKAQSELLGAADEATRAEIQIR
IEANEALVKAL
//
>1e79G [c.49.2] ATP SYNTHASE GAMMA CHAIN
ATLKDITRRLKSIKNIQKITKSMKMVAAAKYARAERELKPARVYGVGSLALYEKADIKTP
ELIIGVSSDRGLCGAIHSSVAKQMKSEAANLKEVKIIGVGDKIRSILHRTHSDQFLVTFK
EVGRRPPTFGDASVIALELLNSGYEFDEGSIIFNRFRSVISYKTEEKPIFSLDTISSAES
MSIYDDIDADVLRNYQEYSLANIIYYSLKESTTSEQSARMTAMDNASKNASEMIDKLTLT
FNRTRQAVITKELIEIISGAAAL
//
>1e79I [a.137.8] ATP SYNTHASE EPSILON CHAIN
VAYWRQAGLSYIRYSQICAKAVRDALKTEFKANAMKTSGSTIKIVKV
//
>1e7p_1A [c.3.1 - d.168.1 - a.7.3] FUMARATE REDUCTASE FLAVOPROTEIN SUBUNIT
MKVQYCDSLVIGGGLAGLRAAVATQQKGLSTIVLSLIPVKRSHSAAAQGGMQASLGNSKM
SDGDNEDLHFMDTVKGSDWGCDQKVARMFVNTAPKAIRELAAWGVPWTRIHKGDRMAIIN
AQKTTITEEDFRHGLIHSRDFGGTKKWRTCYTADATGHTMLFAVANECLKLGVSIQDRKE
AIALIHQDGKCYGAVVRDLVTGDIIAYVAKGTLIATGGYGRIYKNTTNAVVCEGTGTAIA
LETGIAQLGNMEAVQFHPTPLFPSGILLTEGCRGDGGILRDVDGHRFMPDYEPEKKELAS
RDVVSRRMIEHIRKGKGVQSPYGQHLWLDISILGRKHIETNLRDVQEICEYFAGIDPAEK
WAPVLPMQHYSMGGIRTDYRGEAKLKGLFSAGEAACWDMHGFNRLGGNSVSEAVVAGMIV
GEYFAEHCANTQVDLETKTLEKFVKGQEAYMKSLVESKGTEDVFKIKNRMKDVMDDNVGI
FRDGPHLEKAVKELEELYKKSKNVGIKNKRLHANPELEEAYRVPMMLKVALCVAKGALDR
TESRGAHNREDYPKRDDINWLNRTLASWPNPEQTLPTLEYEALDVNEMEIAPGYRGYGAK
GNYIENPLSVKRQEEIDKIQSELEAAGKDRHAIQEALMPYELPAKYKARNERLGD
//
>1e7p_1B [d.15.4 - a.1.2] FUMARATE REDUCTASE IRON-SULFUR PROTEIN
MGRMLTIRVFKYDPQSAVSKPHFQEYKIEEAPSMTIFIVLNMIRETYDPDLNFDFVCRAG
ICGSCGMMINGRPSLACRTLTKDFEDGVITLLPLPAFKLIKDLSVDTGNWFNGMSQRVES
WIHAQKEHDISKLEERIEPEVAQEVFELDRCIECGCCIAACGTKIMREDFVGAAGLNRVV
RFMIDPHDERTDEDYYELIGDDDGVFGCMTLLACHDVCPKNLPLQSKIAYLRRKMVSVN
//
>1e8oA [d.49.1] SIGNAL RECOGNITION PARTICLE 9 KDA PROTEIN
PQYQTWEEFSRAAEKLYLADPMKARVVLKYRHSDGNLCVKVTDDLVCLVYKTDQAQDVKK
IEKFHSQLMRLMVA
//
>1e8oB [d.49.1] SIGNAL RECOGNITION PARTICLE 14 KDA PROTEIN
VLLESEQFLTELTRLFQKCRTSGSVYITLKKYDNKCLLRATDGKKKISTVVSSKEVNKFQ
MAYSNLLRANMDGLK
//
>1e96A [c.37.1] RAS-RELATED C3 BOTULINUM TOXIN SUBSTRATE 1
PQAIKCVVVGDGAVGKTCLLISYTTNAFPGEYIPTVFDNYSANVMVDGKPVNLGLWDTAG
LEDYDRLRPLSYPQTDVFLICFSLVSPASFENVRAKWYPEVRHHCPNTPIILVGTKLDLR
DDKDTIEKLKEKKLTPITYPQGLAMAKEIGAVKYLECSALTQRGLKTVFDEAIRAVLC
//
>1e96B [a.118.8] NEUTROPHIL CYTOSOL FACTOR 2 (NCF-2) TPR DOMAIN,
SLVEAISLWNEGVLAADKKDWKGALDAFSAVQDPHSRICFNIGCMYTILKNMTEAEKAFT
RSINRDKHLAVAYFQRGMLYYQTEKYDLAIKDLKEALIQLRGNQLIDYKILGLQFKLFAC
EVLYNIAFMYAKKEEWKKAEEQLALATSMKSEPRHSKIDKAMECVWKQKLYEPVVIPVGK
LFRP
//
>1e9zB [b.92.1 - c.1.9] UREASE BETA SUBUNIT
MKKISRKEYVSMYGPTTGDKVRLGDTDLIAEVEHDYTIYGEELKFGGGKTLREGMSQSNN
PSKEELDLIITNALIVDYTGIYKADIGIKDGKIAGIGKGGNKDMQDGVKNNLSVGPATEA
LAGEGLIVTAGGIDTHIHFISPQQIPTAFASGVTTMIGGGTGPADGTNATTITPGRRNLK
WMLRAAEEYSMNLGFLAKGNASNDASLADQIEAGAIGFxIHEDWGTTPSAINHALDVADK
YDVQVAIHTDTLNEAGCVEDTMAAIAGRTMHTFHTEGAGGGHAPDIIKVAGEHNILPAST
NPTIPFTVNTEAEHMDMLMVCHHLDKSIKEDVQFADSRIRPQTIAAEDTLHDMGAFSITS
SDSQAMGRVGEVITRTWQTADKNKKEFGRLKEEKGDNDNFRIKRYLSKYTINPAIAHGIS
EYVGSVEVGKVADLVLWSPAFFGVKPNMIIKGGFIALSQMGDANASIPTPQPVYYREMFA
HHGKAKYDANITFVSQAAYDKGIKEELGLERQVLPVKNCRNVTKKDMQFNNTTAHIEVNP
ETYHVFVDGKEVTSKPANKVSLAQLFSIF
//
>1e9zA [d.8.1 - b.85.3] UREASE ALPHA SUBUNIT
MKLTPKELDKLMLHYAGELAKKRKEKGIKLNYVEAVALISAHIMEEARAGKKTAAELMQE
GRTLLKPDDVMDGVASMIHEVGIEAMFPDGTKLVTVHTPIEANGKLVPGELFLKNEDITI
NEGKKAVSVKVKNVGDRPVQIGSHFHFFEVNRCLDFDREKTFGKRLDIAAGTAVRFEPGE
EKSVELIDIGGNRRIFGFNALVDRQADNESKKIALHRAKERGFHGAKSDDNYVKTIKE
//
>1eah_21 [b.121.4] POLIOVIRUS TYPE 2 COAT PROTEINS VP1 TO VP4
ANNLPDTQSSGPAHSKETPALTAVETGATNPLVPSDTVQTRHVIQKRTRSESTVESFFAR
GACVAIIEVDNDSKLFSVWKITYKDTVQLRRKLEFFTYSRFDMEFTFVVTSNYTDANNGH
ALNQVYQIMYIPPGAPIPGKWNDYTWQTSSNPSVFYTYGAPPARISVPYVGIANAYSHFY
DGFAKVPLAGQASTEGDSLYGAASLNDFGSLAVRVVNDHNPTKLTSKIRVYMKPKHVRVW
CPRPPRAVPYYGPGVDYKDGLAPLPGKGLTTY
//
>1eah_22 [b.121.4] POLIOVIRUS TYPE 2 COAT PROTEINS VP1 TO VP4
SVRVMQLTLGNSTITTQEAANSVVAYGRWPEYIKDSEANPVDQPTEPDVAACRFYTLDTV
TWRKESRGWWWKLPDALKDMGLFGQNMFYHYLGRAGYTVHVQCNASKFHQGALGVFAVPE
MCLAGDSTTHMFTKYENANPGEKGGEFKGSFTLDTNATNPARNFCPVDYLFGSGVLAGNA
FVYPHQIINLRTNNCATLVLPYVNSLSIDSMTKHNNWGIAILPLAPLDFATESSTEIPIT
LTIAPMCCEFNGLRNITVPRTQ
//
>1eah_23 [b.121.4] POLIOVIRUS TYPE 2 COAT PROTEINS VP1 TO VP4
GLPVLNTPGSNQYLTADNYQSPCAIPEFDVTPPIDIPGEVRNMMELAEIDTMIPLNLTNQ
RKNTMDMYRVELNDAAHSDTPILCLSLSPASDPRLAHTMLGEILNYYTHWAGSLKFTFLF
CGSMMATGKLLVSYAPPGAEAPKSRKEAMLGTHVIWDIGLQSSCTMVVPWISNTTYRQTI
NDSFTEGGYISMFYQTRVVVPLSTPRKMDILGFVSACNDFSVRLLRDTTHISQEA
//
>1eah_24 [b.121.4] POLIOVIRUS TYPE 2 COAT PROTEINS VP1 TO VP4
GAQVSSQKVGAHENSNRAYGGSTINYTTINYYRDSASNAASKQDFAQDPSKFTEPIKDVL
IKTAPTLN
//
>1eai_1A [b.47.1] PROTEIN (ELASTASE)
VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVDRELTFRVVVGEH
NLNQNDGTEQYVGVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQLGVLPRAGTI
LANNSPCYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWGSTVKNSMVCAGGDGV
RSGCQGDSGGPLHCLVNGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSAYISWINNVIASN
//
>1eai_1C [g.22.1] PROTEIN (CHYMOTRYPSIN/ELASTASE ISOINHIBITOR 1)
GQESCGPNEVWTECTGCEMKCGPDENTPCPLMCRRPSCECSPGRGMRRTNDGKCIPASQC
P
//
>1eapA [b.1.1 - b.1.1] IGG2B-KAPPA 17E8 FAB (LIGHT CHAIN)
DIELTQSPSSLSASLGGKVTITCKASQDIKKYIGWYQHKPGKGPRLLIHYTSTLLPGIPS
RFRGSGSGRDYSFSISNLEGGDIATYYCLQYYNLRTFGGGTKLEIKRADAAPTVSIFPPS
SEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERAQGVLNSWTDQDSKDSTYSMSSTLTL
TKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1eapB [b.1.1 - b.1.1] IGG2B-KAPPA 17E8 FAB (HEAVY CHAIN)
EVQLQESGTELVKPGASVKISCKASGYISTDHAIHWVKQRPEQGLEWIGYISPGNGDIKY
NEKFKVKATLTADQSSSTAYMQLNSLTSEDSAVYFCKRSYYGSSYVDYWGQGTTLTVSSA
KTTPPSVYPLAPGCGDTTGSSVTLGCLVKGYFPESVTVTWNSGGLSSSVHTFPALLQSGL
YTMSSSVTVPGGGWPSATVTCSVAHPASSTTVDKKL
//
>1eawA [b.47.1] SUPPRESSOR OF TUMORIGENICITY 14
VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTA
FLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPICLPD
ASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVINQTTCENLLPQQITPRMMCVGFL
SGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKENTG
V
//
>1eawB [g.8.1] PANCREATIC TRYPSIN INHIBITOR
RPDFCLEPPYTGPCKARIIRYFYNAKAGLCQTFVYGGCRAKRNNFKSAEDCMRTCG
//
>1eay_1A [c.23.1] CHEY
ADKELKFLVVDDFSTMRRIVRNLLKELGFNNVEEAEDGVDALNKLQAGGYGFVISDWNMP
NMDGLELLKTIRADGAMSALPVLMVTAEAKKENIIAAAQAGASGYVVKPFTAATLEEKLN
KIFEKLGM
//
>1eay_1C [d.58.24] CHEA
PRRIILSRLKAGEVDLLEEELGHLTTLTDVVKGADSLSAILPGDIAEDDITAVLCFVIEA
DQITFET
//
>1ebdB (A) [c.3.1 - c.3.1 - d.87.1] DIHYDROLIPOAMIDE DEHYDROGENASE
AIETETLVVGAGPGGYVAAIRAAQLGQKVTIVEKGNLGGVCLNVGCIPSKALISASHRYE
QAKHSEEMGIKAENVTIDFAKVQEWKASVVKKLTGGVEGLLKGNKVEIVKGEAYFVDANT
VRVVNGDSAQTYTFKNAIIATGSRPIELPNFKFSNRILDSTGALNLGEVPKSLVVIGGGY
IGIELGTAYANFGTKVTILEGAGEILSGFEKQMAAIIKKRLKKKGVEVVTNALAKGAEER
EDGVTVTYEANGETKTIDADYVLVTVGRRPNTDELGLEQIGIKMTNRGLIEVDQQCRTSV
PNIFAIGDIVPGPALAHKASYEGKVAAEAIAGHPSAVDYVAIPAVVFSDPECASVGYFEQ
QAKDEGIDVIAAKFPFAANGRALALNDTDGFLKLVVRKEDGVIIGAQIIGPNASDMIAEL
GLAIEAGMTAEDIALTIHAHPTLGEIAMEAAEVAL
//
>1ebdC [a.9.1] DIHYDROLIPOAMIDE ACETYLTRANSFERASE
IAMPSVRKYAREKGVDIRLVQGTGKNGRVLKEDIDAFLAGG
//
>1ed3_2D (A) [d.19.1 - b.1.1] CLASS I MAJOR HISTOCOMPATIBILITY ANTIGEN RT1-AA
GSHSLRYFYTAVSRPGLGEPRFIAVGYVDDTEFVRFDSDAENPRMEPRARWMEREGPEYW
EQQTRIAKEWEQIYRVDLRTLRGYYNQSEGGSHTIQEMYGCDVGSDGSLLRGYRQDAYDG
RDYIALNEDLKTWTAADFAAQITRNKWERARYAERLRAYLEGTCVEWLSRYLELGKETLL
RSDPPEAHVTLHPRPEGDVTLRCWALGFYPADITLTWQLNGEDLTQDMELVETRPAGDGT
FQKWASVVVPLGKEQNYTCRVEHEGLPKPLSQRWE
//
>1ed3_2E (B) [b.1.1] BETA-2-MICROGLOBULIN
IQKTPQIQVYSRHPPENGKPNFLNCYVSQFHPPQIEIELLKNGKKIPNIEMSDLSFSKDW
SFYILAHTEFTPTETDVYACRVKHVTLKEPKTVTWDRDM
//
>1eerA [a.26.1] ERYTHROPOIETIN
APPRLICDSRVLERYLLEAKEAEKITTGCAEHCSLNEKITVPDTKVNFYAWKRMEVGQQA
VEVWQGLALLSEAVLRGQALLVKSSQPWEPLQLHVDKAVSGLRSLTTLLRALGAQKEAIS
NSDAASAAPLRTITADTFRKLFRVYSNFLRGKLKLYTGEACRTGDR
//
>1eerB [b.1.2 - b.1.2] ERYTHROPOIETIN RECEPTOR
DPKFESKAALLAARGPEELLCFTERLEDLVCFWEEAASAGVGPGQYSFSYQLEDEPWKLC
RLHQAPTARGAVRFWCSLPTADTSSFVPLELRVTAASGAPRYHRVIHINEVVLLDAPVGL
VARLADESGHVVLRWLPPPETPMTSHIRYEVDVSAGQGAGSVQRVEILEGRTECVLSNLR
GRTRYTFAVRARMAEPSFGGFWSEWSEPVSLLT
//
>1ef1_1A [d.15.1 - a.11.2 - b.55.1] MOESIN
TISVRVTTmDAELEFAIQPNTTGKQLFDQVVKTIGLREVWFFGLQYQDTKGFSTWLKLNK
KVTAQDVRKESPLLFKFRAKFYPEDVSEELIQDITQRLFFLQVKEGILNDDIYCPPETAV
LLASYAVQSKYGDFNKEVHKSGYLAGDKLLPQRVLEQHKLNKDQWEERIQVWHEEHRGmL
REDAVLEYLKIAQDLEmYGVNYFSIKNKKGSELWLGVDALGLNIYEQNDRLTPKIGFPWS
EIRNISFNDKKFVIKPIDKKAPDFVFYAPRLRINKRILALCmGNHELYmRRRKP
//
>1ef1_1C [a.137.5] MOESIN
AEASADLRADAMAKDRSEEERTTEAEKNERVQKHLKALTSELANARDESKKTANDmIHAE
NmRLGRDKYKTLRQIRQGNTKQRIDEFESm
//
>1efnA [b.34.2] FYN TYROSINE KINASE
ALFVALYDYEAITEDDLSFHKGEKFQILNSSEGDWWEARSLTTGETGYIPSNYVAPV
//
>1efnB [d.102.1] HIV-1 NEF PROTEIN
RPQVPLRPMTYKAAVDLSHFLKEKGGLEGLIHSQRRQDILDLWIYHTQGYFPDWQNYTPG
PGVRYPLTFGWCYKLVPVREVLEWRFDSRLAFHHVARELHPEYF
//
>1efp_1A [c.26.2 - c.31.1] PROTEIN (ELECTRON TRANSFER FLAVOPROTEIN)
AVLLLGEVTNGALNRDATAKAVAAVKALGDVTVLCAGASAKAAAEEAAKIAGVAKVLVAE
DALYGHRLAEPTAALIVGLAGDYSHIAAPATTDAKNVMPRVAALLDVMVLSDVSAILDAD
TFERPIYAGNAIQVVKSKDAKKVFTIRTASFDAAGEGGTAPVTETAAAADPGLSSWVADE
VAESDRPELTSARRVVSGGRGLGSKESFAIIEELADKLGAAVGASRAAVDSGYAPNDWQV
GQTGKVVAPELYVAVGISGAIQHLAGMKDSKVIVAINKDEEAPIFQIADYGLVGDLFSVV
PELTGKL
//
>1efp_1B [c.26.2] PROTEIN (ELECTRON TRANSFER FLAVOPROTEIN)
MKVLVPVKRLIDYNVKARVKSDGSGVDLANVKMSMNPFDEIAVEEAIRLKEKGQAEEIIA
VSIGVKQAAETLRTALAMGADRAILVVAADDVQQDIEPLAVAKILAAVARAEGTELIIAG
KQAIDNDMNATGQMLAAILGWAQATFASKVEIEGAKAKVTREVDGGLQTIAVSLPAVVTA
DLRLNEPRYASLPNIMKAKKKPLDEKTAADYGVDVAPRLEVVSVREPEGRKAGIKVGSVD
ELVGKL
//
>1efuD (B) [a.5.2 - d.43.1 - d.43.1] ELONGATION FACTOR TS
AEITASLVKELRERTGAGMMDCKKALTEANGDIELAIENMRKSGAIKAAKKAGNVAADGV
IKTKIDGNYGIILEVNCQTDFVAKDAGFQAFADKVLDAAVAGKITDVEVLKAQFEEERVA
LVAKIGENINIRRVAALEGDVLGSYQHGARIGVLVAAKGADEELVKHIAMHVAASKPEFI
KPEDVSAEVVEKEYQVQLDIAMQSGKPKEIAEKMVEGRMKKFTGEVSLTGQPFVMEPSKT
VGQLLKEHNAEVTGFIRFEVGEGIEKVETDFAAEVAAMSKQS
//
>1efuC (A) [c.37.1 - b.43.3 - b.44.1] ELONGATION FACTOR TU
KPHVNVGTIGHVDHGKTTLTAAITTVLAKTYGGTSHVEYDTPTRHYAHVDCPGHADYVKN
MITGAAQMDGAILVVAATDGPMPQTREHILLGRQVGVPYIIVFLNKCDMVDDEELLELVE
MEVRELLSQYDFPGDDTPIVRGSALKALEGDAEWEAKILELAGFLDSYIPEPERAIDKPF
LLPIEDVFSISGRGTVVTGRVERGIIKVGEEVEIVGIKETQKSTCTGVEMFRKLLDEGRA
GENVGVLLRGIKREEIERGQVLAKPGTIKPHTKFESEVYILSKDEGGRHTPFFKGYRPQF
YFRTTDVTGTIELPEGVEMVMPGDNIKMVVTLIHPIAMDDGLRFAIREGGRTVGAGVVAK
VLS
//
>1efxA [d.19.1 - b.1.1] HLA-CW3 (HEAVY CHAIN)
GSHSMRYFYTAVSRPGRGEPHFIAVGYVDDTQFVRFDSDAASPRGEPRAPWVEQEGPEYW
DRETQKYKRQAQTDRVSLRNLRGYYNQSEAGSHIIQRMYGCDVGPDGRLLRGYDQYAYDG
KDYIALNEDLRSWTAADTAAQITQRKWEAAREAEQLRAYLEGLCVEWLRRYLKNGKETLQ
RAEHPKTHVTHHPVSDHEATLRCWALGFYPAEITLTWQWDGEDQTQDTELVETRPAGDGT
FQKWAAVVVPSGEEQRYTCHVQHEGLPEPLTLRWEPSS
//
>1efxB [b.1.1] BETA-2-MICROGLOBULIN
MIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKD
WSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM
//
>1efxD [b.1.1 - b.1.1] NATURAL KILLER CELL RECEPTOR KIR2DL2
VHRKPSLLAHPGRLVKSEETVILQCWSDVRFEHFLLHREGKFKDTLHLIGEHHDGVSKAN
FSIGPMMQDLAGTYRCYGSVTHSPYQLSAPSDPLDIVITGLYEKPSLSAQPGPTVLAGES
VTLSCSSRSSYDMYHLSREGEAHECRFSAGPKVNGTFQADFPLGPATHGGTYRCFGSFRD
SPYEWSNSSDPLLVSVI
//
>1egjA [b.1.2] CYTOKINE RECEPTOR COMMON BETA CHAIN PRECURSOR
IQMAPPSLNVTKDGDSYSLRWETMKMRYEHIDHTFEIQYRKDTATWKDSKTETLQNAHSM
ALPALEPSTRYWARVRVRTSRTGYNGIWSEWSEARSWDTES
//
>1egjL [b.1.1 - b.1.1] ANTIBODY (LIGHT CHAIN)
NIVLTQSPASLAVSLGQRATISCRANESVYSYGDSFMHWYQQKPGQPPKLLIYLASNLAS
GVPARFSGSGSRTDFTLTIDPVETDDAATYYCQQNNEDPWTFGGGTKLEIKRGDAAPTVS
IFPPSSEQLTSGGASVVCFLNNFYPKDANVAWKIDGSERQNGVLNSWTDQDSKDSTYSMS
STLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNR
//
>1egjH [b.1.1 - b.1.1] ANTIBODY (HEAVY CHAIN)
EVQLQQSGPELVKPGTSVKMSCKASGYTFTDYYMKWVKHSHGKSLEWIGDINPSNGGTLY
NQKFKGKATLTVDKSSSTASMQLSRLTSEDSAVYYCSRGDGIHGGFAYWGQGTTVTVSSA
KTTAPSVYPLAPVCGDTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDL
YTLSSSVTVTSSTWPSQSITCNVAHPASSTKVDKKIVPQV
//
>1egpA [d.40.1] EGLIN-C
LKSFPEVVGKTVDQAREYFTLHYPQYNVYFLPEGSPVTL
//
>1egpB [d.40.1] EGLIN-C
YNRVRVFYNPGTNVVNHVPHVG
//
>1egvA [c.1.19] PROPANEDIOL DEHYDRATASE
MRSKRFEALAKRPVNQDGFVKEWIEEGFIAMESPNDPKPSIKIVNGAVTELDGKPVSDFD
LIDHFIARYGINLNRAEEVMAMDSVKLANMLCDPNVKRSEIVPLTTAMTPAKIVEVVSHM
NVVEMMMAMQKMRARRTPSQQAHVTNVKDNPVQIAADAAEGAWRGFDEQETTVAVARYAP
FNAIALLVGSQVGRPGVLTQCSLEEATELKLGMLGHTCYAETISVYGTEPVFTDGDDTPW
SKGFLASSYASRGLKMRFTSGSGSEVQMGYAEGKSMLYLEARCIYITKAAGVQGLQNGSV
SCIGVPSAVPSGIRAVLAENLICSSLDLECASSNDQTFTHSDMRRTARLLMQFLPGTDFI
SSGYSAVPNYDNMFAGSNEDAEDFDDYNVIQRDLKVDGGLRPVREEDVIAIRNKAARALQ
AVFAGMGLPPITDEEVEAATYAHGSKDMPERNIVEDIKFAQEIINKNRNGLEVVKALAQG
GFTDVAQDMLNIQKAKLTGDYLHTSAIIVGDGQVLSAVNDVNDYAGPATGYRLQGERWEE
IKNIPGALDPN
//
>1egvG [a.23.2] PROPANEDIOL DEHYDRATASE
SARVSDYPLANKHPEWVKTATNKTLDDFTLENVLSNKVTAQDMRITPETLRLQASIAKDA
GRDRLAMNFERAAELTAVPDDRILEIYNALRPYRSTKEELLAIADDLESRYQAKICAAFV
REAATLYVERKKLKGDD
//
>1ehkA [f.24.1] BA3-TYPE CYTOCHROME-C OXIDASE
AYPEKKATLYFLVLGFLALIVGSLFGPFQALNYGNVDAYPLLKRLLPFVQSYYQGLTLHG
VLNAIVFTQLFAQAIMVYLPARELNMRPNMGLMWLSWWMAFIGLVVAALPLLANEATVLY
TFYPPLKGHWAFYLGASVFVLSTWVSIYIVLDLWRRWKAANPGKVTPLVTYMAVVFWLMW
FLASLGLVLEAVLFLLPWSFGLVEGVDPLVARTLFWWTGHPIVYFWLLPAYAIIYTILPK
QAGGKLVSDPMARLAFLLFLLLSTPVGFHHQFADPGIDPTWKMIHSVLTLFVAVPSLMTA
FTVAASLEFAGRLRGGRGLFGWIRALPWDNPAFVAPVLGLLGFIPGGAGGIVNASFTLDY
VVHNTAWVPGHFHLQVASLVTLTAMGSLYWLLPNLTGKPISDAQRRLGLAVVWLWFLGMM
IMAVGLHWAGLLNVPRRAYIAQVPDAYPHAAVPMVFNVLAGIVLLVALLLFIYGLFSVLL
SRLAEAPLPFAEVISGPEDRRLVLAMDRIGFWFAVAAILVVLAYGPTLVQLFGHLNPVPG
WRLW
//
>1ehkC [f.23.9] BA3-TYPE CYTOCHROME-C OXIDASE
EEKPKGALAVILVLTLTILVFWLGVYAVFFARG
//
>1ehlL [b.1.1 - b.1.1] ANTI-(6-4) PHOTOPRODUCT ANTIBODY 64M-2 FAB
DVLMTQTPLSLPVSLGDQASISCRSSQSIVHSNGNTYLEWYLQKPGQSPKLLIYKVSNRF
SGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCFQGSLVPTFGGGTKLEIKRADAAPTVS
IFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMS
STLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNE
//
>1ehlH [b.1.1 - b.1.1] ANTI-(6-4) PHOTOPRODUCT ANTIBODY 64M-2 FAB
EVQLQQSGTVLARPGASVKMSCKASGYSFTSFWMHWVKQRPGQGLEWIGTIYPGNSDTSY
NQKFKGKAKLTAVTSASTAYMEVSSLTNEDSAVYYCTRRSGYKYYALDYWGQGTSVTVSS
AKTTAPSVYPLAPVCGDGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDLY
TLSSSVTVTSSTWPSQSITCNVAHPASSTKVDKKIEP
//
>1eiyB [a.6.1 - b.40.4 - b.153.1 - a.6.1 - d.104.1 - d.58.13] PHENYLALANYL-TRNA SYNTHETASE
MRVPFSWLKAYVPELESPEVLEERLAGLGFETDRIERVFPIPRGVVFARVLEAHPIPGTR
LKRLVLDAGRTVEVVSGAENARKGIGVALALPGTELPGLGQKVGERVIQGVRSFGMALSP
RELGVGEYGGGLLEFPEDALPPGTPLSEAWPEEVVLDLEVTPNRPDALGLLGLARDLHAL
GYALVEPEAALKAEALPLPFALKVEDPEGAPHFTLGYAFGLRVAPSPLWMQRALFAAGMR
PINNVVDVTNYVMLERAQPMHAFDLRFVGEGIAVRRAREGERLKTLDGVERTLHPEDLVI
AGWRGEESFPLGLAGVMGGAESEVREDTEAIALEVACFDPVSIRKTARRHGLRTEASHRF
ERGVDPLGQVPAQRRALSLLQALAGARVAEALLEAGSPKPPEAIPFRPEYANRLLGTSYP
EAEQIAILKRLGCRVEGEGPTYRVTPPSHRLDLRLEEDLVEEVARIQGYETIPLALPAFF
PAPDNRGVEAPYRKEQRLREVLSGLGFQEVYTYSFMDPEDARRFRLDPPRLLLLNPLAPE
KAALRTHLFPGLVRVLKENLDLDRPERALLFEVGRVFREREETHLAGLLFGEGVGLPWAK
ERLSGYFLLKGYLEALFARLGLAFRVEAQAFPFLHPGVSGRVLVEGEEVGFLGALHPEIA
QELELPPVHLFELRLPLPDKPLAFQDPSRHPAAFRDLAVVVPAPTPYGEVEALVREAAGP
YLESLALFDLYQGPPLPEGHKSLAFHLRFRHPKRTLRDEEVEEAVSRVAEALRARGFGLR
GLDTP
//
>1eiyA [a.2.7 - d.104.1] PHENYLALANYL-TRNA SYNTHETASE
LAAIQNARDLEELKALKARYLGKKGLLTQEMKGLSALPLEERRKRGQELNAIKAALEAAL
EAREKALEEAALKEALERERVDVSLPGASLFSGGLHPITLMERELVEIFRALGYQAVEGP
EVESEFFNFDALNIPEHHPARDMWDTFWLTGEGFRLEGPLGEEVEGRLLLRTHTSPMQVR
YMVAHTPPFRIVVPGRVFRFEQTDATHEAVFHQLEGLVVGEGIAMAHLKGAIYELAQALF
GPDSKVRFQPVYFPFVEPGAQFAVWWPEGGKWLELGGAGMVHPKVFQAVDAYRERLGLPP
AYRGVTGFAFGLGVERLAMLRYGIPDIRYFFGGRLKFLEQFKGVL
//
>1ej6_3E (D) [i.7.1] SIGMA2
ARAAFLFKTVGFGGLQNVPINDELSSHLLRAGNSPWQLTQFLDWISLGRGLATSALVPTA
GSRYYQMSCLLSGTLQIPFRPNHRWGDIRFLRLVWSAPTLDGLVVAPPQVLAQPALQAQA
DRVYDCDDYPFLARDPRFKHRVYQQLSAVTLLNLTGFGPISYVRVDEDMWSGDVNQLLMN
YFGHTFAEIAYTLCQASANRPWEHDGTYARMTQIILSLFWLSYVGVIHQQNTYRTFYFQC
NRRGDAAEVWILSCSLNHSAQIRPGNRSLFVMPTSPDWNMDVNLILSSTLTGCLCSGSQL
PLIDNNSVPAVSRNIHGWTGRAGNQLHGFQVRRMVTEFCDRLRRDGVMTQAQQNQIEALA
DQTQQFKRDKLEAWAREDDQYNQANPNSTMFRTKPFTNAQWGRGNTGATSAAIAALI
//
>1ej6_37 (B) [i.7.1] LAMBDA1
NKKTAQLLHADTPRLVTWDAGLCTSFKIVPIVPAQVPQDVLAYTFFTSSYAIQSPFPEAA
VSRIVVHTRWASNVDFDRDSSVIMAPPTENNIHLFKQLLNTETLSVRGANPLMFRANVLH
MLLEFVLDNLYLNRHTGFSQDHTPFTEGANLRSLPGPDAEKWYSIMYPTRMGTPNVSKIC
NFVASCVRNRVGRFDRAQMMNGAMSEWVDVFETSDALTVSIRGRWMARLARMNINPTEIE
WALTECAQGYVTVTSPYAPSVNRLMPYRISNAERQISQIIRIMNIGNNATVIQPVLQDIS
VLLQRISPLQIDPTIISNTMSTVSESTTQTLSPASSILGKLRPFSSFRVALAGWLYNGVV
TTVIDDSSYPKDGGSVTSLENLWDFFILALALPLTTDPCAPVKAFMTLANMMVGFETIPM
DNQIYTQSRRASAFSTPHTWPRCFMNIQLISPIDAPILRQWAEIIHRYWPNPSQIRYGAP
NVFGSANLFTPPEVLLLPIDHQPANVTTPTLDFTNELTNWRARVCELMKNLVDNQRYQPG
WTQSLVSSMRGTLDKLKLIKSMTPMYLQQLAPVELAVIAPMLPFPPFQVPYVRLDRDRVP
TMVGVTRQSRDTITQPALSLSTTNTTVGVPLALDARAITVALLSGKYPPDLVTNVWYADA
IYPMYADTEVFSNLQRDMITCEAVQTLVTLVAQISETQYPVDRYLDWIPSLRASAATAAT
FAEWVNTSMKTAFDLSDMLLEPLLSGDPRMTQLAIQYQQYNGRTFNVIPEMPGSVIADCV
QLTAEVFNHEYNLFGIARGDIIIGRVQSTHLWSPLAPPPDLVFDRDTPGVHIFGRDCRIS
FGMNGAAPMIRDETGMMVPFEGNWIFPLALWQMNTRYFNQQFDAWIKTGELRIRIEMGAY
PYMLHYYDPRQYANAWNLTSAWLEEITPTSIPSVPFMVPISSDHDISSAPAVQYIISTEY
NDRSLFCTNSSSPQTIAGPDKHIPVERYNILTNPDAPPTQIQLPEVVDLYNVVTRYAYET
PPITAVVMGVP
//
>1ej6_38 (C) [i.7.1] LAMBDA1
MKRIPRKTKGKSPATTEPGTSNREQYRARPGIASVQRATESAELPMKNNDEGTPDKKGNT
RGDLVNEHSEAKDEADEATQKQAKDTDKSKAQVTYSDTGINNANELSRSGNVDNEGGSNQ
KPMSTRIAEATSAIVSKHPAYQCHVCSAVLFSPLDLDAHVASHGLHGNEIQRHITEFISS
WQNHPIVQVSADVENKKTAQLLHADTPRLVTWDAGLCTSFKIVPIVPAQVPQDVLAYTFF
TSSYAIQSPFPEAAVSRIVVHTRWASNVDFDRDSSVIMAPPTENNIHLFKQLLNTETLSV
RGANPLMFRANVLHMLLEFVLDNLYLNRHTGFSQDHTPFTEGANLRSLPGPDAEKWYSIM
YPTRMGTPNVSKICNFVASCVRNRVGRFDRAQMMNGAMSEWVDVFETSDALTVSIRGRWM
ARLARMNINPTEIEWALTECAQGYVTVTSPYAPSVNRLMPYRISNAERQISQIIRIMNIG
NNATVIQPVLQDISVLLQRISPLQIDPTIISNTMSTLSPASSILGKLRPSNSDFSSFRVA
LAGWLYNGVVTTVIDDSSYPKDGGSVTSLENLWDFFILALALPLTTDPCAPVKAFMTLAN
MMVGFETIPMDNQIYTQSRRASAFSTPHTWPRCFMNIQLISPIDAPILRQWAEIIHRYWP
NPSQIRYGAPNVFGSANLFTPPEVLLLPIDHQPANVTTPTLDFTNELTNWRARVCELMKN
LVDNQRYQPGWTQSLVSSMRGTLDKLKLIKSMTPMYLQQLAPVELAVIAPMLPFPPFQVP
YVRLDRDRVPTMVGVTRQSRDTITQPALSLSTTNTTVGVPLALDARAITVALLSGKYPPD
LVTNVWYADAIYPMYADTEVFSNLQRDMITCEAVQTLVTLVAQISETQYPVDRYLDWIPS
LRASAATAATFAEWVNTSMKTAFDLSDMLLEPLLSGDPRMTQLAIQYQQYNGRTFNVIPE
MPGSVIADCVQLTAEVFNHEYNLFGIARGDIIIGRVQSTHLWSPLAPPPDLVFDRDTPGV
HIFGRDCRISFGMNGAAPMIRDETGMMVPFEGNWIFPLALWQMNTRYFNQQFDAWIKTGE
LRIRIEMGAYPYMLHYYDPRQYANAWNLTSAWLEEITPTSIPSVPFMVPISSDHDISSAP
AVQYIISTEYNDRSLFCTNSSSPQTIAGPDKHIPVERYNILTNPDAPPTQIQLPEVVDLY
NVVTRYAYETPPITAVVMGVP
//
>1ej6_39 (D) [i.7.1] SIGMA2
ARAAFLFKTVGFGGLQNVPINDELSSHLLRAGNSPWQLTQFLDWISLGRGLATSALVPTA
GSRYYQMSCLLSGTLQIPFRPNHRWGDIRFLRLVWSAPTLDGLVVAPPQVLAQPALQAQA
DRVYDCDDYPFLARDPRFKHRVYQQLSAVTLLNLTGFGPISYVRVDEDMWSGDVNQLLMN
YFGHTFAEIAYTLCQASANRPWEHDGTYARMTQIILSLFWLSYVGVIHQQNTYRTFYFQC
NRRGDAAEVWILSCSLNHSAQIRPGNRSLFVMPTSPDWNMDVNLILSSTLTGCLCSGSQL
PLIDNNSVPAVSRNIHGWTGRAGNQLHGFQVRRMVTEFCDRLRRDGVMTQAQQNQIEALA
DQTQQFKRDKLEAWAREDDQYNQANPNSTMFRTKPFTNAQWGRGNTGATSAAIAALI
//
>1ej6_3E (D) [i.7.1] SIGMA2
ARAAFLFKTVGFGGLQNVPINDELSSHLLRAGNSPWQLTQFLDWISLGRGLATSALVPTA
GSRYYQMSCLLSGTLQIPFRPNHRWGDIRFLRLVWSAPTLDGLVVAPPQVLAQPALQAQA
DRVYDCDDYPFLARDPRFKHRVYQQLSAVTLLNLTGFGPISYVRVDEDMWSGDVNQLLMN
YFGHTFAEIAYTLCQASANRPWEHDGTYARMTQIILSLFWLSYVGVIHQQNTYRTFYFQC
NRRGDAAEVWILSCSLNHSAQIRPGNRSLFVMPTSPDWNMDVNLILSSTLTGCLCSGSQL
PLIDNNSVPAVSRNIHGWTGRAGNQLHGFQVRRMVTEFCDRLRRDGVMTQAQQNQIEALA
DQTQQFKRDKLEAWAREDDQYNQANPNSTMFRTKPFTNAQWGRGNTGATSAAIAALI
//
>1ej6_4C [i.7.1] LAMBDA1
MKRIPRKTKGKSPATTEPGTSNREQYRARPGIASVQRATESAELPMKNNDEGTPDKKGNT
RGDLVNEHSEAKDEADEATQKQAKDTDKSKAQVTYSDTGINNANELSRSGNVDNEGGSNQ
KPMSTRIAEATSAIVSKHPAYQCHVCSAVLFSPLDLDAHVASHGLHGNEIQRHITEFISS
WQNHPIVQVSADVENKKTAQLLHADTPRLVTWDAGLCTSFKIVPIVPAQVPQDVLAYTFF
TSSYAIQSPFPEAAVSRIVVHTRWASNVDFDRDSSVIMAPPTENNIHLFKQLLNTETLSV
RGANPLMFRANVLHMLLEFVLDNLYLNRHTGFSQDHTPFTEGANLRSLPGPDAEKWYSIM
YPTRMGTPNVSKICNFVASCVRNRVGRFDRAQMMNGAMSEWVDVFETSDALTVSIRGRWM
ARLARMNINPTEIEWALTECAQGYVTVTSPYAPSVNRLMPYRISNAERQISQIIRIMNIG
NNATVIQPVLQDISVLLQRISPLQIDPTIISNTMSTLSPASSILGKLRPSNSDFSSFRVA
LAGWLYNGVVTTVIDDSSYPKDGGSVTSLENLWDFFILALALPLTTDPCAPVKAFMTLAN
MMVGFETIPMDNQIYTQSRRASAFSTPHTWPRCFMNIQLISPIDAPILRQWAEIIHRYWP
NPSQIRYGAPNVFGSANLFTPPEVLLLPIDHQPANVTTPTLDFTNELTNWRARVCELMKN
LVDNQRYQPGWTQSLVSSMRGTLDKLKLIKSMTPMYLQQLAPVELAVIAPMLPFPPFQVP
YVRLDRDRVPTMVGVTRQSRDTITQPALSLSTTNTTVGVPLALDARAITVALLSGKYPPD
LVTNVWYADAIYPMYADTEVFSNLQRDMITCEAVQTLVTLVAQISETQYPVDRYLDWIPS
LRASAATAATFAEWVNTSMKTAFDLSDMLLEPLLSGDPRMTQLAIQYQQYNGRTFNVIPE
MPGSVIADCVQLTAEVFNHEYNLFGIARGDIIIGRVQSTHLWSPLAPPPDLVFDRDTPGV
HIFGRDCRISFGMNGAAPMIRDETGMMVPFEGNWIFPLALWQMNTRYFNQQFDAWIKTGE
LRIRIEMGAYPYMLHYYDPRQYANAWNLTSAWLEEITPTSIPSVPFMVPISSDHDISSAP
AVQYIISTEYNDRSLFCTNSSSPQTIAGPDKHIPVERYNILTNPDAPPTQIQLPEVVDLY
NVVTRYAYETPPITAVVMGVP
//
>1ej6_4E (D) [i.7.1] SIGMA2
ARAAFLFKTVGFGGLQNVPINDELSSHLLRAGNSPWQLTQFLDWISLGRGLATSALVPTA
GSRYYQMSCLLSGTLQIPFRPNHRWGDIRFLRLVWSAPTLDGLVVAPPQVLAQPALQAQA
DRVYDCDDYPFLARDPRFKHRVYQQLSAVTLLNLTGFGPISYVRVDEDMWSGDVNQLLMN
YFGHTFAEIAYTLCQASANRPWEHDGTYARMTQIILSLFWLSYVGVIHQQNTYRTFYFQC
NRRGDAAEVWILSCSLNHSAQIRPGNRSLFVMPTSPDWNMDVNLILSSTLTGCLCSGSQL
PLIDNNSVPAVSRNIHGWTGRAGNQLHGFQVRRMVTEFCDRLRRDGVMTQAQQNQIEALA
DQTQQFKRDKLEAWAREDDQYNQANPNSTMFRTKPFTNAQWGRGNTGATSAAIAALI
//
>1ejaA [b.47.1] TRYPSIN
IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYKSRIQVRLGEHNIDVLEG
NEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSCAAAGTECLISG
WGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSYPGQITGNMICVGFLEGGKDSCQGDSGGP
VVCNGQLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIAAN
//
>1ejaB [g.3.15] BDELLASTASIN
TTPCGPVTCSGAQMCEVDKCVCSDLHCKVKCEHGFKKDDNGCEYACICADAPQ
//
>1ejoL [b.1.1 - b.1.1] IGG2A MONOCLONAL ANTIBODY (LIGHT CHAIN)
DIVLTQSPASLAVSLGQRATISCRASESVDSYGNSFMHWYQQKPGQPPKLLIYRASNLES
GIPARFSGSGSRTDFTLTINPVEADDVATYYCQQSNEDPLTFGAGTKLELKRADAAPTVS
IFPPSSEQLTSGGASVVCFLNNFYPKDINVRWKIDGSERQNGVLNSWTDQDSKDSTYSMS
STLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRA
//
>1ejoH [b.1.1 - b.1.1] IGG2A MONOCLONAL ANTIBODY (HEAVY CHAIN)
QMLVESGGDLVKPGGSLKLSCAASGFTFSSYTMSWVRQTPEKRLEWVATISSGGAYTYYP
DSVKGRFTISDDNAESTLYLQMSSLRSEDTAMYYCVRRAFDSDVGFASWGHRTLVTVSAA
KTTAPSVYPLAPVCGSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDLYTLSS
SVTVTSSTWPSQSITCNVAHPASSTKVDKKIEPR
//
>1ejxC [b.92.1 - c.1.9] UREASE ALPHA SUBUNIT
SNISRQAYADMFGPTVGDKVRLADTELWIEVEDDLTTYGEEVKFGGGKVIRDGMGQGQML
AADCVDLVLTNALIVDHWGIVKADIGVKDGRIFAIGKAGNPDIQPNVTIPIGAATEVIAA
EGKIVTAGGIDTHIHWICPQQAEEALVSGVTTMVGGGTGPAAGTHATTCTPGPWYISRML
QAADSLPVNIGLLGKGNVSQPDALREQVAAGVIGLxIHEDWGATPAAIDCALTVADEMDI
QVALHSDTLNESGFVEDTLAAIGGRTIHTFHTEGAGGGHAPDIITACAHPNILPSSTNPT
LPYTLNTIDEHLDMLMVCVAFAESRIRRETIAAEDVLHDLGAFSLTSSDSQAMGRVGEVI
LRTWQVAHRMKVQRGALAEETGDNDNFRVKRYIAKYTINPALTHGIAHEVGSIEVGKLAD
LVVWSPAFFGVKPATVIKGGMIAIAPMGDINASIPTPQPVHYRPMFGALGSARHHCRLTF
LSQAAAANGVAERLNLRSAIAVVKGCRTVQKADMVHNSLQPNITVDAQTYEVRVDGELIT
SEPADVLPMAQRYFLF
//
>1ejxB [b.85.3] UREASE BETA SUBUNIT
MIPGEYHVKPGQIALNTGRATCRVVVENHGDRPIQVGSHYHFAEVNPALKFDRQQAAGYR
LNIPAGTAVRFEPGQKREVELVAFAGHRAVFGFRGEVMGPL
//
>1ejxA [d.8.1] UREASE GAMMA SUBUNIT
MELTPREKDKLLLFTAALVAERRLARGLKLNYPESVALISAFIMEGARDGKSVASLMEEG
RHVLTREQVMEGVPEMIPDIQVEATFPDGSKLVTVHNPII
//
>1ejxD (C) [b.92.1 - c.1.9] UREASE ALPHA SUBUNIT
SNISRQAYADMFGPTVGDKVRLADTELWIEVEDDLTTYGEEVKFGGGKVIRDGMGQGQML
AADCVDLVLTNALIVDHWGIVKADIGVKDGRIFAIGKAGNPDIQPNVTIPIGAATEVIAA
EGKIVTAGGIDTHIHWICPQQAEEALVSGVTTMVGGGTGPAAGTHATTCTPGPWYISRML
QAADSLPVNIGLLGKGNVSQPDALREQVAAGVIGLxIHEDWGATPAAIDCALTVADEMDI
QVALHSDTLNESGFVEDTLAAIGGRTIHTFHTEGAGGGHAPDIITACAHPNILPSSTNPT
LPYTLNTIDEHLDMLMVCVAFAESRIRRETIAAEDVLHDLGAFSLTSSDSQAMGRVGEVI
LRTWQVAHRMKVQRGALAEETGDNDNFRVKRYIAKYTINPALTHGIAHEVGSIEVGKLAD
LVVWSPAFFGVKPATVIKGGMIAIAPMGDINASIPTPQPVHYRPMFGALGSARHHCRLTF
LSQAAAANGVAERLNLRSAIAVVKGCRTVQKADMVHNSLQPNITVDAQTYEVRVDGELIT
SEPADVLPMAQRYFLF
//
>1ekc_2F [x.x.x]
MRRYEVNIVLNPNLDQSQLALEKEIIQRALENYGARVEKVEELGLRRLAYPIAKDPQGYF
LWYQVEMPEDRVNDLARELRIRDNVRRVMVVKSQEPFL
//
>1ekc_2H [x.x.x]
RNVEVLKRFLSETGKILPRRRTGLSGKEQRILAKTIKRARILGLLPFTEK
//
>1em8_1A [c.128.1] DNA POLYMERASE III CHI SUBUNIT
MKNATFYLLDNDTTVDGLSAVEQLVCEIAAERWRSGKRVLIACEDEKQAYRLDEALWARP
AESFVPHNLAGEGPRGGAPVEIAWPQKRSSSRRDILISLRTSFADFATAFTEVVDFVPYE
DSLKQLARERYKAYRVAGFNLNTATWK
//
>1em8_1B [c.126.1] DNA POLYMERASE III PSI SUBUNIT
GEIAIAIPAHVRLVMVANDLPALTDPLVSDVLRALTVSPDQVLQLTPEKIAMLPQGSHCN
SWRLGTDEPLSLEGAQVASPALTDLRANPTARAALWQQICTYEHDFFPRN
//
>1emtL [b.1.1 - b.1.1] IGG ANTIBODY (LIGHT CHAIN)
DIQMTQTTSSLSASLGDRVTFSCSASQDISNYLNWYQQKPDGTIKLLIYYTSSLRSGVPS
RFSGSGSGTDYSLTINNLEPEDIATYFCQQYSRLPFTFGSGTKLEIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1emtH [b.1.1 - b.1.1] IGG ANTIBODY (HEAVY CHAIN)
QVHLQESGPELVRPGASVKISCKTSGYVFSSSWMNWVKQRPGQGLKWIGRIYPGNGNTNY
NEKFKGKATLTADKSSNTAYMQLSSLTSVDSAVYFCATSSAYWGQGTLLTVSAAKTTPPS
VYPLAPGNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTLSSSVTVPS
SPRPSETVTCNVAHPASSTKVDKKIVPR
//
>1eo8A [b.19.1] HEMAGGLUTININ (HA1 CHAIN)
STATLCLGHHAVPNGTLVKTITDDQIEVTNATELVQSSSTGKICNNPHRILDGIDCTLID
ALLGDPHCDVFQNETWDLFVERSKAFSNCYPYDVPDYASLRSLVASSGTLEFITEGFTWT
GVTQNGGSNACKRGPGSGFFSRLNWLTKSGSTYPVLNVTMPNNDNFDKLYIWGIHHPSTN
QEQTSLYVQASGRVTVSTRRSQQTIIPNIGSRPWVRGLSSRISIYWTIVKPGDVLVINSN
GNLIAPRGYFKMRTGKSSIMRSDAPIDTCISECITPNGSIPNDKPFQNVNKITYGACPKY
VKQNTLKLATGMRNVPEKQ
//
>1eo8H [b.1.1 - b.1.1] ANTIBODY (HEAVY CHAIN)
QVQLQQSGAELMKPGPSVKISCKATGYSFSTYFIEWIRQRPGHGLEWIGEILPGSDNTNF
NEKFKDRATFTADTPSNTAYMQLSSLTSEDSAVYYCARPTGRLWFSYWGQGTLVTVSAAK
TTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLY
TLSSSVTVPSSPRPSETVTCNVAHPASSTKVDKKIVP
//
>1eo8G (L) [b.1.1 - b.1.1] ANTIBODY (LIGHT CHAIN)
QIILTQSPAIMSASPGEKVTMTCSASSDISYMHWYQQKSDTSPKIWIYDTSKLASGVPAR
FSGSGSGTSYSLTISTMEAEDAATYYCHQRSSYPTFGGGTKLEIKRADAAPTVSIFPPSK
IQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLTLT
KDEYERHNSYTCEATHKTSTSPIVKSFNRN
//
>1eo8I (H) [b.1.1 - b.1.1] ANTIBODY (HEAVY CHAIN)
QVQLQQSGAELMKPGPSVKISCKATGYSFSTYFIEWIRQRPGHGLEWIGEILPGSDNTNF
NEKFKDRATFTADTPSNTAYMQLSSLTSEDSAVYYCARPTGRLWFSYWGQGTLVTVSAAK
TTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLY
TLSSSVTVPSSPRPSETVTCNVAHPASSTKVDKKIVP
//
>1ep3A [c.1.4] DIHYDROOROTATE DEHYDROGENASE B (PYRD SUBUNIT)
MTENNRLSVKLPGLDLKNPIIPASGCFGFGEEYAKYYDLNKLGSIMVKATTLHPRFGNPT
PRVAETASGMLNAIGLQNPGLEVIMTEKLPWLNENFPELPIIANVAGSEEADYVAVCAKI
GDAANVKAIELNISCPNVKHGGQAFGTDPEVAAALVKACKAVSKVPLYVKLSPNVTDIVP
IAKAVEAAGADGLTMINTLMGVRFDLKTRQPILANITGGLSGPAIKPVALKLIHQVAQDV
DIPIIGMGGVANAQDVLEMYMAGASAVAVGTANFADPFVCPKIIDKLPELMDQYRIESLE
SLIQEVKEGKK
//
>1ep3B [b.43.4 - c.25.1] DIHYDROOROTATE DEHYDROGENASE B (PYRK SUBUNIT)
SQLQEMMTVVSQREVAYNIFEMVLKGTLVDEMDLPGQFLHLAVPNGAMLLRRPISISSWD
KRAKTCTILYRIGDETTGTYKLSKLESGAKVDVMGPLGNGFPVAEVTSTDKILIIGGGIG
VPPLYELAKQLEKTGCQMTILLGFASENVKILENEFSNLKNVTLKIATDDGSYGTKGHVG
MLMNEIDFEVDALYTCGAPAMLKAVAKKYDQLERLYISMESRMACGIGACYACVEHDKED
ESHALKVCEDGPVFLGKQLSL
//
>1eptA [b.47.1] PORCINE E-TRYPSIN
IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK
//
>1eptB [b.47.1] PORCINE E-TRYPSIN
SRIQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATV
SLPRSCAAAGTECLISGWGNTK
//
>1eptC [b.47.1] PORCINE E-TRYPSIN
SSGSSYPSLLQCLKAPVLSNSSCKSSYPGQITGNMICVGFLQGGKDSCQGDSGGPVVCNG
QLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIAAN
//
>1eqzE [a.22.1] PROTEIN (HISTONE H2A)
GRGKQGGKARAKAKSRSSRAGLQFPVGRVHRLLRKGNYAERVGAGAPVYLAAVLEYLTAE
ILELAGNAARDNKKTRIIPRHLQLAIRNDEELNKLLGKVTIAQGGVLPNIQAVLLPKKTD
SHKAKAK
//
>1eqzF [a.22.1] PROTEIN (HISTONE H2B)
TKTQKKGDKKRKKSRKESYSIYVYKVLKQVHPDTGISSKAMGIMNSFVNDIFERIAGEAS
RLAHYNKRSTITSREIQTAVRLLLPGELAKHAVSEGTKAVTKYTSSK
//
>1es0A [d.19.1 - b.1.1] H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN
DIEADHVGFYGTTVYQSPGDIGQYTHEFDGDELFYVDLDKKKTVWRLPEFGQLILFEPQG
GLQNIAAEKHNLGILTKRSNFTPATNEAPQATVFPKSPVLLGQPNTLICFVDNIFPPVIN
ITWLRNSKSVTDGVYETSFLVNRDHSFHKLSYLTFIPSDDDIYDCKVEHWGLEEPVLKHW
SS
//
>1es0B [d.19.1 - b.1.1] 65 KD GLUTAMIC ACID DECARBOXYLASE+H-2 CLASS II
YEIAPVFVLLEYVTRHFVHQFKGECYFTNGTQRIRLVTRYIYNREEYLRFDSDVGEYRAV
TELGRHSAEYYNKQYLERTRAELDTACRHNYEETEVPTSLRRLEQPNVAISLSNTLVCSV
TDFYPAKIKVRWFRNGQEETVGVSSTQLIRNGDWTFQVLVMLEMTPHQGEVYTCHVEHPS
LKSPITVEWS
//
>1eth_1A [c.69.1 - b.12.1] TRIACYLGLYCEROL ACYL-HYDROLASE
SEVCFPRLGCFSDDAPWAGIVQRPLKILPWSPKDVDTRFLLYTNQNQNNYQELVADPSTI
TNSNFRMDRKTRFIIHGFIDKGEEDWLSNICKNLFKVESVNCICVDWKGGSRTGYTQASQ
NIRIVGAEVAYFVEVLKSSLGYSPSNVHVIGHSLGSHAAGEAGRRTNGTIERITGLDPAE
PCFQGTPELVRLDPSDAKFVDVIHTDAAPIIPNLGFGMSQTVGHLDFFPNGGKQMPGCQK
NILSQIVDIDGIWEGTRDFVACNHLRSYKYYADSILNPDGFAGFPCDSYNVFTANKCFPC
PSEGCPQMGHYADRFPGKTNGVSQVFYLNTGDASNFARWRYKVSVTLSGKKVTGHILVSL
FGNEGNSRQYEIYKGTLQPDNTHSDEFDSDVEVGDLQKVKFIWYNVINPTLPRVGASKIT
VERNDGKVYDFCSQETVREEVLLTLNPC
//
>1eth_1B [g.3.10 - g.3.10] COLIPASE
PRGIIINLDEGELCLNSAQCKSNCCQHDTILSLSRCALKARENSECSAFTLYGVYYKCPC
ERGLTCEGDKSLVGSITNTNFGICHNV
//
>1etrL [b.47.1] EPSILON-THROMBIN
TFGAGEADCGLRPLFEKKQVQDQTEKELFESYIEGR
//
>1etrH [b.47.1] EPSILON-THROMBIN
IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLL
VRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCL
PDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKASTRIR
ITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFY
THVFRLKKWIQKVIDRLGS
//
>1etsL [b.47.1] EPSILON-THROMBIN
TFGAGEADCGLRPLFEKKQVQDQTEKELFESYIEGR
//
>1etsH [b.47.1] EPSILON-THROMBIN
IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLL
VRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCL
PDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKASTRIR
ITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFY
THVFRLKKWIQKVIDRLGS
//
>1ettL [b.47.1] EPSILON-THROMBIN
TFGAGEADCGLRPLFEKKQVQDQTEKELFESYIEGR
//
>1ettH [b.47.1] EPSILON-THROMBIN
IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLL
VRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCL
PDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKASTRIR
ITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFY
THVFRLKKWIQKVIDRLGS
//
>1etz_1L [b.1.1 - b.1.1] FAB NC10.14 - LIGHT CHAIN
FAVVTQESALTTSPGETVTLTCRSSTGAVTTSNYAIWVQEKPDHLFSGLIGGTNNRVPGV
PARFSGSLIGDKAALTVTGAQTEDEAIYFCALWYSNHWVFGGGTKLTVLGQPKSSPSVTL
FTPSSEELETNKATLVCTITDFYPGVVTVDWKVDGTPVTQGMETTQPSKQSNNKYMASSY
LTLTARAWERHSSYSCQVTHEGHTVEKSLSRAECS
//
>1etz_1H [b.1.1 - b.1.1] FAB NC10.14 - HEAVY CHAIN
QVTLKESGPGILQPSQTLSLTCSFSGFSLSTSGMGVGWIRQPSGEGLEWLADIWWNDKKY
YNPSLKSRLTVSKDTSSNQVFLKITSVDTSDTATYHCARRTFSYYYGSSFYYFDNWGQGT
TLTVSSAKTTPPSVYPLAPGCGDTTGSSVTLGCLVKGYFPESVTVTWNSGSLSSSVHTFP
ALLQSGLYTMSSSVTVPSSTWPSQTVTCSVAHPASSTTVDKKLEPSGP
//
>1eucA [c.2.1 - c.23.4] SUCCINYL-COA SYNTHETASE, ALPHA CHAIN
CSYTASRKHLYVDKNTKVICQGFTGKQGTFHSQQALEYGTNLVGGTTPGKGGKTHLGLPV
FNTVKEAKEQTGATASVIYVPPPFAAAAINEAIDAEVPLVVCITEGIPQQDMVRVKHRLL
RQGKTRLIGPNCPGVINPGECKIGIMPGHIHKKGRIGIVSRSGTLTYEAVHQTTQVGLGQ
SLCVGIGGDPFNGTDFTDCLEIFLNDPATEGIILIGEIGGNAEENAAEFLKQHNSGPKSK
PVVSFIAGLTAPPGRRMGHAGAIIAGGKGGAKEKITALQSAGVVVSMSPAQLGTTIYKEF
EKRKML
//
>1eucB [d.142.1 - c.23.4] SUCCINYL-COA SYNTHETASE, BETA CHAIN
MVNLQEYQSKKLMSDNGVKVQRFFVADTANEALEAAKRLNAKEIVLKAQILAGGRGKGVF
SSGLKGGVHLTKDPEVVGQLAKQMIGYNLATKQTPKEGVKVNKVMVAEALDISRETYLAI
LMDRSCNGPVLVGSPQGGVDIEEVAASNPELIFKEQIDIIEGIKDSQAQRMAENLGFLGP
LQNQAADQIKKLYNLFLKIDATQVEVNPFGETPEGQVVCFDAKINFDDNAEFRQKDIFAM
DDKSENEPIENEAAKYDLKYIGLDGNIACFVNGAGLAMATCDIIFLNGGKPANFLDLGGG
VKESQVYQAFKLLTADPKVEAILVNIFGGIVNxAIIANGITKACRELELKVPLVVRLEGT
NVHEAQNILTNSGLPITSAVDLEDAAKKAVASVT
//
>1euvA [d.3.1] ULP1 PROTEASE
GSLVPELNEKDDDQVQKALASRENTQLMNRDNIEITVRDFKTLAPRRWLNDTIIEFFMKY
IEKSTPNTVAFNSFFYTNLSERGYQGVRRWMKRKKTQIDKLDKIFTPINLNQSHWALGII
DLKKKTIGYVDSLSNGPNAMSFAILTDLQKYVMEESKHTIGEDFDLIHLDCPQQPNGYDC
GIYVCMNTLYGSADAPLDFDYKDAIRMRRFIAHLILTDALK
//
>1euvB [d.15.1] UBITQUTIN-LIKE PROTEIN SMT3
PETHINLKVSDGSSEIFFKIKKTTPLRRLMEAFAKRQGKEMDSLRFLYDGIRIQADQTPE
DLDMEDNDIIEAHREQIGG
//
>1ev1_21 [b.121.4] ECHOVIRUS 1
GDVQNAVEGAMVRVADTVQTSATNSERVPNLTAVETGHTSQAVPGDTMQTRHVINNHVRS
ESTIENFLARSACVFYLEYKTGTKEDSNSFNNWVITTRRVAQLRRKLEMFTYLRFDMEIT
VVITSSQDQSTSQNQNAPVLTHQIMYVPPGGPIPVSVDDYSWQTSTNPSIFWTEGNAPAR
MSIPFISIGNAYSNFYDGWSHFSQAGVYGFTTLNNMGQLFFRHVNKPNPAAITSVARIYF
KPKHVRAWVPRPPRLCPYINSTNVNFEPKPVTEVRTNIITT
//
>1ev1_22 [b.121.4] ECHOVIRUS 1
GYSDRVRSITLGNSTITTQECANVVVGYGEWPEYLSDNEATAEDQPTQPDVATCRFYTLD
SVQWENGSPGWWWKFPDALRDMGLFGQNMYYHYLGRAGYTIHVQCNASKFHQGCILVVCV
PEAEMGSAQTSGVVNYEHISKGEIASRFTTTTTAEDHGVQAAVWNAGMGVGVGNLTIFPH
QWINLRTNNSATIVMPYVNSVPMDNMYRHHNFTLMIIPFVPLDFSAGASTYVPITVTVAP
MCAEYNGLRLAGHQ
//
>1ev1_23 [b.121.4] ECHOVIRUS 1
GLPTMNTPGSNQFLTSDDFQSPSAMPQFDVTPEMHIPGEVRNLMEIAEVDSVMPINNDSA
AKVSSMEAYRVELSTNTNAGTQVFGFQLNPGAESVMNRTLMGEILNYYAHWSGSIKITFV
FCGSAMTTGKFLLSYAPPGAGAPKTRKDAMLGTHVVWDVGLQSSCVLCIPWISQTHYRFV
EKDPYTNAGFVTCWYQTSVVSPASNQPKCYMMCMVSACNDFSVRMLRDTKFIEQTSFYQ
//
>1ev1_24 [b.121.4] ECHOVIRUS 1
GAQVSTQKTGAHETSIIHYTNINYYKDAASNSANRQDFTQDPGKFTEPMKDVMIKTLPAL
N
//
>1ev1_2A (1) [b.121.4] ECHOVIRUS 1
GDVQNAVEGAMVRVADTVQTSATNSERVPNLTAVETGHTSQAVPGDTMQTRHVINNHVRS
ESTIENFLARSACVFYLEYKTGTKEDSNSFNNWVITTRRVAQLRRKLEMFTYLRFDMEIT
VVITSSQDQSTSQNQNAPVLTHQIMYVPPGGPIPVSVDDYSWQTSTNPSIFWTEGNAPAR
MSIPFISIGNAYSNFYDGWSHFSQAGVYGFTTLNNMGQLFFRHVNKPNPAAITSVARIYF
KPKHVRAWVPRPPRLCPYINSTNVNFEPKPVTEVRTNIITT
//
>1ev1_2C (3) [b.121.4] ECHOVIRUS 1
GLPTMNTPGSNQFLTSDDFQSPSAMPQFDVTPEMHIPGEVRNLMEIAEVDSVMPINNDSA
AKVSSMEAYRVELSTNTNAGTQVFGFQLNPGAESVMNRTLMGEILNYYAHWSGSIKITFV
FCGSAMTTGKFLLSYAPPGAGAPKTRKDAMLGTHVVWDVGLQSSCVLCIPWISQTHYRFV
EKDPYTNAGFVTCWYQTSVVSPASNQPKCYMMCMVSACNDFSVRMLRDTKFIEQTSFYQ
//
>1evtD [b.1.1 - b.1.1] PROTEIN (FIBROBLAST GROWTH FACTOR RECEPTOR 1)
NRMPVAPYWTSPEKMEKKLHAVPAAKTVKFKCPSSGTPNPTLRWLKNGKEFKPDHRIGGY
KVRYATWSIIMDSVVPSDKGNYTCIVENEYGSINHTYQLDVVERSPHRPILQAGLPANKT
VALGSNVEFMCKVYSDPQPHIQWLKHIPYVQILKTAEVLHLRNVSFEDAGEYTCLAGNSI
GLSHHSAWLTVL
//
>1evtB (A) [b.42.1] PROTEIN (FIBROBLAST GROWTH FACTOR 1)
YKKPKLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAM
DTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLKKNGSCKRGPRTHYGQ
KAILFLPLPVS
//
>1ewyA [b.43.4 - c.25.1] FERREDOXIN-NADP REDUCTASE
TQAKAKHADVPVNLYRPNAPFIGKVISNEPLVKEGGIGIVQHIKFDLTGGNLKYIEGQSI
GIIPPGVDKNGKPEKLRLYSIASTRHGDDVDDKTISLCVRQLEYKHPESGETVYGVCSTY
LTHIEPGSEVKITGPVGKEMLLPDDPEANVIMLATGTGIAPMRTYLWRMFKDAERAANPE
YQFKGFSWLVFGVPTTPNILYKEELEEIQQKYPDNFRLTYAISREQKNPQGGRMYIQDRV
AEHADELWQLIKNQKTHTYICGLRGMEEGIDAALSAAAAKEGVTWSDYQKDLKKAGRWHV
ETY
//
>1ewyC [d.15.4] FERREDOXIN I
ATFKVTLINEAEGTKHEIEVPDDEYILDAAEEQGYDLPFSCRAGACSTCAGKLVSGTVDQ
SDQSFLDDDQIEAGYVLTCVAYPTSDVVIQTHKEEDLY
//
>1exbA [c.1.7] KV BETA2 PROTEIN
LQFYRNLGKSGLRVSCLGLGTWVTFGGQITDEMAEHLMTLAYDNGINLFDTAEVYAAGKA
EVVLGNIIKKKGWRRSSLVITTKIFWGGKAETERGLSRKHIIEGLKASLERLQLEYVDVV
FANRPDPNTPMEETVRAMTHVINQGMAMYWGTSRWSSMEIMEAYSVARQFNLIPPICEQA
EYHMFQREKVEVQLPELFHKIGVGAMTWSPLACGIVSGKYDSGIPPYSRASLKGYQWLKD
KILSEEGRRQQAKLKELQAIAERLGCTLPQLAIAWCLRNEGVSSVLLGASNAEQLMENIG
AIQVLPKLSSSIVHEIDSILGNKPYS
//
>1exbE [d.42.1] POTASSIUM CHANNEL KV1.1
CERVVINISGLRFETQLKTLAQFPNTLLGNPKKRMRYFDPLRNEYFFDRNRPSFDAILYY
YQSGGRLRRPVNVPLDMFSEEIKFYELGEEA
//
>1exuA [d.19.1 - b.1.1] IGG RECEPTOR FCRN LARGE SUBUNIT P51
HLSLLYHLTAVSSPAPGTPAFWVSGWLGPQQYLSYNSLRGEAEPCGAWYWEKETTDLRIK
EKLFLEAFKALGGKGPYTLQGLLGCELGPDNTSVPTAKFALNGEEFMNFDLKQGTWGGDW
PEALAISQRWQQQDKAANKELTFLLFSCPHRLREHLERGRGNLEWKEPPSMRLKARPSSP
GFSVLTCSAFSFYPPELQLRFLRNGLAAGTGQGDFGPNSDGSFHASSSLTVKSGDEHHYC
CIVQHAGLAQPLRVEL
//
>1exuB [b.1.1] BETA-2-MICROGLOBULIN
IQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDW
SFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM
//
>1eysC [a.138.1] PHOTOSYNTHETIC REACTION CENTER
CEGPPPGTEQIGYRGVGMENYYVKRQRALSIQANQPVESLPAADSTGPKASEVYQSVQVL
KDLSVGEFTRTMVAVTTWVSPKEGCNYCHVPGNWASDDIYTKVVSRRMFELVRAANSDWK
AHVAETGVTCYTCHRGNPVPKYAWVTDPGPKYPSGLKPTGQNYGSKTVAYASLPFDPLTP
FLDQANEIRITGNAALAGSNPASLKQAEWTFGLMMNISDSLGVGCTSCHNTRAFNDWTQS
TPKRTTAWYAIRHVRDINQNYIWPLNDVLPASRKGPYGDPLRVSCMTCHQAVNKPLYGAQ
MAKDYPGLYK
//
>1eysL [f.26.1] PHOTOSYNTHETIC REACTION CENTER
AMLSFEKKYRVRGGTLIGGDLFDFWVGPFYVGFFGVVGFCFTLLGVLLIVWGATIGPTGP
TSDLQTYNLWRISIAPPDLSYGLRMAPLTEGGLWQIITICAAGAFISWALREVEICRKLG
IGFHVPFAFSFAIGAYLVLVFVRPLLMGAWGHGFPYGILSHLDWVSNVGYQFLHFHYNPA
HMLAISFFFTNCLALSMHGSLILSVTNPQRGEPVKTSEHENTFFRDIVGYSIGALAIHRL
GLFLALSAAFWSAVCILISGPFWTRGWPEWWNWWLELPLW
//
>1eysM [f.26.1] PHOTOSYNTHETIC REACTION CENTER
PEYQNIFTAVQVRAPAYPGVPLPKGNLPRIGRPIFSYWLGKIGDAQIGPIYLGLTGTLSI
FFGLVAISIIGFNMLASVHWDVFQFLKHFFWLGLEPPPPQYGLRIPPLSEGGWWLIAGLF
LTLSILLWWVRTYKRAEALGMSQHLSWAFAAAIFFYLVLGFIRPVMMGSWAKAVPFGIFP
HLDWTAAFSIRYGNLYYNPFHMLSIAFLYGSALLFAMHGATILSVSRFGGDREIDQITHR
GTAAEGAALFWRWTMGFNATMESIHRWAWWCAVLTVITAGIGILLSGTVVDNWYLWAVKH
GMAPAYPEVVTAVNPYET
//
>1eysH [f.23.10 - b.41.1] PHOTOSYNTHETIC REACTION CENTER
HYIDAAQITIWAFWLFFFGLIIYLRREDKREGYPLDSPDLPDPKTFVLPHNGGTVVAPRV
EAPVAVNATPFSPAPGSPLVPNGDPMLSGFGPAASPDRPKHCDLTFEGLPKIVPMRVAKE
FSIAEGDPDPRGMTVVGLDGEVAGTVSDVWVDRSEPQIRYLEVEVAANKKKVLLPIGFSR
FDKKARKVKVDAIKAAHFANVPTLSNPDQVTLYEEDKVCAYYAGGKLYATAERAGPLL
//
>1eyxB [a.1.1] R-PHYCOERYTHRIN
MLDAFSRVISNADAKAAYVGGSDLQALRTFISDGNKRLDAVNYIVSNSSCIVSDAISGMI
CENPGLITPGGxCYTNRRMAACLRDGEIILRYISYALLAGDSSVLEDRCLNGLKETYIAL
GVPTNSTVRAVSIMKAAVGAFISNTASQRKGEVIEGDCSALAAEIASYCDRISAAVS
//
>1eyxA [a.1.1] R-PHYCOERYTHRIN
MKSVITTVISAADSAGRFPSSSDLESVQGNIQRASARLEAAEKLASNHEAVVKEAGDACF
GKYGYLKNPGEAGENQEKINKCYRDIDHYMRLVNYSLVIGGTGPLDEWGIAGAREVYRTL
NLPTSAYIAAFAFTRDRLCGPRDMSAQAGVEYSTALDYIINSLS
//
>1ezsA [b.16.1] ECOTIN
PYPQAEKGMKRQVIQLTPQEDESTLKVELLIGQTLEVDCNLHRLGGKLENKTAYYVFDKV
SSPVSTRMACPDGKKEKKFVTAYLGDAGMLRYNSKLPIVVYTPDNVDVKYRVWKAEEKID
NAVVR
//
>1ezsD (C) [b.47.1] TRYPSIN II, ANIONIC
IVGGYTCQENSVPYQVSLNSGYHFCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLEG
DEQFVNAAKIIKHPNFDRKTLNNNIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLISG
WGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDSGGP
VVCNGELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAAN
//
>1ezuB (A) [b.16.1] ECOTIN
SVQPLEKIAPYPQAEKGMKRQVIQLTPQEDESTLKVELLIGQTLEVDCNLHRLGGKLENK
TLEGWGFPYYVFDKVSSPVSTMMACPDGKKEKKFVTAYLGDAGMLRYNSKLPIVVYTPDN
VDVKYRVWKAEEKIDNAVVR
//
>1ezuC [b.47.1] TRYPSIN II, ANIONIC
IVGGYTCQENSVPYQVSLNSGYHFCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLEG
DEQFVNAAKIIKHPNFDRKTLNNNIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLISG
WGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDSGGP
VVCNGELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAAN
//
>1ezvA [d.185.1 - d.185.1] UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX CORE
AEVTQLSNGIVVATEHNPAHTASVGVVFGSGAANENPYNNGVSNLWKNIFLSKENSAVAA
KEGLALSSNISRDFQSYIVSSLPGSTDKSLDFLNQSFIQQKANLLSSSNFEATKKSVLKQ
VQDFEDNDHPNRVLEHLHSTAFQNTPLSLPTRGTLESLENLVVADLESFANNHFLNSNAV
VVGTGNIKHEDLVNSIESKNLSLQTGTKPVLKKKAAFLGSEVRLRDDTLPKAWISLAVEG
EPVNSPNYFVAKLAAQIFGSYNAFEPASRLQGIKLLDNIQEYQLCDNFNHFSLSYKDSGL
WGFSTATRNVTMIDDLIHFTLKQWNRLTISVTDTEVERAKSLLKLQLGQLYESGNPVNDA
NLLGAEVLIKGSKLSLGEAFKKIDAITVKDVKAWAGKRLWDQDIAIAGTGQIEGLLDYMR
IRSDMSMMRW
//
>1ezvE [f.23.12 - b.33.1] UBIQUINOL-CYTOCHROME C REDUCTASE IRON-SULFUR
KSTYRTPNFDDVLKENNDADKGRSYAYFMVGAMGLLSSAGAKSTVETFISSMTATADVLA
MAKVEVNLAAIPLGKNVVVKWQGKPVFIRHRTPHEIQEANSVDMSALKDPQTDADRVKDP
QWLIMLGICTHLGCVPIGEAGDFGGWFCPCHGSHYDISGRIRKGPAPLNLEIPAYEFDGD
KVIVG
//
>1ezvG [f.23.13] UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX
GPPSGKTYMGWWGHMGGPKQKGITSYAVSPYAQKPLQGIFHNAVFNSFRRFKSQFLYVLI
PAGIYWYWWKNGNEYNEFLYSKAGREELERVNV
//
>1ezvY [b.1.1] LIGHT CHAIN (VL) OF FV-FRAGMENT
DIELTQTPVSLAASLGDRVTISCRASQDINNFLNWYQQKPDGTIKLLIYYTSRLHAGVPS
RFSGSGSGTDYSLTISNLEPEDIATYFCQHHIKFPWTFGAGTKLEIK
//
>1ezxA [e.1.1] ALPHA-1-ANTITRYPSIN
NKITPNLAEFAFSLYRQLAHQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFN
LTEIPEAQIHEGFQELLRTLNQPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAF
TVNFGDTEEAKKQINDYVEKGTQGKIVDLVKELDRDTVFALVNYIFFKGKWERPFEVKDT
EEEDFHVDQVTTVKVPMMKRLGMFNIQHCKKLSSWVLLMKYLGNATAIFFLPDEGKLQHL
ENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSNGADLSGVTE
EAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPM
//
>1ezxC [b.47.1] TRYPSIN
CGGSLINSQWVVSAAHCYKSASKSIVHPSYNSNTLNNDIMLIKLKISLPTSCASAGTQCL
ICLKAPILSDSSCKSAYPGQITSNMFCAGYLCQGDSGGPVVCSGKLQGIVSWGSGCAQKP
GVYTKVCNYVSWIKQTIASN
//
>1f02A (T) [j.67.1] TRANSLOCATED INTIMIN RECEPTOR
MDQAANAAESATKDQLTQEAFKNPENQKVNIDANGNAIPSGELKDDIVEQIAQQAKEAGE
VARQQA
//
>1f02B (I) [b.1.14 - b.1.14 - d.169.1] INTIMIN
ASITEIKADKTTAVANGQDAITYTVKVMKGDKPVSNQEVTFTTTLGKLSNSTEKTDTNGY
AKVTLTSTTPGKSLVSARVSDVAVDVKAPEVEFFTTLTIDDGNIEIVGTGVKGKLPTVWL
QYGQVNLKASGGNGKYTWRSANPAIASVDASSGQVTLKEKGTTTISVISSDNQTATYTIA
TPNSLIVPNMSKRVTYNDAVNTCKNFGGKLPSSQNELENVFKAWGAANKYEYYKSSQTII
SWVQQTAQDAKSGVASTYDLVKQNPLNNIKASESNAYATCVK
//
>1f0cA [e.1.1] ICE INHIBITOR
MDIFREIASSMKGENVFISPPSISSVLTILYYGANGSTAEQLSKYVDISFKSMNKVYGRY
SAVFKDSFLRKIGDNFQTVDFTDCRTVDAINKCVDIFTEGKINPLLDEPLSPDTCLLAIS
AVYFKAKWLMPFEKEFTSDYPFYVSPTEMVDVSMMSMYGEAFNHASVKESFGNFSIIELP
YVGDTSMVVILPDNIDGLESIEQNLTDTNFKKWCDSMDAMFIDVHIPKFKVTGSYNLVDA
LVKLGLTEVFGSTGDYSNMCNSDVSVDAMIHKTYIDVNEEYTEAAAATCALVADC
//
>1f0cB [e.1.1] ICE INHIBITOR
STVTNEFCADHPFIYVIRHVDGKILFVGRYCSPTT
//
>1f11_2C (A) [b.1.1 - b.1.1] F124 IMMUNOGLOBULIN (KAPPA LIGHT CHAIN)
DMVLTQSPASLAVSLGQRATISCKASQSVDYDGDSYMNWYQQKPGQPPKLLIYVASNLKS
GIPARFSGSGSGTDFTLNIHPVEEEDAATYYCQQSNEDPFTFGSGTKLEIKRADAAPTVS
IFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMS
STLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRN
//
>1f11_2D (B) [b.1.1 - b.1.1] F124 IMMUNOGLOBULIN (IGG1 HEAVY CHAIN)
EVQLQQSGPELVKPGASVKMSCKASGYTFTDYYMKWVKQSHGKSLEWIGDINPNNGGTGY
NQKFKGKATLTVDKSSSTAYMQLNSLTSEDSAVYYCANDYGSTYGFAYWGQGTLVTVSAA
KTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDL
YTLSSSVTVPSSPRPSETVTCNVAHPASSTKVDKKIVP
//
>1f2sE [b.47.1] TRYPSIN
IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEG
NEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISG
WGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGP
VVCSGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN
//
>1f2sI [g.3.2] TRYPSIN INHIBITOR A
RICPRIWMECKRDSDCMAECICVMGHCG
//
>1f2tA [c.37.1] RAD50 ABC-ATPASE
MKLERVTVKNFRSHSDTVVEFKEGINLIIGQNGSGKSSLLDAILVGLYWPLRIKDIKKDE
FTKVGARDTYIDLIFEKDGTKYRITRRFLKGEIHAMKRLVGNEWKHVTEPSSKAISAFME
KLIPYNIFLNAIYIRQGQIDAILES
//
>1f2tB [c.37.1] RAD50 ABC-ATPASE
AREAALSKIGELASEIFAEFTEGKYSEVVVRAEENKVRLFVVWEGKERPLTFLSGGERIA
LGLAFRLAMSLYLAGEISLLILDEPTPYLDEERRRKLITIMERYLKKIPQVILVSHDEEL
KDAADHVIRISLENGSSKVEVVS
//
>1f34A [b.50.1] PEPSIN A
IGDEPLENYLDTEYFGTIGIGTPAQDFTVIFDTGSSNLWVPSVYCSSLACSDHNQFNPDD
SSTFEATxQELSITYGTGSMTGILGYDTVQVGGISDTNQIFGLSETEPGSFLYYAPFDGI
LGLAYPSISASGATPVFDNLWDQGLVSQDLFSVYLSSNDDSGSVVLLGGIDSSYYTGSLN
WVPVSVEGYWQITLDSITMDGETIACSGGCQAIVDTGTSLLTGPTSAIANIQSDIGASEN
SDGEMVISCSSIDSLPDIVFTINGVQYPLSPSAYILQDDDSCTSGFEGMDVPTSSGELWI
LGDVFIRQYYTVFDRANNKVGLAPVA
//
>1f34B [d.62.1] MAJOR PEPSIN INHIBITOR PI-3
QFLFSMSTGPFICTVKDNQVFVANLPWTMLEGDDIQVGKEFAARVEDCTNVKHDMAPTCT
KPPPFCGPQDMKMFNFVGCSVLGNKLFIDQKYVRDLTAKDHAEVQTFREKIAAFEEQQEN
QPPAGGLSPPPPPSFCTV
//
>1f3d_1L [b.1.1 - b.1.1] CATALYTIC ANTIBODY 4B2
DVLMTQTPLSLPVSLGDQVSISCRSSQSIFHSDGKTYLEWHLQKPGQSPKLLIYKVSKRF
SGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCFQGSHVPYTFGGGTKLEIKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNA
//
>1f3d_1H [b.1.1 - b.1.1] CATALYTIC ANTIBODY 4B2
EIQLQQSGPELVKPGASVKVSCKASGYSFIDYNIHWVKQSHGKSLEWIGYIVPYSGGTTF
NQKFKGKATLTVDKSSSTAFMHLNSLTFEDSAVYYCANDYDGVYWGQGTTLTVSSAKTTP
PSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTLS
SSVTVPSSTWPSETVTCNVAHPASSTKVDKKIVPRDC
//
>1f3mA [j.66.1] SERINE/THREONINE-PROTEIN KINASE PAK-ALPHA
PSDFEHTIHVGFDAVTGEFTGMPEQWARLLQTSNITKSEQKKNPQAVLDVLEFYNSKKTS
NSQKYMSFTD
//
>1f3mC [d.144.1] SERINE/THREONINE-PROTEIN KINASE PAK-ALPHA
SDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK
KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA
VCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITTMVGTPYWMAPEV
VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR
DFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATK
//
>1f3u_3E (A) [b.65.1] TRANSCRIPTION INITIATION FACTOR IIF, BETA
AERGELDLTGAKQNTGVWLVKVPKYLSQQWAKASGRGEVGKLRIAKTQGRTEVSFTLNED
LANIHDIGGKPASVSAPREHPFVLQSVGGQTLTVFTESSSDKLSLEGIVVQRAECRPA
//
>1f3u_3F [b.65.1] TRANSCRIPTION INITIATION FACTOR IIF, ALPHA
GPSSQNVTEYVVRVPKNTTKKYNIMAFNAADKVNFATWNQARLERDLSNKKIYQEEEMRK
LREEARRKKYGIVLKEFRPEDQPWLLRVNGKSGRKFKGIKKGGVTENTSYYIFTQCPDGA
FEAFPVHNWYNFTPLARHRTLTAEEAEEEWERRN
//
>1f3vA [d.58.22] TUMOR NECROSIS FACTOR RECEPTOR TYPE 1 ASSOCIATED
HEEWVGSAYLFVESSLDKVVLSDAYAHPQQKVAVYRALQAALAESGGSPDVLQMLKIHRS
DPQLIVQLRFCGRQPCGRFLRAYREGALRAALQRSLAAALAQHSVPLQLELRAGAERLDA
LLADEERCLSCILAQQPDRLRDEELAELEDALRNLKCG
//
>1f3vB [h.1.2 - b.8.1] TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED
KDLAmADLEQKVLEmEASTYDGVFIWKISDFPRKRQEAVAGRIPAIFSPAFYTSRYGYKm
CLRIYLNGDGTGRGTHLSLFFVVmKGPNDALLRWPFNQKVTLmLLDQNNREHVIDAFRPD
VTSSSFQRPVNDmNIASGCPLFCPVSKmEAKNSYVRDDAIFIKAIVDLTGL
//
>1f45A [b.1.1 - b.1.2 - b.1.2] INTERLEUKIN-12 BETA CHAIN
IWELKKDVYVVELDWYPDAPGEMVVLTCDTPEEDGITWTLDQSSEVLGSGKTLTIQVKEF
GDAGQYTCSHSLLLLHKKEDGIWSTDILKDQKEPKNKTFLRCEAKNYSGRFTCWWLTTIS
TDLTFSVKSSRGSSDPQGVTCGAATLSAEEYEYSVECQEDSACPAAEESLPIEVMVDAVH
KLKYENYTSSFFIRDIIKPDPPKNLQLKPLKNSRQVEVSWEYPDTWSTPHSYFSLTFCVQ
VQKDRVFTDKTSATVICRSISVRAQDRYYSSSWSEWASVPCS
//
>1f45B [a.26.1] INTERLEUKIN-12 ALPHA CHAIN
QNLLRAVSNMLQKARQTLEFYPCSTVEACLPLELTKNESCTSFITNGSSFMMALCLSSIY
EDLKMYQVEFKTMNAKLLMDPKRQIFLDQNMLAVIDELMQALYKTKIKLCILLHAFRIRA
VTIDRVMSYLNAS
//
>1f4xL [b.1.1 - b.1.1] ANTIBODY S-20-4, FAB FRAGMENT, LIGHT CHAIN
QAVVTQESALTTSPGETVTLTCRSSTGTVTTSNYANWVQEKPDHLFTGLIGATNNRAAGV
PVRFSGSLIGGKAALTITGAQTEDEAIYFCALWYSGHWVFGGGTKLTVLGQPKSSPSVTL
FPPSSEELETNKATLVCTITDFYPGVVTVDWKVDGTPVTQGMETTNPSKQSNNKYMASSY
LTLTARAWERHSSYSCQVTHEGHTVEKSLS
//
>1f4xH [b.1.1 - b.1.1] ANTIBODY S-20-4, FAB FRAGMENT, HEAVY CHAIN
EVQLEESGGGLVTPGGSLRLSCAASGYVFSTYDMSWVRQTPEKRLEWVAFISSGGGRTSY
PDTVKGRFTISRDDAKNTLYLQMSSLQSEDTAMYYCTRHFYAVLDYWGRGTTLTVSSAKT
TPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYT
LSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKIVP
//
>1f59_1A [a.118.1] IMPORTIN BETA-1
MELITILEKTVSPDRLELEAAQKFLERAAVENLPTFLVELSRVLANPGNSQVARVAAGLQ
IKNSLTSKDPDIKAQYQQRWLAIDANARREVKNYVLHTLGTETYRPSSASQCVAGIACAE
IPVNQWPELIPQLVANVTNPNSTEHMKESTLEAIGYICQDIDPEQLQDKSNEILTAIIQG
MRKEEPSNNVKLAATNALLNSLEFTKANFDKESERHFIMQVVCEATQCPDTRVRVAALQN
LVKIMSLYYQYMETYMGPALFAITIEAMKSDIDEVALQGIEFWSNVCDEEMDLAIEASEA
AEQGRPPEHTSKFYAKGALQYLVPILTQTLTKQDENDDDDDWNPCKAAGVCLMLLATCCE
DDIVPHVLPFIKEHIKNPDWRYRDAAVMAFGCILEGPEPSQLKPLVIQAMPTLIELMKDP
SVVVRDTAAWTVGRICELLP
//
>1f59_1C [j.70.1] FXFG NUCLEOPORIN REPEATS
DDSKPAFSFGuuuuuuuuAFSF
//
>1f59_2B (A) [a.118.1] IMPORTIN BETA-1
MELITILEKTVSPDRLELEAAQKFLERAAVENLPTFLVELSRVLANPGNSQVARVAAGLQ
IKNSLTSKDPDIKAQYQQRWLAIDANARREVKNYVLHTLGTETYRPSSASQCVAGIACAE
IPVNQWPELIPQLVANVTNPNSTEHMKESTLEAIGYICQDIDPEQLQDKSNEILTAIIQG
MRKEEPSNNVKLAATNALLNSLEFTKANFDKESERHFIMQVVCEATQCPDTRVRVAALQN
LVKIMSLYYQYMETYMGPALFAITIEAMKSDIDEVALQGIEFWSNVCDEEMDLAIEASEA
AEQGRPPEHTSKFYAKGALQYLVPILTQTLTKQDENDDDDDWNPCKAAGVCLMLLATCCE
DDIVPHVLPFIKEHIKNPDWRYRDAAVMAFGCILEGPEPSQLKPLVIQAMPTLIELMKDP
SVVVRDTAAWTVGRICELLP
//
>1f59_2D [j.70.1] FXFG NUCLEOPORIN REPEATS
KPAFSFGuuuuuuuuAFSFG
//
>1f5q_1A [d.144.1] CYCLIN DEPENDENT KINASE 2
MENFQKVEKEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN
IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR
VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST
AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK
WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
//
>1f5q_1B [a.74.1 - a.74.1] GAMMA HERPESVIRUS CYCLIN
FQGFLDSSLLNEEDCRQMIYRSEREHDARMVGVNVDQHFTSQYRKVLTTWMFCVCKDLRQ
DNNVFPLAVALLDELFLSTRIDRENYQSTAAVALHIAGKVRAYMPIKATQLAYLCGGATT
ADKLLTLEVKSLDTLSWVADRCLSTDLICYILHIMHAPREDYLNIYNLCRPKIFCALCDG
RSAMKRPVLITLACMHLTMNQKYDYYENRIDGVCKSLYITKEELHQCCDLVDIAIVSFDE
NYFKINA
//
>1f66E [a.22.1] HISTONE H3
GEVKKPHRYRPGTVALREIRRYQKSTELLIRKLPFQRLVREIAQDFKTDLRFQSSAVMAL
QEASEAYLVALFEDTNLCAIHAKRVTIMPKDIQLARRIRGERA
//
>1f66D [a.22.1] HISTONE H2B
KTRKESYAIYVYKVLKQVHPDTGISSKAMSIMNSFVNDVFERIAGEASRLAHYNKRSTIT
SREIQTAVRLLLPGELAKHAVSEGTKAVTKYTSAK
//
>1f66C [a.22.1] HISTONE H2A.Z
AVSRSQRAGLQFPVGRIHRHLKSRTTSHGRVGATAAVYSAAILEYLTAEVLELAGNASKD
LKVKRITPRHLQLAIRGDEELDSLIKATIAGGGVIPHIHKSLI
//
>1f66F [a.22.1] HISTONE H4
RHRKVLRDNIQGITKPAIRRLARRGGVKRISGLIYEETRGVLKVFLENVIRDAVTYTEHA
KRKTVTAMDVVYALKRQGRTLYGFGG
//
>1f6aA [b.1.1 - b.1.1] HIGH AFFINITY IMMUNOGLOBULIN EPSILON RECEPTOR
VPQKPKVSLNPPWNRIFKGENVTLTCNGNNFFEVSSTKWFHNGSLSEETNSSLNIVNAKF
EDSGEYKCQHQQVAESEPVYLEVFSDWLLLQASAEVVMEGQPLFLRCHGWRNWDVYKVIY
YKDGEALKYWYENHAISITNAAAEDSGTYYCTGKVWQLDYESEPLNITVIKAP
//
>1f6aD [b.1.1 - b.1.1] IG EPSILON CHAIN C REGION
CDSNPRGVSAYLSRPSPFDLFIRKSPTITCLVVDLAPSKGTVNLTWSRASGKPVNHSTRK
EEKQRNGTLTVTSTLPVGTRDWIEGETYQCRVTHPHLPRALMRSTTKTSGPRAAPEVYAF
ATPEWPGSRDKRTLACLIQNFMPEDISVQWLHNEVQLPDARHSTTQPRKTKGSGFFVFSR
LEVTRAEWEQKDEFICRAVHEAASPSQTVQRAVSVN
//
>1f6fA [a.26.1] PLACENTAL LACTOGEN
AQHPPYCRNQPGKCQIPLQSLFDRATTVANYNSKLAGEMVNRFDEQYVINCHTSSITTPN
SKAEAINTEDKILFKLVISLLHSWDEPLHHAVTELANPALLTKAQEIKEKAKVLVDGVEV
IQKRIHPGEKNEPYPVWSEQSSLTSQDENVRRVAFYRLFHCLHRDSSKIYTYLRILKCRL
TSC
//
>1f6fB [b.1.2 - b.1.2] PROLACTIN RECEPTOR
GKPEIHKCRSPDKETFTCWWNPGTDGGLPTNYSLTYSKEGEKTTYECPDYKTSGPNSCFF
SKQYTSIWKIYIITVNATNQMGSSSSDPLYVDVTYIVEPEPPRNLTLEVKKKTYLWVKWS
PPTITDVKTGWFTMEYEIRLKPEEAEEWEIHFTGHQTQFKVFDLYPGQKYLVQTRCKPDH
GYWSRWSQESSVEMP
//
>1f6fC [b.1.2 - b.1.2] PROLACTIN RECEPTOR
KPEIHKCRSPDKETFTCWWNPGTTNYSLTYSKEGEKTTYECPDYKTSGPNSCFFSKQYTS
IWKIYIITVNATSSSDPLYVDVTYIVEPEPPRNLTLEVKKTYLWVKWSPPTMEYEIRLKE
WEIHFTGHQTQFKVFDLYPGQKYLVQTRCKPDHGYWSRWSQESSVEMPN
//
>1f6m_2A (C) [c.47.1] THIOREDOXIN 1
SDKIIHLTDDSFDTDVLKADGAILVDFWAEWCGPSKMIAPILDEIADEYQGKLTVAKLNI
DQNPGTAPKYGIRGIPTLLLFKNGEVAATKVGALSKGQLKEFLDANLA
//
>1f6m_2B (A) [c.3.1 - c.3.1] THIOREDOXIN REDUCTASE
GTTKHSKLLILGSGPAGYTAAVYAARANLQPVLITGMEKGGQLTTTTEVENWPGDPNDLT
GPLLMERMHEHATKFETEIIFDHINKVDLQNRPFRLNGDNGEYTCDALIIATGASARYLG
LPSEEAFKGRGVSASATCDGFFYRNQKVAVIGGGNTAVEEALYLSNIASEVHLIHRRDGF
RAEKILIKRLMDKVENGNIILHTNRTLEEVTGDQMGVTGVRLRDTQNSDNIESLDVAGLF
VAIGHSPNTAIFEGQLELENGYIKVQSGIHGNATQTSIPGVFAAGDVMDHIYRQAITSAG
TGCMAALDAERYLDGLADAK
//
>1f80B (A) [d.150.1] HOLO-(ACYL CARRIER PROTEIN) SYNTHASE
AYGIGLDITELKRIASMAGRQKRFAERILTRSELDQYYELSEARKNEFLAGRFAAKEAFS
KAFGTGIGRQLSFQDIEIRKDQNGKPYIICTKLSQAAVHVSITHTKEYAAAQVVIERL
//
>1f80D [a.28.1] ACYL CARRIER PROTEIN
SADTLERVTKIIVDRLGVDEADVKLEASFKEDLGADxLDVVELVMELEDEFDMEISDEDA
EKIATVGDAVNYIQ
//
>1f8uA [c.69.1] ACETYLCHOLINESTERASE
DAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATT
FQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFY
SGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQ
ENVAAFGGDPTSVTLFGQSAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEA
RRRATQLAHLVGCPNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSD
TPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQV
SDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVF
EHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPN
EPPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSAT
//
>1f8uB [g.7.1] FASCICULIN II
TMCYSHTTTSRAILTNCGENSCYRKSRRHPPKMVLGRGCGCPPGDDNLEVKCCTSPDKCN
Y
//
>1f8v_37 (A) [b.121.4] MATURE CAPSID PROTEIN BETA
NRRNKARKVVSRSTALVPMAPASQRTGPAPRKPRKRNQALVRNPRLTDAGLAFLKCAFAA
PDFSVDPGKGIPDNFHGRTLAIKDCNTTSVVFTPNTDTYIVVAPVPGFAYFRAEVAVGAQ
PTTFVGVPYPTYATNFGAGSQNGLPAVNNYSKFRYASMACGLYPTSNMMQFSGSVQVWRV
DLNLSEAVNPAVTAITPAPGVFANFVDKRINGLRGIRPLAPRDNYSGNFIDGAYTFAFDK
STDFEWCDFVRSLEFSESNVLGAATAMKLLAPGGGTDTTLTGLGNVNTLVYKISTPTGAV
NTAILRTWNCIELQPYTDSALFQFSGVSPPFDPLALECYHNLKMRFPVAVSSREN
//
>1f8v_38 (D) [b.121.4] MATURE CAPSID PROTEIN GAMMA
SKFWEGVLRVLNQISGTHQLTGMYM
//
>1f90L [b.1.1 - b.1.1] FAB FRAGMENT OF MONOCLONAL ANTIBODY
DVQMTQTPLTLSVTIGQPASISCESSQSLLYSNGKTYLNWLLQRPGQSPKRLIYLVSKLD
SGVPDRFTGSGSGTDFTLRISRVEAEDLGVYYCVQGTHFPRTFGGGTKLEIKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1f90H [b.1.1 - b.1.1] FAB FRAGMENT OF MONOCLONAL ANTIBODY
GVQLQESGPGLVKPSQSLSLTCTVTGYSITSDYAWNWIRQFPGNKLEWMGYITYSGSTGY
NPSLKSRISITRDTSKNQFFLQLNSVTTEDTATYYCASYDDYTWFTYWGQGTLVTVSAAK
TTPPSVFPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLY
TLSSSVTVPSSPRPSETVTCNVAHPASSTKVDKKIVPRDC
//
>1f93_1A [d.74.1] DIMERIZATION COFACTOR OF HEPATOCYTE NUCLEAR
AGKAHRLSAEERDQLLPNLRAVGWNELEGRDAIFKQFHFKDFNRAFGFmTRVALQAEKLD
HHPEWFNVYNKVHITLSTHECAGLSERDINLASFIEQVAVSmT
//
>1f93_1F [a.34.2] HEPATOCYTE NUCLEAR FACTOR 1-ALPHA
LSQLQTELLAALLESGLSKEALIQALG
//
>1f99F (B) [a.1.1] R-PHYCOCYANIN
MLDAFAKVVAQADARGEFLSNTQIDALLAIVSEGNKRLDVVNKITNNASAIVTNAARALF
AEQPQLISPGGNAYTSRRMAACLRDMEIVLRYVSYAMIAGDASVLDDRCLNGLRETYQAL
GTPGASVAVAIQKMKDAALALVNDTTGTPAGDCASLVAEIATYFDRAAAAVA
//
>1f99G (A) [a.1.1] R-PHYCOCYANIN
MKTPLTEAIAAADSQGRFLSNTELQVVNGRYNRATSSLEAAKALTANADRLISGAANAVY
SKFPYTTQMPGPNYSSTAIGKAKCARDIGYYLRMVTYCLVVGGTGPMDDYLVAGLEEINR
TFELSPSWYIEALKYIKNNHGLSGDVANEANTYIDYAINTLS
//
>1fakA (L) [g.32.1 - g.3.11 - g.3.11] PROTEIN (BLOOD COAGULATION FACTOR VIIA)
RTKLFWISYSDGDQCASSPCQNGGSCKDQLQSYICFCLPAFEGRNCETHKDDQLICVNEN
GGCEQYCSDHTGTKRSCRCHEGYSLLADGVSCTPTVEYPCGKIPILEK
//
>1fakB (H) [b.47.1] PROTEIN (BLOOD COAGULATION FACTOR VIIA)
IVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHD
LSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERT
LAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKSPNITEYMFCAGYSDG
SKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSEP
RPGVLLRAPFP
//
>1fakC (T) [b.1.2 - b.1.2] PROTEIN (SOLUBLE TISSUE FACTOR)
TVAAYNLTWKSTNFKTILEWEPKPVNQVYTVQISTKSGDWKSKCFYTTDTECDLTDEIVK
DVKQTYLARVFSYPAGEPLYENSPEFTPYLETNLGQPTIQSFEQKVNVTVEDERTLVRRN
NTFLSLRDVFGKDLIYTLYYWGKKTAKTNTNEFLIDVYCFSVQAVIPSRTVNRKSTDSPV
ECM
//
>1fakD (I) [g.8.1] PROTEIN (5L15)
APDFCLEPPYDGPCRALHLRYFYNAKAGLCQTFYYGGCLAKRNNFESAEDCMRTC
//
>1fapA [d.26.1] FK506-BINDING PROTEIN
GVQVETISPGDGRTFPKRGQTCVVHYTGMLEDGKKFDSSRDRNKPFKFMLGKQEVIRGWE
EGVAQMSVGQRAKLTISPDYAYGATGHPGIIPPHATLVFDVELLKLE
//
>1fapB [a.24.7] FRAP
RVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRD
LMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRIS
//
>1favA [h.3.2] HIV-1 ENVELOPE PROTEIN CHIMERA
IEDKIEEILSKIYHIENEIARIKKLIGEARQLLSGIVQQQNNLLRAIEAQQHLLQLTVWG
IKQLQARILAVERYLKDQ
//
>1favD [x.x.x]
NNYTSLIHSLIEESQNQQEKNEQELLEL
//
>1fbi_1L [b.1.1 - b.1.1] IGG1 F9.13.7 FAB (LIGHT CHAIN)
DIQMTQTTSSLSASLGDRVTISCRASQDISNYLNWYQKKPDGTVKLLIYYTSRLHSGVPS
RFSGSGSGTDYSLTIRNLEQEDIATYFCQQGYTLPYTFGGGTKLEIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1fbi_1H [b.1.1 - b.1.1] IGG1 F9.13.7 FAB (HEAVY CHAIN)
QVQLQQPGAELVKPGASVKLSCKASGYTFTSYWMHWVKQGPGQGLEWIGEIDPSDSYPNY
NEKFKGKATLTVDKSSSTAYMQLSSLTSEDSAVYYCASLYYYGTSYGVLDYWGQGTSVTV
SSAKTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQ
SDLYTLSSSVTVPSSPRPSETVTCNVAHPASSTKVDKKIVP
//
>1fbi_1X [d.2.1] GUINEA FOWL LYSOZYME
KVFGRCELAAAMKRHGLDNYRGYSLGNWVCAAKFESNFNSQATNRNTDGSTDYGVLQINS
RWWCNDGRTPGSRNLCNIPCSALQSSDITATANCAKKIVSDGNGMNAWVAWRKHCKGTDV
RVWIKGCRL
//
>1fbvA [a.48.1 - a.39.1 - d.93.1 - g.44.1] SIGNAL TRANSDUCTION PROTEIN CBL
PPGTVDKKMVEKCWKLMDKVVRLCQNPKLALKNSPPYILDLLPDTYQHLRTILSRYEGKM
ETLGENEYFRVFMENLMKKTKQTISLFKEGKERMYEENSQPRRNLTKLSLIFSHMLAELK
GIFPSGLFQGDTFRITKADAAEFWRKAFGEKTIVPWKSFRQALHEVHPISSGLEAMALKS
TIDLTCNDYISVFEFDIFTRLFQPWSSLLRNWNSLAVTHPGYMAFLTYDEVKARLQKFIH
KPGSYIFRLSCTRLGQWAIGYVTADGNILQTIPHNKPLFQALIDGFREGFYLFPDGRNQN
PDLTGLCEPTPQDHIKVTQEQYELYCEMGSTFQLCKICAENDKDVKIEPCGHLMCTSCLT
SWQESEGQGCPFCRCEIKGTEPIVVDPF
//
>1fbvC [d.20.1] UBIQUITIN-CONJUGATING ENZYME E12-18 KDA UBCH7
SRRLMKELEEIRKCGMKNFRNIQVDEANLLTWQGLIVPDNPPYDKGAFRIEINFPAEYPF
KPPKITFKTKIYHPNIDEKGQVCLPVISAENWKPATKTDQVIQSLIALVNDPQPEHPLRA
DLAEEYSKDRKKFCKNAEEFTKKY
//
>1fc2C [a.8.1] FRAGMENT B OF PROTEIN A COMPLEX
FNKEQQNAFYEILHLPNLNEEQRNGFIQSLKDDPSQSANLLAE
//
>1fc2D [b.1.1 - b.1.1] IMMUNOGLOBULIN FC
PSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPQVKFNWYVDGVQVHNAKTKPREQQYN
STYRVVSVLTVLHQNWLDGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREE
MTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRW
QQGNVFSCSVMHEALHNHYTQKSLSL
//
>1fccA [b.1.1 - b.1.1] IGG1 MO61 FC
PSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPQVKFNWYVDGVQVHNAKTKPREQQYN
STYRVVSVLTVLHQNWLDGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREE
MTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRW
QQGNVFSCSVMHEALHNHYTQKSLSL
//
>1fccC [d.15.7] STREPTOCOCCAL PROTEIN G (C2 FRAGMENT)
TTYKLVINGKTLKGETTTEAVDAATAEKVFKQYANDNGVDGEWTYDDATKTFTVTE
//
>1fcd_2B (A) [c.3.1 - c.3.1 - d.87.1] FLAVOCYTOCHROME C SULFIDE DEHYDROGENASE (FLAVIN-
AGRKVVVVGGGTGGATAAKYIKLADPSIEVTLIEPNTDYYTCYLSNEVIGGDRKLESIKH
GYDGLRAHGIQVVHDSATGIDPDKKLVKTAGGAEFGYDRCVVAPGIELIYDKIEGYSEEA
AAKLPHAWKAGEQTAILRKQLEDMADGGTVVIAPPAAPFRCPPGPYERASQVAYYLKAHK
PMSKVIILDSSQTFSKQSQFSKGWERLYGFGTENAMIEWHPGPDSAVVKVDGGEMMVETA
FGDEFKADVINLIPPQRAGKIAQIAGLTNDAGWCPVDIKTFESSIHKGIHVIGDASIANP
MPKSGYSANSQGKVAAAAVVVLLKGEEPGTPSYLNTCYSILAPAYGISVAAIYRPNADGS
AIESVPDSGGVTPVDAPDWVLEREVQYAYSWYNNIVHDTFG
//
>1fcd_2D (C) [a.3.1 - a.3.1] FLAVOCYTOCHROME C SULFIDE DEHYDROGENASE
EPTAEMLTNNCAGCHGTHGNSVGPASPSIAQMDPMVFVEVMEGFKSGEIASTIMGRIAKG
YSTADFEKMAGYFKQQTYQPAKQSFDTALADTGAKLHDKYCEKCHVEGGKPLADEEDYHI
LAGQWTPYLQYAMSDFREERRPMEKKMASKLRELLKAEGDAGLDALFAFYASQQ
//
>1fdhA [a.1.1] HEMOGLOBIN F (DEOXY) (ALPHA CHAIN)
VLSPADKTNVKAAWGKVGAHAGEYGAEALERMFLSFPTTKTYFPHFDLSHGSAQVKGHGK
KVADALTNAVAHVDDMPNALSALSDLHAHKLRVDPVNFKLLSHCLLVTLAAHLPAEFTPA
VHASLDKFLASVSTVLTSKYR
//
>1fdhG [a.1.1] HEMOGLOBIN F (DEOXY) (GAMMA CHAIN)
GHFTEEDKATITSLWGKVNVEDAGGETLGRLLVVYPWTQRFFDSFGNLSSASAIMGNPKV
KAHGKKVLTSLGDAIKHLDDLKGTFAQLSELHCDKLHVDPENFKLLGNVLVTVLAIHFGK
EFTPEVQASWQKMVTGVASALSSRYH
//
>1fdlL [b.1.1 - b.1.1] IGG1-KAPPA D1.3 FAB (LIGHT CHAIN)
DIQMTQSPASLSASVGETVTITCRASGNIHNYLAWYQQKQGKSPQLLVYYTTTLADGVPS
RFSGSGSGTQYSLKINSLQPEDFGSYYCQHFWSTPRTFGGGTKLEIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1fdlH [b.1.1 - b.1.1] IGG1-KAPPA D1.3 FAB (HEAVY CHAIN)
QVQLKESGPGLVAPSQSLSITCTVSGFSLTGYGVNWVRQPPGKGLEWLGMIWGDGNTDYN
SALKSRLSISKDNSKSQVFLKMNSLHTDDTARYYCARERDYRLDYWGQGTTLTVSSASTT
PPSVFPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTL
SSSVTVPSSPRPSETVTCNVAHPASSTKVDKKIVPRDC
//
>1fdlY [d.2.1] HEN EGG WHITE LYSOZYME
KVFGRCELAAAMKRHGLDNYRGYSLGNWVCAAKFESNFNTQATNRNTDGSTDYGILQINS
RWWCNDGRTPGSRNLCNIPCSALLSSDITASVNCAKKIVSDGNGMNAWVAWRNRCKGTDV
QAWIRGCRL
//
>1fe8_1A [c.62.1] VON WILLEBRAND FACTOR
PDCSQPLDVILLLDGSSSFPASYFDEmKSFAKAFISKANIGPRLTQVSVLQYGSITTIDV
PWNVVPEKAHLLSLVDVmQREGGPSQIGDALGFAVRYLTSEmHGARPGASKAVVILVTDV
SVDSVDAAADAARSNRVTVFPIGIGDRYDAAQLRILAGPAGDSNVVKLQRIEDLPTmVTL
GNSFLHKLCS
//
>1fe8_1H [b.1.1 - b.1.1] IMMUNOGLOBULIN IGG RU5
DVKLVQSGPGLVAPSQSLSITCTVSGFSLTTYGVSWVRQPPGKGLEWLGVIWGDGNTTYH
SALISRLSISKDNSRSQVFLKLNSLHTDDTATYYCAGNYYGMDYWGQGTSVTVSSAETTA
PSVYKLEPVSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDLYTLSSSVTVT
SSTWPSQSITCNVAHPASSTKVDKKIEPRG
//
>1fe8_1B (L) [b.1.1 - b.1.1] IMMUNOGLOBULIN IGG RU5
DIAMTQTTSSLSASLGQKVTISCRASQDIGNYLNWYQQKPDGTVRLLIYYTSRLHSGVPS
RFSGSGSGTDYSLTISNLESEDIATYFCQNGGTNPWTFGGGTKLEVKRADAAPTTSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNR
//
>1fe8_1C (A) [c.62.1] VON WILLEBRAND FACTOR
PDCSQPLDVILLLDGSSSFPASYFDEmKSFAKAFISKANIGPRLTQVSVLQYGSITTIDV
PWNVVPEKAHLLSLVDVmQREGGPSQIGDALGFAVRYLTSEmHGARPGASKAVVILVTDV
SVDSVDAAADAARSNRVTVFPIGIGDRYDAAQLRILAGPAGDSNVVKLQRIEDLPTmVTL
GNSFLHKLCS
//
>1fe8_1D (H) [b.1.1 - b.1.1] IMMUNOGLOBULIN IGG RU5
DVKLVQSGPGLVAPSQSLSITCTVSGFSLTTYGVSWVRQPPGKGLEWLGVIWGDGNTTYH
SALISRLSISKDNSRSQVFLKLNSLHTDDTATYYCAGNYYGMDYWGQGTSVTVSSAETTA
PSVYKLEPVSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDLYTLSSSVTVT
SSTWPSQSITCNVAHPASSTKVDKKIEPRG
//
>1ffp_1A [d.19.1 - b.1.1] H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, D-B,
PHSMRYFETAVSRPGLEEPRYISVGYVDNKEFVRFDSDAENPRYEPRAPWMEQEGPEYWE
RETQKAKGQEQWFRVSLRNLLGYYNQSAGGSHTLQQMSGCDLGSDWRLLRGYLQFAYEGR
DYIALNEDLKTWTAADMAAQITRRKWEQSGAAEHYKAYLEGECVEWLHRYLKNGNATLLR
TDSPKAHVTHHPRSKGEVTLRCWALGFYPADITLTWQLNGEELTQDMELVETRPAGDGTF
QKWASVVVPLGKEQNYTCRVYHEGLPEPLTLRW
//
>1ffp_1B [b.1.1] BETA-2 MICROGLOBULIN BETA CHAIN
MIQKTPQIQVYSRHPPENGKPNILNCYVTQFHPPHIEIQMLKNGKKIPKVEMSDMSFSKD
WSFYILAHTEFTPTETDTYACRVKHDSMAEPKTVYWDRDM
//
>1fft_2F (A) [f.24.1] UBIQUINOL OXIDASE
VDHKRLGIMYIIVAIVMLLRGFADAIMMRSQQALASAGEAGFLPPHHYDQIFTAHGVIMI
FFVAMPFVIGLMNLVVPLQIGARDVAFPFLNNLSFWFTVVGVILVNVSLGVGEFAQTGWL
AYPPLSGIEYSPGVGVDYWIWSLQLSGIGTTLTGINFFVTILKMRAPGMTMFKMPVFTWA
SLCANVLIIASFPILTVTVALLTLDRYLGTHFFTNDMGGNMMMYINLIWAWGHPEVYILI
LPVFGVFSEIAATFSRKRLFGYTSLVWATVCITVLSFIVWLHHFFTMGAGANVNAFFGIT
TMIIAIPTGVKIFNWLFTMYQGRIVFHSAMLWTIGFIVTFSVGGMTGVLLAVPGADFVLH
NSLFLIAHFHNVIIGGVVFGCFAGMTYWWPKAFGFKLNETWGKRAFWFWIIGFFVAFMPL
YALGFMGMTRRLSQQIDPQFHTMLMIAASGAVLIALGILCLVIQMYVSIRDRDQNRDLTG
DPWGGRTLEWATSSPPPFYNF
//
>1fft_2G (B) [f.17.2 - b.6.1] UBIQUINOL OXIDASE
SALLDPKGQIGLEQRSLILTAFGLMLIVVIPAILMAVGFAWKYRASNKDAKYSPNWSHSN
KVEAVVWTVPILIIIFLAVLTWKTTHALEPSKPLAHDEKPITIEVVSMDWKWFFIYPEQG
IATVNEIAFPANTPVYFKVTSNSVMNSFFIPRLGSQIYAMAGMQTRLHLIANEPGTYDGI
SASYSGPGFSGMKFKAIATPDRAAFDQWVAKAKQSPNTMSDMAAFEKLAAPSEYNQVEYF
SNVKPDLFADVINKFMA
//
>1fft_2H (C) [f.25.1] UBIQUINOL OXIDASE
HDAGGTKIFGFWIYLMSDCILFSILFATYAVLVNGTAGGPTGKDIFELPFVLVETFLLLF
SSITYGMAAIAMYKNNKSQVISWLALTWLFGAGFIGMEIYEFHHLIVNGMGPDRSGFLSA
FFALVGTHGLHVTSGLIWMAVLMVQIARRGLTSTNRTRIMCLSLFWHFLDVVWICVFTVV
YLMGA
//
>1ffuA [d.15.4 - a.56.1] CUTS, IRON-SULFUR PROTEIN OF CARBON MONOXIDE
KKIITVNVNGKAQEKAVEPRTLLIHFLREELNLTGAHIGCETSHCGACTVDIDGRSVKSC
THLAVQCDGSEVLTVEGLANKGVLHAVQEGFYKEHGLQCGFCTPGMLMRAYRFLQENPNP
TEAEIRMGMTGNLCRCTGYQNIVKAVQYAARKLQE
//
>1ffuC [d.145.1 - d.87.2] CUTM, FLAVOPROTEIN OF CARBON MONOXIDE
MIPPRFEYHAPKSVGEAVALLGQLGSDAKLLAGGHSLLPMMKLRFAQPEHLIDINRIPEL
RGIREEGSTVVIGAMTVENDLISSPIVQARLPLLAEAAKLIADPQVRNRGTIGGDIAHGD
PGNDHPALSIAVEAHFVLEGPNGRRTVPADGFFLGTYMTLLEENEVMVEIRVPAFAAGTG
WAYEKLKRKTGDWATAGCAVVMRKSGGTVSHIRIALTNVAPTALRAEAAEAALLGKAFTK
EAVQAAADAAIAICEPAEDLRGDADYKTAMAGQMVKRALNAAWARCA
//
>1ffvA [d.15.4 - a.56.1] CUTS, IRON-SULFUR PROTEIN OF CARBON MONOXIDE
KKIITVNVNGKAQEKAVEPRTLLIHFLREELNLTGAHIGCETSHCGACTVDIDGRSVKSC
THLAVQCDGSEVLTVEGLANKGVLHAVQEGFYKEHGLQCGFCTPGMLMRAYRFLQENPNP
TEAEIRMGMTGNLCRCTGYQNIVKAVQYAARKLQE
//
>1ffvB [d.41.1 - d.133.1] CUTL, MOLYBDOPROTEIN OF CARBON MONOXIDE
DAEARELALAGMGASRLRKEDARFIQGKGNYVDDIKMPGMLHMDIVRAPIAHGRIKKIHK
DAALAMPGVHAVLTAEDLKPLKLHWMPTLAGDVAAVLADEKVHFQMQEVAIVIADDRYIA
ADAVEAVKVEYDELPVVIDPIDALKPDAPVLREDLAGKTSGAHGPREHHNHIFTWGAGDK
AATDAVFANAPVTVSQHMYYPRVHPCPLETCGCVASFDPIKGDLTTYITSQAPHVVRTVV
SMLSGIPESKVRIVSPDIGGGFGNKVGIYPGYVCAIVASIVLGRPVKWVEDRVENISTTA
FARDYHMDGELAATPDGKILGLRVNVVADHGAFDACADPTKFPAGLFHICSGSYDIPRAH
CSVKGVYTNKAPGGVAYxxSFRVTEAVYLIERMVDVLAQKLNMDKAEIRAKNFIRKEQFP
YTTQFGFEYDSGDYHTALKKVLDAVDYPALRAEQAARRADPNSPTLMGIGLVTFTEVVGA
GPSKMCDILGVGMFDSCEIRIHPTGSAIARMGTITQGQGHQTTYAQIIATELGIPSEVIQ
VEEGDTSTAPYGLGTYGSRSTPVAGAAIALAARKIHAKARKIAAHMLEVNENDLDWEVDR
FKVKGDDSKFKTMADIAWQAYHQPPAGLEPGLEAVHYYDPPNFTYPFGIYLCVVDIDRAT
GETKVRRFYALDDCGTRINPMIIEGQIHGGLTEGYAVAMGQQMPFDAQGNLLGNTLMDYF
LPTAVETPHWETDHTVTPSPHHPIGAKGVAESPHVGSIPTFTAAVVDAFAHVGVTHLDMP
HTSYRVWKSLKEHNLAL
//
>1ffvC [d.145.1 - d.87.2] CUTM, FLAVOPROTEIN OF CARBON MONOXIDE
MIPPRFEYHAPKSVGEAVALLGQLGSDAKLLAGGHSLLPMMKLRFAQPEHLIDINRIPEL
RGIREEGSTVVIGAMTVENDLISSPIVQARLPLLAEAAKLIADPQVRNRGTIGGDIAHGD
PGNDHPALSIAVEAHFVLEGPNGRRTVPADGFFLGTYMTLLEENEVMVEIRVPAFAQGTG
WAYEKLKRKTGDWATAGCAVVMRKSGNTVSHIRIALTNVAPTALRAEAAEAALLGKAFTK
EAVQAAADAAIAICEPAEDLRGDADYKTAMAGQMVKRALNAAWARCA
//
>1fg9B (A) [a.26.1] INTERFERON GAMMA
MQDPYVKEAENLKKYFNAGHSDVADNGTLFLGILKNWKEESDRKIMQSQIVSFYFKLFKN
FKDDQSIQKSVETIKEDMNVKFFNSNKKKRDDFEKLTNYSVTDLNVQRKAIHELIQVMAE
LSPAAKT
//
>1fg9D [b.1.2 - b.1.2] INTERFERON-GAMMA RECEPTOR ALPHA CHAIN
SVPTPTNVTIESYNMNPIVYWEYQIMPQVPVFTVEVKNYGVKNSEWIDACINISHHYCNI
SDHVGDPSNSLWVRVKARVGQKESAYAKSEEFAVCRDGKIGPPKLDIRKEEKQIMIDIFH
PSVFVNGDEQETTCYIRVYNVYVRMNGSEIQYKILTQKEDDCDEIQCQLAIPVSSLNSQY
CVSAEGVLHVWGVTTEKSKEVCITI
//
>1fgvL [b.1.1] H52 FV (LIGHT CHAIN)
DIQMTQSPSSLSASVGDRVTITCRASQDINNYLNWYQQKPGKAPKLLIYYTSTLESGVPS
RFSGSGSGTDYTLTISSLQPEDFATYYCQQGNTLPPTFGAGTKVEIK
//
>1fgvH [b.1.1] H52 FV (HEAVY CHAIN)
EVQLVESGGGLVQPGGSLRLSCATSGYTFTEYTMHWMRQAPGKGLEWVAGINPKNGGTSY
ADSVKGRFTISVDKSKNTLYLQMNSLRAEDTAVYYCARWRGLDVRYFDVWGQGTLVTVSS
//
>1fh5L [b.1.1 - b.1.1] MONOCLONAL ANTIBODY MAK33
DIVLTQSPATLSVTPGESVSLSCRASQSISNNLHWYQQKSHESPRLLIKYASQSISGIPS
RFSGSGSGTDFTLSINSVETEDFGMYYCQQSNSWPLTFGAGTKLELKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNE
//
>1fh5H [b.1.1 - b.1.1] MONOCLONAL ANTIBODY MAK33
SGGGLVKPAGSLKLSCAASGFTFSSYYMYWVRQTPDKRLEWVATISDGGSYTYYPDSVKG
RFTISRDNAKNNLYLQMSSLKSEDTAMYYCARDAMDYWGQGTLVTVSAAKTTPPSVYPLA
VTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTLSSSVTVTSSTWPSETVTC
NVAHPASSTKVDKKIVPR
//
>1fhp_2n [x.x.x]
DKKTTTLLEDRLLTTRNGHTTSTTQSSVGVTYGYATAEDFVSGPNTSGLETRVVQAERFF
KTHLFDWVTSDSFGRCHLLELPTDHKGVYGSLTDSYAYMRNGWDVEVTAVGNQFNGGCLL
VAMVPELCSIQKRELYQLTLFPHQFINPRTNMTAHITVPFVGVNRYDQYKVHKPWTLVVM
VVAPLTVNTEGAPQIKVYANIAPTNVHVAGEFPSKE
//
>1fhp_2o [x.x.x]
GIFPVACSDGYGGLVTTDPKTADPVYGKVFNPPRNQLPGRFTNLLDVAEACPTFLRFEGG
VPYVTTKTDSDRVLAQFDMSLAAKHMSNTFLAGLAQYYTQYSGTINLHFMFTGPTDAKAR
YMVAYAPPGMEPPKTPEAAAHCIHAEWDTGLNSKFTFSIPYLSAADYTYTASCVAETTNV
QGWVCLFQITHGKADGDALVVLASAGKDFELRLPVDARAE
//
>1fhp_2a [x.x.x]
TTSAGESADPVTTTVENYGGETQIQRRQHTDVSFIMDRFVKVTPQNQINILDLMQVPSHT
LVGALLRASTYYFSDLEIAVKHEGDLTWVPNGAPEKALDNTTNPTAYHKAPLTRLALPYT
APHRVLATVYNGECAALPTSFNYGAIKATRVTELLYRMKRAETYCPRPLLAIHPTEARHK
QKIVAPVKDKKTTTLLEDRLLTTRNGHTTSTTQSSVGVTYGYATAEDFVSGPNTSGLETR
VVQAERFFKTHLFDWVTSDSFGRCHLLELPTDHKGVYGSLTDSYAYMRNGWDVEVTAVGN
QFNGGCLLVAMVPELCSIQKRELYQLTLFPHQFINPRTNMTAHITVPFVGVNRYDQYKVH
KPWTLVVMVVAPLTVNTEGAPQIKVYANIAPTNVHVAGEFPSKEGIFPVACSDGYGGLVT
TDPKTADPVYGKVFNPPRNQLPGRFTNLLDVAEACPTFLRFEGGVPYVTTKTDSDRVLAQ
FDMSLAAKHMSNTFLAGLAQYYTQYSGTINLHFMFTGPTDAKARYMVAYAPPGMEPPKTP
EAAAHCIHAEWDTGLNSKFTFSIPYLSAADYTYTASCVAETTNVQGWVCLFQITHGKADG
DALVVLASAGKDFELRLPVDARAESGNTGSIINNYYMQQYQNSMDTQLGNDWFSKLASSA
FSGLFGALLADKKTTTLLEDRLLTTRNGHTTSTTQSSVGVTYGYATAEDFVSGPNTSGLE
TRVVQAERFFKTHLFDWVTSDSFGRCHLLELPTDHKGVYGSLTDSYAYMRNGWDVEVTAV
GNQFNGGCLLVAMVPELCSIQKRELYQLTLFPHQFINPRTNMTAHITVPFVGVNRYDQYK
VHKPWTLVVMVVAPLTVNTEGAPQIKVYANIAPTNVHVAGEFPSKEGIFPVACSDGYGGL
VTTDPKTADPVYGKVFNPPRNQLPGRFTNLLDVAEACPTFLRFEGGVPYVTTKTDSDRVL
AQFDMSLAAKHMSNTFLAGLAQYYTQYSGTINLHFMFTGPTDAKARYMVAYAPPGMEPPK
TPEAAAHCIHAEWDTGLNSKFTFSIPYLSAADYTYTASCVAETTNVQGWVCLFQITHGKA
DGDALVVLASAGKDFELRLPVDARAESGNTGSIINNYYMQQYQNSMDTQLGNDWFSKLAS
SAFSGLFGALLATTSAGESADPVTTTVENYGGETQIQRRQHTDVSFIMDRFVKVTPQNQI
NILDLMQVPSHTLVGALLRASTYYFSDLEIAVKHEGDLTWVPNGAPEKALDNTTNPTAYH
KAPLTRLALPYTAPHRVLATVYNGECAALPTSFNYGAIKATRVTELLYRMKRAETYCPRP
LLAIHPTEARHKQKIVAPVKDKKTTTLLEDRLLTTRNGHTTSTTQSSVGVTYGYATAEDF
VSGPNTSGLETRVVQAERFFKTHLFDWVTSDSFGRCHLLELPTDHKGVYGSLTDSYAYMR
NGWDVEVTAVGNQFNGGCLLVAMVPELCSIQKRELYQLTLFPHQFINPRTNMTAHITVPF
VGVNRYDQYKVHKPWTLVVMVVAPLTVNTEGAPQIKVYANIAPTNVHVAGEFPSKEGIFP
VACSDGYGGLVTTDPKTADPVYGKVFNPPRNQLPGRFTNLLDVAEACPTFLRFEGGVPYV
TTKTDSDRVLAQFDMSLAAKHMSNTFLAGLAQYYTQYSGTINLHFMFTGPTDAKARYMVA
YAPPGMEPPKTPEAAAHCIHAEWDTGLNSKFTFSIPYLSAADYTYTASCVAETTNVQGWV
CLFQITHGKADGDALVVLASAGKDFELRLPVDARAESGNTGSIINNYYMQQYQNSMDTQL
GNDWFSKLASSAFSGLFGALLADKKTTTLLEDRLLTTRNGHTTSTTQSSVGVTYGYATAE
DFVSGPNTSGLETRVVQAERFFKTHLFDWVTSDSFGRCHLLELPTDHKGVYGSLTDSYAY
MRNGWDVEVTAVGNQFNGGCLLVAMVPELCSIQKRELYQLTLFPHQFINPRTNMTAHITV
PFVGVNRYDQYKVHKPWTLVVMVVAPLTVNTEGAPQIKVYANIAPTNVHVAGEFPSKEGI
FPVACSDGYGGLVTTDPKTADPVYGKVFNPPRNQLPGRFTNLLDVAEACPTFLRFEGGVP
YVTTKTDSDRVLAQFDMSLAAKHMSNTFLAGLAQYYTQYSGTINLHFMFTGPTDAKARYM
VAYAPPGMEPPKTPEAAAHCIHAEWDTGLNSKFTFSIPYLSAADYTYTASCVAETTNVQG
WVCLFQITHGKADGDALVVLASAGKDFELRLPVDARAESGNTGSIINNYYMQQYQNSMDT
QLGNDWFSKLASSAFSGLFGALLA
//
>1fhp_2a [x.x.x]
TTSAGESADPVTTTVENYGGETQIQRRQHTDVSFIMDRFVKVTPQNQINILDLMQVPSHT
LVGALLRASTYYFSDLEIAVKHEGDLTWVPNGAPEKALDNTTNPTAYHKAPLTRLALPYT
APHRVLATVYNGECAALPTSFNYGAIKATRVTELLYRMKRAETYCPRPLLAIHPTEARHK
QKIVAPVKDKKTTTLLEDRLLTTRNGHTTSTTQSSVGVTYGYATAEDFVSGPNTSGLETR
VVQAERFFKTHLFDWVTSDSFGRCHLLELPTDHKGVYGSLTDSYAYMRNGWDVEVTAVGN
QFNGGCLLVAMVPELCSIQKRELYQLTLFPHQFINPRTNMTAHITVPFVGVNRYDQYKVH
KPWTLVVMVVAPLTVNTEGAPQIKVYANIAPTNVHVAGEFPSKEGIFPVACSDGYGGLVT
TDPKTADPVYGKVFNPPRNQLPGRFTNLLDVAEACPTFLRFEGGVPYVTTKTDSDRVLAQ
FDMSLAAKHMSNTFLAGLAQYYTQYSGTINLHFMFTGPTDAKARYMVAYAPPGMEPPKTP
EAAAHCIHAEWDTGLNSKFTFSIPYLSAADYTYTASCVAETTNVQGWVCLFQITHGKADG
DALVVLASAGKDFELRLPVDARAESGNTGSIINNYYMQQYQNSMDTQLGNDWFSKLASSA
FSGLFGALLATTSAGESADPVTTTVENYGGETQIQRRQHTDVSFIMDRFVKVTPQNQINI
LDLMQVPSHTLVGALLRASTYYFSDLEIAVKHEGDLTWVPNGAPEKALDNTTNPTAYHKA
PLTRLALPYTAPHRVLATVYNGECAALPTSFNYGAIKATRVTELLYRMKRAETYCPRPLL
AIHPTEARHKQKIVAPVKDKKTTTLLEDRLLTTRNGHTTSTTQSSVGVTYGYATAEDFVS
GPNTSGLETRVVQAERFFKTHLFDWVTSDSFGRCHLLELPTDHKGVYGSLTDSYAYMRNG
WDVEVTAVGNQFNGGCLLVAMVPELCSIQKRELYQLTLFPHQFINPRTNMTAHITVPFVG
VNRYDQYKVHKPWTLVVMVVAPLTVNTEGAPQIKVYANIAPTNVHVAGEFPSKEGIFPVA
CSDGYGGLVTTDPKTADPVYGKVFNPPRNQLPGRFTNLLDVAEACPTFLRFEGGVPYVTT
KTDSDRVLAQFDMSLAAKHMSNTFLAGLAQYYTQYSGTINLHFMFTGPTDAKARYMVAYA
PPGMEPPKTPEAAAHCIHAEWDTGLNSKFTFSIPYLSAADYTYTASCVAETTNVQGWVCL
FQITHGKADGDALVVLASAGKDFELRLPVDARAESGNTGSIINNYYMQQYQNSMDTQLGN
DWFSKLASSAFSGLFGALLATTSAGESADPVTTTVENYGGETQIQRRQHTDVSFIMDRFV
KVTPQNQINILDLMQVPSHTLVGALLRASTYYFSDLEIAVKHEGDLTWVPNGAPEKALDN
TTNPTAYHKAPLTRLALPYTAPHRVLATVYNGECAALPTSFNYGAIKATRVTELLYRMKR
AETYCPRPLLAIHPTEARHKQKIVAPVK
//
>1fhp_2a [x.x.x]
TTSAGESADPVTTTVENYGGETQIQRRQHTDVSFIMDRFVKVTPQNQINILDLMQVPSHT
LVGALLRASTYYFSDLEIAVKHEGDLTWVPNGAPEKALDNTTNPTAYHKAPLTRLALPYT
APHRVLATVYNGECAALPTSFNYGAIKATRVTELLYRMKRAETYCPRPLLAIHPTEARHK
QKIVAPVK
//
>1fi8C [b.16.1] ECOTIN
PLEKIAPYPQAEKGMKRQVIQLTPQEDESTLKVELLIGQTLEVDCLHRLGGKLENKTLEG
WGYDYYVFDKVSSPIEPD
//
>1fi8D [b.16.1] ECOTIN
KFVTAYLGDAGMLRYNSKLPIVVYTPDNVDVKYRVWKAEEKIDNAVVR
//
>1fi8E [b.16.1] ECOTIN
PLEKIAPYPQAEKGMKRQVIQLTPQEDESTLKVELLIGQTLEVDCLHRLGGKLENKTLEG
WGYDYYVFDSSPIEPD
//
>1fi8B [b.47.1] NATURAL KILLER CELL PROTEASE 1
IIGGHEAKPHSRPYMAYLQIMDEYSGSKKCGGFLIREDFVLTAAHCSGSKIQVTLGAHNI
KEQEKMQQIIPVVKIIPHPAYNSKTISNDIMLLKLKSKAKRSSAVKPLNLPRRNVKVKPG
DVCYVAGWGKLGPMGKYSDTLQEVELTVQEDQKCESYLKNYFDKANEICAGDPKIKRASF
RGDSGGPLVCKKVAAGIVSYGQNDGSTPRAFTKVSTFLSWIKKTMKK
//
>1figL [b.1.1 - b.1.1] IGG1-KAPPA 1F7 FAB (LIGHT CHAIN)
ENVLTQSPAIMSASPGEKVTMACRASSSVSSTYLHWYQQKSGASPKLLIYSTSNLASGVP
ARFSGSGSGTSYSLTISSVEAEDAATYYCQQYSGYPLTFGAGTKLELKRADAAPTVSIFP
PSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTL
TLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1figH [b.1.1 - b.1.1] IGG1-KAPPA 1F7 FAB (HEAVY CHAIN)
DVQLQQSGPELEKPGASVKISCKASGFSLPGHNINWIVQRNGKSLEWIGNIDPYYGGTNF
NPKFKGKATLTVDKSSSTLYMHLTSLQSEDSAVYYCARRRDGNYGFTYWGQGTLVTVSAA
KTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDL
YTLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKI
//
>1fj1_1A [b.1.1 - b.1.1] HYBRIDOMA ANTIBODY LA2 (LIGHT CHAIN)
DIQMTQSPSSLSATLGGKVTITCKASQDINKYIAWYQHKPGKGPRLLIHYTSTLQPGNPS
RFSGSGSGRDYSFSISNLEAEDIAIYYCLQYDNLQRTFGGGTKVEIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNE
//
>1fj1_1B [b.1.1 - b.1.1] HYBRIDOMA ANTIBODY LA2 (HEAVY CHAIN)
QIQLVQSGPELKKPGETVKISCKASGYTFTDYSMYWVKQAPGKGLKRMGWINTETGEPTY
ADDFKGRFALSLDTSASTAYLHISNLKNEDTATYFCARGLDSWGQGTSVTVSSAKTTPPS
VYPLAPGCGDTTGSSVTLGCLVKGYFPESVTVTWNSGSLSSSVHTFPALLQSGLYTMSSS
VTVPSSTWPSQTVTCSVAHPASSTTVDKKLEPS
//
>1fj1_1F (E) [b.76.1] OUTER SURFACE PROTEIN A
SLDEKNSVSVDLPGEMKVLVSKEKNKDGKYDLIATVDKLELKGTSDKNNGSGVLEGVKAD
KCKVKLTISDDLGQTTLEVFKEDGKTLVSKKVTSKDKSSTEEKFNEKGEVSEKIITRADG
TRLEYTGIKSDGSGKAKEVLKGYVLEGTLTAEKTTLVVKEGTVTLSKNISKSGEVSVELN
DTDSSAATKKTAAWNSGTSTLTITVNSKKTKDLVFTKENTITVQQYDSNGTKLEGSAVEI
TKLDEIKNALK
//
>1fl5_1L [b.1.1 - b.1.1] ANTIBODY GERMLINE PRECURSOR TO ANTIBODY 28B4
ELVMTQTPLSLPVSLGDQASISCRSSQSIVHSNGNTYLEWYLQKPGQSPKLLIYKVSNRF
SGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCFQGSHVPRTFGGGTKLEIKRTVAAPSV
FIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSL
SSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRG
//
>1fl5_1H [b.1.1 - b.1.1] ANTIBODY GERMLINE PRECURSOR TO ANTIBODY 28B4
QVQLVESGGGLVQPGGSLRLSCATSGFTFTDYYMSWVRQPPGKALEWLGFIRNKANGYTT
EYSASVKGRFTISRDNSQSILYLQMNTLRAEDSATYYCARDGSYAMDYWGQGTSVTVSSA
STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG
LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEP
//
>1flcE (A) [c.23.10 - b.19.1] HAEMAGGLUTININ-ESTERASE-FUSION GLYCOPROTEIN
EKIKICLQKQVNSSFSLHNGFGGNLYATEEKRMFELVKPKAGASVLNQSTWIGFGDSRTD
KSNSAFPRSADVSAKTADKFRFLSGGSLMLSMFGPPGKVDYLYQGCGKHKVFYEGVNWSP
HAAINCYRKNWTDIKLNFQKNIYELASQSHCMSLVNALDKTIPLQVTAGTAGNCNNSFLK
NPALYTQEVKPSENKCGKENLAFFTLPTQFGTYECKLHLVASCYFIYDSKEVYNKRGCDN
YFQVIYDSFGKVVGGLDNRVSPYTGNSGDTPTMQCDMLQLKPGRYSVRSSPRFLLMPERS
YCFDMKEKGPVTAVQSIWGKGRESDYAVDQACLSTPGCMLIQKQKPYIGEADDHHGDQEM
RELLSGLDYEARCISQSGWVNETSPFTEKYLLPPKFGRCPLAAKEESIPKIPDGLLIPTS
GTDTTVT
//
>1flcF (B) [h.3.1] HAEMAGGLUTININ-ESTERASE-FUSION GLYCOPROTEIN
IDDLIIGVLFVAIVETGIGGYLLGSRKESGGGVTKESAEKGFEKIGNDIQILKSSINIAI
EKLNDRISHDEQAIRDLTLEIENARSEALLGELGIIRALLVGNISIGLQESLWELASEIT
NRAGDLAVEVSPGCWIIDNNICDQSCQNFIFKFNETAPVPTI
//
>1fleE [b.47.1] ELASTASE
VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVDRELTFRVVVGEH
NLNQNNGTEQYVGVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQLGVLPRAGTI
LANNSPCYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWGSTVKNSMVCAGGDGV
RSGCQGDSGGPLHCLVNGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSAYISWINNVIASN
//
>1fleI [g.3.14] ELAFIN
TKPGSCPIILIRCAMLNPPNRCLKDTDCPGIKKCCEGSCGMACFVPQ
//
>1fll_1A [h.1.2 - b.8.1] TNF RECEPTOR ASSOCIATED FACTOR 3
LESVDKSAGQVARNTGLLESQLSRHDQMLSVHDIRLADMDLRFQVLETASYNGVLIWKIR
DYKRRKQEAVMGKTLSLYSQPFYTGYFGYKMCARVYLNGDGMGKGTHLSLFFVIMRGEYD
ALLPWPFKQKVTLMLMDQGSSRRHLGDAFKPDPNSSSFKKPTGEMNIASGCPVFVAQTVL
ENGTYIKDDTIFIKVIVDTSDLPDP
//
>1fll_1B (X) [x.x.x] B-CELL SURFACE ANTIGEN CD40
KTAAPVQETLHGSQPVTQEDG
//
>1flrL [b.1.1 - b.1.1] 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT
DVVMTQTPLSLPVSLGDQASISCRSSQSLVHSNGNTYLRWYLQKPGQSPKVLIYKVSNRF
SGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQSTHVPWTFGGGTKLEIKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1flrH [b.1.1 - b.1.1] 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT
EVKLDETGGGLVQPGRPMKLSCVASGFTFSDYWMNWVRQSPEKGLEWVAQIRNKPYNYET
YYSDSVKGRFTISRDDSSVYLQMNNLRVEDMGIYYCTGSYYGMDYWGQGTSVTVSSAKTT
APSVYPLAPVCGDTTSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDLYTLS
SSVTVTSSTWPSQSITCNVAHPASSTKVDKKIEPR
//
>1fltW [g.17.1] VASCULAR ENDOTHELIAL GROWTH FACTOR
HEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPT
EESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKD
//
>1fltX [b.1.1] FMS-LIKE TYROSINE KINASE 1
GRPFVEMYSEIPEIIHMTEGRELVIPCRVTSPNITVTLKKFPLDTLIPDGKRIIWDSRKG
FIISNATYKEIGLLTCEATVNGHLYKTNYLTHRQT
//
>1fm6_1A [a.123.1] RETINOIC ACID RECEPTOR RXR-ALPHA
NEDMPVERILEAELAVEPKTETYVEANMGLNPSSPNDPVTNICQAADKQLFTLVEWAKRI
PHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIF
DRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYASLEAYCKH
KYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLEAP
//
>1fm6_1D [a.123.1] PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA
PESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFK
HITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEI
IYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLA
IFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQI
VTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY
//
>1fmaA (E) [d.41.5] MOLYBDOPTERIN CONVERTIN FACTOR, SUBUNIT 2
AETKIVVGPQPFSVGEEYPWLAERDEDGAVVTFTGKVRVNALTLEHYPGMTEKALAEIVD
EARNRWPLGRVTVIHRIGELWPGDEIVFVGVTSAHRSSAFEAGQFIMDYLKTRAPFWKRE
ATPEGDRWVEARESDQQAAKRW
//
>1fmaB (D) [d.15.3] MOLYBDOPTERIN CONVERTIN FACTOR, SUBUNIT 1
MIKVLFFAQVRELVGTDATEVAADFPTVEALRQHMAAQSDRWALALEDGKLLAAVNQTLV
SFDHPLTDGDEVAFFPPVTGG
//
>1fmd_21 [b.121.4] FOOT-AND-MOUTH DISEASE VIRUS (SUBUNIT VP1)
TTTTGESADPVTTTVENYGGETQVQRRHHTDVAFVLDRFVKVTVSDNQHTLDVMQAHKDN
IVGALLRAATYYFSDLEIAVTHTGKLTWVPNGAPVSALNNTTNPTAYHKGPVTRLALPYT
APHRVLATAYTGAHLPTSFNFGAVKAETITELLVRMKRAELYCPRPILPIQPTGDRHKQP
LVAPAKQ
//
>1fmd_22 [b.121.4] FOOT-AND-MOUTH DISEASE VIRUS (SUBUNIT VP2)
DKKTEETTLLEDRILTTRNGHTTSTTQSSVGVTFGYATAEDSTSGPNTSALETRVHQAER
FFKMALFDWVPSQNFGHMHKVVLPHEPKGVYGGLVKSYAYMRNGWDVEVTAVGNQFNGGC
LLVALVPEMGDISDREKYQLTLYPHQFINPRTNMTAHITVPYVGVNRYDQYKQHRPWTLV
VMVVAPLTTNTAGAQQIKVYANIAPTNVHVAGELPSKE
//
>1fmd_23 [b.121.4] FOOT-AND-MOUTH DISEASE VIRUS (SUBUNIT VP3)
GIFPVACSDGYGNMVTTDPKTADPAYGKVYNPPRTALPGRFTNYLDVAEACPTFLMFENV
PYVSTRTDGQRLLAKFDVSLAAKHMSNTYLAGLAQYYTQYTGTINLHFMFTGPTDAKARY
MVAYVPPGMDAPDNPEEAAHCIHAEWDTGLNSKFTFSIPYISAADYTYTASHEAETTCVQ
GWVCVYQITHGKADADALVVSASAGKDFELRLPVDARQQ
//
>1fmd_24 [b.121.4] FOOT-AND-MOUTH DISEASE VIRUS (SUBUNIT VP4)
SGNTGSIINNYYMQQYQNSMDTQLGNDWFSKLASSAFSGLFGALLA
//
>1fmd_2G (3) [b.121.4] FOOT-AND-MOUTH DISEASE VIRUS (SUBUNIT VP3)
GIFPVACSDGYGNMVTTDPKTADPAYGKVYNPPRTALPGRFTNYLDVAEACPTFLMFENV
PYVSTRTDGQRLLAKFDVSLAAKHMSNTYLAGLAQYYTQYTGTINLHFMFTGPTDAKARY
MVAYVPPGMDAPDNPEEAAHCIHAEWDTGLNSKFTFSIPYISAADYTYTASHEAETTCVQ
GWVCVYQITHGKADADALVVSASAGKDFELRLPVDARQQ
//
>1fmd_2z (4) [b.121.4] FOOT-AND-MOUTH DISEASE VIRUS (SUBUNIT VP4)
SGNTGSIINNYYMQQYQNSMDTQLGNDWFSKLASSAFSGLFGALLA
//
>1fmd_23 [b.121.4] FOOT-AND-MOUTH DISEASE VIRUS (SUBUNIT VP3)
GIFPVACSDGYGNMVTTDPKTADPAYGKVYNPPRTALPGRFTNYLDVAEACPTFLMFENV
PYVSTRTDGQRLLAKFDVSLAAKHMSNTYLAGLAQYYTQYTGTINLHFMFTGPTDAKARY
MVAYVPPGMDAPDNPEEAAHCIHAEWDTGLNSKFTFSIPYISAADYTYTASHEAETTCVQ
GWVCVYQITHGKADADALVVSASAGKDFELRLPVDARQQ
//
>1fmd_24 [b.121.4] FOOT-AND-MOUTH DISEASE VIRUS (SUBUNIT VP4)
SGNTGSIINNYYMQQYQNSMDTQLGNDWFSKLASSAFSGLFGALLA
//
>1fmd_2G (3) [b.121.4] FOOT-AND-MOUTH DISEASE VIRUS (SUBUNIT VP3)
TTTTGESADPVTTTVENYGGETQVQRRHHTDVAFVLDRFVKVTVSDNQHTLDVMQAHKDN
IVGALLRAATYYFSDLEIAVTHTGKLTWVPNGAPVSALNNTTNPTAYHKGPVTRLALPYT
APHRVLATAYTGAHLPTSFNFGAVKAETITELLVRMKRAELYCPRPILPIQPTGDRHKQP
LVAPAKQ
//
>1fmd_2I (3) [b.121.4] FOOT-AND-MOUTH DISEASE VIRUS (SUBUNIT VP3)
GIFPVACSDGYGNMVTTDPKTADPAYGKVYNPPRTALPGRFTNYLDVAEACPTFLMFENV
PYVSTRTDGQRLLAKFDVSLAAKHMSNTYLAGLAQYYTQYTGTINLHFMFTGPTDAKARY
MVAYVPPGMDAPDNPEEAAHCIHAEWDTGLNSKFTFSIPYISAADYTYTASHEAETTCVQ
GWVCVYQITHGKADADALVVSASAGKDFELRLPVDARQQ
//
>1fmd_2p (4) [b.121.4] FOOT-AND-MOUTH DISEASE VIRUS (SUBUNIT VP4)
SGNTGSIINNYYMQQYQNSMDTQLGNDWFSKLASSAFSGLFGALLA
//
>1fmoE [d.144.1] CAMP-DEPENDENT PROTEIN KINASE
ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK
ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL
RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK
GRTWxLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS
GKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEA
PFIPKFKGPGDTSNFDDYEEEEIRVxINEKCGKEFTEF
//
>1fmoI [x.x.x] HEAT STABLE RABBIT SKELETAL MUSCLE INHIBITOR
TTYADFIASGRTGRRNAIHD
//
>1fn4_2C (A) [b.1.1 - b.1.1] MONOCLONAL ANTIBODY AGAINST ACETYLCHOLINE
DIKLTQSPSLLSASVGDRVTLSCKGSQNINNYLAWYQQKLGEAPKLLIYNTNSLQTGIPS
RFSGSGSGTDYTLTISSLQPEDVATYFCYQYNNGYTFGAGTKLELKRTAPTVSIFPPSTE
QLATGGASVVCLMNNFYPRDISVKWKIDGTERRDGVLDSVTDQDSKDSTYSMSSTLSLTK
ADYESHNLYTCEVVHKTSSSPVVKSFNRNEC
//
>1fn4_2D (B) [b.1.1 - b.1.1] MONOCLONAL ANTIBODY AGAINST ACETYLCHOLINE
QVQLLESGPGLVRPSETLSLTCTVSGFSLTSFSVSWVRHPSGKGPEWMGRMWYDGYTAYN
SALKSRLSISRDTSKNQVFLKMNSLQTDDTGTYYCTRDLYGGYPLGFWYFDFWGPGTMVT
VSSVFPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGALSSGVHTFPAVLQSGLYTL
TSSVTVPSSTWSSQAVTCNVAHPASSTKVDKKIVPRDC
//
>1fnsB (A) [c.62.1] VON WILLEBRAND FACTOR
MYCSRLLDLVFLLDGSSRLSEAEFEVLKAFVVDMMERLRVSQKWVRVAVVEYHDGSHAYI
GLKDRKRPSELRRIASQVKYAGSQVASTSEVLKYTLFQIFSKIDRPEASRIALLLMASQE
PQRMSRNFVRYVQGLKKKKVIVIPVGIGPHANLKQIRLIEKQAPENKAFVLSSVDELEQQ
RDEIVSYLCDLAPEAP
//
>1fnsC (H) [b.1.1 - b.1.1] IMMUNOGLOBULIN NMC-4 IGG1
QVQLKESGPGLVAPSQSLSITCTVSGFSLTDYGVDWVRQPPGKGLEWLGMIWGDGSTDYN
SALKSRLSITKDNSKSQVFLKMNSLQTDDTARYYCVRDPADYGNYDYALDYWGQGTSVTV
SSAKTTPPSVYPLAPGSSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYT
LSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKIVPRDCG
//
>1fnsD (L) [b.1.1 - b.1.1] IMMUNOGLOBULIN NMC-4 IGG1
DIQMTQSPSSLSASLGDRVTISCSASQDINKYLNWYQQKPDGAVKLLIFYTSSLHSGVPS
RFSGSGSGTDYSLTISNLEPEDIATYYCQQYEKLPWTFGGGTKLEVKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1fntA [d.153.1] PROTEASOME COMPONENT C7-ALPHA
HITIFSPEGRLYQVEYAFKATNQTNINSLAVRGKDCTVVISQKKVPDKLLDPTTVSYIFC
ISRTIGMVVNGPIPDARNAALRAKAEAAEFRYKYGYDMPCDVLAKRMANLSQIYTQRAYM
RPLGVILTFVSVDEELGPSIYKTDPAGYYVGYKATATGPKQQEITTNLENHFKKSKIDHI
NEESWEKVVEFAITHMIDALGTEFSKNDLEVGVATKDKFFTLSAENIEERLVAIAEQD
//
>1fntC [d.153.1] PROTEASOME COMPONENT Y13
RYDSRTTIFSPEGRLYQVEYALESISHAGTAIGIMASDGIVLAAERKVTSTLLEQDTSTE
KLYKLNDKIAVAVAGLTADAEILINTARIHAQNYLKTYNEDIPVEILVRRLSDIKQGYTQ
HGGLRPFGVSFIYAGYDDRYGYQLYTSNPSGNYTGWKAISVGANTSAAQTLLQMDYKDDM
KVDDAIELALKTLSKTTDSSALTYDRLEFATIRKGANDGEVYQKIFKPQEIKDILVKTGI
T
//
>1fntD [d.153.1] PROTEASOME COMPONENT PRE6
DRALSIFSPDGHIFQVEYALEAVKRGTCAVGVKGKNCVVLGCERRSTLKLQDTRITPSKV
SKIDSHVVLSFSGLNADSRILIEKARVEAQSHRLTLEDPVTVEYLTRYVAGVQQRYTQSG
GVRPFGVSTLIAGFDPRDDEPKLYQTEPSGIYSSWSAQTIGRNSKTVREFLEKNYDRKEP
PATVEECVKLTVRSLLEVVQTGAKNIEITVVKPDSDIVALSSEEINQYVTQIEQEKQEQ
//
>1fntE [d.153.1] PROTEASOME COMPONENT PUP2
EYDRGVSTFSPEGRLFQVEYSLEAIKLGSTAIGIATKEGVVLGVEKRATSPLLESDSIEK
IVEIDRHIGCAMSGLTADARSMIEHARTAAVTHNLYYDEDINVESLTQSVCDLALRFGEG
ASGEERLMSRPFGVALLIAGHDADDGYQLFHAEPSGTFYRYNAKAIGSGSEGAQAELLNE
WHSSLTLKEAELLVLKILKQVMEEKLDENNAQLSCITKQDGFKIYDNEKTAELIKELKEK
EAAE
//
>1fntF [d.153.1] PROTEASOME COMPONENT PRE5
FRNNYDGDTVTFSPTGRLFQVEYALEAIKQGSVTVGLRSNTHAVLVALKRNADELSSYQK
KIIKCDEHMGLSLAGLAPDARVLSNYLRQQCNYSSLVFNRKLAVERAGHLLCDKAQKNTQ
SYGGRPYGVGLLIIGYDKSGAHLLEFQPSGNVTELYGTAIGARSQGAKTYLERTLDTFIK
IDGNPDELIKAGVEAISQSLRDESLTVDNLSIAIVGKDTPFTIYDGEAVAKYI
//
>1fntG [d.153.1] PROTEASOME COMPONENT C1
DLSNSVFSPDGRNFQVEYAVKAVENGTTSIGIKCNDGVVFAVEKLITSKLLVPQKNVKIQ
VVDRHIGCVYSGLIPDGRHLVNRGREEAASFKKLYKTPIPIPAFADRLGQYVQAHTLYNS
VRPFGVSTIFGGVDKNGAHLYMLEPSGSYWGYKGAATGKGRQSAKAELEKLVDHHPEGLS
AREAVKQAAKIIYLAHEDNKEKDFELEISWCSLSETNGLHKFVKGDLLQEAIDFAQKEIN
//
>1fntH [d.153.1] PROTEASOME COMPONENT PRE3
TSIMAVTFKDGVILGADSRTTTGAYIANRVTDKLTRVHDKIWCCRSGSAADTQAIADIVQ
YHLELYTSQYGTPSTETAASVFKELCYENKDNLTAGIIVAGYDDKNKGEVYTIPLGGSVH
KLPYAIAGSGSTFIYGYCDKNFRENMSKEETVDFIKHSLSQAIKWDGSSGGVIRMVVLTA
AGVERLIFYPDEYEQL
//
>1fntK [d.153.1] PROTEASOME COMPONENT C11
MDIILGIRVQDSVILASSKAVTRGISVLKDSDDKTRQLSPHTLMSFAGEAGDTVQFAEYI
QANIQLYSIREDYELSPQAVSSFVRQELAKSIRSRRPYQVNVLIGGYDKKKNKPELYQID
YLGTKVELPYGAHGYSGFYTFSLLDHHYRPDMTTEEGLDLLKLCVQELEKRMPMDFKGVI
VKIVDKDGIRQVDDFQAQ
//
>1fntL [d.153.1] PROTEASOME COMPONENT PRE2
TTTLAFRFQGGIIVAVDSRATAGNWVASQTVKRVIEINPFLLGTMAGGAADCQFWETWLG
SQCRLHELREKERISVAAASKILSNLVYQYKGAGLSMGTMICGYTRKEGPTIYYVDSDGT
RLKGDIFCVGSGQTFAYGVLDSNYKWDLSVEDALYLGKRSILAAAHRDAYSGGSVNLYHV
TEDGWIYHGNHDVGELFWKVKEEEGSFNNVIG
//
>1fntM [d.153.1] PROTEASOME COMPONENT C5
QFNPYGDNGGTILGIAGEDFAVLAGDTRNITDYSINSRYEPKVFDCGDNIVMSANGFAAD
GDALVKRFKNSVKWYHFDHNDKKLSINSAARNIQHLLYGKRFFPYYVHTIIAGLDEDGKG
AVYSFDPVGSYEREQCRAGGAAASLIMPFLDNQVNFKNQYEPGTNGKVKKPLKYLSVEEV
IKLVRDSFTSATERHIQVGDGLEILIVTKDGVRKEFYELKRD
//
>1fntN [d.153.1] PROTEASOME COMPONENT PRE4
TQQPIVTGTSVISMKYDNGVIIAADNLGSYGSLLRFNGVERLIPVGDNTVVGISGDISDM
QHIERLLKDLVTENAYDNPLADAEEALEPSYIFEYLATVMYQRRSKMNPLWNAIIVAGVQ
SNGDQFLRYVNLLGVTYSSPTLATGFGAHMANPLLRKVVDRESDIPKTTVQVAEEAIVNA
MRVLYYRDARSSRNFSLAIIDKNTGLTFKKNLQVENMKWDFAKDIKGYGTQKI
//
>1fntO (A) [d.153.1] PROTEASOME COMPONENT C7-ALPHA
HITIFSPEGRLYQVEYAFKATNQTNINSLAVRGKDCTVVISQKKVPDKLLDPTTVSYIFC
ISRTIGMVVNGPIPDARNAALRAKAEAAEFRYKYGYDMPCDVLAKRMANLSQIYTQRAYM
RPLGVILTFVSVDEELGPSIYKTDPAGYYVGYKATATGPKQQEITTNLENHFKKSKIDHI
NEESWEKVVEFAITHMIDALGTEFSKNDLEVGVATKDKFFTLSAENIEERLVAIAEQD
//
>1fntQ (C) [d.153.1] PROTEASOME COMPONENT Y13
RYDSRTTIFSPEGRLYQVEYALESISHAGTAIGIMASDGIVLAAERKVTSTLLEQDTSTE
KLYKLNDKIAVAVAGLTADAEILINTARIHAQNYLKTYNEDIPVEILVRRLSDIKQGYTQ
HGGLRPFGVSFIYAGYDDRYGYQLYTSNPSGNYTGWKAISVGANTSAAQTLLQMDYKDDM
KVDDAIELALKTLSKTTDSSALTYDRLEFATIRKGANDGEVYQKIFKPQEIKDILVKTGI
T
//
>1fntZ (L) [d.153.1] PROTEASOME COMPONENT PRE2
TTTLAFRFQGGIIVAVDSRATAGNWVASQTVKRVIEINPFLLGTMAGGAADCQFWETWLG
SQCRLHELREKERISVAAASKILSNLVYQYKGAGLSMGTMICGYTRKEGPTIYYVDSDGT
RLKGDIFCVGSGQTFAYGVLDSNYKWDLSVEDALYLGKRSILAAAHRDAYSGGSVNLYHV
TEDGWIYHGNHDVGELFWKVKEEEGSFNNVIG
//
>1fnta (M) [d.153.1] PROTEASOME COMPONENT C5
QFNPYGDNGGTILGIAGEDFAVLAGDTRNITDYSINSRYEPKVFDCGDNIVMSANGFAAD
GDALVKRFKNSVKWYHFDHNDKKLSINSAARNIQHLLYGKRFFPYYVHTIIAGLDEDGKG
AVYSFDPVGSYEREQCRAGGAAASLIMPFLDNQVNFKNQYEPGTNGKVKKPLKYLSVEEV
IKLVRDSFTSATERHIQVGDGLEILIVTKDGVRKEFYELKRD
//
>1fnte (c) [a.24.8] PROTEASOME ACTIVATOR PROTEIN PA26
AALIQNLRDSYTETSSFAVIEEWAAGTLQEIEGIAKAAAEAHGVIRNSTYGRAQAEKSPE
QLLGVLQRYQDLCHNVYCQAETIRTVIAIRIPEHKEEDNLGVAVQHAVLKIIDELEIKTL
GSGEKSGSGGAPTPIGMYALRESPSLLLELRQIDADFMLKVELATTHLSTMVRAVINAYL
LNWKKLIQPRTGTDHMVS
//
>1fntf (c) [a.24.8] PROTEASOME ACTIVATOR PROTEIN PA26
AALIQNLRDSYTETSSFAVIEEWAAGTLQEIEGIAKAAAEAHGVIRNSTYGRAQAEKSPE
QLLGVLQRYQDLCHNVYCQAETIRTVIAIRIPEHKEEDNLGVAVQHAVLKIIDELEIKTL
GSGEKSGSGGAPTPIGMYALRESPSLLLELRQIDADFMLKVELATTHLSTMVRAVINAYL
LNWKKLIQPRTGTDHMVS
//
>1fntg (c) [a.24.8] PROTEASOME ACTIVATOR PROTEIN PA26
AALIQNLRDSYTETSSFAVIEEWAAGTLQEIEGIAKAAAEAHGVIRNSTYGRAQAEKSPE
QLLGVLQRYQDLCHNVYCQAETIRTVIAIRIPEHKEEDNLGVAVQHAVLKIIDELEIKTL
GSGEKSGSGGAPTPIGMYALRESPSLLLELRQIDADFMLKVELATTHLSTMVRAVINAYL
LNWKKLIQPRTGTDHMVS
//
>1fntk (c) [a.24.8] PROTEASOME ACTIVATOR PROTEIN PA26
AALIQNLRDSYTETSSFAVIEEWAAGTLQEIEGIAKAAAEAHGVIRNSTYGRAQAEKSPE
QLLGVLQRYQDLCHNVYCQAETIRTVIAIRIPEHKEEDNLGVAVQHAVLKIIDELEIKTL
GSGEKSGSGGAPTPIGMYALRESPSLLLELRQIDADFMLKVELATTHLSTMVRAVINAYL
LNWKKLIQPRTGTDHMVS
//
>1fntp (c) [a.24.8] PROTEASOME ACTIVATOR PROTEIN PA26
AALIQNLRDSYTETSSFAVIEEWAAGTLQEIEGIAKAAAEAHGVIRNSTYGRAQAEKSPE
QLLGVLQRYQDLCHNVYCQAETIRTVIAIRIPEHKEEDNLGVAVQHAVLKIIDELEIKTL
GSGEKSGSGGAPTPIGMYALRESPSLLLELRQIDADFMLKVELATTHLSTMVRAVINAYL
LNWKKLIQPRTGTDHMVS
//
>1fo0H [d.19.1 - b.1.1] PROTEIN (ALLOGENEIC H-2KB MHC CLASS I MOLECULE)
MGPHSLRYFVTAVSRPGLGEPRYMEVGYVDDTEFVRFDSDAENPRYEPRARWMEQEGPEY
WERETQKAKGNEQSFRVDLRTLLGYYNQSKGGSHTIQVISGCEVGSDGRLLRGYQQYAYD
GCDYIALNEDLKTWTAADMAALITKHKWEQAGEAERLRAYLEGTCVEWLRRYLKNGNATL
LRTDSPKAHVTHHSRPEDKVTLRCWALGFYPADITLTWQLNGEELIQDMELVETRPAGDG
TFQKWASVVVPLGKEQYYTCHVYHQGLPEPLTLRWE
//
>1fo0B [b.1.1] PROTEIN (BM3.3 T CELL RECEPTOR BETA-CHAIN)
VTLLEQNPRWRLVPRGQAVNLRCILKNSQYPWMSWYQQDLQKQLQWLFTLRSPGDKEVKS
LPGADYLATRVTDTELRLQVANMSQGRTLYCTCSADRVGNTLYFGEGSRLIV
//
>1fo0A [b.1.1] PROTEIN (BM3.3 T CELL RECEPTOR ALPHA-CHAIN)
KVTQTQTSISVMEKTTVTMDCVYETQDSSYFLFWYKQTASGEIVFLIRQDSYKKENATVG
HYSLNFQKPKSSIGLIITATQIEDSAVYFCAMRGDYGGSGNKLIFGTGTLLSVKP
//
>1fod_21 [b.121.4] FOOT AND MOUTH DISEASE VIRUS
TTSAGESADPVTTTVENYGGETQIQRRQHTDVSFIMDRFVKVTPQNQINILDLMQVPSHT
LVGGLLRASTYYFSDLEIAVKHEGDLTWVPNGAPEKALDNTTNPTAYHKAPLTRLALPYT
APHRVLATVYNGECRYSRNAVPNLRGDLQVLAQKVARTLPTSFNYGAIKATRVTELLYRM
KRAETYCPRPLLAIHPTEARHKQKIVAPVK
//
>1fod_22 [b.121.4] FOOT AND MOUTH DISEASE VIRUS
EETTLLEDRILTTRNGHTTSTTQSSVGVTYGYATAEDFVSGPNTSGLETRVVQAERFFKT
HLFDWVTSDSFGRCHLLELPTDHKGVYGSLTDSYAYMRNGWDVEVTAVGNQFNGGCLLVA
MVPELCSIQKRELYQLTLFPHQFINPRTNMTAHITVPFVGVNRYDQYKVHKPWTLVVMVV
APLTVNTEGAPQIKVYANIAPTNVHVAGEFPSKE
//
>1fod_24 [b.121.4] FOOT AND MOUTH DISEASE VIRUS
SGNTGSIINNYYMQQYQNSMDTQLGNDWFSKLASSAFSGLFGALLA
//
>1fod_2G (3) [b.121.4] FOOT AND MOUTH DISEASE VIRUS
GIFPVACSDGYGGLVTTDPKTADPVYGKVFNPPRNQLPGRFTNLLDVAEACPTFLRFEGG
VPYVTTKTDSDRVLAQFDMSLAAKHMSNTFLAGLAQYYTQYSGTINLHFMFTGPTDAKAR
YMVAYAPPGMEPPKTPEAAAHCIHAEWDTGLNSKFTFSIPYLSAADYTYTASDVAETTNV
QGWVCLFQITHGKADGDALVVLASAGKDFELRLPVDARAE
//
>1fod_2H (4) [b.121.4] FOOT AND MOUTH DISEASE VIRUS
SGNTGSIINNYYMQQYQNSMDTQLGNDWFSKLASSAFSGLFGALLA
//
>1fod_24 [b.121.4] FOOT AND MOUTH DISEASE VIRUS
SGNTGSIINNYYMQQYQNSMDTQLGNDWFSKLASSAFSGLFGALLA
//
>1fod_2G (3) [b.121.4] FOOT AND MOUTH DISEASE VIRUS
TTSAGESADPVTTTVENYGGETQIQRRQHTDVSFIMDRFVKVTPQNQINILDLMQVPSHT
LVGGLLRASTYYFSDLEIAVKHEGDLTWVPNGAPEKALDNTTNPTAYHKAPLTRLALPYT
APHRVLATVYNGECRYSRNAVPNLRGDLQVLAQKVARTLPTSFNYGAIKATRVTELLYRM
KRAETYCPRPLLAIHPTEARHKQKIVAPVK
//
>1fod_2H (4) [b.121.4] FOOT AND MOUTH DISEASE VIRUS
EETTLLEDRILTTRNGHTTSTTQSSVGVTYGYATAEDFVSGPNTSGLETRVVQAERFFKT
HLFDWVTSDSFGRCHLLELPTDHKGVYGSLTDSYAYMRNGWDVEVTAVGNQFNGGCLLVA
MVPELCSIQKRELYQLTLFPHQFINPRTNMTAHITVPFVGVNRYDQYKVHKPWTLVVMVV
APLTVNTEGAPQIKVYANIAPTNVHVAGEFPSKE
//
>1fod_2I (3) [b.121.4] FOOT AND MOUTH DISEASE VIRUS
GIFPVACSDGYGGLVTTDPKTADPVYGKVFNPPRNQLPGRFTNLLDVAEACPTFLRFEGG
VPYVTTKTDSDRVLAQFDMSLAAKHMSNTFLAGLAQYYTQYSGTINLHFMFTGPTDAKAR
YMVAYAPPGMEPPKTPEAAAHCIHAEWDTGLNSKFTFSIPYLSAADYTYTASDVAETTNV
QGWVCLFQITHGKADGDALVVLASAGKDFELRLPVDARAE
//
>1fod_2p (4) [b.121.4] FOOT AND MOUTH DISEASE VIRUS
SGNTGSIINNYYMQQYQNSMDTQLGNDWFSKLASSAFSGLFGALLA
//
>1foe_1A [a.87.1 - b.55.1] T-LYMPHOMA INVASION AND METASTASIS INDUCING
QLSDADKLRKVICELLETERTYVKDLNCLmERYLKPLQKETFLTQDELDVLFGNLTEmVE
FQVEFLKTLEDGVRLVPDLEKLEKVDQFKKVLFSLGGSFLYYADRFKLYSAFCASHTKVP
KVLVKAKTDTAFKAFLDAQNPRQQHSSTLESYLIKPIQRVLKYPLLLRELFALTDAESEE
HYHLDVAIKTmNKVASHINEmQKIHEEFGAVFDQLIAEQTGEKKEVADLSmGDLLLHTSV
IWLNPPASLGKWKKEPELAAFVFKTAVVLVYKDGSKQKKKLVGSHRLSIYEEWDPFRFRH
mIPTEALQVRALPSADAEANAVCEIVHVKSESEGRPERVFHLCCSSPESRKDFLKSVHSI
LRDKHRRQ
//
>1foe_1B [c.37.1] RAS-RELATED C3 BOTULINUM TOXIN SUBSTRATE
MQAIKCVVVGDGAVGKTCLLISYTTNAFPGEYIPTVFDNYSANVMVDGKPVNLGLWDTAG
QEDYDRLRPLSYPQTDVFLICFSLVSPASFENVRAKWYPEVRHHCPNTPIILVGTKLDLR
DDKDTIEKLKEKKLTPITYPQGLAMAKEIGAVKYLECSALTQRGLKTVFDEAIRAVL
//
>1forL [b.1.1 - b.1.1] IGG2A-KAPPA 17-IA FAB (LIGHT CHAIN)
QIVLTQSPAIMSAFPGEKVTITCSATSSVNYMHWFQQKPGTSPKLWIYSSSNLASGVPAR
FSGSGSGTSYSLTISRMEAEDAATYYCQQRSSYPITFGSGTKLEIKRADAAPTVSIFPPS
SEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLTL
TKDEYERHNSYTCEATHKTSTSPIVKSFNR
//
>1forH [b.1.1 - b.1.1] IGG2A-KAPPA 17-IA FAB (HEAVY CHAIN)
QGQLQQSGAELVRPGSSVKISCKASGYAFSSFWVNWVKQRPGQGLEWIGQIYPGDGDNKY
NGKFKGKATLTADKSSTTAYMQLYSLTSEDSAVYFCARSGNYPYAMDYWGQGTSVTVSSA
KTTAPSVYPLAPVCGGTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSGL
YTLSSSVTVTSSTWPSQTITCNVAHPASSTKVDKKIEPR
//
>1fos_2G [h.1.3] P55-C-FOS PROTO-ONCOGENE PROTEIN
RRIRRERNKMAAAKSRNRRRELTDTLQAETDQLEDEKSALQTEIANLLKEKEKLEFILA
//
>1fos_2H [h.1.3] C-JUN PROTO-ONCOGENE PROTEIN
ERKRMRNRIAASKSRKRKLERIARLEEKVKTLKAQNSELASTANMLREQVAQLKQKVM
//
>1fpn_21 [b.121.4] COAT PROTEIN VP1
LVVPNINSSNPTTSNSAPALDAAETGHTSSVQPEDVIETRYVQTSQTRDEMSLESFLGRS
GCIHESKLEVTLANYNKENFTVWAINLQEMAQIRRKFELFTYTRFDSEITLVPCISALSQ
DIGHITMQYMYVPPGAPVPNSRDDYAWQSGTNASVFWQHGQAYPRFSLPFLSVASAYYMF
YDGYDEQDQNYGTANTNNMGSLCSRIVTEKHIHKVHIMTRIYHKAKHVKAWCPRPPRALE
YTRAHRTNFKIEDRSIQTAIVTRPIITTA
//
>1fpn_22 [b.121.4] COAT PROTEIN VP2
RIIQITRGDSTITSQDVANAIVAYGVWPHYLSSKDASAIDKPSQPDTSSNRFYTLRSVTW
SSSSKGWWWKLPDALKDMGIFGENMFYHYLGRSGYTIHVQCNASKFHQGTLIVALIPEHQ
IASALHGNVNVGYNYTHPGETGREVKAETRLNPDLQPTEEYWLNFDGTLLGNITIFPHQF
INLRSNNSATIIAPYVNAVPMDSMRSHNNWSLVIIPICPLETSSAINTIPITISISPMCA
EFSGARAKRQ
//
>1fpn_23 [b.121.4] COAT PROTEIN VP3
GLPVFITPGSGQFLTTDDFQSPCALPWYHPTKEISIPGEVKNLVEICQVDSLVPINNTDT
YINSENMYSVVLQSSINAPDKIFSIRTDVASQPLATTLIGEISSYFTHWTGSLRFSFMFC
GTANTTVKLLLAYTPPGIAEPTTRKDAMLGTHVIWDVGLQSTISMVVPWISASHYRNTSP
GRSTSGYITCWYQTRLVIPPQTPPTARLLCFVSGCKDFCLRMARDTNLHLQSGAIAQ
//
>1fpn_24 [b.121.4] COAT PROTEIN VP4
AQVSRQNYFNINYFKDAASNGASKL
//
>1fpn_2f (3) [b.121.4] COAT PROTEIN VP3
LVVPNINSSNPTTSNSAPALDAAETGHTSSVQPEDVIETRYVQTSQTRDEMSLESFLGRS
GCIHESKLEVTLANYNKENFTVWAINLQEMAQIRRKFELFTYTRFDSEITLVPCISALSQ
DIGHITMQYMYVPPGAPVPNSRDDYAWQSGTNASVFWQHGQAYPRFSLPFLSVASAYYMF
YDGYDEQDQNYGTANTNNMGSLCSRIVTEKHIHKVHIMTRIYHKAKHVKAWCPRPPRALE
YTRAHRTNFKIEDRSIQTAIVTRPIITTAGLPVFITPGSGQFLTTDDFQSPCALPWYHPT
KEISIPGEVKNLVEICQVDSLVPINNTDTYINSENMYSVVLQSSINAPDKIFSIRTDVAS
QPLATTLIGEISSYFTHWTGSLRFSFMFCGTANTTVKLLLAYTPPGIAEPTTRKDAMLGT
HVIWDVGLQSTISMVVPWISASHYRNTSPGRSTSGYITCWYQTRLVIPPQTPPTARLLCF
VSGCKDFCLRMARDTNLHLQSGAIAQ
//
>1fpn_2h (3) [b.121.4] COAT PROTEIN VP3
GLPVFITPGSGQFLTTDDFQSPCALPWYHPTKEISIPGEVKNLVEICQVDSLVPINNTDT
YINSENMYSVVLQSSINAPDKIFSIRTDVASQPLATTLIGEISSYFTHWTGSLRFSFMFC
GTANTTVKLLLAYTPPGIAEPTTRKDAMLGTHVIWDVGLQSTISMVVPWISASHYRNTSP
GRSTSGYITCWYQTRLVIPPQTPPTARLLCFVSGCKDFCLRMARDTNLHLQSGAIAQ
//
>1fpn_2i (4) [b.121.4] COAT PROTEIN VP4
AQVSRQNYFNINYFKDAASNGASKL
//
>1fpn_2e (2) [b.121.4] COAT PROTEIN VP2
RIIQITRGDSTITSQDVANAIVAYGVWPHYLSSKDASAIDKPSQPDTSSNRFYTLRSVTW
SSSSKGWWWKLPDALKDMGIFGENMFYHYLGRSGYTIHVQCNASKFHQGTLIVALIPEHQ
IASALHGNVNVGYNYTHPGETGREVKAETRLNPDLQPTEEYWLNFDGTLLGNITIFPHQF
INLRSNNSATIIAPYVNAVPMDSMRSHNNWSLVIIPICPLETSSAINTIPITISISPMCA
EFSGARAKRQ
//
>1fptB (H) [b.1.1 - b.1.1] IGG2A-KAPPA C3 FAB (HEAVY CHAIN)
QVQLQQSGAELVRPGTSVKVSCKASGYAFTNYLIQWIKQRPGQGLEWIGVINPGSGGTDY
NANFKGKATLTADKSSSIVYMQLSSLTSDDSAVYFCARDFYDYDVGFDYWGQGTTLTVSS
AKTTAPSVYPLAPVCGDTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSD
LYTLSSSVTVTSSTWPSQSITCNVAHPASSTKVDKKIEPR
//
>1fptC (L) [b.1.1 - b.1.1] IGG2A-KAPPA C3 FAB (LIGHT CHAIN)
DVVMTQTPLSLPVSLGDQASISCSSSQSLVHSNGKTYLHWYLQKPGQSPKLLIYKVSNRF
SGVPDRFSGSGSGTYFTLKISRVEAEDLGVYFCSQSTHVPYTFGGGTKLEIKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSEVQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1fq1B [d.144.1] CELL DIVISION PROTEIN KINASE 2
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH
PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS
HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYxHEVVTLWYRAPEILLGCKYY
STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF
PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
//
>1fq1A [c.45.1] CYCLIN-DEPENDENT KINASE INHIBITOR 3
EDEQTPIHISWLSLSRVNCSQFLGLCALPGCKFKDVRRNVQKDTEELKSCGIQDIFVFCT
RGELSKYRVPNLLDLYQQCGIITHHHPIADGGTPDIASCCEIMEELTTCLKNYRKTLIHS
YGGLGRSCLVAACLLLYLSDTISPEQAIDSLRDLRGSGAIQTIKQYNYLHEFRDKLAAHL
SSR
//
>1fq9D [b.1.1 - b.1.1] FIBROBLAST GROWTH FACTOR RECEPTOR 1
MPVAPYWTSPEKMEKKLHAVPAAKTVKFKCPSSGTPQPTLRWLKNGKEFKPDHRIGGYKV
RYATWSIIMDSVVPSDKGNYTCIVENEYGSINHTYQLDVVERSPHRPILQAGLPANKTVA
LGSNVEFMCKVYSDPQPHIQWLKHVQILKTAGVNTTDKEMEVLHLRNVSFEDAGEYTCLA
GNSIGLSHHSAWLTVL
//
>1fq9B (A) [b.42.1] FIBROBLAST GROWTH FACTOR 2
HFKDPKRLYCKNGGFFLRIHPDGRVDGVREKSDPHIKLQLQAEERGVVSIKGVSANRYLA
MKEDGRLLASKSVTDECFFFERLESNNYNTYRSRKYTSWYVALKRTGQYKLGSKTGPGQK
AILFLPMSA
//
>1fqjA [c.37.1 - a.66.1] CHIMERA OF GUANINE NUCLEOTIDE-BINDING PROTEIN
RTVKLLLLGAGESGKSTIVKQMKIIHQDGYSLEECLEFIAIIYGNTLQSILAIVRAMTTL
NIQYGDSARQDDARKLMHMADTIEEGTMPKEMSDIIQRLWKDSGIQACFDRASEYQLNDS
AGYYLSDLERLVTPGYVPTEQDVLRSRVKTTGIIETQFSFKDLNFRMFDVGGQRSERKKW
IHCFEGVTAIIFCVALSDYDLVLAEDEEMNRMHESMKLFDSICNNKWFTDTSIILFLNKK
DLFEEKIKKSPLTICYPEYAGSNTYEEAGNYIKVQFLELNMRRDVKEIYSHMTCATDTQN
VKFVFDAVTDIIIKENL
//
>1fqjC [j.51.1] RETINAL ROD RHODOPSIN-SENSITIVE CGMP 3',5'-
FGDDIPGMEGLGTDITVICPWEAFNHLELHELAQYGII
//
>1fqkD [a.91.1] REGULATOR OF G-PROTEIN SIGNALING 9
FWDLNAKLVDIPTKMRVERWAFNFSELIRDPKGRQSFQHFLRKEFSGENLGFWEACEDLK
YGDQSKVKEKAEEIYKLFLAPGARRWINIDGKTMDITVKGLKHPHRYVLDAAQTHIYMLM
KKDSYARYLKSPIYKEMLAKAIE
//
>1fqkC [c.37.1 - a.66.1] CHIMERA OF GUANINE NUCLEOTIDE-BINDING PROTEIN
TVKLLLLGAGESGKSTIVKQMKIIHQDGYSLEECLEFIAIIYGNTLQSILAIVRAMTTLN
IQYGDSARQDDARKLMHMADTIEEGTMPKEMSDIIQRLWKDSGIQACFDRASEYQLNDSA
GYYLSDLERLVTPGYVPTEQDVLRSRVKTTGIIETQFSFKDLNFRMFDVGGQRSERKKWI
HCFEGVTAIIFCVALSDYDLVLAEDEEMNRMHESMKLFDSICNNKWFTDTSIILFLNKKD
LFEEKIKKSPLTICYPEYAGSNTYEEAGNYIKVQFLELNMRRDVKEIYSHMTCATDTQNV
KFVFDAVTDIIIKENLK
//
>1fqv_1A [a.158.1 - c.10.1] SKP2
VSWDSLPDELLLGIFSCLCLPELLKVSGVCKRWYRLASDESLWQTLDLTGKNLHPDVTGR
LLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLE
GLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHV
QVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQL
NYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQINCSHFT
TIARPTIGNKKNQEIWGIKCRLTLQ
//
>1fqv_1B [d.42.1 - a.157.1] SKP1
PSIKLQSSDGEIFEVDVEIAKQSVTIKTMLEDLGMDPVPLPNVNAAILKKVIQWCTHHKD
DIPVWDQEFLKVDQGTLFELILAANYLDIKGLLDVTCKTVANMIKGKTPEEIRKTFNIKN
DFTEEEEAQVRKENQWC
//
>1fr2A [a.28.2] COLICIN E9 IMMUNITY PROTEIN
LKHSISDYTEAEFLQLVTTICNADTSSEEELVKLVTHFAEMTEHPSGSDLIYYPKEGDDD
SPSGIVNTVKQWRAANGKSGFKQ
//
>1fr2B [d.4.1] COLICIN E9
ESKRNKPGKATGKGKPVGDKWLDDAGKDSGAPIPDRIADKLRDKEFKSFDDFRKAVWEEV
SKDPELSKNLNPSNKSSVSKGYSPFTPKNQQVGGRKVYELHHDKPISQGGEVYDMDNIRV
TTPKRHIDIHR
//
>1fr5_2i (B) [d.85.1] BACTERIOPHAGE FR CAPSID
ASNFEEFVLVDNGGTGDVKVAPSNFANGVAEWISSNSRSQAYKVTCSVRQSSANNRKYTV
KVEVPKVAWRSYMNMELTIPVFATNDDCALIVKALQGTFKTGNPIATAIAANSGIY
//
>1fr5_2o (B) [d.85.1] BACTERIOPHAGE FR CAPSID
ASNFEEFVLVDNGGTGDVKVAPSNFANGVAEWISSNSRSQAYKVTCSVRQSSANNRKYTV
KVEVPKVAWRSYMNMELTIPVFATNDDCALIVKALQGTFKTGNPIATAIAANSGIYASNF
EEFVLVDNGGTGDVKVAPSNFANGVAEWISSNSRSQAYKVTCSVRQSSANNRKYTVKVEV
PKVATGVELPVAAWRSYMNMELTIPVFATNDDCALIVKALQGTFKTGNPIATAIAANSGI
Y
//
>1fr5_2p (B) [d.85.1] BACTERIOPHAGE FR CAPSID
ASNFEEFVLVDNGGTGDVKVAPSNFANGVAEWISSNSRSQAYKVTCSVRQSSANNRKYTV
KVEVPKVATGVELPVAAWRSYMNMELTIPVFATNDDCALIVKALQGTFKTGNPIATAIAA
NSGIY
//
>1fr5_2p (B) [d.85.1] BACTERIOPHAGE FR CAPSID
ASNFEEFVLVDNGGTGDVKVAPSNFANGVAEWISSNSRSQAYKVTCSVRQSSANNRKYTV
KVEVPKVAWRSYMNMELTIPVFATNDDCALIVKALQGTFKTGNPIATAIAANSGIY
//
>1frgH [b.1.1 - b.1.1] IGG2A 26/9 FAB (HEAVY CHAIN)
EVLLVESGGDLVKPGGFLKLSCAASGFTFSSFGMSWVRHTPDKRLEWVATISNGGGYTYY
QDSVKGRFTISRDNAKNTLFLEMTSLKSEDAGLYYCARRERYDEKGFAYWGRGTLVTVSA
AKTTAPSVYPLAPVCGDTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSD
LYTLSSSVTVTSSTWPSQSITCNVAHPASSTKVDKKIEPR
//
>1frgL [b.1.1 - b.1.1] IGG2A 26/9 FAB (LIGHT CHAIN)
DIVMTQSPSSLTVTAGEKVTMSCKSSQSLFNSGKRKNFLTWYHQKPGQPPKLLIYWASTR
ESGVPDRFSGSGSGTDFTLTITSVQAEDLAIYYCQNDYSHPLTFGAGTKLELKRADAAPT
VSIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYS
MSSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNR
//
>1frt_1A [d.19.1 - b.1.1] NEONATAL FC RECEPTOR
AEPRLPLMYHLAAVSDLSTGLPSFWATGWLGAQQYLTYNNLRQEADPCGAWIWENQVSWY
WEKETTDLKSKEQLFLEAIRTLENQINGTFTLQGLLGCELAPDNSSLPTAVFALNGEEFM
RFNPRTGNWSGEWPETDIVGNLWMKQPEAARKESEFLLTSCPERLLGHLERGRQNLEWKE
PPSMRLKARPGNSGSSVLTCAAFSFYPPELKFRFLRNGLASGSGNCSTGPNGDGSFHAWS
LLEVKRGDEHHYQCQVEHEGLAQPLTVDL
//
>1frt_1B [b.1.1] BETA 2-MICROGLOBULIN
IQKTPQIQVYSRHPPENGKPNFLNCYVSQFHPPQIEIELLKNGKKIPNIEMSDLSFSKDW
SFYILAHTEFTPTETDVYACRVKHVTLKEPKTVTWDRDM
//
>1frt_1C [b.1.1 - b.1.1] IGG FC
SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPQVKFNWYVDGVQVHNAKTKPREQQYNS
TYRVVSVLTVLHQNWLDGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEM
TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ
QGNVFSCSVMHEALHNHYTQKSLSL
//
>1frv_2C (A) [e.19.1] HYDROGENASE
AKKRPSVVYLHNAECTGCSESLLRTVDPYVDELILDVISMDYHETLMAGAGHAVEEALHE
AIKGDFVCVIEGGIPMGDGGYWGKVGRRNMYDICAEVAPKAKAVIAIGTCATYGGVQAAK
PNPTGTVGVNEALGKLGVKAINIAGCPPNPMNFVGTVVHLLTKGMPELDKQGRPVMFFGE
TVHDNCPRLKHFEAGEFATSFGSPEAKKGYCLYELGCKGPDTYNNCPKQLFNQVNWPVQA
GHPCIACSEPNFWDLYSPFYSA
//
>1frv_2D (B) [e.18.1] HYDROGENASE
NKIVVDPITRIEGHLRIEVEVEGGKIKNAWSMSTLFRGLEMILKGRDPRDAQHFTQRACG
VCTYVHALASVRAVDNCVGVKIPENATLMRNLTMGAQYMHDHLVHFYHLHALDWVNVANA
LNADPAKAARLANDLSPRKTTTESLKAVQAKVKALVESGQLGIFTNAYFLGGHPAYVLPA
EVDLIATAHYLEALRVQVKAARAMAIFGAKNPHTQFTVVGGCTNYDSLRPERIAEFRKLY
KEVREFIEQVYITDLLAVAGFYKNWAGIGKTSNFLTCGEFPTDEYDLNSRYTPQGVIWGN
DLSKVDDFNPDLIEEHVKYSWYEGADAHHPYKGVTKPKWTEFHGEDRYSWMKAPRYKGEA
FEVGPLASVLVAYAKKHEPTVKAVDLVLKTLGVGPEALFSTLGRTAARGIQCLTAAQEVE
VWLDKLEANVKAGKDDLYTDWQYPTESQGVGFVNAPRGMLSHWIVQRGGKIENFQHVVPS
TWNLGPRCAERKLSAVEQALIGTPIADPKRPVEILRTVHSYDPCIACGVH
//
>1fs0A (G) [c.49.2] ATP SYNTHASE GAMMA SUBUNIT
KITKAMEMVAASKMRKSQDRMAASRPYAETMRKVIGHLAHYKHPYLEDRDVKRVGYLVVS
TDRGLCGGLNINLFKKLLAEMKTWTDKGVQCDLAMIGSKGVSFFNSVGGNVVAQVTGMGD
NPSLSELIGPVKVMLQAYDEGRLDKLYIVSNKFINTMSQVPTISQLLPLPKHKSWDYLYE
PDPKALLDTLLRRYVESQVYQGVVENLASEQAARMVAMK
//
>1fs0B (E) [b.93.1 - a.2.10] ATP SYNTHASE EPSILON SUBUNIT
AMTYHLDVVSAEQQMFSGLVEKIQVTGSEGELGIYPGHAPLLTAIKPGMIRIVKQHGHEE
FIYLSGGILEVQPGNVTVLADTAIRGQDLDEARAMEAKRKAEEHDVDYAQASAELAKAIA
QLRVIELT
//
>1fs1A [a.158.1] CYCLIN A/CDK2-ASSOCIATED P19
WDSLPDELLLGIFSCLCLPELLKVSGVCKRWYRLASDESLW
//
>1fs1B [d.42.1 - a.157.1] CYCLIN A/CDK2-ASSOCIATED P45
PSIKLQSSDGEIFEVDVEIAKQSVTIKTMLEDLGMDPVPLPNVNAAILKKVIQWCTHHKD
DPVWDQEFLKVDQGTLFELILAANYLDIKGLLDVTCKTVANMIKGKTPEEIRKTFN
//
>1fs2A [a.158.1 - c.10.1] SKP2
PGVSWDSLPDELLLGIFSCLCLPELLKVSGVCKRWYRLASDESLWQTLDEFRVQHMDLSN
SVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQT
LLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCP
NLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI
VPDGTLQLLKEALPHLQIN
//
>1fs2B [d.42.1 - a.157.1] SKP1
PSIKLQSSDGEIFEVDVEIAKQSVTIKTMLEDLGMDPVPLPNVNAAILKKVIQWCTHHKD
DKRTDDIPVWDQEFLKVDQGTLFELILAANYLDIKGLLDVTCKTVANMIKGKTPEEIRKT
FNIKNDFT
//
>1fsk_1A [d.129.3] MAJOR POLLEN ALLERGEN BET V 1-A
GVFNYETETTSVIPAARLFKAFILDGDNLFPKVAPQAISSVENIEGNGGPGTIKKISFPE
GLPFKYVKDRVDEVDHTNFKYNYSVIEGGPIGDTLEKISNEIKIVATPDGGSILKISNKY
HTKGDHEVKAEQVKASKEMGETLLRAVESYLLAHSDAYN
//
>1fsk_1B [b.1.1 - b.1.1] IMMUNOGLOBULIN KAPPA LIGHT CHAIN
NIVLTQSPKSMSVSVGERVTLSCKASENVDTYVFWFQQKPDQSPKLLLYGPSNRYTGVPD
RFTGSGSTTDFTLTISSVQAEDLADYHCGQSYSYPYTFGGGTKLEIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1fsk_1C [b.1.1 - b.1.1] ANTIBODY HEAVY CHAIN FAB
QVQLQQPGTELVRPGASVILSCKASGYTFTSYWINWVKQRPGQGLEWVGNIFPSDSYTNY
NQKFKDKATLTVDKSSSTAYMQVNSPTSEDSAVYYCTRGARDTWFAYWGQGTLVTVSVAK
TTPPSVFPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLY
TLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKIVPRDC
//
>1fsk_4K (B) [b.1.1 - b.1.1] IMMUNOGLOBULIN KAPPA LIGHT CHAIN
NIVLTQSPKSMSVSVGERVTLSCKASENVDTYVFWFQQKPDQSPKLLLYGPSNRYTGVPD
RFTGSGSTTDFTLTISSVQAEDLADYHCGQSYSYPYTFGGGTKLEIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1fsk_4L (C) [b.1.1 - b.1.1] ANTIBODY HEAVY CHAIN FAB
QVQLQQPGTELVRPGASVILSCKASGYTFTSYWINWVKQRPGQGLEWVGNIFPSDSYTNY
NQKFKDKATLTVDKSSSTAYMQVNSPTSEDSAVYYCTRGARDTWFAYWGQGTLVTVSVAK
TTPPSVFPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLY
TLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKIVPRDC
//
>1fssA [c.69.1] ACETYLCHOLINESTERASE
SELLVNTKSGKVMGTRVPVLSSHISAFLGIPFAEPPVGNMRFRRPEPKKPWSGVWNASTY
PNNCQQYVDEQFPGFSGSEMWNPNREMSEDCLYLNIWVPSPRPKSTTVMVWIYGGGFYSG
SSTLDVYNGKYLAYTEEVVLVSLSYRVGAFGFLALHGSQEAPGNVGLLDQRMALQWVHDN
IQFFGGDPKTVTIFGESAGGASVGMHILSPGSRDLFRRAILQSGSPNCPWASVSVAEGRR
RAVELGRNLNCNLNSDEELIHCLREKKPQELIDVEWNVLPFDSIFRFSFVPVIDGEFFPT
SLESMLNSGNFKKTQILLGVNKDEGSFFLLYGAPGFSKDSESKISREDFMSGVKLSVPHA
NDLGLDAVTLQYTDWMDDNNGIKNRDGLDDIVGDHNVICPLMHFVNKYTKFGNGTYLYFF
NHRASNLVWPEWMGVIHGYEIEFVFGLPLVKELNYTAEEEALSRRIMHYWATFAKTGNPN
EPHSQESKWPLFTTKEQKFIDLNTEPMKVHQRLRVQMCVFWNQFLPKLLNAT
//
>1fssB [g.7.1] FASCICULIN II
TMCYSHTTTSRAILTNCGENSCYRKSRRHPPKMVLGRGCGCPPGDDNLEVKCCTSPDKCN
Y
//
>1ft8A [d.58.7 - c.10.2] TIP ASSOCIATING PROTEIN
NWFKITIPYGRKYDKAWLLSMIQSKCSVPFTPIEFHYENTRAQFFVEDASTASALKAVNY
KILDRENRRISIIINSSAPPHTELKPEQVEQLKLIMSKRYDGSQQVLDLKGLRSDPDLVA
QNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSG
NELKSERELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLDGHELPPPI
AF
//
>1ft8D [c.10.2] TIP ASSOCIATING PROTEIN
LKPEQVEQLKLIMSKRYDGSQQVLDLKGLRSDPDLVAQNIDVVLNRRSCMAATLRIIEEN
IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLD
GNSLCDTFRDQSTYISAIRERFPKLLRLDGHELPPPIAFDVE
//
>1ft8E [d.58.7] TIP ASSOCIATING PROTEIN
WFKITDKAWLLSMIQSKCSVPFTPIEFHQFFVEDASTASALKAV
//
>1fumN [x.x.x]
AEMKNLKIEVVRYNPEVDTAPHSAFYEVPYDATTSLLDALGYIKDNLAPDLSYRWSCRMA
ICGSCGMMVNNVPKLACKTFLRDYTDGMKVEALANFPIERDLVVDMTHFIESLEAIKPYI
IGNSRTADQGTNIQTPAQMAKYHQFSGCINCGLCYAACPQFGLNPEFIGPAAITLAHRYN
EDSRDHGKKERMAQLNSQNGVWSCTFVGYCSEVCPKHVDPAAAIQQGKVESSKDFLIATL
KPR
//
>1fumM [x.x.x]
QTFQADLAIVGAGGAGLRAAIAAAQANPNAKIALISKVYPMRSHTVAAEGGSAAVAQDHD
SFEYHFHDTVAGGDWLCEQDVVDYFVHHCPTEMTQLELWGCPWSRRPDGSVNVRRFGGMK
IERTWFAADKTGFHMLHTLFQTSLQFPQIQRFDEHFVLDILVDDGHVRGLVAMNMMEGTL
VQIRANAVVMATGGAGRVYRYNTNGGIVTGDGMGMALSHGVPLRDMEFVQYHPTGLPGSG
ILMTEGCRGEGGILVNKNGYRYLQDYGMGPETPLGEPKNKYMELGPRDKVSQAFWHEWRK
GNTISTPRGDVVYLDLRHLGEKKLHERLPFICELAKAYVGVDPVKEPIPVRPTAHYTMGG
IETDQNCETRIKGLFAVGECSSVGLHGANRLGSNSLAELVVFGRLAGEQATERAATAGNG
NEAAIEAQAAGVEQRLKDLVNQDGGENWAKIRDEMGLAMEEGCGIYRTPELMQKTIDKLA
ELQERFKRVRITDTSSVFNTDLLYTIELGHGLNVAECMAHSAMARKESRGAHQRLDEGCT
ERDDVNFLKHTLAFRDADGTTRLEYSDVKITTLPP
//
>1fuyA [c.1.2] TRYPTOPHAN SYNTHASE ALPHA CHAIN
MERYENLFAQLNDRREGAFVPFVTLGDPGIEQSLKIIDTLIDAGADALELGVPFSDPLAD
GPTIQNANLRAFAAGVTPAQCFEMLALIREKHPTIPIGLLMYANLVFNNGIDAFYARCEQ
VGVDSVLVADVPVEESAPFRQAALRHNIAPIFICPPNADDDLLRQVASYGRGYTYLLSRS
GVTGAENLHHLIEKLKEYHAAPALQGFGISSPEQVSAAVRAGAAGAISGSAIVKIIEKNL
ASPKQMLAELRSFVSAMKAASR
//
>1fuyB [c.79.1] TRYPTOPHAN SYNTHASE BETA CHAIN
TTLLNPYFGEFGGMYVPQILMPALNQLEEAFVSAQKDPEFQAQFADLLKNYAGRPTALTK
CQNITAGTRTTLYLKREDLLHGGAHKTNQVLGQALLAKRMGKSEIIAETGAGQHGVASAL
ASALLGLKCRIYMGAKDVERQSPNVFRMRLMGAEVIPVHSGSATLKDLWNEALRDWSGSY
ETAHYMLGTAAGPHPYPTIVREFQRMIGEETKAQILDKEGRLPDAVIACVGGGSNAIGMF
ADFINDTSVGLIGVEPGGHGIETGEHGAPLKHGRVGIYFGMKAPMMQTADGQIEESYSIS
AGLDFPSVGPQHAYLNSIGRADYVSITDDEALEAFKTLCRHEGIIPALESSHALAHALKM
MREQPEKEQLLVVNLSGRGDKDIFTVHDILKAR
//
>1fv1_1A [d.19.1 - b.1.1] MAJOR HISTOCOMPATIBILITY COMPLEX ALPHA CHAIN
EEHVIIQAEFYLNPDQSGEFMFDFDGDEIFHVDMAKKETVWRLEEFGRFASFEAQGALAN
IAVDKANLEIMTKRSNYTPITNVPPEVTVLTNSPVELREPNVLICFIDKFTPPVVNVTWL
RNGKPVTTGVSETVFLPREDHLFRKFHYLPFLPSTEDVYDCRVEHWGLDEPLLKHWEFD
//
>1fv1_1B [d.19.1 - b.1.1] MAJOR HISTOCOMPATIBILITY COMPLEX BETA CHAIN
GDTRPRFLQQDKYECHFFNGTERVRFLHRDIYNQEEDLRFDSDVGEYRAVTELGRPDAEY
WNSQKDFLEDRRAAVDTYCRHNYGVGESFTVQRRVEPKVTVYPARTQTLQHHNLLVCSVN
GFYPGSIEVRWFRNSQEEKAGVVSTGLIQNGDWTFQTLVMLETVPRSGEVYTCQVEHPSV
TSPLTVEWRA
//
>1fv1_1C [x.x.x] MYELIN BASIC PROTEIN
NPVVHFFKNIVTPRTPPPSQ
//
>1fv4H [x.x.x]
AQLRQFYVAAQGISWSYRPEPTNSSLNLSVTSFKKIVYREYEPYFKKEKPQSTISGLLGP
TLYAEVGDIIKVHFKNKADKPLSIHPQGIRYSKLSEGASYLDHTFPAEKMDDAVAPGREY
TYEWSISEDSGPTHDDPPCLTHIYYSHENLIEDFNSGLIGPLLICKKGTLTEGGTQKTFD
KQIVLLFAVFDESKSWSQSSSLMYTVNGYVNGTMPDITVCAHDHISWHLLGMSSGPELFS
IHFNGQVLEQNHHKVSAITLVSATSTTANMTVGPEGKWIISSLTPKHLQAGMQAYIDIKN
CPKKTRNLKKITREQRRHMKRWEYFIAAEEVIWDYAPVIPANMDKKYRSQHLDNFSNQIG
KHYKKVMYTQYEDESFTKHTVNPNMKEDGILGPIIRAQVRDTLKIVFKNMASRPYSIYPH
GVTFSPYEDEVNSSFTSGRNNTMIRAVQPGETYTYKWNILEFDEPTENDAQCLTRPYYSD
VDIMRDIASGLIGLLLICKSRSLDRRGIQRAADIEQQAVFAVFDENKSWYLEDNINKFCE
NPDEVKRDDPKFYESNIMSTINGYVPESITTLGFCFDDTVQWHFCSVGTQNEILTIHFTG
HSFIYGKRHEDTLTLFPMRGESVTVTMDNVGTWMLTSMNSSPRSKKLRLKFRDVKCIPDD
DED
//
>1fv4L [x.x.x]
SNNGNRRNYYIAAEEISWDYSEFVQRETDIEDSDDIPEDTTYKKVVFRKYLDSTFTKRDP
RGEYEEHLGILGPIIRAEVDDVIQVRFKNLASRPYSLHAHGLSYEKSSEGKTYEDDSPEW
FKEDNAVQPNSSYTYVWHATERSGPESPGSACRAWAYYSAVNPEKDIHSGLIGPLLICQK
GILHKDSNMPVDMREFVLLFMTFDEKKSWYYEKKSRSSWRLTSSEMKKSHEFHAINGMIY
SLPGLKMYEQEWVRLHLLNIGGSQDIHVVHFHGQTLLENGNKQHQLGVWPLLPGSFKTLE
MKASKPGWWLLNTEVGENQRAGMQTPFLIMDRDCRMPMGLSTGIISDSQIKASEFLGYWE
PRLARLNNGGSYNAWSVEKLAAEFASKPWIQVDMQKEVIITGIQTQGAKHYLKSCYTTEF
YVAYSSNQINWQIFKGNSTRNVMYFNGNSDASTIKENQFDPPIVARYIRISPTRAYNRPT
LRLELQGCEVNGCSTPLGMENGKIENKQITASSFKKSWWGDYWEPFRARLNAQGRVNAWQ
AKANNNKQWLEIDLLKIKKITAIITQGCKSLSSEMYVKSYTIHYSEQGVEWKPYRLKSSM
VDKIFEGNTNTKGHVKNFFNPPIISRFIRVIPKTWNQSITLRLELFGCDIY
//
>1fvc_2C [b.1.1] IGG1-KAPPA 4D5 FV (LIGHT CHAIN)
DIQMTQSPSSLSASVGDRVTITCRASQDVNTAVAWYQQKPGKAPKLLIYSASFLYSGVPS
RFSGSRSGTDFTLTISSLQPEDFATYYCQQHYTTPPTFGQGTKVEIKR
//
>1fvc_2D (B) [b.1.1] IGG1-KAPPA 4D5 FV (HEAVY CHAIN)
EVQLVESGGGLVQPGGSLRLSCAASGFNIKDTYIHWVRQAPGKGLEWVARIYPTNGYTRY
ADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCSRWGGDGFYAMDYWGQGTLVTVSS
//
>1fvd_2C (A) [b.1.1 - b.1.1] IGG1-KAPPA 4D5 FAB (LIGHT CHAIN)
DIQMTQSPSSLSASVGDRVTITCRASQDVNTAVAWYQQKPGKAPKLLIYSASFLESGVPS
RFSGSRSGTDFTLTISSLQPEDFATYYCQQHYTTPPTFGQGTKVEIKRTVAAPSVFIFPP
SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT
LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
//
>1fvd_2D (B) [b.1.1 - b.1.1] IGG1-KAPPA 4D5 FAB (HEAVY CHAIN)
EVQLVESGGGLVQPGGSLRLSCAASGFNIKDTYIHWVRQAPGKGLEWVARIYPTNGYTRY
ADSVKGRFTISADTSKNTLYLQMNSLRAEDTAVYYCSRWGGDGFYAMDVWGQGTLVTVSS
ASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSS
GLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC
//
>1fx0C (B) [b.49.1 - c.37.1 - a.69.1] ATP SYNTHASE BETA CHAIN
NLGRIAQIIGPVLNVAFPPGKMPNIYNALIVKGRDTAGQPMNVTCEVQQLLGNNRVRAVA
MSATDGLTRGMEVIDTGAPLSVPVGGPTLGRIFNVLGEPVDNLRPVDTRTTSPIHRSAPA
FTQLDTKLSIFETGIKVVNLLAPYRRGGKIGLFGGAGVGKTVLIMELINNIAKAHGGVSV
FGGVGERTREGNDLYMEMKESGVINEQNIAESKVALVYGQMNEPPGARMRVGLTALTMAE
YFRDVNEQDVLLFIDNIFRFVQAGSEVSALLGRMPSAVGYQPTLSTEMGSLQERITSTKE
GSITSIQAVYVPADDLTDPAPATTFAHLDATTVLSRGLAAKGIYPAVDPLDSTSTMLQPR
IVGEEHYEIAQRVKETLQRYKELQDIIAILGLDELSEEDRLTVARARKIERFLSQPFFVA
EVFTGSPGKYVGLAETIRGFQLILSGELDSLPEQAFYLVGNIDEATA
//
>1fx0D (A) [b.49.1 - c.37.1 - a.69.1] ATP SYNTHASE ALPHA CHAIN
KVVNTGTVLQVGDGIARIHGLDEVMAGELVEFEEGTIGIALNLESNNVGVVLMGDGLMIQ
EGSSVKATGRIAQIPVSEAYLGRVINALAKPIDGRGEITASESRLIESPAPGIMSRRSVY
EPLQTGLIAIDAMIPVGRGQRELIIGDRQTGKTAVATDTILNQQGQNVICVYVAIGQKAS
SVAQVVTNFQERGAMEYTIVVAETADSPATLQYLAPYTGAALAEYFMYRERHTLIIYDDL
SKQAQAYRQMSLLLRRPPGREAYPGDVFYLHSRLLERAAKLSSLLGEGSMTALPIVETQA
GDVSAYIPTNVISITDGQIFLSADLFNAGIRPAINVGISVSRVGSAAQIKAMKKVAGKLK
LELAQFAELEAFAQFASDLDKATQNQLARGQRLRELLKQPQSAPLTVEEQVMTIYTGTNG
YLDSLELDQVRKYLVELRTYVKTNKPEFQEIISSTKTFTEEAEALLKEAIQEQMERF
//
>1fxkA [a.2.5] PREFOLDIN
QNVQHQLAQFQQLQQQAQAISVQKQTVEmQINETQKALEELSRAADDAEVYKSSGNILIR
VAKDELTEELQEKLETLQLREKTIERQEERVmKKLQEmQVNIQEAmK
//
>1fxkC [a.2.5] PROTEIN (PREFOLDIN)
AALAEIVAQLNIYQSQVELIQQQMEAVRATISELEILEKTLSDIQGKDGSETLVPVGAGS
FIKAELKDTSEVIMSVGAGVAIKKNFEDAMESIKSQKNELESTLQKMGENLRAITDIMMK
LSPQAEELLAAVA
//
>1fyh_1A [a.26.1 - a.26.1] INTERFERON-GAMMA
MQDPYVKEAENLKKYFNAGHSDVADNGTLFLGILKNWKEESDRKIMQSQIVSFYFKLFKN
FKDDQSIQKSVETIKEDMNVKFFNSNKKKRDDFEKLTNYSVTDLNVQRKAIDELIQVMAE
LGANVSGEFVKEAENLKKYFNDNGTLFLGILKNWKEESDRKIMQSQIVSFYFKLFKNFKD
DQSIQKSVETIKEDMNVKFFNSNKKKRDDFEKLTNYSVTDLNVQRKAIHELIQVMAELSP
AA
//
>1fyh_1B [b.1.2 - b.1.2] INTERFERON-GAMMA RECEPTOR ALPHA CHAIN
VPTPTNVTIESYNMNPIVYWEYQIMPQVPVFTVEVKNYGVKNSEWIDACINISHHYCNIS
DHVGDPSNSLWVRVKARVGQKESAYAKSEEFAVCRDGKIGPPKLDIRKEEKQIMIDIFHP
SVFVETTCYIRVYNVYVRMNGSEIQYKILTQKEDDCDEIQCQLAIPVSSLNSQYCVSAEG
VLHVWGVTTEKSKEVCITIFN
//
>1fytA [d.19.1 - b.1.1] HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR
KEEHVIIQAEFYLNPDQSGEFMFDFDGDEIFHVDMAKKETVWRLEEFGRFASFEAQGALA
NIAVDKANLEIMTKRSNYTPITNVPPEVTVLTNSPVELREPNVLICFIDKFTPPVVNVTW
LRNGKPVTTGVSETVFLPREDHLFRKFHYLPFLPSTEDVYDCRVEHWGLDEPLLKHWEFD
//
>1fytB [d.19.1 - b.1.1] HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR-1
TRPRFLWQLKFECHFFNGTERVRLLERCIYNQEESVRFDSDVGEYRAVTELGRPDAEYWN
SQKDLLEQRRAAVDTYCRHNYGVGESFTVQRRVEPKVTVYPSLLVCSVSGFYPGSIEVRW
FRNGQEEKAGVVSTGLIQNGDWTFQTLVMLETVPRSGEVYTCQVEHPSVTSPLTVEWRA
//
>1fytD [b.1.1 - b.1.1] T-CELL RECEPTOR ALPHA CHAIN
QSVTQLGSHVSVSEGALVLLRCNYSSSVPPYLFWYVQYPNQGLQLLLKYTSAATLVKGIN
GFEAEFKKSETSFHLTKPSAHMSDAAEYFCAVSESPFGNEKLTFGTGTRLTIIPNIQNPD
PAVYQLRSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKTVLDMRSMDFKSNSAVAWSNKS
DFACANAFNNSIIPEDTF
//
>1fytE [b.1.1 - b.1.1] T-CELL RECEPTOR BETA CHAIN
KVTQSSRYLVKRTGEKVFLECVQDMDHENMFWYRQDPGLGLRLIYFSYDVKMKEKGDIPE
GYSVSREKKERFSLILESASTNQTSMYLCASSSTGLPYGYTFGSGTRLTVVEDLNKVFPP
EVAVFEPSEAEISHTQKATLVCLATGFFPDHVELSWWVNGKEVHSGVSTDPQPLKEQPAL
NDSRYSLSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRA
//
>1fza_1A [h.1.8] FIBRINOGEN
VSEDLRSRIEVLKRKVIEKVQHIQLLQKNVRAQLVDMKRLEVDIDIKIRSCRGSCSRALA
REVDLKDYEDQQKQLEQVIAKDLLP
//
>1fza_1B [h.1.8 - d.171.1] FIBRINOGEN
KHQLYIDETVNSNIPTNLRVLRSILENLRSKIQKLESDVSAQMEYCRTPCTVSCNIPVVS
GKECEEIIRKGGETSEMYLIQPDSSVKPYRVYCDMNTENGGWTVIQNRQDGSVDFGRKWD
PYKQGFGNVATNTDGKNYCGLPGEYWLGNDKISQLTRMGPTELLIEMEDWKGDKVKAHYG
GFTVQNEANKYQISVNKYRGTAGNALMDGASQLMGENRTMTIHNGMFFSTYDRDNDGWLT
SDPRKQCSKEDGGGWWYNRCHAANPNGRYYWGGQYTWDMAKHGTDDGVVWMNWKGSWYSM
RKMSMKIRPFFPQ
//
>1fzoA [d.19.1 - b.1.1] H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, K-B
GPHSLRYFVTAVSRPGLGEPRFISVGYVDNTEFVRFDSDAENPRYEPRARWMEQEGPEYW
ERETQKAKGNEQSFRVDLRTLLGYYNQSKGGSHTIQVISGCEVGSDGRLLRGYQQYAYDG
xDYIALNEDLKTWTAADMAALITKHKWEQAGEAERLRAYLEGTCVEWLRRYLKNGNATLL
RTDSPKAHVTHHSRPEDKVTLRCWALGFYPADITLTWQLNGEELIQDMELVETRPAGDGT
FQKWASVVVPLGKEQYYTCHVYHQGLPEPLTLRW
//
>1fzoB [b.1.1] PROTEIN (BETA-2-MICROGLOBULIN)
IQKTPQIQVYSRHPPENGKPNILNCYVTQFHPPHIEIQMLKNGKKIPKVEMSDMSFSKDW
SFYILAHTEFTPTETDTYACRVKHDSMAEPKTVYWDRDM
//
>1g0bA [a.1.1] HEMOGLOBIN ALPHA CHAIN
VLSAADKTNVKAAWSKVGGHAGEYGAEALERMFLGFPTTKTYFPHFDLSHGSAQVKAHGK
KVGDALTLAVGHLDDLPGALSDLSNLHAHKLRVDPVNFKLLSHCLLSTLAVHLPNDFTPA
VHASLDKFLSSVSTVLTSKYR
//
>1g0bB [a.1.1] HEMOGLOBIN BETA CHAIN
VQLSGEEKAAVLALWDKVNEEEVGGEALGRLLVVYPWTQRFFDSFGDLSNPGAVMGNPKV
KAHGKKVLHSFGEGVHHLDNLKGTFAALSELHCDKLHVDPENFRLLGNVLVVVLARHFGK
DFTPELQASYQKVVAGVANALAHKYH
//
>1g0uB [d.153.1] PROTEASOME COMPONENT Y13
TIFSPEGRLYQVEYALESISHAGTAIGIMASDGIVLAAERKVTSTLLEQDTSTEKLYKLN
DKIAVAVAGLTADAEILINTARIHAQNYLKTYNEDIPVEILVRRLSDIKQGYTQHGGLRP
FGVSFIYAGYDDRYGYQLYTSNPSGNYTGWKAISVGANTSAAQTLLQMDYKDDMKVDDAI
ELALKTLSKTTDSSALTYDRLEFATIRKGANDGEVYQKIFKPQEIKDILVKTGIT
//
>1g0uC [d.153.1] PROTEASOME COMPONENT PRE6
RALSIFSPDGHIFQVEYALEAVKRGTCAVGVKGKNCVVLGCERRSTLKLQDTRITPSKVS
KIDSHVVLSFSGLNADSRILIEKARVEAQSHRLTLEDPVTVEYLTRYVAGVQQRYTQSGG
VRPFGVSTLIAGFDPRDDEPKLYQTEPSGIYSSWSAQTIGRNSKTVREFLEKNYDRKEPP
ATVEECVKLTVRSLLEVVQTGAKNIEITVVKPDSDIVALSSEEINQYVTQIEQEKQEQ
//
>1g0uD [d.153.1] PROTEASOME COMPONENT PUP2
VSTFSPEGRLFQVEYSLEAIKLGSTAIGIATKEGVVLGVEKRATSPLLESDSIEKIVEID
RHIGCAMSGLTADARSMIEHARTAAVTHNLYYDEDINVESLTQSVCDLAAAAAMSRPFGV
ALLIAGHDADDGYQLFHAEPSGTFYRYNAKAIGSGSEGAQAELLNEWHSSLTLKEAELLV
LKILKQVMEEKLDENNAQLSCITKQDGFKIYDNEKTAELIKELKEKEAAE
//
>1g0uI [d.153.1] PROTEASOME COMPONENT PUP3
SDPSSINGGIVVAMTGKDCVAIACDLRLGSQSLGVSNKFEKIFHYGHVFLGITGLATDVT
TLNEMFRYKTNLYKLKEERAIEPETFTQLVSSSLYERRFGPYFVGPVVAGINSKSGKPFI
AGFDLIGCIDEAKDFIVSGTASDQLFGMCESLYEPNLEPEDLFETISQALLNAADRDALS
GWGAVVYIIKKDEVVKRYLKMRQD
//
>1g0uL [d.153.1] PROTEASOME COMPONENT C5
QFNPYGDNGGTILGIAGEDFAVLAGDTRNITDYSINSRYEPKVFDCGDNIVMSANGFAAD
GDALVKRFKNSVKWYHFDHNDKKLSINSAARNIQHLLYGKRFFPYYVHTIIAGLDEDGKG
AVYSFDPVGSYEREQCRAGGAAASLIMPFLDNQVNFKNQYEPGTNGKVKKPLKYLSVEEV
IKLVRDSFTSATERHIQVGDGLEILIVTKDGVRKEFYELKRD
//
>1g0uR (D) [d.153.1] PROTEASOME COMPONENT PUP2
VSTFSPEGRLFQVEYSLEAIKLGSTAIGIATKEGVVLGVEKRATSPLLESDSIEKIVEID
RHIGCAMSGLTADARSMIEHARTAAVTHNLYYDEDINVESLTQSVCDLAAAAAMSRPFGV
ALLIAGHDADDGYQLFHAEPSGTFYRYNAKAIGSGSEGAQAELLNEWHSSLTLKEAELLV
LKILKQVMEEKLDENNAQLSCITKQDGFKIYDNEKTAELIKELKEKEAAE
//
>1g0uS (E) [d.153.1] PROTEASOME COMPONENT PRE5
NYDGDTVTFSPTGRLFQVEYALEAIKQGSVTVGLRSNTHAVLVALKRNADELSSYQKKII
KCDEHMGLSLAGLAPDARVLSNYLRQQCNYSSLVFNRKLAVERAGHLLCDKAQKNTQSAG
GRPYGVGLLIIGYDKSGAHLLEFQPSGNVTELYGTAIGARSQGAKTYLERTLDTFIKIDG
NPDELIKAGVEAISQSLRDESLTVDNLSIAIVGKDTPFTIYDGEAVAKYI
//
>1g0uW (I) [d.153.1] PROTEASOME COMPONENT PUP3
SDPSSINGGIVVAMTGKDCVAIACDLRLGSQSLGVSNKFEKIFHYGHVFLGITGLATDVT
TLNEMFRYKTNLYKLKEERAIEPETFTQLVSSSLYERRFGPYFVGPVVAGINSKSGKPFI
AGFDLIGCIDEAKDFIVSGTASDQLFGMCESLYEPNLEPEDLFETISQALLNAADRDALS
GWGAVVYIIKKDEVVKRYLKMRQD
//
>1g0uY (K) [d.153.1] PROTEASOME COMPONENT PRE2
TTTLAFRFQGGIIVAVDSRATAGNWVASQTVKKVIEINPFLLGTMAGGAADCQFWETWLG
SQCRLHELREKERISVAAASKILSNLVYQYKGAGLSMGTMICGYTRKEGPTIYYVDSDGT
RLKGDIFCVGSGQTFAYGVLDSNYKWDLSVEDALYLGKRSILAAAHRDAYSGGSVNLYHV
TEDGWIYHGNHDVGELFWKVKEEEGSFNNVIG
//
>1g0uZ (L) [d.153.1] PROTEASOME COMPONENT C5
QFNPYGDNGGTILGIAGEDFAVLAGDTRNITDYSINSRYEPKVFDCGDNIVMSANGFAAD
GDALVKRFKNSVKWYHFDHNDKKLSINSAARNIQHLLYGKRFFPYYVHTIIAGLDEDGKG
AVYSFDPVGSYEREQCRAGGAAASLIMPFLDNQVNFKNQYEPGTNGKVKKPLKYLSVEEV
IKLVRDSFTSATERHIQVGDGLEILIVTKDGVRKEFYELKRD
//
>1g0yR [b.1.1 - b.1.1 - b.1.1] INTERLEUKIN-1 RECEPTOR, TYPE I
CKEREEKIILVSSANEIDVRPCPLNPNEHKGTITWYKDDSKTPVSTEQASRIHQHKEKLW
FVPAKVEDSGHYYCVVRNSSYCLRIKISAKFVENEPNLCYNAQAIFKQKLPVAGDGGLVC
PYMEFFKNENNELPKLQWYKDCKPLLLDNIHFSGVKDRLIVMNVAEKHRGNYTCHASYTY
LGKQYPITRVIEFITLEENKPTRPVIVSPANETMEVDLGSQIQLICNVTGQLSDIAYWKW
NGSVIDEDDPVLGEDYYSVENPANKRRSTLITVLNISEIESRFYKHPFTCFAKNTHGIDA
AYIQLIYPVT
//
>1g0yI [k.19.1] ANTAGONIST PEPTIDE AF10847
ETPFTWEESNAYYWQPYALPL
//
>1g1x_1A [d.58.14] 30S RIBOSOMAL PROTEIN S6
MRRYEVNIVLNPNLDQSQLALEKEIIQRALENYGARVEKVEELGLRRLAYPIAKDPQGYF
LWYQVEMPEDRVNDLARELRIRDNVRRVMVVKSQEPFL
//
>1g1x_1C [a.4.8] 30S RIBOSOMAL PROTEIN S18
DLRDYRNVEVLKRFLILPRTGLSGKEQRILAKTIKRARILGLLPFT
//
>1g2c_4U (A) [h.3.2] FUSION PROTEIN (F)
LEGEVNKIKSALLSTNKAVVSLSNGVSVLTSKVLDLKNYIDKQLLPIVNK
//
>1g2c_4V (T) [h.3.2] FUSION PROTEIN (F)
PLVFPSDEFDASISQVNEKINQSLAFIRKSDELLHNVN
//
>1g3iF [c.37.1] ATP-DEPENDENT HSLU PROTEASE ATP-BINDING SUBUNIT
SEMTPREIVSELDQHIIGQADAKRAVAIALRNRWRRMQLQEPLRHEVTPKNILMIGPTGV
GKTEIARRLAKLANAPFIKVEATKFTEVDSIIRDLTDSAMKLVRQQEIAKNRARINPEEL
KQKAIDAVEQNGIVFIDEIDKICKKGADVSREGVQRDLLPLVEGSTVSTKHGMVKTDHIL
FIASGAFQVARPSDLIPELQGRLPIRVELTALSAADFERILTEPHASLTEQYKALMATEG
VNIAFTTDAVKKIAEAAFRVNEKTENIGARRLHTVMERLMDKISFSASDMNGQTVNIDAA
YVADALGEVVENEDLSRFIL
//
>1g3iL (G) [d.153.1] ATP-DEPENDENT PROTEASE HSLV
TTIVSVRRNGQVVVGGDGQVSLGNTVMKGNARKVRRLYNGKVLAGFAGGTADAFTLFELF
ERKLEMHQGHLLKSAVELAKDWRTDRALRKLEAMLIVADEKESLIITGIGDVVQPEEDQI
LAIGSGGNYALSAARALVENTELSAHEIVEKSLRIAGDICVFTNTNFTIEELP
//
>1g3j_1A [a.118.1] BETA-CATENIN ARMADILLO REPEAT REGION
HAVVNLINYQDDAELATRAIPELTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQ
MVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLF
YAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKL
IILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDP
SQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYK
NKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPV
VVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRFVE
GVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELA
QDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSE
//
>1g3j_1B [j.71.1] TCF3-CBD (CATENIN BINDING DOMAIN)
PQLNSGGGDELGANDELIRFKDEGEQEEDLADVKSSLVNES
//
>1g3j_2C [a.118.1] BETA-CATENIN ARMADILLO REPEAT REGION
HHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKM
VALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSR
VLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLL
GTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITE
PAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPA
NHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGQQFVEGVRMEEIVEGCTGALHILARDVH
NRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLH
SRNEGVATYAAAVLFRMSE
//
>1g3j_2D [j.71.1] TCF3-CBD (CATENIN BINDING DOMAIN)
PQLNSGGGDELGANDELIRFKDEDLADVKSSLVN
//
>1g3nA [d.144.1] CYCLIN-DEPENDENT KINASE 6
ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL
ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ
LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP
EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA
LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ
//
>1g3nB [d.211.1] CYCLIN-DEPENDENT KINASE 6 INHIBITOR
GNELASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMKLGNPEIARRLLLRGANPDL
KDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEGHLRVVEFLVKH
TASNVGHRNHKGDTACDLARLYGRNEVVSLMQANG
//
>1g3nE (A) [d.144.1] CYCLIN-DEPENDENT KINASE 6
ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL
ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ
LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP
EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA
LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ
//
>1g3nG (C) [a.74.1 - a.74.1] V-CYCLIN
LCEDRIFYNILEIEPRFLTSDSVFGTFQQSLTSHMRKLLGTWMFSVCQEYNLEPNVVALA
LNLLDRLLLIKQVSKEHFQKTGSACLLVASKLRSLTPISTSSLCYAAADSFSRQELIDQE
KELLEKLAWRTEAVLATDVTSFLLLKLVGGSQHLDFWHHEVNTLITKALVDPLTGSLPAS
IISAAGCALLVPANVIPQGVVPQLASILGCDVSVLQAAVEQILTSVSDFDLRI
//
>1g4bH (M) [d.153.1] ATP-DEPENDENT PROTEASE HSLV
TTIVSVRRNGHVVIAGDGQATLGNTVMKGNVKKVRRLYNDKVIAGFAGGTADAFTLFELF
ERKLEMHQGHLVKAAVELAKDWRTDRMLRKLEALLAVADETASLIITGNGDVVQPENDLI
AIGSGGPYAQAAARALLENTELSAREIAEKALDIAGDICIYTNHFHTIEELSY
//
>1g4bJ (E) [c.37.1] ATP-DEPENDENT HSL PROTEASE ATP-BINDING SUBUNIT
SEMTPREIVSELDKHIIGQDNAKRSVAIALRNRWRRMQLNEELRHEVTPKNILMIGPTGV
GKTEIARRLAKLANAPFIKVEATKFTEVGYVGKEVDSIIRDLTDAAVKMVRVQAIEKNRY
RAEELAEERILDVLIPPAKNNWGQTEQQQEPSAARQAFRKKLREGLKIKDAMKLLIEEEA
AKLVNPEELKQDAIDAVEQHGIVFIDEIDKICKRGESSGPDVSREGVQRDLLPLVEGCTV
STKHGMVKTDHILFIASGAFQIAKPSDLIPELQGRLPIRVELQALTTSDFERILTEPNAS
ITVQYKALMATEGVNIEFTDSGIKRIAEAAWQVNESTENIGARRLHTVLERLMEEISYDA
SDLSGQNITIDADYVSKHLDALVADEDLSRFIL
//
>1g4uS [a.24.11 - c.45.1] PROTEIN TYROSINE PHOSPHATASE SPTP
SKQPLLDIALKGLKRTLPQLEQMDGNSLRENFQEMASGNGPLRSLMTNLQNLNKIPEAKQ
LNDYVTTLTNIQVGVARFSQWGTCGGEVERWVDKASTHELTQAVKKIHVIAKELKNVTAE
LEKIEAGAPMPQTMSGPTLGLARFAVSSIPINQQTQVKLSDGMPVPVNTLTFDGKPVALA
GSYPKNTPDALEAHMKMLLEKECSCLVVLTSEDQMQAKQLPPYFRGSYTFGEVHTNSQKV
SSASQGEAIDQYNMQLSCGEKRYTIPVLHVKNWPDHQPLPSTDQLEYLADRVKNKHLPMI
HCLGGVGRTGTMAAALVLKDNPHSNLEQVRADFRDSRNNRMLEDASQFVQLKAMQAQLLM
//
>1g4uR [c.37.1] RAS-RELATED C3 BOTULINUM TOXIN SUBSTRATE 1
MQAIKCVVVGDGAVGKTCLLISYTTNAFPGEYIPTVFDNYSANVMVDGKPVNLGLWDTAG
QEDYDRLRPLSYPQTDVSLICFSLVSPASFENVRAKWYPEVRHHCPNTPIILVGTKLDLR
DDKDTIEKLKEKKLTPITYPQGLAMAKEIGAVKYLECSALTQRGLKTVFDEAIRAVLCPP
//
>1g4yA (B) [f.15.1] CALCIUM-ACTIVATED POTASSIUM CHANNEL RSK2
DTQLTKRVKNAAANVLRETWLIYKNTKLVKKIDHAKVRKHQRKFLQAIHQLRSVKMEQRK
LNDQANTLVDLAKTQLHHHHH
//
>1g4yC (R) [a.39.1] CALMODULIN
ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN
GTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEE
VDEMIREADIDGDGQVNYEEFVQMMTA
//
>1g65C [d.153.1] PROTEIN (PROTEASOME COMPONENT PRE6)
GYDRALSIFSPDGHIFQVEYALEAVKRGTCAVGVKGKNCVVLGCERRSTLKLQDTRITPS
KVSKIDSHVVLSFSGLNADSRILIEKARVEAQSHRLTLEDPVTVEYLTRYVAGVQQRYTQ
SGGVRPFGVSTLIAGFDPRDDEPKLYQTEPSGIYSSWSAQTIGRNSKTVREFLEKNYDRK
EPPATVEECVKLTVRSLLEVVQTGAKNIEITVVKPDSDIVALSSEEINQYVTQIEQEKQE
Q
//
>1g65I [d.153.1] PROTEIN (PROTEASOME COMPONENT PUP3)
SDPSSINGGIVVAMTGKDCVAIACDLRLGSQSLGVSNKFEKIFHYGHVFLGITGLATDVT
TLNEMFRYKTNLYKLKEERAIEPETFTQLVSSSLYERRFGPYFVGPVVAGINSKSGKPFI
AGFDLIGCIDEAKDFIVSGTASDQLFGMCESLYEPNLEPEDLFETISQALLNAADRDALS
GWGAVVYIIKKDEVVKRYLKMRQD
//
>1g65J [d.153.1] PROTEIN (PROTEASOME COMPONENT C11)
MDIILGIRVQDSVILASSKAVTRGISVLKDSDDKTRQLSPHTLMSFAGEAGDTVQFAEYI
QANIQLYSIREDYELSPQAVSSFVRQELAKSIRSRRPYQVNVLIGGYDKKKNKPELYQID
YLGTKVELPYGAHGYSGFYTFSLLDHHYRPDMTTEEGLDLLKLCVQELEKRMPMDFKGVI
VKIVDKDGIRQVDDFQAQ
//
>1g65R (D) [d.153.1] PROTEIN (PROTEASOME COMPONENT PUP2)
DRGVSTFSPEGRLFQVEYSLEAIKLGSTAIGIATKEGVVLGVEKRATSPLLESDSIEKIV
EIDRHIGCAMSGLTADARSMIEHARTAAVTHNLYYDEDINVESLTQSVCDLALRFGEGAS
GEERLMSRPFGVALLIAGHDADDGYQLFHAEPSGTFYRYNAKAIGSGSEGAQAELLNEWH
SSLTLKEAELLVLKILKQVMEEKLDENNAQLSCITKQDGFKIYDNEKTAELIKELKEKEA
AE
//
>1g65S (E) [d.153.1] PROTEIN (PROTEASOME COMPONENT PRE5)
FRNNYDGDTVTFSPTGRLFQVEYALEAIKQGSVTVGLRSNTHAVLVALKRNADELSSYQK
KIIKCDEHMGLSLAGLAPDARVLSNYLRQQCNYSSLVFNRKLAVERAGHLLCDKAQKNTQ
SYGGRPYGVGLLIIGYDKSGAHLLEFQPSGNVTELYGTAIGARSQGAKTYLERTLDTFIK
IDGNPDELIKAGVEAISQSLRDESLTVDNLSIAIVGKDTPFTIYDGEAVAKYI
//
>1g6vA [b.74.1] CARBONIC ANHYDRASE
HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNG
HAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHW
NTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGL
LPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDN
WRPAQPLKNRQIKASF
//
>1g6vK [b.1.1] ANTIBODY HEAVY CHAIN
QVQLVESGGGSVQAGGSLRLSCAASGYTVSTYCMGWFRQAPGKEREGVATILGGSTYYGD
SVKGRFTISQDNAKNTVYLQMNSLKPEDTAIYYCAGSTVASTGWCSRLRPYDYHYRGQGT
QVTVSS
//
>1g73A [a.7.4] SECOND MITOCHONDRIA-DERIVED ACTIVATOR OF
AVPIAQKSEPHSLSSEALMRRAVSLVTDSTSTDLSQTTYALIEAITEYTKAVYTLTSLYR
QYTSLLGKMNSEEEDEVWQVIIGARAEMTSKHQEYLKLETTWMTAVGLSEMAAEAAYQTG
ADQASITARNHIQLVKLQVEEVHQLSRKAETKLAEAQ
//
>1g73C [g.52.1] INHIBITORS OF APOPTOSIS-LIKE PROTEIN ILP
LPRNPSMADYEARIFTFGTWIYSVNKEQLARAGFYALGEGDKVKCFHCGGGLTDWKPSED
PWEQHAKWYPGCKYLLEQKGQEYINNIHL
//
>1g7cA [c.37.1 - b.43.3 - b.44.1] ELONGATION FACTOR 1-ALPHA
EKSHINVVVIGHVDSGKSTTTGHLIYKCGGIDKRTIEKFEKEAAELGKGSFKYAWVLDKL
KAERERGITIDIALWKFETPKYQVTVIDAPGHRDFIKNMITGTSQADCAILIIAGGVGEF
EAGISKDGQTREHALLAFTLGVRQLIVAVNKMDSVKWDESRFQEIVKETSNFIKKVGYNP
KTVPFVPISGWNGDNMIEATTNAPWYKGWEKETKAGVVKGKTLLEAIDAIEQPSRPTDKP
LRLPLQDVYKIGGIGTVPVGRVETGVIKPGMVVTFAPAGVTTEVKSVEMHHEQLEQGVPG
DNVGFNVKNVSVKEIRRGNVCGDAKNDPPKGCASFNATVIVLNHPGQISAGYSPVLDCHT
AHIACRFDELLEKNDRRSGKKLEDHPKFLKSGDAALVKFVPSKPMCVEAFSEYPPLGRFA
VRDMRQTVAVGVIKSVDKTE
//
>1g7cB [d.58.12] ELONGATION FACTOR 1-BETA
PAAKSIVTLDVKPWDDETNLEEMVANVKAIEMEGLTWGAHQFIPIGFGIKKLQINCVVED
DKVSLDDLQQSIEEDEDHVQSTDIAAMQKL
//
>1g7hB [b.1.1] ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY
QVQLQESGPGLVAPSQSLSITCTVSGFSLTGYGVNWVRQPPGKGLEWLGMIWGDGNTDYN
SALKSRLSISKDNSKSQVFLKMNSLHTDDTARYYCARERDYRLDYWGQGTTLTVSS
//
>1g7hC [d.2.1] LYSOZYME C
KVFGRCELAAAMKRHGLDNYRGYSLGNWVCAAKFESNFNTQATNRNTDGSTDYGILQINS
RWWCNDGRTPGSRNLCNIPCSALLSSDITASVNCAKKIVSDGNGMNAWVAWRNRCKGTDV
QAWIRGCRL
//
>1g8k_3E (A) [c.81.1 - b.52.2] ARSENITE OXIDASE
NDRITLPPANAQRTNMTCHFCIVGCGYHVYKWPELEEGGRAPEQNALGLDFRKQLPPLAV
TLTPAMTNVVTEHDGARYDIMVVPDKACVVNSGLSSTRGGKMASYMYTPTGDGKERLSAP
RLYAADEWVDTTWDHAMALYAGLIKKTLDKDGPQGVFFSCFDHGGAGGGFENTWGTGKLM
FSAIQTPMVRIHNRPAYNSECHATREMGIGELNNAYEDAQLADVIWSIGNNPYESQTNYF
LNHWLPNLQGATTSKKKERFPNENFPQARIIFVDPRETPSVAIARHVAGNDRVLHLAIEP
GTDTALFNGLFTYVVEQGWIDKPFIEAHTKGFDDAVKTNRLSLDECSNITGVPVDMLKRA
AEWSYKPKASGQAPRTMHAYEKGIIWGNDNYVIQSALLDLVIATHNVGRRGTGCVRMGGH
QEGYTRPPYPGDKKIYIDQELIKGKGRIMTWWGCNNFQTSNNAQALREAILQRSAIVKQA
MQKARGATTEEMVDVIYEATQNGGLFVTSINLYPTKLAEAAHLMLPAAHPGEMNLTSMNG
ERRIRLSEKFMDPPGTAMADCLIAARIANALRDMYQKDGKAEMAAQFEGFDWKTEEDAFN
DGFRRAGQPGAPAIDSQGGSTGHLVTYDRLRKSGNNGVQLPVVSWDESKGLVGTEMLYTE
GKFDTDDGKAHFKPAPWNGLPATVQQQKDKYRFWLNNGRNNEVWQTAYHDQYNSLMQERY
PMAYIEMNPDDCKQLDVTGGDIVEVYNDFGSTFAMVYPVAEIKRGQTFMLFGYVNGIQGD
VTTDWTDRDIIPYYKGTWGDIRKVGSMSEFKRTVSFKSRRFG
//
>1g8k_3F (B) [b.33.1] ARSENITE OXIDASE
RTTLAYPATAVSVAKNLAANEPVSFTYPDTSSPCVAVKLGAPVPGGVGPDDDIVAYSVLC
THMGCPTSYDSSSKTFSCPCHFTEFDAEKAGQMICGEATADLPRVLLRYDAASDALTAVG
VDGLIYGRQANVI
//
>1g9iE [b.47.1] TRYPSINOGEN, CATIONIC
IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEG
NEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISG
WGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGP
VVCSGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN
//
>1g9iI [x.x.x] BOWMAN-BIRK TYPE TRYPSIN INHIBITOR
EPCCDSCRCTKSIPPQCHCANI
//
>1g9mG [d.172.1] ENVELOPE GLYCOPROTEIN GP120
EVVLVNVTENFNMWKNDMVEQMHEDIISLWDQSLKPCVKLTPLCVGAGSCNTSVITQACP
KVSFEPIPIHYCAPAGFAILKCNNKTFNGTGPCTNVSTVQCTHGIRPVVSTQLLLNGSLA
EEEVVIRSVNFTDNAKTIIVQLNTSVEINCTGAGHCNISRAKWNNTLKQIASKLREQFGN
NKTIIFKQSSGGDPEIVTHSFNCGGEFFYCNSTQLFNSTWFNGSDTITLPCRIKQIINMW
QKVGKAMYAPPISGQIRCSSNITGLLLTRDGGNSNNESEIFRPGGGDMRDNWRSELYKYK
VVKIE
//
>1g9mH [b.1.1 - b.1.1] ANTIBODY 17B, HEAVY CHAIN
QVQLLESGAEVKKPGSSVKVSCKASGDTFIRYSFTWVRQAPGQGLEWMGRIITILDVAHY
APHLQGRVTITADKSTSTVYLELRNLRSDDTAVYFCAGVYEGEADEGEYRNNGFLKHWGQ
GTLVTVTSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPQPVTVSWNSGALTSGVHT
FPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK
//
>1g9nG [d.172.1] ENVELOPE GLYCOPROTEIN GP120
LENVTENFNMWKNNMVEQMHEDIISLWDQSLKPCVKLTPLCVGAGSCNTSVITQACPKVS
FEPIPIHYCAPAGFAILKCNDKKFNGTGPCTNVSTVQCTHGIRPVVSTQLLLNGSLAEEE
IVIRSENFTNNAKTIIVQLNESVVINCTGAGHCNLSKTQWENTLEQIAIKLKEQFGNNKT
IIFNPSSGGDPEIVTHSFNCGGEFFYCNSTQLFTWNDTRKLNNTGRNITLPCRIKQIINM
WQEVGKAMYAPPIRGQIRCSSNITGLLLTRDGGKDTNGTEIFRPGGGDMRDNWRSELYKY
KVVKIE
//
>1g9nC [b.1.1 - b.1.1] T-CELL SURFACE GLYCOPROTEIN CD4
KKVVLGKKGDTVELTCTASQKKSIQFHWKNSNQIKILGNQGSFLTKGPSKLNDRADSRRS
LWDQGNFPLIIKNLKIEDSDTYICEVEDQKEEVQLLVFGLTANSDTHLLQGQSLTLTLES
PPGSSPSVQCRSPRGKNIQGGKTLSVSQLELQDSGTWTCTVLQNQKKVEFKIDIVVLAFQ
K
//
>1g9nL [b.1.1 - b.1.1] ANTIBODY 17B, LIGHT CHAIN
ELELTQSPATLSVSPGERATLSCRASESVSSDLAWYQQKPGQAPRLLIYGASTRATGVPA
RFSGSGSGAEFTLTISSLQSEDFAVYYCQQYNNWPPRYTFGQGTRLEIKRTVAAPSVFIF
PPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQKSKDSTYSLSST
LTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRG
//
>1g9nH [b.1.1 - b.1.1] ANTIBODY 17B, HEAVY CHAIN
QVQLLESGAEVKKPGSSVKVSCKASGDTFIRYSFTWVRQAPGQGLEWMGRIITILDVAHY
APHLQGRVTITADKSTSTVYLELRNLRSDDTAVYFCAGVYEGEADEGEYRNNGFLKHWGQ
GTLVTVTSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPQPVTVSWNSGALTSGVHT
FPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK
//
>1gaq_1A [b.43.4 - c.25.1] FERREDOXIN-NADP+ REDUCTASE
ESKKQEEGVVTNLYKPKEPYVGRCLLNTKITGDDAPGETWHMVFSTEGKIPYREGQSIGV
IADGVDKNGKPHKVRLYSIASSAIGDFGDSKTVSLCVKRLIYTNDAGEIVKGVCSNFLCD
LQPGDNVQITGPVGKEMLMPKDPNATIIMLATGTGIAPFRSFLWKMFFEKHDDYKFNGLG
WLFLGVPTSSSLLYKEEFGKMKERAPENFRVDYAVSREQTNAAGERMYIQTRMAEYKEEL
WELLKKDNTYVYMCGLKGMEKGIDDIMVSLAEKDGIDWFDYKKQLKRGDQWNVEVY
//
>1gaq_1B [d.15.4] FERREDOXIN I
ATYNVKLITPEGEVELQVPDDVYILDQAEEDGIDLPYSCRAGSCSSCAGKVVSGSVDQSD
QSYLDDGQIADGWVLTCHAYPTSDVVIETHKEEELTGA
//
>1gcqC [b.34.2] VAV PROTO-ONCOGENE
GSHMPKMEVFQEYYGIPPPPGAFGPFLRLNPGDIVELTKAEAEHNWWEGRNTATNEVGWF
PCNRVHPYV
//
>1gcqB [b.34.2] GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2
TYVQALFDFDPQEDGELGFRRGDFIHVMDNSDPNWWKGACHGQTGMFPRNYVTPVNR
//
>1gcvA [a.1.1] HEMOGLOBIN
AFTACEKQTIGKIAQVLAKSPEAYGAECLARLFVTHPGSKSYFEYKDYSAAGAKVQVHGG
KVIRAVVKAAEHVDDLHSHLETLALTHGKKLLVDPQNFPMLSECIIVTLATHLTEFSPDT
HCAVDKLLSAICQELSSRYR
//
>1gcvB [a.1.1] HEMOGLOBIN
VHWTQEERDEISKTFQGTDMKTVVTQALDRMFKVYPWTNRYFQKRTDFRSSIHAGIVVGA
LQDAVKHMDDVKTLFKDLSKKHADDLHVDPGSFHLLTDCIIVELAYLRKDCFTPHIQGIW
DKFFEVVIDAISKQYH
//
>1gff_21 [b.121.5] BACTERIOPHAGE G4 CAPSID PROTEINS GPF, GPG, GPJ
VPHDLSHLVFEAGKIGRLKTISWTPVVAGDSFECDMVGAIRLSPLRRGLAVDSRVDIFSF
YIPHRHIYGQQWINFMKDGVNASPLPPVTCSSGWDSAAYLGTIPSSTLKVPKFLHQGYLN
IYNNYFKPPWSDDLTYANPSNMPSEDYKWGVRVANLKSIWTAPLPPDTRTSENMTTGTST
IDIMGLQAAYAKLHTEQERDYFMTRYRDIMKEFGGHTSYDGDNRPLLLMRSEFWASGYDV
DGTDQSSLGQFSGRVQQTFNHKVPRFYVPEHGVIMTLAVTRFPPTHEMEMHYLVGKENLT
YTDIACDPALMANLPPREVSLKEFFHSSPDSAKFKIAEGQWYRTQPDRVAFPYNALDGFP
FYSALPSTDLKDRVLVNTNNYDEIFQSMQLAHWNMQTKFNINVYRHMPTTRDSIMTS
//
>1gff_29 (2) [b.121.5] BACTERIOPHAGE G4 CAPSID PROTEINS GPF, GPG, GPJ
MFQKFISKHNAPINSTQLAATKTPAVAAPVLSVPNLSRSTILINATTTAVTTHSGLCHVV
RIDETNPTNHHALSIAGSLSNVPADMIAFAIRFEVADGVVPTAVPALYDVYPIETFNNGK
AISFKDAVTIDSHPRTVGNDVYAGIMLWSNAWTASTISGVLSVNQVNREATVLQPLK
//
>1gg2A [c.37.1 - a.66.1] G PROTEIN GI ALPHA 1
LSAEDKAAVERSKMIDRNLREDGEKAAREVKLLLLGAGESGKSTIVKQMKIIHEAGYSEE
ECKQYKAVVYSNTIQSIIAIIRAMGRLKIDFGDAARADDARQLFVLAGAAEEGFMTAELA
GVIKRLWKDSGVQACFNRSREYQLNDSAAYYLNDLDRIAQPNYIPTQQDVLRTRVKTTGI
VETHFTFKDLHFKMFDVGAQRSERKKWIHCFEGVTAIIFCVALSDYDLVLAEDEEMNRMH
ESMKLFDSICNNKWFTDTSIILFLNKKDLFEEKIKKSPLTICYPEYAGSNTYEEAAAYIQ
CQFEDLNKRKDTKEIYTHFTCATDTKNVQFVFDAVTDVIIKNNL
//
>1gg2B [b.69.4] G PROTEIN GI BETA 1
SELDQLRQEAEQLKNQIRDARKACADATLSQITNNIDPVGRIQMRTRRTLRGHLAKIYAM
HWGTDSRLLVSASQDGKLIIWDSYTTNKVHAIPLRSSWVMTCAYAPSGNYVACGGLDNIC
SIYNLKTREGNVRVSRELAGHTGYLSCCRFLDDNQIVTSSGDTTCALWDIETGQQTTTFT
GHTGDVMSLSLAPDTRLFVSGACDASAKLWDVREGMCRQTFTGHESDINAICFFPNGNAF
ATGSDDATCRLFDLRADQELMTYSHDNIICGITSVSFSKSGRLLLAGYDDFNCNVWDALK
ADRAGVLAGHDNRVSCLGVTDDGMAVATGSWDSFLKIWN
//
>1ggcL [b.1.1 - b.1.1] IGG2A-KAPPA 50.1 FAB (LIGHT CHAIN)
DIVLTQSPGSLAVSLGQRATISCRASESVDDDGNSFLHWYQQKPGQPPKLLIYRSSNLIS
GIPDRFSGSGSRTDFTLTINPVEADDVATYYCQQSNEDPLTFGAGTKLEIKRADAAPTVS
IFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMS
STLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNR
//
>1ggcH [b.1.1 - b.1.1] IGG2A-KAPPA 50.1 FAB (HEAVY CHAIN)
QVQLQESGPGILQPSQTLSLTCSFSGFSLSTYGMGVSWIRQPSGKGLEWLAHIFWDGDKR
YNPSLKSRLKISKDTSNNQVFLKITSVDTADTATYYCVQEGYIYWGQGTSVTVSSAKTTA
PSVYPLAPVCGDTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDLYTLS
SSVTVTSSTWPSQSITCNVAHPASSTKVDKKIEPR
//
>1ggpA [d.165.1] PROTEIN (LECTIN 1 A CHAIN)
STDASYNADIKEERDAAEGPMAHGIPALNAGALDEARAYATVDSANTDEEVSVAVDVTNL
AVVAYRAGSNSYFHAAAPGSSLSHLFSRSSQHTLGFDNTYGDMAQAAGSNRKAIPLGAAA
LESGIASLNSKNPLARTLMVIIQMLVEAARFRYIQNNVDVSIETQSAFAADAAMISLENN
WANLSALVQGSSGGQGTFASSATLQNAEDEPIIVDAVYHPTVAAVLALMLRKAC
//
>1ggpB [b.42.2 - b.42.2] PROTEIN (LECTIN 1 B CHAIN)
CAAATVRIAGRDGFCADVNGEGQNGAAIILKKCAENDNQLWTLKREATIRSNGGCLTTAA
AEQAKAGIYDCTQATAELSAWEIADNGTIINPASSLVLSSGAANSLLDLGVQTNSYASAQ
GWRTGNETSASVTQISGSAQLCMQAGNGPANLWMSECRAGKAEQQWALLTDKSIRSETNS
DNCLTSAADAGPKTILLALCSGPASQRWVFDDDGSILSLYDDKQMDSEGAAAAAKQIILW
WNAAEPNQIWLALF
//
>1gh6B [a.74.1 - a.74.1] RETINOBLASTOMA-ASSOCIATED PROTEIN
MNTIQQLMMILNSASDQPSENLISYFNNCTVNPKESILKRVKDIGYIFKEKFAKAVGAGC
VAIGSQRYKLGVRLYYRVMESMLKSEEERLSIQNFSKLLNDNIFHMSLLACALEVVMATY
SRSTTDLSFPWILNVLNLKAFDFYKVIESFIKAEGNLTREMIKHLERCEHRIMESLAWLS
DSPLFDLIKQSKLVPRGSTSLSLFYKKVYRLAYLRLNTLCERLLSEHPELEHIIWTLFQH
TLQNEYELMRDRHLDQIMMCSMYGICKVKNIDLKFKIIVTAYKDLPHAVQETFKRVLIKE
EEYDSIIVFYNSVFMQRLKTNILQYA
//
>1gh6A [a.2.3] LARGE T ANTIGEN
SHMREESLQLMDLLGLERSAWGNIPLMRKAYLKKCKEFHPDKGGDEEKMKKMNTLYKKME
DGVKYAHQPDFGGFWDATEIPTYGTDEWEQWWNAFNEENLFCSEEMPSSDDEAT
//
>1ghfL [b.1.1 - b.1.1] ANTI-ANTI-IDIOTYPE GH1002 FAB FRAGMENT
DIQMTQTTSSLSASLGDRVTISCRESQDISNSLNWYQQKPDGTVKLLIYYTSRLHSGVPS
RFSGSGTGTDYSLTISNLEQEDFATYFCQQGNTLPYTFGGGTKLEIKRADAAQTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNR
//
>1ghfH [b.1.1 - b.1.1] ANTI-ANTI-IDIOTYPE GH1002 FAB FRAGMENT
VQLQQSGPELKKPGETVKISCKLWYTFTDYGMNWVKQAPGKGLKWMGWIQTNTEEPTYGA
EFKGRFAFSLETSAFTAYKQINNLKNEDMATYFCARVEAGFDYWAQGTTLTVSSAKTTPP
SVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTLSS
SVTVPSSPRPSETVTCNVAHPASSTKVDKKII
//
>1ghqA [a.102.4] COMPLEMENT C3
MLDAERLKHLIVTPSGAGEQNMIGMTPTVIAVHYLDETEQWEKFGLEKRQGALELIKKGY
TQQLAFRQPSSAFAAFVKRAPSTWLTAYVVKVFSLAVNLIAIDSQVLCGAVKWLILEKQK
PDGVFQEDAPVIHQEMIGGLRNNNEKDMALTAFVLISLQEAKDICEEQVNSLPGSITKAG
DFLEANYMNLQRSYTVAIAGYALAQMGRLKGPLLNKFLTTAKDKNRWEDPGKQLYNVEAT
SYALLALLQLKDFDFVPPVVRWLNEQRYYGGGYGSTQATFMVFQALAQYQKDAPSDHQEL
NLDVSLQ
//
>1ghqB [g.18.1 - g.18.1] CR2/CD121/C3D/EPSTEIN-BARR VIRUS RECEPTOR
AISCGSPPPILNGRISYYSTPIAVGTVIRYSCSGTFRLIGEKSLLCITKDKVDGTWDKPA
PKCEYFNKYSSCPEPIVPGGYKIRGSTPYRHGDSVTFACKTNFSMNGNKSVWCQANNMWG
PTRLPTCVS
//
>1gkaA [b.60.1] CRUSTACYANIN A1 SUBUNIT
KIPNFVVPGKCASVDRNKLWAEQTPNRNSYAGVWYQFALTNNPYQLIEKCVRNEYSFDGK
QFVIKSTGIAYDGNLLKRNGKLYPNPFGEPHLSIDYENSFAAPLVILETDYSNYACLYSC
IDYNFGYHSDFSFIFSRSANLADQYVKKCEAAFKNINVDTTRFVKTVQGSSCPYDTQKTV
//
>1gkaB [b.60.1] CRUSTACYANIN A2 SUBUNIT
DGIPSFVTAGKCASVANQDNFDLRRYAGRWYQTHIIENAYQPVTRCIHSNYEYSTNDYGF
KVTTAGFNPNDEYLKIDFKVYPTKEFPAAHMLIDAPSVFAAPYEVIETDYETYSCVYSCI
TTDNYKSEFAFVFSRTPQTSGPAVEKTAAVFNKNGVEFSKFVPVSHTAECVYRA
//
>1gl0A (I) [g.4.1] PROTEASE INHIBITOR LCMI I
KCTPGQVKQQDCNTCTCTPTGVWGCTLMGCQP
//
>1gl0B (E) [b.47.1] CHYMOTRYPSINOGEN A
CGVPAIQPVLSIVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSD
VVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLP
SASDDFAAGTTCVTTGWGLTRYTNANTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG
ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAA
N
//
>1gl1_1A [b.47.1] ALPHA-CHYMOTRYPSIN
CGVPAIQPVLSGIVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTS
DVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCL
PSASDDFAAGTTCVTTGWGLTRYNTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGAS
GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN
//
>1gl1_1I [g.4.1] PROTEASE INHIBITOR LCMI II
ISCEPGKTFKDKCNTCRCGADGKSAACTLKACPN
//
>1gl2C [h.1.15] VESICLE TRANSPORT V-SNARE PROTEIN VTI1-LIKE 1
MNRATQSIERSHRIATETDQIGTEIIEELGEQRDQLERTKSRLVNTNENLSKSRKILRS
//
>1gl2A [h.1.15] ENDOBREVIN
RVRNLQSEVEGVKNIMTQNVERILARGENLDHLRNKTEDLEATSEHFKTTSQK
//
>1gl2B [h.1.15] SYNTAXIN 7
HERESSIRQLEADIMDINEIFKDLGMMIHEQGDVIDSIEANVESAEVHVQQANQQLSRA
//
>1gl2D [h.1.15] SYNTAXIN 8
DAGLDALSSIISRQKQMGQEIGNELDEQNEIIDDLANLVENTDEKLRTEARRVT
//
>1gl4A [g.3.11 - d.22.1] NIDOGEN-1
TCANNRHQCSVHAECRDYATGFCCRCVANYTGNGRQCVAEGSPQRVNGKVKGRIFVGSSQ
VPVVFENTDLHSYVVMNHGRSYTAISTIPETVGYSLLPLAPIGGIIGWMFAVEQDGFKNG
FSITGGEFTRQAEVTFLGHPGKLVLKQQFSGIDEHGHLTISTELEGRVPQIPYGASVHIE
PYTELYHYSSSVITSSSTREYTVMEPDQDGAAPSHTHIYQWRQTITFQECAHDDARPALP
STQQLSVDSVFVLYNKEERILRYALSNSIGPVR
//
>1gl4B [b.1.1] BASEMENT MEMBRANE-SPECIFIC HEPARAN SULFATE
PIMVTVEEQRSQSVRPGADVTFICTAKSKSPAYTLVWTRLHNGKLPSRAMDFNGILTIRN
VQPSDAGTYVCTGSNMFAMDQGTATLHVQ
//
>1glbA (F) [b.84.3] GLUCOSE-SPECIFIC PROTEIN IIIGLC
GLFDKLKSLVSTIEIIAPLSGEIVNIEDVPDVVFAEKIVGDGIAIKPTGNKMVAPVDGTI
GKIFETNHAFSIESDSGVELFVHFGIDTVELKGEGFKRIAEEGQRVKVGDTVIEFDLPLL
EEKAKSTLTPVVISNMDEIKELIKLSGSVTVGETPVIRIKK
//
>1glbB (G) [c.55.1 - c.55.1] GLYCEROL KINASE
KYIVALDQGTTSSRAVVMDHDANIISVSQREFEQIYPKPGWVEHDPMEIWATQSSTLVEV
LAKADISSDQIAAIGITNQRETTIVWEKETGKPIYNAIVWQCRRTAEICEHLKRDGLEDY
IRSNTGLVIDPYFSGTKVKWILDHVEGSRERARRGELLFGTVDTWLIWKMTQGRVHVTDY
TNASRTMLFNIHTLDWDDKMLEVLDIPREMLPEVRRSSEVYGQTNIIPISGIAGDQQAAL
FGQLCVKEGMAKNTYGTGCFMLMNTGEKAVKSENGLLTTIACGPTGEVNYALEGAVFMAG
ASIQWLRDEMKLINDAYDSEYFATKVQNTNGVYVVPAFTGLGAPYWDPYARGAIFGLTRG
VNANHIIRATLESIAYQTRDVLEAMQADSGIRLHALRVDGGAVANNFLMQFQSDILGTRV
ERPEVREVTALGAAYLAGLAVGFWQNLDELQEKAVIEREFRPGIETTERNYRYAGWKKAV
KRAMAWEEH
//
>1gng_1A [d.144.1] GLYCOGEN SYNTHASE KINASE-3 BETA
KVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN
RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV
IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS
xICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT
PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC
AHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARI
//
>1gng_1X [x.x.x] FRATTIDE
DPHRLLQQLVLSGNLIKEAVRRLHS
//
>1go3_1E [d.230.1 - b.40.4] DNA-DIRECTED RNA POLYMERASE SUBUNIT E
MYKILEIADVVKVPPEEFGKDLKETVKKILMEKYEGRLDKDVGFVLSIVDVKDIGEGKVV
HGDGSAYHPVVFETLVYIPEMYELIEGEVVDVVEFGSFVRLGPLDGLIHVSQIMDDYVSY
DPKAIIGKETGKVLEIGDYVRARIVAISLKASKIALTMRQPYLGKLEWIEEEKAKKQ
//
>1go3_1F [a.60.8] DNA-DIRECTED RNA POLYMERASE SUBUNIT F
MIGKKILGERYVTVSEAAEIMYNRAQIGELSYEQGCALDYLQKFAKLDKEEAKKLVEELI
SLGIDEKTAVKIADILPEDLDDLRAIYYKRELPENAEEILEIVRKYI
//
>1go4B [d.135.1] MITOTIC SPINDLE ASSEMBLY CHECKPOINT PROTEIN
GITLRGSAEIVAEFFSFGINSILYQRGIYPSETFTRVQKYGLTLLVTTDLELIKYLNNVV
EQLKDWLYKCSVQKLVVVISNIESGEVLERWQFDIECDKTAKDDSAPREKSQKAIQDEIR
SVIAQITATVTFLPLLEVSCSFDLLIYTDKDLVVPEKWEESGPQFITNSEEVRLRSFTTT
IHKVNSMVAYKIPVN
//
>1go4F (E) [h.1.22] MAD1 (MITOTIC ARREST DEFICIENT)-LIKE 1
FSREEADTLRLKVEELEGERSRLEEEKRMLEAQLERRALQGDYDQSRTKVLHMSLNPTSV
ARQRLREDHSQLQAECERLRGLLRAME
//
>1gotA [c.37.1 - a.66.1] GT-ALPHA/GI-ALPHA CHIMERA
SAEEKHSRELEKKLKEDAEKDARTVKLLLLGAGESGKSTIVKQmKIIHQDGYSLEECLEF
IAIIYGNTLQSILAIVRAmTTLNIQYGDSARQDDARKLmHmADTIEEGTmPKEmSDIIQR
LWKDSGIQACFDRASEYQLNDSAGYYLSDLERLVTPGYVPTEQDVLRSRVKTTGIIETQF
SFKDLNFRmFDVGGQRSERKKWIHCFEGVTAIIFCVALSDYDLVLAEDEEmNRmHESmKL
FDSICNNKWFTDTSIILFLNKKDLFEEKIKKSPLTICYPEYAGSNTYEEAGNYIKVQFLE
LNmRRDVKEIYSHmTCATDTQNVKFVFDAVTDIIIKEN
//
>1gotB [b.69.4] GT-BETA
SELDQLRQEAEQLKNQIRDARKACADATLSQITNNIDPVGRIQMRTRRTLRGHLAKIYAM
HWGTDSRLLLSASQDGKLIIWDSYTTNKVHAIPLRSSWVMTCAYAPSGNYVACGGLDNIC
SIYNLKTREGNVRVSRELAGHTGYLSCCRFLDDNQIVTSSGDTTCALWDIETGQQTTTFT
GHTGDVMSLSLAPDTRLFVSGACDASAKLWDVREGMCRQTFTGHESDINAICFFPNGNAF
ATGSDDATCRLFDLRADQELMTYSHDNIICGITSVSFSKSGRLLLAGYDDFNCNVWDALK
ADRAGVLAGHDNRVSCLGVTDDGMAVATGSWDSFLKIWN
//
>1gpo_1L [b.1.1 - b.1.1] ANTIBODY M41
DIELTQSPATLSVTPGNSVSISCRASQSLVNEDGNTYLFWYQQKSHESPRLLIKYASQSI
SGIPSRFSGSGSGTDFTLSINSVETEDLAVYFCQQITDWPFTFGGGTKLEIKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNR
//
>1gpo_1H [b.1.1 - b.1.1] ANTIBODY M41
EVKLQESGPSLVKPSQTLSLTCSVTGDSITSDFWSWIRQFPGNRLEYMGFVQYSGETAYN
PSLKSRISITRDTSKNQYYLDLNSVTTEDTAVYYCANWHGDYWGQGTTVTVSSAKTTPPS
VYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTLSSS
VTVPSSTWPSETVTCNVAHPASSTKVDKKIVPRD
//
>1gpqB [d.233.1] INHIBITOR OF VERTEBRATE LYSOZYME
DDLTISSLAKGETTKAAFNQMVQGHKLPAWVMKGGTYTPAQTVTLGDETYQVMSACKPHD
CGSQRIAVMWSEKSNQMTGLFSTIDEKTSQEKLTWLNVNDALSIDGKTVLFAALTGSLEN
HPDGFNFR
//
>1gpqC [d.2.1] LYSOZYME C
KVFGRCELAAAMKRHGLDNYRGYSLGNWVCAAKFESNFNTQATNRNTDGSTDYGILQINS
RWWCNDGRTPGSRNLCNIPCSALLSSDITASVNCAKKIVSDGNGMNAWVAWRNRCKGTDV
QAWIRGC
//
>1gpw_2C (A) [c.1.2] HISF PROTEIN
MLAKRIIACLNVKDGRVVKGTNFENLRDSGDPVELGKFYSEIGIDELVFLDITASVEKRK
TMLELVEKVAEQIDIPFTVGGGIHDFETASELILRGADKVSINTAAVENPSLITQIAQTF
GSQAVVVAIDAKRVDGEFMVFTYSGKKNTGILLRDWVVEVEKRGAGEILLTSIDRDGTKS
GYDTEMIRFVRPLTTLPIIASGGAGKMEHFLEAFLAGADAALAASVFHFREIDVRELKEY
LKKHGVNVRLEGL
//
>1gpw_2D [c.23.16] AMIDOTRANSFERASE HISH
MRIGIISVGPGNIMNLYRGVKRASENFEDVSIELVESPRNDLYDLLFIPGVGHFGEGMRR
LRENDLIDFVRKHVEDERYVVGVCLGMQLLFEESEEAPGVKGLSLIEGNVVKLRSRRLPH
MGWNEVIFKDTFPNGYYYFVHTYRAVCEEEHVLGTTEYDGEIFPSAVRKGRILGFQFHPE
KSSKIGRKLLEKVIECSLSRR
//
>1gruG (A) [i.16.1] GROEL
AAKDVKFGNDARVKMLRGVNVLADAVKVTLGPKGRNVVLDKSFGAPTITKDGVSVAREIE
LEDKFENMGAQMVKEVASKANDAAGDGTTTATVLAQAIITEGLKAVAAGMNPMDLKRGID
KAVTAAVEELKALSVPCSDSKAIAQVGTISANSDETVGKLIAEAMDKVGKEGVITVEDGT
GLQDELDVVEGMQFDRGYLSPYFINKPETGAVELESPFILLADKKISNIREMLPVLEAVA
KAGKPLLIIAEDVEGEALATLVVNTMRGIVKVAAVKAPGFGDRRKAMLQDIATLTGGTVI
SEEIGMELEKATLEDLGQAKRVVINKDTTTIIDGVGEEAAIQGRVAQIRQQIEEATSDYD
REKLQERVAKLAGGVAVIKVGAATEVEMKEKKARVEDALHATRAAVEEGVVAGGGVALIR
VASKLADLRGQNEDQNVGIKVALRAMEAPLRQIVLNCGEEPSVVANTVKGGDGNYGYNAA
TEEYGNMIDMGILDPTKVTRSALQYAASVAGLMITTECMVTDLP
//
>1gruU [x.x.x]
NIRPLHDRVIVKRKEVETKSAGGIVMNIRPLHDRVIVKRKEVETKSAGGIVLTGSAAAKS
TRGEVLAVGNGRILENGEVKPLDVKVGDIVIFNDGYGVKSEKIDNEEVLIMSESDILAIV
EA
//
>1guaA [c.37.1] RAP1A
MREYKLVVLGSGGVGKSALTVQFVQGIFVDEYDPTIEDSYRKQVEVDCQQCMLEILDTAG
TEQFTAMRDLYMKNGQGFALVYSITAQSTFNDLQDLREQILRVKDTEDVPMILVGNKCDL
EDERVVGKEQGQNLARQWCNCAFLESSAKSKINVNEIFYDLVRQINR
//
>1guaB [d.15.1] C-RAF1
NTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWN
TDAASLIGEELQVDFL
//
>1guxA [a.74.1] RETINOBLASTOMA PROTEIN
NTIQQLMMILNSASDQPSENLISYFNNCTVNPKESILKRVKDIGYIFKEKFAKAVGQGCV
EIGSQRYKLGVRLYYRVMESMLKSENFSKLLNDNIFHMSLLACALEVVMATYSFPWILNV
LNLKAFDFYKVIESFIKAEGNLTREMIKHLERCEHRIMESLAWLSDSPLFDLIKQSK
//
>1guxB [a.74.1] RETINOBLASTOMA PROTEIN
TSLSLFYKKVYRLAYLRLNTLCERLLSEHPELEHIIWTLFQHTLQNEYELMRDRHLDQIM
MCSMYGICKVKNIDLKFKIIVTAYKDLPHAVQETFKRVLIKEEEYDSIIVFYNSVFMQRL
KTNILQYASTRPPTLSPIPHI
//
>1gvnC [a.8.2] EPSILON
AVTYEKTFEIEIINELSASVYNRVLNYVLNHELNKNDSQLLEVNLLNQLKLAKRVNLFDY
SLEELQAVHEYWRSMNRYSKQVLNK
//
>1gvnD [c.37.1] ZETA
ANIVNFTDKQFENRLNDNLEELIQGKKAVESPTAFLLGGQPGSGKTSLRSAIFEETQGNV
IVIDNDTFKQQHPNFDELVKLYEKDVVKHVTPYSNRMTEAIISRLSDQGYNLVIEGTGRT
TDVPIQTATMLQAKGYETKMYVMAVPKINSYLGTIERYETMYADDPMTARATPKQAHDIV
VKNLPTNLETLHKTGLFSDIRLYNREGVKLYSSLETPSISPKETLEKELNRKVSGKEIQP
TLERIEQKMVLNKHQETPEFKAIQQKLESL
//
>1gw5_1A [a.118.1] ADAPTOR-RELATED PROTEIN COMPLEX 2 ALPHA 2
GMRGLAVFISDIRNCKSKEAEIKRINKELANIRSKFKGDKALDGYSKKKYVCKLLFIFLL
GHDIDFGHMEAVNLLSSNRYTEKQIGYLFISVLVNSNSELIRLINNAIKNDLASRNPTFM
GLALHCIANVGSREMAEAFAGEIPKILVAGDTMDSVKQSAALCLLRLYRTSPDLVPMGDW
TSRVVHLLNDQHLGVVTAATSLITTLAQKNPEEFKTSVSLAVSRLSRIVTSASTDLQDYT
YYFVPAPWLSVKLLRLLQCYPPPEDPAVRGRLTECLETILNKAQEPPKSKKVQHSNAKNA
VLFEAISLIIHHDSEPNLLVRACNQLGQFLQHRETNLRYLALESMCTLASSEFSHEAVKT
HIETVINALKTERDVSVRQRAVDLLYAMCDRSNAQQIVAEMLSYLETADYSIREEIVLKV
AILAEKYAVDYTWYVDTILNLIRIAGDYVSEEVWYRVIQIVINRDDVQGYAAKTVFEALQ
APACHENLVKVGGYILGEFGuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuu
uuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuu
//
>1gw5_1B [a.118.1] ADAPTER-RELATED PROTEIN COMPLEX 2 BETA 1 SUBUNIT
SKYFTTNKKGEIFELKAELNNEKKEKRKEAVKKVIAAMTVGKDVSSLFPDVVNCMQTDNL
ELKKLVYLYLMNYAKSQPDMAIMAVNSFVKDCEDPNPLIRALAVRTMGCIRVDKITEYLC
EPLRKCLKDEDPYVRKTAAVCVAKLHDINAQMVEDQGFLDSLRDLIADSNPMVVANAVAA
LSEISESHPNSNLLDLNPQNINKLLTALNECTEWGQIFILDCLSNYNPKDDREAQSICER
VTPRLSHANSAVVLSAVKVLMKFLELLPKDSDYYNMLLKKLAPPLVTLLSGEPEVQYVAL
RNINLIVQKRPEILKQEIKVFFVKYNDPIYVKLEKLDIMIRLASQANIAQVLAELKEYAT
EVDVDFVRKAVRAIGRCAIKVEQSAERCVSTLLDLIQTKVNYVVQEAIVVIRDIFRKYPN
KYESIIATLCENLDSLDEPDARAAMIWIVGEYAERIDNADELLESFLEGFHDESTQVQLT
LLTAIVKLFLKKPSETQELVQQVLSuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuu
uuuuuuuuuuuIEPTLLDELICHIGSLASVYHKPPNAFV
//
>1gw5_1M [d.110.4] CLATHRIN COAT ASSEMBLY PROTEIN AP50
MIGGLFIYNHKGEVLISRVYRDDIGRNAVDAFRVNVIHARQQVRSPVTNIARTSFFHVKR
SNIWLAAVTKQNVNAAMVFEFLYKMCDVMAAYFGKISEENIKNNFVLIYELLDEILDFGY
PQNSETGALKTFITQQGIKSQIGWRREGIKYRRNELFLDVLESVNLLMSPQGQVLSAHVS
GRVVMKSYLSGMPECKFGMNDKIVIKIAIDDCTFHQCVRLSRSISFIPPDGEFELMRYRT
TKDIILPFRVIPLVREVGRTKLEVKVVIKSNFKPSLLAQKIEVRIPTPLNTSGVQVICMK
GKAKYKASENAIVWKIKRMAGMKESQISAEIELLPTNDKKKWARPPISMNFEVPFAPSGL
KVRYLKVFEPKLNYSDHDVIKWVRYIGRSGIYETRC
//
>1gw5_1S [d.110.4] CLATHRIN COAT ASSEMBLY PROTEIN AP17
MIRFILIQNRAGKTRLAKWYMQFDDDEKQKLIEEVHAVVTVRDAKHTNFVEFRNFKIIYR
RYAGLYFCICVDVNDNNLAYLEAIHNFVEVLNEYFHNVCELDLVFNFYKVYTVVDEMFLA
GEIRETSQTKVLKQLLMLQSLE
//
>1gw5_2A [a.118.1] ADAPTOR-RELATED PROTEIN COMPLEX 2 ALPHA 2
GMRGLAVFISDIRNCKSKEAEIKRINKELANIRSKFKGDKALDGYSKKKYVCKLLFIFLL
GHDIDFGHMEAVNLLSSNRYTEKQIGYLFISVLVNSNSELIRLINNAIKNDLASRNPTFM
GLALHCIANVGSREMAEAFAGEIPKILVAGDTMDSVKQSAALCLLRLYRTSPDLVPMGDW
TSRVVHLLNDQHLGVVTAATSLITTLAQKNPEEFKTSVSLAVSRLSRIVTSASTDLQDYT
YYFVPAPWLSVKLLRLLQCYPPPEDPAVRGRLTECLETILNKAQEPPKSKKVQHSNAKNA
VLFEAISLIIHHDSEPNLLVRACNQLGQFLQHRETNLRYLALESMCTLASSEFSHEAVKT
HIETVINALKTERDVSVRQRAVDLLYAMCDRSNAQQIVAEMLSYLETADYSIREEIVLKV
AILAEKYAVDYTWYVDTILNLIRIAGDYVSEEVWYRVIQIVINRDDVQGYAAKTVFEALQ
APACHENLVKVGGYILGEFGuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuu
uuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuu
//
>1gw5_2B [a.118.1] ADAPTER-RELATED PROTEIN COMPLEX 2 BETA 1 SUBUNIT
SKYFTTNKKGEIFELKAELNNEKKEKRKEAVKKVIAAMTVGKDVSSLFPDVVNCMQTDNL
ELKKLVYLYLMNYAKSQPDMAIMAVNSFVKDCEDPNPLIRALAVRTMGCIRVDKITEYLC
EPLRKCLKDEDPYVRKTAAVCVAKLHDINAQMVEDQGFLDSLRDLIADSNPMVVANAVAA
LSEISESHPNSNLLDLNPQNINKLLTALNECTEWGQIFILDCLSNYNPKDDREAQSICER
VTPRLSHANSAVVLSAVKVLMKFLELLPKDSDYYNMLLKKLAPPLVTLLSGEPEVQYVAL
RNINLIVQKRPEILKQEIKVFFVKYNDPIYVKLEKLDIMIRLASQANIAQVLAELKEYAT
EVDVDFVRKAVRAIGRCAIKVEQSAERCVSTLLDLIQTKVNYVVQEAIVVIRDIFRKYPN
KYESIIATLCENLDSLDEPDARAAMIWIVGEYAERIDNADELLESFLEGFHDESTQVQLT
LLTAIVKLFLKKPSETQELVQQVLSuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuu
uuuuuuuuuuuIEPTLLDELICHIGSLASVYHKPPNAFV
//
>1gw5_2M [d.110.4] CLATHRIN COAT ASSEMBLY PROTEIN AP50
MIGGLFIYNHKGEVLISRVYRDDIGRNAVDAFRVNVIHARQQVRSPVTNIARTSFFHVKR
SNIWLAAVTKQNVNAAMVFEFLYKMCDVMAAYFGKISEENIKNNFVLIYELLDEILDFGY
PQNSETGALKTFITQQGIKSQIGWRREGIKYRRNELFLDVLESVNLLMSPQGQVLSAHVS
GRVVMKSYLSGMPECKFGMNDKIVIKIAIDDCTFHQCVRLSRSISFIPPDGEFELMRYRT
TKDIILPFRVIPLVREVGRTKLEVKVVIKSNFKPSLLAQKIEVRIPTPLNTSGVQVICMK
GKAKYKASENAIVWKIKRMAGMKESQISAEIELLPTNDKKKWARPPISMNFEVPFAPSGL
KVRYLKVFEPKLNYSDHDVIKWVRYIGRSGIYETRC
//
>1gw5_2S [d.110.4] CLATHRIN COAT ASSEMBLY PROTEIN AP17
MIRFILIQNRAGKTRLAKWYMQFDDDEKQKLIEEVHAVVTVRDAKHTNFVEFRNFKIIYR
RYAGLYFCICVDVNDNNLAYLEAIHNFVEVLNEYFHNVCELDLVFNFYKVYTVVDEMFLA
GEIRETSQTKVLKQLLMLQSLE
//
>1gw5_2C (B) [a.118.1] ADAPTER-RELATED PROTEIN COMPLEX 2 BETA 1 SUBUNIT
SKYFTTNKKGEIFELKAELNNEKKEKRKEAVKKVIAAMTVGKDVSSLFPDVVNCMQTDNL
ELKKLVYLYLMNYAKSQPDMAIMAVNSFVKDCEDPNPLIRALAVRTMGCIRVDKITEYLC
EPLRKCLKDEDPYVRKTAAVCVAKLHDINAQMVEDQGFLDSLRDLIADSNPMVVANAVAA
LSEISESHPNSNLLDLNPQNINKLLTALNECTEWGQIFILDCLSNYNPKDDREAQSICER
VTPRLSHANSAVVLSAVKVLMKFLELLPKDSDYYNMLLKKLAPPLVTLLSGEPEVQYVAL
RNINLIVQKRPEILKQEIKVFFVKYNDPIYVKLEKLDIMIRLASQANIAQVLAELKEYAT
EVDVDFVRKAVRAIGRCAIKVEQSAERCVSTLLDLIQTKVNYVVQEAIVVIRDIFRKYPN
KYESIIATLCENLDSLDEPDARAAMIWIVGEYAERIDNADELLESFLEGFHDESTQVQLT
LLTAIVKLFLKKPSETQELVQQVLSuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuu
uuuuuuuuuuuIEPTLLDELICHIGSLASVYHKPPNAFV
//
>1gw5_2D (M) [d.110.4] CLATHRIN COAT ASSEMBLY PROTEIN AP50
MIGGLFIYNHKGEVLISRVYRDDIGRNAVDAFRVNVIHARQQVRSPVTNIARTSFFHVKR
SNIWLAAVTKQNVNAAMVFEFLYKMCDVMAAYFGKISEENIKNNFVLIYELLDEILDFGY
PQNSETGALKTFITQQGIKSQIGWRREGIKYRRNELFLDVLESVNLLMSPQGQVLSAHVS
GRVVMKSYLSGMPECKFGMNDKIVIKIAIDDCTFHQCVRLSRSISFIPPDGEFELMRYRT
TKDIILPFRVIPLVREVGRTKLEVKVVIKSNFKPSLLAQKIEVRIPTPLNTSGVQVICMK
GKAKYKASENAIVWKIKRMAGMKESQISAEIELLPTNDKKKWARPPISMNFEVPFAPSGL
KVRYLKVFEPKLNYSDHDVIKWVRYIGRSGIYETRC
//
>1gw5_2E (A) [a.118.1] ADAPTOR-RELATED PROTEIN COMPLEX 2 ALPHA 2
GMRGLAVFISDIRNCKSKEAEIKRINKELANIRSKFKGDKALDGYSKKKYVCKLLFIFLL
GHDIDFGHMEAVNLLSSNRYTEKQIGYLFISVLVNSNSELIRLINNAIKNDLASRNPTFM
GLALHCIANVGSREMAEAFAGEIPKILVAGDTMDSVKQSAALCLLRLYRTSPDLVPMGDW
TSRVVHLLNDQHLGVVTAATSLITTLAQKNPEEFKTSVSLAVSRLSRIVTSASTDLQDYT
YYFVPAPWLSVKLLRLLQCYPPPEDPAVRGRLTECLETILNKAQEPPKSKKVQHSNAKNA
VLFEAISLIIHHDSEPNLLVRACNQLGQFLQHRETNLRYLALESMCTLASSEFSHEAVKT
HIETVINALKTERDVSVRQRAVDLLYAMCDRSNAQQIVAEMLSYLETADYSIREEIVLKV
AILAEKYAVDYTWYVDTILNLIRIAGDYVSEEVWYRVIQIVINRDDVQGYAAKTVFEALQ
APACHENLVKVGGYILGEFGuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuu
uuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuu
//
>1gw5_2F (S) [d.110.4] CLATHRIN COAT ASSEMBLY PROTEIN AP17
MIRFILIQNRAGKTRLAKWYMQFDDDEKQKLIEEVHAVVTVRDAKHTNFVEFRNFKIIYR
RYAGLYFCICVDVNDNNLAYLEAIHNFVEVLNEYFHNVCELDLVFNFYKVYTVVDEMFLA
GEIRETSQTKVLKQLLMLQSLE
//
>1gxd_1A [a.20.1 - d.92.1 - g.14.1 - g.14.1 - g.14.1 - b.66.1] 72 KDA TYPE IV COLLAGENASE
APSPIIKFPGDVAPKTDKELAVQYLNTFYGCPKESCNLFVLKDTLKKMQKFFGLPQTGDL
DQNTIETMRKPRCGNPDVANYNFFPRKPKWDKNQITYRIIGYTPDLDPETVDDAFARAFQ
VWSDVTPLRFSRIHDGEADIMINFGRWEHGDGYPFDGKDGLLAHAFAPGTGVGGDSHFDD
DELWTLGEGQVVRVKYGNADGEYCKFPFLFNGKEYNSCTDTGRSDGFLWCSTTYNFEKDG
KYGFCPHEALFTMGGNAEGQPCKFPFRFQGTSYDSCTTEGRTDGYRWCGTTEDYDRDKKY
GFCPETAMSTVGGNSEGAPCVFPFTFLGNKYESCTSAGRSDGKMWCATTANYDDDRKWGF
CPDQGYSLFLVAAHAFGHAMGLEHSQDPGALMAPIYTYTKNFRLSQDDIKGIQELYGASP
DTPTLGPVTPEICKQDIVFDGIAQIRGEIFFFKDRFIWRTVTPRDKPMGPLLVATFWPEL
PEKIDAVYEAPQEEKAVFFAGNEYWIYSASTLERGYPKPLTSLGLPPDVQRVDAAFNWSK
NKKTYIFAGDKFWRYNEVKKKMDPGFPKLIADAWNAIPDNLDAVVDLQGGGHSYFFKGAY
YLKLENQSLKSVKFGSIKSDWLGC
//
>1gxd_1C [b.40.3] METALLOPROTEINASE INHIBITOR 2
CSCSPVHPQQAFCNADVVIRAKAVSEKEVDSGNDIYGNPIKRIQYEIKQIKMFKGPEKDI
EFIYTAPSSAVCGVSLDVGGKKEYLIAGKAEGDGKMHITLCDFIVPWDTLSTTQKKSLNH
RYQMGCECKITRCPMIPCYISSPDECLWMDWVTEKNINGHQAKFFACIKRSDGSCAWYRG
AAPPKQEFLDIE
//
>1gxsA [c.69.1] HYDROXYNITRILE LYASE
QQEDDRILGLPGQPNGVAFGMYGGYVTIDDNNGRALYYWFQEADTADPAAAPLVLWLNGG
PGCSSIGLGAMQELGAFRVHTNGESLLLNEYAWNKAANILFAESPAGVGFSYSNTSSDLS
MGDDKMAQDTYTFLVKWFERFPHYNYREFYIAGESGHFIPQLSQVVYRNRNNSPFINFQG
LLVSSGLTNDHEDMIGMFESWWHHGLISDETRDSGLKVCPGTSFMHPTPECTEVWNKALA
EQGNINPYTIYTPTCDREPSPYQRRFW
//
>1gxsB [c.69.1] HYDROXYNITRILE LYASE
LPPYDPCAVFNSINYLNLPEVQTALHANVSGIVEYPWTVCSNTIFDQWGQAADDLLPVYR
ELIQAGLRVWVYSGDTDSVVPVSSTRRSLAALELPVKTSWYPWYMAPTEREVGGWSVQYE
GLTYVTVRGAGHLVPVHRPAQAFLLFKQFLKGEPMPAE
//
>1gzh_1A [b.2.5] CELLULAR TUMOR ANTIGEN P53
SSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPG
TRVRAMAIYKQSQHMTEVVRRCPHHERCAPPQHLIRVEGLRVEYLDDRNTFRHSVVVPYE
PPECTTIHYNYMCNSSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVRVCACPGRDRRTE
EENLRKK
//
>1gzh_1B [c.15.1 - c.15.1] TUMOR SUPPRESSOR P53-BINDING PROTEIN 1
LNKTLFLGYAFLLTMATTSDKLASRSPPFNKQYTESQLRAGAGYILEDFNTAYQCLLIAD
QHCRTRKYFLCLASGIPCVSHVWVHDSCHANQLQNYRNYLLPAGYSLEEQRILDWQPREN
PFQNLKVLLVSDQQQNFLELWSEILMTGGAASVKQHHSSAHNKDIALGVFDVVVTDPSCP
ASVLKCAEALQLPVVSQEWVIQCLIVGERIGFKQHPKYKHDYVS
//
>1gzh_2C [b.2.5] CELLULAR TUMOR ANTIGEN P53
SSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPG
TRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRH
SVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVRV
CACPGRDRRTEEENL
//
>1gzh_2D [c.15.1 - c.15.1] TUMOR SUPPRESSOR P53-BINDING PROTEIN 1
NKTLFLGYAFLLTMATFNKQYTESQLRAGAGYILEDFNENTAYQCLLIADQHCRTRKYFL
CLASGIPCVSHVWVHDSCHANQLQNYRNYLLPAGYSLEEQRILDWQPRENPFQNLKVLLV
SDQQQNFLELWSEILMTGGAASVKQHHSSAHNKDIALGVFDVVVTDPSCPASVLKCAEAL
QLPVVSQEWVIQCLIVGERIGFKQHPKYKHDY
//
>1gzpA [d.19.1 - b.1.1] T-CELL SURFACE GLYCOPROTEIN CD1B
FQGPTSFHVIQTSSFTNSTWAQTQGSGWLDDLQIHGWDSDSGTAIFLKPWSKGNFSDKEV
AELEEIFRVYIFGFAREVQDFAGDFQMKYPFEIQGIAGCELHSGGAIVSFLRGALGGLDF
LSVKNASCVPSPEGGSRAQKFCALIIQYQGIMETVRILLYETCPRYLLGVLNAGKADLQR
QVKPEAWLSSGPSPGPGRLQLVCHVSGFYPKPVWVMWMRGEQEQQGTQLGDILPNANWTW
YLRATLDVADGEAAGLSCRVKHSSLEGQDIILYWGP
//
>1gzpB [b.1.1] B2-MICROGLOBULIN
MIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKD
WSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM
//
>1gzs_1A [c.37.1] GTP-BINDING PROTEIN
MQTIKCVVVGDGAVGKTCLLISYTTNKFPSEYVPTVFDNYAVTVMIGGEPYTLGLFDTAG
QEDYDRLRPLSYPQTDVFLVCFSVVSPSSFENVKEKWVPEITHHCPKTPFLLVGTQIDLR
DDPSTIEKLAKNKQKPITPETAEKLARDLKAVKYVECSALTQKGLKNVFDEAILAALE
//
>1gzs_1B [a.168.1] SOPE
GSLTNKVVKDFMLQTLNDIDIRGSASKDPAYASQTREAILSAVYSKNKDQCCNLLISKGI
NIAPFLQEIGEAAKNAGLPGTTKNDVFTPSGAGANPFITPLISSANSKYPRMFINQHQQA
SFKIYAEKIIMTEVAPLFNECAMPTPQQFQLILENIANKYIQNTP
//
>1h0dA [b.1.1 - b.1.1] ANTIBODY FAB FRAGMENT, LIGHT CHAIN
DIVLTQSPASLAVSLGQRATISCRASESVDNYGISFMSWFQQKPGQPPKLLIYAASNQGS
GVPARFSGSGSGTDFSLNIHPMEEDDTAMYFCQQSKEVPLTFGAGTKLELKRADAAPTVS
IFPPSSEQLTSGGASVVCFLNNFYPKDINVRWKIDGSERQNGVLNSWTDQDSKDSTYSMS
STLTLTKDEYERHNSYTCEATHAASPIVKSFNRNEC
//
>1h0dB [b.1.1 - b.1.1] ANTIBODY FAB FRAGMENT, HEAVY CHAIN
EVMLVESGGGLVKPGGSLKLSCAASGFTFSSYTMSWVRQTPEKRLEWVATISSGGGNTYY
PDSVKGRFTISRDIAKNTLYLQMSSLRSEDTALYYCTRLGDYGYAYTMDYWGQGTSVTVS
SAKTTPPSVYPLAPGGGGGGGAMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQS
DLYTLSSSVTVPSSPWPSETVTCNVAHPASSTKVDKKIVPRDC
//
>1h0dC [d.5.1] ANGIOGENIN
xDNSRYTHFLTQHYDAKPQGRDDRYCESIMRRRGLTSPCKDINTFIHGNKRSIKAICENK
NGNPHRENLRISKSSFQVTTCKLHGGSPWPPCQYRATAGFRNVVVACENGLPVHLDQSIF
RRP
//
>1h0dD (C) [d.5.1] ANGIOGENIN
xDNSRYTHFLTQHYDAKPQGRDDRYCESIMRRRGLTSPCKDINTFIHGNKRSIKAICENK
NGNPHRENLRISKSSFQVTTCKLHGGSPWPPCQYRATAGFRNVVVACENGLPVHLDQSIF
RRP
//
>1h0h_1A [c.81.1 - b.52.2] FORMATE DEHYDROGENASE (LARGE SUBUNIT)
ATMALKTVDAKQTTSVCCYCSVGCGLIVHTDKKTNRAINVEGDPDHPINEGSLCAKGAST
WQLAENERRPANPLYRAPGSDQWEEKSWDWMLDTIAERVAKTREATFVTKNAKGQVVNRC
DGIASVGSAAMDNEECWIYQAWLRSLGLFYIEHQARIcHSATVAALAESYGRGAMTNHWI
DLKNSDVILMMGSNPAENHPISFKWVMRAKDKGATLIHVDPRYTRTSTKCDLYAPLRSGS
DIAFLNGMTKYILEKELYFKDYVVNYTNASFIVGEGFAFEEGLFAGYNKETRKYDKSKWG
FERDENGNPKRDETLKHPRCVFQIMKKHYERYDLDKISAICGTPKELILKVYDAYCATGK
PDKAGTIMYAMGWTQHTVGVQNIRAMSINQLLLGNIGVAGGGVNALRGEANVQGSTDHGL
LMHIYPGYLGTARASIPTYEEYTKKFTPVSKDPQSANWWSNFPKYSASYIKSMWPDADLN
EAYGYLPKGEDGKDYSWLTLFDDMFQGKIKGFFAWGQNPACSGANSNKTREALTKLDWMV
NVNIFDNETGSFWRGPDMDPKKIKTEVFFLPCAVAIEKEGSISNSGRWMQWRYVGPEPRK
NAIPDGDLIVELAKRVQKLLAKTPGKLAAPVTKLKTDYWVNDHGHFDPHKIAKLINGFAL
KDFKVGDVEYKAGQQIATFGHLQADGSTTSGCWIYTGSYTEKGNMAARRDKTQTDMQAKI
GLYPGWTWAWPVNRRIIYNRASVDLNGKPYAPEKAVVEWNAAEKKWVGDVPDGPWPPQAD
KEKGKRAFIMKPEGYAYLYGPGREDGPLPEYYEPMECPVIEHPFSKTLHNPTALHFATEE
KAVCDPRYPFICSTYRVTEHWQTGLMTRNTPWLLEAEPQMFCEMSEELATLRGIKNGDKV
ILESVRGKLWAKAIITKRIKPFAIQGQQVHMVGIPWHYGWSFPKNGGDAANILTPSVGNP
NTGIPETKAFMVNVTKA
//
>1h0h_1B [d.58.1] FORMATE DEHYDROGENASE (SMALL SUBUNIT)
SKGFFVDTTRCTACRGCQVACKQWHGNPATPTENTGFHQNPPDFNFHTYKLVRMHEQEID
GRIDWLFFPDQCRHCIAPPCKATADMEDESAIIHDDATGCVLFTPKTKDLEDYESVISAC
PYDVPRKVAESNQMAKCDMCIDRITNGLRPACVTSCPTGAMNFGDLSEMEAMASARLAEI
KAAYSDAKLCDPDDVRVIFLTAHNPKLYHEYAVA
//
>1h1vA [c.55.1 - c.55.1] ACTIN
TTALVCDNGSGLVKAGFAGDDAPRAVFPSIVGRPRHMVGMGQKDSYVGDEAQSKRGILTL
KYPIEHGIITNWDDMEKIWHHTFYNELRVAPEEHPTLLTEAPLNPKANREKMTQIMFETF
NVPAMYVAIQAVLSLYASGRTTGIVLDSGDGVTHNVPIYEGYALPHAIMRLDLAGRDLTD
YLMKILTERGYSFVTTAEREIVRDIKEKLCYVALDFENEMATAASSSSLEKSYELPDGQV
ITIGNERFRCPETLFQPSFIGMESAGIHETTYNSIMKCDIDIRKDLYANNVMSGGTTMYP
GIADRMQKEITALAPSTMKIKIIAPPERKYSVWIGGSILASLSTFQQMWITKQEYDEAGP
SIVHRKCF
//
>1h1vG [d.109.1 - d.109.1 - d.109.1] GELSOLIN
MDDDGTGQKQIWRIEGSNKVPVDPATYGQFYGGDSYIILYNYRHGQIIYNWQGAQSTQDE
VAASAILTAQLDEELGGTPVQSRVVQGKEPAHLMSLFGGKPMIIYKGGTSREGGQTAPAS
TRLFQVRANSAGATRAVEVLPKAGALNSNDAFVLKTPSAAYLWVGTGASEAEKTGAQELL
RVLRAQPVQVAEGSEPDGFWEALGGKAAYRTSPRLKDKKMDAHPPRLFACSNKIGRFVIE
EVPGELMQEDLATDDVMLLDTWDQVFVWVGKDSQEEEKTEALTSAKRYIETDPANRDRRT
PITVVKQGFEPPSFVGWFLGWDDDYWS
//
>1h2kA [b.82.2] FACTOR INHIBITING HIF1
EPREEAGALGPAWDESQLRSYSFPTRPIPRLSQSDPRAEELIENEEPVVLTDTNLVYPAL
KWDLEYLQENIGNGDFSVYSASTHKFLYYDEKKMANFQNFKPRSNREEMKFHEFVEKLQD
IQQRGGEERLYLQQTLNDTVGRKIVMDFLGFNWNWINKQQGKRGWGQLTSNLLLIGMEGN
VTPAHYDEQQNFFAQIKGYKRCILFPPDQFECLYPYPVHHPCDRQSQVDFDNPDYERFPN
FQNVVGYETVVGPGDVLYIPMYWWHHIESLLNGGITITVNFWYKGAPTPEYPLKAHQKVA
IMRNIEKMLGEALGNPQEVGPLLNTMIKGRYN
//
>1h2kS [j.96.1] HYPOXIA-INDUCIBLE FACTOR 1 ALPHA
LTSYDCEVNAPILLQGEELLRALD
//
>1h2tC [a.118.1 - a.118.1 - a.118.1] 80 KDA NUCLEAR CAP BINDING PROTEIN
DHLESLICKVGEKSACSLESNLEGLAGVLEADLPNYKSKILRLLCTVARLLPEKLTIYTT
LVGLLNARNYNFGGEFVEAMIRQLKESLKANNYNEAVYLVRFLSDLVNCHVIAAPSMVAM
FENFVSVTQEEDVPQVRRDWYVYAFLSSLPWVGKELYEKKDAEMDRIFANTESYLKRRQK
THVPMLQVWTADKPHPQEEYLDCLWAQIQKLKKDRWQERHILRPYLAFDSILCEALQHNL
PPFTPPPHTEDSVYPMPRVIFRMFDYTDDPEGPVMPGSHSVERFVIEENLHCIIKSHWKE
RKTCAAQLVSYPGKNKIPLNYHIVEVIFAELFQLPAPPHIDVMYTTLLIELCKLQPGSLP
QVLAQATEMLYMRLDTMNTTCVDRFINWFSHHLSNFQFRWSWEDWSDCLSQDPESPKPKF
VREVLEKCMRLSYHQRILDIVPPTFSALCPSNPTCIYKYGDESSNSLPGHSVALCLAVAF
KSKATNDEIFSILKDVPNSFNPLKIEVFVQTLLHLAAKSFSHSFSALAKFHEVFKTLAES
DEGKLHVLRVMFEVWRNHPQMIAVLVDKMIRTQIVDCAAVANWIFSSELSRDFTRLFVWE
ILHSTIRKMNKHVGAQSEQKNLFLVIFQRFIMILTEHLVRCETDGTSVLTPWYKNCIERL
QQIFLQHHQIIQQYMVTLENLLFTAELDPHILAVFQQFCALQA
//
>1h2tZ [d.58.7] 20 KDA NUCLEAR CAP BINDING PROTEIN
LLKALRSDSYVELSQYRDQHFRGDNEEQEKLLKKSCTLYVGNLSFYTTEEQIYELFSKSG
DIKKIIMGLDKMKKTACGFCFVEYYSRADAENAMRYINGTRLDDRIIRTDWDAGFKEGRQ
YGRGRSGGQVRDEYRQDYDAGRGGY
//
>1h3oD (B) [a.22.1] TRANSCRIPTION INITIATION FACTOR TFIID 20/15 KDA
HmVLTKKKLQDLVREVDPNEQLDEDVEEmLLQIADDFIESVVTAACQLARHRKSSTLEVK
DVQLHLERQWNmWI
//
>1h3oC (A) [a.22.1] TRANSCRIPTION INITIATION FACTOR TFIID 135 KDA
mFLLQAPLQRRILEIGKKHGITELHPDVVSYVSHATQQRLQNLVEKISE
//
>1h3pH [b.1.1 - b.1.1] ANTIBODY FAB FRAGMENT
EVQLVESGGGLVKPGGSLKLSCAASGFTFSSYAMSWVRQSPEKRLEWVAEVSSDGSYAYY
PDTLTGRFTISRDNAKNTLYLEMTSLRSEDTAMYYCASFNWDVAYWGQGTLVTVSAAKTT
PPSVYPLAPGSNSMVTLGCLVKGYFPEPVTVTWNSGSLSGVHTFPAVLQSDLYTLSSSVT
VPSSPRPSETVTCNVAHPASSTKVDKKIVPRDC
//
>1h3pL [b.1.1 - b.1.1] ANTIBODY FAB FRAGMENT
DIVMTQSPSSLAVSVGEKVTMSCRSSQSLLNTRTRKSYLAWFQQKPGQSPKMLIYWASTR
ESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCKQSYSLYTFGGGTKLEIKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1h4iA [b.70.1] METHANOL DEHYDROGENASE SUBUNIT 1
NDKLVELSKSDDNWVMPGKNYDSNNFSDLKQINKGNVKQLRPAWTFSTGLLNGHEGAPLV
VDGKMYIHTSFPNNTFALGLDDPGTILWQDKPKQNPAARAVACCDLVNRGLAYWPGDGKT
PALILKTQLDGNVAALNAETGETVWKVENSDIKVGSTLTIAPYVVKDKVIIGSSGAELGV
RGYLTAYDVKTGEQVWRAYATGPDKDLLLASDFNIKNPHYGQKGLGTGTWEGDAWKIGGG
TNWGWYAYDPGTNLIYFGTGNPAPWNETMRPGDNKWTMTIFGRDADTGEAKFGYQKTPHD
EWDYAGVNVMMLSEQKDKDGKARKLLTHPDRNGIVYTLDRTDGALVSANKLDDTVNVFKS
VDLKTGQPVRDPEYGTRMDHLAKDICPSAMGYHNQGHDSYDPKRELFFMGINHICMDWEP
FMLPYRAGQFFVGATLNMYPGPKGDRQNYEGLGQIKAYNAITGDYKWEKMERFAVWGGTM
ATAGDLVFYGTLDGYLKARDSDTGDLLWKFKIPSGAIGYPMTYTHKGTQYVAIYYGVGGW
PGVGLVFDLADPTAGLGAVGAFKKLANYTQMGGGVVVFSLDGKGPYDDPNVGEWK
//
>1h4iB [a.137.2] METHANOL DEHYDROGENASE SUBUNIT 2
YDGTKCKAAGNCWEPKPGFPEKIAGSKYDPKHDPKELNKQADSIKQMEERNKKRVENFKK
TGKFEYDVAKISA
//
>1h59A [g.1.1] INSULIN-LIKE GROWTH FACTOR IA
PETLCGAELVDALQFVCGDRGFYFNKPTGYTGIVDECCFRSCDLRRLEMYCAPL
//
>1h59B [g.3.9] INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5
SALAEGQSCGVYTERCAQGLRCLPRQDEEKPLHALLHGRGVCLNE
//
>1h6k_2A [a.118.1 - a.118.1 - a.118.1] CBP80
TEDHLESLICKVGEKSACSLESNLEGLAGVLEADLPNYKSKILRLLCTVARLLPEKLTIY
TTLVGLLNARNYNFGGEFVEAMIRQLKESLKANNYNEAVYLVRFLSDLVNCHVIAAPSMV
AMFENFVSVTQEEDVPQVRRDWYVYAFLSSLPWVGKELYEKKDAEMDRIFANTESYLKRR
QKTHVPMLQVWTADKPHPQEEYLDCLWAQIQKLKKDRWQERHILRPYLAFDSILCEALQH
NLPPFTPPPHTEDSVYPMPRVIFRMFDYTDDPEGPVMPGSHSVERFVIEENLHCIIKSHW
KERKTCAAQLVSYPGKNKIPLNYHIVEVIFAELFQLPAPPHIDVMYTTLLIELCKLQPGS
LPQVLAQATEMLYMRLDTMNTTCVDRFINWFSHHLSNFQFRWSWEDWSDCLSQDPESPKP
KFVREVLEKCMRLSYHQRILDIVPPTFSALCPSNPTCIYKYGDESSNSLPGHSVALCLAV
AFKSKATNDEIFSILKDVPNFNPLKIEVFVQTLLHLAAKSFSHSFSALAKFHEVFKTLAE
SDEGKLHVLRVMFEVWRNHPQMIAVLVDKMIRTQIVDCAAVANWIFSSELSRDFTRLFVW
EILHSTIRKMNKHVLKIQKELEEAKEKEQIERLQEKVESAQSEQKNLFLVIFQRFIMILT
EHLVRCETDGTSVLTPWYKNCIERLQQIFLQHHQIIQQYMVTLENLLFTAELDPHILAVF
QQFCALQA
//
>1h6k_2X [d.58.7] 20 KDA NUCLEAR CAP BINDING PROTEIN
KSCTLYVGNLSFYTTEEQIYELFSKSGDIKKIIMGLDKMCGFCFVEYYSRADAENAMRYI
NGTRLDDRIIRTDWDAG
//
>1h8eD [b.49.1 - c.37.1 - a.69.1] BOVINE MITOCHONDRIAL F1-ATPASE
TTGRIVAVIGAVVDVQFDEGLPPILNALEVQGRETRLVLEVAQHLGESTVRTIAMDGTEG
LVRGQKVLDSGAPIRIPVGPETLGRIMNVIGEPIDERGPIKTKQFAAIHAEAPEFVEMSV
EQEILVTGIKVVDLLAPYAKGGKIGLFGGAGVGKTVLIMELINNVAKAHGGYSVFAGVGE
RTREGNDLYHEMIESGVINLKDATSKVALVYGQMNEPPGARARVALTGLTVAEYFRDQEG
QDVLLFIDNIFRFTQAGSEVSALLGRIPSAVGYQPTLATDMGTMQERITTTKKGSITSVQ
AIYVPADDLTDPAPATTFAHLDATTVLSRAIAELGIYPAVDPLDSTSRIMDPNIVGSEHY
DVARGVQKILQDYKSLQDIIAILGMDELSEEDKLTVSRARKIQRFLSQPFQVAEVFTGHL
GKLVPLKETIKGFQQILAGEYDHLPEQAFYMVGPIEEAVAKADKLAE
//
>1h8eA [b.49.1 - c.37.1 - a.69.1] BOVINE MITOCHONDRIAL F1-ATPASE
ADTSVDLEETGRVLSIGDGIARVHGLRNVQAEEMVEFSSGLKGMSLNLEPDNVGVVVFGN
DKLIKEGDIVKRTGAIVDVPVGEELLGRVVDALGNAIDGKGPIGSKARRRVGLKAPGIIP
RISVREPMQTGIKAVDSLVPIGRGQRELIIGDRQTGKTSIAIDTIINQKRFNDGTDEKKK
LYCIYVAIGQKRSTVAQLVKRLTDADAMKYTIVVSATASDAAPLQYLAPYSGCSMGEYFR
DNGKHALIIYDDLSKQAVAYRQMSLLLRRPPGREAYPGDVFYLHSRLLERAAKMNDAFGG
GSLTALPVIETQAGDVSAYIPTNVISITDGQIFLETELFYKGIRPAINVGLSVSRVGSAA
QTRAMKQVAGTMKLELAQYREVAAFLDAATQQLLSRGVRLTELLKQGQYSPMAIEEQVAV
IYAGVRGYLDKLEPSKITKFENAFLSHVISQHQALLGKIRTDGKISEESDAKLKEIVTNF
LAGFEA
//
>1h8eH [b.93.1] BOVINE MITOCHONDRIAL F1-ATPASE
QMSFTFASPTQVFFNSANVRQVDVPTQTGAFGILAAHVPTLQVLRPGLVVVHAEDGTTSK
YFVSSGSVTVNADSSVQLLAEEAVTLDML
//
>1h8eG [c.49.2] BOVINE MITOCHONDRIAL F1-ATPASE
ATLKDITRRLKSIKNIQKITKSMKMVAAAKYARAERELKPARVYGVGSLALYEKADILII
GVSSDRGLCGAIHSSVAKQMKSEAANLKEVKIIGVGDKIRSILHTFKEVGRRPPTFGDAS
VIALELLNEGSIIFNRFRSVISYKTEEKPIFSLDTISSAESMSIYDDIDADVLRNYQEYS
LANIIYYSLKESTTSEQSARMTAMDNASKNASEMIDKLTLTFNRTRQAVITKELIEIISG
AAA
//
>1h8eI [a.137.8] BOVINE MITOCHONDRIAL F1-ATPASE
VAYWRQAGLSYIRYSQICAKAVRDATSGSTIKIVKV
//
>1h8t_2D [b.121.4] ECHOVIRUS 11 COAT PROTEIN VP4
GAQVSTQKTGAHESIIHYTNINYYKDAASNSANRQDFTQDPGKFTEPVKDIMVKSLPALN
//
>1h8t_2I (D) [b.121.4] ECHOVIRUS 11 COAT PROTEIN VP4
GAQVSTQKTGAHESIIHYTNINYYKDAASNSANRQDFTQDPGKFTEPVKDIMVKSLPALN
SDRVRSITLGNSTITTQESANVVVGYGRWPEYLRDDEATAEDQPTQPDVATCRFYTLESV
TWEKDSPGWWWKFPDALKDMGLFGQNMYYHYLGRAGYTIHVQCNASKFHQGCLLVVCVPE
AEMGCSTVDGTVNEHGLSEGETAKKFSATGTNGTNTVQSIVTNAGMGVGVGNLTIFPHQW
INLRTNNCATIVMPYINNVPMDNMFRHHNFTLMIIPFVPLNYSSDFSTYVPITVTVAPMC
AEYNGLRLSTAL
//
>1h8t_2D [b.121.4] ECHOVIRUS 11 COAT PROTEIN VP4
GAQVSTQKTGAHESIIHYTNINYYKDAASNSANRQDFTQDPGKFTEPVKDIMVKSLPALN
//
>1h8tA [b.121.4] ECHOVIRUS 11 COAT PROTEIN VP1
GDVVEAVENAVARVADTIGSGPSNSQAVPALTAVETGHTSQVTPSDTVQTRHVKNYHSRS
ESSIENFLSRSACVYMGEYHTTNSDQTKLFASWTISARRMVQMRRKLEIFTYVRFDVEVT
FVITSKQDQGTQLGQDMPPLTHQIMYIPPGGPIPKSVTDYTWQTSTNPSIFWTEGNAPPR
MSIPFISIGNAYSNFYDGWSHFSQNGVYGYNTLNHMGQIYVRHVNGSSPLPMTSTVRMYF
KPKHVKAWVPRPPRLCQYKNASTVNFSPTDITDKRNSITYIPDTVKPDV
//
>1h8tB [b.121.4] ECHOVIRUS 11 COAT PROTEIN VP2
SDRVRSITLGNSTITTQESANVVVGYGRWPEYLRDDEATAEDQPTQPDVATCRFYTLESV
TWEKDSPGWWWKFPDALKDMGLFGQNMYYHYLGRAGYTIHVQCNASKFHQGCLLVVCVPE
AEMGCSTVDGTVNEHGLSEGETAKKFSATGTNGTNTVQSIVTNAGMGVGVGNLTIFPHQW
INLRTNNCATIVMPYINNVPMDNMFRHHNFTLMIIPFVPLNYSSDFSTYVPITVTVAPMC
AEYNGLRLSTAL
//
>1h8tC [b.121.4] ECHOVIRUS 11 COAT PROTEIN VP3
GLPVINTPGSNQFLTSDDFQSPSAMPQFDVTPELNIPGEVQNLMEIAEVDSVVPVNNVAG
NLETMDIYRIPVQSGNHQSSQVFGFQVQPGLDGVFKHTLLGEILNYYAHWSGSIKLTFVF
CGSAMATGKFLLAYAPPGANAPKSRKDAMLGTHIIWDVGLQSSCVLCIPWISQTHYRLVQ
QDEYTSAGNVTCWYQTGIVVPAGTPTSCSIMCFVSACNDFSVRLLKDTPFIQQAALLQ
//
>1h8tD [b.121.4] ECHOVIRUS 11 COAT PROTEIN VP4
GAQVSTQKTGAHESIIHYTNINYYKDAASNSANRQDFTQDPGKFTEPVKDIMVKSLPALN
//
>1h9d_2C (A) [b.2.5] CORE-BINDING FACTOR ALPHA SUBUNIT1
VLADHPGELVRTDSPNFLCSVLPTHWRCNKTLPIAFKVVALGDVPDGTLVTVMAGNDENY
SAELRNATAAMKNQVARFNDLRFVGRSGRGKSFTLTITVFTNPPQVATYHRAIKITVDGP
REPRR
//
>1h9d_2D [b.54.1] CORE-BINDING FACTOR CBF-BETA
PRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATG
TNLSLQFFPASWQTPSREYVDLEREAGKVYLKAPMILNGVCVIWKGWIDLQRLDGMGCLE
FDEERAQQE
//
>1h9hE [b.47.1] TRYPSIN
IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYKSRIQVRLGEHNIDVLEG
NEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSCAAAGTECLISG
WGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSYPGQITGNMICVGFLEGGKDSCQGDSGGP
VVCNGQLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIAAN
//
>1h9hI [g.3.2] TRYPSIN INHIBITOR II
GCPRILIRCKQDSDCLAGCVCGPNGFCGSP
//
>1h9iE [b.47.1] TRYPSIN
IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYKSRIQVRLGEHNIDVLEG
NEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSCAAAGTECLISG
WGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSYPGQITGNMICVGFLEGGKDSCQGDSGGP
VVCNGQLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIAAN
//
>1h9iI [g.3.2] TRYPSIN INHIBITOR II
GCPRILIRCKQDSDCLAGCVCTNNKFCGSP
//
>1ha7_1K (A) [a.1.1] C-PHYCOCYANIN ALPHA CHAIN
MKTPLTEAVSIADSQGRFLSSTEIQVAFGRFRQAKAGLEAAKALTSKADSLISGAAQAVY
NKFPYTTQMQGPNYAADQRGKDKCARDIGYYLRMVTYCLIAGGTGPMDEYLIAGIDEINR
TFELSPSWYIEALKYIKANHGLSGDAATEANSYLDYAINALS
//
>1ha7_1L (B) [a.1.1] C-PHYCOCYANIN BETA CHAIN
MFDAFTKVVSQADTRGEMLSTAQIDALSQMVAESNKRLDAVNRITSNASTIVSNAARSLF
AEQPQLIAPGGxAYTSRRMAACLRDMEIILRYVTYAVFAGDASVLEDRCLNGLRETYLAL
GTPGSSVAVGVGKMKEAALAIVNDPAGITPGDCSALASEIASYFDRACAAVS
//
>1hbmA [x.x.x]
ADKLFINALKKKFEESPEEKKTTFYTLGGWKQSERKTEFVNAGKEVAAKRGIPQYNPDIG
TPLGQRVLMPYQVSTTDTYVEGDDLHFVNNAAMQQMWDDIRRTVIVGLNHAHAVIEKRLG
KEVTPETITHYLETVNHAMPGAAVVQEHMVETHPALVADSYVKVFTGNDEIADEIDPAFV
IDINKQFPEDQAETLKAEVGDGIWQVVRIPTIVSRTCDGATTSRWSAMQIGMSMISAYKQ
AAGEAATGDFAYAAKxAEVIHMGTYLPVRxARGENEPGGVPFGYLADICQSSRVNYEDPV
RVSLDVVATGAMLYDQIWLGSYMSGGVGFTQYATAAYTDNILDDFTYFGKEYVEDKYGLC
EAPNNMDTVLDVATEVTFYGLEQYEEYPALLEDQFGGSxRAAVVAAAAGCSTAFATGNAQ
TGLSGWYLSMYLHKEQHSRLGFYYDLQDQxGASNVFSIRGDEGLPLELRGPNYPNYAMNV
GHQGEYAGISQAPHAARGDAFVFNPLVKIAFADDNLVFDFTNVRGEFAKGALREFEPAGE
RALITPA
//
>1hbmC [d.58.31] METHYL-COENZYME M REDUCTASE I GAMMA SUBUNIT
AQYYPGTTKVAQNRRNFCNPEYELEKLREISDEDVVKILGHRAPGEEYPSVHPPLEEMDE
PEDAIREMVEPIDGAKAGDRVRYIQFTDSMYFAPAQPYVRSRAYLCRYRGADAGTLSGRQ
IIETRERDLEKISKELLETEFFDPARSGVRGKSVHGHSLRLDEDGMMFDMLRRQIYNKDT
GRVEMVKNQIGDELDEPVDLGEPLDEETLMEKTTIYRVDGEAYRDDVEAVEIMQRIHVLR
SQGGFNL
//
>1hbrD [a.1.1] PROTEIN (HEMOGLOBIN D)
VHWTAEEKQLITGLWGKVNVAECGAEALARLLIVYPWTQRFFASFGNLSSPTAILGNPMV
RAHGKKVLTSFGDAVKNLDNIKNTFSQLSELHCDKLHVDPENFRLLGDILIIVLAAHFSK
DFTPECQAAWQKLVRVVAHALARKYH
//
>1hbrC [a.1.1] PROTEIN (HEMOGLOBIN D)
MLTAEDKKLIQQAWEKAASHQEEFGAEALTRMFTTYPQTKTYFPHFDLSPGSDQVRGHGK
KVLGALGNAVKNVDNLSQAMAELSNLHAYNLRVDPVNFKLLSQCIQVVLAVHMGKDYTPE
VHAAFDKFLSAVSAVLAEKY
//
>1hbuB [d.58.31 - a.89.1] METHYL-COENZYME M REDUCTASE I BETA SUBUNIT
AKFEDKVDLYDDRGNLVEEQVPLEALSPLRNPAIKSIVQGIKRTVAVNLEGIENALKTAK
VGGPACKIMGRELDLDIVGNAESIAAAAKEMIQVTEDDDTNVELLGGGKRALVQVPSARF
DVAAEYSAAPLVTATAFVQAIINEFDVSMYDANMVKAAVLGRYPQSVEYMGANIATMLDI
PQKLEGPGYALRNIMVNHVVAATLKNTLQAAALSTILEQTAMFEMGDAVGAFERMHLLGL
AYQGMNADNLVFDLVKANGKEGTVGSVIADLVERALEDGVIKVEKELTDYKVYGTDDLAM
WNAYAAAGLMAATMVNQGAARAAQGVSSTLLYYNDLIEFETGLPSVDFGKVEGTAVGFSF
FSHSIYGGGGPGIFNGNHIVTRHSKGFAIPCVAAAMALDAGTQMFSPEATSGLIKEVFSQ
VDEFREPLKYVVEAAAEIKNEI
//
>1hbuC [d.58.31] METHYL-COENZYME M REDUCTASE I GAMMA SUBUNIT
AQYYPGTTKVAQNRRNFCNPEYELEKLREISDEDVVKILGHRAPGEEYPSVHPPLEEMDE
PEDAIREMVEPIDGAKAGDRVRYIQFTDSMYFAPAQPYVRSRAYLCRYRGADAGTLSGRQ
IIETRERDLEKISKELLETEFFDPARSGVRGKSVHGHSLRLDEDGMMFDMLRRQIYNKDT
GRVEMVKNQIGDELDEPVDLGEPLDEETLMEKTTIYRVDGEAYRDDVEAVEIMQRIHVLR
SQGGFNL
//
>1hbuD [x.x.x]
ADKLFINALKKKFEESPEEKKTTFYTLGGWKQSERKTEFVNAGKEVAAKRGIPQYNPDIG
TPLGQRVLMPYQVSTTDTYVEGDDLHFVNNAAMQQMWDDIRRTVIVGLNHAHAVIEKRLG
KEVTPETITHYLETVNHAMPGAAVVQEHMVETHPALVADSYVKVFTGNDEIADEIDPAFV
IDINKQFPEDQAETLKAEVGDGIWQVVRIPTIVSRTCDGATTSRWSAMQIGMSMISAYKQ
AAGEAATGDFAYAAKxAEVIHMGTYLPVRxARGENEPGGVPFGYLADICQSSRVNYEDPV
RVSLDVVATGAMLYDQIWLGSYMSGGVGFTQYATAAYTDNILDDFTYFGKEYVEDKYGLC
EAPNNMDTVLDVATEVTFYGLEQYEEYPALLEDQFGGSxRAAVVAAAAGCSTAFATGNAQ
TGLSGWYLSMYLHKEQHSRLGFYYDLQDQxGASNVFSIRGDEGLPLELRGPNYPNYAMNV
GHQGEYAGISQAPHAARGDAFVFNPLVKIAFADDNLVFDFTNVRGEFAKGALREFEPAGE
RALITPA
//
>1hbx_1B [d.88.1] SERUM RESPONSE FACTOR
KKTRGRVKIKMEFIDNKLRRYTTFSKRKTGIMKKAYELSTLTGTQVLLLVASETGHVYTF
ATRKLQPMITSETGKALIQTCLNSPD
//
>1hbx_1G [a.4.5] ETS-DOMAIN PROTEIN ELK-4
DSAITLWQFLLQLLQKPQNKHMICWTSNDGQFKLLQAEEVARLWGIRKNKPNMNYDKLSR
ALRYYYVKNIIKKVNGQKFVYKFVSYPEILNMSRNDYIHSGLYSSFTLNSLN
//
>1hcfB [g.17.1] NEUROTROPHIN-4
TAPASRRGELAVCDAVSGWVTDRRTAVDLRGREVEVLGEVPAASPLRQYFFETRCKADAE
EGGPGAGGGGCRGVDRRHWVSECKAKQSYVRALTADAQGRVGWRWIRIDTACVCTLLSRT
G
//
>1hcfA [g.17.1] NEUROTROPHIN-4
GVSETAPASRRGELAVCDAVSGWVTDRRTAVDLRGREVEVLGEVPAAGGSPLRQYFFETR
CKADPGAGGGGCRGVDRRHWVSECKAKQSYVRALTADAQGRVGWRWIRIDTACVCTLLSR
T
//
>1hcfX [b.1.1] BDNF/NT-3 GROWTH FACTORS RECEPTOR
SHMAPTITFLESPTSDHHWCIPFTVKGNPKPALQWFYNGAILNESKYICTKIHVTNHTEY
HGCLQLDNPTHMNNGDYTLIAKNEYGKDEKQISAHFMGWPG
//
>1hcfY (X) [b.1.1] BDNF/NT-3 GROWTH FACTORS RECEPTOR
SHMAPTITFLESPTSDHHWCIPFTVKGNPKPALQWFYNGAILNESKYICTKIHVTNHTEY
HGCLQLDNPTHMNNGDYTLIAKNEYGKDEKQISAHFMGWPG
//
>1hdsA [a.1.1] HEMOGLOBIN S (DEOXY) (ALPHA CHAIN)
VLSAANKSNVKAAWGKVGGNAPAYGAQALQRMFLSFPTTKTYFPHFDLSHGSAQQKAHGQ
KVANALTKAQGHLNDLPGTLSNLSNLHAHKLRVNPVNFKLLSHSLLVTLASHLPTNFTPA
VHANLNKFLANDSTVLTSKYR
//
>1hdsB [a.1.1] HEMOGLOBIN S (DEOXY) (BETA CHAIN)
MLTAEEKAAVTGFWGKVDVDVVGAQALGRLLVVYPWTQRFFQHFGNLSSAGAVMNNPKVK
AHGKRVLDAFTQGLKHLDDLKGAFAQLSGLHCNKLHVNPQNFRLLGNVLALVVARNFGGQ
FTPNVQALFQKVVAGVANALAHKYH
//
>1hdtH [b.47.1] ALPHA-THROMBIN
IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL
VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL
PDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIR
ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFY
THVFRLKKWIQKVIDQFGE
//
>1hdtL [x.x.x]
ADCEGSGLRPLFEKKSLEDKTERELLESYIDGR
//
>1he1_1A [a.24.11] EXOENZYME S
ASSAVVFKQMVLQQALPMTLKGLDKASELATLTPEGLAREHSRLASGDGALRSLSTALAG
IRAGSQVEESRIQAGRLLERSIGGIALQQWGTTGGAASQLVLDASPELRREITDQLHQVM
SEVALLRQAVESEVS
//
>1he1_1C [c.37.1] RAS-RELATED C3 BOTULINUM TOXIN SUBSTRATE 1
PQAIKCVVVGDGAVGKTCLLISYTTNAFPGEYIPTVFDNYSANVMVDGKPVNLGLWDTAG
QEDYDRLRPLSYPQTDVFLICFSLVSPASFENVRAKWYPEVRHHCPNTPIILVGTKLDLR
DDKDTIEKLKEKKLTPITYPQGLAMAKEIGAVKYLECSALTQRGLKTVFDEAIRAV
//
>1he8A [d.15.1 - b.7.1 - a.118.1 - d.144.1] PHOSPHATIDYLINOSITOL 3-KINASE CATALYTIC SUBUNIT,
SEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVT
SKPLPEYLWKKIANNCIFIKIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPE
SQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKESL
WDCDRKFRVKIRGIDIPVLPLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSI
KIKDLPKGALLNLQIYCKVRLLYYVNLLLIDHRFLLRRGEYVLHMWQISNADKLTSATNP
DKENSMSISILLDNYCHPISALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYL
LQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAY
LRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSSQVISQLKQKLENLQNSQLPESFRVPY
DPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQI
LRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTFKDEVLNHWLKE
KSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHERVPFV
LTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTDIEYIRDAL
TVGKNEEDAKKYFLDQIEVCRDKGWTVQF
//
>1he8B [c.37.1] TRANSFORMING PROTEIN P21/H-RAS-1
MTEYKLVVVGAVGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAG
QEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDL
AARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH
//
>1hezC (A) [b.1.1 - b.1.1] KAPPA LIGHT CHAIN OF IG
DIQMTQSPSSLSASVGDRVTITCRTSQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPS
RFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPRTFGQGTKVEIKRTVAAPSVFIFPP
SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT
LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
//
>1hezE [d.15.7] PROTEIN L
EVTIKVNLIFADGKIQTAEFKGTFEEATAEAYRYADLLAKVNGEYTADLEDGGNHMNIKF
A
//
>1hezA [b.1.1 - b.1.1] KAPPA LIGHT CHAIN OF IG
DIQMTQSPSSLSASVGDRVTITCRTSQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPS
RFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPRTFGQGTKVEIKRTVAAPSVFIFPP
SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT
LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
//
>1hezB [b.1.1 - b.1.1] HEAVY CHAIN OF IG
QVQLVESGGGVVQPGRSLRLSCAASGFTFSGYGMHWVRQAPGKGLEWVALISYDESNKYY
ADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKVKFYDPTAPNDYWGQGTLVTVS
SGSASAPTLFPLVSCVAVGCLAQDFLPDSITFSWKYKNNSDISSTRGFPSVLRGGKYAAT
SQVLLPSHVVCKVQHPNGNKEKDVPLP
//
>1hfe_1S [a.137.4] PROTEIN (FE-ONLY HYDROGENASE (E.C.1.18.99.1)
VKQIKDYMLDRINGVYGADAKFPVRASQDNTQVKALYKSYLEKPLGHKSHDLLHTHWFDK
SKGVKELTTAGKLPNPRASEFEGPYPYE
//
>1hfe_1L [x.x.x]
SRTVMERIEYEMHTPDPKADPDKLHFVQIDEAKCIGCDTCSQYCPTAAIFGEMGEPHSIP
HIEACINCGQCLTHCPENAIYEAQSWVPEVEKKLKDGKVKCIAMPAPAVRYALGDAFGMP
VGSVTTGKMLAALQKLGFAHCWDTEFTADVTIWEEGSEFVERLTKKSDMPLPQFTSCCPG
WQKYAETYYPELLPHFSTCKSPIGMNGALAKTYGAERMKYDPKQVYTVSIMPCIAKKYEG
LRPELKSSGMRDIDATLTTRELAYMIKKAGIDFAKLPDGKRDSLMGESTGGATIFGVTGG
VMEAALRFAYEAVTGKKPDSWDFKAVRGLDGIKEATVNVGGTDVKVAVVHGAKRFKQVCD
DVKAGKSPYHFIEYMACPGGCVCGGGQPVMPGVLEA
//
>1hghA [b.19.1] HEMAGGLUTININ, CHAIN HA1
QDLPGNDNSTATLCLGHHAVPNGTLVKTITDDQIEVTNATELVQSSSTGKICNNPHRILD
GIDCTLIDALLGDPHCDVFQNETWDLFVERSKAFSNCYPYDVPDYASLRSLVASSGTLEF
ITEGFTWTGVTQNGGSNACKRGPGSGFFSRLNWLTKSGSTYPVLNVTMPNNDNFDKLYIW
GIHHPSTNQEQTSLYVQASGRVTVSTRRSQQTIIPNIGSRPWVRGLSSRISIYWTIVKPG
DVLVINSNGNLIAPRGYFKMRTGKSSIMRSDAPIDTCISECITPNGSIPNDKPFQNVNKI
TYGACPKYVKQNTLKLATGMRNVPEKQT
//
>1hghB [h.3.1] HEMAGGLUTININ, CHAIN HA1
GLFGAIAGFIENGWEGMIDGWYGFRHQNSEGTGQAADLKSTQAAIDQINGKLNRVIEKTN
EKFHQIEKEFSEVEGRIQDLEKYVEDTKIDLWSYNAELLVALENQHTIDLTDSEMNKLFE
KTRRQLRENAEEMGNGCFKIYHKCDNACIESIRNGTYDHDVYRDEALNNRFQIKG
//
>1hh4_1A [c.37.1] RAS-RELATED C3 BOTULINUM TOXIN SUBSTRATE 1
PQAIKCVVVGDGAVGKTCLLISYTTNAFPGEYIPTVFDNYSANVMVDGKPVNLGLWDTAG
QEDYDRLRPLSYPQTDVSLICFSLVSPASFENVRAKWYPEVRHHCPNTPIILVGTKLDLR
DDKDTIEKLKEKKLTPITYPQGLAMAKEIGAVKYLECSALTQRGLKTVFDEAIRAVLCPP
PVKKRKRKC
//
>1hh4_1D [b.1.18] RHO GDP-DISSOCIATION INHIBITOR 1
EQLAQIAAENEEDEHSVNYKPPAQKSIQEIQELDKDDESLRKYKEALLGRNVPNVVVTGL
TLVCSSAPGPLELDLTGDLESFKKQSFVLKEGVEYRIKISFRVNREIVSGMKYIQHTYRK
GVKIDKTDYMVGSYGPRAEEYEFLTPVEEAPKGMLARGSYSIKSRFTDDDKTDHLSWEWN
LTIKKD
//
>1hia_1A [b.47.1] KALLIKREIN
IIGGRECEKNSHPWQVAIYHYSSFQCGGVLVNPKWVLTAAHCKNDNYEVWLGRHNLFENE
NTAQFFGVTADFPHPGFNLS
//
>1hia_1B [b.47.1] KALLIKREIN
GKDYSHDLMLLRLQSPAKITDAVKVLELPTQEPELGSTCEASGWGSIEPGPDDFEFPDEI
QCVQLTLLQNTFCADAHPDKVTESMLCAGYLPGGKDTCMGDSGGPLICNGMWQGITSWGH
TPCGSANKPSIYTKLIFYLDWIDDTITENP
//
>1hia_1I [g.3.15] HIRUSTASIN
TCGGETCSAAQVCLKGKCVCNEVHCRIRCKYGLKKDENGCEYPCSCAK
//
>1him_1H [b.1.1 - b.1.1] IGG2A-KAPPA 17/9 FAB (HEAVY CHAIN)
DIVMTQSPSSLTVTAGEKVTMSCTSSQSLFNSGKQKNYLTWYQQKPGQPPKVLIYWASTR
ESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCQNDYSNPLTFGGGTKLELKRADAAPT
VSIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYS
MSSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNR
//
>1him_1L [b.1.1 - b.1.1] IGG2A-KAPPA 17/9 FAB (LIGHT CHAIN)
EVQLVESGGDLVKPGGSLKLSCAASGFSFSSYGMSWVRQTPDKRLEWVATISNGGGYTYY
PDSVKGRFTISRDNAKNTLYLQMSSLKSEDSAMYYCARRERYDENGFAYWGQGTLVTVSA
AKTTAPSVYPLAPVGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDLYTLS
SSVTVTSSTWPSQSITCNVAHPASSTKVDKKIEP
//
>1hjaB [b.47.1] ALPHA-CHYMOTRYPSIN
IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGS
SSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTT
CVTTGWGLTRY
//
>1hjaC [b.47.1] ALPHA-CHYMOTRYPSIN
ANTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVSSCMGDSGGPLVCKKNGAWT
LVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN
//
>1hjaI [g.68.1] OVOMUCOID INHIBITOR
VDCSEYPKPACTKEYRPLCGSDNKTYGNKCNFCNAVVESNGTLTLSHFGKC
//
>1hl6_1A [d.58.7] CG8781 PROTEIN
AEEFEVDEDGDQGIVRLKEKAKHRKGRGFGPGPQRSVEGWILFVTSIHEEAQEDEIQEKF
CDYGEIKNIHLNLDRRTGFSKGYALVEYETHKQALAAKEALNGAEIMGQTIQVDWCFVK
//
>1hl6_1B [d.232.1] MAGO NASHI PROTEIN
EDFYLRYYVGHKGKFGHEFLEFEFRPDGKLRYANNSNTMIRKEAFVHQSVMEELKRIIID
SEIMQEDDLPWPPPDRVGRQELEIVIGDEHISFTTSKTLVDVNRSKDPEGLRCFYYLVQD
LKCLVFSLIGLHFKIKP
//
>1hl6_2D [d.232.1] MAGO NASHI PROTEIN
DFYLRYYVGHKFGHEFLEFEFRPDGKLRYANNSNYKNDTMIRKEAFVHQSVMEELKRIII
DSEIMQEDDLPWPPPDRVGRQELEIVIGDEHISFTTSKTGSLVDVNRSKDPEGLRCFYYL
VQDLKCLVFSLIGLHFKIKPIPR
//
>1hl6_2C [d.58.7] CG8781 PROTEIN
EFEVDEDGDQGIVRLKEKAKHRKGRGFPGPQRSVEGWILFVTSIHEEAQEDEIQEKFCDY
GEIKNIHLNLFSKGYALVEYETHKQALAAKEALNGAEIMGQTIQVDWCFVK
//
>1hleA [e.1.1] HORSE LEUKOCYTE ELASTASE INHIBITOR
MEQLSTANTHFAVDLFRALNESDPTGNIFISPLSISSALAMIFLGTRGNTAAQVSKALYF
DTVEDIHSRFQSLNADINKPGAPYILKLANRLYGEKTYNFLADFLASTQKMYGAELASVD
FQQAPEDARKEINEWVKGQTEGKIPELLVKGMVDNMTKLVLVNAIYFKGNWQQKFMKEAT
RDAPFRLNKKDTKTVKMMYQKKKFPYNYIEDLKCRVLELPYQGKELSMIILLPDDIEDES
TGLEKIEKQLTLDKLREWTKPENLYLAEVNVHLPRFKLEESYDLTSHLARLGVQDLFNRG
KADLSGMSGARDLFVSKIIHKSFVDLNEEGTEAAAATAGTILLA
//
>1hleB [e.1.1] HORSE LEUKOCYTE ELASTASE INHIBITOR
EENFNADHPFIFFIRHNPSANILFLGRFSSP
//
>1hnzC [d.52.3 - d.53.1] 30S RIBOSOMAL PROTEIN S3
GNKIHPIGFRLGITRDWESRWYAGKKQYRHLLLEDQRIRGLLEKELYSAGLARVDIERAA
DNVAVTVHVAKPGVVIGRGGERIRVLREELAKLTGKNVALNVQEVQNPNLSAPLVAQRVA
EQIERRFAVRRAIKQAVQRVMESGAKGAKVIVSGRIGGAEQARTEWAAQGRVPLHTLRAN
IDYGFALARTTYGVLGVKAYIFLGEV
//
>1hnzN [g.39.1] 30S RIBOSOMAL PROTEIN S14
ARKALIEKAKRTPKFKVRAYTRCVRCGRARSVYRFFGLCRICLRELAHKGQLPGVRKASW
//
>1hq6A [d.155.1] HISTIDINE DECARBOXYLASE
SELDAKLNKLGVDRIAISPYKQWTRGYMEPGNIGNGYVTGLKVDAGVRRAETKNAYIGQI
NMTTAS
//
>1hq6B [d.155.1] HISTIDINE DECARBOXYLASE
FTGVQGRVIGYDILRSPEVDKAKPLFTETQWDGSELPIYDAKPLQDALVEYFGTEQDRRH
YPAPGSFIVCANKGVTAERPKNDADMKPGQGYGVWSAIAISFAKDPTKDSSMFVEDAGVW
ETPNEDELLEYLEGRRKAMAKSIAECGQDAHASFESSWIGFAYTMMEPGQIGNAITVAPY
VSLPIDSIPGGSILTPDKDMEIMENLTMPEWLEKMGYKSLSANNALKY
//
>1hqmA [i.8.1] DNA-DIRECTED RNA POLYMERASE
LKAPVFTATTQGDHYGEFVLEPLERGFGVTLGNPLRRILLSSIPGTAVTSVYIEDVLHEF
STIPGVKEDVVEIILNLKELVVRFLDPRWRTTLILRAEGPKEVRAVDFTPSADVEIMNPD
LHIATLEEGGKLYMEVRVDRGVGYVPAERHGIKDRINAIPVDAIFSPVRRVAFQVEDTRL
GQRTDLDKLTLRIWTDGSVTPLEALNQAVAILKEHLNYFANPE
//
>1hqmB [i.8.1] DNA-DIRECTED RNA POLYMERASE
ESKLKAPVFTATTQGDHYGEFVLEPLERGFGVTLGNPLRRILLSSIPGTAVTSVYIEDVL
HEFSTIPGVKEDVVEIILNLKELVVRFLDPRWRTTLILRAEGPKEVRAVDFTPSADVEIM
NPDLHIATLEEGGKLYMEVRVDRGVGYVPAERHGIKDRINAIPVDAIFSPVRRVAFQVED
TRLGQRTDLDKLTLRIWTDGSVTPLEALNQAVAILKEHLNYFANPEASL
//
>1hqmC [i.8.1] DNA-DIRECTED RNA POLYMERASE
KIKRFGRIREVIPLPPLTEIQVESYKKALQADVPPEKRENVGIQAAFKETFPIEEGDKGK
GGLVLDFLEYRIGDPPFSQDECREKDLTYQAPLYARLQLIHKDTGLIKEDEVFLGHLPLM
TEDGSFIINGADRVIVSQIHRSPGVYFTPDPARPGRYIASIIPLPKRGPWIDLEVEASGV
VTMKVNKRKFPLVLLLRVLGYDQETLVRELSAYGDLVQGLLDEAVLAMRPEEAMVRLFTL
LRPGDPPKKDKALAYLFGLLADPKRYDLGEAGRYKAEEKLGVGLSGRTLVRFEDGEFKDE
VFLPTLRYLFALTAGVPGHEVDDIDHLGNRRIRTVGELMADQFRVGLARLARGVRERMVM
GSPDTLTPAKLVNSRPLEAALREFFSRSQLSQFKDETNPLSSLRHKRRISALGPGGLTRE
RAGFDVRDVHRTHYGRICPVETPEGANIGLITSLAAYARVDALGFIRTPYRRVKNGVVTE
EVVYMTASEEDRYTIAQANTPLEGDRIATDRVVARRRGEPVIVAPEEVEFMDVSPKQVFS
LNTNLIPFLEHDDANRALMGSNMQTQAVPLIRAQAPVVMTGLEERVVRDSLAALYAEEDG
EVVKVDGTRIAVRYEDGRLVHPLRRYARSNQGTAFDQRPRVRVGQRVKKGDLLADGPASE
EGFLALGQNVLVAIMPFDGYNFEDAIVISEELLKRDFYTSIHIERYEIEARDTKLGPERI
TRDIPHLSEAALRDLDEEGIVRIGAEVKPGDILVGRTSFKGEQEPSPEERLLRSIFGEKA
RDVKDTSLRVPPGEGGIVVGRLRLRRGDPGVELKPGVREVVRVFVAQKRKLQVGDKLANR
HGNKGVVAKILPVEDMPHLPDGTPVDVILNPLGVPSRMNLGQILETHLGLAGYFLGQRYI
SPVFDGATEPEIKELLAEAFNLYFGKRQGEGFGVDKREKEVLARAEKLGLVSPGKSPEEQ
LKELFDLGKVVLYDGRTGEPFEGPIVVGQMFIMKLYHMVEDKMHARSTGPYSLITQQPLG
GKAQFGGQRFGEMEVWALEAYGAAHTLQEMLTIKSDDIEGRNAAYQAIIKGEDVPEPSVP
ESFRVLVKELQALALDVQTLDEKDNPVDIFEGL
//
>1hqmD [i.8.1] DNA-DIRECTED RNA POLYMERASE
KEVRKVRIALASPEKIRSWSYGEVEKPETEGKVCERCGVEVTRSIVRRYRMGHIELATPA
AHIWFVKDVPSKIGTLLDLFATELEQVLYFNKYIVLDPKGAVLDGVPVEKRQLLTDuuuu
uuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuIDARMGAEAIQELLKELDLEKLERELLE
EMKHPSRARRAKARKRLEVVRAFLDSGNRPEWMILEAVPVLPPDATSDLNDLYRRLINRN
NRLKKLLAQGAPEIIIRNEKRMLQEAVDAVIDNGRRGSPVTNPGSERPLRSLTDILSGKQ
GRFRQNLLGKRVDYSGRSVIVVGPQLKLHQCGLPKRMALELFKPFLLKKMEEKAFAPNVK
AARRMLERQRDIKDEVWDALEEVIHGKVVLLNRAPTLHRLGIQAFQPVLVEGQSIQLHPL
VCEAFNADFDGDQMAVHVPLSSFAQAEARIQMLSAHNLLSPASGEPLAKPSRDIILGLYY
ITQVRKEKKGAGMAFATPEEALAAYERGEVALNAPIVVAGRETSVGRLKFVFANPDEALL
AVAHGLLDLQDTVTTRYLGRRLETNPGRILFARIVGEAVGDEKVAQELIQMDVPQEKNSL
KDLVYQAFLRLGMEKTARLLDALKYYGFTLSTTSGIITIGIDDAVIPEEKQRYLEEADRK
LRQIEQAYEMGFLTDRERYDQVIQLWTETTEKVTQAVFNNFEENYPFNPLYVMAQSGARG
NPQQIRQLCGMRGLMQKPSGETFEVPVRSSFREGLTVLEYFISSHGARKGGADTALRTAD
SGYLTRKLVDVAHEIVVREADCGTTKYISVPLFQMDEVTRTLRLRKRSDIESGLYGRVLA
REVEALGRRLEEGRYLSLEDVHFLIKAAEAGEVREVPVRSPLTCQTRYGVCQKCYGYDLS
MARPVSIGEAVGVVAAESIGEPGTQLTMRTGTDITQGLPRVIELFEARRPKAKAVISEID
GVVRIEEGEDRLSVFVESEGFSKEYKLPKDARLLVKDGDYVEAGQPLTRGAIDPHQLLEA
KGPEAVERYLVDEIQKVYRAQGVKLHDKHIEIVVRQMLKYVEVTDPGDSPLLEGQVLEKW
DVEALNERLIAVPVAWKPLLMGVTKSALSTKSWLSAASFQNTTHVLTEAAIAGKKDELIG
LKENVILGRLIPAGTGSDFVRFTQVVDQRTLKAIE
//
>1hqmE [i.8.1] DNA-DIRECTED RNA POLYMERASE
MAEPGIDKLFGMVDSKYRLTVVVAKRAQQLLRHRFKNTVLEPEERPKMRTLEGLYDDPNA
VTWAMKELLTGRLFFGENLVPEDRLQKEMERLYPTEEE
//
>1hqrD [b.40.2 - d.15.6] STREPTOCOCCAL PYROGENIC EXOTOXIN C
KDISNVKSDLLYAYTITPYDYKDCRVNFSTTHTLNIDTQKYRGKDYYISSEMSYEASQKF
KRDDHVDVFGLFYILNSHTGEYIYGGITPAQNNKVNHKLLGNLFISGESQQNLNNKIILE
KDIVTFQEIDFKIRKYLMDNYKIYDATSPYVSGRIEIGTKDGKHEQIDLFDSPNEGTRSD
IFAKYKDNRIINMKNFSHFDIYLEK
//
>1hqrB [d.19.1 - b.1.1] HLA-DR BETA CHAIN
DTRPRFLQQDKYECHFFNGTERVRFLHRDIYNQEEDLRFDSDVGEYRAVTELGRPDAEYW
NSQKDFLEDRRAAVDTYCRHNYGVGESFTVQRRVEPKVTVYPAHNLLVCSVNGFYPGSIE
VRWFRNSQEEKAGVVSTGLIQNGDWTFQTLVMLETVPEVYTCQVEHPSVTSPLTVEWRA
//
>1hr0F [d.58.14] 30S RIBOSOMAL PROTEIN S6
MRRYEVNIVLNPNLDQSQLALEKEIIQRALENYGARVEKVEELGLRRLAYPIAKDPQGYF
LWYQVEMPEDRVNDLARELRIRDNVRRVMVVKSQEPFLANA
//
>1hr0L [b.40.4] 30S RIBOSOMAL PROTEIN S12
PTINQLVRKGREKVRKKSKVPALKGAPFRRGVCTVVRTVTPKKPNSALRKVAKVRLTSGY
EVTAYIPGEGHNLQEHSVVLIRGGRVKDLPGVRYHIVRGVYDAAGVKDRKKSRSKYGTKK
PKEA
//
>1hr0R [a.4.8] 30S RIBOSOMAL PROTEIN S18
PSRKAKVKATLGEFDLRDYRNVEVLKRFLSETGKILPRRRTGLSGKEQRILAKTIKRARI
LGLLPFTEKLVRK
//
>1hr0W [b.40.4] TRANSLATION INITIATION FACTOR
AKEKDTIRTEGVVTEALPNATFRVKLDSGPEILAYISGKMRMHYIRILPGDRVVVEITPY
DPTRGRIVYRK
//
>1hr8_4C [d.185.1 - d.185.1] MITOCHONDRIAL PROCESSING PEPTIDASE ALPHA SUBUNIT
TDNFKLSSLANGLKVATSNTPGHFSALGLYIDAGSRFEGRNLKGCTHILDRLAFKSTEHV
EGRAMAETLELLGGNYQCTSSRENLMYQASVFNQDVGKMLQLMSETVRFPKITEQELQEQ
KLSAEYEIDEVWMKPELVLPELLHTAAYSGETLGSPLICPRGLIPSISKYYLLDYRNKFY
TPENTVAAFVGVPHEKALELTGKYLGDWQSTHPPITKKVAQYTGGESCIPPAPVFGNLPE
LFHIQIGFEGLPIDHPDIYALATLQTLLGGGGGPGKGMYSRLYTHVLNQYYFVENCVAFN
HSYSDSGIFGISLSCIPQAAPQAVEVIAQQMYNTFANKDLRLTEDEVSRAKNQLKSSLLM
NLESKLVELEDMGRQVLMHGRKIPVNEMISKIEDLKPDDISRVAEMIFTGNVNNAGNGKG
RATVVMQGDRGSFGDVENVLKAYGLGNS
//
>1hr8_4D [d.185.1 - d.185.1] MITOCHONDRIAL PROCESSING PEPTIDASE BETA SUBUNIT
ASQIPGTRTSKLPNGLTIATEYIPNTSSATVGIFVDAGSRAENVKNNGTAHFLQHLAFKG
TQNRPQQGIELEIENIGSHLNAYTSRENTVYYAKSLQEDIPKAVDILSDILTKSVLDNSA
IERERDVIIRESEEVDKMYDEVVFDHLHEITYKDQPLGRTILGPIKNIKSITRTDLKDYI
TKNYKGDRMVLAGAGAVDHEKLVQYAQKYFGHVPKSESPVPLGSPRGPLPVFCRGERFIK
ENTLPTTHIAIALEGVSWSAPDYFVALATQAIVGNWDRAIGTGTNSPSPLAVAASQNGSL
ANSYMSFSTSYADSGLWGMYIVTDSNEHNVRLIVNEILKEWKRIKSGKISDAEVNRAKAQ
LKAALLLSLDGSTAIVEDIGRQVVTTGKRLSPEEVFEQVDKITKDDIIMWANYRLQNKPV
SMVALGNTSTVPNVSYIEEKLNQ
//
>1hri_21 [b.121.4] HUMAN RHINOVIRUS 14 COAT PROTEIN (SUBUNIT VP1)
TVASISSGPKHTQKVPILTANETGATMPVLPSDSIETRTTYMHFNGSETDVECFLGRAAC
VHVTEIQNKDATGIDNHREAKLFNDWKINLSSLVQLRKKLELFTYVRFDSEYTILATASQ
PDSANYSSNLVVQAMYVPPGAPNPKEWDDYTWQSASNPSVFFKVGDTSRFSVPYVGLASA
YNCFYDGYSHDDAETQYGITVLNHMGSMAFRIVNEHDEHKTLVKIRVYHRAKHVEAWIPR
APRALPYTSIGRTNYPKNTEPVIKKRKGDIKSY
//
>1hri_24 [b.121.4] HUMAN RHINOVIRUS 14 COAT PROTEIN (SUBUNIT VP4)
INYYKDAASTSSAGQSLSMDPSKFTEPVKDLMLKGAPALN
//
>1hrpA [g.17.1] HUMAN CHORIONIC GONADOTROPIN
TQDCPECTLQENPFFSQPGAPILQCMGCCFSRAYPTPLRSKKTMLVQKNVTSESTCCVAK
SYNRVTVMGGFKVENHTACHCSTCYY
//
>1hrpB [g.17.1] HUMAN CHORIONIC GONADOTROPIN
KEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPTMTRVLQGVLPALPQVVCNYRD
VRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDCGGPKDHPLTCD
//
>1hrtA (L) [b.47.1] THROMBIN (SMALL SUBUNIT)
TFGAGEADCGLRPLFEKKQVQDQTEKELFESYIEGR
//
>1hrtB (H) [b.47.1] THROMBIN (LARGE SUBUNIT)
IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLL
VRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCL
PDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKASTRIR
ITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFY
THVFRLKKWIQKVIDRLGS
//
>1hrtC (I) [g.3.15] HIRUDIN
VVYTDCTESGQNLCLCEGSNVCGQGNKCILGSDGEKNQCVTGEGTPKPQSHNDGDFEEIP
EEYLQ
//
>1htrA (P) [b.50.1] PROGASTRICSIN (PRO SEGMENT)
AVVKVPLKKFKSIRETMKEKGLLGEFLRTHKYDPAWKYRFGDL
//
>1htrC (B) [b.50.1] GASTRICSIN
SVTYEPMAYMDAAYFGEISIGTPPQNFLVLFDTGSSNLWVPSVYCQSQACTSHSRFNPSE
SSTYSTNGQTFSLQYGSGSLTGFFGYDTLTVQSIQVPNQEFGLSENEPGTNFVYAQFDGI
MGLAYPALSVDEATTAMQGMVQEGALTSPVFSVYLSNQQGSSGGAVVFGGVDSSLYTGQI
YWAPVTQELYWQIGIEEFLIGGQASGWCSEGCQAIVDTGTSLLTVPQQYMSALLQATGAQ
EDEYGQFLVNCNSIQNLPSLTFIINGVEFPLPPSSYILSNNGYCTVGVEPTYLSSQNGQP
LWILGDVFLRSYYSVYDLGNNRVGFATAA
//
>1hwgA [a.26.1] GROWTH HORMONE
FPTIPLSRLFDNAMLRAHRLHQLAFDTYQEFEEAYIPKEQKYSFLQNPQTSLCFSESIPT
PSNREETQQKSNLELLRISLLLIQSWLEPVQFLRSVFANSLVYGASDSNVYDLLKDLEEG
IQTLMGRLEDGSPRTGQIFKQTYSKFDDALLKNYGLLYCFRKDMDKVETFLRIVQCRSVE
GSCG
//
>1hwgB [b.1.2 - b.1.2] GROWTH HORMONE BINDING PROTEIN
EPKFTKCRSPERETFSCHWTDEPIQLFYTRRNTQEWTQEWKECPDYVSAGENSCYFNSSF
TSIWIPYCIKLTSNGGTVDEKCFSVDEIVQPDPPIALNWTLLNVSLTGIHADIQVRWEAP
RNADIQKGWMVLEYELQYKEVNETKWKMMDPILTTSVPVYSLKVDKEYEVRVRSKQRNSG
NYGEFSEVLYVTLP
//
>1hwnB [b.42.2 - b.42.2] EBULIN
GETCAIPAPFTRRIVGRDGLCVDVRNGYDTDGTPIQLWPCGTQRNQQWTFYNDKTIRSMG
KCMTANGLNSGSYIMITDCSTAAEDATKWEVLIDGSIINPSSGLVMTAPSGASRTTLLLE
NNIHAASQGWTVSNDVQPIATLIVGYNEMCLQANGENNNVWMEDCDVTSVQQQWALFDDR
TIRVNNSRGLCVTSNGYVSKDLIVIRKCQGLATQRWFFNSDGSVVNLKSTRVMDVKESDV
SLQEVIIFPATGNPNQQWRTQVP
//
>1hwnA [d.165.1] EBULIN
IDYPSVSFNLAGAKSTTYRDFLKNLRDRVATGTYEVNGLPVLRRESEVQVKNRFVLVRLT
NYNGDTVTSAVDVTNLYLVAFSANGNSYFFKDATELQKSNLFLGTTQHTLSFTGNYDNLE
TAAGTRRESIELGPNPLDGAITSLWYDGGVARSLLVLIQMVPEAARFRYIEQEVRRSLQQ
LTSFTPNALMLSMENNWSSMSLEVQLSGDNVSPFSGTVQLQNYDHTPRLVDNFEELYKIT
GIAILLFRCVATKT
//
>1hx1A [c.55.1 - c.55.1] HEAT SHOCK COGNATE 71 KDA
PAVGIDLGTTYSCVGVFQHGKVEIIANDQGNRTTPSYVAFTDTERLIGDAAKNQVAMNPT
NTVFDAKRLIGRRFDDAVVQSDMKHWPFMVVNDAGRPKVQVEYKGETKSFYPEEVSSMVL
TKMKEIAEAYLGKTVTNAVVTVPAYFNDSQRQATKDAGTIAGLNVLRIINEPTAAAIAYG
LDKKVGAERNVLIFDLGGGTFDVSILTIEDGIFEVKSTAGDTHLGGEDFDNRMVNHFIAE
FKRKHKKDISENKRAVRRLRTACERAKRTLSSSTQASIEIDSLYEGIDFYTSITRARFEE
LNADLFRGTLDPVEKALRDAKLDKSQIHDIVLVGGSTRIPKIQKLLQDFFNGKELNKSIN
PDEAVAYGAAVQAAILS
//
>1hx1B [a.7.7] BAG-FAMILY MOLECULAR CHAPERONE REGULATOR-1
GNSPQEEVELKKLKHLEKSVEKIADQLEELNKELTGIQQGFLPKDLQAEALCKLDRRVKA
TIEQFMKILEEIDTLILPENFKDSRLKRKGLVKKVQAFLAECDTVEQNICQE
//
>1hxm_4G (A) [b.1.1 - b.1.1] GAMMA-DELTA T-CELL RECEPTOR
AIELVPEHQTVPVSIGVPATLRCSMKGEAIGNYYINWYRKTQGNTMTFIYREKDIYGPGF
KDNFQGDIDIAKNLAVLKILAPSERDEGSYYCACDTLGMGGEYTDKLIFGKGTRVTVEPR
SQPHTKPSVFVMKNGTNVACLVKEFYPKDIRINLVSSKKITEFDPAIVISPSGKYNAVKL
GKYEDSNSVTCSVQHDNKTVHSTDFE
//
>1hxm_4H (B) [b.1.1 - b.1.1] GAMMA-DELTA T-CELL RECEPTOR
AGHLEQPQISSTKTLSKTARLECVVSGITISATSVYWYRERPGEVIQFLVSISYDGTVRK
ESGIPSGKFEVDRIPETSTSTLTIHNVEKQDIATYYCALWEAQQELGKKIKVFGPGTKLI
ITDKQLDADVSPKPTIFLPSIAETKLQKAGTYLCLLEKFFPDVIKIHWEEKKSNTILGSQ
EGNTMKTNDTYMKFSWLTVPEKSLDKEHRCIVRHENNKNGVDQEIIFPPI
//
>1hxs_21 [b.121.4] GENOME POLYPROTEIN, COAT PROTEIN VP1
GSSSTAATSRDALPNTEASGPTHSKEIPALTAVETGATNPLVPSDTVQTRHVVQHRSRSE
SSIESFFARGACVTIMTVDNPASTTNKDKLFAVWKITYKDTVQLRRKLEFFTYSRFDMEL
TFVVTANFTETNNGHALNQVYQIMYVPPGAPVPEKWDDYTWQTSSNPSIFYTYGTAPARI
SVPYVGISNAYSHFYDGFSKVPLKDQSAALGDSLYGAASLNDFGILAVRVVNDHNPTKVT
SKIRVYLKPKHIRVWCPRPPRAVAYYGPGVDYKDGTLTPLSTKDLTTY
//
>1hxs_22 [b.121.4] GENOME POLYPROTEIN, COAT PROTEIN VP2
ACGYSDRVLQLTLGNSTITTQEAANSVVAYGRWPEYLRDSEANPVDQPTEPDVAACRFYT
LDTVSWTKESRGWWWKLPDALRDMGLFGQNMYYHYLGRSGYTVHVQCNASKFHQGALGVF
AVPEMCLAGDSNTTTMHTSYQNANPGEKGGTFTGTFTPDNNQTSPARRFCPVDYLLGNGT
LLGNAFVFPHQIINLRTNNCATLVLPYVNSLSIDSMVKHNNWGIAILPLAPLNFASESSP
EIPITLTIAPMCCEFNGLRNITLPRLQ
//
>1hxs_23 [b.121.4] GENOME POLYPROTEIN, COAT PROTEIN VP3
GLPVMNTPGSNQYLTADNFQSPCALPEFDVTPPIDIPGEVKNMMELAEIDTMIPFDLSAT
KKNTMEMYRVRLSDKPHTDDPILCLSLSPASDPRLSHTMLGEILNYYTHWAGSLKFTFLF
CGSMMATGKLLVSYAPPGADPPKKRKEAMLGTHVIWDIGLQSSCTMVVPWISNTTYRQTI
DDSFTEGGYISVFYQTRIVVPLSTPREMDILGFVSACNDFSVRLLRDTTHIEQKA
//
>1hxs_24 [b.121.4] GENOME POLYPROTEIN, COAT PROTEIN VP4
GAQVSSQKVGAHENSNRAYGGSTINYTTINYYRDSASNAASKQDFSQDPSKFTEPIKDVL
IKTAPMLN
//
>1hxyD [b.40.2 - d.15.6] ENTEROTOXIN H
DLHDKSELTDLALANAYGQYNHPFIKENIKSDEISGEKDLIFRNQGDSGNDLRVKFATAD
LAQKFKNKNVDIYGASFYYKCEKISENISECLYGGTTLNSEKLAQERVIGANVWVDGIQK
ETELIRTNKKNVTLQELDIKIRKILSDKYKIYYKDSEISKGLIEFDMKTPRDYSFDIYDL
KGENDYEIDKIYEDNKTLKSDDISHIDVNLYT
//
>1hxyB [d.19.1 - b.1.1] HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR-1
TRPRFLWQLKFECHFFNGTERVRLLERCIYNQEESVRFDSDVGEYRAVTELGRPDAEYWN
SQKDLLEQRRAAVDTYCRHNYGVGESFTVQRRVEPKVTVYPHNLLVCSVSGFYPGSIEVR
WFRNGQEEKAGVVSTGLIQNGDWTFQTLVMLETVPRSGEVYTCQVEHPSVTSPLTVEWRA
//
>1hyrC [d.19.1 - b.1.1] MHC CLASS I CHAIN-RELATED PROTEIN A
MEPHSLRYNLTVLSWDGSVQSGFLTEVHLDGQPFLRCDRQKCRAKPQGQWAEDVLGNKTW
DRETRDLTGNGKDLRMTLAHIKDQKEGLHSLQEIRVCEIHEDNSTRSSQHFYYDGELFLS
QNLETKEWTMPQSSRAQTLAMNVRNFLKEDAMKTKTHYHAMHADCLQELRRYLKSGVVLR
RTVPPMVNVTRSEASEGNITVTCRASGFYPWNITLSWRQDGVSLSHDTQQWGDVLPDGNG
TYQTWVATRICQGEEQRFTCYMEHSGNHSTHPVPS
//
>1hyrA [d.169.1] NKG2-D TYPE II INTEGRAL MEMBRANE PROTEIN
ESYCGPCPKNWICYKNNCYQFFDESKNWYESQASCMSQNASLLKVYSKEDQDLLKLVKSY
HWMGLVHIPTNGSWQWEDGSILSPNLLTIIEMQKGDCALYASSFKGYIENCSTPNTYICM
QRTV
//
>1hys_2C [b.1.1 - b.1.1] FAB-28 MONOCLONAL ANTIBODY FRAGMENT LIGHT CHAIN
DIQMTQTTSSLSASLGDRVTISCSASQDISSYLNWYQQKPEGTVKLLIYYTSSLHSGVPS
AFSGSGSGTDYSLTISNLEPEDFATYYCQQYSKFPWTFGGGTKLEIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVAWAIDGSAAANGVLNSWTDQDSKDSTYSMSSTLT
LTADAYEAANSYTCAATHKTSTSPIVKSFNANEC
//
>1hys_2D [b.1.1 - b.1.1] FAB-28 MONOCLONAL ANTIBODY FRAGMENT HEAVY CHAIN
QITLKESGPGIVQPSQPFRLTCTFSGFSLSTSGIGVTWIRQPSGKGLEWLATIWWDDDNR
YNPSLKSRLTVSKDTSNNQAFLNMMTVETADTAIYYCAQSAITSVTDSAMDHWGQGTSVT
VSSAATTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVL
QSDLYTLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKI
//
>1hzh_1M (L) [b.1.1 - b.1.1] IMMUNOGLOBULIN LIGHT CHAIN
EIVLTQSPGTLSLSPGERATFSCRSSHSIRSRRVAWYQHKPGQAPRLVIHGVSNRASGIS
DRFSGSGSGTDFTLTITRVEPEDFALYYCQVYGASSYTFGQGTKLERKRTVAAPSVFIFP
PSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTL
TLSKADYEKHKVYACEVTHQGLRSPVTKSFNRGEC
//
>1hzh_1K [b.1.1 - b.1.1 - b.1.1 - b.1.1] IMMUNOGLOBULIN HEAVY CHAIN
QVQLVQSGAEVKKPGASVKVSCQASGYRFSNFVIHWVRQAPGQRFEWMGWINPYNGNKEF
SAKFQDRVTFTADTSANTAYMELRSLRSADTAVYYCARVGPYSWDDSPQDNYYMDVWGKG
TTVIVSSASTKGPSVFPLAPSTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSS
GLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKAEPKSCDKCPPCPAPELLGGPSV
FLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTY
RVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTK
NQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQG
NVFSCSVMHEALHNHYTQKSLSLS
//
>1i1qA [d.161.1] ANTHRANILATE SYNTHASE COMPONENT I
KPTLELLTCDAAYRENPTALFHQVCGDRPATLLLESADIDSKDDLKSLLLVDSALRITAL
GDTVTIQALSDNGASLLPLLDTALPAGVENDVLPAGRVLRFPPVSPLLDENARLCSLSVF
DAFRLLQGVVNIPTQEREAMFFGGLFAYDLVAGFEALPHLEAGNNCPDYCFYLAETLMVI
DHQKKSTRIQASLFTASDREKQRLNARLAYLSQQLTQPAPPLPVTPVPDMRCECNQSDDA
FGAVVRQLQKAIRAGEIFQVVPSRRFSLPCPSPLAAYYVLKKSNPSPYMFFMQDNDFTLF
GASPESSLKYDAASRQIEIYPIAGTRPRGRRADGTLDRDLDSRIELDMRTDHKELSEHLM
LVDLARNDLARICTPGSRYVADLTKVDRYSYVMHLVSRVVGELRHDLDALHAYRACMNMG
TLSGAPKVRAMQLIADAEGQRRGSYGGAVGYFTAHGDLDTCIVIRSALVENGIATVQAGA
GIVLDSVPQSEADETRNKARAVLRAIATAHHA
//
>1i1qB [c.23.16] ANTHRANILATE SYNTHASE COMPONENT II
ADILLLDNIDSFTWNLADQLRTNGHNVVIYRNHIPAQTLIDRLATMKNPVLMLSPGPGVP
SEAGCMPELLTRLRGKLPIIGICLGHQAIVEAYGGYVGQILHGKATSIEHDGQAMFAGLA
NPLPVARYHSSNVPAGLTINAHFNGMVMAVRHDADRVCGFQFHPESILTTQGARLLEQTL
AWAQQK
//
>1i1rA [b.1.2 - b.1.2 - b.1.2] INTERLEUKIN-6 RECEPTOR BETA CHAIN
LLDPCGYISPESPVVQLHSNFTAVCVLKEKCMDYFHVNANYIVWKTNHFTIPKEQYTIIN
RTASSVTFTDIASLNIQLTCNILTFGQLEQNVYGITIISGLPPEKPKNLSCIVNEGKKMR
CEWDGGRETHLETNFTLKSEWATHKFADCKAKRDTPTSCTVDYSTVYFVNIEVWVEAENA
LGKVTSDHINFDPVYKVKPNPPHNLSVINSEELSSILKLTWTNPSIKSVIILKYNIQYRT
KDASTWSQIPPEDTASTRSSFTVQDLKPFTEYVFRIRCMKEDGKGYWSDWSEEASGITYE
D
//
>1i1rC (B) [a.26.1] VIRAL IL-6
EFEKDLLIQRLNWMLWVIDECFRDLCYRTGICKGILEPAAIFHLKLPAINDTDHCGLIGF
NETSCLKKLADGFFEFEVLFKFLTTEFGKSVINVDVMELLTKTLGWDIQEELNKLTKTHY
SPPKFDRGLLGRLQGLKYWVRHFASFYVLSAMEKFAGQAVRVLDSIP
//
>1i2mA [c.37.1] GTP-BINDING NUCLEAR PROTEIN RAN
QVQFKLVLVGDGGTGKTTFVKRHLKKYVATLGVEVHPLVFHTNRGPIKFNVWDTAGQEKF
GGLRDGYYIQAQCAIIMFDVTSRVTYKNVPNWHRDLVRVCENIPIVLCGNKVDIKDRKVK
AKSIVFHRKKNLQYYDISAKSNYNFEKPFLWLARKLIGDPNLEFV
//
>1i2mB [b.69.5] REGULATOR OF CHROMOSOME CONDENSATION 1
KVSHRSHSTEPGLVLTLGQGDVGQLGLGENVMERKKPALVSIPEDVVQAEAGGMHTVCLS
KSGQVYSFGCNDEGALGRDTSVEGSEMVPGKVELQEKVVQVSAGDSHTAALTDDGRVFLW
GSFRDNNGVIGLLEPMKKSMVPVQVQLDVPVVKVASGNDHLVMLTADGDLYTLGCGEQGQ
LGRVPELFANRGGRQGLERLLVPKCVMLKHVRFQDAFCGAYFTFAISHEGHVYGFGLSNY
HQLGTPGTESCFIPQNLTSFKNSTKSWVGFSGGQHHTVCMDSEGKAYSLGRAEYGRLGLG
EGAEEKSIPTLISRLPAVSSVACGASVGYAVTKDGRVFAWGMGTNYQLGTGQDEDAWSPV
EMMGKQLENRVVLSVSSGGQHTVLLVKD
//
>1i3gL [b.1.1] ANTIBODY FV FRAGMENT
DIVLTQSHKFMSTSVGDRVSITCKASQDVGTAVAWYQQKPGQSPKLLIYWASTRHTGVPD
RFTGSGSGTDFTLTISNVQSEDLADYFCQQYSSYPLTFGAGTKLEL
//
>1i3gH [b.1.1] ANTIBODY FV FRAGMENT
QVQLQQPGAELVRPGASVKLSCKASGYTFTSYWINWVKQRPGQGLEWIGNIYPSDSYTNY
NQKFKDKATLTVDKSSSTAYMQLSSLTSEDSAVYFCARWGYWGQGTLVTVS
//
>1i3oC [c.17.1] CASPASE 3
SLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDL
TREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSL
TGKPKLFIIQAARGTELDCGIETD
//
>1i3oA [c.17.1] CASPASE 3
SLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDL
TREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSL
TGKPKLFIIQAARGTELDCGIET
//
>1i3oB [c.17.1] CASPASE 3
SGVDDDMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHI
LTRVNRKVATEFESFSFDATFHAKKQIPCIVSMLTKELYFY
//
>1i3oD (B) [c.17.1] CASPASE 3
SGVDDDMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHI
LTRVNRKVATEFESFSFDATFHAKKQIPCIVSMLTKELYFY
//
>1i3oF [g.52.1] BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 4
THADYLLRTGQVVDISDTIYPRNPAMYSEEARLKSLTPRELASAGLYYTGIGDQVQCFAC
GGKLKNWEPGDRAWSEHRRHFPNCFFVLGRNLN
//
>1i3oE [g.52.1] BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 4
FALDRPSETHADYLLRTGQVVDISDTIYPRNPAMYSEEARLKSFQNWPDYAHLTPRELAS
AGLYYTGIGDQVQCFACGGKLKNWEPGDRAWSEHRRHFPNCFFVLGRNLNI
//
>1i3qB [e.29.1] DNA-DIRECTED RNA POLYMERASE II 140KD POLYPEPTIDE
DESAPITAEDSWAVISAFFREKGLVSQQLDSFNQFVDYTLQDIICEDSTLIEISFGKIYV
TKPMVNESDGVTHALYPQEARLRNLTYSSGLFVDVKKRTYEKVFIGRLPIMLRSKNCYLS
EATESDLYKLKECPFDMGGYFIINGSEKVLIAQERSAGNIVQVFKKAAPSPISHVAEIRS
ALEKGSRFISTLQVKLYGREGSSARTIKATLPYIKQDIPIVIIFRALGIIPDGEILEHIC
YDVNDWQMLEMLKPCVEDGFVIQDRETALDFIGKEKRIQYAKDILQKEFLPHITQLEGFE
SRKAFFLGYMINRLLLCALDRKDQDDRDHFGKKRLDLAGPLLAQLFKTLFKKLTKDIFRY
MQRTVELAINAKTITSGLKYALATGNWGAGVSQVLNRYTYSSTLSHLRRTNTPIAKPRQL
HNTHWGLVCPAETPEGQACGLVKNLSLMSCISVGTDPMPIITFLSEWGMEPLEDYVPHQS
PDATRVFVNGVWHGVHRNPARLMETLRTLRRKGDINPEVSMIRDIREKELKIFTDAGRVY
RPLFIVEDDESLGHKELKVRKGHIAKLMATEYQDEYTWSSLLNEGLVEYIDAEEEESILI
AMQPEDLEPDVDPAKRIRVSHHATTFTHCEIHPSMILGVAASIIPFPDHNQSPRNTYQSA
MGKQAMGVFLTNYNVRMDTMANILYYPQKPLGTTRAMEYLKFRELPAGQNAIVAIACYSG
YNQEDSMIMNQSSIDRGLFRSLFFRSYMDQEKKYGMSITETFEKPQRTNTLRMKHGTYDK
LDDDGLIAPGVRVSGEDVIIGKTTPISSKRDASTPLRSTENGIVDQVLVTTNQDGLKFVK
VRVRTTKIPQIGDKFASRHGQKGTIGITYRREDMPFTAEGIVPDLIINPHAIPSRMTVAH
LIECLLSKVAALSGNEGDASPFTDITVEGISKLLREHGYQSRGFEVMYNGHTGKKLMAQI
FFGPTYYQRLRHMVDDKIHARARGPGLRFGEMERDCMIAHGAASFLKERLMEASDAFRVH
ICGICGLMTVIAKLNHNQFECKGCDNKIDIYQIHIPYAAKLLFQELMAMNITPRLYTDRS
RDF
//
>1i3qJ [a.4.11] DNA-DIRECTED RNA POLYMERASE II 8.3KD POLYPEPTIDE
MIVPVRCFSCGKVVGDKWESYLNLLQEDELDEGTALSRLGLKRYCCRRMILTHVDLIEKF
LRYNP
//
>1i4dA [a.238.1] ARFAPTIN 2
SRTVDLELELQIELLRETKRKYESVLQLGRALTAHLYSLLQTQHALGDAFADLSQKSPEL
QEEFGYNAETQKLLCKNGETLLGAVNFFVSSINTLVTKTMEDTLMTVKQYEAARLEYDAY
RTDLEELSESAQATFQAHRDKYEKLRGDVAIKLKFLEENKIKVMHKQLLLFHNAVSAYFA
GNQKQLEQ
//
>1i4dD [c.37.1] RAS-RELATED C3 BOTULINUM TOXIN SUBSTRATE 1
QAIKCVVVGDGAVGKTCLLISYTTNAFPGEYIPTVFDNYSANVMVDGKPVNLGLWDTAGQ
EDYDRLRPLSYPQTDVFLICFSLVSPASFENVRAKWYPEVRHHCPNTPIILVGTKLDLRD
DKDTIEKLKEKKLTPITYPQGLAMAKEIGAVKYLECSALTQRGLKTVFDEAIRAVLC
//
>1i5kB [g.14.1] PLASMINOGEN
EECMHGSGENYDGKISKTMSGLECQAWDSQSPHAHGYIPSKFPNKNLKKNYCRNPDRDLR
PWCFTTDPNKRWEYCDIPRC
//
>1i5kD (C) [x.x.x] M PROTEIN
EKLTADAELQRLKNERHEEAELERLK
//
>1i6hA [e.29.1] DNA-DIRECTED RNA POLYMERASE II LARGEST SUBUNIT
VGQQYSSAPLRTVKEVQFGLFSPEEVRAISVAKIRFPETMDETQTRAKIGGLNDPRLGSI
DRNLKCQTCQEGMNECPGHFGHIDLAKPVFHVGFIAKIKKVCECVCMHCGKLLLDEHNEL
MRQALAIKDSKKRFAAIWTLCKTKMVCETDVPSLVSRGGCGNTQPTIRKDGLKLVGSWKL
RVLSTEEILNIFKHISVKDFTSLGFNEVFSRPEWMILTCLPVPPPPVRPSEDDLTFKLAD
ILKANISLETLEHNGAPHHAIEEAESLLQFHVATYMDNDIAGQPQAPVKSIRARLKGKEG
RIRGNLMGKRVDFSARTVISGDPNLELDQVGVPKSIAKTLTYPEVVTPYNIDRLTQLVRN
GPNEHPGAKYVIRDSGDRIDLRYSKRAGDIQLQYGWKVERHIMDNDPVLFNRQPSLHKMS
MMAHRVKVIPYSTFRLNLSVTSPYNADFDGDEMNLHVPQSEETRAELSQLCAVPLQIVSP
QSNKPCMGIVQDTLCGIRKLTLRDTFIELDQVLNMLYWVPDWDGVIPTPAIIKPKPLWSG
KQILSVAIPNGIHLQRFDEGTTLLSPKDNGMLIIDGQIIFGVVEKKTVGSSNGGLIHVVT
REKGPQVCAKLFGNIQKVVNFWLLHNGFSTGIGDTIADGPTMREITETIAEAKKKVLDVT
KEAQANLLTAKHGMTLRESFEDNVVRFLNEARDKAGRLAEVNLKDLNNVKQMVMAGSKGS
FINIAQMSACVGQQSVEGKRIAFGFVDRTLPHFSKDDYSPESKGFVENSYLRGLTPQEFF
FHAMGGREGLIDTAVKTAETGYIQRRLVKALEDIMVHYDNTTRNSLGNVIQFIYGEDGMD
AAHIEKQSLDTIGGSDAAFEKRYRVDLLNTDHTLDPSLLESGSEILGDLKLQVLLDEEYK
QLVKDRKFLREVFVDGEANWPLPVNIRRIIQNAQQTFHIDHTKPSDLTIKDIVLGVKDLQ
ENLLVLRGKNEIIQNAQRDAVTLFCCLLRSRLATRRVLQEYRLTKQAFDWVLSNIEAQFL
RSVVHPGEMVGVLAAQSIGEPATQMTLKKVTSGVPRLKEILNVAKNMKTPSLTVYLEPGH
AADQEQAKLIRSAIEHTTLKSVTIASEIYYDPDPRSTVIPEDEEIIQLHFSLQQSPWLLR
LELDRAAMNDKDLTMGQVGERIKQTFKNDLFVIWSEDNDEKLIIRCRVVAEEDHMLKKIE
NTMLENITLRGVENIERVVMMKYDRKVPSPTGEYVKEPEWVLETDGVNLSEVMTVPGIDP
TRIYTNSFIDIMEVLGIEAGRAALYKEVYNVIASDGSYVNYRHMALLVDVMTTQGGLTSV
TRHGFNRSNTGALMRCSFEETVEILFEAGASAELDDCRGVSENVILGQMAPIGTGAFDVM
I
//
>1i6hN (C) [d.74.3 - d.181.1] DNA-DIRECTED RNA POLYMERASE II 45KD POLYPEPTIDE
EEGPQVKIREASKDNVDFILSNVDLAMANSLRRVMIAEIPTLAIDSVEVETNTTVLADEF
IAHRLGLIPLQSMDIEQLEYSRDCFCEDHCDKCSVVLTLQAFGESESTTNVYSKDLVIVS
NLMGRNIGHPIIQDKEGNGVLICKLRKGQELKLTCVAKKGIAKEHAKWGPAAAIEFEYDP
WNKLKHTDYWYEQDSAKEWPQSKNCEYEDPPNEGDPFDYKAQADTFYMNVESVGSIPVDQ
VVVRGIDTLQKKVASILLALTQMDQD
//
>1i6vB [d.74.3 - d.181.1] DNA-DIRECTED RNA POLYMERASE
ESKLKAPVFTATTQGDHYGEFVLEPLERGFGVTLGNPLRRILLSSIPGTAVTSVYIEDVL
HEFSTIPGVKEDVVEIILNLKELVVRFLDPKMASTTLILRAEGPKEVRAVDFTPSADVEI
MNPDLHIATLEEGGKLYMEVRVDRGVGYVPAERHGIKDRINAIPVDAIFSPVRRVAFQVE
DTRLGQRTDLDKLTLRIWTDGSVTPLEALNQAVAILKEHLNYFANPEASS
//
>1i6vC [e.29.1] DNA-DIRECTED RNA POLYMERASE
KIKRFGRIREVIPLPPLTEIQVESYKKALQADVPPEKRENVGIQAAFKETFPIEEGDKGK
GGLVLDFLEYRIGDPPFSQDECREKDLTYQAPLYARLQLIHKDTGLIKEDEVFLGHLPLM
TEDGSFIINGADRVIVSQIHRSPGVYFTPDPARPGRYIASIIPLPKRGPWIDLEVEASGV
VTMKVNKRKFPLVLLLRVLGYDQETLVRELSAYGDLVQGLLDEAVLAMRPEEAMVRLFTL
LRPGDPPKKDKALAYLFGLLADPKRYDLGEAGRYKAEEKLGVGLSGRTLVRFEDGEFKDE
VFLPTLRYLFALTAGVPGHEVDDIDHLGNRRIRTVGELMADQFRVGLARLARGVRERMVM
GSPDTLTPAKLVNSRPLEAALREFFSRSQLSQFKDETNPLSSLRHKRRISALGPGGLTRE
RAGFDVRDVHRTHYGRICPVETPEGANIGLITSLAAYARVDALGFIRTPYRRVKNGVVTE
EVVYMTASEEDRYTIAQANTPLEGDRIATDRVVARRRGEPVIVAPEEVEFMDVSPKQVFS
LNTNLIPFLEHDDANRALMGSNMQTQAVPLIRAQAPVVMTGLEERVVRDSLAALYAEEDG
EVVKVDGTRIAVRYEDGRLVHPLRRYARSNQGTAFDQRPRVRVGQRVKKGDLLADGPASE
EGFLALGQNVLVAIMPFDGYNFEDAIVISEELLKRDFYTSIHIERYEIEARDTKLGPERI
TRDIPHLSEAALRDLDEEGIVRIGAEVKPGDILVGRTSFKGEQEPSPEERLLRSIFGEKA
RDVKDTSLRVPPGEGGIVVGRLRLRRGDPGVELKPGVREVVRVFVAQKRKLQVGDKLANR
HGNKGVVAKILPVEDMPHLPDGTPVDVILNPLGVPSRMNLGQILETHLGLAGYFLGQRYI
SPVFDGATEPEIKELLAEAFNLYFGKRQGEGFGVDKREKEVLARAEKLGLVSPGKSPEEQ
LKELFDLGKVVLYDGRTGEPFEGPIVVGQMFIMKLYHMVEDKMHARSTGPYSLITQQPLG
GKAQFGGQRFGEMEVWALEAYGAAHTLQEMLTIKSDDIEGRNAAYQAIIKGEDVPEPSVP
ESFRVLVKELQALALDVQTLDEKDNPVDVFEGL
//
>1i6vD [e.29.1] DNA-DIRECTED RNA POLYMERASE
KEVRKVRIALASPEKIRSWSYGEVEKPETEAKVCERCAVEVTRSIVRRYRMAHIELATPA
AHIWFVKDVPSKIATLLDLSATELEQVLYFNKYIVLDPKAAVLDAVPVEKRQLLTDuuuu
uuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuIDARMGAEAIQELLKELDLEKLERELLE
EMKHPSRARRAKARKRLEVVRAFLDSGNRPEWMILEAVPVLPPDATSDLNDLYRRLINRN
NRLKKLLAQGAPEIIIRNEKRMLQEAVDAVIDNGRRGSPVTNPGSERPLRSLTDILSGKQ
GRFRQNLLGKRVDYSGRSVIVVGPQLKLHQCGLPKRMALELFKPFLLKKMEEKAFAPNVK
AARRMLERQRDIKDEVWDALEEVIHGKVVLLNRAPTLHRLGIQAFQPVLVEGQSIQLHPL
VCEAFNADFDGDQMAVHVPLSSFAQAEARIQMLSAHNLLSPASGEPLAKPSRDIILGLYY
ITQVRKEKKGAGMAFATPEEALAAYERGEVALNAPIVVAGRETSVGRLKFVFANPDEALL
AVAHGLLDLQDTVTTRYLGRRLETSPGRILFARIVGEAVGDEKVAQELIQMDVPQEKNSL
KDLVYQAFLRLGMEKTARLLDALKYYGFTLSTTSGITIGIDDAVIPEEKQRYLEEADRKL
RQIEQAYEMGFLTDRERYDQVIQLWTETTEKVTQAVFNNFEENYPFNPLYVMAQSGARGN
PQQIRQLCGMRGLMQKPSGETFEVPVRSSFREGLTVLEYFISSHGARKGGADTALRTADS
GYLTRKLVDVAHEIVVREADCGTTNYISVPLFQMDEVTRTLRLRKRSDIESGLYGRVLAR
EVEALGRRLEEGRYLSLEDVHFLIKAAEAGEVREVPVRSPLTCQTRYGVCQKCYGYDLSM
ARPVSIGEAVGVVAAESIGEPGTQLTMRTGTDITQGLPRVIELFEARRPKAKAVISEIDG
VVRIEEGEDRLSVFVESEGFSKEYKLPKDARLLVKDGDYVEAGQPLTRGAIDPHQLLEAK
GPEAVERYLVDEIQKVYRAQGVKLHDKHIEIVVRQMLKYVEVTDPGDSRLLEGQVLEKWD
VEALNERLIAVPVAWKPLLMGVTKSALSTKSWLSAASFQNTTHVLTEAAIAGKKDELIGL
KENVILGRLIPAGTGSDFVRFTQVVDQRTLKAIE
//
>1i6vE [a.143.1] DNA-DIRECTED RNA POLYMERASE
MAEPGIDKLFGMVDSKYRLTVVVAKRAQQLLRHRFKNTVLEPEERPKMRTLEGLYDDPNA
VTWAMKELLTGRLFFGENLVPEDRLQKEMERLYPTEEE
//
>1i7q_1A [d.161.1] ANTHRANILATE SYNTHASE
TKPQLTLLKVQASYRGDPTTLFHQLCGARPATLLLESAEINDKQNLQSLLVIDSALRITA
LGHTVSVQALTANGPALLPLLDEALPPEVRNQARPNGRELTFPAIDAVQDEDARLRSLSV
FDALRTILTLVDSPADEREAVMLGGLFAYDLVAGFENLPALRQDQRCPDFCFYLAETLLV
LDHQRGSARLQASVFSEQASEAQRLQHRLEQLQAELQQPPQPIPHQKLENMQLSCNQSDE
EYGAVVSELQEAIRQGEIFQVVPSRRFSLPCPAPLGPYQTLKDNNPSPYMFFMQDDDFTL
FGASPESALKYDAGNRQIEIYPIAGTRPRGRRADGSLDLDLDSRIELEMRTDHKELAEHL
MLVDLARNDLARICQAGSRYVADLTKVDRYSFVMHLVSRVVGTLRADLDVLHAYQACMNM
GTLSGAPKVRAMQLIAALRSTRRGSYGGRVGYFTAVRNLDTCIVIRSAYVEDGHRTVQAG
AGVVQDSIPEREADETRNKARAVLRAIATAHHAKEVF
//
>1i7q_1B [x.x.x]
ADILLLDNVDSFTYNLVDQLRASGHQVVIYRNQIGAEVIIERLQHMEQPVLMLSPGPGTP
SEAGCMPELLQRLRGQLPIIGICLGHQAIVEAYGGQVGQAGEILHGKASAIAHDGEGMFA
GMANPLPVARYHSLVGSNIPADLTVNARFGEMVMAVRDDRRRVCGFQFHPESILTTHGAR
LLEQTLAWALAKx
//
>1i7wC [a.118.1] BETA-CATENIN
QDDAELATRAIPELTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTM
QNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNL
LLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQ
ALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCL
WTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVG
GIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPS
HWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTVRMEEIVEGCT
GALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAE
GATAPLTELLHSRNEGVATYAAAVLFRMS
//
>1i7wD [j.71.1] EPITHELIAL-CADHERIN
DVAPIDENLKAADSDPTAPPYDSLLVFDYEGxGxEAASLxSLYDYLNEWGNRFKKLADMY
//
>1i7x_1A [a.118.1] BETA-CATENIN
VNLINYQDDAELATRAIPELTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVS
AIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAI
TTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIIL
ASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQR
LVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKM
MVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVK
LLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSFVEG
VRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQ
DKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSED
//
>1i7x_1B [j.71.1] EPITHELIAL-CADHERIN
VTRNDVAPTLMSVPQYRPRPANPDEIGNFIDENLKAADSDPTAPPYDSLLVFDYEGS
//
>1i7x_2C [a.118.1] BETA-CATENIN
HAVVNLINYQDDAELATRAIPELTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQ
MVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLF
YAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKL
IILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDP
SQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYK
NKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPV
VVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRFVEG
VRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQ
DKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSE
//
>1i7x_2D [j.71.1] EPITHELIAL-CADHERIN
RNDVAPGNFIDENLKAADSDPTAPPYDSLLVFDYEGSESDQDQDYDYLNEWGNRFKKLAD
MYG
//
>1i7zA [b.1.1 - b.1.1] CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION
DLVLTQSPASLAVSLGQRATISCRASKSVSTSGYNYMHWYQQKPGQPPKLLIYLASNLAS
GVPARFSGSGSGTDFTLNIHPVEEEDAATYYCLYSREFPPWTFGGGTKLEIKRTVAAPSV
FIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSL
SSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
//
>1i7zB [b.1.1 - b.1.1] CHIMERA OF IG GAMMA-1 CHAIN: HUMAN CONSTANT
QVQLQQSGPELKKPGETVKISCKTSGYSFTNYGMNWVKQAPGKGLKWMGWINTYTGEPTY
ADDFRGRFAFSLATSASTAYLQIINLKNEDTATYFCETYDSPLGDYWGQGTTVTVSSAST
KGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLY
SLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC
//
>1i85A [b.1.1] T LYMPHOCYTE ACTIVATION ANTIGEN CD86
MLKIQAYFNETADLPCQFANSQNQSLSELVVFWQDQENLVLNEVYLGKEKFDSVHSKYMG
RTSFDSDSWTLRLHNLQIKDKGLYQCIIHHKKPTGMIRIHQMNSELSVLA
//
>1i85B [b.1.1] T LYMPHOCYTE ACTIVATION ANTIGEN CD86
LKIQAYFNETADLPCQFANSQNQSLSELVVFWQDQENLVLNEVYLGKEKFDSVHSKYMGR
TSFDSDSWTLRLHNLQIKDKGLYQCIIHHKKPTGMIRIHQMNSELSVLA
//
>1i85C [b.1.1] CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4
MHVAQPAVVLASSRGIASFVCEYASPGKATEVRVTVLRQADSQVTEVCAATYMMGNELTF
LDDSICTGTSSGNQVNLTIQGLRAMDTGLYICKVELMYPPPYYLGIGNGTQIYVIDPE
//
>1i85D [b.1.1] CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4
MHVAQPAVVLASSRGIASFVCEYAATEVRVTVLRQQVTEVCAATYMMGNELTFLDDSICT
GTSSGNQVNLTIQGLRAMDTGLYICKVELMYPPPYYLGIGNGTQIYVIDPE
//
>1i8iB [b.1.1] EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY
QVKLQQSGGGLVKPGASLKLSCVTSGFTFRKFGMSWVRQTSDKCLEWVASISTGGYNTYY
SDNVKGRFTISRENAKNTLYLQMSSLKSEDTALYYCTRGYSSTSYAMDYWGQGTTVTVS
//
>1i8iA [b.1.1] EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY
DIELTQSPASLSVATGEKVTIRCMTSTDIDDDMNWYQQKPGEPPKFLISEGNTLRPGVPS
RFSSSGTGTDFVFTIENTLSEDVGDYYCLQSFNVPLTFGCGTKLEI
//
>1i8l_1A [b.1.1 - b.1.1] T LYMPHOCYTE ACTIVATION ANTIGEN CD80
VIHVTKEVKEVATLSCGHNVSVEELAQTRIYWQKEKKMVLTMMSGDMNIWPEYKNRTIFD
ITNNLSIVILALRPSDEGTYECVVLKYEKDAFKREHLAEVTLSVKADFPTPSISDFEIPT
SNIRRIICSTSGGFPEPHLSWLENGEELNAINTTVSQDPETELYAVSSKLDFNMTTNHSF
MCLIKYGHLRVNQTFNWNT
//
>1i8l_1C [b.1.1] CYTOTOXIC T-LYMPHOCYTE PROTEIN 4
MHVAQPAVVLASSRGIASFVCEYASPGKATEVRVTVLRQADSQVTEVCAATYMMGNELTF
LDDSICTGTSSGNQVNLTIQGLRAMDTGLYICKVELMYPPPYYLGIGNGAQIYVIDPE
//
>1i8m_1A (L) [b.1.1 - b.1.1] ANTIBODY LIGHT CHAIN FAB
ELQMTQSPASLSASVGETVTITCRASENIYSYLAWYQQKQGKSPQLLVYNAKTLAEGVPS
RFSGSGSGTQFSLKINSLQPEDFGSYYCQHHYGTPLTFGAGTKLELKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNE
//
>1i8m_1B (H) [b.1.1 - b.1.1] ANTIBODY HEAVY CHAIN FAB
QVKLLESGPELVKPGASVKMSCKASGYTFTSYVMHWVKQKPGQGLEWIGYINPYNDGTKY
NEKFKGKATLTSDKSSSTAYMELSSLTSEDSAVYYCVRGGYRPYYAMDYWGQGTSVTVSS
AKTTPPSVYPLAPSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTLSSS
VTVPSSTWPSETVTCNVAHPASSTKVDKKIVPR
//
>1i9iL [b.1.1 - b.1.1] RECOMBINANT MONOCLONAL ANTI-TESTOSTERONE FAB
DVVVTQTPLSLPVSLGDQASISCRSSQSIVHSNGNSYLEWYLQKPGQSPKLLIYKVSNRF
SGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCFQGSHVPPTFGGGTKLEIKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1i9iH [b.1.1 - b.1.1] RECOMBINANT MONOCLONAL ANTI-TESTOSTERONE FAB
EVKLVESGGGLVKPGGSLKLSCAASGFTFSTYALSWVRQTADKRLEWVASIVSGGNTYYS
GSVKGRFTISRDIARNILYLQMSSLRSEDTAMYYCAREYYGYVGLAYWGQGTLVTVSAAK
TTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLY
TLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKIVPRDC
//
>1i9rA [b.22.1] CD40 LIGAND
NPQIAAHVISEASSKTTSVLQWAEKGYYTMSNNLVTLENGKQLTVKRQGLYYIYAQVTFC
SNREASSQAPFIASLCLKSPGRFERILLRAANTHSSAKPCGQQSIHLGGVFELQPGASVF
VNVTDPSQVSHGTGFTSFGLLKL
//
>1i9rB (A) [b.22.1] CD40 LIGAND
NPQIAAHVISEASSKTTSVLQWAEKGYYTMSNNLVTLENGKQLTVKRQGLYYIYAQVTFC
SNREASSQAPFIASLCLKSPGRFERILLRAANTHSSAKPCGQQSIHLGGVFELQPGASVF
VNVTDPSQVSHGTGFTSFGLLKL
//
>1i9rL [b.1.1 - b.1.1] IMMUNOGLOBULIN L
DIVLTQSPATLSVSPGERATISCRASQRVSSSTYSYMHWYQQKPGQPPKLLIKYASNLES
GVPARFSGSGSGTDFTLTISSVEPEDFATYYCQHSWEIPPTFGGGTKLEIKRTVAAPSVF
IFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLS
STLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNR
//
>1i9rM (L) [b.1.1 - b.1.1] IMMUNOGLOBULIN L
DIVLTQSPATLSVSPGERATISCRASQRVSSSTYSYMHWYQQKPGQPPKLLIKYASNLES
GVPARFSGSGSGTDFTLTISSVEPEDFATYYCQHSWEIPPTFGGGTKLEIKRTVAAPSVF
IFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLS
STLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNR
//
>1i9rK (H) [b.1.1 - b.1.1] IMMUNOGLOBULIN H
QVQLVQSGAEVVKPGASVKLSCKASGYIFTSYYMYWVKQAPGQGLEWIGEINPSNGDTNF
NEKFKSKATLTVDKSASTAYMELSSLRSEDTAVYYCTRSDGRNDMDSWGQGTLVTVSSAS
TKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGL
YSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK
//
>1iaiA (M) [b.1.1 - b.1.1] ANTI-IDIOTYPIC FAB 409.5.3 (IGG2A)
DIQLTQSPAFMAASPGEKVTITCSVSSSISSSNLHWYQQKSETSPKPWIYGTSNLASGVP
VRFSGSGSGTSYSLTISSMEAEDAATYYCQQWNSYPYTFGGGTKLEIKRADAAPTVSIFP
PSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTL
TLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1iaiB (I) [b.1.1 - b.1.1] ANTI-IDIOTYPIC FAB 409.5.3 (IGG2A)
EVKLQESGGGLVQPGGSMKLSCVASGFTFNNYWMSWVRQSPEKGLEWVAEIRLNSDNFAT
HYAESVKGKFIISRDDSKSRLYLQMNSLRAEDTGIYYCVLRPLFYYAVDYWGQGTSVTVS
SAKTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQS
DLYTLSSSVTVPSTWRPSETVTCNVAHPASSTKVDKKI
//
>1iaiC (H) [b.1.1 - b.1.1] IDIOTYPIC FAB 730.1.4 (IGG1) OF VIRUS
QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLKWMAWINTYTGEPTY
ADDFKGRFAFSLETSASTAYLQINNLKNEDTATYFCARDGYYENYYAMDYWGQGTSVTVS
SAKTTAPSVYPLAPVCGDTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQS
DLYTLSSSVTVTSSTTPSQSITCNVAHPASSTKVDKKID
//
>1iaiD (L) [b.1.1 - b.1.1] IDIOTYPIC FAB 730.1.4 (IGG1) OF VIRUS
DIVMTQSHKFMSTSVGDRVSITCKASQDVSTAVAWYQQKPGQSPKLLIYSASYQYTGVPD
RFTGSGSRTDFTFTINSVQAEDLAVYYCHQHYSTPFTFGSGTKLEIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1iarA [a.26.1] PROTEIN (INTERLEUKIN-4)
HKCDITLQEIIKTLNSLTEQKTLCTELTVTDIFAASKNTTEKETFCRAATVLRQFYSHHE
KDTRCLGATAQQFHRHKQLIRFLKRLDRNLWGLAGLNSCPVKEANQSTLENFLERLKTIM
REKYSKCSS
//
>1iarB [b.1.2 - b.1.2] PROTEIN (INTERLEUKIN-4 RECEPTOR ALPHA CHAIN)
FKVLQEPTCVSDYMSISTCEWKMNGPTNCSTELRLLYQLVFLLSEAHTCIPENNGGAGCV
CHLLMDDVVSADNYTLDLWAGQQLLWKGSFKPSEHVKPRAPGNLTVHDTLLLTWSNPYPP
DNYLYNHLTYAVNIWSENDPADFRIYNVTYLEPSLRIAAGISYRARVRAWAQAYNTTWSE
WSPSTKWH
//
>1ib1_2C (A) [a.118.7] 14-3-3 ZETA ISOFORM
DKNELVQKAKLAEQAERYDDMAACMKSVTEQGAELSNEERNLLSVAYKNVVGARRSSWRV
VSSIEQKTEGAEKKQQMAREYREKIETELRDICNDVLSLLEKFLIPNASQAESKVFYLKM
KGDYYRYLAEVAAGDDKKGIVDQSQQAYQEAFEISKKEMQPTHPIRLGLALNFSVFYYEI
LNSPEKACSLAKTAFDEAIAELDTLSEESYKDSTLIMQLLRDNLTLW
//
>1ib1_2G (E) [d.108.1] SEROTONIN N-ACETYLTRANSFERASE
SGIPGSPGRQRRHxLPANEFRCLTPEDAAGVFEIEREAFISVSGNCPLNLDEVQHFLTLC
PELSLGWFVEGRLVAFIIGSLWDEERLTQESLALHRPRGHSAHLHALAVHRSFRQQGKGS
VLLWRYLHHVGAQPAVRRAVLMCEDALVPFYQRFGFHPAGPCAIVVGSLTFTEMHCSLR
//
>1ibgL [b.1.1 - b.1.1] IGG2B-KAPPA 40-50 FAB (LIGHT CHAIN)
IVLTQSPASLAVSLGQRATISCRASKSVSTSGYSHIHWYQQKPGQPPKLLIYLASILESG
VPARFSGSGSGTDFTLNIHPVEEEDAATYYCQHSREYPLTFGAGTELELKRADAAPTVSI
FPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSS
TLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1ibgH [b.1.1 - b.1.1] IGG2B-KAPPA 40-50 FAB (HEAVY CHAIN)
VHLVQSGPGLVAPSQSLSITCTVSGFSLTTYGVHWFRQPPGKGLEWLGLIWAGGNTDYNS
ALMSRLSINKDNSKSQVFLKMNSLQADDTAMYYCARFRFASYYDYAVDYWGQGTSVTVSS
AKTTPPSVYPLAPGCGDTTGSSVTSGCLVKGYFPEPVTVTWNSGSLSSSVHTFPALLQSG
LYTMSSSVTVPSSTWPSQTVTCSVAHPASSTTVDKKL
//
>1ibr_1B [a.118.1] IMPORTIN BETA-1 SUBUNIT
ELITILEKTVSPDRLELEAAQKFLERAAVENLPTFLVELSRVLANPGNSQVARVAAGLQI
KNSLTSKDPDIKAQYQQRWLAIDANARREVKNYVLQTLGTETYRPSSASQCVAGIACAEI
PVNQWPELIPQLVANVTNPNSTEHMKESTLEAIGYICQDIDPEQLQDKSNEILTAIIQGM
RKEEPSNNVKLAATNALLNSLEFTKANFDKESERHFIMQVVCEATQCPDTRVRVAALQNL
VKIMSLYYQYMETYMGPALFAITIEAMKSDIDEVALQGIEFWSNVCDEEMDLAIEASEAA
EQGRPPEHTSKFYAKGALQYLVPILTQTLTKQDENDDDDDWNPCKAAGVCLMLLATCCED
DIVPHVLPFIKEHIKNPDWRYRDAAVMAFGCILEGPEPSQLKPLVIQAMPTLIELMKDPS
VVVRDTAAWTVGRICELLPEAAINDVYLAPLLQCLIEG
//
>1ibr_1A [c.37.1] GTP-BINDING NUCLEAR PROTEIN RAN
VQFKLVLVGDGGTGKTTFVKRHLTGEFEKKYVATLGVEVHPLVFHTNRGPIKFNVWDTAG
QEKFGGLRDGYYIQAQCAIIMFDVTSRVTYKNVPNWHRDLVRVCENIPIVLCGNKVDIKD
RKVKAKSIVFHRKKNLQYYDISAKSNYNFEKPFLWLARKLIGDPNLEF
//
>1ibtC [d.155.1] HISTIDINE DECARBOXYLASE BETA CHAIN
SELDAKLNKLGVDRIAISPYKQWTRGYMEPGNIGNGYVTGLKVDAGVRDVLDGIVSYDRA
ETKNAYIGQINMTTAS
//
>1ibtD (B) [d.155.1] HISTIDINE DECARBOXYLASE ALPHA CHAIN
FTGVQGRVIGYDILRSPEVDKAKPLFTETQWDGSELPIYDAKPLQDALVEYFGTEQDRRH
YPAPGSFIVCANKGVTAERPKNDADMKPGQGYGVWSAIAISFAKDPTKDSSMFVEDAGVW
ETPNEDELLEYLEGRRKAMAKSIAECGQDAHASFESSWIGFAYTMMEPGQIGNAITVAPY
VSLPIDSIPGGSILTPDKDMEIMENLTMPEWLEKMGYKSLSANNALKY
//
>1icf_1A [d.3.1] PROTEIN (CATHEPSIN L: HEAVY CHAIN)
APRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQ
GNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEK
ALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFEST
//
>1icf_1I [g.28.1] PROTEIN (INVARIANT CHAIN)
LTKCQEEVSHIPAVHPGSFRPKCDENGNYLPLQCYGSIGYCWCVFPNGTEVPNTRSRGHH
NCSES
//
>1id3B [a.22.1] HISTONE H4
DNIQGITKPAIRRLARRGGVKRISGLIYEEVRAVLKSFLESVIRDSVTYTEHAKRKTVTS
LDVVYALKRQGRTLYGFGG
//
>1id3C [a.22.1] HISTONE H2A.1
QSRSAKAGLTFPVGRVHRLLRRGNYAQRIGSGAPVYLTAVLEYLAAEILELAGNAARDNK
KTRIIPRHLQLAIRNDDELNKLLGNVTIAQGGVLPNIHQNLLPKKSAKAT
//
>1id3D [a.22.1] HISTONE H2B.2
RKETYSSYIYKVLKQTHPDTGISQKSMSILNSFVNDIFERIATEASKLAAYNKKSTISAR
EIQTAVRLILPGELAKHAVSEGTRAVTKYSSST
//
>1id3E (A) [a.22.1] HISTONE H3
PHRYKPGTVALREIRRFQKSTELLIRKLPFQRLVREIAQDFKTDLRFQSSAIGALQESVE
AYLVSLFEDTNLAAIHAKRVTIQKKEIKLARRLRGER
//
>1id3F [a.22.1] HISTONE H4
HRKILRDNIQGITKPAIRRLARRGGVKRISGLIYEEVRAVLKSFLESVIRDSVTYTEHAK
RKTVTSLDVVYALKRQGRTLYGFGG
//
>1id3G [a.22.1] HISTONE H2A.1
KASQSRSAKAGLTFPVGRVHRLLRRGNYAQRIGSGAPVYLTAVLEYLAAEILELAGNAAR
DNKKTRIIPRHLQLAIRNDDELNKLLGNVTIAQGGVLPNIHQNLLPKK
//
>1ie7A [d.8.1] UREASE GAMMA SUBUNIT
xHLNPAEKEKLQIFLASELLLRRKARGLKLNYPEAVAIITSFIMEGARDGKTVAMLMEEG
KHVLTRDDVMEGVPEMIDDIQAEATFPDGTKLVTVHNPIS
//
>1ie7G (C) [b.92.1 - c.1.9] UREASE ALPHA SUBUNIT
MKINRQQYAESYGPTVGDEVRLADTDLWIEVEKDYTTYGDEVNFGGGKVLREGMGENGTY
TRTENVLDLLLTNALILDYTGIYKADIGVKDGYIVGIGKGGNPDIMDGVTPNMIVGTATE
VIAAEGKIVTAGGIDTHVHFINPDQVDVALANGITTLFGGGTGPAEGSKATTVTPGPWNI
EKMLKSTEGLPINVGILGKGHGSSIAPIMEQIDAGAAGLxIHEDWGATPASIDRSLTVAD
EADVQVAIHSDTLNEAGFLEDTLRAINGRVIHSFHVEGAGGGHAPDIMAMAGHPNVLPSS
TNPTRPFTVNTIDEHLDMLMVCHHLKNNIPEDVAFADSRIRPETIAAEDILHDLGIISMM
STDALAMGRAGEMVLRTWQTADKMKKQRGPLAEEKNGSDNFRLKRYVSKYTINPAIAQGI
AHEVGSIEEGKFADLVLWEPKFFGVKADRVIKGGIIAYAQIGDPSASIPTPQPVMGRRMY
GTVGDLIHDTNITFMSKSSIQQGVPAKLGLKRRIGTVKNCRNIGKKDMKWNDVTTDIDIN
PETYEVKVDGEVLTCEPVKELPMAQRYFLF
//
>1igcH [b.1.1 - b.1.1] IGG1-KAPPA MOPC21 FAB (HEAVY CHAIN)
DVQLVESGGGLVQPGGSRKLSCAASGFTFSSFGMHWVRQAPEKGLEWVAYISSGSSTLHY
ADTVKGRFTISRDNPKNTLFLQMTSLRSEDTGMYYCARWGNYPYYAMDYWGQGTSVTVSS
AKTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSD
LYTLSSSVTVPSSPRPSETVTCNVAHPASSTKVDKKIVPRDC
//
>1igcA [d.15.7] STREPTOCOCCAL PROTEIN G (DOMAIN III)
AVTTYKLVINGKTLKGETTTKAVDAETAEKAFKQYANDNGVDGVWTYDDATKTFTVTE
//
>1igcL [b.1.1 - b.1.1] IGG1-KAPPA MOPC21 FAB (LIGHT CHAIN)
NIVMTQSPKSMSMSVGERVTLTCKASENVVTYVSWYQQKPEQSPKLLIYGASNRYTGVPD
RFTGSGSATDFTLTISSVQAEDLADYHCGQGNSYPYTFGGGTKLEIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDSERQNGVLNSWTDQDSKDSTYSMSSTLTL
TKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1igfJ (H) [b.1.1 - b.1.1] IGG1-KAPPA B13I2 FAB (HEAVY CHAIN)
EVQLVESGGDLVKPGGSLKLSCAASGFTFSRCAMSWVRQTPEKRLEWVAGISSGGSYTFY
PDTVKGRFIISRNNARNTLSLQMSSLRSEDTAIYYCTRYSSDPFYFDYWGQGTTLTVSSA
KTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDL
YTLSSSVTVPSSPRPSETVTCNVAHPASSTKVDKKIVP
//
>1igfM (L) [b.1.1 - b.1.1] IGG1-KAPPA B13I2 FAB (LIGHT CHAIN)
DVLMTQTPLSLPVSLGDQASISCRSNQTILLSDGDTYLEWYLQKPGQSPKLLIYKVSNRF
SGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCFQGSHVPPTFGGGTKLEIKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1igiL [b.1.1 - b.1.1] IGG2A-KAPPA 26-10 FAB (LIGHT CHAIN)
DVVMTQTPLSLPVSLGDQASISCRSSQSLVHSNGNTYLNWYLQKAGQSPKLLIYKVSNRF
SGVPDRFSGSGSGTDFTLKISRVEAEDLGIYFCSQTTHVPPTFGGGTKLEIKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNE
//
>1igiH [b.1.1 - b.1.1] IGG2A-KAPPA 26-10 FAB (HEAVY CHAIN)
VQLQQSGPELVKPGASVRMSCKSSGYIFTDFYMNWVRQSHGKSLDYIGYISPYSGVTGYN
QKFKGKATLTVDKSSSTAYMELRSLTSEDSAVYYCAGSSGNKWAMDYWGHGASVTVSSAK
TTAPSVYPLAPVCGDTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDLY
TLSSSVTVTSSTWPSQSITCNVAHPASSTKVDKKIEP
//
>1igmL [b.1.1] IGM-KAPPA POT FV (LIGHT CHAIN)
DIQMTQSPSSLSASVGDRVTITCQASQDISNYLAWYQQKPGKAPELRIYDASNLETGVPS
RFSGSGSGTDFTFTISSLQPEDIATYYCQQYQNLPLTFGPGTKVDIKRTVAAPSV
//
>1igmH [b.1.1] IGM-KAPPA POT FV (HEAVY CHAIN)
EVHLLESGGNLVQPGGSLRLSCAASGFTFNIFVMSWVRQAPGKGLEWVSGVFGSGGNTDY
ADAVKGRFTITRDNSKNTLYLQMNSLRAEDTAIYYCAKHRVSYVLTGFDSWGQGTLVTVS
SGSASAPTL
//
>1igtA [b.1.1 - b.1.1] IGG2A INTACT ANTIBODY - MAB231
DIVLTQSPSSLSASLGDTITITCHASQNINVWLSWYQQKPGNIPKLLIYKASNLHTGVPS
RFSGSGSGTGFTLTISSLQPEDIATYYCQQGQSYPLTFGGGTKLEIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1igtB [b.1.1 - b.1.1 - b.1.1 - b.1.1] IGG2A INTACT ANTIBODY - MAB231
EVKLQESGGGLVQPGGSLKLSCATSGFTFSDYYMYWVRQTPEKRLEWVAYISNGGGSTYY
PDTVKGRFTISRDNAKNTLYLQMSRLKSEDTAMYYCARHGGYYAMDYWGQGTTVTVSSAK
TTAPSVYPLAPVCGDTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDLY
TLSSSVTVTSSTWPSQSITCNVAHPASSTKVDKKIEPRGPTIKPCPPCKCPAPNLLGGPS
VFIFPPKIKDVLMISLSPIVTCVVVDVSEDDPDVQISWFVNNVEVHTAQTQTHREDYNST
LRVVSALPIQHQDWMSGKEFKCKVNNKDLPAPIERTISKPKGSVRAPQVYVLPPPEEEMT
KKQVTLTCMVTDFMPEDIYVEWTNNGKTELNYKNTEPVLDSDGSYFMYSKLRVEKKNWVE
RNSYSCSVVHEGLHNHHTTKSFSR
//
>1igyD [x.x.x]
ELARPGASVKMSCKASGYTFTTYTIHWIKQRPGQGLEWIGYINPSSVYTNYNQRFKDKAT
LTRDRSSNTANIHLSSLTSDDSAVYYCVREGEVPYWGQGTTVTVSSAKTTPPSVYPLAPG
SAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTLSSSVTVPSSP
RPSETVTCNVAHPASSTKVDKKIVPRDCGCKPCICTVPEVSSVFIFPPKPKDTLLITVTP
KVTCVVVDISKDDPEVQFSWFVDNVEVHTAQTQPREEQFNSTFRVVSALPIMHQDWLNGK
EFKCRVNSAAFPAPIEKTISKTKGKPRAPQVYTIPPPKEQMAKDKVSLTCMITDFFPEDI
TVEWQSDGQAPENYKNTQPIMDTDGSYFVYSKLNVQKSNWEAGNTFTCSVLHEGLHNHHT
EKSLSH
//
>1igyC (A) [b.1.1 - b.1.1] IGG1 INTACT ANTIBODY MAB61.1.3
KCAHTVSKSMSMSVGERVTLTCKASENVVTYVSWYQQKPEQSPKLLIYGASNRYTGVPDR
FTGSGSATDFTLTISSVQAEDLADYHCGQGYSYPYTFGGGTKLEIKRADAAPTVSIFPPS
SEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLTL
TKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1ii8A [c.37.1] RAD50 ABC-ATPASE
MKLERVTVKNFRSHSDTVVEFKEGINLIIGQNGSGKSSLLDAILVGLYWPLRIKDIKKDE
FTKVGARDTYIDLIFEKDGTKYRITRRFLKGYSSGEIHAMKRLVGNEWKHVTEPSSKAIS
AFMEKLIPYNIFLNAIYIRQGQIDAILESDEAREKVVREVLNLDKFETAYKKLSELKKTI
NNRIKEYRDILARTE
//
>1ii8B [c.37.1] RAD50 ABC-ATPASE
RERVKKEIKDLEKAKDFTEELIEKVKKYKALAREAALSKIGELASEIFAEFTEGKYSEVV
VRAEENKVRLFVVWEGKERPLTFLSGGERIALGLAFRLAMSLYLAGEISLLILDEPTPYL
DEERRRKLITIMERYLKKIPQVILVSHDEELKDAADHVIRISLENGSSKVEVVS
//
>1iil_2B [b.42.1] HEPARIN-BINDING GROWTH FACTOR 2
PPGHFKDPKRLYCKNGGFFLRIHPDGRVDGVREKSDPHIKLQLQAEERGVVSIKGVSANR
YLAMKEDGRLLASKSVTDECFFFERLESNNYNTYRSRKYTSWYVALKRTGQYKLGSKTGP
GQKAILFLPMSAK
//
>1iil_2F (E) [b.1.1 - b.1.1] FIBROBLAST GROWTH FACTOR RECEPTOR 2
NKRAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKV
RNQHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHLDVVERSRHRPILQAGLPANASTV
VGGDVEFVCKVYSDAQPHIQWIKHVPYLKVLKAAGVNTTDKEIEVLYIRNVTFEDAGEYT
CLAGNSIGISFHSAWLTVLP
//
>1iil_4D [b.42.1] HEPARIN-BINDING GROWTH FACTOR 2
PGHFKDPKRLYCKNGGFFLRIHPDGRVDGVREKSDPHIKLQLQAEERGVVSIKGVSANRY
LAMKEDGRLLASKSVTDECFFFERLESNNYNTYRSRKYTSWYVALKRTGQYKLGSKTGPG
QKAILFLPMSAK
//
>1iil_4H (G) [b.1.1 - b.1.1] FIBROBLAST GROWTH FACTOR RECEPTOR 2
NKRAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKV
RNQHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHLDVVERSRHRPILQAGLPANASTV
VGGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKAAGVNTTDKEIEVLYI
RNVTFEDAGEYTCLAGNSIGISFHSAWLTVLPAPG
//
>1ijdA [f.3.1] LIGHT-HARVESTING PROTEIN B-800/820, ALPHA CHAIN
xNQGKIWTVVPPAFGLPLMLGAVAITALLVHAAVLTHTTWYAAFLQ
//
>1ijdB [f.3.1] LIGHT-HARVESTING PROTEIN B-800/820, BETA CHAIN
AEVLTSEQAEELHKHVIDGTRVFLVIAAIAHFLAFTLTPW
//
>1ijkA [c.62.1] VON WILLEBRAND FACTOR
PPLHDFYCSRLLDLVFLLDGSSRLSEAEFEVLKAFVVDMMERLRVSQKWVRVAVVEYHDG
SHAYIGLKDRKRPSELRRIASQVKYAGSQVASTSEVLKYTLFQIFSKIDRPEASRIALLL
MASQEPQRMSRNFVRYVQGLKKKKVIVIPVGIGPHANLKQIRLIEKQAPENKAFVLSSVD
ELEQQRDEIVSYLCDLAPE
//
>1ijkB [d.169.1] BOTROCETIN
DCPSGWSSYEGNCYKFFQQKMNWADAERFCSEQAKGGHLVSIKIYSKEKDFVGDLVTKNI
QSSDLYAWIGLRVENKEKQCSSEWSDGSSVSYENVVERTVKKCFALEKDLGFVLWINLYC
AQKNPFVCKSPPP
//
>1ijkC [d.169.1] BOTROCETIN
DCPPDWSSYEGHCYRFFKEWMHWDDAEEFCTEQQTGAHLVSFQSKEEADFVRSLGDVVWI
GLSDVWNKCRFEWTDGMEFDYDDYYLIAEYECVASKPTNNKWWIIPCTRFKNFVCEFQA
//
>1ik9A [b.59.1 - h.1.11] DNA REPAIR PROTEIN XRCC4
MERKISRIHLVSEPSITHFLQVSWEKTLESGFVITLTDGHSAWTGTVSESEISQEADDMA
MEKGKYVGELRKALLSADVYTFNFSKESAYFFFEKNLKDVSFRLGSFNLEKVENPAEVIR
ELIAYALDTIAENQAKNEHLQKENERLLRDWNDVQGRFEKAVSAKEALETDLYKRFILVL
NEKKTKIRSLHNKLLNAAQEREKDIKQ
//
>1ik9C [x.x.x] DNA LIGASE IV
AREYDCYGDSYFIDTDLNQLKEVFSGIK
//
>1ikfL [b.1.1 - b.1.1] IGG1-KAPPA R45-45-11 FAB (LIGHT CHAIN)
DIQMTQTTSSLSASLGDRVTISCRASQDISTYLNWYQQKPDGTVKLLIFYTSRLRSGVPS
RFSGSGSGTDYSLTISNLEQEDIATYFCQQGSRIPPTFGGGTKLEILRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRAA
//
>1ikfH [b.1.1 - b.1.1] IGG1-KAPPA R45-45-11 FAB (HEAVY CHAIN)
EVKLVESGGGLVQPGGSLKLSCATSGFTFSDYYMYWVRQNSEKRLEWVAFISNGGGSAFY
ADIVKGRFTISRDNAKNTLYLQMSRLKSEDTAMYYCTRHTLYDTLYGNYPVWFADWGQGT
LVTVSAAKTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFP
AVLQSDLYTLSSSVTVPSSSRPSETVTCNVAHPASSTKVDKKIVPRD
//
>1iknC [b.1.18] PROTEIN (NF-KAPPA-B P50D SUBUNIT)
ASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVH
RQFAIVFKTPKYKDVNITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEE
//
>1iknD [d.211.1] PROTEIN (I-KAPPA-B-ALPHA)
DGDSFLHLAIIHEEKALTMEVIRLAFLNFQNNLQQTPLHLAVITNQPEIAEALLGAGCDP
ELRDFRGNTPLHLACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLASIHGYLG
IVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLT
WGRPSTRIQQQLGQLTLENLQMLPESEDEESYDTE
//
>1il1B [b.1.1 - b.1.1] MONOCLONAL ANTIBODY G3-519 (LIGHT CHAIN)
DIVMSQSPSSLAVSVGEKVTMSCKSSQSLLYSRNQMNYLSWYQQKPGQSPKLLIYWASTR
ESGVPDRFTGSGSGTDFTLTISSVKAEDLAVYYCQQYYHYRTFGGGTRLEIRRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1il1A [b.1.1 - b.1.1] MONOCLONAL ANTIBODY G3-519 (HEAVY CHAIN)
QLQQSGAELVRSGASVKLSCATSDFNIKDYYIHWVRQRPEQGLEWIGWLDPENGDTESAP
KFQGKATMTADTSSNTAYLQLSSLTSEASAVYYCNAISTTRDYYALDYWGQGTSVTVSSA
KTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDL
YTLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKIVPR
//
>1im3_1A [d.19.1 - b.1.1] HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2
GSHSMRYFFTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGPEYW
DGETRKVKAHSQTHRVDLGTLRGYYNQSEAGSHTVQRMYGCDVGSDWRFLRGYHQYAYDG
KDYIALKEDLRSWTAADMAAQTTKHKWEAAHVAEQLRAYLEGTCVEWLRRYLENGKETLQ
RTDAPKTHMTHHAVSDHEATLRCWALSFYPAEITLTWQRDGEDQTQDTELVETRPAGDGT
FQKWAAVVVPSGQEQRYTCHVQHEGLPKPLTLRWE
//
>1im3_1D [b.1.18] CYTOMEGALOVIRUS PROTEIN US2
PWFQIEDNRCYIDNGKLFARGSIVGNMSRFVFDPKADYGGVGENLYVHADDVEFVPGESL
KWNVRNLDVMPIFETLALRLVLQGDVIWLRCVPEL
//
>1im9A [d.19.1 - b.1.1] HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, CW-4
GSHSMRYFSTSVSWPGRGEPRFIAVGYVDDTQFVRFDSDAASPRGEPREPWVEQEGPEYW
DRETQKYKRQAQADRVNLRKLRGYYNQSEDGSHTLQRMFGCDLGPDGRLLRGYNQFAYDG
KDYIALNEDLRSWTAADTAAQITQRKWEAAREAEQRRAYLEGTCVEWLRRYLENGKETLQ
RAEHPKTHVTHHPVSDHEATLRCWALGFYPAEITLTWQWDGEDQTQDTELVETRPAGDGT
FQKWAAVVVPSGEEQRYTCHVQHEGLPEPLTLRWK
//
>1im9D [b.1.1 - b.1.1] KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR 2DL1
RKPSLLAHPGPLVKSEETVILQCWSDVMFEHFLLHREGMFNDTLRLIGEHHDGVSKANFS
ISRMTQDLAGTYRCYGSVTHSPYQVSAPSDPLDIVIIGLYEKPSLSAQPGPTVLAGENVT
LSCSSRSSYDMYHLSREGEAHERRLPAGPKVNGTFQADFPLGPATHGGTYRCFGSFHDSP
YEWSKSSDPLLVSVT
//
>1im9E (A) [d.19.1 - b.1.1] HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, CW-4
GSHSMRYFSTSVSWPGRGEPRFIAVGYVDDTQFVRFDSDAASPRGEPREPWVEQEGPEYW
DRETQKYKRQAQADRVNLRKLRGYYNQSEDGSHTLQRMFGCDLGPDGRLLRGYNQFAYDG
KDYIALNEDLRSWTAADTAAQITQRKWEAAREAEQRRAYLEGTCVEWLRRYLENGKETLQ
RAEHPKTHVTHHPVSDHEATLRCWALGFYPAEITLTWQWDGEDQTQDTELVETRPAGDGT
FQKWAAVVVPSGEEQRYTCHVQHEGLPEPLTLRWK
//
>1im9F (B) [b.1.1] BETA-2 MICROGLOBULIN
MIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKD
WSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM
//
>1indL [b.1.1 - b.1.1] IGG1-LAMBDA CHA255 FAB (LIGHT CHAIN)
AVVTQESALTTSPGETVTLTCRSSTGAVTTSNYANWVQEKPDHLFTGLIGGTNNRAPGVP
ARFSGSLIGDKAALTITGAQTEDEARYFCALWYSNLWVFGGGTKLTVLGQPKSSPSVTLF
PPSSEELETNKATLVCTIIDFYPGVVTVDWKVDGTPVTQGMETTQPSKQSNNKYMASSYL
TLTAREWERHSSYSCQVTHEGHTVEKSLSRA
//
>1indH [b.1.1 - b.1.1] IGG1-LAMBDA CHA255 FAB (HEAVY CHAIN)
EVTLVESGGDSVKPGGSLKLSCAASGFTLSGETMSWVRQTPEKRLEWVATTLSGGGFTFY
SASVKGRFTISRDNAQNNLYLQLNSLRSEDTALYFCASHRFVHWGHGTLVTVSAKTTPPS
VYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLESDLYTLSSS
VTVPSSPRPSETVTCNVAHPASSTKVDKKIVPR
//
>1iodA [d.169.1] COAGULATION FACTOR X BINDING PROTEIN
DCSSGWSSYEGHCYKVFKQSKTWADAESFCTKQVNGGHLVSIESSGEADFVGQLIAQKIK
SAKIHVWIGLRAQNKEKQCSIEWSDGSSISYENWIEEESKKCLGVHIETGFHKWENFYCE
QQDPFVCEA
//
>1iodB [d.169.1] COAGULATION FACTOR X BINDING PROTEIN
DCPSDWSSYEGHCYKPFNEPKNWADAENFCTQQHTGSHLVSFQSTEEADFVVKLAFQTFD
YGIFWMGLSKIWNQCNWQWSNAAMLKYTDWAEESYCVYFKSTNNKWRSITCRMIANFVCE
FQA
//
>1iodG [g.32.1] COAGULATION FACTOR X GLA DOMAIN
ANSFLxxVKQGNLxRxCLxxACSLxxARxVFxDAxQTDxFWSKY
//
>1iq5_1A [a.39.1] CALMODULIN
LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTI
DFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDE
MIREADIDGDGQVNYEEFVQMMTA
//
>1iq5_1B [x.x.x] CA2+/CALMODULIN DEPENDENT KINASE KINASE
IPRLDTLILVKAMGHRKRFGNPFR
//
>1iqdA [b.1.1 - b.1.1] HUMAN MONOCLONAL BO2C11 FAB LIGHT CHAIN
IALTQSPGTLSLSPGERATLSCRASQSFSSSYLAWYQQKPGQAPRLLIYGASTRATGIPD
RFSGSGSGTDFTLTISRLEPEDFAVYYCQKYGTSAITFGQGTRLEIKGTVAAPSVFIFPP
SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT
LSKADYEKHKVYACEVTHQGLVTKSFNR
//
>1iqdB [b.1.1 - b.1.1] HUMAN MONOCLONAL BO2C11 FAB HEAVY CHAIN
QVQLVQSGAEVKKPGASVKVSCKVSGYTLTELPVHWVRQAPGKGLEWVGSFDPESGESIY
AREFQGSVTMTADTSTNIAYMELSSLRSDDTAVYYCAVPDPDAFDIWGQGTMVTVSSAST
KGPSVFPLATAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVT
ATYTCNVDHKPSNTKVDKRV
//
>1iqdC [b.18.1] HUMAN FACTOR VIII
CSMPLGMESKAISDAQITASSYFTNMFATWSPSKARLHLQGRSNAWRPQVNNPKEWLQVD
FQKTMKVTGVTTQGVKSLLTSMYVKEFLISSSQDGHQWTLFFQNGKVKVFQGNQDSFTPV
VNCLDPPLLTRYLRIHPQSWVHQIALRMEVLGCEAQ
//
>1iqwL [b.1.1 - b.1.1] ANTIBODY M-HFE7A, LIGHT CHAIN
DIVLTQSPASLAVSLGQRATISCKASQSVDYDGDSYMNWYQQKPGQPPKLLIYAASNLES
GIPARFSGSGSGTDFTLNIHPVEEEDAATYYCQQSNEDPRTFGGGTKLEIKRADAAPTVS
IFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMS
STLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNR
//
>1iqwH [b.1.1 - b.1.1] ANTIBODY M-HFE7A, HEAVY CHAIN
QVQLQQPGAELVKPGASVKLSCKASGYTFTSYWMQWVKQRPGQGLEWIGEIDPSDSYTNY
NQKFKGKATLTVDTSSSTAYMQLSSLTSEDSAVYYCARNRDYSNNWYFDVWGTGTTVTVS
SAKTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQS
DLYTLSSSVTVPSSTWPSQTVTCNVAHPASSTKVDKKIVPR
//
>1ir1C (A) [d.58.9 - c.1.14] LARGE SUBUNIT OF RUBISCO
EFKAGVKDYKLTYYTPEYETLDTDILAAFRVSPQPGVPPEEAGAAVAAESSTGTWTTVWT
DGLTNLDRYKGRCYHIEPVAGEENQYICYVAYPLDLFEEGSVTNMFTSIVGNVFGFKALR
ALRLEDLRIPVAYVKTFQGPPHGIQVERDKLNKYGRPLLGCTIKPKLGLSAKNYGRAVYE
CLRGGLDFTxDDENVNSQPFMRWRDRFLFCAEALYKAQAETGEIKGHYLNATAGTCEDMM
KRAVFARELGVPIVMHDYLTGGFTANTTLSHYCRDNGLLLHIHRAMHAVIDRQKNHGMHF
RVLAKALRLSGGDHIHSGTVVGKLEGERDITLGFVDLLRDDYTEKDRSRGIYFTQSWVST
PGVLPVASGGIHVWHMPALTEIFGDDSVLQFGGGTLGHPWGNAPGAVANRVALEACVQAR
NEGRDLAREGNTIIREATKWSPELAAACEVWKEIKFEFPAMDTV
//
>1ir1U (S) [d.73.1] SMALL SUBUNIT OF RUBISCO
xKVWPTQNMKRYETLSYLPPLTTDQLARQVDYLLNNKWVPCLEFETDHGFVYREHHNSPG
YYDGRYWTMWKLPMFGCTDPAQVLNELEECKKEYPNAFIRIIGFDSNRQVQCVSFIAYKP
AGY
//
>1iraX [b.42.1] INTERLEUKIN-1 RECEPTOR ANTAGONIST
SSKMQAFRIWDVNQKTFYLRNNQLVAGYLQGPNVNLEEKIDVVPIEPHALFLGIHGGKMC
LSCVKSGDETRLQLEAVNITDLSENRKQDKRFAFIRSDSGPTTSFESAACPGWFLCTAME
ADQPVSLTNMPDEGVMVTKFYFQED
//
>1iraY [b.1.1 - b.1.1 - b.1.1] INTERLEUKIN-1 RECEPTOR
DKCKEREEKIILVSSANEIDVRPCPLNPNEHKGTITWYKDDSKTPVSTEQASRIHQHKEK
LWFVPAKVEDSGHYYCVVRNSSYCLRIKISAKFVENEPNLCYNAQAIFKQKLPVAGDGGL
VCPYMEFFKNENNELPKLQWYKDCKPLLLDNIHFSGVKDRLIVMNVAEKHRGNYTCHASY
TYLGKQYPITRVIEFITLEENKPTRPVIVSPANETMEVDLGSQIQLICNVTGQLSDIAYW
KWNGSVIDEDDPVLGEDYYSVENPANKRRSTLITVLNISEIESRFYKHPFTCFAKNTHGI
DAAYIQLIYPV
//
>1ireA [d.149.1] NITRILE HYDRATASE
TENILRKSDEEIQKEITARVKALESMLIEQGILTTSMIDRMAEIYENEVGPHLGAKVVVK
AWTDPEFKKRLLADGTEACKELGIGGLQGEDMMWVENTDEVHHVVVCTLxSxYPWPVLGL
PPNWFKEPQYRSRVVREPRQLLKEEFGFEVPPSKEIKVWDSSSEMRFVVLPQRPAGTDGW
SEEELATLVTRESMIGVEPAKAV
//
>1ireB [b.34.4] NITRILE HYDRATASE
MNGVYDVGGTDGLGPINRPADEPVFRAEWEKVAFAMFPATFRAGFMGLDEFRFGIEQMNP
AEYLESPYYWHWIRTYIHHGVRTGKIDLEELERRTQYYRENPDAPLPEHEQKPELIEFVN
QAVYGGLPASREVDRPPKFKEGDVVRFSTASPKGHARRARYVRGKTGTVVKHHGAYIYPD
TAGNGLGECPEHLYTVRFTAQELWGPEGDPNSSVYYDCWEPYIELVDT
//
>1iruA [d.153.1] 20S PROTEASOME
SRGSSAGFDRHITIFSPEGRLYQVEYAFKAINQGGLTSVAVRGKDCAVIVTQKKVPDKLL
DSSTVTHLFKITENIGCVMTGMTADSRSQVQRARYEAANWKYKYGYEIPVDMLCKRIADI
SQVYTQNAEMRPLGCCMILIGIDEEQGPQVYKCDPAGYYCGFKATAAGVKQTESTSFLEK
KVKKKFDWTFEQTVETAITCLSTVLSIDFKPSEIEVGVVTVENPKFRILTEAEIDAHLVA
LAER
//
>1iruB [d.153.1] 20S PROTEASOME
AERGYSFSLTTFSPSGKLVQIEYALAAVAGGAPSVGIKAANGVVLATEKKQKSILYDERS
VHKVEPITKHIGLVYSGMGPDYRVLVHRARKLAQQYYLVYQEPIPTAQLVQRVASVMQEY
TQSGGVRPFGVSLLICGWNEGRPYLFQSDPSGAYFAWKATAMGKNYVNGKTFLEKRYNED
LELEDAIHTAILTLKESFEGQMTEDNIEVGICNEAGFRRLTPTEVKDYLAAIA
//
>1iruC [d.153.1] 20S PROTEASOME
SRRYDSRTTIFSPEGRLYQVEYAMEAIGHAGTCLGILANDGVLLAAERRNIHKLLDEVFF
SEKIYKLNEDMACSVAGITSDANVLTNELRLIAQRYLLQYQEPIPCEQLVTALCDIKQAY
TQFGGKRPFGVSLLYIGWDKHYGFQLYQSDPSGNYGGWKATCIGNNSAAAVSMLKQDYKE
GEMTLKSALALAIKVLNKTMDVSKLSAEKVEIATLTRENGKTVIRVLKQKEVEQLIKKHE
EEEAKAEREK
//
>1iruD [d.153.1] 20S PROTEASOME
SYDRAITVFSPDGHLFQVEYAQEAVKKGSTAVGVRGRDIVVLGVEKKSVAKLQDERTVRK
ICALDDNVCMAFAGLTADARIVINRARVECQSHRLTVEDPVTVEYITRYIASLKQRYTQS
NGRRPFGISALIVGFDFDGTPRLYQTDPSGTYHAWKANAIGRGAKSVREFLEKNYTDEAI
ETDDLTIKLVIKALLEVVQSGGKNIELAVMRRDQSLKILNPEEIEKYVAEIEKEKEENEK
KKQ
//
>1iruE [d.153.1] 20S PROTEASOME
YDRGVNTFSPEGRLFQVEYDIEAIKLGSTAIGIQTSEGVCLAVEKRITSPLMEPSSIEKI
VEIDAHIGCAMSGLIADAKTLIDKARVETQNHWFTYNETMTVESVTQAVSNLALQFGEED
ADPGAMSRPFGVALLFGGVDEKGPQLFHMDPSGTFVQCDARAIGSASEGAQSSLQELYHK
SMTLKEAIKSSLIILKQVMEEKLNATNIELATVQPGQNFHMFTKEELEEVIKDI
//
>1iruF [d.153.1] 20S PROTEASOME
NQYDNDVTVWSPQGRIHQIEYAMEAVKQGSATVGLKSKTHAVLVALKRAQSELAAHQKKI
LHVDNHIGISIAGLTADARLLCNFMRQECLDSRFVFDRPLPVSRLVSLIGSKTQIPTQRY
GRRPYGVGLLIAGYDDMGPHIFQTCPSANYFDCRAMSIGARSQSARTYLERHMSEFMECN
LNELVKHGLRALRETLPAEQDLTTKNVSIGIVGKDLEFTIYDDDDVSPFLEGLEERPQ
//
>1iruG [d.153.1] 20S PROTEASOME
SSIGTGYDLSASTFSPDGRVFQVEYAMKAVENSSTAIGIRCKDGVVFGVEKLVLSKLYEE
GSNKRLFNVDRHVGMAVAGLLADARSLADIAREEASNFRSNFGYNIPLKHLADRVAMYVH
AYTLYSAVRPFGCSFMLGSYSVNDGAQLYMIDPSGVSYGYWGCAIGKARQAAKTEIEKLQ
MKEMTCRDIVKEVAKIIYIVHDEVKDKAFELELSWVGELTNGRHEIVPKDIREEAEKYAK
ESLKE
//
>1iruH [d.153.1] 20S PROTEASOME
TTIMAVQFDGGVVLGADSRTTTGSYIANRVTDKLTPIHDRIFCCRSGSAADTQAVADAVT
YQLGFHSIELNEPPLVHTAASLFKEMCYRYREDLMAGIIIAGWDPQEGGQVYSVPMGGMM
VRQSFAIGGSGSSYIYGYVDATYREGMTKEECLQFTANALALAMERDGSSGGVIRLAAIA
ESGVERQVLLGDQIPKFAVATL
//
>1iruI [d.153.1] 20S PROTEASOME
TTIAGVVYKDGIVLGADTRATEGMVVADKNCSKIHFISPNIYCCGAGTAADTDMTTQLIS
SNLELHSLSTGRLPRVVTANRMLKQMLFRYRGYIGAALVLGGVDVTGPHLYSIYPHGSTD
KLPYVTMGSGSLAAMAVFEDKFRPDMEEEEAKNLVSEAIAAGIFNDLGSGSNIDLCVISK
NKLDFLRPYTVPNKKGTRLGRYRCEKGTTAVLTEKITPLE
//
>1iruJ [d.153.1] 20S PROTEASOME
SIMSYNGGAVMAMKGKNCVAIAADRRFGIQAQLVTTDFQKIFPMGDRLYIGLAGLATDVQ
TVAQRLKFRLNLYELKEGRQIKPYTLMSMVANLLYEKRFGPYYTEPVIAGLDPKTFKPFI
CSLDLIGCPMVTDDFVVSGTCAEQMYGMCESLWEPNMDPDHLFETISQAMLNAVDRDAVS
GMGVIVHIIEKDKITTRTLKARMD
//
>1iruK [d.153.1] 20S PROTEASOME
MEYLIGIQGPDYVLVASDRVAASNIVQMKDDHDKMFKMSEKILLLCVGEAGDTVQFAEYI
QKNVQLYKMRNGYELSPTAAANFTRRNLADCLRSRTPYHVNLLLAGYDEHEGPALYYMDY
LAALAKAPFAAHGYGAFLTLSILDRYYTPTISRERAVELLRKCLEELQKRFILNLPTFSV
RIIDKNGIHDLDNISFPKQ
//
>1iruL [d.153.1] 20S PROTEASOME
TTTLAFKFRHGVIVAADSRATAGAYIASQTVKKVIEINPYLLGTMAGGAADCSFWERLLA
RQCRIYELRNKERISVAAASKLLANMVYQYKGMGLSMGTMICGWDKRGPGLYYVDSEGNR
ISGATFSVGSGSVYAYGVMDRGYSYDLEVEQAYDLARRAIYQATYRDAYSGGAVNLYHVR
EDGWIRVSSDNVADLHEKYSG
//
>1iruS (E) [d.153.1] 20S PROTEASOME
YDRGVNTFSPEGRLFQVEYDIEAIKLGSTAIGIQTSEGVCLAVEKRITSPLMEPSSIEKI
VEIDAHIGCAMSGLIADAKTLIDKARVETQNHWFTYNETMTVESVTQAVSNLALQFGEED
ADPGAMSRPFGVALLFGGVDEKGPQLFHMDPSGTFVQCDARAIGSASEGAQSSLQELYHK
SMTLKEAIKSSLIILKQVMEEKLNATNIELATVQPGQNFHMFTKEELEEVIKDI
//
>1iruT (F) [d.153.1] 20S PROTEASOME
NQYDNDVTVWSPQGRIHQIEYAMEAVKQGSATVGLKSKTHAVLVALKRAQSELAAHQKKI
LHVDNHIGISIAGLTADARLLCNFMRQECLDSRFVFDRPLPVSRLVSLIGSKTQIPTQRY
GRRPYGVGLLIAGYDDMGPHIFQTCPSANYFDCRAMSIGARSQSARTYLERHMSEFMECN
LNELVKHGLRALRETLPAEQDLTTKNVSIGIVGKDLEFTIYDDDDVSPFLEGLEERPQ
//
>1iruU (G) [d.153.1] 20S PROTEASOME
SSIGTGYDLSASTFSPDGRVFQVEYAMKAVENSSTAIGIRCKDGVVFGVEKLVLSKLYEE
GSNKRLFNVDRHVGMAVAGLLADARSLADIAREEASNFRSNFGYNIPLKHLADRVAMYVH
AYTLYSAVRPFGCSFMLGSYSVNDGAQLYMIDPSGVSYGYWGCAIGKARQAAKTEIEKLQ
MKEMTCRDIVKEVAKIIYIVHDEVKDKAFELELSWVGELTNGRHEIVPKDIREEAEKYAK
ESLKE
//
>1iruZ (L) [d.153.1] 20S PROTEASOME
TTTLAFKFRHGVIVAADSRATAGAYIASQTVKKVIEINPYLLGTMAGGAADCSFWERLLA
RQCRIYELRNKERISVAAASKLLANMVYQYKGMGLSMGTMICGWDKRGPGLYYVDSEGNR
ISGATFSVGSGSVYAYGVMDRGYSYDLEVEQAYDLARRAIYQATYRDAYSGGAVNLYHVR
EDGWIRVSSDNVADLHEKYSG
//
>1iru1 (M) [d.153.1] 20S PROTEASOME
RFSPYVFNGGTILAIAGEDFAIVASDTRLSEGFSIHTRDSPKCYKLTDKTVIGCSGFHGD
CLTLTKIIEARLKMYKHSNNKAMTTGAIAAMLSTILYSRRFFPYYVYNIIGGLDEEGKGA
VYSFDPVGSYQRDSFKAGGSASAMLQPLLDNQVGFKNMQNVEHVPLSLDRAMRLVKDVFI
SAAERDVYTGDALRICIVTKEGIREETVSLRKD
//
>1iru2 (N) [d.153.1] 20S PROTEASOME
TQNPMVTGTSVLGVKFEGGVVIAADMLGSYGSLARFRNISRIMRVNNSTMLGASGDYADF
QYLKQVLGQMVIDEELLGDGHSYSPRAIHSWLTRAMYSRRSKMNPLWNTMVIGGYADGES
FLGYVDMLGVAYEAPSLATGYGAYLAQPLLREVLEKQPVLSQTEARDLVERCMRVLYYRD
ARSYNRFQTATVTEKGVEIEGPLSTETNWDIAHMISG
//
>1it9L [b.1.1 - b.1.1] HUMANIZED ANTIBODY HFE7A, LIGHT CHAIN
EIVLTQSPGTLSLSPGERATLSCKASQSVDYDGDSYMNWYQQKPGQAPRLLIYAASNLES
GIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQSNEDPRTFGQGTKLEIKRTVAAPSVF
IFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLS
STLTLSKADYEKHKVYACEVTHQGLSSPVTKSFN
//
>1it9H [b.1.1 - b.1.1] HUMANIZED ANTIBODY HFE7A, HEAVY CHAIN
QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWMQWVKQAPGQGLEWMGEIDPSDSYTNY
NQKFKGKATLTVDTSTSTAYMELSSLRSEDTAVYYCARNRDYSNNWYFDVWGEGTLVTVS
SASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQS
SGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKV
//
>1itbA [b.42.1] INTERLEUKIN-1 BETA
APVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVAL
GLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNW
YISTSQAENMPVFLGGTKGGQDITDFTMQFVSS
//
>1itbB [b.1.1 - b.1.1 - b.1.1] TYPE 1 INTERLEUKIN-1 RECEPTOR
CKEREEKIILVSSANEIDVRPCPLNPNEHKGTITWYKDDSKTPVSTEQASRIHQHKEKLW
FVPAKVEDSGHYYCVVRNSSYCLRIKISAKFVENEPNLCYNAQAIFKQKLPVAGDGGLVC
PYMEFFKNENNELPKLQWYKDCKPLLLDNIHFSGVKDRLIVMNVAEKHRGNYTCHASYTY
LGKQYPITRVIEFITLEENKPTRPVIVSPANETMEVDLGSQIQLICNVTGQLSDIAYWKW
NGSVIDEDDPVLGEDYYSVENPANKRRSTLITVLNISEIESRFYKHPFTCFAKNTHGIDA
AYIQLIYPVT
//
>1ivo_1A [c.10.2 - g.3.9 - c.10.2 - g.3.9] EPIDERMAL GROWTH FACTOR RECEPTOR
EEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEV
AGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILH
GAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEE
NCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCP
PLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRK
CKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTP
PLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNI
TSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQV
CHALCSPEGCWGPEPRDCVSCRNVSRGRECV
//
>1ivo_1C [g.3.11] EPIDERMAL GROWTH FACTOR
ECPLSHDGYCLHDGVCMYIEALDKYACNCVVGYIGERCQYRDLKWWE
//
>1iw7_1C [e.29.1] RNA POLYMERASE BETA SUBUNIT
MEIKRFGRIREVIPLPPLTEIQVESYRRALQADVPPEKRENVGIQAAFRETFPIEEEDKG
KGGLVLDFLEYRLGEPPFPQDECREKDLTYQAPLYARLQLIHKDTGLIKEDEVFLGHIPL
MTEDGSFIINGADRVIVSQIHRSPGVYFTPDPARPGRYIASIIPLPKRGPWIDLEVEPNG
VVSMKVNKRKFPLVLLLRVLGYDQETLARELGAYGELVQGLMDESVFAMRPEEALIRLFT
LLRPGDPPKRDKAVAYVYGLIADPRRYDLGEAGRYKAEEKLGIRLSGRTLARFEDGEFKD
EVFLPTLRYLFALTAGVPGHEVDDIDHLGNRRIRTVGELMTDQFRVGLARLARGVRERML
MGSEDSLTPAKLVNSRPLEAAIREFFSRSQLSQFKDETNPLSSLRHKRRISALGPGGLTR
ERAGFDVRDVHRTHYGRICPVETPEGANIGLITSLAAYARVDELGFIRTPYRRVVGGVVT
DEVVYMTATEEDRYTIAQANTPLEGNRIAAERVVARRKGEPVIVSPEEVEFMDVSPKQVF
SVNTNLIPFLEHDDANRALMGSNMQTQAVPLIRAQAPVVMTGLEERVVRDSLAALYAEED
GEVAKVDGNRIVVRYEDGRLVEYPLRRFYRSNQGTALDQRPRVVVGQRVRKGDLLADGPA
SENGFLALGQNVLVAIMPFDGYNFEDAIVISEELLKRDFYTSIHIERYEIEARDTKLGPE
RITRDIPHLSEAALRDLDEEGVVRIGAEVKPGDILVGRTSFKGESEPTPEERLLRSIFGE
KARDVKDTSLRVPPGEGGIVVRTVRLRRGDPGVELKPGVREVVRVYVAQKRKLQVGDKLA
NRHGNKGVVAKILPVEDMPHLPDGTPVDVILNPLGVPSRMNLGQILETHLGLAGYFLGQR
YISPIFDGAKEPEIKELLAQAFEVYFGKRKGEGFGVDKREVEVLRRAEKLGLVTPGKTPE
EQLKELFLQGKVVLYDGRTGEPIEGPIVVGQMFIMKLYHMVEDKMHARSTGPYSLITQQP
LGGKAQFGGQRFGEMEVWALEAYGAAHTLQEMLTLKSDDIEGRNAAYEAIIKGEDVPEPS
VPESFRVLVKELQALALDVQTLDEKDNPVDIFEGLASKR
//
>1iw7_1D [e.29.1] RNA POLYMERASE BETA SUBUNIT
KKEVRKVRIALASPEKIRSWSYGEVEKPETINYRTLKPERDGLFDERIFGPIKDYECACG
KYKRQRFEGKVCERCGVEVTKSIVRRYRMGHIELATPAAHIWFVKDVPSKIGTLLDLSAT
ELEQVLYFSKYIVLDPKGAILNGVPVEKRQLLTDEEYRELRYGKQETYPLPPGVDALVKD
GEEVVKGQELAPGVVSRLDGVALYRFPRRVRVEYVKKERAGLRLPLAAWVEKEAYKPGEI
LAELPEPYLFGDKIVAAIDPEEEVIAEAEGVVHLHEPASILVVKARVYPFEDDVEVSTGD
RVAPGDVLADGGKVKSDVYGRVEVDLVRNVVRVVESYDIDARMGAEAIQQLLKELDLEAL
EKELLEEMKHPSRARRAKARKRLEVVRAFLDSGNRPEWMILEAVPVLPPDLRPMVQVDGG
RFATSDLNDLYRRLINRNNRLKKLLAQGAPEIIIRNEKRMLQEAVDALLDNGRRGAPVTN
PGSDRPLRSLTDILSGKQGRFRQNLLGKRVDYSGRSVIVVGPQLKLHQCGLPKRMALELF
KPFLLKKMEEKGIAPNVKAARRMLERQRDIKDEVWDALEEVIHGKVVLLNRAPTLHRLGI
QAFQPVLVEGQSIQLHPLVCEAFNADFDGDQMAVHVPLSSFAQAEARIQMLSAHNLLSPA
SGEPLAKPSRDIILGLYYITQVRKEKKGAGLEFATPEEALAAHERGEVALNAPIKVAGRE
TSVGRLKYVFANPDEALLAVAHGIVDLQDVVTVRYMGKRLETSPGRILFARIVAEAVEDE
KVAWELIQLDVPQEKNSLKDLVYQAFLRLGMEKTARLLDALKYYGFTFSTTSGITIGIDD
AVIPEEKKQYLEEADRKLLQIEQAYEMGFLTDRERYDQILQLWTETTEKVTQAVFKNFEE
NYPFNPLYVMAQSGARGNPQQIRQLCGLRGLMQKPSGETFEVPVRSSFREGLTVLEYFIS
SHGARKGGADTALRTADSGYLTRKLVDVTHEIVVREADCGTTNYISVPLFQPDEVTRSLR
LRKRADIEAGLYGRVLAREVEVLGVRLEEGRYLSMDDVHLLIKAAEAGEIQEVPVRSPLT
CQTRYGVCQKCYGYDLSMARPVSIGEAVGIVAAQSIGEPGTQLTMRTFHTGGVAGAADIT
QGLPRVIELFEARRPKAKAVISEIDGVVRIEETEEKLSVFVESEGFSKEYKLPKEARLLV
KDGDYVEAGQPLTRGAIDPHQLLEAKGPEAVERYLVEEIQKVYRAQGVKLHDKHIEIVVR
QMMKYVEVTDPGDSRLLEGQVLEKWDVEALNERLIAEGKTPVAWKPLLMGVTKSALSTKS
WLSAASFQNTTHVLTEAAIAGKKDELIGLKENVILGRLIPAGTGSDFVRFTQVVDQKTLK
AIEEARKEAVEA
//
>1iw7_1F [a.177.1 - a.4.13 - a.4.13] RNA POLYMERASE SIGMA-70 SUBUNIT
KISTSDPVRQYLHEIGQVPLLTLEEEVELARKVEEGMEAIKKLSEITGLDPDLIREVVRA
KILGSARVRHIPGLKETLDPKTVEEIDQKLKSLPKEHKRYLHIAREGEAARQHLIEANLR
LVVSIAKKYTGRGLSFLDLIQEGNQGLIRAVEKFEYKRRFKFSTYATWWIRQAINRAIAD
QARTIRIPVHMVETINKLSRTARQLQQELGREPTYEEIAEAMGPGWDAKRVEETLKIAQE
PVSLETPIGDEKDSFYGDFIPDEHLPSPVDAATQSLLSEELEKALSKLSEREAMVLKLRK
GLIDGEEVGAFFGVTRERIRQIENKALRKLKYHESRTRKLRDFLD
//
>1iwpA [c.1.19] GLYCEROL DEHYDRATASE ALPHA SUBUNIT
MKRSKRFAVLAQRPVNQDGLIGEWPEEGLIAMDSPFDPVSSVKVDNGLIVELDGKRRDQF
DMIDRFIADYAINVERTEQAMRLEAVEIARMLVDIHVSREEIIAITTAITPAKAVEVMAQ
MNVVEMMMALQKMRARRTPSNQCHVTNLKDNPVQIAADAAEAGIRGFSEQETTVGIARYA
PFNALALLVGSQCGRPGVLTQCSVEEATELELGMRGLTSYAETVSVYGTEAVFTDGDDTP
WSKAFLASAYASRGLKMRYTSGTGSEALMGYSESKSMLYLESRCIFITKGAGVQGLQNGA
VSCIGMTGAVPSGIRAVLAENLIASMLDLEVASANDQTFSHSDIRRTARTLMQMLPGTDF
IFSGYSAVPNYDNMFAGSNFDAEDFDDYNILQRDLMVDGGLRPVTEAETIAIRQKAARAI
QAVFRELGLPPIADEEVEAATYAHGSNEMPPRNVVEDLSAVEEMMKRNITGLDIVGALSR
SGFEDIASNILNMLRQRVTGDYLQTSAILDRQFEVVSAVNDINDYQGPGTGYRISAERWA
EIKNIPGVVQPDTIE
//
>1iwpG [a.23.2] GLYCEROL DEHYDRATASE GAMMA SUBUNIT
KTMRVQDYPLATRCPEHILTPTGKPLTDITLEKVLSGEVGPQDVRISRQTLEYQAQIAEQ
MQRHAVARNFRRAAELIAIPDERILAIYNALRPFRSSQAELLAIADELEHTWHATVNAAF
VRESAEVYQQRHKLRKGS
//
>1iwpL (A) [c.1.19] GLYCEROL DEHYDRATASE ALPHA SUBUNIT
MKRSKRFAVLAQRPVNQDGLIGEWPEEGLIAMDSPFDPVSSVKVDNGLIVELDGKRRDQF
DMIDRFIADYAINVERTEQAMRLEAVEIARMLVDIHVSREEIIAITTAITPAKAVEVMAQ
MNVVEMMMALQKMRARRTPSNQCHVTNLKDNPVQIAADAAEAGIRGFSEQETTVGIARYA
PFNALALLVGSQCGRPGVLTQCSVEEATELELGMRGLTSYAETVSVYGTEAVFTDGDDTP
WSKAFLASAYASRGLKMRYTSGTGSEALMGYSESKSMLYLESRCIFITKGAGVQGLQNGA
VSCIGMTGAVPSGIRAVLAENLIASMLDLEVASANDQTFSHSDIRRTARTLMQMLPGTDF
IFSGYSAVPNYDNMFAGSNFDAEDFDDYNILQRDLMVDGGLRPVTEAETIAIRQKAARAI
QAVFRELGLPPIADEEVEAATYAHGSNEMPPRNVVEDLSAVEEMMKRNITGLDIVGALSR
SGFEDIASNILNMLRQRVTGDYLQTSAILDRQFEVVSAVNDINDYQGPGTGYRISAERWA
EIKNIPGVVQPDTIE
//
>1iwpE (B) [c.51.3] GLYCEROL DEHYDRATASE BETA SUBUNIT
FTLKTREGGVASADERADEVVIGVGPAFDKHQHHTLIDMPHGAILKELIAGVEEEGLHAR
VVRILRTSDVSFMAWDAANLSGSGIGIGIQSKGTTVIHQRDLLPLSNLELFSQAPLLTLE
TYRQIGKNAARYARKESPSPVPVVNDQMVRPKFMAKAALFHIKETKHVVQDAEPVTLHID
LVRE
//
>1ixrB [b.40.4 - a.60.2 - a.5.1] HOLLIDAY JUNCTION DNA HELICASE RUVA
MIRYLRGLVLKKEAGGFVLLAGGVGFFLQAPTPFLQALEEGKEVGVHTHLLLKEEGLSLY
GFPDEENLALFELLLSVSGVGPKVALALLSALPPRLLARALLEGDARLLTSASGVGRRLA
ERIALELKGKVPPHLLAGEKVESEAAEEAVMALAALGFKEAQARAVVLDLLAQNPKARAQ
DLIKEALKRLR
//
>1ixrC [c.37.1 - a.4.5] RUVB
ALRPKTLDEYIGQERLKQKLRVYLEAAKARKEPLEHLLLFGPPGLGKTTLAHVIAHELGV
NLRVTSGPAIEKPGDLAAILANSLEEGDILFIDEIHRLSRQAEEHLYPAMEDFVMDIVIG
QGPAARTIRLELPRFTLIGATTRPGLITAPLLSRFGIVEHLEYYTPEELAQGVMRDARLL
GVRITEEAALEIGRRSRGTMRVAKRLFRRVRDFAQVAGEEVITRERALEALAALGLDELG
LEKRDREILEVLILRFGGGPVGLATLATALSEDPGTLEEVHEPYLIRQGLLKRTPRGRVA
TELARRHL
//
>1ixsA [a.5.1] HOLLIDAY JUNCTION DNA HELICASE RUVA
ESEAAEEAVMALAALGFKEAQARAVVLDLLAQNPKARAQDLIKEALKRLR
//
>1ixsB [c.37.1 - a.4.5] RUVB
LALRPKTLDEYIGQERLKQKLRVYLEAAKARKEPLEHLLLFGPPGLGKTTLAHVIAHELG
VNLRVTSGPAIEKPGDLAAILANSLEEGDILFIDEIHRLSRQAEEHLYPAMEDFVMDIVI
GQGPAARTIRLELPRFTLIGATTRPGLITAPLLSRFGIVEHLEYYTPEELAQGVMRDARL
LGVRITEEAALEIGRRSRGTMRVAKRLFRRVRDFAQVAGEEVITRERALEALAALGLDEL
GLEKRDREILEVLILRFGGGPVGLATLATALSEDPGTLEEVHEPYLIRQGLLKRTPRGRV
ATELAYRHLGYPPPV
//
>1ixxA [d.169.1] COAGULATION FACTORS IX/X-BINDING PROTEIN
DCLSGWSSYEGHCYKAFEKYKTWEDAERVCTEQAKGAHLVSIESSGEADFVAQLVTQNMK
RLDFYIWIGLRVQGKVKQCNSEWSDGSSVSYENWIEAESKTCLGLEKETDFRKWVNIYCG
QQNPFVCEA
//
>1ixxB [d.169.1] COAGULATION FACTORS IX/X-BINDING PROTEIN
DCPSDWSSYEGHCYKPFSEPKNWADAENFCTQQHAGGHLVSFQSSEEADFVVKLAFQTFG
HSIFWMGLSNVWNQCNWQWSNAAMLRYKAWAEESYCVYFKSTNNKWRSRACRMMAQFVCE
FQA
//
>1iyj_1A [x.x.x] DELETED IN SPLIT HAND/SPLIT FOOT PROTEIN 1
QPVDLGLLEEDDEFEEFPHVWEDNWDDDNVEDDFSNQLRAELEKH
//
>1iyj_1B [a.170.1 - b.40.4 - b.40.4 - a.171.1 - b.40.4] BREAST CANCER SUSCEPTIBILITY
FPQFNKDLMSSLQNARDLQDIRIKNKERHHLCPQPGSLYLTKSSTLPRISLQAAVGDSVP
SACSPKQLYMYGVSKACISVNSKNAEYFQFAIEDHFGKEALCAGKGFRLADGGWLIPSDD
GKAGKEEFYRALCDTPGVDPKLISSVWVSNHYRWIVWKLAAMEFAFPKEFANRCLNPERV
LLQLKYRYDVEIDNSSRSALKKILERDDTAAKTLVLCVSDIISLSKVDTIELTDGWYAVK
AQLDPPLLALVKSGRLTVGQKIITQGAELVGSPDACAPLEAPDSLRLKISANSTRPARWH
SKLGFFHDPRPFPLPLSSLFSDGGNVGCVDVIVQRVYPLQWVEKTVSGSYIFRNEREEEK
EALRFSRDVSTVWKLRVTSYKKREKSALLSIWRPSSDLPSLLTEGQRYRIYHLSVSKSKN
KFEWPSIQLTATKRTQYQQLPVSSETLLQLYQPRELLPFSKLSDPAFQPPCSEVDVVGVV
VSVVKPIGLAPLVYLSDECLHLLVVKFGIDLNEDIKPRVLIAASNLQWRPESTSRVPTLF
AGNFSVFSASPKEAHFQERVTNMKHAIENIDTFYKEAEKKLIQVLKGDSPK
//
>1izlA [i.5.1] PHOTOSYSTEM II: SUBUNIT PSBA
WFGVIMIPTLLAATICFVIAFIAAPPVDIDGIREPVSGSLLYGNNIITGAVVPSSNHFYP
IWEAASLDEWLYNGGPYQLIIFHFLLGASCYMGRQWELSYRLGMRPWICVAYSAPLASAF
AVFLIYPIGQGSFSDGMPLGISGTFNFMIVFQAEHNILMHPFHQLGVAGVFGGALFCAMH
GSLVTSSLIRETTETESANYGYKFGAHGYFGRLIFQYASFNNSRSLHFFLAAWRVVGVWF
AALGISTMAFNLNGFNFNHSVIDAKGNVINTWADIINRANLGMEVMHERNAHNFPLDLA
//
>1izlC [i.5.1] PHOTOSYSTEM II: SUBUNIT PSBC
KLLGAHVAHAGLIVFWAGAMTLFELAHFIPEKPMYEQGLILIPHIATLGWGVGPGGEVVD
TFPFFVVGVVHLISSAVLGFGGVYHAIRGPETLEEYWKDKNKMTTILGFHLIVLGIGALL
LVAKAMFFGGLYDTWAPGGGDVRVIKSPFGGEGWIVSVNNLEDVVGGHIWIGLICIAGGI
WHIARRAFIWSGEAYLSYSLGALSMMGFIATCFVWFNNTVYPuuuuuuuuuuuuuuuuuu
uuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuV
GGVATEINSVNFVSPRSWLATSHFVLAFFFLVGHLWHAGRARAAAAGFE
//
>1izlV [i.5.1] PHOTOSYSTEM II: SUBUNIT PSBV
ELTPEVLTVPLNSEGKTITLTEKQYLEGKRLFQYACASCHVGGITKTNPSLDLRTETLAL
ATPPRDNIEGLVDYMKNPTTYDGEQEIAEVHPSLRSADIFPKMRNLTEKDLVAIAGHILV
EPKILGDKW
//
>1izlJ (A) [i.5.1] PHOTOSYSTEM II: SUBUNIT PSBA
WFGVIMIPTLLAATICFVIAFIAAPPVDIDGIREPVSGSLLYGNNIITGAVVPSSNHFYP
IWEAASLDEWLYNGGPYQLIIFHFLLGASCYMGRQWELSYRLGMRPWICVAYSAPLASAF
AVFLIYPIGQGSFSDGMPLGISGTFNFMIVFQAEHNILMHPFHQLGVAGVFGGALFCAMH
GSLVTSSLIRETTETESANYGYKFGAHGYFGRLIFQYASFNNSRSLHFFLAAWRVVGVWF
AALGISTMAFNLNGFNFNHSVIDAKGNVINTWADIINRANLGMEVMHERNAHNFPLDLA
//
>1izlM [i.5.1] PHOTOSYSTEM II: SUBUNIT PSBC
INLSGKLLGAHVAHAGLIVFWAGAMTLFELAHFIPEKPMYEQGLILIPHIATLGWGVDTF
PFFVVGVVHLISSAVLGFGGVYHAIRGPETLWKDKNKMTTILGFHLIVLGIGALLLVAKA
MFFLYDTWAPGGGDVRVIKSPFGGEGWIVSVNNLEDVVGGHIWIGLICIAGGIWHILTTG
WARRAFIWSGEAYLSYSLGALSMMGFIATCFVWFNNTVYPuuuuuuuuuuuuuuuuuuuu
uuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuVGG
VATEINSVNFVSPRSWLATSHFVLAFFFLVGHLWHAGRARAAAAGFE
//
>1izlN (D) [i.5.1] PHOTOSYSTEM II: SUBUNIT PSBD
GILLFPCAYLALGGWLTGTTFVTSWYTHGLASSYLEGCNFLTVAVSTEAQGDFTRWCQLG
GLWTFIALHGAFGLIGFMLRQFEIARLVGVRPYNAIAFSAPIAVFVSVFLIYPLGFAPSF
GVAAIFRFLLFFQGFHNWTLNPFHMMGVAGVLGGALLCAIHGATVENTYSMVTANRFWSQ
IFGIAFSNKRWLHFFMLFVPVTGLWMSAIGVVGLALNLRSYDFISQEIRAAEDPEFETFY
TKNLLLNEGIRAWMAPQDQPHENFVFPEEVLPRGNAL
//
>1izlW (K) [i.5.1] PHOTOSYSTEM II: SUBUNIT PSBK
AYAIFDPLVDVLPVIPVLFLALAFVWQ
//
>1izl0 [i.5.1] PHOTOSYSTEM II: SUBUNIT PSBV
ELTPEVLTVPLTEKQYLEGKRLFQYACASCHVGGITKTNPSLDLRTETLALATPPRDNIE
GLVDYMKNPTTYDGEQEIAEVHPSLRSADIFPKMRNLTEKDLVAIAGHILVEPKI
//
>1izn_1A [e.43.1] CAPZ ALPHA-1 SUBUNIT
RVSDEEKVRIAAKFITHAPPGEFNEVFNDVRLLLNNDNLLREGAAHAFAQYNMDQFTPVK
IEGYDDQVLITEHGDLGNGRFLDPRNKISFKFDHLRKEASDPQPEDTESALKQWRDACDS
ALRAYVKDHYPNGFCTVYGKSIDGQQTIIACIESHQFQPKNFWNGRWRSEWKFTITPPTA
QVAAVLKIQVHYYEDGNVQLVSHKDIQDSVQVSSDVQTAKEFIKIIENAENEYQTAISEN
YQTMSDTTFKALRRQLPVTRTKIDWNKILSYKIGK
//
>1izn_1B [e.43.1] CAPZ BETA-1 SUBUNIT
SDQQLDCALDLMRRLPPQQIEKNLSDLIDLVPSLCEDLLSSVDQPLKIARDKVVGKDYLL
CDYNRDGDSYRSPWSNKYDPPLEDGAMPSARLRKLEVEANNAFDQYRDLYFEGGVSSVYL
WDLDHGFAGVILIKKAGDGSKKIKGCWDSIHVVEVQEKSSGRTAHYKLTSTVMLWLQTNK
TGSGTMNLGGSLTRQMEKDETVSDSSPHIANIGRLVEDMENKIRSTLNEIYFGKTKDIVN
GLRSIDAIPDNQKYKQLQRELSQVLTQRQI
//
>1j05_2L [b.1.1] ANTI-CEA MAB T84.66, LIGHT CHAIN
DIVLTQSPASLAVSLGQRATMSCRAGESVDIFGVGFLHWYQQKPGQPPKLLIYRASNLES
GIPVRFSGTGSRTDFTLIIDPVEADDVATYYCQQTNEDPYTFGGGTKLEI
//
>1j05_2H [b.1.1] ANTI-CEA MAB T84.66, HEAVY CHAIN
EVQLQQSGAELVEPGASVKLSCTASGFNIKDTYMHWVKQRPEQGLEWIGRIDPANGNSKY
VPKFQGKATITADTSSNTAYLQLTSLTSEDTAVYYCAPFGYYVSDYAMAYWGQGTSVTVS
//
>1j1d_1A [a.39.1] TROPONIN C
MDDIYKAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEM
IDEVDEDGSGTVDFDEFLVMMVRSMKDDSKSEEELSDLFRMFDKNADGYIDLEELKIMLQ
ATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKGVE
//
>1j1d_1B [h.1.25] TROPONIN T
QTEREKKKKILAERRKVLAIDHLNEDQLREKAKELWQTIYNLEAEKFDLQEKFKQQKYEI
NVLRNRINDN
//
>1j1d_1C [h.1.25] TROPONIN I
AKKKSKISASRKLQLKTLLLQIAKQELEREAEERRGEKGRALSTRAQPLELAGLGFAELQ
DLARQLHARVDKVDEERYDIEAKVTKNITEIADLTQKIFDLRRRVRISADAMMQALLG
//
>1j1e_2D [a.39.1] TROPONIN C
MDDIYKAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLNPTPEELQEMID
EVDEDGSGTVDFDEFLVMMVRSMKDDSKGKSEEELSDLFRMFDKNADGYIDLEELKIMLQ
ATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKGVE
//
>1j1e_2E [h.1.25] TROPONIN T
QTEREKKKKILAERRKVLAIDHLNEDQLREKAKELWQTIYNLEAEKFDLQEKFKQQKYEI
NVLRNRINDNQKVSK
//
>1j1e_2F [h.1.25] TROPONIN I
KISASRKLQLKTLLLQIAKQELEREAEERRGEKGRALSTRAQPLELAGLGFAELQDLARQ
LHARVDKVDEERYDIEAKVTKNITEIADLTQKIFDLRRISADAMMQALLGARAKESLDLR
AHLKQVKKEDTEKENREVGDW
//
>1j1pL [b.1.1] LYSOZYME BINDING IG KAPPA CHAIN V23-J2 REGION
DIVLTQSPATLSVTPGNSVSLSCRASQSIGNNLHWYQQKSHESPRLLIKYASQSISGIPS
RFSGSGSGTDFTLSINSVETEDFGMYFCQQANSWPYTFGGGTKLEIK
//
>1j1pH [b.1.1] IG VH,ANTI-LYSOZYME
DVQLQESGPSLVKPSQTLSLTCSVTGDSITSDYWSWIRKFPGNRLEYMGYVSYSGSTYYN
PSLKSRISITRDTSKNQYYLDLNSVTTEDTATYYCANWDGDYWGQGTLVTVSAA
//
>1j1pY [d.2.1] LYSOZYME C
KVFGRCELAAAMKRHGLDNYRGYSLGNWVCAAKFESNFNTQATNRNTDGSTDYGILQINS
RWWCNDGRTPGSRNLCNIPCSALLSSDITASVNCAKKIVSDGNGMNAWVAWRNRCKGTDV
QAWIRGCRL
//
>1j2jA [c.37.1] ADP-RIBOSYLATION FACTOR 1
GSMRILMVGLDAAGKTTILYKLKLGEIVTTIPTIGFNVETVEYKNISFTVWDVGGLDKIR
PLWRHYFQNTQGLIFVVDSNDRERVNEAREELMRMLAEDELRDAVLLVFANKQDLPNAMN
AAEITDKLGLHSLRHRNWYIQATCATSGDGLYEGLDWLSNQLRNQ
//
>1j2jB [a.7.8] ADP-RIBOSYLATION FACTOR BINDING PROTEIN GGA1
IFEDEEKSKMLARLLKSSHPEDLRAANKLIKEMVQEDQKRM
//
>1j34A [d.169.1] COAGULATION FACTOR IX-BINDING PROTEIN A CHAIN
DCPSGWSSYEGHCYKPFKLYKTWDDAERFCTEQAKGGHLVSIESAGEADFVAQLVTENIQ
NTKSYVWIGLRVQGKEKQCSSEWSDGSSVSYENWIEAESKTCLGLEKETGFRKWVNIYCG
QQNPFVCEA
//
>1j34B [d.169.1] COAGULATION FACTOR IX-BINDING PROTEIN B CHAIN
DCPSDWSSYEGHCYKPFSEPKNWADAENFCTQQHAGGHLVSFQSSEEADFVVKLAFQTFG
HSIFWMGLSNVWNQCNWQWSNAAMLRYKAWAEESYCVYFKSTNNKWRSRACRMMAQFVCE
FQA
//
>1j34C [g.32.1] COAGULATION FACTOR IX
YNSGKLxxFVRGNLxRxCKxxKCSFxxARxVFxNTxKTTxFWKQYV
//
>1j5oB [e.8.1] REVERSE TRANSCRIPTASE
PISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPV
FAIKKKDSTKWRKLVDFRELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPL
DEDFRKYTAFTIPSINNETPGIRYQYNVLPQGWKGSPAIFQSSMTKILEPFKKQNPDIVI
YQYIDDLYVGSDLEIGQHRTKIEELRQHLLRWGLTTPDKKHQKEPPFLWMGYELHPDKWT
VQPIVLPEKDSWTVNDIQKLVGKLNWASQIYPGIKVRQLSKLLRGTKALTEVIPLTEEAE
LELAENREILKEPVHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMRGA
HTNDVKQLTEAVQKITTESIVIWGKTPKFKLPIQKETWETWWTEYWQATWIPEWEFVNTP
PLVKLWYQLE
//
>1j5oH [b.1.1 - b.1.1] ANTIBODY (HEAVY CHAIN)
QITLKESGPGIVQPSQPFRLTCTFSGFSLSTSGIGVTWIRQPSGKGLEWLATIWWDDDNR
YNPSLKSRLTVSKDTSNNQAFLNMMTVETADTAIYYCAQSAITSVTDSAMDHWGQGTSVT
VSSAATTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVL
QSDLYTLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKI
//
>1j7dB [d.20.1] UBIQUITIN-CONJUGATING ENZYME E2-17 KDA
AGLPRRIIKETQRLLAEPVPGIKAEPDESNARYFHVVIAGPQDSPFEGGTFKLELFLPEE
YPMAAPKVRFMTKIYHPNVDKLGRICLDILKDKWSPALQIRTVLLSIQALLSAPNPDDPL
ANDVAEQWKTNEAQAIETARAWTRLYAMN
//
>1j7dA [d.20.1] MMS2
GVKVPRNFRLLEELEEGQKGVGDGTVSWGLEDDEDMTLTRWTGMIIGPPRTNYENRIYSL
KVECGPKYPEAPPSVRFVTKINMNGINNSSGMVDARSIPVLAKWQNSYSIKVVLQELRRL
MMSKENMKLPQPPEGQTYNN
//
>1j7vA (L) [a.26.1] INTERLEUKIN-10
SCTHFPGNLPNMLRDLRDAFSRVKTFFQMKDQLDNLLLKESLLEDFKGYLGCQALSEMIQ
FYLEEVMPQAENQDPDIKAHVNSLGENLKTLRLRLRRCHRFLPCENKSKAVEQVKNAFNK
LQEKGIYKAMSEFDIFINYIEAYMTMKIRN
//
>1j7vB (R) [b.1.2 - b.1.2] INTERLEUKIN-10 RECEPTOR ALPHA CHAIN
GTELPSPPSVWFEAEFFHHILHWTPIPQQSESTCYEVALLRYGIESWNSISQCSQTLSYD
LTAVTLDLYHSNGYRARVRAVDGSRHSQWTVTNTRFSVDEVTLTVGSVNLEIHNGFILGK
IQLPRPKMAPAQDTYESIFSHFREYEIAIRKVPGQFTFTHKKVKHEQFSLLTSGEVGEFC
VQVKPSVASRSNKGMWSKEECISLT
//
>1j8hB [d.19.1 - b.1.1] HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR-4
TRPRFLEQVKHECHFFNGTERVRFLDRYFYHQEEYVRFDSDVGEYRAVTELGRPDAEYWN
SQKDLLEQKRAAVDTYCRHNYGVGESFTVQRRVYPEVTVYPANLLVCSVNGFYPGSIEVR
WFRNGQEEKTGVVSTGLIQNGDWTFQTLVMLETVPRSGEVYTCQVEHPSVTSPLTVEWRA
//
>1j8hD [b.1.1 - b.1.1] T-CELL RECEPTOR ALPHA CHAIN
QSVTQLGSHVSVSEGALVLLRCNYSSSVPPYLFWYVQYPNQGLQLLLKYTSAATLVKGIN
GFEAEFKKSETSFHLTKPSAHMSDAAEYFCAVSESPFGNEKLTFGTGTRLTIIPNIQNPD
PAVYQLRSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKTVLDMRSMDFKSNSAVAWSNKS
DFACANAFNNSIIPEDTF
//
>1j9cT [b.1.2 - b.1.2] TISSUE FACTOR
SGTTNTVAAYNLTWKSTNFKTILEWEPKPVNQVYTVQISTKSGDWKSKCFYTTDTECDLT
DEIVKDVKQTYLARVFSYPAGNVESTGSAGEPLYENSPEFTPYLETNLGQPTIQSFEQVG
TKVNVTVEDERTLVRRNNTFLSLRDVFGKDLIYTLYYWKSSSSGKKTAKTNTNEFLIDVD
KGENYCFSVQAVIPSRTVNRKSTDSPVECM
//
>1j9cL [g.3.11 - g.3.11] FACTOR VIIA LIGHT CHAIN
DQCASSPCQNGGSCKDQLQSYICFCLPAFEGRNCETHKDDQLICVNENGGCEQYCSDHTG
TKRSCRCHEGYSLLADGVSCTPTVEYPCGKIPILE
//
>1j9cH [b.47.1] FACTOR VIIA HEAVY CHAIN
IVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHD
LSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERT
LAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGY
SDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMR
SEPRPGVLLRAPFP
//
>1jatA [d.20.1] UBIQUITIN-CONJUGATING ENZYME E2-17.5 KDA
AASLPKRIIKETEKLVSDPVPGITAEPHDDNLRYFQVTIEGPEQSPYEDGIFELELYLPD
DYPMEAPKVRFLTKIYHPNIDRLGRICLDVLKTNWSPALQIRTVLLSIQALLASPNPNDP
LANDVAEDWIKNEQGAKAKAREWTKLYAKKKP
//
>1jatB [d.20.1] UBIQUITIN-CONJUGATING ENZYME VARIANT MMS2
SKVPRNFRLLEELEKGEKESCSYGLADSDDITMTKWNGTILGPPHSNHENRIYSLSIDCG
PNYPDSPPKVTFISKINLPCVNPTTGEVQTDFHTLRDWKRAYTMETLLLDLRKEMATPAN
KKLRQPKEGETF
//
>1jb0A [f.29.1] PHOTOSYSTEM I P700 CHLOROPHYLL A APOPROTEIN A1
RVVVDNDPVPTSFEKWAKPGHFDRTLARGPQTTTWIWNLHALAHDFDTHTSDLEDISRKI
FSAHFGHLAVVFIWLSGMYFHGAKFSNYEAWLADPTGIKPSAQVVWPIVGQGILNGDVGG
GFHGIQITSGLFQLWRASGITNEFQLYCTAIGGLVMAGLMLFAGWFHYHKRAPKLEWFQN
VESMLNHHLAGLLGLGSLAWAGHQIHVSLPINKLLDAGVAAKDIPLPHEFILNPSLMAEL
YPKVDWGFFSPFFTFNWAAYSDFLTFNGGLNPVTGGLWLSDTAHHHLAIAVLFIIAGHMY
RTNWGIGHSLKEILEAHKGPFTGAGHKGLYEVLTTSWHAQLAINLAMMGSLSIIVAQHMY
AMPPYPYLATDYPTQLSLFTHHMWIGGFLVVGGAAHGAIFMVRDYDPAMNQNNVLDRVLR
HRDAIISHLNWVCIFLGFHSFGLYVHNDTMRAFGRPQDMFSDTGIQLQPVFAQWVQNLHT
LAPGGTAPNAAATASVAFGGDVVAVGGKVAMMPIVLGTADFMVHHIHAFTIHVTVLILLK
GVLFARSSRLIPDKANLGFRFPCDGPGRGGTCQVSGWDHVFLGLFWMYNCISVVIFHFSW
KMQSDVWGTVAPDGTVSHITGGNFAQSAITINGWLRDFLWAQASQVIGSYGSALSAYGLL
FLGAHFIWAFSLMFLFSGRGYWQELIESIVWAHNKLKVAPAIQPRALSIIQGRAVGVAHY
LLGGIATTWAFFLARIISVG
//
>1jb0B [f.29.1] PHOTOSYSTEM I P700 CHLOROPHYLL A APOPROTEIN A2
ATKFPKFSQDLAQDPTTRRIWYAIAMAHDFESHDGMTEENLYQKIFASHFGHLAIIFLWV
SGSLFHVAWQGNFEQWVQDPVNTRPIAHAIWDPQFGKAAVDAFTQAGASNPVDIAYSGVY
HWWYTIGMRTNGDLYQGAIFLLILASLALFAGWLHLQPKFRPSLSWFKNAESRLNHHLAG
LFGVSSLAWAGHLIHVAIPESRGQHVGWDNFLSTMPHPAGLAPFFTGNWGVYAQNPDTAS
HVFGTAQGAGTAILTFLGGFHPQTESLWLTDMAHHHLAIAVLFIVAGHMYRTQFGIGHSI
KEMMDAKDFFGTKVEGPFNMPHQGIYETYNNSLHFQLGWHLACLGVITSLVAQHMYSLPP
YAFIAQDHTTMAALYTHHQYIAGFLMVGAFAHGAIFLVRDYDPAQNKGNVLDRVLQHKEA
IISHLSWVSLFLGFHTLGLYVHNDVVVAFGTPEKQILIEPVFAQFIQAAHGKLLYGFDTL
LSNPDSIASTAWPNYGNVWLPGWLDAINSGTNSLFLTIGPGDFLVHHAIALGLHTTTLIL
VKGALDARGSKLMPDKKDFGYAFPCDGPGRGGTCDISAWDAFYLAMFWMLNTIGWVTFYW
HWKHLGVWEGNVAQFNESSTYLMGWLRDYLWLNSSQLINGYNPFGTNNLSVWAWMFLFGH
LVWATGFMFLISWRGYWQELIETLVWAHERTPLANLVRWKDKPVALSIVQARLVGLAHFS
VGYILTYAAFLIASTAAKF
//
>1jb0C [d.58.1] PHOTOSYSTEM I IRON-SULFUR CENTER
AHTVKIYDTCIGCTQCVRACPTDVLEMVPWDGCKAGQIASSPRTEDCVGCKRCETACPTD
FLSIRVYLGAETTRSMGLAY
//
>1jb0D [d.187.1] PHOTOSYSTEM 1 REACTION CENTRE SUBUNIT II
TTLTGQPPLYGGSTGGLLSAADTEEKYAITWTSPKEQVFEMPTAGAAVMREGENLVYFAR
KEQCLALAAQQLRPRKINDYKIYRIFPDGETVLIHPKDGVFPEKVNKGREAVNSVPRSIG
QNPNPSQLKFTGKKPYDP
//
>1jb0E [b.34.4] PHOTOSYSTEM 1 REACTION CENTRE SUBUNIT IV
VQRGSKVKILRPESYWYNEVGTVASVDQTPGVKYPVIVRFDKVNYTGYSGSASGVNTNNF
ALHEVQEVA
//
>1jb0F [f.23.16] PHOTOSYSTEM 1 REACTION CENTRE SUBUNIT III
DVAGLVPCKDSPAFQKRAAAAVNTTADPASGQKRFERYSQALCGEDGLPHLVVDGRLSRA
GDFLIPSVLFLYIAGWIGWVGRAYLIAVRNSGEANEKEIIIDVPLAIKCMLTGFAWPLAA
LKELASGELTAKDNEITVSPR
//
>1jb0I [f.23.17] PHOTOSYSTEM 1 REACTION CENTRE SUBUNIT VIII
MMGSYAASFLPWIFIPVVCWLMPTVVMGLLFLYIEGEA
//
>1jb0J [f.23.18] PHOTOSYSTEM 1 REACTION CENTRE SUBUNIT IX
MKHFLTYLSTAPVLAAIWMTITAGILIEFNRFYPDLLFHPL
//
>1jb0K [f.30.1] PHOTOSYSTEM 1 REACTION CENTRE SUBUNIT X
ILCNLFAIALGRYIQSRGKGPGLGLPELLATTSFGHLLAAGVVSGL
//
>1jb0L [f.31.1] PHOTOSYSTEM 1 REACTION CENTRE SUBUNIT XI
LVKPYNGDPFVGHLSTPISDSGLVKTFIGNLPAYRQGLSPILRGLEVGMAHGYFLIGPWV
KLGPLRDSDVANLGGLISGIALILVATACLAAYGLVSFQKGGSSSDPLKTSEGWSQFTAG
FFVGAMGSAFVAFFLLENFLVVDGIMTGLFN
//
>1jb0M [f.23.19] PHOTOSYSTEM 1 REACTION CENTRE SUBUNIT XII
MALTDTQVYVALVIALLPAVLAFRLSTELYK
//
>1jb0X [f.23.20] PHOTOSYSTEM I SUBUNIT PSAX
PTYAFRTFWAVLLLAINFLVAAYYFAAAA
//
>1jbpE [d.144.1] CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC
GxEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNH
YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM
FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA
KRVKGRTWxLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYE
KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR
KVEAPFIPKFKGPGDTSNFDDYEEEEIRVxINEKCGKEFTEF
//
>1jbpS [x.x.x] CAMP-DEPENDENT PROTEIN KINASE INHIBITOR,
TTYADFIASGRTGRRASIHD
//
>1jckA [b.1.1 - b.1.1] 14.3.D T CELL ANTIGEN RECEPTOR
AVTQSPRNKVAVTGGKVTLSCQQTNNHNNMYWYRQDTGHGLRLIHYSYGAGSTEKGDIPD
GYKASRPSQEQFSLILELATPSQTSVYFCASGGGRGSYAEQFFGPGTRLTVLEDLRQVTP
PKVSLFEPSKAEIANKQKATLVCLARGFFPDHVELSWWVNGKEVHSGVSTDPQAYKESNY
SYCLSSRLRVSATFWHNPRNHFRCQVQFHGLSEEDKWPEGSPKPVTQNISAEAWGRAD
//
>1jckB [b.40.2 - d.15.6] STAPHYLOCOCCAL ENTEROTOXIN C3
ESQPDPMPDDLHKSSEFTGTMGNMKYLYDDHYVSATKVKSVDKFLAHDLIYNINDKKLNN
YDKVKTELLNEDLANKYKDEVVDVYGSNYYVNCYFSSKDNVGKVTSGKTCMYGGITKHEG
NHFDNGNLQNVLIRVYENKRNTISFEVQTDKKSVTAQELDIKARNFLINKKNLYEFNSSP
YETGYIKFIESNGNTFWYDMMPAPGDKFDQSKYLMIYKDNKMVDSKSVKIEVHLTTKNG
//
>1jd2R (K) [d.153.1] PROTEASOME COMPONENT PRE2
TTTLAFRFQGGIIVAVDSRATAGNWVASQTVKKVIEINPFLLGTMAGGAADCQFWETWLG
SQCRLHELREKERISVAAASKILSNLVYQYKGAGLSMGTMICGYTRKEGPTIYYVDSDGT
RLKGDIFCVGSGQTFAYGVLDSNYKWDLSVEDALYLGKRSILAAAHRDAYSGGSVNLYHV
TEDGWIYHGNHDVGELFWKVKEEEGSFNNVIG
//
>1jd2Y (D) [d.153.1] PROTEASOME COMPONENT PUP2
DRGVSTFSPEGRLFQVEYSLEAIKLGSTAIGIATKEGVVLGVEKRATSPLLESDSIEKIV
EIDRHIGCAMSGLTADARSMIEHARTAAVTHNLYYDEDINVESLTQSVCDLALRFGEGAS
GEERLMSRPFGVALLIAGHDADDGYQLFHAEPSGTFYRYNAKAIGSGSEGAQAELLNEWH
SSLTLKEAELLVLKILKQVMEEKLDENNAQLSCITKQDGFKIYDNEKTAELIKELKEKEA
AE
//
>1jdhA [a.118.1] BETA-CATENIN
AVVNLIRAIPELTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQN
TNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLL
HQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQAL
VNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWT
LRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGI
EALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHW
PLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQFVEGVRMEEIVEGCTG
ALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEG
ATAPLTELLHSRNEGVATYAAAVLFRMS
//
>1jdhB [j.71.1] HTCF-4
LGANDELISFKDEGEQEEKSSENSSAERDLADVKSSLV
//
>1jebA [a.1.1] HEMOGLOBIN ZETA CHAIN
SLTKTERTIIVSMWAKISTQADTIGTETLERLFLSHPQTKTYFPHFDLHPGSAQLRAHGS
KVVAAVGDAVKSIDDIGGALSKLSELHAYILRVDPVNFKLLSHCLLVTLAARFPADFTAE
AHAAWDKFLSVVSSVLTEKYR
//
>1jebB [a.1.1] HEMOGLOBIN BETA-SINGLE CHAIN
VHLTDAEKAAVSGLWGKVNADEVGGEALGRLLVVYPWTQRYFDSFGDLSSASAIMGNAKV
KAHGKKVITAFNDGLNHLDSLKGTFASLSELHCDKLHVDPENFRLLGNMIVIVLGHHLGK
DFTPAAQAAFQKVVAGVAAALAH
//
>1jekA [h.3.2] ENV POLYPROTEIN
QSLANATAAQQEVLEASYAMVQHIAKGIRILEARVARVEA
//
>1jekB [h.3.2] ENV POLYPROTEIN
WQQWEEEIEQHEGNLSLLLREAALQVHIAQRDAR
//
>1jelL [x.x.x]
DVLMTQTPLSLPVSLGDQASISCRSSQSIVHGNGNTYLEWYLQKPGQSPKLLIYSISSRF
SGVPDRFSGSGSGTDFTLKISRVQAEDLGVYYCFQGSHVPYTFGGGTKLEIKRADAAPTV
SIFPPSSEQLTAGGASVVCFLNNFYPKDINVKWKIGDEARQGGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNAA
//
>1jelH [x.x.x]
QVQLQQSGPELVRPGSSVKISCKGSGYTFTTYAMHWVKQSHAKSLEWIGLISPSSGYTSY
NGEFKGKATMTVDKSSSTAYMELARLTSEDSAIYYCARVMGEQYFDVWGAGTTVTVSSAA
TTPPSVYPLAPGSAAGTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQGDLY
TLSSSVTVPSSPRPSETVTCNVAHPASSTKVDKKI
//
>1jelP [x.x.x]
MFEQEVTITAPNGLHTRPAAQFVKEAKGFTSEITVTSNGKSASAKSLFKLQTLGLTQGTV
VTISAEGEDEQKAVEHLVKLMAELE
//
>1jeqA [c.62.1 - b.131.1 - a.140.2] KU70
RDSLIFLVDASKAMFESQSEDELTPFDMSIQCIQSVYISKIISSDRDLLAVVFYGTEKDK
NSVNFKNIYVLQELDNPGAKRILELDQFKGQQGQKRFQDMMGHGSDYSLSEVLWVCANLF
SDVQFKMSHKRIMLFTNEDNPHGNDSAKASRARTKAGDLRDTGIFLDLMHLKKPGGFDIS
LFYRDIISIVHFEESSKLEDLLRKVRAKETRKRALSRLKLKLNKDIVISVGIYNLVQKAL
KPPPIKLYRETNEPVKTKTRTFNTSTGGLLLPSDTKRSQIYGSRQIILEKEETEELKRFD
DPGLMLMGFKPLVLLKKHHYLRPSLFVYPEESLVIGSSTLFSALLIKCLEKEVAALCRYT
PRRNIPPYFVALVPQEEELDDQKIQVTPPGFQLVFLPFADDKRKMPFTEKIMATPEQVGK
MKAIVEKLRFTYRSDSFENPVLQQHFRNLEALALDLMEPEQAVDLTLPKVEAMNKRLGSL
VDEFKELVYPPDYNPEGYSEEELKTHISKGTLGKFTVPMLKEACRAYGLKSGLKKQELLE
ALTKHFQD
//
>1jeqB [c.62.1 - b.131.1] KU80
NKAAVVLCMDVGFTMSNSIPGIESPFEQAKKVITMFVQRQVFAENKDEIALVLFGTDGTD
NPLSGGDQYQNITVHRHLMLPDFDLLEDIESKIQPGSQQADFLDALIVSMDVIQHETIGK
KFEKRHIEIFTDLSSRFSKSQLDIIIHSLKKCDISLQFFLPFSLPFRLGGHGFPLKGITE
QQKEGLEIVKMVMISLEGEDGLDEIYSFSESLRKLCVFKKIERHSIHWPCRLTIGSNLSI
RIAAYKSILQERVKKTWTVVDAKTLKKEDIQKETVYCLNDDDETEVLKEDIIQGFRYGSD
IVPFDEEQMKYKSEGKCFSVLGFCKSSQVQRRFFMGNQVLKVFAARDDEAAAVALSSLIH
ALDDLDMVAIVRYAYDKRANPQVGVAFPHIKHNYECLVYVQLPFMEDLRQYMFSSLKNSK
KYAPTEAQLNAVDALIDSMSLAKKDEKTDTLEDLFPTTKIPNPRFQRLFQCLLHRALHPR
EPLPPIQQHIWNMLNPPAEVTTKSQIPLSKIKTLFPLIEA
//
>1jfeA [x.x.x]
CKYEKNWPICVDDDWGTKCPSGCRMQGIIDDTDQNYSQRIDNIRQQLADSQNKYKTSNRV
IVETINILKPGLEGAQQLDENYGHVSTELRRRIVTLKQRVATQVNRIKALQNSIQEQVVE
MKRLEVDIDIKIRACKGSCARSFDYQVDKEGYDNIQKHLTQASSIDMHPDFQTTTLSTLK
MRPLKDSNVPE
//
>1jfeC [x.x.x]
NCCILDERFGSYCPTTCGIADFFNKYRLTTDGELLEIEGLLQQATNSTGSIEYLIQHIKT
IYPSEKQTLPQSIEQLTQKSKKIIEEIIRYENTILAHENTIQQLTDMHIMNSNKITQLKQ
KIAQLESHCQEPCKDTAEIQETTGRDCQDIANKGARKSGLYFIKPQKAKQSFLVYCEIDT
YGNGWTVLQRRLDGSEDFRRNWVQYKEGFGHLSPDDTTEFWLGNEKIHLITTQSTLPYAL
RIELEDWSGKKGTADYAVFKVGTEEDKYRLTYAYFIGGEAGDAFDGFNFGDDPSDKSYTY
HNGMRFSTFDNDNDNFEGNCAEQDGSGWWMNRCHAGHLNGPYYIGGVYSRDTGTNSYDNG
IIWATWRDRWYSMKKTTMKIIPFNRLS
//
>1jffA [c.32.1 - d.79.2] TUBULIN ALPHA CHAIN
RECISIHVGQAGVQIGNACWELYCLEHGIQPDGHVPRAVFVDLEPTVIDEVRTGTYRQLF
HPEQLITGKEDAANNYARGHYTIGKEIIDLVLDRIRKLADQCTGLQGFSVFHSFGGGTGS
GFTSLLMERLSVDYGKKSKLEFSIYPAPQVSTAVVEPYNSILTTHTTLEHSDCAFMVDNE
AIYDICRRNLDIERPTYTNLNRLIGQIVSSITASLRFDGALNVDLTEFQTNLVPYPRGHF
PLATYAPVISAEKAYHEQLSVAEITNACFEPANQMVKCDPRHGKYMACCLLYRGDVVPKD
VNAAIATIKTKRTIQFVDWCPTGFKVGINYEPPTVVPGGDLAKVQRAVCMLSNTTAIAEA
WARLDHKFDLMYAKRAFVHWYVGEGMEEGEFSEAREDMAALEKDYEEVGVDS
//
>1jffB [c.32.1 - d.79.2] TUBULIN BETA CHAIN
REIVHIQAGQCGNQIGAKFWEVISDEHGIDPTGSYHGDSDLQLERINVYYNEAAGNKYVP
RAILVDLEPGTMDSVRSGPFGQIFRPDNFVFGQSGAGNNWAKGHYTEGAELVDSVLDVVR
KESESCDCLQGFQLTHSLGGGTGSGMGTLLISKIREEYPDRIMNTFSVVPSPKVSDTVVE
PYNATLSVHQLVENTDETYCIDNEALYDICFRTLKLTTPTYGDLNHLVSATMSGVTTCLR
FPGQLNADLRKLAVNMVPFPRLHFFMPGFAPLTSRGSQQYRALTVPELTQQMFDAKNMMA
ACDPRHGRYLTVAAVFRGRMSMKEVDEQMLNVQNKNSSYFVEWIPNNVKTAVCDIPPRGL
KMSATFIGNSTAIQELFKRISEQFTAMFRRKAFLHWYTGEGMDEMEFTEAESNMNDLVSE
YQQYQD
//
>1jfiC [d.129.1 - d.129.1] TATA-BOX-BINDING PROTEIN (TBP)
SHMSGIVPQLQNIVSTVNLGCKLDLKTIALRARNAEYNPKRFAAVIMRIREPRTTALIFS
SGKMVCTGAKSEEQSRLAARKYARVVQKLGFPAKFLDFKIQNMVGSCDVKFPIRLEGLVL
THQQFSSYEPELFPGLIYRMIKPRIVLLIFVSGKVVLTGAKVRAEIYEAFENIYPILKGF
RKT
//
>1jfiA [a.22.1] TRANSCRIPTION REGULATOR NC2 ALPHA CHAIN
ARFPPARIKKIMQTDEEIGKVAAAVPVIISRALELFLESLLKKACQVTQSRTMTTSHLKQ
CIE
//
>1jfiB [a.22.1] TRANSCRIPTION REGULATOR NC2 BETA CHAIN
DDLTIPRAAINKMIKETLPNVRVANDARELVVNCCTEFIHLISSEANEICNKSEKKTISP
EHVIQALESLGFGSYISEVKEVLQECKTVALKRRKASSRLENLGIPEEELLRQQQELFAK
ARQQQAELAQQEWLQ
//
>1jgvL [b.1.1 - b.1.1] ANTIBODY LIGHT CHAIN
EVVMTQSPLSLPVSLGDQASISCRSSQSLVHSNGNTYLHWYLQKPGQSPKLLIYKVSNRF
SGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQSTHVPPLTFGAGTKLELKRADAAPT
VSIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYS
MSSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1jgvH [b.1.1 - b.1.1] ANTIBODY HEAVY CHAIN
EVKLVESRGGLVKPGGSLQLSCAASGFTFSGYAMSWFRLTPEKRLEWVASIYNGFRIHYL
DSVKGRFTISSDYARNILYLQMSTLRSEDTAMYYCSRGDAYSRYFDVWGAGTTVTVSAAK
TTAPSVYPLAPVCGDTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDLY
TLSSSVTVTSSTWPSQSITCNVAHPASSTKVDKKIEPR
//
>1jhkL [b.1.1 - b.1.1] IG KAPPA-CHAIN
DIQMTQSPASLSASVGETVTITCRASGNIHNYLAWYQQKQGKSPQLLVYNAKTLADGVPS
RFSGSGSGTQYSLKINSLQPEDFGTYYCHHFWSTPWTFGGGTKLEVKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNE
//
>1jhkH [b.1.1 - b.1.1] IG GAMMA-1-CHAIN
IQLVQSGPELKKPGETVRISCKASDYTSGMQWVQQMPGKGLKWIGWLNTQSGVPEYAEDF
KGRFAFSLETTAYLQINNLKNEDTATYFCATWGGNSAYWGQGTTLTVSSAKTTPPSVYPL
APGTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTLSSSVTVPSSTW
PSETVTCNVAHPASSTKVDKKIVPR
//
>1jhlL [b.1.1] IGG1-KAPPA D11.15 FV (LIGHT CHAIN)
DIELTQSPSYLVASPGETITINCRASKSISKSLAWYQEKPGKTNNLLIYSGSTLQSGIPS
RFSGSGSGTDFTLTISSLEPEDFAMYICQQHNEYPWTFGGGTKLEIKR
//
>1jhlH [b.1.1] IGG1-KAPPA D11.15 FV (HEAVY CHAIN)
QVQLQQSGAELVRPGASVKLSCKASGYTFISYWINWVKQRPGQGLEWIGNIYPSDSYTNY
NQKFKDKATLTVDKSSSTAYMQLSSPTSEDSAVYYCTRDDNYGAMDYWGQGTTVTV
//
>1jhlA [d.2.1] PHEASANT EGG WHITE LYSOZYME
KVYGRCELAAAMKRMGLDNYRGYSLGNWVCAAKFESNFNTGATNRNTDGSTDYGILQINS
RWWCNDGRTPGSKNLCHIPCSALLSSDITASVNCAKKIVSDGDGMNAWVAWRKHCKGTDV
NVWIRGCRL
//
>1jiwA (I) [b.61.2] PROTEINASE INHIBITOR
SSLILLSASDLAGQWTLQQDEAPAICHLELRDSEVAEASGYDLGGDTACLTRWLPSEPRA
WRPTPAGIALLERGGLTLMLLGRQGEGDYRVQKGDGGQLVLRRAT
//
>1jiwB (P) [d.92.1 - b.80.7] ALKALINE METALLOPROTEINASE
GRSDAYTQVDNFLHAYARGGDELVNGHPSYTVDQAAEQILREQASWQKAPGDSVLTLSYS
FLTKPNDFFNTPWKYVSDIYSLGKFSAFSAQQQAQAKLSLQSWSDVTNIHFVDAGQGDQG
DLTFGNFSSSVGGAAFAFLPDVPDALKGQSWYLINSSYSANVNPANGNYGRQTLTHEIGH
TLGLSHPGDYNAGEGDPTYADATYAEDTRAYSVMSYWEEQNTGQDFKGAYSSAPLLDDIA
AIQKLYGANLTTRTGDTVYGFNSNTERDFYSATSSSSKLVFSVWDAGGNDTLDFSGFSQN
QKINLNEKALSDVGGLKGNVSIAAGVTVENAIGGSGSDLLIGNDVANVLKGGAGNDILYG
GLGADQLWGGAGADTFVYGDIAESSAAAPDTLRDFVSGQDKIDLSGLDAFVNGGLVLQYV
DAFAGKAGQAILSYDAASKAGSLAIDFSGDAHADFAINLIGQATQADIVV
//
>1jj2E [d.141.1 - d.141.1] RIBOSOMAL PROTEIN L6
PRVELEIPEDVDAEQDHLDITVEGDNGSVTRRLWYPDIDVSVDGDTVVIESDEDNAKTMS
TIGTFQSHIENMFHGVTEGWEYGMEVFYSHFPMQVNVEGDEVVIENFLGEKAPRRTTIHG
DTDVEIDGEELTVSGPDIEAVGQTAADIEQLTRINDKDVRVFQDGVYITRKP
//
>1jj2I [c.21.1] RIBOSOMAL PROTEIN L13
AEFDADVIVDARDCIMGRVASQVAEQALDGETVAVVNAERAVITGREEQIVEKYEKRVDI
GNDNGYFYPKRPDGIFKRTIRGMLPHKKQRGREAFESVRVYLGNPYDEDGEVLDGTSLDR
LSNIKFVTLGEISETLGANKTW
//
>1jjoC [e.1.1] NEUROSERPIN
ENQYVMKLANSLFVQNGFHVNEEFLQMLKMYFNAEVNHVDFSQNVAVANSINKWVENYTN
SLLKDLVSPEDFDGVTNLALINAVYFKGNWKSQFRPENTRTFSFTKDDESEVQIPMMYQQ
GEFYYGEFSDGSNEAGGIYQVLEIPYEGDEISMMLALSRQEVPLATLEPLLKAQLIEEWA
NSVKKQKVEVYLPRFTVEQEIDLKDILKALGVTEFLSKAVHKSCIEVNEEGSEAAAASGM
IAIS
//
>1jjoA [e.1.1] NEUROSERPIN
TITEWSVNMYNHLRGTGEDENILFSPLSIALAMGMMELGA
//
>1jjoE [e.1.1] NEUROSERPIN
YPQVIVDHPFLYLIRNRKSGIILFMGRVMNPHH
//
>1jjuA [a.3.1 - a.3.1 - b.61.4 - b.1.18 - b.1.18] QUINOHEMOPROTEIN AMINE DEHYDROGENASE
VTGEEVLQNACAACHVQHEDGRWERIDAARKTPEGWDMTVTRMMRNHGVALEPEERAAIV
RHLSDTRGLSLAETEERRYILEREPVAWDEGPDTSMTQTCGRCHSYARVALQRRTPEDWK
HLVNFHLGQFPTLEYQALARDRDWWGIAQAEIIPFLARTYPLGEAPDAYADDASGAYVLA
GRQPGRGDYTGRLVLKKAGEDYEVTMTLDFADGSRSFSGTGRILGAGEWRATLSDGTVTI
RQIFALQDGRFSGRWHDADSDVIGGRLAAVKADAAPQVLAVAPARLKIGEETQLRVAGTG
LGSDLTLPEGVAGSVESAGNGVTVLKLTATGTPGPVSLELGGQKVDLVAYDRPDRISIVP
DLTIARIGGNGGPIPKVPAQFEAMGWLNGPDGQPGTGDDIALGAFPASWATDNFDEEAEK
MQDAKYAGSIDDTGLFTPAEAGPNPERPMQTNNAGNLKVIATVDAEGEPLSAEAHLYATV
QRFVDAPIR
//
>1jjuC [a.137.9] QUINOHEMOPROTEIN AMINE DEHYDROGENASE
MNALVGCTTSFDPGWEVDAFGAVSNLCQPMEADLYGCADPCWxPAQVADTLNTYPNWSAG
ADDVMQDWRKLQSVFPETK
//
>1jk0A [a.25.1] RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE SMALL CHAIN
LNKELETLREENRVKSDMLKEKLSKDAENHKAYLKSHQVHRHKLKEMEKEEPLLNEDKER
TVLFPIKYHEIWQAYKRAEASFWTAEEIDLSKDIHDWNNRMNENERFFISRVLAFFAASD
GIVNENLVENFSTEVQIPEAKSFYGFQIMIENIHSETYSLLIDTYIKDPKESEFLFNAIH
TIPEIGEKAEWALRWIQDADALFGERLVAFASIEGVFFSGSFASIFWLKKRGMMPGLTFS
NELICRDEGLHTDFACLLFAHLKNKPDPAIVEKIVTEAVEIEQRYFLDALPVALLGMNAD
LMNQYVEFVADRLLVAFGNKKYYKVENPFDFMEN
//
>1jk0B [a.25.1] RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE SMALL CHAIN
FQKERHDMKEAEKDEILLMENSRRFVMFPIKYHEIWAAYKKVEASFWTAEEIELAKDTED
FQKLTDDQKTYIGNLLALSILIENFSAQLQNPEGKSFYGFQIMMENIYSEVYSMMVDAFF
KDPKNIPLFKEIANLPEVKHKAAFIERWISNDDSLYAERLVAFAAKEGIFQAGNYASMFW
LTDKKIMPGLAMANRNICRDRGAYTDFSCLLFAHLRTKPNPKIIEKIITEAVEIEKEYYS
NSLPHTYIEFVADGLLQGFGNEKYY
//
>1jk8B [d.19.1 - b.1.1] MHC CLASS II HLA-DQ8
SPEDFVYQFKGMCYFTNGTERVRLVTRYIYNREEYARFDSDVGVYRAVTPLGPPAAEYWN
SQKEVLERTRAELDTVCRHNYQLELRTTLQRRVEPTVTISPSRTEALNHHNLLVCSVTDF
YPAQIKVRWFRNDQEETTGVVSTPLIRNGDWTFQILVMLEMTPQRGDVYTCHVEHPSLQN
PIIVEWRAQS
//
>1jk8A [d.19.1 - b.1.1] MHC CLASS II HLA-DQ8
VADHVASYGVNLYQSYGPSGQYSHEFDGDEEFYVDLERKETVWQLPLFRRFRRFDPQFAL
TNIAVLKHNLNIVIKRSNSTAATNEVPEVTVFSKSPVTLGQPNTLICLVDNIFPPVVNIT
WLSNGHSVTEGVSETSFLSKSDHSFFKISYLTFLPSDDEIYDCKVEHWGLDEPLLKHWEP
E
//
>1jk9A [b.1.8] SUPEROXIDE DISMUTASE
VQAVAVLKGDAGVSGVVKFEQASESEPTTVSYEIAGNSPNAERGFHIFEFGDATNGCVSA
GPHFNPFKKTHGAPTDEVRHVGDMGNVKTDENGVAKGSFKDSLIKLIGPTSVVGRSVVIH
AGQDDLGKGDTEESLKTGNAGPRPACGVIGLTN
//
>1jk9B [d.58.17 - b.1.8] COPPER CHAPERONE FOR SUPEROXIDE DISMUTASE
TNDTYEATYAIPMHCENCVNDIKACLKNVPGINSLNFDIEQQIMSVESSVAPSTIINTLR
NCGKDAIIRGAGKPNSSAVAILETFQKYTIDQKKDTAVRGLARIVQVGENKTLFDITVNG
VPEAGNYHASIHEKGDVSKGVESTGKVWHKFDEPIECFNESDLGKNLYSGKTFLSAPLPT
WQLIGRSFVISKSLNHPENEPSSVKDYSFLGVIARSAGVWENNKQVCACTGKTVWEERKD
ALA
//
>1jl4B [d.19.1 - b.1.1] H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-K
GSFVHQFQPFCYFTNGTQRIRLVIRYIYNREEYVRFDSDVGEYRAVTELGRPDAEYWNKQ
YLERTRAELDTVCRHNYEKTETPTSLRRLEQPSVVISLSRTEALNHHNTLVCSVTDFYPA
KIKVRWFRNGQEETVGVSSTQLIRNGDWTFQVLVMLEMTPRRGEVYTCHVEHPSLTSPIT
VEWRA
//
>1jl4D [b.1.1 - b.1.1] T-CELL SURFACE GLYCOPROTEIN CD4
KVVLGKKGDTVELTCTASQKKSIQFHWKNSNQIKILGNQGSFLTKGPSKLNDRADSRRSL
WDQGNFPLIIKNLKIEDSDTYICEVEDQKEEVQLLVFGLTANSDTHLLQGQSLTLTLESP
PGSSPSVQCRSPRGKNIQGGKTLSVSQLELQDSGTWTCTVLQNQKKVEFKIDIVVLA
//
>1jmaA [b.1.1] GLYCOPROTEIN D
KYALADASLKMADPNRFRGKDLPVLDQLTDPPGVRRVYHIQAGLPDPFQPPSLPITVYYA
VLERACRSVLLNAPSEAPQIVRGASEDVRKQPYNLTIAWFRMGGNCAIPITVMEYTECSY
NKSLGACPIRTQPRWNYYDSFSAVSEDNLGFLMHAPAFETAGTYLRLVKINDWTEITQFI
LEHRAKGSCKYALPLRIPPSACLSPQAYQQGVTVDSIGMLPRFIPENQRTVAVYSLKIAG
WHGPKAPYTSTLLPPELSE
//
>1jmaB [g.24.1 - g.24.1] HERPESVIRUS ENTRY MEDIATOR
CKEDEYPVGSECCPKCSPGYRVKEACGELTGTVCEPCPPGTYIAHLNGLSKCLQCQMCDP
AMGLRASRNCSRTENAVCGCSPGHFCIVQDHCAACRAYAT
//
>1jmoH [b.47.1] THROMBIN, HEAVY CHAIN
IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL
VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL
PDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIR
ITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFY
THVFRLKKWIQKVIDQFGE
//
>1jmoA [e.1.1] HEPARIN COFACTOR II
GEEDDDxLDLEKIFSEDDDxIDIVDSLSVSPTDSDVSAGNILQLFHGKSRIQRLNILNAK
FAFNLYRVLKDQVNTFDNIFIAPVGISTAMGMISLGLKGETHEQVHSILHFKDFVNASSK
YEITTIHNLFRKLTHRLFRRNFGYTLRSVNDLYIQKQFPILLDFKTKVREYYFAEAQIAD
FSDPAFISKTNNHIMKLTKGLIKDALENIDPATQMMILNCIYFKGSWVNKFPVEMTHNHN
FRLNEREVVKVSMMQTKGNFLAANDQELDCDILQLEYVGGISMLIVVPHKMSGMKTLEAQ
LTPRVVERWQKSMTNRTREVLLPKFKLEKNYNLVESLKLMGIRMLFDKNGNMAGISDQRI
AIDLFKHQGTITVNEEGTQATTVTTVGFMPLSTQVRFTVDRPFLFLIYEHRTSCLLFMGR
VANPSRS
//
>1jmtA [d.58.7] SPLICING FACTOR U2AF 35 KDA SUBUNIT
SQTIALLNIYRNPQDGLRSAVSDVEMQEHYDEFFEEVFTEMEEKYGEVEEMNVCDNLGDH
LVGNVYVKFRREEDAEKAVIDLNNRWFNGQPIHAELSP
//
>1jmtB [x.x.x] SPLICING FACTOR U2AF 65 KDA SUBUNIT
KYWDVPPPGFEHITPMQYKAMQA
//
>1jmuB [e.35.1] PROTEIN MU-1
PGGVPWIAIGDETSVTSPGALRRMTSKDIDEPLVVVTEHAIANFTKAEMALEFNREFLDK
LRVLSVSPKYSDLLTYVDCYVGVSARQALNNFQKQVPVITPTRQTMYVDSIQAALKALEK
WEIDLRVAQTLLPTNVPIGEVSCPMQSVVKLLDDQLPDDSLIRRYPKEAAVALAKRNGGI
QWMDVSEGTVMNEAVNAVAASALAPSASAPPLEEKSKLTEQAMDLVTAAEPEIIASLVPV
PAPVFAIPPKPADYNVRTLKIDEATWLRMIPKTMGTLFQIQVTDNTGTNWHFNLRGGTRV
VNLDQIAPMRFVLDLGGKSYKETSWDPNGKKVGFIVFQSKIPFELWTAASQIGQATVVNY
VQLYAEDSSFTAQSIIATTSLAYNYEPEQLNKTDPEMNYYLLATFIDSAAITPTNMTQPD
VWDALLTMSPLSAGEVTVKGAVVSEVVPAELIGSYTPESLNASLPNDAARCMIDRASKIA
EAIKIDDDAGPDEYSPNSVPIQGQLAISQLETGYGVRIFNPKGILSKIASRAMQAFIGDP
STIITQAAPVLSDKNNWIALAQGVKTSLRTKSLSAGVKTAVSKLSSSESIQNWTQGFLDK
VSTHFPAP
//
>1jmuA [e.35.1] PROTEIN MU-1
TINVTGDGNVFKPSAETSSTAVPSLSLSPGMLN
//
>1jmuF (B) [e.35.1] PROTEIN MU-1
PGGVPWIAIGDETSVTSPGALRRMTSKDIDEPLVVVTEHAIANFTKAEMALEFNREFLDK
LRVLSVSPKYSDLLTYVDCYVGVSARQALNNFQKQVPVITPTRQTMYVDSIQAALKALEK
WEIDLRVAQTLLPTNVPIGEVSCPMQSVVKLLDDQLPDDSLIRRYPKEAAVALAKRNGGI
QWMDVSEGTVMNEAVNAVAASALAPSASAPPLEEKSKLTEQAMDLVTAAEPEIIASLVPV
PAPVFAIPPKPADYNVRTLKIDEATWLRMIPKTMGTLFQIQVTDNTGTNWHFNLRGGTRV
VNLDQIAPMRFVLDLGGKSYKETSWDPNGKKVGFIVFQSKIPFELWTAASQIGQATVVNY
VQLYAEDSSFTAQSIIATTSLAYNYEPEQLNKTDPEMNYYLLATFIDSAAITPTNMTQPD
VWDALLTMSPLSAGEVTVKGAVVSEVVPAELIGSYTPESLNASLPNDAARCMIDRASKIA
EAIKIDDDAGPDEYSPNSVPIQGQLAISQLETGYGVRIFNPKGILSKIASRAMQAFIGDP
STIITQAAPVLSDKNNWIALAQGVKTSLRTKSLSAGVKTAVSKLSSSESIQNWTQGFLDK
VSTHFPAP
//
>1jmuI (G) [d.196.1] SIGMA 3 PROTEIN
MEVCLPNGHQIVDLINNAFEGRVSIYSAQEGWDKTISAQPDMMVCGGAVVCMHCLGVVGS
LQRKLKHLPHHRCNQQIRHQDYVDVQFADRVTAHWKRGMLSFVCQMHAMMNDVSPEDLDR
VRTEGGSLVELNWLQVDPNSMFRSIHSSWTDPLQVVDDLDTKLDQYWTALNLMIDSSDLV
PNFMMRDPSHAFNGVRLEGDARQTQFSRTFDSRSSLEWGVMVYDYSELEHDPSKGRAYRK
ELVTPARDFGHFGLSHYSRATTPILGKMPAVFSGMLTGNCKMYPFIKGTAKLKTVRKLVD
SVNHAWGVEKIRYALGPGGMTGWYNRTMQQAPIVLTPAALTMFSDTTKFGDLDYPVMIGD
PMILG
//
>1jmxA [a.3.1 - a.3.1 - b.61.4 - b.1.18 - b.1.18] AMINE DEHYDROGENASE
EQGPSLLQNKCMGCHIPEGNDTYSRISHQRKTPEGWLMSIARMQVMHGLQISDDDRRTLV
KYLADKQGLAPSETDGVRYAMERRLNTVEQFDTQLSETCGRCHSGARVALQRRPAKEWEH
LVNFHLGQWPSLEYQAQARDRDWLPIALQQVVPDLAKRYPLESAAWAEWQKARPKADALP
GQWAFSGHMLAKGDVRGVMSVTPDQGDTFKVEVKGAYADGTPFNGSGSAILYNGYEWRGN
VKVGDANLRQVFAALDGEMKGRMFEAEHDERGLDFTAVKEGKARLLAVQPAFIKAGGESE
ITLVGSGLAGKPDLGAGVEVTEVLEQTPTLVRLKARAAADAKPGQREVAVGTLKGVNLAV
YDKVEEVKVVPAFSIARIGENGASVPKVQGRFEAEAWGKDANGQPLRIGYLPASWKVEPF
NERAVEDEDVKFAGKMQADGVFVPGGAGPNPERKMMTNNAGNLKVIATLADGGQTGEGHM
IVTVQRWNNPPLP
//
>1jmxB [b.69.2] AMINE DEHYDROGENASE
GPALKAGHEYMIVTNYPNNLHVVDVASDTVYKSCVMPDKFGPGTAMMAPDNRTAYVLNNH
YGDIYGIDLDTCKNTFHANLSSVPGEVGRSMYSFAISPDGKEVYATVNPTQRLNDHYVVK
PPRLEVFSTADGLEAKPVRTFPMPRQVYLMRAADDGSLYVAGPDIYKMDVKTGKYTVALP
LRNWNRKGYSAPDVLYFWPHQSPRHEFSMLYTIARFATADLLYGYLSVDLKTGKTHTQEF
ADLTELYFTGLRSPKDPNQIYGVLNRLAKYDLKQRKLIKAANLDHTYYCVAFDKKGDKLY
LGGTFNDLAVFNPDTLEKVKNIKLPGGDMSTTTPQVFIR
//
>1jmzA [a.3.1 - a.3.1 - b.61.4 - b.1.18 - b.1.18] AMINE DEHYDROGENASE
EQGPSLLQNKCMGCHIPEGNDTYSRISHQRKTPEGWLMSIARMQVMHGLQISDDDRRTLV
KYLADKQGLAPSETDGVRYAMERRLNTVEQFDTQLSETCGRCHSGARVALQRRPAKEWEH
LVNFHLGQWPSLEYQAQARDRDWLPIALQQVVPDLAKRYPLESAAWAEWQKARPKADALP
GQWAFSGHMLAKGDVRGVMSVTPDQGDTFKVEVKGAYADGTPFNGSGSAILYNGYEWRGN
VKVGDANLRQVFAALDGEMKGRMFEAEHDERGLDFTAVKEGKARLLAVQPAFIKAGGESE
ITLVGSGLAGKPDLGAGVEVTEVLEQTPTLVRLKARAAADAKPGQREVAVGTLKGVNLAV
YDKVEEVKVVPAFSIARIGENGASVPKVQGRFEAEAWGKDANGQPLRIGYLPASWKVEPF
NERAVEDEDVKFAGKMQADGVFVPGGAGPNPERKMMTNNAGNLKVIATLADGGQTGEGHM
IVTVQRWNNPPLP
//
>1jmzB [b.69.2] AMINE DEHYDROGENASE
GPALKAGHEYMIVTNYPNNLHVVDVASDTVYKSCVMPDKFGPGTAMMAPDNRTAYVLNNH
YGDIYGIDLDTCKNTFHANLSSVPGEVGRSMYSFAISPDGKEVYATVNPTQRLNDHYVVK
PPRLEVFSTADGLEAKPVRTFPMPRQVYLMRAADDGSLYVAGPDIYKMDVKTGKYTVALP
LRNWNRKGYSAPDVLYFWPHQSPRHEFSMLYTIARFATADLLYGYLSVDLKTGKTHTQEF
ADLTELYFTGLRSPKDPNQIYGVLNRLAKYDLKQRKLIKAANLDHTYYCVAFDKKGDKLY
LGGTFNDLAVFNPDTLEKVKNIKLPGGDMSTTTPQVFIR
//
>1jmzG [a.137.9] AMINE DEHYDROGENASE
AVAGCTATTDPGWEVDAFGGVSSLCQPMEADLYGCSDPCWxPAQVPDMMSTYQDWNAQAS
NSAEDWRNLGTVFPKDK
//
>1jn5A [d.17.4] P15
VDFKTYVDQACRAAEEFVNVYYTTMDKRRRLLSRLYMGTATLVWNGNAVSGQESLSEFFE
MLPSSEFQISVVDCQPVHDEATPSQTTVLVVICGSVKFEGNKQRDFNQNFILTAQASPSN
TVWKIASDCFRFQDWA
//
>1jn5B [d.17.4] TAP
APPCKGSYFGTENLKSLVLHFLQQYYAIYDSGDRQGLLDAYHDGACCSLSIPFIARSSLA
EYFKDSRNVKKLKDPTLRFRLLKHTRLNVVAFLNELPKTQHDVNSFVVDISAQTSTLLCF
SVNGVFKEVDGKSRDSLRAFTRTFIAVPASNSGLCIVNDELFVRNASSEEIQRAFAMPAP
TP
//
>1jn9A [d.153.1] PUTATIVE L-ASPARAGINASE
GKAVIAIHGGAGAISRAQMSLQQELRYIEALSAIVETGQKMLEAGESALDVVTEAVRLLE
ExPLFNAGIGAVFTRDETHELDACVMDGNTLKAGAVAGVSHLRNPVLAARLVMEQSPHVM
MIGEGAENFAFARGMERVSPEIFSTSLRYEQLLAARKE
//
>1jn9B [d.153.1] PUTATIVE L-ASPARAGINASE
TVGAVALDLDGNLAAATSTGGMTNKLPGRVGDSPLVGAGCYANNASVAVSCTGTGEVFIR
ALAAYDIAALMDYGGLSLAEACERVVMEKLPALGGSGGLIAIDHEGNVALPFNTEGMYRA
WGYAGDTPTTGIYR
//
>1jnc_1B [x.x.x]
TACPEESPLLVGPMLIEFNIPVDLKLVEQQNPKVKLGGRYTPMDCISPHKVAIIIPFRNR
QEHLKYWLYYLHPILQRQQLDYGIYVINQAGESMFNRAKLLNVGFKEALKDYDYNCFVFS
DVDLIPMNDHNTYRCFSQPRHISVAMDKFGFSLPYVQYFGGVSALSKQQFLSINGFPNNY
WGWGGEDDDIYNRLAFRGMSVSRPNAVIGKCRMIRHSRDKKNEPNPQRFDRIAHTKETML
SDGLNSLTYMVLEVQRYPLYTKITVDIGTPS
//
>1jnc_1A [x.x.x]
TELTKCKVSHAIKDMDGYQGISLLEWTCVLFHTSGYDSQAVVNDNGSTEYGLFQISERFW
CKSSEFPESENICGISCDKLLDDELDDDIVCAKKIVAIKGIDYWKAYKPMCSEKLEQWRC
EKP
//
>1jnh_2C (A) [b.1.1 - b.1.1] MONOCLONAL ANTI-ESTRADIOL 10G6D6 IMMUNOGLOBULIN
QAVVTQESALTTSPGETVTLTCRSSSGAITTSHYANWIQEKPDHLFTGLISGTNNRAPGV
PARFSGSLIGDKAALTITGAQTEDEAIYICALWFSNQFIFGSGTKVTVKSSPSVTLFPPS
SEELETNKATLVCTITDFYPGVVTVDWKVDGTPVTQGMETTQPSKQSNNKYMASSYLTLT
ARAWERHSSYSCQVTHEGHTVEKSLSAA
//
>1jnh_2D (B) [b.1.1 - b.1.1] MONOCLONAL ANTI-ESTRADIOL 10G6D6 IMMUNOGLOBULIN
EVQLQQSGAELARPGASVKLSCRTSGYSFTTYWMQWVRQRPGQGLEWIAAIYPGDDDARY
TQKFKGKATLTADRSSSIVYLQLNSLTSEDSAVYSCSRGRSLYYTMDYWGQGTSVTVTTP
PSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVSWNTGSLSSGVHTFPAVLQSDLYTLS
SSVTVPSSTWPSETVTCNVAHPASSTKVDKKIVP
//
>1jnnA (L) [b.1.1 - b.1.1] MONOCLONAL ANTI-ESTRADIOL 17E12E5 IMMUNOGLOBULIN
QIVMTQTPASLSASVGETVTITCRASGNIYNYLAWYQQKQGKSPQLLVYNAKTLVDGVPL
RFSGSGSGTQYSLKINSLQPEDFGNYYCHHFWNTPYTFGGGTKLEIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNR
//
>1jnnB (H) [b.1.1 - b.1.1] MONOCLONAL ANTI-ESTRADIOL 17E12E5 IMMUNOGLOBULIN
EVQLQQSGAELVKPGASVRLSCSASGFNIKDTYMFWVKQRPEQGLDWIGRINPANGISKY
DPRFQGKATLTADTSSNTAYLQLDNLTSEDTAVYYCAIEKDLPWGQGTLVTVSVAKTTPP
SVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTLSS
SVTVPSSTWPSETVTCNVAHPASSTKVDKKIVPR
//
>1jpsH [b.1.1 - b.1.1] IMMUNOGLOBULIN FAB D3H44, HEAVY CHAIN
EVQLVESGGGLVQPGGSLRLSCAASGFNIKEYYMHWVRQAPGKGLEWVGLIDPEQGNTIY
DPKFQDRATISADNSKNTAYLQMNSLRAEDTAVYYCARDTAAYFDYWGQGTLVTVSSAST
KGPSVFPLAPSSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSS
VVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEP
//
>1jpsT [b.1.2 - b.1.2] TISSUE FACTOR
NTVAAYNLTWKSTNFKTILEWEPKPVNQVYTVQISTKSGDWKSKCFYTTDTECDLTDEIV
KDVKQTYLARVFSYPAGNVEPLYENSPEFTPYLETNLGQPTIQSFEQVGTKVNVTVEDER
TLVRRNNTFLSLRDVFGKDLIYTLYYWKSSSSGKKTAKTNTNEFLIDVDKGENYCFSVQA
VIPSRTVNRKSTDSPVECMG
//
>1jptL [b.1.1 - b.1.1] IMMUNOGLOBULIN FAB D3H44, LIGHT CHAIN
DIQMTQSPSSLSASVGDRVTITCRASRDIKSYLNWYQQKPGKAPKVLIYYATSLAEGVPS
RFSGSGSGTDYTLTISSLQPEDFATYYCLQHGESPWTFGQGTKVEIKRTVAAPSVFIFPP
SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT
LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGE
//
>1jptH [b.1.1 - b.1.1] IMMUNOGLOBULIN FAB D3H44, HEAVY CHAIN
EVQLVESGGGLVQPGGSLRLSCAASGFNIKEYYMHWVRQAPGKGLEWVGLIDPEQGNTIY
DPKFQDRATISADNSKNTAYLQMNSLRAEDTAVYYCARDTAAYFDYWGQGTLVTVSSAST
KGPSVFPLAPSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSV
VTVPSSSLGTQTYICNVNHKPSNTKVDKKVEP
//
>1jpw_2B (A) [a.118.1] BETA-CATENIN
RAIPELTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVET
ARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAK
MAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRT
YTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSD
AATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRT
VLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKAT
VGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRFVEGVRMEEIVEGCTGALHIL
ARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPL
TELLHSRNEGVATYAAAVLFRM
//
>1jpw_2E (D) [j.71.1] TRANSCRIPTION FACTOR 7-LIKE 2
GANDELISFKDEGDLADVKSSLVN
//
>1jqjC [c.37.1 - a.80.1] DNA POLYMERASE III, DELTA SUBUNIT
MIRLYPEQLRAQLNEGLRAAYLLLGNDPLLLQESQDAVRQVAAAQGFEEHHTFSIDPNTD
WNAIFSLCQAMSLFASRQTLLLLLPENGPNAAINEQLLTLTGLLHDDLLLIVRGNKLSKA
QENAAWFTALANRSVQVTCQTPEQAQLPRWVAARAKQLNLELDDAANQVLCYCYEGNLLA
LAQALERLSLLWPDGKLTLPRVEQAVNDAAHFTPFHWVDALLMGKSKRALHILQQLRLEG
SEPVILLRTLQRELLLLVNLKRQSAHTPLRALFDKHRVWRRGMMGEALNRLSQTQLRQAV
QLLTRTELTLKQDYGQAELEGLSLLLCH
//
>1jqjB (A) [d.131.1 - d.131.1 - d.131.1] DNA POLYMERASE III, BETA CHAIN
MKFTVEREHLLKPLQQVSGPLGGRPTLPILGNLLLQVADGTLSLTGTDLEMEMVARVALV
QPHEPGATTVPARKFFDICRGLPEGAEIAVQLEGERMLVRSGRSRFSLSTLPAADFPNLD
DWQSEVEFTLPQATMKRLIEATQFSMAHQDVRYYLNGMLFETEGEELRTVATDGHRLAVC
SMPIGQSLPSHSVIVPRKGVIELMRMLDGGDNPLRVQIGSNNIRAHVGDFIFTSKLVDGR
FPDYRRVLPKNPDKHLEAGCDLLKQAFARAAAASNEKFRGVRLYVSENQLKITANNPEQE
EAEEILDVTYSGAEMEIGFNVSYVLDVLNALKCENVRMMLTDSVSSVQIEDAASQSAAYV
VMPMRL
//
>1jqlA [d.131.1 - d.131.1 - d.131.1] DNA POLYMERASE III, BETA CHAIN
MKFTVEREHLLKPLQQVSGPLGGRPTLPILGNLLLQVADGTLSLTGTDLEMEMVARVALV
QPHEPGATTVPARKFFDICRGLPEGAEIAVQLEGERMLVRSGRSRFSLSTLPAADFPNLD
DWQSEVEFTLPQATMKRLIEATQFSMAHQDVRYYLNGMLFETEGEELRTVATDGHRLAVC
SMPIGQSLPSHSVIVPRKGVIELMRMLDGGDNPLRVQIGSNNIRAHVGDFIFTSKLVDGR
FPDYRRVLPKNPDKHLEAGCDLLKQAFARAAAASNEKFRGVRLYVSENQLKITANNPEQE
EAEEILDVTYSGAEMEIGFNVSYVLDVLNALKCENVRMMLTDSVSSVQIEDAASQSAAYV
VMPMRL
//
>1jqlB [c.37.1] DNA POLYMERASE III, DELTA SUBUNIT
MIRLYPEQLRAQLNEGLRAAYLLLGNDPLLLQESQDAVRQVAAAQGFEEHHTFSIDPNTD
WNAIFSLCQAMSLFASRQTLLLLLPENGPNAAINEQLLTLTGLLHDDLLLIVRGNKLSKA
QENAAWFTALANRSVQVTCQ
//
>1jrhL [b.1.1 - b.1.1] ANTIBODY A6
SVEMTQSPSSFSVSLGDRVTITCKASEDIYNRLAWYQQKPGNAPRLLISGATSLETEVPS
RFSGSGSGKDYTLSITSLQTEDVATYYCQQYWSTWTFGGGTKLEIKRADAAPTVSIFPCF
LNNFYPKDINVKGVLNSWTDQDSKDSTYSMSSTCEATHKTSTSPIVK
//
>1jrhH [b.1.1 - b.1.1] ANTIBODY A6
AVKLQESGPGILKPSQTLSLTCSFSGFSLTTYGMGVGWIRQSSGKGLEWLAHIWWDDDKY
YNPSLKSRLTISKDTSRNQVFLKITSVATADTATYYCARRAPFYGNHAMDYWGQGTTVTV
SSAKTTPCLVYFPEPVTVTWNSGSSGVHTFPAVLQSDLYTLSSSVTCNVAHPASSTKVDK
//
>1jrhI [b.1.2] INTERFERON-GAMMA RECEPTOR ALPHA CHAIN
SVPTPTNVTIESYNMNPIVYWEYQIMPQVPVFTVEVKNYGVKNSEWIDACINISHHYCNI
SDHVGDPSNSLWVRVKARVGQKESAYAKSEEFAVS
//
>1jsiA [b.19.1] HAEMAGGLUTININ (HA1 CHAIN)
DKICIGYQSTNSTETVDTLTETNVPVTHAKELLHTSHNGMLCATNLGHPLILDTCTIEGL
IYGNPSCDLLLGGREWSYIVERPSAVNGMCYPGNVENLEELRSLFSSASSYQRIQIFPDT
IWNVSYSGTSSACSDSFYRSMRWLTQKNNAYPIQDAQYTNNRGKSILFMWGINHPPTDTV
QTNLYTRTDTTTSVTTEDINRTFKPVIGPRPLVNGLHGRIDYYWSVLKPGQTLRVRSNGN
LIAPWYGHILSGESHGRILKTDLNSGNCVVQCQTERGGLNTTLPFHNVSKYAFGNCPKYV
GVKSLKLAVGLRNVPAR
//
>1jsiB [h.3.1] HAEMAGGLUTININ (HA2 CHAIN)
GLFGAIAGFIEGGWPGLVAGWYGFQHSNDQGVGMAADSDSTQKAIDKITSKVNNIVDKMN
KQYGIIDHEFSEIETRLNMINNKIDDQIQDIWTYNAELLVLLENQKTLDEHDANVNNLYN
KVKRALGSNAMEDGKGCFELYHKCDDQCMETIRNGTYNRR
//
>1jsmA [b.19.1] HAEMAGGLUTININ (HA1 CHAIN)
DQICIGYHANNSTEQVDTIMEKNVTVTHAQDILEKTHNGKLCDLNGVKPLILRDCSVAGW
LLGNPMCDEFLNVPEWSYIVEKDNPVNGLCYPENFNDYEELKHLLSSTNHFEKIRIIPRS
SWSNHDASSGVSSACPYNGRSSFFRNVVWLIKKNNAYPTIKRSYNNTNQEDLLILWGIHH
PNDAAEQTKLYQNPTTYVSVGTSTLNQRSVPEIATRPKVNGQSGRMEFFWTILKPNDAIN
FESNGNFIAPEYAYKIVKKGGSAIMKSGLEYGNCNTKCQTPMGAINSSMPFHNIHPLTIG
ECPKYVKSGRLVLATGLRNVP
//
>1jsmB [h.3.1] HAEMAGGLUTININ (HA2 CHAIN)
GLFGAIAGFIEGGWQGMVDGWYGYHHSNEQGSGYAADKESTQKAIDGTTNKVNSIIDKMN
TQFEAVGKEFNNLERRIENLNKKMEDGFLDVWTYNAELLVLMENERTLDFHDSNVKNLYD
KVRLQLRDNAKELGNGCFEFYHKCDNECMESVKNGTYDYP
//
>1jsuA [d.144.1] CYCLIN-DEPENDENT KINASE-2
GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT
ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN
LLINTEGAIKLADFGLARAFGVPVRTYxHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI
FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV
PPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
//
>1jsuB [a.74.1 - a.74.1] CYCLIN A
VPDYHEDIHTYLREMEVKCKPKVGYMKKQPDITNSMRAILVDWLVEVGEEYKLQNETLHL
AVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRM
EHLVLKVLTFDLAAPTVNQFLTQYFLHQQPANCKVESLAMFLGELSLIDADPYLKYLPSV
IAGAAFHLALYTVTGQSWPESLIRKTGYTLESLKPCLMDLHQTYLKAPQHAQQSIREKYK
NSKYHGVSLLNPPETLNL
//
>1jsuC [j.55.1] P27
KPSACRNLFGPVDHEELTRDLEKHCRDMEEASQRKWNFDFQNHKPLEGKYEWQEVEKGSL
PEFYYRPPR
//
>1jtdA [e.3.1] TEM-1 BETA-LACTAMASE
PETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDA
GQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPK
ELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASRQQ
LIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGS
QATMDERNRQIAEIGASLIKHW
//
>1jtdB [b.69.5] BETA-LACTAMASE INHIBITOR PROTEIN II
VAATSVVAWGGNNDWGEATVPAEAQSGVDAIAGGYFHGLALKGGKVLGWGANLNGQLTMP
AATQSGVDAIAAGNYHSLALKDGEVIAWGGNEDGQTTVPAEARSGVDAIAAGAWASYALK
DGKVIAWGDDSDGQTTVPAEAQSGVTALDGGVYTALAVKNGGVIAWGDNYFGQTTVPAEA
QSGVDDVAGGIFHSLALKDGKVIAWGDNRYKQTTVPTEALSGVSAIASGEWYSLALKNGK
VIAWGSSRTAPSSVQSGVSSIEAGPNAAYALKG
//
>1jthA [h.1.15] SNAP25
LEEMQRRADQLADESLESTRRMLQLVEESKDAGIRTLVMLDEQGEQLERIEEGMDQINKD
MK
//
>1jthB [h.1.15] SYNTAXIN 1A
ALSEIETRHSEIIKLENSIRELHDMFMDMAMLVESQGEMIDRIEYNVEHAVDYVERAVSD
TKKAVKY
//
>1jthC [h.1.15] SNAP25
ELEEMQRRADQLADESLESTRRMLQLVEESKDAGIRTLVMLDEQGEQLERIEEGMDQINK
DMKEAEKNL
//
>1jthD [h.1.15] SYNTAXIN 1A
IETRHSEIIKLENSIRELHDMFMDMAMLVESQGEMIDRIEYNVEHAVDYVE
//
>1jtp_1A [b.1.1] SINGLE-DOMAIN ANTIBODY
DVQLQASGGGSVQAGGSLRLSCAASGYTIGPYCMGWFRQAPGKEREGVAAINMGGGITYY
ADSVKGRFTISQDNAKNTVYLLMNSLEPEDTAIYYCAADSTIYASYYECGHGLSTGGYGY
DSWGQGTQVTVSSRR
//
>1jtp_1L [d.2.1] LYSOZYME C
KVYGRCELAAAMKRLGLDNYRGYSLGNWVCAAKFESNFNTHATNRNTDGSTDYGILQINS
RWWCNDGRTPGSKNLCNIPCSALLSSDITASVNCAKKIASGGNGMNAWVAWRNRCKGTDV
HAWIRGCRL
//
>1jtrA [x.x.x]
QSVTQPDARVTVSEGASLQLRCKYSYSATPYLFWYVQYPRQGLQLLLKYYSGDPVVQGVN
GFEAEFSKSNSSFHLRKASVHWSDSAVYFCAVSGFASALTFGSGTKVIVLPYIQNPEPAV
YALKDPRSQDSTLCLFTDFDSQINVPKTMESGTFITDATVLDMKAMDSKSNGAIAWSNQT
SFTCQDIFKETNATYPSSDVPC
//
>1jtrB [x.x.x]
EAAVTQSPRNKVAVTGGKVTLSCNQTNNHNNMYWYRQDTGHGLRLIHYSYGAGSTEKGDI
PDGYKASRPSQENFSLILELATPSQTSVYFCASGGGGTLYFGAGTRLSVLEDLRNVTPPK
VSLFEPSKAEIANKQKATLVCLARGFFPDHVELSWWVNGKEVHSGVSTDPQAYKESNYSY
CLSSRLRVSATFWHNPRNHFRCQVQFHGLSEEDKWPEGSPKPVTQNISAEAWGRADC
//
>1jtrH [x.x.x]
GPHSLRYFVTAVSRPGLGEPRYMEVGYVDDTEFVRFDSDAENPRYEPRARWMEQEGPEYW
ERETQKAKGNEQSFRVSLRTLLGYYNQSAGGSHTIQVISGCEVGSDGRLLRGYQQYAYDG
CDYIALNEDLKTWTAADMAALITKHKWEQAGEAERLRAYLEGTCVEWLRRYLKNGNATLL
RTDSPKAHVTHHSRPEDKVTLRCWALGFYPADITLTWQLNGEELIQDMELVETRPAGDGT
FQKWASVVVPLGKEQYYTCHVYHQGLPEPLTLRW
//
>1jttB (L) [d.2.1] LYSOZYME
KVFGRCELAAAMKRHGLDNYRGYSLGNWVCAAKFESNFNTQATNRNTDGSTDYGILQINS
RWWCNDGRTPGSRNLCNIPCSALLSSDITASVNCAKKIVSDGNGMNAWVAWRNRCKGTDV
QAWIRGCRL
//
>1jttC (A) [b.1.1] VH SINGLE-DOMAIN ANTIBODY
DVQLQASGGGSVQAGGSLRLSCAASGYTIGPYCMGWFRQAPGKEREGVAAINMGGGITYY
ADSVKGRFTISQDNAKNTVYLLMNSLEPEDTAIYYCAADSTIYASYYECGHGLSTGGYGY
DSWGQGTQVTVSS
//
>1jv5B [b.1.1] IG CHAIN HEAVY CHAIN PRECURSOR V REGION
QVQLQQPGAELVKPGTSVKLSCKASGYNFTSYWINWVKLRPGQGLEWIGDIYPGSGITNY
NEKFKSKATLTVDTSSSTAYMQLSSLASEDSALYYCAGQYGNLWFAYWGQGTLVTVS
//
>1jv5A [b.1.1] IG KAPPA CHAIN PRECURSOR V REGION
DIQMTQTTSSLSASLGDRVTISCRASQDINNYLNWYQQKPDGTVKLLIHYTSRLHSGVPS
RFSGSGSGTDYSLTISNLEQEDIATYFCQQGNTLPWTFGGGTKLEIK
//
>1jwaA (B) [c.111.1] MOLYBDOPTERIN BIOSYNTHESIS MOEB PROTEIN
AELSDQEMLRYNRQIILRGFDFDGQEALKDSRVLIVGLGGLGCAASQYLASAGVGNLTLL
DFDTVSLSNLQRQTLHSDATVGQPKVESARDALTRINPHIAITPVNALLDDAELAALIAE
HDLVLDCTDNVAVRNQLNAGCFAAKVPLVSGAAIRMEGQITVFTYEAGVMAPLIGVIGSL
QAMEAIKMLAGYGKPASGKIVMYDAMTCQFREMKLMR
//
>1jwaC (D) [d.15.3] MOLYBDOPTERIN [MPT] CONVERTING FACTOR, SUBUNIT 1
MIKVLFFAQVRELVGTDATEVAADFPTVEALRQHMAAQSDRWALALEDGKLLAAVNQTLV
SFDHPLTDGDEVAFFPPVTGG
//
>1jwbA (B) [c.111.1] MOLYBDOPTERIN BIOSYNTHESIS MOEB PROTEIN
AELSDQEMLRYNRQIILRGFDFDGQEALKDSRVLIVGLGGLGCAASQYLASAGVGNLTLL
DFDTVSLSNLQRQTLHSDATVGQPKVESARDALTRINPHIAITPVNALLDDAELAALIAE
HDLVLDCTDNVAVRNQLNAGCFAAKVPLVSGAAIRMEGQITVFTYQDGEPCYRCLSRLFG
EAGVMAPLIGVIGSLQAMEAIKMLAGYGKPASGKIVMYDAMTCQFREMKLMRNPGCEVCG
//
>1jwbC (D) [d.15.3] MOLYBDOPTERIN [MPT] CONVERTING FACTOR, SUBUNIT 1
IKVLFFAQVRELVGTDATEVAADFPTVEALRQHMAAQSDRWALALEDGKLLAAVNQTLVS
FDHPLTDGDEVAFFPPVTGG
//
>1jwiA [d.169.1] BITISCETIN
CLPDWSSYKGHCYKVFKKVGTWEDAEKFCVENSGHLASIDSKEEADFVTKLASQTLFVYD
AWIGLRDESKTQQCSPQWTDGSSVVYENVDEPTKCFGLDVHTEYRTWTDLPCGEKNPFIC
KS
//
>1jwiB [d.169.1] PLATELET AGGREGATION INDUCER
GCLPDWSSYKGHCYKVFKVEKTWADAEKFCKELVNGGHLMSVNSREEGEFISKLALEKMR
IVLVWIGLSHFWRICPLRWTDGARLDYRALSDEPICFVAESFHNKWIQWTCNRKKSFVCK
YRV
//
>1jwuA [d.19.1 - b.1.1] HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR
EEHVIIQAEFYLNPDQSGEFMFDFDGDEIFHVDMAKKETVWRLEEFGRFASFEAQGALAN
IAVDKANLEIMTKRSNYTPITNVPPEVTVLTNSPVELREPNVLICFIDKFTPPVVNVTWL
RNGKPVTTGVSETVFLPREDHLFRKFHYLPFLPSTEDVYDCRVEHWGLDEPLLKHWEFDA
//
>1jwuB [d.19.1 - b.1.1] HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR-1
GDTRPRFLWQLKFECHFFNGTERVRLLERCIYNQEESVRFDSDVGEYRAVTELGRPDAEY
WNSQKDLLEQRRAAVDTYCRHNYGVGESFTVQRRVEPKVTVYPSKTQHHNLLVCSVSGFY
PGSIEVRWFRNGQEEKAGVVSTGLIQNGDWTFQTLVMLETVPRSGEVYTCQVEHPSVTSP
LTVEWRA
//
>1jwyA [c.37.1 - b.34.3] MYOSIN II HEAVY CHAIN
DPIHDRTSDYHKYLKVKQFKLTVSDKRYIWYNPDPKERDSYECGEIVSETSDSFTFKTVD
GQDRQVKKDDANQRNPIKFDGVEDMSELSYLNEPAVFHNLRVRYNQDLIYTYSGLFLVAV
NPFKRIPIYTQEMVDIFKGRRRNEVAPHIFAISDVAYRSMLDDRQNQSLLITGESGAGKT
ENTKKVIQYLASVAGSGVLEQQILQANPILEAFGNAKTTRNNNSSRFGKFIEIQFNSAGF
ISGASIQSYLLEKSRVVFQSETERNYHIFYQLLAGATAEEKKALHLAGPESFNYLNQSGC
VDIKGVSDSEEFKITRQAMDIVGFSQEEQMSIFKIIAGILHLGNIKFEKGAGEGAVLKDK
TALNAASTVFGVNPSVLEKALMEPRILAGRDLVAQHLNVEKSSSSRDALVKALYGRLFLW
LVKKINNVLCQERKAYFIGVLDISGFEIFKVNSFEQLCINYTNEKLQQFFNHHMFKLEQE
EYLKEKINWTFIDFGLDSQATIDLIDGRQPPGILALLDEQSVFPNATDNTLITKLHSHFS
KKNAKYEEPRFSKTEFGVTHYAGQVMYEIQDWLEKNKDPLQQDLELCFKDSSDNVVTKLF
NDPNIASRAKKGANFITVAAQYKEQLASLMATLETTNPHFVRCIIPNNKQLPAKLEDKVV
LDQLRCNGVLEGIRITRKGFPNRIIYADFVKRYYLLAPNVPRDAEDSQKATDAVLKHLNI
DPEQYRFGITKIFFRAGQLARIEEAREQRISEI
//
>1jwyB [c.37.1] DYNAMIN A GTPASE DOMAIN
DQLIPVINKLQDVFNTLGSDPLDLPQIVVVGSQSSGKSSVLENIVGRDFLPRPLILQLTH
LPIADDGSQTQEWGEFLHKPNDMFYDFSEIREEIIRDTDISAQPINLKIYSPHVVNLTLV
DLPGITDIEQQIRRMVMAYIKKQNAIIVAVTPANTDLANSDALQLAKEVDPEGKRTIGVI
TKLDLMDKGTDAMEVLTGRVIPLTLGFIGVINRSQEDIIAKKSIRESLKSEILYFKNHPI
YKSIANRSGTAYLSKTLNKLLMFHIRDTLPDLKVKVSKMLS
//
>1jy2O [h.1.8] FIBRINOGEN BETA CHAIN
RKPPDADGCLHADPDLGVLCPTGCKLQDTLVRQERPIRKSIEDLRNTVDSV
//
>1jy2N [h.1.8] FIBRINOGEN ALPHA CHAIN
GWPFCSDEDWNTKCPSGCRMKGLIDEVDQDFTSRINKLRDSLF
//
>1jy2P [h.1.8] FIBRINOGEN GAMMA-B CHAIN
RDNCCILDERFGSYCPTTCGIADFLNNYQTSVDKDLRTLEGILY
//
>1jy2Q (N) [h.1.8] FIBRINOGEN ALPHA CHAIN
GWPFCSDEDWNTKCPSGCRMKGLIDEVDQDFTSRINKLRDSLF
//
>1jy2R [h.1.8] FIBRINOGEN BETA CHAIN
RKPPDADGCLHADPDLGVLCPTGCKLQDTLVRQERPIRKSIEDLRNTVDS
//
>1jyoE [d.184.1] PROTEIN TYROSINE PHOSPHATASE SPTP
DKAYVAPEKFSSKVLTWLGKMPLFKNTEVVQKHTENIRVQDQKILQTFLHALTEKYGETA
VNDALLMSRINMNKPLTQRLAVQITECVKAADEGFINLIKSK
//
>1jyoD (A) [d.198.1] SICP
LQAHQDIIANIGEKLGLPLTFDDNNQCLLLLDSDIFTSIEAKDDIWLLNGMIIPLSPVCG
DSIWRQIMVINGELAANNEGTLAYIDAAETLLLIHAITDLTNTYHIISQLESFVNQQEAL
KNILQEYAKV
//
>1jzdB [d.17.3 - c.47.1] THIOL:DISULFIDE INTERCHANGE PROTEIN DSBC
DDAAIQQTLAKMGIKSSDIQPAPVAGMKTVLTNSGVLYITDDGKHIIQGPMYDVSGTAPV
NVTNKMLLKQLNALEKEMIVYKAPQEKHVITVFTDITCGYSHKLHEQMADYNALGITVRY
LAFPRQGLDSDAEKEMKAIWCAKDKNKAFDDVMAGKSVAPASCDVDIADHYALGVQLGVS
GTPAVVLSNGTLVPGYQPPKEMKEFLDEHQKMTS
//
>1jzdC [b.1.17] THIOL:DISULFIDE INTERCHANGE PROTEIN DSBD
RSQFVPADQAFAFDFQQNQHDLNLTWQIKDGYYLYRKQIRITPEHAKIADVQLPQGVWHE
DEFYGKSEIYRDRLTLPVTINQASAGATLTVTYQGAADAGFCYPPETKTVPLSEVVAN
//
>1k3bB [d.3.1] DIPEPTYDIL-PEPTIDASE I LIGHT CHAIN
LPTSWDWRNVHGINFVSPVRNQASCGSCYSFASMGMLEARIRILTNNSQTPILSPQEVVS
CSQYAQGCEGGFPYLIAGKYAQDFGLVEEACFPYTGTDSPCKMKEDCFRYYSSEYHYVGG
FYGGCNEALMKLELVHHGPMAVAFEVYDDFLHYKKGIYHHTGLR
//
>1k3bA [b.61.5] DIPEPTYDIL-PEPTIDASE I EXCLUSION DOMAIN
DTPANCTYLDLLGTWVFQVGSSGSQRDVNCSVMGPQEKKVVVYLQKLDTAYDDLGNSGHF
TIIYNQGFEIVLNDYKWFAFFKYKEEGSKVTTYCNETMTGWVHDVLGRNWACFTGKKVG
//
>1k3bC [d.3.1] DIPEPTYDIL-PEPTIDASE I HEAVY CHAIN
DPFNPFELTNHAVLLVGYGTDSASGMDYWIVKNSWGTGWGENGYFRIRRGTDECAIESIA
VAATPIPKL
//
>1k3zA [b.1.18] TRANSCRIPTION FACTOR P65
TAELKICRVNRNSGSCLGGDEIFLLCDKVQKEDIEVYFTGPGWEARGSFSQADVHRQVAI
VFRTPPYADPSLQAPVRVSMQLRRPSDRELSEPMEFQYLPDTDDRHRIEEKRKRTYETFK
SIMKKSPFNG
//
>1k3zD [d.211.1] TRANSCRIPTION FACTOR INHIBITOR I-KAPPA-B-BETA
GYVTEDGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVE
KLYAAGAGVLVAERGGHTALHLACRVRAHTCACVLLQPRPSHPRDEDWRLQLEAENYDGH
TPLHVAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPT
ARMYGGRTPLGSALLRPNPILARLLRAHGAPEPEDGGDKLS
//
>1k5d_1J (A) [c.37.1] GTP-BINDING NUCLEAR PROTEIN RAN
QVQFKLVLVGDGGTGKTTFVKRHLTGEFEKKYVATLGVEVHPLVFHTNRGPIKFNVWDTA
GQEKFGGLRDGYYIQAQCAIIMFDVTSRVTYKNVPNWHRDLVRVCENIPIVLCGNKVDIK
DRKVKAKSIVFHRKKNLQYYDISAKSNYNFEKPFLWLARKLIGDPNLEFVAMPALAPPEV
VMDPALAAQYEHDLEVAQTTALPDED
//
>1k5d_1K (B) [b.55.1] RAN-SPECIFIC GTPASE-ACTIVATING PROTEIN
NHDPQFEPIVSLPEQEIKTLEEDEEELFKMRAKLFRFASENDLPEWKERGTGDVKLLKHK
EKGAIRLLMRRDKTLKICANHYITPMMELKPNAGSDRAWVWNTHADFADECPKPELLAIR
FLNAENAQKFKTKFEECRKEIEEREK
//
>1k5d_3D (A) [c.37.1] GTP-BINDING NUCLEAR PROTEIN RAN
QVQFKLVLVGDGGTGKTTFVKRHLTGEFEKKYVATLGVEVHPLVFHTNRGPIKFNVWDTA
GQEKFGGLRDGYYIQAQCAIIMFDVTSRVTYKNVPNWHRDLVRVCENIPIVLCGNKVDIK
DRKVKAKSIVFHRKKNLQYYDISAKSNYNFEKPFLWLARKLIGDPNLEFVAMPALAPPEV
VMDPALAAQYEHDLEVAQTTALPDED
//
>1k5d_3F (C) [c.10.1] RAN GTPASE ACTIVATING PROTEIN 1
ARFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKD
LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKH
TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK
TFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK
SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEK
MPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEE
//
>1k5m_23 (A) [b.121.4] COAT PROTEIN VP1 (P1D)
EEVIVEKTKQTVASISSGPKHTQKVPILTANETGATMPVLPSDSIETRTTYMHFNGSETD
VECFLGRAACVHVTEIQNKDATGIDNHREAKLFNDWKINLSSLVQLRKKLELFTYVRFDS
EYTILATASQPDSANYSSNLVVQAMYVPPGAPNPKEWDDYTWQSASNPSVFFKVGDTSRF
SVPYVGLASAYNCFYDGYSHDDAETQYGITVLNHMGSMAFRIVNEHDEHKTLVKIRVYHR
AKHVEAWIPRAPRALPYTSIGRTNYPKNTEPVIKKRKGDIKSY
//
>1k5m_24 (B) [b.121.4] CHIMERA OF HRV14 COAT PROTEIN VP2 (P1B) AND THE
GYSDRVQQITLGNSTITTQEAANAVVCYAEWPEYLPDVDASDVNKTSKPDTSVCRFYTLD
SKTWTTGSKGWCWKLPDALKDMGVFGQNMFFHSLGRSGYTVHVQCNATKFHSGCLLVVVI
PEHQLASHEGGNVSVKYTFTHPGERGIDLSSAADTIGPGRAFYTTKNNEVGGPVKDVIYN
MNGTLLGNLLIFPHQFINLRTNNTATIVIPYINSVPIDSMTRHNNVSLMVIPIAPLTVPT
GATPSLPITVTIAPMCTEFSGIRSKSIVPQ
//
>1k5m_25 (C) [b.121.4] COAT PROTEIN VP3 (P1C)
GLPTTTLPGSGQFLTTDDRQSPSALPNYEPTPRIHIPGKVHNLLEIIQVDTLIPMNNTHT
KDEVNSYLIPLNANRQNEQVFGTNLFIGDGVFKTTLLGEIVQYYTHWSGSLRFSLMYTGP
ALSSAKLILAYTPPGARGPQDRREAMLGTHVVWDIGLQSTIVMTIPWTSGVQFRYTDPDT
YTSAGFLSCWYQTSLILPPETTGQVYLLSFISACPDFKLRLMKDTQTISQTVALTE
//
>1k5m_26 (D) [b.121.4] COAT PROTEIN VP4 (P1A)
INYYKDAASTSSAGQSLSMDPSKFTEPVKDLMLKGAPALN
//
>1k5nA [d.19.1 - b.1.1] MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-
GSHSMRYFHTSVSRPGRGEPRFITVGYVDDTLFVRFDSDAASPREEPRAPWIEQEGPEYW
DRETQICKAKAQTDREDLRTLLRYYNQSEAGSHTLQNMYGCDVGPDGRLLRGYHQHAYDG
KDYIALNEDLSSWTAADTAAQITQRKWEAARVAEQLRAYLEGECVEWLRRYLENGKETLQ
RADPPKTHVTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDRT
FQKWAAVVVPSGEEQRYTCHVQHEGLPKPLTLRWEP
//
>1k5nB [b.1.1] BETA-2-MICROGLOBULIN, LIGHT CHAIN
MIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKD
WSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM
//
>1k6qL [b.1.1 - b.1.1] IMMUNOGLOBULIN FAB D3, LIGHT CHAIN
DIKMTQSPSSMSASLGESVTITCKASRDIKSYLSWYQQKPWKSPKTLIYYATSLADGVPS
RFSGSGSGQDYSLTISSLESDDTATYYCLQHGESPFTFGSGTKLELKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATPIVKSFN
//
>1k6qH [b.1.1 - b.1.1] IMMUNOGLOBULIN FAB D3, HEAVY CHAIN
EVQLQQSGAELVRPGALVKLSCKASGFNIKDYYMHWVKQRPEQGLELIGWIDPENGNTIY
DPKFQDKASITADTSSNTAYLQLSSLTSEDTAVYYCARDTAAYFDYWGQGTTLTVSSAKT
TPPSVYPLAPGSANSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTLSS
SVTVPSSTWPSETVTCNVAHPASSTKVDKKKIP
//
>1k83A [e.29.1] DNA-DIRECTED RNA POLYMERASE II LARGEST SUBUNIT
QYSSAPLRTVKEVQFGLFSPEEVRAISVAKIRFPEKIGGLNDPRLGSIDRNLKCQTCQEG
MNECPGHFGHIDLAKPVFHVGFIAKIKKVCECVCMHCGKLLLDEHNELMRQALAIKDSKK
RFAAIWTLCKTKMVCETDVPSEDDPTQLVSRGGCGNTQPTIRKDGLKLVGSWKKEPELRV
LSTEEILNIFKHISVKDFTSLGFNEVFSRPEWMILTCLPVPPPPVRDDLTFKLADILKAN
ISLETLEHNGAPHHAIEEAESLLQFHVATYMDNDIAGQSIRARLKGKEGRIVDFSARTVI
SGDPNLELDQVGVPKSIAKTLTYPEVVTPYNIDRLTQLVRNGPNEHPGAKYVIRDSGDRI
DLRYSKRAGDIQLQYGWKVERHIMDNDPVLFNRQPSLHKMSMMAHRVKVIPYSTFRLNLS
VTSPYNADFDGDEMNLHVPQSEETRAELSQLCAVPLQIVSPQSNKPCMGIVQDTLCGIRK
LTLRDTFIELDQVLNMLYWVPDWDGVIPTPAIIKPKPLWSGKQILSVAIPNGIHLQRFDE
GTTLLSPKDNGMLIIDGQIIFGVVEKKTVGSSNGGLIHVVTREKGPQVCAKLFGNIQKVV
NFWLLHNGFSTGIGDTIADGPTMREITETIAEAKKKVLDVTKEAQANLLTAKHGMTLRES
FEDNVVRFLNEARDKAGRLAEVNLKDLNNVKQMVMAGSKGSFINIAQMSACVGQQSVEGK
RIAFGFVDRTLPHFSKDDYSPESKGFVENSYLRGLTPQEFFFHAMGGREGLIDTAVKTAE
TGYIQRRLVKALEDIMVHYDNTTRNSLGNVIQFIYGEDGMDAAHIEKQSLDTIGGSDAAF
EKRYRVDLLNTDHTLDPSLLESGSEILGDLKLQVLLDEEYKQLVKDRKFLREVFVDGEAN
WPLPVNIRRIIQNAQQTFHIDHTKPSDLTIKDIVLGVKDLQENLLVLRGKNEIIQNAQRD
AVTLFCCLLRSRLATRRVLQEYRLTKQAFDWVLSNIEAQFLRSVVHPGEMVGVLAAQSIG
EPATQMTLKKVTSGVPRLKEILNVAKNMKTPSLTVYLEPGHAADQEQAKLIRSAIEHTTL
KSVTIASEIYYDPDPRSTVIPEDEEIIQLHFSQQSPWLLRLELDRAAMNDKDLTMGQVGE
RIKQTFKNDLFVIWSEDNDEKLIIRCRVVAEEDHMLKKIENTMLENITLRGVENIERVVM
MKYDRKVPSPTGEYVKEPEWVLETDGVNLSEVMTVPGIDPTRIYTNSFIDIMEVLGIEAG
RAALYKEVYNVIASDGSYVNYRHMALLVDVMTTQGGLTSVTRHGFNRSNTGALMRCSFEE
TVEILFEAGASAELDDCRGVSENVILGQMAPIGTGAFDVMIDEESL
//
>1k83I [g.41.3 - g.41.3] DNA-DIRECTED RNA POLYMERASE II 14.2KD
MTTFRFCRDCNNMLYPREDKENNRLLFECRTCSYVEEAGSPLVYRHELITNIGETAGVVQ
DIGSDPTLPRSDRECPKCHSRENVFFQSQQRRKDTSMVLFFVCLSCSHIFTSDQKNKRTQ
FS
//
>1k8aD [b.43.3] RIBOSOMAL PROTEIN L3
PQPSRPRKGSLGFGPRKRSTSETPRFNSWPSDDGQPGVQGFAGYKAGMTHVVLVNDEPNS
PREGMEETVPVTVIETPPMRAVALRAYEDTPYGQRPLTEVWTDEFHSELDRTLDVPEDHD
PDAAEEQIRDAHEAGDLGDLRLITHTVPDAVPSVPKKKPDVMETRVGGGSVSDRLDHALD
IVEDGGEHAMNDIFRAGEYADVAGVTKGKGTQGPVKRWGVQKRKGKHARQGWRRRIGNLG
PWNPSRVRSTVPQQGQTGYHQRTELNKRLIDIGEGDEPTVDGGFVNYGEVDGPYTLVKGS
VPGPDKRLVRFRPAVRPNDQPRLDPEVRYVSNESNQG
//
>1k8aH [d.79.3] RIBOSOMAL PROTEIN L7AE
PVYVDFDVPADLEDDALEALEVARDTGAVKKGTNETTKSIERGSAELVFVAEDVQPEEIV
MHIPELADEKGVPFIFVEQQDDLGHAAGLEVGSAAAAVTDAGAAATVLEEIADKVEELR
//
>1k8aL [b.39.1] RIBOSOMAL PROTEIN L14
MEALGADVTQGLEKGSLITCADNTGARELKVISVHGYSGTKNRHPKAGLGDKITVSVTKG
TPEMRRQVLEAVVVRQRKPIRRPDGTRVKFEDNAAVIVDENEDPRGTELKGPIAREVAQR
FGSVASAATMIV
//
>1k8aN [d.12.1] RIBOSOMAL PROTEIN L15E
ARSAYSYIREAWKRPKEGQIAELMWHRMQEWRNEPAVVRIERPTRLDRARSLGYKAKQGI
IVVRVAIRKGSSRRTRFNKGRRSKRMMVNRITRKKNIQRIAEERANRKFPNLRVLNSYSV
GEDGRHKWHEVILIDPDHPAIKSDDQLSWISRTRHRLRTFRGLTSAGRRCRGLRGQGKGS
EKVRPSLRVNGAKA
//
>1k8dA [d.19.1 - b.1.1] QA-2 ANTIGEN
GQHSLQYFHTAVSRPGLGEPWFISVGYVDDTQFVRFDSDAENPRMEPRARWMEQEGPEYW
ERETQIAKGHEQSFRGSLRTAQSYYNQSKGGSHTLQWMYGCDMGSDGRLLRGYLQFAYEG
RDYIALNEDLKTWTAVDMAAQITRRKWEQAGIAEKDQAYLEGTCMQSLRRYLELGKETLL
RTDPPKAHVTHHPRSYGAVTLRCWALGFYPADITLTWQLNGEELTQDMELVETRPAGDGT
FQKWASVVVPLGKEQNYTCHVNHEGLPEPLTLRW
//
>1k8dB [b.1.1] BETA-2-MICROGLOBULIN
IQKTPQIQVYSRHPPENGKPNILNCYVTQFHPPHIEIQMLKNGKKIPKVEMSDMSFSKDW
SFYILAHTEFTPTETDTYACRVKHDSMAEPKTVYWDRDM
//
>1k8iB [d.19.1 - b.1.1] MHC CLASS II H2-M BETA 2 CHAIN
GFVAHVESTCVLNDAGTPQDFTYCVSFNKDLLACWDPDVGKIVPCEFGVLSRLAEIISNI
LNEQESLIHRLQNGLQDCATHTQPFWDVLTHRTRAPSVRVAQTTPFNTREPVMLACYVWG
FYPADVTITWMKNGQLVPSHSNKEKTAQPNGDWTYQTVSYLALTPSYGDVYTCVVQHSGT
SEPIRGDWTP
//
>1k8iA [d.19.1 - b.1.1] MHC CLASS II H2-M ALPHA CHAIN
QNHTFRHTLFCQDGIPNIGLSETYDEDELFSFDFSQNTRVPRLPDFAEWAQGQGDASAIA
FDKSFCEMLMREVSPKLEGQIPVSRGLPVAEVFTLKPLEFGKPNTLVCFISNLFPPTLTV
NWQLHSAPVEGASPTSISAVDGLTFQAFSYLNFTPEPFDLYSCTVTHEIDRYTAIAYWVP
Q
//
>1k8rA [c.37.1] TRANSFORMING PROTEIN P21/H-RAS-1
MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAG
QEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDL
AARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH
//
>1k8rB [d.15.1] PROTEIN KINASE BYR2
CILRFIACNGQTRAVQSRGDYQKTLAIALKKFSLEDASKFIVCVSQSSRIKLITEERDRL
IIVPKEKPCPSFEDLRRSWEIE
//
>1k90A [e.41.1] CALMODULIN-SENSITIVE ADENYLATE CYCLASE
RIDVLKGEKALKASGLVPEHADAFKKIARELNTYILFRPVNKLATNLIKSGVATKGLNVH
GKSSDWGPVAGYIPFDQDLSKKHGQQLAVEKGNLENKKSITEHEGEIGKIPLKLDHLRIE
ELKENGIILKGKKEIDNGKKYYLLESNNQVYEFRISDENNEVQYKTKEGKITVLGEKFNW
RNIEVMAKNVEGVLKPLTADYDLFALAPSLTEIKKQIPQKEWDKVVNTPNSLEKQKGVTN
LLIKYGIERKPDSTKGTLSNWQKQMLDRLNEAVKYTGYTGGDVVNHGTEQDNEEFPEKDN
EIFIINPEGEFILTKNWEMTGRFIEKNITGKDYLYYFNRSYNKIAPGNKAYIEWTDPITK
AKINTIPTSAEFIKNLSSIRRSSSVKKIAGYLSDYYNSANHIFSQEKKRKISIFRGIQAY
NEIENVLKSKQIAPEYKNYFQYLKERITNQVQLLLTHQKFKLLYKQLNFTENETDNFEVF
QKIID
//
>1k90D [a.39.1] CALMODULIN
TEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTID
FPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEM
IREADIDGDGQVNYEEFVQMMTA
//
>1k9oI [e.1.1] ALASERPIN
GETDLQKILRESNDQFTAQMFSEVVKANPGQNVVLSAFSVLPPLGQLALASVGESHDELL
RALALPNDNVTKDVFADLNRGVRAVKGVDLKMASKIYVAKGLELNDDFAAVSRDVFGSEV
QNVDFVKSVEAAGAINKWVEDQTNNRIKNLVDPDALDETTRSVLVNAIYFKGSWKDKFVK
ERTMDRDFHVSKDKTIKVPTMIGKKDVRYADVPELDAKMIEMSYEGDQASMIIILPNQVD
GITALEQKLKDPKALSRAEERLYNTEVEITLPKFKIETTTDLKEVLSNMNIKKLFTPGAA
RLENLLKTKESLTVDAAIQKAFIEVNEEGAEAAAANAFGIVPKSLILYPEVHIDRPFYFE
LKIDGIPMFNGKVIEP
//
>1k9oE [b.47.1] TRYPSIN II ANIONIC
IVGGYTCQENSVPYQVSLNSGYHFCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLEG
NEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLISG
WGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDAGGP
VVCNGELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAAN
//
>1ka9H [c.23.16] IMIDAZOLE GLYCEROL PHOSPHTATE SYNTHASE
MKALLIDYGSGNLRSAAKALEAAGFSVAVAQDPKAHEEADLLVLPGQGHFGQVMRAFQES
GFVERVRRHLERGLPFLGICVGMQVLYEGSEEAPGVRGLGLVPGEVRRFRAGRVPQMGWN
ALEFGGAFAPLTGRHFYFANSYYGPLTPYSLGKGEYEGTPFTALLAKENLLAPQFHPEKS
GKAGLAFLALARRYF
//
>1ka9F [c.1.2] IMIDAZOLE GLYCEROL PHOSPHTATE SYNTHASE
SLAKRIVPCLDVHAGRVVKGVNFVNLRDAGDPVEAARAYDEAGADELVFLDISATHEERA
ILLDVVARVAERVFIPLTVGGGVRSLEDARKLLLSGADKVSVNSAAVRRPELIRELADHF
GAQAVVLAIDARWRGDFPEVHVAGGRVPTGLHAVEWAVKGVELGAGEILLTSMDRDGTKE
GYDLRLTRMVAEAVGVPVIASGGAGRMEHFLEAFQAGAEAALAASVFHFGEIPIPKLKRY
LAEKGVHVRLD
//
>1kb5A [b.1.1] KB5-C20 T-CELL ANTIGEN RECEPTOR
QQVRQSPQSLTVWEGETAILNCSYEDSTFNYFPWYQQFPGEGPALLISIRSVSDKKEDGR
FTIFFNKREKKLSLHITDSQPGDSATYFCAARYQGGRALIFGTGTTVSVSPGSAD
//
>1kb5B [b.1.1] KB5-C20 T-CELL ANTIGEN RECEPTOR
VTLLEQNPRWRLVPRGQAVNLRCILKNSQYPWMSWYQQDLQKQLQWLFTLRSPGDKEVKS
LPGADYLATRVTDTELRLQVANMSQGRTLYCTCSAAPDWGASAETLYFGSGTRLTVL
//
>1kb5H [b.1.1 - b.1.1] ANTIBODY DESIRE-1
EVQLQQSGPELEKPGASVKISCKASGYSFTGYNMNWVKQSNGKSLEWIGNIDPYYGGISY
NQKFKGRATLTVDKSSSTAYMQLKSLTSEDSAVYYCARSRTDLYYFDYWGQGTTLTVSSA
KTTAPSVYPLAPVCGDTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDL
YTLSSSVTVTSSTWPSQSITCNVAHPASSTKVDKKIEPR
//
>1kb5L [b.1.1 - b.1.1] ANTIBODY DESIRE-1
DIQMTQSPASLSASVGETVTITCRASKNIYSYLAWYQQKQGKSPQLLVYNAKTLGEGVPS
RFSGSGSGTQFSLKINSLQPEDFGSYYCQHHYGTPYTFGGGTKLEIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1kb5E (H) [b.1.1 - b.1.1] ANTIBODY DESIRE-1
EVQLQQSGPELEKPGASVKISCKASGYSFTGYNMNWVKQSNGKSLEWIGNIDPYYGGISY
NQKFKGRATLTVDKSSSTAYMQLKSLTSEDSAVYYCARSRTDLYYFDYWGQGTTLTVSSA
KTTAPSVYPLAPVCGDTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDL
YTLSSSVTVTSSTWPSQSITCNVAHPASSTKVDKKIEPR
//
>1kb5F (L) [b.1.1 - b.1.1] ANTIBODY DESIRE-1
DIQMTQSPASLSASVGETVTITCRASKNIYSYLAWYQQKQGKSPQLLVYNAKTLGEGVPS
RFSGSGSGTQFSLKINSLQPEDFGSYYCQHHYGTPYTFGGGTKLEIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1kc5A (L) [b.1.1 - b.1.1] PC287 IMMUNOGLOBULIN
DIVLTQSPKSMSMSVGEKVTLSCKASENVDTYVSWYQQRPEQPPALLIYGASNRYTGVPD
RFTGSGSATDFTLTISSVQAEDLADYHCGQSYSYPLTFGGGTKLELKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVANSWTAQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPVVKSFNRNEC
//
>1kc5B (H) [b.1.1 - b.1.1] PC287 IMMUNOGLOBULIN
QVKLQQSGPGLVKPSQSLSLTCTVTGYSITSDYAWNWIRQFPGNKLEWMAYISYSGSTTY
NPSLKSRISITRDTSKNQFFLQLNSVTTEDTAIYYCARGGTGFDYWGAGTTLTVSAAATT
PPSVYPLAPGSATAAASMVTLGCLVKGYFPEPVTVTWNSGALSSGVHTFPAVLQSDLYTL
SSSVTVPSSPWPSETVTCNVAHPASSTKVDKKIVPRD
//
>1kcgC [d.19.1] ULBP3 PROTEIN
DAHSLWYNFTIIHLPRHGQQWCEVQSQVDQKNFLSYDCGSDKVLSMGHLEEQLYATDAWG
KQLEMLREVGQRLRLELADTEPLTLQVRMSCECEADGYIRGSWQFSFDGRKFLLFDSNNR
KWTVVHAGARRMKEKWEKDSGLTTFFKMVSMRDCKSWLRDFLMHRKKRLE
//
>1kcgA [d.169.1] NKG2-D TYPE II INTEGRAL MEMBRANE PROTEIN
SYCGPCPKNWICYKNNCYQFFDESKNWYESQASCMSQNASLLKVYSKEDQDLLKLVKSYH
WMGLVHIPTNGSWQWEDGSILSPNLLTIIEMQKGDCALYASSFKGYIENCSTPNTYICMQ
RT
//
>1kcrL [b.1.1 - b.1.1] PC283 IMMUNOGLOBULIN
DIVLTQSPKSMSMSVGERVTLSCKASENVGTYVSWYQQKPEQSPKLLIYGASNRYTGVPD
RFTGSGSATDFTLKISSVQAEDLADYHCGQTYSYPTFGGGTKLAIKRADAAPTVSIFPPS
SEQLTAGGASVVCFLNNFYPKDINVKWKIDGSERQNGVANSWTAQDSADSTYSMSSTLTL
TKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1kcrH [b.1.1 - b.1.1] PC283 IMMUNOGLOBULIN
QVALQESGPGLVKPSQSLSLTCTVTGYSITSDYAWNWIRQFPGNKLEWMGYIRNGGSTTY
NPSLASRISITRDTSKNQFFLQLNSVTTEDTATYYCARGGTGFTYWGAGTLVTVSAAATT
PPSVYPLAPGSAAAAAAMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSALYTL
SSSVTVPSSPRPSATVTCNVAHPASSTKVDKKIVPRDC
//
>1kcvL [b.1.1 - b.1.1] PC282 IMMUNOGLOBULIN
DIVMTQSPKSMGMSVGEAVTLNCKASENVGTYVSWYQQKPGQSPVLLIYGASNRYTGVPD
RFTGSGSATDFTLTISSVQADDDADYYCGQSYSSPLTFGGGTKLELKRADAAPTSSIFPP
SSEQLSSGGASVVCFLNSFYPKSIAVKWKVDGSKRANGTANSWTDQDSASSTYSMSSTLT
LTKDKYERHNSYTCEATHKTSSSPVVKSFNRNEC
//
>1kcvH [b.1.1 - b.1.1] PC282 IMMUNOGLOBULIN
QVTLSQSGPGLVKPSQSLSLTCTVTSYSITSDYAWNWIRQFAGQSLEWMGYISYSGSTSY
NPSLKSRISITRDTSKNQFFLQLNSVTTDDTATYYCARGGTGFPYWGTGTNVTVSAASTT
APSVFPLVPGSATAAASAVTLGCLVKGYFPEPVTVAWNEGALSSGVLTVSAVLQSGLYTL
SSNTTVASGTWPSASVTCLVAHPKSSTAADKKIEPKD
//
>1kdqA [b.47.1] CHYMOTRYPSIN B, B CHAIN
VNGEDAIPGSWPWQVSLQDKTGFHFCGGSLISEDWVVTAAHCGVKTSDVVVAGEFDQGSD
EENIQVLKIAQVFKNPKFNMFTVRNDITLLKLATPAQFSETVSAVSLPNVDDDFPPGTVC
ATTGWGKTKY
//
>1kdqB [b.47.1] CHYMOTRYPSIN B, C CHAIN
TPEKLQQAALPIVSEADCKKSWGSKITDVMTCAGASGVDSCMGDSGGPLVCQKDGVWTLA
GIVSWGSGVCSTSTPAVYSRVTALMPWVQQILEAN
//
>1kemL [b.1.1 - b.1.1] 28B4 FAB
DVLMTQTPLSLPVSLGDQASISCRFSQSIVHSNGNTYLEWYLQKSGQSPKLLIYKVSNRF
SGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCFQGSHVPRTFGGGTKLEIKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRN
//
>1kemH [b.1.1 - b.1.1] 28B4 FAB
EVKLVESGGGLGQPGGSLRLSCATSGFTFTDYYFNWARQPPGKALEWLGFIRNKAKGYTT
EYSASVKGRFTISRDNSQGILYLQMNTLRAEDSATYYCARWGSYAMDYWGQGTSVTVSSA
KTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDL
YTLSSSVTVPSSPRPSETVTCNVAHPASSTKVDKKIVP
//
>1kenA [b.19.1] HEMAGGLUTININ HA1
STATLCLGHHAVPNGTLVKTITDDQIEVTNATELVQSSSTGKICNNPHRILDGIDCTLID
ALLGDPHCDVFQNETWDLFVERSKAFSNCYPYDVPDYASLRSLVASSGTLEFITEGFTWT
GVTQNGGSNACKRGPGSGFFSRLNWLTKSGSTYPVLNVTMPNNDNFDKLYIWGIHHPSTN
QEQTSLYVQASGRVTVSTRRSQQTIIPNIGSRPWVRGLSSRISIYWTIVKPGDVLVINSN
GNLIAPRGYFKMRTGKSSIMRSDAPIDTCISECITPNGSIPNDKPFQNVNKITYGACPKY
VKQNTLKLATGMRNVPEKQT
//
>1kenC (A) [b.19.1] HEMAGGLUTININ HA1
STATLCLGHHAVPNGTLVKTITDDQIEVTNATELVQSSSTGKICNNPHRILDGIDCTLID
ALLGDPHCDVFQNETWDLFVERSKAFSNCYPYDVPDYASLRSLVASSGTLEFITEGFTWT
GVTQNGGSNACKRGPGSGFFSRLNWLTKSGSTYPVLNVTMPNNDNFDKLYIWGIHHPSTN
QEQTSLYVQASGRVTVSTRRSQQTIIPNIGSRPWVRGLSSRISIYWTIVKPGDVLVINSN
GNLIAPRGYFKMRTGKSSIMRSDAPIDTCISECITPNGSIPNDKPFQNVNKITYGACPKY
VKQNTLKLATGMRNVPEKQT
//
>1kenL [b.1.1 - b.1.1] INFLUENZA VIRUS INFECTIVITY NEUTRALIZING
QIVLTQSPAIMSASPGEKVTLTCSASSTITSSFLYWYQQKPGSSPKLWIYSTSNLASGVP
ARFSGSGSGTSYSLTISSLEAEDGASYFCHQWETFPRTFGGGTKLEIKRADAAPTVSIFP
PSKIQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTL
TLTKDEYERHNSYTCEATHKTSTSPIVKSFNRN
//
>1kenH [b.1.1 - b.1.1] INFLUENZA VIRUS INFECTIVITY NEUTRALIZING
DVHLQESGPGLVKPSQSLSLTCYVTGYSITSGYYWTWIRQFPGNKLEWMGYISYDGSNNY
NPSLKNRISITRDTSKNQFFLKLNSVTAEDTASYYCAAFYYDYDFFFDYWGQGTTLTVSS
AKTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSD
LYTLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKIVPRD
//
>1kenU (L) [b.1.1 - b.1.1] INFLUENZA VIRUS INFECTIVITY NEUTRALIZING
QIVLTQSPAIMSASPGEKVTLTCSASSTITSSFLYWYQQKPGSSPKLWIYSTSNLASGVP
ARFSGSGSGTSYSLTISSLEAEDGASYFCHQWETFPRTFGGGTKLEIKRADAAPTVSIFP
PSKIQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTL
TLTKDEYERHNSYTCEATHKTSTSPIVKSFNRN
//
>1kf6N (B) [d.15.4 - a.1.2] FUMARATE REDUCTASE IRON-SULFUR PROTEIN
AEMKNLKIEVVRYNPEVDTAPHSAFYEVPYDATTSLLDALGYIKDNLAPDLSYRWSCRMA
ICGSCGMMVNNVPKLACKTFLRDYTDGMKVEALANFPIERDLVVDMTHFIESLEAIKPYI
IGNSRTADQGTNIQTPAQMAKYHQFSGCINCGLCYAACPQFGLNPEFIGPAAITLAHRYN
EDSRDHGKKERMAQLNSQNGVWSCTFVGYCSEVCPKHVDPAAAIQQGKVESSKDFLIATL
KPR
//
>1kf6O (C) [f.21.2] FUMARATE REDUCTASE 15 KDA HYDROPHOBIC PROTEIN
TTKRKPYVRPMTSTWWKKLPFYRFYMLREGTAVPAVWFSIELIFGLFALKNGPEAWAGFV
DFLQNPVIVIINLITLAAALLHTKTWFELAPKAANIIVKDEKMGPEPIIKSLWAVTVVAT
IVILFVALYW
//
>1kf9_1A [a.26.1] PHAGE DISPLAY DERIVED VARIANT HUMAN GROWTH
FPTIPLSRLADNAWLRADRLNQLAFDTYQEFEEAYIPKEQIHSFWWNPQTSLCPSESIPT
PSNKEETQQKSNLELLRISLLLIQSWLEPVQFLRSVFANSLVYGASDSNVYDLLKDLEEG
IQTLMGRLLLKNYGLLYCFNKDMSKVSTYLRTVQCRSSCG
//
>1kf9_1B [b.1.2 - b.1.2] EXTRACELLULAR DOMAIN HUMAN GROWTH HORMONE
PKFTKCRSPERETFSCHWTPIQLFYTRRNTQEWTQEWKECPDYVSAGENSCYFNSSFTSI
WIPYCIKLTSNGGTVDEKCFSVDEIVQPDPPIALNWTLLNVSLTGIHADIQVRWEAPRNA
DIQKGWMVLEYELQYKEVNETKWKMMDPILTTSVPVYSLKVDKEYEVRVRSKQRNSGNYG
EFSEVLYVTLPQM
//
>1kf9_1C [b.1.2 - b.1.2] EXTRACELLULAR DOMAIN HUMAN GROWTH HORMONE
PKFTKCRSPERETFSCHWTIQLFYTRRNEWKECPDYVSAGENSCYFNSSFTSIWIPYCIK
LKCFSVDEIVQPDPPIALNWTLLNVSLTGIHADIQVRWEAPRNADIQKGWMVLEYELQYK
EVNETKWKMMDPILTTSVPVYSLKVDKEYEVRVRSKQRNSGNYGEFSEVLYVTLP
//
>1kfa_2I [b.1.1 - b.1.1] MONOCLONAL ANTIBODY HEAVY CHAIN
MLVESGGGLVKPGGSLKLSCAASGFTFSSYAMSWVRQTPERRLEWVATITTRGYTFYPDS
VKGRFTVSRDNARNTLNLQMSSLRSEDTAMFYCTREGLLLDYFTMDYWGQGTSVTVSSAK
TTPPSVYPLAPMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTLSSSVTV
PSSSRPSETVTCNVAHPASSTKVDKKIVP
//
>1kfa_2M [b.1.1 - b.1.1] MONOCLONAL ANTIBODY LIGHT CHAIN
DVVMTQTPLSLSVSLGDQASISCRSSQSLVHSNGNTYLHWYLQKPGQSPKLLIYKVSSRF
SGFPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQSTHVPFTFGSGTKLEIKRADAGPTV
SSFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHASYTCEAAHKTSTSPIAKS
//
>1kfuL [d.3.1 - b.14.1 - a.39.1] M-CALPAIN LARGE SUBUNIT
AGIAAKLAKDREAAEGLGSHERAIKYLNQDYEALRNECLEAGTLFQDPSFPAIPSALGFK
ELGPYSSKTRGMRWKRPTEICADPQFIIGGATRTDICQGALGDCWLLAAIASLTLNEEIL
ARVVPLNQSFQENYAGIFHFQFWQYGEWVEVVVDDRLPTKDGELLFVHSAEGSEFWSALL
EKAYAKINGCYEALSGGATTEGFEDFTGGIAEWYELKKPPPNLFKIIQKALQKGSLLGCS
IDITSAADSEAITFQKLVKGHAYSVTGAEEVESNGSLQKLIRIRNPWGEVEWTGRWNDNC
PSWNTIDPEERERLTRRHEDGEFWMSFSDFLRHYSRLEICNLTPDTLTSDTYKKWKLTKM
DGNWRRGSTAGGCRNYPNTFWMNPQYLIKLEEEDEDEEDGESGCTFLVGLIQKHRRRQRK
MGEDMHTIGFGIYEVPEELSGQTNIHLSKNFFLTNRARERSDTFINLREVLNRFKLPPGE
YILVPSTFEPNKDGDFCIRVFSEKKADYQAVDDEIEANLEEFDISEDDIDDGVRRLFAQL
AGEDAEISAFELQTILRRVLAKRQDIKSDGFSIETCKIMVDMLDSDGSGKLGLKEFYILW
TKIQKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKMPCQLHQVIVARFADDQLIIDFDN
FVRCLVRLETLFKIFKQLDPENTGTIELDLISWLCFSVL
//
>1kfuS [a.39.1] M-CALPAIN SMALL SUBUNIT
THYSNIEANESEEVRQFRRLFAQLAGDDMEVSATELMNILNKVVTRHPDLKTDGFGIDTC
RSMVAVMDSDTTGKLGFEEFKYLWNNIKRWQAIYKQFDTDRSGTICSSELPGAFEAAGFH
LNEHLYNMIIRRYSDESGNMDFDNFISCLVRLDAMFRAFKSLDKDGTGQIQVNIQEWLQL
TMYS
//
>1kfxL [d.3.1 - b.14.1 - a.39.1] M-CALPAIN LARGE SUBUNIT
AGIAAKLAKDREAAEGLGSHERAIKYLNQDYEALRNECLEAGTLFQDPSFPAIPSALGFK
ELGPYSSKTRGMRWKRPTEICADPQFIIGGATRTDICQGALGDCWLLAAIASLTLNEEIL
ARVVPLNQSFQENYAGIFHFQFWQYGEWVEVVVDDRLPTKDGELLFVHSAEGSEFWSALL
EKAYAKINGCYEALSGGATTEGFEDFTGGIAEWYELKKPPPNLFKIIQKALQKGSLLGCS
IDKGHAYSVTGAEEVESNGSLQKLIRIRNPWGEVEWTGRWMSFSDFLRHYSRLEICNLTP
DTLTSDTYKKWKLTKMDGNWRRGSTAGGCRNYPNTFWMNPQYLIKLEEEDECTFLVGLIQ
KHRRRQRKMGEDMHTIGFGIYEVPEETNIHLSKNFFLTNRARERSDTFINLREVLNRFKL
PPGEYILVPSTFEPNKDGDFCIRVFSEKKADYQAVDDEIEANLEEFDISEDDIDDGVRRL
FAQLAGEDAEISAFELQTILRRVLAKRKSDGFSIETCKIMVDMLDSDGSGKLGLKEFYIL
WTKIQKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKMPCQLHQVIVARFADDQLIIDFD
NFVRCLVRLETLFKIFKQLDPENTGTIELDLISWLCFSVL
//
>1kfxS [a.39.1] M-CALPAIN SMALL SUBUNIT
NESEEVRQFRRLFAQLAGDDMEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMD
SDTTGKLGFEEFKYLWNNIKRWQAIYKQFDTDRSGTICSSELPGAFEAAGFHLNEHLYNM
IIRRYSDESGNMDFDNFISCLVRLDAMFRAFKSLDKDGTGQIQVNIQEWLQLTMYS
//
>1kg0B [d.19.1 - b.1.1] MHC CLASS II RECEPTOR HLA-DR1
TRPRFLWQLKFECHFFNGTERVRLLERCIYNQEESVRFDSDVGEYRAVTELGRPDAEYWN
SQKDLLEQRRAAVDTYCRHNYGVGESFTVQRRVEPKVTVYPSKTQPLQHHNLLVCSVSGF
YPGSIEVRWFRNGQEEKAGVVSTGLIQNGDWTFQTLVMLETVPRSGEVYTCQVEHPSVTS
PLTVEWRA
//
>1kg0C [d.169.1] GP42 PROTEIN
HTFQVPQNYTKANCTYCNTREYTFSYKGCCFYFTKKKHTWNGCFQACAEKYPCTYFYGPT
PDILPVVTRNLNAIESLWVGVYRVGEGNWTSLDGGTFKVYQIFGSHCTYVSKFSTVPVSH
HECSFLKPCLCVSQRS
//
>1kgcD [b.1.1 - b.1.1] T-CELL RECEPTOR ALPHA CHAIN
KTTQPNSMESNEEEPVHLPCNHSTISGTDYIHWYRQLPSQGPEYVIHGLTSNVNNRMASL
AIAEDRKSSTLILHRATLRDAAVYYCILPLAGGTSYGKLTFGQGTILTVHPNIQNPDPAV
YQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKTVLDMRSMDFKSNSAVAWSNKS
DFACANAFNNSIIPEDTFFPS
//
>1kgcE [b.1.1 - b.1.1] T-CELL RECEPTOR BETA CHAIN
GVSQSPRYKVAKRGQDVALRCDPISGHVSLFWYQQALGQGPEFLTYFQNEAQLDKSGLPS
DRFFAERPEGSVSTLKIQRTQQEDSAVYLCASSLGQAYEQYFGPGTRLTVTEDLKNVFPP
EVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVSTDPQPLKEQPAL
NDSRYCLSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRA
D
//
>1kgy_2C (A) [b.18.1] EPHRIN TYPE-B RECEPTOR 2
AEETLMDSTTATAELGWMVHPPSGWEEVSGYDENMNTIRTYQVCNVFESSQNNWLRTKFI
RRRGAHRIHVEMKFSVRDCSSIPSVPGSCKETFNLYYYEADFDLATKTFPNWMENPWVKV
DTIAADESFSQVDLGGRVMKINTEVRSFGPVSRNGFYLAFQDYGGCMSLIAVRVFYRKCP
R
//
>1kgy_2G (E) [b.6.1] EPHRIN-B2
IVLEPIYWNSSNSKFLPGGGLVLYPQIGDKLDIICPKVDSKTVGQYEYYKVYMVDKDQAD
RCTIKKENTPLLNCARPDQDVKFTIKFQEFSPNLWGLEFQKNKDYYIISTSNGSLEGLDN
QEGGVCQTRAMKILMKVG
//
>1ki1_1B [a.87.1 - b.55.1] INTERSECTIN LONG FORM
DMLTPTERKRQGYIHELIVTEENYVNDLQLVTEIFQKPLMESELLTEKEVAMIFVNWKEL
IMCNIKLLKALRVRKKMSGEKMPVKMIGDILSAQLPHMQPYIRFCSRQLNGAALIQQKTD
EAPDFKEFVKRLEMDPRCKGMPLSSFILKPMQRVTRYPLIIKNILENTPENHPDHSHLKH
ALEKAEELCSQVNEGVREKENSDRLEWIQAHVQCEGLSEQLVFNSVTNCLGPRKFLHSGK
LYKAKNNKELYGFLFNDFLLLTQITKPKVFSPKSNLQYMYKTPIFLNEVLVKLPTDPSGD
FHISHIDRVYTLRAESINERTAWVQKIKAASELYIETEKKKR
//
>1ki1_1A [c.37.1] G25K GTP-BINDING PROTEIN, PLACENTAL ISOFORM
MQTIKCVVVGDGAVGKTCLLISYTTNKFPSEYVPTVFDNYAVTVMIGGEPYTLGLFDTAG
QEDYDRLRPLSYPQTDVFLVCFSVVSPSSFENVKEKWVPEITHHCPKTPFLLVGTQIDLR
DDPSTIEKLAKNKQKPITPETAEKLARDLKAVKYVECSALTQKGLKNVFDEAILAALE
//
>1kigH [b.47.1] FACTOR XA
IVGGRDCAEGECPWQALLVNEENEGFCGGTILNEFYVLTAAHCLHQAKRFTVRVGDRNTE
QEEGNEMAHEVEMTVKHSRFVKETYDFDIAVLRLKTPIRFRRNVAPACLPEKDWAEATLM
TQKTGIVSGFGRTHEKGRLSSTLKMLEVPYVDRSTCKLSSSFTITPNMFCAGYDTQPEDA
CQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKFGVYTKVSNFLKWIDKIMKARAGAAG
S
//
>1kigL [g.3.11] FACTOR XA
CSLDNGGCDQFCREERSEVRCSCAHGYVLGDDSKSCVSTERFPCGKFTQGR
//
>1kigI [g.8.1] ANTICOAGULANT PEPTIDE
YNRLCIKPRDWIDECDSNEGGERAYFRNGKGGCDSFWICPEDHTGADYYSSYRDCFNACI
//
>1kilA [h.1.15] SYNAPTOBREVIN SNARE MOTIF
SNRRLQQTQAQVDEVVDIMRVNVDKVLERDQKLSELDDRADALQAGASQFETSAAKLKRK
YWWKN
//
>1kilB [h.1.15] SYNTAXIN SNARE MOTIF SHORT
LSEIETRHSEIIKLENSIRELHDMFMDMAMLVESQGEMIDRIEYNVEHAVDYVERAVSD
//
>1kilE [h.1.15] COMPLEXIN I SNARE-COMPLEX BINDING REGION
KKEEERQEALRQAEEERKAKYAKMEAEREVMRQGIRDKYGI
//
>1kj2_1H [d.19.1 - b.1.1] ALLOGENEIC H-2KB MHC CLASS I MOLECULE
GPHSLRYFVTAVSRPGLGEPRYMEVGYVDDTEFVRFDSDAENPRYEPRARWMEQEGPEYW
ERETQKAKGNEQSFRVDLRTLLGYYNQSKGGSHTIQVISGCEVGSDGRLLRGYQQYAYDG
CDYIALNEDLKTWTAADMAALITKHKWEQAGEAERLRAYLEGTCVEWLRRYLKNGNATLL
RTDSPKAHVTHHSRPEDKVTLRCWALGFYPADITLTWQLNGEELIQDMELVETRPAGDGT
FQKWASVVVPLGKEQYYTCHVYHQGLPEPLTLRWEP
//
>1kj2_1A [b.1.1] KB5-C20 T-CELL RECEPTOR ALPHA-CHAIN
QQVRQSPQSLTVWEGETAILNCSYEDSTFNYFPWYQQFPGEGPALLISIRSVSDKKEDGR
FTIFFNKREKKLSLHITDSQPGDSATYFCAARYQGGRALIFGTGTTVSVSP
//
>1kj2_1B [b.1.1] KB5-C20 T-CELL RECEPTOR BETA-CHAIN
VTLLEQNPRWRLVPRGQAVNLRCILKNSQYPWMSWYQQDLQKQLQWLFTLRSPGDKEVKS
LPGADYLATRVTDTELRLQVANMSQGRTLYCTCSAAPDWGASAETLYFGSGTRLTVL
//
>1kjvA [d.19.1 - b.1.1] MATURE ALPHA CHAIN OF MAJOR HISTOCOMPATIBILITY
GSHSLRYFDIAVSRPGLGEPRYISVGYVDDTEFARYDSDAENRRYQPRARWMEREGPEYW
ERNTPIYKGKEQTFRVNLRTLRGYYNQSEGGSHTIQEMYGCDVGSDGSLLRGYEQFAYDG
RDYIALNEDLKTWTAADFAARISRNKLERDGFADLHRAYLEGECVESLRRYLELGKETLL
RSDPPKAHVTLHPRPEGDVTLRCWALGFYPADITLTWQLNGEDLTQDMELVETRPAGDGT
FQKWASVVVPLGKEQNYTCRVEHEGLPKPLSQRWEP
//
>1kjvB [b.1.1] BETA-2-MICROGLOBULIN
MIQKTPQIQVYSRHPPENGKPNFLNCYVSQFHPPQIEIELLKNGKKIPNIEMSDLSFSKD
WSFYILAHTEFTPTETDVYACRVKHVTLKEPKTVTWDRDM
//
>1kk8A [c.37.1 - b.34.3] MYOSIN HEAVY CHAIN, STRIATED MUSCLE
MNIDFSDPDFQYLAVDRKKLMKTAAFDGKKNCWVPDEKEGFASAEIQSSKGDEITVKIVA
DSSTRTVKKDDIQSMNPPKFEKLEDMANMTYLNEASVLYNLRSRYTSGLIYTYSGLFCIA
VNPYRRLPIYTDSVIAKYRGKRKTEIPPHLFSVADNAYQNMVTDRENQSCLITGESGAGK
TENTKKVIMYLAKVACAVKKKEGSLEDQIIQANPVLEAYGNAKTTRNNNSSRFGKFIRIH
FGPTGKIAGADIETYLLEKSRVTYQQSAERNYHIFYQICSNAIPELNDVMLVTPDSGLYS
FINQGCLTVDNIDDVEEFKLCDEAFDILGFTKEEKQSMFKCTASILHMGEMKFKQEQAES
DGTAEAEKVAFLCGINAGDLLKALLKPKVKMVTKGQNMNQVVNSVGALAKSLYDRMFNWL
VRRVNKTLDTKAKRNYYIGVLDIAGFEIFDFNSFEQLCINYTNERLQQFFNHHMFILEQE
EYKKEGIAWEFIDFGMDLQMCIDLIEKPMGILSILEEECMFPKADDKSFQDKLYQNHMGK
NRMFTKPGKPTRPNQGPAHFELHHYAGNVPYSITGWLEKNKDPINENVVALLGASKEPLV
AELFKAQTISAVHRESLNKLMKNLYSTHPHFVRCIIPNELKQPGLVDAELVLHQLQCNGV
LERKGFPSRLIYSEFKQRYSILAPNAIPQDGKTVSEKILAGLQMDPAEYRLGTTKVFFKA
GVLGNLEEMRDERLSKIISMFQAHIRGYLIRKAYKKLQDQRIGLSVIQRNIRKWLVLRNW
QWWKLYSKVKPLL
//
>1kk8B [a.39.1] MYOSIN REGULATORY LIGHT CHAIN, STRIATED ADDUCTOR
PQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLKEAPGPLNFTMF
LSIFSDKLSGTDSEETIRNAFAMFDEQETKKLNIEYIKDLLENMGDNFNKDEMRMTFKEA
PVEGGKFDYVKFTAMIKGS
//
>1kk8C [a.39.1] MYOSIN ESSENTIAL LIGHT CHAIN,STRIATED ADDUCTOR
PKLSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAVGGTHKMGE
KSLPFEEFLPAYEGLMDCEQGTFADYMEAFKTFDREGQGFISGAELRHVLTALGERLSDE
DVDEIIKLTDLQEDLEGNVKYEDFVKKVMAGPYP
//
>1kklA [c.91.1] HPRK PROTEIN
ERRSMHGVLVDIYGLGVLITGDSGVGKSETALELVQRGHRLIADDRVDVYQQDEQTIVGA
APPILSHLLEIRGLGIIDVMNLFGAGAVREDTTISLIVHLENWTPDEQTQLIFDVPVPKI
TVPVKVGRNLAIIIEVAAMNFRAKSMGYDATKTFEKNLNHLIEHNEE
//
>1kklH [d.94.1] PHOSPHOCARRIER PROTEIN HPR
QKTFKVTADSGIHARPATVLVQTASKYDADVNLEYNGKTVNLKSIMGVMSLGIAKGAEIT
ISASGADENDALNALEETMKSERLGE
//
>1kkmA [c.91.1] HPRK PROTEIN
ERRSMHGVLVDIYGLGVLITGDSGVGKSETALELVQRGHRLIADDRVDVYQQDEQTIVGA
APPILSHLLEIRGLGIIDVMNLFGAGAVREDTTISLIVHLENWTPDKTFDRLGSGEQTQL
IFDVPVPKITVPVKVGRNLAIIIEVAAMNFRAKSMGYDATKTFEKNLNHLIEHNEE
//
>1kkmI (H) [d.94.1] PHOSPHOCARRIER PROTEIN HPR
AQKTFKVTADSGIHARPATVLVQTASKYDADVNLEYNGKTVNLKxIMGVMSLGIAKGAEI
TISASGADENDALNALEETMKSERLGE
//
>1kluD [b.40.2 - d.15.6] ENTEROTOXIN TYPE C-3
ESQPDPMPDDLHKSSEFTGTMGNMKYLYDDHYVSATKVKSVDSFFKWDLIYNISDKKLKN
YDKVKTELLNEDLAKKYKDEVVDVYGSNYYVNCYFSGGKTCMYGGITKHEGNHFDNGNLQ
NVLVRVYENKRNTISFEVQTDKKSVTAQELDIKARNFLINKKNLYEFNSSPYETGYIKFI
ENNGNTFWYDMMPAPGDKFDQSKYLMMYNDNKTVDSKSVKIEVHLTTKNG
//
>1kluJ (B) [d.19.1 - b.1.1] HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR-1
GDTRPRFLWQLKFECHFFNGTERVRLLERCIYNQEESVRFDSDVGEYRAVTELGRPDAEY
WNSQKDLLEQRRAAVDTYCRHNYGVGESFTVQRRVEPKVTVYPSKTQPLQHHNLLVCSVS
GFYPGSIEVRWFRNGQEEKAGVVSTGLIQNGDWTFQTLVMLETVPRSGEVYTCQVEHPSV
TSPLTVEWRA
//
>1kmiA (Z) [h.4.11] CHEMOTAXIS PROTEIN CHEZ
SIKPADEHSAGDIIARIGSLTRMLRDSLRELGLDQAIAEAAEAIPDARDRLYYVVQMTAQ
AAERALNSVEASQPHQDQMEKSAKALTQRWDDWFADPIDLADARELVTDTRQFLADVPAH
TSFTNAQLLKIMMAQDFQDLTGQVIKRMMDVIQEIERQLLMVLLSQDQVDDLLDSLG
//
>1kmiB (Y) [c.23.1] CHEMOTAXIS PROTEIN CHEY
ADKELKFLVVDDFSTMRRIVRNLLKELGFNNVEEAEDGVDALNKLQAGGYGFVISDWNMP
NMDGLELLKTIRADGAMSALPVLMVTAEAKKENIIAAAQAGASGYVVKPFTAATLEEKLN
KIFEKLGM
//
>1kn1A [a.1.1] ALLOPHYCOCYANIN
SIVTKSIVNADAEARYLSPGELDRIKSFVLSGARRVRIAQTLTENRERIVKQAGDQLFQK
RPDVVSPGGNAYGEEMTATCLRDLDYYLRLVTYGIVSGDVTPIEEIGLVGVREMYKSLGT
PISAVAEGVKCMKSVASSLLSGEDSAEAGFYFDYVVGAMQ
//
>1kn1B [a.1.1] ALLOPHYCOCYANIN
MQDAITSVINSSDVQGKYLDSSAIEKLKGYFQTGELRVRAATTIAANAANIIKEAVAKSL
LYSDITRPGGNMYTTRRYAACIRDLDYYLRYATYAMLAGDPSILDERVLNGLKETYNSLG
VPIGATIQAIQAMKEVTSGLVGPDAGKEMGLYFDYICSGLS
//
>1kn2H [b.1.1 - b.1.1] IG ANTIBODY D2.3 (HEAVY CHAIN)
EMQLQQSGAELLRPGTSVKLSCKTSGYIFTSYWIHWVKQRSGQGLEWIARIYPGTGSTYY
NEKFKGKATLTADKSSSTAYMQLSTLKSEDSAVYFCTRWGFIPVREDYVMDYWGQGTLVT
VSSAKTTAPSVYPLAPVCGDTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVL
QSDLYTLSSSVTVTSSTWPSQSITCNVAHPASSTKVDKKIEP
//
>1kn2L [b.1.1 - b.1.1] IG ANTIBODY D2.3 (LIGHT CHAIN)
DIVMTQSPLTLSVTIGQPASISCKSSQSLLYSNGKTYLNWLLQRPGQSPKRLIHLVSKLD
SGVPDRITGSGSGTDFTLKISRVEAADLGVYYCVQGTHFPYTFGGGTKLEILRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1kpr_2C (A) [d.19.1 - b.1.1] HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA
GSHSLKYFHTSVSRPGRGEPRFISVGYVDDTQFVRFDNDAASPRMVPRAPWMEQEGSEYW
DRETRSARDTAQIFRVNLRTLRGYYNQSEAGSHTLQWMHGCELGPDGRFLRGYEQFAYDG
KDYLTLNEDLRSWTAVDTAAQISEQKSNDASEAEHQRAYLEDTCVEWLHKYLEKGKETLL
HLEPPKTHVTHHPISDHEATLRCWALGFYPAEITLTWQQDGEGHTQDTELVETRPAGDGT
FQKWAAVVVPSGEEQAYTCHVQHEGLPEPVTLRW
//
>1kpr_2D (B) [b.1.1] BETA-2-MICROGLOBULIN
MIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKD
WSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM
//
>1kpsA [d.20.1] UBIQUITIN-LIKE PROTEIN SUMO-1 CONJUGATING ENZYME
SMSGIALSRLAQERKAWRKDHPFGFVAVPTKNPDGTMNLMNWECAIPGKKGTPWEGGLFK
LRMLFKDDYPSSPPKCKFEPPLFHPNVYPSGTVCLSILEEDKDWRPAITIKQILLGIQEL
LNEPNIQDPAQAEAYTIYCQNRVEYEKRVRAQAKKFAPS
//
>1kpsB [a.118.12] RAN-GTPASE ACTIVATING PROTEIN 1
TDLSTFLSFPSPEKLLRLGPKVSVLIVQQTDTSDPEKVVSAFLKVASVFRDDASVKTAVL
DAIDALMKKAFSCSSFNSNTFLTRLLIHMGLLKSEDKIKAIPSLHGPLMVLNHVVRQDYF
PKALAPLLLAFVTKPNGALETCSFARHNLLQTLYNI
//
>1kqfB [d.58.1 - f.23.22] FORMATE DEHYDROGENASE, NITRATE-INDUCIBLE, IRON-
AMETQDIIKRSATNSITPPSQVRDYKAEVAKLIDVSTCIGCKACQVACSEWNDIRDEVGH
CVGVYDNPADLSAKSWTVMRFSETEQNGKLEWLIRKDGCMHCEDPGCLKACPSAGAIIQY
ANGIVDFQSENCIGCGYCIAGCPFNIPRLNKEDNRVYKCTLCVDRVSVGQEPACVKTCPT
GAIHFGTKKEMLELAEQRVAKLKARGYEHAGVYNPEGVGGTHVMYVLHHADQPELYHGLP
KDPKIDTSVSLWKGALKPLAAAGFIATFAGLIFHYIGIGPNKEVDDDEE
//
>1kqfC [f.21.1] FORMATE DEHYDROGENASE, NITRATE-INDUCIBLE,
SKSKMIVRTKFIDRACHWTVVICFFLVALSGISFFFPTLQWLTQTFGTPQMGRILHPFFG
IAIFVALMFMFVRFVHHNIPDKKDIPWLLNIVEVLKGNEHKVADVGKYNAGQKMMFWSIM
SMIFVLLVTGVIIWRPYFAQYFPMQVVRYSLLIHAAAGIILIHAILIHMYMAFWVKGSIK
GMIEGKVSRRWAKKHHPRWYREIEKAEAKKESEEGI
//
>1kqgA [c.81.1 - b.52.2] FORMATE DEHYDROGENASE, NITRATE-INDUCIBLE, MAJOR
QARNYKLLRAKEIRNTCTYCSVGCGLLMYSLGDGAKNAREAIYHIEGDPDHPVSRGALCP
KGAGLLDYVNSENRLRYPEYRAPGSDKWQRISWEEAFSRIAKLMKADRDANFIEKNEQGV
TVNRWLSTGMLCASGASNETGMLTQKFARSLGMLAVDNQARVcHGPTVASLAPTFGRGAM
TNHWVDIKNANVVMVMGGNAAEAHPVGFRWAMEAKNNNDATLIVVDPRFTRTASVADIYA
PIRSGTDITFLSGVLRYLIENNKINAEYVKHYTNASLLVRDDFAFEDGLFSGYDAEKRQY
DKSSWNYQLDENGYAKRDETLTHPRCVWNLLKEHVSRYTPDVVENICGTPKADFLKVCEV
LASTSAPDRTTTFLYALGWTQHTVGAQNIRTMAMIQLLLGNMGMAGGGVNALRGHSNIQG
LTDLGLLSTSLPGYLTLPSEKQVDLQSYLEANTPKATLADQVNYWSNYPKFFVSLMKSFY
GDAAQKENNWGYDWLPKWDQTYDVIKYFNMMDEGKVTGYFCQGFNPVASFPDKNKVVSCL
SKLKYMVVIDPLVTETSTFWQNHGESNDVDPASIQTEVFRLPSTCFAEEDGSIANSGRWL
QWHWKGQDAPGEARNDGEILAGIYHHLRELYQSEGGKGVEPLMKMSWNYKQPHEPQSDEV
AKENNGYALEDLYDANGVLIAKKGQLLSSFAHLRDDGTTASSCWIYTGSWTEQGNQMANR
DNSDPSGLGNTLGWAWAWPLNRRVLYNRASADINGKPWDPKRMLIQWNGSKWTGNDIPDF
GNAAPGTPTGPFIMQPEGMGRLFAINKMAEGPFPEHYEPIETPLGTNPLHPNVVSNPVVR
LYEQDALRMGKKEQFPYVGTTYRLTEHFHTWTKHALLNAIAQPEQFVEISETLAAAKGIN
NGDRVTVSSKRGFIRAVAVVTRRLKPLNVNGQQVETVGIPIHWGFEGVARKGYIANTLTP
NVGDANSQTPEYKAFLVNIEKA
//
>1kqgB [d.58.1 - f.23.22] FORMATE DEHYDROGENASE, NITRATE-INDUCIBLE, IRON-
AMETQDIIKRSATNSITPPSQVRDYKAEVAKLIDVSTCIGCKACQVACSEWNDIRDEVGH
CVGVYDNPADLSAKSWTVMRFSETEQNGKLEWLIRKDGCMHCEDPGCLKACPSAGAIIQY
ANGIVDFQSENCIGCGYCIAGCPFNIPRLNKEDNRVYKCTLCVDRVSVGQEPACVKTCPT
GAIHFGTKKEMLELAEQRVAKLKARGYEHAGVYNPEGVGGTHVMYVLHHADQPELYHGLP
KDPKIDTSVSLWKGALKPLAAAGFIATFAGLIFHYIGIGPNKEVDDDEE
//
>1krl_1A [d.17.1] MONELLIN, CHAIN A
REIKGYEYQLYVYASDKLFRADISEDYKTRGRKLLRFNGPVPPP
//
>1krl_1B [d.17.1] MONELLIN, CHAIN B
GEWEIIDIGPFTQNLGKFAVDEENKIGQYGRLTFNKVIRPCMKKTIYE
//
>1ksgA [c.37.1] ARF-LIKE PROTEIN 2
SMGLLTILKKMKQKERELRLLMLGLDNAGKTTILKKFNGEDVDTISPTLGFNIKTLEHRG
FKLNIWDVGGQKSLRSYWRNYFESTDGLIWVVDSADRQRMQDCQRELQSLLVEERLAGAT
LLIFANKQDLPGALSCNAIQEALELDSIRSHHWRIQGCSAVTGEDLLPGIDWLLDDISSR
//
>1ksgB [b.1.18] RETINAL ROD RHODOPSIN-SENSITIVE CGMP 3',5'-
KDERAREILRGFKLNWMNLRDAETGKILWQGTEDLSVPGVEHEARVPKKILKCKAVSREL
NFSSTEQMEKFRLEQKVYFKGQCLEEWFFEFGFVIPNSTNTWQSLIIETKFFDDDLLVST
SRVRLFYV
//
>1ksjA [c.37.1] ARF-LIKE PROTEIN 2
RELRLLmLGLDNAGKTTILKKFNGEDVDTISPTLGFNIKTLEHRGFKLNIWDVGGQKSLR
SYWRNYFESTDGLIWVVDSADRQRmQDCQRELQSLLVEERLAGATLLIFANKQDLPGALS
xNAIQEALELDSIRSHHWRIQGCSAVTGEDLLPGIDWLLDDISSR
//
>1ksjB [b.1.18] RETINAL ROD RHODOPSIN-SENSITIVE CGMP 3',5'-
SAKDERAREILRGFKLNWmNLRDAETGKILWQGTEDLSVPGVEHEARVPKKILKCKAVSR
ELNFSSTEQmEKFRLEQKVYFKGQxLEEWFFEFGFVIPNSTNTWQSLIEPASVLTGNVII
ETKFFDDDLLVSTSRVRLFYV
//
>1ktdC (A) [d.19.1 - b.1.1] H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, E-D
IKEEHTIIQAEFYLLPDKRGEFMFDFDGDEIFHVDIEKSETIWRLEEFAKFASFEAQGAL
ANIAVDKANLDVMKERSNNTPDANVAPEVTVLSRSPVNLGEPNILICFIDKFSPPVVNVT
WLRNGRPVTEGVSETVFLPRDDHLFRKFHYLTFLPSTDDFYDCEVDHWGLEEPLRKTWEF
EE
//
>1ktdD (B) [d.19.1 - b.1.1] FUSION PROTEIN CONSISTING OF CYTOCHROME C
AADLIAYLKQASAKGGGGSLVGGGSGGGGSRPWFLEYCKSECHFYNGTQRVRLLVRYFYN
LEENLRFDSDVGEFRAVTELGRPDAENWNSQPEFLEQKRAEVDTVCRHNYEIFDNFLVPR
RVEPTVTVYPTKTQPLEHHNLLVCSVSDFYPGNIEVRWFRNGKEEKTGIVSTGLVRNGDW
TFQTLVMLETVPQSGEVYTCQVEHPSLTDPVTVEW
//
>1ktkA [b.40.2 - d.15.6] EXOTOXIN TYPE C
KKDISNVKSDLLYAYTITPYDYKDCRVNFSTTHTLNIDTQKYRGKDYYISSEMSYEASFK
RDDHVDVFGLFYILNSHTGEYIYGGITPAQNNKVNHKLLGNLFISESQQNLNNKIILEKD
IVTFQEIDFKIRKYLMDNYKIYDATSPYVSGRIEIGTKDGKHEQIDLFDSPNEGTRSDIF
AKYKDNRIINMKNFSHFDIYLEK
//
>1ktkB [b.40.2 - d.15.6] EXOTOXIN TYPE C
KKDISNVKSDLLYAYTITPYDYKDCRVNFSTTHTLNIDTQKYRGKDYYISSEMSYEASQK
FKRDDHVDVFGLFYILNSHTGEYIYGGITPAQNNKVNHKLLGNLFIQNLNNKIILEKDIV
TFQEIDFKIRKYLMDNYKIYDATSPYVSGRIEIGTKDGKHEQIDLFDSPNEGTRSDIFAK
YKDNRIINMKNFSHFDIYLE
//
>1ktkE [b.1.1 - b.1.1] T-CELL RECEPTOR BETA CHAIN
GAVVSQHPSRVIAKSGTSVKIECRSLDFQATTMFWYRQFPKQSLMLMATSAEGSKATYEQ
GVEKDKFLINHASLTLSTLTVTSAHPEDSSFYICSALAGSGSSTDTQYFGPGTRLTVLED
LKNFPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVSTDPQPL
KEQPALNDSRYALSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSA
EAWGRAD
//
>1ktkF [b.1.1 - b.1.1] T-CELL RECEPTOR BETA CHAIN
VSQHPSRVIAKSGTSVKIECRSLDFQATTMFWYRQFPKQSLMLMATSAEGSKATGVEKKF
LINHASLTLSTLTVTSAHPEDSSFYICYFGPGTRLTVPPEVAVFEPVCLATGFNDSRYAL
SSRLQNPRNHFRVQFYVTQIVSAE
//
>1ktpB [a.1.1] C-PHYCOCYANIN BETA SUBUNIT
MLDAFAKVVAQADARGEFLTNAQFDALSNLVKEGNKRLDAVNRITSNASTIVANAARALF
AEQPQLIQPGGxAYTNRRMAACLRDMEIILRYVTYAILAGDSSVLDDRCLNGLRETYQAL
GTPGSSVAVAIQKMKDAAIAIANDPNGITPGDCSALMSEIAGYFDRAAAAVA
//
>1ktpA [a.1.1] C-PHYCOCYANIN ALPHA SUBUNIT
MKTPITEAIAAADTQGRFLSNTELQAVDGRFKRAVASMEAARALTNNAQSLIDGAAQAVY
QKFPYTTTMQGSQYASTPEGKAKCARDIGYYLRMITYCLVAGGTGPMDEYLIAGLSEINS
TFDLSPSWYIEALKYIKANHGLTGQAAVEANAYIDYAINALS
//
>1ktrA (L) [b.1.1] ANTI-HIS TAG ANTIBODY 3D5 VARIABLE LIGHT CHAIN
DILMTQTPSSLPVSLGDQASISCRSSQSIVHSNGNTYLEWYLQKPGQSPKLLIYKVSNRF
SGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCFQGSHVPFTFGSGTKLEIKR
//
>1ktrB (H) [b.1.1] ANTI-HIS TAG ANTIBODY 3D5 VARIABLE HEAVY CHAIN
QVQLQQSGPEDVKPGASVKISCKASGYTFTDYYMNWVKQSPGKGLEWIGDINPNNGGTSY
NQKFKGRATLTVDKSSSTAYMELRSLTSEDSSVYYCESQSGAYWGQGTTVTVSA
//
>1ku6A [c.69.1] ACETYLCHOLINESTERASE
REDPQLLVRVRGGQLRGIRLKAPGGPVSAFLGIPFAEPPVGSRRFMPPEPKRPWSGVLDA
TTFQNVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPASPTPVLIWIYGGG
FYSGAASLDVYDGRFLAQVEGAVLVSMNYRVGTFGFLALPGSREAPGNVGLLDQRLALQW
VQENIAAFGGDPMSVTLFGESAGAASVGMHILSLPSRSLFHRAVLQSGTPNGPWATVSAG
EARRRATLLARLVGCPGGNDTELIACLRTRPAQDLVDHEWHVLPQESIFRFSFVPVVDGD
FLSDTPEALINTGDFQDLQVLVGVVKDEGSYFLVYGVPGFSKDNESLISRAQFLAGVRIG
VPQASDLAAEAVVLHYTDWLHPEDPTHLRDAMSAVVGDHNVVCPVAQLAGRLAAQGARVY
AYIFEHRASTLTWPLWMGVPHGYEIEFIFGLPLDPSLNYTTEERIFAQRLMKYWTNFART
GDPNDPRDSKSPQWPPYTTAAQQYVSLNLKPLEVRRGLRAQTCAFWNRFLPKLLS
//
>1ku6B [g.7.1] FASCICULIN 2
TMCYSHTTTSRAILTNCGENSCYRKSRRHPPKMVLGRGCGCPPGDDNLEVKCCTSPDKCN
Y
//
>1kve_2C (A) [d.70.1] SMK TOXIN
WSLRWRMQKSTTIAAIAGCSGAATFGGLAGGIVGCIAAGILAILQGFEVNWHNGGGGDRS
NPV
//
>1kve_2D (B) [d.70.1] SMK TOXIN
GEATTIWGVGADEAIDKGTPSKNDLQNMSADLAKNGFKGHQGVACSTVKDGNKDVYMIKF
SLAGGSNDPGGSPCSDD
//
>1kx4A [a.22.1] HISTONE H3
PHRYRPGTVALREIRRYQKSTELLIRKLPFQRLVREIAQDFKTDLRFQSSAVMALQEASE
AYLVALFEDTNLCAIHAKRVTIMPKDIQLARRIRGERA
//
>1kx4B [a.22.1] HISTONE H4
KVLRDNIQGITKPAIRRLARRGGVKRISGLIYEETRGVLKVFLENVIRDAVTYTEHAKRK
TVTAMDVVYALKRQGRTLYGFGG
//
>1kx5C [a.22.1] HISTONE H2A.1
SGRGKQGGKTRAKAKTRSSRAGLQFPVGRVHRLLRKGNYAERVGAGAPVYLAAVLEYLTA
EILELAGNAARDNKKTRIIPRHLQLAVRNDEELNKLLGRVTIAQGGVLPNIQSVLLPKKT
ESSKSKSK
//
>1kx5E (A) [a.22.1] HISTONE H3
ARTKQTARKSTGGKAPRKQLATKAARKSAPATGGVKKPHRYRPGTVALREIRRYQKSTEL
LIRKLPFQRLVREIAQDFKTDLRFQSSAVMALQEASEAYLVALFEDTNLCAIHAKRVTIM
PKDIQLARRIRGERA
//
>1kxq_1A [c.1.8 - b.71.1] ALPHA-AMYLASE, PANCREATIC
QYAPQTQSGRTSIVHLFEWRWVDIALECERYLGPKGFGGVQVSPPNENIVVTNPSRPWWE
RYQPVSYKLCTRSGNENEFRDMVTRCNNVGVRIYVDAVINHMCGSGAAAGTGTTCGSYCN
PGSREFPAVPYSAWDFNDGKCKTASGGIESYNDPYQVRDCQLVGLLDLALEKDYVRSMIA
DYLNKLIDIGVAGFRIDASKHMWPGDIKAVLDKLHNLNTNWFPAGSRPFIFQEVIDLGGE
AIKSSEYFGNGRVTEFKYGAKLGTVVRKWSGEKMSYLKNWGEGWGFMPSDRALVFVDNHD
NQRGHGAGGSSILTFWDARLYKIAVGFMLAHPYGFTRVMSSYRWARNFVNGEDVNDWIGP
PNNNGVIKEVTINADTTCGNDWVCEHRWREIRNMVWFRNVVDGQPFANWWDNGSNQVAFG
RGNRGFIVFNNDDWQLSSTLQTGLPGGTYCDVISGDKVGNSCTGIKVYVSSDGTAQFSIS
NSAEDPFIAIHAESKL
//
>1kxq_1H (E) [b.1.1] ANTIBODY VHH FRAGMENT CABAMD9
QVQLVESGGGSVQAGGSLSLSCAASTYTDTVGWFRQAPGKEREGVAAIYRRTGYTYSADS
VKGRFTLSQDNNKNTVYLQMNSLKPEDTGIYYCATGNSVRLASWEGYFYWGQGTQVTVSS
//
>1kxt_1A [c.1.8 - b.71.1] ALPHA-AMYLASE, PANCREATIC
QYAPQTQSGRTSIVHLFEWRWVDIALECERYLGPKGFGGVQVSPPNENIVVTNPSRPWWE
RYQPVSYKLCTRSGNENEFRDMVTRCNNVGVRIYVDAVINHMCGSGAAAGTGTTCGSYCN
PGSREFPAVPYSAWDFNDGKCKTASGGIESYNDPYQVRDCQLVGLLDLALEKDYVRSMIA
DYLNKLIDIGVAGFRIDASKHMWPGDIKAVLDKLHNLNTNWFPAGSRPFIFQEVIDLGGE
AIKSSEYFGNGRVTEFKYGAKLGTVVRKWSGEKMSYLKNWGEGWGFMPSDRALVFVDNHD
NQRGHGAGGSSILTFWDARLYKIAVGFMLAHPYGFTRVMSSYRWARNFVNGEDVNDWIGP
PNNNGVIKEVTINADTTCGNDWVCEHRWREIRNMVWFRNVVDGQPFANWWDNGSNQVAFG
RGNRGFIVFNNDDWQLSSTLQTGLPGGTYCDVISGDKVGNSCTGIKVYVSSDGTAQFSIS
NSAEDPFIAIHAESKL
//
>1kxt_1B [b.1.1] IMMUNOGLOBULIN VHH FRAGMENT
QVQLVASGGGSVQAGGSLRLSCAASTFSSYPMGWYRQAPGKECELSARIFSDGSANYADS
VKGRFTISRDNAANTAYLQMDSLKPEDTAVYYCAAGPGSGKLVVAGRTCYGPNYWGQGTQ
VTV
//
>1kxv_2B (A) [c.1.8 - b.71.1] ALPHA-AMYLASE, PANCREATIC
QYAPQTQSGRTSIVHLFEWRWVDIALECERYLGPKGFGGVQVSPPNENIVVTNPSRPWWE
RYQPVSYKLCTRSGNENEFRDMVTRCNNVGVRIYVDAVINHMCGSGAAAGTGTTCGSYCN
PGSREFPAVPYSAWDFNDGKCKTASGGIESYNDPYQVRDCQLVGLLDLALEKDYVRSMIA
DYLNKLIDIGVAGFRIDASKHMWPGDIKAVLDKLHNLNTNWFPAGSRPFIFQEVIDLGGE
AIKSSEYFGNGRVTEFKYGAKLGTVVRKWSGEKMSYLKNWGEGWGFMPSDRALVFVDNHD
NQRGHGAGGSSILTFWDARLYKIAVGFMLAHPYGFTRVMSSYRWARNFVNGEDVNDWIGP
PNNNGVIKEVTINADTTCGNDWVCEHRWREIRNMVWFRNVVDGQPFANWWDNGSNQVAFG
RGNRGFIVFNNDDWQLSSTLQTGLPGGTYCDVISGDKVGNSCTGIKVYVSSDGTAQFSIS
NSAEDPFIAIHAESKL
//
>1kxv_2D [b.1.1] CAMELID VHH DOMAIN CAB10
QVQLVESGGGTVPAGGSLRLSCAASGNTLCTYDMSWYRRAPGKGRDFVSGIDNDGTTTYV
DSVAGRFTISQGNAKNTAYLQMDSLKPDDTAMYYCKPSLRYGLPGCPIIPWGQGTQVTVS
S
//
>1kyoC [f.21.1 - f.32.1] CYTOCHROME B
MAFRKSNVYLSLVNSYIIDSPQPSSINYWWNMGSLLGLCLVIQIVTGIFMAMHYSSNIEL
AFSSVEHIMRDVHNGYILRYLHANGASFFFMVMFMHMAKGLYYGSYRSPRVTLWNVGVII
FTLTIATAFLGYCCVYGQMSHWGATVITNLFSAIPFVGNDIVSWLWGGFSVSNPTIQRFF
ALHYLVPFIIAAMVIMHLMALHIHGSSNPLGITGNLDRIPMHSYFIFKDLVTVFLFMLIL
ALFVFYSPNTLGHPDNYIPGNPLVTPASIVPEWYLLPFYAILRSIPDKLLGVITMFAAIL
VLLVLPFTDRSVVRGNTFKVLSKFFFFIFVFNFVLLGQIGACHVEVPYVLMGQIATFIYF
AYFLIIVPVISTIENVLFYIGRVNK
//
>1kyoD [a.3.1 - f.23.11] CYTOCHROME C1, HEME PROTEIN
MTAAEHGLHAPAYAWSHNGPFETFDHASIRRGYQVYREVCAACHSLDRVAWRTLVGVSHT
NEEVRNMAEEFEYDDEPDEQGNPKKRPGKLSDYIPGPYPNEQAARAANQGALPPDLSLIV
KARHGGCDYIFSLLTGYPDEPPAGVALPPGSNYNPYFPGGSIAMARVLFDDMVEYEDGTP
ATTSQMAKDVTTFLNWCAEPEHDERKRLGLKTVIILSSLYLLSIWVKKFKWAGIKTRKFV
FNPPK
//
>1kyoF [f.28.1] UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX 17 KD
DTDQLEDLREHFKNTEEGKALVHHYEECAERVKIQQQQPGYADLEHKEDCVEEFFHLQHY
LDTATAPRLFDKLK
//
>1kyoL (A) [d.185.1 - d.185.1] UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX CORE
AEVTQLSNGIVVATEHNPAHTASVGVVFGSGAANENPYNNGVSNLWKNIFLSKENSAVAA
KEGLALSSNISRDFQSYIVSSLPGSTDKSLDFLNQSFIQQKANLLSSSNFEATKKSVLKQ
VQDFEDNDHPNRVLEHLHSTAFQNTPLSLPTRGTLESLENLVVADLESFANNHFLNSNAV
VVGTGNIKHEDLVNSIESKNLSLQTGTKPVLKKKAAFLGSEVRLRDDTLPKAWISLAVEG
EPVNSPNYFVAKLAAQIFGSYNAFEPASRLQGIKLLDNIQEYQLCDNFNHFSLSYKDSGL
WGFSTATRNVTMIDDLIHFTLKQWNRLTISVTDTEVERAKSLLKLQLGQLYESGNPVNDA
NLLGAEVLIKGSKLSLGEAFKKIDAITVKDVKAWAGKRLWDQDIAIAGTGQIEGLLDYMR
IRSDMSMMRW
//
>1kyoN (C) [f.21.1 - f.32.1] CYTOCHROME B
MAFRKSNVYLSLVNSYIIDSPQPSSINYWWNMGSLLGLCLVIQIVTGIFMAMHYSSNIEL
AFSSVEHIMRDVHNGYILRYLHANGASFFFMVMFMHMAKGLYYGSYRSPRVTLWNVGVII
FTLTIATAFLGYCCVYGQMSHWGATVITNLFSAIPFVGNDIVSWLWGGFSVSNPTIQRFF
ALHYLVPFIIAAMVIMHLMALHIHGSSNPLGITGNLDRIPMHSYFIFKDLVTVFLFMLIL
ALFVFYSPNTLGHPDNYIPGNPLVTPASIVPEWYLLPFYAILRSIPDKLLGVITMFAAIL
VLLVLPFTDRSVVRGNTFKVLSKFFFFIFVFNFVLLGQIGACHVEVPYVLMGQIATFIYF
AYFLIIVPVISTIENVLFYIGRVNK
//
>1kyoP (E) [f.23.12 - b.33.1] UBIQUINOL-CYTOCHROME C REDUCTASE IRON-SULFUR
KSTYRTPNFDDVLKENNDADKGRSYAYFMVGAMGLLSSAGAKSTVETFISSMTATADVLA
MAKVEVNLAAIPLGKNVVVKWQGKPVFIRHRTPHEIQEANSVDMSALKDPQTDADRVKDP
QWLIMLGICTHLGCVPIGEAGDFGGWFCPCHGSHYDISGRIRKGPAPLNLEIPAYEFDGD
KVIVG
//
>1kyoS (H) [f.23.13] UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX
GPPSGKTYMGWWGHMGGPKQKGITSYAVSPYAQKPLQGIFHNAVFNSFRRFKSQFLYVLI
PAGIYWYWWKNGNEYNEFLYSKAGREELERVNV
//
>1kyoU (J) [b.1.1] HEAVY CHAIN (VH) OF FV-FRAGMENT
EVKLQESGAGLVQPSQSLSLTCSVTGYSITSGYYWNWIRLFPGNKLEWVGYISNVGDNNY
NPSLKDRLSITRDTSKNQFFLKLNSVTTEDTATYYCARSEYYSVTGYAMDYWGQGTTVTV
SSAWRHP
//
>1kyoV (K) [b.1.1] LIGHT CHAIN (VL) OF FV-FRAGMENT
DIELTQTPVSLAASLGDRVTISCRASQDINNFLNWYQQKPDGTIKLLIYYTSRLHAGVPS
RFSGSGSGTDYSLTISNLEPEDIATYFCQHHIKFPWTFGAGTKLEIK
//
>1kzg_2C [a.87.1 - b.55.1] GUANINE NUCLEOTIDE EXCHANGE FACTOR DBS
EEEESLAILRRHVMNELLDTERAYVEELLCVLEGYAAEMDNPLMAHLISTGLQNKKNILF
GNMEEIYHFHNRIFLRELESCIDCPELVGRCFLERMEEFQIYEKYCQNKPRSESLWRQCS
DCPFFQECQKKLDHKLSLDSYLLKPVQRITKYQLLLKEMLKYSKHCEGAEDLQEALSSIL
GILKAVNDSMHLIAITGYDGNLGDLGKLLMQGSFSVWTDHKELARFKPMQRHLFLHEKAV
LFCKKREENGEGYEKAPSFSYKQSLNMTAVGITENVKGDTKKFEIWYNAREEVYIIQAPT
PEIKAAWVNEIRKVLTSQLQACREASQHRA
//
>1kzg_2D [c.37.1] CDC42 HOMOLOG
MQTIKCVVVGDGAVGKTCLLISYTTNKFPSEYVPTVFDNYAVTVMIGGEPYTLGLFDTAG
QEDYDRLRPLSYPQTDVFLVCFSVVSPSSFENVKEKWVPEITHHCPKTPFLLVGTQIDLR
DDPSTIEKLAKNKQKPITPETAEKLARDLKAVKYVECSALTQKGLKNVFDEAILAAL
//
>1l0lA [d.185.1 - d.185.1] UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX CORE
TATYAQALQSVPETQVSQLDNGLRVASEQSSQPTCTVGVWIDAGSRYESEKNNGAGYFVE
HLAFKGTKNRPGNALEKEVESMGAHLNAYSTREHTAYYIKALSKDLPKAVELLADIVQNC
SLEDSQIEKERDVILQELQENDTSMRDVVFNYLHATAFQGTPLAQSVEGPSENVRKLSRA
DLTEYLSRHYKAPRMVLAAAGGLEHRQLLDLAQKHFSGLSGTYDEDAVPTLSPCRFTGSQ
ICHREDGLPLAHVAIAVEGPGWAHPDNVALQVANAIIGHYDCTYGGGAHLSSPLASIAAT
NKLCQSFQTFNICYADTGLLGAHFVCDHMSIDDMMFVLQGQWMRLCTSATESEVLRGKNL
LRNALVSHLDGTTPVCEDIGRSLLTYGRRIPLAEWESRIAEVDARVVREVCSKYFYDQCP
AVAGFGPIEQLPDYNRIRSGMFWLRF
//
>1l0lG [f.23.13] UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX
GRQFGHLTRVRHVITYSLSPFEQRAFPHYFSKGIPNVLRRTRACILRVAPPFVAFYLVYT
WGTQEFEKSKRKNPAAYEN
//
>1l0lH [f.28.1] UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX 11 KDA
GDPKEEEEEEEELVDPLTTVREQCEQLEKCVKARERLELCDERVSSRSQTEEDCTEELLD
FLHARDHCVAHKLFNSLK
//
>1l0lJ [f.23.14] UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX 7.2 KDA
APTLTARLYSLLFRRTSTFALTIVVGALFFERAFDQGADAIYEHINEGKLWKHIKHKYEN
//
>1l0nD [a.3.1 - f.23.11] CYTOCHROME C1, HEME PROTEIN
SDLELHPPSYPWSHRGLLSSLDHTSIRRGFQVYKQVCSSCHSMDYVAYRHLVGVCYTEDE
AKALAEEVEVQDGPNEDGEMFMRPGKLSDYFPKPYPNPEAARAANNGALPPDLSYIVRAR
HGGEDYVFSLLTGYCEPPTGVSLREGLYFNPYFPGQAIGMAPPIYNEVLEFDDGTPATMS
QVAKDVCTFLRWAAEPEHDHRKRMGLKMLLMMGLLLPLVYAMKRHKWSVLKSRKLAYRPP
K
//
>1l0nF [f.27.1] UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX 14 KDA
VSASSRWLEGIRKWYYNAAGFNKLGLMRDDTIHENDDVKEAIRRLPENLYDDRVFRIKRA
LDLSMRQQILPKEQWTKYEEDKSYLEPYLKEVIRERKEREEWAKK
//
>1l0oB (A) [d.122.1] ANTI-SIGMA F FACTOR
MRNEMHLQFSARSENESFARVTVAAFVAQLDPTMDELTEIKTVVSEAVTNAIIHGYNNDP
NGIVSISVIIEDGVVHLTVRDEGVGIPDIEEARQPLFTTKPELERSGMGFTIMENFMDEV
IVESEVNKGTTVYLKKHIVKS
//
>1l0oC [a.4.13] SIGMA FACTOR
DGTVKVSRSLKEMGNKIRKAKDELSKTRGRAPTVTEIADHLGISPEDVVLAQEAVRL
//
>1l0vB [d.15.4 - a.1.2] FUMARATE REDUCTASE IRON-SULFUR PROTEIN
AEMKNLKIEVVRYNPEVDTAPHSAFYEVPYDATTSLLDALGYIKDNLAPDLSYRWSCRMA
ICGSCGMMVNNVPKLACKTFLRDYTDGMKVEALANFPIERDLVVDMTHFIESLEAIKPYI
IGNSRTADQGTNIQTPAQMAKYHQFSGCINCGLCYAACPQFGLNPEFIGPAAITLAHRYN
EDSRDHGKKERMAQLNSQNGVWSCTFVGYCSEVCPKHVDPAAAIQQGKVESSKDFLIATL
KPR
//
>1l0vC [f.21.2] FUMARATE REDUCTASE 15 KDA HYDROPHOBIC PROTEIN
TTKRKPYVRPMTSTWWKKLPFYRFYMLREGTAVPAVWFSIELIFGLFALKNGPEAWAGFV
DFLQNPVIVIINLITLAAALLHTKTWFELAPKAANIIVKDEKMGPEPIIKSLWAVTVVAT
IVILFVALYW
//
>1l0vD [f.21.2] FUMARATE REDUCTASE 13 KDA HYDROPHOBIC PROTEIN
MINPNPKRSDEPVFWGLFGAGGMWSAIIAPVMILLVGILLPLGLFPGDALSYERVLAFAQ
SFIGRVFLFLMIVLPLWCGLHRMHHAMHDLKIHVPAGKWVFYGLAAILTVVTLIGVVTI
//
>1l1o_1E (B) [b.40.4] REPLICATION PROTEIN A 32 KDA SUBUNIT
QHIVPCTISQLLSATLVDEVFRIGNVEISQVTIVGIIRHAEKAPTNIVYKIDDMTAAPMD
VRQWVDTDNTVVPPETYVKVAGHLRSFQNKKSLVAFKIMPLEDMNEFTTHILEVINAHMV
LSK
//
>1l1o_1F [b.40.4] REPLICATION PROTEIN A 70 KDA DNA-BINDING SUBUNIT
NTNWKTLYEVKSENLGQGDKPDYFSSVATVVYLRKENCMYQACPTQDCNKKVIDQQNGLY
RCEKCDTEFPNFKYRMILSVNIADFQENQWVTCFQESAEAILGQNAAYLGELKDKNEQAF
EEVFQNANFRSFIFRVRVKVEIKATVMDVKPVDYREYGRRLVMSIRRSALM
//
>1l1o_1D (A) [b.40.4] REPLICATION PROTEIN A 14 KDA SUBUNIT
DMMDLPRSRINAGMLAQFIDKPVCFVGRLEKIHPTGKMFILSDGEGKNGTIELMEPLDEE
ISGIVEVVGRVTAKATILCTSYVQFKEDSHPFDLGLYNEAVKIIHDFPQFYPLGI
//
>1l2g_1A [b.1.1] GLYCOPROTEIN D
PNRFRGKDLPVLDQLTDPPGVRRVYHIQAGLPDPFQPPSLPITVYYAVLERACRSVLLNA
PSEAPQIVRGASEDVRKQPYNLTIAWFRMGGNCAIPITVMEYTECSYNKSLGACPIRTQP
RWNYYDSFSAVSEDNLGFLMHAPAFETAGTYLRLVKINDWTEITQFILEHRAKGSCKYAL
PLRIPPSACLSPQAYQQGVTVDSIGMLPRFIPENQRTVAVYSLKIAGWHGPKAPYTSTLL
PP
//
>1l2g_1A [b.1.1] GLYCOPROTEIN D
PNRFRGKDLPVLDQLTDPPGVRRVYHIQAGLPDPFQPPSLPITVYYAVLERACRSVLLNA
PSEAPQIVRGASEDVRKQPYNLTIAWFRMGGNCAIPITVMEYTECSYNKSLGACPIRTQP
RWNYYDSFSAVSEDNLGFLMHAPAFETAGTYLRLVKINDWTEITQFILEHRAKGSCKYAL
PLRIPPSACLSPQAYQQGVTVDSIGMLPRFIPENQRTVAVYSLKIAGWHGPKAPYTSTLL
PP
//
>1l2g_1B (A) [b.1.1] GLYCOPROTEIN D
PNRFRGKDLPVLDQLTDPPGVRRVHIQAGLPDPQPPSLPITVYAVLERACRSVLLNAPSE
QIVRGASEDVRKQPYNTIAWFRMGGNCAIITVMEYTCSYNKSLGCPIRTQPRWNYYDSSA
VSEDNGFLMHAPAFETAGTYLRLVKINDWTEITQFILEHRAKGSCKAPRIPPSACLSPQA
YQQGVTVDIGMLPRFIPENQRTVAVYSLKIAGWHGPKAPYTSTLLPPPNRFRGKDLPVLD
QLTDPPGVRRVYIQAGLPDQPPSLPITVYAVLERACRSVLLNAPSEAIVRASEDVRKQPY
NLTIAWFRMGGNCAPIVMEYTECSYNKSLGACPIRQPRWNYYDSFSAVSEDNGFLMHAPA
FETAGTYLLVKINDWTEITQILEHRAKGKYALPLRIPPSACLSPQAYQQGVTVDSIGMLP
RFIPENQRTVAVYSLKIAGWHGPKTSTLPP
//
>1l2w_2C (B) [d.198.1] YOPE REGULATOR
YSFEQAITQLFQQLSLSIPDTIEPVIGVKVGEFACHITEHPVGQILMFTLPSLDNNDEKE
TLLSHNIFSQDILKPILSWDEVGGHPVLWNRQPLNSLDNNSLYTQLEMLVQGAERLQ
//
>1l2w_2J [d.198.1] OUTER MEMBRANE VIRULENCE PROTEIN YOPE
VGEMSGRSVSQQTSDQYANNLAGRTESPQGSSLASRIIERLSSVAHSVIGFIQRMF
//
>1l4aA [h.1.15] SYNAPTOBREVIN
QPVQQSKRLQQTQAQVEEVVDIMRVNVDKVLERDSKISELDDRADALQAGASQFEASAGK
LKRKFW
//
>1l4aB [h.1.15] S-SYNTAXIN
GKSASGIIMETQQAKQTLADIEARHADIMKLETSIRELHDMFMDMAMLVESQGEMIDRIE
YNVEAAVDYIETAKVDTKKAVK
//
>1l4aC [h.1.15] S-SNAP25 FUSION PROTEIN
KTELEEIQQQCNQVTDDSLESTRRMLNMCEESKEAGIRTLVMLDEQGEQLDRIEEGLDQI
NQDMKDAEKNLEG
//
>1l4aD [h.1.15] S-SNAP25 FUSION PROTEIN
PSSGYVTRITNDAREDDMENNMKEVSSMIGNLRNMAIDMGNEIGSQNRQVDRIQQKAESN
ESRIDEANKKATKLL
//
>1l4aE [h.1.15] SYNAPHIN A
ERRKEKHRKMEEEREEMRQTIRDKYGLK
//
>1l4dA [b.47.1] PLASMINOGEN
APSFDCGKPQVEPKKCPGRVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAA
HCLEKSPRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLEPTRKDIALLKLSSPAVITDKV
IPACLPSPNYVVADRTECFITGWGETQGTFGAGLLKEAQLPVIENKVCNRYEFLNGRVQS
TELCAGHLAGGTDSCQGDAGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVT
WIEGVMRNN
//
>1l4dD (B) [d.15.5] STREPTOKINASE
NNSQLVVSVAGTVEGTNQDISLKFFEIDLTSRPAMPHKLEKADLLKAIQEQLIANVHSND
DYFEVIDFASDATITDRNGKVYFADKDGSVTLPTQPVQEFLLSGHVRVRPYK
//
>1l5hB [c.92.2] NITROGENASE MOLYBDENUM-IRON PROTEIN BETA CHAIN
SQQVDKIKASYPLFLDQDYKDMLAKKRDGFEEKYPQDKIDEVFQWTTTKEYQELNFQREA
LTVNPAKACQPLGAVLCALGFEKTMPYVHGSQGCVAYFRSYFNRHFREPVSCVSDSMTED
AAVFGGQQNMKDGLQNCKATYKPDMIAVSTTCMAEVIGDDLNAFINNSKKEGFIPDEFPV
PFAHTPSFVGSHVTGWDNMFEGIARYFTLKSMDDKVVGSNKKINIVPGFETYLGNFRVIK
RMLSEMGVGYSLLSDPEEVLDTPADGQFRMYAGGTTQEEMKDAPNALNTVLLQPWHLEKT
KKFVEGTWKHEVPKLNIPMGLDWTDEFLMKVSEISGQPIPASLTKERGRLVDMMTDSHTW
LHGKRFALWGDPDFVMGLVKFLLELGCEPVHILCHNGNKRWKKAVDAILAASPYGKNATV
YIGKDLWHLRSLVFTDKPDFMIGNSYGKFIQRDTLHKGKEFEVPLIRIGFPIFDRHHLHR
STTLGYEGAMQILTTLVNSILERLDEETRGMQATDYNHDLVR
//
>1l5hA [c.92.2] NITROGENASE MOLYBDENUM-IRON PROTEIN ALPHA CHAIN
NKKSQPGLMTIRGCAYAGSKGVVWGPIKDMIHISHGPVGCGQYSRAGRRNYYIGTTGVNA
FVTMNFTSDFQEKDIVFGGDKKLAKLIDEVETLFPLNKGISVQSECPIGLIGDDIESVSK
VKGAELSKTIVPVRCEGFRGVSQSLGHHIANDAVRDWVLGKRDEDTTFASTPYDVAIIGD
YNIGGDAWSSRILLEEMGLRCVAQWSGDGSISEIELTPKVKLNLVHCYRSMNYISRHMEE
KYGIPWMEYNFFGPTKTIESLRAIAAKFDESIQKKCEEVIAKYKPEWEAVVAKYRPRLEG
KRVMLYIGGLRPRHVIGAYEDLGMEVVGTGYEEFEEFVKRIKPDLIGSGIKEKFIFQKMG
IPFREMHSWDYSGPYHGFDGFAIFARDMDMTLNNPCWKKLQAPWE
//
>1l6xA [b.1.1 - b.1.1] IMMUNOGLOBULIN GAMMA-1 HEAVY CHAIN CONSTANT
GPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQY
NSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRD
ELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSR
WQQGNVFSCSVMHEALHNHYTQKSLSL
//
>1l6xB [k.13.1] MINIMIZED B-DOMAIN OF PROTEIN A Z34C
FNMQCQRRFYEALHDPNLNEEQRNAKIKSIRDDC
//
>1l7iL [b.1.1 - b.1.1] CHIMERA OF FAB2C4: 
DIQMTQSPSSLSASVGDRVTITCKASQDVSIGVAWYQQKPGKAPKLLIYSASYRYTGVPS
RFSGSGSGTDFTLTISSLQPEDFATYYCQQYYIYPYTFGQGTKVEIKRTVAAPSVFIFPP
SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT
LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
//
>1l7iH [b.1.1 - b.1.1] CHIMERA OF FAB2C4: 
EVQLVESGGGLVQPGGSLRLSCAASGFTFTDYTMDWVRQAPGKGLEWVADVNPNSGGSIY
NQRFKGRFTLSVDRSKNTLYLQMNSLRAEDTAVYYCARNLGPSFYFDYWGQGTLVTVSSA
STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG
LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC
//
>1l7tL [b.1.1 - b.1.1] ANTI-TESTOSTERONE (LIGHT CHAIN)
DVVVTQTPLSLPVSLGDQASISCRSSEVIVTRNGYTPIEWYLQKPGQSPKLLIYKAYKRF
PGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCFDGSTVPPKFGGGTKLEIKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRDEC
//
>1l7tH [b.1.1 - b.1.1] ANTI-TESTOSTERONE (HEAVY CHAIN)
EVKLVESGGGLVKPGGSLKLSCAASGFTFSRYALSWVRQTADKRLEWVASIVSGGNTYYS
GSVKGRFTISRDIARNILYLQMSSLRSEDTAMYYCARAYYGYVGLVHWGQGTLVTVSSAK
TTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLY
TLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKIVPRDC
//
>1l9bM [f.26.1] REACTION CENTER PROTEIN M CHAIN
FSTLLGWFGNAQLGPIYLGSLGVLSLFSGLMWFFTIGIWFWYQAGWNPAVFLRDLFFFSL
EPPAPEYGLSFAAPLKEGGLWLIASFFMFVAVWSWWGRTYLRAQALGMGKHTAWAFLSAI
WLWMVLGFIRPILMGSWSEAVPYGIFSHLDWTNNFSLVHGNLFYNPFHGLSIAFLYGSAL
LFAMHGATILAVSRFGGERELEQIADRGTAAERAALFWRWTMGFNATMEGIHRWAIWMAV
LVTLTGGIGILLSGTVVDNWYVWGQNH
//
>1l9bC [a.3.1] CYTOCHROME C-2
QEGDPEAGAKAFNQCQTCHVIVDDSGTTIAGRNAKTGPNLYGVVGRTAGTQADFKGYGEG
MKEAGAKGLAWDEEHFVQYVQDPTKFLKEYTGDAKAKGKMTFKLKKEADAHNIWAYLQQV
AVRP
//
>1la6A [a.1.1] HEMOGLOBIN ALPHA-1 CHAIN
SLSDKDKAAVRALWSKIGKSSDAIGNDALSRMIVVYPQTKIYFSHWPDVTPGSPNIKAHG
KKVMGGIALAVSKIDDLKTGLMELSEQHAYKLRVDPSNFKILNHCILVVISTMFPKEFTP
EAHVSLDKFLSGVALALAERYR
//
>1la6B [a.1.1] HEMOGLOBIN BETA-1/2 CHAIN
VEWTDKERSIISDIFSHMDYDDIGPKALSRCLVVYPWTQRYFIMSNANVAAHGIKVLHGL
DRGMKNMDNIADAYTDLSTLHSEKLHVDPDNFKLLSDCITIVLAAKMGHAFTAETQGAFQ
KFLAAVVSALGK
//
>1lb1_3E (A) [a.87.1 - b.55.1] GUANINE NUCLEOTIDE EXCHANGE FACTOR DBS
EEEESLAILRRHVMNELLDTERAYVEELLCVLEGYAAEMDNPLMAHLISTGLQNKKNILF
GNMEEIYHFHNRIFLRELESCIDCPELVGRCFLERMEEFQIYEKYCQNKPRSESLWRQCS
DCPFFQECQKKLDHKLSLDSYLLKPVQRITKYQLLLKEMLKYSKHCEGAEDLQEALSSIL
GILKAVNDSMHLIAITGYDGNLGDLGKLLMQGSFSVWTDHKKGLARFKPMQRHLFLHEKA
VLFCKKREENGEGYEKAPSYSYKQSLNMTAVGITENVKGDTKKFEIWYNAREEVYIIQAP
TPEIKAAWVNEIRKVLTSQLQACR
//
>1lb1_3F (B) [c.37.1] TRANSFORMING PROTEIN RHOA
AIRKKLVIVGDGACGKTCLLIVFSKDQFPEVYVPTVFENYVADIEVDGKQVELALWDTAG
QEDYDRLRPLSYPDTDVILMCFSIDSPDSLENIPEKWTPEVKHFCPNVPIILVGNKKDLR
NDEHTRRELAKMKQEPVKPEEGRDMANRIGAFGYMECSAKTKDGVREVFEMATRAALQ
//
>1lb2A [b.82.3 - a.4.5] CATABOLITE GENE ACTIVATOR PROTEIN
PTLEWFLSHCHIHKYPSKSTLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGD
FIGELGLFEEGQERSAWVRAKTACEVAEISYKKFRQLIQVNPDILMRLSAQMARRLQVTS
EKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCSRETVGRILK
MLEDQNLISAHGKTIVVYGTR
//
>1lb2B [a.60.3] DNA-DIRECTED RNA POLYMERASE ALPHA CHAIN
DPILLRPVDDLELTVRSANCLKAEAIHYIGDLVQRTEVELLKTPNLGKKSLTEIKDVLAS
RGLSLGMRLENW
//
>1ld9_1A [d.19.1 - b.1.1] MHC CLASS I H-2LD HEAVY CHAIN
GPHSMRYFETAVSRPGLGEPRYISVGYVDNKEFVRFDSDAENPRYEPQAPWMEQEGPEYW
ERITQIAKGQEQWFRVNLRTLLGYYNQSAGGTHTLQWMYGCDVGSDGRLLRGYEQFAYDG
CDYIALNEDLKTWTAADMAAQITRRKWEQAGAAEYYRAYLEGECVEWLHRYLKNGNATLL
RTDSPKAHVTHHPRSKGEVTLRCWALGFYPADITLTWQLNGEELTQDMELVETRPAGDGT
FQKWASVVVPLGKEQNYTCRVYHEGLPE
//
>1ld9_1B [b.1.1] BETA-2 MICROGLOBULIN
IQKTPQIQVYSRHPPENGKPNILNCYVTQFHPPHIEIQMLKNGKKIPKVEMSDMSFSKDW
SFYILAHTEFTPTETDTYACRVKHDSMAEPKTVYWDRDM
//
>1ldkA [a.118.17] CULLIN HOMOLOG
IGLDQIWDDLRAGIQQVYTRQSMAKSRYMELYTHVYNYCTSQFVGLELYKRLKEFLKNYL
TNLLKDGEDLMDESVLKFYTQQWEDYRFSSKVLNGICAYLNRHWVRRECKGIYEIYSLAL
VTWRDCLFRPLNKQVTNAVLKLIEKERNGETINTRLISGVVQSYVELGLNEDLTVYKESF
ESQFLADTERFYTRESTEFLQQNPVTEYMKKAEARLLEEQRRVQVYLHESTQDELARKCE
QVLIEKHLEIFHTEFQNLLDADKNEDLGRMYNLVSRIQDGLGELKKLLETHIHNQGLAAI
EKCGEAALNDPKMYVQTVLDVHKKYNALVMSAFNNDAGFVAALDKACGRFINNNAVTK
//
>1ldkB [e.40.1 - a.4.5] CULLIN HOMOLOG
MAQSSSKSPELLARYCDSLLKKSSKNPEEAELEDTLNQVMVVFKYIEDKDVFQKFYAKML
AKRLVHQNSASDDAEASMISKLKQACGFEYTSKLQRMFQDIGVSKDLNEQFKKHLTNSEP
LDLDFSIQVLSSGSWPFQQSCTFALPSELERSYQRFTAFYASRHSGRKLTWLYQLSKGEL
VTNCFKNRYTLQASTFQMAILLQYNTEDAYTVQQLTDSTQIKMDILAQVLQILLKSKLLV
LEDENANVDEVELKPDTLIKLYLGYKNKKLRVNINVPMKTEQKQEQETTHKNIEEDRKLL
IQAAIVRIMKMRKVLKHQQLLGEVLTQLSSRFKPRVPVIKKCIDILIEKEYLERVDGEKD
TYSYLA
//
>1ldkD [d.42.1 - a.157.1] CYCLIN A/CDK2-ASSOCIATED PROTEIN P19
PSIKLQSSDGEIFEVDVEIAKQSVTIKTMLEDLGMDPVPLPNVNAAILKKVIQWCTHHKD
DDIPVWDQEFLKVDQGTLFELILAANYLDIKGLLDVTCKTVANMIKGKTPEEIRKTFN
//
>1ldkC [g.44.1] RING-BOX PROTEIN 1
KKRFEVKKWNAVALWAWDIVVDNCAICRNHIMDLCIECQANQASATSEECTVAWGVCNHA
FHFHCISRWLKTRQVCPLDNREWEFQKY
//
>1ldtA [x.x.x]
KKVCACPKILKPVCGSDGRTYANSCIARCNGVSIKSEGSCPGIN
//
>1ldtB (T) [b.47.1] TRYPSIN
IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYKSRIQVRLGEHNIDVLEG
NEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSCAAAGTECLISG
WGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSYPGQITGNMICVGFLEGGKDSCQGDSGGP
VVCNGQLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIAAN
//
>1le5_1A [b.2.5 - b.1.18] NUCLEAR FACTOR NF-KAPPA-B P65 SUBUNIT
MAYVEIIEQPKQRGMRFRYKCEGRSAGSIPGERSTDTTKTHPTIKINGYTGPGTVRISLV
TKDPPHRPHPHELVGKDCRDGYYEADLCPDRSIHSFQNLGIQCVKKRDLEQAISQRIQTN
NNPFHVPIEEQRGDYDLNAVRLCFQVTVRDPAGRPLLLTPVLSHPIFDNRAPNTAELKIC
RVNRNSGSCLGGDEIFLLCDKVQKEDIEVYFTGPGWEARGSFSQADVHRQVAIVFRTPPY
ADPSLQAPVRVSMQLRRPSDRELSEPMEFQYLPD
//
>1le5_1B [b.2.5 - b.1.18] NUCLEAR FACTOR NF-KAPPA-B P50 SUBUNIT
MGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQL
VTNGKNIHLHAHSLVGKHCEDGVCTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTE
ACIRGYNPGLLVHSDLAYLQAEGGGDRQLTDREKEIIRQAAVQQTKEMDLSVVRLMFTAF
LPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDD
IQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDVNITKPASVFVQLRRKSDL
ETSEPKPFLYYPE
//
>1lfd_2D (B) [c.37.1] RAS
MTEYKLVVVGAGGVGKSALTIQLIQNHFVDKYDPTIEDSYRKQVVIDGETCLLDILDTAG
QEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDL
AARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQHK
//
>1lfd_2C (A) [d.15.1] RALGDS
GDCCIIRVSLDVDNGNMYKSILVTSQDKAPTVIRKAMDKHNLDEDEPEDYELLQIISEDH
KLKIPENANVFYAMNSAANYDFILKKR
//
>1lgh_1A [f.3.1] LIGHT HARVESTING COMPLEX II
SNPKDDYKIWLVINPSTWLPVIWIVATVVAIAVHAAVLAAPGFNWIALGAAKSAAK
//
>1lgh_1B [f.3.1] LIGHT HARVESTING COMPLEX II
RSLSGLTEEEAIAVHDQFKTTFSAFIILAAVAHVLVWVWKPWF
//
>1liaD (A) [a.1.1] R-PHYCOERYTHRIN
MKSVITTTISAADAAGRYPSTSDLQSVQGNIQRAAARLEAAEKLGSNHEAVVKEAGDACF
SKYGYNKNPGEAGENQEKINKCYRDIDHYMRLINYTLVVGGTGPLDEWGIAGAREVYRTL
NLPSAAYIAAFVFTRDRLCIPRDMSAQAGVEFCTALDYLINSLS
//
>1liaF (B) [a.1.1] R-PHYCOERYTHRIN
MLDAFSRVVVNSDSKAAYVSGSDLQALKTFINDGNKRLDAVNYIVSNSSCIVSDAISGMI
CENPGLITPGGNCYTNRRMAACLRDGEIILRYVSYALLAGDASVLEDRCLNGLKETYIAL
GVPTNSTVRAVSIMKAAAVCFISNTASQRKVEVIEGDCSALASEVASYCDRVVAAVS
//
>1lj2B [h.1.13] NONSTRUCTURAL RNA-BINDING PROTEIN 34
MHSLQNVIPQQQAHIAELQVYNNKLERDLQNKIGSLTSSIEWYLRSMELDPEIKADIEQQ
INSIDAINPLHAFDDLESVIRNLISDYDKLFLMFKGLIQRSNYQYSFGSE
//
>1lj2D [x.x.x] EUKARYOTIC PROTEIN SYNTHESIS INITIATION FACTOR
PKRERKTIRIRDPNQGGKDITEEIMSG
//
>1lk3_1A [a.26.1] INTERLEUKIN-10
NMLRDLRDAFSRVKTFFQMKDQLDNLLLKESLLEDFKGYLGCQALSEMIQFYLEEVMPQA
ENQDPDIKAHVNSLGENLKTLRLRLRRCHRFLPCEKSKAVEQVKNAFNKLQEKGIYKAMS
EFDIFINYIEAYMTMK
//
>1lk3_1L [b.1.1 - b.1.1] 9D7 LIGHT CHAIN
DTVLTQPPALTVSPGEKLTISCKASESVTSRMHWYQQKPGQQPKLLIYKASNLASGVPAR
FSGSGSGTDFTLTIDPVEADDTAIYFCQQSWNGPLTFGAGTKLELKRADAAPTVSIFPPS
TEQLATGGASVVCLMNNFYPRDISVKWKIDGTERRDGVLDSVTDQDSKDSTYSMSSTLSL
TKADYESHNLYTCEVVHKTSSSPVVKSFNR
//
>1lk3_1H [b.1.1 - b.1.1] 9D7 HEAVY CHAIN
QVNLLQSGAALVKPGASVKLSCKASGYTFTDFYIHWVKQSHGKSLEWIGYINPNSGYTNY
NEKFKNKATLTVDKSTSTGYMELSRLTSEDSANYSCTRGVPGNNWFPYWGQGTLVTVSSA
ETTAPSVYPLAPGTALKSNSMVTLGCLVKGYFPEPVTVTWNSGALSSGVHTFPAVLQSGL
YTLTSSVTVPSSTWPSQTVTCNVAHPASSTKVDKKIVPR
//
>1lk3_2M (L) [b.1.1 - b.1.1] 9D7 LIGHT CHAIN
DTVLTQPPALTVSPGEKLTISCKASESVTSRMHWYQQKPGQQPKLLIYKASNLASGVPAR
FSGSGSGTDFTLTIDPVEADDTAIYFCQQSWNGPLTFGAGTKLELKRADAAPTVSIFPPS
TEQLATGGASVVCLMNNFYPRDISVKWKIDGTERRDGVLDSVTDQDSKDSTYSMSSTLSL
TKADYESHNLYTCEVVHKTSSSPVVKSFNR
//
>1lk3_2I (H) [b.1.1 - b.1.1] 9D7 HEAVY CHAIN
QVNLLQSGAALVKPGASVKLSCKASGYTFTDFYIHWVKQSHGKSLEWIGYINPNSGYTNY
NEKFKNKATLTVDKSTSTGYMELSRLTSEDSANYSCTRGVPGNNWFPYWGQGTLVTVSSA
ETTAPSVYPLAPGTALKSNSMVTLGCLVKGYFPEPVTVTWNSGALSSGVHTFPAVLQSGL
YTLTSSVTVPSSTWPSQTVTCNVAHPASSTKVDKKIVPR
//
>1lm8V [b.3.3] VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR
RPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLF
RDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLD
IVRSLYEDLEDHPNVQKDLERLTQERIAHQ
//
>1lm8C [d.42.1] ELONGIN C
MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPNEVNFREIPSHVLSKVCMYFTYKVRYT
NSSTEIPEFPIAPEIALELLMAANFLDC
//
>1lnu_3E (A) [d.19.1 - b.1.1] H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-B
IEADHVGTYGISVYQSPGDIGQYTFEFDGDELFYVDLDKKETVWMLPEFGQLASFDPQGG
LQNIAVVKHNLGVLTKRSNSTPATNEAPQATVFPKSPVLLGQPNTLICFVDNIFPPVINI
TWLRNSKSVADGVYETSFFVNRDYSFHKLSYLTFIPSDDDIYDCKVEHWGLEEPVLKHWE
PE
//
>1lnu_3F (B) [d.19.1 - b.1.1] H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A BETA
FEAQKAKANKAVDGGGGSLVPRGSGGGGSERHFVYQFMGECYFTNGTQRIRYVTRYIYNR
EEYVRYDSDVGEHRAVTELGRPDAEYWNSQPEILERTRAELDTVCRHNYEGPETHTSLRR
LEQPNVVISLSRTEALNHHNTLVCSVTDFYPAKIKVRWFRNGQEETVGVSSTQLIRNGDW
TFQVLVMLEMTPRRGEVYTCHVEHPSLKSPITVEWKA
//
>1lo0_1X [b.1.1 - b.1.1] IF KAPPA LIGHT CHAIN
DVLMTQTPLSLPVSLGDQVSIFCTSSQTIVHTNGNTYLEWYLQKPGQSPKLLIYKVSNRF
SGVPDRFSGSGSGTDFTLKISRVETEDLGIYYCFQGSHFPLAFGAGTKLELKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1lo0_1Y [b.1.1 - b.1.1] IG GAMMA 2A HEAVY CHAIN
EVKLVESGGGLVKPGGSLKLSCAASGFSFRNYGMSWVRQTPEKRLEWVASISYGGLIYYP
DSIKGRFTISRDIAQNILYLQMSSLRSEDTAMYHCIRGDSFLVWFTFWGQGTLVTVSAAK
TTAPSVYPLAPVCGDTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDLY
TLSSSVTVTSSTWPSQSITCNVAHPASSTQVDKKIEPRGP
//
>1lo4L [b.1.1 - b.1.1] IF KAPPA LIGHT CHAIN
DVLLTQTPLSLPVSLGDQASISCRSSQTIVHTNGNTYFEWYLQKPGQSPHLLIYKVSNRL
SGVPDRFSGSGSGTDFTLKISRVEAEDLGLYYCFQGSHSPWTFGGGTKLELKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRN
//
>1lo4H [b.1.1 - b.1.1] IG GAMMA 2A HEAVY CHAIN
ELKLVETGGDLVKPGGSLTLSCEASGFTLRTYGMSWVRQTPQMRLEWVASISYGGLLYFS
DSVKGRFTISRDIVRNILTLQMSRLRSEDTAIYYCARGTSFVRYFDVWGAGTTVTVSSAK
TTAPSVYPLAPVCGDTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDLY
TLSSSVTVTSSTWPSQSITCNVAHPASSTQVDKKIVPRAA
//
>1lo5A [d.19.1 - b.1.1] HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR
EHVIIQAEFYLNPDQSGEFMFDFDGDEIFHVDMAKKETVWRLEEFGRFASFEAQGALANI
AVDKANLEIMTKRSNYTPITNVPPEVTVLTNSPVELREPNVLICFIDKFTPPVVNVTWLR
NGKPVTTGVSETVFLPREDHLFRKFHYLPFLPSTEDVYDCRVEHWGLDEPLLKHWEFDA
//
>1lo5D [b.40.2 - d.15.6] ENTEROTOXIN A
SEKSEEINEKDLRKKSELQGTALGNLKQIYYYNEKAKTENKESHDQFLQHTILFKGFFTD
HSWYNDLLVDFDSKDIVDKYKGKKVDLYGAYYGYQCAGGTPNKTACMYGGVTLHDNNRLT
EEKKVPINLWLDGKQNTVPLETVKTNKKNVTVQELDLQARRYLQEKYNLYNSDVFDGKVQ
RGLIVFHTSTEPSVNYDLFGAQGQYSNTLLRIYRDNKTINSENMHIAIYLYTS
//
>1lofC [b.29.1] LEGUME ISOLECTIN I (ALPHA CHAIN)
TETTSFSITKFGPDQQNLIFQGDGYTTKERLTLTKAVRNTVGRALYSSPIHIWDSKTGNV
ANFVTSFTFVIDAPNSYNVADGFTFFIAPVDTKPQTGGGYLGVFNSKDYDKTSQTVAVEF
DTFYNTAWDPSNGDRHIGIDVNSIKSINTKSWKLQNGKEANVVIAFNAATNVLTVSLTYP
//
>1lofD [b.29.1] LEGUME ISOLECTIN I (BETA CHAIN)
ETSYTLNEVVPLKEFVPEWVRIGFSATTGAEFAAHEVLSWYFHSELAGTSSN
//
>1lotA [a.126.1 - a.126.1 - a.126.1] VITAMIN D-BINDING PROTEIN
LERGRDYEKNKVCKEFSHLGKEDFTSLSLVLYSRKFPSGTFEQVSQLVKEVVSLTEACCA
EGADPDCYDTRTSALSAKSCESNSPFPVHPHQPQEFPTYVEPTNDEICEAFRKDPKEYAN
QFMWEYSTNYGQAPLSLLVSYTKSYLSMVGSCCTSASPTVCFLKERLQLKHLSLLTTLSN
RVCSQYAAYGEKKSRLSNLIKLAQKVPTADLEDVLPLAEDITNILSKCCESASEDCMAKE
LPEHTVKLCDNLSTKNSKFEDCCQEKTAMDVFVCTYFMPAAQLPELPDVELPTNKDVCDP
GNTKVMDKYTFELSRRTHLPEVFLSKVLEPTLKSLGECCDVEDSTTCFNAKGPLLKKELS
SFIDKGQELCADYSENTFTEYKKKLAERLKAKLPDATPTELAKLVNKRSDFASNCCSINS
PPLYCDSEIDAELKNI
//
>1lotB [c.55.1 - c.55.1] ACTIN, ALPHA SKELETAL MUSCLE
DETTALVCDNGSGLVKAGFAGDDAPRAVFPSIVGRPRDSYVGDEAQSKRGILTLKYPIEx
GIITNWDDMEKIWHHTFYNELRVAPEEHPTLLTEAPLNPKANREKMTQIMFETFNVPAMY
VAIQAVLSLYASGRTTGIVLDSGDGVTHNVPIYEGYALPHAIMRLDLAGRDLTDYLMKIL
TERGYSFVTTAEREIVRDIKEKLCYVALDFENEMATAASSSSLEKSYELPDGQVITIGNE
RFRCPETLFQPSFIGMESAGIHETTYNSIMKCDIDIRKDLYANNVMSGGTTMYPGIADRM
QKEITALAPSTMKIKIIAPPERKYSVWIGGSILASLSTFQQMWITKQEYDEAGPSIVHRK
//
>1lp9_1E [b.1.1 - b.1.1] T-CELL RECEPTOR ALPHA CHAIN
MDSVTQTEGLVTLTEGLPVMLNCTYQSTYSPFLFWYVQHLNEAPKLLLKSFTDNKRPEHQ
GFHATLHKSSSSFHLQKSSAQLSDSALYYCALFLASSSFSKLVFGQGTSLSVVPNIQNPE
PAVYQLKDPRSQDSTLCLFTDFDSQINVPKTMESGTFITDKTVLDMKAMDSKSNGAIAWS
NQTSFTCQDIFKET
//
>1lp9_1F [b.1.1 - b.1.1] T-CELL RECEPTOR BETA CHAIN
EAAVTQSPRSKVAVTGGKVTLSCHQTNNHDYMYWYRQDTGHGLRLIHYSYVADSTEKGDI
PDGYKASRPSQENFSLILELASLSQTAVYFCASSDWVSYEQYFGPGTRLTVLEDLRNVTP
PKVSLFEPSKAEIANKQKATLVCLARGFFPDHVELSWWVNGKEVHSGVSTDPQAYKESNY
SYALSSRLRVSATFWHNPRNHFRCQVQFHGLSEEDKWPEGSPKPVTQNISAEAWGRA
//
>1lp9_2L (E) [b.1.1 - b.1.1] T-CELL RECEPTOR ALPHA CHAIN
MDSVTQTEGLVTLTEGLPVMLNCTYQSTYSPFLFWYVQHLNEAPKLLLKSFTDNKRPEHQ
GFHATLHKSSSSFHLQKSSAQLSDSALYYCALFLASSSFSKLVFGQGTSLSVVPNIQNPE
PAVYQLKDPRSQDSTLCLFTDFDSQINVPKTMESGTFITDKTVLDMKAMDSKSNGAIAWS
NQTSFTCQDIFKET
//
>1lp9_2H (A) [d.19.1 - b.1.1] HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2
GSHSMRYFFTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGPEYW
DGETRKVKAHSQTHRVDLGTLRGYYNQSEAGSHTVQRMYGCDVGSDWRFLRGYHQYAYDG
KDYIALKEDLRSWTAADMAAQTTKHKWEAAHVAEQLRAYLEGTCVEWLRRYLENGKETLQ
RTDAPKTHMTHHAVSDHEATLRCWALSFYPAEITLTWQRDGEDQTQDTELVETRPAGDGT
FQKWAAVVVPSGQEQRYTCHVQHEGLPKPLTLRWE
//
>1lp9_2M (F) [b.1.1 - b.1.1] T-CELL RECEPTOR BETA CHAIN
EAAVTQSPRSKVAVTGGKVTLSCHQTNNHDYMYWYRQDTGHGLRLIHYSYVADSTEKGDI
PDGYKASRPSQENFSLILELASLSQTAVYFCASSDWVSYEQYFGPGTRLTVLEDLRNVTP
PKVSLFEPSKAEIANKQKATLVCLARGFFPDHVELSWWVNGKEVHSGVSTDPQAYKESNY
SYALSSRLRVSATFWHNPRNHFRCQVQFHGLSEEDKWPEGSPKPVTQNISAEAWGRA
//
>1lpaA [g.3.10 - g.3.10] COLIPASE
GIIINLDEGELCLNSAQCKSNCCQHDTILSLLRCALKARENSECSAFTLYGVYYKCPCER
GLTCEGDKSLVGSITNTNFGICHNV
//
>1lpaB [c.69.1 - b.12.1] LIPASE
KEVCYERLGCFSDDSPWSGITERPLHILPWSPKDVNTRFLLYTNENPNNFQEVAADSSSI
SGSNFKTNRKTRFIIHGFIDKGEENWLANVCKNLFKVESVNCICVDWKGGSRTGYTQASQ
NIRIVGAEVAYFVEFLQSAFGYSPSNVHVIGHSLGAHAAGEAGRRTNGTIGRITGLDPAE
PCFQGTPELVRLDPSDAKFVDVIHTDGAPIVPNLGFGMSQVVGHLDFFPNGGVEMPGCKK
NILSQIVDIDGIWEGTRDFAACNHLRSYKYYTDSIVNPDGFAGFPCASYNVFTANKCFPC
PSGGCPQMGHYADRYPGKTNDVGQKFYLDTGDASNFARWRYKVSVTLSGKKVTGHILVSL
FGNKGNSKQYEIFKGTLKPDSTHSNEFDSDVDVGDLQMVKFIWYNNVINPTLPRVGASKI
IVETNVGKQFNFCSPETVREEVLLTLTPC
//
>1lqsA (L) [a.26.1] INTERLEUKIN-10-LIKE PROTEIN
TKPQCRPEDYATRLQDLRVTFHRVKPTLQREDDYSVWLDGTVVKGCWGCSVMDWLLRRYL
EIVFPAGDHVYPGLKTELHSMRSTLESIYKDMRQCPLLGCGDKSVISRLSQEAERKSDNG
TRKGLSELDTLFSRLEEYLHSR
//
>1lqsC (R) [b.1.2 - b.1.2] INTERLEUKIN-10 RECEPTOR ALPHA CHAIN
GTELPSPPSVWFEAEFFHHILHWTPIPQQSESTCYEVALLRYGIESWNSISQCSQTLSYD
LTAVTLDLYHSNGYRARVRAVDGSRHSQWTVTNTRFSVDEVTLTVGSVNLEIHNGFILGK
IQLPRPKMAPAQDTYESIFSHFREYEIAIRKVPGQFTFTHKKVKHEQFSLLTSGEVGEFC
VQVKPSVASRSNKGMWSKEECISLTRQ
//
>1lqv_2B [d.19.1] ENDOTHELIAL PROTEIN C RECEPTOR
LQRLHMLQISYFRDPYHVWYQGNASLGGHLTHVLEGPDTNTTIIQLQPLQEPESWARTQS
GLQSYLLQFHGLVRLVHQERTLAFPLTIRCFLGCELPPEGSRAHVFFEVAVNGSSFVSFR
PERALWQADTQVTSGVVTFTLQQLNAYNRTRYELREFLEDTCVQYVQKHISAE
//
>1lqv_2D (C) [g.32.1] VITAMIN-K DEPENDENT PROTEIN C
ANSFLxxLRHSSLxRxCIxxICDFxxAKxIFQN
//
>1lrwA [b.70.1] METHANOL DEHYDROGENASE SUBUNIT 1
NDQLVELAKDPANWVMTGRDYNAQNYSEMTDINKENVKQLRPAWSFSTGVLHGHEGTPLV
VGDRMFIHTPFPNTTFALDLNEPGKILWQNKPKQNPTARTVACCDVVNRGLAYWPGDDQV
KPLIFRTQLDGHIVAMDAETGETRWIMENSDIKVGSTLTIAPYVIKDLVLVGSSGAELGV
RGYVTAYDVKSGEMRWRAFATGPDEELLLAEDFNAPNPHYGQKNLGLETWEGDAWKIGGG
TNWGWYAYDPEVDLFYYGSGNPAPWNETMRPGDNKWTMAIWGREATTGEAKFAYQKTPHD
EWDYAGVNVMMLSEQEDKQGQMRKLLTHPDRNGIVYTLDRTNGDLISADKMDDTVNWVKE
VQLDTGLPVRDPEFGTRMDHKARDICPSAMGYHNQGHDSYDPERKVFMLGINHICMDWEP
FMLPYRAGQFFVGATLTMYPGPKGDRGNASGLGQIKAYDAISGEMKWEKMERFSVWGGTM
ATAGGLTFYATLDGFIKARDSDTGDLLWKFKLPSGVIGHPMTYKHDGRQYVAIMYGVGGW
PGVGLVFDLADPTAGLGSVGAFKRLQEFTQMGGGVMVFSLDGESPYSDPNVGEYAPGEPT
//
>1lrwB [a.137.2] METHANOL DEHYDROGENASE SUBUNIT 2
YDGTNCKAPGNCWEPKPDYPAKVEGSKYDPQHDPAELSKQGESLAVMDARNEWRVWNMKK
TGKFEYDVKKIDGYDETKAPPAE
//
>1lshA [f.7.1 - a.118.4 - f.7.1] LIPOVITELLIN (LV-1N, LV-1C)
xFQPGKVYRYSYDAFSISGLPEPGVNRAGLSGEMKIEIHGHTHNQATLKITQVNLKYFLG
PWPSDSFYPLTGGYDHFIQQLEVPVRFDYSAGRIGDIYAPPQVTDTAVNIVRGILNLFQL
SLKKNQQTFELQETGVEGICQTTYVVQEGYRTNEMAVVKTKDLNNCDHKVYKTMGTAYAE
RCPTCQKMNKNLRSTAVYNYAIFDEPSGYIIKSAHSEEIQQLSVFDIKEGNVVIESRQKL
ILEGIQSAPAASQAASLQNRGGLMYKFPSSAITKMSSLFVTKGKNLESEIHTVLKHLVEN
NQLSVHEDAPAKFLRLTAFLRNVDAGVLQSIWHKLHQQKDYRRWILDAVPAMATSEALLF
LKRTLASEQLTSAEATQIVASTLSNQQATRESLSYARELLNTSFIRNRPILRKTAVLGYG
SLVFRYCANTVSCPDELLQPLHDLLSQSSDRAKEEEIVLALKALGNAGQPNSIKKIQRFL
PGQGKSLDEYSTRVQAEAIMALRNIAKRDPRKVQEIVLPIFLNVAIKSELRIRSCIVFFE
SKPSVALVSMVAVRLRREPNLQVASFVYSQMRSLSRSSNPEFRDVAAACSVAIKMLGSKL
DRLGCRYSKAVHVDTFNARTMAGVSADYFRINSPSGPLPRAVAAKIRGQGMGYASDIVEF
GLRAEGLQELLYDWKSVPEERPLASGYVKVHGQEVVFAELDKKMQEQIGAVVSKLEQGMD
VLLTKGYVVSEVRYMQPVCIGIPMDLNLLVSGVTTNRANLSASFSSLPADMKLADLLATN
IELRVAATTSMSQHAVAIMGLTTDLAKAGMQTHYKTSAGLGVNGKIEMNARESNFKASLK
PFQQKTVVVLSTMESIVFVRDPSGSRILPVLPPKMTQKQIHDIMTARPVMRRKQSCSKSA
ALSSKVCFSARLRNAAFIRNALLYKITGDYVSKVYVQPTSSKAQITKVELELQAG
//
>1lshB [f.7.1] LIPOVITELLIN (LV-2)
SKPKVVIVLRAVRADGKQQGLQTTLYYGLTSNGLPKAKIVAVELSDLSVWKLCAKFRLSA
HMKAKAAIGWGKNCQQYRAMLEASTGNLQSHPAARVDIKWGRLPSSLQRAKNALLENGAP
VIASKLEMEIMPKANQKHQVSVILAAMTPRRMNIIVKLPKVTYFQQGILLPFTF
//
>1lt3A [d.166.1] HEAT-LABILE ENTEROTOXIN
RLYRADSRPPDEIKRSGGLMPRGHNEYFDRGTQMNICLYDHARGTQTGFVRYDDGYVSTS
LSLRSAHLAGQSILSGYSTYYIYVIATAPNMFNVNDVLGVYSPHPYEQEVSALGGIPYSQ
IYGWYRVNFGVIDERLHRNREYRDRYYRNLNIAPAEDGYRLACFPPDHQAWREEPWIHHA
PQGCGGDTCNEETQNLSTIYLREYQSKVKRQIFSDYQSEVDIYNRI
//
>1lt3F (D) [b.40.2] HEAT-LABILE ENTEROTOXIN
APQTITELCSEYRNTQIYTINDKILSYTESMAGKREMVIITFKSGETFQVEVPGSQHIDS
QKKAIERMKDTLRITYLTETKIDKLCVWNNKTPNSIAAISMKN
//
>1ltaE (D) [b.40.2] HEAT-LABILE ENTEROTOXIN, SUBUNIT B
APQTITELCSEYRNTQIYTINDKILSYTESMAGKREMVIITFKSGETFQVEVPGSQHIDS
QKKAIERMKDTLRITYLTETKIDKLCVWNNKTPNSIAAISMKN
//
>1ltaC [d.166.1] HEAT-LABILE ENTEROTOXIN, SUBUNIT A
GDTCNEETQNLSTIYLREYQSKVKRQIFSDYQSEVDIYNRIRDEL
//
>1ltaA [d.166.1] HEAT-LABILE ENTEROTOXIN, SUBUNIT A
NGDRLYRADSRPPDEIKRSGGLMPRGHNEYFDRGTQMNINLYDHARGTQTGFVRYDDGYV
STSLSLRSAHLAGQSILSGYSTYYIYVIATAPNMFNVNDVLGVYSPHPYEQEVSALGGIP
YSQIYGWYRVNFGVIDERLHRNREYRDRYYRNLNIAPAEDGYRLAGFPPDHQAWREEPWI
HHAPQGCG
//
>1ltgC [d.166.1] HEAT-LABILE ENTEROTOXIN
GDTCNEETQNLSTIYLREYQSKVKRQIFSDYQSEVDIYNRI
//
>1ltgA [d.166.1] HEAT-LABILE ENTEROTOXIN
RLYKADSRPPDEIKRSGGLMPRGHNEYFDRGTQMNINLYDHARDGYVSTSLSLRSAHLAG
QSILSGYSTYYIYVIATAPNMFNVNDVLGVYSPHPYEQEVSALGGIPYSQIYGWYRVNFG
VIDERLHRNREYRDRYYRNLNIAPAEDGYRLAGFPPDHQAWREEPWIHHAPQGCG
//
>1ltxA [a.118.6 - b.7.4 - c.10.2] RAB GERANYLGERANYLTRANSFERASE ALPHA SUBUNIT
KLKLYQSATQAVFQKRQAGELDESVLELTSQILGANPDFATLWNCRREVLQHLETEKSPE
ESAALVKAELGFLESCLRVNPKSYGTWHHRCWLLSRLPEPNWARELELCARFLEADERNF
HCWDYRRFVAAQAAVAPAEELAFTDSLITRNFSNYSSWHYRSCLLPQLHPQGRLPENVLL
KELELVQNAFFTDPNDQSAWFYHRWLLGRAEPVLCCVHVSREEACLSVCFSRPLTVGSRM
GTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKEC
VLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILL
MRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHK
DLTVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVANLPRLQ
ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT
//
>1ltxR [c.3.1 - d.16.1] RAB ESCORT PROTEIN 1
ADNLPSDFDVIVIGTGLPESIIAAACSRSGQRVLHVDSRSYYGGNWASFSFSGLLSWLKE
YQENTENSMWQEQILENEEAIPLSSKDKTIQHVEVFCYASQDKNRITYSQIIKEGRRFNI
DLVSKLLYSRGLLIDLLIKSNVSRYAEFKNITRILAFREGTVEQVPCSRADVFNSKQLTM
VEKRMLMKFLTFCVEYEEHPDEYRAYEGTTFSEYLKTQKLTPNLQYFVLHSIAMTSTSCT
VDGLKATKKFLQCLGRYGNTPFLFPLYGQGELPQCFCRMCAVFGGIYCLRHSVQCLVVDK
ESRKCKAVIDQFGQRIISKHFIIEDSYLSENTCSRVQYRQISRAVLITDGSVLKTDADQQ
VSILTVPAEEPGSFAVRVIELCSSTMTCMKGTYLVHLTCMSSKTAREDLERVVQKLFTPY
TEIEEKPRLLWALYFNMRDSSDISRDCYNDLPSNVYVCSGPDSGLGNDNAVKQAETLFQQ
ICPNEDFPEDIVLD
//
>1lujA [a.118.1] BETA-CATENIN
TRAIPELTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVE
TARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGA
KMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMR
TYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLS
DAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVR
TVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKA
TVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRGVRMEEIVEGCTGALHILAR
DVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTE
LLHSRNEGVATYAAAVLFRMS
//
>1lujB [a.161.1] BETA-CATENIN-INTERACTING PROTEIN ICAT
GAPAKSPEEMYIQQKVRVLLMLRKMGSNLTASEEEFLRTYAGVVSSQLSQLPQHSIDQAA
EDVVMAFSRSE
//
>1lw6E [c.41.1] SUBTILISIN BPN'
AQSVPYGVSQIKAPALHSQGYTGSNVKVAVIDSGIDSSHPDLKVAGGASMVPSETNPFQD
NNSHGTHVAGTVAALNNSIGVLGVAPSASLYAVKVLGADGSGQYSWIINGIEWAIANNMD
VINMSLGGPSGSAALKAAVDKAVASGVVVVAAAGNEGTSGSSSTVGYPGKYPSVIAVGAV
DSSNQRASFSSVGPELDVMAPGVSIQSTLPGNKYGAYNGTSMASPHVAGAAALILSKHPN
WTNTQVRSSLENTTTKLGDSFYYGKGLINVQAAAQHHHHHH
//
>1lw6I [d.40.1] SUBTILISIN-CHYMOTRYPSIN INHIBITOR-2A
KTEWPELVGKSVEEAKKVILQDKPAAQIIVLPVGTIVTMEYRIDRVRLFVDKLDNIAQVP
RVG
//
>1lwu_1A [h.1.8] FIBRINOGEN ALPHA-1 CHAIN
NELEVRYSEVLRELERRIIHLQRRINMQLQQLTLLQHNIKTQVSQILRVEVDIDVALRAC
KGSCARYLEYRLDKEKNLQLEKAASYIANLKFERFEEVV
//
>1lwu_1B [h.1.8 - d.171.1] FIBRINOGEN BETA CHAIN
AQKEIENRYKEVKIRIESTVAGSLRSMKSVLEHLRAKMQRMEEAIKTQKELCSAPCTVNC
RVPVVSGMHCEDIYRNGGRTSEAYYIQPDLFSEPYKVFCDMESHGGGWTVVQNRVDGSSN
FARDWNTYKAEFGNIAFGNGKSICNIPGEYWLGTKTVHQLTKQHTQQVLFDMSDWEGSSV
YAQYASFRPENEAQGYRLWVEDYSGNAGNALLEGATQLMGDNRTMTIHNGMQFSTFDRDN
DNWNPGDPTKHCSREDAGGWWYNRCHAANPNGRYYWGGIYTKEQADYGTDDGVVWMNWKG
SWYSMRQMAMKLRPK
//
>1lwu_1C [h.1.8 - d.171.1] FIBRINOGEN GAMMA CHAIN
KTVQKILEEVRILEQIGVSHDAQIQELSEMWRVNQQFVTRLQQQLVDIRQTCSRPCQDTT
ANKISPITGKDCQQVVDNGGKDSGLYYIKPLKAKQPFLVFCEIENGNGWTVIQHRHDGSV
NFTRDWVSYREGFGYLAPTLTTEFWLGNEKIHLLTGQQAYRLRIDLTDWENTHRYADYGH
FKLTPESDEYRLFYSMYLDGDAGNAFDGFDFGDDPQDKFYTTHLGMLFSTPERDNDKYEG
SCAEQDGSGWWMNRCHAGHLNGKYYFGGNYRKTDVEFPYDDGIIWATWHDRWYSLKMTTM
KLLPMGRDLSGHGGQQQ
//
>1lwu_2H (B) [h.1.8 - d.171.1] FIBRINOGEN BETA CHAIN
AQKEIENRYKEVKIRIESTVAGSLRSMKSVLEHLRAKMQRMEEAIKTQKELCSAPCTVNC
RVPVVSGMHCEDIYRNGGRTSEAYYIQPDLFSEPYKVFCDMESHGGGWTVVQNRVDGSSN
FARDWNTYKAEFGNIAFGNGKSICNIPGEYWLGTKTVHQLTKQHTQQVLFDMSDWEGSSV
YAQYASFRPENEAQGYRLWVEDYSGNAGNALLEGATQLMGDNRTMTIHNGMQFSTFDRDN
DNWNPGDPTKHCSREDAGGWWYNRCHAANPNGRYYWGGIYTKEQADYGTDDGVVWMNWKG
SWYSMRQMAMKLRPK
//
>1lwu_2I [h.1.8 - d.171.1] FIBRINOGEN GAMMA CHAIN
KTVQKILEEVRILEQIGVSHDAQIQELSEMWRVNQQFVTRLQQQLVDIRQTCSRPCQDTT
ANKISPITGKDCQQVVDNGGKDSGLYYIKPLKAKQPFLVFCEIENGNGWTVIQHRHDGSV
NFTRDWVSYREGFGYLAPTLTTEFWLGNEKIHLLTGQQAYRLRIDLTDWENTHRYADYGH
FKLTPESDEYRLFYSMYLDGDAGNAFDGFDFGDDPQDKFYTTHLGMLFSTPERDNDKYEG
SCAEQDGSGWWMNRCHAGHLNGKYYFGGNYRKTDVEFPYDDGIIWATWHDRWYSLKMTTM
KLLPMGRDLSGHG
//
>1lx5A [g.17.1] BONE MORPHOGENETIC PROTEIN 7
QACKKHELYVSFRDLGWQDWIIAPEGYAAYYCEGECAFPLNSYMNATNHAIVQTLVHFIN
PETVPKPCCAPTQLNAISVLYFDDSSNVILKKYRNMVVRACGCH
//
>1lx5B [g.7.1] ACTIVIN TYPE II RECEPTOR
ETQECLFFNANWERDRTNQTGVEPCYGDKDKRRHCFATWKNISGSIEIVKQGCWLDDINC
YDRTDCIEKKDSPEVYFCCCEGNMCNEKFSYFPE
//
>1lyw_1D (B) [b.50.1] CATHEPSIN D
GGVKVERQVFGEATKQPGITFIAAKFDGILGMAYPRISVNNVLPVFDNLMQQKLVDQNIF
SFYLSRDPDAQPGGELMLGGTDSKYYKGSLSYLNVTRKAYWQVHLDQVEVASGLTLCKEG
CEAIVDTGTSLMVGPVDEVRELQKAIGAVPLIQGEYMIPCEKVSTLPAITLKLGGKGYKL
SPEDYTLKVSQAGKTLCLSGFMGMDIPPPSGPLWILGDVFIGRYYTVFDRDNNRVGFAEA
A
//
>1lyw_1C (A) [b.50.1] CATHEPSIN D
IPEVLKNYMDAQYYGEIGIGTPPQCFTVVFDTGSSNLWVPSIHCKLLDIACWIHHKYNSD
KSSTYVKNGTSFDIHYGSGSLSGYLSQDTVSVPCQ
//
>1m06_27 (F) [b.121.5] CAPSID PROTEIN
REIVDLSHLAFDCGMLGRLKTVSWTPVIAGDSFELDAVGALRLSPLRRGLAIDSKVDFFT
FYIPHRHVYGDQWIQFMRDGVNAQPLPSVTCNRYPDHAGYVGTIVPANNRIPKFLHQSYL
NIYNNYFRAPWMPERTEANPSNLNEDDARYGFRCCHLKNIWSAPLPPETKLAEEMGIESN
SIDIMGLQAAYAQLHTEQERTYFMQRYRDVISSFGGSTSYDADNRPLLVMHTDFWASGYD
VDGTDQSSLGQFSGRVQQTFKHSVPRFFVPEHGVMMTLALIRFPPISPLEHHYLAGKSQL
TYTDLAGDPALIGNLPPREISYRDLFRDGRSGIKIKVAESIWYRTHPDYVNFKYHDLHGF
PFLDDAPGTSTGDNLQEAILVRHQDYDACFQSQQLLQWNKQARYNVSVYRHMPTVRDSIM
TS
//
>1m06_28 (G) [b.121.5] MAJOR SPIKE PROTEIN
MYQNFVTKHDTAIQTSRFSVTGNVIPAAPTGNIPVINGGSITAERAVVNLYANMNVSTSS
DGSFIVAMKVDTSPTDPNCVISAGVNLSFAGTSYPIVGIVRFESASEQPTSIAGSEVEHY
PIEMSVGSGGVCSARDCATVDIHPRTSGNNVFVGVICSSAKWTSGRVIGTIATTQVIHEY
QVLQPLK
//
>1m06_29 (J) [x.x.x] SMALL CORE PROTEIN
MKKARRSPSRRKGARLWYVGGSQF
//
>1m06_2Q (F) [b.121.5] CAPSID PROTEIN
REIVDLSHLAFDCGMLGRLKTVSWTPVIAGDSFELDAVGALRLSPLRRGLAIDSKVDFFT
FYIPHRHVYGDQWIQFMRDGVNAQPLPSVTCNRYPDHAGYVGTIVPANNRIPKFLHQSYL
NIYNNYFRAPWMPERTEANPSNLNEDDARYGFRCCHLKNIWSAPLPPETKLAEEMGIESN
SIDIMGLQAAYAQLHTEQERTYFMQRYRDVISSFGGSTSYDADNRPLLVMHTDFWASGYD
VDGTDQSSLGQFSGRVQQTFKHSVPRFFVPEHGVMMTLALIRFPPISPLEHHYLAGKSQL
TYTDLAGDPALIGNLPPREISYRDLFRDGRSGIKIKVAESIWYRTHPDYVNFKYHDLHGF
PFLDDAPGTSTGDNLQEAILVRHQDYDACFQSQQLLQWNKQARYNVSVYRHMPTVRDSIM
TS
//
>1m10A [c.62.1] VON WILLEBRAND FACTOR
HDFYCSRLLDLVFLLDGSSRLSEAEFEVLKAFVVDMMEQLRISQKWVRVAVVEYHDGSHA
YIGLKDRKRPSELRRIASQVKYAGSQVASTSEVLKYTLFQIFSKIDRPEASRIALLLMAS
QEPQRMSRNFVRYVQGLKKKKVIVIPVGIGPHANLKQIRLIEKQAPENKAFVLSSVDELE
QQRDEIVSYLCDLAPEAPP
//
>1m10B [c.10.2] GLYCOPROTEIN IB ALPHA
HPICEVSKVASHLEVNCDKRQLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQL
NLDRCELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL
RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNQLTELPAGLLNGLENLDTLLLQ
ENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEILYFRRWLQDNAENVYVWKQGVDVKAVT
SNVASVQCDNSDKFPVYKYPGKGCPTL
//
>1m1eA [a.118.1] BETA-CATENIN
RAIPELTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVET
ARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAK
MAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRT
YTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSD
AATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRT
VLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKAT
VGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRQFVEGVRMEEIVEGCTGALHI
LARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAP
LTELLHSRNEGVATYAAAVLFRMSEDKPQDYK
//
>1m1eB [a.161.1] ICAT
KSPEEMYIQQKVRVLLMLRKMGSNLTASEEEFLRTYAGVVNSQLSQIDQGAEDVVMAFSR
SETED
//
>1m1j_1D [h.1.8] FIBRINOGEN ALPHA SUBUNIT
SCKYEKNWPICVDDDWGTKCPSGCRMQGIIDDTDQNYSQRIDNIRQQLADSQNKYKTSNR
VIVETINILKPGLEGAQQLDENYGHVSTELRRRIVTLKQRVATQVNRIKALQNSIQEQVV
EMKRLEVDIDIKIRACKGSCARSFDYQVDKEGYDNIQKHLTQASSIDMHPDFQTTTLSTL
KMRPLKDSNVPEHF
//
>1m1j_1E [h.1.8 - d.171.1] FIBRINOGEN BETA CHAIN
IYPDAGGCKHPLDELGVLCPTGCELQTTLLKQEKTVKPVLRDLKDRVAKFSDTSTTMYQY
VNMIDNKLVKTQKQRKDNDIILSEYNTEMELHYNYIKDNLDNNIPSSLRVLRAVIDSLHK
KIQKLENAIATQTDYCRSPCVASCNIPVVSGRECEDIYRKGGETSEMYIIQPDPFTTPYR
VYCDMETDNGGWTLIQNRQDGSVNFGRAWDEYKRGFGNIAKSGGKKYCDTPGEYWLGNDK
ISQLTKIGPTKVLIEMEDWNGDKVSALYGGFTIHNEGNKYQLSVSNYKGNAGNALMEGAS
QLYGENRTMTIHNGMYFSTYDRDNDGWLTTDPRKQCSKEDGGGWWYNRCHAANPNGRYYW
GGTYSWDMAKHGTDDGIVWMNWKGSWYSMKKMSMKIKPYFP
//
>1m1j_1F [h.1.8 - d.171.1] FIBRINOGEN GAMMA CHAIN
RENCCILDERFGSYCPTTCGIADFFNKYRLTTDGELLEIEGLLQQATNSTGSIEYLIQHI
KTIYPSEKQTLPQSIEQLTQKSKKIIEEIIRYENTILAHENTIQQLTDMHIMNSNKITQL
KQKIAQLESHCQEPCKDTAEIQETTGRDCQDIANKGARKSGLYFIKPQKAKQSFLVYCEI
DTYGNGWTVLQRRLDGSEDFRRNWVQYKEGFGHLSPDDTTEFWLGNEKIHLITTQSTLPY
ALRIELEDWSGKKGTADYAVFKVGTEEDKYRLTYAYFIGGEAGDAFDGFNFGDDPSDKSY
TYHNGMRFSTFDNDNDNFEGNCAEQDGSGWWMNRCHAGHLNGPYYIGGVYSRDTGTNSYD
NGIIWATWRDRWYSMKKTTMKIIPFNRLS
//
>1m27A [d.93.1] SH2 DOMAIN PROTEIN 1A
MDAVAVYHGKISRETGEKLLLATGLDGSYLLRDSESVPGVYCLCVLYHGYIYTYRVSQTE
TGSWSAETAPGVHKRYFRKIKNLISAFQKPDQGIVIPLQYPVEK
//
>1m27C [b.34.2] PROTO-ONCOGENE TYROSINE-PROTEIN KINASE FYN
VTLFVALYDYEARTEDDLSFHKGEKFQILNSSEGDWWEARSLTTGETGYIPSNYVAPVDS
I
//
>1m2o_2C (A) [b.2.8 - g.41.10 - c.62.1 - a.71.2 - d.109.2] PROTEIN TRANSPORT PROTEIN SEC23
DFETNEDINGVRFTWNVFPSTRSDANSNVVPVGCLYTPLKEYDELNVAPYNPVVCSGPHC
KSILNPYCVIDPRNSSWSCPICNSRNHLPPQYTNENMPLELQSTTIEYITNKPVTVPPIF
FFVVDLTSETENLDSLKESIITSLSLLPPNALIGLITYGNVVQLHDLSSETIDRCNVFRG
DREYQLEALTEMLTGQKPTVTPFSLNRFFLPLEQVEFKLNQLLENLSPDQWSVPAGHRPL
RATGSALNIASLLLQGCYKNIPARIILFASGPGTVAPGLIVNSELKDPLRSHHDIDSDHA
QHYKKACKFYNQIAQRVAANGHTVDIFAGCYDQIGMSEMKQLTDSTGGVLLLTDAFSTAI
FKQSYLRLFAKDEEGYLKMAFNGNMAVKTSKDLKVQGLIGHASAVKKTDANNISESEIGI
GATSTWKMASLSPYHSYAIFFEIANTHLAYTQFITTYQHSSGTNRIRVTTVANQLLPFGT
PAIAASFDQEAAAVLMARIAVHKAETDDGADVIRWLDRTLIKLCQKYADYNKDDPQSFRL
APNFSLYPQFTYYLRRSQFLSVFNNSPDETAFYRHIFTREDTTNSLIMIQPTLTSFSMED
DPQPVLLDSISVKPNTILLLDTFFFILIYHGEQIAQWRKAGYQDDPQYADFKALLEEPKL
EAAELLVDRFPLPRFIDTEAGGSQARFLLSKLNPSTIVLTDDVSLQNFMTHLQQVAVS
//
>1m2o_2D [c.37.1] GTP-BINDING PROTEIN SAR1
GKLLFLGLDNAGKTTLLHMLKNDRLATLQPTWHPTSEELAIGNIKFTTFDLGGHIQARRL
WKDYFPEVNGIVFLVDAADPERFDEARVELDALFNIAELKDVPFVILGNKIDAPNAVSEA
ELRSALGLLNTTGRPVEVFMCSVVMRNGYLEAFQWLSQ
//
>1m2zA [a.123.1] GLUCOCORTICOID RECEPTOR
ATLPQLTPTLVSLLEVIEPEVLYAGYDSSVPDSTWRIMTTLNMLGGRQVIAAVKWAKAIP
GFRNLHLDDQMTLLQYSWMSLMAFALGWRSYRQSSANLLCFAPDLIINEQRMTLPCMYDQ
CKHMLYVSSELHRLQVSYEEYLCMKTLLLLSSVPKDGLKSQELFDEIRMTYIKELGKAIV
KREGNSSQNWQRFYQLTKLLDSMHEVVENLLNYCFQTFLDKTMSIEFPEMLAEIITNQIP
KYSNGNIKKLLFHQK
//
>1m2zB [x.x.x] NUCLEAR RECEPTOR COACTIVATOR 2
PVSPKKKENALLRYLLDKDDT
//
>1m34_1B [c.92.2] NITROGENASE MOLYBDENUM-IRON PROTEIN BETA CHAIN
SQQVDKIKASYPLFLDQDYKDMLAKKRDGFEEKYPQDKIDEVFQWTTTKEYQELNFQREA
LTVNPAKACQPLGAVLCALGFEKTMPYVHGSQGCVAYFRSYFNRHFREPVSCVSDSMTED
AAVFGGQQNMKDGLQNCKATYKPDMIAVSTTCMAEVIGDDLNAFINNSKKEGFIPDEFPV
PFAHTPSFVGSHVTGWDNMFEGIARYFTLKSMDDKVVGSNKKINIVPGFETYLGNFRVIK
RMLSEMGVGYSLLSDPEEVLDTPADGQFRMYAGGTTQEEMKDAPNALNTVLLQPWHLEKT
KKFVEGTWKHEVPKLNIPMGLDWTDEFLMKVSEISGQPIPASLTKERGRLVDMMTDSHTW
LHGKRFALWGDPDFVMGLVKFLLELGCEPVHILCHNGNKRWKKAVDAILAASPYGKNATV
YIGKDLWHLRSLVFTDKPDFMIGNSYGKFIQRDTLHKGKEFEVPLIRIGFPIFDRHHLHR
STTLGYEGAMQILTTLVNSILERLDEETRGMQATDYNHDLVR
//
>1m34_1F (E) [c.37.1] NITROGENASE IRON PROTEIN 1
AMRQCAIYGKGGIGKSTTTQNLVAALAEMGKKVMIVGCDPKADSTRLILHSKAQNTIMEM
AAEAGTVEDLELEDVLKAGYGGVKCVESGGPEPGVGCAGRGVITAINFLEEEGAYEDDLD
FVFYDVLGDVVCGGFAMPIRENKAQEIYIVCSGEMMAMYAANNISKGIVKYANSGSVRLG
GLICNSRNTDREDELIIALANKLGTQMIHFVPRDNVVQRAEIRRMTVIEYDPKAKQADEY
RALARKVVDNKLLVIPNPITMDELEELLMEFGIM
//
>1m45A [a.39.1] MYOSIN LIGHT CHAIN
TRANKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINASLASSLTLDQITGL
IEVNEKELDATTKAKTEDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLK
GVEVDSNGEIDYKKFIEDVLRQ
//
>1m45B [x.x.x] IQ2 MOTIF FROM MYO2P, A CLASS V MYOSIN
QISQAIKYLQNNIKGFIIRQRVNDE
//
>1m46A [a.39.1] MYOSIN LIGHT CHAIN
SATRANKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINADSSLRDASSLTL
DQITGLIEVNEKELDATTKAKTEDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAE
VDELLKGVEVDSNGEIDYKKFIEDVLRQ
//
>1m46B [x.x.x] IQ4 MOTIF FROM MYO2P, A CLASS V MYOSIN
SVLRTITNLQKKIRKELKQRQLKQE
//
>1m4uA [g.17.1] NOGGIN
MQHYLHIRPAPSDNLPLVDLIEHPDPIFDPKEKDLNETLLRSLLGGHYDPGFMATSPPED
RPGGAEDLAELDQLLRQRPSGAMPSEIKGLEFSEGLAQGKKQRLSKKLRRKLQMWLWSQT
FCPVLYAWNDLGSRFWPRYVKVGSCFSKRSCSVPEGMVCKPSKSVHLTVLRWRCQRRGGQ
RCGWIPIQYPIISECKCSC
//
>1m4uB (L) [g.17.1] BONE MORPHOGENETIC PROTEIN-7
ENSSSDQRQACKKHELYVSFRDLGWQDWIIAPEGYAAYYCEGECAFPLNSYMNATNHAIV
QTLVHFINPETVPKPCCAPTQLNAISVLYFDDSSNVILKKYRNMVVRACGCH
//
>1m56_1B [f.17.2 - b.6.1] CYTOCHROME C OXIDASE
LEIIGRPQPGGTGFQPSASPVATQIHWLDGFILVIIAAITIFVTLLILYAVWRFHEKRNK
VPARFTHNSPLEIAWTIVPIVILVAIGAFSLPVLFNQQEIPEADVTVKVTGYQWYWGYEY
PDEEISFESYMIGSPATGGDNRMSPEVEQQLIEAGYSRDEFLLATDTAMVVPVNKTVVVQ
VTGADVIHSWTVPAFGVKQDAVPGRLAQLWFRAEREGIFFGQCSELCGISHAYMPITVKV
VSEEAYAAWLEQARGGTYEL
//
>1m56_1J (D) [f.23.8] CYTOCHROME C OXIDASE
GHVAGSMDITQQEKTFAGFVRMVTWAAVVIVAALIFLALANA
//
>1m56_1I (C) [f.25.1] CYTOCHROME C OXIDASE
AHAKNHDYHILPPSIWPFMASVGAFVMLFGAVLWMHGSGPWMGLIGLVVVLYTMFGWWSD
VVTESLEGDHTPVVRLGLRWGFILFIMSEVMFFSAWFWSFFKHALYPMGPESPIIDGIFP
PEGIITFDPWHLPLINTLILLCSGCAATWAHHALVHENNRRDVAWGLALAIALGALFTVF
QAYEYSHAAFGFAGNIYGANFFMATGFHGFHVIVGTIFLLVCLIRVQRGHFTPEKHVGFE
AAIWYWHFVDVVWLFLFASIYIWGQ
//
>1m57A [f.24.1] CYTOCHROME C OXIDASE
RGFFTRWFMSTNHKDIGVLYLFTGGLVGLISVAFTVYMRMELMAPGVQFMCAEHLESGLV
KGFFQSLWPSAVENCTPNGHLWNVMITGHGILMMFFVVIPALFGGFGNYFMPLHIGAPDM
AFPRMNNLSYWLYVAGTSLAVASLFAPGGNGQLGSGIGWVLYPPLSTSESGYSTDLAIFA
VHLSGASSILGAINMITTFLNMRAPGMTMHKVPLFAWSIFVTAWLILLALPVLAGAITML
LTDRNFGTTFFQPSGGGDPVLYQHILWFFGHPQVYIIVLPAFGIVSHVIATFAKKPIFGY
LPMVYAMVAIGVLGFVVWAHHMYTAGLSLTQQSYFMMATMVIAVPTGIKIFSWIATMWGG
SIELKTPMLWALGFLFLFTVGGVTGIVLSQASVDRYYHDTYYVVAHFHYVMSLGAVFGIF
AGIYFWIGKMSGRQYPEWAGKLHFWMMFVGANLTFFPQHFLGRQGMPRRYIDYPEAFATW
NFVSSLGAFLSFASFLFFLGVIFYTLTRGARVTANNYWNEHADTLEWTLTSPPPEHTFEQ
LPKREDW
//
>1m57C [f.25.1] CYTOCHROME C OXIDASE
AHAKNHDYHILPPSIWPFMASVGAFVMLFGAVLWMHGSGPWMGLIGLVVVLYTMFGWWSD
VVTESLEGDHTPVVRLGLRWGFILFIMSEVMFFSAWFWSFFKHALYPMGPESPIIDGIFP
PEGIITFDPWHLPLINTLILLCSGCAATWAHHALVHENNRRDVAWGLALAIALGALFTVF
QAYEYSHAAFGFAGNIYGANFFMATGFHGFHVIVGTIFLLVCLIRVQRGHFTPEKHVGFE
AAIWYWHFVDVVWLFLFASIYIWGQ
//
>1m5nA (Q) [x.x.x] PARATHYROID HORMONE-RELATED PROTEIN
YLTQETNKVETYKEQPLKTPGKKKKGKP
//
>1m5nB (S) [a.118.1] IMPORTIN BETA-1 SUBUNIT
MELITILEKTVSPDRLELEAAQKFLERAAVENLPTFLVELSRVLANPGNSQVARVAAGLQ
IKNSLTSKDPDIKAQYQQRWLAIDANARREVKNYVLQTLGTETYRPSSASQCVAGIACAE
IPVNQWPELIPQLVANVTNPNSTEHMKESTLEAIGYICQDIDPEQLQDKSNEILTAIIQG
MRKEEPSNNVKLAATNALLNSLEFTKANFDKESERHFIMQVVCEATQCPDTRVRVAALQN
LVKIMSLYYQYMETYMGPALFAITIEAMKSDIDEVALQGIEFWSNVCDEEMDLAIEASEA
AEQGRPPEHTSKFYAKGALQYLVPILTQTLTKQDENDDDDDWNPCKAAGVCLMLLATCCE
DDIVPHVLPFIKEHIKNPDWRYRDAAVMAFGCILEGPEPSQLKPLVIQAMPTLIELMKDP
SVVVRDTAAWTVGRICELLPEAAINDVYLAPLLQCLIEGLSAEPRVASNVCWAFSSLAEA
AYEAA
//
>1m63_3A [d.159.1] SERINE/THREONINE PROTEIN PHOSPHATASE 2B
MSEPKAIDPKLSTTDRVVKAVPFPPSHRLTAKEVFDNDGKPRVDILKAHLMKEGRLEESV
ALRIITEGASILRQEKNLLDIDAPVTVCGDIHGQFFDLMKLFEVGGSPANTRYLFLGDYV
DRGYFSIECVLYLWALKILYPKTLFLLRGNHECRHLTEYFTFKQECKIKYSERVYDACMD
AFDCLPLAALMNQQFLCVHGGLSPEINTLDDIRKLDRFKEPPAYGPMCDILWSDPLEDFG
NEKTQEHFTHNTVRGCSYFYSYPAVCEFLQHNNLLSILRAHEAQDAGYRMYRKSQTTGFP
SLITIFSAPNYLDVYNNKAAVLKYENNVMNIRQFNCSPHPYWLPNFMDVFTWSLPFVGEK
VTEMLVNVLNIC
//
>1m63_3E (C) [b.62.1] PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A
MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGF
MCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTE
WLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE
//
>1m6kB [x.x.x]
WDKTPKGMEIWNSNHTPKTWMQFSVVWVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDER
NNGLTEAWLESSLKISPEEQIQFLRKIINHNLPVKNSAIENTIENMYLQDLDNSTKLYGK
TGAGFTANRTLQNGWFEGFIISKSGHKYVFVSALTGNLGSNLTSSIKAKKNAITILNTLN
L
//
>1m6kF [x.x.x]
LFEGTEGCFLLYDASTNAEIAQFNKAKCATQMAPDSTFxIALSLMAFDAEIIDQKTIF
//
>1m7dA [b.1.1 - b.1.1] LIGHT CHAIN OF THE MONOCLONAL ANTIBODY FAB
DVVLTQTPLSLPVRLGDQASISCRSSQSLLHSDGNTYLHWYLQKPGQSPKLLIYKVSNRF
SGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQTTHVPTFGGGTKLEIKRADAAPTVS
IFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMS
STLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNR
//
>1m7dB [b.1.1 - b.1.1] HEAVY CHAIN OF THE MONOCLONAL ANTIBODY FAB
EVKVEESGGGLVQPGGSMKLSCVASGFTFSNYWMEWVRQSPEKGLEWVAEIRLKSNNYAT
HYAESVKGRFTISRDDSKSSVYLQMNNLRAEDTGIYYCTRGGAVGAMDYWGQGTSVTVSS
ATTTAPSVYPLVPGCSDTSGSSVTLGCLVKGYFPEPVTVKWNYGALSSGVRTVSSVLQSG
FYSLSSLVTVPSSTWPSQTVICNVAHPASKVDLIKEPSGP
//
>1m93A [e.1.1] SERINE PROTEINASE INHIBITOR 2
MDIFREIASSMKGENVFISPPSISSVLTILYYGANGSTAEQLSKYV
//
>1m93B [e.1.1] SERINE PROTEINASE INHIBITOR 2
DISFKSMNKVYGRYSAVFKDSFLRKIGDNFQTVDFTDSRTVDAINKSVDIFTEGKINPLL
DEPLSPDTSLLAISAVYFKAKWLMPFEKEFTSDYPFYVSPTEMVDVSMMSMYGEAFNHAS
VKESFGNFSIIELPYVGDTSMVVILPDNIDGLESIEQNLTDTNFKKWSDSMDAMFIDVHI
PKFKVTGSYNLVDALVKLGLTEVFGSTGDYSNMSNSDVSVDAMIHKTYIDVNEEYTEAAA
ATSAL
//
>1m93C [e.1.1] SERINE PROTEINASE INHIBITOR 2
TNEFSADHPFIYVIRHVDGKILFVGRYSSPT
//
>1ma9A [a.126.1 - a.126.1 - a.126.1] VITAMIN D-BINDING PROTEIN
LERGRDYEKNKVCKEFSHLGKEDFTSLSLVLYSRKFPSGTFEQVSQLVKEVVSLTEACCA
EGADPDCYDTRTSALSAKSCESNSPFPVHPGTAECCTLCMAALKHQPQEFPTYVEPTNDE
ICEAFRKDPKEYANQFMWEYSTNYGQAPLSLLVSYTKSYLSMVGSCCTSASPTVCFLKER
LQLKHLSLLTTLSNRVCSQYAAYGEKKSRLSNLIKLAQKVPTADLEDVLPLAEDITNILS
KCCESASEDCMAKELPEHTVKLCDNLSTKNSKFEDCCQEKTAMDVFVCTYFMPAAQLPEL
PDVELPTNKDNTKVMDKYTFELSRRTHLPEVFLSKVLEPTLKSLGECCSTTCFNAKGPLL
KKELSSFIDKGQELCADYSENTFTEYKKKLAERLKAKLPEATPTELAKLVNKRSDFASNC
CSINSPPLYCDSEIDAELKNIL
//
>1ma9B [c.55.1 - c.55.1] ACTIN, ALPHA SKELETAL MUSCLE
TTALVCDNGSGLVKAGFAGDDAPRAVFPSIVGRPRHDSYVGDEAQSKRGILTLKYPIExG
IITNWDDMEKIWHHTFYNELRVAPEEHPTLLTEAPLNPKANREKMTQIMFETFNVPAMYV
AIQAVLSLYASGRTTGIVLDSGDGVTHNVPIYEGYALPHAIMRLDLAGRDLTDYLMKILT
ERGYSFVTTAEREIVRDIKEKLCYVALDFENEMATAASSSSLEKSYELPDGQVITIGNER
FRCPETLFQPSFIGMESAGIHETTYNSIMKCDIDIRKDLYANNVMSGGTTMYPGIADRMQ
KEITALAPSTMKIKIIAPPERKYSVWIGGSILASLSTFQQMWITKQEYDEAGPSIVH
//
>1mabA [x.x.x]
AAAAEERIGADTSVDLEETGRVLSIGDGIARVHGLRNVQAEEMVEFSSGLKGMSLNLEPD
NVGVVVFGNDKLIKEGDIVKRTGAIVDVPVGDELLGRVVDALGNAIDGKGPVGSKIRRRV
GLKAPGIIPRISVREPMQTGIKAVDSLVPIGRGQRELIIGDRQTGKTSIAIDTIINQKRF
NDGTDEKKKLYCIYVAIGQKRSTVAQLVKRLTDADAMKYTIVVSATASDAAPLQYLAPYS
GCSMGEYFRDNGKHALIIYDDLSKQAVAYRQMSLLLRRPPGREAYPGDVFYLHSRLLERA
AKMNDSFGGGSLTALPVIETQAGDVSAYIPTNVISITDGQIFLETELFYKGIRPAINVGL
SVSRVGSAAQTRAMKQVAGTMKLELAQYREVAAFAQFGSDLDAATQQLLSRGVRLTELLK
QGQYSPMAIEEQVAVIYAGVRGYLDKLEPSKITKFESAFLSHVVSQHQALLGNIRTDGKI
SEQSDAKLKEIVTNFLAGFEP
//
>1mabG [c.49.2] PROTEIN (F1-ATPASE GAMMA CHAIN)
RDITRRLKSIKNIQKITKSMKMVAAAKYARAERELKPARVYGTGSLCGAIHSSVAKQMKL
ANIIYYSLKESTTSEQSARMTAMDNASKNASDMIDKLTLTFNRTRQAVITKELIEIISGA
AALD
//
>1mabF [x.x.x]
RDITRRLKSIKNIQKITKSMKMVAAAKYARAERELKPARVYGTGSLGAIHSSVAKQMKLA
NIIYYSLKESTTSEQSARMTAMDNASKNASDMIDKLTLTFNRTRQAVITELEISGALD
//
>1mabI (B) [b.49.1 - c.37.1 - a.69.1] PROTEIN (F1-ATPASE BETA CHAIN)
SAAPKAGTATGQIVAVIGAVVDVQFDEGLPPILNALEVQGRESRLVLEVAQHLGESTVRT
IAMDGTEGLVRGQKVLDSGAPIKIPVGPETLGRIMNVIGEPIDERGPIKTKQFAPIHAEA
PEFIEMSVEQEILVTGIKVVDLLAPYAKGGKIGLFGGAGVGKTVLIMELINNVAKAHGGY
SVFAGVGERTREGNDLYHEMIESGVINLKDATSKVALVYGQMNEPPGARARVALTGLTVA
EYFRDQEGQDVLLFIDNIFRFTQAGSEVSALLGRIPSAVGYQPTLATDMGTMQERITTTK
KGSITSVQAIYVPADDLTDPAPATTFAHLDATTVLSRAIAELGIYPAVDPLDSTSRIMDP
NIVGSEHYDVARGVQKILQDYKSLQDIIAILGMDELSEEDKLTVSRARKIQRFLSQPFQV
AEVFTGHMGKLVPLKETIKGFQQILAGDYDHLPEQAFYMVGPIEEAVAKADKLAEEH
//
>1mamL [b.1.1 - b.1.1] IGG2B-KAPPA YST9.1 FAB (LIGHT CHAIN)
DIQMTQTTSSLSASLGDRVTISCRASQDIYNYLNWYQQKPDGTVKLLIYYTSRLHSGVPS
RFSGSGSGTDYSLTISNLNQEDMATYICQQGNTLPFTFGSGTKLEIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1mamH [b.1.1 - b.1.1] IGG2B-KAPPA YST9.1 FAB (HEAVY CHAIN)
EVKLVESGGGLVQPGGSLRLSCATSGFTFTDYYMSWVRQPPGKALEWLGFIRNKADGYTT
EYSASVKGRFTISRDNSQSILYLQMNTLRAEDSATYYCTRDPYGPAAYWGQGTLVTVSAA
KTTPPSVYPLAPGCGDTTGSSVTLGCLVKGYFPESVTVTWNSGSLSSSVHTFPALLQSGL
YTMSSSVTVPSSTWPSQTVTCSVAHPASSTTVDKKLE
//
>1mcoA (H) [b.1.1 - b.1.1 - b.1.1 - b.1.1] IGG1 MCG INTACT ANTIBODY (HEAVY CHAIN)
PLVLQESGPGLVKPSEALSLTCTVSGDSINTILYYWSWIRQPPGKGLEWIGYIYYSGSTY
GNPSLKSRVTISVNTSKNQFYSKLSSVTAADTAVYYCARVPLVVNPWGQGTLVTVSSAST
KGPSVFPLAPSSKSTSGGTAALGCLVKDYFPQPVTVSWNSGALTSGVHTFPAVLQSSGLY
SLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVAPELLGGPSVFLFPPKPKDTLMISR
TPEVTCVVVDVSHEDPQVKFNWYVDGVQVHNAKTKPREQQYNSTYRVVSVLTVLHQNWLD
GKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPS
DIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNH
YTQKSLSL
//
>1mcoB (L) [b.1.1 - b.1.1] IGG1 MCG INTACT ANTIBODY (LIGHT CHAIN)
PSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV
PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT
LFPPSSEELQANKATEVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS
YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS
//
>1mctA [b.47.1] BETA-TRYPSIN
IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYKSRIQVRLGEHNIDVLEG
NEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSCAAAGTECLISG
WGNTKSSGSSYPSLLQCLKAPVLSNSSCKSSYPGQITGNMICVGFLQGGKDSCQGDSGGP
VVCNGQLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIAAN
//
>1mctI [g.3.2] TRYPSIN INHIBITOR A
RICPRIWMECTRDSDCMAKCICVAGHCG
//
>1mcvA [b.47.1] ELASTASE 1
VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVDRELTFRVVVGEH
NLNQNDGTEQYVGVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQLGVLPRAGTI
LANNSPCYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWGSTVKNSMVCAGGDGV
RSGCQGDSGGPLHCLVNGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSAYISWINNVIASN
//
>1mcvI [g.3.2] HEI-TOE I
PCTLEYMRCKQDSDCLAGCVCGPNGFCG
//
>1mdaL [x.x.x]
VDPRAKWQPQDNDIQACDYWRHCSIAGNICDCSAGSLTSCPPGTLVASGSWVGSCYNPPD
PNKYITAYRDCCGYNVSGRCACLNTEGELPVYNKDANDIIWCFGGEDGMTYHCSISPVSG
A
//
>1mdaM [x.x.x]
VDPRAKWQPQDNDIQACDYWRHCSIAGNICDCSAGSLTSCPPGTLVASGSWVGSCYNPPD
PNKYITAYRDCCGYNVSGRCACLNTEGELPVYNKDANDIIWCFGGEDGMTYHCSISPVSG
A
//
>1mdaJ (H) [b.69.2] METHYLAMINE DEHYDROGENASE (HEAVY SUBUNIT)
EKSKVAGSAAAASAAAASDGSSCDHGPGAISRRSHITLPAYFAGTTENWVSCAGCGVTLG
HSLGAFLSLAVAGHSGSDFALASTSFARSAKGKRTDYVEVFDPVTFLPIADIELPDAPRF
SVGPRVHIIGNCASSACLLFFLFGSSAAAGLSVPGASDDQLTKSASCFHIHPGAAATHYL
GSCPASLAASDLAAAPAAAGIVGAQCTGAQNCSSQAAQANYPGMLVWAVASSILQGDIPA
AGATMKAAIDGNESGRKADNFRSAGFQMVAKLKNTDGIMILTVEHSRSCLAAAENTSSVT
ASVGQTSGPISNGHDSDAIIAAQDGASDNYANSAGTEVLDIYDAASDQDQSSVELDKGPE
SLSVQNEA
//
>1mdaA [b.6.1] AMICYANIN
ATIPSESPFAAAEVADGAIVVDIAKMKYETPELHVKVGDTVTWINREAMPHNVHFVAGVL
GEAALKGPMMKKEQAYSLTFTEAGTYDYHCTPHPFMRGKVVVE
//
>1mec_22 [b.121.4] MENGO VIRUS COAT PROTEIN (SUBUNIT VP2)
DQNTEEMENLSDRVSQDTAGNTVTNTQSTVGRLVGYGTVHDGEHPASCADTASEKILAVE
RYYTFKVNDWTSTQKPFEYIRIPLPHVLSGEDGGVFGATLRRHYLVKTGWRVQVQCNASQ
FHAGSLLVFMAPEYPTLDVFAMDNRWSKDNLPNGTRTQTNRKGPFAMDHQNFWQWTLYPH
QFLNLRTNTTVDLEVPYVNIAPTSSWTQHASWTLVIAVVAPLTYSTGASTSLDITASIQP
VRPVFNGLRHEVLSRQ
//
>1mec_23 [b.121.4] MENGO VIRUS COAT PROTEIN (SUBUNIT VP1)
SPIPVTIREHAGTWYSTLPDSTVPIYGKTPVAPANYMVGEYKDFLEIAQIPTFIGNKMPN
AVPYIEASNTAVKTQPLAVYQVTLSCSCLANTFLAALSRNFAQYRGSLVYTFVFTGTAMM
KGKFLIAYTPPGAGKPTSRDQAMQATYAIWDLGLNSSYSFTVPFISPTHFRMVGTDQANI
TNVDGWVTVWQLTPLTYPPGCPTSAKILTMVSAGKDFSLKMPISPAPWSPQ
//
>1mec_2a (4) [b.121.4] MENGO VIRUS COAT PROTEIN (SUBUNIT VP1)
GVENAEKGVTENTDATADFVAQPVYLPENQTKVAFFYDRSSPIGRFAVKSGSLESGFAPF
SNKACPNSVILTPGPQFDPAYDQLRPQRLTEIWGNGNEETSEVFPLKTKQDYSFCLFSPF
VYYKCDLEVTLSPHTSGAHGLLVRWCPTGTPTKPTTQVLHEVSSLSEGRTPQVYSAGPGT
SNQISFVVPYNSPLSVLPAVWYNGHKRFDNTGDLGIAPNSDFGTLFFAGTKPDIKFTVYL
RYKNMRVFCPRPTVFFPWPTSGDKIDMTPRAGVL
//
>1mec_2f (2) [b.121.4] MENGO VIRUS COAT PROTEIN (SUBUNIT VP2)
DQNTEEMENLSDRVSQDTAGNTVTNTQSTVGRLVGYGTVHDGEHPASCADTASEKILAVE
RYYTFKVNDWTSTQKPFEYIRIPLPHVLSGEDGGVFGATLRRHYLVKTGWRVQVQCNASQ
FHAGSLLVFMAPEYPTLDVFAMDNRWSKDNLPNGTRTQTNRKGPFAMDHQNFWQWTLYPH
QFLNLRTNTTVDLEVPYVNIAPTSSWTQHASWTLVIAVVAPLTYSTGASTSLDITASIQP
VRPVFNGLRHEVLSRQ
//
>1mec_2h (4) [b.121.4] MENGO VIRUS COAT PROTEIN (SUBUNIT VP1)
NNSSSEGNEGVIINNFYSNQYQNSIDLSANATGSDPPKTYGQFSNLLSGAVNAFSNMLPL
LA
//
>1mec_2a (4) [b.121.4] MENGO VIRUS COAT PROTEIN (SUBUNIT VP1)
GVENAEKGVTENTDATADFVAQPVYLPENQTKVAFFYDRSSPIGRFAVKSGSLESGFAPF
SNKACPNSVILTPGPQFDPAYDQLRPQRLTEIWGNGNEETSEVFPLKTKQDYSFCLFSPF
VYYKCDLEVTLSPHTSGAHGLLVRWCPTGTPTKPTTQVLHEVSSLSEGRTPQVYSAGPGT
SNQISFVVPYNSPLSVLPAVWYNGHKRFDNTGDLGIAPNSDFGTLFFAGTKPDIKFTVYL
RYKNMRVFCPRPTVFFPWPTSGDKIDMTPRAGVLDQNTEEMENLSDRVSQDTAGNTVTNT
QSTVGRLVGYGTVHDGEHPASCADTASEKILAVERYYTFKVNDWTSTQKPFEYIRIPLPH
VLSGEDGGVFGATLRRHYLVKTGWRVQVQCNASQFHAGSLLVFMAPEYPTLDVFAMDNRW
SKDNLPNGTRTQTNRKGPFAMDHQNFWQWTLYPHQFLNLRTNTTVDLEVPYVNIAPTSSW
TQHASWTLVIAVVAPLTYSTGASTSLDITASIQPVRPVFNGLRHEVLSRQSPIPVTIREH
AGTWYSTLPDSTVPIYGKTPVAPANYMVGEYKDFLEIAQIPTFIGNKMPNAVPYIEASNT
AVKTQPLAVYQVTLSCSCLANTFLAALSRNFAQYRGSLVYTFVFTGTAMMKGKFLIAYTP
PGAGKPTSRDQAMQATYAIWDLGLNSSYSFTVPFISPTHFRMVGTDQANITNVDGWVTVW
QLTPLTYPPGCPTSAKILTMVSAGKDFSLKMPISPAPWSPQNNSSSEGNEGVIINNFYSN
QYQNSIDLSANATGSDPPKTYGQFSNLLSGAVNAFSNMLPLLAGVENAEKGVTENTDATA
DFVAQPVYLPENQTKVAFFYDRSSPIGRFAVKSGSLESGFAPFSNKACPNSVILTPGPQF
DPAYDQLRPQRLTEIWGNGNEETSEVFPLKTKQDYSFCLFSPFVYYKCDLEVTLSPHTSG
AHGLLVRWCPTGTPTKPTTQVLHEVSSLSEGRTPQVYSAGPGTSNQISFVVPYNSPLSVL
PAVWYNGHKRFDNTGDLGIAPNSDFGTLFFAGTKPDIKFTVYLRYKNMRVFCPRPTVFFP
WPTSGDKIDMTPRAGVLDQNTEEMENLSDRVSQDTAGNTVTNTQSTVGRLVGYGTVHDGE
HPASCADTASEKILAVERYYTFKVNDWTSTQKPFEYIRIPLPHVLSGEDGGVFGATLRRH
YLVKTGWRVQVQCNASQFHAGSLLVFMAPEYPTLDVFAMDNRWSKDNLPNGTRTQTNRKG
PFAMDHQNFWQWTLYPHQFLNLRTNTTVDLEVPYVNIAPTSSWTQHASWTLVIAVVAPLT
YSTGASTSLDITASIQPVRPVFNGLRHEVLSRQSPIPVTIREHAGTWYSTLPDSTVPIYG
KTPVAPANYMVGEYKDFLEIAQIPTFIGNKMPNAVPYIEASNTAVKTQPLAVYQVTLSCS
CLANTFLAALSRNFAQYRGSLVYTFVFTGTAMMKGKFLIAYTPPGAGKPTSRDQAMQATY
AIWDLGLNSSYSFTVPFISPTHFRMVGTDQANITNVDGWVTVWQLTPLTYPPGCPTSAKI
LTMVSAGKDFSLKMPISPAPWSPQNNSSSEGNEGVIINNFYSNQYQNSIDLSANATGSDP
PKTYGQFSNLLSGAVNAFSNMLPLLAGVENAEKGVTENTDATADFVAQPVYLPENQTKVA
FFYDRSSPIGRFAVKSGSLESGFAPFSNKACPNSVILTPGPQFDPAYDQLRPQRLTEIWG
NGNEETSEVFPLKTKQDYSFCLFSPFVYYKCDLEVTLSPHTSGAHGLLVRWCPTGTPTKP
TTQVLHEVSSLSEGRTPQVYSAGPGTSNQISFVVPYNSPLSVLPAVWYNGHKRFDNTGDL
GIAPNSDFGTLFFAGTKPDIKFTVYLRYKNMRVFCPRPTVFFPWPTSGDKIDMTPRAGVL
TEEMENLSDRVSQDTAGNTVTNTQSTVGRLVGYGTVHDGEHPASCADTASEKILAVERYY
TFKVNDWTSTQKPFEYIRIPLPHVLSGEDGGVFGATLRRHYLVKTGWRVQVQCNASQFHA
GSLLVFMAPEYPTLDVFAMDNRWSKDNLPNGTRTQTNRKGPFAMDHQNFWQWTLYPHQFL
NLRTNTTVDLEVPYVNIAPTSSWTQHASWTLVIAVVAPLTYSTGASTSLDITASIQPVRP
VFNGLRHEVLSRQSPIPVTIREHAGTWYSTLPDSTVPIYGKTPVAPANYMVGEYKDFLEI
AQIPTFIGNKMPNAVPYIEASNTAVKTQPLAVYQVTLSCSCLANTFLAALSRNFAQYRGS
LVYTFVFTGTAMMKGKFLIAYTPPGAGKPTSRDQAMQATYAIWDLGLNSSYSFTVPFISP
THFRMVGTDQANITNVDGWVTVWQLTPLTYPPGCPTSAKILTMVSAGKDFSLKMPISPAP
WSPQNNSSSEGNEGVIINNFYSNQYQNSIDLSANATGSDPPKTYGQFSNLLSGAVNAFSN
MLPLLA
//
>1mec_41 [b.121.4] MENGO VIRUS COAT PROTEIN (SUBUNIT VP1)
GVENAEKGVTENTDATADFVAQPVYLPENQTKVAFFYDRSSPIGRFAVKSGSLESGFAPF
SNKACPNSVILTPGPQFDPAYDQLRPQRLTEIWGNGNEETSEVFPLKTKQDYSFCLFSPF
VYYKCDLEVTLSPHTSGAHGLLVRWCPTGTPTKPTTQVLHEVSSLSEGRTPQVYSAGPGT
SNQISFVVPYNSPLSVLPAVWYNGHKRFDNTGDLGIAPNSDFGTLFFAGTKPDIKFTVYL
RYKNMRVFCPRPTVFFPWPTSGDKIDMTPRAGVL
//
>1mec_42 [b.121.4] MENGO VIRUS COAT PROTEIN (SUBUNIT VP2)
DQNTEEMENLSDRVSQDTAGNTVTNTQSTVGRLVGYGTVHDGEHPASCADTASEKILAVE
RYYTFKVNDWTSTQKPFEYIRIPLPHVLSGEDGGVFGATLRRHYLVKTGWRVQVQCNASQ
FHAGSLLVFMAPEYPTLDVFAMDNRWSKDNLPNGTRTQTNRKGPFAMDHQNFWQWTLYPH
QFLNLRTNTTVDLEVPYVNIAPTSSWTQHASWTLVIAVVAPLTYSTGASTSLDITASIQP
VRPVFNGLRHEVLSRQ
//
>1mec_4q (3) [b.121.4] MENGO VIRUS COAT PROTEIN (SUBUNIT VP1)
SPIPVTIREHAGTWYSTLPDSTVPIYGKTPVAPANYMVGEYKDFLEIAQIPTFIGNKMPN
AVPYIEASNTAVKTQPLAVYQVTLSCSCLANTFLAALSRNFAQYRGSLVYTFVFTGTAMM
KGKFLIAYTPPGAGKPTSRDQAMQATYAIWDLGLNSSYSFTVPFISPTHFRMVGTDQANI
TNVDGWVTVWQLTPLTYPPGCPTSAKILTMVSAGKDFSLKMPISPAPWSPQ
//
>1mec_4r (4) [b.121.4] MENGO VIRUS COAT PROTEIN (SUBUNIT VP1)
NNSSSEGNEGVIINNFYSNQYQNSIDLSANATGSDPPKTYGQFSNLLSGAVNAFSNMLPL
LA
//
>1mec_4a (4) [b.121.4] MENGO VIRUS COAT PROTEIN (SUBUNIT VP1)
GVENAEKGVTENTDATADFVAQPVYLPENQTKVAFFYDRSSPIGRFAVKSGSLESGFAPF
SNKACPNSVILTPGPQFDPAYDQLRPQRLTEIWGNGNEETSEVFPLKTKQDYSFCLFSPF
VYYKCDLEVTLSPHTSGAHGLLVRWCPTGTPTKPTTQVLHEVSSLSEGRTPQVYSAGPGT
SNQISFVVPYNSPLSVLPAVWYNGHKRFDNTGDLGIAPNSDFGTLFFAGTKPDIKFTVYL
RYKNMRVFCPRPTVFFPWPTSGDKIDMTPRAGVLDQNTEEMENLSDRVSQDTAGNTVTNT
QSTVGRLVGYGTVHDGEHPASCADTASEKILAVERYYTFKVNDWTSTQKPFEYIRIPLPH
VLSGEDGGVFGATLRRHYLVKTGWRVQVQCNASQFHAGSLLVFMAPEYPTLDVFAMDNRW
SKDNLPNGTRTQTNRKGPFAMDHQNFWQWTLYPHQFLNLRTNTTVDLEVPYVNIAPTSSW
TQHASWTLVIAVVAPLTYSTGASTSLDITASIQPVRPVFNGLRHEVLSRQSPIPVTIREH
AGTWYSTLPDSTVPIYGKTPVAPANYMVGEYKDFLEIAQIPTFIGNKMPNAVPYIEASNT
AVKTQPLAVYQVTLSCSCLANTFLAALSRNFAQYRGSLVYTFVFTGTAMMKGKFLIAYTP
PGAGKPTSRDQAMQATYAIWDLGLNSSYSFTVPFISPTHFRMVGTDQANITNVDGWVTVW
QLTPLTYPPGCPTSAKILTMVSAGKDFSLKMPISPAPWSPQNNSSSEGNEGVIINNFYSN
QYQNSIDLSANATGSDPPKTYGQFSNLLSGAVNAFSNMLPLLAGVENAEKGVTENTDATA
DFVAQPVYLPENQTKVAFFYDRSSPIGRFAVKSGSLESGFAPFSNKACPNSVILTPGPQF
DPAYDQLRPQRLTEIWGNGNEETSEVFPLKTKQDYSFCLFSPFVYYKCDLEVTLSPHTSG
AHGLLVRWCPTGTPTKPTTQVLHEVSSLSEGRTPQVYSAGPGTSNQISFVVPYNSPLSVL
PAVWYNGHKRFDNTGDLGIAPNSDFGTLFFAGTKPDIKFTVYLRYKNMRVFCPRPTVFFP
WPTSGDKIDMTPRAGVLDQNTEEMENLSDRVSQDTAGNTVTNTQSTVGRLVGYGTVHDGE
HPASCADTASEKILAVERYYTFKVNDWTSTQKPFEYIRIPLPHVLSGEDGGVFGATLRRH
YLVKTGWRVQVQCNASQFHAGSLLVFMAPEYPTLDVFAMDNRWSKDNLPNGTRTQTNRKG
PFAMDHQNFWQWTLYPHQFLNLRTNTTVDLEVPYVNIAPTSSWTQHASWTLVIAVVAPLT
YSTGASTSLDITASIQPVRPVFNGLRHEVLSRQSPIPVTIREHAGTWYSTLPDSTVPIYG
KTPVAPANYMVGEYKDFLEIAQIPTFIGNKMPNAVPYIEASNTAVKTQPLAVYQVTLSCS
CLANTFLAALSRNFAQYRGSLVYTFVFTGTAMMKGKFLIAYTPPGAGKPTSRDQAMQATY
AIWDLGLNSSYSFTVPFISPTHFRMVGTDQANITNVDGWVTVWQLTPLTYPPGCPTSAKI
LTMVSAGKDFSLKMPISPAPWSPQNNSSSEGNEGVIINNFYSNQYQNSIDLSANATGSDP
PKTYGQFSNLLSGAVNAFSNMLPLLA
//
>1meeA [c.41.1] MESENTERICOPEPTIDASE
AQSVPYGISQIKAPALHSQGYTGSNVKVAVIDSGIDSSHPDLNVRGGASFVPSETNPYQD
GSSHGTHVAGTIAALNNSIGVLGVAPSASLYAVKVLDSTGSGQYSWIINGIEWAISNNMD
VINMSLGGPTGSTALKTVVDKAVSSGIVVAAAAGNEGSSGSTSTVGYPAKYPSTIAVGAV
NSANQRASFSSAGSELDVMAPGVSIQSTLPGGTYGAYNGTSMATPHVAGAAALILSKHPT
WTNAQVRDRLESTATYLGSSFYYGKGLINVQAAAQ
//
>1meeI [d.40.1] EGLIN C
LKSFPEVVGKTVDQAREYFTLHYPQYNVYFLPEGSPVTLDLRYNRVRVFYNPGTNVVNHV
PHVG
//
>1mel_1A [b.1.1] VH SINGLE-DOMAIN ANTIBODY
VQLQASGGGSVQAGGSLRLSCAASGYTIGPYCMGWFRQAPGKEREGVAAINMGGGITYYA
DSVKGRFTISQDNAKNTVYLLMNSLEPEDTAIYYCAADSTIYASYYECGHGLSTGGYGYD
SWGQGTQVTVSS
//
>1mel_1L [d.2.1] LYSOZYME
KVFGRCELAAAMKRHGLDNYRGYSLGNWVCAAKFESNFNTQATNRNTDGSTDYGILQINS
RWWCNDGRTPGSRNLCNIPCSALLSSDITASVNCAKKIVSDGNGMNAWVAWRNRCKGTDV
QAWIRGC
//
>1mexL [b.1.1 - b.1.1] FAB 29G12 LIGHT CHAIN
DIVMTQSQKFMSTSLGNRVSVTCKASQNVGTNVAWFQQKPGQSPKTLIYSASYRYSGVPD
RFTGSGSGTDFTLTINNVQSEDLAEYFCQQYNSYPYTFGGGTKLEIKRADAAPTVSIFPP
SSEQLTGGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNE
//
>1mexH [b.1.1 - b.1.1] FAB 29G12 HEAVY CHAIN
QVQLQQSDAELVKPGASVKISCKASGYTFTDHAIHWVKQKPGLEWIGYISPGNGDIKYNE
KFKGKATLTADKSSSTAYMQLNSLTSEDSAVYFCKMEYLDYWGQGTTLTVSSGGTTPPSV
YPLAPGSAAQTNSVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTLSSSVT
VPSSTWPSQSVTCNVAHPASSTAVDKKIAPA
//
>1mfdL [b.1.1 - b.1.1] IGG1-LAMBDA SE155-4 FAB (LIGHT CHAIN)
QAVVTQESALTTSPGETVTLTCRSSTGTVTSGNHANWVQEKPDHLFTGLIGDTNNRAPGV
PARFSGSLIGDKAALTITGAQPEDEAIYFCALWCNNHWIFGGGTKLTVLGQPKSSPSVTL
FPPSSEELETNKATLVCTITDFYPGVVTVDWKVDGTPVTQGMETTQPSKQSNNKYMASSY
LTLTARAWERHSSYSCQVTHEGHTVEKSLSRA
//
>1mfdH [b.1.1 - b.1.1] IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN)
EVQVQQSGTVLARPGASVKMSCKASGYTFTNYWMHWIKQRPGQGLEWIGAIYPGNSATFY
NHKFRAKTKLTAVTSTITAYMELSSLTNEDSAVYYCTRGGHGYYGDYWGQGASLTVSSAK
TTPPSVYPLAPGMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTLSSSVT
VPSSTWPSETVTCNVAHPASSTKVDKKIVPR
//
>1mg2_2K (C) [b.6.1] AMICYANIN
DKATIPSESPFAAAEVADGAIVVDIAKMKYETPELHVKVGDTVTWINREAMPHNVHFVAG
VLGEAALKGPMMKKEQAYSLTFTEAGTYDYHCTPHPFMRGKVVVE
//
>1mg2_2J (B) [g.21.1] METHYLAMINE DEHYDROGENASE, LIGHT CHAIN
TDPRAKWVPQDNDIQACDYWRHCSIDGNICDCSGGSLTNCPPGTKLATASxVASCYNPTD
GQSYLIAYRDCCGYNVSGRCPCLNTEGELPVYRPEFANDIIWCFGAEDDAMTYHCTISPI
VGKAS
//
>1mg2_2M (A) [b.69.2] METHYLAMINE DEHYDROGENASE, HEAVY CHAIN
EAETQAQETQGQAAARAAAADLAAGQDDEPRILEAPAPDARRVYVNDPAHAAAVTQQFVI
DGEAGRVIGMIDGGFLPNPVVADDGSFIAHASTVFSRIARGERTDYVEVFDPVTLLPTAD
IELPDAPRFLVGTYPWMTSLTPDGKTLLFYQFSPAPAVGVVDLEGKAFKRMLDVPDCYHI
FPTAPDTFFMHCRDGSLAKVAFGTEGTPEITHTEVFHPEDEFLINHPAYSQKAGRLVWPT
YTGKIHQIDLSSGDAKFLPAVEALTEAERADGWRPGGWQQVAYHRALDRIYLLVDQRDEW
RHKTASRFVVVLDAKTGERLAKFEMGHEIDSINVSQDEKPLLYALSTGDKTLYIHDAESG
EELRSVNQLGHGPQVITTADMG
//
>1mg3_1A [b.69.2] METHYLAMINE DEHYDROGENASE, HEAVY CHAIN
EAETQAQETQGQAAARAAAADLAAGQDDEPRILEAPAPDARRVYVNDPAHAAAVTQQFVI
DGEAGRVIGMIDGGFLPNPVVADDGSFIAHASTVFSRIARGERTDYVEVFDPVTLLPTAD
IELPDAPRFLVGTYPWMTSLTPDGKTLLFYQFSPAPAVGVVDLEGKAFKRMLDVPDCYHI
FPTAPDTFFMHCRDGSLAKVAFGTEGTPEITHTEVFHPEDEFLINHPAYSQKAGRLVWPT
YTGKIHQIDLSSGDAKFLPAVEALTEAERADGWRPGGWQQVAYHRALDRIYLLVDQRDEW
RHKTASRFVVVLDAKTGERLAKFEMGHEIDSINVSQDEKPLLYALSTGDKTLYIHDAESG
EELRSVNQLGHGPQVITTADMG
//
>1mg3_1C [b.6.1] AMICYANIN
DKATIPSESPFAAAEVADGAIVVDIAKMKYETPELHVKVGDTVTWINREAMPHNVHFVAG
VLGEAALKGPMMKKEQAYSLTFTEAGTYDYHCTPHPFMRGKVVVE
//
>1mg3_1D [a.3.1] CYTOCHROME C-L
APQFFNIIDGSPLNFDDAMEEGRDTEAVKHFLETGENVYNEDPEILPEAEELYAGMCSGC
HGHYAEGKIGPGLNDAYWTYPGNETDVGLFSTLYGGATGQMGPMWGSLTLDEMLRTMAWV
RHLYTGDPKDASWLTDEQKAGFTPFQP
//
>1mg3_2K (C) [b.6.1] AMICYANIN
DKATIPSESPFAAAEVADGAIVVDIAKMKYETPELHVKVGDTVTWINREAMPHNVHFVAG
VLGEAALKGPMMKKEQAYSLTFTEAGTYDYHCTPHPFMRGKVVVE
//
>1mg3_2I (A) [b.69.2] METHYLAMINE DEHYDROGENASE, HEAVY CHAIN
EAETQAQETQGQAAARAAAADLAAGQDDEPRILEAPAPDARRVYVNDPAHAAAVTQQFVI
DGEAGRVIGMIDGGFLPNPVVADDGSFIAHASTVFSRIARGERTDYVEVFDPVTLLPTAD
IELPDAPRFLVGTYPWMTSLTPDGKTLLFYQFSPAPAVGVVDLEGKAFKRMLDVPDCYHI
FPTAPDTFFMHCRDGSLAKVAFGTEGTPEITHTEVFHPEDEFLINHPAYSQKAGRLVWPT
YTGKIHQIDLSSGDAKFLPAVEALTEAERADGWRPGGWQQVAYHRALDRIYLLVDQRDEW
RHKTASRFVVVLDAKTGERLAKFEMGHEIDSINVSQDEKPLLYALSTGDKTLYIHDAESG
EELRSVNQLGHGPQVITTADMG
//
>1mh5_1A [b.1.1 - b.1.1] IMMUNOGLOBULIN MS6-164
DIVMTQAAPSVSVTPGESVSISCRSSKSLLHSNGNTYLYWFLQRPGQSPQLLIYRMSNLA
SGVPDRFSGSGSGTAFTLRISRVEAEDVGVYYCLQHLEYPFTFGAGTKLELKRADAAPTV
SIFPPASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLTLTKR
HNSYTCEATSPIVKSFN
//
>1mh5_1B [b.1.1 - b.1.1] IMMUNOGLOBULIN MS6-164
VQLQQPGAELVKPGASVKLSCKASGYTFTSNWINWVKQRPGQGLEWIGNIYPDSYRTNYN
EKFKRKATLTVDTSSSTAYMQLSSLTSDDSAVYYCVRKHYSYDGVVYWGQGTLVTVSAAK
TTAPSVYPLAPVVTLGCLVKGYFPEPVTLTWVHTFPAVLQSDLYTLSSSVTV
//
>1mh5_2L [b.1.1 - b.1.1] IMMUNOGLOBULIN MS6-164
DIVMTQAAPSVSVTPGESVSISCRSSKSLLHSNGNTYLYWFLQRPGQSPQLLIYRMSNLA
SGVPDRFSGSGSGTAFTLRISRVEAEDVGVYYCLQHLEYPFTFGAGTKLELKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATSPIVKSFNRN
//
>1mh5_2H [b.1.1 - b.1.1] IMMUNOGLOBULIN MS6-164
VQLQQPGAELVKPGASVKLSCKASGYTFTSNWINWVKQRPGQGLEWIGNIYPDSYRTNYN
EKFKRKATLTVDTSSSTAYMQLSSLTSDDSAVYYCVRKHYSYDGVVYWGQGTLVTVSAAK
TTAPSVYPLAPSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDLYTLSSSVT
VITCNVAHPA
//
>1mhc_1A [d.19.1 - b.1.1] MHC CLASS I ANTIGEN H2-M3
GSHSLRYFHTAVSRPGRGEPQYISVGYVDDVQFQRCDSIEEIPRMEPRAPWMEKERPEYW
KELKLKVKNIAQSARANLRTLLRYYNQSEGGSHILQWMVSCEVGPDMRLLGAHYQAAYDG
SDYITLNEDLSSWTAVDMVSQITKSRLESAGTAEYFRAYVEGECLELLHRFLRNGKEILQ
RADPPKAHVAHHPRPKGDVTLRCWALGFYPADITLTWQKDEEDLTQDMELVETRPSGDGT
FQKWAAVVVPSGEEQRYTCYVHHEGLTEPLALKWRS
//
>1mhc_1B [b.1.1] MHC CLASS I ANTIGEN H2-M3
IQKTPQIQVYSRHPPENGKPNILNCYVTQFHPPHIEIQMLKNGKKIPKVEMSDMSFSKDW
SFYILAHTEFTPTETDTYACRVKHDSMAEPKTVYWDRDM
//
>1mhmB [d.156.1] S-ADENOSYLMETHIONINE DECARBOXYLASE
FEKRLEISFVEPGLFGKGLRSLSKAQLDEILGPAECTIVDNLSNDYVDSYVLSE
//
>1mhmA [d.156.1] S-ADENOSYLMETHIONINE DECARBOXYLASE
SLFVYSYKIIIKTCGTTKLLLAIPPILRLAETLSLKVQDVRYTRGSRHFSEEVAVLDGYF
GKLAAGSKAVIMGSPDKTQKWHVYSASAGSVQSNDPVYTLEMCMTGLDREKASVFYKTEE
SSAAHMTVRSGIRKILPKSEICDFEFEPCGYSMNSIEGAAVSTIHITPEDGFTYASFESV
GYNPKTMELGPLVERVLACFEPAEFSVALHADVATKLLERICSVDVKGYSLAEWSPEEFG
EGGSIVYQKFTRT
//
>1mhpA [c.62.1] INTEGRIN ALPHA 1, (RESIDUES 169-360)
TQLDIVIVLDGSNSIYPWESVIAFLNDLLKRMDIGPKQTQVGIVQYGENVTHEFNLNKYS
STEEVLVAANKIVQRGGRQTMTALGIDTARKEAFTEARGARRGVKKVMVIVTDGESHDNY
RLKQVIQDCEDENIQRFSIAILGTEKFVEEIKSIASEPTEKHFFNVSDELALVTIVKALG
ERIF
//
>1mhpH [b.1.1 - b.1.1] FAB FRAGMENT, HEAVY CHAIN
EVQLVESGGGLVQPGGSLRLSCAASGFTFSRYTMSWVRQAPGKGLEWVATISGGGHTYYL
DSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCTRGFGDGGYFDVWGQGTLVTVSSAS
TKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGL
YSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK
//
>1mhpL [b.1.1 - b.1.1] FAB FRAGMENT, LIGHT CHAIN
IQLTQSPSSLSASVGDRVTITCSASSSVNHMFWYQQKPGKAPKPWIYLTSNLASGVPSRF
SGSGSGTDYTLTISSLQPEDFATYYCQQWSGNPWTFGQGTKVEIKRTVAAPSVFIFPPSD
EQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLS
KADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
//
>1mhpB [c.62.1] INTEGRIN ALPHA 1, (RESIDUES 169-360)
TQLDIVIVLDGSNSIYPWESVIAFLNDLLKRMDIGPKQTQVGIVQYGENVTHEFNLNKYS
STEEVLVAANKIVQRGGRQTMTALGIDTARKEAFTEARGARRGVKKVMVIVTDGESHDNY
RLKQVIQDCEDENIQRFSIAILGHYNRGNLSTEKFVEEIKSIASEPTEKHFFNVSDELAL
VTIVKALGERIF
//
>1mhpY [b.1.1] FAB FRAGMENT, LIGHT CHAIN
IQLTQSPSSLSASVGDRVTITCSASSSVNHMFWYQQKPGKAPKPWIYLTSNLASGVPSRF
SGSGSGTDYTLTISSLQPEDFATYYCQQWSGNPWTFGQGTKVEIK
//
>1mhpX [b.1.1] FAB FRAGMENT, HEAVY CHAIN
EVQLVESGGGLVQPGGSLRLSCAASGFTFSRYTMSWVRQAPGKGLEWVATISGGGHTYYL
DSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCTRGFGDGGYFDVWGQGTLVTVSS
//
>1mhw_2B (A) [d.3.1] CATHEPSIN L
APRSVDWREKGYVTPVKNQGQCGSxWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQ
GNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEK
ALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFES
//
>1mhw_2D (C) [d.3.1] CATHEPSIN L
NKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV
//
>1mhyA (B) [a.25.1] METHANE MONOOXYGENASE HYDROXYLASE
KRGLTDPERAAIIAAAVPDHALDTQRKYHYFIQPRWKPLSEYEQLSCYAQPNPDWIAGGL
DWGDWTQKFHGGRPSWGNESTELRTTDWYRHRDPARRWHHPYVKDKSEEARYTQRFLAAY
SSEGSIRTIDPYWRDEILNKYFGALLYSEYGLFNAHSSVGRDCLSDTIRQTAVFAALDKV
DNAQMIQMERLFIAKLVPGFDASTDVPKKIWTTDPIYSGARATVQEIWQGVQDWNEILWA
GHAVYDATFGQFARREFFQRLATVYGDTLTPFFTAQSQTYFQTTRGAIDDLFVYCLANDS
EFGAHNRTFLNAWTEHYLASSVAALKDFVGLYAKVEKVAGATDSAGVSEALQRVFGDWKI
DYADKIGFRVDVDQKVDAVLAGY
//
>1mhyC (D) [a.25.1] METHANE MONOOXYGENASE HYDROXYLASE
NRAPVGVEPQEVHKWLQSFNWDFKENRTKYPTKYHMANETKEQFKVIAKEYARMEAAKDE
RQFGTLLDGLTRLGAGNKVHPRWGETMKVISNFLEVGEYNAIAASAMLWDSATAAEQKNG
YLAQVLDEIRHTHQCAFINHYYSKHYHDPAGHNDARRTRAIGPLWKGMKRVFADGFISGD
AVECSVNLQLVGEACFTNPLIVAVTEWASANGDEITPTVFLSVETDELRHMANGYQTVVS
IANDPASAKFLNTDLNNAFWTQQKYFTPVLGYLFEYGSKFKVEPWVKTWNRWVSEDWGGI
WIGRLGKYGVESPRSLRDAKRDAYWAHHDLALAAYAMWPLGFARLALPDEEDQAWFEANY
PGWADHYGKIFNEWKKLGYEDPKSGFIPYQWLLANGHDVYIDRVSQVPFIPSLAKGTGSL
RVHEFNGKKHSLTDDWGERQWLIEPERYECHNVFEQYEGRELSEVIAEGHGVRSDGKTLI
AQPHTRGDNLWTLEDIKRAGCVFPDPLAKF
//
>1mhyE (G) [a.23.3] METHANE MONOOXYGENASE HYDROXYLASE
AKREPIHDNSIRTEWEAKIAKLTSVDQATKFIQDFRLAYTSPFRKSYDIDVDYQYIERKI
EEKLSVLKTEKLPVADLITKATTGEDAAAVEATWIAKIKAAKSKYEAEAIHIEFRQLYKP
PVLPVNVFLRTDAALGTVLMEIRNTDYYGTPLEGLRKERGVKVLHLQ
//
>1mhzA (B) [a.25.1] METHANE MONOOXYGENASE HYDROXYLASE
KRGLTDPERAAIIAAAVPDHALDTQRKYHYFIQPRWKPLSEYEQLSCYAQPNPDWIAGGL
DWGDWTQKFHGGRPSWGNESTELRTTDWYRHRDPARRWHHPYVKDKSEEARYTQRFLAAY
SSEGSIRTIDPYWRDEILNKYFGALLYSEYGLFNAHSSVGRDCLSDTIRQTAVFAALDKV
DNAQMIQMERLFIAKLVPGFDASTDVPKKIWTTDPIYSGARATVQEIWQGVQDWNEILWA
GHAVYDATFGQFARREFFQRLATVYGDTLTPFFTAQSQTYFQTTRGAIDDLFVYCLANDS
EFGAHNRTFLNAWTEHYLASSVAALKDFVGLYAKVEKVAGATDSAGVSEALQRVFGDWKI
DYADKIGFRVDVDQKVDAVLAGY
//
>1mhzC (D) [a.25.1] METHANE MONOOXYGENASE HYDROXYLASE
NRAPVGVEPQEVHKWLQSFNWDFKENRTKYPTKYHMANETKEQFKVIAKEYARMEAAKDE
RQFGTLLDGLTRLGAGNKVHPRWGETMKVISNFLEVGEYNAIAASAMLWDSATAAEQKNG
YLAQVLDEIRHTHQCAFINHYYSKHYHDPAGHNDARRTRAIGPLWKGMKRVFADGFISGD
AVECSVNLQLVGEACFTNPLIVAVTEWASANGDEITPTVFLSVETDELRHMANGYQTVVS
IANDPASAKFLNTDLNNAFWTQQKYFTPVLGYLFEYGSKFKVEPWVKTWNRWVSEDWGGI
WIGRLGKYGVESPRSLRDAKRDAYWAHHDLALAAYAMWPLGFARLALPDEEDQAWFEANY
PGWADHYGKIFNEWKKLGYEDPKSGFIPYQWLLANGHDVYIDRVSQVPFIPSLAKGTGSL
RVHEFNGKKHSLTDDWGERQWLIEPERYECHNVFEQYEGRELSEVIAEGHGVRSDGKTLI
AQPHTRGDNLWTLEDIKRAGCVFPDPLAKF
//
>1mi5A [d.19.1 - b.1.1] MHC HEAVY CHAIN
GSHSMRYFDTAMSRPGRGEPRFISVGYVDDTQFVRFDSDAASPREEPRAPWIEQEGPEYW
DRNTQIFKTNTQTDRESLRNLRGYYNQSEAGSHTLQSMYGCDVGPDGRLLRGHNQYAYDG
KDYIALNEDLRSWTAADTAAQITQRKWEAARVAEQDRAYLEGTCVEWLRRYLENGKDTLE
RADPPKTHVTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDRT
FQKWAAVVVPSGEEQRYTCHVQHEGLPKPLTLRWEPS
//
>1mi5D [b.1.1 - b.1.1] TCR ALPHA CHAIN
KTTQPNSMESNEEEPVHLPCNHSTISGTDYIHWYRQLPSQGPEYVIHGLTSNVNNRMASL
AIAEDRKSSTLILHRATLRDAAVYYCILPLAGGTSYGKLTFGQGTILTVHPNIQNPDPAV
YQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKTVLDMRSMDFKSNSAVAWSNKS
DFACANAFNNSIIPEDTFFPS
//
>1mi5E [b.1.1 - b.1.1] TCR BETA CHAIN
GVSQSPRYKVAKRGQDVALRCDPISGHVSLFWYQQALGQGPEFLTYFQNEAQLDKSGLPS
DRFFAERPEGSVSTLKIQRTQQEDSAVYLCASSLGQAYEQYFGPGTRLTVTEDLKNVFPP
EVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVSTDPQPLKEQPAL
NDSRYALSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRA
D
//
>1mieL [b.1.1 - b.1.1] IMMUNOGLOBULIN MS5-393
EIVMTQAAPSVPVTPGESVSISCRSSKSLLHSNGNTYLNWFLQRPGQSPQLLIYRMSNLA
SGVPDRFSGSGSETAFTLRTSRVEAEDVGVYYCMQHLEYPFTFGSGTKLELKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNE
//
>1mieH [b.1.1 - b.1.1] IMMUNOGLOBULIN MS5-393
QQPGAELVKPGASVKLSCWINWVKQRPGQGLEWIGNVYPGSSSTNYNEKFKNKATLTVDT
SSSTAYMQLSSLTSDDSAFYYCVRPYWGQGTLVTVSAAKTTAPSVYPLAPVSSVTLGCLV
KGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDLYTLSSSVTVTSSTWPSQSITCNVAHPAS
STKVDKKIEPR
//
>1mimL [b.1.1 - b.1.1] CHIMERIC SDZ CHI621
QIVSTQSPAIMSASPGEKVTMTCSASSSRSYMQWYQQKPGTSPKRWIYDTSKLASGVPAR
FSGSGSGTSYSLTISSMEAEDAATYYCHQRSSYTFGGGTKLEIKRTVAAPSVFIFPPSDE
QLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSK
ADYEKHKVYACEVTHQGLSSPVTKSFNRGE
//
>1mimH [b.1.1 - b.1.1] CHIMERIC SDZ CHI621
QLQQSGTVLARPGASVKMSCKASGYSFTRYWMHWIKQRPGQGLEWIGAIYPGNSDTSYNQ
KFEGKAKLTAVTSASTAYMELSSLTHEDSAVYYCSRDYGYYFDFWGQGTTLTVSSASTKG
PSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSL
SSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEP
//
>1mioD (B) [c.92.2] NITROGENASE MOLYBDENUM IRON PROTEIN (BETA CHAIN)
LDATPKEIVERKALRINPAKTCQPVGAMYAALGIHNCLPHSHGSQGCCSYHRTVLSRHFK
EPAMASTSSFTEGASVFGGGSNIKTAVKNIFSLYNPDIIAVHTTCLSETLGDDLPTYISQ
MEDAGSIPEGKLVIHTNTPSYVGSHVTGFANMVQGIVNYLSENTGAKNGKINVIPGFVGP
ADMREIKRLFEAMDIPYIMFPDTSGVLDGPTTGEYKMYPEGGTKIEDLKDTGNSDLTLSL
GSYASDLGAKTLEKKCKVPFKTLRTPIGVSATDEFIMALSEATGKEVPASIEEERGQLID
LMIDAQQYLQGKKVALLGDPDEIIALSKFIIELGAIPKYVVTGTPGMKFQKEIDAMLAEA
GIEGSKVKVEGDFFDVHQWIKNEGVDLLISNTYGKFIAREENIPFVRFGFPIMDRYGHYY
NPKVGYKGAIRLVEEITNVILDKIERECTEEDFEVVR
//
>1mioC (A) [c.92.2] NITROGENASE MOLYBDENUM IRON PROTEIN (ALPHA
SENLKDEILEKYIPKTKKTRSGHIVIKTEETPNPEIVANTRTVPGIITARGCAYAGCKGV
VMGPIKDMVHITHGPIGCSFYTWGGRRFKSKPENGTGLNFNEYVFSTDMQESDIVFGGVN
KLKDAIHEAYEMFHPAAIGVYATCPVGLIGDDILAVAATASKEIGIPVHAFSCEGYKGVS
QSAGHHIANNTVMTDIIGKGNKEQKKYSINVLGEYNIGGDAWEMDRVLEKIGYHVNATLT
GDATYEKVQNADKADLNLVQCHRSINYIAEMMETKYGIPWIKCNFIGVDGIVETLRDMAK
CFDDPELTKRTEEVIAEEIAAIQDDLDYFKEKLQGKTACLYVGGSRSHTYMNMLKSFGVD
SLVAGFEFAHRDDYEGREVIPTIKIDADSKNIPEITVTPDEQKYRVVIPEDKVEELKKAG
VPLSSYGGMMKEMHDGTILIDDMNHHDMEVVLEKLKPDMFFAGIKEKFVIQKGGVLSKQL
HSYDYNGPYAGFRGVVNFGHELVNGIYTPAWKMITPPWKKASSES
//
>1miuB [x.x.x] DELETED IN SPLIT HAND/SPLIT FOOT PROTEIN 1
PVDLGLLEEDDEFEEFPAEHVWEDNWDDDDFSNQLRAELEKH
//
>1miuA [a.170.1 - b.40.4 - b.40.4 - a.171.1 - b.40.4] BREAST CANCER TYPE 2 SUSCEPTIBILITY PROTEIN
KDLMSSLQSARDLQDMRIKNKERRHLRLQPGSLYLTKSSTLPRISLQAAVGDRAPSACSP
KQLYIYGVSKECINVNSKNAEYFQFDIQDHFGKEDLCAGKGFQLADGGWLIPSNDGKAGK
EEFYRALCDTPGVDPKLISSIWVANHYRWIVWKLAAMEFAFPKEFANRCLNPERVLLQLK
YRYDVEIDNSRRSALKKILERDDTAAKTLVLCISDIVDTIELTDGWYAVRAQLDPPLMAL
VKSGKLTVGQKIITQGAELVGSPDACAPLEAPDSLRLKISANSTRPARWHSRLGFFRDPR
PFPLPLSSLFSDGGNVGCVDIIVQRVYPLQWVEKTVSGLYIFRSEREEEKEALRFAEAQQ
KKLEALFTKVHTEFKSRTLTRQQVHALQDGAELYAAVQYASDPDHLEACFSEEQLRALNN
YRQMLNDKKQARIQSEFRKALESAEKEEGLSRDVTTVWKLRVTSYKKKEKSALLSIWRPS
SDLSSLLTEGKRYRIYHLAVSKSKSKFERPSIQLTATKRTQYQQLPVSSETLLQVYQPRE
SLHFSRLSDPAFQPPCSEVDVVGVVVSVVKPIGLAPLVYLSDECLNLLVVKFGIDLNEDI
KPRVLIAASNLQCQPESTSGVPTLFAGHFSIFSASPKEAYFQEKVNNLKHAIENIDTFYK
EAEKKLIHVLE
//
>1mj8L [b.1.1 - b.1.1] IMMUNOGLOBULIN MS6-126
EIVMTQAAPSVPVTPGESVSISCRSSKSLLHSNGNTYLYWFLQRPGQSPQLLIYRMSNLA
SGVPDRFSGSGSGTAFTLRISRVEAEDVGVYYCLQHLEYPFTFGAGTKLELKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHPIVKSFNRNEC
//
>1mj8H [b.1.1 - b.1.1] IMMUNOGLOBULIN MS6-126
VQLQQPGAELVKPGASVKLSCKASGYTFTSNWINWVKQRPGQGLEWIGNIYPGSGYTNYN
ERFKSKATLTVDTSSSTAYMQLSSLTSDDSAVYYCARKHYFYDGVVYWGQGTLVTVSAAK
TTAPSVYPLAPVCSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDLYTLSSS
VTVTSSTWPSQSITCNVAHPASSTKVDKKIEPRGPT
//
>1mjeB [x.x.x] DELETED IN SPLIT HAND/SPLIT FOOT PROTEIN 1
PVDLGLLEEDDEFEEFPAEHVWEDNWDDDDFSNQLRAELEKH
//
>1mjeA [a.170.1 - b.40.4 - b.40.4 - a.171.1 - b.40.4] BREAST CANCER 2
KDLMSSLQSARDLQDMRIKNKERRHLRLQPGSLYLTKSSTLPRISLQAAVGDRAPSACSP
KQLYIYGVSKECINVNSKNAEYFQFDIQDHFGKEDLCAGKGFQLADGGWLIPSNDGKAGK
EEFYRALCDTPGVDPKLISSIWVANHYRWIVWKLAAMEFAFPKEFANRCLNPERVLLQLK
YRYDVEIDNSRRSALKKILERDDTAAKTLVLCISDIVDTIELTDGWYAVRAQLDPPLMAL
VKSGKLTVGQKIITQGAELVGSPDACAPLEAPDSLRLKISANSTRPARWHSRLGFFRDPR
PFPLPLSSLFSDGGNVGCVDIIVQRVYPLQWVEKTVSGLYIFRSEREEEKEALRFAEAQQ
KKLEALFTKVHTLSRDVTTVWKLRVTSYKKKEKSALLSIWRPSSDLSSLLTEGKRYRIYH
LAVSKSKSKFERPSIQLTATKRTQYQQLPVSSETLLQVYQPRESLHFSRLSDPAFQPPCS
EVDVVGVVVSVVKPIGLAPLVYLSDECLNLLVVKFGIDLNEDIKPRVLIAASNLQCQPES
TSGVPTLFACHFSIFSASPKEAYFQEKVNNLKHAIENIDTFYKEAEKKLIHVLEGDSPKW
//
>1mjj_1A [b.1.1 - b.1.1] IMMUNOGLOBULIN MS6-12
DIVMTQAAPSVPVTPGESVSISCRSSKSLLHSNGNTYLYWFLQRPGQSPQLLIYRMSNLA
SGVPDRFSGSGSGTAFTLRISRVEAEDVGVYYCLQHLEYPFTFGAGTKLELKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNE
//
>1mjj_1B [b.1.1 - b.1.1] IMMUNOGLOBULIN MS6-12
xVQLQQPGAELVKPGASVKLSCKASGYTFTNYWINWVKQRPGQGLEWIGNIYPGSSYTHY
NEKFKNKATLTVDTSSSTAYMQLSSLTSDDSAVYYCANKLGWFPYWGQGTLVTVSAAKTT
APSVYPLAPVCSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDLYTLSSSVT
VTSSTWPSQSITCNVAHPASSTKVDKKIEPR
//
>1mkx_1L [b.47.1] ALPHA-THROMBIN
EADCGLRPLFEKKQVQDQTEKELFESYIE
//
>1mkx_1H [b.47.1] ALPHA-THROMBIN
IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLL
VRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCL
PDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKASTRIR
ITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFY
THVFRLKKWIQKVID
//
>1mlbA [b.1.1 - b.1.1] IGG1-KAPPA D44.1 FAB (LIGHT CHAIN)
DIELTQSPATLSVTPGDSVSLSCRASQSISNNLHWYQQKSHESPRLLIKYVSQSSSGIPS
RFSGSGSGTDFTLSINSVETEDFGMYFCQQSNSWPRTFGGGTKLEIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1mlbB [b.1.1 - b.1.1] IGG1-KAPPA D44.1 FAB (HEAVY CHAIN)
QVQLQESGAEVMKPGASVKISCKATGYTFSTYWIEWVKQRPGHGLEWIGEILPGSGSTYY
NEKFKGKATFTADTSSNTAYMQLSSLTSEDSAVYYCARGDGNYGYWGQGTTLTVSSASTT
PPSVFPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTL
SSSVTVPSSPRPSETVTCNVAHPASSTKVDKKIVPRDC
//
>1mlc_1A [b.1.1 - b.1.1] IGG1-KAPPA D44.1 FAB (LIGHT CHAIN)
DIELTQSPATLSVTPGDSVSLSCRASQSISNNLHWYQQKSHESPRLLIKYVSQSSSGIPS
RFSGSGSGTDFTLSINSVETEDFGMYFCQQSNSWPRTFGGGTKLEIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1mlc_1B [b.1.1 - b.1.1] IGG1-KAPPA D44.1 FAB (HEAVY CHAIN)
QVQLQESGAEVMKPGASVKISCKATGYTFSTYWIEWVKQRPGHGLEWIGEILPGSGSTYY
NEKFKGKATFTADTSSNTAYMQLSSLTSEDSAVYYCARGDGNYGYWGQGTTLTVSSASTT
PPSVFPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTL
SSSVTVPSSPRPSETVTCNVAHPASSTKVDKKIVPRDC
//
>1mlc_1E [d.2.1] HEN EGG WHITE LYSOZYME
KVFGRCELAAAMKRHGLDNYRGYSLGNWVCAAKFESNFNTQATNRNTDGSTDYGILQINS
RWWCNDGRTPGSRNLCNIPCSALLSSDITASVNCAKKIVSDGNGMNAWVAWRNRCKGTDV
QAWIRGCRL
//
>1mlc_2C (A) [b.1.1 - b.1.1] IGG1-KAPPA D44.1 FAB (LIGHT CHAIN)
DIELTQSPATLSVTPGDSVSLSCRASQSISNNLHWYQQKSHESPRLLIKYVSQSSSGIPS
RFSGSGSGTDFTLSINSVETEDFGMYFCQQSNSWPRTFGGGTKLEIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1mlc_2D (B) [b.1.1 - b.1.1] IGG1-KAPPA D44.1 FAB (HEAVY CHAIN)
QVQLQESGAEVMKPGASVKISCKATGYTFSTYWIEWVKQRPGHGLEWIGEILPGSGSTYY
NEKFKGKATFTADTSSNTAYMQLSSLTSEDSAVYYCARGDGNYGYWGQGTTLTVSSASTT
PPSVFPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTL
SSSVTVPSSPRPSETVTCNVAHPASSTKVDKKIVPRDC
//
>1mlc_2F (E) [d.2.1] HEN EGG WHITE LYSOZYME
KVFGRCELAAAMKRHGLDNYRGYSLGNWVCAAKFESNFNTQATNRNTDGSTDYGILQINS
RWWCNDGRTPGSRNLCNIPCSALLSSDITASVNCAKKIVSDGNGMNAWVAWRNRCKGTDV
QAWIRGCRL
//
>1mnmB [d.88.1] PROTEIN (MCM1 TRANSCRIPTIONAL REGULATOR)
RRKIEIKFIENKTRRHVTFSKRKHGIMKKAFELSVLTGTQVLLLVVSETGLVYTFSTPKF
EPIVTQQEGRNLIQACLNAPD
//
>1mnmC [a.4.1] PROTEIN (MAT ALPHA-2 TRANSCRIPTIONAL REPRESSOR)
GLVFNVVTQDMINKSTKPYRGHRFTKENVRILESWFAKNIENPYLDTKGLENLMKNTSLS
RIQIKNWVSNRRRKEKT
//
>1mox_2B [c.10.2 - g.3.9 - c.10.2 - g.3.9] EPIDERMAL GROWTH FACTOR RECEPTOR
LEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQE
VAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEIL
HGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGE
ENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTC
PPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVR
KCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHT
PPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLN
ITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQ
VCHALCSPEGCWGPEPRDCVS
//
>1mox_2D [g.3.11] TRANSFORMING GROWTH FACTOR ALPHA
SHFNDCPDSHTQFCFHGTCRFLVQEDKPACVCHSGYVGARCEHADLLA
//
>1mpaL [b.1.1 - b.1.1] MN12H2 IGG2A-KAPPA
DIVMTQTPLSLPVSLGDKASISCRSSQALVHSNGNTYLHWYLQKPGQSPKLLIYKVSNRF
SGVPDRFSGSGSGTDFTLKISRVEAEDLGVFFCSQSTHVPRTFGGGTKLEIKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1mpaH [b.1.1 - b.1.1] MN12H2 IGG2A-KAPPA
EVNLQQSGTVLARPGASVRMSCKASGYSFTSYWLHWIKQRPGQGLEWIGGIYPGNRDTRY
TQRFKDKAKLTAVTSANTAYMELSSLTNEDSAVYYCSIIYFDYADFIMDYWGQGTTVTVS
SAKTTAPSVYPLAPVCGDTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQS
DLYTLSSSVTVTSSTWPSQSITCNVAHPASSTKVDKKIEPRGPTI
//
>1mq8A [b.1.1 - b.1.1] INTERCELLULAR ADHESION MOLECULE-1
QTSVSPSKVILPRGGSVLVTCSTSCDQPKLLGIETPLPKKELLLPGNNRKVYELSNVQED
SQPMCYSNCPDGQSTAKTFLTVYWTPERVELAPLPSWQPVGKNLTLRCQVEGGAPRANLT
VVLLRGEKELKREPAVGEPAEVTTTVLVRRDHHGANFSCRTELDLRPQGLELFENTSAPY
QLQT
//
>1mq8B [c.62.1] INTEGRIN ALPHA-L
VDLVFLFDGSMSLQPDEFQKILDFMKDVMKKCSNTSYQFAAVQFSTSYKTEFDFSDYVKR
KDPDALLKHVKHMLLLTNTFGAINYVATEVFREELGARPDATKVLIIITDGEATDSGNID
AAKDIIRYIIGIGKHFQTKESQETLHKFASKPASEFVKILDTFEKLKDLCTELQKKI
//
>1mqsA [e.25.1] SLY1 PROTEIN
KDISLRDmQISAILKmLFLNKDLNNNDNITTITDDIFNQQEIIWKVLILDIKSTATISSV
LRVNDLLKAGITVHSLIKQDRSPLPDVPAIYFVSPTKENIDIIVNDLKSDKYSEFYINFT
SSLPRNLLEDLAQQVSITGKSDKIKQVYDQYLDFIVTEPELFSLEISNAYLTLNDPKTTE
EEITGLCANIADGLFNTVLTINSIPIIRAAKGGPAEIIAEKLGTKLRDFVINTNSERGVL
IILDRNIDFASmFSHSWIYQCmVFDIFKLSRNTVTIPLATKKYDIEPNDFFWmENSHLPF
PEAAENVEAALNTYKEEAAEITRKTEVVKKLPELTAKKNTIDTHmNIFAALLSQLESKSL
DTFFEVEQDPGSTKTRSRFLDILKDGKTNNLEDKLRSFIVLYLTSTTGLPKDFVQNVENY
FKENDYDINALKYVYKLREFmQLSNmSLQNKSLYGLTEGKLQGGVGSLISGIKKLLPEKK
TIPITNVVDAImDPLNSSQKNLETTDSYLYIDPKITRGSHTRKPKRQSYNKSLVFVVGGG
NYLEYQNLQEWAHSQLHNPKKVmYGSTAITTPAEFLNEISRLGASNSS
//
>1mqsB [x.x.x] INTEGRAL MEMBRANE PROTEIN SED5
GAMAGMNIKDRTSEFQQSVLSYKKRN
//
>1mqt_2A [b.121.4] POLYPROTEIN
RVADTVGSGPVNSESIPALTAAETGHTSQVVPSDTMQTRHVKNYHSRSESTVENFLCRSA
CVFYTTYKNHDSDGDNFAYWVINARQVAQLRRKLEMFTYARFDLELTFVITSTQEQSTTQ
GQDTPVLTHQIMYVPPGGPVPTKVNSYSWQTSTNPSVFWTEGNAPPRMSIPFIGIGNAYS
MFYDGWARFDKQGTYGISTLNSMGTLYMRHVNGGGPGPIVSTVRIYFKPKHVKTWVPRPP
RLCQYKKAGNVNFIPTSVTEGRTDITTMKTT
//
>1mqt_2B [b.121.4] POLYPROTEIN CAPSID PROTEIN
GYSDRVRSITLGNSTITTQECANVVVGYGVWPAYLKDEEATAEDQPTQPDVATCRFYTLE
SVMWQQGSPGWWWKFPDALSNMGLFGQNMQYHYLGRAGYTIHVQCNASKFHQGCLLVVCV
PEAEMGCATLANKPDPKSLSKGEIASTFESQNSTGETAVQANVINAGMGVGVGNLTIFPH
QWINLRTNNSATIVMPYINSVPMDNMFRHNNFTLMVIPFAPLSYSAGATTYVPITVTVAP
MCAEYNGLRLAGKQ
//
>1mqt_2C [b.121.4] POLYPROTEIN CAPSID PROTEIN
GLPTLATPGSNQFLTSDDFQSPSAMPQFDVTPEMDIPGQVNNLMEIAEVDSVVPVNNTEG
KEMSIEAYQIPVQSNPTNGSQVFGFPLTPGASSVLNRTLLGEILNYYAHWSGSIKLTFMF
CGSAMATGKFLLAYSPPGAGAPTTRKEAMLGTHVIWDVGLQSSCVLCIPWISQTHYRYVV
MDEYTAGGYITCWYQTNIVVPADAQSDCKILCFVSACNDFSVRMLKDTPFIKQDNFFQ
//
>1mqt_2D [b.121.4] POLYPROTEIN CAPSID PROTEIN
GAQVSTQKTGIHYTNINYYKDAASNSANRQDFTQDPGKFTEPVKDIMVKSMPALN
//
>1mr1_2B [b.26.1] MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 4
APEYWCSIAYFEMDVQVGETFKVPSSCPIVTVDGYVDPSGGDRFCLGQLSNVHRTEAIER
ARLHIGKGVQLECKGEGDVWVRCLSDHAVFVQSYYLDREAGRAPGDAVHKIYPSAYIKVF
DLRQCHRQMQQQAAVDDLRRLCILRMSFVKGWGPDYPRQSIKETPCWIEIHLHRALQLLD
EVLHTMPIADPQP
//
>1mr1_2C [d.217.1] SKI ONCOGENE
SHMRVYHECFGKCKGLLVPELYSSPSAACIQCLDCRLMYPPHKFVVHSHKALENRTCHWG
FDSANWRAYILLSQDYTGKEEQARLGRCLDDVKEKFD
//
>1mrdL [b.1.1 - b.1.1] IGG2B-KAPPA JEL103 FAB (LIGHT CHAIN)
DVVMTQTPLSLPVSLGDQASISCRSSQSLVHSNGNTYLHWYLQKPGQSPKLLIYKVSNRF
SGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQSTHVPRTFGGGTKLEIKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGKERQNGVLNSWTDQNSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNR
//
>1mrdH [b.1.1 - b.1.1] IGG2B-KAPPA JEL103 FAB (HEAVY CHAIN)
VQLQQSGAELVKPGASVKLSCKASGYTFTSYWMQWVKQRPGQGLEWIGEIDPSDSYTNYN
QKFKGKATLTVDSTAYMQLSSLTSEDSAVYYCANLRGYFDYWGQGTTLTVSSAKTTPPSV
YPLAPGTTGSSVTLGCLVKGYFPESVTVTWNSGSLSSSVHTFPALLQSGLYTMSSSVTVP
SSTWPSQTVTCSVAHPASSTTVDKKLEP
//
>1mtn_1B [b.47.1] ALPHA-CHYMOTRYPSIN
IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGS
SSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTT
CVTTGWGLTRY
//
>1mtn_1C [b.47.1] ALPHA-CHYMOTRYPSIN
ANTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVSSCMGDSGGPLVCKKNGAWT
LVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN
//
>1mtn_1D [g.8.1] BASIC PANCREATIC TRYPSIN INHIBITOR
RPDFCLEPPYTGPCKARIIRYFYNAKAGLCQTFVYGGCRAKRNNFKSAEDCMRTCGGA
//
>1mtn_2F (B) [b.47.1] ALPHA-CHYMOTRYPSIN
IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGS
SSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTT
CVTTGWGLTRY
//
>1mtn_2G (C) [b.47.1] ALPHA-CHYMOTRYPSIN
ANTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVSSCMGDSGGPLVCKKNGAWT
LVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN
//
>1mtn_2H (D) [g.8.1] BASIC PANCREATIC TRYPSIN INHIBITOR
RPDFCLEPPYTGPCKARIIRYFYNAKAGLCQTFVYGGCRAKRNNFKSAEDCMRTCGGA
//
>1mtpA [e.1.1] SERINE PROTEINASE INHIBITOR (SERPIN), CHAIN A
GGFLRDDHLEFALHLHRRLAEAVPDGEVIWSPYSVACALGVLAAGARATTRTELTTLLGT
DPAPLLAALDRAVTDSPDLASRTVLWVSADVPVRSSFRATMHDRPDSDVRTADFRTNPEG
VRATVNADIADATRGMIRELLPQGAVTPDLRAILTNALWAKARWTTPFEAHLTREGTFRT
PRGPKRVPFMHRTKTMPYATARGWRMVTLHAHDELAVDVLLPPGTNAAAVPTAPLLTALH
RRSASTSVELALPRFELTQPHQLVEVLAEAGVRTLFTASADLSGISTVPLYVDTVIHQAR
LRVDERGAEGAAATAAMMLL
//
>1mtpB [e.1.1] SERINE PROTEINASE INHIBITOR (SERPIN), CHAIN B
TIRFSVDRPFHIVVRRRGAILFLGSIADPHDPGPA
//
>1mtyE (D) [a.25.1] METHANE MONOOXYGENASE HYDROXYLASE
AANRAPTSVNAQEVHRWLQSFNWDFKNNRTKYATKYKMANETKEQFKLIAKEYARMEAVK
DERQFGSLQVALTRLNAGVRVHPKWNETMKVVSNFLEVGEYNAIAATGMLWDSAQAAEQK
NGYLAQVLDEIRHTHQCAYVNYYFAKNGQDPAGHNDARRTRTIGPLWKGMKRVFSDGFIS
GDAVECSLNLQLVGEACFTNPLIVAVTEWAAANGDEITPTVFLSIETDELRHMANGYQTV
VSIANDPASAKYLNTDLNNAFWTQQKYFTPVLGMLFEYGSKFKVEPWVKTWDRWVYEDWG
GIWIGRLGKYGVESPRSLKDAKQDAYWAHHDLYLLAYALWPTGFFRLALPDQEEMEWFEA
NYPGWYDHYGKIYEEWRARGCEDPSSGFIPLMWFIENNHPIYIDRVSQVPFCPSLAKGAS
TLRVHEYNGEMHTFSDQWGERMWLAEPERYECQNIFEQYEGRELSEVIAELHGLRSDGKT
LIAQPHVRGDKLWTLDDIKRLNCVFKNPVKAF
//
>1mtyC (B) [a.25.1] METHANE MONOOXYGENASE HYDROXYLASE
ERRRGLTDPEMAAVILKALPEAPLDGNNKMGYFVTPRWKRLTEYEALTVYAQPNADWIAG
GLDWGDWTQKFHGGRPSWGNETTELRTVDWFKHRDPLRRWHAPYVKDKAEEWRYTDRFLQ
GYSADGQIRAMNPTWRDEFINRYWGAFLFNEYGLFNAHSQGAREALSDVTRVSLAFWGFD
KIDIAQMIQLERGFLAKIVPGFDESTAVPKAEWTNGEVYKSARLAVEGLWQEVFDWNESA
FSVHAVYDALFGQFVRREFFQRLAPRFGDNLTPFFINQAQTYFQIAKQGVQDLYYNCLGD
DPEFSDYNRTVMRNWTGKWLEPTIAALRDFMGLFAKLPAGTTDKEEITASLYRVVDDWIE
DYASRIDFKADRDQIVKAVLAGLK
//
>1mtyH (G) [a.23.3] METHANE MONOOXYGENASE HYDROXYLASE
LGIHSNDTRDAWVNKIAHVNTLEKAAEMLKQFRMDHTTPFRNSYELDNDYLWIEAKLEEK
VAVLKARAFNEVDFRHKTAFGEDAKSVLDGTVAKMNAAKDKWEAEKIHIGFRQAYKPPIM
PVNYFLDGERQLGTRLMELRNLNYYDTPLEELRKQRGVRVVH
//
>1mvfA [b.1.1] IMMUNOGLOBULIN HEAVY CHAIN VARIABLE REGION
QVQLVESGGGSVQAGGSLRLSCAASGFTYSRKYMGWFRQAPGKEREGVAAIFIDNGNTIY
ADSVQGRFTISQDNAKNTVYLQMNSLKPEDTAMYYCAASSRWMDYSALTAKAYNSWGQGT
QVTVSS
//
>1mvfE (D) [b.129.1] PEMI-LIKE PROTEIN 1
SSVKRWGNSPAVRIPATLMQALNLNIDDEVKIDLVDGKLIIEPV
//
>1mvwG (A) [i.15.1] SKELETAL MUSCLE MYOSIN II
DAEMAAFGEAAPYLRxSEKERIEAQNxPFDAxSSVFVVHPKQSFVxGTIQSxEGGxVTVx
TEGGETLTVKEDQVFSMNPPxYDxIEDMAMMTHLHEPAVLYNLxERYAAWMIYTYSGLFC
VTVNPYxWLPVYNPxVVLAYRGKKRQEAPPHIFSISDNAYQFMLTDRENQSILITGESGA
GKTVNTxRVIQYFATIAASGEKKKEEQSGKMQGTLEDQIISANPLLEAFGNAxTVRNDNS
SRFGxFIRIHFGATGKLASADIETYLLExSRVTFQLPAERSYHIFYQIMSNxxPELIDML
LITTNPYDYHYVSEGEITVPSIDDQEELMATDSAIDILGFSADExTAIYxLTGAVMHYGN
LKFxQxQREEQAEPDGTEVADxAAYLMGLNSAELLKALCYPRVGVGNEAVTxGETVSEVH
NSVGALAxAVYExMFLWMVIRINQQLDTKQPRQYFIGVLDIAGFEIFDFNSFEQLCINFT
NExLQQFFNHHMFVLEQEEYxxEGIEWEFIDFGMDLAACIELIExPMGIFSILEEECMFP
KATDTSFxNxLYDEHLGKSNNFQKPKPAKGKAEAHFSLVHYAGTVDYNISGWLExNxDPL
NETVIGLYQxSSVxTLALLFATYGGEAEGGGGKKGGKKKGSSFQTVSALFRENLNxLMAN
LRSTHPHFVRCIIPNETxTPGAMEHELVLHQLRCNGVLEGIRICRKGFPSRVLYADFKQR
YRVLNASAIPEGQFMDSKKASEKLLGGGDVDHTQYAFGHTxVFFxAGLLGLLEEMRDDxL
AEIITATQARCRGFLMRVEYRAMVERRESIFCIQYNVRSFMNVxHWPWMxLFFxIxPLLK
//
>1mvwH (B) [i.15.1] SKELETAL MUSCLE MYOSIN II REGULATORY LIGHT
FDETEIEDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKNEELDAMIKEASGPINFT
VFLTMFGEKLKGADPEDVIMGAFKVLDPDGKGSIKKSFLEELLTTGGGRFTPEEIKNMWA
AFPPDVAGNVDYKNICYVITHGEDA
//
>1mvwJ (A) [i.15.1] SKELETAL MUSCLE MYOSIN II
DAEMAAFGEAAPYLRxSEKERIEAQNxPFDAxSSVFVVHPKQSFVxGTIQSxEGGxVTVx
TEGGETLTVKEDQVFSMNPPxYDxIEDMAMMTHLHEPAVLYNLxERYAAWMIYTYSGLFC
VTVNPYxWLPVYNPxVVLAYRGKKRQEAPPHIFSISDNAYQFMLTDRENQSILITGESGA
GKTVNTxRVIQYFATIAASGEKKKEEQSGKMQGTLEDQIISANPLLEAFGNAxTVRNDNS
SRFGxFIRIHFGATGKLASADIETYLLExSRVTFQLPAERSYHIFYQIMSNxxPELIDML
LITTNPYDYHYVSEGEITVPSIDDQEELMATDSAIDILGFSADExTAIYxLTGAVMHYGN
LKFxQxQREEQAEPDGTEVADxAAYLMGLNSAELLKALCYPRVGVGNEAVTxGETVSEVH
NSVGALAxAVYExMFLWMVIRINQQLDTKQPRQYFIGVLDIAGFEIFDFNSFEQLCINFT
NExLQQFFNHHMFVLEQEEYxxEGIEWEFIDFGMDLAACIELIExPMGIFSILEEECMFP
KATDTSFxNxLYDEHLGKSNNFQKPKPAKGKAEAHFSLVHYAGTVDYNISGWLExNxDPL
NETVIGLYQxSSVxTLALLFATYGGEAEGGGGKKGGKKKGSSFQTVSALFRENLNxLMAN
LRSTHPHFVRCIIPNETxTPGAMEHELVLHQLRCNGVLEGIRICRKGFPSRVLYADFKQR
YRVLNASAIPEGQFMDSKKASEKLLGGGDVDHTQYAFGHTxVFFxAGLLGLLEEMRDDxL
AEIITATQARCRGFLMRVEYRAMVERRESIFCIQYNVRSFMNVxHWPWMxLFFxIxPLLK
//
>1mvwW (1) [i.15.1] RABBIT SKELETAL MUSCLE ACTIN
DEDETTALVCDNGSGLVKAGFAGDDAPRAVFPSIVGRPRHQGVMVGMGQKDSYVGDEAQS
KRGILTLKYPIEHGIITNWDDMEKIWHHTFYNELRVAPEEHPTLLTEAPLNPKANREKMT
QIMFETFNVPAMYVAIQAVLSLYASGRTTGIVLDSGDGVTHNVPIYEGYALPHAIMRLDL
AGRDLTDYLMKILTERGYSFVTTAEREIVRDIKEKLCYVALDFENEMATAASSSSLEKSY
ELPDGQVITIGNERFRCPETLFQPSFIGMESAGIHETTYNSIMKCDIDIRKDLYANNVMS
GGTTMYPGIADRMQKEITALAPSTMKIKIIAPPERKYSVWIGGSILASLSTFQQMWITKQ
EYDEAGPSIVHR
//
>1mxe_2B (A) [a.39.1] CALMODULIN
LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTI
DFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGFISAAELRHVMTNLGEKLTDEEVDE
MIREADIDGDGQVNYEEFVTMMTS
//
>1mxe_2F (E) [x.x.x] TARGET SEQUENCE OF RAT CALMODULIN-DEPENDENT
IKKNFAKSKWKQAFNATAVVRHMRK
//
>1mz8C (A) [a.28.2] COLICIN E7 IMMUNITY PROTEIN
MELKNSISDYTEAEFVQLLKEIEKENVAATDDVLDVLLEHFVKITEHPDGTDLIYYPSDN
RDDSPEGIVKEIKEWRAANGKPGFKQG
//
>1mz8D [d.4.1] COLICIN E7
RNKPGKATGKGKPVNNKWLNNAGKDLGSPVPDRIANKLRDKEFKSFDDFRKKFWEEVSKD
PELSKQFSRNNNDRMKVGKAPKTRTQDVSGKRTSFELHHEKPISQNGGVYDMDNISVVTP
KRHIDIHRGK
//
>1mzwA [b.62.1] U-SNRNP-ASSOCIATED CYCLOPHILIN
NSSPVNPVVFFDVSIGGQEVGRMKIELFADVVPKTAENFRQFCTGEFRKDGVPIGYKGST
FHRVIKDFMIQGGDFVNGDGTGVASIYRGPFADENFKLRHSAPGLLSMANSGPSTNGCQF
FITCSKCDWLDGKHVVFGKIIDGLLVMRKIENVPTGPNNKPKLPVVISQCGEM
//
>1mzwB [x.x.x] U4/U6 SNRNP 60KDA PROTEIN
EVKASLRALGEPITLFGEGPAERRERLRNIL
//
>1n0l_1A [b.1.11 - b.7.2] CHAPERONE PROTEIN PAPD
AVSLDRTRAVFDGSEKSmTLDISNDNKQLPYLAQAWIENENQEKIITGPVIATPPVQRLE
PGAKSmVRLSTTPDISKLPQDRESLFYFNLREIPPRSEKANVLQIALQTKIKLFYRPAAI
KTRPNEVWQDQLILNKVSGGYRIENPTPYYVTVIGLGGSEKQAEEGEFETVmLSPRSEQT
VKSANYNTPYLSYINDYGGRPVLSFICNGSRCSVK
//
>1n0l_1B [b.2.3] MATURE FIMBRIAL PROTEIN PAPE
VPACTVSNTTVDWQDVENGNHEKEFTVNmRCPYNLGTmKVTITATNTYNNAILVQSSDGL
LVYLYNSNAGNIGTAITLGTPFTPGKITGNNADKTISLHAKLGYKPFSATATLVASYS
//
>1n0l_2C (A) [b.1.11 - b.7.2] CHAPERONE PROTEIN PAPD
AVSLDRTRAVFDGSEKSmTLDISNDNKQLPYLAQAWIENENQEKIITGPVIATPPVQRLE
PGAKSmVRLSTTPDISKLPQDRESLFYFNLREIPPRSEKANVLQIALQTKIKLFYRPAAI
KTRPNEVWQDQLILNKVSGGYRIENPTPYYVTVIGLGGSEKQAEEGEFETVmLSPRSEQT
VKSANYNTPYLSYINDYGGRPVLSFICNGSRCSVK
//
>1n0l_2D [b.2.3] MATURE FIMBRIAL PROTEIN PAPE
VPACTVSNTTVDWEKEFTVNmRCPYNLGTmKVTITATNTYNNAILVQGLLVYLYNSNAGN
IGTAITLGTPFTPGKITGNNADKTISLHAKLGYKPFSATATLVASYS
//
>1n0wA [c.37.1] DNA REPAIR PROTEIN RAD51 HOMOLOG 1
EIIQITTGSKELDKLLQGGIETGSITEmFGEFRTGKTQICHTLAVTCQLPIDRGGGEGKA
mYIDTEGTFRPERLLAVAERYGLSGSDVLDNVAYARAFNTDHQTQLLYQASAmmVESRYA
LLIVDSATALYRELSARQmHLARFLRmLLRLADEFGVAVVITNAHASTTRLYLRKGRGET
RICKIYDSPCLPEAEAmFAINADGVGDAKD
//
>1n0wB [j.97.1] BREAST CANCER TYPE 2 SUSCEPTIBILITY PROTEIN
PTLLGFHTASGKKVKIAKESLDKVKNLFDEKEQ
//
>1n0xM (L) [b.1.1 - b.1.1] IMMUNOGLOBULIN LIGHT CHAIN
EIVLTQSPGTLSLSPGERATFSCRSSHSIRSRRVAWYQHKPGQAPRLVIHGVSNRASGIS
DRFSGSGSGTDFTLTITRVEPEDFALYYCQVYGASSYTFGQGTKLERKRTVAAPSVFIFP
PSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTL
TLSKADYEKHKVYACEVTHQGLRSPVTKSFNRGEC
//
>1n0xK [b.1.1 - b.1.1] IMMUNOGLOBULIN HEAVY CHAIN
QVQLVQSGAEVKKPGASVKVSCQASGYRFSNFVIHWVRQAPGQRFEWMGWINPYNGNKEF
SAKFQDRVTFTADTSANTAYMELRSLRSADTAVYYCARVGPYSWDDSPQDNYYMDVWGKG
TTVIVSSASTKGPSVFPLAPSGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQS
SGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC
//
>1n0xR [x.x.x] B2.1 PEPTIDE
HERSYMFSDLENRCIAAExK
//
>1n1jA [a.22.1] NF-YB
IYLPIANVARIMKNAIPQTGKIAKDAKECVQECVSEFISFITSEASERCHQEKRKTINGE
DILFAMSTLGFDSYVEPLKLYLQKFRE
//
>1n1jB [a.22.1] NF-YC
LPLARIKKIMKLDEDVKMISAEAPVLFAKAAQIFITELTLRAWIHTEDNKRRTLQRNDIA
MAITKFDQFDFLIDIVPR
//
>1n2cD (B) [c.92.2] NITROGENASE MOLYBDENUM-IRON PROTEIN
SQQVDKIKASYPLFLDQDYKDMLAKKRDGFEEKYPQDKIDEVFQWTTTKEYQELNFQREA
LTVNPAKACQPLGAVLCALGFEKTMPYVHGSQGCVAYFRSYFNRHFREPVSCVSDSMTED
AAVFGGQQNMKDGLQNCKATYKPDMIAVSTTCMAEVIGDDLNAFINNSKKEGFIPDEFPV
PFAHTPSFVGSHVTGWDNMFEGIARYFTLKSMDDKVVGSNKKINIVPGFETYLGNFRVIK
RMLSEMGVGYSLLSDPEEVLDTPADGQFRMYAGGTTQEEMKDAPNALNTVLLQPWHLEKT
KKFVEGTWKHEVPKLNIPMGLDWTDEFLMKVSEISGQPIPASLTKERGRLVDMMTDSHTW
LHGKRFALWGDPDFVMGLVKFLLELGCEPVHILCHNGNKRWKKAVDAILAASPYGKNATV
YIGKDLWHLRSLVFTDKPDFMIGNSYGKFIQRDTLHKGKEFEVPLIRIGFPIFDRHHLHR
STTLGYEGAMQILTTLVNSILERLDEETRGMQATDYNHDLVR
//
>1n2cC (A) [c.92.2] NITROGENASE MOLYBDENUM-IRON PROTEIN
MSREEVESLIQEVLEVYPEKARKDRNKHLAVNDPAVTQSKKCIISNKKSQPGLMTIRGCA
YAGSKGVVWGPIKDMIHISHGPVGCGQYSRAGRRNYYIGTTGVNAFVTMNFTSDFQEKDI
VFGGDKKLAKLIDEVETLFPLNKGISVQSECPIGLIGDDIESVSKVKGAELSKTIVPVRC
EGFRGVSQSLGHHIANDAVRDWVLGKRDEDTTFASTPYDVAIIGDYNIGGDAWSSRILLE
EMGLRCVAQWSGDGSISEIELTPKVKLNLVHCYRSMNYISRHMEEKYGIPWMEYNFFGPT
KTIESLRAIAAKFDESIQKKCEEVIAKYKPEWEAVVAKYRPRLEGKRVMLYIGGLRPRHV
IGAYEDLGMEVVGTGYEFAHNDDYDRTMKEMGDSTLLYDDVTGYEFEEFVKRIKPDLIGS
GIKEKFIFQKMGIPFREMHSWDYSGPYHGFDGFAIFARDMDMTLNNPCWKKLQAPWEA
//
>1n2cH (E) [c.37.1] NITROGENASE IRON PROTEIN
AMRQCAIYGKGGIGKSTTTQNLVAALAEMGKKVMIVGCDPKADSTRLILHSKAQNTIMEM
AAEAGTVEDLELEDVLKAGYGGVKCVESGGPEPGVGCAGRGVITAINFLEEEGAYEDDLD
FVFYDVLGDVVCGGFAMPIRENKAQEIYIVCSGEMMAMYAANNISKGIVKYANSGSVRLG
GLICNSRNTDREDELIIALANKLGTQMIHFVPRDNVVQRAEIRRMTVIEYDPKAKQADEY
RALARKVVDNKLLVIPNPITMDELEELLMEFGIM
//
>1n2dA [a.39.1] MYOSIN LIGHT CHAIN
ATRANKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINADSSLRDASSLTLD
QITGLIEVNEKELDATTKAKTEDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEV
DELLKGVEVDSNGEIDYKKFIEDVLRQ
//
>1n2dC [x.x.x] IQ2 AND IQ3 MOTIFS FROM MYO2P, A CLASS V MYOSIN
QISQAIKYLQNNIKGFIIRQRVNDEMKVNCATLLQAAYRGHSIRANVF
//
>1n4x_1L [b.1.1] IMMUNOGLOBULIN KAPPA CHAIN VARIABLE REGION
MDILMTQTPLYLPVSLGDQASISCRSSQTIVHNNGNTYLEWYLQKPGQSPQLLIYKVSNR
FSGVPDRFSGSGSGTDFTLKISRVEAEDLGIYYCFQGSHFPPTFGGGTKLEIA
//
>1n4x_1H [b.1.1] IMMUNOGLOBULIN HEAVY CHAIN VARIABLE REGION
EVQLQQSGPELKKPGETVKISCKATNYAFTDYSMHWVKQAPGGDLKYVGWINTETDEPTF
ADDFKGRFAFSLDTSTSTAFLQINNLKNEDTATYFCVRDRHDYGEIFTYWGQGTTVTVSA
//
>1n5a_3D [d.19.1 - b.1.1] H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, D-B
GPHSMRYFETAVSRPGLEEPRYISVGYVDNKEFVRFDSDAENPRYEPRAPWMEQEGPEYW
ERETQKAKGQEQWFRVSLRNLLGYYNQSAGGSHTLQQMSGCDLGSDWRLLRGYLQFAYEG
RDYIALNEDLKTWTAADMAAQITRRKWEQSGAAEHYKAYLEGECVEWLHRYLKNGNATLL
RTDSPKAHVTHHPRSKGEVTLRCWALGFYPADITLTWQLNGEELTQDMELVETRPAGDGT
FQKWASVVVPLGKEQNYTCRVYHEGLPEPLTLRW
//
>1n5a_3A (E) [b.1.1] BETA-2-MICROGLOBULIN
IQKTPQIQVYSRHPPENGKPNILNCYVTQFHPPHIEIQMLKNGKKIPKVEMSDMSFSKDW
SFYILAHTEFTPTETDTYACRVKHDSMAEPKTVYWDRDM
//
>1n62_1E [d.41.1 - d.133.1] CARBON MONOXIDE DEHYDROGENASE LARGE CHAIN
RAEKLQGMGCKRKRVEDIRFTQGKGNYVDDVKLPGMLFGDFVRSSHAHARIKSIDTSKAK
ALPGVFAVLTAADLKPLNLHYMPTLAGDVQAVLADEKVLFQNQEVAFVVAKDRYVAADAI
ELVEVDYEPLPVLVDPFKAMEPDAPLLREDIKDKMTGAHGARKHHNHIFRWEIGDKEGTD
ATFAKAEVVSKDMFTYHRVHPSPLETCQCVASMDKIKGELTLWGTFQAPHVIRTVVSLIS
GLPEHKIHVIAPDIGGGFGNKVGAYSGYVCAVVASIVLGVPVKWVEDRMENLSTTSFARD
YHMTTELAATKDGKILAMRCHVLADHGAFDACADPSKWPAGFMNICTGSYDMPVAHLAVD
GVYTNKASGGVAYRCSFRVTEAVYAIERAIETLAQRLEMDSADLRIKNFIQPEQFPYMAP
LGWEYDSGNYPLAMKKAMDTVGYHQLRAEQKAKQEAFKRGETREIMGIGISFFTEIVGAG
PSKNCDILGVSMFDSAEIRIHPTGSVIARMGTKSQGQGHETTYAQIIATELGIPADDIMI
EEGNTDTAPYGLGTYGSRSTPTAGAATAVAARKIKAKAQMIAAHMLEVHEGDLEWDVDRF
RVKGLPEKFKTMKELAWASYNSPPPNLEPGLEAVNYYDPPNMTYPFGAYFCIMDIDVDTG
VAKTRRFYALDDCGTRINPMIIEGQVHGGLTEAFAVAMGQEIRYDEQGNVLGASFMDFFL
PTAVETPKWETDYTVTPSPHHPIGAKGVGESPHVGGVPCFSNAVNDAYAFLNAGHIQMPH
DAWRLWKVGEQLGLHV
//
>1n62_1D [d.15.4 - a.56.1] CARBON MONOXIDE DEHYDROGENASE SMALL CHAIN
AKAHIELTINGHPVEALVEPRTLLIHFIREQQNLTGAHIGCDTSHCGACTVDLDGMSVKS
CTMFAVQANGASITTIEGMAAPDGTLSALQEGFRMMHGLQCGYCTPGMIMRSHRLLQENP
SPTEAEIRFGIGGNLCRCTGYQNIVKAIQYAAAKINGVP
//
>1n62_1F (C) [d.145.1 - d.87.2] CARBON MONOXIDE DEHYDROGENASE MEDIUM CHAIN
MIPGSFDYHRPKSIADAVALLTKLGEDARPLAGGHSLIPIMKTRLATPEHLVDLRDIGDL
VGIREEGTDVVIGAMTTQHALIGSDFLAAKLPIIRETSLLIADPQIRYMGTIGGNAANGD
PGNDMPALMQCLGAAYELTGPEGARIVAARDYYQGAYFTAIEPGELLTAIRIPVPPTGHG
YAYEKLKRKIGDYATAAAAVVLTMSGGKCVTASIGLTNVANTPLWAEEAGKVLVGTALDK
PALDKAVALAEAITAPASDGRGPAEYRTKMAGVMLRRAVERAKARA
//
>1n6jA [d.88.1] MYOCYTE-SPECIFIC ENHANCER FACTOR 2B
GRKKIQISRILDQRNRQVTFTKRKFGLMKKAYELSVLCDCEIALIIFNSANRLFQYASTD
MDRVLLKYTEYSEPHESRTNTDILETLKRRGIG
//
>1n6jG [x.x.x] CALCINEURIN-BINDING PROTEIN CABIN 1
SPKGSISEETKQKLKSAILSAQSAAN
//
>1n6qB [e.8.1] REVERSE TRANSCRIPTASE
PISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPV
FAIKKKDSTKWRKLVDFRELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPL
DEDFRKYTAFTIPSINNETPGIRYQYNVLPQGWKGSPAIFQSSMTKILEPFKKQNPDIVI
YQYMDDLYVGSDLEIGQHRTKIEELRQHLLRWGLTTPDKKHQKEPPFLWMGYELHPDKWT
VQPIVLPEKDSWTVNDIQKLVGKLNWASQIYPGIKVRQLSKLLRGTKALTEVIPLTEEAE
LELAENREILKEPVHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMRGA
HTNDVKQLTEAVQKITTESIVIWGKTPKFKLPIQKETWETWWTEYWQATWIPEWEFVNTP
PLVKLWYQL
//
>1n6qL [b.1.1 - b.1.1] MONOCLONAL ANTIBODY (LIGHT CHAIN)
DIQMTQTTSSLSASLGDRVTISCSASQDISSYLNWYQQKPEGTVKLLIYYTSSLHSGVPS
RFSGSGSGTDYSLTISNLEPEDIATYYCQQYSKFPWTFGGGTKLEIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNR
//
>1n6qH [b.1.1 - b.1.1] MONOCLONAL ANTIBODY (HEAVY CHAIN)
QITLKESGPGIVQPSQPFRLTCTFSGFSLSTSGIGVTWIRQPSGKGLEWLATIWWDDDNR
YNPSLKSRLTVSKDTSNNQAFLNMMTVETADTAIYYCAQSAITSVTDSAMDHWGQGTSVT
VSSAKTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVL
QSDLYTLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKIVPADC
//
>1n8oB [b.47.1] CHYMOTRYPSIN A, B CHAIN
IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGS
SSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTT
CVTTGWGLTRY
//
>1n8oC [b.47.1] CHYMOTRYPSIN A, C CHAIN
ANTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVSSCMGDSGGPLVCKKNGAWT
LVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN
//
>1n8oE [b.16.1] ECOTIN
QPLEKIAPYPQAEKGMKRQVIQLTPQEDESTLKVELLIGQTLEVDCNLHRLGGKLENKTL
EGWGYDYYVFDKVSSPVSTMMACPDKEKKFVTAYLGDAGMLRYNSKLPIVVYTPDNVDVK
YRVWKAEEKIDNAVVR
//
>1n8zA [b.1.1 - b.1.1] HERCEPTIN FAB (ANTIBODY) - LIGHT CHAIN
DIQMTQSPSSLSASVGDRVTITCRASQDVNTAVAWYQQKPGKAPKLLIYSASFLYSGVPS
RFSGSRSGTDFTLTISSLQPEDFATYYCQQHYTTPPTFGQGTKVEIKRTVAAPSVFIFPP
SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT
LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
//
>1n8zC [c.10.2 - g.3.9 - c.10.2 - g.3.9] RECEPTOR PROTEIN-TYROSINE KINASE ERBB-2
TQVCTGTDMKLRLPASPETHLDMLRHLYQGCQVVQGNLELTYLPTNASLSFLQDIQEVQG
YVLIAHNQVRQVPLQRLRIVRGTQLFEDNYALAVLDNGDPLSPGGLRELQLRSLTEILKG
GVLIQRNPQLCYQDTILWKDIFHKNNQLALTLIDTNRSRACHPCSPMCKGSRCWGESSED
CQSLTRTVCAGGCARCKGPLPTDCCHEQCAAGCTGPKHSDCLACLHFNHSGICELHCPAL
VTYNTDTFESMPNPEGRYTFGASCVTACPYNYLSTDVGSCTLVCPLHNQEVTATQRCEKC
SKPCARVCYGLGMEHLREVRAVTSANIQEFAGCKKIFGSLAFLPESFDSNTAPLQPEQLQ
VFETLEEITGYLYISAWPDSLPDLSVFQNLQVIRGRILHNGAYSLTLQGLGISWLGLRSL
RELGSGLALIHHNTHLCFVHTVPWDQLFRNPHQALLHTANRPEDECVGEGLACHQLCARG
HCWGPGPTQCVNCSQFLRGQECVEECRVLQGLPREYVNARHCLPCHPECQPQNGSVTCFG
PEADQCVACAHYKDPPFCVARCPSIWKFPDEEGACQPCPIN
//
>1na1_2B [b.121.4] COAT PROTEIN VP2
GYSDRVQQITLGNSTITTQEAANAVVCYAEWPEYLPDVDASDVNKTSKPDTSVCRFYTLD
SKTWTTGSKGWCWKLPDALKDMGVFGQNMFFHSLGRSGYTVHVQCNATKFHSGCLLVVVI
PEHQLASHEGGNVSVKYTFTHPGERGIDLSSANEVGGPVKDVLYNMNGTLLGNLLIFPHQ
FINLRTNNTATIVIPYINSVPIDSMTRHNNVSLMVIPIAPLTVPTGATPSLPITVTIAPM
CTEFSGIRSKSIVPQ
//
>1na1_2D [b.121.4] COAT PROTEIN VP4
INYYKDAASTSSAGQSLSMDPSKFTEPVKDLMLKGAPALN
//
>1na1_2D [b.121.4] COAT PROTEIN VP4
INYYKDAASTSSAGQSLSMDPSKFTEPVKDLMLKGAPALN
//
>1na1_2n (C) [b.121.4] COAT PROTEIN VP3
GLPTTTLPGSGQFLTTDDRQSPSALPNYEPTPRIHIPGKVHNLLEIIQVDTLIPMNNTHT
KDEVNSYLIPLNANRQNEQVFGTNLFIGDGVFKTTLLGEIVQYYTHWSGSLRFSLMYTGP
ALSSAKLILAYTPPGARGPQDRREAMLGTHVVWDIGLQSTIVMTIPWTSGVQFRYTDPDT
YTSAGFLSCWYQTSLILPPETTGQVYLLSFISACPDFKLRLMKDTQTISQTVALTE
//
>1nak_2M (L) [b.1.1 - b.1.1] FAB 83.1 - LIGHT CHAIN
DVVMTQSPVSLPVSLGDQASISCRSSQSLGHSSGNTYLHWFLQKPGQSPKLLIYKVSNRF
SGVPDRFSGSGSGTDFTFKISRVEAEDLGVYFCFQTTHDPYTFGGGTKLEIKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRN
//
>1nak_2I (H) [b.1.1 - b.1.1] FAB 83.1 - HEAVY CHAIN
EVQLQESGPSLVKPSQTLSLTCSVTGVSITSGYWNWIRKFPGNKFEYMGYISKSGSAYYN
PSLKSRISFTRDTSKNQFYLKLNSVTTEDTATYYCAIDDFDIWGAGTTVTVSSAKTTPPS
VYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTLSSS
VTVPSSPRPSETVTCNVAHPASSTKVDKKIVPRD
//
>1namA [b.1.1] BM3.3 T CELL RECEPTOR ALPHA-CHAIN
QKVTQTQTSISVMEKTTVTMDCVYETQDSSYFLFWYKQTASGEIVFLIRQDSYKKENATV
GHYSLNFQKPKSSIGLIITATQIEDSAVYFCAMRGDYGGSGNKLIFGTGTLLSVKP
//
>1namH [d.19.1 - b.1.1] H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, K-B
GPHSLRYFVTAVSRPGLGEPRYMEVGYVDDTEFVRFDSDAENPRYEPRARWMEQEGPEYW
ERETQKAKGNEQSFRVDLRTLLGYYNQSKGGSHTIQVISGCEVGSDGRLLRGYQQYAYDG
CDYIALNEDLKTWTAADMAALITKHKWEQAGEAERLRAYLEGTCVEWLRRYLKNGNATLL
RTDSPKAHVTHHSRPEDKVTLRCWALGFYPADITLTWQLNGEELIQDMELVETRPAGDGT
FQKWASVVVPLGKEQYYTCHVYHQGLPEPLTLRWE
//
>1nb3_3B (A) [d.3.1] CATHEPSIN H
YPPSMDWRKKGNFVSPVKNQGSCGSCWTFSTTGALESAVAIATGKMLSLAEQQLVDCAQN
FNNHGCQGGLPSQAFEYIRYNKGIMGEDTYPYKGQDDHCKFQPDKAIAFVKDVANITMND
EEAMVEAVALYNPVSFAFEVTNDFLMYRKGIYSSTSCHKTPDKVNHAVLAVGYGEENGIP
YWIVKNSWGPQWGMNGYFLIERGKNMCGLAACASYPIPLV
//
>1nb3_3J (I) [d.17.1] STEFIN A
MIPGGLSEAKPATPEIQEIVDKVKPQLEEKTNETYGKLEAVQYKTQVVAGTNYYIKVRAG
DNKYMHLKVFKSLPGQNEDLVLTGYQVDKNKDDELTGF
//
>1nbf_2B (A) [d.3.1] UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 7
KKHTGYVGLKNQGATCYMNSLLQTLFFTNQLRKAVYMMPTEGDDSSKSVPLALQRVFYEL
QHSDKPVGTKKLTKSFGWETLDSFMQHDVQELCRVLLDNVENKMKGTCVEGTIPKLFRGK
MVSYIQCKEVDYRSDRREDYYDIQLSIKGKKNIFESFVDYVAVEQLDGDNKYDAGEHGLQ
EAEKGVKFLTLPPVLHLQLMRFMYDPQTDQNIKINDRFEFPEQLPLDEFLQKTDPKDPAN
YILHAVLVHSGDNHGGHYVVYLNPKGDGKWCKFDDDVVSRCTKEEAIEHNYGGHDDDLSV
RHCTNAYMLVYIRESKLSEVLQAVTDHDIPQQLVERLQEEKRIEAQK
//
>1nbf_2C [d.15.1] UBIQUITIN ALDEHYDE
MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYN
IQKESTLHLVLRLRGx
//
>1nbvL [b.1.1 - b.1.1] IGG2B-KAPPA BV04-01 FAB (LIGHT CHAIN)
DVVMTQTPLSLPVSLGDQASISCRSSQSLVHSNGNTYLHWYLQKPGQSPKLLIYKVSNRF
SGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQSTHVPLTFGAGTKLELKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1nbvH [b.1.1 - b.1.1] IGG2B-KAPPA BV04-01 FAB (HEAVY CHAIN)
EVQPVETGGGLVQPKGSLKLSCAASGFSFNTNAMNWVRQAPGKGLEWVARIRSKSNNYAT
YYADSVKDRFTISRDDSQNMLYLQMNNLKTEDTAMYYCVRDQTGTAWFAYWGQGTLVTVS
AAKTTPPSVYPLAPGCGDTTGSSVTLGCLVKGYFPESVTVTWNSGSLSSSVHTFPALLQS
GLYTMSSSVTVPSSTWPSQTVTCSVAHPASSTTVDKKLE
//
>1nbwC [c.55.1 - c.8.6 - c.55.1] GLYCEROL DEHYDRATASE REACTIVASE ALPHA SUBUNIT
LIAGIDIGNATTEVALASDYPQARAFVASGIVATTGMKGTRDNIAGTLAALEQALAKTPW
SMSDVSRIYLNEAAPVIGDVAMETITETIITESTMIGHNPQTPGGVGVGVGTTIALGRLA
TLPAAQYAEGWIVLIDDAVDFLDAVWWLNEALDRGINVVAAILKKDDGVLVNNRLRKTLP
VVDEVTLLEQVPEGVMAAVEVAAPGQVVRILSNPYGIATFFGLSPEETQAIVPIARALIG
NRSAVVLKTPQGDVQSRVIPAGNLYISGEKRRGEADVAEGAEAIMQAMSACAPVRDIRGE
PGTHAGGMLERVRKVMASLTGHEMSAIYIQDLLAVDTFIPRKVQGGMAGECAMENAVGMA
AMVKADRLQMQVIARELSARLQTEVVVGGVEANMAIAGALTTPGCAAPLAILDLGAGSTD
AAIVNAEGQITAVHLAGAGNMVSLLIKTELGLEDLSLAEAIKKYPLAKVESLFSIRHENG
AVEFFREALSPAVFAKVVYIKEGELVPIDNASPLEKIRLVRRQAKEKVFVTNCLRALRQV
SPGGSIRDIAFVVLVGGSSLDFEIPQLITEALSHYGVVAGQGNIRGTEGPRNAVATGLLL
AGQA
//
>1nbwD (B) [c.51.3] GLYCEROL DEHYDRATASE REACTIVASE BETA SUBUNIT
PPGVRLFYDPRGHHAGAINELCWGLEEQGVPCQTITYDGGGDAAALGALAARSSPLRVGI
GLSASGEIALTHAQLPADAPLATGHVTDSDDQLRTLGANAGQLVKVLPLSERN
//
>1nbzA [b.1.1 - b.1.1] ANTIBODY KAPPA LIGHT CHAIN
DIVLTQSPATLSVTPGDSVSLSCRASQSISNNLHWYQQKSHESPRLLIKYASQSISGIPS
RFSGSGSGTDFTLSINSVETEDFGMYFCQQSNSWPYTFGGGTKLEIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNE
//
>1nbzB [b.1.1 - b.1.1] IMMUNOGLOBULIN GAMMA 1 CHAIN
EVQLQESGPSLVKPSQTLSLTCSVTGDSVTSDYWSWIRKFPGNKLEYMGYISYSGSTYYH
PSLKSRISITRDTSKNQYYLQLNSVTTEDTATYYCASWGGDVWGAGTTVTVSSAKTTAPS
VYPLAPVCGDTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDLYTLSSS
VTVTSSTWPSQSITCNVAHPASSTKVDKK
//
>1nc4_1A [b.1.1 - b.1.1] MONOCLONAL ANTIBODY 2D12.5, LAMBDA LIGHT CHAIN
QAVVTQESALTTSPGETVTLTCRSSTGAVTTSNYANWVQEKPDHLFTGLIGGNNNRPPGV
PARFSGSLIGDKAALTIAGTQTEDEAIYFCALWYSNHWVFGGGTRLTVLGQPKSSPSVTL
FPPSSEELETNKATLVCTITDFYPGVVTVDWKVDGTPVTQGMETTQPSKQSNNKYMASSY
LTLTARAWERHSSYSCQVTHEGHTVEKSLSP
//
>1nc4_1B [b.1.1 - b.1.1] MONOCLONAL ANTIBODY 2D12.5, IGG1 GAMMA HEAVY
xVKLQESGPGLVQPSQSLSITCTVSGFSLTDYGVHWVRQSPGKGLEWLGVIWSGGGTAYT
AAFISRLNIYKDNSKNQVFFEMNSLQANDTAMYYCARRGSYPYNYFDVWGQGTTVTVSSA
KTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDL
YTLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKIVPR
//
>1ncaA (N) [b.68.1] INFLUENZA A SUBTYPE N9 NEURAMINIDASE
IRDFNNLTKGLCTINSWHIYGKDNAVRIGEDSDVLVTREPYVSCDPDECRFYALSQGTTI
RGKHSNGTIHDRSQYRALISWPLSSPPTVYNSRVECIGWSSTSCHDGKTRMSICISGPNN
NASAVIWYNRRPVTEINTWARNILRTQESECVCHNGVCPVVFTDGSATGPAETRIYYFKE
GKILKWEPLAGTAKHIEECSCYGERAEITCTCRDNWQGSNRPVIRIDPVAMTHTSQYICS
PVLTDNPRPNDPTVGKCNDPYPGNNNNGVKGFSYLDGVNTWLGRTISIASRSGYEMLKVP
NALTDDKSKPTQGQTIVLNTDWSGYSGSFMDYWAEGECYRACFYVELIRGRPKEDKVWWT
SNSIVSMCSSTEFLGQWDWPDGAKIEYFL
//
>1ncaB (L) [b.1.1 - b.1.1] IGG2A-KAPPA NC41 FAB (LIGHT CHAIN)
DIVMTQSPKFMSTSVGDRVTITCKASQDVSTAVVWYQQKPGQSPKLLIYWASTRHIGVPD
RFAGSGSGTDYTLTISSVQAEDLALYYCQQHYSPPWTFGGGTKLEIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1nccA (N) [b.68.1] INFLUENZA A SUBTYPE N9 NEURAMINIDASE
IRDFNNLTKGLCTINSWHIYGKDNAVRIGEDSDVLVTREPYVSCDPDECRFYALSQGTTI
RGKHSNGTIHDRSQYRALISWPLSSPPTVYNSRVECIGWSSTSCHDGKTRMSICISGPNN
NASAVIWYNRRPVTEINTWARNILRTQESECVCHNGVCPVVFTDGSATGPAETRIYYFKE
GKILKWEPLAGTAKHIEECSCYGERAEITCTCRDNWQGSNRPVIRIDPVAMTHTSQYICS
PVLTDNPRPNDPTVGKCNDPYPGNNNNGVKGFSYLDGVNTWLGRTISRASRSGYEMLKVP
NALTDDKSKPTQGQTIVLNTDWSGYSGSFMDYWAEGECYRACFYVELIRGRPKEDKVWWT
SNSIVSMCSSTEFLGQWDWPDGAKIEYFL
//
>1nccC (H) [b.1.1 - b.1.1] IGG2A-KAPPA NC41 FAB (HEAVY CHAIN)
QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLKWMGWINTNTGEPTY
GEEFKGRFAFSLETSASTANLQINNLKNEDTATFFCARGEDNFGSLSDYWGQGTTVTVSS
AKTTAPSVYPLAPVCGDTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSD
LYTLSSSVTVTSSTWPSQSITCNVAHPASSTKVDKKIEPRG
//
>1ncdB (H) [b.1.1 - b.1.1] IGG2A-KAPPA NC41 FAB (HEAVY CHAIN)
QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLEWMGWINTNTGEPTY
GEEFKGRFAFSLETSASTANLQINNLKNEDKATFFCARGEDNFGSLSDYWGQGTTLTVSS
AKTTAPSVYPLAPVCGDTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSD
LYTLSSSVTVTSSTWPSQSITCNVAHPASSTKVDKKIEPRG
//
>1ncdC (L) [b.1.1 - b.1.1] IGG2A-KAPPA NC41 FAB (LIGHT CHAIN)
DIVMTQSPKFMSTSVGDRVTITCKASQDVSTAVVWYQQKPGQSPKLLIYWASTRHIGVPD
RFAGSGSGTDYTLTISSVQAEDLALYYCQQHYSPPWTFGGGTKLEIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1ncq_2C [b.121.4] COAT PROTEIN VP3
GLPTTTLPGSGQFLTTDDRQSPSALPNYEPTPRIHIPGKVHNLLEIIQVDTLIPMNNTHT
KDEVNSYLIPLNANRQNEQVFGTNLFIGDGVFKTTLLGEIVQYYTHWSGSLRFSLMYTGP
ALSSAKLILAYTPPGARGPQDRREAMLGTHVVWDIGLQSTIVMTIPWTSGVQFRYTDPDT
YTSAGFLSCWYQTSLILPPETTGQVYLLSFISACPDFKLRLMKDTQTISQTVALTE
//
>1ncq_2D [b.121.4] COAT PROTEIN VP4
INYYKDAASTSSAGQSLSMDPSKFTEPVKDLMLKGAPALN
//
>1ncq_2D [b.121.4] COAT PROTEIN VP4
INYYKDAASTSSAGQSLSMDPSKFTEPVKDLMLKGAPALN
//
>1ncr_2D [b.121.4] COAT PROTEIN VP4
GAQVSRQSLNYFNINYFKDAASSGASRLD
//
>1ncr_27 (A) [b.121.4] COAT PROTEIN VP1
NPVERYVDEVLNEVLVVPNINQSHPTTSNAAPVLDAAETGHTNKIQPEDTIETRYVQSSQ
TLDEMSVESFLGRSGCIHESVLDIVDNYNDQSFTKWNINLQEMAQIRRKFEMFTYARFDS
EITMVPSVAAKDGHIGHIVMQYMYVPPGAPIPTTRDDYAWQSGTNASVFWQHGQPFPRFS
LPFLSIASAYYMFYDGYDGDTYKSRYGTVVTNDMGTLCSRIVTSEQLHKVKVVTRIYHKA
KHTKAWCPRPPRAVQYSHTHTTNYKLSSEVHNDVAIRPRTNLTTV
//
>1ncr_2D [b.121.4] COAT PROTEIN VP4
GAQVSRQSLNYFNINYFKDAASSGASRLD
//
>1ndgA [b.1.1 - b.1.1] ANTIBODY KAPPA LIGHT CHAIN
DIVLTQSPATLSVTPGDSVSLSCRASQSISNNLHWYQQKSHESPRLLIKYASQSISGIPS
RFSGSGSGTDFTLSINSVETEDFGMYFCQQSNSWPYTFGGGTKLEIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNE
//
>1ndgB [b.1.1 - b.1.1] IMMUNOGLOBULIN GAMMA 1 CHAIN
EVQLQESGPSLVKPSQTLSLTCSVTGDSIIRDYWSWIRKFPGNKLEYMGYISFSGNTFYH
PSLKSRISITRDTSKNQHYLQLSSVTTEDTATYYCANWDGTYWGEGTLVTVSAAKTTAPS
VYPLAPVCGDTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDLYTLSSS
VTVTSSTWPSQSITCNVAHPASSTAVDKK
//
>1ndgC [d.2.1] LYSOZYME C
KVFGRCELAAAMKRHGLDNYRGYSLGNWVCAAKFESNFNTQATNRNTDGSTDYGILQINS
AWWCNDGRTPGSRNLCNIPCSALLSSDITASVNCAKKIVSDGNGMNAWVAWRNRCKGTDV
QAWIRGCR
//
>1ndoE [b.33.1 - d.129.3] NAPTHALENE 1,2-DIOXYGENASE
MNYNNKILVSESGLSQKHLIHGDEELFQHELKTIFARNWLFLTHDSLIPAPGDYVTAKMG
IDEVIVSRQNDGSIRAFLNVCRHRGKTLVSVEAGNAKGFVCSYHGWGFGSNGELQSVPFE
KDLYGESLNKKCLGLKEVARVESFHGFIYGCFDQEAPPLMDYLGDAAWYLEPMFKHSGGL
ELVGPPGKVVIKANWKAPAENFVGDAYHVGWTHASSLRSGESIFSSLAGNAALPPEGAGL
QMTSKYGSGMGVLWDGYSGVHSADLVPELMAFGGAKQERLNKEIGDVRARIYRSHLNCTV
FPNNSMLTCSGVFKVWNPIDANTTEVWTYAIVEKDMPEDLKRRLADSVQRTFGPAGFWES
DDNDNMETASQNGKKYQSRDSDLLSNLGFGEDVYGDAVYPGVVGKSAIGETSYRGFYRAY
QAHVSSSNWAEFEHASSTWHTELTK
//
>1ndoF (B) [d.17.4] NAPTHALENE 1,2-DIOXYGENASE
MINIQEDKLVSAHDAEEILRFFNCHDSALQQEATTLLTQEAHLLDIQAYRAWLEHCVGSE
VQYQVISRELRAASERRYKLNEAMNVYNENFQQLKVRVEHQLDPQNWGNSPKLRFTRFIT
NVQAAMDVNDKELLHIRSNVILHRARRGNQVDVFYAAREDKWKRGEGGVRKLVQRFVDYP
ERILQTHNLMVFL
//
>1nenA [c.3.1 - d.168.1 - a.7.3] SUCCINATE DEHYDROGENASE FLAVOPROTEIN SUBUNIT
MKLPVREFDAVVIGAGGAGMRAALQISQSGQTCALLSKVFPTRSHTVSAQGGITVALGNT
HEDNWEWHMYDTVKGSDYIGDQDAIEYMCKTGPEAILELEHMGLPFSRLDDGRIYQRPFG
GQSKNFGGEQAARTAAAADRTGHALLHTLYQQNLKNHTTIFSEWYALDLVKNQDGAVVGC
TALCIETGEVVYFKARATVLATGGAGRIYQSTTNAHINTGDGVGMAIRAGVPVQDMEMWQ
FHPTGIAGAGVLVTEGCRGEGGYLLNKHGERFMERYAPNAKDLAGRDVVARSIMIEIREG
RGCDGPWGPHAKLKLDHLGKEVLESRLPGILELSRTFAHVDPVKEPIPVIPTCHYMMGGI
PTKVTGQALTVNEKGEDVVVPGLFAVGEIACVSVHGANRLGGNSLLDLVVFGRAAGLHLQ
ESIAEQGALRDASESDVEASLDRLNRWNNNRNGEDPVAIRKALQECMQHNFSVFREGDAM
AKGLEQLKVIRERLKNARLDDTSSEFNTQRVECLELDNLMETAYATAVSANFRTESRGAH
SRFDFPDRDDENWLCHSLYLPESESMTRRSVNMEPKLRPAFPPKIRTY
//
>1nenB [d.15.4 - a.1.2] SUCCINATE DEHYDROGENASE IRON-SULFUR PROTEIN
MRLEFSIYRYNPDVDDAPRMQDYTLEADEGRDMMLLDALIQLKEKDPSLSFRRSCREGVC
GSDGLNMNGKNGLACITPISALNQPGKKIVIRPLPGLPVIRDLVVDMGQFYAQYEKIKPY
LLNNGQNPPAREHLQMPEQREKLDGLYECILCACCSTSCPSFWWNPDKFIGPAGLLAAYR
FLIDSRDTETDSRLDGLSDAFSVFRCHSIMNCVSVCPKGLNPTRAIGHIKSMLLQRNA
//
>1nenC [f.21.2] SUCCINATE DEHYDROGENASE CYTOCHROME B-556 SUBUNIT
MIRNVKKQRPVNLDLQTIRFPITAIASILHRVSGVITFVAVGILLWLLGTSLSSPEGFEQ
ASAIMGSFFVKFIMWGILTALAYHVVVGIRHMMMDFGYLEETFEAGKRSAKISFVITVVL
SLLAGVLVW
//
>1nenD [f.21.2] SUCCINATE DEHYDROGENASE HYDROPHOBIC MEMBRANE
SNASALGRNGVHDFILVRATAIVLTLYIIYMVGFFATSGELTYEVWIGFFASAFTKVFTL
LALFSILIHAWIGMWQVLTDYVKPLALRLMLQLVIVVALVVYVIYGFVVVWGV
//
>1nex_2D (B) [a.158.1 - b.69.4] CDC4 PROTEIN
LKRDLITSLPFEISLKIFNYLQFEDIINSLGVSQNWNKIIRKSTSLWKKLLISENFVSPK
GFNSLNLKLSQKYPKLSQQDRLRLSFLENIFILKNWYNPKFVPQRTTLRGHmTSVITCLQ
FEDNYVITGADDKmIRVYDSINKKFLLQLSGHDGGVWALKYAHGGILVSGSTDRTVRVWD
IKKGCCTHVFEGHNSTVRCLDIVEYKNIKYIVTGSRDNTLHVWKLPKDYPLVFHTPEENP
YFVGVLRGHmASVRTVSGHGNIVVSGSYDNTLIVWDVAQmKCLYILSGHTDRIYSTIYDH
ERKRCISASmDTTIRIWDLENGELmYTLQGHTALVGLLRLSDKFLVSAAADGSIRGWDAN
DYSRKFSYHHTNLSAITTFYVSDNILVSGSENQFNIYNLRSGKLVHANILKDADQIWSVN
FKGKTLVAAVEKDGQSFLEILDFS
//
>1nex_2C [d.42.1 - a.157.1] CENTROMERE DNA-BINDING PROTEIN COMPLEX CBF3
SNVVLVSGEGERFTVDKKIAERSLLLKNYLIVmPVPNVRSSVLQKVIEWAEHHRDSNFPV
DSWDREFLKVDQEmLYEIILAANYLNIKPLLDAGCKVVAEmIRGRSPEEIRRTFNIVNDF
TPEEEAAIRR
//
>1nez_1A [d.19.1 - b.1.1] H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, TLA(C)
GSHSLRYFYTALSRPAISEPWYIAVGYLDDTQFARFDSAGETGTYKLSAPWVEQEGPEYW
ARETEIVTSNAQFFRENLQTMLDYYNLSQNGSHTIQVMYGCEVEFFGSLFRAYEQHGYDG
QDYIALNEDLKTWTAADMAAEITRSKWEQAGYTELRRTYLEGPCKDSLLRYLENRKKTQE
CTDPPKTHVTHHARPEGDVTLRCWALGFYPAHITLTWQLNGEELIQDTELVETRPAGDGT
FQKWAAVVVPSGEEQKYTCHVYHEGLPEPLTLRW
//
>1nez_1B [b.1.1] BETA-2-MICROGLOBULIN
IQKTPQIQVYSRHPPENGKPNILNCYVTQFHPPHIEIQMLKNGKKIPKVEMSDMSFSKDW
SFYILAHTEFTPTETDTYACRVKHDSMAEPKTVYWDRDM
//
>1nf3_1A [c.37.1] G25K GTP-BINDING PROTEIN, PLACENTAL ISOFORM
GAMGIQTIKCVVVGDGAVGKTCLLISYTTNKFPSEYVPTVFDNYAVTVMIGGEPYTLGLF
DTAGLEDYDRLRPLSYPQTDVFLVCFSVVSPSSFENVKEKWVPEITHHCPKTPFLLVGTQ
IDLRDDPSTIEKLAKNKQKPITPETAEKLARDLKAVKYVECSALTQKGLKNVFDEAILAA
LEPPEPKKSRRCVL
//
>1nf3_1C [b.36.1] PAR-6B
IVISMPQDFRPVSSIIDVDILPETHRRVRLCKYGTEKPLGFYIRDGSSVRVTPHGLEKVP
GIFISRLVPGGLAQSTGLLAVNDEVLEVNGIEVSGKSLDQVTDMMIANSRNLIITVRPAN
QRN
//
>1nfd_1D (B) [b.1.1 - b.1.1] N15 ALPHA-BETA T-CELL RECEPTOR
DSGVVQSPRHIIKEKGGRSVLTCIPISGHSNVVWYQQTLGKELKFLIQHYEKVERDKGFL
PSRFSVQQFDDYHSEMNMSALELEDSAMYFCASSLRWGDEQYFGPGTRLTVLEDLRNVTP
PKVSLFEPSKAEIANKQKATLVCLARGFFPDHVELSWWVNGKEVHSGVSTDPQAYKESNY
SYSLSSRLRVSATFWHNPRNHFRCQVQFHGLSEEDKWPEGSPKPVTQNISAEAWGRADC
//
>1nfd_1H (F) [b.1.1 - b.1.1] H57 FAB
EVYLVESGGDLVQPGSSLKVSCAASGFTFSDFWMYWVRQAPGKGLEWVGRIKNIPNNYAT
EYADSVRGRFTISRDDSRNSIYLQMNRLRVDDTAIYYCTRAGRFDHFDYWGQGTMVTVSS
ATTTAPSVYPLAPACDSTTSTTDTVTLGCLVKGYFPEPVTVSWNSGALTSGVHTFPSVLH
SGLYSLSSSVTVPSSTWPKQPITCNVAHPASSTKVDKKIEPR
//
>1nfd_1G (E) [b.1.1 - b.1.1] H57 FAB
YELIQPSSASVTVGETVKITCSGDQLPKNFAYWFQQKSDKNILLLIYMDNKRPSGIPERF
SGSTSGTTATLTISGAQPEDEAAYYCLSSYGDNNDLVFGSGTQLTVLRGPKSSPKVTVFP
PSPEELRTNKATLVCLVNDFYPGSATVTWKANGATINDGVKTTKPSKQGQNYMTSSYLSL
TADQWKSHNRVSCQVTHEGETVEKSLSPAECL
//
>1nfd_2A [b.1.1 - b.1.1] N15 ALPHA-BETA T-CELL RECEPTOR
DSVTQTEGLVTVTEGLPVKLNCTYQTTYLTIAFFWYVQYLNEAPQVLLKSSTDNKRTEHQ
GFHATLHKSSSSFHLQKSSAQLSDSALYYCALSEGGNYKYVFGAGTRLKVIAHIQNPEPA
VYQLKDPRSQDSTLCLFTDFDSQINVPKTMESGTFITDKTVLDMKAMDSKSNGAIAWSNQ
TSFTCQDIFKETNATYPSSDVPC
//
>1nfd_2B [b.1.1 - b.1.1] N15 ALPHA-BETA T-CELL RECEPTOR
DSGVVQSPRHIIKEKGGRSVLTCIPISGHSNVVWYQQTLGKELKFLIQHYEKVERDKGFL
PSRFSVQQFDDYHSEMNMSALELEDSAMYFCASSLRWGDEQYFGPGTRLTVLEDLRNVTP
PKVSLFEPSKAEIANKQKATLVCLARGFFPDHVELSWWVNGKEVHSGVSTDPQAYKESNY
SYSLSSRLRVSATFWHNPRNHFRCQVQFHGLSEEDKWPEGSPKPVTQNISAEAWGRADC
//
>1nfi_1A [b.2.5 - b.1.18] NF-KAPPA-B P65
YVEIIEQPKQRGMRFRYKCEGRSAGSIPGERSTDTTKTHPTIKINGYTGPGTVRISLVTK
DPPHRPHPHELVGKDCRDGFYEAELCPDRCIHSFQNLGIQCVKKRDLEQAISQRIQTNNN
PFQVPIEEQRGDYDLNAVRLCFQVTVRDPSGRPLRLPPVLPHPIFDNRAPNTAELKICRV
NRNSGSCLGGDEIFLLCDKVQKEDIEVYFTGPGWEARGSFSQADVHRQVAIVFRTPPYAD
PSLQAPVRVSMQLRRPSDRELSEPMEFQYLPDTDDRHRIEEKRKRTYETFKSIM
//
>1nfi_1B [b.1.18] NF-KAPPA-B P50
SNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHR
QFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEI
//
>1nfi_2C [b.2.5 - b.1.18] NF-KAPPA-B P65
YVEIIEQPKQRGMRFRYKCEGRSAGSIPGERSTDTTKTHPTIKINGYTGPGTVRISLVTK
DPPHRPHPHELVGKDCRDGFYEAELCPDRCIHSFQNLGIQCVKKRDLEQAISQRIQTNNN
PFQVPIEEQRGDYDLNAVRLCFQVTVRDPSGRPLRLPPVLPHPIFDNRAPNTAELKICRV
NRNSGSCLGGDEIFLLCDKVQKEDIEVYFTGPGWEARGSFSQADVHRQVAIVFRTPPYAD
PSLQAPVRVSMQLRRPSDRELSEPMEFQYLPDTDDRHRIEEKRKRTYETFKSIMKKSPFS
//
>1nfi_2E [d.211.1] I-KAPPA-B-ALPHA
LTEDGDSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEA
LLGAGCDPELRDFRGNTPLHLACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHL
ASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQ
GYSPYQLTWGRPSTRIQQQLGQLTLENLQMLP
//
>1ngm_1A [d.129.1 - d.129.1] TRANSCRIPTION INITIATION FACTOR TFIID
SGIVPTLQNIVATVTLGCRLDLKTVALHARNAEYNPKRFAAVIMRIREPKTTALIFASGK
MVVTGAKSEDDSKLASRKYARIIQKIGFAAKFTDFKIQNIVGSCDVKFPIRLEGLAFSHG
TFSSYEPELFPGLIYRMVKPKIVLLIFVSGKIVLTGAKQREEIYQAFEAIYPVLSEFRKM
//
>1ngm_1B [j.104.1] TRANSCRIPTION FACTOR IIIB BRF1 SUBUNIT
GSYCPRNLHLLPTTDTYLSKVSDDPDNLEDVDDEELNAHLLNEEASKLKERIWIGLNADF
LLEQESKRLKQE
//
>1ngm_2M (A) [d.129.1 - d.129.1] TRANSCRIPTION INITIATION FACTOR TFIID
SGIVPTLQNIVATVTLGCRLDLKTVALHARNAEYNPKRFAAVIMRIREPKTTALIFASGK
MVVTGAKSEDDSKLASRKYARIIQKIGFAAKFTDFKIQNIVGSCDVKFPIRLEGLAFSHG
TFSSYEPELFPGLIYRMVKPKIVLLIFVSGKIVLTGAKQREEIYQAFEAIYPVLSEFRKM
//
>1ngm_2N (J) [j.104.1] TRANSCRIPTION FACTOR IIIB BRF1 SUBUNIT
KVSDDPDNLEDVDDEELNAHLLNEEASKLKERIWIGLNADFLLEQESKRLKQE
//
>1ngpL [b.1.1 - b.1.1] N1G9 (IGG1-LAMBDA)
QAVVTQESALTTSPGETVTLTCRSSTGAVTTSNYANWVQEKPDHLFTGLIGGTNNRAPGV
PARFSGSLIGDKAALTITGAQTEDEAIYFCALWYSNHWVFGGGTKLTVLGQPKSSPSVTL
FPPSSEELETNKATLVCTITDFYPGVVTVDWKVDGTPVTQGMETTQPSKQSNNKYMASSY
LTLTARAWERHSSYSCQVTHEGHTVEKSLSR
//
>1ngpH [b.1.1 - b.1.1] N1G9 (IGG1-LAMBDA)
QVQLQQPGAELVKPGASVKLSCKASGYTFTSYWMHWVKQRPGRGLEWIGRIDPNSGGTKY
NEKFKSKATLTVDKPSSTAYMQLSSLTSEDSAVYYCARYDYYGSSYFDYWGQGTTLTVSS
AKTTPPSVYPLAPGSSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTLS
SSVTVPSSPWPSETVTCNVAHPASSTKVDKKIVPR
//
>1ngw_2A (L) [b.1.1 - b.1.1] MATURE METAL CHELATASE CATALYTIC ANTIBODY, LIGHT
ELVMTQTPKFMSTTVGDRVSITCKASQNVGTPVAWYQQKPGQSPKLLIYSASNRYTGVPD
RFTGSGSGTDFTLTISNMQSEDLADYFCQQYSSYPLTFGGGTKVEIKRTVAAPSVFIFPP
SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT
LSKADYEKHKVYACEVTHQGLSSPVTKSFNRNE
//
>1ngw_2B (H) [b.1.1 - b.1.1] MATURE METAL CHELATASE CATALYTIC ANTIBODY, HEAVY
QVQLLESGAELVKPGASVKLSCKASGYTFTSYWMHWVKQRPGRGLEWIGMIDPNSGGTKY
NEKFKSKATLTVDKPSNTAYMQLSSLTSEDSAVYYCTRRDMDYWGAGTTVTVSSASTKGP
SVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLS
SVVTVPSSSLGTQTYICNVNHKPSNTKVDKKIVPKS
//
>1nh2A [d.129.1 - d.129.1] TRANSCRIPTION INITIATION FACTOR TFIID
SGIVPTLQNIVATVTLGCRLDLKTVALHARNAEYNPKRFAAVIMRIREPKTTALIFASGK
MVVTGAKSEDDSKLASRKYARIIQKIGFAAKFTDFKIQNIVGSCDVKFPIRLEGLAFSHG
TFSSYEPELFPGLIYRMVKPKIVLLIFVSGKIVLTGAKQREEIYQAFEAIYPVLSEFRKM
//
>1nh2C [b.56.1] TRANSCRIPTION INITIATION FACTOR IIA LARGE CHAIN
DYLIENLMLCLYDKVTRTKARWKCSLKDGVVTINRNDYTFQKAQVEAEWV
//
>1nh2D [a.32.1 - b.56.1] TRANSCRIPTION INITIATION FACTOR IIA SMALL CHAIN
GYYELYRRSTIGNSLVDALDTLISDGRIEASLAMRVLETFDKVVAETLKDNTQSKLTVKG
NLDTYGFCDDVWTFIVKNCQVTVEDQSVISVDKLRIVACNSKKS
//
>1nh2B [a.32.1] TRANSCRIPTION INITIATION FACTOR IIA LARGE CHAIN
NAEASRVYEIIVESVVNEVREDFENAGIDEQTLQDLKNIWQKKLTE
//
>1nj9_1L [b.1.1 - b.1.1] IMMUNOGLOBULIN VARIABLE CHAIN
QAVVTQESALTTSPGETVTLTCRSSTGTITSDNYANWVQEKPDHLFSGLIGVNNARPPGV
PARFSGSLTGDKAVLTITGAQTEDEAIYFCALWYSNHWVFGGGTKLTVLGQPKSSPSVTL
FPPSSEELETNKATLVCTITDFYPGVVTVDWKVDGTPVTQGMETTQPSKQSNNKYMASSY
LTLTAREWERHSSYSCQVTHEGHTVEKSLSRA
//
>1nj9_1H [b.1.1 - b.1.1] IMMUNOGLOBULIN HEAVY CHAIN
EVQLQQSGPELVKPGASVKVSCKASGYSFTDYNMYWVKQNHGESLEWIAYIDPSNGDTFY
NQKFQGKATVTLDKSSSTAFMHLNSLTSEDSAVYYCARGGGLFAFWGQGTLVTVSAKTTP
PSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTLS
SSVTVPSSPRPSETVTCNVAHPASSTKVDKKIVPR
//
>1nkp_1A [a.38.1] MYC PROTO-ONCOGENE PROTEIN
GHMNVKRRTHNVLERQRRNELKRSFFALRDQIPELENNEKAPKVVILKKATAYILSVQAE
EQKLISEEDLLRKRREQLKHKLEQLGGC
//
>1nkp_1B [a.38.1] MAX PROTEIN
DKRAHHNALERKRRDHIKDSFHSLRDSVPSLQGEKASRAQILDKATEYIQYMRRKNHTHQ
QDIDDLKRQNALLEQQVRALGGC
//
>1nl0H [b.1.1 - b.1.1] ANTI-FACTOR IX ANTIBODY, 10C12, CHAIN H
GVQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAIISYDGSKKYY
ADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARASIAAARVLDYWGRGTMVTVSS
ASTKGPSVFPLAPTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSV
VTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCD
//
>1nl0G [g.32.1] FACTOR IX
YNSGKLxxFVQGNLxRxCMxxKCSFxxARxVFxNTxRTTxFWKQY
//
>1nldL [b.1.1 - b.1.1] FAB1583
DVVMTQTPLTLSVTIGQPASISCKSSQSLLDSDGKTYLNWLLQRPGQSPKRLIYLVSKLD
SGVPDRFTGSGSGTDFTLKISRVEAEDLGVYYCWQGTHFPRTFGGGTKLEIKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1nldH [b.1.1 - b.1.1] FAB1583
QVKLQQSGPGLVQPSQSLSITCTVSGFSLTCYGVHWVRQSPGKGLEWLGVIWSGGDTDYN
AAFISRLSITKDNSKSQVFFKMNSLQPNDRAIYYCARRGGDFWGQGTTVTVSSASTTAPS
VYPLAPVSGDQTNSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDLYTLSSS
VTVTSSPWPSETITCNVAHPASSTKVDKKIEPRGC
//
>1nlw_1A [a.38.1] MAD PROTEIN
SRSTHNEMEKNRRAHLRLSLEKLKGLVPLGPDSSRHTTLSLLTKAKLHIKKLEDSDRKAV
HQIDQLQREQRHLKRQLEK
//
>1nlw_1B [a.38.1] MAX PROTEIN
KRAHHNALERKRRDHIKDSFHSLRDSVPSLQGEKASRAQILDKATEYIQYMRRKNHTHQQ
DIDDLKRQNALLEQQV
//
>1nmbN [b.68.1] N9 NEURAMINIDASE
REFNNLTKGLCTINSWHIYGKDNAVRIGEDSDVLVTREPYVSCDPDECRFYALSQGTTIR
GKHSNGTIHDRSQYRDLISWPLSSPPTVYNSRVECIGWSSTSCHDGRARMSICISGPNNN
ASAVIWYNRRPVTEINTWARNILRTQESECVCQNGVCPVVFTDGSATGPAETRIYYFKEG
KILKWEPLTGTAKHIEECSCYGEQAGVTCTCRDNWQGSNRPVIQIDPVAMTHTSQYICSP
VLTDNPRPNDPTVGKCNDPYPGNNNNGVKGFSYLDGGNTWLGRTISIASRSGYEMLKVPN
ALTDDRSKPTQGQTIVLNTDWSGYSGSFMDYWAEGECYRACFYVELIRGRPKEDKVWWTS
NSIVSMCSSTEFLGQWNWPDGAKIEYFL
//
>1nmbL [b.1.1] FAB NC10
DIQMTQTTSSLSASLGDRVTISCRASQDISNYLNWYQQNPDGTVKLLIYYTSNLHSEVPS
RFSGSGSGTDYSLTISNLEQEDIATYFCQQDFTLPFTFGGGTKLEIRRA
//
>1nmbH [b.1.1] FAB NC10
QVQLQQPGAELVKPGASVRMSCKASGYTFTNYNMYWVKQSPGQGLEWIGIFYPGNGDTSY
NQKFKDKATLTADKSSNTAYMQLSSLTSEDSAVYYCARSGGSYRYDGGFDYWGQGTTLTV
SS
//
>1nmeA [c.17.1] CASPASE-3
SGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNK
NDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRC
RSLTGKPKLFIIQACRGTELDCGIET
//
>1nmeB [c.17.1] CASPASE-3
KIPVDADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVAT
EFESFSFDATFHAKKQIPCIVSMLTKELYFYH
//
>1nmu_1A [c.94.1] MALTOSE-BINDING PERIPLASMIC PROTEIN
EEGKLVIWINGDKGYNGLAEVGKKFEKDTGIKVTVEHPDKLEEKFPQVAATGDGPDIIFW
AHDRFGGYAQSGLLAEITPDKAFQDKLYPFTWDAVRYNGKLIAYPIAVEALSLIYNKDLL
PNPPKTWEEIPALDKELKAKGKSALMFNLQEPYFTWPLIAADGGYAFKYENGKYDIKDVG
VDNAGAKAGLTFLVDLIKNKHMNADTDYSIAEAAFNKGETAMTINGPWAWSNIDTSKVNY
GVTVLPTFKGQPSKPFVGVLSAGINAASPNKELAKEFLENYLLTDEGLEAVNKDKPLGAV
ALKSYEEELAKDPRIAATMENAQKGEIMPNIPQMSAFWYAVRTAVINAASGRQTVDEALK
DAQTNSSS
//
>1nmu_1B [d.79.3] 60S RIBOSOMAL PROTEIN L30
APVKSQESINQKLALVIKSGKYTLGYKSTVKSLRQGKSKLIIIAANTPVLRKSELEYYAM
LSKTKVYYFQGGNNELGTAVGKLFRVGVVSILEAGDSDILTTLA
//
>1nov_2A [b.121.4] NODAMURA VIRUS COAT PROTEINS
NMLKMSAPGLDFLKCAFASPDFSTDPGKGIPDKFQGLVLPKKHCLTQSITFTPGKQTMLL
VAPIPGIACLKAEANVGASFSGVPLASVEFPGFDQLFGTSATDTAANVTAFRYASMAAGV
YPTSNLMQFAGSIQVYKIPLKQVLNSYSQTVATVPPTNLAQNTIAIDGLEALDALPNNNY
SGSFIEGCYSQSVCNEPEFEFHPIMEGYASVPPANVTNAQASMFTNLTFSGARYTGLGDM
DAIAILVTTPTGAVNTAVLKVWACVEYRPNPNSTLYEFARESPANDEYALAAYRKIARDI
PIAVACKDN
//
>1nov_2D [x.x.x] NODAMURA VIRUS COAT PROTEINS
ATFWERVRSILKSGLNFAST
//
>1npeA [b.68.5] NIDOGEN
GTHLLFAQTGKIERLPLERNTMKKTEAKAFLHIPAKVIIGLAFDCVDKVVYWTDISEPSI
GRASLHGGEPTTIIRQDLGSPEGIALDHLGRTIFWTDSQLDRIEVAKMDGTQRRVLFDTG
LVNPRGIVTDPVRGNLYWTDWNRDNPKIETSHMDGTNRRILAQDNLGLPNGLTFDAFSSQ
LCWVDAGTHRAECLNPAQPGRRKVLEGLQYPFAVTSYGKNLYYTDWKTNSVIAMDLAISK
EMDTFHPHKQTRLYGITIALSQC
//
>1npeB [g.3.11 - g.3.11 - g.3.11] LAMININ GAMMA-1 CHAIN
QPCPCPGGSSCAIVPKTKEVVCTHCPTGTAGKRCELCDDGYFGDPLGSNGPVRLCRPCQC
NDNIDPNAVGNCNRLTGECLKCIYNTAGFYCDRCKEGFFGNPLAPNPADKCKACACNPYG
TVQQQSSCNPVTGQCQCLPHVSGRDCGTCDPGYYNLQSGQGCER
//
>1nqlA [c.10.2 - g.3.9 - c.10.2 - g.3.9] EPIDERMAL GROWTH FACTOR RECEPTOR
EKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVA
GYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHG
AVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEEN
CQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPP
LMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKC
KKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPP
LDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNIT
SLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVC
HALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCKLLEGEPREFVENSECIQCHPECLPQA
MNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTY
GCTGPGLEGCPT
//
>1nqlB [g.3.11] EPIDERMAL GROWTH FACTOR
DSECPLSHDGYCLHDGVCMYIEALDKYACNCVVGYIGERCQYRDLKWW
//
>1nrjA [d.110.4] SIGNAL RECOGNITION PARTICLE RECEPTOR ALPHA
MFDQLAVFTPQGQVLYQYNCLGKKFSEIQINSFISQLITSPVTRKESVANANTDGFDFNL
LTINFNALFYLNKQPELYFVVTFAEQTLELNQETQQTLALVLKLWNSLHLSESILKNRQG
QNEKNKHNYVDILQGIEDDLKKFEQYF
//
>1nrjB [c.37.1] SIGNAL RECOGNITION PARTICLE RECEPTOR BETA
SYQPSIIIAGPQNSGKTSLLTLLTTDSVRPTVVSQEPLSAADYDGSGVTLVDFPGHVKLR
YKLSDYLKTRAKFVKGLIFMVDSTVDPKKLTTTAEFLVDILSITESSCENGIDILIACNK
SELFTARPPSKIKDALESEIQKVIERRKKSLNELDVLGFKFANLEASVVAFEGSINKRKI
SQWREWIDEKL
//
>1nsnL [b.1.1 - b.1.1] IGG FAB (IGG1, KAPPA)
DIVLTQSPSSLAVSLGQRATISCRASQSVSTSSFRYMHWYQQKPGQPPRLLIKYASNLES
GVPARFSGSGSGTDFTLNIHPVEEEDTATYYCQHSWEIPYTFGGGTKLEIKRADAAPTVS
IFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMS
STLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNE
//
>1nsnH [b.1.1 - b.1.1] IGG FAB (IGG1, KAPPA)
DVQLQESGPGLVKPSQSLSLTCTVTGYSITSDYAWNWIRQFPGNKLEWMGYITYSGTTSY
NPSLKSRISISRDTSKNQFFMQLNSVTTEDTGTFYCTRGNGDWGQGTTLTVSSAKTTPPS
VYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTLSSS
VTVPSSPRPSETVTCNVAHPASSTKVDKKI
//
>1nsnS [b.40.1] STAPHYLOCOCCAL NUCLEASE
TKKLHKEPATLIKAIDGDTVKLMYKGQPMTFRLLLVDTPETKHPKKGVEKYGPEASAFTK
KMVENAKKIEVEFDKGQRTDKYGRGLAYIYADGKMVNEALVRQGLAKVAYVYKPNNTHEQ
HLRKSEAQAKKEKLNIWS
//
>1nt2A [c.66.1] FIBRILLARIN-LIKE PRE-RRNA PROCESSING PROTEIN
KELMRNVYLLDDTLVTKSKYGSHYGEKVFDGYREWVPWRSKLAAMILKGHRLKLRGDERV
LYLGAASGTTVSHLADIVDEGIIYAVEYSAKPFEKLLELVRERNNIIPLLFDASKPWKYS
GIVEKVDLIYQDIAQKNQIEILKANAEFFLKEKGEVVIMVKARSIDSTAEPEEVFKSVLK
EMEGDFKIVKHGSLMPYHRDHIFIHAYRF
//
>1nt2B [a.183.1] CONSERVED HYPOTHETICAL PROTEIN
LRYNLWFGVYDGKEIKLSENFEESFLKAENPSPLPFNVSEVGAKALGKDYYRILRKTALA
VSEKMVEKELRREDRYVVALVKALEEIDESINMLNEKLEDIRAVKESEITEKFEKKIREL
RELRRDVEREIEEVMEKIAPNMTELVGAKVAAKLLERAGSMERLVRLPASKIQVIGAEHG
IIFLHPFIRTLPKAKRGKMARFLAAKLAIAAKIDYFRGEIDESLYESIRRRYEELR
//
>1ntkA [d.185.1 - d.185.1] UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX CORE
TATYAQALQSVPETQVSQLDNGLRVASEQSSQPTCTVGVWIDAGSRYESEKNNGAGYFVE
HLAFKGTKNRPGNALEKEVESMGAHLNAYSTREHTAYYIKALSKDLPKAVELLADIVQNC
SLEDSQIEKERDVILQELQENDTSMRDVVFNYLHATAFQGTPLAQSVEGPSENVRKLSRA
DLTEYLSRHYKAPRMVLAAAGGLEHRQLLDLAQKHFSGLSGTYDEDAVPTLSPCRFTGSQ
ICHREDGLPLAHVAIAVEGPGWAHPDNVALQVANAIIGHYDCTYGGGAHLSSPLASIAAT
NKLCQSFQTFNICYADTGLLGAHFVCDHMSIDDMMFVLQGQWMRLCTSATESEVLRGKNL
LRNALVSHLDGTTPVCEDIGRSLLTYGRRIPLAEWESRIAEVDARVVREVCSKYFYDQCP
AVAGFGPIEQLPDYNRIRSGMFWLRF
//
>1ntkI [d.184.1] UBIQUINOL-CYTOCHROME C REDUCTASE 8 KDA PROTEIN
MLSVAARSGPFAPVLSATSRGVAGALRPLVQAAVPATSESPVLDLKRSVLCRESLRG
//
>1ntkJ [f.23.14] UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX 7.2 KDA
APTLTARLYSLLFRRTSTFALTIVVGALFFERAFDQGADAIYEHINEGKLWKHIKHKYEN
//
>1ntkK [f.23.15] UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX 6.4 KDA
MLTRFLGPRYRQLARNWVPTAQLWGAVGAVGLVWATDWRLILDWVPYINGKFK
//
>1ntmE [f.23.12 - b.33.1] UBIQUINOL-CYTOCHROME C REDUCTASE IRON-SULFUR
SHTDIKVPDFSDYRRPEVLDSTKSSKESSEARKGFSYLVTATTTVGVAYAAKNVVSQFVS
SMSASADVLAMSKIEIKLSDIPEGKNMAFKWRGKPLFVRHRTKKEIDQEAAVEVSQLRDP
QHDLERVKKPEWVILIGVCTHLGCVPIANAGDFGGYYCPCHGSHYDASGRIRKGPAPLNL
EVPSYEFTSDDMVIVG
//
>1ntmJ [f.23.14] UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX 7.2 KDA
VAPTLTARLYSLLFRRTSTFALTIVVGALFFERAFDQGADAIYEHINEGKLWKHIKHKYE
//
>1ntzB [d.185.1 - d.185.1] UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX CORE
VPPHPQDLEFTRLPNGLVIASLENYAPASRIGLFIKAGSRYENSNNLGTSHLLRLASSLT
TKGASSFKITRGIEAVGGKLSVTSTRENMAYTVECLRDDVDILMEFLLNVTTAPEFRRWE
VAALQPQLRIDKAVALQNPQAHVIENLHAAAYRNALANSLYCPDYRIGKVTPVELHDYVQ
NHFTSARMALIGLGVSHPVLKQVAEQFLNIRGGLGLSGAKAKYHGGEIREQNGDSLVHAA
LVAESAAIGSAEANAFSVLQHVLGAGPHVKRGSNATSSLYQAVAKGVHQPFDVSAFNASY
SDSGLFGFYTISQAASAGDVIKAAYNQVKTIAQGNLSNPDVQAAKNKLKAGYLMSVESSE
GFLDEVGSQALAAGSYTPPSTVLQQIDAVADADVINAAKKFVSGRKSMAASGNLGHTPFI
DEL
//
>1ntzF [f.27.1] UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX 14 KDA
VSASSRWLEGIRKWYYNAAGFNKLGLMRDDTIHENDDVKEAIRRLPENLYDDRVFRIKRA
LDLSMRQQILPKEQWTKYEEDKSYLEPYLKEVIRERKEREEWAKK
//
>1ntzL (F) [f.27.1] UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX 14 KDA
VSASSRWLEGIRKWYYNAAGFNKLGLMRDDTIHENDDVKEAIRRLPENLYDDRVFRIKRA
LDLSMRQQILPKEQWTKYEEDKSYLEPYLKEVIRERKEREEWAKK
//
>1ntzO (K) [f.23.15] UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX 6.4 KDA
MLTRFLGPRYRQLARNWVPTAQLWGAVGAVGLVWATDWRLILDWVPYINGKFK
//
>1nunA [b.42.1] FIBROBLAST GROWTH FACTOR-10
SYNHLQGDVRWRKLFSFTKYFLKIEKNGKVSGTKKENCPYSILEITSVEIGVVAVKAINS
NYYLAMNKKGKLYGSKEFNNDCKLKERIEENGYNTYASFNWQHNGRQMYVALNGKGAPRR
GQKTRRKNTSAHFLPMVVH
//
>1nunB [b.1.1 - b.1.1] FIBROBLAST GROWTH FACTOR RECEPTOR 2 ISOFORM 2
KRAPYWTNTEKmEKRLHAVPAANTVKFRCPAGGNPmPTmRWLKNGKEFKQEHRIGGYKVR
NQHWSLImESVVPSDKGNYTCVVENEYGSINHTYHLDVVERSPHRPILQAGLPANASTVV
GGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKHSGINSSNAEVLALFNV
TEADAGEYICKVSNYIGQANQSAWLTVLP
//
>1nvm_1C [c.1.10 - a.5.7] 4-HYDROXY-2-OXOVALERATE ALDOLASE
FNPSKKLYISDVTLRDGSHAIRHQYTLDDVRAIARALDKAKVDSIEVAHGDGLQGSSFNY
GFGRHTDLEYIEAVAGEISHAQIATLLLPGIGSVHDLKNAYQAGARVVRVATHCTEADVS
KQHIEYARNLGMDTVGFLMMSHMIPAEKLAEQGKLMESYGATCIYMADSGGAMSMNDIRD
RMRAFKAVLKPETQVGMHAHHNLSLGVANSIVAVEEGCDRVDASLAGMGAGAGNAPLEVF
IAVAERLGWNHGTDLYTLMDAADDIVRPLQDRPVRVDRETLGLGYAGVYSSFLRHAEIAA
AKYNLKTLDILVELGHRRMVGGQEDMIVDVALDLLAA
//
>1nvm_1D [c.2.1 - d.81.1] ACETALDEHYDE DEHYDROGENASE (ACYLATING)
QKLKVAIIGSGNIGTDLMIKVLRNAKYLEMGAMVGIDAASDGLARAQRMGVTTTYAGVEG
LIKLPEFADIDFVFDATSASAHVQNEALLRQAKPGIRLIDLTPAAIGPYCVPVVNLEEHL
GKLNVNMVTCGGQATIPMVAAVSRVAKVHYAEIVASISSKSAGPGTRANIDEFTETTSKA
IEVIGGAAKGKAIIIMNPAEPPLIMRDTVYVLSAAADQAAVAASVAEMVQAVQAYVPGYR
LKQQVQFDVIPESAPLNIPGLGRFSGLKTSVFLEVEGAAHYLPAYAGNLDIMTSAALATA
ERMAQSML
//
>1nvpA [d.129.1 - d.129.1] TATA BOX BINDING PROTEIN
SGIVPQLQNIVSTVNLGCKLDLKTIALRARNAEYNPKRFAAVIMRIREPRTTALIFSSGK
MVCTGAKSEEQSRLAARKYARVVQKLGFPAKFLDFKIQNMVGSCDVKFPIRLEGLVLTHQ
QFSSYEPELFPGLIYRMIKPRIVLLIFVSGKVVLTGAKVRAEIYEAFENIYPILKGFRK
//
>1nvpC [b.56.1] TRANSCRIPTION INITIATION FACTOR IIA BETA CHAIN
DTENVVVCQYDKIHRSKNKWKFHLKDGIMNLNGRDYIFSKAIGDAEW
//
>1nvpB [a.32.1] TRANSCRIPTION INITIATION FACTOR IIA ALPHA CHAIN
TVPKLYRSVIEDVINDVRDIFLDDGVDEQVLMELKTLWENKLM
//
>1nvpD [a.32.1 - b.56.1] TRANSCRIPTION INITIATION FACTOR IIA GAMMA CHAIN
YQLYRNTTLGNSLQESLDELIQSQQITPQLALQVLLQFDKAINAALAQRVRNRVNFRGSL
NTYRFCDNVWTFVLNDVEFREVTELIKVDKVKIVACD
//
>1nw9A [g.52.1] BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 4
LPRNPSMADYEARIFTFGTWIYSVNKEQLARAGFYALGEGDKVKCFHCGGGLTDWKPSED
PWEQHAKWYPGCKYLLEQKGQEYINNIHLTH
//
>1nw9B [c.17.1] CASPASE 9, APOPTOSIS-RELATED CYSTEINE PROTEASE
GALESLRGNADLAYILSMEPCGHCLIINNVNFCRESGLRTRTGSNIDCEKLRRRFSSLHF
MVEVKGDLTAKKMVLALLELARQDHGALDCCVVVILSHGCQASHLQFPGAVYGTDGCPVS
VEKIVNIFNGTSCPSLGGKPKLFFIQACGATPFQSSLPTPSDIFVSYSTFPGFVSWRDPK
SGSWYVETLDDIFEQWAHSEDLQSLLLRVANAVSVKGIYKQMPGCFNFLRKKLFFKTS
//
>1ny7_21 [b.121.4] COWPEA MOSAIC VIRUS, SMALL (S) SUBUNIT
GPVCAEASDVYSPCMIASTPPAPFSDVTAVTFDLINGKITPVGDDNWNTHIYNPPIMNVL
RTAAWKSGTIHVQLNVRGAGVKRADWDGQVFVYLRQSMNPESYDARTFVISQPGSAMLNF
SFDIIGPNSGFEFAESPWANQTTWYLECVATNPRQIQQFEVNMRFDPNFRVAGNILMPPF
PLSTETPPL
//
>1ny7_22 [b.121.4 - b.121.4] COWPEA MOSAIC VIRUS, LARGE (L) SUBUNIT
MEQNLFALSLDDTSSVRGSLLDTKFAQTRVLLSKAMAGGDVLLDEYLYDVVNGQDFRATV
AFLRTHVITGKIKVTATTNISDNSGCCLMLAINSGVRGKYSTDVYTICSQDSMTWNPGCK
KNFSFTFNPNPCGDSWSAEMISRSRVRMTVICVSGWTLSPTTDVIAKLDWSIVNEKCEPT
IYHLADCQNWLPLNRWMGKLTFPQGVTSEVRRMPLSIGGGAGATQAFLANMPNSWISMWR
YFRGELHFEVTKMSSPYIKATVTFLIAFGNLSDAFGFYESFPHRIVQFAEVEEKCTLVFS
QQEFVTAWSTQVNPRTTLEADGCPYLYAIIHDSTTGTISGDFNLGVKLVGIKDFCGIGSN
PGIDGSRLL
//
>1nys_1A [g.7.1] ACTIVIN RECEPTOR
ETRECIYYNANWELERTNQSGLERCEGDKRLHCYASWRNSSGTIELVKKGCWLDDFNCYD
RQECVATEENPQVYFCCCEGNFCNERFTHLP
//
>1nys_1B [g.17.1] INHIBIN BETA A CHAIN
LECDGNICCKKQFFVSFKDIGWNDWIIAPSGYHANYCEGECPSHILKSCCVPTKLRPMSM
LYYDDGQNIIKKDIQNMIVEECGCS
//
>1nys_2C [g.7.1] ACTIVIN RECEPTOR
ETRECIYYNANWELERTNQSGLERCEGEQDKRLHCYASWRNSSGTIELVKKGCWLDDFNC
YDRQECVATEENPQVYFCCCEGNFCNERFTHL
//
>1nys_2D [g.17.1] INHIBIN BETA A CHAIN
ICCKKQFFVSFKDIWNDWIIAPSGYHANYCGECPSLKSCCVPTKLRPMSMLYYDDGQNII
KKDIQNMIVEECGCS
//
>1nyu_2C [g.7.1] ACTIVIN RECEPTOR
TRECIYYNANWLERTNQSGLERCEGEQDKRLHCYASWTIELVKKGCWLDFNCYECVATEE
NPQVYFCCCEGNFCNERFTHLPE
//
>1nyu_2D [g.17.1] INHIBIN BETA A CHAIN
CCKKFFVSIIAPSGYHNYCEGECPCCVPTKLRPMSMLYYDDGIIKKDIQNMIVEECGCS
//
>1o19S (A) [i.15.1] SKELETAL MUSCLE MYOSIN II
DAEMAAFGEAAPYLRxSEKERIEAQNxPFDAxSSVFVVHPKQSFVxGTIQSxEGGxVTVx
TEGGETLTVKEDQVFSMNPPxYDxIEDMAMMTHLHEPAVLYNLxERYAAWMIYTYSGLFC
VTVNPYxWLPVYNPxVVLAYRGKKRQEAPPHIFSISDNAYQFMLTDRENQSILITGESGA
GKTVNTxRVIQYFATIAASGEKKKEEQSGKMQGTLEDQIISANPLLEAFGNAxTVRNDNS
SRFGxFIRIHFGATGKLASADIETYLLExSRVTFQLPAERSYHIFYQIMSNxxPELIDML
LITTNPYDYHYVSEGEITVPSIDDQEELMATDSAIDILGFSADExTAIYxLTGAVMHYGN
LKFxQxQREEQAEPDGTEVADxAAYLMGLNSAELLKALCYPRVGVGNEAVTxGETVSEVH
NSVGALAxAVYExMFLWMVIRINQQLDTKQPRQYFIGVLDIAGFEIFDFNSFEQLCINFT
NExLQQFFNHHMFVLEQEEYxxEGIEWEFIDFGMDLAACIELIExPMGIFSILEEECMFP
KATDTSFxNxLYDEHLGKSNNFQKPKPAKGKAEAHFSLVHYAGTVDYNISGWLExNxDPL
NETVIGLYQxSSVxTLALLFATYGGEAEGGGGKKGGKKKGSSFQTVSALFRENLNxLMAN
LRSTHPHFVRCIIPNETxTPGAMEHELVLHQLRCNGVLEGIRICRKGFPSRVLYADFKQR
YRVLNASAIPEGQFMDSKKASEKLLGGGDVDHTQYAFGHTxVFFxAGLLGLLEEMRDDxL
AEIITATQARCRGFLMRVEYRAMVERRESIFCIQYNVRSFMNVxHWPWMxLFFxIxPLLK
//
>1o19U (C) [i.15.1] SKELETAL MUSCLE MYOSIN II ESSENTIAL LIGHT CHAIN
SKAAADDFKEAFLLFDRTGDAKITASQVGDIARALGQNPTNAEINKILGNPSKEEMNAAA
ITFEEFLPMLQAAANNKDQGTFEDFVEGLRVFDKEGNGTVMGAELRHVLATLGEKMTEEE
VEELMKGQEDSNGCINYEAFVKHIMSV
//
>1o5dL [g.3.11 - g.3.11] COAGULATION FACTOR VII
GDQCASSPCQNGGSCKDQLQSYICFCLPAFEGRNCETHKDDQLICVNENGGCEQYCSDHT
GTKRSCRCHEGYSLLADGVSCTPTVEYPCGKIPILE
//
>1o5dH [b.47.1] COAGULATION FACTOR VII
IVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHD
LSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERT
LAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGY
SDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMR
SEPRPGVLLRAPFP
//
>1o5dT [b.1.2 - b.1.2] TISSUE FACTOR
TVAAYNLTWKSTNFKTILEWEPKPVNQVYTVQISTKSGDWKSKCFYTTDTECDLTDEIVK
DVKQTYLARVFSYPAGNVESTGSAGEPLYENSPEFTPYLETNLGDERTLVRRNNTFLSLR
DVFGKDLIYTLYYSVQAVIPSRTVNRKSTDS
//
>1o5fL [d.170.1] SERINE PROTEASE HEPSIN
PLYPVQVSSADARLMVFDKTEGTWRLLCSSRSNARVAGLSCEEMGFLRALTHSELDVRTA
GAAGTSGFFCVDEGRLPHTQRLLEVISVCDCPRGRFLAAICQDCGRRKLP
//
>1o5fH [b.47.1] SERINE PROTEASE HEPSIN
IVGGRDTSLGRWPWQVSLRYDGAHLCGGSLLSGDWVLTAAHCFPERNRVLSRWRVFAGAV
AQASPHGLQLGVQAVVYHGGYLPFNSNDIALVHLSSPLPLTEYIQPVCLPAAGQALVDGK
ICTVTGWGNTQYYGQQAGVLQEARVPIISNDVCNGADFYGNQIKPKMFCAGYPEGGIDAC
QGDSGGPFVCEDSISRTPRWRLCGIVSWGTGCALAQKPGVYTKVSDFREWIFQAIKTHSE
ASGMVTQL
//
>1o7dA [c.6.2] LYSOSOMAL ALPHA-MANNOSIDASE
GYKTCPKVKPDMLNVHLVPHTHDDVGWLKTVDQYFYGIYNNIQPAGVQYILDSVISSLLA
NPTRRFIYVEIAFFSRWWRQQTNATQKIVRELVRQGRLEFANGGWVMNDEATTHYGAIID
QMTLGLRFLEETFGSDGRPRVAWHIDPFGHSREQASLFAQMGFDGFFFGRLDYQDKKVRK
KTLQMEQVWRASTSLKPPTADLFTSVLPNMYNPPEGLCWDMLCADKPVVEDTRSPEYNAK
ELVRYFLKLATDQGKLYRTKHTVMTMGSDFQYENANTWFKNLDKLIQLVNA
//
>1o7dB [c.6.2 - a.8.3] LYSOSOMAL ALPHA-MANNOSIDASE
IRVNVLYSTPACYLWELNKANLSWSVKKDDFFPYADGPYMFWTGYFSSRPALKRYERLSY
NFLQVCNQLEALAGP
//
>1o7dC [a.8.3 - b.30.5] LYSOSOMAL ALPHA-MANNOSIDASE
GDSAPLNEAMAVLQHHDAVSGTSRQHVANDYARQLSEGWRPCEVLMSNALAHLSGLKEDF
AFCRKLNISICPLTQTAERFQVIVYNPLGRKVDWMVRLPVSKHVYLVKDPGGKIVPSDVV
TIPSSDSQELLFSALVPAVGFSIYSVSQMP
//
>1o7dD [b.30.5] LYSOSOMAL ALPHA-MANNOSIDASE
RDLVIQNEYLRARFDPNTGLLMELENLLLLPVRQAFYWYNASTGNNLSSQASGAYIFRPN
QNKPLFVSHWAQTHLVKASLVQEVHQNFSAWCSQVVRLYPRQRHLELEWTVGPIPVGDGW
GKEVISRFDTALATRGLFYTDSNGREILERRRNYRPTWKLNQTEPVAGNYYPVNSRIYIT
DGNMQLTVLTDRSQGGSSLRDGSLELMVHRRLLKDDARGVGEPLNKEGSGLWVRGRHLVL
LDKKETAAARHRLQAEMEVLAPQVVLAQG
//
>1o7dE [b.30.5] LYSOSOMAL ALPHA-MANNOSIDASE
PRTQFSGLRRELPPSVRLLTLARWGPETLLLRLEHQFAVGEDSGRNLSSPVTLDLTNLFS
AFTITNLRETTLAANQLLAYASRLQWTTDATITLQPMEIRTFLASVQW
//
>1o94_3E [c.26.2] ELECTRON TRANSFER FLAVOPROTEIN BETA-SUBUNIT
MKILVAVKQTAALEEDFEIREDGMDVDEDFMMYDLNEWDDFSLEEAMKIKESSDTDVEVV
VVSVGPDRVDESLRKCLAKGADRAVRVWDDAAEGSDAIVVGRILTEVIKKEAPDMVFAGV
QSSDQAYASTGISVASYLNWPHAAVVADLQYKPGDNKAVIRRELEGGMLQEVEINCPAVL
TIQLGINKPRYASLRGIKQAATKPIEEVSLADIGLSANDVGAAQSMSRVRRMYIPE
//
>1o94_3F (D) [c.26.2] ELECTRON TRANSFER FLAVOPROTEIN ALPHA-SUBUNIT
SKILVIAEHRRNDLRPVSLELIGAANGLKKSGEDKVVVAVIGSQADAFVPALSVNGVDEL
VVVKGSSIDFDPDVFEASVSALIAAHNPSVVLLPHSVDSLGYASSLASKTGYGFATDVYI
VEYQGDELVATRGGYNQKVNVEVDFPGKSTVVLTIRPSVFKPLEGAGSPVVSNVDAPSVQ
SRSQNKDYV
//
>1o9k_1A [a.74.1] RETINOBLASTOMA TUMOUR SUPPRESSOR PROTEIN
MNTIQQLMMILNSASDQPSENLISYFNNCTVNPKESILKRVKDIGYIFKEKFAKAVGQGC
VEIGSQRYKLGVRLYYRVMESMLKSEEERLSIQNFSKLLNDNIFHMSLLACALEVVMATY
SRSSGTDLSFPWILNVLNLKAFDFYKVIESFIKAEGNLTREMIKHLERCEHRIMESLAWL
SDSPLFDLIKQSK
//
>1o9k_1B [a.74.1] RETINOBLASTOMA TUMOUR SUPPRESSOR PROTEIN
STSLSLFYKKVYRLAYLRLNTLCERLLSEHPELEHIIWTLFQHTLQNEYELMRDRHLDQI
MMCSMYGICKVKNIDLKFKIIVTAYKDLPHAVQETFKRVLIKEEEYDSIIVFYNSVFMQR
LKTNILQYASTRPPTLSPIPHIP
//
>1oaqH [b.1.1] HEAVY CHAIN
EVQLQQSGAELVKPGASVKLSCKASGYTFTSYWMHWVKQRPGRGLEWIGRIDPNGGGTKY
NEKFKSKATLTVDKPSSTAYMQLSSLTSEDSAVYYCARMWYYGTYYFDYWGQGTTLTVSS
//
>1oaqL [b.1.1] LIGHT CHAIN
QAVVTQESALTTSPGETVTLTCRSSTGAVTTSNYANWVQEKPDHLFTGLIGGTNNRAPGV
PARFSGSLIGNKAALTITGAQTEDEAIYFCALWYSNHLVFGGGTKLTVLG
//
>1oar_2I [b.1.1] IMMUNOGLOBULIN E
PGASVKLSCKASGYTFTSYWMHWVKQRLEWIGRIDGTKYNEKFKSKATLTVSTAYMQLSS
LDSAVYYCARMWYYGTYYFDYWGQGTTL
//
>1oar_2M [b.1.1] IMMUNOGLOBULING E
VVTQESALTTSPGETVTLTCRAVTTSNYANWVQEKPDHLFTGLIGGTNNRAPGVPARFSG
SLIGNKAALTITGAQTEDEAIYFCALWYSNHLVFGGGTKLTVL
//
>1oar_4K [b.1.1] IMMUNOGLOBULIN E
PGASVKLSCKTSYWMHWVKQRLEWIGRIDGTKYNEKFKSKATLTVSTAYMQLSSLDSAVY
YCARMWYYGTYYFDYWGQGTTL
//
>1oar_4O [b.1.1] IMMUNOGLOBULING E
VVTQESALTTSPGETVTLTCRSSTAVTTSNYANWVQEKPDHLFTGLIGGTNNRAPGVPAR
FSGSLIGNKAALTITGAQTEDEAIYFCALWYSNHLVFGGGTKLTVL
//
>1oaz_1A [c.47.1] THIOREDOXIN 1
SDKIIHLTDDSFDTDVLKADGAILVDFWAEWCGPIEESDDRRYDLVGPCKMIAPILDEIL
TVAKLNIDQNPGTAPKYGIRGIPTLLLFKNGEVAATKVGALSKGQLKEFLDANLA
//
>1oaz_1L [b.1.1] IMMUNOGLOBULIN E
AVVTQESALTTSPGETVTLTCRSSTGAVTTSNYANWVQEKPDHLFTGLIGGTNNRAPGVP
ARFSGSLIGNKAALTITGAQTEDEAIYFCALWYSNHLVFGGGTKLTVL
//
>1oaz_2B (A) [c.47.1] THIOREDOXIN 1
SDKIIHLTDDSFDTDVLKADGAILVDFWAEWCGPIEESDDRRYDLVGPCKMIAPILDEIL
TVAKLNIDQNPGTAPKYGIRGIPTLLLFKNGEVAATKVGALSKGQLKEFLDANLA
//
>1oaz_2J (H) [b.1.1] IMMUNOGLOBULIN E
EVQLQQSGAELVKPGASVKLSCKASGYTFTSYWMHWVKQRPGRGLEWIGRIDPNGGGTKY
NEKFKSKATLTVDKPSSTAYMQLSSLTSEDSAVYYCARMWYYGTYYFDYWGQGTTLTVSS
AA
//
>1ob1_1A [b.1.1 - b.1.1] ANTIBODY, HEAVY CHAIN
DIVMTQTPAIMSAFLGERVTMTCTATSSLSSSYLHWYQQKPGSSPKLWIYTTSNLASGVP
SRFSGSGSGTSYSLTISSMEAEDAATYYCHQFHHSPYTFGGGTKLEIKRADAAPTVSIFP
PSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTL
TLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1ob1_1B [b.1.1 - b.1.1] ANTIBODY, LIGHT CHAIN
ELQLVQSGPQLKKPGETVRISCKASGYTFTTAGIQWVQRLPGKDLKWIGWINTHSGVPQY
ADDFKGRFAFSLETSASTAFLQIINLKNEDTATYFCARNYYRFDGGMDFWGQGTSVTVSS
AKTTAPSVYPLAPVCGDTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSD
LYTLSSSVTVTSSTWPSQSITCNVAHPASSTKVDKKIEP
//
>1ob1_1C [g.3.11 - g.3.11] MEROZOITE SURFACE PROTEIN 1
NISQHQCVKKQCPQNSGCFRHLDEREECKCLLNYKQEGDKCVENPNPTCNENNGGCDADA
KCTEEDSGSNGKKITCECTKPDSYPLFDGIFCSHH
//
>1oc0A [e.1.1] PLASMINOGEN ACTIVATOR INHIBITOR-1
SYVAHLASDFGVRVFQQVAQASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFK
IDDKGMAPALRHLYKELMGPWNKDEISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVD
FSEVERARFIINDWVKTHTKGMISHLLGTGAVDQLTRLVLVNALYFNGQWKTPFPDSSTH
RRLFHKSDGSTVSVPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFIAAPYEKEV
PLSALTNILSAQLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLGMTDMFRQFQAD
FTSLSDQEPLHVALALQKVKIEVNESGTVASSAPEEIIIDRPFLFVVRHNPTGTVLFMGQ
VMEP
//
>1oc0B [g.64.1] VITRONECTIN
ESCKGRCTEGFNVDKKCQCDELCSYYQSCCTDYTAEC
//
>1occA [f.24.1] CYTOCHROME C OXIDASE
MFINRWLFSTNHKDIGTLYLLFGAWAGMVGTALSLLIRAELGQPGTLLGDDQIYNVVVTA
HAFVMIFFMVMPIMIGGFGNWLVPLMIGAPDMAFPRMNNMSFWLLPPSFLLLLASSMVEA
GAGTGWTVYPPLAGNLAHAGASVDLTIFSLHLAGVSSILGAINFITTIINMKPPAMSQYQ
TPLFVWSVMITAVLLLLSLPVLAAGITMLLTDRNLNTTFFDPAGGGDPILYQHLFWFFGH
PEVYILILPGFGMISHIVTYYSGKKEPFGYMGMVWAMMSIGFLGFIVWAHHMFTVGMDVD
TRAYFTSATMIIAIPTGVKVFSWLATLHGGNIKWSPAMMWALGFIFLFTVGGLTGIVLAN
SSLDIVLHDTYYVVAHFHYVLSMGAVFAIMGGFVHWFPLFSGYTLNDTWAKIHFAIMFVG
VNMTFFPQHFLGLSGMPRRYSDYPDAYTMWNTISSMGSFISLTAVMLMVFIIWEAFASKR
EVLTVDLTTTNLEWLNGCPPPYHTFEEPTYVNLK
//
>1occC [f.25.1] CYTOCHROME C OXIDASE
MTHQTHAYHMVNPSPWPLTGALSALLMTSGLTMWFHFNSMTLLMIGLTTNMLTMYQWWRD
VIRESTFQGHHTPAVQKGLRYGMILFIISEVLFFTGFFWAFYHSSLAPTPELGGCWPPTG
IHPLNPLEVPLLNTSVLLASGVSITWAHHSLMEGDRKHMLQALFITITLGVYFTLLQASE
YYEAPFTISDGVYGSTFFVATGFHGLHVIIGSTFLIVCFFRQLKFHFTSNHHFGFEAGAW
YWHFVDVVWLFLYVSIYWWGS
//
>1occD [f.23.1] CYTOCHROME C OXIDASE
SVVKSEDYALPSYVDRRDYPLPDVAHVKNLSASQKALKEKEKASWSSLSIDEKVELYRLK
FKESFAEMNRSTNEWKTVVGAAMFFIGFTALLLIWEKHYVYGPIPHTFEEEWVAKQTKRM
LDMKVAPIQGFSAKWDYDKNEWKK
//
>1occF [g.41.5] CYTOCHROME C OXIDASE
ASGGGVPTDEEQATGLEREVMLAARKGQDPYNILAPKATSGTKEDPNLVPSITNKRIVGC
ICEEDNSTVIWFWLHKGEAQRCPSCGTHYKLVPHQLAH
//
>1occT (G) [f.23.2] CYTOCHROME C OXIDASE
ASAAKGDHGGTGARTWRFLTFGLALPSVALCTLNSWLHSGHRERPAFIPYHHLRIRTKPF
SWGDGNHTFFHNPRVNPLPTGYEK
//
>1occI [f.23.3] CYTOCHROME C OXIDASE
STALAKPQMRGLLARRLRFHIVGAFMVSLGFATFYKFAVAEKRKKAYADFYRNYDSMKDF
EEMRKAGIFQSAK
//
>1ocoA [f.24.1] CYTOCHROME C OXIDASE
MFINRWLFSTNHKDIGTLYLLFGAWAGMVGTALSLLIRAELGQPGTLLGDDQIYNVVVTA
HAFVMIFFMVMPIMIGGFGNWLVPLMIGAPDMAFPRMNNMSFWLLPPSFLLLLASSMVEA
GAGTGWTVYPPLAGNLAHAGASVDLTIFSLHLAGVSSILGAINFITTIINMKPPAMSQYQ
TPLFVWSVMITAVLLLLSLPVLAAGITMLLTDRNLNTTFFDPAGGGDPILYQHLFWFFGH
PEVYILILPGFGMISHIVTYYSGKKEPFGYMGMVWAMMSIGFLGFIVWAHHMFTVGMDVD
TRAYFTSATMIIAIPTGVKVFSWLATLHGGNIKWSPAMMWALGFIFLFTVGGLTGIVLAN
SSLDIVLHDTYYVVAHFHYVLSMGAVFAIMGGFVHWFPLFSGYTLNDTWAKIHFAIMFVG
VNMTFFPQHFLGLSGMPRRYSDYPDAYTMWNTISSMGSFISLTAVMLMVFIIWEAFASKR
EVLTVDLTTTNLEWLNGCPPPYHTFEEPTYVNLK
//
>1ocoG [f.23.2] CYTOCHROME C OXIDASE
ASAAKGDHGGTGARTWRFLTFGLALPSVALCTLNSWLHSGHRERPAFIPYHHLRIRTKPF
SWGDGNHTFFHNPRVNPLPTGYEK
//
>1ocoH [a.51.1] CYTOCHROME C OXIDASE
YQTAPFDSRFPNQNQTRNCWQNYLDFHRCEKAMTAKGGDVSVCEWYRRVYKSLCPISWVS
TWDDRRAEGTFPGKI
//
>1ocoJ [f.23.4] CYTOCHROME C OXIDASE
FENRVAEKQKLFQEDNGLPVHLKGGATDNILYRVTMTLCLGGTLYSLYCLGWASFP
//
>1ocrA [f.24.1] CYTOCHROME C OXIDASE
MFINRWLFSTNHKDIGTLYLLFGAWAGMVGTALSLLIRAELGQPGTLLGDDQIYNVVVTA
HAFVMIFFMVMPIMIGGFGNWLVPLMIGAPDMAFPRMNNMSFWLLPPSFLLLLASSMVEA
GAGTGWTVYPPLAGNLAHAGASVDLTIFSLHLAGVSSILGAINFITTIINMKPPAMSQYQ
TPLFVWSVMITAVLLLLSLPVLAAGITMLLTDRNLNTTFFDPAGGGDPILYQHLFWFFGH
PEVYILILPGFGMISHIVTYYSGKKEPFGYMGMVWAMMSIGFLGFIVWAHHMFTVGMDVD
TRAYFTSATMIIAIPTGVKVFSWLATLHGGNIKWSPAMMWALGFIFLFTVGGLTGIVLAN
SSLDIVLHDTYYVVAHFHYVLSMGAVFAIMGGFVHWFPLFSGYTLNDTWAKIHFAIMFVG
VNMTFFPQHFLGLSGMPRRYSDYPDAYTMWNTISSMGSFISLTAVMLMVFIIWEAFASKR
EVLTVDLTTTNLEWLNGCPPPYHTFEEPTYVNLK
//
>1ocrD [f.23.1] CYTOCHROME C OXIDASE
SVVKSEDYALPSYVDRRDYPLPDVAHVKNLSASQKALKEKEKASWSSLSIDEKVELYRLK
FKESFAEMNRSTNEWKTVVGAAMFFIGFTALLLIWEKHYVYGPIPHTFEEEWVAKQTKRM
LDMKVAPIQGFSAKWDYDKNEWKK
//
>1ocrJ [f.23.4] CYTOCHROME C OXIDASE
FENRVAEKQKLFQEDNGLPVHLKGGATDNILYRVTMTLCLGGTLYSLYCLGWASFPHK
//
>1ocrM [f.23.7] CYTOCHROME C OXIDASE
ITAKPAKTPTSPKEQAIGLSVTFLSFLLPAGWVLYHLDNYKKS
//
>1ocrP (C) [f.25.1] CYTOCHROME C OXIDASE
MTHQTHAYHMVNPSPWPLTGALSALLMTSGLTMWFHFNSMTLLMIGLTTNMLTMYQWWRD
VIRESTFQGHHTPAVQKGLRYGMILFIISEVLFFTGFFWAFYHSSLAPTPELGGCWPPTG
IHPLNPLEVPLLNTSVLLASGVSITWAHHSLMEGDRKHMLQALFITITLGVYFTLLQASE
YYEAPFTISDGVYGSTFFVATGFHGLHVIIGSTFLIVCFFRQLKFHFTSNHHFGFEAGAW
YWHFVDVVWLFLYVSIYWWGS
//
>1ocrU (H) [a.51.1] CYTOCHROME C OXIDASE
KIKNYQTAPFDSRFPNQNQTRNCWQNYLDFHRCEKAMTAKGGDVSVCEWYRRVYKSLCPI
SWVSTWDDRRAEGTFPGKI
//
>1oczA [f.24.1] CYTOCHROME C OXIDASE
MFINRWLFSTNHKDIGTLYLLFGAWAGMVGTALSLLIRAELGQPGTLLGDDQIYNVVVTA
HAFVMIFFMVMPIMIGGFGNWLVPLMIGAPDMAFPRMNNMSFWLLPPSFLLLLASSMVEA
GAGTGWTVYPPLAGNLAHAGASVDLTIFSLHLAGVSSILGAINFITTIINMKPPAMSQYQ
TPLFVWSVMITAVLLLLSLPVLAAGITMLLTDRNLNTTFFDPAGGGDPILYQHLFWFFGH
PEVYILILPGFGMISHIVTYYSGKKEPFGYMGMVWAMMSIGFLGFIVWAHHMFTVGMDVD
TRAYFTSATMIIAIPTGVKVFSWLATLHGGNIKWSPAMMWALGFIFLFTVGGLTGIVLAN
SSLDIVLHDTYYVVAHFHYVLSMGAVFAIMGGFVHWFPLFSGYTLNDTWAKIHFAIMFVG
VNMTFFPQHFLGLSGMPRRYSDYPDAYTMWNTISSMGSFISLTAVMLMVFIIWEAFASKR
EVLTVDLTTTNLEWLNGCPPPYHTFEEPTYVNLK
//
>1oczB [f.17.2 - b.6.1] CYTOCHROME C OXIDASE
MAYPMQLGFQDATSPIMEELLHFHDHTLMIVFLISSLVLYIISLMLTTKLTHTSTMDAQE
VETIWTILPAIILILIALPSLRILYMMDEINNPSLTVKTMGHQWYWSYEYTDYEDLSFDS
YMIPTSELKPGELRLLEVDNRVVLPMEMTIRMLVSSEDVLHSWAVPSLGLKTDAIPGRLN
QTTLMSSRPGLYYGQCSEICGSNHSFMPIVLELVPLKYFEKWSASML
//
>1oczF [g.41.5] CYTOCHROME C OXIDASE
ASGGGVPTDEEQATGLEREVMLAARKGQDPYNILAPKATSGTKEDPNLVPSITNKRIVGC
ICEEDNSTVIWFWLHKGEAQRCPSCGTHYKLVPHQLAH
//
>1oczI [f.23.3] CYTOCHROME C OXIDASE
STALAKPQMRGLLARRLRFHIVGAFMVSLGFATFYKFAVAEKRKKAYADFYRNYDSMKDF
EEMRKAGIFQSAK
//
>1oczJ [f.23.4] CYTOCHROME C OXIDASE
FENRVAEKQKLFQEDNGLPVHLKGGATDNILYRVTMTLCLGGTLYSLYCLGWASFP
//
>1oczT (G) [f.23.2] CYTOCHROME C OXIDASE
ASAAKGDHGGTGARTWRFLTFGLALPSVALCTLNSWLHSGHRERPAFIPYHHLRIRTKPF
SWGDGNHTFFHNPRVNPLPTGYEK
//
>1oczE [a.118.11] CYTOCHROME C OXIDASE
SHGSHETDEEFDARWVTYFNKPDIDAWELRKGMNTLVGYDLVPEPKIIDAALRACRRLND
FASAVRILEVVKDKAGPHKEIYPYVIQELRPTLNELGISTPEELGLDKV
//
>1oczP (C) [f.25.1] CYTOCHROME C OXIDASE
MTHQTHAYHMVNPSPWPLTGALSALLMTSGLTMWFHFNSMTLLMIGLTTNMLTMYQWWRD
VIRESTFQGHHTPAVQKGLRYGMILFIISEVLFFTGFFWAFYHSSLAPTPELGGCWPPTG
IHPLNPLEVPLLNTSVLLASGVSITWAHHSLMEGDRKHMLQALFITITLGVYFTLLQASE
YYEAPFTISDGVYGSTFFVATGFHGLHVIIGSTFLIVCFFRQLKFHFTSNHHFGFEAGAW
YWHFVDVVWLFLYVSIYWWGS
//
>1oedB [f.36.1] ACETYLCHOLINE RECEPTOR PROTEIN, BETA CHAIN
PLFYIVYTIIPCILISILAILVFYLPPDAGEKMSLSISALLAVTVFLLLLADKVPETSLS
VPIIIRYLMFIMILVAFSVILSVVVLNLHHRSAMVADRLFLYVFFVICSIGTFSIFLDAS
HNVPPDN
//
>1oedE [f.36.1] ACETYLCHOLINE RECEPTOR PROTEIN, GAMMA CHAIN
PLFYIINIIAPCVLISSLVVLVYFLPAQAGGQKCTLSISVLLAQTIFLFLIAQKVPETSL
NVPLIGKYLIFVMFVSMLIVMNCVIVLNVSLRTGKVIDKACFWIALLLFSIGTLAIFLTG
HFNQVPEF
//
>1oedC [f.36.1] ACETYLCHOLINE RECEPTOR PROTEIN, DELTA CHAIN
PLFYVINFITPCVLISFLASLAFYLPAESGEKMSTAISVLLAQAVFLLLTSQRLPETALA
VPLIGKYLMFIMSLVTGVIVNCGIVLNFHFRTGQTIDRLSMFIITPVMVLGTIFIFVMGN
FNHPPAK
//
>1oedD (A) [f.36.1] ACETYLCHOLINE RECEPTOR PROTEIN, ALPHA CHAIN
PLYFVVNVIIPCLLFSFLTGLVFYLPTDSGEKMTLSISVLLSLTVFLLVIVELIPSTSSA
VPLIGKYMLFTMIFVISSIIITVVVINTHHRSAMVIDHILLCVFMLICIIGTVSVFAGRL
IELSQEG
//
>1oey_4D [d.15.2] NEUTROPHIL CYTOSOL FACTOR 2
mAYTLKVHYKYTVVmKTQPGLPYSQVRDmVSKKLELRLEHTKLSYRPRDSNELVPLSEDS
mKDAWGQVKNYCLTLWCEN
//
>1oey_4M [d.15.2] NEUTROPHIL CYTOSOL FACTOR 4
TNWLRVYYYEDTISTIKDIAVEEDLSSTPLLKDLLELTRREFQREDIALNYRDAEGDLVR
LLSDEDVALmVRQARKRLFPWKLHITQKDNYRVYNTmP
//
>1of5A [d.17.4] MRNA EXPORT FACTOR MEX67
QQFFFENDALGQSSTDFATNFLNLWDNNREQLLNLYSPQSQFSVSVDSTSIGQESINSIF
KTLPKTKHHLQEQPNEYSMETISYPQINGFVITLHGFFEETSNNKLSKKSFDRTWVIVPM
NNSVIIASDLLTVRAYSTGAWKTASIAIAQAAGS
//
>1of5B [d.17.4] MRNA TRANSPORT REGULATOR MTR2
NQAQITATFTKKILAHLDDPDSNLAQFVQLFNPNCRIIFNATPFAQATVFLQMWQNQVVQ
TQHALTGVDYHAIPGSGTLICNVNCKVRFDWGPYFGISLQLIIDDRIFRNDFNGVISGFN
YNMVYKPE
//
>1ofh_1A [c.37.1] ATP-DEPENDENT HSL PROTEASE ATP-BINDING SUBUNIT
SEMTPREIVSELDQHIIGQADAKRAVAIALRNRWRRMQLQEPLRHEVTPKNILMIGPTGV
GKTEIARRLAKLANAPFIKVEATKFTEVGYVGKEVDSIIRDLTDSAGGAIDAVEQNGIVF
IDEIDKICKKGEYSGADVSREGVQRDLLPLVEGSTVSTKHGMVKTDHILFIASGAFQVAR
PSDLIPELQGRLPIRVELTALSAADFERILTEPHASLTEQYKALMATEGVNIAFTTDAVK
KIAEAAFRVNEKTENIGARRLHTVMERLMDKISFSASDMNGQTVNIDAAYVADALGEVVE
NEDLSRFIL
//
>1ofh_1G [d.153.1] ATP-DEPENDENT PROTEASE HSLV
TTIVSVRRNGQVVVGGDGQVSLGNTVMKGNARKVRRLYNGKVLAGFAGGTADAFTLFELF
ERKLEMHQGHLLKSAVELAKDWRTDRALRKLEAMLIVADEKESLIITGIGDVVQPEEDQI
LAIGSGGNYALSAARALVENTELSAHEIVEKSLRIAGDICVFTNTNFTIEELP
//
>1ofsC (A) [b.29.1] PEA LECTIN ALPHA CHAIN
TETTSFLITKFSPDQQNLIFQGDGYTTKEKLTLTKAVKNTVGRALYSSPIHIWDRETGNV
ANFVTSFTFVINAPNSYNVADGFTFFIAPVDTKPQTGGGYLGVFNSAEYDKTTQTVAVEF
DTFYNAAWDPSNRDRHIGIDVNSIKSVNTKSWKLQNGEEANVVIAFNAATNVLTVSLTYP
N
//
>1ofsD (B) [b.29.1] PEA LECTIN BETA CHAIN
VTSYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFHSELSG
//
>1ofuA [c.32.1 - d.79.2] CELL DIVISION PROTEIN FTSZ
TAVIKVIGVGGGGGNAVNHMAKNNVEGVEFICANTDAQALKNIAARTVLQLGPGVTKGLG
AGANPEVGRQAALEDRERISEVLEGADMVFITTGMGGGTGTGAAPIIAEVAKEMGILTVA
VVTRPFPFEGRKRMQIADEGIRALAESVDSLITIPNEKLLTILGKDASLLAAFAKADDVL
AGAVRGISDIIKRPGMINVDFADVKTVMSEMGMAMMGTGCASGPNRAREATEAAIRNPLL
EDVNLQGARGILVNITAGPDLSLGEYSDVGNIIEQFASEHATVKVGTVIDADMRDELHVT
VVATGLG
//
>1ofuX [c.37.1] HYPOTHETICAL PROTEIN PA3008
PAAFSELSLSGLPGHCLTLLAPILRELSEEQDARWLTLIAPPASLTHEWLRRAGLNRERI
LLLQAKDNAAALALSCEALRLGRSHTVVSWLEPLSRAARKQLSRAAQLGQAQSLNIRL
//
>1ogaA [d.19.1 - b.1.1] HLA CLASS I HISTOCOMPATIBILITY ANTIGEN
GSHSMRYFFTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGPEYW
DGETRKVKAHSQTHRVDLGTLRGYYNQSEAGSHTVQRMYGCDVGSDWRFLRGYHQYAYDG
KDYIALKEDLRSWTAADMAAQTTKHKWEAAHVAEQLRAYLEGTCVEWLRRYLENGKETLQ
RTDAPKTHMTHHAVSDHEATLRCWALSFYPAEITLTWQRDGEDQTQDTELVETRPAGDGT
FQKWAAVVVPSGQEQRYTCHVQHEGLPKPLTLRWEP
//
>1ogaD [b.1.1 - b.1.1] T-CELL RECEPTOR ALPHA CHAIN V REGION
QLLEQSPQFLSIQEGENLTVYCNSSSVFSSLQWYRQEPGEGPVLLVTVVTGGEVKKLKRL
TFQFGDARKDSSLHITAAQPGDTGLYLCAGAGSQGNLIFGKGTKLSVKPNIQNPDPAVYQ
LRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKTVLDMRSMDFKSNSAVAWSNKSDF
ACANAFNNSIIPEDTFFPS
//
>1ogaE [b.1.1 - b.1.1] T-CELL RECEPTOR BETA CHAIN C REGION
GITQSPKYLFRKEGQNVTLSCEQNLNHDAMYWYRQDPGQGLRLIYYSQIVNDFQKGDIAE
GYSVSREKKESFPLTVTSAQKNPTAFYLCASSSRSSYEQYFGPGTRLTVTEDLKNVFPPE
VAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVSTDPQPLKEQPALN
DSRYSLSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD
//
>1ogy_5I (A) [c.81.1 - b.52.2] PERIPLASMIC NITRATE REDUCTASE
IRWSKAPCRFCGTGCGVMVGTRDGQVVATHGDTQAEVNRGLNCVKGYFLSKIMYGEDRLT
TPLLRMKDGVYHKEGEFAPVSWDEAFDVMAAQAKLVLKEKAPEAVGMFGSGQWTIWEGYA
ASKLMRAGFRSNNLDPNARHCMASAATAFMRTFGMDEPMGCYDDFEAADAFVLWGSNMAE
MHPILWSRLTDRRLSHEHVRVAVLSTFTHRSSDLSDTPIIFRPGTDRAILNYIAHHIIST
GRVNRDFVDRHTNFALGATDIGYGLRPEHQLQLAAKGAADAGAMTPTDFETFAALVSEYT
LEKAAEISGVEPALLEELAELYADPDRKWMSLWTMGFNQHVRGVWANHMVYNLHLLTGKI
SEPGNSPFSLTGQPFACGTAREVGTFAHRLPADMVVTNPEHRAHAEEIWKLPAGLLPDWV
GAHAVEQDRKLHDGEINFYWVQVNNNMQAAPNIDQETYPGYRNPENFIVVSDAYPTVTGR
AADLVLPAAMWVEKEGAYGNAERRTHFWHQLVEAPGEARSDLWQLMEFSKRFTTDEVWPE
EILSAAPAYRGKTLFEVLFANGSVDRFPASDVNPDHANHEAALFGFYPQKGLFEEYAAFG
RGHGHDLAPFDTYHEVRGLHWPVVEGEETRWRYREGFDPYVKPGEGLRFYGKPDGRAVIL
GVPYEPPAESPDEEFGFWLVTGRVLEHWHSGSMTLRWPELYKAFPGAVCFMHPEDARSRG
LNRGSEVRVISRRGEIRTRLETRGRNRMPRGVVFVPWFDASQLINKVTLDANDPISRQTD
FKKCAVKIE
//
>1ogy_5J (B) [a.138.1] DIHEME CYTOCHROME C NAPB MOLECULE: NITRATE
DAPRLTGADRPMSEVAAPPLPETITDDRRVGRNYPEQPPVIPHSIEGYQLSVNANRCLEC
HRRQYSGLVAAPMISITHFQDREGQMLADVSPRRYFCTACHVPQTNAQPLVTNEFRDMLT
LMPASN
//
>1ohhA [b.49.1 - c.37.1 - a.69.1] ATP SYNTHASE ALPHA CHAIN HEART ISOFORM,
DLEETGRVLSIGDGIARVHGLRNVQAEEMVEFSSGLKGMSLNLEPDNVGVVVFGNDKLIK
EGDIVKRTGAIVDVPVGEELLGRVVDALGNAIDGKGPIGSKARRRVGLKAPGIIPRISVR
EPMQTGIKAVDSLVPIGRGQRELIIGDRQTGKTSIAIDTIINQKRFNDGTDEKKKLYCIY
VAIGQKRSTVAQLVKRLTDADAMKYTIVVSATASDAAPLQYLAPYSGCSMGEYFRDNGKH
ALIIYDDLSKQAVAYRQMSLLLRRPPGREAYPGDVFYLHSRLLERAAKMNDAFGGGSLTA
LPVIETQAGDVSAYIPTNVISITDGQIFLETELFYKGIRPAINVGLSVSRVGSAAQTRAM
KQVAGTMKLELAQYREVAAFAQFGSDLDAATQQLLSRGVRLTELLKQGQYSPMAIEEQVA
VIYAGVRGYLDKLEPSKITKFENAFLSHVISQHQALLGKIRTDGKISEESDAKLKEIVTN
FLAGFEA
//
>1ohhC [b.49.1 - c.37.1 - a.69.1] ATP SYNTHASE ALPHA CHAIN HEART ISOFORM,
ADTSVDLEETGRVLSIGDGIARVHGLRNVQAEEMVEFSSGLKGMSLNLEPDNVGVVVFGN
DKLIKEGDIVKRTGAIVDVPVGEELLGRVVDALGNAIDGKGPIGSKARRRVGLKAPGIIP
RISVREPMQTGIKAVDSLVPIGRGQRELIIGDRQTGKTSIAIDTIINQKRFNDGTDEKKK
LYCIYVAIGQKRSTVAQLVKRLTDADAMKYTIVVSATASDAAPLQYLAPYSGCSMGEYFR
DNGKHALIIYDDLSKQAVAYRQMSLLLRRPPGREAYPGDVFYLHSRLLERAAKMNDAFGG
GSLTALPVIETQAGDVSAYIPTNVISITDGQIFLETELFYKGIRPAINVGLSVSRVGSAA
QTRAMKQVAGTMKLELAQYREVAAFADLDAATQQLLSRGVRLTELLKQGQYSPMAIEEQV
AVIYAGVRGYLDKLEPSKITKFENAFLSHVISQHQALLGKIRTDGKISEESDAKLKEIVT
NFLAGFEA
//
>1ohhD [b.49.1 - c.37.1 - a.69.1] ATP SYNTHASE BETA CHAIN, MITOCHONDRIAL
TTGRIVAVIGAVVDVQFDEGLPPILNALEVQGRETRLVLEVAQHLGESTVRTIAMDGTEG
LVRGQKVLDSGAPIRIPVGPETLGRIMNVIGEPIDERGPIKTKQFAAIHAEAPEFVEMSV
EQEILVTGIKVVDLLAPYAKGGKIGLFGGAGVGKTVLIMELINNVAKAHGGYSVFAGVGE
RTREGNDLYHEMIESGVINLKDATSKVALVYGQMNEPPGARARVALTGLTVAEYFRDQEG
QDVLLFIDNIFRFTQAGSEVSALLGRIPSAVGYQPTLATDMGTMQERITTTKKGSITSVQ
AIYVPADDLTDPAPATTFAHLDATTVLSRAIAELGIYPAVDPLDSTSRIMDPNIVGSEHY
DVARGVQKILQDYKSLQDIIAILGMDELSEEDKLTVSRARKIQRFLSQPFQVAEVFTGHL
GKLVPLKETIKGFQQILAGEYDHLPEQAFYMVGPIEEAVAKADKLAEEH
//
>1ohhG [c.49.2] ATP SYNTHASE GAMMA CHAIN, MITOCHONDRIAL
ATLKDITRRLKSIKNIQKITKSMKMVAAAKLCGAIHSSVAKQTTSEQSARMTAMDNASKN
ASEMIDKLTLTFNRTRQAVITKELIEIISGAAAL
//
>1ohhH [h.4.8] ATPASE INHIBITOR, MITOCHONDRIAL
SGDNVRSSAGAVRDAGGAFGKREQAEEERYFRARAKE
//
>1ol5A [d.144.1] SERINE/THREONINE KINASE 6
SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV
EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN
ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRxxLCGTLDYLPPEMIE
GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISR
LLKHNPSQRPMLREVLEHPWITANS
//
>1ol5B [x.x.x] RESTRICTED EXPRESSION PROLIFERATION ASSOCIATED
SYSYDAPSDFINFSSNIDSWFEEKANLEN
//
>1onq_1A [d.19.1 - b.1.1] T-CELL SURFACE GLYCOPROTEIN CD1A
PLSFHVIWIASFYNHSWKQNLVSGWLSDLQTHTWDSNSSTIVFLWPWSRGNFSNEEWKEL
ETLFRIRTIRSFEGIRRYAHELQFEYPFEIQVTGGCELHSGKVSGSFLQLAYQGSDFVSF
QNNSWLPYPVAGNMAKHFCKVLNQNQHENDITHNLLSDTCPRFILGLLDAGKAHLQRQVK
PEAWLSHGPSPGPGHLQLVCHVSGFYPKPVWVMWMRGEQEQQGTQRGDILPSADGTWYLR
ATLEVAAGEAADLSCRVKHSSLEGQDIVLYWHHH
//
>1onq_1B [b.1.1] BETA-2-MICROGLOBULIN
IQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDW
SFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM
//
>1oo0A [d.232.1] MAGO NASHI PROTEIN
EDFYLRYYVGHKGKFGHEFLEFEFRPDGKLRYANNSNYKNDTMIRKEAFVHQSVMEELKR
IIIDSEIMQEDDLPWPPPDRVGRQELEIVIGDEHISFTTSKTGSLVDVNRSKDPEGLRCF
YYLVQDLKCLVFSLIGLHFKIKPI
//
>1oo0B [d.58.7] CG8781-PA
PGPQRSVEGWILFVTSIHEEAQEDEIQEKFCDYGEIKNIHLNLDRRTGFSKGYALVEYET
HKQALAAKEALNGAEIMGQTIQVDWCFVKGPK
//
>1ookB [b.47.1] HUMAN ALPHA THROMBIN
IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL
VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL
PDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIR
ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFY
THVFRLKKWIQKVIDQFGE
//
>1ookG [c.10.2] PLATELET GLYCOPROTEIN IB ALPHA CHAIN PRECURSOR
HPICEVSKVASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQL
NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL
RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ
ENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEILYFRRWLQDNAENVYVWKQGVDVKAMT
SNVASVQCDNSDKFPVYKYPGKGCPTLGDEGDTDLxDYxPEEDT
//
>1oop_26 (A) [b.121.4] COAT PROTEIN VP1
RVADTIGSGPVNSESIPALTAAETGHTSQVVPSDTMQTRHVKNYHSRSESTVENFLCRSA
CVFYTTYENHDSDGDNFAYWVINTRQVAQLRRKLEMFTYARFDLELTFVITSTQEQPTVR
GQDAPVLTHQIMYVPPGGPVPTKVNSYSWQTSTNPSVFWTEGSAPPRMSVPFIGIGNAYS
MFYDGWARFDKQGTYGISTLNNMGTLYMRHVNDGGPGPIVSTVRIYFKPKHVKTWVPRPP
RLCQYQKAGNVNFEPTGVTEGRTDITTMKTT
//
>1oop_27 (B) [b.121.4] COAT PROTEIN VP2
SDRVRSITLGNSTITTQECANVVVGYGVWPTYLKDEEATAEDQPTQPDVATCRFYTLESV
MWQQSSPGWWWKFPDALSNMGLFGQNMQYHYLGRAGYTIHVQCNASKFHQGCLLVVCVPE
AEMGCATLANKPDPKSLSKGEIANMFESQNSTGETAVQANVINAGMGVGVGNLTIFPHQW
INLRTNNSATIVMPYINSVPMDNMFRHNNFTLMVIPFAPLSYSTGATTYVPITVTVAPMC
AEYNGLRLAGKQ
//
>1oop_28 (C) [b.121.4] COAT PROTEIN VP3
GLPTLSTPGSNQFLTSDDFQSPSAMPQFDVTPEMDIPGQVNNLMEIAEVDSVVPVNNTEG
KVMSIEAYQIPVQSNPTNGSQVFGFPLTPGANSVLNRTLLGEILNYYAHWSGSIKLTFMF
CGSAMATGKFLLAYSPPGAGAPTTRKEAMLGTHVIWDVGLQSSCVLCIPWISQTHYRYVV
MDEYTAGGYITCWYQTNIVVPADAQSDCKILCFVSACNDFSVRMLKDTPFIKQDNFFQ
//
>1oop_29 (D) [b.121.4] COAT PROTEIN VP4
GAQVSTQKTGAHEIHYTNINYYKDAASNSANRQDFTQDPGKFTEPVKDIMVKSMPALN
//
>1op9A [b.1.1] HL6 CAMEL VHH FRAGMENT
QVQLQESGGGSVQAGGSLRLSCSASGYTYISGWFRQAPGKEREGVAAIRSSDGTTYYADS
VKGRFTISQDNAKNTVYLQMNSLKPEDTAMYYCAATEVAGWPLDIGIYDYWGQGTEVTVS
S
//
>1op9B [d.2.1] LYSOZYME C
KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQIN
SRYWCNDGKTPGAVNACHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRD
VRQYVQGCGV
//
>1opgL [b.1.1 - b.1.1] OPG2 FAB (LIGHT CHAIN)
DELLTQSPATLSVTPGDSVSLSCRASQSISNNLHWYQQKSHESPRLLIKYASQSISGIPS
RFSGSGSGTDFTLSINSVETEDFGMYFCQQSNSWPLTFGGGSKLEIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1opgH [b.1.1 - b.1.1] OPG2 FAB (HEAVY CHAIN)
EVQLVQSGGGLVNPGRSLKLSCAASGFTFSSYGMSWVRQTPEKRLEWVAAISGGGTYIHY
PDSVKGRFTISRDNAKNNLYLQMSSLRSEDTALYYCTRHPFYRYDGGNYYAMDHWGQGTS
VTVSAAKTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPA
VLQSDLYTLSSSVTVPSSPRPSETVTCNVAHPASSTKVDKKIVPRDC
//
>1ophA [e.1.1] ALPHA-1-ANTITRYPSIN PRECURSOR
HPTFNKITPNLAEFAFSLYRQLAHQSNSTNILFSPVSIAAAFAMLSLGAKGDTHDEILEG
LNFNLTEIPEAQIHEGFQELLRTLNQPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYH
SEAFTVNFGDTEEAKKQINDYVEKGTQGKIVDLVKELDRDTVFALVNYIFFKGKWERPFE
VKDTEEEDFHVDQVTTVKVPMMKRLGMFNIQHSKKLSSWVLLMKYLGNATAIFFLPDEGK
LQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSNGADLS
GVTEEAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPRSIPPEVKFNKPFVFLIIEQNT
KAPLFMGRVVNPTQK
//
>1ophB [b.47.1] TRYPSINOGEN, CATIONIC PRECURSOR
IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEG
NEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISG
WGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDAGGP
VVCSGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN
//
>1oqd_2E (A) [b.22.1] TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER
VTQDCLQLIADSETPTIQKGSYTFVPWLLSFKRGSALEEKENKILVKETGYFFIYGQVLY
TDKTYAMGHLIQRKKVHVFGDELSLVTLFRCIQNMPETLPNNSCYSAGIAKLEEGDELQL
AIPRENAQISLDGDVTFFGALKLL
//
>1oqd_2F (A) [b.22.1] TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER
VTQDCLQLIADSETPTIQKGSYTFVPWLLSFKRGSALEEKENKILVKETGYFFIYGQVLY
TDKTYAMGHLIQRKKVHVFGDELSLVTLFRCIQNMPETLPNNSCYSAGIAKLEEGDELQL
AIPRENAQISLDGDVTFFGALKLL
//
>1oqd_2N [g.24.1] TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY
CSQNEYFDSLLHACIPCQLRC
//
>1oqd_2O (K) [g.24.1] TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY
CSQNEYFDSLLHACIPCQLRCSSNTPPLTCQRYCNASVT
//
>1oqe_1A [b.22.1] TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER
VTQDCLQLIADSETPTIQKGSYTFVPWLLSFKRGSALEEKENKILVKETGYFFIYGQVLY
TDKTYAMGHLIQRKKVHVFGDELSLVTLFRCIQNMPETLPNNSCYSAGIAKLEEGDELQL
AIPRENAQISLDGDVTFFGALKLL
//
>1oqe_1K [g.24.1] TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY
PTPCVPAECFDLLVRHCVACGLLRTPRPKPA
//
>1oqe_2E (A) [b.22.1] TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER
VTQDCLQLIADSETPTIQKGSYTFVPWLLSFKRGSALEEKENKILVKETGYFFIYGQVLY
TDKTYAMGHLIQRKKVHVFGDELSLVTLFRCIQNMPETLPNNSCYSAGIAKLEEGDELQL
AIPRENAQISLDGDVTFFGALKLL
//
>1oqe_2N [g.24.1] TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY
PTPCVPAECFDLLVRHCVACGLLR
//
>1oqlA [d.165.1] MISTLETOE LECTIN I
YERLRLRVTHQTTGDEYFRFITLLRDYVSSGSFSNEIPLLRQSTIPVSDAQRFVLVELTN
QGGDSITAAIDVTNLYVVAYQAGDQSYFLRDAPRGAETHLFTGTTRSSLPFNGSYPDLER
YAGHRDQIPLGIDQLIQSVTALRFPGGSTRTQARSILILIQMISEAARFNPILWRARQYI
NSGASFLPDVYMLELETSWGQQSTQVQHSTDGVFNNPIRLAIPPGNFVTLTNVRDVIASL
AIMLFVCG
//
>1oqlB [b.42.2 - b.42.2] MISTLETOE LECTIN I
DDVTCSASEPTVRIVGRNGMCVDVRDDDFRDGNQIQLWPSKSNNDPNQLWTIKRDGTIRS
NGSCLTTYGYTAGVYVMIFDCNTAVREATLWQIWGNGTIINPRSNLVLAASSGIKGTTLT
VQTLDYTLGQGWLAGNDTAPREVTIYGFRDLCMESNGGSVWVETCVSSQKNQRWALYGDG
SIRPKQNQDQCLTCGRDSVSTVINIVSCSAGSSGQRWVFTNEGAILNLKNGLAMDVAQAN
PKLRRIIIYPATGKPNQMWLPVP
//
>1or7A [a.177.1 - a.4.13] RNA POLYMERASE SIGMA-E FACTOR
SHMSEQLTDQVLVERVQKGDQKAFNLLVVRYQHKVASLVSRYVPSGDVPDVVQEAFIKAY
RALDSFRGDSAFYTWLYRIAVNTAKNYLVAQGRRPPSSDVDAIEAENFESGGANLMLSEE
LRQIVFRTIESLPEDLRMAITLRELDGLSYEEIAAIMDCPVGTVRSRIFRAREAIDNKVQ
P
//
>1or7C [a.180.1] SIGMA-E FACTOR NEGATIVE REGULATORY PROTEIN
MQKEQLSALMDGETLDSELLNELAHNPEMQKTWESYHLIRDSMRGDTPEVLHFDISSRVM
AAIEEE
//
>1or7F [a.180.1] SIGMA-E FACTOR NEGATIVE REGULATORY PROTEIN
MQKEQLSALMDGETLDSELLNELAHNPEMQKTWESYHLIRDSMRGDTPEVLHFDISSRVM
AAIE
//
>1or7B [a.177.1 - a.4.13] RNA POLYMERASE SIGMA-E FACTOR
SHMSEQLTDQVLVERVQKGDQKAFNLLVVRYQHKVASLVSRYVPSGDVPDVVQEAFIKAY
RALDSFRGDSAFYTWLYRIAVNTAKNYLVAQGRNLMLSEELRQIVFRTIESLPEDLRMAI
TLRELDGLSYEEIAAIMDCPVGTVRSRIFRAREAIDNKVQPLIR
//
>1orqA [b.1.1 - b.1.1] 6E1 FAB LIGHT CHAIN
ENVLTQSPAIMSPSPGEKVTMTCRARSSVSSSYLHWYQQKSGASPKLWIYSTSNLASGVP
ARFSGSGSGTSYSLTISSVEAEDTATYYCQQYSGNPWTFGGGTKLEIKRADAAPTVSIFP
PSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTL
TLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1orqB [b.1.1 - b.1.1] 6E1 FAB HEAVY CHAIN
DVQLQESGPGLVKPSQSLSLTCTVTGYSITSLYAWNWIRQFPGNKLEWMGYINYSGYTSY
NPSLKSRISITRDTSKNQFFLQLHSVTTEDTATYSCTRGVDYFAMDYWGQGASVTVSSAK
TTAPSVYPLAPVCGDTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPALLQSDLY
TLSSSVTVTSNTWPSQSITCNVAHPASSTKVDKKIVPRD
//
>1orqC [f.14.1] POTASSIUM CHANNEL
IGDVMEHPLVELGVSYAALLSVIVVVVECTMQLSGEYLVRLYLVDLILVIILWADYAYRA
YKSGDPAGYVKKTLYEIPALVPAGLLALIEGHLAGLGLFRLVRLLRFLRILLIISRGSKF
LSAIADAADKIRFYHLFGAVMLTVLYGAFAIYIVEYPDPNSSIKSVFDALWWAVVTATTV
GYGDVVPATPIGKVIGIAVMLTGISALTLLIGTVSNMFQKILV
//
>1orsA [b.1.1 - b.1.1] 33H1 FAB LIGHT CHAIN
QIVLTQSPAIMSASLGDRVTMTCTASSSVSSSYLHWYQQKPGSSPKLWIYSTSNLASGVP
ARFSGSGSGTSYSLTISSMEAEDAATYYCHQFHRSLTFGSGTKLEIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1orsB [b.1.1 - b.1.1] 33H1 FAB HEAVY CHAIN
DVQLQESGPGLVKPSQSLSLTCTVTGYSITNNYAWNWIRQFPGNKLEWMGYINYSGTTSY
NPSLKSRISITRDTSKNQFFLQLNSVTTEDTATYFCVRGYDYFAMDYWGQGTSVTVSSAK
TTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLY
TLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKIVPRDCG
//
>1orsC [f.14.1] POTASSIUM CHANNEL
DVMEHPLVELGVSYAALLSVIVVVVEYTMQLSGEYLVRLYLVDLILVIILWADYAYRAYK
SGDPAGYVKKTLYEIPALVPAGLLALIEGHLAGLGLFRLVRLLRFLRILLIISRGSKFLS
AIADAADKLVPR
//
>1oryA [a.24.19] FLAGELLAR PROTEIN FLIS
EAYFQNQVETATPLEQIILLYDKAIECLERAIEIYDQVNELEKRKEFVENIDRVYDIISA
LKSFLDHEKGKEIAKNLDTIYTIILNTLVKVDKTKEELQKILEILKDLREAWEEVKKK
//
>1oryB [x.x.x] FLAGELLIN
NVDFAKEMTEFTKYQIRMQSGVAMLAQANALPQLVLQLL
//
>1ospL [b.1.1 - b.1.1] FAB 184.1
DIQMSQSSSSFSVSLGDRVTITCKASEDIYSRLAWYQQKPGNAPRLLISGATSLETWVPS
RFSGSDSGKDYTLSITSLQTEDVATYFCQQYWSPPPTFGGGTKLEIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1ospH [b.1.1 - b.1.1] FAB 184.1
EVQLQESGPSLVKPSQTLSLTCSVTGEPITSGFWDWIRKFPGNKLEFMGYIRYGGGTYYN
PSLKSPISITRDTSKNHYYLQLNSVVTEDTATYYCARSRDYYGSSGFAFWGEGTLVTVSA
AKTTPPSVYPLAPGCGDTTGSSVTLGCLVKGYFPESVTVTWNSGSLSSSVHTFPALLQSG
LYTMSSSVTVPSSTWPSQTVTCSVAHPASSTTVDKKLE
//
>1ospO [b.76.1] OUTER SURFACE PROTEIN A
SLDEKNSVSVDLPGEMKVLVSKEKNKDGKYDLIATVDKLELKGTSDKNNGSGVLEGVKAD
KCKVKLTISDDLGQTTLEVFKEDGKTLVSKKVTSKDKSSTEEKFNEKGEVSEKIITRADG
TRLEYTGIKSDGSGKAKEVLKGYVLEGTLTAEKTTLVVKEGTVTLSKNISKSGEVSVELN
DTDSSAATKKTAAWNSGTSTLTITVNSKKTKDLVFTKENTITVQQYDSNGTKLEGSAVEI
TKLDEIKNALK
//
>1otsB [f.20.1] VOLTAGE-GATED CLC-TYPE CHLORIDE CHANNEL ERIC
RRQLIRQLLERDKTPLAILFMAAVVGTLVGLAAVAFDKGVAWLQNQRMGALVHTADNYPL
LLTVAFLCSAVLAMFGYFLVRKYAPEAGGSGIPEIEGALEDQRPVRWWRVLPVKFFGGLG
TLGGGMVLGREGPTVQIGGNIGRMVLDIFRLKGDEARHTLLATGAAAGLAAAFNAPLAGI
LFIIEEMRPQFRYTLISIKAVFIGVIMSTIMYRIFNHEVALIDVGKLSDAPLNTLWLYLI
LGIIFGIFGPIFNKWVLGMQDLLHRVHGGNITKWVLMGGAIGGLCGLLGFVAPATSGGGF
NLIPIATAGNFSMGMLVFIFVARVITTLLCFSSGAPGGIFAPMLALGTVLGTAFGMVAVE
LFPQYHLEAGTFAIAGMGALLAASIRAPLTGIILVLEMTDNYQLILPMIITGLGATLLAQ
FTGGKPLYSAILARTLAKQEA
//
>1otsE (C) [b.1.1 - b.1.1] FAB FRAGMENT (HEAVY CHAIN)
VRLLESGGGLVQPGGSLKLSCAASGFDYSRYWMSWVRQAPGKGLKWIGEINPVSSTINYT
PSLKDKFIISRDNAKDTLYLQISKVRSEDTALYYCARLYYGYGYWYFDVWGAGTTVTVSS
AKTTPPSVYPLAPGSAAAAASMVTLGCLVKGYFPEPVTVTWNSGSLAAGVHTFPAVLQAA
LYTLSSSVTVPSSSWPSETVTCNVAHPASSTKVDKKIVPRA
//
>1otuE (C) [b.1.1 - b.1.1] FAB FRAGMENT (HEAVY CHAIN)
VRLLESGGGLVQPGGSLKLSCAASGFDYSRYWMSWVRQAPGKGLKWIGEINPVSSTINYT
PSLKDKFIISRDNAKDTLYLQISKVRSEDTALYYCARLYYGYGYWYFDVWGAGTTVTVSS
AKTTPPSVYPLAPGSAAAAASMVTLGCLVKGYFPEPVTVTWNSGSLAAGVHTFPAVLQAA
LYTLSSSVTVPSSSWPSETVTCNVAHPASSTKVDKKIVPRA
//
>1otuF (D) [b.1.1 - b.1.1] FAB FRAGMENT (LIGHT CHAIN)
DIVLTQSPAIMSAAPGDKVTMTCSASSSVSYIHWYQQKSGTSPKRWIYDTSKLTSGVPVR
FSGSGSGTSYSLTINTMEAEDAATYYCQQWSSHPQTFGGGTKLEILRADAAPTVSIFPPS
SEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLTL
TKDEYERHNSYTCEATHKTSTSPIVKSFNRA
//
>1outA [a.1.1] HEMOGLOBIN I
SLTAKDKSVVKAFWGKISGKADVVGAEALGRMLTAYPQTKTYFSHWADLSPGSGPVKKHG
GIIMGAIGKAVGLMDDLVGGMSALSDLHAFKLRVDPGNFKILSHNILVTLAIHFPSDFTP
EVHIAVDKFLAAVSAALADKYR
//
>1outB [a.1.1] HEMOGLOBIN I
VEWTDAEKSTISAVWGKVNIDEIGPLALARVLIVYPWTQRYFGSFGNVSTPAAIMGNPKV
AAHGKVVCGALDKAVKNMGNILATYKSLSETHANKLFVDPDNFRVLADVLTIVIAAKFGA
SFTPEIQATWQKFMKVVVAAMGSRYF
//
>1ow0A [b.1.1 - b.1.1] IG ALPHA-1 CHAIN C REGION
CHPRLSLHRPALEDLLLGSEANLTCTLTGLRDASGVTFTWTPSSGKSAVQGPPERDLCGC
YSVSSVLPGCAEPWNHGKTFTCTAAYPESKTPLTATLSKSGNTFRPEVHLLPPPSEELAL
NELVTLTCLARGFSPKDVLVRWLQGSQELPREKYLTWASRQEPSQGTTTFAVTSILRVAA
EDWKKGDTFSCMVGHEALPLAFTQKTIDR
//
>1ow0C [b.1.1 - b.1.1] IMMUNOGLOBULIN ALPHA FC RECEPTOR
PMPFISAKSSPVIPLDGSVKIQCQAIREAYLTQLMIIKNSTYREIGRRLKFWNETDPEFV
IDHMDANKAGRYQCQYRIGHYRFRYSDTLELVVTGLYGKPFLSADRGLVLMPGENISLTC
SSAHIPFDRFSLAKEGELSLPQHQSGEHPANFSLGPVDLNVSGIYRCYGWYNRSPYLWSF
PSNALELVVT
//
>1ow3A [a.116.1] RHO-GTPASE-ACTIVATING PROTEIN 1
PLPNQQFGVSLQHLQEKNPEQEPIPIVLRETVAYLQAHALTTEGIFRRSANTQVVREVQQ
KYNMGLPVDFDQYNELHLPAVILKTFLRELPEPLLTFDLYPHVVGFLNIDESQRVPATLQ
VLQTLPEENYQVLRFLTAFLVQISAHSDQNKMTNTNLAVVFGPNLLWAKDAAITLKAINP
INTFTKFLLDHQGELF
//
>1ow3B [c.37.1] TRANSFORMING PROTEIN RHOA
AIRKKLVIVGDGACGKTCLLIVNSKDQFPEVYVPTVFENYVADIEVDGKQVELALWDTAG
QEDYDRLRPLSYPDTDVILMCFSIDSPDSLENIPEKWTPEVKHFCPNVPIILVGNKKDLR
NDEHTRRELAKMKQEPVKPEEGRDMANRIGAFGYMECSAKTKDGVREVFEMATRAALQA
//
>1owfA [a.55.1] INTEGRATION HOST FACTOR ALPHA-SUBUNIT
ALTKAEMSEYLFDKLGLSKRDAKELVELFFEEIRRALENGEQVKLSGFGNFDLRDKNQRP
GRNPKTGEDIPITARRVVTFRPGQKLKSRVENASPK
//
>1owfB [a.55.1] INTEGRATION HOST FACTOR BETA-SUBUNIT
MTKSELIERLATQQSHIPAKTVEDAVKEMLEHMASTLAQGERIAIRGFGSFSLHYRAPRT
GRNPKTGDKVELEGKYVPHFKPGKELRDRANIYG
//
>1oxbA [a.24.10] YPD1P
STIPSEIINWTILNEIISMDDDDSDFSKGLIIQFIDQAQTTFAQMQRQLDGEKNLTELDN
LGHFLKGSSAALGLQRIAWVCERIQNLGRKMEHFFPNKTELVNTLSDKSIINGINIDEDD
EEIKIQVDDKDENSIYLILIAKALNQSRLEFKLARIELSKYYNTNL
//
>1oxbB [c.23.1] SLN1
SVKILVVEDNHVNQEVIKRMLNLEGIENIELACDGQEAFDKVKELTSKGENYNMIFMDVQ
MPKVDGLLSTKMIRRDLGYTSPIVALTAFADDSNIKECLESGMNGFLSKPIKRPKLKTIL
TEFC
//
>1oxk_2C (A) [a.24.10] YPD1P
STIPSEIINWTILNEIISMDDFSKGLIIQFIDQAQTTFAQMQRQLDGEKNLTELDNLGHF
LKGSSAALGLQRIAWVCERIQNLGRKMEHFFPNKTELVNTLSDKSIINGINIDEDDEEIK
DENSIYLILIAKALNQSRLEFKLARIELSKYYNTNL
//
>1oxk_2D (B) [c.23.1] SLN1
SVKILVVEDNHVNQEVIKRMLNLEGIENIELACDGQEAFDKVKELTSKGENYNMIFMDVQ
MPKVDGLLSTKMIRRDLGYTSPIVALTAFADDSNIKECLESGMNGFLSKPIKRPKLKTIL
TEFCAAYQ
//
>1oyvA [c.41.1] SUBTILISIN CARLSBERG
AQTVPYGIPLIKADKVQAQGFKGANVKVAVLDTGIQASHPDLNVVGGASFVAGEAYNTDG
NGHGTHVAGTVAALDNTTGVLGVAPSVSLYAVKVLNSSGSGSYSGIVSGIEWATTNGMDV
INMSLGGASGSTAMKQAVDNAYARGVVVVAAAGNSGNSGSTNTIGYPAKYDSVIAVGAVD
SNSNRASFSSVGAELEVMAPGAGVYSTYPTNTYATLNGTSMASPHVAGAAALILSKHPNL
SASQVRNRLSSTATYLGSSFYYGKGLINVEAAAQ
//
>1oyvI [g.69.1] WOUND-INDUCED PROTEINASE INHIBITOR-II
KACTRECGNLGFGICPRSEGSPLNPICINCCSGYKGCNYYNSFGKFICEGESDPKRPNAC
TFNCDPNIAYSRCGCTTCCTGYKGCYYFGKDGKFVCEGESDEPK
//
>1oz7A [d.169.1] ECHICETIN A-CHAIN
MCPPGWSSNGVYCYMLFKEPKTWDEAEKFCNKQGKDGHLLSIESKKEEILVDIVVSENIG
KMYKIWTGLSERSKEQHCSSRWSDGSFFRSYEIAIRYSECFVLEKQSVFRTWVATPCENT
FPFMCKYPVPR
//
>1oz7B [d.169.1] ECHICETIN B-CHAIN
NCLPDWSVYEGYCYKVFKERMNWADAEKFCTKQHKDGHLVSFRNSKEVDFVISLAFPMLK
NDLVWIGLTDYWRDCNWEWSDGAQLDYKAWDNERHCFIYKNTDNQWTRRDCTWTFSFVCK
CPA
//
>1ozbA [d.33.1] PROTEIN-EXPORT PROTEIN SECB
PVLQIQRIYVKDVSFEAPNLPHIFQQEWKPKLGFDLSTETTQVGDDLYEVVLNISVETTL
EDSGDVAFICEVKQAGVFTISGLEDVQMAHCLTSQCPNMLFPYARELVSNLVNRGTFPAL
NLSPVNFDALFVEYMNRQQAENAE
//
>1ozbI [g.74.1] PREPROTEIN TRANSLOCASE SECA SUBUNIT
IGRNEPCPCGSGKKYKHCHGSRVA
//
>1p0sA (E) [b.16.1] ECOTIN PRECURSOR
VQPLEKIAPYPQAEKGMKRQVIQLTPQEDESTLKVELLIGQTLEVDCNLHRLGGKLENKT
LEGWGYDYYVFDKVSSPVSTRMACPDGKKEKKFVTAYLGDAGMLRYNSKLPIVVYTPDNV
DVKYRVWKAEEKIDNAVVR
//
>1p0sB (H) [b.47.1] COAGULATION FACTOR X PRECURSOR
IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTE
QEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLM
TQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDA
CQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTR
//
>1p0sC (L) [g.32.1 - g.3.11] COAGULATION FACTOR X PRECURSOR
SFLxxMKKGHLxRxCMxxTCSYxxARxVFxDSDKTNxFWNKYKDGDQKLCSLDNGDCDQF
CHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLE
//
>1p1zA [d.19.1 - b.1.1] H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, K-B
HSLRYFVTAVSRPGLGEPRYMEVGYVDDTEFVYEPRARWMEQEGPEYWERETQKAKGNEQ
SFRVDLRTLLGYYNQSKGGSHTIQVISGCEVRGYQQYAYDGCDYIALNEDLKTWTAADMA
ALITKHKWEQAGEAERLRAYLEGTCVEWLRRYLKNGNATLLRTDSPKAHVTHHSRPEDKV
TLRCWALGFYPADITLTWQLNGEELIQDMELVETRPAGDGTFQKWASVVVPLGKEQYYTC
HVYHQGLPEPLTLRW
//
>1p1zB [b.1.1] BETA-2-MICROGLOBULIN
IQKTPQIQVYSRHPPENGKPNILNCYVTQFHPPHIEIQMLKNGKKIPKVEMSSFSKDWSF
YILAHTEFTPTETDTYACRVKHDSMAEPKTVYWDRDM
//
>1p1zD [d.169.1] LY49-C ANTIGEN
VYWFCYSTKCYYFIMNKTTWSGCKANCQHYSVPILKIEDEDELKFLQRHVIPENYWIGLS
YDKKKKEWAWIDNGPSKLDMKIRKMNFKSRGCVFLSKARIEDIDCNIPYYCICGKKLD
//
>1p22A [a.158.1 - b.69.4] F-BOX/WD-REPEAT PROTEIN 1A
SPAIMLQRDFITALPARGLDHIAENILSYLDAKSLCAAELVCKEWYRVTSDGMLWKKLIE
RMVRTDSLWRGLAERRGWGQYLFPPNSFYRALYPKIIQDIETIESNWRCGRHSLQRIHCR
SETSKGVYCLQYDDQKIVSGLRDNTIKIWDKNTLECKRILTGHTGSVLCLQYDERVIITG
SSDSTVRVWDVNTGEMLNTLIHHCEAVLHLRFNNGMMVTCSKDRSIAVWDMASPTDITLR
RVLVGHRAAVNVVDFDDKYIVSASGDRTIKVWNTSTCEFVRTLNGHKRGIACLQYRDRLV
VSGSSDNTIRLWDIECGACLRVLEGHEELVRCIRFDNKRIVSGAYDGKIKVWDLVAALDP
RAPAGTLCLRTLVEHSGRVFRLQFDEFQIVSSSHDDTILIWD
//
>1p22B [d.42.1 - a.157.1] SKP1
PSIKLQSSDGEIFEVDVEIAKQSVTIKTMLEDLGMDPVPLPNVNAAILKKVIQWCTHHIP
VWDQEFLKVDQGTLFELILAANYLDIKGLLDVTCKTVANMIKGKTPEEIRKTFNIKNDFT
EEEEAQVRKEN
//
>1p2c_1B [b.1.1 - b.1.1] HEAVY CHAIN VH+CH1 ANTI-LYSOZYME ANTIBODY
EVQLQESGAELMKPGASVKISCKATGYTFTTYWIEWIKQRPGHSLEWIGEILPGSDSTYY
NEKVKGKVTFTADASSNTAYMQLSSLTSEDSAVYYCARGDGFYVYWGQGTTLTVSSASTT
PPSVYPLAPGSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTLSSSVTV
PSSPWPSETVTCNVAHPASSTKVDKKIVPR
//
>1p2c_1C [d.2.1] LYSOZYME C
KVFGRCELAAAMKRHGLDNYRGYSLGNWVCAAKFESNFNTQATNRNTDGSTDYGILQINS
RWWCNDGRTPGSRNLCNIPCSALLSSDITASVNCAKKIVSDGNGMNAWVAWRNRCKGTDV
QAWIRGCRL
//
>1p3qQ [a.5.2] VACUOLAR PROTEIN SORTING-ASSOCIATED PROTEIN VPS9
SSLIKKIEENERKDTLNTLQNmFPDmDPSLIEDVCIAAASGPCVD
//
>1p3qR [a.5.2] VACUOLAR PROTEIN SORTING-ASSOCIATED PROTEIN VPS9
LQNmFPDmDPSLIEDVCIAAASRIGPCVDALLSLSE
//
>1p3qV [d.15.1] UBIQUITIN
MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYN
IQKESTLHLVLRL
//
>1p3qU [d.15.1] UBIQUITIN
MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYN
IQKESTLHLVLRLR
//
>1p4bL [b.1.1] ANTIBODY VARIABLE LIGHT CHAIN
ADAVVTQESALTTSPGETVTLTCRSSTGAVTTSNYASWVQEKPDHLFTGLIGGTNNRAPG
VPARFSGSLIGDKAALTITGAQTEDEAIYFCALWYSNHWVFGGGTKLTVL
//
>1p4bH [b.1.1] ANTIBODY VARIABLE HEAVY CHAIN
DVQLQQSGPGLVAPSQSLSITCTVSGFSLTDYGVNWVRQSPGKGLEWLGVIWGDGITDYN
SALKSRLSVTKDNSKSQVFLKMNSLQSGDSARYYCVTGLFDYWGQGTTLTVS
//
>1p4lA [d.19.1 - b.1.1] MHC CLASS I H-2KB HEAVY CHAIN
PHSLRYFVTAVSRPGLGEPRYMEVGYVDDTEFVRFDSDAENPRYEPRARWMEQEGPEYWE
RETQKAKGNEQSFRVDLRTLLGYYNQSKGGSHTIQVISGCEVGSDGRLLRGYQQYAYDGC
DYIALNEDLKTWTAADMAALITKHKWEQAGEAERLRAYLEGTCVEWLRRYLKNGNATLLR
TDSPKAHVTHHSRPEDKVTLRCWALGFYPADITLTWQLNGEELIQDMELVETRPAGDGTF
QKWASVVVPLGKEQYYTCHVYHQGLPEPLTLRW
//
>1p4lD [d.169.1] LY49-C
RGVKYWFCYSTKCYYFIMNKTTWSGCKANCQHYGVPILKIEDEDELKFLQRHVIPGNYWI
GLSYDKKKKEWAWIDNGPSKLDMKIKKMNFKSRGCVFLSKARIEDIDCNIPYYCICGKKL
DK
//
>1p5vA [b.1.11 - b.7.2] CHAPERONE PROTEIN CAF1M
FASKEYGVTIGESRIIYPLDAAGVMVSVKNTQDYPVLIQSRIYDPFVVTPPLFRLDAKQQ
NSLRIAQAGGVFPRDKESLKWLCVKGIPKDVGVFVQFAINNCIKLLVRPNELKGTPIQFA
ENLSWKVDGGKLIAENPSPFYMNIGELTFGGKSIPSHYIPPKSTWAFDLPNVSWRIINDQ
GGLDRLYSKNV
//
>1p5vB [b.2.3] F1 CAPSULE ANTIGEN
VEPARITLTYKEGAPITIMDNGNIDTELLVGTLTLGGYKTGTTSTSVNFTDAAGDPMYLT
FTSQDGNNHQFTTKVIGKDSRDFDISPKVNGENLVGDDVVLATGSQDFFVRSIGSKGGKL
AAGKYTDAVTVTVSNQ
//
>1p6aA [b.21.1] FIBER PROTEIN
TPYDPLTLWTTPDPPPNCSLIQELDAKLTLCLTKNGSIVNGIVSLVGVKGNLLNIQSTTT
TVGVHLVFDEQGRLITSTPTALVPQAYWGYRQGQSVSTNTVTNGLGFMPNVSAYPRPNAS
EAKSQMVSLTYLQGDTSKPITMKVAFNGITSLNGYSLTFMWSGLSNYINQPFSTPSCSFS
YITQE
//
>1p6aB [b.1.1] COXSACKIEVIRUS AND ADENOVIRUS RECEPTOR
GITTPEEMIEKAKGETAYLPCKFTLSPEDQGPLDIEWLISPADNQKVDQVIILYSGDKIY
DDYYPDLKGRVHFTSNDLKSGDASINVTNLQLSDIGTYQCKVKKAPGVANKKIHLVVLVK
PSGA
//
>1p7qA [d.19.1 - b.1.1] HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2
GSHSMRYFFTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGPEYW
DGETRKVKAHSQTHRVDLGTLRGYYNQSEAGSHTVQRMYGCDVGSDWRFLRGYHQYAYDG
KDYIALKEDLRSWTAADMAAQTTKHKWEAAHVAEQLRAYLEGTCVEWLRRYLENGKETLQ
RTDAPKTHMTHHAVSDHEATLRCWALSFYPAEITLTWQRDGEDQTQDTELVETRPAGDGT
FQKWAAVVVPSGQEQRYTCHVQHEGLPKPLTLRWEP
//
>1p7qB [b.1.1] BETA-2-MICROGLOBULIN
IQRTPKIQVYSRHPAENFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYL
LYYTEFTPTDEYACRVNHVTLSQPKIVKWDRDM
//
>1p7qD [b.1.1 - b.1.1] LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR 1
PKPTLWAEPGSVITQGSPVTLRCQTQEYRLYREKKTAPWITRIPQELVKKGQFPIPSITW
EHAGRYRCYYRSESSDPLELVVTGAYIKPTLSAQPSPVVNSGGNVTLQCDSQVAFDGFIL
CKEGEHPQCLNSQPHARGSSRAIFSVGPVSPSRRWWYRCYAYDSNSPYEWSLPSDLLELL
VLG
//
>1p9mA [b.1.2 - b.1.2 - b.1.2] INTERLEUKIN-6 RECEPTOR BETA CHAIN
LLDPCGYISPESPVVQLHSNFTAVCVLKEKCMDYFHVNANYIVWKTNHFTIPKEQYTIIN
RTASSVTFTDIASLNIQLTCNILTFGQLEQNVYGITIISGLPPEKPKNLSCIVNEGKKMR
CEWDGGRETHLETNFTLKSEWATHKFADCKAKRDTPTSCTVDYSTVYFVNIEVWVEAENA
LGKVTSDHINFDPVYKVKPNPPHNLSVINSEELSSILKLTWTNPSIKSVIILKYNIQYRT
KDASTWSQIPPEDTASTRSSFTVQDLKPFTEYVFRIRCMKEDGKGYWSDWSEEASGIT
//
>1p9mB [a.26.1] INTERLEUKIN-6
LTSSERIDKQIRYILDGISALRKETCNKCESSKEALAENNLNLPKMAEKDGCFQSGFNEE
TCLVKIITGLLEFEVYLEYLQNRFESSEEQARAVQMSTKVLIQFLQKKAKNLDAITTPDP
TTNASLLTKLQAQNQWLQDMTTHLILRSFKEFLQSSLRALRQM
//
>1p9mC [b.1.2 - b.1.2] INTERLEUKIN-6 RECEPTOR ALPHA CHAIN
EEPQLSCFRKSPLSNVVCEWGPRSTPSLTTKAVLLVRKFQNSPAEDFQEPCQYSQESQKF
SCQLAVPEGDSSFYIVSMCVASSVGSKFSKTQTFQGCGILQPDPPANITVTAVARNPRWL
SVTWQDPHSWNSSFYRLRFELRYRAERSKTFTTWMVKDLQHHCVIHDAWSGLRHVVQLRA
QEEFGQGEWSEWSPEAMGTPW
//
>1p9mD (B) [a.26.1] INTERLEUKIN-6
LTSSERIDKQIRYILDGISALRKETCNKCESSKEALAENNLNLPKMAEKDGCFQSGFNEE
TCLVKIITGLLEFEVYLEYLQNRFESSEEQARAVQMSTKVLIQFLQKKAKNLDAITTPDP
TTNASLLTKLQAQNQWLQDMTTHLILRSFKEFLQSSLRALRQM
//
>1pbxA [a.1.1] HEMOGLOBIN (CARBONMONOXY) (ALPHA CHAIN)
SLSDKDKAAVRALWSKIGKSADAIGNDALSRMIVVYPQTKTYFSHWPDVTPGSPHIKAHG
KKVMGGIALAVSKIDDLKTGLMELSEQHAYKLRVDPANFKILNHCILVVISTMFPKEFTP
EAHVSLDKFLSGVALALAERYR
//
>1pbxB [a.1.1] HEMOGLOBIN (CARBONMONOXY) (BETA CHAIN)
VEWTDKERSIISDIFSHMDYDDIGPKALSRCLIVYPWTQRHFSGFGNLYNAEAIIGNANV
AAHGIKVLHGLDRGVKNMDNIAATYADLSTLHSEKLHVDPDNFKLLSDCITIVLAAKMGH
AFTAETQGAFQKFLAVVVSALGKQYH
//
>1pbyA [a.3.1 - a.3.1 - b.61.4 - b.1.18 - b.1.18] QUINOHEMOPROTEIN AMINE DEHYDROGENASE 60 KDA
VTGEEVLQNACAACHVQHEDGRWERIDAARKTPEGWDMTVTRMMRNHGVALEPEERAAIV
RHLSDTRGLSLAETEERRYILEREPVAWDEGPDTSMTQTCGRCHSYARVALQRRTPEDWK
HLVNFHLGQFPTLEYQALARDRDWWGIAQAEIIPFLARTYPLGEAPDAYADDASGAYVLA
GRQPGRGDYTGRLVLKKAGEDYEVTMTLDFADGSRSFSGTGRILGAGEWRATLSDGTVTI
RQIFALQDGRFSGRWHDADSDVIGGRLAAVKADAAPQVLAVAPARLKIGEETQLRVAGTG
LGSDLTLPEGVAGSVESAGNGVTVLKLTATGTPGPVSLELGGQKVDLVAYDRPDRISIVP
DLTIARIGGNGGPIPKVPAQFEAMGWLNGPDGQPGTGDDIALGAFPASWATDNFDEEAEK
MQDAKYAGSIDDTGLFTPAEAGPNPERPMQTNNAGNLKVIATVDAEGEPLSAEAHLYATV
QRFVDAPIR
//
>1pbyB [b.69.2] QUINOHEMOPROTEIN AMINE DEHYDROGENASE 40 KDA
RDYILAPARPDKLVVIDTEKMAVDKVITIADAGPTPMVPMVAPGGRIAYATVNKSESLVK
IDLVTGETLGRIDLSTPEERVKSLFGAALSPDGKTLAIYESPVRLELTHFEVQPTRVALY
DAETLSRRKAFEAPRQITMLAWARDGSKLYGLGRDLHVMDPEAGTLVEDKPIQSWEAETY
AQPDVLAVWNQHESSGVMATPFYTARKDIDPADPTAYRTGLLTMDLETGEMAMREVRIMD
VFYFSTAVNPAKTRAFGAYNVLESFDLEKNASIKRVPLPHSYYSVNVSTDGSTVWLGGAL
GDLAAYDAETLEKKGQVDLPGNASMSLASVRLFTRDE
//
>1pbyC [a.137.9] QUINOHEMOPROTEIN AMINE DEHYDROGENASE 9 KDA
MNALVGCTTSFDPGWEVDAFGAVSNLCQPMEADLYGCADPCWxPAQVADTLNTYPNWSAG
ADDVMQDWRKLQSVFPETK
//
>1pc8A [d.165.1] HIMALAYAN MISTLETOE RIBOSOME-INACTIVATING
YERLDLDVTSQTTGEEYFRFITLLRDYVSSGSFSNEIPLLRQSGGGVEAARFVLVELTNE
GGDSITAAIDVTNLYVVAYQAGSQSYFLSGPGTHLFTGTTRSSLPFNGSYPDLEQYAGHR
KQIPLGIDQLIQSVTALRFPGNTRTQARSILILIQMISEAARFNPILWRARQYINSGASF
LPDVYMLELETSWGQQSTQVQQSTEGVFNNPIRLAIPGNFVTLTNVRDVIASLAIMLFVC
//
>1pc8B [b.42.2 - b.42.2] HIMALAYAN MISTLETOE RIBOSOME-INACTIVATING
CSASEPTVRIVGRNGMNVDVRDDDFHDGNQIQLWPSKSNNDPNQLWTIKRDGTIRSNGSC
LTTYGYTAGVYVMIFDCNTAVREATIWQIWGNGTIINPRSNLALAASSGIKGTTLTVQTL
DYTLGQGWLAGNDTAPREVTIYGFNDLCMESNGGSVWVETCVSQQNDRWALYGDGSIRPE
QNQDQCLTSGRDSVAGINIVSCSGGSSGQRWVFTNEGAILNLKNGLAMDVANPGLGQIII
YPATGKPNQMWLPVP
//
>1pcaA [d.58.3] PROCARBOXYPEPTIDASE A PCPA
KEDFVGHQVLRISVDDEAQVQKVKELEDLEHLQLDFWRGPARPGFPIDVRVPFPSIQAVK
VFLEAHGIRYTIMIEDVQLLLDEEQEQMFASQGR
//
>1pcaB [x.x.x]
ARTTSTFNYATYHTLEEIYDFMDILVAEHPALVSKLQIGRSYEGRPIYVLKFSTGGSNRP
AIWIDSGIHSREWITQASGVWFAKKITENYGQNSSFTAILDSMDIFLEIVTNPNGFAFTH
SDNRLWRKTRSKASGSLCVGSDSNRNWDAGFGGAGASSSPCAETYHGKYPNSEVEVKSIT
DFVKNNGNIKAFISIHSYSQLLLYPYGYKTQSPADKSELNQIAKSAVAALKSLYGTSYKY
GSIITVIYQASGGVIDWTYNQGIKYSFSFELRDTGRRGFLLPASQIIPTAQETWLALLTI
MEHTLNNS
//
>1pdkA [b.1.11 - b.7.2] PROTEIN (CHAPERONE PROTEIN PAPD)
AVSLDRTRAVFDGSEKSMTLDISNDNKQLPYLAQAWIENENQEKIITGPVIATPPVQRLE
PGAKSMVRLSTTPDISKLPQDRESLFYFNLREIPPRSEKANVLQIALQTKIKLFYRPAAI
KTRPNEVWQDQLILNKVSGGYRIENPTPYYVTVIGLGGSEKQAEEGEFETVMLSPRSEQT
VKSANYNTPYLSYINDYGGRPVLSFICNGSRCSVK
//
>1pdkB [b.2.3] PROTEIN (PROTEIN PAPK)
LLDRPCHVSGDSLNKHVVFKTRASRDFWYPPGRSPTESFVIRLENCHATAVGKIVTLTFK
GTEEAALPGHLKVTGVNAGRLGIALLDTDGSSLLKPGTSHNKGQGEKVTGNSLELPFGAY
VVATPEALRTKSVVPGDYEATATFELTYR
//
>1pfxC [b.47.1] FACTOR IXA
IVGGENAKPGQFPWQVLLNGKIDAFCGGSIINEKWVVTAAHCIEPGVKITVVAGEYNTEE
TEPTEQRRNVIRAIPHHSYNATVNKYSHDIALLELDEPLTLNSYVTPICIADKEYTNIFL
KFGSGYVSGWGRVFNRGRSATILQYLKVPLVDRATCLRSTKFTIYSNMFCAGFHEGGKDS
CQGDSGGPHVTEVEGTSFLTGIISWGEECAVKGKYGIYTKVSRYVNWIKEKTKLT
//
>1pfxL [g.32.1 - g.3.11 - g.3.11] FACTOR IXA
YNSGKLxxFVRGNLxRxCIxxKCSFxxARxVFxNTxKTNxFWKQYVDGDQCEPNPCLNGG
LCKxDINSYECWCQVGFEGKNCELDATCNIKNGRCKQFCKTGADSKVLCSCTTGYRLAPD
QKSCKPAVPFPCGRVSVSHSPTTLTR
//
>1pg7_1L [b.1.1 - b.1.1] HUMANIZED ANTIBODY D3H44
DIQMTQSPSSLSASVGDRVTITCRASRDIKSYLNWYQQKPGKAPKVLIYYATSLAEGVPS
RFSGSGSGTDYTLTISSLQPEDFATYYCLQHGESPWTFGQGTKVEIKRTVAAPSVFIFPP
SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT
LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGE
//
>1pg7_1W [b.1.1 - b.1.1] MURINE ANTIBODY 6A6 FAB FRAGMENT
QAVVTQESALTSSPGETVTLTCRSSTGAVTTSNYANWVQEKPDHLFTGVIGGTNNRAPGV
PARFSGSLIGDKAALTITGAQTEDEAIYFCALWYSNHWVFGGGTKLTVLGQPKSSPSVNL
FPPSSEELKTKKATLVCTITEFYPGAVRVDWKADGTPVTQGDETTQPSKQSNNKYMASSY
LTLTAEAWESHSSYSCHVTHEGQSVEKSLS
//
>1pg7_1X [b.1.1 - b.1.1] MURINE ANTIBODY 6A6 FAB FRAGMENT
EVQLQQSGPELVKPGASVKISCKASGYSFTGHLLNWVKQSHGKNLEWIGLVHPHNGAITY
NQKFKDKATLTVDRSSTTAYIELVRLTSNDSAVYYCAREDFRYHYSMDYWGQGTSVTVSS
AKTTPPSVYPLAPVCGDTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSD
LYTLSSSVTVTSSTWPSQSVTCNVAHPASSTKVDKKIVPK
//
>1pg7_2M (L) [b.1.1 - b.1.1] HUMANIZED ANTIBODY D3H44
DIQMTQSPSSLSASVGDRVTITCRASRDIKSYLNWYQQKPGKAPKVLIYYATSLAEGVPS
RFSGSGSGTDYTLTISSLQPEDFATYYCLQHGESPWTFGQGTKVEIKRTVAAPSVFIFPP
SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT
LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGE
//
>1pg7_2Z (X) [b.1.1 - b.1.1] MURINE ANTIBODY 6A6 FAB FRAGMENT
EVQLQQSGPELVKPGASVKISCKASGYSFTGHLLNWVKQSHGKNLEWIGLVHPHNGAITY
NQKFKDKATLTVDRSSTTAYIELVRLTSNDSAVYYCAREDFRYHYSMDYWGQGTSVTVSS
AKTTPPSVYPLAPVCGDTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSD
LYTLSSSVTVTSSTWPSQSVTCNVAHPASSTKVDKKIVPK
//
>1pgl_2z (1) [b.121.4] BEAN POD MOTTLE VIRUS SMALL (S) SUBUNIT
SISQQTVWNQMATVRTPLNFDSSKQSFCQFSVDLLGGGISVDKTGDWITLVQNSPISNLL
RVAAWKKGCLMVKVVMSGNAAVKRSDWASLVQVFLTNSNSTEHFDACRWTKSEPHSWELI
FPIEVCGPNNGFEMWSSEWANQTSWHLSFLVDNPKQSTTFDVLLGISQNFEIAGNTLMPA
FSVPQ
//
>1pgl_20 (2) [b.121.4 - b.121.4] BEAN POD MOTTLE VIRUS LARGE (L) SUBUNIT
METNLFKLSLDDVETPKGSMLDLKISQSKIALPKNTVGGTILRSDLLANFLTEGNFRASV
DLQRTHRIKGMIKMVATVGIPENTGIALACAMNSSIRGRASSDIYTICSQDCELWNPACT
KAMTMSFNPNPCSDAWSLEFLKRTGFHCDIICVTGWTATPMQDVQVTIDWFISSQECVPR
TYCVLNPQNPFVLNRWMGKLTFPQGTSRSVKRMPLSIGGGAGAKSAILMNMPNAVLSMWR
YFVGDLVFEVSKMTSPYIKCTVSFFIAFGNLADDTINFEAFPHKLVQFGEIQEKVVLKFS
QEEFLTAWSTQVRPATTLLADGCPYLYAMVHDSSVSTIPGDFVIGVKLTIIENMCAYGLN
PGISGSRLLG
//
>1pgrE [a.26.1] PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)
GPASSLPQSFLLKCLEQVRKIQGDGAALQEKLCATYKLCHPEELVLLGHSLGIPWAPLSS
CPSQALQLAGCLSQLHSGLFLYQGLLQALEGISPELGPTLDTLQLDVADFATTIWQQMEE
LGMAAMPAFASAFQRRAGGVLVASHLQSFLEVSYRVLRHLAQP
//
>1pgrF [b.1.2 - b.1.2] PROTEIN (G-CSF RECEPTOR)
AGYPPASPSNLSCLMHLTTNSLVCQWEPGPETHLPTSFILKSFRSRADCQYQGDTIPDCV
AKKRQNNCSIPRKNLLLYQYMAIWVQAENMLGSSESPKLCLDPMDVKLEPPMLQALDIGP
DHQPGCLWLSWKPWKPSEYMEQECELRYQPQLKGANWTLVFHLPSSKDQFELCGLHQAPV
YTLQMRCIRSSLPGFWSPWSPGLQLRPTM
//
>1ph1A [b.40.4 - b.40.4 - b.40.4] TELOMERE-BINDING PROTEIN ALPHA SUBUNIT
KYEYVELAKASLTSAQPQHFYAVVIDATFPYKTNQERYICSLKIVDPTLYLKQDASDYAT
LVLYAKRFEDLPIIHRAGDIIRVHRATLRLYNGQRQFNANVFYSSSWALFSTDKRSVTQE
INNQDAVSDTTPFSFSSKHATIEKNEISILQNLRKWANQYFSSYSVISSDMYTALNKAQA
QKGDFDVVAKILQVHELDEYTNELKLKDASGQVFYTLSLKLKFPHVRTGEVVRIRSATYD
ETSTQKKVLILSHYSNIITFIQSSKLAKELRAKIQDDHSVEVASLKKNVSLNAVVLTEVD
KKHAALPSTSLQDLFHHADSDKELQAQDTFRTQFYVTKIEPSDVKEWVKGYDRKTKKSSS
LKGASGKGDNIFQVQFLVKDASTQLNNNTYRVLLYTQDGLGANFFNVKADNLHKNADARK
KLEDSAELLTKFNSYVDAVVERRNGFYLIKDTKLIY
//
>1ph1B [b.40.4] TELOMERE-BINDING PROTEIN BETA SUBUNIT
PQQQSAFKQLYTELFNNEGDFSKVSSNLKKPLKCYVKESYPHFLVTDGYFFVAPYFTKEA
VNEFHAKFPNVNIVDLTDKVIVINNWSLELRRVNSAEVFTSYANLEARLIVHSFKPNLQE
RLNPTRYPVNLFRDDEFKTTIQHFRHTALQAAINKTVKGDNLVDISKVADAAGKKGKVDA
GIVKASASKGDEFSDFSFKEGNTATLKIADIFVQEKG
//
>1phnA [a.1.1] PHYCOCYANIN
MKTPITEAIAAADNQGRFLSNTELQAVNGRYQRAAASLEAARSLTSNAERLINGAAQAVY
SKFPYTSQMPGPQYASSAVGKAKCARDIGYYLRMVTYCLVVGGTGPMDEYLIAGLEEINR
TFDLSPSWYVEALNYIKANHGLSGQAANEANTYIDYAINALS
//
>1phnB [a.1.1] PHYCOCYANIN
MLDAFAKVVAQADARGEFLSNTQLDALSKMVSEGNKRLDVVNRITSNASAIVTNAARALF
SEQPQLIQPGGxAYTNRRMAACLRDMEIILRYVSYAIIAGDSSILDDRCLNGLRETYQAL
GVPGASVAVGIEKMKDSAIAIANDPSGITTGDCSALMAEVGTYFDRAATAVQ
//
>1piv_22 [b.121.4] POLIOVIRUS TYPE 3 (SUBUNIT VP2)
ACGYSDRVLQLTLGNSTITTQEAANSVVAYGRWPEFIRDDEANPVDQPTEPDVATCRFYT
LDTVMWGKESKGWWWKLPDALRDMGLFGQNMYYHYLGRSGYTVHVQCNASKFHQGALGVF
AIPEYCLAGDSDKQRYTSYANANPGERGGKFYSQFNKDNAVTSPKREFCPVDYLLGCGVL
LGNAFVYPHQIINLRTNNSATIVLPYVNALAIDSMVKHNNWGIAILPLSPLDFAQDSSVE
IPITVTIAPMCSEFNGLRNVTAPKFQ
//
>1piv_24 [b.121.4] POLIOVIRUS TYPE 3 (SUBUNIT VP4)
GAQVSSQKVGAHENSSTINYTTINYYKDSASNAASKQDYSQDPSKFTEPLKDVLIKTAPA
LN
//
>1pjmA [x.x.x] RETINOBLASTOMA-ASSOCIATED PROTEIN
CGKRSAEGSNPPKPLKKLRG
//
>1pjmB [a.118.1] IMPORTIN ALPHA-2 SUBUNIT
QGTVNWSVEDIVKGINSNNLESQLQATQAARKLLSREKQPPIDNIIRAGLIPKFVSFLGK
TDCSPIQFESAWALTNIASGTSEQTKAVVDGGAIPAFISLLASPHAHISEQAVWALGNIA
GDGSAFRDLVIKHGAIDPLLALLAVPDLSTLACGYLRNLTWTLSNLCRNKNPAPPLDAVE
QILPTLVRLLHHNDPEVLADSCWAISYLTDGPNERIEMVVKKGVVPQLVKLLGATELPIV
TPALRAIGNIVTGTDEQTQKVIDAGALAVFPSLLTNPKTNIQKEATWTMSNITAGRQDQI
QQVVNHGLVPFLVGVLSKADFKTQKEAAWAITNYTSGGTVEQIVYLVHCGIIEPLMNLLS
AKDTKIIQVILDAISNIFQAAEKLGETEKLSIMIEECGGLDKIEALQRHENESVYKASLN
LIEKYFS
//
>1pjnA [x.x.x] HISTONE-BINDING PROTEIN N1/N2
RKKRKTEEESPLKDKAKKSKG
//
>1pjnB [a.118.1] IMPORTIN ALPHA-2 SUBUNIT
GTVNWSVEDIVKGINSNNLESQLQATQAARKLLSREKQPPIDNIIRAGLIPKFVSFLGKT
DCSPIQFESAWALTNIASGTSEQTKAVVDGGAIPAFISLLASPHAHISEQAVWALGNIAG
DGSAFRDLVIKHGAIDPLLALLAVPDLSTLACGYLRNLTWTLSNLCRNKNPAPPLDAVEQ
ILPTLVRLLHHNDPEVLADSCWAISYLTDGPNERIEMVVKKGVVPQLVKLLGATELPIVT
PALRAIGNIVTGTDEQTQKVIDAGALAVFPSLLTNPKTNIQKEATWTMSNITAGRQDQIQ
QVVNHGLVPFLVGVLSKADFKTQKEAAWAITNYTSGGTVEQIVYLVHCGIIEPLMNLLSA
KDTKIIQVILDAISNIFQAAEKLGETEKLSIMIEECGGLDKIEALQRHENESVYKASLNL
IEKYFS
//
>1pk1_1A [a.60.1] POLYHOMEOTIC-PROXIMAL CHROMATIN PROTEIN
PPISSWSVDDVSNFIRELPGCQDYVDDFIQQEIDGQALLLLKEKHLVNAmGmKLGPARKI
VAKVESIK
//
>1pk1_1B [a.60.1] SEX COMB ON MIDLEG CG9495-PA
RSQPIDWTIEEVIQYIESNDNSLAVHGDLFRKHEIDGKALLRLNSERMMKYMGLKLGPAL
KICNLVNKVN
//
>1pkq_1A [b.1.1 - b.1.1] (8-18C5) CHIMERIC FAB, LIGHT CHAIN
DIELTQSPSSLAVSAGEKVTMSCKSSQSLLNSGNQKNYLAWYQQKPGLPPKLLIYGASTR
ESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCQNDHSYPLTFGAGTKLEIKRTVAAPS
VFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYS
LSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGE
//
>1pkq_1B [b.1.1 - b.1.1] (8-18C5) CHIMERIC FAB, HEAVY CHAIN
EVKLHESGAGLVKPGASVEISCKATGYTFSSFWIEWVKQRPGHGLEWIGEILPGRGRTNY
NEKFKGKATFTAETSSNTAYMQLSSLTSEDSAVYYCATGNTMVNMPYWGQGTTVTVSSAS
TKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGL
YSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC
//
>1pkq_1E [b.1.1] MYELIN OLIGODENDROCYTE GLYCOPROTEIN
GSGQFRVIGPGHPIRALVGDEAELPCRISPGKNATGMEVGWYRSPFSRVVHLYRNGKDQD
AEQAPEYRGRTELLKESIGEGKVALRIQNVRFSDEGGYTCFFRDHSYQEEAAVELKVEDP
F
//
>1plgA (H) [b.1.1 - b.1.1] IGG2A=KAPPA=
QIQLQQSGPELVRPGASVKISCKASGYTFTDYYIHWVKQRPGEGLEWIGWIYPGSGNTKY
NEKFKGKATLTVDTSSSTAYMQLSSLTSEDSAVYFCARGGKFAMDYWGQGTSVTVSSAKT
TAPSVYPLAPVCGDTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDLYT
LSSSVTVTSSTWPSQSITCNVAHPASSTKVDKKIE
//
>1plgB (L) [b.1.1 - b.1.1] IGG2A=KAPPA=
DVVMTQTPLSLPVSLGDQASISCRSSQSLVHSNGNTYLYWYLQKPGQSPKPLIYRVSNRF
SGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCFQGTHVPYTFGGGTRLEIKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFN
//
>1poiC (A) [c.124.1] GLUTACONATE COENZYME A-TRANSFERASE
SKVMTLKDAIAKYVHSGDHIALGGFTTDRKPYAAVFEILRQGITDLTGLGGAAGGDWDML
IGNGRVKAYINCYTANSGVTNVSRRFRKWFEAGKLTMEDYSQDVIYMMWHAAALGLPFLP
VTLMQGSGLTDEWGISKEVRKTLDKVPDDKFKYIDNPFKPGEKVVAVPVPQVDVAIIHAQ
QASPDGTVRIWGGKFQDVDIAEAAKYTIVTCEEIISDEEIRRDPTKNDIPGMCVDAVVLA
PYGAHPSQCYGLYDYDNPFLKVYDKVSKTQEDFDAFCKEWVFDLKDHDEYLNKLGATRLI
NLKVVPGLGYHIDMTKE
//
>1poiD (B) [c.124.1] GLUTACONATE COENZYME A-TRANSFERASE
DYTNYTNKEMQAVTIAKQIKNGQVVTVGTGLPLIGASVAKRVYAPDCHIIVESGLMDCSP
VEVPRSVGDLRFMAHCGCIWPNVRFVGFEINEYLHKANRLIAFIGGAQIDPYGNVNSTSI
GDYHHPKTRFTGSGGANGIATYSNTIIMMQHEKRRFMNKIDYVTSPGWIDGPGGRERLGL
PGDVGPQLVVTDKGILKFDEKTKRMYLAAYYPTSSPEDVLENTGFDLDVSKAVELEAPDP
AVIKLIREEIDPGQAFIQVP
//
>1pov_20 [b.121.4] POLIOVIRUS NATIVE EMPTY CAPSID (TYPE 1)
GAQVSSQKVGAHINYTTINYYRDSASNAASKQIKDVLIKTAPMLNSPNIEACGYLQLTLG
NSTITTQEAANSVVAYGRWPEYLRDVAACRFYTLDTVSWTKESRGWWWKLPDALRDMGLF
GQNMYYHYLGRSGYTVHVQCNASKFHQGALGVFAVPEMCLAGDSNTTTMHTSYQNANPGE
KGGTFTGTFTPDNNQTSPARRFCPVDYLLGNGTLLGNAFVFPHQIINLRTNNCATLVLPY
VNSLSIDSMVKHNNWGIAILPLAPLNFASESSPEIPITLTIAPMCCEFNGLRNITLPRLQ
//
>1pov_21 [b.121.4] POLIOVIRUS NATIVE EMPTY CAPSID (TYPE 1)
QHRSRSESSIESFFARGACVTIMTVDNPASTTNKDKLFAVWKITYKDTVQLRRKLEFFTY
SRFDMELTFVVTANFTETNNGHALNQVYQIMYVPPGAPVPEKWDDYTWQTSSNPSIFYTY
GTAPARISVPYVGISNAYSHFYDGFSKVPLKDQSAALGDSLYGAASLNDFGILAVRVVND
HNPTKVTSKIRVYLKPKHIRVWCPRPPRAVAYYGPGVDYKDGTLTPLSTKDLTTY
//
>1pov_2J (0) [b.121.4] POLIOVIRUS NATIVE EMPTY CAPSID (TYPE 1)
GAQVSSQKVGAHINYTTINYYRDSASNAASKQIKDVLIKTAPMLNSPNIEACGYLQLTLG
NSTITTQEAANSVVAYGRWPEYLRDVAACRFYTLDTVSWTKESRGWWWKLPDALRDMGLF
GQNMYYHYLGRSGYTVHVQCNASKFHQGALGVFAVPEMCLAGDSNTTTMHTSYQNANPGE
KGGTFTGTFTPDNNQTSPARRFCPVDYLLGNGTLLGNAFVFPHQIINLRTNNCATLVLPY
VNSLSIDSMVKHNNWGIAILPLAPLNFASESSPEIPITLTIAPMCCEFNGLRNITLPRLQ
//
>1pov_2F (3) [b.121.4] POLIOVIRUS NATIVE EMPTY CAPSID (TYPE 1)
QHRSRSESSIESFFARGACVTIMTVDNPASTTNKDKLFAVWKITYKDTVQLRRKLEFFTY
SRFDMELTFVVTANFTETNNGHALNQVYQIMYVPPGAPVPEKWDDYTWQTSSNPSIFYTY
GTAPARISVPYVGISNAYSHFYDGFSKVPLKDQSAALGDSLYGAASLNDFGILAVRVVND
HNPTKVTSKIRVYLKPKHIRVWCPRPPRAVAYYGPGVDYKDGTLTPLSTKDLTTY
//
>1pov_2F (3) [b.121.4] POLIOVIRUS NATIVE EMPTY CAPSID (TYPE 1)
GLPVMNTPGSNQYLTADNFQSPCALPEFDVTPPIDIPGEVKNMMELAEIDTMIPFDLSAT
KKNTMEMYRVRLSDKPHTDDPILCLSLSPASDPRLSHTMLGEILNYYTHWAGSLKFTFLF
CGSMMATGKLLVSYAPPGADPPKKRKEAMLGTHVIWDIGLQSSCTMVVPWISNTTYRQTI
DDSFTEGGYISVFYQTRIVVPLSTPREMDILGFVSACNDFSVRLLRDTTHIEQKALAQ
//
>1ppbH [x.x.x]
IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL
VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL
PDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIR
ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCRDDGKYGFY
THVFRLKKWIQKVIDQFGE
//
>1ppbL [x.x.x]
GSGEADCFTGLRPLFEKKSLEDKTERELLESYIDGR
//
>1ppeE [b.47.1] TRYPSIN
IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEG
NEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISG
WGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGP
VVCSGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN
//
>1ppeI [g.3.2] TRYPSIN INHIBITOR CMTI-I
RVCPRILMECKKDSDCLAECVCLEHGYCG
//
>1ppfE [b.47.1] HUMAN LEUKOCYTE ELASTASE
IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNL
SRREPTRQVFAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGV
QCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSNVCTLVRGRQAGVCFGDSGSPLVCN
GLIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSIIQ
//
>1ppfI [g.68.1] TURKEY OVOMUCOID INHIBITOR (OMTKY3)
LAAVSVDCSEYPKPACTLEYRPLCGSDNKTYGNKCNFCNAVVESNGTLTLSHFGKC
//
>1ppjA [d.185.1 - d.185.1] UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX CORE
ATYAQALQSVPETQVSQLDNGLRVASEQSSQPTCTVGVWIDAGSRYESEKNNGAGYFVEH
LAFKGTKNRPGNALEKEVESMGAHLNAYSTREHTAYYIKALSKDLPKAVELLADIVQNCS
LEDSQIEKERDVILQELQENDTSMRDVVFNYLHATAFQGTPLAQSVEGPSENVRKLSRAD
LTEYLSRHYKAPRMVLAAAGGLEHRQLLDLAQKHFSGLSGTYDEDAVPTLSPCRFTGSQI
CHREDGLPLAHVAIAVEGPGWAHPDNVALQVANAIIGHYDCTYGGGAHLSSPLASIAATN
KLCQSFQTFNICYADTGLLGAHFVCDHMSIDDMMFVLQGQWMRLCTSATESEVLRGKNLL
RNALVSHLDGTTPVCEDIGRSLLTYGRRIPLAEWESRIAEVDARVVREVCSKYFYDQCPA
VAGFGPIEQLPDYNRIRSGMF
//
>1ppjC [f.21.1 - f.32.1] CYTOCHROME B
NNAFIDLPAPSNISSWWNFGSLLGICLILQILTGLFLAMHYTSDTTTAFSSVTHICRDVN
YGWIIRYMHANGASMFFICLYMHVGRGLYYGSYTFLETWNIGVILLLTVMATAFMGYVLP
WGQMSFWGATVITNLLSAIPYIGTNLVEWIWGGFSVDKATLTRFFAFHFILPFIIMAIAM
VHLLFLHETGSNNPTGISSDVDKIPFHPYYTIKDILGALLLILALMLLVLFAPDLLGDPD
NYTPANPLNTPPHIKPEWYFLFAYAILRSIPNKLGGVLALAFSILILALIPLLHTSKQRS
MMFRPLSQCLFWALVADLLTLTWIGGQPVEHPYITIGQLASVLYFLLILVLMPTAGTIEN
KLLKW
//
>1ppjI [d.184.1] UBIQUINOL-CYTOCHROME C REDUCTASE IRON-SULFUR
AAVPATSESPVLVLCRESLRGQAAGRPLVASVSLNVPASVRY
//
>1ppjO [d.185.1 - d.185.1] UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX CORE
EVPPPQDLEFTRLPNGLVIASLENYAPASRIGLFIKAGSRYENSNNLGTSHLLRLASSLT
TKGASSFKITRGIEAVGGKLSVTSTRENMAYTVECLRDDVDILMEFLLNVTTAPEFRRWE
VAALQPQLRIDKAVALQNPQAHVIENLHAAAYRNALANSLYCPDYRIGKVTPVELHDYVQ
NHFTSARMALIGLGVSHPVLKQVAEQFLNIRGGLGLSGAKAKYHGGEIREQNGDSLVHAA
LVAESAAIGSAEANAFSVLQHVLGAGPHVKRGSNATSSLYQAVAPFDVSAFNASYSDSGL
FGFYTISQAASAGDVIKAAYNQVKTIAQGNLSNPDVQAAKNKLKAGYLMSVESSEGFLDE
VGSQALAAGSYTPPSTVLQQIDAVADADVINAAKKFVSGRKSMAASGNLGHTPFIDEL
//
>1ppjR [f.23.12 - b.33.1] UBIQUINOL-CYTOCHROME C REDUCTASE IRON-SULFUR
SHTDIKVPDFSDYRRPEVLDSTKSSKESSEARKGFSYLVTATTTVGVAYAAKNVVSQFVS
SMSASADVLAMSKIEIKLSDIPEGKNMAFKWRGKPLFVRHRTKKEIDQEAAVEVSQLRDP
QHDLERVKKPEWVILIGVCTHLGCVPIANAGDFGGYYCPCHGSHYDASGRIRKGPAPLNL
EVPSYEFTSDDMVIVG
//
>1ppjV (I) [d.184.1] UBIQUINOL-CYTOCHROME C REDUCTASE IRON-SULFUR
AAVPATSESPVLVLCRESLRGQAAGRPLVASVSLNVPASVRY
//
>1pq1A [f.1.4] APOPTOSIS REGULATOR BCL-X
MSQSNRELVVDFLSYKLSQKGYSWSQFSREVIPMAAVKQALREAGDEFELRYRRAFSDLT
SQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIASW
MATYLNDHLEPWIQENGGWDTFVDLYG
//
>1pq1B [x.x.x] BCL2-LIKE PROTEIN 11
DLRPEIRIAQELRRIGDEFNETYTRRVFANDYR
//
>1pqzA [d.19.1 - b.1.1] MCMV M144
GSESGLRYAYTLVVDGTANTARCFGTGHVDGEAFVGYSNNKTHGIGRWVNASHVEEENKE
FVRQCKELQAELDKMQNNSAVIGVKTVQLDVGCTSKIEKHYAYDGNETEDDTATSASERA
RDCQKKLTEYRKLVLASAVSPQLEVERRSSGREGGMRLRCFARDYYPADLEIRWWKDDGG
GGALPQTSKQHHDPLPSGQGLYQKHIDVYVDGGLEHVYSCRVKGIATGLELQIVRWKG
//
>1pqzB [b.1.1] BETA-2-MICROGLOBULIN
IQKTPQIQVYSRHPPENGKPNILNCYVTQFHPPHIEIQMLKNGKKIPKVEMSDMSFSKDW
SFYILAHTEFTPTETDTYACRVKHDSMAEPKTVYWDRDM
//
>1prt_1A [d.166.1] PERTUSSIS TOXIN (SUBUNIT S1)
DPPATVYRYDSRPPEDVFQNGFTAWGNNDNVLEHLTGRSCQVGSSNSAFVSTSSSRRYTE
VYLEHRMQEAVEAERAGRGTGHFIGYIYEVRADNNFYGAASSYFEYVDTYGDNAGRILAG
ALATYQSEYLAHRRIPPENIRRVTRVYHNGITGETTTTEYSNARYVSQQTRANPNPYTSR
RSVASIVGTLVRMAPVVGACMARQAESSEEAMVLVYYESIAYSF
//
>1prt_1D [b.40.2] PERTUSSIS TOXIN (SUBUNIT S4)
DVPYVLVKTNMVVTSVAMKPYEVTPTRMLVCGIAAKLGAAASSPDAHVPFCFGKDLKRPG
SSPMEVMLRAVFMQQRPLRMFLGPKQLTFEGKPALELIRMVECSGKQDCP
//
>1prt_1E (D) [b.40.2] PERTUSSIS TOXIN (SUBUNIT S4)
DVPYVLVKTNMVVTSVAMKPYEVTPTRMLVCGIAAKLGAAASSPDAHVPFCFGKDLKRPG
SSPMEVMLRAVFMQQRPLRMFLGPKQLTFEGKPALELIRMVECSGKQDCP
//
>1prt_1B [d.169.1 - b.40.2] PERTUSSIS TOXIN (SUBUNIT S2)
GIVIPPQEQITQHGSPYGRCANKTRALTVAELRGSGDLQEYLRHVTRGWSIFALYDGTYL
GGEYGGVIKDGTPGGAFDLKTTFCIMTTRNTGQPATDHYYSNVTATRLLSSTNSRLCAVF
VRSGQPVIGACTSPYDGKYWSMYSRLRKMLYLIYVAGISVRVHVSKEEQYYDYEDATFET
YALTGISICNPGSSLC
//
>1prt_1C [d.169.1 - b.40.2] PERTUSSIS TOXIN (SUBUNIT S3)
GIVIPPKALFTQQGGAYGRCPNGTRALTVAELRGNAELQTYLRQITPGWSIYGLYDGTYL
GQAYGGIIKDAPPGAGFIYRETFCITTIYKTGQPAADHYYSKVTATRLLASTNSRLCAVF
VRDGQSVIGACASPYEGRYRDMYDALRRLLYMIYMSGLAVRVHVSKEEQYYDYEDATFQT
YALTGISLCNPAASIC
//
>1pskL [b.1.1 - b.1.1] ANTIBODY
QIVLTQSPAIMSASPGEKVTITCSASSSVSNIHWFQQKPGTFPKLWIYSTSTLASGVPGR
FSGSGSGTSYSLTISRMGAEDAATYYCQQRSGYPFTFGSGTKLEIKRADAAPTVSIFPPS
SEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLTL
TKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1pskH [b.1.1 - b.1.1] ANTIBODY
EVQLQQSGPELVKPGASVKISCKTSGYTFTKYTMHWVKQSHGKSLEWIGDINPNNGGTNY
NQKFKGTATLTVHKSSTTAYMELRSLTSEDSAVYYCTSKSFDYWGQGTTLTVSSAKTTAP
SVYPLAPVAVTLGCLVKGYFPEPVTLTWNSSGVHTFPAVLQSDLYTLSSSVTVTSSTWPS
QSITCNVAHPASSTKVDK
//
>1pto_1A [d.166.1] PERTUSSIS TOXIN (SUBUNIT S1)
DPPATVYRYDSRPPEDVFQNGFTAWGNNDNVLEHLTGRSCQVGSSNSAFVSTSSSRRYTE
VYLEHRMQEAVEAERAGRGTGHFIGYIYEVRADNNFYGAASSYFEYVDTYGDNAGRILAG
ALATYQSEYLAHRRIPPENIRRVTRVYHNGITGETTTTEYSNARYVSQQTRANPNPYTSR
RSVASIVGTLVRMAPVVGACMARQAESSEEAMVLVYYESIAYSF
//
>1pto_1F [b.40.2] PERTUSSIS TOXIN (SUBUNIT S5)
LPTHLYKNFTVQELALKLKGKNQEFCLTAFMSGRSLVRACLSDAGHEHDTWFDTMLGFAI
SAYALKSRIALTVEDSPYPGTPGDLLELQICPLNGYCE
//
>1pufA [a.4.1] HOMEOBOX PROTEIN HOX-A9
NNPAANWLHARSTRKKRCPYTKHQTLELEKEFLFNMYLTRDRRYEVARLLNLTERQVKIW
FQNRRMKMKKINKDRAK
//
>1pufB [a.4.1] PRE-B-CELL LEUKEMIA TRANSCRIPTION FACTOR-1
ARRKRRNFNKQATEILNEYFYSHLSNPYPSEEAKEELAKKCGITVSQVSNWFGNKRIRYK
KNIGKFQEEANIY
//
>1pumA [d.165.1] LECTIN I A CHAIN
YERLSLRTVQQTTGAEYFSFITLLRDFVSSGSFSNQIPLLRQSTIPVSEGQRFVLVELTN
AGGDSITAAIDVTNLYVVAYRAGDQSYFLKDAPAGAETQDFAGTTRSSLPFNGSYPDLER
YAGHRDQIPLGIDQLIASVTALRFPGGSTRTQARSILILIQMISEAARFNPILWRARQYI
NSGASFLPDVYMLELETSWGQQSTQVQHSTDGVFNNPIALALSPGSVVTLTNVRDVIASL
AIMLFVCGE
//
>1pumB [b.42.2 - b.42.2] LECTIN I B CHAIN
DDVTCSASEPIVRIVGRNGMTVDVRDDDFQDGNQIQLWPSKSNNDPNQLWTIKKDGTIRS
NGSCLTTYGYTAGVYVMIFDCNTAVREATIWQIWGNGTIINPRSNLVLAASSGIKGTTLT
VQTLDYTLGQGWLAGNDTAPREVTIYGFRDLCMESAGGSVWVETCTAGQENQRWALYGDG
SIRPKQNQSQCLTNGRDSVSTVINIVSCSAGSSGQRWVFTNAGAILNLKNGLAMDVAQAN
PALARIIIYPATGNPNQMWLPVP
//
>1pvc_21 [b.121.4] POLIOVIRUS TYPE 3, SABIN STRAIN
QDSLPDTKASGPAHSKEVPALTAVETGATNPLAPSDTVQTRHVVQRRSRSESTIESFFAR
GACVAIIEVDNEQPTTRAQKLFAMWRITYKDTVQLRRKLEFFTYSRFDMEFTFVVTANFT
NANNGHALNQVYQIMYIPPGAPTPKSWDDYTWQTSSNPSIFYTYGAAPARISVPYVGLAN
AYSHFYDGFAKVPLKTDANDQIGDSLYSAMTVDDFGVLAVRVVNDHNPTKVTSKVRIYMK
PKHVRVWCPRPPRAVPYYGPGVDYRNNLDPLSEKGLTTY
//
>1pvc_22 [b.121.4] POLIOVIRUS TYPE 3, SABIN STRAIN
ACGYSDRVLQLTLGNSTITTQEAANSVVAYGRWPEFIRDDEANPVDQPTEPDVATCRFYT
LDTVMWGKESKGWWWKLPDALRDMGLFGQNMYYHYLGRSGYTVHVQCNASKFHQGALGVF
AIPEYCLAGDSDKQRYTSYANANPGERGGKFYSQFNKDNAVTSPKREFCPVDYLLGCGVL
LGNAFVYPHQIINLRTNNSATIVLPYVNALAIDSMVKHNNWGIAILPLSPLDFAQDSSVE
IPITVTIAPMCSEFNGLRNVTAPKFQ
//
>1pvc_23 [b.121.4] POLIOVIRUS TYPE 3, SABIN STRAIN
GLPVLNTPGSNQYLTSDNHQSPCAIPEFDVTPPIDIPGEVKNMMELAEIDTMIPLNLEST
KRNTMDMYRVTLSDSADLSQPILCLSLSPAFDPRLSHTMLGEVLNYYTHWAGSLKFTFLF
CGSMMATGKILVAYAPPGAQPPTSRKEAMLGTHVIWDLGLQSSCTMVVPWISNVTYRQTT
QDSFTEGGYISMFYQTRIVVPLSTPKSMSMLGFVSACNDFSVRLLRDTTHISQSA
//
>1pvc_24 [b.121.4] POLIOVIRUS TYPE 3, SABIN STRAIN
GAQVSSQKVGAHENSSTINYTTINYYKDSASNAASKQDYSQDPSKFTEPLKDVLIKTAPA
LN
//
>1pvh_2C (A) [b.1.2 - b.1.2] INTERLEUKIN-6 RECEPTOR BETA CHAIN
GLPPEKPKNLSCIVNEGKKMRCEWDGGRETHLETNFTLKSEWATHKFADCKAKRDTPTSC
TVDYSTVYFVNIEVWVEAENALGKVTSDHINFDPVYKVKPNPPHNLSVINSEELSSILKL
TWTNPSIKSVIILKYNIQYRTKDASTWSQIPPEDTASTRSSFTVQDLKPFTEYVFRIRCM
KEDGKGYWSDWSEEASGITYE
//
>1pvh_2D (B) [a.26.1] LEUKEMIA INHIBITORY FACTOR
CAIRHPCHNNLMNQIRSQLAQLNGSANALFILYYTAQGEPFPNNLDKLCGPNVTDFPPFH
ANGTEKAKLVELYRIVVYLGTSLGNITRDQKILNPSALSLHSKLNATADILRGLLSNVLC
RLCSKYHVGHVDVTYGPDTSGKDVFQKKKLGCQLLGKYKQIIAVLAQAF
//
>1pyaC (A) [d.155.1] PYRUVOYL-DEPENDENT HISTIDINE DECARBOXYLASE (L-
SELDAKLNKLGVDRIAISPYKQWTRGYMEPGNIGNGYVTGLKVDAGVRDKSDDDVLDGIV
SYDRAETKNAYIGQINMTTAS
//
>1pyaD (B) [d.155.1] PYRUVOYL-DEPENDENT HISTIDINE DECARBOXYLASE (L-
FTGVQGRVIGYDILRSPEVDKAKPLFTETQWDGSELPIYDAKPLQDALVEYFGTEQDRRH
YPAPGSFIVCANKGVTAERPKNDADMKPGQGYGVWSAIAISFAKDPTKDSSMFVEDAGVW
ETPNEDELLEYLEGRRKAMAKSIAECGQDAHASFESSWIGFAYTMMEPGQIGNAITVAPY
VSLPIDSIPGGSILTPDKDMEIMENLTMPEWLEKMGYKSLSANNALKY
//
>1pyoA [c.17.1] CASPASE-2
LQVKPCTPEFYQTHFQLAYRLQSRPRGLALVLSNVHFTGEKELEFRSGGDVDHSTLVTLF
KLLGYDVHVLCDQTAQEMQEKLQNFAQLPAHRVTDSCIVALLSHGVEGAIYGVDGKLLQL
QEVFQLFDNANCPSLQNKPKMFFIQACRGDETDRGVDQQ
//
>1pyoB [c.17.1] CASPASE-2
PKMRLPTRSDMICGYACLKGTAAMRNTKRGSWYIEALAQVFSERACDMHVADMLVKVNAL
IKDREGYAPGTEFHRCKEMSEYCSTLCRHLYLFPGHPP
//
>1pysA [d.104.1] PHENYLALANYL-TRNA SYNTHETASE
RVDVSLPGASLFSGGLHPITLMERELVEIFRALGYQAVEGPEVESEFFNFDALNIPEHHP
ARDMWDTFWLTGEGFRLEGPLGEEVEGRLLLRTHTSPMQVRYMVAHTPPFRIVVPGRVFR
FEQTDATHEAVFHQLEGLVVGEGIAMAHLKGAIYELAQALFGPDSKVRFQPVYFPFVEPG
AQFAVWWPEGGKWLELGGAGMVHPKVFQAVDAYRERLGLPPAYRGVTGFAFGLGVERLAM
LRYGIPDIRYFFGGRLKFLEQFKGVL
//
>1pysB [a.6.1 - b.40.4 - b.153.1 - a.6.1 - d.104.1 - d.58.13] PHENYLALANYL-TRNA SYNTHETASE
MRVPFSWLKAYVPELESPEVLEERLAGLGFETDRIERVFPIPRGVVFARVLEAHPIPGTR
LKRLVLDAGRTVEVVSGAENARKGIGVALALPGTELPGLGQKVGERVIQGVRSFGMALSP
RELGVGEYGGGLLEFPEDALPPGTPLSEAWPEEVVLDLEVTPNRPDALGLLGLARDLHAL
GYALVEPEAALKAEALPLPFALKVEDPEGAPHFTLGYAFGLRVAPSPLWMQRALFAAGMR
PINNVVDVTNYVMLERAQPMHAFDLRFVGEGIAVRRAREGERLKTLDGVERTLHPEDLVI
AGWRGEESFPLGLAGVMGGAESEVREDTEAIALEVACFDPVSIRKTARRHGLRTEASHRF
ERGVDPLGQVPAQRRALSLLQALAGARVAEALLEAGSPKPPEAIPFRPEYANRLLGTSYP
EAEQIAILKRLGCRVEGEGPTYRVTPPSHRLDLRLEEDLVEEVARIQGYETIPLALPAFF
PAPDNRGVEAPYRKEQRLREVLSGLGFQEVYTYSFMDPEDARRFRLDPPRLLLLNPLAPE
KAALRTHLFPGLVRVLKENLDLDRPERALLFEVGRVFREREETHLAGLLFGEGVGLPWAK
ERLSGYFLLKGYLEALFARLGLAFRVEAQAFPFLHPGVSGRVLVEGEEVGFLGALHPEIA
QELELPPVHLFELRLPLPDKPLAFQDPSRHPAAFRDLAVVVPAPTPYGEVEALVREAAGP
YLESLALFDLYQGPPLPEGHKSLAFHLRFRHPKRTLRDEEVEEAVSRVAEALRARGFGLR
GLDTP
//
>1pytA [d.58.3] PROCARBOXYPEPTIDASE A
KEDFVGHQVLRITAADEAEVQTVKELEDLEHLQLDFWRGPGQPGSPIDVRVPFPSLQAVK
VFLEAHGIRYRIMIEDVQSLLDEEQEQMFASQSR
//
>1pytB [c.56.5] PROCARBOXYPEPTIDASE A
ARSTNTFNYATYHTLDEIYDFMDLLVAEHPQLVSKLQIGRSYEGRPIYVLKFSTGGSNRP
AIWIDLGIHSREWITQATGVWFAKKFTEDYGQDPSFTAILDSMDIFLEIVTNPDGFAFTH
SQNRLWRKTRSVTSSSLCVGVDANRNWDAGFGKAGASSSPCSETYHGKYANSEVEVKSIV
DFVKDHGNFKAFLSIHSYSQLLLYPYGYTTQSIPDKTELNQVAKSAVEALKSLYGTSYKY
GSIITTIYQASGGSIDWSYNQGIKYSFTFELRDTGRYGFLLPASQIIPTAQETWLGVLTI
MEHTLNNLY
//
>1pytC [b.47.1] PROPROTEINASE E
SRPSSRVVNGEDAVPYSWSWQVSLQYEKDGAFHHTCGGSLIAPDWVVTAGHCISTSRTYQ
VVLGEYDRSVLQGSEQVIPINAGDLFVHPLWNSNCVACGNDIALVKLSRSAQLGDKVQLA
NLPPAGDILPNEAPCYISGWGRLYTGGPLPDKLQEALLPVVDYEHCSQYDWWGITVKKTM
VCAGGDTRSGCDGDSGGPLNCPAADGSWQVHGVTSFVSAFGCNTIKKPTVFTRVSAFIDW
INETIASN
//
>1pytD [b.47.1] CHYMOTRYPSINOGEN C
CGAPIFQPNLSARVVGGEDAIPHSWPWQISLQYLRDNTWRHTCGGTLITPNHVLTAAHCI
SNTLTYRVALGKNNLEVEDEAGSLYVGVDTIFVHEKWNSFLVRNDIALIKLAETVELGDT
IQVACLPSEGSLLPQDYPCFVTGWGRLYTNGPIAAELQQGLQPVVDYATCSQRDWWGTTV
KETMVCAGGDGVISACNGDSGGPLNCQADGQWDVRGIVSFGSGLSCNTFKKPTVFTRVSA
YIDWINQKLQL
//
>1pyuC [b.52.2] ASPARTATE 1-DECARBOXYLASE BETA CHAIN
MIRTMLQGKLHRVKVTHADLHYEG
//
>1pyuD [b.52.2] ASPARTATE 1-DECARBOXYLASE ALFA CHAIN
CCAIDQDFLDAAGILENEAIDIWNVTNGKRFSTYAIAAERGSRIISVNGAAAHCASVGDI
VIIASFVTMPDEEARTWRPNVAYFEGDNEMK
//
>1q0yL [b.1.1 - b.1.1] FAB 9B1, LIGHT CHAIN
DAVVTQESALTTSPGETVTLTCRSSTGAVTTSNYANWVQEKPDHLFTGLIGGTNNRAPGV
PARFSGSLIGDKAALTITGAQTEDEAIYFCALWSNNKLVFGGGTKLTVLGQPKSSPTVTL
FPPSSEELSTAKATLVCTITDFYPGVVTVDWKVDGTPVTAGMETTQPSKQSNNKYMASSY
LTLTARAWERHSSYSCQVTHEGHSSNKTLSRA
//
>1q0yH [b.1.1 - b.1.1] FAB 9B1, HEAVY CHAIN
EVQLQQSGAELMKPGASVKISCKATGYTFSSYWIEWVKQRPGHGLEWIGEILPGSGDTIF
NEKFKGKATFTADTSSNTAYMQLSSLTSEDSAVYYCARWVLDYYGMDYWGQGTSLTVSSA
STTPPSVYPLAPGGSAMVTLGCLVKGYFPEPVTVVWNKGSLSTGTHTFPAVLAADLYTLS
SSVTVSASSWPGQSVTCNVAHPASSTKVDKKIAPS
//
>1q40_1A [d.17.4] MRNA TRANSPORT REGULATOR MTR2
QDPTQQLEPFLKRFLASLDLLYTQSQPFPNVESYATQLGSNLKRSSAIIVNGQPIIPSPQ
EDCKLQFQKKWLQTPLSSHQLTSYDGHLIPGTGTFVVHFSAKVRFDQSGRNRLGESADLF
QENNQRPIWGSWFGVDVNLVVDENVmQDGEIINSmDYRFTYVPND
//
>1q40_1B [d.17.4] MRNA EXPORT FACTOR MEX67
SRNLATNFIANYLKLWDANRSELmILYQNESQFSmQVDSSHPHLIESGSTDFGYYLNNSR
NLTRVSSIKARmAKLSIGQEQIYKSFQQLPKTRHDIIATPELFSmEVYKFPTLNGImITL
HGSFDEVAQPEVDGSASRYHSGPKHKRIPLSKKSFDRTFVVIPGSmIVASDTLLIRPYTS
DFPWKV
//
>1q40_2C [d.17.4] MRNA TRANSPORT REGULATOR MTR2
QDPTQQLEPFLKRFLASLDLLYTQPTSQPFPNVESYATQLGSNLKRSSAIIVNGQPIIPS
PQEDCKLQFQKKWLQTPLSSHQLTSYDGHLIPGTGTFVVHFSAKVRFDQSGRNRLGESAD
LFQQRPIWGSWFGVDVNLVVDENVmQDGEIINSmDYRFTYVPND
//
>1q40_2D [d.17.4] MRNA EXPORT FACTOR MEX67
DSRNLATNFIANYLKLWDANRSELmILYQNESQFSmQVDSSHPHLSGSTDFGYYLNNSRN
LTRVSSIKARmAKLSIGQEQIYKSFQQLPKTRHDIIATPELFSmEVYKFPTLNGImITLH
GSFDEVAQPEVDGSKRIPLSKKSFDRTFVVIPGPSmIVASDTLLIRPYTSDFPWK
//
>1q5rA [d.153.1] PROTEASOME ALPHA-TYPE SUBUNIT 1
AEQIMRDRSELARKGIARGRSVVVLTFRDGVLFVAENPSTALHKVSELYDRLGFAAVGKY
NEFENLRRAGIVHADMRGYSYDRRDVTGRSLANAYAQTLGTIFTEQPKPYEVEICVAEVG
RVGSPKAPQLYRITYDGSIVDEQHFVVMGGTTEPIATAMRESYRADLDLEAAVGIAVNAL
RQGGVDVASLEVAVLDQSRPRRAFRRIAGTALEQLVPAE
//
>1q5rH [d.153.1] PROTEASOME BETA-TYPE SUBUNIT 1
LSFGSNLSSFTDYLRGHAPELLPENRDLAPHGTTIVALTYKGGVLLAGDRRATQGNLIAS
RDVEAVYVTDEYSAAGIAGTAGIAIELVRLFAVELEHYEKIEGVPLTFDGKANRLASMVR
GNLGAAMQGLAVVPLLVGYDLDADDESRAGRIVSYDVVGGRYEERAGYHAVGSGSLFAKS
ALKKIYSPDSDEETALRAAIESLYDAADDDSATGGPDLTRGIYPTAVTITQAGAVHVSEE
TTSELARRIVA
//
>1q7lA [c.56.5] AMINOACYLASE-1
EEEHPSVTLFRQYLRIRTVQPKPDYGAAVAFFEETARQLGLGCQKVEVAPGYVVTVLTWP
GTNPTLSSILLNSHTDVVPVFKEHWSHDPFEAFKDSEGYIYARGAQDMKCVSIQYLEAVR
RLKVEGHRFPRTIHMTFVPDEEVGGHQGMELFVQRPEFHALRAGFALDEGIANPTDAFTV
FYSERSPWWVRV
//
>1q7lB [c.56.5] AMINOACYLASE-1
NPWWAAFSRVCKDMNLTLEPEIMPAAGDNRYIRAVGVPALGFSPMNRTPVLLHDHDERLH
EAVFLRGVDIYTRLLPALASVPALPSDS
//
>1q82C [b.40.4 - b.34.5] 50S RIBOSOMAL PROTEIN L2P
GRRIQGQRRGRGTSTFRAPSHRYKADLEHRKVEDGDVIAGTVVDIEHDPARSAPVAAVEF
EDGDRRLILAPEGVGVGDELQVGVDAEIAPGNTLPLAEIPEGVPVCNVESSPGDGGKFAR
ASGVNAQLLTHDRNVAVVKLPSGEMKRLDPQCRATIGVVGGGGRTDKPFVKAGNKHHKMK
ARGTKWPNVRGVAMNAVDHPFGGGGRQHPGKPKSISRNAPPGRKVGDIASKRTGRGG
//
>1q821 [g.41.8] L37AE 50S RIBOSOMAL PROTEIN
RTGRFGPRYGLKIRVRVADVEIKHKKKHKCPVCGFKKLKRAGTGIWMCGHCGYKIAGGCY
QPETVAGKAVMKA
//
>1q90A [b.2.6 - b.84.2 - f.23.23] APOCYTOCHROME F
YPVFAQQNYANPREANGRIVCANCHLAQKAVEIEVPQAVLPDTVFEAVIELPYDKQVKQV
LANGKKGDLNVGMVLILPEGFELAPPDRVPAEIKEKVGNLYYQPYSPEQKNILVVGPVPG
KKYSEMVVPILSPDPAKNKNVSYLKYPIYFGGNRGRGQVYPDGKKSNNTIYNASAAGKIV
AITALSEKKGGFEVSIEKANGEVVVDKIPAGPDLIVKEGQTVQADQPLTNNPNVGGFGQA
ETEIVLQNPARIQGLLVFFSFVLLTQVLLVLKKKQFEKVQLAEMNFHHHHHH
//
>1q90B [f.21.1] CYTOCHROME B6
VYDWFEERLEIQAIADDITSKYVPPHVNIFYCIGGITFTCFLVQVATGFAMTFYYRPTVA
EAFASVQYIMTDVNFGWLIRSIHRWSASMMVLMMVLHVFRVYLTGGFKRPRELTWVTGVI
MAVCTVSFGVTGYSLPWDQVGYWAVKIVTGVPDAIPGVGGFIVELLRGGVGVGQATLTRF
YSLHTFVLPLLTAVFMLMHFLMIRKQGISGPL
//
>1q90C [b.33.1] CYTOCHROME B6-F COMPLEX IRON-SULFUR SUBUNIT
QAAKDALGNDIKAGEWLKTHLAGDRSLSQGLKGDPTYLIVTADSTIEKYGLNAVCTHLGC
VVPWVAAENKFKCPCHGSQYNAEGKVVRGPAPLSLALAHCDVAEGLVTFSTWTETDFRTG
LEPWWA
//
>1q90D [f.32.1] CYTOCHROME B6-F COMPLEX SUBUNIT 4
TKKPDLSDPVLKAKLAKGMGHNTYGEPAWPNDLLYMFPVVILGTFACVIGLSVLDPAAMG
EPANPFATPLEILPEWYFYPVFQILRVVPNKLLGVLLMAAVPAGLITVPFIESINKFQNP
YRRPIATILFLLGTLVAVWLGIGSTFPIDISLTLGL
//
>1q90R [f.23.12] CYTOCHROME B6-F COMPLEX IRON-SULFUR SUBUNIT
SSEVPDMNKRNIMNLILAGGAGLPITTLALGYGAFFVPP
//
>1q90L [f.23.24] CYTOCHROME B6F COMPLEX SUBUNIT PETL
MLTITSYVGLLIGALVFTLGIYLGLLKVVKLI
//
>1q90N [f.23.27] CYTOCHROME B6F COMPLEX SUBUNIT PETN
GEPAIVQIGWAATCVMFSFSLSLVVWGRSGL
//
>1q90G [f.23.26] CYTOCHROME B6F COMPLEX SUBUNIT PETG
MVEPLLCGIVLGLVPVTIAGLFVTAYLQYL
//
>1q90M [f.23.25] CYTOCHROME B6F COMPLEX SUBUNIT PETM
EAEFIAGTALTMVGMTLVGLAIGFVLLRVESLVE
//
>1q94A [d.19.1 - b.1.1] HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-11
GSHSMRYFYTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGPEYW
DQETRNVKAQSQTDRVDLGTLRGYYNQSEDGSHTIQIMYGCDVGPDGRFLRGYRQDAYDG
KDYIALNEDLRSWTAADMAAQITKRKWEAAHAAEQQRAYLEGRCVEWLRRYLENGKETLQ
RTDPPKTHMTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGT
FQKWAAVVVPSGEEQRYTCHVQHEGLPKPLTLRWE
//
>1q94B [b.1.1] BETA-2-MICROGLOBULIN
MIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKD
WSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM
//
>1q9tA [b.1.1 - b.1.1] S25-2 FAB (IGG1K) LIGHT CHAIN
DIVMSQSPSSLAVSAGEKVTMSCKSSQSLLNSRTRKNYLAWYQQKPGQSPKLLIYWASTR
ESGVPDRFTGSGSGTDFTLTITSVQAEDLAVYYCKQSYNLRTFGGGTKLEIKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1q9tB [b.1.1 - b.1.1] S25-2 FAB (IGG1K) HEAVY CHAIN
EVKLVESGGGLVQSGGSLRLSCATSGFTFTDYYMSWVRQPPGKALEWLGFIRNKANGYTT
EYSPSVKGRFTISRDNSQSILYLQMNTLRAEDSATYYCARDHDGYYERFSYWGQGTLVTV
SAAKTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQ
SDLYTLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKIVPRDC
//
>1q9w_2C (A) [b.1.1 - b.1.1] S45-18 FAB (IGG1K) LIGHT CHAIN
DIVMSQFPSSLAVSAGEKVTMSCKSSQSLLNSRTRKSYLAWYQQKPGQFPKLLIYWAATR
ESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCKQSYNLRTFGGGTKLEIKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1q9w_2D (B) [b.1.1 - b.1.1] S45-18 FAB (IGG1K) HEAVY CHAIN
EVILVESGGGLVQPGGSLRLSCSTSGFTFTDYYMSWVRQPPGKALEWLGFIRNKPKGYTT
EYSASVKGRFTISRDNSQSILYLQMNTLRAEDSATYYCVRDIYSFGSRDGMDYWGQGTSV
TVSSAKTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAV
LQSDLYTLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKIVPRDC
//
>1qa9_2C (A) [b.1.1] HUMAN CD2 PROTEIN
TNALETWGALGQDINLDIPSFQMSDDIDDIKWEKTSDKKKIAQFRKEKETFKEKDTYELL
KNGALKIKHLKTDDQDIYKVSIYDTKGKNVLEKIFDLKIQER
//
>1qa9_2D (B) [b.1.1] HUMAN CD58 PROTEIN
SSQQIYGVKYGNVTFHVPSNQPLKEVLWKKQKDKVAELENSEFRAFSSFKNRVYLDTKSG
SLTIYNLTSSDEDEYEMESPNITDSMKFFLYVGES
//
>1qabD [b.3.4] PROTEIN (TRANSTHYRETIN)
CPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEQFVEGIY
KVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVV
//
>1qabE [b.60.1] PROTEIN (RETINOL BINDING PROTEIN)
CAVSSFRVKENFDKARFSGTWYAMAKKDPEGLFLQDNIVAEFSVDETGQMSATAKGRVRL
LNNWDVCADMVGTFTDTEDPAKFKMKYWGVASFLQKGNDDHWIVDTDYDTYAVQYSCRLL
NLDGTCADSYSFVFSRDPNGLPPEAQKIVAQRQEELCLAAQYRLIVHNGYCDGRSERNLL
//
>1qavA [b.36.1] ALPHA-1 SYNTROPHIN (RESIDUES 77-171)
GSLQRRRVTVRKADAGGLGISIKGGRENKMPILISKIFKGLAADQTEALFVGDAILSVNG
EDLSSATHDEAVQALKKTGKEVVLEVKYMK
//
>1qavB [b.36.1] NEURONAL NITRIC OXIDE SYNTHASE (RESIDUES 1-130)
QPNVISVRLFKRKVGGLGFLVKERVSKPPVIISDLIRGGAAEQSGLIQAGDIILAVNDRP
LVDLSYDSALEVLRGIASETHVVLILRGPEGFTTHLETTFTGDGTPKTIRVTQPL
//
>1qbkB [a.118.1] KARYOPHERIN BETA2
YEWKPDEQGLQQILQLLKESQSPDTTIQRTVQQKLEQLNQYPDFNNYLIFVLTKLKSEDE
PTRSLSGLILKNNVKAHFQNFPNGVTDFIKSECLNNIGDSSPLIRATVGILITTIASKGE
LQNWPDLLPKLCSLLDSEDYNTCEGAFGALQKICEDSAEILDSDRPLNImIPKFLQFFKH
SSPKIRSHAVACVNQFIISRTQALmLHIDSFTENLFALAGDEEPEVRKNVCRALVmLLEV
RMDRLLPHmHNIVEYmLQRTQDQDENVALEACEFWLTLAEQPICKDVLVRHLPKLIPVLV
NGmKYSDIDIILLKGDVEEDETIPDSEQDIRPRFHRSRTVAQQHDEDDDDDDEIDDDDTI
SDWNLRKCSAAALDVLANVYRDELLPHILPLLKELLFHHEWVVKESGILVLGAIAEGCmQ
GmIPYLPELIPHLIQCLSDKKALVRSITCWTLSRYAHWVVSQPPDTYLKPLmTELLKRIL
DSNKRVQEAACSAFATLEEEACTELVPYLAYILDTLVFAFSKYQHKNLLILYDAIGTLAD
SVGHHLNKPEYIQmLmPPLIQKWNmLKDEDKDLFPLLECLSSVATALQSGFLPYCEPVYQ
RCVNLVQKTLAQAmLNNAQPDQYEAPDKDFmIVALDLLSGLAEGLGGNIEQLVARSNILT
LmYQCmQDKmPEVRQSSFALLGDLTKACFQHVKPCIADFmPILGTNLNPEFISVCNNATW
AIGEISIQmGIEmQPYIPmVLHQLVEIINRPNTPKTLLENTAITIGRLGYVCPQEVAPmL
QQFIRPWCTSLRNIRDNEEKDSAFRGICTmISVNPSGVIQDFIFFCDAVASWINPKDDLR
DmFCKILHGFKNQVGDENWRRFSDQFPLPLKERLAAFYG
//
>1qbkC [c.37.1] RAN
QVQFKLVLVGDGGTGKTTFVKRHLTGEFEKKYVATLGVEVHPLVFHTNRGPIKFNVWDTA
GQEKFGGLRDGYYIQAQCAIImFDVTSRVTYKNVPNWHRDLVRVCENIPIVLCGNKVDIK
DRKVKAKSIVFHRKKNLQYYDISAKSNYNFEKPFLWLARKLIGDPNLEFVAmPALAPPEV
VmDPALAAQY
//
>1qblL [b.1.1 - b.1.1] FABE8A
DIQMTQSPASLSASVGETVTITCRASGNIHNYLAWYQQKQGKSPQLLVYNAKTLADGVPS
RFSGSGSGTQYSLKINSLQPEDFGSYYCQHFWSTPWTFGGGTKLEIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1qblH [b.1.1 - b.1.1] FABE8A
EVQLQQSGAELVKPGASVKLSCTASGFNIKDTYMHWVKQRPEKGLEWIGRIDPASGNTKY
DPKFQDKATITADTSSNTAYLQLSSLTSEDTAVYYCAGYDYGNFDYWGQGTTLTVSSAET
TPPSVYPLAPGTAALKSSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYT
LTSSVTVPSSTWPSQTVTCNVAHPASSTKVDKKIVPRNC
//
>1qdlA [d.161.1] PROTEIN (ANTHRANILATE SYNTHASE (TRPE-SUBUNIT))
AMEVHPISEFASPFEVFKCIERDFKVAGLLESIRYSVIAWSTNGYLKIHDDPVNILNGYL
KDLKLADIPGLFKGGMIGYISYDAVRFWEKIRDLKPAAEDWPYAEFFTPDNIIIYDHNEG
KVYVNADLSSVGGCGDIGEFKVSFYDESLNKNSYERIVSESLEYIRSGYIFQVVLSRFYR
YIFSGDPLRIYYNLRRINPSPYMFYLKFDEKYLIGSSPELLFRVQDNIVETYPIAGTRPR
GADQEEDLKLELELMNSEKDKAEHLMLVDLARNDLGKVCVPGTVKVPELMYVEKYSHVQH
IVSKVIGTLKKKYNALNVLSATFPAGTVSGAPKPMAMNIIETLEEYKRGPYAGAVGFISA
DGNAEFAIAIRTAFLNKELLRIHAGAGIVYDSNPESEYFETEHKLKALKTAIGVR
//
>1qdlB [c.23.16] PROTEIN (ANTHRANILATE SYNTHASE (TRPG-SUBUNIT))
MDLTLIIDNYDSFVYNIAQIVGELGSYPIVIRNDEISIKGIERIDPDRLIISPGPGTPEK
REDIGVSLDVIKYLGKRTPILGVCLGHQAIGYAFGAKIRRARKVFHGKISNIILVNNSPL
SLYYGIAKEFKATRYHSLVVDEVHRPLIVDAISAEDNEIMAIHHEEYPIYGVQFHPESVG
TSLGYKILYNFLNRV
//
>1qfuA [b.19.1] PROTEIN (HEMAGGLUTININ (HA1 CHAIN))
STATLCLGHHAVPNGTLVKTITDDQIEVTNATELVQSSSTGKICNNPHRILDGIDCTLID
ALLGDPHCDVFQNETWDLFVERSKAFSNCYPYDVPDYASLRSLVASSGTLEFITEGFTWT
GVTQNGGSNACKRGPGSGFFSRLNWLTKSGSTYPVLNVTMPNNDNFDKLYIWGIHHPSTN
QEQTSLYVQASGRVTVSTRRSQQTIIPNIGSRPWVRGLSSRISIYWTIVKPGDVLVINSN
GNLIAPRGYFKMRTGKSSIMRSDAPIDTCISECITPNGSIPNDKPFQNVNKITYGACPKY
VKQNTLKLATGMRNVPE
//
>1qfuH [b.1.1 - b.1.1] PROTEIN (IMMUNOGLOBULIN IGG1-KAPPA ANTIBODY
QVQLQQPGAELVRPGASVKLSCKASGYTLTTYWMNWFKQRPDQGLEWIGRIDPYDSETHY
NQKFKDKAILTVDRSSSTAYMQLSSLTSEDSAVYYCTRFLQITTIIYGMDYWGQGTSVTV
SSAKTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQ
SDLYTLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKIVPRD
//
>1qfuG (L) [b.1.1 - b.1.1] PROTEIN (IMMUNOGLOBULIN IGG1-KAPPA ANTIBODY
DVVMTQTPLSLPVSLGDQASISCRSSQTLVHSNGNTYLHWYLQKPGQSPKLLIYKVSNRF
SGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQNTHVPYTFGGGTKLEIKRADAAPTV
SIFPPSKIQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRN
//
>1qfuI (H) [b.1.1 - b.1.1] PROTEIN (IMMUNOGLOBULIN IGG1-KAPPA ANTIBODY
QVQLQQPGAELVRPGASVKLSCKASGYTLTTYWMNWFKQRPDQGLEWIGRIDPYDSETHY
NQKFKDKAILTVDRSSSTAYMQLSSLTSEDSAVYYCTRFLQITTIIYGMDYWGQGTSVTV
SSAKTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQ
SDLYTLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKIVPRD
//
>1qfwA [g.17.1] GONADOTROPIN ALPHA SUBUNIT
DCPECTLQENPFFSQPGAPILQCMGCCFSRAYPTPLRSKKTMLVQKNVTSESTCCVAKSY
NRVTVMGGFKVENHTACHCSTCYYHKS
//
>1qfwB [g.17.1] GONADOTROPHIN BETA SUBUNIT
KEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPTMTRVLQGVLPALPQVVCNYRD
VRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDCGGPKDHPLTCD
//
>1qfwL [b.1.1] ANTIBODY (ANTI ALPHA SUBUNIT) (LIGHT CHAIN)
DIELTQSPDSLAVSLGQRATISCRASDSYGNSFMQWYQQKPGQPPKLLIYRASNLESGIP
ARFSGTGSRTDFTLTINPVEADDVATYYCQQSDEYPYMYTFGGGTKLEIKR
//
>1qfwH [b.1.1] ANTIBODY (ANTI ALPHA SUBUNIT) (HEAVY CHAIN)
QLQQSGAELVKPGASVKLSCKASDYTFTSYWMHWVKQRPGQGLEWIGEINPTNGRTYYNE
KATLTVAASASTAAMQASSLTSEDSAVYYCARRYGNSFDYWGQGTTVTVSS
//
>1qfwM [b.1.1] ANTIBODY (ANTI BETA SUBUNIT) (LIGHT CHAIN)
DIELTQSPKSMSMSVGERVTLSCKASETVDSFVSWYQQKPEQSPKLLIFGASNRFSGVPD
RFTGSGSATDFTLTISSVQAEDFADYHCGQTYNHPYTFGGGTKLEIK
//
>1qfwI [b.1.1] ANTIBODY (ANTI BETA SUBUNIT) (HEAVY CHAIN)
QVQLQESGGHLVKPGGSLKLSCAASGFAFSSFDMSWIRQTPEKRLEWVASITNVGTYTYY
PGSVKGRFSISRDNARNTLNLQMSSLRSEDTALYFCARQGTAAQPYWYFDVWGAGTTVTV
//
>1qgc_3A (1) [i.6.1] PROTEIN (VIRUS CAPSID PROTEIN)
TTTTGESADPVTTTVENYGGETQVQRRHHTDVAFVLDRFVKVTVSDNQHTLDVMQAHKDN
IVGALLRAATYYFSDLEIAVTHTGKLTWVPNGAPVSALNNTTNPTAYHKGPVTRLALPYT
APHRVLATAYTGTSFNFGAVKAETITELLVRMKRAELYCPRPILPIQPTGDRHKQPLVAP
AKQ
//
>1qgc_3D (4) [i.6.1] PROTEIN (INMUNOGLOBULINE)
DIVLTQSPASLAVSLGQRATISCRASESVDSSGHSFMHWYQQKPGQPPKLLIYRASNLES
GIPDRFSGSGSRTDFTLTIDPVEADDVATYYCQQSNEVPLTFGAGTKLDLKRADAAPTVS
IFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMS
STLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEEVMLVESGGGLVKPGGSLKLSCT
ASGFIFNRCAMSWVRQTPEKRLEWVATISSGGTYTYYPDSVKGRFTISRDNAKNTLYLQM
SSLRSADTAMYYCVRREDGGDEGFAYWGQGTVVTVSAAKTTPPSVYPLAPGSAAAAASMV
TLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTLSSSVTVPSSTWPSETVTCN
VAHPASSTKVDKKIVPR
//
>1qgc_3E (5) [i.6.1] PROTEIN (GH-LOOP FROM VIRUS CAPSID PROTEIN VP1)
TTAYTASARGDLAHLTTTAARTLP
//
>1qgc_3H (3) [i.6.1] PROTEIN (VIRUS CAPSID PROTEIN)
GIFPVACSDGYGNMVTTDPKTADPAYGKVYNPPRTALPGRFTNYLDVAEACPTFLMFENV
PYVSTRTDGQRLLAKFDVSLAAKHMSNTYLAGLAQYYTQYTGTINLHFMFTGPTDAKARY
MVAYVPPGMDAPDNPEEAAHCIHAEWDTGLNSKFTFSIPYISAADYTYTASHEAETTCVQ
GWVCVYQITHGKADADALVVSASAGKDFELRLPVDARQQ
//
>1qgc_3e (3) [i.6.1] PROTEIN (VIRUS CAPSID PROTEIN)
TTTTGESADPVTTTVENYGGETQVQRRHHTDVAFVLDRFVKVTVSDNQHTLDVMQAHKDN
IVGALLRAATYYFSDLEIAVTHTGKLTWVPNGAPVSALNNTTNPTAYHKGPVTRLALPYT
APHRVLATAYTGTSFNFGAVKAETITELLVRMKRAELYCPRPILPIQPTGDRHKQPLVAP
AKQ
//
>1qgc_3f (4) [i.6.1] PROTEIN (INMUNOGLOBULINE)
DKKTEETTLLEDRILTTRNGHTTSTTQSSVGVTFGYATAEDSTSGPNTSALETRVHQAER
FFKMALFDWVPSQNFGHMHKVVLPHEPKGVYGGLVKSYAYMRNGWDVEVTAVGNQFNGGC
LLVALVPEMGDISDREKYQLTLYPHQFINPRTNMTAHITVPYVGVNRYDQYKQHRPWTLV
VMVVAPLTTNTAGAQQIKVYANIAPTNVHVAGELPSKE
//
>1qgc_3i (5) [i.6.1] PROTEIN (GH-LOOP FROM VIRUS CAPSID PROTEIN VP1)
TTAYTASARGDLAHLTTTAARTLP
//
>1qgc_3e (3) [i.6.1] PROTEIN (VIRUS CAPSID PROTEIN)
GIFPVACSDGYGNMVTTDPKTADPAYGKVYNPPRTALPGRFTNYLDVAEACPTFLMFENV
PYVSTRTDGQRLLAKFDVSLAAKHMSNTYLAGLAQYYTQYTGTINLHFMFTGPTDAKARY
MVAYVPPGMDAPDNPEEAAHCIHAEWDTGLNSKFTFSIPYISAADYTYTASHEAETTCVQ
GWVCVYQITHGKADADALVVSASAGKDFELRLPVDARQQ
//
>1qgc_3f (4) [i.6.1] PROTEIN (INMUNOGLOBULINE)
DIVLTQSPASLAVSLGQRATISCRASESVDSSGHSFMHWYQQKPGQPPKLLIYRASNLES
GIPDRFSGSGSRTDFTLTIDPVEADDVATYYCQQSNEVPLTFGAGTKLDLKRADAAPTVS
IFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMS
STLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEEVMLVESGGGLVKPGGSLKLSCT
ASGFIFNRCAMSWVRQTPEKRLEWVATISSGGTYTYYPDSVKGRFTISRDNAKNTLYLQM
SSLRSADTAMYYCVRREDGGDEGFAYWGQGTVVTVSAAKTTPPSVYPLAPGSAAAAASMV
TLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTLSSSVTVPSSTWPSETVTCN
VAHPASSTKVDKKIVPR
//
>1qgeD [c.69.1] PROTEIN (TRIACYLGLYCEROL HYDROLASE)
ADTYAATRYPVILVHGLAGTDKFANVVDYWYGIQSDLQSHGAKVYVANLSGFQSDDGPNG
RGEQLLAYVKQVLAATGATKVNLIGHSQGGLTSRYVAAVAPQLVASVTTIGTPHRGSEFA
DFVQDVLKTDPTGLSSTVIAAFVNVFGTLVSSSHNTDQDALAALRTLTTAQTATYNRNFP
SAGLGAPGSCQTGAATETVGGSQHLLYSWGGTAIQPTST
//
>1qgeE [c.69.1] PROTEIN (TRIACYLGLYCEROL HYDROLASE)
VVGATDTSTGTLDVANVTDPSTLALLATGAVMINRASGQNDGLVSRCSSLFGQVISTSYH
WNHLDEINQLLGVRGANAEDPVAVIRTHVNRLKLQGV
//
>1qgkA [a.118.1] PROTEIN (IMPORTIN BETA SUBUNIT)
MELITILEKTVSPDRLELEAAQKFLERAAVENLPTFLVELSRVLANPGNSQVARVAAGLQ
IKNSLTSKDPDIKAQYQQRWLAIDANARREVKNYVLHTLGTETYRPSSASQCVAGIACAE
IPVNQWPELIPQLVANVTNPNSTEHMKESTLEAIGYICQDIDPEQLQDKSNEILTAIIQG
MRKEEPSNNVKLAATNALLNSLEFTKANFDKESERHFIMQVVCEATQCPDTRVRVAALQN
LVKIMSLYYQYMETYMGPALFAITIEAMKSDIDEVALQGIEFWSNVCDEEMDLAIEASEA
AEQGRPPEHTSKFYAKGALQYLVPILTQTLTKQDENDDDDDWNPCKAAGVCLMLLATCCE
DDIVPHVLPFIKEHIKNPDWRYRDAAVMAFGCILEGPEPSQLKPLVIQAMPTLIELMKDP
SVVVRDTAAWTVGRICELLPEAAINDVYLAPLLQCLIEGLSAEPRVASNVCWAFSSLAEA
AYEAADVADDQEEPATYCLSSSFELIVQKLLETTDRPDGHQNNLRSSAYESLMEIVKNSA
KDCYPAVQKTTLVIMERLQQVLQMESHIQSTSDRIQFNDLQSLLCATLQNVLRKVQHQDA
LQISDVVMASLLRMFQSTAGSGGVQEDALMAVSTLVEVLGGEFLKYMEAFKPFLGIGLKN
YAEYQVCLAAVGLVGDLCRALQSNIIPFCDEVMQLLLENLGNENVHRSVKPQILSVFGDI
ALAIGGEFKKYLEVVLNTLQQASQAQVDKSDYDMVDYLNELRESCLEAYTGIVQGLKGDQ
ENVHPDVMLVQPRVEFILSFIDHIAGDEDHTDGVVACAAGLIGDLCTAFGKDVLKLVEAR
PMIHELLTEGRRSKTNKAKTLARWATKELRKLKNQA
//
>1qgkB [x.x.x] PROTEIN (IMPORTIN ALPHA-2 SUBUNIT)
AARLHRFKNKGKDSTEMRRRRIEVNVELRKAKKDDQMLKRRNVS
//
>1qgrA [a.118.1] PROTEIN (IMPORTIN BETA SUBUNIT)
MELITILEKTVSPDRLELEAAQKFLERAAVENLPTFLVELSRVLANPGNSQVARVAAGLQ
IKNSLTSKDPDIKAQYQQRWLAIDANARREVKNYVLHTLGTETYRPSSASQCVAGIACAE
IPVNQWPELIPQLVANVTNPNSTEHMKESTLEAIGYICQDIDPEQLQDKSNEILTAIIQG
MRKEEPSNNVKLAATNALLNSLEFTKANFDKESERHFIMQVVCEATQCPDTRVRVAALQN
LVKIMSLYYQYMETYMGPALFAITIEAMKSDIDEVALQGIEFWSNVCDEEMDLAIEASEA
AEQGRPPEHTSKFYAKGALQYLVPILTQTLTKQDENDDDDDWNPCKAAGVCLMLLATCCE
DDIVPHVLPFIKEHIKNPDWRYRDAAVMAFGCILEGPEPSQLKPLVIQAMPTLIELMKDP
SVVVRDTAAWTVGRICELLPEAAINDVYLAPLLQCLIEGLSAEPRVASNVCWAFSSLAEA
AYEAADVADDQEEPATYCLSSSFELIVQKLLETTDRPDGHQNNLRSSAYESLMEIVKNSA
KDCYPAVQKTTLVIMERLQQVLQMESHIQSTSDRIQFNDLQSLLCATLQNVLRKVQHQDA
LQISDVVMASLLRMFSGGVQEDALMAVSTLVEVLGGEFLKYMEAFKPFLGIGLKNYAEYQ
VCLAAVGLVGDLCRALQSNIIPFCDEVMQLLLENLGNENVHRSVKPQILSVFGDIALAIG
GEFKKYLEVVLNTLQQASQAQVDKSDYDMVDYLNELRESCLEAYTGIVQGLKGDQENVHP
DVMLVQPRVEFILSFIDHIAGDEDHTDGVVACAAGLIGDLCTAFGKDVLKLVEARPMIHE
LLTEGRRSKTNKAKTLARWATKELRKLKNQA
//
>1qgrB [x.x.x] PROTEIN (IMPORTIN ALPHA-2 SUBUNIT)
RRRRIEVNVELRKAKKDDQMLKRR
//
>1qgwB [d.184.1] PROTEIN (CRYPTOPHYTAN PHYCOERYTHRIN (ALPHA-2
AMDxSAKAPVITIFDHRGCSRAPKEYTGAKAGGKDDEMMVKAQSVKIEVSTGTAEGVLAT
SLAKMTK
//
>1qgwD [a.1.1] PROTEIN (CRYPTOPHYTAN PHYCOERYTHRIN (BETA CHAIN)
MLDAFSRVVTNADSKAAYVGGADLQALKKFISEGNKRLDSVNSIVSNASCIVSDAVSGMI
CENPSLISPSGxCYTNRRMAACLRDGEIILRYVSYALLSGDASVLEDRCLNGLKETYSSL
GVPANSNARAVSIMKACAVAFVNNTASQKKLSTPQGDCSGLASEVGGYFDKVTAAIS
//
>1qh8D (B) [c.92.2] PROTEIN (NITROGENASE MOLYBDENUM IRON PROTEIN)
SQTIDKINSCYPLFEQDEYQELFRNKRQLEEAHDAQRVQEVFAWTTTAEYEALNFRREAL
TVDPAKACQPLGAVLCSLGFANTLPYVHGSQGCVAYFRTYFNRHFKEPIACVSDSMTEDA
AVFGGNNNMNLGLQNASALYKPEIIAVSTTCMAEVIGDDLQAFIANAKKDGFVDSSIAVP
HAHTPSFIGSHVTGWDNMFEGFAKTFTADYQGQPGKLPKLNLVTGFETYLGNFRVLKRMM
EQMAVPCSLLSDPSEVLDTPADGHYRMYSGGTTQQEMKEAPDAIDTLLLQPWQLLKSKKV
VQEMWNQPATEVAIPLGLAATDELLMTVSQLSGKPIADALTLERGRLVDMMLDSHTWLHG
KKFGLYGDPDFVMGLTRFLLELGCEPTVILSHNANKRWQKAMNKMLDASPYGRDSEVFIN
CDLWHFRSLMFTRQPDFMIGNSYGKFIQRDTLAKGKAFEVPLIRLGFPLFDRHHLHRQTT
WGYEGAMNIVTTLVNAVLEKLDSDTSQLGKTDYSFDLVR
//
>1qh8C (A) [c.92.2] PROTEIN (NITROGENASE MOLYBDENUM IRON PROTEIN)
TNATGERNLALIQEVLEVFPETARKERRKHMMVSDPKMKSVGKCIISNRKSQPGVMTVRG
CAYAGSKGVVFGPIKDMAHISHGPVGCGQYSRAGRRNYYTGVSGVDSFGTLNFTSDFQER
DIVFGGDKKLSKLIEEMELLFPLTKGITIQSECPVGLIGDDISAVANASSKALDKPVIPV
RCEGFRGVSQSLGHHIANDVVRDWILNNREGQPFETTPYDVAIIGDYNIGGDAWASRILL
EEMGLRVVAQWSGDGTLVEMENTPFVKLNLVHCYRSMNYIARHMEEKHQIPWMEYNFFGP
TKIAESLRKIADQFDDTIRANAEAVIARYEGQMAAIIAKYRPRLEGRKVLLYMGGLRPRH
VIGAYEDLGMEIIAAGYEFAHNDDYDRTLPDLKEGTLLFDDASSYELEAFVKALKPDLIG
SGIKEKYIFQKMGVPFRQMHSWDYSGPYHGYDGFAIFARDMDMTLNNPAWNELTAPWL
//
>1qhhA [c.37.1] PROTEIN (PCRA (SUBUNIT))
MNFLSEQLLAHLNKEQQEAVRTTEGPLLIMAGAGSGKTRVLTHRIAYLMAEKHVAPWNIL
AITFTNKAAREMRERVQSLLGGAAEDVWISTFHSMCVRILRRDIDRIGINRNFSILDPTD
QLSVMKTILKEKNIDPKKFEPRTILGTISAAKNELLPPEQFAKR
//
>1qhhB [c.37.1] PROTEIN (PCRA (SUBUNIT))
YYEKVVSDVYQEYQQRLLRNHSLDFDDLIMTTIQLFDRVPDVLHYYQYKFQYIHIDEYQD
TNRAQYTLVKKLAERFQNICAVGDADQSIYRWRGADIQNILSFERDYPNAKVILLEQNYR
STKRILQAANEVIEHNVNRKPKRIWTENPEGKPILYYEAMNEADEAQFVAGRIREAVERG
ERRYRDFAVLYRTNAQSRVMEEMLLKANIPYQIVGGLKFYDRKEIKDILAYLRVIANPDD
DLSLLRIINVPKRGIGASTI
//
>1qhhC [c.37.1] PROTEIN (PCRA (SUBUNIT))
LFEALGELEMIGLGAKAAGALAAFRSQLEQWTQLQEYVSVTELVEEVLDKSGYREMLKAE
RTIEAQSRLENLDEFLSVTKHFENVSDDKSLIAFLTDLALIS
//
>1qhhD [c.37.1] PROTEIN (PCRA (SUBUNIT))
GDAVMLMTLHAAKGLEFPVVFLIGMEEGIFPHNRSLEDDDEMEEERRLAYVGITRAEEEL
VLTSAQMRTLFGNIQMDPPSRFLNEIPAHLLETASR
//
>1qj2G [x.x.x]
KAHIELTINGHPVEALVEPRTLLIHFIREQQNLTGAHIGCDTSHCGACTVDLDGMSVKSC
TMFAVQANGASITTIEGMAAPDGTLSALQEGFRMMHGLQCGYCTPGMIMRSHRLLQENPS
PTEAEIRFGIGGNLCRCTGYQNIVKAIQYAAAKINGVPF
//
>1qj2I [x.x.x]
MIPGSFDYHRPKSIADAVALLTKLGEDARPLAGGHSLIPIMKTRLATPEHLVDLRDIGDL
VGIREEGTDVVIGAMTTQHALIGSDFLAAKLPIIRETSLLIADPQIRYMGTIGGNAANGD
PGNDMPALMQCLGAAYELTGPEGARIVAARDYYQGAYFTAIEPGELLTAIRIPVPPTGHG
YAYEKLKRKIGDYATAAAAVVLTMSGGKCVTASIGLTNVANTPLWAEEAGKVLVGTALDK
PALDKAVALAEAITAPASDGRGPAEYRTKMAGVMLRRAVERAKAR
//
>1qjz_2H (B) [b.121.4] COAT PROTEIN
MDSSEVVKVKQASIPAPGSILSQPNTEQSPAIVLPFQFEATTFGTAETAAQVSLQTADPI
TKLTAPYRHAQIVECKAILTPTDLAVSNPLTVYLAWVPANSPATPTQILRVYGGQSFVLG
GAISAAKTIEVPLNLDSVNRMLKDSVTYTDTPKLLAYSRAPTNPSKIPTASIQISGRIRL
SKPMLIAN
//
>1qjz_2a (B) [b.121.4] COAT PROTEIN
MDSSEVVKVKQASIPAPGSILSQPNTEQSPAIVLPFQFEATTFGTAETAAQVSLQTADPI
TKLTAPYRHAQIVECKAILTPTDLAVSNPLTVYLAWVPANSPATPTQILRVYGGQSFVLG
GAISAAKTIEVPLNLDSVNRMLKDSVTYTDTPKLLAYSRAPTNPSKIPTASIQISGRIRL
SKPMLIANMDSSEVVKVKQASIPAPGSILSQPNTEQSPAIVLPFQFEATTFGTAETAAQV
SLQTADPITKLTAPYRHAQIVECKAILTPTDLAVSNPLTVYLAWVPANSPATPTQILRVY
GGQSFVLGGAISAAKTIEVPLNLDSVNRMLKDSVTYTDTPKLLAYSRAPTNPSKIPTASI
QISGRIRLSKPMLIAN
//
>1qkzA [d.15.7] PROTEIN G-PRIME
VTTYKLVINGKTLKGETTTKAVDAATAEKVFKQYANDNGVDGEWTYDDATKTFTVTEK
//
>1qkzL [b.1.1 - b.1.1] ANTIBODY
NIVMTQTPLSLPVSLGDQASISCRSSQSLVHSNGNTYLHWYLQKPGQSPKLLIYTVSNRF
SGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQSTHFPTFGGGTKLEIKRADAAPTVS
IFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGKERQNGVLNSWTDQDSTYSMSSTL
TLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNE
//
>1qkzH [b.1.1 - b.1.1] ANTIBODY
DVKLVESGGGLVKPGRSLKLSCAASGFTFSDYYMFWVRQTPEQRLEWVATISDGGAYTYY
PDSVKGRFTISRDNAKNNLYLQMNSLKSEDTGMYYCARDPLEYYGMDYWGQGTSVAVSSA
KTTAPSVYPLAPVCGDTTGSSVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDL
YTLSSSVNVTSSTWPSQSITCNVAHPASSTKVDKKIVPR
//
>1qlbB [d.15.4 - a.1.2] FUMARATE REDUCTASE IRON-SULFUR PROTEIN
MGRMLTIRVFKYDPQSAVSKPHFQEYKIEEAPSMTIFIVLNMIRETYDPDLNFDFVCRAG
ICGSCGMMINGRPSLACRTLTKDFEDGVITLLPLPAFKLIKDLSVDTGNWFNGMSQRVES
WIHAQKEHDISKLEERIEPEVAQEVFELDRCIECGCCIAACGTKIMREDFVGAAGLNRVV
RFMIDPHDERTDEDYYELIGDDDGVFGCMTLLACHDVCPKNLPLQSKIAYLRRKMVSVN
//
>1qlbC [f.21.2] FUMARATE REDUCTASE CYTOCHROME B SUBUNIT
MTNESILESYSGVTPERKKSRMPAKLDWWQSATGLFLGLFMIGHMFFVSTILLGDNVMLW
VTKKFELDFIFEGGKPIVVSFLAAFVFAVFIAHAFLAMRKFPINYRQYLTFKTHKDLMRH
GDTTLWWIQAMTGFAMFFLGSVHLYIMMTQPQTIGPVSSSFRMVSEWMWPLYLVLLFAVE
LHGSVGLYRLAVKWGWFDGETPDKTRANLKKLKTLMSAFLIVLGLLTFGAYVKKGLEQTD
PNIDYKYFDYKRTH
//
>1qle_1A [f.24.1] CYTOCHROME C OXIDASE POLYPEPTIDE I-BETA
GFFTRWFMSTNHKDIGILYLFTAGIVGLISVCFTVYMRMELQHPGVQYMCLEGARLIADA
SAECTPNGHLWNVMITYHGVLMMFFVVIPALFGGFGNYFMPLHIGAPDMAFPRLNNLSYW
MYVCGVALGVASLLAPGGNDQMGSGVGWVLYPPLSTTEAGYSMDLAIFAVHVSGASSILG
AINIITTFLNMRAPGMTLFKVPLFAWSVFITAWLILLSLPVLAGAITMLLMDRNFGTQFF
DPAGGGDPVLYQHILWFFGHPEVYIIILPGFGIISHVISTFAKKPIFGYLPMVLAMAAIG
ILGFVVWAHHMYTAGMSLTQQAYFMLATMTIAVPTGIKVFSWIATMWGGSIEFKTPMLWA
FGFLFLFTVGGVTGVVLSQAPLDRVYHDTYYVVAHFHYVMSLGAVFGIFAGVYYWIGKMS
GRQYPEWAGQLHFWMMFIGSNLIFFPQHFLGRQGMPRRYIDYPVEFAYWNNISSIGAYIS
FASFLFFIGIVFYTLFAGKRVNVPNYWNEHADTLEWTLPSPPPEHTFETLPKREDWDR
//
>1qle_1C [f.25.1] CYTOCHROME C OXIDASE POLYPEPTIDE III
AHVKNHDYQILPPSIWPFFGAIGAFVMLTGAVAWMKGITFFGLPVEGPWMFLIGLVGVLY
VMFGWWADVVNEGETGEHTPVVRIGLQYGFILFIMSEVMFFVAWFWAFIKNALYPMGPDS
PIKDGVWPPEGIVTFDPWHLPLINTLILLLSGVAVTWAHHAFVLEGDRKTTINGLIVAVI
LGVCFTGLQAYEYSHAAFGLADTVYAGAFYMATGFHGAHVIIGTIFLFVCLIRLLKGQMT
QKQHVGFEAAAWYWHFVDVVWLFLFVVIYIWGR
//
>1qle_1D [f.23.8] CCYTOCHROME C OXIDASE
TDHKHGEMDIRHQQATFAGFIKGATWVSILSIAVLVFLALANS
//
>1qle_2C [f.25.1] CYTOCHROME C OXIDASE POLYPEPTIDE III
AHVKNHDYQILPPSIWPFFGAIGAFVMLTGAVAWMKGITFFGLPVEGPWMFLIGLVGVLY
VMFGWWADVVNEGETGEHTPVVRIGLQYGFILFIMSEVMFFVAWFWAFIKNALYPMGPDS
PIKDGVWPPEGIVTFDPWHLPLINTLILLLSGVAVTWAHHAFVLEGDRKTTINGLIVAVI
LGVCFTGLQAYEYSHAAFGLADTVYAGAFYMATGFHGAHVIIGTIFLFVCLIRLLKGQMT
QKQHVGFEAAAWYWHFVDVVWLFLFVVIYIWGR
//
>1qle_2E (H) [b.1.1] HEAVY CHAIN ANTIBODY FV FRAGMENT
EVKLQESGGDLVQPGGSLKLSCAASGFTFSSYTMSWVRQTPEKRLEWVASINNGGGRTYY
PDTVKGRFTISRDNAKNTLYLQMSSLKSEDTAMYYCVRHEYYYAMDYWGQGTTVTVSSA
//
>1qlfA [d.19.1 - b.1.1] MHC CLASS I H-2DB HEAVY CHAIN
GPHSMRYFETAVSRPGLEEPRYISVGYVDNKEFVRFDSDAENPRYEPRAPWMEQEGPEYW
ERETQKAKGQEQWFRVSLRNLLGYYNQSAGGSHTLQQMSGCDLGSDWRLLRGYLQFAYEG
RDYIALNEDLKTWTAADMAAQITRRKWEQSGAAEHYKAYLEGECVEWLHRYLKNGNATLL
RTDSPKAHVTHHPRSKGEVTLRCWALGFYPADITLTWQLNGEELTQDMELVETRPAGDGT
FQKWASVVVPLGKEQNYTCRVYHEGLPEPLTLRWEP
//
>1qlfB [b.1.1] HUMAN BETA-2-MICROGLOBULIN
IQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDW
SFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM
//
>1qmoA [b.29.1] MANNOSE BINDING LECTIN, FRIL
AQSLSFSFTKFDPNQEDLIFQGHATSTNNVLQVTKLDSAGNPVSSSAGRVLYSAPLRLWE
DSAVLTSFDTIINFEISTPYTSRIADGLAFFIAPPDSVISYHGGFLGLFPNAN
//
>1qmoE [b.29.1] MANNOSE BINDING LECTIN, FRIL
SNVVAVEFDTYLNPDYGDPNYIHIGIDVNSIRSKVTAKWDWQNGKIATAHISYNSVSKRL
SVTSYYAGSKPATLSYDIELHTVLPEWVRVGLSASTGQDKERNTVHSWSFTSSLWTN
//
>1qo0D [c.23.1] AMIR
SANSLLGSLRELQVLVLNPPGEVSDALVLQLIRIGCSVRQCWPPPEAFDVPVDVVFTSIF
QNRHHDEIAALLAAGTPRTTLVALVEYESPAVLSQIIELECHGVITQPLDAHRVLPVLVS
ARRISEEMAKLKQKTEQLQDRIAGQARINQAKVLLMQRHGWDEREAHQHLSREAMKRREP
ILKIAQELL
//
>1qo0B [c.93.1] AMIC
RPLIGLLFSETGVTADIERSQRYGALLAVEQLNREGGVGGRPIETLSQDPGGDPDRYRLC
AEDFIRNRGVRFLVGCYMSHTRKAVMPVVERADALLCYPTPYEGFEYSPNIVYGGPAPNQ
NSAPLAAYLIRHYGERVVFIGSDYIYPRESNHVMRHLYRQHGGTVLEEIYIPLYPSDDDL
QRAVERIYQARADVVFSTVVGTGTAELYRAIARRYGDGRRPPIASLTTSEAEVAKMESDV
AEGQVVVAPYFSSIDTPASRAFVQACHGFFPENATITAWAEAAYWQTLLLGRAAQAAGNW
RVEDVQRHLYDIDIDAPQGPVRVERQNNHSRLSSRIAEIDARGVFQVRWQSPEPIRPDPY
VVVHNLDDWSASMG
//
>1qo3A [d.19.1 - b.1.1] MHC CLASS I H-2DD HEAVY CHAIN
SHSLRYFVTAVSRPGFGEPRYMEVGYVDNTEFVRFDSDAENPRYEPRARWIEQEGPEYWE
RETRRAKGNEQSFRVDLRTALRYYNQSAGGSHTLQWMAGCDVESDGRLLRGYWQFAYDGC
DYIALNEDLKTWTAADMAAQITRRKWEQAGAAERDRAYLEGECVEWLRRYLKNGNATLLR
TDPPKAHVTHHRRPEGDVTLRCWALGFYPADITLTWQLNGEELTQEMELVETRPAGDGTF
QKWASVVVPLGKEQKYTCHVEHEGLPEPLTLRWG
//
>1qo3B [b.1.1] BETA-2-MICROGLOBULIN
MIQKTPQIQVYSRHPPENGKPNILNCYVTQFHPPHIEIQMLKNGKKIPKVEMSDMSFSKD
WSFYILAHTEFTPTETDTYACRVKHASMAEPKTVYWDRDM
//
>1qo3C [d.169.1] LY49A
STVLDSLQHKVYWFCYGMKCYYFVMDRKTWSGCKQTCQSSSLSLLKIDDEDELKFLQLVV
PSDSCWVGLSYDNKKKDWAWIDNRPSKLALNTRKYNIRDGGCMLLSKTRLDNGNCDQVFI
CICGKRLD
//
>1qpwC (A) [a.1.1] PORICINE HEMOGLOBIN (ALPHA SUBUNIT)
VLSAADKANVKAAWGKVGGQAGAHGAEALERMFLGFPTTKTYFPHFNLSHGSDQVKAHGQ
KVADALTKAVGHLDDLPGALSALSDLHAHKLRVDPVNFKLLSHCLLVTLAAHHPDDFNPS
VHASLDKFLANVSTVLTSKYR
//
>1qpwD (B) [a.1.1] PORICINE HEMOGLOBIN (BETA SUBUNIT)
VHLSAEEKEAVLGLWGKVNVDEVGGEALGRLLVVYPWTQRFFESFGDLSNADAVMGNPKV
KAHGKKVLQSFSDGLKHLDNLKGTFAKLSELHCDQLHVDPENFRLLGNVIVVVLARRLGH
DFNPDVQAAFQKVVAGVANALAHKYH
//
>1qqp_23 [b.121.4] PROTEIN (GENOME POLYPROTEIN)
GIFPVACSDGYGGLVTTDPKTADPVYGKVFNPPRNQLPGRFTNLLDVAEACPTFLRFEGG
VPYVTTKTDSDRVLAQFDMSLAAKHMSNTFLAGLAQYYTQYSGTINLHFMFTGPTDAKAR
YMVAYAPPGMEPPKTPEAAAHCIHAEWDTGLNSKFTFSIPYLSAADYTYTASDVAETTNV
QGWVCLFQITHGKADGDALVVLASAGKDFELRLPVDARAE
//
>1qqp_2N (4) [b.121.4] PROTEIN (GENOME POLYPROTEIN)
SGNTGSIINNYYMQQYQNSMDTQLGNDWFSKLASSAFSGLFGALLA
//
>1qs0A [c.36.1] 2-OXOISOVALERATE DEHYDROGENASE ALPHA-SUBUNIT
NEYAPLRLHVPEPTGRPGCQTDFSYLRLNDAGQARKPPVDVDAADTADLSYSLVRVLDEQ
GDAQGPWAEDIDPQILRQGmRAmLKTRIFDSRmVVAQRQKKmSFYmQSLGEEAIGSGQAL
ALNRTDmCFPTYRQQSILmARDVSLVEmICQLLSNERDPLKGRQLPImYSVREAGFFTIS
GNLATQFVQAVGWAmASAIKGDTKIASAWIGDGATAESDFHTALTFAHVYRAPVILNVVN
NQWAISTFQAIAGGESTTFAGRGVGCGIASLRVDGNDFVAVYAASRWAAERARRGLGPSL
IEWVTYRAGPHSTSDDPSKYRPADDWSHFPLGDPIARLKQHLIKIGHWSEEEHQATTAEF
EAAVIAAQKEAEQYGTLANGHIPSAASmFEDVYKEmPDHLRRQRQEL
//
>1qs0B [c.36.1 - c.48.1] 2-OXOISOVALERATE DEHYDROGENASE BETA-SUBUNIT
ATTTmTmIQALRSAmDVmLERDDNVVVYGQDVGYFGGVFRCTEGLQTKYGKSRVFDAPIS
ESGIVGTAVGmGAYGLRPVVEIQFADYFYPASDQIVSEmARLRYRSAGEFIAPLTLRmPC
GGGIYGGQTHSQSPEAmFTQVCGLRTVmPSNPYDAKGLLIASIECDDPVIFLEPKRLYNG
PFDGHHDRPVTPWSKHPHSAVPDGYYTVPLDKAAITRPGNDVSVLTYGTTVYVAQVAAEE
SGVDAEVIDLRSLWPLDLDTIVESVKKTGRCVVVHEATRTCGFGAELVSLVQEHCFHHLE
APIERVTGWDTPYPHAQEWAYFPGPSRVGAALKKVmEV
//
>1qsfA [d.19.1 - b.1.1] MHC CLASS I HLA-A
GSHSMRYFFTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGPEYW
DGETRKVKAHSQTHRVDLGTLRGYYNQSEAGSHTVQRMYGCDVGSDWRFLRGYHQYAYDG
KDYIALKEDLRSWTAADMAAQTTKHKWEAAHVAEQLRAYLEGTCVEWLRRYLENGKETLQ
RTDAPKTHMTHHAVSDHEATLRCWALSFYPAEITLTWQADGEDQTQDTELVETRPAGDGT
FQKWAAVVVPSGQEQRYTCHVQHEGLPKPLTLRW
//
>1qsfD [b.1.1 - b.1.1] HMAN T-CELL RECEPTOR
KEVEQNSGPLSVPEGAIASLNCTYSDRGSQSFFWYRQYSGKSPELIMSIYSNGDKEDGRF
TAQLNKASQYVSLLIRDSQPSDSATYLCAVTTDSWGKLQFGAGTQVVVTPDIQNPDPAVY
QLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKTVLDMRSMDFKSNSAVAWSNKSD
FACANAFNNSIIPEDTFFPS
//
>1qtnA [c.17.1] CASPASE-8
DKVYQMKSKPRGYCLIINNHNFAKAREKVPKLHSIRDRNGTHLDAGALTTTFEELHFEIK
PHDDCTVEQIYEILKIYQLMDHSNMDCFICCILSHGDKGIIYGTDGQEAPIYELTSQFTG
LKCPSLAGKPKVFFIQACQGDNYQKGIPVETD
//
>1qtnB [c.17.1] CASPASE-8
TRYIPDEADFLLGMATVNNCVSYRNPAEGTWYIQSLCQSLRERCPRGDDILTILTEVNYE
VSNKDDKKNMGKQMPQPTFTLRKKLVFPSD
//
>1qtxA [k.21.1] PROTEIN (CALMODULIN)
ADQLTDEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN
GTIDFPEFLNLMARKMKDTDSEEELKEAFRVFDKDGNGFISAAELRHVMTNLGEKLTDEE
VDEMIREADVDGDGQVNYEEFVQVMMAK
//
>1qtxB [x.x.x] PROTEIN (RS20)
RRKWQKTGHAVRAIGRLSSS
//
>1qun_1A [b.1.11 - b.7.2] PAPD-LIKE CHAPERONE FIMC
GVALGATRVIYPAGQKQVQLAVTNNDENSTYLIQSWVENADGVKDGRFIVTPPLFAMKGK
KENTLRILDATNNQLPQDRESLFWMNVKAIPSMDKSKLTENTLQLAIISRIKLYYRPAKL
ALPPDQAAEKLRFRRSANSLTLINPTPYYLTVTELNAGTRVLENALVPPMGESAVKLSNI
TYRTINDYGALTPKMTGVME
//
>1qun_1B [b.2.3 - b.2.3] MANNOSE-SPECIFIC ADHESIN FIMH
FACKTANGTAIPIGGGSANVYVNLAPVVNVGQNLVVDLSTQIFCHNDYPETITDYVTLQR
GSAYGGVLSNFSGTVKYSGSSYPFPTTSETPRVVYNSRTDKPWPVALYLTPVSSAGGVAI
KAGSLIAVLILRQTNNYNSDDFQFVWNIYANNDVVVPTGGCDVSARDVTVTLPDYPGSVP
IPLTVYCAKSQNLGYYLSGTTADAGNSIFTNTASFSPAQGVGVQLTRNGTIIPANNTVSL
GAVGTSAVSLGLTANYARTGGQVTAGNVQSIIGVTFVYQ
//
>1qvhB [x.x.x]
IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL
VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL
PDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIR
ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFY
THVFRLKKWIQKVIDQFG
//
>1qvhG [x.x.x]
DWPFCSDEDWNYKCPSGCRMKGLIDEVNQDFTNRINKLKNSL
//
>1qvhH [x.x.x]
ERKAPDAGGCLHADPDLGVLCPTGCQLQEALLQQERPIRNSVDELNNNVE
//
>1qvhI [x.x.x]
DNCCILDERFGSYCPTTCGIADFLSTYQTKVDKDLQSLED
//
>1qvhJ [x.x.x]
DWPFCSDEDWNYKCPSGCRMKGLIDEVNQDFTNRINKLKNSL
//
>1r09_21 [b.121.4] HUMAN RHINOVIRUS 14 COAT PROTEIN (SUBUNIT VP1)
TVASISSGPKHTQKVPILTANETGATMPVLPSDSIETRTTYMHFNGSETDVECFLGRAAC
VHVTEIQNKDATGIDNHREAKLFNDWKINLSSLVQLRKKLELFTYVRFDSEYTILATASQ
PDSANYSSNLVVQAMYVPPGAPNPKEWDDYTWQSASNPSVFFKVGDTSRFSVPYVGLASA
YNCFYDGYSHDDAETQYGITVLNHMGSMAFRIVNEHDEHKTLVKIRVYHRAKHVEAWIPR
APRALPYTSIGRTNYPKNTEPVIKKRKGDIKSY
//
>1r09_22 [b.121.4] HUMAN RHINOVIRUS 14 COAT PROTEIN (SUBUNIT VP2)
GYSDRVQQITLGNSTITTQEAANAVVCYAEWPEYLPDVDASDVNKTSKPDTSVCRFYTLD
SKTWTTGSKGWCWKLPDALKDMGVFGQNMFFHSLGRSGYTVHVQCNATKFHSGCLLVVVI
PEHQLASHEGGNVSVKYTFTHPGERGIDLSSANEVGGPVKDVLYNMNGTLLGNLLIFPHQ
FINLRTNNTATIVIPYINSVPIDSMTRHNNVSLMVIPIAPLTVPTGATPSLPITVTIAPM
CTEFSGIRSKSIVPQ
//
>1r0aB [e.8.1] REVERSE TRANSCRIPTASE
PISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPV
FAIKKKDSTKWRKLVDFRELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPL
DEDFRKYTAFTIPSINNETPGIRYQYNVLPQGWKGSPAIFQSSMTKILEPFKKQNPDIVI
YQYMDDLYVGSDLEIGQHRTKIEELRQHLLRWGLTTPDKKHQKEPPFLWMGYELHPDKWT
VQPIVLPEKDSWTVNDIQKLVGKLNWASQIYPGIKVRQLSKLLRGTKALTEVIPLTEEAE
LELAENREILKEPVHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMRGA
HTNDVKQLTEAVQKITTESIVIWGKTPKFKLPIQKETWETWWTEYWQATWIPEWEFVNTP
PLVKLWYQL
//
>1r0aH [b.1.1 - b.1.1] MONOCLONAL ANTIBODY (HEAVY CHAIN)
QITLKESGPGIVQPSQPFRLTCTFSGFSLSTSGIGVTWIRQPSGKGLEWLATIWWDDDNR
YNPSLKSRLTVSKDTSNNQAFLNMMTVETADTAIYYCAQSAITSVTDSAMDHWGQGTSVT
VSSAKTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVL
QSDLYTLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKIVPADC
//
>1r0aL [b.1.1 - b.1.1] MONOCLONAL ANTIBODY (LIGHT CHAIN)
DIQMTQTTSSLSASLGDRVTISCSASQDISSYLNWYQQKPEGTVKLLIYYTSSLHSGVPS
RFSGSGSGTDYSLTISNLEPEDIATYYCQQYSKFPWTFGGGTKLEIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNR
//
>1r0rE [c.41.1] SUBTILISIN CARLSBERG
AQTVPYGIPLIKADKVQAQGFKGANVKVAVLDTGIQASHPDLNVVGGASFVAGEAYNTDG
NGHGTHVAGTVAALDNTTGVLGVAPSVSLYAVKVLNSSGSGSYSGIVSGIEWATTNGMDV
INMSLGGASGSTAMKQAVDNAYARGVVVVAAAGNSGNSGSTNTIGYPAKYDSVIAVGAVD
SNSNRASFSSVGAELEVMAPGAGVYSTYPTNTYATLNGTSMASPHVAGAAALILSKHPNL
SASQVRNRLSSTATYLGSSFYYGKGLINVEAAAQ
//
>1r0rI [g.68.1] OVOMUCOID
VDCSEYPKPACTLEYRPLCGSDNKTYGNKCNFCNAVVESNGTLTLSHFGKC
//
>1r0tA [x.x.x]
IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYKSRIQVRLGEHNIDVLEG
NEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSCAAAGTECLISG
WGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSYPGQITGNMICVGFLEGGKDSCQGDSGGP
VVCNGQLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIAAN
//
>1r0tB [x.x.x]
VPMDCSRYPNTTSEEGKVMILCNKALNPVCGTDGVTYDNECVLCAHNLEQGTSVGKKHDG
EC
//
>1r1a_21 [b.121.4] HUMAN RHINOVIRUS 1A COAT PROTEIN (SUBUNIT VP1)
NYIDEVLNEVLVVPNIKESHHTTSNSAPLLDAAETGHTSNVQPEDAIETRYVITSQTRDE
MSIESFLGRSGCVHISRIKVDYTDYNGQDINFTKWKITLQEMAQIRRKFELFTYVRFDSE
ITLVPCIAGRGDDIGHIVMQYMYVPPGAPIPSKRNDFSWQSGTNMSIFWQHGQPFPRFSI
PFLSIASAYYMFYDGYDGDNTSSKYGSVVTNDMGTICSRIVTEKQKLSVVITTHIYHKAK
HTKAWCPRPPRAVPYTHSHVTNYMPETGDVTTAIVRRNTITTA
//
>1r1a_22 [b.121.4] HUMAN RHINOVIRUS 1A COAT PROTEIN (SUBUNIT VP2)
DRIMQITRGDSTISSDDVANAVVGYGVWPHYLTPQDATAINKPTQPDTSSNRFYTLESKH
WNGSSKGWWWKLPDALKDMGIFGENMYYHFLGRSGYTVHVQCNASKFHQGTLLVAMIPEH
QLASAKHGSVTAGYKLTHPGEAGRDVSQERDASLRQPSDDSWLNFDGTLLGNLLIFPHQF
INLRSNNSATLIVPYVNAVPMDSMLRHNNWCLVIIPISPLRSETTSSNIVPITVSISPMC
AEFSGARAKNIKQ
//
>1r1a_23 [b.121.4] HUMAN RHINOVIRUS 1A COAT PROTEIN (SUBUNIT VP3)
GLPVYITPGSGQFMTTDDMQSPCALPWYHPTKEISIPGEVKNLIEMCQVDTLIPVNNVGN
NVGNVSMYTVQLGNQTGMAQKVFSIKVDITSTPLATTLIGEIASYYTHWTGSLRFSFMFC
GTANTTLKLLLAYTPPGIDEPTTRKDAMLGTHVVWDVGLQSTISLVVPWVSASHFRLTAD
NKYSMAGYITCWYQTNLVVPPSTPQTADMLCFVSACKDFCLRMARDTDLHIQSGPIEQ
//
>1r1a_2a (4) [b.121.4] HUMAN RHINOVIRUS 1A COAT PROTEIN (SUBUNIT VP4)
NYIDEVLNEVLVVPNIKESHHTTSNSAPLLDAAETGHTSNVQPEDAIETRYVITSQTRDE
MSIESFLGRSGCVHISRIKVDYTDYNGQDINFTKWKITLQEMAQIRRKFELFTYVRFDSE
ITLVPCIAGRGDDIGHIVMQYMYVPPGAPIPSKRNDFSWQSGTNMSIFWQHGQPFPRFSI
PFLSIASAYYMFYDGYDGDNTSSKYGSVVTNDMGTICSRIVTEKQKLSVVITTHIYHKAK
HTKAWCPRPPRAVPYTHSHVTNYMPETGDVTTAIVRRNTITTA
//
>1r1a_2l (1) [b.121.4] HUMAN RHINOVIRUS 1A COAT PROTEIN (SUBUNIT VP1)
NYIDEVLNEVLVVPNIKESHHTTSNSAPLLDAAETGHTSNVQPEDAIETRYVITSQTRDE
MSIESFLGRSGCVHISRIKVDYTDYNGQDINFTKWKITLQEMAQIRRKFELFTYVRFDSE
ITLVPCIAGRGDDIGHIVMQYMYVPPGAPIPSKRNDFSWQSGTNMSIFWQHGQPFPRFSI
PFLSIASAYYMFYDGYDGDNTSSKYGSVVTNDMGTICSRIVTEKQKLSVVITTHIYHKAK
HTKAWCPRPPRAVPYTHSHVTNYMPETGDVTTAIVRRNTITTA
//
>1r1a_2a (4) [b.121.4] HUMAN RHINOVIRUS 1A COAT PROTEIN (SUBUNIT VP4)
NYIDEVLNEVLVVPNIKESHHTTSNSAPLLDAAETGHTSNVQPEDAIETRYVITSQTRDE
MSIESFLGRSGCVHISRIKVDYTDYNGQDINFTKWKITLQEMAQIRRKFELFTYVRFDSE
ITLVPCIAGRGDDIGHIVMQYMYVPPGAPIPSKRNDFSWQSGTNMSIFWQHGQPFPRFSI
PFLSIASAYYMFYDGYDGDNTSSKYGSVVTNDMGTICSRIVTEKQKLSVVITTHIYHKAK
HTKAWCPRPPRAVPYTHSHVTNYMPETGDVTTAIVRRNTITTADRIMQITRGDSTISSDD
VANAVVGYGVWPHYLTPQDATAINKPTQPDTSSNRFYTLESKHWNGSSKGWWWKLPDALK
DMGIFGENMYYHFLGRSGYTVHVQCNASKFHQGTLLVAMIPEHQLASAKHGSVTAGYKLT
HPGEAGRDVSQERDASLRQPSDDSWLNFDGTLLGNLLIFPHQFINLRSNNSATLIVPYVN
AVPMDSMLRHNNWCLVIIPISPLRSETTSSNIVPITVSISPMCAEFSGARAKNIKQGLPV
YITPGSGQFMTTDDMQSPCALPWYHPTKEISIPGEVKNLIEMCQVDTLIPVNNVGNNVGN
VSMYTVQLGNQTGMAQKVFSIKVDITSTPLATTLIGEIASYYTHWTGSLRFSFMFCGTAN
TTLKLLLAYTPPGIDEPTTRKDAMLGTHVVWDVGLQSTISLVVPWVSASHFRLTADNKYS
MAGYITCWYQTNLVVPPSTPQTADMLCFVSACKDFCLRMARDTDLHIQSGPIEQNYIDEV
LNEVLVVPNIKESHHTTSNSAPLLDAAETGHTSNVQPEDAIETRYVITSQTRDEMSIESF
LGRSGCVHISRIKVDYTDYNGQDINFTKWKITLQEMAQIRRKFELFTYVRFDSEITLVPC
IAGRGDDIGHIVMQYMYVPPGAPIPSKRNDFSWQSGTNMSIFWQHGQPFPRFSIPFLSIA
SAYYMFYDGYDGDNTSSKYGSVVTNDMGTICSRIVTEKQKLSVVITTHIYHKAKHTKAWC
PRPPRAVPYTHSHVTNYMPETGDVTTAIVRRNTITTADRIMQITRGDSTISSDDVANAVV
GYGVWPHYLTPQDATAINKPTQPDTSSNRFYTLESKHWNGSSKGWWWKLPDALKDMGIFG
ENMYYHFLGRSGYTVHVQCNASKFHQGTLLVAMIPEHQLASAKHGSVTAGYKLTHPGEAG
RDVSQERDASLRQPSDDSWLNFDGTLLGNLLIFPHQFINLRSNNSATLIVPYVNAVPMDS
MLRHNNWCLVIIPISPLRSETTSSNIVPITVSISPMCAEFSGARAKNIKQGLPVYITPGS
GQFMTTDDMQSPCALPWYHPTKEISIPGEVKNLIEMCQVDTLIPVNNVGNNVGNVSMYTV
QLGNQTGMAQKVFSIKVDITSTPLATTLIGEIASYYTHWTGSLRFSFMFCGTANTTLKLL
LAYTPPGIDEPTTRKDAMLGTHVVWDVGLQSTISLVVPWVSASHFRLTADNKYSMAGYIT
CWYQTNLVVPPSTPQTADMLCFVSACKDFCLRMARDTDLHIQSGPIEQ
//
>1r1a_2a (4) [b.121.4] HUMAN RHINOVIRUS 1A COAT PROTEIN (SUBUNIT VP4)
NYIDEVLNEVLVVPNIKESHHTTSNSAPLLDAAETGHTSNVQPEDAIETRYVITSQTRDE
MSIESFLGRSGCVHISRIKVDYTDYNGQDINFTKWKITLQEMAQIRRKFELFTYVRFDSE
ITLVPCIAGRGDDIGHIVMQYMYVPPGAPIPSKRNDFSWQSGTNMSIFWQHGQPFPRFSI
PFLSIASAYYMFYDGYDGDNTSSKYGSVVTNDMGTICSRIVTEKQKLSVVITTHIYHKAK
HTKAWCPRPPRAVPYTHSHVTNYMPETGDVTTAIVRRNTITTADRIMQITRGDSTISSDD
VANAVVGYGVWPHYLTPQDATAINKPTQPDTSSNRFYTLESKHWNGSSKGWWWKLPDALK
DMGIFGENMYYHFLGRSGYTVHVQCNASKFHQGTLLVAMIPEHQLASAKHGSVTAGYKLT
HPGEAGRDVSQERDASLRQPSDDSWLNFDGTLLGNLLIFPHQFINLRSNNSATLIVPYVN
AVPMDSMLRHNNWCLVIIPISPLRSETTSSNIVPITVSISPMCAEFSGARAKNIKQGLPV
YITPGSGQFMTTDDMQSPCALPWYHPTKEISIPGEVKNLIEMCQVDTLIPVNNVGNNVGN
VSMYTVQLGNQTGMAQKVFSIKVDITSTPLATTLIGEIASYYTHWTGSLRFSFMFCGTAN
TTLKLLLAYTPPGIDEPTTRKDAMLGTHVVWDVGLQSTISLVVPWVSASHFRLTADNKYS
MAGYITCWYQTNLVVPPSTPQTADMLCFVSACKDFCLRMARDTDLHIQSGPIEQ
//
>1r1kB (A) [a.123.1] ULTRASPIRACLE PROTEIN
VQELSIERLLEMESLVADPSEEFQFLRVGPDSNVPPKFRAPVSSLCQIGNKQIAALVVWA
RDIPHFSQLEMEDQILLIKGSWNELLLFAIAWRSMEFLTERTTSPPQLMCLMPGMTLHRN
SALQAGVGQIFDRVLSELSLKMRTLRVDQAEYVALKAIILLNPDVKGLKNRQEVEVLREK
MFLCLDEYCRRSRSSEEGRFAALLLRLPALRSISLKSFEHLFFFHLVADTSIAGYIRDAL
R
//
>1r1kC (D) [a.123.1] ECDYSONE RECEPTOR
VPPLTANQKSLIARLVWYQEGYEQPSEEDLKRVTQTWDSDMPFRQITEMTILTVQLIVEF
AKGLPGFAKISQSDQITLLKACSSEVMMLRVARRYDAATDSVLFANNQAYTRDNYRKAGM
AYVIEDLLHFCRCMYSMMMDNVHYALLTAIVIFSDRPGLEQPLLVEEIQRYYLNTLRVYI
LNQNSASPRCAVIFGKILGILTEIRTLGMQNSNMCISLKLKNRKLPPFLEEIWDVA
//
>1r24_2C (A) [b.1.1 - b.1.1] PROTEIN (IGG3-KAPPA ANTIBODY (LIGHT CHAIN))
DIQMTQITSSLSVSLGDRVIISCRASQDIGNFLNWYQQKPDGSLKLLIYYTSRLQSGVPS
RFSGWGSGTDYSLTISNLEEEDIATFFCQQGKTLPYTFGGGTKLEIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIV
//
>1r24_2D (B) [b.1.1 - b.1.1] PROTEIN (IGG3-KAPPA ANTIBODY (HEAVY CHAIN))
DVQLVESGGGLVQPGGSRKLSCAASGFTFSNFGMHWVRQAPEKGLEWVAYISSGGSSINY
ADTVKGRFTISRDNPKNTLFLQMTSLRSEDTAIYYCTRGGTGTRSLYYFDYWGQGATLIV
SSATTTAPSVYPLVPGCSDTSGSSVTLGCLVKGYFPGPVTVKWNYGALSSGVRTVSSVLQ
SGFYSLSSLVTVPSSTWPSQTVICNVAHPASKTDLIK
//
>1r2cC [a.138.1] PHOTOSYNTHETIC REACTION CENTER CYTOCHROME C
CFEPPPATTTQTGFRGLSMGEVLHPATVKAKKERDAQYPPALAAVKAEGPPVSQVYKNVK
VLGNLTEAEFLRTMTAITEWVSPQEGCTYCHDENNLASEAKYPYVVARRMLEMTRAINTN
WTQHVAQTGVTCYTCHRGTPLPPYVRYLEPTLPLNNRETPTHVERVETRSGYVVRLAKYT
AYSALNYDPFTMFLANDKRQVRVVPQTALPLVGVSRGKERRPLSDAYATFALMMSISDSL
GTNCTFCHNAQTFESWGKKSTPQRAIAWWGIRMVRDLNMNYLAPLNASLPASRLGRQGEA
PQADCRTCHQGVTKPLFGASRLKDYPELGPIK
//
>1r2cM [f.26.1] REACTION CENTER PROTEIN M CHAIN
ADYQTIYTQIQARGPHITVSGEWGDNDRVGKPFYSYWLGKIGDAQIGPIYLGASGIAAFA
FGSTAILIILFNMAAEVHFDPLQFFRQFFWLGLYPPKAQYGMGIPPLHDGGWWLMAGLFM
TLSLGSWWIRVYSRARALGLGTHIAWNFAAAIFFVLCIGCIHPTLVGSWSEGVPFGIWPH
IDWLTAFSIRYGNFYYCPWHGFSIGFAYGCGLLFAAHGATILAVARFGGDREIEQITDRG
TAVERAALFWRWTIGFNATIESVHRWGWFFSLMVMVSASVGILLTGTFVDNWYLWCVKHG
AAPDYPAYLPATPDPASLPGAPK
//
>1r2cH [f.23.10 - b.41.1] REACTION CENTER PROTEIN H CHAIN
xYHGALAQHLDIAQLVWYAQWLVIWTVVLLYLRREDRREGYPLVEPLGLVKLAPEDGQVY
ELPYPKTFVLPHGGTVTVPRRRPETRELKLAQTDGFEGAPLQPTGNPLVDAVGPASYAER
AEVVDATVDGKAKIVPLRVATDFSIAEGDVDPRGLPVVAADGVEAGTVTDLWVDRSEHYF
RYLELSVAGSARTALIPLGFCDVKKDKIVVTSILSEQFANVPRLQSRDQITLREEDKVSA
YYAGGLLYATPERAESLL
//
>1r3h_2C (A) [d.19.1 - b.1.1] MHC H2-TL-T10-129
GSHSLRYFYTAVSRPGLGEPWFIIVGYVDDMQVLRFSSKEETPRMAPWLEQEEADDWEQQ
THIVTIQGQLSERNLMTLVHFYNKSMDDSHTLQWLQDCDVEPDRHLCLWYNQLAYDSEDL
PTLSENPSSCTQHLEGHCSDVLQKYLEKGKERLLRSDPPKAHVTRHPRPEGDVTLRCWAL
GFYPADITLTWQKDGEELTVEFVETRPAGDGTFQKWAAVVVPLGKVQSYTCHVDHEGLPE
PLTLRWEP
//
>1r3h_2D (B) [b.1.1] BETA-2-MICROGLOBULIN
IQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDW
SFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM
//
>1r3iA (C) [f.14.1] VOLTAGE-GATED POTASSIUM CHANNEL
SALHWRAAGAATVLLVIVLLAGSYLAVLAERGAPGAQLITYPRALWWSVETATTVGYGDL
YPVTLWGRCVAVVVMVAGITSFGLVTAALATWFVGREQERRGH
//
>1r3iB (L) [b.1.1 - b.1.1] ANTIBODY FAB FRAGMENT LIGHT CHAIN
DILLTQSPAILSVSPGERVSFSCRASQSIGTDIHWYQQRTNGSPRLLIKYASESISGIPS
RFSGSGSGTDFTLSINSVESEDIANYYCQQSNRWPFTFGSGTKLEIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRN
//
>1r4pA [d.165.1] SHIGA-LIKE TOXIN TYPE II A SUBUNIT
REFTIDFSTQQSYVSSLNSIRTEISTPLEHISQGTTSVSVINHTPPGSYFAVDIRGLDVY
QARFDHLRLIIEQNNLYVAGFVNTATNTFYRFSDFTHISVPGVTTVSMTTDSSYTTLQRV
AALERSGMQISRHSLVSSYLALMEFSGNTMTRDASRAVLRFVTVTAEALRFRQIQREFRQ
ALSETAPVYTMTPGDVDLTLNWGRISNVLPEYRGEDGVRVGRISFNNISAILGTVAVILN
CHECQITGDRPVIKINNTLWESNTAAAFLNRKSQFLYTTGK
//
>1r4pC (B) [b.40.2] SHIGA-LIKE TOXIN TYPE II B SUBUNIT
ADCAKGKIEFSKYNEDDTFTVKVDGKEYWTSRWNLQPLLQSAQLTGMTVTIKSSTCESGS
GFAEVQFNND
//
>1r4q_2K (B) [b.40.2] SHIGELLA TOXIN CHAIN B
TPDCVTGKVEYTKYNDDDTFTVKVGDKELFTNRWNLQSLLLSAQITGMTVTIKTNACHNG
GGFSEVIFR
//
>1r4q_2L [d.165.1] SHT CYTOTOXIN A SUBUNIT
KEFTLDFSTAKTYVDSLNVIRSAIGTPLQTISSGGTSLLMIDSGTGDNLFAVDVRGIDPE
EGRFNNLRLIVERNNLYVTGFVNRTNNVFYRFADFSHVTFPGTTAVTLSGDSSYTTLQRV
AGISRTGMQINRHSLTTSYLDLMSHSGTSLTQSVARAMLRFVTVTAEALRFRQIQRGFRT
TLDDLSGRSYVMTAEDVDLTLNWGRLSSVLPDYHGQDSVRVGRISFGSINAILGSVALIL
NCHFPSMCPADGRVRGITHNKILWDSSTLGAILMRRT
//
>1r6o_2B [a.174.1] ATP-DEPENDENT CLP PROTEASE ATP-BINDING SUBUNIT
MLNQELELSLNMAFARAREHRHEFMTVEHLLLALLSNPSAREALEACSVDLVALRQELEA
FIEQTTPVLPASEEERDTQPTLSFQRVLQRAVFHVQSSGRNEVTGANVLVAIFSEQESQA
AYLLRKHEVSRLDVVNFISHG
//
>1r6o_2D [d.45.1] ATP-DEPENDENT CLP PROTEASE ADAPTOR PROTEIN CLPS
NDWLDFDQALKPPSMYKVILVNDDYTPMEFVIDVLQKFFSYDVERATQLMLAVHYQGKAI
CGVFTAEVAETKVAMVNKYARENEHPLLCTLEKA
//
>1r8oA [b.42.4] KUNITZ TRYPSIN INHIBITOR
RLVDTDGKPIENDGAEYYILPSVRGKGGGLVLAKSGGEKCPLSVVQSPSELSNGLPVRFK
ASPRSKYISVGMLLGIEVIESPECAPKPSMWSVKSG
//
>1r8oB [b.42.4] KUNITZ TRYPSIN INHIBITOR
WKLPSVTVGNPKVSVFGGPFKIEEGKSGYKDVYSSSKGRDLDDGIEVNKKKEKRLVVKDG
NPFIIRFKKSG
//
>1r8sA [c.37.1] ADP-RIBOSYLATION FACTOR 1
MRILMVGLDAAGKTTILYKLKLGEIVTTIPTIGFNVETVEYKNISFTVWDVGGQDKIRPL
WRHYFQNTQGLIFVVDSNDRERVNEAREELMRMLAEDELRDAVLLVFANKQDLPNAMNAA
EITDKLGLHSLRHRNWYIQATCATSGDGLYEGLDWLSNQL
//
>1r8sC [x.x.x]
NRKMAMGRKKFNMDPKKGIQFLVENELLQNTPEEIARFLYKGEGLNKYLGEREELNLAVL
HAFVDLHEFTDLNLVQALRQFLWSFRLPGKAQKIDRMMEAFAQRYCLCNPGVFQSTDTCY
VLSYSVIMLNTDLHNPNVRDKMGLERFVAMNRGINEGGDLPEELLRNLYDSIRNEPFKIP
ED
//
>1rb8_2F [b.121.5] CAPSID PROTEIN
REIVDLSHLAFDCGMLGRLKTVSWTPVIAGDSFELDAVGALRLSPLRRGLAIDSKVDFFT
FYIPHRHVYGDQWIQFMRDGVNAQPLPSVTCNRYPDHAGYVGTIVPANNRIPKFLHQSYL
NIYNNYFRAPWMPERTEANPSNLNEDDARYGFRCCHLKNIWSAPLPPETKLAEEMGIESN
SIDIMGLQAAYAQLHTEQERTYFMQRYRDVISSFGGSTSYDADNRPLLVMHTDFWASGYD
VDGTDQSSLGQFSGRVQQTFKHSVPRFFVPEHGVMMTLALIRFPPISPLEHHYLAGKSQL
TYTDLAGDPALIGNLPPREISYRDLFRDGRSGIKIKVAESIWYRTHPDYVNFKYHDLHGF
PFLDDAPGTSTGDNLQEAILVRHQDYDACFQSQQLLQWNKQARYNVSVYRHMPTVRDSIM
TS
//
>1rb8_2F [b.121.5] CAPSID PROTEIN
REIVDLSHLAFDCGMLGRLKTVSWTPVIAGDSFELDAVGALRLSPLRRGLAIDSKVDFFT
FYIPHRHVYGDQWIQFMRDGVNAQPLPSVTCNRYPDHAGYVGTIVPANNRIPKFLHQSYL
NIYNNYFRAPWMPERTEANPSNLNEDDARYGFRCCHLKNIWSAPLPPETKLAEEMGIESN
SIDIMGLQAAYAQLHTEQERTYFMQRYRDVISSFGGSTSYDADNRPLLVMHTDFWASGYD
VDGTDQSSLGQFSGRVQQTFKHSVPRFFVPEHGVMMTLALIRFPPISPLEHHYLAGKSQL
TYTDLAGDPALIGNLPPREISYRDLFRDGRSGIKIKVAESIWYRTHPDYVNFKYHDLHGF
PFLDDAPGTSTGDNLQEAILVRHQDYDACFQSQQLLQWNKQARYNVSVYRHMPTVRDSIM
TS
//
>1rb8_2C (J) [x.x.x] SMALL CORE PROTEIN
ARPGRPQPLRGTKKGARLWYVGGQQF
//
>1rblA [d.58.9 - c.1.14] RIBULOSE 1,5 BISPHOSPHATE CARBOXYLASE/OXYGENASE
SAAGYKAGVKDYKLTYYTPDYTPKDTDLLAAFRFSPQPGVPADEAGAAIAAESSTGTWTT
VWTDLLTDMDRYKGKCYHIEPVAGEENSYFAFIAYPLDLFEEGSVTNILTSIVGNVFGFK
AIRSLRLEDIRFPVALVKTFQGPPHGIQVERDLLNKYGRPMLGCTIKPKLGLSAKNYGRA
VYECLRGGLDFTKDDENINSQPFQRWRDRFLFVADAIHKSQAETGEIKGHYLNVTAPTCE
EMMKRAEFAKELGMPIIMHDFLTAGFTANTTLAKWCRDNGVLLHIHRAMHAVIDRQRNHG
IHFRVLAKCLRLSGGDHLHSGTVVGKLEGDKASTLGFVDLMREDHIEADRSRGVFFTQDW
ASMPGVLPVASGGIHVWHMPALVEIFGDDSVLQFGGGTLGHPWGNAPGATANRVALEACV
QARNEGRDLYREGGDILREAGKWSPELAAALDLWKEIKFEFETMDKL
//
>1rblM [d.73.1] RIBULOSE 1,5 BISPHOSPHATE CARBOXYLASE/OXYGENASE
SMKTLPKERRFETFSYLPPLSDRQIAAQIEYMIEQGFHPLIEFNEHSNPEEFYWTMWKLP
LFACAAPQQVLDEVRECRSEYGDCYIRVAGFDNIKECQTSSFIVHRPGR
//
>1rboA (L) [d.58.9 - c.1.14] RIBULOSE BISPHOSPHATE CARBOXYLASE/OXYGENASE
ASVGFKAGVKDYKLTYYTPEYETLDTDILAAFRVSPQPGVPPEEAGAAVAAESSTGTWTT
VWTDGLTNLDRYKGRCYHIEPVAGEENQYICYVAYPLDLFEEGSVTNMFTSIVGNVFGFK
ALRALRLEDLRIPVAYVKTFQGPPHGIQVERDKLNKYGRPLLGCTIKPKLGLSAKNYGRA
VYECLRGGLDFTKDDENVNSQPFMRWRDRFLFCAEALYKAQAETGEIKGHYLNATAGTCE
DMMKRAVFARELGVPIVMHDYLTGGFTANTTLSHYCRDNGLLLHIHRAMHAVIDRQKNHG
MHFRVLAKALRLSGGDHIHSGTVVGKLEGERDITLGFVDLLRDDYTEKDRSRGIYFTQSW
VSTPGVLPVASGGIHVWHMPALTEIFGDDSVLQFGGGTLGHPWGNAPGAVANRVALEACV
QARNEGRDLAREGNTIIREATKWSPELAAACEVWKEIKFEFPAMDTV
//
>1rboD (S) [d.73.1] RIBULOSE BISPHOSPHATE CARBOXYLASE/OXYGENASE
MQVWPILNLKKYETLSYLPPLTTDQLARQVDYLLNNKWVPCLEFETDHGFVYREHHNSPG
YYDGRYWTMWKLPMFGCTDPAQVLNELEECKKEYPNAFIRIIGFDSNREVQCISFIAYKP
AGY
//
>1rdtA [a.123.1] RETINOIC ACID RECEPTOR RXR-ALPHA
EDMPVERILEAELAVEPDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGW
NELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLTELVSKMRDMQMDKT
ELGCLRAIVLFNPDSKGLSNPAEVEALREKVYASLEAYCKHKYPEQPGRFAKLLLRLPAL
RSIGLKCLEHLFFFKLIGDTPIDTFLMEMLE
//
>1rdtD [a.123.1] PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA
AESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMEVAIRIFQG
CQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEG
QGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVK
PIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMS
LHPLLQEIYKDLY
//
>1re0A [c.37.1] ADP-RIBOSYLATION FACTOR 1
MRILMVGLDAAGKTTILYKLKLGEIVTTIPTIGFNVETVEYKNISFTVWDVGGQDKIRPL
WRHYFQNTQGLIFVVDSNDRERVNEAREELMRMLAEDELRDAVLLVFANKQDLPNAMNAA
EITDKLGLHSLRHRNWYIQATCATSGDGLYEGLDWLSNQLRN
//
>1re0B [a.118.3] ARF GUANINE-NUCLEOTIDE EXCHANGE FACTOR 1
GSHMASDRKTEFILCVETFNEKAKKGIQMLIEKGFIDSDSNRDIASFLFLNNGRLNKKTI
GLLLCDPKKTSLLKEFIDLFDFKGLRVDEAIRILLTKFRLPGESQQIERIVEAFSSKYSA
DQSVQPDADSVFVLSYSIIMLNTDSHNPQVKDHMTFDDYSNNLRGCYNGKDFPRWYLHKI
YTSIKVKEIVMPEEH
//
>1rf3A [h.1.2 - b.8.1] TNF RECEPTOR ASSOCIATED FACTOR 3
NTGLLESQLSRHDQMLSVHDIRLADMDLRFQVLETASYNGVLIWKIRDYKRRKQEAVMGK
TLSLYSQPFYTGYFGYKMCARVYLNGDGMGKGTHLSLFFVIMRGEYDALLPWPFKQKVTL
MLMDQGSSRRHLGDAFKPDPNSSSFKKPTGEMNIASGCPVFVAQTVLENGTYIKDDTIFI
KVIVDTSDLPDP
//
>1rf3B [j.116.1] 24-RESIDUE PEPTIDE FROM LYMPHOTOXIN-B RECEPTOR
PYPIPEEGDPGPPGLSTPHQEDGK
//
>1rfnA [b.47.1] PROTEIN (COAGULATION FACTOR IX)
VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEE
TEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFL
KFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTKFTIYNNMFCAGFHEGGRDS
CQGDSGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKEKTKLT
//
>1rfnB [g.3.11] PROTEIN (COAGULATION FACTOR IX)
MTCNIKNGRCEQFCKNSADNKVVCSCTEGYRLAENQKSCEPAVPFPCGRVSVSQTSK
//
>1rgiG [d.109.1 - d.109.1 - d.109.1] GELSOLIN
VVEHPEFLKAGKEPGLQIWRVEKFDLVPVPPNLYGDFFTGDAYVILKTVQLRNGILQYDL
HYWLGNECSQDESGAAAIFTVQLDDYLNGRAVQHREVQGFESATFLGYFKSGLKYKKGGV
ASGFKHVVPNEVVVQRLLQVKGRRVVRATEVPVSWESFNNGDCFILDLGNNIYQWCGSKS
NRFERLKATQVSKGIRDNERSGRAQVSVFEEGAEPEAMLQVLGPKPTLPEATEDTVKEDA
ANRKLAKLYKVSNGAGPMVVSLVADENPFAQGALRSEDCFILDHGKDGKIFVWKGKQANM
EERKAALKTASDFISKMDYPKQTQVSVLPEGGETPLFRQFFKNWRD
//
>1rgiA [c.55.1 - c.55.1] ACTIN, ALPHA SKELETAL MUSCLE
TTALVCDNGSGLVKAGFAGDDAPRAVFPSIVGRPRKDSYVGDEAQSKRGILTLKYPIEHG
IITNWDDMEKIWHHTFYNELRVAPEEHPTLLTEAPLNPKANREKMTQIMFETFNVPAMYV
AIQAVLSLYASGRTTGIVLDSGDGVTHNVPIYEGYALPHAIMRLDLAGRDLTDYLMKILT
ERGYSFAEREIVRDIKEKLCYVALDFENEMATAASSSSLEKSYELPDGQVITIGNERFRC
PETLFQPSFIGMESAGIHETTYNSIMKCDIDIRKDLYANNVMSGGTTMYPGIADRMQKEI
TALAPSTMKIKIIAPPERKYSVWIGGSILASLSTFQQMWITKQEYDEAF
//
>1rh5A [f.41.1] PREPROTEIN TRANSLOCASE SECY SUBUNIT
KKLIPILEKIPEVELPVKEITFKEKLKWTGIVLVLYFIMGCIDVYTAGAQIPAIFEFWQT
ITASRIGTLITLGIGPIVTAGIIMQLLVGSGIIQMDLSIPENRALFQGCQKLLSIIMCFV
EAVLFVGAGAFGILTPLLAFLVIIQIAFGSIILIYLDEIVSKYGIGSGIGLFIAAGVSQT
IFVGALGPEGYLWKFLNSLIQGVPNIEYIAPIIGTIIVFLMVVYAECMRVEIPLAHGRIK
GAVGKYPIKFVYVSNIPVILAAALFANIQLWGLALYRMGIPILGHYEGGRAVDGIAYYLS
TPYGLSSVISDPIHAIVYMIAMIITCVMFGIFWVETTGLDPKSMAKRISEKAIEHRLKRY
IPPLTVMSSAFVGFLATIANFIGALGGGTGVLLTVSIVYRMYEQLLRERT
//
>1rh5C [f.23.29] SECBETA
ETFSKIRVKPEHVIGVTVAFVIIEAILTYGRF
//
>1rhh_1A [b.1.1 - b.1.1] FAB X5, LIGHT CHAIN
ELVLTQSPGTLSLSAGERATLSCRASQSVSSGSLAWYQQKPGQAPRLLIYGASTRATGIP
DRFSGSGSGTDFTLTIGRLEPEDLAVYYCQQYGTSPYTFGQGTKLEIKRTVAAPSVFIFP
PSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSRDSTYSLGSTL
TLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
//
>1rhh_1B [b.1.1 - b.1.1] FAB X5, HEAVY CHAIN
QLLEQSGAEVKKPGSSVQVSCKASGGTFSMYGFNWVRQAPGHGLEWMGGIIPIFGTSNYA
QKFRGRVTFTADQATSTAYMELTNLRSDDTAVYYCARDFGPDWEDGDSYDGSGRGFFDFW
GQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGV
HTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC
//
>1rhi_21 [b.121.4] HUMAN RHINOVIRUS 3 COAT PROTEIN
QTLASVSSGPKHTQSVPALTANETGATLPTRPSDNVETRTTYMHFNGSETDVESFLGRAA
CVHVTEIKNKNAAGLDNHRKEGLFNDWKINLSSLVQLRKKLELFTYVRFDSEYTILATAS
QPEASSYSSNLTVQAMYVPPGAPNPKEWDDYTWQSASNPSVFFKVGETSRFSVPFVGIAS
AYNCFYDGYSHDDPDTPYGITVLNHMGSMAFRVVNEHDVHTTIVKIRVYHRAKHVEAWIP
RAPRALPYVSIGRTNYPRDSKTIVKKRTNIKTY
//
>1rhi_22 [b.121.4] HUMAN RHINOVIRUS 3 COAT PROTEIN
GYSDRVQQITLGNSTITTQEARNAIVCYAEWPEYLSDNDASDVNKTSKPDISVCRFYTLD
SKTWKATSKGWCWKLPDALKDMGVFGQNMFYHSLGRTGYTIHVQCNATKFHSGCLLVVVI
PEHQLASHEGGTVSVKYKYTHPGDRGIDLDTVEVAGGPTSDAIYNMDGTLLGNLLIFPHQ
FINMRTNNTATIVVPYINSVPIDSMTRHNNVSLMVVPIAPLNAPTGSSPTLPVTVTIAPM
CTEFTGIRSRSIVPQ
//
>1rhi_23 [b.121.4] HUMAN RHINOVIRUS 3 COAT PROTEIN
GLPTTTLPGSGQFLTTDDRQSPSALPSYEPTPRIHIPGKVRNLLEIIQVGTLIPMNNTGT
NDNVTNYLIPLHADRQNEQIFGTKLYIGDGVFKTTLLGEIAQYYTHWSGSLRISLMYTGP
ALSSAKIILAYTPPGTRGPEDKKEAMLGTHVVWDIGLQSTIVMTIPWTSGVQFRYTDPDT
YTSAGYLSCWYLTSLILPPQTSGQVYLLSFISACPDFKLRLMKDTQTISQTDALTE
//
>1rhi_24 [b.121.4] HUMAN RHINOVIRUS 3 COAT PROTEIN
YTVINYYKDAASSSSAGQSFSMDPSKFTEPVKDLMLKGAPALN
//
>1rhi_2a (4) [b.121.4] HUMAN RHINOVIRUS 3 COAT PROTEIN
QTLASVSSGPKHTQSVPALTANETGATLPTRPSDNVETRTTYMHFNGSETDVESFLGRAA
CVHVTEIKNKNAAGLDNHRKEGLFNDWKINLSSLVQLRKKLELFTYVRFDSEYTILATAS
QPEASSYSSNLTVQAMYVPPGAPNPKEWDDYTWQSASNPSVFFKVGETSRFSVPFVGIAS
AYNCFYDGYSHDDPDTPYGITVLNHMGSMAFRVVNEHDVHTTIVKIRVYHRAKHVEAWIP
RAPRALPYVSIGRTNYPRDSKTIVKKRTNIKTY
//
>1rhi_2l (1) [b.121.4] HUMAN RHINOVIRUS 3 COAT PROTEIN
QTLASVSSGPKHTQSVPALTANETGATLPTRPSDNVETRTTYMHFNGSETDVESFLGRAA
CVHVTEIKNKNAAGLDNHRKEGLFNDWKINLSSLVQLRKKLELFTYVRFDSEYTILATAS
QPEASSYSSNLTVQAMYVPPGAPNPKEWDDYTWQSASNPSVFFKVGETSRFSVPFVGIAS
AYNCFYDGYSHDDPDTPYGITVLNHMGSMAFRVVNEHDVHTTIVKIRVYHRAKHVEAWIP
RAPRALPYVSIGRTNYPRDSKTIVKKRTNIKTY
//
>1rhi_2a (4) [b.121.4] HUMAN RHINOVIRUS 3 COAT PROTEIN
QTLASVSSGPKHTQSVPALTANETGATLPTRPSDNVETRTTYMHFNGSETDVESFLGRAA
CVHVTEIKNKNAAGLDNHRKEGLFNDWKINLSSLVQLRKKLELFTYVRFDSEYTILATAS
QPEASSYSSNLTVQAMYVPPGAPNPKEWDDYTWQSASNPSVFFKVGETSRFSVPFVGIAS
AYNCFYDGYSHDDPDTPYGITVLNHMGSMAFRVVNEHDVHTTIVKIRVYHRAKHVEAWIP
RAPRALPYVSIGRTNYPRDSKTIVKKRTNIKTYGYSDRVQQITLGNSTITTQEARNAIVC
YAEWPEYLSDNDASDVNKTSKPDISVCRFYTLDSKTWKATSKGWCWKLPDALKDMGVFGQ
NMFYHSLGRTGYTIHVQCNATKFHSGCLLVVVIPEHQLASHEGGTVSVKYKYTHPGDRGI
DLDTVEVAGGPTSDAIYNMDGTLLGNLLIFPHQFINMRTNNTATIVVPYINSVPIDSMTR
HNNVSLMVVPIAPLNAPTGSSPTLPVTVTIAPMCTEFTGIRSRSIVPQGLPTTTLPGSGQ
FLTTDDRQSPSALPSYEPTPRIHIPGKVRNLLEIIQVGTLIPMNNTGTNDNVTNYLIPLH
ADRQNEQIFGTKLYIGDGVFKTTLLGEIAQYYTHWSGSLRISLMYTGPALSSAKIILAYT
PPGTRGPEDKKEAMLGTHVVWDIGLQSTIVMTIPWTSGVQFRYTDPDTYTSAGYLSCWYL
TSLILPPQTSGQVYLLSFISACPDFKLRLMKDTQTISQTDALTEYTVINYYKDAASSSSA
GQSFSMDPSKFTEPVKDLMLKGAPALNQTLASVSSGPKHTQSVPALTANETGATLPTRPS
DNVETRTTYMHFNGSETDVESFLGRAACVHVTEIKNKNAAGLDNHRKEGLFNDWKINLSS
LVQLRKKLELFTYVRFDSEYTILATASQPEASSYSSNLTVQAMYVPPGAPNPKEWDDYTW
QSASNPSVFFKVGETSRFSVPFVGIASAYNCFYDGYSHDDPDTPYGITVLNHMGSMAFRV
VNEHDVHTTIVKIRVYHRAKHVEAWIPRAPRALPYVSIGRTNYPRDSKTIVKKRTNIKTY
GYSDRVQQITLGNSTITTQEARNAIVCYAEWPEYLSDNDASDVNKTSKPDISVCRFYTLD
SKTWKATSKGWCWKLPDALKDMGVFGQNMFYHSLGRTGYTIHVQCNATKFHSGCLLVVVI
PEHQLASHEGGTVSVKYKYTHPGDRGIDLDTVEVAGGPTSDAIYNMDGTLLGNLLIFPHQ
FINMRTNNTATIVVPYINSVPIDSMTRHNNVSLMVVPIAPLNAPTGSSPTLPVTVTIAPM
CTEFTGIRSRSIVPQGLPTTTLPGSGQFLTTDDRQSPSALPSYEPTPRIHIPGKVRNLLE
IIQVGTLIPMNNTGTNDNVTNYLIPLHADRQNEQIFGTKLYIGDGVFKTTLLGEIAQYYT
HWSGSLRISLMYTGPALSSAKIILAYTPPGTRGPEDKKEAMLGTHVVWDIGLQSTIVMTI
PWTSGVQFRYTDPDTYTSAGYLSCWYLTSLILPPQTSGQVYLLSFISACPDFKLRLMKDT
QTISQTDALTEYTVINYYKDAASSSSAGQSFSMDPSKFTEPVKDLMLKGAPALN
//
>1rhi_2a (4) [b.121.4] HUMAN RHINOVIRUS 3 COAT PROTEIN
QTLASVSSGPKHTQSVPALTANETGATLPTRPSDNVETRTTYMHFNGSETDVESFLGRAA
CVHVTEIKNKNAAGLDNHRKEGLFNDWKINLSSLVQLRKKLELFTYVRFDSEYTILATAS
QPEASSYSSNLTVQAMYVPPGAPNPKEWDDYTWQSASNPSVFFKVGETSRFSVPFVGIAS
AYNCFYDGYSHDDPDTPYGITVLNHMGSMAFRVVNEHDVHTTIVKIRVYHRAKHVEAWIP
RAPRALPYVSIGRTNYPRDSKTIVKKRTNIKTYGYSDRVQQITLGNSTITTQEARNAIVC
YAEWPEYLSDNDASDVNKTSKPDISVCRFYTLDSKTWKATSKGWCWKLPDALKDMGVFGQ
NMFYHSLGRTGYTIHVQCNATKFHSGCLLVVVIPEHQLASHEGGTVSVKYKYTHPGDRGI
DLDTVEVAGGPTSDAIYNMDGTLLGNLLIFPHQFINMRTNNTATIVVPYINSVPIDSMTR
HNNVSLMVVPIAPLNAPTGSSPTLPVTVTIAPMCTEFTGIRSRSIVPQGLPTTTLPGSGQ
FLTTDDRQSPSALPSYEPTPRIHIPGKVRNLLEIIQVGTLIPMNNTGTNDNVTNYLIPLH
ADRQNEQIFGTKLYIGDGVFKTTLLGEIAQYYTHWSGSLRISLMYTGPALSSAKIILAYT
PPGTRGPEDKKEAMLGTHVVWDIGLQSTIVMTIPWTSGVQFRYTDPDTYTSAGYLSCWYL
TSLILPPQTSGQVYLLSFISACPDFKLRLMKDTQTISQTDALTEYTVINYYKDAASSSSA
GQSFSMDPSKFTEPVKDLMLKGAPALN
//
>1ri8A [b.1.1] CAMELID ANTIBODY HEAVY CHAIN
VQLVESGGGSVQAGGSLRLSCAVSGYKDRNYCMGWFRRAPGKEREGVAVIDSSGRTAYAD
SVKGRFTISRDVALDTAYLQMNSLKPEDTAMYYCAAGWSSLGSCGTNRNRYNYWGQGTQV
TVSS
//
>1ri8B [d.2.1] LYSOZYME C
KVFGRCELAAAMKRHGLDNYRGYSLGNWVCAAKFESNFNTQATNRNTDGSTDYGILQINS
RWWCNDGRTPGSRNLCNIPCSALLSSDITASVNCAKKIVSDGNGMNAWVAWRNRCKGTDV
QAWIRGCRL
//
>1rihL [b.1.1 - b.1.1] LIGHT CHAIN OF ANTIBODY 14F7
DLVLTQSPATLSVTPGDSVSFSCRASQSISNNLHWYQQRTHESPRLLIKYASQSISGIPS
RFSGSGSGTDFTLSISSVETEDFGMYFCQQSNRWPLTFGAGTKLELKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRN
//
>1rihH [b.1.1 - b.1.1] HEAVY CHAIN OF ANTIBODY 14F7
QVQLQQSGNELAKPGASMKMSCRASGYSFTSYWIHWLKQRPDQGLEWIGYIDPATAYTES
NQKFKDKAILTADRSSNTAFMYLNSLTSEDSAVYYCARESPRLRRGIYYYAMDYWGQGTT
VTVSSAKTTPPSVYPLAPGSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDL
YTLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKIVPRDC
//
>1riuL [b.1.1 - b.1.1] FAB M82G2, LIGHT CHAIN
DIVMTQAAPSVPVTPGESVSISCRSSKSLLHSNGYTYLHWFLQRPGQSPQLLIYRVSNLA
SGVPDRFSGSGSGTAFTLRFSRVEAEDVGVYYCMQHLEYPFTFGSGTKLEIKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPQDITVSWKIDGAERSSGVLNSWTDQDSSDSTYSM
SSTLTLTKDEYERHSSYTCEATHKTSTSPITKSFNRGE
//
>1riuH [b.1.1 - b.1.1] FAB M82G2, HEAVY CHAIN
EVTLQESGGGLVQPGGSMKLSCAASGFTFSDAWVDWVRQSPGKGLEWVAEIRNKANNHAT
KYTESVKGRFTISRDDSKSSVYLQMNSLRAEDTGIYYCTSVPQLGRGFAYWGQGTLVTVS
AASTTPPSVYPLAPGSGGAGSMVTLGCLVKGYFPEPVTVTWNSGALSSGVHTFPAVLQSD
LYTLSSSVTVPSSTWPSQTVTCNVAHPASSTQVDKKIVPK
//
>1rj9A [a.24.13 - c.37.1] SIGNAL RECOGNITION PROTEIN
NLEEVLEELEMALLAADVGLSATEEILQEVRASGRKDLKEAVKEKLVGMLEPDERRATLR
KLGFNPQKPKPVEPKGRVVLVVGVNGVGKTTTIAKLGRYYQNLGKKVMFCAGDTFRAAGG
TQLSEWGKRLSIPVIQGPEGTDSAALAYDAVQAMKARGYDLLFVDTAGRLHTKHNLMEEL
KKVKRAIAKADPEEPKEVWLVLDAVTGQNGLEQAKKFHEAVGLTGVIVTKLDGTAKGGVL
IPIVRTLKVPIKFVGVGEGPDDLQPFDPEAFVEALLE
//
>1rj9B [a.24.13 - c.37.1] SIGNAL RECOGNITION PARTICLE PROTEIN
GRLRGRGRITEEDLKATLREIRRALMDADVNLEVTRDFVERVREEALGKQVLESLTPAEV
ILATVYEALKEALGGEARLPVLKDRNLWFLVGLQGSGKTTTAAKLALYYKGKGRRPLLVA
ADTQRPAAREQLRLLGEKVGVPVLEVMDGESPESIRRRVEEKARLEARDLILVDTAGRLQ
IDEPLMGELARLKEVLGPDEVLLVLDAMTGQEALSVARAFDEKVGVTGLVLTKLDGDARG
GAALSARHVTGKPIYFAGVSEKPEGLEPFYPERLAGRILGMG
//
>1rjcA [b.1.1] CAMELID HEAVY CHAIN ANTIBODY
VQLQASGGGSVQAGQSLRLSCATSATSSSNCMGWFRQAPGKEREGVAVIDTGRGNTAYAD
SVQGRLTISLDNNTLYLQMNSLKPEDTAMYYCAADTSTWYRGYCGTNPNYFSYWGQGTQV
TVS
//
>1rjcB [d.2.1] LYSOZYME C
KVFGRCELAAAMKRHGLDNYRGYSLGNWVCAAKFESNFNTQATNRNTDGSTDYGILQINS
RWWCNDGRTPGSRNLCNIPCSALLSSDITASVNCAKKIVSDGNGMNAWVAWRNRCKGTDV
QAWIRGCRL
//
>1rjlA [b.1.1 - b.1.1] FAB H6831 L-CHAIN
DIQMNQSPSSLSASLGDTITITCHASQNINVWLNWFQQKPGSIPKLLIYMASNLHTGVPS
RFSGSGSGTGFTLTISSLQPEDIATYYCQQGQSFPLTFGGGTKLEIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRN
//
>1rjlB [b.1.1 - b.1.1] FAB H6831 H-CHAIN
QVQLQQPGSVLVRPGASVKLSCKASGFTFTSSWMHWAKQRPGQGLEWIGEIHPNSGNTHY
NEKFKGKATLTVDTSSSTAYVDLSSLTSEDSAVYYCARMRYGDYYAMDNWGQGTSVTVSS
AKTTAPPVYPLAPVCGDTTGSSVTLGCLVKGYFPESVTLLWNSGSLSSGVHTFPAVLQSD
LYTLSSSVTVTSSTWPSQSITCNVAHPASSTKVDKKIEPRG
//
>1rjlC [b.76.1] OUTER SURFACE PROTEIN B
TVEIKEGTVTLKREIEKDGKVKVFLNDTAGSNKKTGKWEDSTSTLTISADSKKTKDLVFL
TDGTITVQQYNTAGTSLEGSASEIKNLSELKNALK
//
>1rk8A [d.58.7] CG8781-PA PROTEIN
PQRSVGWILFVTSIHEEAQEDEIQEKFCDYGEIKNIHLNLDRRTGFSKGYALVEYETHKQ
ALAAKEALNGAEIMGQTIQVDWCFVKG
//
>1rk8B [d.232.1] MAGO NASHI PROTEIN
EDFYLRYYVGHEFLEFEFRPDGKLRYANMIRKEAFVHQSVMEELKRIIIDSEIMQEDDLP
WPPPDRVGRQELEIVIGDEHISFTTSKTGSLVDVNRSKDPEGLRCFYYLVQDLKCLVFSL
IGLHFKI
//
>1rk8C [b.72.3] WITHIN THE BGCN GENE INTRON PROTEIN
TYLQSSEGKFIPATKRPDGTWRKARRVKDGYVP
//
>1rkeA [a.24.9 - a.24.9] VINCULIN
HHHHMPVFHTRTIESILEPVAQQISHLVIMHEEGEVDGKAIPDLTAPVAAVQAAVSNLVR
VGKETVQTTEDQILKRDMPPAFIKVENACTKLVQAAQMLQSDPYSVPARDYLIDGSRGIL
SGTSDLLLTFDEAEVRKIIRVCKGILEYLTVAEVVETMEDLVTYTKNLGPGMTKMAKMID
ERQQELTHQEHRVMLVNSMNTVKELLPVLISAMKIFVTTKNSKNQGIEEALKNRNFTVEK
MSAEINEIIRVLQLTSWDEDAW
//
>1rkeB [a.24.9] VCL PROTEIN
DEEFPEQKAGEVINQPMMMAARQLHDEARKWSSKGNDIIAAAKRMALLMAEMSRLVRGGS
GTKRALIQCAKDIAKASDEVTRLAKEVAKQCTDKRIRTNLLQVCERIPTISTQLKILSTV
KATMLDEESEQATEMLVHNAQNLMQSVKETVREAEAASIKIRTDAGFTLRWVRKTP
//
>1rlbA [b.3.4] TRANSTHYRETIN
TGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEQF
VEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTN
PKE
//
>1rlbF (E) [b.60.1] RETINOL BINDING PROTEIN
ERDCRVSSFRVKENFDKARFAGTWYAMAKKDPEGLFLQDNIVAEFSVDENGHMSATAKGR
VRLLNNWDVCADMVGTFTDTEDPAKFKMKYWGVASFLQKGNDDHWIIDTDYETFAVQYSC
RLLNLDGTCADSYSFVFARDPSGFSPQVQKIVRQRQEELCLARQYRLIPHNGYC
//
>1rlcA (L) [d.58.9 - c.1.14] RIBULOSE 1,5 BISPHOSPHATE CARBOXYLASE/OXYGENASE
LTYYTPEYQTKDTDILAAFRVTPQPGVPPEEAGAAVAAESSTVWTDGLTSLDRYKGRCYR
IERVVGEKDQYIAYVAYPLDLFEEGSVTNMFTSIVGNVFGFKALRALRLEDLRIPPAYVK
TFQGPPHGIQVERDKLNKYGRPLLGCTIKPKLGLSAKNYGRAVYECLRGGLDFTKDDENV
NSQPFMRWRDRFLFCAEALYKAQAETGEIKGHYLNATAGTCEEMIKRAVFARELGVPIVM
HDYLTGGFTANTSLAHYCRDNGLLLHIHRAMHAVIDRQKNHGIHFRVLAKALRMSGGDHI
HSGTVVGKLEGERDITLGFVDLLRDDFVEQDRSRGIYFTQDWVSLPGVLPVASGGIHVWH
MPALTEIFGDDSVLQFGGGTLGHPWGNAPGAVANRVALEACVKARNEGRDLAQEGNEIIR
EACKWSPELAAACEVWKEIVF
//
>1rlcB (S) [d.73.1] RIBULOSE 1,5 BISPHOSPHATE CARBOXYLASE/OXYGENASE
MQVWPPINKKKYETLSYLPDLSQEQLLSEVEYLLKNGWVPCLEFETEHGFVYRENNKSPG
YYDGRYWTMWKLPMFGCTDATQVLAEVEEAKKAYPQAWIRIIGFDNVRQVQCISFIAYKP
EGY
//
>1rm1A [d.129.1 - d.129.1] TATA-BOX BINDING PROTEIN
SGIVPTLQNIVATVTLGCRLDLKTVALHARNAEYNPKRFAAVIMRIREPKTTALIFASGK
MVVTGAKSEDDSKLASRKYARIIQKIGFAAKFTDFKIQNIVGSCDVKFPIRLEGLAFSHG
TFSSYEPELFPGLIYRMVKPKIVLLIFVSGKIVLTGAKQREEIYQAFEAIYPVLSEFRKM
//
>1rm1B [a.32.1 - b.56.1] TRANSCRIPTION INITIATION FACTOR IIA SMALL CHAIN
PGYYELYRRSTIGNSLVDALDTLISDGRIEASLAMRVLETFDKVVAETLKDNTQSKLTVK
GNLDTYGFCDDVWTFIVKNCQVTVEVISVDKLRIVACNSKK
//
>1rm1C [x.x.x] TRANSCRIPTION INITIATION FACTOR IIA LARGE CHAIN
SNAEASRVYEIIVESVVNEVREDFENAGIDEQTLQDLKNIWQKKLTETKVTTFSWDNQFN
DYLISEDGPDENLMLCLYDKVTRTKARWKCSLKDGVVTINRNDYTFQKAQVEAEWV
//
>1rm6D [d.41.1 - d.133.1] 4-HYDROXYBENZOYL-COA REDUCTASE ALPHA SUBUNIT
GTVGVRTPLVDGVEKVTGKAKYTADIAAPDALVGRILRSPHAHARILAIDTSAAEALEGV
IAVCTGAETPVPFGVLPIAENEYPLARDKVRYRGDPVAAVAAIDEVTAEKALALIKVDYE
VLPAYMTPKAAMKAGAIALHDDKPNNILREVHAEFGDVAAAFAEADLIREKTYTFAEVNH
VHMELNATLAEYDPVRDMLTLNTTTQVPYYVHLKVAACLQMDSARIRVIKPFLGGGFGAR
TEALHFEIIAGLLARKAKGTVRLLQTREETFIAHRGRPWTEVKMKIGLKKDGKIAALALE
ATQAGGAYAGYGIITILYTGALMHGLYHIPAIKHDAWRVYTNTPPCGAMRGHGTVDTRAA
FEALLTEMGEELGIDSLKIRQINMLPQIPYVTMYAQRVMSYGVPECLEKVKAASGWEERK
GKLPKGRGLGIALSHFVSGTSTPKHWTGEPHATVNLKLDFDGGITLLTGAADIGQGSNTM
ASQVAAEVLGVRLSRIRVISADSALTPKDNGSYSSRVTFMVGNASISAAEELKGVLVKAA
AKKLDAREEDIEVIDEMFMVSGSQDPGLSFQEVVKAAMVDSGTITVKGTYTCPTEFQGDK
KIRGSAIGATMGFCYAAQVVEASVDEITGKVTAHKVWVAVDVGKALNPLAVEGQTQGGVW
MGMGQALSEETVYDNGRMVHGNILDYRVPTIVESPDIEVIIVESMDPNGPFGAKEASEGM
LAGFLPAIHEAVYEAVGVRATDFPLSPDRITELLDAKEAA
//
>1rm6F (C) [d.15.4 - a.56.1] 4-HYDROXYBENZOYL-COA REDUCTASE GAMMA SUBUNIT
MKNILRLTLNGRAREDLVPDNMLLLDYLRETVGLTGTKQGCDGGECGACTVLVDDRPRLA
CSTLAHQVAGKKVETVESLATQGTLSKLQAAFHEKLGTQCGFCTPGMIMASEALLRKNPS
PSRDEIKAALAGNLCRCTGYVKIIKSVETAAAARLCE
//
>1rm6E (B) [d.145.1 - d.87.2] 4-HYDROXYBENZOYL-COA REDUCTASE BETA SUBUNIT
MNILTDFRTHRPATLADAVNALAAEATLPLGAGTDLLPNLRRGLGHPAALVDLTGIDGLA
TISTLADGSLRIGAGATLEAIAEHDAIRTTWPALAQAAESVAGPTHRAAATLGGNLCQDT
RCTFYNQSEWWRSGNGYCLKYKGDKCHVIVKSDRCYATYHGDVAPALMVLDARAEIVGPA
GKRTVPVAQLFRESGAEHLTLEKGELLAAIEVPPTGAWSAAYSKVRIRDAVDFPLAGVAA
ALQRDGDRIAGLRVAITGSNSAPLMVPVDALLGGNWDDAAAETLAQLVRKTSNVLRTTIT
GVKYRRRVLLAISRKVVDQLWEA
//
>1rmfL [b.1.1 - b.1.1] IGG2A-KAPPA R6.5 FAB (LIGHT CHAIN)
DVVMTQSPLSLPVSLGDQASISCRSSQSLVHSNGNNYLHWYLQKSGQAPKLLIYKVSNRF
SGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQSTHVPLTFGGGTKLEIKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1rmfH [b.1.1 - b.1.1] IGG2A-KAPPA R6.5 FAB (HEAVY CHAIN)
QVQLQQSGPELVRPGVSVKISCKGSGYTFIDYAIHWVKESHAKSLEWIGVISAYSGDTNY
NQKFKGKATMTVDKSSNTAYLELARLTSEDSAIYYCARGGWLLLSFDYWGQGTTLTVSSA
KTTAPSVTPLAPVCGDTTGSSVTLGVLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDL
YTLSSSVTVTSSTWPSQSITCNVAHPASSTKVDKKI
//
>1rmu_21 [b.121.4] HUMAN RHINOVIRUS 14 COAT PROTEIN (SUBUNIT VP1)
TVASISSGPKHTQKVPILTANETGATMPVLPSDSIETRTTYMHFNGSETDVECFLGRAAC
VHVTEIQNKDATGIDNHREAKLFNDWKINLSSLVQLRKKLELFTYVRFDSEYTILATASQ
PDSANYSSNLVVQAMYVPPGAPNPKEWDDYTWQSASNPSVFFKVGDTSRFSVPYVGLASA
YNYFYDGYSHDDAETQYGITVLNHMGSMAFRIVNEHDEHKTLVKIRVYHRAKHVEAWIPR
APRALPYTSIGRTNYPKNTEPVIKKRKGDIKSY
//
>1rmu_23 [b.121.4] HUMAN RHINOVIRUS 14 COAT PROTEIN (SUBUNIT VP3)
GLPTTTLPGSGQFLTTDDRQSPSALPNYEPTPRIHIPGKVHNLLEIIQVDTLIPMNNTHT
KDEVNSYLIPLNANRQNEQVFGTNLFIGDGVFKTTLLGEIVQYYTHWSGSLRFSLMYTGP
ALSSAKLILAYTPPGARGPQDRREAMLGTHVVWDIGLQSTIVMTIPWTSGVQFRYTDPDT
YTSAGFLSCWYQTSLILPPETTGQVYLLSFISACPDFKLRLMKDTQTISQTVALTE
//
>1rmu_2a (4) [b.121.4] HUMAN RHINOVIRUS 14 COAT PROTEIN (SUBUNIT VP4)
TVASISSGPKHTQKVPILTANETGATMPVLPSDSIETRTTYMHFNGSETDVECFLGRAAC
VHVTEIQNKDATGIDNHREAKLFNDWKINLSSLVQLRKKLELFTYVRFDSEYTILATASQ
PDSANYSSNLVVQAMYVPPGAPNPKEWDDYTWQSASNPSVFFKVGDTSRFSVPYVGLASA
YNYFYDGYSHDDAETQYGITVLNHMGSMAFRIVNEHDEHKTLVKIRVYHRAKHVEAWIPR
APRALPYTSIGRTNYPKNTEPVIKKRKGDIKSY
//
>1rmu_2l (1) [b.121.4] HUMAN RHINOVIRUS 14 COAT PROTEIN (SUBUNIT VP1)
TVASISSGPKHTQKVPILTANETGATMPVLPSDSIETRTTYMHFNGSETDVECFLGRAAC
VHVTEIQNKDATGIDNHREAKLFNDWKINLSSLVQLRKKLELFTYVRFDSEYTILATASQ
PDSANYSSNLVVQAMYVPPGAPNPKEWDDYTWQSASNPSVFFKVGDTSRFSVPYVGLASA
YNYFYDGYSHDDAETQYGITVLNHMGSMAFRIVNEHDEHKTLVKIRVYHRAKHVEAWIPR
APRALPYTSIGRTNYPKNTEPVIKKRKGDIKSY
//
>1rmu_2a (4) [b.121.4] HUMAN RHINOVIRUS 14 COAT PROTEIN (SUBUNIT VP4)
TVASISSGPKHTQKVPILTANETGATMPVLPSDSIETRTTYMHFNGSETDVECFLGRAAC
VHVTEIQNKDATGIDNHREAKLFNDWKINLSSLVQLRKKLELFTYVRFDSEYTILATASQ
PDSANYSSNLVVQAMYVPPGAPNPKEWDDYTWQSASNPSVFFKVGDTSRFSVPYVGLASA
YNYFYDGYSHDDAETQYGITVLNHMGSMAFRIVNEHDEHKTLVKIRVYHRAKHVEAWIPR
APRALPYTSIGRTNYPKNTEPVIKKRKGDIKSYGYSDRVQQITLGNSTITTQEAANAVVC
YAEWPEYLPDVDASDVNKTSKPDTSVCRFYTLDSKTWTTGSKGWCWKLPDALKDMGVFGQ
NMFFHSLGRSGYTVHVQCNATKFHSGCLLVVVIPEHQLASHEGGNVSVKYTFTHPGERGI
DLSSANEVGGPVKDVLYNMNGTLLGNLLIFPHQFINLRTNNTATIVIPYINSVPIDSMTR
HNNVSLMVIPIAPLTVPTGATPSLPITVTIAPMCTEFSGIRSKSIVPQGLPTTTLPGSGQ
FLTTDDRQSPSALPNYEPTPRIHIPGKVHNLLEIIQVDTLIPMNNTHTKDEVNSYLIPLN
ANRQNEQVFGTNLFIGDGVFKTTLLGEIVQYYTHWSGSLRFSLMYTGPALSSAKLILAYT
PPGARGPQDRREAMLGTHVVWDIGLQSTIVMTIPWTSGVQFRYTDPDTYTSAGFLSCWYQ
TSLILPPETTGQVYLLSFISACPDFKLRLMKDTQTISQTVALTEINYYKDAASTSSAGQS
LSMDPSKFTEPVKDLMLKGAPALNTVASISSGPKHTQKVPILTANETGATMPVLPSDSIE
TRTTYMHFNGSETDVECFLGRAACVHVTEIQNKDATGIDNHREAKLFNDWKINLSSLVQL
RKKLELFTYVRFDSEYTILATASQPDSANYSSNLVVQAMYVPPGAPNPKEWDDYTWQSAS
NPSVFFKVGDTSRFSVPYVGLASAYNYFYDGYSHDDAETQYGITVLNHMGSMAFRIVNEH
DEHKTLVKIRVYHRAKHVEAWIPRAPRALPYTSIGRTNYPKNTEPVIKKRKGDIKSYGYS
DRVQQITLGNSTITTQEAANAVVCYAEWPEYLPDVDASDVNKTSKPDTSVCRFYTLDSKT
WTTGSKGWCWKLPDALKDMGVFGQNMFFHSLGRSGYTVHVQCNATKFHSGCLLVVVIPEH
QLASHEGGNVSVKYTFTHPGERGIDLSSANEVGGPVKDVLYNMNGTLLGNLLIFPHQFIN
LRTNNTATIVIPYINSVPIDSMTRHNNVSLMVIPIAPLTVPTGATPSLPITVTIAPMCTE
FSGIRSKSIVPQGLPTTTLPGSGQFLTTDDRQSPSALPNYEPTPRIHIPGKVHNLLEIIQ
VDTLIPMNNTHTKDEVNSYLIPLNANRQNEQVFGTNLFIGDGVFKTTLLGEIVQYYTHWS
GSLRFSLMYTGPALSSAKLILAYTPPGARGPQDRREAMLGTHVVWDIGLQSTIVMTIPWT
SGVQFRYTDPDTYTSAGFLSCWYQTSLILPPETTGQVYLLSFISACPDFKLRLMKDTQTI
SQTVALTEINYYKDAASTSSAGQSLSMDPSKFTEPVKDLMLKGAPALN
//
>1rmu_2a (4) [b.121.4] HUMAN RHINOVIRUS 14 COAT PROTEIN (SUBUNIT VP4)
TVASISSGPKHTQKVPILTANETGATMPVLPSDSIETRTTYMHFNGSETDVECFLGRAAC
VHVTEIQNKDATGIDNHREAKLFNDWKINLSSLVQLRKKLELFTYVRFDSEYTILATASQ
PDSANYSSNLVVQAMYVPPGAPNPKEWDDYTWQSASNPSVFFKVGDTSRFSVPYVGLASA
YNYFYDGYSHDDAETQYGITVLNHMGSMAFRIVNEHDEHKTLVKIRVYHRAKHVEAWIPR
APRALPYTSIGRTNYPKNTEPVIKKRKGDIKSYGYSDRVQQITLGNSTITTQEAANAVVC
YAEWPEYLPDVDASDVNKTSKPDTSVCRFYTLDSKTWTTGSKGWCWKLPDALKDMGVFGQ
NMFFHSLGRSGYTVHVQCNATKFHSGCLLVVVIPEHQLASHEGGNVSVKYTFTHPGERGI
DLSSANEVGGPVKDVLYNMNGTLLGNLLIFPHQFINLRTNNTATIVIPYINSVPIDSMTR
HNNVSLMVIPIAPLTVPTGATPSLPITVTIAPMCTEFSGIRSKSIVPQGLPTTTLPGSGQ
FLTTDDRQSPSALPNYEPTPRIHIPGKVHNLLEIIQVDTLIPMNNTHTKDEVNSYLIPLN
ANRQNEQVFGTNLFIGDGVFKTTLLGEIVQYYTHWSGSLRFSLMYTGPALSSAKLILAYT
PPGARGPQDRREAMLGTHVVWDIGLQSTIVMTIPWTSGVQFRYTDPDTYTSAGFLSCWYQ
TSLILPPETTGQVYLLSFISACPDFKLRLMKDTQTISQTVALTEINYYKDAASTSSAGQS
LSMDPSKFTEPVKDLMLKGAPALN
//
>1rp3_1A [a.177.1 - a.4.13 - a.4.13] RNA POLYMERASE SIGMA FACTOR SIGMA-28 (FLIA)
HMKNPYSNQIEREELILKYLPLVKAIATNIKKHLPEDVDIRDLISYGVIGLIKAVDNLST
ENPKRAEAYIKLRIKGAIYDYLRSLDFGSRQVREKERRIKEVVEKLKEKLGREPTDEEVA
KELGISTEELFKTLDKINFSYILSLEEVFRDFARDYSELIPSSTNVEEEVIKRELTEKVK
EAVSKLPEREKLVIQLIFYEELPAKEVAKILETSVSRVSQLKAKALERLREMLSN
//
>1rp3_1B [a.137.11] ANTI SIGMA FACTOR FLGM
VNRIELSRLIGLLLETSGTNKIEDKVTLSKIAQELSKNDVEEKDLEKKVKELKEKIEKGE
YEVSDEKVVKGLIEFFT
//
>1rp3_2C [a.177.1 - a.4.13 - a.4.13] RNA POLYMERASE SIGMA FACTOR SIGMA-28 (FLIA)
KNPYSNQIEREELILKYLPLVKAIATNIKKHLPEDVDIRDLISYGVIGLIKAVDNLSTEN
PKRAEAYIKLRIKGAIYDYLRSLDFGSRQVREKERRIKEVVEKLKEKLGREPTDEEVAKE
LGISTEELFKTLDKINFSYILSLEEVFRDFARDYSELIPSSTNVEEEVIKRELTEKVKEA
VSKLPEREKLVIQLIFYEELPAKEVAKILETSVSRVSQLKAKALERLREMLSNP
//
>1rp3_2D [a.137.11] ANTI SIGMA FACTOR FLGM
NRIELSRLIGLLLETEDKVTLSKIAQELSKNDVEEKDLEKKVKELKEKIEKGEYEVSDEK
VVKGLIEFFT
//
>1rp3_3E [a.177.1 - a.4.13 - a.4.13] RNA POLYMERASE SIGMA FACTOR SIGMA-28 (FLIA)
KNPYSNQIEREELILKYLPLVKAIATNIKKHLPEDVDIRDLISYGVIGLIKAVDNLSTEN
PKRAEAYIKLRIKGAIYDYLRSLDFGSRQVREKERRIKEVVEKLKEKLGREPTDEEVAKE
LGISTEELFKTLDKINFSYILSLEEVFRDFARDYSELIPSSTNVEEEVIKRELTEKVKEA
VSKLPEREKLVIQLIFYEELPAKEVAKILETSVSRVSQLKAKALERLREMLSNPL
//
>1rp3_3F [a.137.11] ANTI SIGMA FACTOR FLGM
RIELSRLIGLLLETDKVTLSKIAQELSKNDDLEKKVKELKEKIEKGEYEVSDEKVVKGLI
EFFT
//
>1rp3_4G [a.177.1 - a.4.13 - a.4.13] RNA POLYMERASE SIGMA FACTOR SIGMA-28 (FLIA)
MKNPYSNQIEREELILKYLPLVKAIATNIKKHLPEDVDIRDLISYGVIGLIKAVDNLSTE
NPKRAEAYIKLRIKGAIYDYLRSLDFGSRQVREKERRIKEVVEKLKEKLGREPTDEEVAK
ELGISTEELFKTLDKINFSYILSLEEVFRDFARDYSEEVIKRELTEKVKEAVSKLPEREK
LVIQLIFYEELPAKEVAKILETSVSRVSQLKAKALERLREMLSNPL
//
>1rp3_4H [a.137.11] ANTI SIGMA FACTOR FLGM
MVNRIELSRLIGLLLETEKRKDKVTLSKIAQELSKNDLEKKVKELKEKIEKGEYEVSDEK
VVKGLIEFFT
//
>1rpq_2Z (W) [k.30.1] PEPTIDE E131
VQCPHFCYELDYELCPDVCYV
//
>1rpq_2D [b.1.1 - b.1.1] HIGH AFFINITY IMMUNOGLOBULIN EPSILON RECEPTOR
KPKVSLNPPWNRIFKGENVTLTCNGNNFFVSSTKWFHNGSLSEETNSSLNIVNAKFEDSG
EYKCQHQQVNESEPVYLEVFSDWLLLQASAEVVMEGQPLFLRCHGWRNWDVYKVIYYKDG
EALKYWYENHNISITNATVEDSGTYYCTGKVWQLDYESEPLNITVIK
//
>1rqqA [d.144.1] INSULIN RECEPTOR
DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN
EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL
QEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIxETDxxRKG
GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG
YLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSFPEVSFFHSEENK
//
>1rqqD (C) [d.93.1] ADAPTOR PROTEIN APS
LELSDYPWFHGTLSRVKAAQLVLAGGPRSHGLFVIRQSETRPGECVLTFNFQGKAKHLRL
SLNGQCHVQHLWFQSVFDMLRHF
//
>1rrp_1A [c.37.1] RAN
QVQFKLVLVGDGGTGKTTFVKRHLTGEFEKKYVATLGVEVHPLVFHTNRGPIKFNVWDTA
GQEKFGGLRDGYYIQAQCAIIMFDVTSRVTYKNVPNWHRDLVRVCENIPIVLCGNKVDIK
DRKVKAKSIVFHRKKNLQYYDISAKSNYNFEKPFLWLARKLIGDPNLEFVAMPALAPPEV
VMDPALAAQYEHDLEVAQTTALPD
//
>1rrp_1B [b.55.1] NUCLEAR PORE COMPLEX PROTEIN NUP358
HFEPVVPLPDKIEVKTGEEDEEEFFCNRAKLFRFDVESKEWKERGIGNVKILRHKTSGKI
RLLMRREQVLKICANHYISPDMKLTPNAGSDRSFVWHALDYADELPKPEQLAIRFKTPEE
AALFKCKFEEAQSI
//
>1ru9L [b.1.1 - b.1.1] IMMUNOGLOBULIN IGG2A, LIGHT CHAIN
DVVMTQSPKTISVTIGQPASISCKSSQRLLNSNGKTFLNWLLQRPGQSPKRLIYLGTKLD
SGVPDRFTGSGSGTDFTLKISRVEAEDLGVYYCWQGTHFPYTFGGGTKLEIKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSxTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1ru9H [b.1.1 - b.1.1] IMMUNOGLOBULIN IGG2A, HEAVY CHAIN
RVQLQxSGPGLVKPSQSLSLTCTVTGYSITSDFAWNWIRQFPGNKLEWMGYINYSGFTSH
NPSLKSRISITRDTSKNQFFLQLNSVTTEDTATYYCAGLLWYDGGAGSWGQGTLVTVSAA
KTTAPSVYPLAPVCGDTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDL
YTLSSSVTVTSSTWPSQSITCNVAHPASSTKVDKKIEPRGPT
//
>1ruyH [b.19.1] HEMAGGLUTININ
DTLCIGYHANNSTDTVDTVLEKNVTVTHSVNLLEDSHNGKLCRLGGIAPLQLGKCNIAGW
LLGNPECDLLLTVSSWSYIVETPNSDNGTCYPGDFIDYEELREQLSSVSSFERFEIFPKT
SSWPNHNTNKGVTAACPYAGASSFYRNLLWLVKKGNSYPKLSKSYVNNKGKEVLVLWGVH
HPPTSTDQQNLYQNADAYVSVGSSKYNRRFTPEIAARPKVRGQAGRMNYYWTLLEPGDTI
TFEATGNLVAPRYAFALNRGSGSGIIISNAPVHDCNTKCQTPHGAINSSLPFQNIHPVTI
GECPKYVKSTKLRMATGLRNIPAR
//
>1ruyI [h.3.1] HEMAGGLUTININ
GLFGAIAGFIEGGWTGLIDGWYGYHHQNEQGSGYAADQKSTQNAIDGITNKVNSVIEKMN
TQFTAVGKEFNKLEKRIENLNNKVDDGFLDIWTYNAELLVLLENERTLDFHDSNVKNLYE
KVRSQLKNNAKEIGNGCFEFYHKCDNECMESVRNGTYDYP
//
>1rv6W [g.17.1] PLACENTA GROWTH FACTOR (PLGF)
EVVPFQEVWGRSYCRALERLVDVVSEYPSEVEHMFSPSCVSLLRCTGCCGDENLHCVPVE
TANVTMQLLKIRSGDRPSYVELTFSQHVRCECRPL
//
>1rv6X [b.1.1] FLT1 PROTEIN
RPFVEMYSEIPEIIHMTEGRELVIPCRVTSPNITVTLKKFPLDTLIPDGKRIIWDSRKGF
IISNATYKEIGLLTCEATVNGHLYKTNYLTHR
//
>1rvf_3D (H) [b.1.1] FAB 17-IA
INYYKDAASTSSAGQSLSMDPSKFTEPVKDLMLKGAPALN
//
>1rvf_32 [b.121.4] HUMAN RHINOVIRUS 14 COAT PROTEIN
GYSDRVQQITLGNSTITTQEAANAVVCYAEWPEYLPDVDASDVNKTSKPDTSVCRFYTLD
SKTWTTGSKGWCWKLPDALKDMGVFGQNMFFHSLGRSGYTVHVQCNATKFHSGCLLVVVI
PEHQLASHEGGNVSVKYTFTHPGERGIDLSSANEVGGPVKDVLYNMNGTLLGNLLIFPHQ
FINLRTNNTATIVIPYINSVPIDSMTRHNNVSLMVIPIAPLTVPTGATPSLPITVTIAPM
CTEFSGIRSKSIVPQ
//
>1rvf_3D (H) [b.1.1] FAB 17-IA
QGQLQQSGAELVRPGSSVKISCKASGYAFSSFWVNWVKQRPGQGLEWIGQIYPGDGDNKY
NGKFKGKATLTADKSSTTAYMQLYSLTSEDSAVYFCARSGNYPYAMDYWGQGTSVTVSS
//
>1rvf_42 [b.121.4] HUMAN RHINOVIRUS 14 COAT PROTEIN
GYSDRVQQITLGNSTITTQEAANAVVCYAEWPEYLPDVDASDVNKTSKPDTSVCRFYTLD
SKTWTTGSKGWCWKLPDALKDMGVFGQNMFFHSLGRSGYTVHVQCNATKFHSGCLLVVVI
PEHQLASHEGGNVSVKYTFTHPGERGIDLSSANEVGGPVKDVLYNMNGTLLGNLLIFPHQ
FINLRTNNTATIVIPYINSVPIDSMTRHNNVSLMVIPIAPLTVPTGATPSLPITVTIAPM
CTEFSGIRSKSIVPQ
//
>1rvf_4H [b.1.1] FAB 17-IA
QGQLQQSGAELVRPGSSVKISCKASGYAFSSFWVNWVKQRPGQGLEWIGQIYPGDGDNKY
NGKFKGKATLTADKSSTTAYMQLYSLTSEDSAVYFCARSGNYPYAMDYWGQGTSVTVSS
//
>1rvx_1E (A) [b.19.1] HEMAGGLUTININ
DTICIGYHANNSTDTVDTVLEKNVTVTHSVNLLEDSHNGKLCRLKGIAPLQLGKCNIAGW
LLGNPECDPLLPVRSWSYIVETPNSENGICYPGDFIDYEELREQLSSVSSFERFEIFPKE
SSWPNHNTNGVTAACSHEGKSSFYRNLLWLTEKEGSYPKLKNSYVNKKGKEVLVLWGIHH
PPNSKEQQNLYQNENAYVSVVTSNYNRRFTPEIAERPKVRDQAGRMNYYWTLLKPGDTII
FEANGNLIAPMYAFALRRGFGSGIITSNASMHECNTKCQTPLGAINSSLPYQNIHPVTIG
ECPKYVRSAKLRMVTGLRNIPAR
//
>1rvx_1F [h.3.1] HEMAGGLUTININ
GLFGAIAGFIEGGWTGMIDGWYGYHHQNEQGSGYAADQKSTQNAINGITNKVNSVIEKMN
IQFTAVGKEFNKLEKRMENLNNKVDDGFLDIWTYNAELLVLLENERTLDFHDSNVKNLYE
KVKSQLKNNAKEIGNGCFEFYHKCDNECMESVRNGTYDY
//
>1ry1W [i.22.1] SIGNAL RECOGNITION PARTICLE 54 KDA PROTEIN
QFTLRDMYEQFQNIMKMGPFSQILGMIPGFGTDFMSKGNEQESMARLKKLMTIMDSMNDQ
ELDSTDGAKVFSKQPGRIQRVARGSGVSTRDVQELLTQYTKFAQMVKKM
//
>1ry1U [i.22.1] SIGNAL RECOGNITION PARTICLE PROTEIN
MFQQLSARLQEAIGRLRGRGRITEEDLKATLREIRRALMDADVNLEVARDFVERVREEAL
GKQVLESLTPAEVILATVYEALKEALGGEARLPVLKDRNLWFLVGLQGSGKTTTAAKLAL
YYKGKGRRPLLVAADTQRPAAREQLRLLGEKVGVPVLEVMDGESPESIRRRVEEKARLEA
RDLILVDTAGRLQIDEPLMGELARLKEVLGPDEVLLVLDAMTGQEALSVARAFDEKVGVT
GLVLTKLDGDARGGAALSARHVTGKPIYFAGVSEKPEGLEPFYPERLAGRILGM
//
>1ry7A [b.42.1] HEPARIN-BINDING GROWTH FACTOR 1
EITTFTALTEKFNLPPGNYKKPKLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAE
SVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFV
GLKKNGSCKRGPRTHYGQKAILFLPLPVSSD
//
>1ry7B [b.1.1 - b.1.1] FIBROBLAST GROWTH FACTOR RECEPTOR 3
APYWTRPERMDKKLLAVPAANTVRFRCPAAGNPTPSISWLKNGREFRGEHRIGGIKLRHQ
QWSLVMESVVPSDRGNYTCVVENKFGSIRQTYTLDVLERSPHRPILQAGLPANQTAVLGS
DVEFHCKVYSDAQPHIQWLKHVEVNGSKVGPDGTPYVTVLKTAGANTTDKELEVLSLHNV
TFEDAGEYTCLAGNSIGFSHHSAWLVVLPAEEE
//
>1rypD [d.153.1] 20S PROTEASOME
GYDRALSIFSPDGHIFQVEYALEAVKRGTCAVGVKGKNCVVLGCERRSTLKLQDTRITPS
KVSKIDSHVVLSFSGLNADSRILIEKARVEAQSHRLTLEDPVTVEYLTRYVAGVQQRYTQ
SGGVRPFGVSTLIAGFDPRDDEPKLYQTEPSGIYSSWSAQTIGRNSKTVREFLEKNYDRK
EPPATVEECVKLTVRSLLEVVQTGAKNIEITVVKPDSDIVALSSEEINQYVTQIEQEKQE
Q
//
>1rypE [d.153.1] 20S PROTEASOME
DRGVSTFSPEGRLFQVEYSLEAIKLGSTAIGIATKEGVVLGVEKRATSPLLESDSIEKIV
EIDRHIGCAMSGLTADARSMIEHARTAAVTHNLYYDEDINVESLTQSVCDLALRFGEGAS
GEERLMSRPFGVALLIAGHDADDGYQLFHAEPSGTFYRYNAKAIGSGSEGAQAELLNEWH
SSLTLKEAELLVLKILKQVMEEKLDENNAQLSCITKQDGFKIYDNEKTAELIKELKEKEA
AE
//
>1rypF [d.153.1] 20S PROTEASOME
FRNNYDGDTVTFSPTGRLFQVEYALEAIKQGSVTVGLRSNTHAVLVALKRNADELSSYQK
KIIKCDEHMGLSLAGLAPDARVLSNYLRQQCNYSSLVFNRKLAVERAGHLLCDKAQKNTQ
SYGGRPYGVGLLIIGYDKSGAHLLEFQPSGNVTELYGTAIGARSQGAKTYLERTLDTFIK
IDGNPDELIKAGVEAISQSLRDESLTVDNLSIAIVGKDTPFTIYDGEAVAKYI
//
>1rypG [d.153.1] 20S PROTEASOME
GTGYDLSNSVFSPDGRNFQVEYAVKAVENGTTSIGIKCNDGVVFAVEKLITSKLLVPQKN
VKIQVVDRHIGCVYSGLIPDGRHLVNRGREEAASFKKLYKTPIPIPAFADRLGQYVQAHT
LYNSVRPFGVSTIFGGVDKNGAHLYMLEPSGSYWGYKGAATGKGRQSAKAELEKLVDHHP
EGLSAREAVKQAAKIIYLAHEDNKEKDFELEISWCSLSETNGLHKFVKGDLLQEAIDFAQ
KEIN
//
>1rypH [d.153.1] 20S PROTEASOME
LKKGEVSLGASIMAVTFKDGVILGADSRTTTGAYIANRVTDKLTRVHDKIWCCRSGSAAD
TQAIADIVQYHLELYTSQYGTPSTETAASVFKELCYENKDNLTAGIIVAGYDDKNKGEVY
TIPLGGSVHKLPYAIAGSGSTFIYGYCDKNFRENMSKEETVDFIKHSLSQAIKWDGSSGG
VIRMVVLTAAGVERLIFYPDEYEQL
//
>1rypI [d.153.1] 20S PROTEASOME
TTIVGVKFNNGVVIAADTRSTQGPIVADKNCAKLHRISPKIWCAGAGTAADTEAVTQLIG
SNIELHSLYTSREPRVVSALQMLKQHLFKYQGHIGAYLIVAGVDPTGSHLFSIHAHGSTD
VGYYLSLGSGSLAAMAVLESHWKQDLTKEEAIKLASDAIQAGIWNDLGSGSNVDVCVMEI
GKDAEYLRNYLTPNVREEKQKSYKFPRGTTAVLKESIVNICD
//
>1rypJ [d.153.1] 20S PROTEASOME
SDPSSINGGIVVAMTGKDCVAIACDLRLGSQSLGVSNKFEKIFHYGHVFLGITGLATDVT
TLNEMFRYKTNLYKLKEERAIEPETFTQLVSSSLYERRFGPYFVGPVVAGINSKSGKPFI
AGFDLIGCIDEAKDFIVSGTASDQLFGMCESLYEPNLEPEDLFETISQALLNAADRDALS
GWGAVVYIIKKDEVVKRYLKMRQD
//
>1rypZ (L) [d.153.1] 20S PROTEASOME
TTTLAFRFQGGIIVAVDSRATAGNWVASQTVKRVIEINPFLLGTMAGGAADCQFWETWLG
SQCRLHELREKERISVAAASKILSNLVYQYKGAGLSMGTMICGYTRKEGPTIYYVDSDGT
RLKGDIFCVGSGQTFAYGVLDSNYKWDLSVEDALYLGKRSILAAAHRDAYSGGSVNLYHV
TEDGWIYHGNHDVGELFWKVKEEEGSFNNVIG
//
>1ryp1 (M) [d.153.1] 20S PROTEASOME
QFNPYGDNGGTILGIAGEDFAVLAGDTRNITDYSINSRYEPKVFDCGDNIVMSANGFAAD
GDALVKRFKNSVKWYHFDHNDKKLSINSAARNIQHLLYGKRFFPYYVHTIIAGLDEDGKG
AVYSFDPVGSYEREQCRAGGAAASLIMPFLDNQVNFKNQYEPGTNGKVKKPLKYLSVEEV
IKLVRDSFTSATERHIQVGDGLEILIVTKDGVRKEFYELKRD
//
>1rz7L [b.1.1 - b.1.1] FAB 48D LIGHT CHAIN
IQMTQSPSSVSASVGDRVTITCRASQDISTWLAWYQQKPGKAPKLLIYAASTLQSGVPSR
FSGSGSGTDFSLTINSLQPEDFATYYCQQANSFFTFGGGTKVEIKRTVAAPSVFIFPPSD
EQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLS
KADYEKHKLYACEVTHQGLSSPVTKSFNRGE
//
>1rz7H [b.1.1 - b.1.1] FAB 48D HEAVY CHAIN
EVQLVQSGAEVKKPGATVKISCKASGYTFSDFYMYWVRQAPGKGLEWMGLIDPEDADTMY
AEKFRGRVTITADTSTDTGYLELSSLRSEDTAVYYCAADPWELNAFNVWGQGTLVSVSSA
STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG
LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEP
//
>1rzfL [b.1.1 - b.1.1] FAB E51 LIGHT CHAIN
QSILTQPPSVSAAPGQKVTISCSGSSSNIGNNDVSWYQQFPGTVPKLVIYENNERPSGIP
DRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLSAVVFGGGSKVTVLGQPKAAPSVT
LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASS
YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPT
//
>1rzfH [b.1.1 - b.1.1] FAB E51 HEAVY CHAIN
VQLVQSGAEVNKPGSSVKVSCQASGATLNSHAFSWVRQAPGQGLEWMAGIIPIFGSSHYA
QKFRGRVTISADESTRTVYLHLRGLRSDDTAVYYCASNSIAGGYYYDMDVWGQGTTVTVS
SASTKGPSVFPLAPTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLY
SLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPK
//
>1rzg_1A [b.1.1 - b.1.1] FAB 412D LIGHT CHAIN
EVQLVQSGAEVKKPGSSVKVSCKASGGTFSNYAINWVRQAPGQGLEWMGGIIPIFNIAHY
AQRFQGRVSITADESTSTAYMELSSLRSEDTAVFYCASPYPNDxGMSWYFDLWGRGTLVT
VSPASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVL
QSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK
//
>1rzg_1B [b.1.1 - b.1.1] FAB 412D HEAVY CHAIN
DIQMTQSPSTLSASVGDRVTITCRASQSISNWLAWYQQKPGRAPKLLMYKASSLKSGVPS
RFSGSGSGTEFTLTISSLQSDDFATYYCQQHDSSPYTFGQGTKLEIKRTVAAPSVFIFPP
SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT
LSKADYEKHKLYACEVTHQGLSSPVTKSFNRGE
//
>1rzhL [f.26.1] REACTION CENTER PROTEIN L CHAIN
ALLSFERKYRVPGGTLVGGNLFDFWVGPFYVGFFGVATFFFAALGIILIAWSAVLQGTWN
PQLISVYPPALEYGLGGAPLAKGGLWQIITICATGAFVSWALREVEICRKLGIGYHIPFA
FAFAILAYLTLVLFRPVMMGAWGYAFPYGIWTHLDWVSNTGYTYGNFHYNPAHMIAISFF
FTNALALALHGALVLSAANPEKGKEMRTPDHENTFFRDLVGYSIGTLGIHRLGLLLSLSA
VFFSALCMIITGTIWFDQWVDWWQWWVKLPWWANIPGGING
//
>1rzhH [f.23.10 - b.41.1] REACTION CENTER PROTEIN H CHAIN
DLASLAIYSFWIFLAGLIYYLQTENMREGYPLENEDGTPAANQGPFPLPKPKTFILPHGR
GTLTVPGPESEDRPIALARTAVSEGFPHAPTGDPMKDGVGPASWVARRDLPELDGHGHNK
IKPMKAAAGFHVSAGKNPIGLPVRGCDLEIAGKVVDIWVDIPEQMARFLEVELKDGSTRL
LPMQMVKVQSNRVHVNALSSDLFAGIPTIKSPTEVTLLEEDKICGYVAGGLMYAAPKR
//
>1rzi_1A [b.1.1 - b.1.1] FAB 47E LIGHT CHAIN
IQMTQSPSLSASVGDRVTITCRASQSISSYLNWYQQKPGKVPKLLIYAASSLQSGVPSRF
SGSGSGTDFTLTISSLQPEDFATYYCQQSYSTSHTFGQGTKLEIKRTVAAPSVFIFPPSD
EQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLS
KADYEKHKVYACEVTHQGLSSPVTKSFNRGE
//
>1rzi_1B [b.1.1 - b.1.1] FAB 47E HEAVY CHAIN
QVQLLQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPVFGSANY
AQKFQGRVTITADEATSTTYMELSSLRSEDTAVYFCAKGGHGMDVWGQGTTVTVASASTK
GPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYS
LSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEP
//
>1rzoA [d.165.1] AGGLUTININ
KQYPIINFTTADATVESYTNFIRAVRSHLTTGADVRHEIPVLPNRVGLPISQRFILVELS
NHAELSVTLALDVTNAYVVGCRAGNSAYFFHPDNQEDAEAITHLFTDVQNSFTFAFGGNY
DRLEQLGGLRENIELGTGPLEDAISALYYYSTCGTQIPTLARSFMVCIQMISEAARFQYI
EGEMRTRIRYNRRSAPDPSVITLENSWGRLSTAIQESNQGAFASPIQLQRRNGSKFNVYD
VSILIPIIALMVYRCAPPP
//
>1rzoB [b.42.2 - b.42.2] AGGLUTININ
ADVCMDPEPIVRIVGRNGLCVDVTGEEFFDGNPIQLWPCKSNTDWNQLWTLRKDSTIRSN
GKCLTISKSSPRQQVVIYNCSTATVGATRWQIWDNRTIINPRSGLVLAATSGNSGTKLTV
QTNIYAVSQGWLPTNNTQPFVTTIVGLYGMCLQANSGKVWLEDCTSEKAEQQWALYADGS
IRPQQNRDNCLTTDANIKGTVVKILSCGPASSGQRWMFKNDGTILNLYNGLVLDVRRSDP
SLKQIIVHPFHGNLNQIWLPLF
//
>1rzr_2D [a.35.1 - c.93.1] GLUCOSE-RESISTANCE AMYLASE REGULATOR
MNVTIYDVAREASVSmATVSRVVNGNPNVKPSTRKKVLETIERLGYRPNAVARGLASKKT
TTVGVIIPDISNIFYAELARGIEDIATmYKYNIILSNSDQNQDKELHLLNNmLGKQVDGI
IFmSGNVTEEHVEELKKSPVPVVLAASIESTNQIPSVTIDYEQAAFDAVQSLIDSGHKNI
AFVSGTLEEPINHAKKVKGYKRALTESGLPVRDSYIVEGDYTYDSGIEAVEKLLEEDEKP
TAIFVGTDEmALGVIHGAQDRGLNVPNDLEIIGFDNTRLSTmVRPQLTSVVQPmYDIGAV
AmRLLTKYmNKETVDSSIVQLPHRIEFRQSTK
//
>1rzr_2Y (T) [d.94.1] PHOSPHOCARRIER PROTEIN HPR
AQKTFTVTADSGIHARPATTLVQAASKFDSDINLEFNGKTVNLKxIMGVMSLGIQKGATI
TISAEGSDEADALAALEDTMSKEGLGE
//
>1s1cA [c.37.1] TRANSFORMING PROTEIN RHOA
AIRKKLVIVGDGACGKTCLLIVFSKDQFPEVYVPTVFENYVADIEVDGKQVELALWDTAG
QEDYDRLRPLSYPDTDVILMCFSIDSPDSLENIPEKWTPEVKHFCPNVPIILVGNKKDLR
NDEHTRRELAKMKQEPVKPEEGRDMANRIGAFGYMECSAKTKDGVREVFEMATRAALQA
//
>1s1cY [h.1.27] RHO-ASSOCIATED, COILED-COIL CONTAINING PROTEIN
GSMLTKDIEILRRENEELTEKMKKAEEEYKLEKEEEISNLKAAFEKNINTERTLKTQAVN
KLAEIMNRKD
//
>1s1hB [i.1.1] 40S RIBOSOMAL PROTEIN S0-A
AQLLLAANTHLGARNVQVHQEPYVFNARPDGVHVINVGKTWEKLVLAARIIAAIPNPEDV
VAISSRTFGQRAVLKFAAHTGATPIAGRFTPGSFTNYITRSFKEPRLVIVTDPRSDAQAI
KEASYVNIPVIALTDLDSPSEFVDVAIPCNNRGKHSIGLIWYLLAREVLRLRGALVDRTQ
PWSIM
//
>1s1hD [i.1.1] 40S RIBOSOMAL PROTEIN S9-A
YESSRLDAELKLAGEFGLKNKKEIYRISFQLSKIRRAARDLLTRDEKDPKRLFEGNALIR
RLVRVGVLSEDKKKLDYVLALKVEDFLERRLQTQVYKLGLAKSVHHARVLITQRHIAVGK
QIVNIPSFMVRLDSEKHIDFAPTSPFGGARPGRVARRNAARKAEASGEAADEADEADE
//
>1s1hE [i.1.1] 40S RIBOSOMAL PROTEIN S2
GLQDEVMNIKPVQKQTRAGQRTRFKAVVVVGDSNGHVGLGIKTAKEVAGAIRAGIIIAKL
SVIPIRRGYWGTNLGQPHSLATKTTGKCGSVTVRLIPAPRGSGIVASPAVKKLLQLAGVE
DVYTQSNGKTRTLENTLKAAFVAIGNTYG
//
>1s1hH [i.1.1] 40S RIBOSOMAL PROTEIN S22
SSVLADALNAINNAEKTGKRQVLIRPSSKVIIKFLQVMQKHGYIGEFEYIDDHRSGKIVV
QLNGRLNKCGVISPRFNVKIGDIEKWTANLLPARQFGYVILTTSAGIMDHEEARRKHVSG
KILGFVY
//
>1s1hJ [i.1.1] 40S RIBOSOMAL PROTEIN S20
KIRITLTSTKVKQLENVSSNIVKNAEQHNLVKKGPVRLPTKVLKISTRKTPNGEGSKTWE
TYEMRIHKRYIDLEAPVQIVKRITQITIEPGVDVEVV
//
>1s1hM [i.1.1] 40S RIBOSOMAL PROTEIN S18
LRLLNTNVDGNIKIVYALTTIKGVGRRYSNLVCKKADVDLHKRAGELTQEELERIVQIMQ
NPTHYKIPAWFLNRQNDITDGKDYHTLANNVESKLRDDLERLKKIRAHRGIRHFWGLRVR
GQHTKTTGRRR
//
>1s1hN [i.1.1] 40S RIBOSOMAL PROTEIN S29-B
CRVCSSHTGLVRKYDLNICRQCFREKAND
//
>1s1hS [i.1.1] 40S RIBOSOMAL PROTEIN S15
RGMTSKPAGFMKKLRAAKLAAPENEKPAPVRTHMRNMIIVPEMIGSVVGIYNGKAFNQVE
IRPEMLGHYLGEFSITYTPV
//
>1s1iB [i.1.1] 60S RIBOSOMAL PROTEIN L2
GRVIRNQRKGAGSIFTSHTRLRQGAAKLRTLDYAERHGYIRGIVKQIVHDSGRGAPLAKV
VFRDPYKYRLREEIFIANEGVHTGQFIYAGKKASLNVGNVLPLGSVPEGTIVSNVEEKPG
DRGALARASGNYVIIIGHNPDENKTRVRLPSGAKKVISSDARGVIGVIAGGGRVDKPLLK
AGRAFHKYRLKRNSWPKTRGVAMNPVDHPHGGGNHQHIGKASTISRGAVSGQKAGLIAAR
RTGL
//
>1s1iC [i.1.1] 60S RIBOSOMAL PROTEIN L3
APRHGHLGFLPRKRAASIRARVKAFPKDDRSKPVALTSFLGYKAGMTTIVRDLDRPGSKF
HKREVVEAVTVVDTPPVVVVGVVGYVETPRGLRSLTTVWAEHLSDEVKRRFYKNWYKSKK
KAFTKYSAKYAQDGAGIERELARIKKYASVVRVLVHTQIRKTPLAQKKAHLAEIQLNGGS
ISEKVDWAREHFEKTVAVDSVFEQNEMIDAIAVTKGHGFEGVTHRWGTKKLPRKTHRGLR
KVACIGAWHPAHVMWSVARAGQRGYHSRTSINHKIYRVGKGDDEANGATSFDRTKKTITP
MGGFVHYGEIKNDFIMVKGCIPGNRKRIVTLRKSLYTNTSRKALEEVSLKWIDTASKFG
//
>1s1iG [i.1.1] 60S RIBOSOMAL PROTEIN L8-A
AAEKKERLTKEAAAVAEGKSKQDASPKPYAVKYGLNHVVALIENKKAKLVLIANDVDPIE
LVVFLPALCKKMGVPYAIVKGKARLGTLVNQKTSAVAALTEVRAEDEAALAKLVSTIDA
//
>1s1iH [i.1.1] 60S RIBOSOMAL PROTEIN L9-A
EQQIEVPEGVTVSIKSRIVKVVGPRGTLTKNLKHIDVTFTKVNNQLIKVAVHNGGRKHVA
ALRTVKSLVDNMITGVTKGYKYKMRYVYAHFPINVNIVEKDGAKFIEVRNFLGDKKIRNV
PVRDGVTIEFSTNVKDEIVLSGNSVEDVSQNAADLQQICRVRNKDIRKFLDGIYVSHK
//
>1s1iL [i.1.1] 60S RIBOSOMAL PROTEIN L15-A
AYKYLEELQRKKQSDVLRFLQRVRVWEYRQKNVIHRAARPTRPDKARRLGYKAKQGFVIY
RVRVRRGNRKRPVPKGATYGKPTNQGVNELKYQRSLRATAEERVGRRAANLRVLNSYWVN
QDSTYKYFEVILVDPQHKAIRRDARYNWICDPVHKHREARGLTATGKKSRGINKGHKFNN
TKAGRRKTWKRQNT
//
>1s1iM [i.1.1] 60S RIBOSOMAL PROTEIN L16-A
SVEPVVVIDGKGHLVGRLASVVAKQLLNGQKIVVVRAEELNISGEFFRNKLKYHDFLRKA
TAFNKTRGPFHFRAPSRIFYKALRGMVSHKTARGKAALERLKVFEGIPPPYDKKKRVVVP
QALRVLRLKPGRKYTTLGKLSTSVGW
//
>1s1iR [i.1.1] 60S RIBOSOMAL PROTEIN L23
QGTKFRISLGLPVGAIMNCADNSGARNLYIIAVKGSGSRLNRLPAASLGDMVMATVKKGK
PELRKKVMPAIVVRQAKSWRRRDGVFLYFEDNAGVIANPKGEMKGSAITGPVGKECADLW
PRVASNSGVVV
//
>1s1iS [i.1.1] 60S RIBOSOMAL PROTEIN L24-A
EIDSFSGAKIYPGRGTLFVRGDSKIFRFQNSKSASLFKQRKNPRRIAWTVLFR
//
>1s1i9 [i.1.1] 60S RIBOSOMAL PROTEIN L43
ITGKYGVRYGSSLRRQVKKLEIQQHARYDCSFCGKKTVKRGAAGIWTCSCCKKTVAGGAY
TVSTAAAATVRST
//
>1s1q_2C [d.20.1] TUMOR SUSCEPTIBILITY GENE 101 PROTEIN
SESQLKKmVSKYKYRDLTVRETVNVITLYKDLKPVLDSYVFNDGSSRELmNLTGTIPVPY
RGNTYNIPICLWLLDTYPYNPPICFVKPTSSmTIKTGKHVDANGKIYLPYLHEWKHPQSD
LLGLIQVmIVVFGDEPPVF
//
>1s1q_2D [d.15.1] UBIQUITIN
mQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYN
IQKESTLHLVLRLRGG
//
>1s3kL [b.1.1 - b.1.1] HU3S193 FAB FRAGMENT, LIGHT CHAIN
DIQMTQSPSSLSASVGDRVTITCRSSQRIVHSNGNTYLEWYQQTPGKAPKLLIYKVSNRF
SGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCFQGSHVPFTFGQGTKLQITRTVAAPSV
FIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSL
SSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNR
//
>1s3kH [b.1.1 - b.1.1] HU3S193 FAB FRAGMENT, HEAVY CHAIN
EVQLVESGGGVVQPGRSLRLSCSTSGFTFSDYYMYWVRQAPGKGLEWVAYMSNVGAITDY
PDTVKGRFTISRDNSKNTLFLQMDSLRPEDTGVYFCARGTRDGSWFAYWGQGTPVTVSSA
STKGPSVFPLAPGTAALGCLVKDYFPQPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSV
VTVPSSSLGTQTYICNVNHKPSNTKVDKKVEP
//
>1s3sB (A) [b.52.2 - d.31.1 - c.37.1] TRANSITIONAL ENDOPLASMIC RETICULUM ATPASE (TER
PNRLIVDEAINEDNSVVSLSQPKMDELQLFRGDTVLLKGKKRREAVCIVLSDDTCSDEKI
RMNRVVRNNLRVRLGDVISIQPCPDVKYGKRIHVLPIDDTVEGITGNLFEVYLKPYFLEA
YRPIRKGDIFLVRGGMRAVEFKVVETDPSPYCIVAPDTVIHCEGEPIKREDEEESLNEVG
YDDVGGCRKQLAQIKEMVELPLRHPALFKAIGVKPPRGILLYGPPGTGKTLIARAVANET
GAFFFLINGPEIMSKLAGESESNLRKAFEEAEKNAPAIIFIDELDAIAPKREKTHGEVER
RIVSQLLTLMDGLKQRAHVIVMAATNRPNSIDPALRRFGRFDREVDIGIPDATGRLEILQ
IHTKNMKLADDVDLEQVANETHGHVGADLAALCSEAALQAIRKKMDLIDLEDETIDAEVM
NSLAVTMDDFRWALSQ
//
>1s3sF [b.52.2 - d.31.1 - c.37.1] TRANSITIONAL ENDOPLASMIC RETICULUM ATPASE (TER
KQKNRPNRLIVDEAINEDNSVVSLSQPKMDELQLFRGDTVLLKGKKRREAVCIVLSDDTC
SDEKIRMNRVVRNNLRVRLGDVISIQPCPDVKYGKRIHVLPIDDTVEGITGNLFEVYLKP
YFLEAYRPIRKGDIFLVRGGMRAVEFKVVETDPSPYCIVAPDTVIHCEGEPIKREDEEES
LNEVGYDDVGGCRKQLAQIKEMVELPLRHPALFKAIGVKPPRGILLYGPPGTGKTLIARA
VANETGAFFFLINGPEIMSKLAGESESNLRKAFEEAEKNAPAIIFIDELDAIAPKREKTH
GEVERRIVSQLLTLMDGLKQRAHVIVMAATNRPNSIDPALRRFGRFDREVDIGIPDATGR
LEILQIHTKNMKLADDVDLEQVANETHGHVGADLAALCSEAALQAIRKKMDLIDLEDETI
DAEVMNSLAVTMDDFRWALSQ
//
>1s3sG [d.15.1] P47 PROTEIN
FTGEGQKLGSTAPQVLNTSSPAQQAENEAKASSSILINEAEPTTNIQIRLADGGRLVQKF
NHSHRISDIRLFIVDARPAMAATSFVLMTTFPNKELADENQTLKEANLLNAVIVQRLT
//
>1s3sH [d.15.1] P47 PROTEIN
GQKLGSTAPPAQQAENEAKASSSILINEAEPTTNIQIRLADGGRLVQKFNHSHRISDIRL
FIVDARPAMAATSFVLMTTFPNKELADENQTLKEANLLNAVIVQRLT
//
>1s4yA [g.7.1] ACTIVIN RECEPTOR TYPE IIB PRECURSOR
RECIYYNANWELERTNQSGLERCEGEQDKRLHCYASWRNSSGTIELVKKGCWLDDFNCYD
RQECVATEENPQVYFCCCEGNFCNERFTHLP
//
>1s4yB [g.17.1] INHIBIN BETA A CHAIN
GLECDVNICCKKQFFVSFKDIGWNDWIIAPSGYHANYCEGECPSHIAGTSGSSLSFHSTV
INHYRMRPFANLKSCCVPTKLRPMSMLYYDDGQNIIKKDIQNMIVEECGCS
//
>1s4yC [g.7.1] ACTIVIN RECEPTOR TYPE IIB PRECURSOR
TRECIYYNANWELERTNQSGLERCEGEQDKRLHCYASWRNSSGTIELVKKGCWLDDFNCY
DRQECVATEENPQVYFCCCEGNFCNERFTHLPEPG
//
>1s4yD [g.17.1] INHIBIN BETA A CHAIN
CDGKVNICCKKQFFVSFKDIGWNDWIIAPSGYHANYCEGECPSHIAFHSTVINHYRMRGC
CVPTKLRPMSMLYYDDGQNIIKKDIQNMIVEECGCS
//
>1s5cA [d.166.1] CHOLERA ENTEROTOXIN, A CHAIN
NDDKLYRADSRPPDEIKQSGGLMPRMNINLYDHARGTQGFVRHDDGYVSTSISLRSAHLV
GQTILSGHSTYYIYVIATAPNMFNVNDVLGAYSPHPDEQEVSALGGIPYSQIYGWYRVHF
GVLDEQLHRNRGYRDRYYSNLDIAPAADGYGLAGFPPEHRAWREEPWIHHAPPGCGNSNT
CDEKTQSLGVKFLDEYQSKVKRQIFSGYQSDIDTHN
//
>1s5cF (D) [b.40.2] CHOLERA ENTEROTOXIN B-SUBUNIT
TPQNITDLCAEYHNTQIHTLNDKIFSYTESLAGKREMAIITFKNGATFQVEVPGSQHIDS
QKKAIERMKDTLRIAYLTEAKVEKLCVWNNKTPHAIAAISMAN
//
>1s5l_1C [i.5.1] PHOTOSYSTEM II CP43 PROTEIN
WAGNARLINLSGKLLGAHVAHAGLIVFWAGAMTLFELAHFIPEKPMYEQGLILIPHIATL
GWGVGPGGEVVDTFPFFVVGVVHLISSAVLGFGGVYHAIRGPETLEEYSSFFGYDWKDKN
KMTTILGFHLIVLGIGALLLVAKAMFFGGLYDTWAPGGGDVRVITNPTLDPRVIFGYLLK
SPFGGEGWIVSVNNLEDVVGGHIWIGLICIAGGIWHILTTPFGWARRAFIWSGEAYLSYS
LGALSMMGFIATCFVWFNNTVYPSEFYGPTGPEASQAQAMTFLIRDQKLGANVGSAQGPT
GLGKYLMRSPTGEIIFGGETMRFWDFRGPWLEPLRGPNGLDLNKIKNDIQPWQERRAAEY
MTHAPLGSLNSVGGVATEINSVNFVSPRSWLATSHFVLAFFFLVGHLWHAGRARAAAAGF
E
//
>1s5l_1U [a.60.12] PHOTOSYSTEM II 12 KDA EXTRINSIC PROTEIN
AATASTEEELVNVVDEKLGTAYGEKIDLNNTNIAAFIQYRGLYPTLAKLIVKNAPYESVE
DVLNIPGLTERQKQILRENLEHFTVTEVETALVEGGDRYNNGLYK
//
>1s5l_2d (D) [i.5.1] PHOTOSYSTEM II REACTION CENTER D2 PROTEIN
WFDILDDWLKRDRFVFVGWSGILLFPCAYLALGGWLTGTTFVTSWYTHGLASSYLEGCNF
LTVAVSTPANSMGHSLLLLWGPEAQGDFTRWCQLGGLWTFIALHGAFGLIGFMLRQFEIA
RLVGVRPYNAIAFSAPIAVFVSVFLIYPLGQSSWFFAPSFGVAAIFRFLLFFQGFHNWTL
NPFHMMGVAGVLGGALLCAIHGATVENTLFQDGEGASTFRAFNPTQAEETYSMVTANRFW
SQIFGIAFSNKRWLHFFMLFVPVTGLWMSAIGVVGLALNLRSYDFISQEIRAAEDPEFET
FYTKNLLLNEGIRAWMAPQDQPHENFVFPEEVLPRGNAL
//
>1s5l_2f (F) [i.5.1] CYTOCHROME B559 BETA SUBUNIT
YPIFTVRWVAVHTLAVPTIFFLGAIAAMQFIQR
//
>1s5l_2l (L) [f.23.31] PHOTOSYSTEM II REACTION CENTER L PROTEIN
MEPNPNRQPVELNRTSLYLGLLLILVLALLFSSYFFN
//
>1s6cA [a.39.1] KV4 POTASSIUM CHANNEL-INTERACTING PROTEIN
LEQLEAQTNFTKRELQVLYRGFKNExPSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAF
DTTQTGSVKFEDFVTALSILLRGTVHEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMM
GPRQHVDVFFQKMDKNKDGIVTLDEFLESxQEDDNIMRSLQLFQNVM
//
>1s6cB [x.x.x] POTASSIUM VOLTAGE-GATED CHANNEL SUBFAMILY D
MAAGVAAWLPFARAAAIGWMP
//
>1s6v_2C (A) [a.93.1] CYTOCHROME C PEROXIDASE, MITOCHONDRIAL
TTPLVHVASVEKGRSYEDFQKVYNAIALKLREDDEYDNYIGYGPVLVRLAWHTSGTWDKH
DNTGGSYGGTYRFKKEFNDPSNAGLQNGFKFLEPIHKEFPWISSGDLFSLGGVTAVQEMQ
GPKIPWRAGRVDTPEDTTPDNGRLPDADKDADYVRTFFQRLNMNDREVVALMGAHALGKT
HLKNSGYEGPWGAANNCFTNEFYLNLLNEDWKLEKNDANNEQWDSKSGYMMLPTDYSLIQ
DPKYLSIVKEYANDQDKFFKDFSKAFEKLLENGITFPKDAPSPFIFKTLEEQGL
//
>1s6v_2D (B) [a.3.1] CYTOCHROME C, ISO-1
AEFKAGSAKKGATLFKTRCLQCHTVEKGGPHKVGPNLHGIFGRHSGQAEGYSYTDANIKK
NVLWDENNMSEYLTNPKKYIPGTKMCFGGLKKEKDRNDLITYLKKATE
//
>1s70A [d.159.1] SERINE/THREONINE PROTEIN PHOSPHATASE PP1-BETA
HMADGELNVDSLITRLLEVRGCRPGKIVQMTEAEVRGLCIKSREIFLSQPILLELEAPLK
ICGDIHGQYTDLLRLFEYGGFPPEANYLFLGDYVDRGKQSLETICLLLAYKIKYPENFFL
LRGNHECASINRIYGFYDECKRRFNIKLWKTFTDCFNCLPIAAIVDEKIFCCHGGLSPDL
QSMEQIRRIMRPTDVPDTGLLCDLLWSDPDKDVQGWGENDRGVSFTFGADVVSKFLNRHD
LDLICRAHQVVEDGYEFFAKRQLVTLFSAPNYCGEFDNAGGMMSVDETLMCSFQILKPSE
KKAKYQYGG
//
>1s70B [d.211.1] 130 KDA MYOSIN-BINDING SUBUNIT OF SMOOTH MUSCLE
MKMADAKQKRNEQLKRWIGSETDLEPPVVKRKKTKVKFDDGAVFLAACSSGDTEEVLRLL
ERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCGYLD
IAEYLISQGAHVGAVNSEGDTPLDIAEEEAMEELLQNEVNRQGVDIEAARKEEERIMLRD
ARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAA
HWGKEEACRILVENLCDMEAVNKVGQTAFDVADEDILGYLEELQKKQNLLH
//
>1s78_1A [c.10.2 - g.3.9 - c.10.2 - g.3.9] RECEPTOR PROTEIN-TYROSINE KINASE ERBB-2
TQVCTGTDMKLRLPASPETHLDMLRHLYQGCQVVQGNLELTYLPTNASLSFLQDIQEVQG
YVLIAHNQVRQVPLQRLRIVRGTQLFEDNYALAVLDNGDPLSPGGLRELQLRSLTEILKG
GVLIQRNPQLCYQDTILWKDIFHKNNQLALTLIDTNRSRACHPCSPMCKGSRCWGESSED
CQSLTRTVCAGGCARCKGPLPTDCCHEQCAAGCTGPKHSDCLACLHFNHSGICELHCPAL
VTYNTDTFESMPNPEGRYTFGASCVTACPYNYLSTDVGSCTLVCPLHNQEVTAEDGTQRC
EKCSKPCARVCYGLGMEHLREVRAVTSANIQEFAGCKKIFGSLAFLPESFDGDPASNTAP
LQPEQLQVFETLEEITGYLYISAWPDSLPDLSVFQNLQVIRGRILHNGAYSLTLQGLGIS
WLGLRSLRELGSGLALIHHNTHLCFVHTVPWDQLFRNPHQALLHTANRPEDECVGEGLAC
HQLCARGHCWGPGPTQCVNCSQFLRGQECVEECRVLQGLPREYVNARHCLPCHPECQPQN
GSVTCFGPEADQCVA
//
>1s78_1D [b.1.1 - b.1.1] PERTUZUMAB FAB HEAVY CHAIN
EVQLVESGGGLVQPGGSLRLSCAASGFTFTDYTMDWVRQAPGKGLEWVADVNPNSGGSIY
NQRFKGRFTLSVDRSKNTLYLQMNSLRAEDTAVYYCARNLGPSFYFDYWGQGTLVTVSSA
STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG
LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC
//
>1s78_1B (C) [b.1.1 - b.1.1] PERTUZUMAB FAB LIGHT CHAIN
DIQMTQSPSSLSASVGDRVTITCKASQDVSIGVAWYQQKPGKAPKLLIYSASYRYTGVPS
RFSGSGSGTDFTLTISSLQPEDFATYYCQQYYIYPYTFGQGTKVEIKRTVAAPSVFIFPP
SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT
LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
//
>1s78_2B [c.10.2 - g.3.9 - c.10.2 - g.3.9] RECEPTOR PROTEIN-TYROSINE KINASE ERBB-2
TQVCTGTDMKLRLPASPETHLDMLRHLYQGCQVVQGNLELTYLPTNASLSFLQDIQEVQG
YVLIAHNQVRQVPLQRLRIVRGTQLFEDNYALAVLDNGDPLSPGGLRELQLRSLTEILKG
GVLIQRNPQLCYQDTILWKDIFHKNNQLALTLIDTNRSRACHPCSPMCKGSRCWGESSED
CQSLTRTVCAGGCARCKGPLPTDCCHEQCAAGCTGPKHSDCLACLHFNHSGICELHCPAL
VTYNTDTFESMPNPEGRYTFGASCVTACPYNYLSTDVGSCTLVCPLHNQEVTAEDGTQRC
EKCSKPCARVCYGLGMEHLREVRAVTSANIQEFAGCKKIFGSLAFLPESFDGDPASNTAP
LQPEQLQVFETLEEITGYLYISAWPDSLPDLSVFQNLQVIRGRILHNGAYSLTLQGLGIS
WLGLRSLRELGSGLALIHHNTHLCFVHTVPWDQLFRNPHQALLHTANRPEDECVGEGLAC
HQLCARGHCWGPGPTQCVNCSQFLRGQECVEECRVLQGLPREYVNARHCLPCHPECQPQN
GSVTCFGPEADQCVACAHYKDPPFCVAR
//
>1s78_2F (D) [b.1.1 - b.1.1] PERTUZUMAB FAB HEAVY CHAIN
EVQLVESGGGLVQPGGSLRLSCAASGFTFTDYTMDWVRQAPGKGLEWVADVNPNSGGSIY
NQRFKGRFTLSVDRSKNTLYLQMNSLRAEDTAVYYCARNLGPSFYFDYWGQGTLVTVSSA
STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG
LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC
//
>1s78_2A (C) [b.1.1 - b.1.1] PERTUZUMAB FAB LIGHT CHAIN
DIQMTQSPSSLSASVGDRVTITCKASQDVSIGVAWYQQKPGKAPKLLIYSASYRYTGVPS
RFSGSGSGTDFTLTISSLQPEDFATYYCQQYYIYPYTFGQGTKVEIKRTVAAPSVFIFPP
SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT
LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
//
>1s7u_2D [d.19.1 - b.1.1] H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, D-B
GPHSMRYFETAVSRPGLEEPRYISVGYVDNKEFVRFDSDAENPRYEPRAPWMEQEGPEYW
ERETQKAKGQEQWFRVSLRNLLGYYNQSAGGSHTLQQMSGCDLGSDWRLLRGYLQFAYEG
RDYIALNEDLKTWTAADMAAQITRRKWEQSGAAEHYKAYLEGECVEWLHRYLKNGNATLL
RTDSPKAHVTHHPRSKGEVTLRCWALGFYPADITLTWQLNGEELTQDMELVETRPAGDGT
FQKWASVVVPLGKEQNYTCRVYHEGLPEPLTLRW
//
>1s7u_2E (B) [b.1.1] BETA-2-MICROGLOBULIN
IQKTPQIQVYSRHPPENGKPNILNCYVTQFHPPHIEIQMLKNGKKIPKVEMSDMSFSKDW
SFYILAHTEFTPTETDTYACRVKHDSMAEPKTVYWDRDM
//
>1s7u_3G (D) [d.19.1 - b.1.1] H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, D-B
GPHSMRYFETAVSRPGLEEPRYISVGYVDNKEFVRFDSDAENPRYEPRAPWMEQEGPEYW
ERETQKAKGQEQWFRVSLRNLLGYYNQSAGGSHTLQQMSGCDLGSDWRLLRGYLQFAYEG
RDYIALNEDLKTWTAADMAAQITRRKWEQSGAAEHYKAYLEGECVEWLHRYLKNGNATLL
RTDSPKAHVTHHPRSKGEVTLRCWALGFYPADITLTWQLNGEELTQDMELVETRPAGDGT
FQKWASVVVPLGKEQNYTCRVYHEGLPEPLTLRW
//
>1s7u_3H (B) [b.1.1] BETA-2-MICROGLOBULIN
IQKTPQIQVYSRHPPENGKPNILNCYVTQFHPPHIEIQMLKNGKKIPKVEMSDMSFSKDW
SFYILAHTEFTPTETDTYACRVKHDSMAEPKTVYWDRDM
//
>1s9v_1A [d.19.1 - b.1.1] HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DQ(3)
VADHVASYGVNLYQSYGPSGQYTHEFDGDEQFYVDLGRKETVWCLPVLRQFRFDPQFALT
NIAVLKHNLNSLIKRSNSTAATNEVPEVTVFSKSPVTLGQPNILICLVDNIFPPVVNITW
LSNGHSVTEGVSETSFLSKSDHSFFKISYLTLLPSAEESYDCKVEHWGLDKPLLKHWEP
//
>1s9v_1B [d.19.1 - b.1.1] HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DQ(1)
SPEDFVYQFKGMCYFTNGTERVRLVSRSIYNREEIVRFDSDVGEFRAVTLLGLPAAEYWN
SQKDILERKRAAVDRVCRHNYQLELRTTLQRRVEPTVTISPSRNLLVCSVTDFYPAQIKV
RWFRNDQEETAGVVSTPLIRNGDWTFQILVMLEMTPQRGDVYTCHVEHPSLQSPITVEWR
A
//
>1sa0E [a.137.10] STATHMIN 4
ADMEVIELNKCTSGQSFEVILKPPSFDPSLEEIQKKLEAAEERRKYQEAELLKHLAEKRE
HEREVIQKAIEENNNFIKMAKEKLAQKMESNKENREAHLAAMLERLQEKDKHAEEVRKNK
ELKE
//
>1sa0D (B) [c.32.1 - d.79.2] TUBULIN BETA CHAIN
REIVHIQAGQCGNQIGAKFWEVISDEHGIDPTGSYHGDSDLQLERINVYYNEAAGNKYVP
RAILVDLEPGTMDSVRSGPFGQIFRPDNFVFGQSGAGNNWAKGHYTEGAELVDSVLDVVR
KESESCDCLQGFQLTHSLGGGTGSGMGTLLISKIREEYPDRIMNTFSVVPSPKVSDTVVE
PYNATLSVHQLVENTDETYCIDNEALYDICFRTLKLTTPTYGDLNHLVSATMSGVTTCLR
FPGQLNADLRKLAVNMVPFPRLHFFMPGFAPLTSLTVPELTQQMFDAKNMMAACDPRHGR
YLTVAAVFRGRMSMKEVDEQMLNVQNKNSSYFVEWIPNNVKTAVCDIPPRGLKMSATFIG
NSTAIQELFKRISEQFTAMFRRKAFLHWYTGEGMDEMEFTEAESNMNDLVSEYQQYQDA
//
>1sa1A [c.32.1 - d.79.2] TUBULIN ALPHA CHAIN
RECISIHVGQAGVQIGNACWELYCLEHGIQPDGQMPSDGDDSFNTFFSETGAGKHVPRAV
FVDLEPTVIDEVRTGTYRQLFHPEQLITGKEDAANNYARGHYTIGKEIIDLVLDRIRKLA
DQCTGLQGFSVFHSFGGGTGSGFTSLLMERLSVDYGKKSKLEFSIYPAPQVSTAVVEPYN
SILTTHTTLEHSDCAFMVDNEAIYDICRRNLDIERPTYTNLNRLIGQIVSSITASLRFDG
ALNVDLTEFQTNLVPYPRIHFPLATYAPVISAEKAYHEQLSVAEITNACFEPANQMVKCD
PRHGKYMACCLLYRGDVVPKDVNAAIATIKTKRTIQFVDWCPTGFKVGINYEPPTVVPGG
DLAKVQRAVCMLSNTTAIAEAWARLDHKFDLMYAKRAFVHWYVGEGMEEGEFSEAREDMA
ALEKDYEEVGVDS
//
>1sa1B [c.32.1 - d.79.2] TUBULIN BETA CHAIN
REIVHIQAGQCGNQIGAKFWEVISDEHGIDPTGSYHGDSDLQLERINVYYNEAAGNKYVP
RAILVDLEPGTMDSVRSGPFGQIFRPDNFVFGQSGAGNNWAKGHYTEGAELVDSVLDVVR
KESESCDCLQGFQLTHSLGGGTGSGMGTLLISKIREEYPDRIMNTFSVVPSPKVSDTVVE
PYNATLSVHQLVENTDETYCIDNEALYDICFRTLKLTTPTYGDLNHLVSATMSGVTTCLR
FPGQLNADLRKLAVNMVPFPRLHFFMPGFAPLTQYRALTVPELTQQMFDAKNMMAACDPR
HGRYLTVAAVFRGRMSMKEVDEQMLNVQNKNSSYFVEWIPNNVKTAVCDIPPRGLKMSAT
FIGNSTAIQELFKRISEQFTAMFRRKAFLHWYTGEGMDEMEFTEAESNMNDLVSEYQQYQ
DA
//
>1sa1E [a.137.10] STATHMIN 4
MEVIELNKCTSGQSFEVILKPPSFDGVPEFNASLPRRPSLEEIQKKLEAAEERRKYQEAE
LLKHLAEKREHEREVIQKAIEENNNFIKMAKEKLAQKMESNKENREAHLAAMLERLQEKD
KHAEEVRKNKELKE
//
>1sb3B [d.145.1 - d.87.2] 4-HYDROXYBENZOYL-COA REDUCTASE BETA SUBUNIT
MNILTDFRTHRPATLADAVNALAAEATLPLGAGTDLLPNLRRGLGHPAALVDLTGIDGLA
TISTLADGSLRIGAGATLEAIAEHDAIRTTWPALAQAAESVAGPTHRAAATLGGNLCQDT
RCTFYNQSEWWRSGNGYCLKYKGDKCHVIVKSDRCYATYHGDVAPALMVLDARAEIVGPA
GKRTVPVAQLFRESGAEHLTLEKGELLAAIEVPPTGAWSAAYSKVRIRDAVDFPLAGVAA
ALQRDGDRIAGLRVAITGSNSAPLMVPVDALLGGNWDDAAAETLAQLVRKTSNVLRTTIT
GVKYRRRVLLAISRKVVDQLWEA
//
>1sb3C [d.15.4 - a.56.1] 4-HYDROXYBENZOYL-COA REDUCTASE GAMMA SUBUNIT
MKNILRLTLNGRAREDLVPDNMLLLDYLRETVGLTGTKQGCDGGECGACTVLVDDRPRLA
CSTLAHQVAGKKVETVESLATQGTLSKLQAAFHEKLGTQCGFCTPGMIMASEALLRKNPS
PSRDEIKAALAGNLCRCTGYVKIIKSVETAAAARLCEEGAR
//
>1sbbC (A) [b.1.1 - b.1.1] PROTEIN (14.3.D T CELL ANTIGEN RECEPTOR)
AVTQSPRNKVAVTGGKVTLSCQQTNNHNNMYWYRQDTGHGLRLIHYSYGAGSTEKGDIPD
GYKASRPSQEQFSLILELATPSQTSVYFCASGGGRGSYAEQFFGPGTRLTVLEDLRQVTP
PKVSLFEPSKAEIANKQKATLVCLARGFFPDHVELSWWVNGKEVHSGVSTDPQAYKESNY
SYCLSSRLRVSATFWHNPRNHFRCQVQFHGLSEEDKWPEGSPKPVTQNISAEAWGRAD
//
>1sbbD [b.40.2 - d.15.6] PROTEIN (STAPHYLOCOCCAL ENTEROTOXIN B)
ESQPDPKPDELHKSSKFTGLMENMKVLYDDNHVSAINVKSIDQFLYFDLIYSIKDTKLGN
YDNVRVEFKNKDLADKYKDKYVDVFGANYYYQCYFSKKTSHQTDKRKTCMYGGVTEHNGN
QLDKYRSITVRVFEDGKNLLSFDVQTNKKKVTAQELDYLTRHYLVKNKKLYEFNNSPYET
GYIKFIENENSFWYDMMPAPGDKFDQSKYLMMYNDNKMVDSKDVKIEVYLTTKKK
//
>1sbnE [c.41.1] SUBTILISIN NOVO BPN'
AQSVPYGVSQIKAPALHSQGYTGSNVKVAVIDSGIDSSHPDLKVAGGASMVPSETNPFQD
NNSHGTHVAGTVAALNNSIGVLGVAPSASLYAVKVLGADGSGQYSWIINGIEWAIANNMD
VINMSLGGPSGSAALKAAVDKAVASGVVVVAAAGNEGTSGSSSTVGYPGKYPSVIAVGAV
DSSNQRASFSSVGPELDVMAPGVSIQSTLPGNKYGAYNGTSMASPHVAGAAALILSKHPN
WTNTQVRSSLENTTTKLGDSFYYGKGLINVQAAAQ
//
>1sbnI [d.40.1] EGLIN C
KSFPEVVGKTVDQAREYFTLHYPQYNVYFLPEGSPVTRDLRYNRVRVFYNPGTNVVNHVP
HVG
//
>1sbsA (H) [b.1.1 - b.1.1] MONOCLONAL ANTIBODY 3A2
EVNLEESGGGLVQPGGSMKLSCVASGFTFSNYWMNWVRQSPEKGLEWVADIRLKSNNYAT
LYAESVKGRFTISRDDSKSSVYLQMNNLRAEDTGIYYCTRGAYYRYDYAMDYWGQGTSVT
VSSAKTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVL
QSDLYTLSSSVTVPSSPRPSETVTCNVAHPASSTKVDKKIVP
//
>1sbsB (L) [b.1.1 - b.1.1] MONOCLONAL ANTIBODY 3A2
DIVMSQSPSSLAVSVGEKVTMTCKSSQSLLYSSNQMNYLAWYQQKPGQSPKLLIYWASTR
ESGVPDRFTGSGSGTDFTLTISSVEAEDLAVYYCQQYHSYPFTFGSGTKLEIKRADAAPT
VSIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYS
MSSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1sc4A [c.17.1] INTERLEUKIN-1 BETA CONVERTASE
NVKLCSLEEAQRIWKQKSAEIYPIMDKSSRTRLALIICNEEFDSIPRRTGAEVDITGMTM
LLQNLGYSVDVKKNLTASDMTTELEAFAHRPEHKTSDSTFLVFMSHGIREGICGKKHSEQ
VPDILQLNAIFNMLNTKNCPSLKDKPKVIIIQAARGDSPGVVWFKD
//
>1sc4B [c.17.1] INTERLEUKIN-1 BETA CONVERTASE
AIKKAHIEKDFIAFCSSTPDNGSVFIGRLIEHMQEYACSCDVEEIFRKVRFSFEQPDGRA
QMPTTERVTLTRCFYLFPGH
//
>1scjA [c.41.1] SUBTILISIN E
AQSVPYGISQIKAPALHSQGYTGSNVKVAVIDSGIDSSHPDLNVRGGASFVPSETNPYQD
GSSHGTHVAGTIAALNNSIGVLGVSPSASLYAVKVLDSTGSGQYSWIINGIEWAISNNMD
VINMSLGGPTGSTALKTVVDKAVSSGIVVAAAAGNEGSSGSTSTVGYPAKYPSTIAVGAV
NSSNQRASFSSAGSELDVMAPGVSIQSTLPGGTYGAYNGTCMATPHVAGAAALILSKHPT
WTNAQVRDRLESTATYLGNSFYYGKGLINVQAAAQ
//
>1scjB [d.58.3] SUBTILISIN E
EKKYIVGFKQTMSAMSSAKKKDVISQKGGKVEKQFKYVNAAAATLDEKAVKELKKDPSVA
YVEEDHIAHEY
//
>1scmA [x.x.x] MYOSIN HEAVY CHAIN
RLSKIISMFQAHIRGYLIRKAYKKLQDQRIGLSVIQRNIRKWLVLRNWQWWKLYSKVKPL
//
>1scmB [a.39.1] MYOSIN REGULATORY LIGHT CHAIN
LPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLKEAPGPLNFTM
FLSIFSDKLSGTDSEETIRNAFAMFDEQETKKLNIEYIKDLLENMGDNFNKDEMRMTFKE
APVEGGKFDYVKFTAMIK
//
>1sddA [b.6.1 - b.6.1] COAGULATION FACTOR V
AKLRQFYVAAQSIRWNTSFKKIVYREYEAYFQKEKPQSRTSGLLGPTLYAEVGDIMKVHF
KNKAHKPLSIHAQGIKYSKFSEGASYSDHTLPMEKMDDAVAPGQEYTYEWIISEHSGPTH
DDPPCLTHIYYSYVNLVEDFNSGLIGPLLICKKGTLTEDGTQKMFEKQHVLMFAVFDESK
SWNQTSSLMYTVNGYVNGTMPDITVCAHLIGMSSGPELFSIHFNGQVLEQNHHKISAITL
VSATSTTGRWTIASLIPRHFQAGMQAYI
//
>1sddB [b.6.1 - b.6.1 - b.18.1 - b.18.1] COAGULATION FACTOR V
NTGNRKYYYIAAEEISWDYSKFVPEDTVYKKVVFRKYLDSTFTKLDPQGEYEEHLGILGP
VIRAEVDDVIQVRFKNLASRPYSLHAHGLSNAIQPNKTYTYVWHATTRSGPENPGSACRA
WAYYSAVNPEKDIHSGLIGPLLICRKGTLDKETNMPVDMREFVLLFMVFDEKKSWYYDNS
HEFHAINGMIYNLPGLRMYEQEWVRLHLLNLGGSRDIHVVHFHGQTLLENGTQQHQLGVW
PLLPGSFKTLEMKASKPGWWLLDTEVGEIQRAGMQTPFLIVDRECKMPMGLSTGLIADSQ
IQASEFWGYWEPKLARLNNGGSYNAWIAEKLSTEFNPEPWIQVDMQKEVLLTGIQTQGAK
HYLKPYYTTEFCVAYSLDRKNWRIFKGNSTRNVMYFGGNSDASTIKENQIDPPVVARYIR
ISPTGSYNKPALRLELQGCEVNGCSTPLGMESGKIENKQITASSFKKSWWGNYWEPFLAR
LNAQGRVNAWQAKANNNNQWLQIDLLKIKKITAIVTQGCKSLSSEMYVKSYTIHYSDQGT
DWKPYREKSSMVDKIFEGNNNVRGHVKNFFNPPIISRFIRIIPKTWNQSIALRLELFGCD
M
//
>1sebE (A) [d.19.1 - b.1.1] HLA CLASS II HISTOCOMPATIBILITY ANTIGEN
IKEEHVIIQAEFYLNPDQSGEFMFDFDGDEIFHVDMAKKETVWRLEEFGRFASFEAQGAL
ANIAVDKANLEIMTKRSNYTPITNVPPEVTVLTNSPVELREPNVLICFIDKFTPPVVNVT
WLRNGKPVTTGVSETVFLPREDHLFRKFHYLPFLPSTEDVYDCRVEHWGLDEPLLKHWEF
D
//
>1sebH (D) [b.40.2 - d.15.6] ENTEROTOXIN TYPE B
SQPDPKPDELHKSSKFTGLMENMKVLYDDNHVSAINVKSIDQFLYFDLIYSIKDTYDNVR
VEFKNKDLADKYKDKYVDVFGANYYYQCYFSKKKTCMYGGVTEHDKYRSITVRVFEDGKN
LLSFDVQTNKKKVTAQELDYLTRHYLVKNKKLYETGYIKFIENENSFWYDMMPAPGDKFD
QSKYLMMYNDNKMVDSKDVKIEVYLT
//
>1seqL [b.1.1 - b.1.1] MONOCLONAL ANTIBODY MNAC13
DIVLTQSPAIMSASLGSSVTLTCSASSSVSYMHWYQQKSGTSPVLLIYTTSNLASGVPSR
FSGSGSGTFYSLTISSVEASDAADYYCHQWSSYPWTFGGGTKLEIKRADAAPTVSIFPPS
SEQLTSGGASVVCFLNNFYPKSINSKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLTL
TKNEYERHNSYTCEATHKSPIVKSFNRS
//
>1seqH [b.1.1 - b.1.1] MONOCLONAL ANTIBODY MNAC13
EVKLVESGGGLVQPGGSLKLSCAASGFTFSTYTMSWARQTPEKKLEWVAYISKGGGSTYY
PDTVKGRFTISRDNAKNTLYLQMSSLKSEDTALYYCARGAMFGNDFKYPMDRWGQGTSVT
VSSAATTPPSVYPLAPGSQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLKS
DLYTLSSSVTVPSSVWPSETVTCNVAHPASSTTVDKKIVPR
//
>1sfcA [h.1.15] PROTEIN (SYNAPTOBREVIN 2)
NLTSNRRLQQTQAQVDEVVDIMRVNVDKVLERDQKLSELDDRADALQAGASQFETSAAKL
KRKYWWKNL
//
>1sfcB [h.1.15] PROTEIN (SYNTAXIN 1A)
SKQALSEIETRHSEIIKLENSIRELHDMFMDMAMLVESQGEMIDRIEYNVEHAVDYVERA
VSDTKKAVKYQS
//
>1sfcC [h.1.15] PROTEIN (SNAP-25B)
MRNELEEMQRRADQLADESLESTRRMLQLVEESKDAGIRTLVMLDEQGEQLDRVEEGMNH
INQDMKEAEKNLKDLGK
//
>1sfcD [h.1.15] PROTEIN (SNAP-25B)
GGFIRRVTNDARENEMDENLEQVSGIIGNLRHMALDMGNEIDTQNRQIDRIMEKADSNKT
RIDEANQRATKMLG
//
>1sfcI [h.1.15] PROTEIN (SYNAPTOBREVIN 2)
LTSNRRLQQTQAQVDEVVDIMRVNVDKVLERDQKLSELDDRADALQAGASQFETSAAKLK
RKYWWKNLK
//
>1sfcJ [h.1.15] PROTEIN (SYNTAXIN 1A)
SISKQALSEIETRHSEIIKLENSIRELHDMFMDMAMLVESQGEMIDRIEYNVEHAVDYVE
RAVSDTKKAVKYQS
//
>1sfcE [h.1.15] PROTEIN (SYNAPTOBREVIN 2)
SNRRLQQTQAQVDEVVDIMRVNVDKVLERDQKLSELDDRADALQAGASQFETSAAKLKRK
YWWKNLKMM
//
>1sfcF [h.1.15] PROTEIN (SYNTAXIN 1A)
KQALSEIETRHSEIIKLENSIRELHDMFMDMAMLVESQGEMIDRIEYNVEHAVDYVERAV
SDTKKAVKYQSKA
//
>1sfcK [h.1.15] PROTEIN (SNAP-25B)
LEEMQRRADQLADESLESTRRMLQLVEESKDAGIRTLVMLDEQGEQLDRVEEGMNHINQD
MKEAEKNLKDLGK
//
>1sg1A [g.17.1] BETA-NERVE GROWTH FACTOR
EFSVCDSVSVWVGDKTTATDIKGKEVMVLGEVNINNSVFKQYFFETKCRDGCRGIDSKHW
NSYCTTTHTFVKALTMDGKQAAWRFIRIDTACVCVLSRK
//
>1sg1X [g.24.1 - g.24.1 - g.24.1 - g.24.1] TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY
ETCSTGLYTHSGECCKACNLGEGVAQPCGANQTVCEPCLDNVTFSDVVSATEPCKPCTEC
LGLQSMSAPCVEADDAVCRCAYGYYQDEETGHCEACSVCEVGSGLVFSCQDKQNTVCEEC
PEGTYSDEANHVDPCLPCTVCEDTERQLRECTPWADAECE
//
>1sgfA [b.47.1] NERVE GROWTH FACTOR
NSQPWHVAVYRFNKYQCGGVLLDRNWVLTAAHCYNDKYQVWLGKEEPSDQHRLVSKAIPH
PDFNMSLLPQPEDDYSNDLMLLRLSKPADITDVVKPITLPTEEPKLGSTCLASICVNLKL
LPNEDCDKAHEMKVTDAMLCAGEMDGGSYTCEHDSGGPLICDGILQGITSWGPEPCGEPT
EPSVYTKLIKFSSWIRETMANNP
//
>1sgfB [g.17.1] NERVE GROWTH FACTOR
GEFSVCDSVSVWVGDKTTATDIKGKEVTVLAEVNINNSVFRQYFFETKCRASNPVESGCR
GIDSKHWNSYCTTTHTFVKALTTDEKQAAWRFIRIDTACVCVLSRKATR
//
>1sgfG [b.47.1] NERVE GROWTH FACTOR
IVGGFKCEKNSQPWHVAVYRYTQYLCGGVLLDPNWVLTAAHCYDDNYKVWLGKNNLFKDE
PSAQHRFVSKAIPHPGFNMSLMFLEYDYSNDLMLLRLSKPADITDTVKPITLPTEEPKLG
STCLASGWGSITPTKFQFTDDLYCVNLKLLPNEDCAKAHIEKVTDAMLCAGEMDGGKDTC
KGDSGGPLICDGVLQGITSWGHTPCGEPDMPGVYTKLNKFTSWIKDTMAKNP
//
>1sgfY [g.17.1] NERVE GROWTH FACTOR
HMGEFSVCDSVSVWVGDKTTATDIKGKEVTVLAEVNINNSVFRQYFFETKCRASNPVESG
CRGIDSKHWNSYCTTTHTFVKALTTDEKQAAWRFIRIDTACVCVLSRKATR
//
>1shwA [b.6.1] EPHRIN-A5
VADRYAVYWNSSNPRFQRGDYHIDVCINDYLDVFCPHYEDSVPEDKTERYVLYMVNFDGY
SACDHTSKGFKRWECNRPHSPNGPLKFSEKFQLFTPFSLGFEFRPGREYFYISSAIPDNG
RRSCLKLKVFVRPTNSCM
//
>1shwB [b.18.1] EPHRIN TYPE-B RECEPTOR 2
VEETLMDSTTATAELGWMVHPPSGWEEVSGYDENMNTIRTYQVCNVFESSQNNWLRTKFI
RRRGAHRIHVEMKFSVRDCSSIPSVPGSCKETFNLYYYEADFDLATKTFPNWMENPWVKV
DTIAADESFSQVDLGGRVMKINTEVRSFGPVSRNGFYLAFQDYGGCMSLIAVRVFYRKCP
R
//
>1shyA [b.47.1] HEPATOCYTE GROWTH FACTOR
VVNGIPTRTNIGWMVSLRYRNKHICGGSLIKESWVLTARQCFPSRDLKDYEAWLGIHDVH
GRGDEKCKQVLNVSQLVYGPEGSDLVLMKLARPAVLDDFVSTIDLPNYGSTIPEKTSCSV
YGWGYTGLINYDGLLRVAHLYIMGNEKCSQHHRGKVTLNESEICAGAEKIGSGPCEGDYG
GPLVCEQHKMRMVLGVIVPGRGCAIPNRPGIFVRVAYYAKWIHKIILT
//
>1shyB [b.69.12 - g.16.2] HEPATOCYTE GROWTH FACTOR RECEPTOR
KYQLPNFTAETPIQNVILHEHHIFLGATNYIYVLNEEDLQKVAEYKTGPVLEHPDCFPCQ
DCSSKANLSGGVWKDNINMALVVDTYYDDQLISCGSVNRGTCQRHVFPHNHTADIQSEVH
CIFSPQIEEPSQCPDCVVSALGAKVLSSVKDRFINFFVGNTINSSYFPDHPLHSISVRRL
KETKDGFMFLTDQSYIDVLPEFRDSYPIKYVHAFESNNFIYFLTVQRETLDAQTFHTRII
RFCSINSGLHSYMEMPLECILTKEVFNILQAAYVSKPGAQLARQIGASLNDDILFGVFAQ
SKPDSAEPMDRSAMCAFPIKYVNDFFNKINVRCLQHFYGPNHEHCFNRDEYRTEFTTALQ
RVDLFMGQFSEVLLTSISTFIKGDLTIANLGTSEGRFMQVVVSRSGPSTPHVNFLLDSHP
VSPEVIVEHTLNQNGYTLVITGKKITKIPLNGLGCRHFQSCSQCLSAPPFVQCGWCHDKC
VRSEECLSGTWTQQICLPA
//
>1shzA [c.37.1 - a.66.1] GUANINE NUCLEOTIDE-BINDING PROTEIN GALPHA(13)
AREVKLLLLGAGESGKSTFLKQMRIIHGQDFDQRAREEFRPTIYSNVIKGMRVLVDAREK
LHIPWGDNKNQLHGDKLMAFDTRAPMAAQGMVETRVFLQYLPAIRALWEDSGIQNAYDRR
REFQLGESVKYFLDNLDKLGVPDYIPSQQDILLARRPTKGIHETHFTFKDLHFKMFDVGG
QRSERKKWFECFEGVTAIIFCVALSDYDQVLMEDRQTNRMHESMKLFDSICNNKWFTDTS
IILFLNKKDLFEEKIKKSPLTICYPEYAGSNTYEEAAAYIQCQFEDLNKRKDTKEIYTHF
TCATDTKNVQFVFDAVTDVIIKNNLK
//
>1shzC [a.91.1] RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 1
PGLVPVSIIGAEDEDFENELETSQFQSLEQVKRRPAHLMALLQHVALQFEPGPLLCCLHA
DMLGSKKAFLDFYHSFLEKTAVLRVPVPPNVAFELDVQRRFVQEVVQSQQVAVGRQLEDF
RSKRLMGMTPWEQELAQLEAWVGRDRASYEARERHVAERLLMHLEEMQHTISTDEEKSAA
VVNAIGLYMRHLGVRT
//
>1shzF [a.91.1] RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 1
GLVPVSIIGAEDEDFENESQFQSLEQVKRRPAHLMALLQHVALQFEPGPLLCCLHADMLG
PKEAKKAFLDFYHSFLEKTAVLRVPVPPNVAFELVQRRFVQEVVQSQQVAVGRQLEDFRS
KRLMGMTPWEQELAQLEAWSYEARERHVAERLLMHLEEMQHTISTDEEKSAAVVNAIGLY
MRHLGVRT
//
>1shzD [c.37.1 - a.66.1] GUANINE NUCLEOTIDE-BINDING PROTEIN GALPHA(13)
AAREVKLLLLGAGESGKSTFLKQMRIIHGQDFDQRAREEFRPTIYSNVIKGMRVLVDARE
KLHIPWGDNKNQLHGDKLMAFDTRAPMAAQGMVETRVFLQYLPAIRALWEDSGIQNAYDR
RREFQLGESVKYFLDNLDKLGVPDYIPSQQDILLARRPTKGIHETHFTFKDLHFKMFDVG
GQRSERKKWFECFEGVTAIIFCVALSDYDQVLMEDRQTNRMHESMKLFDSICNNKWFTDT
SIILFLNKKDLFEEKIKKSPLTICYPEYAGSNTYEEAAAYIQCQFEDLNKRKDTKEIYTH
FTCATDTKNVQFVFDAVTDVIIKNNLK
//
>1si4A [a.1.1] HEMOGLOBIN ALPHA CHAIN
VLSPADKTNVKAAWGKVGAHAGEYGAEALERMFLSFPTTKTYFPHFDLSHGSAQVKGHGK
KVADALTNAVAHVDDMPNALSALSDLHAHKLRVDPVNFKLLSHCLLVTLAAHLPAEFTPA
VHASLDKFLASVSTVLTSKYR
//
>1si4B [a.1.1] HEMOGLOBIN DELTA CHAIN
VHLTPEEKTAVNALWGKVNVDAVGGEALGRLLVVYPWTQRFFESFGDLSSPDAVMGNPKV
KAHGKKVLGAFSDGLAHLDNLKGTFSQLSELHCDKLHVDPENFRLLGNVLVCVLARNFGK
EFTPQMQAAYQKVVAGVANALAHKYH
//
>1siwA [c.81.1 - b.52.2] RESPIRATORY NITRATE REDUCTASE 1 ALPHA CHAIN
SKFLDRFRYFKQKGETFADGHGQLLNTNRDWEDGYRQRWQHDKIVRSTHGVGSCSWKIYV
KNGLVTWETQQTDYPRTRPDLPNHEPRGCPRGASYSWYLYSANRLKYPMMRKRLMKMWRE
AKALHSDPVEAWASIIEDADKAKSFKQARGRGGFVRSSWQEVNELIAASNVYTIKNYGPD
RVAGFSPIPAMSMVSYASGARYLSLIGGTCLSFYDWYCDLPPASPQTWGEQTDVPESADW
YNSSYIIAWGSNVPQTRTPDAHFFTEVRYKGTKTVAVTPDYAEIAKLCDLWLAPKQGTDA
AMALAMGHVMLREFHLDNPSQYFTDYVRRYTDMPMLVMLEERDGYYAAGRMLRAADLVDA
LGQENNPEWKTVAFNTNGEMVAPNGSIGFRWGEKGKWNLEQRDGKTGEETELQLSLLGSQ
DEIAEVGFPYFGGDGTEHFNKVELENVLLHKLPVKRLQLADGSTALVTTVYDLTLANYGL
ERGLNDVNCATSYDDVKAYTPAWAEQITGVSRSQIIRIAREFADNADKTHGRSMIIVGAG
LNHWYHLDMNYRGLINMLIFCGCVGQSGGGWAHYVGQEKLRPQTGWQPLAFALDWQRPAR
HMNSTSYFYNHSSQWRYETVTAEELLSPMADKSRYTGHLIDFNVRAERMGWLPSAPQLGT
NPLTIAGEAEKAGMNPVDYTVKSLKEGSIRFAAEQPENGKNHPRNLFIWRSNLLGSSGKG
HEFMLKYLLGTEHGIQGKDLGQQGGVKPEEVDWQDNGLEGKLDLVVTLDFRLSSTCLYSD
IILPTATWYEKDDMNTSDMHPFIHPLSAAVDPAWEAKSDWEIYKAIAKKFSEVCVGHLGK
ETDIVTLPIQHDSAAELAQPLDVKDWKKGECDLIPGKTAPHIMVVERDYPATYERFTSIG
PLMEKIGNGGKGIAWNTQSEMDLLRKLNYTKAEGPAKGQPMLNTAIDAAEMILTLAPETN
GQVAVKAWAALSEFTGRDHTHLALNKEDEKIRFRDIQAQPRKIISSPTWSGLEDEHVSYN
AGYTNVHELIPWRTLSGRQQLYQDHQWMRDFGESLLVYRPPIDTRSVKEVIGQKSNGNQE
KALNFLTPHQKWGIHSTYSDNLLMLTLGRGGPVVWLSEADAKDLGIADNDWIEVFNSNGA
LTARAVVSQRVPAGMTMMYHAQERIVNLPGSEITQQRGGIHNSVTRITPKPTHMIGGYAH
LAYGFNYYGTVGSNRDEFVVVRKMKNIDWLDGEGNDQVQE
//
>1siwC [f.21.3] RESPIRATORY NITRATE REDUCTASE 1 GAMMA CHAIN
xQFLNMFFFDIYPYIAGAVFLIGSWLRYDYGQYTWRAASSQMLDRKGMNLASNLFHIGIL
GIFVGHFFGMLTAWLPIEVKQKMAMFAGGASGVLCLIGGVLLLKRRLFSPRVRATTTGAD
ILILSLLVIQCALGLLTIPFSAQHMDGSEMMKLVGWAQSVVTFHGGASQHLDGVAFIFRL
HLVLGMTLFLLFPFSRLIHIWSVPVEYLTRKYQLVRARH
//
>1sksA [c.55.3 - e.8.1] DNA POLYMERASE
MIVSDIEANALLESVTKFHCGVIYDYSTAEYVSYRPSDFGAYLDALEAEVARGGLIVFHN
GHKYDVPALTKLAKLQLNREFHLPRENCIDTLVLSRLIHSNLKDTDMGLLRSGKLPGALE
AWGYRLGEMKGEYKDDFKRMLEEQGEEYVDGMEWWNFNEEMMDYNVQDVVVTKALLEKLL
SDKHYFPPEIDFTDVGYTTFWSESLEAVDIEHRAAWLLAKQERNGFPFDTKAIEELYVEL
AARRSELLRKLTETFGSWYQPKGGTEMFCHPRTGKPLPKYPRIKTPKVGGIFKKPKNREP
CELDTREYVAGAPYTPVEHVVFNPSSRDHIQKKLQEAGWVPTKYTDKGAPVVDDEVLEGV
RVDDPEKQAAIDLIKEYLMIQKRIGQSAEGDKAWLRYVAEDGKIHGSVNPNGAVTGRATH
AFPNLAQIPGVRSPYGEQCRAAFGAEHHLDGITGKPWVQAGIDASGLELRCLAHFMARFD
NGEYAHEILNGDIHTKNQIAAELPTRDNAKTFIYGFLYGAGDEKIGQIVGAGKERGKELK
KKFLENTPAIAALRESIQQTLVEKWKRRWIKGLDGRKVHVRSPHAALNTLLQSAGALICK
LWIIKTEEMLVEKGLKHGWDGDFAYMAWVHDEIQVGCRTEEIAQVVIETAQEAMRWVGDH
WNFRCLLDTEGKMGPNWAICH
//
>1sksB [c.47.1] THIOREDOXIN 1
KIIHLTDDSFDTDVLKADGAILVDFWAEWCGPCKMIAPILDEIADEYQGKLTVAKLNIDQ
NPGTAPKYGIRGIPTLLLFKNGEVAATKVGALSKGQLKEFLDANL
//
>1skyA (E) [b.49.1 - c.37.1 - a.69.1] F1-ATPASE
MTRGRVIQVMGPVVDVKFENGHLPAIYNALKIQHKARNENEVDIDLTLEVALHLGDDTVR
TIAMASTDGLIRGMEVIDTGAPISVPVGQVTLGRVFNVLGEPIDLEGDIPADARRDPIHR
PAPKFEELATEVEILETGIKVVDLLAPYIKGGKIGLFGGAGVGKTVLIQELIHNIAQEHG
GISVFAGVGERTREGNDLYHEMKDSGVISKTAMVFGQMNEPPGARMRVALTGLTMAEYFR
DEQGQDGLLFIDNIFRFTQAGSEVSALLGRMPSAIGYQPTLATEMGQLQERITSTAKGSI
TSIQAIYVPADDYTDPAPATTFSHLDATTNLERKLAEMGIYPAVDPLVSTSRALAPEIVG
EEHYQVARKVQQTLERYKELQDIIAILGMDELSDEDKLVVHRARRIQFFLSQNFHVAEQF
TGQPGSYVPVKETVRGFKEILEGKYDHLPEDRFRLVGRIEEVVEKAKAMG
//
>1skyC (B) [b.49.1 - c.37.1 - a.69.1] F1-ATPASE
SQIQVSDVGTVIQVGDGIARAHGLDNVMSGEAVEFANAVMGMALNLEENNVGIVILGPYT
GIKEGDEVRRTGRIMEVPVGETLIGRVVNPLGQPVDGLGPVETTETRPIESRAPGVMDRR
SVHEPLQTGIKAIDALVPIGRGQRELIIGDRQTGKTSVAIDTIINQKDQNMICIYVAIGQ
KESTVATVVETLAKHGAPDYTIVVTASASQPAPLLFLAPYAGVAMGEYFMIMGKHVLVVI
DDLSKQAAAYRQLSLLLRRPPGREAYPGDIFYLHSRLLERAAKLSDAKGGGSLTALPFVE
TQAGDISAYIPTNVISITDGQIFLQSDLFFSGVRPAINAGLSVSRVGGAAQIKAMKKVAG
TLRLDLAAYRELEFAQFSDDKATQANVARGARTVEVLKQDLHQPIPVEKQVLIIYALTRG
FLDDIPVEDVRRFEKEFYLWLDQNGQHLLEHIRTTKDLPNEDDLNQAIEAFKKTFVVSQ
//
>1sm3L [b.1.1 - b.1.1] SM3 ANTIBODY
IVVTQESALTTSPGETVTLTCRSSTGAVTTSNYANWVQEKPDHLFTGLIGGTNNRAPGVP
ARFSGSLIGDKAALTITGAQTEDEAIYFCALWYSNHWVFGGGTKLTVLGSEKSSPSVTLF
PPSSEELETNKATLVCTITDFYPGVVTVDWKVDGTPVTQGMETTQPSKQSNNKYMASSYL
TLTARAWERHSSYSCQVTHEGHTVEKSLSR
//
>1sm3H [b.1.1 - b.1.1] SM3 ANTIBODY
QVQLQESGGGLVQPGGSMKLSCVASGFTFSNYWMNWVRQSPEKGLEWVAEIRLKSNNYAT
HYAESVKGRFTISRDDSKSSVYLQMNNLRAEDTGIYYCTGVGQFAYWGQGTTVTVSSAKT
TPPTVYPLAPGSMVTLGCLVKGYFPEPVTVTWNSGSLASGVHTFPAVLQSDLYTLSSSVT
VPSSTWPSETVTCNVAHPASSTKVDAKIVPR
//
>1smpA [d.92.1 - b.80.7] SERRATIA METALLO PROTEINASE
TGYDAVDDLLHYHERGNGIQINGKDSFSNEQAGLFITRENQTWNGYKVFGQPVKLTFSFP
DYKFSSTNVAGDTGLSKFSAEQQQQAKLSLQSWADVANITFTEVAAGQKANITFGNYSQD
RPGHYDYGTQAYAFLPNTIWQGQDLGGQTWYNVNQSNVKHPATEDYGRQTFTHEIGHALG
LSHPGDYNAGEGNPTYNDVTYAEDTRQFSLMSYWSETNTGGDNGGHYAAAPLLDDIAAIQ
HLYGANLSTRTGDTVYGFNSNTGRDFLSTTSNSQKVIFAAWDAGGNDTFDFSGYTANQRI
NLNEKSFSDVGGLKGNVSIAAGVTIENAIGGSGNDVIVGNAANNVLKGGAGNDVLFGGGG
ADELWGGAGKDIFVFSAASDSAPGASDWIRDFQKGIDKIDLSFFNKEANSSDFIHFVDHF
SGTAGEALLSYNASSNVTDLSVNIGGHQAPDFLVKIVGQVDVATDFIV
//
>1smpI [b.61.2] ERWINIA CHRYSANTHEMI INHIBITOR
SSLRLPSAAELSGQWVLSGAEQHCDIRLNTDVLDGTTWKLAGDTACLQKLLPEAPVGWRP
TPDGLTLTQADGSAVAFFSRNRDRYEHKLVDGSVRTLKKK
//
>1sp4A [d.3.1] CATHEPSIN B
LPESFDAREQWPNCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHSNG
//
>1sp4B [d.3.1] CATHEPSIN B
RVNVEVSAEDMLTCCGGECGDGCNGGFPSGAWNFWTKKGLVSGGLYNSHVGCRPYSIPPC
EHHVNGSRPPCTGEGDTPKCNKTCEPGYSPSYKEDKHFGCSSYSVANNEKEIMAEIYKNG
PVEGAFSVYSDFLLYKSGVYQHVSGEIMGGHAIRILGWGVENGTPYWLVGNSWNTDWGDN
GFFKILRGQDHCGIESEIVAGMPCT
//
>1spbP [d.58.3] SUBTILISIN BPN' PROSEGMENT
EKKYIVGFKQTMSTMSAAKKKDVISEKGGKVQKQFKYVDAASATLNEKAVKELKKDPSVA
YVEEDHVAHAY
//
>1spbS [c.41.1] SUBTILISIN BPN'
SVPYGVSQIKAPALHSQGYTGSNVKVAVINSGIDSSHPDLNVAGGASFVPSETNPFQDNN
SHGTHVAGTVLAVAPSASLYAVKVLGADGSGQYSWIINGIEWAIANNMDVINMSLGGPSG
SAALKAAVDKAVASGVVVVAAAGNEGTSGSSSTVGYPGKYPSVIAVGAVDSSNQRASFSS
VGPELDVMAPGVSIVSTLPGNKYGAKSGTAMASPHVAGAAALILSKHPNWTNTQVRSSLE
NTTTKLGDSFYYGKGLINVQAAAQ
//
>1spgA [a.1.1] HEMOGLOBIN
SLSATDKARVKALWDKIEGKSAELGAEALGRMLVSFPQTKIYFSEWGQDLGPQTPQVRNH
GAVIMAAVGKAVKSIDNLVGGLSQLSELHAFKLRVDPANFKILAHNIILVISMYFPGDFT
PEVHLSVDKFLACLALALSEKY
//
>1spgB [a.1.1] HEMOGLOBIN
VDWTDAERAAIKALWGKIDVGEIGPQALSRLLIVYPWTQRHFKGFGNISTNAAILGNAKV
AEHGKTVMGGLDRAVQNMDNIKNVYKQLSIKHSEKIHVDPDNFRLLGEIITMCVGAKFGP
SAFTPEIHEAWQKFLAVVVSALGRQY
//
>1sppA [b.23.1] MAJOR SEMINAL PLASMA GLYCOPROTEIN PSP-I
LDYHACGGRLTDDYGTIFTYKGPKTECVWTLQVDPKYKLLVSIPTLNLTCGKEYVEVLEG
APGSKSLGKFCEGLSILNRGSSGMTVKYKRDSGHPASPYEIIFLRDSQG
//
>1sppB [b.23.1] MAJOR SEMINAL PLASMA GLYCOPROTEIN PSP-II
ARINGPDECGRVIKDTSGSISNTDRQKNLCTWTILMKPDQKVRMAIPYLNLACGKEYVEV
FDGLLSGPSYGKLCAGAAIVFLSTANTMTIKYNRISGNSSSPFLIYFYGSSP
//
>1sqbA [d.185.1 - d.185.1] UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX CORE
TATYAQALQSVPETQVSQLDNGLRVASEQSSQPTCTVGVWIDAGSRYESEKNNGAGYFVE
HLAFKGTKNRPGNALEKEVESMGAHLNAYSTREHTAYYIKALSKDLPKAVELLADIVQNC
SLEDSQIEKERDVILQELQENDTSMRDVVFNYLHATAFQGTPLAQSVEGPSENVRKLSRA
DLTEYLSRHYKAPRMVLAAAGGLEHRQLLDLAQKHFSGLSGTYDEDAVPTLSPCRFTGSQ
ICHREDGLPLAHVAIAVEGPGWAHPDNVALQVANAIIGHYDCTYGGGAHLSSPLASIAAT
NKLCQSFQTFNICYADTGLLGAHFVCDHMSIDDMMFVLQGQWMRLCTSATESEVLRGKNL
LRNALVSHLDGTTPVCEDIGRSLLTYGRRIPLAEWESRIAEVDARVVREVCSKYFYDQCP
AVAGFGPIEQLPDYNRIRSGMFWLRF
//
>1sqbC [f.21.1 - f.32.1] CYTOCHROME B
TNIRKSHPLMKIVNNAFIDLPAPSNISSWWNFGSLLGICLILQILTGLFLAMHYTSDTTT
AFSSVTHICRDVNYGWIIRYMHANGASMFFICLYMHVGRGLYYGSYTFLETWNIGVILLL
TVMATAFMGYVLPWGQMSFWGATVITNLLSAIPYIGTNLVEWIWGGFSVDKATLTRFFAF
HFILPFIIMAIAMVHLLFLHETGSNNPTGISSDVDKIPFHPYYTIKDILGALLLILALML
LVLFAPDLLGDPDNYTPANPLNTPPHIKPEWYFLFAYAILRSIPNKLGGVLALAFSILIL
ALIPLLHTSKQRSMMFRPLSQCLFWALVADLLTLTWIGGQPVEHPYITIGQLASVLYFLL
ILVLMPTAGTIENKLLKW
//
>1sqbD [a.3.1 - f.23.11] CYTOCHROME C1, HEME PROTEIN, MITOCHONDRIAL
SDLELHPPSYPWSHRGLLSSLDHTSIRRGFQVYKQVCSSCHSMDYVAYRHLVGVCYTEDE
AKALAEEVEVQDGPNEDGEMFMRPGKLSDYFPKPYPNPEAARAANNGALPPDLSYIVRAR
HGGEDYVFSLLTGYCEPPTGVSLREGLYFNPYFPGQAIGMAPPIYNEVLEFDDGTPATMS
QVAKDVCTFLRWAAEPEHDHRKRMGLKMLLMMGLLLPLVYAMKRHKWSVLKSRKLAYRPP
K
//
>1sqbE [f.23.12 - b.33.1] UBIQUINOL-CYTOCHROME C REDUCTASE IRON-SULFUR
SHTDIKVPDFSDYRRPEVLDSTKSSKESSEARKGFSYLVTATTTVGVAYAAKNVVSQFVS
SMSASADVLAMSKIEIKLSDIPEGKNMAFKWRGKPLFVRHRTKKEIDQEAAVEVSQLRDP
QHDLERVKKPEWVILIGVCTHLGCVPIANAGDFGGYYCPCHGSHYDASGRIRKGPAPLNL
EVPSYEFTSDDMVIVG
//
>1sqbG [f.23.13] UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX
GRQFGHLTRVRHVITYSLSPFEQRAFPHYFSKGIPNVLRRTRACILRVAPPFVAFYLVYT
WGTQEFEKSKRKNPA
//
>1sqkA [c.55.1 - c.55.1] ACTIN, ALPHA SKELETAL MUSCLE
TTALVCDNGSGLVKAGFAGDDAPRAVFPSIVGRPRHQGKDSYVGDEAQSKRGILTLKYPI
EHGIITNWDDMEKIWHHTFYNELRVAPEEHPTLLTEAPLNPKANREKMTQIMFETFNVPA
MYVAIQAVLSLYASGRTTGIVLDSGDGVTHNVPIYEGYALPHAIMRLDLAGRDLTDYLMK
ILTERGYSFVTTAEREIVRDIKEKLCYVALDFENEMATAASSSSLEKSYELPDGQVITIG
NERFRCPETLFQPSFIGMESAGIHETTYNSIMKCDIDIRKDLYANNVMSGGTTMYPGIAD
RMQKEITALAPSTMKIKIIAPPERKYSVWIGGSILASLSTFQQMWITKQEYDEAGPSIVH
//
>1sqkB [j.86.1] CIBOULOT
DLPKVAENLKSQLEGFNQDKLKNAS
//
>1sqvA [d.185.1 - d.185.1] UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX CORE
TATYAQALQSVPETQVSQLDNGLRVASEQSSQPTCTVGVWIDAGSRYESEKNNGAGYFVE
HLAFKGTKNRPGNALEKEVESMGAHLNAYSTREHTAYYIKALSKDLPKAVELLADIVQNC
SLEDSQIEKERDVILQELQENDTSMRDVVFNYLHATAFQGTPLAQSVEGPSENVRKLSRA
DLTEYLSRHYKAPRMVLAAAGGLEHRQLLDLAQKHFSGLSGTYDEDAVPTLSPCRFTGSQ
ICHREDGLPLAHVAIAVEGPGWAHPDNVALQVANAIIGHYDCTYGGGAHLSSPLASIAAT
NKLCQSFQTFNICYADTGLLGAHFVCDHMSIDDMMFVLQGQWMRLCTSATESEVLRGKNL
LRNALVSHLDGTTPVCEDIGRSLLTYGRRIPLAEWESRIAEVDARVVREVCSKYFYDQCP
AVAGFGPIEQLPDYNRIRSGMFWLRF
//
>1sqvK [f.23.15] UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX 6.4 KDA
MLTRFLGPRYRQLARNWVPTASLWGAVGAVGLVWATDWRLILDWVPYINGK
//
>1sqxB [d.185.1 - d.185.1] UBIQUINOL-CYTOCHROME-C REDUCTASE COMPLEX CORE
VPPHPQDLEFTRLPNGLVIASLENYAPASRIGLFIKAGSRYENSNNLGTSHLLRLASSLT
TKGASSFKITRGIEAVGGKLSVTSTRENMAYTVECLRDDVDILMEFLLNVTTAPEFRRWE
VAALQPQLRIDKAVALQNPQAHVIENLHAAAYRNALANSLYCPDYRIGKVTPVELHDYVQ
NHFTSARMALIGLGVSHPVLKQVAEQFLNIRGGLGLSGAKAKYHGGEIREQNGDSLVHAA
LVAESAAIGSAEANAFSVLQHVLGAGPHVKRGSNATSSLYQAVAKGVHQPFDVSAFNASY
SDSGLFGFYTISQAASAGDVIKAAYNQVKTIAQGNLSNPDVQAAKNKLKAGYLMSVESSE
GFLDEVGSQALAAGSYTPPSTVLQQIDAVADADVINAAKKFVSGRKSMAASGNLGHTPFI
DEL
//
>1sqxC [f.21.1 - f.32.1] CYTOCHROME B
TNIRKSHPLMKIVNNAFIDLPAPSNISSWWNFGSLLGICLILQILTGLFLAMHYTSDTTT
AFSSVTHICRDVNYGWIIRYMHANGASMFFICLYMHVGRGLYYGSYTFLETWNIGVILLL
TVMATAFMGYVLPWGQMSFWGATVITNLLSAIPYIGTNLVEWIWGGFSVDKATLTRFFAF
HFILPFIIMAIAMVHLLFLHETGSNNPTGISSDVDKIPFHPYYTIKDILGALLLILALML
LVLFAPDLLGDPDNYTPANPLNTPPHIKPEWYFLFAYAILRSIPNKLGGVLALAFSILIL
ALIPLLHTSKQRSMMFRPLSQCLFWALVADLLTLTWIGGQPVEHPYITIGQLASVLYFLL
ILVLMPTAGTIENKLLKW
//
>1sqxD [a.3.1 - f.23.11] UBIQUINOL-CYTOCHROME C REDUCTASE IRON-SULFUR
SDLELHPPSYPWSHRGLLSSLDHTSIRRGFQVYKQVCSSCHSMDYVAYRHLVGVCYTEDE
AKALAEEVEVQDGPNEDGEMFMRPGKLSDYFPKPYPNPEAARAANNGALPPDLSYIVRAR
HGGEDYVFSLLTGYCEPPTGVSLREGLYFNPYFPGQAIGMAPPIYNEVLEFDDGTPATMS
QVAKDVCTFLRWAAEPEHDHRKRMGLKMLLMMGLLLPLVYAMKRHKWSVLKSRKLAYRPP
K
//
>1sqxE [f.23.12 - b.33.1] CYTOCHROME C1, HEME PROTEIN, MITOCHONDRIAL
SHTDIKVPDFSDYRRPEVLDSTKSSKESSEARKGFSYLVTATTTVGVAYAAKNVVSQFVS
SMSASADVLAMSKIEIKLSDIPEGKNMAFKWRGKPLFVRHRTKKEIDQEAAVEVSQLRDP
QHDLERVKKPEWVILIGVCTHLGCVPIANAGDFGGYYCPCHGSHYDASGRIRKGPAPLNL
EVPSYEFTSDDMVIVG
//
>1sqxI [d.184.1] UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX
MLSVAARSGPFAPVLSATSRGVAGALRPLVQAAVPATSESPVLDLKRSVLCRESLRG
//
>1sqxF [f.27.1] UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX 11 KDA
VSASSRWLEGIRKWYYNAAGFNKLGLMRDDTIHENDDVKEAIRRLPENLYDDRVFRIKRA
LDLSMRQQILPKEQWTKYEEDKSYLEPYLKEVIRERKEREEWAKK
//
>1sr4A [b.42.2] CYTOLETHAL DISTENDING TOXIN SUBUNIT A
LNLLSSSGPNRQVLPSEPSNFMTLMGQNGALLTVWALAKRNWLWAYPNIYSQDFGNIRNW
KMEPGKHREYFRFVNQSLGTCVEAYGNGLIHDICSLDKLAQEFELLPTDSGAVVIKSVSQ
GRCVTYNPVSTTFYSTVTLSVCDGATEPSRDQTWYLAPPVLEATAVN
//
>1sr4B [d.151.1] CYTOLETHAL DISTENDING TOXIN PROTEIN B
NLSDFKVATWNLQGSSAVNESKWNINVRQLLSGEQGADILMVQEAGSLPSSAVRTSRVIQ
HGGTPIEEYTWNLGTRSRPNMVYIYYSRLDVGANRVNLAIVSRRQADEAFIVHSDSSVLQ
SRPAVGIRIGTDVFFTVHALATGGSDAVSLIRNIFTTFNSPPERRVYSWMVVGDFNRAPA
NLEVALRQEPAVSENTIIIAPTEPTHRSGNILDYAILHDAHLPRREQARERIGASLMLNQ
LRSQITSDHFPVSFVRDR
//
>1sr4C [b.42.2] CYTOLETHAL DISTENDING TOXIN PROTEIN C
DPTTYPDVELSPPPRISLRSLLTAQPVKNDHYDSHNYLSTHWELIDYKGKEYEKLRDGGT
LVQFKVVGAAKCFAFLGKGTTDCKDTDHTVFNLIPTNTGAFLIKDALLGFCITSHDFDDL
KLEPCGGSVSGRTFSLAYQWGILPPFGPSKILIP
//
>1srq_2C [e.55.1] GTPASE-ACTIVATING PROTEIN 1
TKVKLECNPTARIYRKHFLGKEHFNYYSLDTALGHLVFSLKYDVIGDQEHLRLLLRTKCR
TYHDVIPITEFPNVVQMAKLVCEDVNVDRFYPVLYPKASRLIVTFDEHVISNNFKFGVIY
QKLGQTSEEELFSTNEESPAFVEFLEFLGQKVKLQDFKGFRGGLDVTHGQTGTESVYCNF
RNKEIMFHVSTKLPYTEGDAQQLQRKRHIGNDIVAVVFQDENTPFVPDMIASNFLHAYVV
VQAEPLYKVSVTARDDVPFFGPPLPDPAVFRKGPEFQEFLLTKLINAEYACYKAEKFAKL
EERTRAALLETLYEELHIHSQSMM
//
>1srq_2D [e.55.1] GTPASE-ACTIVATING PROTEIN 1
YRKHFLGKEHFNYYVFSLKYDVHLRLLLPNVVRFYPVLYPKASRLIVTFDEETLYEELHI
HSQSMM
//
>1stfE [x.x.x]
IPEYVDWRQKGAVTPVKNQGSCGSCWAFSAVVTIEGIIKIRTGNLNQYSEQELLDCDRRS
YGCNGGYPWSALQLVAQYGIHYRNTYPYEGVQRYCRSREKGPYAAKTDGVRQVQPYNQGA
LLYSIANQPVSVVLQAAGKDFQLYRGGIFVGPCGNKVDHAVAAVGYGPNYILIKNSWGTG
WGENGYIRIKRGTGNSYGVCGLYTSSFYPVKN
//
>1stfI [d.17.1] STEFIN B (CYSTATIN B)
MMSGAPSATQPATAETQHIADQVRSQLEEKYNKKFPVFKAVSFKSQVVAGTNYFIKVHVG
DEDFVHLRVFQSLPHENKPLTLSNYQTNKAKHDELTYF
//
>1sv0_1A [a.60.1] ETS DNA-BINDING PROTEIN POKKURI
LPPSLPSDPRLWSREDVLVFLRFCVREFDLPKLDFDLFQMNGKRLCLLTRADFGHRCPGA
GDVLHNVLQMLIIESHS
//
>1sv0_1C [a.60.1] MODULATOR OF THE ACTIVITY OF ETS CG15085-PA
PLGSDGLPLDPRDWTRADVWKWLINMAVSEGLEVTAELPQKFPMNGKALCLMSLDMYLCR
VPVGGKMLYRDFRVRLARAMSR
//
>1svdA [d.58.9 - c.1.14] RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE
TYWMPEYTPLDSDILACFKITPQPGVDREEAAAAVAAESSTGTWTTVWTDLLTDMDYYKG
RAYRIEDVPGDDAAFYAFIAYPIDLFEEGSVVNVFTSLVGNVFGFKAVRGLRLEDVRFPL
AYVKTCGGPPHGIQVERDKMNKYGRPLLGCTIKPKLGLSAKNYGRAVYECLRGGLDFTKD
DENINSQPFMRWRDRFLFVQDATETAEAQTGERKGHYLNVTAPTPEEMYKRAEFAKEIGA
PIIMHDYITGGFTANTGLAKWCQDNGVLLHIHRAMHAVIDRNPNHGIHFRVLTKILRLSG
GDHLHTGTVVGKLEGDRASTLGWIDLLRESFIPEDRSRGIFFDQDWGSMPGVFAVASGGI
HVWHMPALVNIFGDDSVLQFGGGTLGHPWGNAAGAAANRVALEACVEARNQGRDIEKEGK
EILTAAAQHSPELKIAMETWKEIKF
//
>1svdM [d.73.1] RIBULOSE BISPHOSPHATE CARBOXYLASE SMALL CHAIN
EMQDYKQSLKYETFSYLPPMNAERIRAQIKYAIAQGWSPGIEHVEVKNSMNQYWYMWKLP
FFGEQNVDNVLAEIEACRSAYPTHQVKLVAYDNYAQSLGLAFVVYRGN
//
>1svf_2D [h.3.2] PROTEIN (FUSION GLYCOPROTEIN)
SIDPLDISQNLAAVNKSLSDALQHLAQSDTYLSAI
//
>1svf_2A (C) [h.3.2] PROTEIN (FUSION GLYCOPROTEIN)
TAAVALVKANENAAAILNLKNAIQKTNAAVADVVQATQSLGTAVQAVQDHINSVVSPAIT
AA
//
>1svxA [k.37.1] ANKYRIN REPEAT PROTEIN OFF7
SDLGRKLLEAARAGQDDEVRILMANGADVNAADNTGTTPLHLAAYSGHLEIVEVLLKHGA
DVDASDVFGYTPLHLAAYWGHLEIVEVLLKNGADVNAMDSDGMTPLHLAAKWGYLEIVEV
LLKHGADVNAQDKFGKTAFDISIDNGNEDLAEILQKL
//
>1svxB [c.94.1] MALTOSE-BINDING PERIPLASMIC PROTEIN
GKLVIWINGDKGYNGLAEVGKKFEKDTGIKVTVEHPDKLEEKFPQVAATGDGPDIIFWAH
DRFGGYAQSGLLAEITPDKAFQDKLYPFTWDAVRYNGKLIAYPIAVEALSLIYNKDLLPN
PPKTWEEIPALDKELKAKGKSALMFNLQEPYFTWPLIAADGGYAFKYENGKYDIKDVGVD
NAGAKAGLTFLVDLIKNKHMNADTDYSIAEAAFNKGETAMTINGPWAWSNIDTSKVNYGV
TVLPTFKGQPSKPFVGVLSAGINAASPNKELAKEFLENYLLTDEGLEAVNKDKPLGAVAL
KSYEEELAKDPRIAATMENAQKGEIMPNIPQMSAFWYAVRTAVINAASGRQTVDEALKDA
QTGSGGTPG
//
>1sxjA [c.37.1 - a.80.1] ACTIVATOR 1 95 KDA SUBUNIT
DKLWTVKYAPTNLQQVCGNKGSVMKLKNWLANWENSKKNSFKHAGKDGSGVFRAAMLYGP
PGIGKTTAAHLVAQELGYDILEQNASDVRSKTLLNAGVKNALDNMSVVGYFKHQNLNGKH
FVIIMDEVDGMSGGDRGGVGQLAQFCRKTSTPLILICNERNLPKMRPFDRVCLDIQFRRP
DANSIKSRLMTIAIREKFKLDPNVIDRLIQTTRGDIRQVINLLSTISTTTKTINHENINE
ISKAWEKNIALKPFDIAHKMLDGQIYSDIGSRNFTLNDKIALYFDDFDFTPLMIQENYLS
TRPSVLKPGQSHLEAVAEAANCISLGDIVEKKIRSSEQLWSLLPLHAVLSSVYPASKVAG
HMAGRINFTAWLGQNSKSAKYYRLLQEIHYHTRLGuuuuuuuuuuuuuuuuuuuuuuuuu
uuuuuuuuuuuuuuuuuuuuu
//
>1sxjB [c.37.1 - a.80.1] ACTIVATOR 1 37 KDA SUBUNIT
LQLPWVEKYRPQVLSDIVGNKETIDRLQQIAKDGNMPHMIISGMPGIGKTTSVHCLAHEL
LGRSYADGVLELNASDDRGIDVVRNQIKHFAQKKLHLPPGKHKIVILDEADSMTAGAQQA
LRRTMELYSNSTRFAFACNQSNKIIEPLQSQCAILRYSKLSDEDVLKRLLQIIKLEDVKY
TNDGLEAIIFTAEGDMRQAINNLQSTVAGHGLVNADNVFKIVDSPHPLIVKKMLLASNLE
DSIQILRTDLWKKGYSSIDIVTTSFRVTKNLAQVKESVRLEMIKEIGLTHMRILEGVGTY
LQLASMLAKIHKLNNK
//
>1sxjC [c.37.1 - a.80.1] ACTIVATOR 1 40 KDA SUBUNIT
NLPWVEKYRPETLDEVYGQNEVITTVRKFVDEGKLPHLLFYGPPGTGKTSTIVALAREIY
GKNYSNMVLELNASDDRGIDVVRNQIKDFASTRQIFSKGFKLIILDEADAMTNAAQNALR
RVIERYTKNTRFCVLANYAHKLTPALLSQCTRFRFQPLPQEAIERRIANVLVHEKLKLSP
NAEKALIELSNGDMRRVLNVLQSCKATLDNPDEDEISDDVIYECCGAPRPSDLKAVLKSI
LEDDWGTAHYTLNKVRSAKGLALIDLIEGIVKILEDYELQNEETRVHLLTKLADIEYSIS
KGGNDQIQGSAVIGAIKASFEN
//
>1sxjE [c.37.1 - a.80.1] ACTIVATOR 1 40 KDA SUBUNIT
WVDKYRPKSLNALSHNEELTNFLKSLSDQPRDLPHLLLYGPNGTGKKTRCMALLESIFGP
GVYRNVVSSPYHLEITPSNDRIVIQELLKEVAQMEQRYKCVIINEANSLTKDAQAALRRT
MEKYSKNIRLIMVCDSMSPIIAPIKSQCLLIRCPAPSDSEISTILSDVVTNERIQLETKD
ILKRIAQASNGNLRVSLLMLESMALNNELALKSSSPIIKPDWIIVIHKLTRKIVKERSVN
SLIECRAVLYDLLAHCIPANIILKELTFSLLDVETLNTTNKSSIIEYSSVFDERLSLGNK
AIFHLEGFIAKVMCCLD
//
>1sxjG [d.131.1 - d.131.1] PROLIFERATING CELL NUCLEAR ANTIGEN
mASmLEAKFEEASLFKRIIDGFKDCVQLVNFQCKEDGIIAQAVDDSRVLLVSLEIGVEAF
QEYRCDHPVTLGmDLTSLSKILRCGNNTDTLTLIADNTPDSIILLFEDTKKDRIAEYSLK
LmDIDADFLKIEELQYDSTLSLPSSEFSKIVRDLSQLSDSINImITKETIKFVADGDIGS
GSVIIKPFVDmEHPETSIKLEmDQPVDLTFGAKYLLDIIKGSSLSDRVGIRLSSEAPALF
QFDLKSGFLQFFLAPKFN
//
>1sxjD [c.37.1 - a.80.1] ACTIVATOR 1 41 KDA SUBUNIT
PWVEKYRPKNLDEVTAQDHAVTVLKKTLKSANLPHMLFYGPPGTGKTSTILALTKELYGP
DLMKSRILELNASDERGISIVREKVKNFARLTVSKPSKHDLENYPCPPYKIIILDEADSM
TADAQSALRRTMETYSGVTRFCLICNYVTRIIDPLASQCSKFRFKALDASNAIDRLRFIS
EQENVKCDDGVLERILDISAGDLRRGITLLQSASKGAQYLGDGKNITSTQVEELAGVVPH
DILIEIVEKVKSGDFDEIKKYVNTFMKSGWSAASVVNQLHEYYITNDNFDTNFKNQISWL
LFTTDSRLNNGTNEHIQLLNLLVKISQL
//
>1sxjF [d.131.1 - d.131.1] PROLIFERATING CELL NUCLEAR ANTIGEN
ASmLEAKFEEASLFKRIIDGFKDCVQLVNFQCKEDGIIAQAVDDSRVLLVSLEIGVEAFQ
EYRCDHPVTLGmDLTSLSKILRCGNNTDTLTLIADNTPDSIILLFEDTKKDRIAEYSLKL
mDIDADFLKIEELQYDSTLSLPSSEFSKIVRDLSQLSDSINImITKETIKFVADGDIGSG
SVIIKPFVDmEHPETSIKLEmDQPVDLTFGAKYLLDIIKGSSLSDRVGIRLSSEAPALFQ
FDLKSGFLQFFLAPKFND
//
>1sy6L [b.1.1 - b.1.1] OKT3 FAB LIGHT CHAIN
QIVLTQSPAIMSASPGEKVTMTCSASSSVSYMNWYQQKSGTSPKRWIYDTSKLASGVPAH
FRGSGSGTSYSLTISGMEAEDAATYYCQQWSSNPFTFGSGTKLEINRADTAPTVSIFPPS
SEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLTL
TKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1sy6H [b.1.1 - b.1.1] OKT3 FAB HEAVY CHAIN
QVQLQQSGAELARPGASVKMSCKASGYTFTRYTMHWVKQRPGQGLEWIGYINPSRGYTNY
NQKFKDKATLTTDKSSSTAYMQLSSLTSEDSAVYYCARYYDDHYCLDYWGQGTTLTVSSA
KTTAPSVYPLAPVCGGTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDL
YTLSSSVTVTSSTWPSQSITCNVAHPASSTKVDKKIEPR
//
>1sy6A [b.1.1 - b.1.1] T-CELL SURFACE GLYCOPROTEIN CD3 GAMMA/EPSILON
MQSIKGNHLVKVYDYQEDGSVLLTCDAEAKNITWFKDGKMIGFLTEDKKKWNLGSNAKDP
RGMYQCKGSQNKSKPLQVYYRMQTPYKVSISGTTVILTCPQYPGSEILWQHNDKNIGGDE
DDKNIGSDEDHLSLKEFSELEQSGYYVCYPRGSKPEDANFYLYLRARV
//
>1syx_1A [c.47.1] SPLICEOSOMAL U5 SNRNP-SPECIFIC 15 KDA PROTEIN
YMLPHLHNGWQVDQAILSEEDRVVVIRFGHDWDPTCMKMDEVLYSIAEKVKNFAVIYLVD
ITEVPDFNKMYELYDPCTVMFFFRNKHIMIDLGTGNNNKINWAMEDKQEMVDIIETVYRG
ARKGRGLVVSPKDYS
//
>1syx_1B [d.76.1] CD2 ANTIGEN CYTOPLASMIC TAIL-BINDING PROTEIN 2
DVMWEYKWENTGDAELYGPFTSAQMQTWVSEGYFPDGVYCRKLDPPGGQFYNSKRIDFDL
YT
//
>1t01A [a.24.9 - a.24.9] UNNAMED PROTEIN PRODUCT
AMPVFHTRTIESILEPVAQQISHLVIMHEEGEVDGKAIPDLTAPVSAVQAAVSNLVRVGK
ETVQTTEDQILKRDMPPAFIKVENACTKLVRAAQMLQADPYSVPARDYLIDGSRGILSGT
SDLLLTFDEAEVRKIIRVCKGILEYLTVAEVVETMEDLVTYTKNLGPGMTKMAKMIDERQ
QELTHQEHRVMLVNSMNTVKELLPVLISAMKIFVTTKNTKSQGIEEALKNRNFTVEKMSA
EINEIIRVLQLTSWD
//
>1t01B [x.x.x] TALIN 1
GRPLLQAAKGLAGAVSELLRSAQP
//
>1t04_1A [b.1.1 - b.1.1] HUZAF ANTIBODY LIGHT CHAIN
DIQMTQSPSTLSASVGDRVTITCKASENVDTYVSWYQQKPGKAPKLLIYGASNRYTGVPS
RFSGSGSGTDFTLTISSLQPDDFATYYCGQSYNYPFTFGQGTKVEVKRTVAAPSVFIFPP
SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT
LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
//
>1t04_1B [b.1.1 - b.1.1] HUZAF ANTIBODY HEAVY CHAIN
xVQLVQSGAELKKPGSSVKVSCKASGYIFTSSWINWVKQAPGQGLEWIGRIDPSDGEVHY
NQDFKDKATLTVDKSTNTAYMELSSLRSEDTAVYYCARGFLPWFADWGQGTLVTVSSAST
KGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLY
SLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKS
//
>1t08A [a.118.1] BETA-CATENIN
AELATRAIPELTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNT
NDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLH
QEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALV
NIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTL
RNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIE
ALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWP
LIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRQFVEGVRMEEIVEGCT
GALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAE
GATAPLTELLHSRNEGVATYAAAVLFRMSE
//
>1t08B [a.161.1] BETA-CATENIN-INTERACTING PROTEIN 1
GKSPEEMYIQQKVRVLLMLRKMGSNLTASEEEFLRTYAGVVNSQLS
//
>1t0f_1A [c.52.1 - a.4.5] TRANSPOSON TN7 TRANSPOSITION PROTEIN TNSA
NSSFSEVQIARRIKEGRGQGHGKDYIPWLTVQEVPSSGRSHRIYSHKTGRVHHLLSDLEL
AVFLSLEWESSVLDIREQFPLLPSDTRQIAIDSGIKHPVIRGVDQVMSTDFLVDCKDGPF
EQFAIQVKPAAALQDERTLEKLELERRYWQQKQIPWFIFTDKEINPVVKENIEWLYSVKT
EEVSAELLAQLSPLAHILQEKGDENIINVCKQVDIAYDLELGKTLSEIRALTANGFIKFN
IYKSFRANKCADLCISQVVNMEEL
//
>1t0f_1C [x.x.x] TRANSPOSON TN7 TRANSPOSITION PROTEIN TNSC
IKVVKPSDWDSLPDTDLRYIYSQRQPEKTMHERLKGKGVIVDMASLFKQ
//
>1t0jA [b.34.2] VOLTAGE-GATED CALCIUM CHANNEL SUBUNIT BETA2A
RREAERQAQAQLEKAKTKPVAFAVRTNVRYSAAQEDDVPVPGMAISFEAKDFLHVKEKFN
NDWWIGRLVKEGCEIGFIPSPVKLENMRLQHEQRAK
//
>1t0jB [c.37.1] VOLTAGE-GATED CALCIUM CHANNEL SUBUNIT BETA2A
FTPPYDVVPSMRPVVLVGPSLKGYEVTDMMQKALFDFLKHRFEGRISITRVTADISLAKA
IIERSNTRSSLAEVQSEIERIFELARTLQLVVLDADTINHPAQLSKTSLAPIIVYVKISS
PKVLQRLIKSRHLNVQMVAADKLAQCPPQESFDVILDENQLEDACEHLADYLEAYWKATH
PPSSNRT
//
>1t0pA [c.62.1] INTEGRIN ALPHA-L
MGNVDLVFLFDGSMSLQPDEFQKILDFMKDVMKKLSNTSYQFAAVQFSTSYKTEFDFSDY
VKWKDPDALLKHVKHMLLLTNTFGAINYVATEVFREELGARPDATKVLIIITDGEATDSG
NIDAAKDIIRYIIGIGKHFQTKESQETLHKFASKPASEFVCILDTFECLKDLFT
//
>1t0pB [x.x.x] INTERCELLULAR ADHESION MOLECULE-3
QEFLLRVEPQNPVLSAGGSLFVNCSTDCPSSEKIALETSLSKELVASGMGWAAFNLSNVT
GNSRILCSVYCNGSQITGSSNITVYG
//
>1t0rA [a.25.1] TOLUENE, O-XYLENE MONOOXYGENASE OXYGENASE
SMLKREDWYDLTRTTNWTPKYVTENELFPEEMSGARGISMEAWEKYDEPYKITYPEYVSI
QREKDSGAYSIKAALERDGFVDRADPGWVSTMQLHFGAIALEEYAASTAEARMARFAKAP
GNRNMATFGMMDENRHGQIQLYFPYANVKRSRKWDWAHKAIHTNEWAAIAARSFFDDMMM
TRDSVAVSIMLTFAFETGFTNMQFLGLAADAAEAGDHTFASLISSIQTDESRHAQQGGPS
LKILVENGKKDEAQQMVDVAIWRSWKLFSVLTGPIMDYYTPLESRNQSFKEFMLEWIVAQ
FERQLLDLGLDKPWYWDQFMQDLDETHHGMHLGVWYWRPTVWWDPAAGVSPEEREWLEEK
YPGWNDTWGQCWDVITDNLVNGKPELTVPETLPTICNMCNLPIAHTPGNKWNVKDYQLEY
EGRLYHFGSEADRWCFQIDPERYKNHTNLVDRFLKGEIQPADLAGALMYMSLEPGVMGDD
AHDYEWVKAYQ
//
>1t0rC [d.15.12] TOUB
ATFPIMSNFERDFVIQLVPVDTEDTMDQVAEKCAYHSINRRVHPQPEKILRVRRHEDGTL
FPRGMIVSDAGLRPTETLDIIFMD
//
>1t2kD [h.1.3] CYCLIC-AMP-DEPENDENT TRANSCRIPTION FACTOR ATF-2
KRRKFLERNRAAASRSRQKRKVWVQSLEKKAEDLSSLNGQLQSEVTLLRNEVAQLKQLLL
A
//
>1t2kC [h.1.3] TRANSCRIPTION FACTOR AP-1
MKAERKRMRNRIAASKSRKRKLERIARLEEKVKTLKAQNSELASTANMLREQVAQLKQKV
MN
//
>1t34A [c.93.1] ATRIAL NATRIURETIC PEPTIDE RECEPTOR A
SDLTVAVVLPLTNTSYPWSWARVGPAVELALARVKARPDLLPGWTVRMVLGSSENAAGVC
SDTAAPLAAVDLKWEHSPAVFLGPGCVYSAAPVGRFTAHWRVPLLTAGAPALGIGVKDEY
ALTTRTGPSHVKLGDFVTALHRRLGWEHQALVLYADRLGDDRPCFFIVEGLYMRVRERLN
ITVNHQEFVEGDPDHYPKLLRAVRRKGRVIYICSSPDAFRNLMLLALNAGLTGEDYVFFH
LDVFGQSLKSAQGLVPQKPWERGDGQDRSARQAFQAAKIITYKEPDNPEYLEFLKQLKLL
ADKKFNFTVEDGLKNIIPASFHDGLLLYVQAVTETLAQGGTVTDGENITQRMWNRSFQGV
TGYLKIDRNGDRDTDFSLWDMDPETGAFRVVLNYNGTSQELMAVSEHKLYWPLGYPPPDV
PKCGFD
//
>1t34H [x.x.x] ATRIAL NATRIURETIC PEPTIDE FACTOR
CFGGRIDRIGAQSGLGCNSFR
//
>1t3qA [d.15.4 - a.56.1] QUINOLINE 2-OXIDOREDUCTASE SMALL SUBUNIT
SQLMRISATINGKPRVFYVEPRMHLADALREVVGLTGTKIGCEQGVCGSCTILIDGAPMR
SCLTLAVQAEGCSIETVEGLSQGEKLNALQDSFRRHHALQCGFCTAGMLATARSILAENP
APSRDEVREVMSGNLCRCTGYETIIDAITDPAVAEAARRGEV
//
>1t3qB [d.41.1 - d.133.1] QUINOLINE 2-OXIDOREDUCTASE LARGE SUBUNIT
MMKHEVVALKKKSIGTSVLRREDTRLLTGRGRYIADLVLSGMLHVASLRSPFAHARIVSI
DVADAQALPGVELVWCGADVAELSQGIVATMQVEGFQTTIQPLLANGVTRFVGEIVAVVV
ASSRAIAEDAAQLIQVEYEELPAVTGIEAALEGEARANDTLAGNVVSRTSRARDELAPIF
ASSAGVVRGQFSCGRVSACPMETRGAVAQYEWTTQQLILWTATQMPSFVRTMVAMFCAIP
EHLIEVRVPDVGGGFGQKAHLHPEELLVCLLSRALGRPVRWIEDRQENFLGATHAKQQRN
EMGLAFDGDGRFLALENRSITDGGAYNNLPWTQLVESHVGNAVILGVYKVPAVSEESIAV
ATNKCPIGAYRGVGFTAGQIARETLIDRAARQLGLSPFEIRRRNVVMPEDFPFTNRLGQT
HREGTYLQTINLLEEMVNPEAFRQRQAEARARGKYLGLGVSVFNEVTGTGTRTLSFLGTP
TTTHDSATVRIDPTGKVTVTTSLASSGQGHETTLAQIAADVLGVPASDVVIQAGSTKNTY
GFGAYASRGAVIGAGSIGRAASIVRERVKQLAGHLLEAASEDIVIEDGLVHVAGVPAKGM
PFAEVVGAAYFADATHPPGFDATLEATATYDPSDLVLANGGHAAIVEIDASTYATRVTDF
FAVEDCGTMINPMIVEGQIRGGIAQAIGQTLLEEVIYDDFGQLVTTTLMDYLIPTTLDVP
DIRIRHLETPSPLVPGGIKGMGESAMISAPAAVVAAVNDALAHLEVVIETVPITPERIFR
SIQERP
//
>1t3qC [d.145.1 - d.87.2] QUINOLINE 2-OXIDOREDUCTASE MEDIUM SUBUNIT
MKFPAFSYRAPASLQEVIQVLADDPDARIIAGGQSLLPLLAFRLVYPSCLVDLRNVSELF
EISQSAGILSVGAMVTHFRNKTDPTVAKCVPILPKVLAHVAHQAVRNRGTLGGSLAHADA
GAEMPFLMATLGATMYIASSAGVRSVSATDFMKGHYFTDLEAGEVLVRVEIPIPALHWEF
DEYARRKGDYALVMAAAGLSMQGGRCVAARIALGAVEERAHQAIRANDFLVGKVIDESTA
ATAAELATEGLEPRSDIHGSRDLRLSLAKAITQRVILKAAQGAMY
//
>1t3qE (B) [d.41.1 - d.133.1] QUINOLINE 2-OXIDOREDUCTASE LARGE SUBUNIT
MMKHEVVALKKKSIGTSVLRREDTRLLTGRGRYIADLVLSGMLHVASLRSPFAHARIVSI
DVADAQALPGVELVWCGADVAELSQGIVATMQVEGFQTTIQPLLANGVTRFVGEIVAVVV
ASSRAIAEDAAQLIQVEYEELPAVTGIEAALEGEARANDTLAGNVVSRTSRARDELAPIF
ASSAGVVRGQFSCGRVSACPMETRGAVAQYEWTTQQLILWTATQMPSFVRTMVAMFCAIP
EHLIEVRVPDVGGGFGQKAHLHPEELLVCLLSRALGRPVRWIEDRQENFLGATHAKQQRN
EMGLAFDGDGRFLALENRSITDGGAYNNLPWTQLVESHVGNAVILGVYKVPAVSEESIAV
ATNKCPIGAYRGVGFTAGQIARETLIDRAARQLGLSPFEIRRRNVVMPEDFPFTNRLGQT
HREGTYLQTINLLEEMVNPEAFRQRQAEARARGKYLGLGVSVFNEVTGTGTRTLSFLGTP
TTTHDSATVRIDPTGKVTVTTSLASSGQGHETTLAQIAADVLGVPASDVVIQAGSTKNTY
GFGAYASRGAVIGAGSIGRAASIVRERVKQLAGHLLEAASEDIVIEDGLVHVAGVPAKGM
PFAEVVGAAYFADATHPPGFDATLEATATYDPSDLVLANGGHAAIVEIDASTYATRVTDF
FAVEDCGTMINPMIVEGQIRGGIAQAIGQTLLEEVIYDDFGQLVTTTLMDYLIPTTLDVP
DIRIRHLETPSPLVPGGIKGMGESAMISAPAAVVAAVNDALAHLEVVIETVPITPERIFR
SIQERP
//
>1t3qD (A) [d.15.4 - a.56.1] QUINOLINE 2-OXIDOREDUCTASE SMALL SUBUNIT
SQLMRISATINGKPRVFYVEPRMHLADALREVVGLTGTKIGCEQGVCGSCTILIDGAPMR
SCLTLAVQAEGCSIETVEGLSQGEKLNALQDSFRRHHALQCGFCTAGMLATARSILAENP
APSRDEVREVMSGNLCRCTGYETIIDAITDPAVAEAARRGEV
//
>1t44G [d.109.1] CHIMERA OF GELSOLIN DOMAIN 1 AND C-TERMINAL
EHPEFLKAGKEPGLQIWRVEKFDLVPVPTNLYGDFFTGDAYVILKTVQLRNGNLQYDLHY
WLGNECSQDESGAAAIFTVQLDDYLNGRAVQHREVQGFESATFLGYFKSGLKYKKGGVAS
GFKHVETQEKNPLPSKETIEQEKQ
//
>1t44A [c.55.1 - c.55.1] ACTIN, ALPHA
TALVCDNGSGLVKAGFAGDDAPRAVFPSIVGRPDSYVGDEAQSKRGILTLKYPIEHGIIT
NWDDMEKIWHHTFYNELRVAPEEHPTLLTEAPLNPKANREKMTQIMFETFNVPAMYVAIQ
AVLSLYASGRTTGIVLDSGDGVTHNVPIYEGYALPHAIMRLDLAGRDLTDYLMKILTERG
YSFVTTAEREIVRDIKEKLCYVALDFENEMATAASSSSLEKSYELPDGQVITIGNERFRC
PETLFQPSFIGMESAGIHETTYNSIMKCDIDIRKDLYANNVMSGGTTMYPGIADRMQKEI
TALAPSTMKIKIIAPPERKYSVWIGGSILASLSTFQQMWITKQEYDEAGPSIVHRKCF
//
>1t4k_1A [b.1.1 - b.1.1] IMMUNOGLOBULIN IGG1, KAPPA LIGHT CHAIN
DIQMTQSPSSLAVSPGEKVTMSCRSSQSLFNSRTRKNYLAWYQQKPGQSPTKLIYWASTR
ESGVPDRFTGSGSGTDFTLTISSVQAEDLAIYYCKQSYDLPTFGAGTKLELKRSDAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRN
//
>1t4k_1B [b.1.1 - b.1.1] IMMUNOGLOBULIN IGG1, HEAVY CHAIN
EVMLVESGPGLVAPSQSLSITCTVSGFSLSDYGVSWIRQPPGKGLEWLGVIWGDGSTYYA
SALKFRLTISKDSSKSQVFLNMHSLQTDDSAMYYCAKHTYGGPGDSWGQGTSVTVSSAST
TPPSVFPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYT
LSSSVTVPSSPRPSETVTCNVAHPASSTKVDKKIVPR
//
>1t66_1L [b.1.1 - b.1.1] IMMUNOGLOBULIN LIGHT CHAIN
DVVMTQTPLSLPVSLGDQASISCRSSQSLVHSNGNTYLHWYLQKPGQSPKLLIYKVSNRF
SGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQSTHVPWTFGGGTKLEIKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQNSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1t66_1H [b.1.1 - b.1.1] IMMUNOGLOBULIN HEAVY CHAIN
EVKLDETGGGLVQPGRPMKLSCVASGFTFSDYWMNWVRQSPEKGLEWVAQIRNKPYNYET
YYSDSVKGRFTISRDDSKSSVYLQMNNLRAEDMGIYYCTSYGYHGAYWGQGTLVTVSAAK
TTAPSVYPLAPGTAALKSSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSALY
TLTSSVTVPSSSWPSQTVTCNVAHPASSTKVDKKIVPRNC
//
>1t6bX [f.11.1] PROTECTIVE ANTIGEN
SQGLLGYYFSDLNFQAPMVVTSSTTGDLSIPSSELENIPSENQYFQSAIWSGFIKVKKSD
EYTFATSADNHVTMWVDDQEVINKASNSNKIRLEKGRLYQIKIQYQRENPTEKGLDFKLY
WTDSQNKKEVISSDNLQLPELKQVPDRDNDGIPDSLEVEGYTVDVKNKRTFLSPWISNIH
EKKGLTKYKSSPEKWSTASDPYSDFEKVTGRIDKNVSPEARHPLVAAYPIVHVDMENIIL
SKNETISKNTSTSRTHTSEVVSAGFSNSNSSTVAIDHSLSLAGERTWAETMGLNTADTAR
LNANIRYVNTGTAPIYNVLPTTSLVLGKNQTLATIKAKENQLSQILAPNNYYPSKNLAPI
ALNAQDDFSSTPITMNYNQFLELEKTKQLRLDTDQVYGNIATYNFENGRVRVDTGSNWSE
VLPQIQETTARIIFNGKDLNLVERRIAAVNPSDPLETTKPDMTLKEALKIAFGFNEPNGN
LQYQGKDITEFDFNFDQQTSQNIKNQLAELNATNIYTVLDKIKLNAKMNILIRDKRFHYD
RNNIAVGADESVVKEAHREVINSSTEGLLLNIDKDIRKILSGYIVEIEDTEGLKEVINDR
YDMLNISSLRQDGKTFIDFKKYNDKLPLYISNPNYKVNVYAVTKENTIINPSENGDTSTN
GIKKILIFSKKGYEIG
//
>1t6bY [c.62.1] ANTHRAX TOXIN RECEPTOR 2
RAFDLYFVLDKSGSVANNWIEIYNFVQQLAERFVSPEMRLSFIVFSSQATIILPLTGDRG
KISKGLEDLKRVSPVGETYIHEGLKLANEQIQKAGGLKTSSIIIALTDGKLDGLVPSYAE
KEAKISRSLGASVYCVGVLDFEQAQLERIADSKEQVFPVKGGFQALKGII
//
>1t6g_2B (A) [b.50.1] XYLANASE INHIBITOR
LPVLAPVTKDPATSLYTIPFHDGASLVLDVAGPLVWSTCDGGQPPAEIPCSSPTCLLANA
YPAPGCPAPCTAYPYNPVSGACAAGSLSHTRFVANTTDGSKPVSKVNVGVLAACAPSKLL
ASLPRGSTGVAGLANSGLALPAQVASAQKVANRFLLCLPTGGPGVAIFGGGPVPWPQFTQ
SMPYTPLVTKGGSPAHYISARSIVVGDTRVPVPEGALATGGVMLSTRLPYVLLRPDVYRP
LMDAFTKALAAQGAPVARAVEAVAPFGVCYDTKTLGNNLGGYAVPNVQLGLDGGSDWTMT
GKNSMVDVKQGTACVAFVEMKGVAAGDGRAPAVILGGAQMEDFVLDFDMEKKRLGFSRLP
HFTGCGGL
//
>1t6g_2D (C) [b.29.1] ENDO-1,4-BETA-XYLANASE I
AGINYVQNYNGNLGDFTYDESAGTFSMYWEDGVSSDFVVGLGWTTGSSNAITYSAEYSAS
GSSSYLAVYGWVNYPQAEYYIVEDYGDYNPCSSATSLGTVYSDGSTYQVCTDTRTNEPSI
TGTSTFTQYFSVRESTRTSGTVTVANHFNFWAQHGFGNSDFNYQVMAVEAWSGAGSASVT
IS
//
>1t6v_1L [d.2.1] LYSOZYME C
KVFGRCELAAAMKRHGLDNYRGYSLGNWVCAAKFESNFNTQATNRNTDGSTDYGILQINS
RWWCNDGRTPGSRNLCNIPCSALLSSDITASVNCAKKIVSDGNGMNAWVAWRNRCKGTDV
QAWIRGCRL
//
>1t6v_1N [b.1.1] NOVEL ANTIGEN RECEPTOR
RVDQTPRSVTKETGESLTINCVLRDASYALGSTCWYRKKSGEGNEESISKGGRYVETVNS
GSKSFSLRINDLTVEDGGTYRCGLGVAGGYCDYALCSSRYAECGDGTAVTVN
//
>1t8oA [b.47.1] CHYMOTRYPSIN A
CGVPAIQPVLSIVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSD
VVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLP
SASDDFAAGTTCVTTGWGLTRYANTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGAS
GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN
//
>1t8oB [g.8.1] PANCREATIC TRYPSIN INHIBITOR
RPDFCLEPPYTGPCWARIIRYFYNAKAGLCQTFVYGGCRAKRNNFKSAEDCLRTCGGA
//
>1t9gD (B) [e.6.1 - a.29.3] ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN SPECIFIC,
LGFSFEFTEQQKEFQATARKFAREEIIPVAAEYDKTGEYPVPLIRRAWELGLMNTHIPEN
CGGLGLGTFDACLISEELAYGCTGVQTAIEGNSLGQMPIIIAGNDQQKKKYLGRMTEEPL
MCAYCVTEPGAGSDVAGIKTKAEKKGDEYIINGQKMWITNGGKANWYFLLARSDPDPKAP
ANKAFTGFIVEADTPGIQIGRKELNMGQRCSDTRGIVFEDVKVPKENVLIGDGAGFKVAM
GAFDKTRPVVAAGAVGLAQRALDEATKYALERKTFGKLLVEHQAISFMLAEMAMKVELAR
MSYQRAAWEVDSGRRNTYYASIAKAFAGDIANQLATDAVQILGGNGFNTEYPVEKLMRDA
KIYQIYEGTSQIQRLIVAREHIDKYKN
//
>1t9gS [c.26.2] ELECTRON TRANSFER FLAVOPROTEIN BETA-SUBUNIT
LRVLVAVKRVIDYAVKIRVKPDRTGVVTDGVKHSMNPFCEIAVEEAVRLKEKKLVKEVIA
VSCGPAQCQETIRTALAMGADRGIHVEVPPAEAERLGPLQVARVLAKLAEKEKVDLVLLG
KQAIDDDCNQTGQMTAGFLDWPQGTFASQVTLEGDKLKVEREIDGGLETLRLKLPAVVTA
DLRLNEPRYATLPNIMKAKKKKIEVIKPGDLGVDLTSKLSVISVEDPP
//
>1t9gR [c.26.2] ELECTRON TRANSFER FLAVOPROTEIN ALPHA-SUBUNIT,
QSTLVIAEHANDSLAPITLNTITAATRLGGEVSCLVAGTKCDKVAQDLCKVAGIAKVLVA
QHDVYKGLLPEELTPLILATQKQFNYTHICAGASAFGKNLLPRVAAKLEVAPISDIIAIK
SPDTFVRTIYAGNALCTVKCDEKVKVFSVRGTSFDAAATSGGSASSEKASSTSPVEISEW
LDQK
//
>1ta3A [c.1.8] XYLANASE INHIBITOR PROTEIN I
AGGKTGQVTVFWGRNKAEGSLREACDSGMYTMVTMSFLDVFGANGKYHLDLSGHDLSSVG
ADIKHCQSKGVPVSLSIGGYGTGYSLPSNRSALDLFDHLWNSYFGGSKPSVPRPFGDAWL
DGVDLFLEHGTPADRYDVLALELAKHNIRGGPGKPLHLTATVRCGYPPAAHVGRALATGI
FERVHVRTYESDKWCNQNLGWEGSWDKWTAAYPATRFYVGLTADDKSHQWVHPKNVYYGV
APVAQKKDNYGGIMLWDRYFDKQTNYSSLIKYYA
//
>1ta3B [c.1.8] ENDO-1,4-BETA-XYLANASE
ASLNDLFVAAGKSYFGTCSDQALLQNSQNEAIVASQFGVITPENSMKWDALEPSQGNFGW
SGADYLVDYATQHNKKVRGHTLVWHSQLPSWVSSIGDANTLRSVMTNHINEVVGRYKGKI
MHWDVVNEIFNEDGTFRNSVFYNLLGEDFVRIAFETARAADPDAKLYINDYNLDSASYAK
TQAMASYVKKWLAEGVPIDGIGSQAHYSSSHWSSTEAAGALSSLANTGVSEVAITELDIA
GAASSDYLNLLNACLNEQKCVGITVWGVSDKDSWRASDSPLLFDGNYQPKDAYNAIVNAL
S
//
>1tabA (I) [g.3.13] BOWMAN-BIRK TYPE PROTEINASE INHIBITOR
SESSKPCCDQCSCTKSMPPKCRCSDIRNDFCYEPCK
//
>1tabB (E) [b.47.1] TRYPSIN
IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEG
NEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISG
WGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGP
VVCSGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN
//
>1tafA [a.22.1] TFIID TBP ASSOCIATED FACTOR 42
PKDAQVIMSILKELNVQEYEPRVVNQLLEFTFRYVTSILDDAKVYANHARKKTIDLDDVR
LATEVTL
//
>1tafB [a.22.1] TFIID TBP ASSOCIATED FACTOR 62
MLYGSSISAESMKVIAESIGVGSLSDDAAKELAEDVSIKLKRIVQDAAKFMNHAKRQKLS
VRDIDMSLK
//
>1tawA [b.47.1] TRYPSIN
IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEG
NEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISG
WGNTKSSGTSYPDVLKCLKAPILSTSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGP
VVCSGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN
//
>1tawB [g.8.1] PROTEASE INHIBITOR DOMAIN OF ALZHEIMER'S AMYLOID
EVCSEQAETGPCRAMISRWYFDVTEGKCAPFFYGGCGGNRNNFDTEEYCMAVCG
//
>1tb6H [b.47.1] THROMBIN
IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL
VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL
PDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIR
ITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFY
THVFRLKKWIQKVIDQFGE
//
>1tb6I [e.1.1] ANTITHROMBIN-III
PVDICTAKPRDIPMNPMCIYRSPEQKIPEATNRRVWELSKANSRFATTFYQHLADSKNDN
DNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLNCRLYRK
ANKASKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNK
TEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMY
QEGKFRYRRVAEGTQVLELPFKGDDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEE
MMLCVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEGRDDLYVSDAFHKAFL
EVNEEGTAVVIAGRSLNPNRVCFKANRPFLVFIREVPLNTIIFMGRVANPCV
//
>1tbq_1L [b.47.1] THROMBIN
TSEDHFQPFFNEKTFGAGEADCGLRPLFEKKQVQDQTEKELFESYIEGR
//
>1tbq_1H [b.47.1] THROMBIN
IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLL
VRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCL
PDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKASTRIR
ITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFY
THVFRLKKWIQKVIDRLGS
//
>1tbr_2B (H) [b.47.1] THROMBIN
IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLL
VRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCL
PDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKASTRIR
ITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFY
THVFRLKKWIQKVIDRLGS
//
>1tbr_2C (R) [g.68.1 - g.68.1] RHODNIIN
EGGEPCACPHALHRVCGSDGETYSNPCTLNCAKFNGKPELVKVHDGPCEPDEDEDVCQEC
DGDEYKPVCGSDDITYDNNCRLECASISSSPGVELKHEGPCRT
//
>1tcoA [d.159.1] SERINE/THREONINE PHOSPHATASE B2
VPFPPSHRLTAKEVFDNDGKPRVDILKAHLMKEGRLEETVALRIITEGASILRQEKNLLD
IDAPVTVCGDIHGQFFDLMKLFEVGGSPANTRYLFLGDYVDRGYFSIECVLYLWALKILY
PKTLFLLRGNHECRHLTEYFTFKQECKIKYSERVYDACMDAFDCLPLAALMNQQFLCVHG
GLSPEINTLDDIRKLDRFKEPPAYGPMCDILWSDPLEDFGNEKTQEHFTHNTVRGCSYFY
SYPAVCEFLQHNNLLSILRAHEAQDAGYRMYRKSQTTGFPSLITIFSAPNYLDVYNNKAA
VLKYENNVMNIRQFNCSPHPYWLPNFMDVFTWSLPFVGEKVTEMLVNVLNIC
//
>1tcoB [a.39.1] SERINE/THREONINE PHOSPHATASE B2
GNEASYPLEMCSHFDADEIKRLGKRFKKLDLDNSGSLSVEEFMSLPELQQNPLVQRVIDI
FDTDGNGEVDFKEFIEGVSQFSVKGDKEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVG
NNLKDTQLQQIVDKTIINADKDGDGRISFEEFCAVVGGLDIHKKMVVDV
//
>1tcoC [d.26.1] FK506-BINDING PROTEIN
GVQVETISPGDGRTFPKAGQTCVVHYTGMLEDGKKFDSSRDRNKPFKFMLGKQEVIRGWE
EGVAQMSVGQRAKLTISPDYAYGATGHPGIIPPHATLVFDVELLKLE
//
>1tdqA [b.1.2 - b.1.2 - b.1.2] TENASCIN-R
IPVIDGPTQILVRDVSDTVAFVEWTPPRAKVDFILLKYGLVGGEGGKTTFRLQPPLSQYS
VQALRPGSRYEVSISAVRGTNESDASSTQFTTEIDAPKNLRVGSRTATSLDLEWDNSEAE
AQEYKVVYSTLAGEQYHEVLVPKGIGPTTKTTLTDLVPGTEYGVGISAVMNSKQSIPATM
NARTELDSPRDLMVTASSETSISLIWTKASGPIDHYRITFTPSSGISSEVTVPRDRTSYT
LTDLEPGAEYIISITAERGRQQSLESTVDAF
//
>1tdqB [d.169.1] AGGRECAN CORE PROTEIN
EQCEEGWTKFQGHCYRHFPDRETWVDAERRCREQQSHLSSIVTPEEQEFVNKNAQDYQWI
GLNDRTIEGDFRWSDGHSLQFEKWRPNQPDNFFATGEDCVVMIWHERGEWNDVPCNYQLP
FTCKKG
//
>1te1A [c.1.8] XYLANASE INHIBITOR PROTEIN I
AGGKTGQVTVFWGRNKAEGSLREACDSGMYTMVTMSFLDVFGANGKYHLDLSGHDLSSVG
ADIKHCQSKGVPVSLSIGGYGTGYSLPSNRSALDLFDHLWNSYFGGSKPSVPRPFGDAWL
DGVDLFLEHGTPADRYDVLALELAKHNIRGGPGKPLHLTATVRCGYPPAAHVGRALATGI
FERVHVRTYESDKWCNQNLGWEGSWDKWTAAYPATRFYVGLTADDKSHQWVHPKNVYYGV
APVAQKKDNYGGIMLWDRYFDKQTNYSSLIKYYA
//
>1te1B [b.29.1] ENDO-1,4-XYLANASE
QSITTSQTGTNNGYYYSFWTNGGGEVTYTNGDNGEYSVTWVDCGDFTSGKGWNPANAQTV
TYSGEFNPSGNAYLAVYGWTTDPLVEYYILESYGTYNPSSGLTSLGQVTSDGGTYDIYST
QRVNQPSIEGTSTFNQYWSVRTEKRVGGTVTTANHFAAWKALGLEMGTYNYMIVSTEGYE
SSGSSTITVS
//
>1tfkA [d.243.1] COLICIN D
QLDKKYKHAGDFGISDTKKNRETLTKFRDAIEEHLSDKDTVEKGTYRREKGSKVYFNPNT
MNVVIIKSNGEFLSGWKINPDADNGRIYLETGEL
//
>1tfkB [a.24.20] COLICIN D IMMUNITY PROTEIN
KMAMIDLAKLFLASKITAIEFSERICVERRRLYGVKDLSPNILNCGEELFMAAERFEPDA
DRANYEIDDNGLKVEVRSILEKFKLH
//
>1tfx_2B (A) [b.47.1] TRYPSIN
IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYKSRIQVRLGEHNIDVLEG
NEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSCAAAGTECLISG
WGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSYPGQITGNMICVGFLEGGKDSCQGDSGGP
VVCNGQLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIAAN
//
>1tfx_2D (C) [g.8.1] TISSUE FACTOR PATHWAY INHIBITOR
KPDFCFLEEDPGICRGYITRYFYNNQTKQCERFKYGGCLGNMNNFETLEECKNICEDG
//
>1tgsZ [b.47.1] TRYPSINOGEN
DKIVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVV
EGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLI
SGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSG
GPVVCSGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN
//
>1tgsI [g.68.1] PANCREATIC SECRETORY TRYPSIN INHIBITOR (KAZAL
TSPQREATCTSEVSGCPKIYNPVCGTDGITYSNECVLCSENKKRQTPVLIQKSGPC
//
>1th1_2B [a.118.1] BETA-CATENIN
AELATRAIPELTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNT
NDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLH
QEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALV
NIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTL
RNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIE
ALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWP
LIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSQFVEGVRMEEIVE
GCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAI
EAEGATAPLTELLHSRNEGVATYAAAVLFRMSE
//
>1th1_2D [x.x.x] ADENOMATOUS POLYPOSIS COLI PROTEIN
QAAVNAAVQRVQVLPDADxLLHFATESTxxLxALxLDEPFIQKDVELRIMPPVQ
//
>1th8A [d.122.1] ANTI-SIGMA F FACTOR
MRNEMHLQFSARSENESFARVTVAAFVAQLDPTMDELTEIKTVVSEAVTNAIIHGYNNDP
NGIVSISVIIEDGVVHLTVRDEGVGIPDIEEARQPLERSGMGFTIMENFMDEVIVESEVN
KGTTVYLKKHGI
//
>1th8B [c.13.2] ANTI-SIGMA F FACTOR ANTAGONIST
SLAIDLEVKQDVLIVRLSGELDHHTAEELREQVTDVLENRAIRHIVLNLGQLTFMDSSGL
GVILGRYKQIKNVGGQMVVCAVSPAVKRLFDMSGLFKIIRVEADEQFALQALGVA
//
>1ti8A [b.19.1] HEMAGGLUTININ
ICLGHHAVSNGTKVNTLTERGVEVVNATETVERTNVPRICSKGKRTVDLGQCGLLGTITG
PPQCDQFLEFSADLIIERREGSDVCYPGKFVNEEALRQILRESGGIDKETMGFTYSGIRT
NGATSACRRSGSSFYAEMKWLLSNTDNAAFPQMTKSYKNTRKDPALIIWGIHHSGSTTEQ
TKLYGSGNKLITVGSSNYQQSFVPSPGARPQVNGQSGRIDFHWLMLNPNDTVTFSFNGAF
IAPDRASFLRGKSMGIQSSVQVDANCEGDCYHSGGTIISNLPFQNINSRAVGKCPRYVKQ
ESLMLATGMKNVPE
//
>1ti8B [h.3.1] HEMAGGLUTININ
GLFGAIAGFIENGWEGLIDGWYGFRHQNAQGEGTAADYKSTQSAIDQITGKLNRLIEKTN
QQFELIDNEFTEVEKQIGNVINWTRDSMTEVWSYNAELLVAMENQHTIDLTDSEMNKLYE
RVKRQLRENAEEDGTGCFEIFHKCDDDCMASIRNNTYDHSRYREEA
//
>1tiiE (D) [b.40.2] HEAT LABILE ENTEROTOXIN TYPE IIB
GASQFFKDNCNRTTASLVEGVELTKYISDINNNTDGMYVVSSTGGVWRISRAKDYPDNVM
TAEMRKIAMAAVLSGMRVNMCASPASSPNVIWAIELEA
//
>1tiiH (D) [b.40.2] HEAT LABILE ENTEROTOXIN TYPE IIB
GASQFFKDNCNRTTASLVEGVELTKYISDINNNTDGMYVVSSTGGVWRISRAKDYPDNVM
TAEMRKIAMAAVLSGMRVNMCASPASSPNVIWAIELEA
//
>1tiiC [d.166.1] HEAT LABILE ENTEROTOXIN TYPE IIB
TTCASLTNKLSQHDLADFKKYIKRKFTLMTLLSINN
//
>1tiiA [d.166.1] HEAT LABILE ENTEROTOXIN TYPE IIB
NDYFRADSRTPDEVRRSGGLIPRGQDEAYERGTPININLYDHARGTTGNTRYNDGYVSTT
TTLRQAHLLGQNMLGGYNEYYIYVVAAAPNLFDVNGVLGRYSPYPSENEYAALGGIPLSQ
IIGWYRVSFGAIEGGMHRNRDYRRDLFRGLSAAPNEDGYRIAGFPDGFPAWEEVPWREFA
PNSCLP
//
>1tilC (A) [d.122.1] ANTI-SIGMA F FACTOR
MRNEMHLQFSARSENESFARVTVAAFVAQLDPTMDELTEIKTVVSEAVTNAIIHGYNNDP
NGIVSISVIIEDGVVHLTVRDEGVGIPDIEEARQPLFTTKPELERSGMGFTIMENFMDEV
IVESEVNKGTTVYLKKHIVKS
//
>1tilD [c.13.2] ANTI-SIGMA F FACTOR ANTAGONIST
SHMSLAIDLEVKQDVLIVRLSGELDHHTAEELREQVTDVLENRAIRHIVLNLGQLTFMDA
SGLGVILGRYKQIKNVGGQMVVCAVSPAVKRLFDMSGLFKIIRVEADEQFALQALGVA
//
>1tjhL [b.1.1 - b.1.1] ANTI-HIV-1 ANTIBODY 2F5 LIGHT CHAIN
ALQLTQSPSSLSASVGDRITITCRASQGVTSALAWYRQKPGSPPQLLIYDASSLESGVPS
RFSGSGSGTEFTLTISTLRPEDFATYYCQQLHFYPHTFGGGTRVDVRRTVAAPSVFIFPP
SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT
LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEx
//
>1tjhH [b.1.1 - b.1.1] ANTI-HIV-1 ANTIBODY 2F5 HEAVY CHAIN
RITLKESGPPLVKPTQTLTLTCSFSGFSLSDFGVGVGWIRQPPGKALEWLAIIYSDDDKR
YSPSLNTRLTITKDTSKNQVVLVMTRVSPVDTATYFCAHRRGPTTLFGVPIARGPVNAMD
VWGQGITVTISSTSTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTS
GVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSxDK
//
>1tmcA [d.19.1] CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-AW68)
GSHSMRYFYTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGPEYW
DRNTRNVKAQSQTDRVDLGTLRGYYNQSEAGSHTIQMMYGCDVGSDGRFLRGYRQDAYDG
KDYIALKEDLRSWTAADMAAQTTKHKWEAAHVAEQWRAYLEGTCVEWLRRYLENG
//
>1tmcB [b.1.1] BETA 2-MICROGLOBULIN
IQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDW
SFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM
//
>1tme_21 [b.121.4] THEILER'S MURINE ENCEPHALOMYELITIS VIRUS
GSDNAEKGKVSNDDASVDFVAEPVKLPENQTRVAFFYDRAVPIGMLRPGQNIESTFVYQE
NDLRLNCLLLTPLPSFCPDSTSGPVKTKAPVQWRWVRSGGTTNFPLMTKQDYAFLCFSPF
TYYKCDLEVTVSALGTDTVASVLRWAPTGAPADVTDQLIGYTPSLGETRNPHMWLVGAGN
TQISFVVPYNSPLSVLPAAWFNGWSDFGNTKDFGVAPNADFGRLWIQGNTSASVRIRYKK
MKVFCPRPTLFFPWPV
//
>1tme_22 [b.121.4] THEILER'S MURINE ENCEPHALOMYELITIS VIRUS
DRVASDKAGNSATNTQSTVGRLCGYGEAHHGEHPASCADTATDKVLAAERYYTIDLASWT
TTQEAFSHIRIPLPHVLAGEDGGVFGATLRRHYLCKTGWRVQVQCNASQFHAGSLLVFMA
PEFYTGKGTKTGDMEPTDPFTMDTTWRAPQGAPTGYRYDSRTGFFAMNHQNQWQWTVYPH
QILNLRTNTTVDLEVPYVNIAPTSSWTQHANWTLVVAVFSPLQYASGSSSDVQITASIQP
VNPVFNGLRHETVIA
//
>1tme_23 [b.121.4] THEILER'S MURINE ENCEPHALOMYELITIS VIRUS
SPIAVTVREHKGCFYSTNPDTTVPIYGKTISTPNDYMCGEFSDLLELCKLPTFLGNPNSN
NKRYPYFSATNSVPTTSLVDYQVALSCSCMCNSMLAAVARNFNQYRGSLNFLFVFTGAAM
VKGKFLIAYTPPGAGKPTTRDQAMQATYAIWDLGLNSSFVFTAPFISPTHYRQTSYTSAA
SVDGWVTVWQLTPLTYPSGTPVNSDILTLVSAGDDFTLRMPISPTKWVPQ
//
>1tme_24 [b.121.4] THEILER'S MURINE ENCEPHALOMYELITIS VIRUS
SGNEGVIINNFYSNQYQNSIDLSAS
//
>1tmf_21 [b.121.4] THEILER'S MURINE ENCEPHALOMYELITIS VIRUS
GVDNAEKGKVSNDDASVDFVAEPVKLPENQTRVAFFYDRAVPIGMLRPGQNMETTFNYQE
NDYRLNCLLLTPLPSFCPDSSSGPQKTKAPVQWRWVRSGGVNGANFPLMTKQDYAFLCFS
PFTFYKCDLEVTVSALGTDTVASVLRWAPTGAPADVTDQLIGYTPSLGETRNPHMWLVGA
GNSQVSFVVPYNSPLSVLPAAWFNGWSDFGNTKDFGVAPNADFGRLWIQGNTSASVRIRY
KKMKVFCPRPTLFFPWPTPTTTKINADNPVPILELE
//
>1tmf_22 [b.121.4] THEILER'S MURINE ENCEPHALOMYELITIS VIRUS
DQNTEEMENLSDRVASDKAGNSATNTQSTVGRLCGYGKSHHGEHPASCADTATDKVLAAE
RYYTIDLASWTTSQEAFSHIRIPLPHVLAGEDGGVFGATLRRHYLCKTGWRVQVQCNASQ
FHAGSLLVFMAPEFYTGKGTKTGTMEPSDPFTMDTEWRSPQGAPTGYRYDSRTGFFATNH
QNQWQWTVYPHQILNLRTNTTVDLEVPYVNVAPSSSWTQHANWTLVVAVLSPLQYATGSS
PDVQITASLQPVNPVFNGLRHETVIAQ
//
>1tmf_23 [b.121.4] THEILER'S MURINE ENCEPHALOMYELITIS VIRUS
SPIPVTVREHKGCFYSTNPDTTVPIYGKTISTPSDYMCGEFSDLLELCKLPTFLGNPNTN
NKRYPYFSATNSVPATSMVDYQVALSCSCMANSMLAAVARNFNQYRGSLNFLFVFTGAAM
VKGKFLIAYTPPGAGKPTTRDQAMQSTYAIWDLGLNSSFNFTAPFISPTHYRQTSYTSPT
ITSVDGWVTVWQLTPLTYPSGTPTNSDILTLVSAGDDFTLRMPISPTKWVPQ
//
>1tmf_2F (2) [b.121.4] THEILER'S MURINE ENCEPHALOMYELITIS VIRUS
DQNTEEMENLSDRVASDKAGNSATNTQSTVGRLCGYGKSHHGEHPASCADTATDKVLAAE
RYYTIDLASWTTSQEAFSHIRIPLPHVLAGEDGGVFGATLRRHYLCKTGWRVQVQCNASQ
FHAGSLLVFMAPEFYTGKGTKTGTMEPSDPFTMDTEWRSPQGAPTGYRYDSRTGFFATNH
QNQWQWTVYPHQILNLRTNTTVDLEVPYVNVAPSSSWTQHANWTLVVAVLSPLQYATGSS
PDVQITASLQPVNPVFNGLRHETVIAQ
//
>1tmf_2G (3) [b.121.4] THEILER'S MURINE ENCEPHALOMYELITIS VIRUS
SPIPVTVREHKGCFYSTNPDTTVPIYGKTISTPSDYMCGEFSDLLELCKLPTFLGNPNTN
NKRYPYFSATNSVPATSMVDYQVALSCSCMANSMLAAVARNFNQYRGSLNFLFVFTGAAM
VKGKFLIAYTPPGAGKPTTRDQAMQSTYAIWDLGLNSSFNFTAPFISPTHYRQTSYTSPT
ITSVDGWVTVWQLTPLTYPSGTPTNSDILTLVSAGDDFTLRMPISPTKWVPQ
//
>1tmf_2z (4) [b.121.4] THEILER'S MURINE ENCEPHALOMYELITIS VIRUS
NESGNEGVIINNFYSNQYQNSIDLSALSNLL
//
>1tmf_23 [b.121.4] THEILER'S MURINE ENCEPHALOMYELITIS VIRUS
SPIPVTVREHKGCFYSTNPDTTVPIYGKTISTPSDYMCGEFSDLLELCKLPTFLGNPNTN
NKRYPYFSATNSVPATSMVDYQVALSCSCMANSMLAAVARNFNQYRGSLNFLFVFTGAAM
VKGKFLIAYTPPGAGKPTTRDQAMQSTYAIWDLGLNSSFNFTAPFISPTHYRQTSYTSPT
ITSVDGWVTVWQLTPLTYPSGTPTNSDILTLVSAGDDFTLRMPISPTKWVPQ
//
>1tmf_2G (3) [b.121.4] THEILER'S MURINE ENCEPHALOMYELITIS VIRUS
GVDNAEKGKVSNDDASVDFVAEPVKLPENQTRVAFFYDRAVPIGMLRPGQNMETTFNYQE
NDYRLNCLLLTPLPSFCPDSSSGPQKTKAPVQWRWVRSGGVNGANFPLMTKQDYAFLCFS
PFTFYKCDLEVTVSALGTDTVASVLRWAPTGAPADVTDQLIGYTPSLGETRNPHMWLVGA
GNSQVSFVVPYNSPLSVLPAAWFNGWSDFGNTKDFGVAPNADFGRLWIQGNTSASVRIRY
KKMKVFCPRPTLFFPWPTPTTTKINADNPVPILELE
//
>1tmf_2I (3) [b.121.4] THEILER'S MURINE ENCEPHALOMYELITIS VIRUS
SPIPVTVREHKGCFYSTNPDTTVPIYGKTISTPSDYMCGEFSDLLELCKLPTFLGNPNTN
NKRYPYFSATNSVPATSMVDYQVALSCSCMANSMLAAVARNFNQYRGSLNFLFVFTGAAM
VKGKFLIAYTPPGAGKPTTRDQAMQSTYAIWDLGLNSSFNFTAPFISPTHYRQTSYTSPT
ITSVDGWVTVWQLTPLTYPSGTPTNSDILTLVSAGDDFTLRMPISPTKWVPQ
//
>1tmf_2p (4) [b.121.4] THEILER'S MURINE ENCEPHALOMYELITIS VIRUS
NESGNEGVIINNFYSNQYQNSIDLSALSNLL
//
>1tmqA [c.1.8 - b.71.1] PROTEIN (ALPHA-AMYLASE)
xKDANFASGRNSIVHLFEWKWNDIADECERFLQPQGFGGVQISPPNEYLVADGRPWWERY
QPVSYIINTRSGDESAFTDMTRRCNDAGVRIYVDAVINHMTGMNGVGTSGSSADHDGMNY
PAVPYGSGDFHSPCEVNNYQDADNVRNCELVGLRDLNQGSDYVRGVLIDYMNHMIDLGVA
GFRVDAAKHMSPGDLSVIFSGLKNLNTDYGFADGARPFIYQEVIDLGGEAISKNEYTGFG
CVLEFQFGVSLGNAFQGGNQLKNLANWGPEWGLLEGLDAVVFVDNHDNQRTGGSQILTYK
NPKPYKMAIAFMLAHPYGTTRIMSSFDFTDNDQGPPQDGSGNLISPGINDDNTCSNGYVC
EHRWRQVYGMVGFRNAVEGTQVENWWSNDDNQIAFSRGSQGFVAFTNGGDLNQNLNTGLP
AGTYCDVISGELSGGSCTGKSVTVGDNGSADISLGSAEDDGVLAIHVNAKL
//
>1tmqB [a.52.1] PROTEIN (RAGI BIFUNCTIONAL INHIBITOR)
SVGTSCIPGMAIPHNPLDSCRWYVSTRTCGVGPRLATQEMKARCCRQLEAIPAYCRCEAV
RILMDGVVTSSGQHEGRLLQDLPGCPRQVQRAFAPKLVTEVECNLATIHGGPFCLSL
//
>1tnrA [b.22.1] TUMOR NECROSIS FACTOR BETA
KPAAHLIGDPSKQNSLLWRANTDRAFLQDGFSLSNNSLLVPTSGIYFVYSQVVFSGKAYS
PKATSSPLYLAHEVQLFSSQYPFHVPLLSSQKMVYPGLQEPWLHSMYHGAAFQLTQGDQL
STHTDGIPHLVLSPSTVFFGAFAL
//
>1tnrR [g.24.1 - g.24.1 - g.24.1] TUMOR NECROSIS FACTOR RECEPTOR P55
CPQGKYIHPQNNSICCTKCHKGTYLYNDCPGPGQDTDCRECESGSFTASENHLRHCLSCS
KCRKEMGQVEISSCTVDRDTVCGCRKNQYRHYWSENLFQCFNCSLCLNGTVHLSCQEKQN
TVCTCHAGFFLRENECVSC
//
>1tny_2C (A) [a.118.6] GERANYLGERANYLTRANSFERASE TYPE I ALPHA SUBUNIT
FLSLDSPTYVLYRDRAEWADIDPVPQNDGPSPVVQIIYSEKFRDVYDYFRAVLQRDERSE
RAFKLTRDAIELNAANYTVWHFRRVLLRSLQKDLQEEMNYIIAIIEEQPKNYQVWHHRRV
LVEWLKDPSQELEFIADILNQDAKNYHAWQHRQWVIQEFRLWDNELQYVDQLLKEDVRNN
SVWNQRHFVISNTTGYSDRAVLEREVQYTLEMIKLVPHNESAWNYLKGILQDRGLSRYPN
LLNQLLDLQPSHSSPYLIAFLVDIYEDMLENQCDNKEDILNKALELCEILAKEKDTIRKE
YWRYIGRSLQSKHS
//
>1tny_2D (B) [a.102.4] GERANYLGERANYL TRANSFERASE TYPE I BETA SUBUNIT
LDFLRDRHVRFFQRCLQVLPERYSSLETSRLTIAFFALSGLDMLDSLDVVNKDDIIEWIY
SLQVLPTEDRSNLDRCGFRGSSYLGIPFNPSKNPGTAHPYDSGHIAMTYTGLSCLIILGD
DLSRVDKEACLAGLRALQLEDGSFCAVPEGSENDMRFVYCASCICYMLNNWSGMDMKKAI
SYIRRSMSYDNGLAQGAGLESHGGSTFCGIASLCLMGKLEEVFSEKELNRIKRWCIMRQQ
NGYHGRPNKPVDTCYSFWVGATLKLLKIFQYTNFEKNRNYILSTQDRLVGGFAKWPDSHP
DALHAYFGICGLSLMEESGICKVHPALNVSTRTSERLRDLHQSWKT
//
>1toc_2D (B) [b.47.1] THROMBIN
IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLL
VRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCL
PDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKASTRIR
ITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFY
THVFRLKKWIQKVIDRLGS
//
>1toc_2S (R) [g.8.1 - g.8.1] ORNITHODORIN
SLNVLCNNPHTADCNNDAQVDRYFREGTTCLMSPACTSEGYASQHECQQACFVGGEDHSS
EMHSSCLGDPPTSCAEGTDITYYDSDSKTCKVLAASCPSGENTFESEVECQVACGAPIEG
//
>1tpaA (I) [g.8.1] BOVINE PANCREATIC TRYPSIN INHIBITOR
RPDFCLEPPYTGPCKARIIRYFYNAKAGLCQTFVYGGCRAKRNNFKSAEDCMRTCGGA
//
>1tpaB (E) [b.47.1] ANHYDRO-TRYPSIN
IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEG
NEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISG
WGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGP
VVCSGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN
//
>1tpxA [d.6.1] MAJOR PRION PROTEIN
GLGGYMLGSAMSRPLIHFGNDYEDRYYRENMYRYPNQVYYRPVDQYSNQNNFVHDCVNIT
VKQHTVTTTTKGENFTETDIKIMERVVEQMCITQYQRESQAY
//
>1tpxB [b.1.1 - b.1.1] THE VRQ14 FAB
QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNLVKQAPGKGFEWMGWINTFTGEPTY
ADDFKGRFVFSLDTSASTAYLQINNLKNEDTATYFFTRGTDYWGQGTTLTVSSAKTTAPS
VYPLAPVCGDTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDLYTLSSS
VTVTSSTWPSQSITCNVAHPASSTKVDKKIEP
//
>1tpxC [b.1.1 - b.1.1] THE VRQ14 FAB
DVVMSQTPLTLSVTIGQPASISCKSSQSLLDSDGKTYLNWLLQRPGQSPKRLIYLVSRLD
SGVPDRFTGSGSGTDFTLKISRVEAEDLGIYFCWQGSHFPQTFGGGTKLEIKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1tqcA [d.6.1] PRION PROTEIN
GLGGYMLGSAMSRPLIHFGNDYEDRYYRENMYRYPNQVYYRPVDRYSNQNNFVHDCVNIT
VKQHTVTTTTKGENFTETDIKIMERVVEQMCITQYQRESQAY
//
>1tqcC [b.1.1 - b.1.1] VRQ14 FAB LIGHT CHAIN
DVVMSQTPLTLSVTIGQPASISCKSSQSLLDSDGKTYLNWLLQRPGQSPKRLIYLVSRLD
SGVPDRFTGSGSGTDFTLKISRVEAEDLGIYFCWQGSHFPQTFGGGTKLEIKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1tqe_1Q (P) [d.88.1] MYOCYTE-SPECIFIC ENHANCER FACTOR 2B
GRKKIQISRILDQRNRQVTFTKRKFGLMKKAYELSVLCDCEIALIIFNSANRLFQYASTD
MDRVLLKYTEYSEPHESRTNTDILETLKRR
//
>1tqe_1X [x.x.x] HISTONE DEACETYLASE 9
SPKGTGASTEVKQKLQEFLLSKS
//
>1tqy_2C (A) [c.95.1 - c.95.1] BETA-KETOACYL SYNTHASE/ACYL TRANSFERASE
RRVVITGVGVRAPGGNGTRQFWELLTSGRTATRRISFFDPSPYRSQVAAEADFDPVAEGF
GPRELDRMDRASQFAVACAREAFAASGLDPDTLDPARVGVSLGSAVAAATSLEREYLLLS
DSGRDWEVDAAWLSRHMFDYLVPSVMPAEVAWAVGAEGPVTMVSTGCTSGLDSVGNAVRA
IEEGSADVMFAGAADTPITPIVVACFDAIRATTARNDDPEHASRPFDGTRDGFVLAEGAA
MFVLEDYDSALARGARIHAEISGYATRCNAYHMTGLKADGREMAETIRVALDESRTDATD
IDYINAHGSGTRQNDRHETAAYKRALGEHARRTPVSSIKSMVGHSLGAIGSLEIAACVLA
LEHGVVPPTANLRTSDPECDLDYVPLEARERKLRSVLTVGSGFGGFQSAMVLRDAETAGA
A
//
>1tqy_2D (B) [c.95.1 - c.95.1] ACTINORHODIN POLYKETIDE PUTATIVE BETA-KETOACYL
SVLITGVGVVAPNGLGLAPYWSAVLDGRHGLGPVTRFDVSRYPATLAGQIDDFHAPDHIP
GRLLPQTDPSTRLALTAADWALQDAKADPESLTDYDMGVVTANACGGFDFTHREFRKLWS
EGPKSVSVYESFAWFYAVNTGQISIRHGMRGPSSALVAEQAGGLDALGHARRTIRRGTPL
VVSGGVDSALDPWGWVSQIASGRISTATDPDRAYLPFDERAAGYVPGEGGAILVLEDSAA
AEARGRHDAYGELAGCASTFDPAPGSGRPAGLERAIRLALNDAGTGPEDVDVVFADGAGV
PELDAAEARAIGRVFGREGVPVTVPKTTTGRLYSGGGPLDVVTALMSLREGVIAPTAGVT
SVPREYGIDLVLGEPRSTAPRTALVLARGRWGFNSAAVLRRF
//
>1ts5A [b.40.2 - d.15.6] TOXIC SHOCK SYNDROME TOXIN-1
STNDNIKDLLDWYSSGSDTFTNSEVLDNSLGSMRIKNTDGSISLIIFPSPYYSPAFTKGE
KVDLNTKRTKKSQHTSEGTYIHFQISGVTNTEKLPTPIELPLKVKVHGKDSPLKYWPKFD
KKQLAISTLDFEIRHQLTQTHGLYRSSDKTGGYWKITMNDGSTYQSDLSKKFEYNTEKPP
INIDEIKTIEAEIN
//
>1ts5B [x.x.x]
YYSPAFTKGEKVDLNTKRTKKSQHTSEGTYIHFQISGVTNTEKLPTPIELPLKVKVHGKD
SPLKYWPKFDKKQLAISTLDFEIRHQLTQTHGLYRSSDKTGGYWKITMNDGSTYQSDLSK
KFEYNTEKPPINIDEIKTIEAEIN
//
>1ts5D [x.x.x]
YYSPAFTKGEKVDLNTKRTKKSQHTSEGTYIHQSGVTNTEKLPTPIELPLKVVGKDSPLK
YPFKKQLAISTLDFEIRHQLTQTHGLRSSDKTGGYWKITMNDGSTYQSDLSKKFEYNTEK
PPINIDEKTIEAEIN
//
>1ts5F [x.x.x]
STNDNIKDLLDWYSSGSDTFTNSEVLDNSLGSMRIKNTDGSISLIIFPS
//
>1tt5_1A [c.111.1] AMYLOID PROTEIN-BINDING PROTEIN 1
MAQLGKLLKEQKYDRQLRLWGDHGQEALESAHVCLINATATGTEILKNLVLPGIGSFTII
DGNQVSGEDAGNNFFLQRSSIGKNRAEAAMEFLQELNSDVSGSFVEESPENLLDNDPSFF
CRFTVVVATQLPESTSLRLADVLWNSQIPLLICRTYGLVGYMRIIIKEHPVIESHPDNAL
EDLRLDKPFPELREHFQSYDDHSHTPWIVIIAKYLAQWYSETNGRIPKTYKEKEDFRDLI
RQGILKPEDEENFEEAIKNVNTALNTTQIPSSIEDIFNDDRCINITKQTPSFWILARALK
EFVAKEGQGNLPVRGTIPDMIADSGKYIKLQNVYREKAKKDAAAVGNHVAKLLQSIGQAP
ESISEKELKLLCSNSAFLRVVRCRSLAEEYGLDTINKDEIISSMDNPDNEIVLYLMLRAV
DRFHKQQGRYPGVSNYQVEEDIGKLKSCLTGFLQEYGLSVMVKDDYVHEFCRYGAAEPHT
IAAFLGGAAAQEVIKIITKQFVIFNNTYIYSGMSQTSATFQL
//
>1tt5_1B [c.111.1] UBIQUITIN-ACTIVATING ENZYME E1C ISOFORM 1
MKLDWEGRWNHVKKFLERSGPFTHPDFEPSTESLQFLLDTCKVLVIGAGGLGCELLKNLA
LSGFRQIHVIDMDTIDVSNLNRQFLFRPKDIGRPKAEVAAEFLNDRVPNCNVVPHFNKIQ
DFNDTFYRQFHIIVCGLDSIIARRWINGMLISLLNYEDGVLDPSSIVPLIDGGTEGFKGN
ARVILPGMTACIECTLELYPPQVNFPMCTIASMPRLPEHCIEYVRMLQWPKEQPFGEGVP
LDGDDPEHIQWIFQKSLERASQYNIRGVTYRLTQGVVKRIIPAVASTNAVIAAVCATEVF
KIATSAYIPLNNYLVFNDVDGLYTYTFEAERKENCPACSQLPQNIQFLQEVLDYLTNSAS
LQMKSPAITATNRTLYLQSVTSIEERTRPLSKGLVDGQELAVADVTTPQTVLFK
//
>1ttwA [d.198.1] SECRETION CHAPERONE
TYSSLLEEFATELGLEEIETNELGHGAVTIDKIWVVHLAPINEKELVAFMRAGILTGQSQ
LYDILRKNLFSPLSGVIRCALDKDDHWLLWSQLNINDTSGTQLASVLTSLVDKAVTLS
//
>1ttwB [x.x.x] YSCM2
VSTQAITSDERRFAYAVLEH
//
>1tu3_1A [c.37.1] RAS-RELATED PROTEIN RAB-5A
ICQFKLVLLGESAVGKSSLVLRFVKGQFHEFQESTIGAAFLTQTVCLDDTTVKFEIWDTA
GQERYHSLAPMYYRGAQAAIVVYDITNEESFARAKNWVKELQRQASPNIVIALSGNKADL
ANKRAVDFQEAQSYADDNSLLFMETSAKTSMNVNEIFMAIAKKLP
//
>1tu3_1F [h.1.27] RAB GTPASE BINDING EFFECTOR PROTEIN 1
AQRLQTELDVSEQVQRDFVKLSQTLQVQLERIRQADSLERIRAILN
//
>1tu3_2D [c.37.1] RAS-RELATED PROTEIN RAB-5A
KLVLLGESAVGKSSLVLRFVKGQFQESTIGAAFLTQTVCDTTVEIWDTAGQERYHSLAPM
YYRGAQAAIVVYDITNEESFARAKNWVKELIVIALSGNKADLANKRAVDFQEAQSYADDN
SLLFMETSAKTSMNVNEIFMAIAKKLP
//
>1tu3_2I [h.1.27] RAB GTPASE BINDING EFFECTOR PROTEIN 1
AQRLQTELDVSEQVQRDFVKLSQTLQVQLERIRQALERIRAILND
//
>1tue_5K [c.37.1] REPLICATION PROTEIN E1
NMSQWIRFRCSKIDEGGDWRPIVQFLRYQQIEFITFLGALKSFLKGTPKKNCLVFCGPAN
TGKSYFGMSFIHFIQGAVISFVNSTSHFWLEPLTDTKVAMLDDATTTCWTYFDTYMRNAL
DGNPIQLKCPPILLTTNIHPAKDNRWPYLESRITVFEFPNAFPFDKNGNPVYEINDKNWK
CFFERTWSRLDL
//
>1tue_5L [b.91.1] REGULATORY PROTEIN E2
PKETLSERLSALQDKIIDHYENDSKDIDSQIQYWQLIRWENAIFFAAREHGIQTLNHQVV
PAYNISKSKAHKAIELQMALQGLAQSAYKTEDWTLQDTCEELWNTEPTHCFKKGGQTVQV
YFDGNKDNCMTYVAWDSVYYMTDAGTWDKTATCVSHRGLYYVKEGYNTFYIEFKSECEKY
GTGTWEVHFGNNV
//
>1twcA [e.29.1] DNA-DIRECTED RNA POLYMERASE II LARGEST SUBUNIT
GQQYSSAPLRTVKEVQFGLFSPEEVRAISVAKIRFPETMDETQTRAKIGGLNDPRLGSID
RNLKCQTCQEGMNECPGHFGHIDLAKPVFHVGFIAKIKKVCECVCMHCGKLLLDEHNELM
RQALAIKDSKKRFAAIWTLCKTKMVCETDVPSEDDPTQLVSRGGCGNTQPTIRKDGLKLV
GSWKKDRATGDADEPELRVLSTEEILNIFKHISVKDFTSLGFNEVFSRPEWMILTCLPVP
PPPVRPDLTFKLADILKANISLETLEHNGAPHHAIEEAESLLQFHVATYMDSIRARLDFS
ARTVISGDPNLELDQVGVPKSIAKTLTYPEVVTPYNIDRLTQLVRNGPNEHPGAKYVIRD
SGDRIDLRYSKRAGDIQLQYGWKVERHIMDNDPVLFNRQPSLHKMSMMAHRVKVIPYSTF
RLNLSVTSPYNADFDGDEMNLHVPQSEETRAELSQLCAVPLQIVSPQSNKPCMGIVQDTL
CGIRKLTLRDTFIELDQVLNMLYWVPDWDGVIPTPAIIKPKPLWSGKQILSVAIPNGIHL
QRFDEGTTLLSPKDNGMLIIDGQIIFGVVEKKTVGSSNGGLIHVVTREKGPQVCAKLFGN
IQKVVNFWLLHNGFSTGIGDTIADGPTMREITETIAEAKKKVLDVTKEAQANLLTAKHGM
TLRESFEDNVVRFLNEARDKAGRLAEVNLKDLNNVKQMVMAGSKGSFINIAQMSACVGQQ
SVEGKRIAFGFVDRTLPHFSKDDYSPESKGFVENSYLRGLTPQEFFFHAMGGREGLIDTA
VKTAETGYIQRRLVKALEDIMVHYDNTTRNSLGNVIQFIYGEDGMDAAHIEKQSLDTIGG
SDAAFEKRYRVDLLNTDHTLDPSLLESGSEILGDLKLQVLLDEEYKQLVKDRKFLREVFV
DGEANWPLPVNIRRIIQNAQQTFHIDHTKPSDLTIKDIVLGVKDLQENLLVLRGKNEIIQ
NAQRDAVTLFCCLLRSRLATRRVLQEYRLTKQAFDWVLSNIEAQFLRSVVHPGEMVGVLA
AQSIGEPATQMTLKKVTSGVPRLKEILNVAKNMKTPSLTVYLEPGHAADQEQAKLIRSAI
EHTTLKSVTIASEIYYDPDPRSTVIPEDEEIIQLHLQQSPWLLRLELDRAAMNDKDLTMG
QVGERIKQTFKNDLFVIWSEDNDEKLIIRCRVVAEEDHMLKKIENTMLENITLRGVENIE
RVVMMKYDRKVPSPTGEYVKEPEWVLETDGVNLSEVMTVPGIDPTRIYTNSFIDIMEVLG
IEAGRAALYKEVYNVIASDGSYVNYRHMALLVDVMTTQGGLTSVTTVEILFEAGASAELD
DCRGVSENVILGQMAPIGTGAFDVMIDEESL
//
>1twcH [b.40.4] DNA-DIRECTED RNA POLYMERASES I, II, AND III 14.5
SNTLFDDIFQVSEVDPGRYNKVCRIEAASTTQDQCKLTLDINVELFPVAAQDSLTVTIAS
SLTRSWRPPQAGDRSLADDYDYVMYGTAYKFEEVSKDLIAVYYSFGGLLMRLEGNYRNLN
NLKQENAYLLIRR
//
>1twfA [e.29.1] DNA-DIRECTED RNA POLYMERASE II LARGEST SUBUNIT
VGQQYSSAPLRTVKEVQFGLFSPEEVRAISVAKIRFPETMDETQTRAKIGGLNDPRLGSI
DRNLKCQTCQEGMNECPGHFGHIDLAKPVFHVGFIAKIKKVCECVCMHCGKLLLDEHNEL
MRQALAIKDSKKRFAAIWTLCKTKMVCETDVPSEDDPTQLVSRGGCGNTQPTIRKDGLKL
VGSWKKDRATGDADEPELRVLSTEEILNIFKHISVKDFTSLGFNEVFSRPEWMILTCLPV
PPPPVRPSISFNESQRGEDDLTFKLADILKANISLETLEHNGAPHHAIEEAESLLQFHVA
TYMDNDIAGQPQALQKSGRPVKSIRARLKGKEGRIRGNLMGKRVDFSARTVISGDPNLEL
DQVGVPKSIAKTLTYPEVVTPYNIDRLTQLVRNGPNEHPGAKYVIRDSGDRIDLRYSKRA
GDIQLQYGWKVERHIMDNDPVLFNRQPSLHKMSMMAHRVKVIPYSTFRLNLSVTSPYNAD
FDGDEMNLHVPQSEETRAELSQLCAVPLQIVSPQSNKPCMGIVQDTLCGIRKLTLRDTFI
ELDQVLNMLYWVPDWDGVIPTPAIIKPKPLWSGKQILSVAIPNGIHLQRFDEGTTLLSPK
DNGMLIIDGQIIFGVVEKKTVGSSNGGLIHVVTREKGPQVCAKLFGNIQKVVNFWLLHNG
FSTGIGDTIADGPTMREITETIAEAKKKVLDVTKEAQANLLTAKHGMTLRESFEDNVVRF
LNEARDKAGRLAEVNLKDLNNVKQMVMAGSKGSFINIAQMSACVGQQSVEGKRIAFGFVD
RTLPHFSKDDYSPESKGFVENSYLRGLTPQEFFFHAMGGREGLIDTAVKTAETGYIQRRL
VKALEDIMVHYDNTTRNSLGNVIQFIYGEDGMDAAHIEKQSLDTIGGSDAAFEKRYRVDL
LNTDHTLDPSLLESGSEILGDLKLQVLLDEEYKQLVKDRKFLREVFVDGEANWPLPVNIR
RIIQNAQQTFHIDHTKPSDLTIKDIVLGVKDLQENLLVLRGKNEIIQNAQRDAVTLFCCL
LRSRLATRRVLQEYRLTKQAFDWVLSNIEAQFLRSVVHPGEMVGVLAAQSIGEPATQMTL
KKVTSGVPRLKEILNVAKNMKTPSLTVYLEPGHAADQEQAKLIRSAIEHTTLKSVTIASE
IYYDPDPRSTVIPEDEEIIQLHFSLQQSPWLLRLELDRAAMNDKDLTMGQVGERIKQTFK
NDLFVIWSEDNDEKLIIRCRVVAEEDHMLKKIENTMLENITLRGVENIERVVMMKYDRKV
PSPTGEYVKEPEWVLETDGVNLSEVMTVPGIDPTRIYTNSFIDIMEVLGIEAGRAALYKE
VYNVIASDGSYVNYRHMALLVDVMTTQGGLTSVTRHGFNRSNTGALMRCSFEETVEILFE
AGASAELDDCRGVSENVILGQMAPIGTGAFDVMIDEESL
//
>1twfK [d.74.3] DNA-DIRECTED RNA POLYMERASE II 13.6 KDA
MNAPDRFELFLLGEGESKLKIDPDTKAPNAVVITFEKEDHTLGNLIRAELLNDRKVLFAA
YKVEHPFFARFKLRIQTTEGYDPKDALKNACNSIINKLGALKTNFETEWNLQTL
//
>1twhB [e.29.1] DNA-DIRECTED RNA POLYMERASE II 140 KDA
FEDESAPITAEDSWAVISAFFREKGLVSQQLDSFNQFVDYTLQDIICEDSTLIEISFGKI
YVTKPMVNESDGVTHALYPQEARLRNLTYSSGLFVDVKKRTYEKVFIGRLPIMLRSKNCY
LSEATESDLYKLKECPFDMGGYFIINGSEKVLIAQERSAGNIVQVFKKAAPSPISHVAEI
RSALEKGSRFISTLQVKLYGREGSSARTIKATLPYIKQDIPIVIIFRALGIIPDGEILEH
ICYDVNDWQMLEMLKPCVEDGFVIQDRETALDFIGRRGTALGIKKEKRIQYAKDILQKEF
LPHITQLEGFESRKAFFLGYMINRLLLCALDRKDQDDRDHFGKKRLDLAGPLLAQLFKTL
FKKLTKDIFRYMQRTVELAINAKTITSGLKYALATGNWGAGVSQVLNRYTYSSTLSHLRR
TNTPIAKPRQLHNTHWGLVCPAETPEGQACGLVKNLSLMSCISVGTDPMPIITFLSEWGM
EPLEDYVPHQSPDATRVFVNGVWHGVHRNPARLMETLRTLRRKGDINPEVSMIRDIREKE
LKIFTDAGRVYRPLFIVEDDESLGHKELKVRKGHIAKLMATEYQDEYTWSSLLNEGLVEY
IDAEEEESILIAMQPEDLEPDVDPAKRIRVSHHATTFTHCEIHPSMILGVAASIIPFPDH
NQSPRNTYQSAMGKQAMGVFLTNYNVRMDTMANILYYPQKPLGTTRAMEYLKFRELPAGQ
NAIVAIACYSGYNQEDSMIMNQSSIDRGLFRSLFFRSYMDQEKKYGMSITETFEKPQRTN
TLRMKHGTYDKLDDDGLIAPGVRVSGEDVIIGKTTSKRDASTPLRSTENGIVDQVLVTTN
QDGLKFVKVRVRTTKIPQIGDKFASRHGQKGTIGITYRREDMPFTAEGIVPDLIINPHAI
PSRMTVAHLIECLLSKVAALSGNEGDASPFTDITVEGISKLLREHGYQSRGFEVMYNGHT
GKKLMAQIFFGPTYYQRLRHMVDDKIHARARGPGLRFGEMERDCMIAHGAASFLKERLME
ASDAFRVHICGICGLMTVIAKLNHNQFECKGCDNKIDIYQIHIPYAAKLLFQELMAMNIT
PRLYTDRSRDF
//
>1twhL [g.41.9] DNA-DIRECTED RNA POLYMERASES I, II, AND III 7.7
ATLKYICAECSSKLSLSRTDAVRCKDCGHRILLKARTKRLVQFEAR
//
>1tx6_2C (A) [b.47.1] TRYPSIN
IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYKSRIQVRLGEHNIDVLEG
NEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSCAAAGTECLISG
WGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSYPGQITGNMICVGFLEGGKDSCQGDSGGP
VVCNGQLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIAAN
//
>1tx6_2J [g.3.13] BOWMAN-BIRK TYPE TRYPSIN INHIBITOR
RPWKCCDEAVCTRSIPPICTCMDEVFECTCKSCGPSMGDPSRRICQDQYVGDPGPICRPW
ECCDKAICTRSNPPTCRCVDEVKKCAPTCKTCLPSRRVCIDSYFGPVPPRCTPR
//
>1txwC [x.x.x]
CFEPPPATTTQTGFRGLSMGEVLHPATVKAKKERDAQYPPALAAVKAEGPPVSQVYKNVK
VLGNLTEAEFLRTMTAITEWVSPQEGCTYCHDENNLASEAKYPYVVARRMLEMTRAINTN
WTQHVAQTGVTCYTCHRGTPLPPYVRYLEPTLPLNNRETPTHVERVETRSGYVVRLAKYT
AYSALNYDPFTMFLANDKRQVRVVPQTALPLVGVSRGKERRPLSDAYATFALMMSISDSL
GTNCTFCHNAQTFESWGKKSTPQRAIAWWGIRMVRDLNMNYLAPLNASLPASRLGRQGEA
PQADCRTCHQGVTKPLFGASRLKDYPELGPIK
//
>1txwH [x.x.x]
xYHGALAQHLDIAQLVWYAQWLVIWTVVLLYLRREDRREGYPLVEPLGLVKLAPEDGQVY
ELPYPKTFVLPHGGTVTVPRRRPETRELKLAQTDGFEGAPLQPTGNPLVDAVGPASYAER
AEVVDATVDGKAKIVPLRVATDFSIAEGDVDPRGLPVVAADGVEAGTVTDLWVDRSEHYF
RYLELSVAGSARTALIPLGFCDVKKDKIVVTSILSEQFANVPRLQSRDQITLREEDKVSA
YYAGGLLYATPERAESLL
//
>1txwL [x.x.x]
ALLSFERKYRVRGGTLIGGDLFDFWVGPYFVGFFGVSAIFFIFLGVSLIGYAASQGPTWD
PFAISINPPDLKYGLGAAPLLEGGFWQAITVCALGAFISWMLREVEISRKLGIGWHVPLA
FCVPIFMFCVLQVFRPLLLGSWGHAFPYGILSHLDWVNNFGYQYLNWHYNPGHMSSVSFL
FVNAMALGLHGGLILSVANPGDGDKVKTAEHENQYFRDVVGYSIGALSIHRLGLFLASNI
FLTGAFGTIASGPFWTRGWPEWWGWWLDIPFWS
//
>1ty4_1A [f.1.4] APOPTOSIS REGULATOR CED-9
EEPRLDIEGFVVDYFTHRIRQNGmEWFGAPGLPCGVQPEHEmmRVmGTIFEKKHAENFET
FCEQLLAVPRISFSPYQDVVRTVGNAQTDQCPmSYGRLIGLISFGGFVAAKmmESVELQG
QVRNLFVYTSLFIKTRIRNNWKEHNRSWDDFmTLGKQmKEDYER
//
>1ty4_1C [x.x.x] EGG LAYING DEFECTIVE EGL-1, PROGRAMMED CELL
SSIGYEIGSKLAAmCDDFDAQmmSYSAHA
//
>1ty5A [b.69.8] INTEGRIN ALPHA-IIB
LNLDPVQLTFYAGPNGSQFGFSLDFHKDSHGRVAIVVGAPRTLGPSQEETGGVFLCPWRA
EGGQCPSLLFDLRDETRNVGSQTLQTFKARQGLGASVVSWSDVIVACAPWQHWNVLEKTE
EAEKTPVGSCFLAQPESGRRAEYSPCRGNTLSRIYVENDFSWDKRYCEAGFSSVVTQAGE
LVLGAPGGYYFLGLLAQAPVADIFSSYRPGILLWHVSSQSLSFDSSNPEYFDGYWGYSVA
VGEFDGDLNTTEYVVGAPTWSWTLGAVEILDSYYQRLHRLRAEQMASYFGHSVAVTDVNG
DGRHDLLVGAPLYMESRADRKLAEVGRVYLFLQPRGPHALGAPSLLLTGTQLYGRFGSAI
APLGDLDRDGYNDIAVAAPYGGPSGRGQVLVFLGQSEGLRSRPSQVLDSPFPTGSAFGFS
LRGAVDIDDNGYPDLIVGAYGANQVAVYRAQP
//
>1ty5B [g.16.2 - b.1.15 - c.62.1] INTEGRIN BETA-3
GPNICTTRGVSSCQQCLAVSPMCAWCSDEALPLGSPRCDLKENLLKDNCAPESIEFPVSE
ARVLEDRPLSDKGSGDSSQVTQVSPQRIALRLRPDDSKNFSIQVRQVEDYPVDIYYLMDL
SYSMKDDLWSIQNLGTKLATQMRKLTSNLRIGFGAFVDKPVSPYMYISPPEALENPCYDM
KTTCLPMFGYKHVLTLTDQVTRFNEEVKKQSVSRNRDAPEGGFDAIMQATVCDEKIGWRN
DASHLLVFTTDAKTHIALDGRLAGIVQPNDGQCHVGSDNHYSASTTMDYPSLGLMTEKLS
QKNINLIFAVTENVVNLYQNYSELIPGTTVGVLSMDSSNVLQLIVDAYGKIRSKVELEVR
DLPEELSLSFNATCLNNEVIPGLKSCMGLKIGDTVSFSIEAKVRGCPQEKEKSFTIKPVG
FKDSLIVQVTFDCDCACQAQ
//
>1tygB [d.15.3] YJBS
MLQLNGKDVKWKKDTGTIQDLLASYQLENKIVIVERNKEIIGKERYHEVELCDRDVIEIV
HFVGG
//
>1tygA [c.1.31] THIAZOLE BIOSYNTHESIS PROTEIN THIG
MLTIGGKSFQSRLLLGTGKYPSFDIQKEAVAVSESDILTFAVRRMNIFEASQPNFLEQLD
LSKYTLLPNTAGASTAEEAVRIARLAKASGLCDMIKVEVIGCSRSLLPDPVETLKASEQL
LEEGFIVLPYTSDDVVLARKLEELGVHAIMPGASPIGSGQGILNPLNLSFIIEQAKVPVI
VDAGIGSPKDAAYAMELGADGVLLNTAVSGADDPVKMARAMKLAVEAGRLSYEAGRIPLK
QY
//
>1tzhA [b.1.1 - b.1.1] FAB YADS1 LIGHT CHAIN
DIQMTQSPSSLSASVGDRVTITCRASQASYSSVAWYQQKPGKAPKLLIYAASYLYSGVPS
RFSGSGSGTDFTLTISSLQPEDFATYYCQSSASPATFGQGTKVEIKRTVAAPSVFIFPPS
DEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTL
SKADYEKHKVYACEVTHQGLSSPVTKSFNR
//
>1tzhB [b.1.1 - b.1.1] FAB YADS1 HEAVY CHAIN
EVQLVESGGGLVQPGGSLRLSCAASGFDIYDDDIHWVRQAPGKGLEWVAYIAPSYGYTDY
ADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCSRSSDASYSYSAMDYWGQGTLVTV
SSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQ
SSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEP
//
>1tzhW (V) [g.17.1] VASCULAR ENDOTHELIAL GROWTH FACTOR A
VVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEE
SNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPK
//
>1tzhL (A) [b.1.1 - b.1.1] FAB YADS1 LIGHT CHAIN
DIQMTQSPSSLSASVGDRVTITCRASQASYSSVAWYQQKPGKAPKLLIYAASYLYSGVPS
RFSGSGSGTDFTLTISSLQPEDFATYYCQSSASPATFGQGTKVEIKRTVAAPSVFIFPPS
DEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTL
SKADYEKHKVYACEVTHQGLSSPVTKSFNR
//
>1tzhH [b.1.1 - b.1.1] FAB YADS1 HEAVY CHAIN
EVQLVESGGGLVQPGGSLRLSCAASGFDIYDDDIHWVRQAPGKGLEWVAYIAPSYGYTDY
ADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCSRSSDASYSYSAMDYWGQGTLVTV
SSASTKGPSVFPLAPSSGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLY
SLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEP
//
>1tziA [b.1.1 - b.1.1] FAB YADS2 LIGHT CHAIN
DIQMTQSPSSLSASVGDRVTITCRASQSYAYAVAWYQQKPGKAPKLLIYDASYLYSGVPS
RFSGSGSGTDFTLTISSLQPEDFATYYCQQAYSSPDTFGQGTKVEIKRTVAAPSVFIFPP
SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT
LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
//
>1tziB [b.1.1 - b.1.1] FAB YADS2 HEAVY CHAIN
EVQLVESGGGLVQPGGSLRLSCAASGFAIYDYDIHWVRQAPGKGLEWVADIAPYAGATAY
ADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCSRSSYAYYAAMDYWGQGTLVTVSS
ASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSS
GLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKS
//
>1tziC (V) [g.17.1] VASCULAR ENDOTHELIAL GROWTH FACTOR A
EVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTE
ESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKD
//
>1tzyA [a.22.1] HISTONE H2A-IV
KAKSRSSRAGLQFPVGRVHRLLRKGNYAERVGAGAPVYLAAVLEYLTAEILELAGNAARD
NKKTRIIPRHLQLAIRNDEELNKLLGKVTIAQGGVLPNIQAVLLPK
//
>1tzyH [a.22.1] HISTONE H4-VI
RKVLRDNIQGITKPAIRRLARRGGVKRISGLIYEETRGVLKVFLENVIRDAVTYTEHAKR
KTVTAMDVVYALKRQGRTLYGFGG
//
>1tzyF [a.22.1] HISTONE H2B
RKESYSIYVYKVLKQVHPDTGISSKAMGIMNSFVNDIFERIAGEASRLAHYNKRSTITSR
EIQTAVRLLLPGELAKHAVSEGTKAVTKYTSSK
//
>1u0n_2C [d.169.1] BOTROCETIN
DCPPDWSSYEGHCYRFFKEWMHWDDAEEFCTEQQTGAHLVSFQSKEEADFVRSLTSEMLK
GDVVWIGLSDVWNKCRFEWTDGMEFDYDDYYLIAEYECVASKPTNNKWWIIPCTRFKNFV
CEFQA
//
>1u0n_2B [d.169.1] BOTROCETIN
DCPSGWSSYEGNCYKFFQQKMNWADAERFCSEQAKGGHLVSIKIYSKEKDFVGDLVTKNI
QSSDLYAWIGLRVENKEKQCSSEWSDGSSVSYENVVERTVKKCFALEKDLGFVLWINLYC
AQKNPFVCKSPPP
//
>1u0oA [d.169.1] BOTROCETIN
DCPSGWSSYEGNCYKFFQQKMNWADAERFCSEQAKGGHLVSIKIYSKEKDFVGDLVTKNI
QSSDLYAWIGLRVENKEKQCSSEWSDGSSVSYENVVERTVKKCFALEKDLGFVLWINLYC
AQKNPFVCKSPPP
//
>1u0oB [d.169.1] BOTROCETIN
DCPPDWSSYEGHCYRFFKEWMHWDDAEEFCTEQQTGAHLVSFQSKEEADFVRSLTSEMLK
GDVVWIGLSDVWNKCRFEWTDGMEFDYDDYYLIAEYECVASKPTNNKWWIIPCTRFKNFV
CEFQA
//
>1u0oC [c.62.1] VON WILLEBRAND FACTOR
FYCSKLLDLVFLLDGSSMLSEAEFEVLKAFVVGMMERLHISQKRIRVAVVEYHDGSRAYL
ELKARKRPSELRRITSQIKYTGSQVASTSEVLKYTLFQIFGKIDRPEASHITLLLTASQE
PPRMARNLVRYVQGLKKKKVIVIPVGIGPHASLKQIRLIEKQAPENKAFLLSGVDELEQR
RDEIVSYLCDLAPEA
//
>1u0sY [c.23.1] CHEMOTAXIS PROTEIN CHEY
GKRVLIVDDAAFMRMMLKDIITKAGYEVAGEATNGREAVEKYKELKPDIVTMDITMPEMN
GIDAIKEIMKIDPNAKIIVCSAMGQQAMVIEAIKAGAKDFIVKPFQPSRVVEALNKVS
//
>1u0sA [d.58.24] CHEMOTAXIS PROTEIN CHEA
GFKTFYIKVILKEGTQLKSARIYLVFHKLEELKCEVVRTIPSVEEIEEEKFENEVELFVI
SPVDLEKLSEALSSIADIERVIIKEV
//
>1u2vA [c.55.1 - c.55.1] ACTIN-RELATED PROTEIN 3
MAGRLPACVVDCGTGYTKLGYAGNTEPQFIIPSCIAIKEVMKGVDDLDFFIGDEAIEKPT
YATKWPIRHGIVEDWDLMERFMEQVIFKYLRAEPEDHYFLLTEPPLNTPENREYTAEIMF
ESFNVPGLYIAVQAVLALAASWTSRQVGERTLTGTVIDSGDGVTHVIPVAEGYVIGSCIK
HIPIAGRDITYFIQQLLRDREVGIPPEQSLETAKAVKERYSYVCPDLVKEFNKYDTDGSK
WIKQYTGINAISKKEFSIDVGYERFLGPEIFFHPEFANPDFTQPISEVVDEVIQNCPIDV
RRPLYKNIVLSGGSTMFRDFGRRLQRDLKRTVDARLKLSEELKPKPIDVQVITHHMQRYA
VWFGGSMLASTPEFYQVCHTKKDYEEIGPSICRHNPVFGVMS
//
>1u2vD [d.198.2 - d.198.2] ARP2/3 COMPLEX 34KDA SUBUNIT
MILLEVNNRIIEETLALKFENAAAGNKPEAVEVTFADFDGVLYHISNPNGDKTKVMVSIS
LKFYKELQAHGADELLKRVYGSYLVNPESGYNVSLLYDLENLPASKDSIVHQAGMLKRNC
FASVFEKYFQFQEEGKEGENRAVIHYRDDETMYVESKKDRVTVVFSTVFKDDDDVVIGKV
FMQEFKEGRRASHTAPQVLFSHREPPLELKDTDAAVGDNIGYITFVLFPRHTNASARDNT
INLIHTFRDYLHYHIKCSKAYIHTRMRAKTSDFLKVLNRARP
//
>1u2wB [a.4.5] CADMIUM EFFLUX SYSTEM ACCESSORY PROTEIN
GYDEEKVNRIQGDLQTVDISGVSQILKAIADENRAKITYALCQDEELCVCDIANILGVTI
ANASHHLRTLYKQGVVNFRKEGKLALYSLGDEHIRQIMMIALAHKKE
//
>1u2wG [x.x.x]
QDEELCVCDIANILGVTIANASHHLRTLYLYSLGDEHIRQIMMIALAHKKEV
//
>1u2wC [x.x.x]
QDEELCVCDIANILGVTIANASHHLRTLYLYSLGDEHIRQIMMIALAHKKEV
//
>1u2wD [x.x.x]
VNRIQGDLQTVDISGVSQILKAIADENRAKITYALCQDEELCVCDIANILGVTIANASHH
LRTLYKQGVVNFRKEGKLALYSLGDEHIRQIMMIALAHDEEKVNRIQGDLQTVDISGVSQ
ILKAIADENRAKIT
//
>1u2wH [x.x.x]
QDEELCVCDIANILGVTIANASHLRTLYLYSLGDEHIRQIMMLAHKKEV
//
>1u35A [a.22.1] HISTONE H3.1
PHRYRPGTVALREIRRYQKSTELLIRKLPFQRLVREIAQDFKTDLRFQSSAVMALQEACE
AYLVGLFEDTNLCAIHAKRVTIMPKDIQLARRIRGERA
//
>1u35C [a.22.1] H2A HISTONE FAMILY
KTSRSAKAGVIFPVGRMLRYIKKGHPKYRIGVGAPVYMAAVLEYLTAEILELAVNAARDN
KKGRVTPRHILLAVANDEELNQLLKGVTIASGGVLPNIHPELLAKK
//
>1u35G (C) [a.22.1] H2A HISTONE FAMILY
KTSRSAKAGVIFPVGRMLRYIKKGHPKYRIGVGAPVYMAAVLEYLTAEILELAVNAARDN
KKGRVTPRHILLAVANDEELNQLLKGVTIASGGVLPNIHPELLAKK
//
>1u35D [a.22.1] HISTONE 3, H2BA
RKESYSIYVYKVLKQVHPDTGISSKAMGIMNSFVNDIFERIASEASRLAHYNKRSTITSR
EVQTAVRLLLPGELAKHAVSEGTKAVTKYTSSK
//
>1u35F [a.22.1] HIST1H4I PROTEIN
KVLRDNIQGITKPAIRRLARRGGVKRISGLIYEETRGVLKVFLENVIRDAVTYTEHAKRK
TVTAMDVVYALKRQGRTLYGFGG
//
>1u3h_1B [b.1.1] MOUSE TCRVBETA 172.10, EXTRACELLULAR VARIABLE
AVTQSPRNKVAVTGEKVTLSCNQTNNHNNMYWYRQDTGHGLRLIYYSYGAGSTEKGDIPD
GYKASRPSQENFSLTLESATPSQTSVYFCASGDAGGGYEQYFGPGTRLTVL
//
>1u3h_1C [d.19.1 - b.1.1] H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U
IEADHVGSYGIVVYQSPGDIGQYTFEFDGDELFYVDLDKKETIWMLPEFAQLRSFDPQGG
LQNIATGKHNLGVLTKRSNSTPATNEAPQATVFPKSPVLLGQPNTLICFVDNIFPPVINI
TWLRNSKSVADGVYETSFFVNRDYSFHKLSYLTFIPSDDDIYDCKVEHWGLEEPVLKHWE
PE
//
>1u3h_2H (D) [d.19.1 - b.1.1] H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U
GDSERHFVVQFQPFCYFTNGTQRIRYVTRYIYNREEYLRFDSDVGEYRAVTELGRPDAEY
YNKQYLERTRAELDTVCRYNYEETEVPTSLRRLEQPNVVISLSRTEALNHHNTLVCSVTD
FYPAKIKVRWFRNGQEETVGVSSTQLIRNGDWTFQVLVMLEMTPRRGEVYTCHVEHPSLK
SPITVEWRA
//
>1u3h_2E (A) [b.1.1] T-CELL RECEPTOR ALPHA-CHAIN
QVRQSPQSLTVWEGETAILNCSYENSAFDYFPWYQQFPGEGPALLISILSVSDKKEDGRF
TIFFNKREKKLSLHIADSQPGDSATYFCAASANSGTYQRFGTGTKLQVVP
//
>1u3h_2F (B) [b.1.1] MOUSE TCRVBETA 172.10, EXTRACELLULAR VARIABLE
AVTQSPRNKVAVTGEKVTLSCNQTNNHNNMYWYRQDTGHGLRLIYYSYGAGSTEKGDIPD
GYKASRPSQENFSLTLESATPSQTSVYFCASGDAGGGYEQYFGPGTRLTVL
//
>1u58A [d.19.1 - b.1.1] MHC-I HOMOLOG M144
ESGLRYAYTLVVDGTANTRRCFGTGHVDGEAFVGYSNNKTHGIGRWVNASHVEEENKEFV
RQCKELQAELDKMQNNSKVIGVKTVQLDVGCTSKIEKHYAYDGNETECQKKLTEYRKLVL
ASAVSPQLEVERRSSGREGGMRLRCFARDYYPADLEIRWWKDDGGGGALPQTSKQHHDPL
PSGNGLYQKHIDVYVDGGLEHVYSCRVKGIATGLELQIVRWK
//
>1u58B [b.1.1] BETA-2-MICROGLOBULIN
IQKTPQIQVYSRHPPENGKPNILNCYVTQFHPPHIEIQMLKNGKKIPKVEMSDMSFSKDW
SFYILAHTEFTPTETDTYACRVKHASMAEPKTVYWDRD
//
>1u5tA [a.4.5 - a.4.5] APPEARS TO BE FUNCTIONALLY RELATED TO SNF7
VNKTILEKQSVELRDQLMVFQERLVEFAKKHNSELQASPEFRSKFMHMCSSIGIDPLSLF
DRDKHLFTVNDFYYEVCLKVIEICRQTKDMNGGVISFQELEKVHFRKLNVGLDDLEKSID
MLKSLECFEIFQIRGKKFLRSVPNELTSDQTKILEICSILGYSSISLLKANLGWEAVRSK
SALDEMVANGLLWIDYQGGAEALYWDPSWITRQ
//
>1u5tC [a.4.5 - a.4.5] HYPOTHETICAL 23.6 KDA PROTEIN IN YUH1-URA8
SALPPVYSFPPLYTRQPNSLTRRQQISTWIDIISQYCKTKKIWYMSVDGTSKNLFNNEDI
QRSVSQVFIDEIWSQMTKEGKCLPIDQSGRRSSNTTTTRYFILWKSLDSWASLILQWFED
SGKLNQVITLYELSEGDETVNWEFHRMPESLLYYCLKPLCDRNRATMLKDENDKVIAI
//
>1u6aL [b.1.1 - b.1.1] F105 LIGHT CHAIN
EIVLTQSPGTLSLSAGERATLSCRASQSVSSRYLAWYQQKPGQAPRLLIYGASSRATGIP
DRFSGSGSGTDFTLTISRVEPEDFAVYYCQQYDNSVCTFGQGTKLEIKRTVAAPSVFIFP
PSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTL
TLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGE
//
>1u6aH [b.1.1 - b.1.1] F105 HEAVY CHAIN
VQLQESGPGLVKPSETLSLTCTVSGGSISSHYWSWIRQSPGKGLQWIGYIYYSGSTNYSP
SLKSRVTISVETAKNQFSLKLTSMTAADTAVYYCARGPVPAVFYGDYRLDPWGQGTLVTV
SSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQ
SSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEP
//
>1u6gA [a.118.17 - e.40.1 - a.4.5] CULLIN HOMOLOG 1
LDQIWDDLRAGIQQVYTRQSMAKSRYMELYTHVYNYCTSVGLELYKRLKEFLKNYLTNLL
KDGEDLMDESVLKFYTQQWEDYRFSSKVLNGICAYLNRHWVRRECKGIYEIYSLALVTWR
DCLFRPLNKQVTNAVLKLIEKERNGETINTRLISGVVQSYVELGLGPTLTVYKESFESQF
LADTERFYTRESTEFLQQNPVTEYMKKAEARLLEEQRRVQVYLHESTQDELARKCEQVLI
EKHLEIFHTEFQNLLDADKNEDLGRMYNLVSRIQDGLGELKKLLETHIHNQGLAAIEKCG
EAALNDPKMYVQTVLDVHKKYNALVMSAFNNDAGFVAALDKACGRFINNNAVTKMAQSSS
KSPELLARYCDSLLKKEEAELEDTLNQVMVVFKYIEDKDVFQKFYAKMLAKRLVHQNSAS
DDAEASMISKLKQACGFEYTSKLQRMFQDIGVSKDLNEQFKKHLTNSEPLDLDFSIQVLS
SGSWPFQQSCTFALPSELERSYQRFTAFYASRHSGRKLTWLYQLSKGELVTNCFKNRYTL
QASTFQMAILLQYNTEDAYTVQQLTDSTQIKMDILAQVLQILLKSKLLVLEDENANVDEV
ELKPDTLIKLYLGYKNKKLRVNINVPMKTEQKQEQETTHKNIEEDRKLLIQAAIVRIMKM
RKVLKHQQLLGEVLTQLSSRFKPRVPVIKKCIDILIEKEYLERVDGEKDTYSYLA
//
>1u6gB [g.44.1] RING-BOX PROTEIN 1
KKRFEVKKWNAVALWAWDIVVDNCAICRNHIMDLCIECQANQASATSEECTVAWGVCNHA
FHFHCISRWLKTRQVCPLDNREWEFQKY
//
>1u6gC [a.118.1] TIP120 PROTEIN
ASYHISNLLEKMTSSDKDFRFMATNDLMTELQKDSIKLDDDSERKVVKMILKLLEDKNGE
VQNLAVKCLGPLVSKVKEYQVETIVDTLCTNMLSDKEQLRDISSIGLKTVIGELPSALAA
NVCKKITGRLTSAIAKQEDVSVQLEALDIMADMLSRQGGLLVNFHPSILTCLLPQLTSPR
LAVRKRTIIALGHLVMSCFVDLIEHLLSELSKNDSMSTTRTYIQCIAAISRQAGHRIGEY
LEKIIPLVVKFCNVDDDELREYCIQAFESFVRRCPKEVYPHVSTIINICLKYLTYDMSWK
VRRAAAKCLDAVVSTRHEMLPEFYKTVSPALISRFKEREENVKADVFHAYLSLLKQTRPV
GETPLTMLQSQVPNIVKALHKQMKEKSVKTRQCCFNMLTELVNVLPGALTQHIPVLVPGI
IFSLNDKSSSSNLKIDALSCLYVILCNHSPQVFHPHVQALVPPVVACVGDPFYKITSEAL
LVTQQLVKVIRPLDQPSSFDATPYIKDLFTCTIKRLKAADIDQEVKERAISCMGQIICNL
GDNLGSDLPNTLQIFLERLKNEITRLTTVKALTLIAGSPLKIDLRPVLGEGVPILASFLR
KNQRALKLGTLSALDILIKNYSDSLTAAMIDAVLDELPPLISESDMHVSQMAISFLTTLA
KVYPSSLSKISGSILNELIGLVRSPLLQGGALSAMLDFFQALVVTGTNNLGYMDLLRMLT
GPVYSQTHKQSYYSIAKCVAALTRACPKEGPAVVGQFIQDVKNSRSTDSIRLLALLSLGE
VGHHIDLSGQLELKSVILEAFSSPSEEVKSAASYALGSISVGNLPEYLPFVLQEITSQPK
RQYLLLHSLKEIISSASVVGLKPYVENIWALLLKHCECAEEGTRNVVAECLGKLTLIDPE
TLLPRLKGYLISGSSYARSSVVTAVKFTISDHPQPIDPLLKNCIGDFLKTLEDPDLNVRR
VALVTFNSAAHNKPSLIRDLLDTVLPHLYNETKVRKELIREVEMGPFKHTVDDGLDIRKA
AFECMYTLLDSCLDRLDIFEFLNHVEDGLKDHYDIKMLTFLMLVRLSTLCPSAVLQRLDR
LVEPLRATCTTKVKANSVKQEFEKQDELKRSAMRAVAALLTIPEAEKSPLMSEFQSQISS
NPELAA
//
>1u6hA [a.24.9 - a.24.9] VINCULIN
MPVFHTRTIESILEPVAQQISHLVIMHEEGEVDGKAIPDLTAPVSAVQAAVSNLVRVGKE
TVQTTEDQILKRDMPPAFIKVENACTKLVRAAQMLQADPYSVPARDYLIDGSRGILSGTS
DLLLTFDEAEVRKIIRVCKGILEYLTVAEVVETMEDLVTYTKNLGPGMTKMAKMIDERQQ
ELTHQEHRVMLVNSMNTVKELLPVLISAMKIFVTTKNTKSQGIEEALKNRNFTVEKMSAE
INEIIRVLQLTS
//
>1u6hB [x.x.x] TALIN
SRKLLSAAKILADATAKMVEAAKG
//
>1u75A [a.93.1] CYTOCHROME C PEROXIDASE
TTPLVHVASVEKGRSYEDFQKVYNAIALKLREDDEYDNYIGYGPVLVRLAWHISGTWDKH
DNTGGSYGGTYRFKKEFNDPSNAGLQNGFKFLEPIHKEFPWISSGDLFSLGGVTAVQEMQ
GPKIPWRCGRVDTPEDTTPDNGRLPDADKDAGYVRTFFQRLNMNDREVVALMGAHALGKT
HLKNSGYEGPWGAANNVFTNEFYLNLLNEDWKLEKNDANNEQWDSKSGYMMLPTDYSLIQ
DPKYLSIVKEYANDQDKFFKDFSKAFEKLLENGITFPKDAPSPFIFKTLEEQGL
//
>1u75B [a.3.1] CYTOCHROME C
GDVEKGKKIFVQKCAQCHTVEKGGKHKTGPNLHGLFGRKTGQAPGFTYTDANKNKGITWK
EETLMEYLENPKKYIPGTKMIFAGIKKKTEREDLIAYLKKATNE
//
>1u7eA [d.144.1] CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC
EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYA
MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS
HLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR
VKGRTWxLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI
VSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKV
EAPFIPKFKGPGDTSNFDDYEEEEIRVxINEKCGKEFTE
//
>1u7eB [x.x.x] CAMP-DEPENDENT PROTEIN KINASE TYPE I-ALPHA
GRRRRGAISAEVYTEEDAASYVRKVIPKDYKTMAALAKAIEKNVLFSHLDDNERSDIFDA
MFPVSFIAGETVIQQGDEGDNFYVIDQGEMDVYVNNEWATSVGEGGSFGELALIYGTPRA
ATVKAKTNVKLWGIDRDSYRRILMGSTLRKRK
//
>1u7fA [b.26.1] MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3
EPAFWCSISYYELNQRVGETFHASQPSMTVDGFTDPSNSERFCLGLLSNVNRNAAVELTR
RHIGRGVRLYYIGGEVFAECLSDSAIFVQSPNCNQRYGWHPATVCKIPPGCNLKIFNNQE
FAALLAQSVNQGFEAVYQLTRMCTIRMSFVKGWGAEYRRQTVTSTPCWIELHLNGPLQWL
DKVLTQMGSPSIRCSxVx
//
>1u7fB [b.26.1] MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 4
ISNHPAPEYWCSIAYFEMDVQVGETFKVPSSCPIVTVDGYVDPSGGDRFCLGQLSNVHRT
EAIERARLHIGKGVQLECKGEGDVWVRCLSDHAVFVQSYYLDREDAVHKIYPSAYIKVFD
LRQCHRQMQQQAATAQIGVDDLRRLCILRMSFVKGWGPDYPRQSIKETPCWIEIHLHRAL
QLLDEVLHTMPIA
//
>1u7vA [b.26.1] MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 2
EPAFWCSIAYYELNQRVGETFHASQPSLTVDGFTDPSNSERFCLGLLSNVNRNATVEMTR
RHIGRGVRLYYIGGEVFAECLSDSAIFVQSPNCNQRYGWHPATVCKIPPGCNLKIFNNQE
FAALLAQSVNQGFEAVYQLTRMCTIRMSFVKGWGAEYRRQTVTSTPCWIELHLNGPLQWL
DKVLTQMGSPSVRCSxMx
//
>1u7vB [b.26.1] MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 4
ISNHPAPEYWCSIAYFEMDVQVGETFKVPSSCPIVTVDGYVDPSGGDRFCLGQLSNVHRT
EAIERARLHIGKGVQLECKGEGDVWVRCLSDHAVFVQSYYLDREAGRAPGDAVHKIYPSA
YIKVFDLRQCHRQMQQQAATAQAAAAAQIGVDDLRRLCILRMSFVKGWGPDYPRQSIKET
PCWIEIHLHRALQLLDEVLHTMPIADPQ
//
>1u8cA [b.69.8 - b.1.15 - b.1.15 - b.1.15] INTEGRIN ALPHA-V
FNLDVDSPAEYSGPEGSYFGFAVDFFVPSASSRMFLLVGAPKANTTQPGIVEGGQVLKCD
WSSTRRCQPIEFDATGNRDYAKDDPLEFKSHQWFGASVRSKQDKILACAPLYHWRTEMKQ
EREPVGTCFLQDGTKTVEYAPCRSQDIDADGQGFCQGGFSIDFTKADRVLLGGPGSFYWQ
GQLISDQVAEIVSKYDPNVYSIKYNNQLATRTAQAIFDDSYLGYSVAVGDFNGDGIDDFV
SGVPRAARTLGMVYIYDGKNMSSLYNFTGEQMAAYFGFSVAATDINGDDYADVFIGAPLF
MDRGSDGKLQEVGQVSVSLQRASGDFQTTKLNGFEVFARFGSAIAPLGDLDQDGFNDIAI
AAPYGGEDKKGIVYIFNGRSTGLNAVPSQILEGQWAARSMPPSFGYSMKGATDIDKNGYP
DLIVGAFGVDRAILYRARPVITVNAGLEVYPSILNQDNKTCSLPGTALKVSCFNVRFCLK
ADGKGVLPRKLNFQVELLLDKLKQKGAIRRALFLYSRSPSHSKNMTISRGGLMQCEELIA
YLRDESEFRDKLTPITIFMEYRLDYRTAADTTGLQPILNQFTPANISRQAHILLDCGEDN
VCKPKLEVSVDSDQKKIYIGDDNPLTLIVKAQNQGEGAYEAELIVSIPLQADFIGVVRNN
EALARLSCAFKTENQTRQVVCDLGNPMKAGTQLLAGLRFSVHQQSEMDTSVKFDLQIQSS
NLFDKVSPVVSHKVDLAVLAAVEIRGVSSPDHVFLPIPNWEHKENPETEEDVGPVVQHIY
ELRNNGPSSFSKAMLHLQWPYKYNNNTLLYILHYDIDGPMNCTSDMEINPLRIKISSLDI
HTLGCGVAQCLKIVCQVGRLDRGKSAILYVKSLLWTETFMNKENQNHSYSLKSSASFNVI
EFPYKNLPIEDITNSTLVTTNVTWGIQ
//
>1u8cB [g.16.2 - b.1.15 - c.62.1 - g.3.11 - g.3.11 - d.200.1] INTEGRIN BETA-3
GPNICTTRGVSSCQQCLAVSPMCAWCSDEALPLGSPRCDLKENLLKDNCAIEFPVSEARV
LEDRPLSDKGSGDSSQVTQVSPQRIALRLRPDDSKNFSIQVRQVEDYPVDIYYLMDLSYS
MKDDLWSIQNLGTKLATQMRKLTSNLRIGFGAFVDKPVSPYMYISPPEALENPCYDMKTT
CLPMFGYKHVLTLTDQVTRFNEEVKKQSVSRNRDAPEGGFDAIMQATVCDEKIGWRNDAS
HLLVFTTDAKTHIALDGRLAGIVQPNDGQCHVGSDNHYSASTTMDYPSLGLMTEKLSQKN
INLIFAVTENVVNLYQNYSELIPGTTVGVLSMDSSNVLQLIVDAYGKIRSKVELEVRDLP
EELSLSFNATCLNNEVIPGLKSCMGLKIGDTVSFSIEAKVRGCPQEKEKSFTIKPVGFKD
SLIVQVTFDCDCDDFSCVRYKGEMCSGHGQCSCGDCLCDSDWTGYYCNCTTRTDTCMSSN
GLLCSGRGKCECGSCVCIQPGSYGDTCEKCPTCPDACTFKKECVECKKFDREPYMTENTC
NRYCRDEIESVKELKDTGKDAVNCTYKNEDDCVVRFQYYEDSSGKSILYVVEEPECPKG
//
>1uacL [b.1.1] LYSOZYME BINDING IG KAPPA CHAIN V23-J2 REGION
DIVLTQSPATLSVTPGNSVSLSCRASQSIGNNLHWYQQKSHESPRLLIKYASQSISGIPS
RFSGSGSGTDFTLSINSVETEDFGMYFCQQSNSWPYTFGGGTKLEIK
//
>1uacH [b.1.1] IG VH,ANTI-LYSOZYME
DVQLQESGPSLVKPSQTLSLTCSVTGDSITSDYWSWIRKFPGNRLEYMGYVSSFGSTFYN
PSLKSRISITRDTSKNQYYLDLNSVTTEDTATYYCANWDGDYWGQGTLVTVSAA
//
>1uacY [d.2.1] LYSOZYME C
KVYGRCELAAAMKRLGLDNYRGYSLGNWVCAAKFESNFNTHATNRNTDGSTDYGILQINS
RWWCNDGRTPGSKNLCNIPCSALLSSDITASVNCAKKIASGGNGMNAWVAWRNRCKGTDV
HAWIRGCRL
//
>1uadB (A) [c.37.1] RAS-RELATED PROTEIN RAL-A
SLALHKVIMVGSGGVGKSALTLQFMYDEFVEDYEPTKADSYRKKVVLDGEEVQIDILDTA
GQEDYAAIRDNYFRSGEGFLCVFSITEMESFAATADFREQILRVKEDENVPFLLVGNKSD
LEDKRQVSVEEAKNRAEQWNVNYVETSAKTRANVDKVFFDLMREIRARKMEDS
//
>1uadF (C) [b.1.18] EXOCYST COMPLEX COMPONENT SEC5
SRQPPLVTGISPNEGIPWTKVTIRGENLGTGPTDLIGLTICGHNCLLTAEWMSASKIVCR
VGQAKNDKGDIIVTTKSGGRGTSTVSFKLLKP
//
>1ub4A [b.34.6] MAZF PROTEIN
VSRYVPDMGDLIWVDFDPGHRPAVVLSPFMYNNKTGMCLCVPCTTQSKGYPFEVVLSGQE
RDGVALADQVKSIAWRARGATKKGTVAPEELQLIKAKINVLIG
//
>1ub4C [b.129.1] MAZE PROTEIN
IHSSVKRWGNSPAVRIPATLMQALNLNIDDEVKIDLVDGKLIIEPVRKEPVFTLAELVND
ITPENLHENIDWGEP
//
>1ubtS [e.19.1] PERIPLASMIC [NIFE] HYDROGENASE SMALL SUBUNIT
LMGPRRPSVVYLHNAECTGCSESVLRAFEPYIDTLILDTLSLDYHETIMAAAGDAAEAAL
EQAVNSPHGFIAVVEGGIPTAANGIYGKVANHTMLDICSRILPKAQAVIAYGTCATFGGV
QAAKPNPTGAKGVNDALKHLGVKAINIAGCPPNPYNLVGTIVYYLKNKAAPELDSLNRPT
MFFGQTVHEQCPRLPHFDAGEFAPSFESEEARKGWCLYELGCKGPVTMNNCPKIKFNQTN
WPVDAGHPCIGCSEPDFWDAMTPFYQN
//
>1ubtL [e.18.1] PERIPLASMIC [NIFE] HYDROGENASE LARGE SUBUNIT
SSYSGPIVVDPVTRIEGHLRIEVEVENGKVKNAYSSSTLFRGLEIILKGRDPRDAQHFTQ
RTCGVCTYTHALASTRCVDNAVGVHIPKNATYIRNLVLGAQYLHDHIVHFYHLHALDFVD
VTAALKADPAKAAKVASSISPRKTTAADLKAVQDKLKTFVETGQLGPFTNAYFLGGHPAY
YLDPETNLIATAHYLEALRLQVKAARAMAVFGAKNPHTQFTVVGGVTCYDALTPQRIAEF
EALWKETKAFVDEVYIPDLLVVAAAYKDWTQYGGTDNFITFGEFPKDEYDLNSRFFKPGV
VFKRDFKNIKPFDKMQIEEHVRHSWYEGAEARHPWKGQTQPKYTDLHGDDRYSWMKAPRY
MGEPMETGPLAQVLIAYSQGHPKVKAVTDAVLAKLGVGPEALFSTLGRTAARGIETAVIA
EYVGVMLQEYKDNIAKGDNVICAPWEMPKQAEGVGFVNAPRGGLSHWIRIEDGKIGNFQL
VVPSTWTLGPRCDKNKLSPVEASLIGTPVADAKRPVEILRTVHSFDPCIACGVH
//
>1ucy_1L [b.47.1] THROMBIN
TFGAGEADCGLRPLFEKKQVQDQTEKELFESYIEGR
//
>1ucy_1H [b.47.1] THROMBIN
IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLL
VRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCL
PDKQTAAKLLHAGFKGRVTGWGNRRETWTT
//
>1ucy_1E [b.47.1] THROMBIN
SVAEVQPSVLQVVNLPLVERPVCKASTRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFV
MKSPYNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDRLGS
//
>1ucy_2J (L) [b.47.1] THROMBIN
TFGAGEADCGLRPLFEKKQVQDQTEKELFESYIEGR
//
>1ucy_2K [b.47.1] THROMBIN
IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLL
VRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCL
PDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKASTRIR
ITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFY
THVFRLKKWIQKVIDRLGS
//
>1ucy_3M (L) [b.47.1] THROMBIN
TFGAGEADCGLRPLFEKKQVQDQTEKELFESYIEGR
//
>1ucy_3N (K) [b.47.1] THROMBIN
IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLL
VRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCL
PDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKASTRIR
ITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFY
THVFRLKKWIQKVIDRLGS
//
>1udiE [c.18.1] URACIL-DNA GLYCOSYLASE
DWTTFRRVFLIDDAWRPLMEPELANPLTAHLLAEYNRRCQTEEVLPPREDVFSWTRYCTP
DEVRVVIIGQDPYHHPGQAHGLAFSVRANVPPPPSLRNVLAAVKNCYPEARMSGHGCLEK
WARDGVLLLNTTLTVKRGAAASHSRIGWDRFVGGVIRRLAARRPGLVFMLWGTHAQNAIR
PDPRVHCVLKFSHPSPLSKVPFGTCQHFLVANRYLETRSISPIDWSV
//
>1udiI [d.17.5] URACIL-DNA GLYCOSYLASE INHIBITOR PROTEIN
TNLSDIIEKETGKQLVIQESILMLPEEVEEVIGNKPESDILVHTAYDESTDENVMLLTSD
APEYKPWALVIQDSNGENKIKML
//
>1uea_2C (A) [d.92.1] MATRIX METALLOPROTEINASE-3
FRTFPGIPKWRKTHLTYRIVNYTPDLPKDAVDSAVEKALKVWEEVTPLTFSRLYEGEADI
mISFAVREHGDFYPFDGPGNVLAHAYAPGPGINGDAHFDDDEQWTKDTTGTNLFLVAAHE
IGHSLGLFHSANTEALmYPLYHSLTDLTRFRLSQDDINGIQSLYGPPP
//
>1uea_2D (B) [b.40.3] TISSUE INHIBITOR OF METALLOPROTEINASE-1
CTCVPPHPQTAFCNSDLVIRAKFVGTPEVAQTTLYQRYEIKMTKMYKGFQALGDAADIRF
VYTPAMESVCGYFHRSHARSEEFLIAGKLQDGLLHITTCSFVAPWNSLSLAQRRGFTKTY
TVGCEECTVFPCLSIPCKLQSGTHCLWTDQLLQGSEKGFQSRHLACLPREPGLCTWQSLR
S
//
>1uexB [d.169.1] BITISCETIN BETA CHAIN
GCLPDWSSYKGHCYKVFKVEKTWADAEKFCKELVNGGHLMSVNSREEGEFISKLALEKMR
IVLVWIGLSHFWRICPLRWTDGARLDYRALSDEPICFVAESFHNKWIQWTCNRKKSFVCK
YRV
//
>1uexC [c.62.1] VON WILLEBRAND FACTOR
EPPLHDFYCSRLLDLVFLLDGSSRLSEAEFEVLKAFVVDMMERLRISQKWVRVAVVEYHD
GSHAYIGLKDRKRPSELRRIASQVKYAGSQVASTSEVLKYTLFQIFSKIDRPEASRIALL
LMASQEPQRMSRNFVRYVQGLKKKKVIVIPVGIGPHANLKQIRLIEKQAPENKAFVLSSV
DELEQQRDEIVSYLCDLAPEAP
//
>1ughE [c.18.1] PROTEIN (URACIL-DNA GLYCOSYLASE)
MEFFGESWKKHLSGEFGKPYFIKLMGFVAEERKHYTVYPPPHQVFTWTQMCDIKDVKVVI
LGQDPYHGPNQAHGLCFSVQRPVPPPPSLENIYKELSTDIEDFVHPGHGDLSGWAKQGVL
LLNAVLTVRAHQANSHKERGWEQFTDAVVSWLNQNSNGLVFLLWGSYAQKKGSAIDRKRH
HVLQTAHPSPLSVYRGFFGCRHFSKTNELLQKSGKKPIDWKEL
//
>1ughI [d.17.5] PROTEIN (URACIL-DNA GLYCOSYLASE INHIBITOR)
NLSDIIEKETGKQLVIQESILMLPEEVEEVIGNKPESDILVHTAYDESTDENVMLLTSDA
PEYKPWALVIQDSNGENKIKML
//
>1uhdB [b.52.2] ASPARTATE 1-DECARBOXYLASE BETA CHAIN
MTFEMLYSKIHRATITDANLNYIG
//
>1uhdA [b.52.2] ASPARTATE 1-DECARBOXYLASE ALPHA CHAIN
ITIDEDLAKLAKLREGMKVEIVDVNNGERFSTYVILGKKRGEICVNGAAARKVAIGDVVI
ILAYASMNEDEINAHKPSIVLVDEKNEILEKGLEH
//
>1uhlA [a.123.1] RETINOIC ACID RECEPTOR RXR-BETA
EMPVDRILEAELAVEQSPNDPVTNICQAADKQLFTLVEWAKRIPHFSSLPLDDQVILLRA
GWNELLIASFSHRSIDVRDGILLATGLHVHRNSAHSAGVGAIFDRVLTELVSKMRDMRMD
KTELGCLRAIILFNPDAKGLSNPSEVEVLREKVYASLETYCKQKYPEQQGRFAKLLLRLP
ALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLEA
//
>1uhlB [a.123.1] OXYSTEROLS RECEPTOR LXR-ALPHA
MSPEQLGMIEKLVAAQQQCNRRSFEARQQRFAHFTELAIVSVQEIVDFAKQLPGFLQLSR
EDQIALLKTSAIEVMLLETSRRYNPGSESITDFSYNREDFAKAGLQVEFINPIFEFSRAM
NELQLNDAEFALLIAISIFSADRPNVQDQLQVERLQHTYVEALHAYVSIHHPHDRLMFPR
MLMKLVSLRTLSSVHSEQVFALRLQDKKLPPLLSEIWDV
//
>1uj3A [b.1.1 - b.1.1] IGG FAB LIGHT CHAIN
DIQMTQSPSSLSASVGDRVTITCKASQDIKSFLSWYQQKPEKAPKSLIYYATSLADGVPS
RFSGSGSGTDYTLTISSLQPEDFATYYCLQHGESPYTFGGGTKVEIKRTVAAPSVFIFPP
SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT
LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
//
>1uj3B [b.1.1 - b.1.1] IGG FAB HEAVY CHAIN
QVQLLESGAVLARPGTSVKISCKASGFNIKDYYMHWVKQRPGQGLEWIGGNDPANGHSMY
DPKFQGRVTITADTSTSTVFMELSSLRSEDTAVYYCARDSGYAMDYWGQGTLVTVSSAST
KGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLY
SLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVES
//
>1uj3C [b.1.2 - b.1.2] TISSUE FACTOR
TVAAYNLTWKSTNFKTILEWEPKPVNQVYTVQISTKSGDWKSKCFYTTDTECDLTDEIVK
DVKQTYLARVFSYPAGNVESTGSAGEPLYENSPEFTPYLETNLGQPTIQSFEQVGTKVNV
TVEDERTLVRRNNTFLSLRDVFGKDLIYTLYYWKSSSSGKKTAKTNTNEFLIDVDKGENY
CFSVQAVIPSRTVNRKSTDSPVECM
//
>1ukl_2E (C) [a.38.1] STEROL REGULATORY ELEMENT BINDING PROTEIN-2
RSSINDKIIELKDLVmGTDAKmHKSGVLRKAIDYIKYLQQVNHKLRQENmVLKLANQKNK
L
//
>1ukl_2B (A) [a.118.1] IMPORTIN BETA-1 SUBUNIT
MELITILEKTVSPDRLELEAAQKFLERAAVENLPTFLVELSRVLANPGNSQVARVAAGLQ
IKNSLTSKDPDIKAQYQQRWLAIDANARREVKNYVLQTLGTETYRPSSASQCVAGIACAE
IPVSQWPELIPQLVANVTNPNSTEHMKESTLEAIGYICQDIDPEQLQDKSNEILTAIIQG
MRKEEPSNNVKLAATNALLNSLEFTKANFDKESERHFIMQVVCEATQCPDTRVRVAALQN
LVKIMSLYYQYMETYMGPALFAITIEAMKSDIDEVALQGIEFWSNVCDEEMDLAIEASEA
AEQGRPPEHTSKFYAKGALQYLVPILTQTLTKQDENDDDDDWNPCKAAGVCLMLLSTCCE
DDIVPHVLPFIKEHIKNPDWRYRDAAVMAFGSILEGPEPNQLKPLVIQAMPTLIELMKDP
SVVVRDTTAWTVGRICELLPEAAINDVYLAPLLQCLIEGLSAEPRVASNVCWAFSSLAEA
AYEAADVADDQEEPATYCLSSSFELIVQKLLETTDRPDGHQNNLRSSAYESLMEIVKNSA
KDCYPAVQKTTLVIMERLQQVLQMESHIQSTSDRIQFNDLQSLLCATLQNVLRKVQHQDA
LQISDVVMASLLRMFQSTAGSGGVQEDALMAVSTLVEVLGGEFLKYMEAFKPFLGIGLKN
YAEYQVCLAAVGLVGDLCRALQSNILPFCDEVMQLLLENLGNENVHRSVKPQILSVFGDI
ALAIGGEFKKYLEVVLNTLQQASQAQVDKSDFDMVDYLNELRESCLEAYTGIVQGLKGDQ
ENVHPDVMLVQPRVEFILSFIDHIAGDEDHTDGVVACAAGLIGDLCTAFGKDVLKLVEAR
PMIHELLTEGRRSKTNKAKTLATWATKELRKLKNQA
//
>1ukmA [d.169.1] EMS16 A CHAIN
DCPSDWTAYDQHCYLAIGEPQNWYEAERFCTEQAKDGHLVSIQSREEGNFVAQLVSGFMH
RSEIYVWIGLRDRREEQQCNPEWNDGSKIIYVNWKEGESKMCQGLTKWTNFHDWNNINCE
DLYPFVCKFSA
//
>1ukmB [d.169.1] EMS16 B CHAIN
CPLGWSSFDQHCYKVFEPVKNWTEAEEICMQQHKGSRLASIHSSEEEAFVSKLASKALKF
TSMWIGLNNPWKDCKWEWSDNARFDYKAWKRRPYCTVMVVKPDRIFWFTRGCEKSVSFVC
KFLT
//
>1ukvG [c.3.1 - d.16.1 - c.3.1] SECRETORY PATHWAY GDP DISSOCIATION INHIBITOR
TIDTDYDVIVLGTGITECILSGLLSVDGKKVLHIDKQDHYGGEAASVTLSQLYEKFKQNP
ISKEERESKFGKDRDWNVDLIPKFLMANGELTNILIHTDVTRYVDFKQVSGSYVFKQGKI
YKVPANEIEAISSPLMGIFEKRRMKKFLEWISSYKEDDLSTHQGLDLDKNTMDEVYYKFG
LGNSTKEFIGHAMALWTNDDYLQQPARPSFERILLYCQSVARYGKSPYLYPMYGLGELPQ
GFARLSAIYGGTYMLDTPIDEVLYKKDTGKFEGVKTKLGTFKAPLVIADPTYFPEKCKST
GQRVIRAICILNHPVPNTSNADSLQIIIPQSQLGRKSDIYVAIVSDAHNVCSKGHYLAII
STIIETDKPHIELEPAFKLLGPIEEKFMGIAELFEPREDGSKDNIYLSRSYDASSHFESM
TDDVKDIYFRVTGHPLVLKQRQ
//
>1ukvY [c.37.1] GTP-BINDING PROTEIN YPT1
SEYDYLFKLLLIGNSGVGKSCLLLRFSDDTYTNDYISTIGVDFKIKTVELDGKTVKLQIW
DTAGQERFRTITSSYYRGSHGIIIVYDVTDQESFNGVKMWLQEIDRYATSTVLKLLVGNK
CDLKDKRVVEYDVAKEFADANKMPFLETSALDSTNVEDAFLTMARQIKESMSQQNLNETT
QKKEDKGNVNLKGQSLC
//
>1ul1_1X [c.120.1 - a.60.7] FLAP ENDONUCLEASE-1
GIQGLAKLIADVAPSAIRENDIKSYFGRKVAIDASMSIYQFLIAVTTSHLMGMFYRTIRM
MENGIKPVYVFDGKPPQLKSGELAKRLVKVTKQHNDECKHLLSLMGIPYLDAPSEAEASC
AALVKAGKVYAAATEDMDCLTFGSPVLMRHLTASEKKLPIQEFHLSRILQELGLNQEQFV
DLCILLGSDYCESIRGIGPKRAVDLIQKHKSIEEIVRRLDPNKYPVPENWLHKEAHQLFL
EPEVLDPESVELKWSEPNEEELIKFMCGEKQFSEERIRSGVKRLSKSRQGSTQGRLDDFF
KVTGSLSSAKRKE
//
>1ul1_1A [d.131.1 - d.131.1] PROLIFERATING CELL NUCLEAR ANTIGEN
MFEARLVQGSILKKVLEALKDLINEACWDISSSGVNLQSMDSSHVSLVQLTLRSEGFDTY
RCDRNLAMGVNLTSMSKILKCAGNEDIITLRAEDNADTLALVFEAPNQEKVSDYEMKLMD
LDVEQLGIPEQEYSCVVKMPSGEFARICRDLSHIGDAVVISCAKDGVKFSASGELGNGNI
KLSQTSKEEEAVTIEMNEPVQLTFALRYLNFFTKATPLSSTVTLSMSADVPLVVEYKIAD
MGHLKYYLAPKIEDEE
//
>1ul1_2A (Z) [c.120.1 - a.60.7] FLAP ENDONUCLEASE-1
GIQGLAKLIADVAPSAIRENDIKSYFGRKVAIDASMSIYQFLIAVRQGGDVLQNEEGETT
SHLMGMFYRTIRMMENGIKPVYVFDGKPPQLKSGELAKRSERRAEAEKQLQQEQEVEKFT
KRLVKVTKQHNDECKHLLSLMGIPYLDAPSEAEASCAALVKAGKVYAAATEDMDCLTFGS
PVLMRHLTASEAKKLPIQEFHLSRILQELGLNQEQFVDLCILLGSDYCESIRGIGPKRAV
DLIQKHKSIEEIVRRLDPNKYPVPENWLHKEAHQLFLEPEVLDPESVELKWSEPNEEELI
KFMCGEKQFSEERIRSGVKRLSKSRQGSTQGRLDDFFKVTGSLSSAKRK
//
>1ul1_2C [d.131.1 - d.131.1] PROLIFERATING CELL NUCLEAR ANTIGEN
MFEARLVQGSILKKVLEALKDLINEACWDISSSGVNLQSMDSSHVSLVQLTLRSEGFDTY
RCDRNLAMGVNLTSMSKILKCAGNEDIITLRAEDNADTLALVFEAPNQEKVSDYEMKLMD
LDVEQLGIPEQEYSCVVKMPSGEFARICRDLSHIGDAVVISCAKDGVKFSASGELGNGNI
KLSQTSNVDKEEEAVTIEMNEPVQLTFALRYLNFFTKATPLSSTVTLSMSADVPLVVEYK
IADMGHLKYYLAPKI
//
>1uljC [b.33.1 - d.129.3] BIPHENYL DIOXYGENASE LARGE SUBUNIT
WADADIAELVDERTGRLDPRIYTDEALYEQELERIFGRSWLLMGHETQIPKAGDFMTNYM
GEDPVMVVRQKNGEIRVFLNQCRHRGMRICRADGGNAKSFTCSYHGWAYDTGGNLVSVPF
EEQAFPGLRKEDWGPLQARVETYKGLIFANWDADAPDLDTYLGEAKFYMDHMLDRTEAGT
EAIPGIQKWVIPCNWKFAAEQFCSDMYHAGTTSHLSGILAGLTEGIQYRATWGGHGSGFY
IGDPNLLLAIMGPKVTEYWTQGPAAEKASERLGSTERGQQLMAQHMTIFPTCSFLPGINT
IRAWHPRGPNEIEVWAFTVVDADAPEEMKEEYRQQTLRTFSAGGVFEQDDGENWVEIQQV
LRGHKARSRPFNAEMGLGQTDSDNPDYPGTISYVYSEEAARGLYTQWVRMMTSPDWAALD
ATRPA
//
>1uljD [d.17.4] BIPHENYL DIOXYGENASE SMALL SUBUNIT
AFRTKPAPVDPSLQHEIEQFYYWEAKLLNDRRFQEWFDLLAEDIHYFMPIRTTRIMRETA
QEYSGAREYAHFDDNAQMMRGRLRKITSDVSWSENPASRTRHVISNVMIVDGEKPGEYHV
SSVFIVYRNRLERQLDIFAGERKDILRRTGSEAGFELAKRTILIDQSTILSNNLSFFF
//
>1um3_2N [x.x.x]
EIQALADDVTSKYVPPHVNIFYCLGGITLTCFLIQFATGFAMTFYYKPTVTEAYASVQYI
MNEVSFGWLIRSIHRWSASMMVLMMILHVFRVYLTGGFKKPRELTWISGVILAVITVSFG
VTGYSLPWDQVGYWAVKIVSGVPEAIPVVGVLISDLLRGGSSVGQATLTRYYSAHTFVLP
WLIAVFMLLHFLMIRKQGISGP
//
>1um3_2O [x.x.x]
LAKGMGHNYYGEPAWPNDLLYVFPVVIMGTFACIVALSVLDPAMVGEPANPFATPLEILP
EWYLYPVFQILRSLPNKLLGVLLMASVPLGLILVPFIENVNKFQNPFRRPVATTIFLFGT
LVTIWLGIGAALPLDKTL
//
>1um3_2R [x.x.x]
MILGAVFYIVFIALFFGIAVGIIFAIKSIKLI
//
>1um3_2T [x.x.x]
LVLGLVFATLGGLFYAAYQQYKRPNEL
//
>1um3_2S [x.x.x]
MTEEMLYAALLSFGLIFVGWGLGVLLLKIQGAEKE
//
>1um4L [b.1.1 - b.1.1] ANTIBODY 21H3 L CHAIN
LDIQMTQSPSSLSASLGERVSLTCRASQEISGYLYWLQQKPDGTIKRLIYAGSTLDSGVP
KRFSGSRSGSDYSLTISSLESEDFADYYCLQYASYPRTFGGGTKVEIKRTVAAPSVFIFP
PSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTL
TLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGECGAGA
//
>1um4H [b.1.1 - b.1.1] ANTIBODY 21H3 H CHAIN
VQLQQSGPVLVKPGGSVKMSCKASEYTLTSYLFQWVKQKSGQGLEWIGYIYPYNGGTRYN
EKFRGKATLTSDKSSNTAYLELSSLTSEDSAVYYCARSSMSDPGANWGPGTLVTVSSAST
KGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLY
SLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEP
//
>1um9A [c.36.1] 2-OXO ACID DEHYDROGENASE ALPHA SUBUNIT
HRFETFTEEPIRLIGEEGEWLGDFPLDLEGEKLRRLYRDMLAARMLDERYTILIRTGKTS
FIAPAAGHEAAQVAIAHAIRPGFDWVFPYYRDHGLALALGIPLKELLGQMLATKADPNKG
RQMPEHPGSKALNFFTVASPIASHVPPAAGAAISMKLLRTGQVAVCTFGDGATSEGDWYA
GINFAAVQGAPAVFIAENNFPTIADKAHAFGIPGYLVDGMDVLASYYVVKEAVERARRGE
GPSLVELRVYRYGPHRKKDPIPRFRRFLEARGLWNEEWEEDVREEIRAELERGLKEAEEA
GPVPPEWMFEDVFAEKPWHLLRQEALLKEEL
//
>1um9B [c.36.1 - c.48.1] 2-OXO ACID DEHYDROGENASE BETA SUBUNIT
ALMTMVQALNRALDEEMAKDPRVVVLGEDVGKRGGVFLVTEGLLQKYGPDRVMDTPLSEA
AIVGAALGMAAHGLRPVAEIQFADYIFPGFDQLVSQVAKLRYRSGGQFTAPLVVRMPSGG
GVRGGHHHSQSPEAHFVHTAGLKVVAVSTPYDAKGLLKAAIRDEDPVVFLEPKRLYRSVK
EEVPEEDYTLPIGKAALRREGKDLTLICYGTVMPEVLQAAAELAKAGVSAEVLDLRTLMP
WDYEAVMNSVAKTGRVVLVSDAPRHASFVSEVAATIAEDLLDMLLAPPIRVTGFDTPYPY
AQDKLYLPTVTRILNAAKRALDY
//
>1umbC [c.36.1] 2-OXO ACID DEHYDROGENASE ALPHA SUBUNIT
HRFETFTEEPIRLIGEEGEWLGDFPLDLEGEKLRRLYRDMLAARMLDERYTILIRTGKTS
FIAPAAGHEAAQVAIAHAIRPGFDWVFPYYRDHGLALALGIPLKELLGQMLATKADPNKG
RQMPEHPGSKALNFFTVASPIASHVPPAAGAAISMKLLRTGQVAVCTFGDGATSEGDWYA
GINFAAVQGAPAVFIAENNFYAISVDYRHQTHSPTIADKAHAFGIPGYLVDGMDVLASYY
VVKEAVERARRGEGPSLVELRVYRYGPHSSADDDSRYRPKEEVAFWRKKDPIPRFRRFLE
ARGLWNEEWEEDVREEIRAELERGLKEAEEAGPVPPEWMFEDVFAEKPWHLLRQEALLKE
E
//
>1umbD (B) [c.36.1 - c.48.1] 2-OXO ACID DEHYDROGENASE BETA SUBUNIT
ALMTMVQALNRALDEEMAKDPRVVVLGEDVGKRGGVFLVTEGLLQKYGPDRVMDTPLSEA
AIVGAALGMAAHGLRPVAEIQFADYIFPGFDQLVSQVAKLRYRSGGQFTAPLVVRMPSGG
GVRGGHHHSQSPEAHFVHTAGLKVVAVSTPYDAKGLLKAAIRDEDPVVFLEPKRLYRSVK
EEVPEEDYTLPIGKAALRREGKDLTLICYGTVMPEVLQAAAELAKAGVSAEVLDLRTLMP
WDYEAVMNSVAKTGRVVLVSDAPRHASFVSEVAATIAEDLLDMLLAPPIRVTGFDTPYPY
AQDKLYLPTVTRILNAAKRALDY
//
>1unl_2B (A) [d.144.1] CYCLIN-DEPENDENT KINASE 5
MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH
KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR
NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS
TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP
MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP
//
>1unl_2E (D) [a.74.1] CYCLIN-DEPENDENT KINASE 5 ACTIVATOR 1
QASTSELLRCLGEFLCRRCYRLKHLSPTDPVLWLRSVDRSLLLQGWQDQGFITPANVVFL
YMLCRDVISSEVGSDHELQAVLLTCLYLSYSYMGNEISYPLKPFLVESCKEAFWDRCLSV
INLMSSKMLQINADPHYFTQVFSDLKNES
//
>1unnA [d.131.1 - d.131.1 - d.131.1] DNA POLYMERASE III BETA SUBUNIT
MKFTVEREHLLKPLQQVSGPLGGRPTLPILGNLLLQVADGTLSLTGTDLEMEMVARVALV
QPHEPGATTVPARKFFDICRGLPEGAEIAVQLEGERMLVRSGRSRFSLSTLPAADFPNLD
DWQSEVEFTLPQATMKRLIEATQFSMAHQDVRYYLNGMLFETEGEELRTVATDGHRLAVC
SMPIGQSLPSHSVIVPRKGVIELMRMLDGGDNPLRVQIGSNNIRAHVGDFIFTSKLVDGR
FPDYRRVLPKNPDKHLEAGCDLLKQAFARAAILSNEKFRGVRLYVSENQLKITANNPEQE
EAEEILDVTYSGAEMEIGFNVSYVLDVLNALKCENVRMMLTDSVSSVQIEDAASQSAAYV
VMPMRL
//
>1unnD [d.240.1] DNA POLYMERASE IV
HHHVGVERTMAEDIHHWSECEAIIERLYPELERRLAKVKPDLLIARQGVKLKFDDFQQTT
QEHVWPRLNKADLIATARKTWDERRGGRGVRLVGLHVTLLDPQMERQLVLGL
//
>1uosA [d.169.1] CONVULXIN ALPHA
HCPSDWYYYDQHCYRIFNEEMNWEDAEWFCTKQAKGAHLVSIKSAKEADFVAWMVTQNIE
ESFSHVSIGLRVQNKEKQCSTKWSDGSSVSYDNLLDLYITKCSLLKKETGFRKWFVASCI
GKIPFVCKFPPQC
//
>1uosB [d.169.1] CONVULXIN BETA
FCCPSHWSSYDRYCYKVFKQEMTWADAEKFCTQQHTGSHLVSFHSTEEVDFVVKMTHQSL
KSTFFWIGANNIWNKCNWQWSDGTKPEYKEWHEEFECLISRTFDNQWLSAPCSDTYSFVC
KFEA
//
>1upn_2B [b.121.4] ECHOVIRUS 11 COAT PROTEIN VP2
SDRVRSITLGNSTITTQESANVVVGYGRWPEYLRDDEATAEDQPTQPDVATCRFYTLESV
TWEKDSPGWWWKFPDALKDMGLFGQNMYYHYLGRAGYTIHVQCNASKFHQGCLLVVCVPE
AEMGCSTVDGTVNEHGLSEGETAKKFSATGTNGTNTVQSIVTNAGMGVGVGNLTIFPHQW
INLRTNNCATIVMPYINNVPMDNMFRHHNFTLMIIPFVPLNYSSDFSTYVPITVTVAPMC
AEYNGLRLSTAL
//
>1upn_2E [g.18.1 - g.18.1] COMPLEMENT DECAY-ACCELERATING FACTOR
KSCPNPGEIRNGQIDVPGGILFGATISFSCNTGYKLFGSTSSFCLISGSSVQWSDPLPEC
REIYCPAPPQIDNGIIQGERDHYGYRQSVTYACNKGFTMIGEHSIYCTVNNDEGEWSGPP
PECRG
//
>1upn_2E [g.18.1 - g.18.1] COMPLEMENT DECAY-ACCELERATING FACTOR
KSCPNPGEIRNGQIDVPGGILFGATISFSCNTGYKLFGSTSSFCLISGSSVQWSDPLPEC
REIYCPAPPQIDNGIIQGERDHYGYRQSVTYACNKGFTMIGEHSIYCTVNNDEGEWSGPP
PECRG
//
>1upn_2n (C) [b.121.4] ECHOVIRUS 11 COAT PROTEIN VP3
GLPVINTPGSNQFLTSDDFQSPSAMPQFDVTPELNIPGEVQNLMEIAEVDSVVPVNNVAG
NLETMDIYRIPVQSGNHQSSQVFGFQVQPGLDGVFKHTLLGEILNYYAHWSGSIKLTFVF
CGSAMATGKFLLAYAPPGANAPKSRKDAMLGTHIIWDVGLQSSCVLCIPWISQTHYRLVQ
QDEYTSAGNVTCWYQTGIVVPAGTPTSCSIMCFVSACNDFSVRLLKDTPFIQQAALLQ
//
>1upt_2E [c.37.1] ADP-RIBOSYLATION FACTOR-LIKE PROTEIN 1
HmTREmRILILGLDGAGKTTILYRLQVGEVVTTIPTIGFNVETVTYKNLKFQVWDLGGLT
SIRPYWRCYYSNTDAVIYVVDSCDRDRIGISKSELVAmLEEEELRKAILVVFANKQDmEQ
AmTSSEmANSLGLPALKDRKWQIFKTSATKGTGLDEAmEWLVETLKSR
//
>1upt_2F [a.193.1] GOLGI AUTOANTIGEN, GOLGIN SUBFAMILY A MEMBER 4
EPTEFEYLRKVLFEYmmGRETKTmAKVITTVLKFPDDQTQKILEREDARLmSWLRS
//
>1urqA [h.1.15] M-TOMOSYN ISOFORM
IEGVKGAASGVVGELARARLALDERGQKLSDLEERTAAMMSSADSFSKHAHEMMLKY
//
>1urqB [h.1.15] SYNTAXIN 1A
ETRHSEIIKLENSIRELHDMFMDMAMLVESQGEMIDRIEYNVEHAVDYVERAVSDTKKAV
KYQ
//
>1urqC [h.1.15] SYNAPTOSOMAL-ASSOCIATED PROTEIN 25
RRADQLADESLESTRRMLQLVEESKDAGIRTLVMLDEQGEQLDRVEEGMNHINQDMKEAE
KNLKDLGK
//
>1urqD [h.1.15] SYNAPTOSOMAL-ASSOCIATED PROTEIN 25
MASRENEMDENLEQVSGIIGNLRHMALDMGNEIDTQNRQIDRIMEKADSNKTRIDEANQR
AT
//
>1us7A [d.122.1] HEAT SHOCK PROTEIN HSP82
ASETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASDALDKIRYKSLSDPKQLETEPD
LFIRITPKPEQKVLEIRDSGIGMTKAELINNLGTIAKSGTKAFMEALSAGADVSMIGQFG
VGFYSLFLVADRVQVISKSNDDEQYIWESNAGGSFTVTLDEVNERIGRGTILRLFLKDDQ
LEYLEEKRIKEVIKRHSEFVAYPIQL
//
>1us7B [a.205.1] HSP90 CO-CHAPERONE CDC37
HKTFVEKYEKQIKHFGMLRRWDDSQKYLSDNVHLVCEETANYLVIWCIDLEVEEKCALME
QVAHQTIVMQFILELAKSLKVDPRACFRQFFTKIKTADRQYMEGFNDELEAFKERVRGRA
KLRIEKAMKEYEEEERKKRLGPGGLDPVEVYESLPEELQKCMLQDAISKMDPTDAKYHMQ
RCIDSGLWVPNSK
//
>1us8A [c.37.1] DNA DOUBLE-STRAND BREAK REPAIR RAD50 ATPASE
MKLERVTVKNFRSHSDTVVEFKEGINLIIGQNGSGKSSLLDAILVGLYWPLRIDTYIDLI
FEKDGTKYRITRRFLSGEIHAMKRLVGNEWKHVTEPSSKAISAFMEKLIPYNIFLNAIYI
RQGQIDAIL
//
>1us8B [c.37.1] DNA DOUBLE-STRAND BREAK REPAIR RAD50 ATPASE
LAREAALSKIGELASEIFAEFTEGKYSEVVVRAVRLFVVWEGKERPLTFLRGGERIALGL
AFRLAMSLYLAGEISLLILDEPTPYLDEERRRKLITIMERYLKKIPQVILVSHDEELKDA
ADHVIRISLENGSSKVEVVS
//
>1usuA [d.14.1] HEAT SHOCK PROTEIN HSP82
PTKPLWTRNPSDITQEEYNAFYKSISNDWEDPLYVKHFSVEGQLEFRAILFIPKRAPFDL
FESNNIKLYVRRVFITDEAEDLIPEWLSFVKGVVDSEDLPLNLQNKIMKVIRKNIVKKLI
EAFNEIAEDSEQFEKFYSAFSKNIKLGVHEDTQNRAALAKLLRYNSTKSVDELTSLTDYV
TRMPEHQKNIYYITGESLKSVEKSPFLDALKAKNFEVLFLTDPIDEYAFTQLKEFEGKTL
VDITKD
//
>1usuB [d.83.2] AHA1
VDKNCIGWAKEYFKQKIVGVEAKKYAKIKSVSSIEGDCEVNQRGKVISLFDLKITVLIEG
HVDSALPFEGSINVPEVAFDSEASSYQFDISIFKETSELSEAKPLIRSELLPKLRQIFQQ
FGKDLLATHGND
//
>1usv_4G [d.14.1] HEAT SHOCK PROTEIN HSP82
KTKPLWTRNPSDITQEEYNAFYKSISNDWEDPLYVKHFSVEGQLEFRAILFIPKRAPFKK
NNIKLYVRRVFITDEAEDLIPEWLSFVKGVVDSEDLPLNLSREMLQQNKIMKVIRKNIVK
KLIEAFNEIAEDSEQFEKFYSAFSKNIKLGVHEDTQNRAALAKLLRYNSTKSVDELTSLT
DYVTRMPEHQKNIYYITGESLKAVEKSPFLDALKAKNFEVLFLTDPIDEYAFTQLKEFEG
KTLVDITK
//
>1usv_4H [d.83.2] AHA1
WVDKNCIGWAKEYFKQKLVGVEAGSVKDKKYAKIKSVSSIEGDCEVNQRKGKVISLFDLK
ITVLIEGHVDSKDGSALPFEGSINVPEVAFDSEASSYQFDISIFKETSELSEAKPLIRSE
LLPKLRQIFQQFGKDLLATHG
//
>1usyD [d.104.1] ATP PHOSPHORIBOSYLTRANSFERASE REGULATORY SUBUNIT
DFLDFEKVFSFYSKATKKGFSPFFVPALEKAEEPAGNFFLDRKGNLFSIREDFTKTVLNH
RKRYSPDSQIKVWYADFVYRYSGSDLVAEYQLGLEKVPRNSLDDSLEVLEIIVESASEFF
EGPVIVEIGHTGVYEDLLKEIPKDLHEKVLNLIDTKNLAEIEFLSHMKKIDLSRVEKIIE
DSIYRRSPEHLKTMDLPLSVREDLLSASSFLQEKFPTVSVEIDLTLARTIEEYCGLIFTI
YDTSSSRLVAAGGEYTVNGEKGVGGSIFLEGKTC
//
>1usyF [c.94.1] ATP PHOSPHORIBOSYLTRANSFERASE
MLKLAIPKGRLEEKVMTYLKKTGVIFERESSILREGKDIVCFMVRPFDVPTYLVHGVADI
GFCGTDVLLEKETSLIQPFFIPTNISRMVLAGPKGRGIPEGEKRIATKFPNVTQRYCESK
GWHCRIIPLKGSVELAPIAGLSDLIVDITETGRTLKENNLEILDEIFVIRTHVVVNPVSY
RTKREEVVSFLEKLQEVIEHDS
//
>1uugA [c.18.1] URACIL-DNA GLYCOSYLASE
LTWHDVLAEEKQQPYFLNTLQTVASERQSGVTIYPPQKDVFNAFRFTELGDVKVVILGQD
PYHGPGQAHGLAFSVRPGIAIPPSLLNMYKELENTIPGFTRPNHGYLESWARQGVLLLNT
VLTVRAGQAHSHASLGWETFTDKVISLINQHREGVVFLLWGSHAQKKGAIIDKQRHHVLK
APHPSPLSAHRGFFGCNHFVLANQWLEQRGETPIDWMPVLPA
//
>1uugB [d.17.5] URACIL-DNA GLYCOSYLASE INHIBITOR
NLSDIIEKETGKQLVIQESILMLPEEVEEVIGNKPESDILVHTAYDESTDENVMLLTSDA
PEYKPWALVIQDSNGENKIKML
//
>1uuz_1A [d.233.1] INHIBITOR OF VERTEBRATE LYSOZYME
EEQPRLFELLGQPGYKATWHAMFKGESDVPKWVSDASGPSSPSTSLSLEGQPYVLANSCK
PHDCGNNRLLVAFRGDKSAAYGLQVSLPDEPAEVMQTPSKYATYRWYGEPSRQVRELLMK
QLESDPNWK
//
>1uuz_1D [d.2.1] LYSOZYME C
KVFGRCELAAAMKRHGLDNYRGYSLGNWVCAAKFESNFNTQATNRNTDGSTDYGILQINS
RWWCNDGRTPGSRNLCNIPCSALLSSDITASVNCAKKIVSDGNGMNAWVAWRNRCKGTDV
QAWIRGCRL
//
>1uvqA [d.19.1 - b.1.1] HLA CLASS II HISTOCOMPATIBILITY ANTIGEN
DIVADHVASCGVNLYQFYGPSGQYTHEFDGDEQFYVDLERKETAWRWPEFSKFGGFDPQG
ALRNMAVAKHNLNIMIKRYNSTAATNEVPEVTVFSKSPVTLGQPNTLICLVDNIFPPVVN
ITWLSNGQSVTEGVSETSFLSKSDHSFFKISYLTFLPSADEIYDCKVEHWGLDQPLLKHW
EP
//
>1uvqB [d.19.1 - b.1.1] HLA CLASS II HISTOCOMPATIBILITY ANTIGEN
SPEDFVFQFKGMCYFTNGTERVRLVTRYIYNREEYARFDSDVGVYRAVTPQGRPDAEYWN
SQKEVLEGTRAELDTVCRHNYEVAFRGILQRRVEPTVTISPSNLLVCSVTDFYPGQIKVR
WFRNDQEETAGVVSTPLIRNGDWTFQILVMLEMTPQRGDVYTCHVEHPSLQSPITVEWRA
Q
//
>1uvqC [x.x.x] OREXIN
MNLPSTKVSWAAVGGGGSLV
//
>1uw4_2C [d.58.7] UPF3X
LSKVVIRRLPPTLTKEQLQEHLQPMPEHDYFEFFSNDTSLYPHMYARAYINFKNQEDIIL
FRDRFDGYVFLDNKGQEYPAIVEFAPFQKAA
//
>1uw4_2D (B) [a.118.1] REGULATOR OF NONSENSE TRANSCRIPTS 2
RPPLQEYVRKLLYKDLSKVTTEKVLRQMRKLPWQDQEVKDYVICCMINIWNVKYNSIHCV
ANLLAGLVLYQEDVGIHVVDGVLEDIRLGMEVNQPKFNQRRISSAKFLGELYNYRMVESA
VIFRTLYSFTSFGVNPDGSPSSLDPPEHLFRIRLVCTILDTCGQYFDRGSSKRKLDCFLV
YFQRYVWWKKSLEVWTKDHPFPIDIDYMISDTLELLRPKIKLCNSLEESIRQVQDLEREF
LIKLGLV
//
>1uwe_1H [b.1.1 - b.1.1] ANTIBODY 14D9
LLAQSGPELVKPGASVKISCAASAYSITDFTIYWVKQSHGDSLEWIGGIDPHNGGGAYNQ
KFRVKATLTVDTSSSTAYIHLNSLTSEDSAVYYCAIFYGNFFDYWGQGTTVTVSSASTKG
PSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSL
SSVVTVPSSSLGTQTYICNVNHKPSNTAVDKAVEPKSC
//
>1uwe_1L [b.1.1 - b.1.1] ANTIBODY 14D9
LDNVMTQSPSFMSTSVGDRVSVTCAASQNVGTNVAWYQQKPGQPPKALIYSTSYRYSGVP
DRFTGSGSGTDFTLTISNVNSEDLAEYFCQQYNIYPVTFGGGTKLEIKRTVAAPSVFIFP
PSAEQLASGTASVVCLLNNFYPREAAVQWKVDNALQSGNSQESVTEQDSADSTYSLSSTL
TLSKADYEAHAVYACEVTHQGLSSPVTKSFNRG
//
>1uwg_1H [x.x.x]
QLLESGPELVEPGASVKVSCKASAYSITDFNIYWVKQSHGKNLEWIGGIDPHAGGPVYNA
QFNGKATLTVDKSSSTAFMHLNSLTSEDSAVYYCAAFYGNFFDAWGPGTTVTVSSASTKG
PSVFPLAPTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPS
SSLGTQTYICNVAHKPSATKVDKKVEPK
//
>1uwg_1L [b.1.1 - b.1.1] ANTIBODY 14D9
ELVMTQSPKFMSTSVGDRVSVTCKASQNVGTHVAWYQQKPGQSPKTLIYSASYRYSGVPD
RFTGSGSGTDFTLTIRDVQSEDAAEYFCQQYNLFPVTFGGGTKLEIKRTVAAPSVFIFPP
SDEQLKSGTASVVCLLNNFYPREAAVAWKVDNALQSGNSQESVTEQDSADSTYSLSSTLT
LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGE
//
>1uwx_1H [b.1.1] ANTIBODY
VQLQQSGPELKKPGETVKLSCKASGYTFTNFGLNWMKQAPGKGLKWMGWINTYTGESTYA
DDFKGRFAFSLETSASTAYLQINNVKNEDTATYFCARGFYYYGSRYFYFDYWGQGTTLTV
SSAKTTAPSVYPLAPVSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDLYTL
SSSVTVTSSTWPSQSITCNVAHPASSTKVDKKIEPRGP
//
>1uwx_1L (K) [b.1.1 - b.1.1] ANTIBODY
GIVMTQTPASQSASLGESVTITCLASQTIGTWLAWYQQKPGKSPQLLIYAATSLADGVPS
RFSGSGSGTKFSFKISSLQAEDFVSYYCQQLSSTPYTFGGGTKLEIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGKERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNR
//
>1uwx_2B [d.15.7] PROTEIN G-PRIME
VTTYKLVINGKTLKGETTTKAVDAATAEKVFKQYANDNGVDGEWTYDDATKTFTVTEKPE
//
>1uwx_2M (H) [b.1.1] ANTIBODY
VQLQQSGPELKKPGETVKLSCKASGYTFTNFGLNWMKQAPGKGLKWMGWINTYTGESTYA
DDFKGRFAFSLETSASTAYLQINNVKNEDTATYFCARGFYYYGSRYFYFDYWGQGTTLTV
SSAKTTAPSVYPLAPVSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDLYTL
SSSVTVTSSTWPSQSITCNVAHPASSTKVDKKIEPRGP
//
>1uyw_2M (H) [b.1.1] FAB ANTIBODY HEAVY CHAIN
VQLQQSGPELVKPGTSVKISCKTSGYTFTEYTIHWVKEAGGKSLAWIGGIDPNSGGTNYS
PNFKGKATLTVDKSSSTAYMDLRSLSSEDSAVYFCARIYHYDGYFDVWGAGTAVTVSSAK
TTAPSVYPLAPVCGDTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDLY
TLSSSVTVTSSTWPSQSITCNVAHPASSTKVDKKIEPR
//
>1uyw_2N [b.1.1 - b.1.1] FAB ANTIBODY LIGHT CHAIN
NIVMTQSPKSMSMSVGERVTLTCKASENVVTYVSWYQQKPEQSPKLLIYGASNRYTGVPD
RFTGSGSATDFTLTISSVQAEDLADYHCGQGYSYPYTFGGGTKLELKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNR
//
>1uz6_3H [b.1.1 - b.1.1] IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A
EVKLLESGGGLVQPGGSQKLSCAASGFDFSGYWMSWVRQAPGKGLEWIGEINPDSSTINY
TPSLKDKFIISRDNAKNTLYLQMSKVRSEDTALYYCARETGTRFDYWGQGTTLTVSSATT
TAPSVYPLVPGSSVTLGCLVKGYFPEPVTVKWNYGALSSGVRTVSSVLQSGFYSLSSLVT
VPSSTWPSQTVICNVAHPASKTELIKRIEP
//
>1uz6_3L (E) [b.1.1 - b.1.1] IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A
DIVMTQAAFSNPVTLGTSASISCRSSKSLLYSNGITYLYWYLQKPGQSPQLLIYQMSNLA
SGVPDRFSSSGSGTDFTLRISRVEAEDVGVYYCAQNLEVPWTFGGGTKLEIKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATPIVKSFNRRSSKSLLYSNGITYLYWYLQKPGQSPQLLI
YQMSNLASGVPDRFSSSGSGTDFTLRISRVEAEDVGVYYCAQNLEVPWTFGGGTKLEIKR
ADAAPTVSIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDS
KDSTYSMSSTLTLTKDEYERHNSYTCEATESGGGLVQPGGSQKLSCAASGFDFSGYWMSW
VRQAPGKGLEWIGEINPDSSTINYTPSLKDKFIISRDNAKNTLYLQMSKVRSEDTALYYC
ARETGTRFDYWGQGTTLTVSSATTTAPSVYPLVPVTLGCLVKGYFPEPVTVKWNYGALSS
GVRTVSSVLQSGFYSLSSLVTVPSSTWPSQTVICNVAHPASKTELIKRIEP
//
>1uz8_1A [b.1.1 - b.1.1] IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A
DIVMTQAAFSNPVTLGTSASISCRSSKSLLYSNGITYLYWYLQKPGQSPQLLIYQMSNLA
SGVPDRFSSSGSGTDFTLRISRVEAEDVGVYYCAQNLEVPWTFGGGTKLEIKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNE
//
>1uz8_1B [b.1.1 - b.1.1] IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A
EVKLLESGGGLVQPGGSQKLSCAASGFDFSGYWMSWVRQAPGKGLEWIGEINPDSSTINY
TPSLKDKFIISRDNAKNTLYLQMSKVRSEDTALYYCARETGTRFDYWGQGTTLTVSSATT
TAPSVYPLVPGGSSVTLGCLVKGYFPEPVTVKWNYGALSSGVRTVSSVLQSGFYSLSSLV
TVPSSTWPSQTVICNVAHPASKTELIKRIEPR
//
>1uzdE (A) [d.58.9 - c.1.14] RIBULOSE BISPHOSPHATE CARBOXYLASE LARGE CHAIN
AGFKAGVKDYRLTYYTPDYVVRDTDILAAFRMTPQPGVPPEECGAAVAAESSTGTWTTVW
TDGLTSLDRYKGRCYDIEPVPGEDNQYIAYVAYxIDLFEEGSVTNMFTSIVGNVFGFKAL
RALRLEDLRIPPAYVKTFVGxPHGIQVERDKLNKYGRGLLGCTIKPKLGLSAKNYGRAVY
ECLRGGLDFTxDDENVNSQPFMRWRDRFLFVAEAIYKAQAETGEVKGHYLNATAGTCEEM
MKRAVxAKELGVPIIMHDYLTGGFTANTSLAIYCRDNGLLLHIHRAMHAVIDRQRNHGIH
FRVLAKALRMSGGDHLHSGTVVGKLEGEREVTLGFVDLMRDDYVEKDRSRGIYFTQDWxS
MPGVMPVASGGIHVWHMPALVEIFGDDACLQFGGGTLGHPWGNAPGAAANRVALEACTQA
RNEGRDLAREGGDVIRSACKWSPELAAACEVWKEIKFEFDTIDKL
//
>1uzdF (C) [d.73.1] RIBULOSE BISPHOSPHATE CARBOXYLASE SMALL CHAIN 1,
MMVWTPVNNKMFETFSYLPPLTDEQIAAQVDYIVANGWIPCLEFATDHGFVYREHHNSPG
YYDGRYWTMWKLPMFGCRDPMQVLREIVACTKAFPDAYVRLVAFDNQKQVQIMGFLVQRP
KQPANKRSV
//
>1uzhA [d.58.9 - c.1.14] RIBULOSE BISPHOSPHATE CARBOXYLASE LARGE CHAIN
AGFKAGVKDYRLTYYTPDYVVRDTDILAAFRMTPQPGVPPEECGAAVAAESSTGTWTTVW
TDGLTSLDRYKGRCYDIEPVPGEDNQYIAYVAYxIDLFEEGSVTNMFTSIVGNVFGFKAL
RALRLEDLRIPPAYVKTFVGxPHGIQVERDKLNKYGRGLLGCTIKPKLGLSAKNYGRAVY
ECLRGGLDFTxDDENVNSQPFMRWRDRFLFVAEAIYKAQAETGEVKGHYLNATAGTCEEM
MKRAVxAKELGVPIIMHDYLTGGFTANTSLAIYCRDNGLLLHIHRAMHAVIDRQRNHGIH
FRVLAKALRMSGGDHLHSGTVVGKLEGEREVTLGFVDLMRDDYVEKDRSRGIYFTQDWxS
MPGVMPVASGGIHVWHMPALVEIFGDDACLQFGGGTLGHPWGNAPGAAANRVALEACTQA
RNEGRDLAREGGDVIRSACKWSPELAAACEVWKEIKFEFDTIDKL
//
>1uzhI (C) [d.73.1] RIBULOSE BISPHOSPHATE CARBOXYLASE SMALL CHAIN 2,
MMVWTPVNNKMFETFSYLPPLTDEQIAAQVDYIVANGWIPCLEFAEHSNPEEFYWTMWKL
PMFGCRDPMQVLREIVACTKAFPDAYVRLVAFDNQKQVQIMGFLVQRPKTARDFQPANKR
SV
//
>1uzxA [d.20.1] VACUOLAR PROTEIN SORTING-ASSOCIATED PROTEIN
SVPEAVVNWLFKVIQPIYNDGRTTFHDSLALLDNFHSLRPRTRVFTHSDGTPQLLLSIYG
TISTGSIPVImWVPSxYPVKPPFISINLENFDmNTLPIQEYIDSNGWIALPILHCWDPAA
mNLImVVQELmSLLHEPPQD
//
>1uzxB [d.15.1] UBIQUITIN
MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYN
IQKESTLHLVLRLR
//
>1v16A [c.36.1] 2-OXOISOVALERATE DEHYDROGENASE ALPHA SUBUNIT
KPQFPGASAEFIDKLEFIQPNVISGIPIYRVMDRQGQIINPSEDPHLPKEKVLKLYKSMT
LLNTMDRILYESQRQGRISFYMTNYGEEGTHVGSAAALDNTDLVFGQYREAGVLMYRDYP
LELFMAQCYGNISDLGKGRQMPVHYGCKERHFVTISSPLATQIPQAVGAAYAAKRANANR
VVICYFGEGAASEGDAHAGFNFAATLECPIIFFCRNNGYAISTPTSEQYRGDGIAARGPG
YGIMSIRVDGNDVFAVYNATKEARRRAVAENQPFLIEAMTYRIDHPISRLRHYLLSQGWW
DEEQEKAWRKQSRRKVMEAFEQAERKPKPNPNLLFSDVYQEMPAQLRKQQESLARHLQTY
GEHYPLDHFDK
//
>1v16B [c.36.1 - c.48.1] 2-OXOISOVALERATE DEHYDROGENASE BETA SUBUNIT
AHFTFQPEYGQTQKMNLFQSVTSALDNSLAKDPTAVIFGEDVAFGGVFRCTVGLRDKYGK
DRVFNTPLCEQGIVGFGIGIAVTGATAIAEIQFADYIFPAFDQIVNEAAKYRYRSGDLFN
CGSLTIRSPWGCVGHGALYHSQSPEAFFAHCPGIKVVIPRSPFQAKGLLLSCIEDKNPCI
FFEPKILYRAAAEEVPIEPYNIPLSQAEVIQEGSDVTLVAWGTQVHVIREVASMAKEKLG
VSCEVIDLRTIIPWDVDTICKSVIKTGRLLISHEAPLTGGFASEISSTVQEECFLNLEAP
ISRVCGYDTPFPHIFEPFYIPDKWKCYDALRKMINY
//
>1v18A [a.118.1] BETA-CATENIN
TRAIPELTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVE
TARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGA
KMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMR
TYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLS
DAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVR
TVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKA
TVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRQFVEGVRMEEIVEGCTGAL
HILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGAT
APLTELLHSRNEGVATYAAAVLFRMSE
//
>1v18B [x.x.x] ADENOMATOUS POLYPOSIS COLI
ADTLLHFATESTPDGxxLxALxLDEPFIQKDVELRIMPPV
//
>1v29A [d.149.1] NITRILE HYDRATASE A CHAIN
DPRFPHHHPRPQSFWEARAKALESLLIEKRLLSSDAIERVIKHYEHELGPMNGAKVVAKA
WTDPEFKQRLLEDPETVLRELGYFGLQGEHIRVVENTDTVHNVVVCTLCSCYPWPLLGLP
PSWYKEPAYRSRVVKEPRKVLQEFGLDLPDSVEIRVWDSSSEVRFMVLPQRPEGTEGMTE
EELAQIVTRDSMIGVAKVQPPKV
//
>1v29B [b.34.4] NITRILE HYDRATASE B CHAIN
MNGIHDVGGMDGFGKIMYVKEEEDTYFKHDWERLTFGLVAGCMAQGLGMKAFDEFRIGIE
KMRPVDYLTSSYYGHWIATVAYNLLETGVLDEKELEDRTQAFMEKPDTKIQRWENPKLVK
VVEKALLEGLSPVREVSSFPRFEVGERIKTRNIHPTGHTRFPRYVRDKYGVIEEVYGAHV
FPDDAAHRKGENPQYLYRVRFDAEELWGVKQNDSVYIDLWEGYLEPVSH
//
>1v4l_2A [d.169.1] MUCROCETIN ALPHA CHAIN
DFDCIPGWSAYDRYCYQAFSEPKNWEDAESFCEEGVKTSHLVSIESSGEGDFVAQLVAEK
IKTSFQYVWIGLRIQNKEQQCRSEWSDASSVNYENLYKQSSKKCYALKKGTELRTWFNVY
CGRENPFVCKYTPEC
//
>1v4l_2B [d.169.1] MUCROCETIN BETA CHAIN
GFCCPLGWSSYDEHCYQVFQQKMNWEDAEKFCTQQHRGSHLVSFHSSEEVDFVVSKTSPI
LKHDFVWMGLSNVWNECAKEWSDGTKLDYKAWSGQSDCITSKTTDNQWLSMDCSSKRYVV
CKFQA
//
>1v4xA [a.1.1] HEMOGLOBIN ALPHA CHAIN
TTLSDKDKSTVKALWGKISKSADAIGADALGRMLAVYPQTKTYFSHWPDMSPGSGPVKAH
GKKVMGGVALAVSKIDDLTTGLGDLSELHAFKMRVDPSNFKILSHCILVVVAKMFPKEFT
PDAHVSLDKFLASVALALAERYR
//
>1v4xB [a.1.1] HEMOGLOBIN BETA CHAIN
VEWTQQERSIIAGIFANLNYEDIGPKALARCLIVYPWTQRYFGAYGDLSTPDAIKGNAKI
AAHGVKVLHGLDRAVKNMDNINEAYSELSVLHSDKLHVDPDNFRILGDCLTVVIAANLGD
AFTVETQCAFQKFLAVVVFALGRKYH
//
>1v54A [f.24.1] CYTOCHROME C OXIDASE POLYPEPTIDE I
xFINRWLFSTNHKDIGTLYLLFGAWAGMVGTALSLLIRAELGQPGTLLGDDQIYNVVVTA
HAFVMIFFMVMPIMIGGFGNWLVPLMIGAPDMAFPRMNNMSFWLLPPSFLLLLASSMVEA
GAGTGWTVYPPLAGNLAHAGASVDLTIFSLHLAGVSSILGAINFITTIINMKPPAMSQYQ
TPLFVWSVMITAVLLLLSLPVLAAGITMLLTDRNLNTTFFDPAGGGDPILYQHLFWFFGH
PEVYILILPGFGMISHIVTYYSGKKEPFGYMGMVWAMMSIGFLGFIVWAHHMFTVGMDVD
TRAYFTSATMIIAIPTGVKVFSWLATLHGGNIKWSPAMMWALGFIFLFTVGGLTGIVLAN
SSLDIVLHDTYYVVAHFHYVLSMGAVFAIMGGFVHWFPLFSGYTLNDTWAKIHFAIMFVG
VNMTFFPQHFLGLSGMPRRYSDYPDAYTMWNTISSMGSFISLTAVMLMVFIIWEAFASKR
EVLTVDLTTTNLEWLNGCPPPYHTFEEPTYVNLK
//
>1v54K [f.23.5] CYTOCHROME C OXIDASE POLYPEPTIDE VIIB
APDFHDKYGNAVLASGATFCVAVWVYMATQIGIEWNPSPVGRVTPKEWR
//
>1v54Q (D) [f.23.1] CYTOCHROME C OXIDASE SUBUNIT IV ISOFORM 1
SVVKSEDYALPSYVDRRDYPLPDVAHVKNLSASQKALKEKEKASWSSLSIDEKVELYRLK
FKESFAEMNRSTNEWKTVVGAAMFFIGFTALLLIWEKHYVYGPIPHTFEEEWVAKQTKRM
LDMKVAPIQGFSAKWDYDKNEWKK
//
>1v54R (E) [a.118.11] CYTOCHROME C OXIDASE POLYPEPTIDE VA
HETDEEFDARWVTYFNKPDIDAWELRKGMNTLVGYDLVPEPKIIDAALRACRRLNDFASA
VRILEVVKDKAGPHKEIYPYVIQELRPTLNELGISTPEELGLDKV
//
>1v54T (G) [f.23.2] CYTOCHROME C OXIDASE POLYPEPTIDE VIA-HEART
ASAAKGDHGGxGARTWRFLTFGLALPSVALCTLNSWLHSGHRERPAFIPYHHLRIRTKPF
SWGDGNHTFFHNPRVNPLPTGYEK
//
>1v54U (H) [a.51.1] CYTOCHROME C OXIDASE POLYPEPTIDE VIB
KIKNYQTAPFDSRFPNQNQTRNCWQNYLDFHRCEKAMTAKGGDVSVCEWYRRVYKSLCPI
SWVSTWDDRRAEGTFPGKI
//
>1v54X (K) [f.23.5] CYTOCHROME C OXIDASE POLYPEPTIDE VIIB
APDFHDKYGNAVLASGATFCVAVWVYMATQIGIEWNPSPVGRVTPKEWR
//
>1v55A [f.24.1] CYTOCHROME C OXIDASE POLYPEPTIDE I
xFINRWLFSTNHKDIGTLYLLFGAWAGMVGTALSLLIRAELGQPGTLLGDDQIYNVVVTA
HAFVMIFFMVMPIMIGGFGNWLVPLMIGAPDMAFPRMNNMSFWLLPPSFLLLLASSMVEA
GAGTGWTVYPPLAGNLAHAGASVDLTIFSLHLAGVSSILGAINFITTIINMKPPAMSQYQ
TPLFVWSVMITAVLLLLSLPVLAAGITMLLTDRNLNTTFFDPAGGGDPILYQHLFWFFGH
PEVYILILPGFGMISHIVTYYSGKKEPFGYMGMVWAMMSIGFLGFIVWAHHMFTVGMDVD
TRAYFTSATMIIAIPTGVKVFSWLATLHGGNIKWSPAMMWALGFIFLFTVGGLTGIVLAN
SSLDIVLHDTYYVVAHFHYVLSMGAVFAIMGGFVHWFPLFSGYTLNDTWAKIHFAIMFVG
VNMTFFPQHFLGLSGMPRRYSDYPDAYTMWNTISSMGSFISLTAVMLMVFIIWEAFASKR
EVLTVDLTTTNLEWLNGCPPPYHTFEEPTYVNLK
//
>1v55B [f.17.2 - b.6.1] CYTOCHROME C OXIDASE POLYPEPTIDE II
xAYPMQLGFQDATSPIMEELLHFHDHTLMIVFLISSLVLYIISLMLTTKLTHTSTMDAQE
VETIWTILPAIILILIALPSLRILYMMDEINNPSLTVKTMGHQWYWSYEYTDYEDLSFDS
YMIPTSELKPGELRLLEVDNRVVLPMEMTIRMLVSSEDVLHSWAVPSLGLKTDAIPGRLN
QTTLMSSRPGLYYGQCSEICGSNHSFMPIVLELVPLKYFEKWSASML
//
>1v55L [f.23.6] CYTOCHROME C OXIDASE POLYPEPTIDE VIIC
HYEEGPGKNIPFSVENKWRLLAMMTLFFGSGFAAPFFIVRHQLLKK
//
>1v55M [f.23.7] CYTOCHROME C OXIDASE POLYPEPTIDE VIII-HEART
ITAKPAKTPTSPKEQAIGLSVTFLSFLLPAGWVLYHLDNYKKS
//
>1v55O (B) [f.17.2 - b.6.1] CYTOCHROME C OXIDASE POLYPEPTIDE II
xAYPMQLGFQDATSPIMEELLHFHDHTLMIVFLISSLVLYIISLMLTTKLTHTSTMDAQE
VETIWTILPAIILILIALPSLRILYMMDEINNPSLTVKTMGHQWYWSYEYTDYEDLSFDS
YMIPTSELKPGELRLLEVDNRVVLPMEMTIRMLVSSEDVLHSWAVPSLGLKTDAIPGRLN
QTTLMSSRPGLYYGQCSEICGSNHSFMPIVLELVPLKYFEKWSASML
//
>1v55R (E) [a.118.11] CYTOCHROME C OXIDASE POLYPEPTIDE VA
HETDEEFDARWVTYFNKPDIDAWELRKGMNTLVGYDLVPEPKIIDAALRACRRLNDFASA
VRILEVVKDKAGPHKEIYPYVIQELRPTLNELGISTPEELGLDKV
//
>1v5iA [c.41.1] SUBTILISIN BPN'
AQSVPYGVSQIKAPALHSQGYTGSNVKVAVIDSGIDSSHPDLKVAGGASMVPSETNPFQD
NNSHGTHVAGTVAALNNSIGVLGVAPSASLYAVKVLGADGSGQYSWIINGIEWAIANNMD
VINMSLGGPSGSAALKAAVDKAVASGVVVVAAAGNEGTSGSSSTVGYPGKYPSVIAVGAV
DSSNQRASFSSVGPELDVMAPGVSIQSTLPGNKYGAYNGTxMASPHVAGAAALILSKHPN
WTNTQVRSSLENTTTKLGDSFYYGKGLINVQAAAQ
//
>1v5iB [d.58.3] IA-1=SERINE PROTEINASE INHIBITOR
SAGKFIVIFKNDVSEDKIRETKDEVIAEGGTITNEYNMPGMKGFAGELTPQSLTKFQGLQ
GDLIDSIEEDHVAHAY
//
>1v75A [a.1.1] HEMOGLOBIN D ALPHA CHAIN
MLTEDDKQLIQHVWEKVLEHQEDFGAEALERMFIVYPSTKTYFPHFDLHHDSEQIRHHGK
KVVGALGDAVKHIDNLSATLSELSNLHAYNLRVDPVNFKLLSHCFQVVLGAHLGREYTPQ
VQVAYDKFLAAVSAVLAEKYR
//
>1v75B [a.1.1] HEMOGLOBIN A AND D BETA CHAIN
HWTSEEKQYITSLWAKVNVGEVGGEALARLLIVYPWTQRFFASFGNLSSANAILHNAKVL
AHGQKVLTSFGEAVKNLDNIKKTFAQLSELHCEKLHVDPENFKLLGNILIIVLATHFPKE
FTPASQAAWTKLVNAVAHALAL
//
>1v7mL [b.1.1 - b.1.1] MONOCLONAL TN1 FAB LIGHT CHAIN
QVVLTQSPGIMSASPGEKVTITCSASSSVSYMYWFQQKPGTSPKLWIYSTSNLASGVPAR
FRGSGSGTSYSLTISRMEAEDAATYYCQQRSGYPRTFGGGTKLEIKRADAAPTVSIFPPS
SEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLTL
TKDEYERHNSYTCEATHKTSTSPIVKSFNRNE
//
>1v7mH [b.1.1 - b.1.1] MONOCLONAL TN1 FAB HEAVY CHAIN
EVKLEESGGGLVQPGGSMKLSCAASGFTFSDAWMDWVRQSPEKGLEWVAEIRSKVNNHAI
HYAESVKGRFTVSRDDSKSSVYLQMNSLRAEDTGIYYCSGWSFLYWGQGTLVTVSAAKTT
PPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTL
SSSVTVPSSTWPSETVTCNVAHPASSTKVDKKIVPRD
//
>1v7mV [a.26.1] THROMBOPOIETIN
CDLRVLSKLLRDSHVLHSRLSQCPEVHPLPTPVLLPAVDFSLGEWKTQMEETKAQDILGA
VTLLLEGVMAARGQLGPTCLSSLLGQLSGQVRLLLGALQSLLGTQLPPQGRTTAHKDPNA
IFLSFQHLLRGKVRFLMLVGGSTLC
//
>1v7n_1O (L) [b.1.1 - b.1.1] MONOCLONAL TN1 FAB LIGHT CHAIN
QVVLTQSPGIMSASPGEKVTITCSASSSVSYMYWFQQKPGTSPKLWIYSTSNLASGVPAR
FRGSGSGTSYSLTISRMEAEDAATYYCQQRSGYPRTFGGGTKLEIKRADAAPTVSIFPPS
SEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLTL
TKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1v7n_1K (H) [b.1.1 - b.1.1] MONOCLONAL TN1 FAB HEAVY CHAIN
EVKLEESGGGLVQPGGSMKLSCAASGFTFSDAWMDWVRQSPEKGLEWVAEIRSKVNNHAI
HYAESVKGRFTVSRDDSKSSVYLQMNSLRAEDTGIYYCSGWSFLYWGQGTLVTVSAAKTT
PPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTL
SSSVTVPSSTWPSETVTCNVAHPASSTKVDKKIVPRD
//
>1v7pA [d.169.1] EMS16 A CHAIN
DFDCPSDWTAYDQHCYLAIGEPQNWYEAERFCTEQAKDGHLVSIQSREEGNFVAQLVSGF
MHRSEIYVWIGLRDRREEQQCNPEWNDGSKIIYVNWKEGESKMCQGLTKWTNFHDWNNIN
CEDLYPFVCKFSAV
//
>1v7pB [d.169.1] EMS16 B CHAIN
CPLGWSSFDQHCYKVFEPVKNWTEAEEICMQQHKGSRLASIHSSEEEAFVSKLASKALKF
TSMWIGLNNPWKDCKWEWSDNARFDYKAWKRRPYCTVMVVKPDRIFWFTRGCEKSVSFVC
KFLTDPA
//
>1v7pC [c.62.1] INTEGRIN ALPHA-2
LIDVVVVCDESNSIYPWDAVKNFLEKFVQGLDIGPTKTQVGLIQYANNPRVVFNLNTYKT
KEEMIVATSQTSQYGGDLTNTFGAIQYARKYAYSAASGGRRSATKVMVVVTDGESHDGSM
LKAVIDQCNHDNILRFGIAVLGYLNRNALDTKNLIKEIKAIASIPTERYFFNVSDEAALL
EKAGTLGEQIFSI
//
>1v7pD (C) [c.62.1] INTEGRIN ALPHA-2
LIDVVVVCDESNSIYPWDAVKNFLEKFVQGLDIGPTKTQVGLIQYANNPRVVFNLNTYKT
KEEMIVATSQTSQYGGDLTNTFGAIQYARKYAYSAASGGRRSATKVMVVVTDGESHDGSM
LKAVIDQCNHDNILRFGIAVLGYLNRNALDTKNLIKEIKAIASIPTERYFFNVSDEAALL
EKAGTLGEQIFSI
//
>1v9u_21 [b.121.4] COAT PROTEIN VP1
LVVPNINSSNPTTSNSAPALDAAETGHTSSVQPEDVIETRYVQTSQTRDEMSLESFLGRS
GCIHESKLEVTLANYNKENFTVWAINLQEMAQIRRKFELFTYTRFDSEITLVPCISALSQ
DIGHITMQYMYVPPGAPVPNSRDDYAWQSGTNASVFWQHGQAYPRFSLPFLSVASAYYMF
YDGYDEQDQNYGTANTNNMGSLCSRIVTEKHIHKVHIMTRIYHKAKHVKAWCPRPPRALE
YTRAHRTNFKIEDRSIQTAIVTRPIITTA
//
>1v9u_25 [g.12.1] LDL-RECEPTOR CLASS A 3
CRIHEISCGAHSTQCIPVSWRCDGENDCDSGEDEENCGN
//
>1veuA [d.110.7] MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1
DDLKRFLYKKLPSVEGLHAIVVSDRDGVPVIKVANDSAPEHALRPGFLSTFALATDQGSK
LGLSKNKSIICYYNTYQVVQFNRLPLVVSFIASSSANTGLIVSLEKELAPLFEELIKV
//
>1veuB [d.110.7] LATE ENDOSOMAL/LYSOSOMAL MP1 INTERACTING PROTEIN
GmLRPKALTQVLSQANTGGVQSTLLLNNEGSLLAYSGYGDTDARVTAAIASNIWAAYDRN
GNQAFNEDSLKFILmDCmEGRVAITRVANLLLCmYAKETVGFGmLKAKAQALVQYLEEPL
TQVA
//
>1vf5_2O (B) [f.32.1] SUBUNIT IV
LAKGMGHNYYGEPAWPNDLLYVFPVVIMGTFACIVALSVLDPAMVGEPANPFATPLEILP
EWYLYPVFQILRSLPNKLLGVLLMASVPLGLILVPFIENVNKFQNPFRRPVATTIFLFGT
LVTIWLGIGAALPLDKTL
//
>1vf5_2R (E) [f.23.24] PROTEIN PET L
MILGAVFYIVFIALFFGIAVGIIFAIKSIKLI
//
>1vf6A [a.194.1] PALS1-ASSOCIATED TIGHT JUNCTION PROTEIN
VLQVLDRLKMKLQEKGDTSQNEKLSMFYETLKSPLFNQILTLQQSIKQLKGQLNHILE
//
>1vf6C [a.194.1] MAGUK P55 SUBFAMILY MEMBER 5
QDPDVEDLFSSLKHIQHTLVDSQSQEDISLLLQLVQNRDFQNAFKIHNAVT
//
>1vfbA [b.1.1] IGG1-KAPPA D1.3 FV (LIGHT CHAIN)
DIVLTQSPASLSASVGETVTITCRASGNIHNYLAWYQQKQGKSPQLLVYYTTTLADGVPS
RFSGSGSGTQYSLKINSLQPEDFGSYYCQHFWSTPRTFGGGTKLEIK
//
>1vfbB [b.1.1] IGG1-KAPPA D1.3 FV (HEAVY CHAIN)
QVQLQESGPGLVAPSQSLSITCTVSGFSLTGYGVNWVRQPPGKGLEWLGMIWGDGNTDYN
SALKSRLSISKDNSKSQVFLKMNSLHTDDTARYYCARERDYRLDYWGQGTTLTVSS
//
>1vfbC [d.2.1] HEN EGG WHITE LYSOZYME
KVFGRCELAAAMKRHGLDNYRGYSLGNWVCAAKFESNFNTQATNRNTDGSTDYGILQINS
RWWCNDGRTPGSRNLCNIPCSALLSSDITASVNCAKKIVSDGNGMNAWVAWRNRCKGTDV
QAWIRGCRL
//
>1vg0A [c.3.1 - d.16.1] RAB PROTEINS GERANYLGERANYLTRANSFERASE COMPONENT
DNLPSDFDVIVIGTGLPESIIAAACSRSGQRVLHVDSRSYYGGNWASFSFSGLLSWLKEY
QMWQEQILENEEAIPLSSKDKTIQHVEVFCYASQRITYSQIIKEGRRFNIDLVSKLLYSR
GLLIDLLIKSNVSRYAEFKNITRILAFREGTVEQVPCSRADVFNSKQLTMVEKRMLMKFL
TFCVEYEEHPDEYRAYEGTTFSEYLKTQKLTPNLQYFVLHSIAMETTSCTVDGLKATKKF
LQCLGRYGNTPFLFPLYGQGELPQCFCRMCAVFGGIYCLRHSVQCLVVDKESRKCKAVID
QFGQRIISKHFIIEDSYLSENTCSRVQYRQISRAVLITDGSVLRTDADQQVSILTVPAEE
PGSFAVRVIELCSSTMTCMKGTYLVHLTCMSSKTAREDLERVVQKLFTPYTEIEKPRLLW
ALYFNMRDSSDISRDCYNDLPSNVYVCSGPDSGLGNDNAVKQAETLFQQICPNEDFCPAP
P
//
>1vg0B [c.37.1] RAS-RELATED PROTEIN RAB-7
KVLLKVIILGDSGVGKTSLMNQYVNKKFSNIGADFLTKEVMVDDRLVTMQIWDTAGQERF
QSLGVAFYRGADCCVLVFDVTAPNTFKTLDSWRDEFLIQASPRDPENFPFVVLGNKIDLE
NRQVATKRAQAWCYSKNNIPYFETSAKEAINVEQAFQTIARNALKQETEVELYNEFPEPI
KL
//
>1vgeL [b.1.1 - b.1.1] TR1.9 FAB
ELVMTQSPSSLSASVGDRVNIACRASQGISSALAWYQQKPGKAPRLLIYDASNLESGVPS
RFSGSGSGTDFTLTISSLQPEDFAIYYCQQFNSYPLTFGGGTKVEIKRTVAAPSVFIFPP
SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT
LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
//
>1vgeH [b.1.1 - b.1.1] TR1.9 FAB
QVKLLEQSGAEVKKPGASVKVSCKASGYSFTSYGLHWVRQAPGQRLEWMGWISAGTGNTK
YSQKFRGRVTFTRDTSATTAYMGLSSLRPEDTAVYYCARDPYGGGKSEFDYWGQGTLVTV
SSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQ
SSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC
//
>1vgkA [d.19.1 - b.1.1] H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, K-D
GPHSLRYFVTAVSRPGLGEPRFIAVGYVDDTQFVRFDSDADNPRFEPRAPWMEQEGPEYW
EEQTQRAKSDEQWFRVSLRTAQRYYNQSKGGSHTFQRMFGCDVGSDWRLLRGYQQFAYDG
RDYIALNEDLKTWTAADTAALITRRKWEQAGDAEYYRAYLEGECVEWLRRYLELGNETLL
RTDSPKAHVTYHPRSQVDVTLRCWALGFYPADITLTWQLNGEDLTQDMELVETRPAGDGT
FQKWAAVVVPLGKEQNYTCHVHHKGLPEPLTLRW
//
>1vgkB [b.1.1] BETA-2-MICROGLOBULIN
IQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDW
SFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM
//
>1vit_1L [b.47.1] EPSILON THROMBIN
TFGAGEADCGLRPLFEKKQVQDQTEKELFESYIEGR
//
>1vit_1H [b.47.1] ALPHA THROMBIN
IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLL
VRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCL
PDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKASTRIR
ITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFY
THVFRLKKWIQKVIDRLGS
//
>1viwA [c.1.8 - b.71.1] ALPHA-AMYLASE
xKDANFASGRNSIVHLFEWKWNDIADECERFLQPQGFGGVQISPPNEYLVADGRPWWERY
QPVSYIINTRSGNESAFTDMTRRCNDAGVRIYVDAVINHMTGMNGVGTSGSSADHDGMNY
PAVPYGSGDFHSPCEVNNYQDADNVRNCELVGLRDLNAGSDYVRGVLIDYMNHMIDLGVA
GFRVDAAKHMSPGDLSVIFDGLKNLNTDYGFADGARPFIYQEVIDLGGEAISKNEYTGFG
CVLEFQFGVSLGNAFQGGNQLKNLANWGPEWGLLEGLDAVVFVDNHDNQRTGGSQILTYK
NPKPYKMAIAFMLAHPYGTTRIMSSFDFTDNDQGPPQDGSGNLISPGINDDNTCSNGYVC
EHRWRQVYGMVGFRNAVEGTQVENWWSNDDNQIAFSRGSQGFVAFTNGGDLNQNLNTGLP
AGTYCDVISGELSGGSCTGKSVTVGDNGSADISLGSAEDDGVLAIHVNAKL
//
>1viwB [b.29.1] ALPHA-AMYLASE-INHIBITOR
ATETSFIIDAFNKTNLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIRDSTTGNVA
SFDTNFTMNIRTHRQSAVGLDFVLVPVQDTVTVEFDTFLSRISIDVNNNDIKSVPWDVHD
YDGQNAEVRITYNSSTKVFSVSLSNPSTGKSNNVSTTVELEKEVYDWVSVGFSATSGAYQ
WSYETHDVLSWSFSSKFI
//
>1vleQ (M) [c.81.1 - b.52.2] PYROGALLOL HYDROXYTRANSFERASE LARGE SUBUNIT
MGEVVRLTNSSTGGPVFVYVKDGKIIRMTPMDFDDAVDAPSWKIEARGKTFTPPRKTSIA
PYTAGFKSMIYSDLRIPYPMKRKSFDPNGERNPQLRGAGLSKQDPWSDYERISWDEATDI
VVAEINRIKHAYGPSAILSTPSSHHMWGNVGYRHSTYFRFMNMMGFTYADHNPDSWEGWH
WGGMHMWGFSWRLGNPEQYDLLEDGLKHAEMIVFWSSDPETNSGIYAGFESNIRRQWLKD
LGVDFVFIDPHMNHTARLVADKWFSPKIGTDHALSFAIAYTWLKEDSYDKEYVAANAHGF
EEWADYVLGKTDGTPKTCEWAEEESGVPACEIRALARQWAKKNTYLAAGGLGGWGGACRA
SHGIEWARGMIALATMQGMGKPGSNMWSTTQGVPLDYEFYFPGYAEGGISGDCENSAAGF
KFAWRMFDGKTTFPSPSNLNTSAGQHIPRLKIPECIMGGKFQWSGKGFAGGDISHQLHQY
EYPAPGYSKIKMFWKYGGPHLGTMTATNRYAKMYTHDSLEFVVSQSIWFEGEVPFADIIL
PACTNFERWDISEFANCSGYIPDNYQLCNHRVISLQAKCIEPVGESMSDYEIYRLFAKKL
NIEEMFSEGKDELAWCEQYFNATDMPKYMTWDEFFKKGYFVVPDNPNRKKTVALRWFAEG
REKDTPDWGPRLNNQVCRKGLQTTTGKVEFIATSLKNFEEQGYIDEHRPSMHTYVPAWES
QKHSPLAVKYPLGMLSPHPRFSMHTMGDGKNSYMNYIKDHRVEVDGYKYWIMRVNSIDAE
ARGIKNGDLIRAYNDRGSVILAAQVTECLQPGTVHSYESCAVYDPLGTAGKSADRGGCIN
ILTPDRYISKYACGMANNTALVEIEKWDGDKYEIY
//
>1vleR (N) [d.58.1 - b.3.5] PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT
MEQYYMVIDVAKCQDCNNCFMGCMDEHELNEWPGYTASMQRGHRWMNIERRERGTYPRND
INYRPTPCMHCENAPCVAKGNGAVYQREDGIVLIDPEKAKGKKELLDTCPYGVMYWNEEE
NVAQKCTMCAHLLDDESWAPKMPRCAHNCGSFVYEFLKTTPEAMAKKVEEEGLEVIKPEL
GTKPRVYYKNLYRFEKNYVTAGILVQGDCFEGAKVVLKSGGKEVASAETNFFGEFKFDAL
DNGEYTVEIDADGKSYSDTVVIDDKSVDLGFIKL
//
>1volA [a.74.1 - a.74.1] PROTEIN (TRANSCRIPTION FACTOR IIB (TFIIB))
AMMNAFKEITTMADRINLPRNKVDRTNNLFRQAYEQKSLKGRANDAIASACLYIACRQEG
VPRTFKEICAVSRISKKEIGRCFKLILKALETSVDLITTGDFMSRFCSNLCLPKQVQMAA
THIARKAVELDLVPGRSPISVAAAAIYMASQASAEKRTQKEIGDIAGVADVTIRQSYRLI
YPRAPDLFPTDFKFDTPVDKLPQ
//
>1volB [d.129.1 - d.129.1] PROTEIN (TATA BINDING PROTEIN (TBP))
VDLSKHPSGIVPTLQNIVSTVNLDCKLDLKAIALQARNAEYNPKRFAAVIMRIREPKTTA
LIFASGKMVCTGAKSEDFSKMAARKYARIVQKLGFPAKFKDFKIQNIVGSCDVKFPIRLE
GLAYSHAAFSSYEPELFPGLIYRMKVPKIVLLIFVSGKIVITGAKMRDETYKAFENIYPV
LSEFRK
//
>1voqB [i.1.1] 30S RIBOSOMAL PROTEIN S2
VKELLEAGVHFGHERKRWNPKFARYIYAERNGIHIIDLQKTMEELERTFRFIEDLAMRGG
TILFVGTKKQAQDIVRMEAERAGMPYVNQRWLGGMLTNFKTISQRVHRLEELEALFASPE
IEERPKKEQVRLKHELERLQKYLSGFRLLKRLPDAIFVVDPTKEAIAVREARKLFIPVIA
LADTDSDPDLVDYIIPGNDDAIRSIQLILSRAVDLIIQARGGVVEPSPSYALVQ
//
>1voqC [i.1.1] 30S RIBOSOMAL PROTEIN S3
GNKIHPIGFRLGITRDWESRWYAGKKQYRHLLLEDQRIRGLLEKELYSAGLARVDIERAA
DNVAVTVHVAKPGVVIGRGGERIRVLREELAKLTGKNVALNVQEVQNPNLSAPLVAQRVA
EQIERRFAVRRAIKQAVQRVMESGAKGAKVIVSGRIGGAEQARTEWAAQGRVPLHTLRAN
IDYGFALARTTYGVLGVKAYIFLGEV
//
>1voqE [i.1.1] 30S RIBOSOMAL PROTEIN S5
DFEEKMILIRRTARMQAGGRRFRFGALVVVGDRQGRVGLGFGKAPEVPLAVQKAGYYARR
NMVEVPLQNGTIPHEIEVEFGASKIVLKPAAPGTGVIAGAVPRAILELAGVTDILTKELG
SRNPINIAYATMEALRQLRTKADVERLRKG
//
>1voqH [i.1.1] 30S RIBOSOMAL PROTEIN S8
MLTDPIADMLTRIRNATRVYKESTDVPASRFKEEILRILAREGFIKGYERVDVDGKPYLR
VYLKYGPRRQGPDPRPEQVIHHIRRISKPGRRVYVGVKEIPRVRRGLGIAILSTSKGVLT
DREARKLGVGGELICEVW
//
>1voqJ [i.1.1] 30S RIBOSOMAL PROTEIN S10
KIRIKLRGFDHKTLDASAQKIVEAARRSGAQVSGPIPLPTRVRRFTVIRGPFKHKDSREH
FELRTHNRLVDIINPNRKTIEQLMTLDLPTGVEIEIKT
//
>1vorE [i.1.1] 50S RIBOSOMAL PROTEIN L3
MKGILGTKIGMTQIWKNDRAIPVTVVLAGPCPIVQRKTAQTDGYEAVQIGYAPKAERKVN
KPMQGHFAKAGVAPTRILREFRGFAPDGDSVNVDIFAEGEKIDATGTSKGKGTQGVMKRW
NFAGGPASHGSKKWHRRPGSIGQRKTPGRVYKGKRMAGHMGMERVTVQNLEVVEIRAGEN
LILVKGAIPGANGGLVVLRSAAKAS
//
>1vorQ [i.1.1] 50S RIBOSOMAL PROTEIN L19
QTHIKINRGELLRGIEQDHTRQLPDFRPGDTVRVDTKVREGNRTRSQAFEGVVIAINGSG
SRKSFTVRKISFGEGVERVFPFASPLVNQVTIVERGKVRRAKLYYLRELRGKAARIKSDR
SRVMK
//
>1vouI [i.1.1] 50S RIBOSOMAL PROTEIN L9
MQVILLEPSRLGKTGEVVSVKDGYARNWLIPQGLAVSATRTNMKTLEAQLRS
//
>1vouN [i.1.1] 50S RIBOSOMAL PROTEIN L16
TKFRKQFRGRMTGDAKGGDYVAFGDYGLIAMEPAWIKSNQIEACRIVMSRHFRRGGKIYI
RIFPDKPVTKKPAETRMGKGKGAVEYWVSVVKPGRVMFEVAGVTEEQAKEAFRLAGHKLP
IQTK
//
>1vouT [i.1.1] 50S RIBOSOMAL PROTEIN L22
EQTFRNKKQRKQQVKLRKPGFAVAKYVRMSPRKVRLVVDVIRGKSVQDAEDLLRFIPRSA
SEPVAKVLNSAKANALHNDEMLEDRLFVKEAYVDAGPTLKRLIPRARGSANIIKKRTSHI
TIIVAEKGNK
//
>1vouW [i.1.1] GENERAL STRESS PROTEIN CTC
MELTAKPRTPKQKLDESMIAAVAYNKENNVSFALDRKAFDRAFRQQSTTGLFDITVEGGE
TFPALVKAVQMDKRKRAPIHVDFYMVTYGEPVEVSVPVHTTGRSQGEVQGGLVDIVVHNL
QIVAPGPRRIPQELVVDVTKMNIGDHITAGDIKLPEGCTLAADPELTVVSVLP
//
>1vou1 [i.1.1] 50S RIBOSOMAL PROTEIN L31
MQKDLHPKAVPCKIIYQGQVVMETMSTRPEIHVDVWSGVHPFWTGEERFLDTEGRVDKFN
KRFGDSYRRGSKK
//
>1vou2 [i.1.1] 50S RIBOSOMAL PROTEIN L32
AKHPVPKKKTSKSKRDMRRSHHALTAPNLTECPQCHGKKLSHHICPNCGYYDGRQVLA
//
>1vovI [i.1.1] 30S RIBOSOMAL PROTEIN S9
EQYYGTGRRKEAVARVFLRPGNGKVTVNGQDFNEYFQGLVRAVAALEPLRAVDALGRFDA
YITVRGGGKSGQIDAIKLGIARALVQYNPDYRAKLKPLGFLTRDARVVERKKYGKHKARR
APQYSKR
//
>1vovJ [i.1.1] 30S RIBOSOMAL PROTEIN S10
KIRIKLRGFDHKTLDASAQKIVEAARRSGAQVSGPIPLPTRVRRFTVIRGPFKHKDSREH
FELRTHNRLVDIINPNRKTIEQLMTLDLPTGVEIEIKT
//
>1vovM [i.1.1] 30S RIBOSOMAL PROTEIN S13
ARIAGVEIPRNKRVDVALTYIYGIGKARAKEALEKTGINPATRVKDLTEAEVVRLREYVE
NTWKLEGELRAEVAANIKRLMDIGCYRGLRHRRGLPVRGQRTRTNARTRKGPRKTVAGKK
KAPRK
//
>1vova [d.204.1] PROTEIN Y
TMNITSKQMEITPAIRQHVADRLAKLEKWQTHLINPHIILSKEPQGFVADATINTPNGVL
VASGKHEDMYTAINELINKLERQLNKLQHK
//
>1vowI [i.1.1] 50S RIBOSOMAL PROTEIN L9
MQVILLEPSRLGKTGEVVSVKDGYARNWLIPQGLAVSATRTNMKTLEAQLRS
//
>1vowT [i.1.1] 50S RIBOSOMAL PROTEIN L22
EQTFRNKKQRKQQVKLRKPGFAVAKYVRMSPRKVRLVVDVIRGKSVQDAEDLLRFIPRSA
SEPVAKVLNSAKANALHNDEMLEDRLFVKEAYVDAGPTLKRLIPRARGSANIIKKRTSHI
TIIVAEKGNK
//
>1vow1 [i.1.1] 50S RIBOSOMAL PROTEIN L31
MQKDLHPKAVPCKIIYQGQVVMETMSTRPEIHVDVWSGVHPFWTGEERFLDTEGRVDKFN
KRFGDSYRRGSKK
//
>1vow2 [i.1.1] 50S RIBOSOMAL PROTEIN L32
AKHPVPKKKTSKSKRDMRRSHHALTAPNLTECPQCHGKKLSHHICPNCGYYDGRQVLA
//
>1vow3 [i.1.1] 50S RIBOSOMAL PROTEIN L33
AKDGPRIIVKMESSAGTGFYYTTTKNRRNTQAKLELKKYDPVAKKHVVFREKK
//
>1vow5 [i.1.1] 50S RIBOSOMAL PROTEIN L35
PKMKTHKMAKRRIKITGTGKVMAFKSGKRHQNTGKSGDEIRGKGKGFVLAKAEWARMKLM
LPR
//
>1voxG [i.1.1] 30S RIBOSOMAL PROTEIN S7
ARRRRAEVRQLQPDLVYGDVLVTAFINKIMRDGKKNLAARIFYDACKIIQEKTGQEPLKV
FKQAVENVKPRMEVRSRRVGGANYQVPMEVSPRRQQSLALRWLVQAANQRPERRAAVRIA
HELMDAAEGKGGAVKKKEDVERMAEANRAYAHYRW
//
>1voxK [i.1.1] 30S RIBOSOMAL PROTEIN S11
KRQVASGRAYIHASYNNTIVTITDPDGNPITWSSGGVIGYKGSRKGTPYAAQLAALDAAK
KAMAYGMQSVDVIVRGTGAGREQAIRALQASGLQVKSIVDDTPVPHNGCRPKKKFRKAS
//
>1voxL [i.1.1] 30S RIBOSOMAL PROTEIN S12
PTINQLVRKGREKVRKKSKVPALKGAPFRRGVCTVVRTVTPKKPNSALRKVAKVRLTSGY
EVTAYIPGEGHNLQEHSVVLIRGGRVKDLPGVRYHIVRGVYDAAGVKDRKKSRSKYGTKK
PKEA
//
>1voxQ [i.1.1] 30S RIBOSOMAL PROTEIN S17
PKKVLTGVVVSDKMQKTVTVLVERQFPHPLYGKVIKRSKKYLAHDPEEKYKLGDVVEIIE
SRPISKRKRFRVLRLVESGRMDLVEKYLIRRQNYQSLSKRGGKA
//
>1vozG [i.1.1] 30S RIBOSOMAL PROTEIN S7
ARRRRAEVRQLQPDLVYGDVLVTAFINKIMRDGKKNLAARIFYDACKIIQEKTGQEPLKV
FKQAVENVKPRMEVRSRRVGGANYQVPMEVSPRRQQSLALRWLVQAANQRPERRAAVRIA
HELMDAAEGKGGAVKKKEDVERMAEANRAYAHYRW
//
>1vozK [i.1.1] 30S RIBOSOMAL PROTEIN S11
KRQVASGRAYIHASYNNTIVTITDPDGNPITWSSGGVIGYKGSRKGTPYAAQLAALDAAK
KAMAYGMQSVDVIVRGTGAGREQAIRALQASGLQVKSIVDDTPVPHNGCRPKKKFRKAS
//
>1vp0K [i.1.1] 50S RIBOSOMAL PROTEIN L13
VKTYIPKNDEQNWVVVDASGVPLGRLATLIASRIRGKHRPDFTPNMIQGDFVVVINAAQV
ALTGKKLDDKVYTRYTGYQGGLKTETAREALSKHPERVIEHAVFGMLPKGRQGRAMHTRL
KVYAGETHPHSAQKPQVLKTQPL
//
>1vp0M [i.1.1] 50S RIBOSOMAL PROTEIN L15
HDLKPTPGSRKDRKRVGRGPGGTDKTAGRGHKGQKSRSGAGKGAFFEGGRSRLIARLPKR
GFNNVGTTYEVVKLSQLQDLEDTTFDRDTLEAYRLVRRKNRPVKLLASGEISRAVTVHVD
AASAAAIKAVEAAGGRVVLPE
//
>1vp0R [i.1.1] 50S RIBOSOMAL PROTEIN L20
PRAKTGIVRRRRHKKVLKRAKGFWGSRSKQYRNAFQTLLNAATYEYRDRRNKKRDFRRLW
IQRINAGARLHGMNYSTFINGLKRANIDLNRKVLADIAAREPEAFKALVDASRNARQ
//
>1vp0T [i.1.1] 50S RIBOSOMAL PROTEIN L22
EQTFRNKKQRKQQVKLRKPGFAVAKYVRMSPRKVRLVVDVIRGKSVQDAEDLLRFIPRSA
SEPVAKVLNSAKANALHNDEMLEDRLFVKEAYVDAGPTLKRLIPRARGSANIIKKRTSHI
TIIVAEKGNK
//
>1vp0U [i.1.1] 50S RIBOSOMAL PROTEIN L23
SHYDILQAPVISEKAYSAMERGVYSFWVSPKATKTEIKDAIQQAFGVRVIGISTMNVPGK
RKRVGRFIGQRNDRKKAIVRLAEGQSIEALAGQ
//
>1vp0Y [i.1.1] 50S RIBOSOMAL PROTEIN L29
KPSEMRNLQATDFAKEIDARKKELMELRFQAAAGQLAQPHRVRQLRREVAQLNTVKAELA
RKGEQ
//
>1vp02 [i.1.1] 50S RIBOSOMAL PROTEIN L32
AKHPVPKKKTSKSKRDMRRSHHALTAPNLTECPQCHGKKLSHHICPNCGYYDGRQVLA
//
>1vp05 [i.1.1] 50S RIBOSOMAL PROTEIN L35
PKMKTHKMAKRRIKITGTGKVMAFKSGKRHQNTGKSGDEIRGKGKGFVLAKAEWARMKLM
LPR
//
>1vppV [g.17.1] PROTEIN (VASCULAR ENDOTHELIAL GROWTH FACTOR)
EVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTE
ESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKK
//
>1vppX [x.x.x] PROTEIN (PEPTIDE V108)
RGWVEICAADDYGRCLTEAQ
//
>1vq5F [d.79.3] 50S RIBOSOMAL PROTEIN L7AE
PVYVDFDVPADLEDDALEALEVARDTGAVKKGTNETTKSIERGSAELVFVAEDVQPEEIV
MHIPELADEKGVPFIFVEQQDDLGHAAGLEVGSAAAAVTDAGEADADVEDIADKVEELR
//
>1vq5M [d.12.1] 50S RIBOSOMAL PROTEIN L15E
ARSAYSYIRDAWENPGDGQLAELQWQRQQEWRNEGAVERIERPTRLDKARSQGYKAKQGV
IVARVSVRKGSARKRRHKAGRRSKRQGVTRITRRKDIQRVAEERASRTFPNLRVLNSYSV
GQDGRQKWHEVILIDPNHPAIQNDDDLSWICADDQADRVFRGLTGAGRRNRGLSGKGKGS
EKTRPSLRSNGGKA
//
>1vqlK [b.39.1] 50S RIBOSOMAL PROTEIN L14P
MEALGADVTQGLEKGSLITCADNTGARELKVISVHGYSGTKNRLPKAGLGDKITVSVTKG
TPEMRRQVLEAVVVRQRKPIRRPDGTRVKFEDNAAVIVDENEDPRGTELKGPIAREVAQR
FGSVASAATMIV
//
>1vqlU [g.39.1] 50S RIBOSOMAL PROTEIN L24E
RECDYCGTDIEPGTGTMFVHKDGATTHFCSSKCENNADLGREARNLEWTDTAR
//
>1vraA [x.x.x] ARGININE BIOSYNTHESIS BIFUNCTIONAL PROTEIN ARGJ
ETANVLKLETGSVTSAKGFSAVGIHTGVKRKRKDLGAIVCEVPASSAAVYTLNKVQAAPL
KVTQESIAVEGKLQAmIVNSGIANACTGKRGLDDAYTmRAVGAETFHIPEHYVAVTSTGV
IGEFLPmDVITNGIRQLKPEATIEGAHAFNEAILTTDTVEKHTCYQTIVNGKTVTVGGVA
KGSGmIHPNmA
//
>1vraB [x.x.x] ARGININE BIOSYNTHESIS BIFUNCTIONAL PROTEIN ARGJ
TmLSFVTTDANIDHGHLQGALSAITNETFNRITVDGDTSTNDmVVVmASGLAENETLTPE
HPDWANFYKALQLACEDLAKQIARDGEGATKLIEVEVTGAANDQEAGmVAKQIVGSDLVK
TAIYGADANWGRIICAIGYSGCEVNQETIDIAIGPIVTLKQSEPTGFSEEEATAYLKEAD
PVKISVNLHIGNGTGKAWGCDLTYDYVRINAGY
//
>1vrkA [k.21.1] CALMODULIN
ADQLTDEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN
GTIDFPEFLNLMARKMKDTDSEEKLKEAFRVFDKDGNGFISAAELRHVMTNLGEKLTDEE
VDEMIREADVDGDGQVNYEEFVQVMMAK
//
>1vrkB [x.x.x] RS20
RRKxQKTGHAVRAIGRLSSS
//
>1vrnC [a.138.1] PHOTOSYNTHETIC REACTION CENTER CYTOCHROME C
CFEPPPATTTQTGFRGLSMGEVLHPATVKAKKERDAQYPPALAAVKAEGPPVSQVYKNVK
VLGNLTEAEFLRTMTAITEWVSPQEGCTYCHDENNLASEAKYPYVVARRMLEMTRAINTN
WTQHVAQTGVTCYTCHRGTPLPPYVRYLEPTLPLNNRETPTHVERVETRSGYVVRLAKYT
AYSALNYDPFTMFLANDKRQVRVVPQTALPLVGVSRGKERRPLSDAYATFALMMSISDSL
GTNCTFCHNAQTFESWGKKSTPQRAIAWWGIRMVRDLNMNYLAPLNASLPASRLGRQGEA
PQADCRTCHQGVTKPLFGASRLKDYPELGPIK
//
>1vrnH [f.23.10 - b.41.1] REACTION CENTER PROTEIN H CHAIN
xYHGALAQHLDIAQLVWYAQWLVIWTVVLLYLRREDRREGYPLVEPLGLVKLAPEDGQVY
ELPYPKTFVLPHGGTVTVPRRRPETRELKLAQTDGFEGAPLQPTGNPLVDAVGPASYAER
AEVVDATVDGKAKIVPLRVATDFSIAEGDVDPRGLPVVAADGVEAGTVTDLWVDRSEHYF
RYLELSVAGSARTALIPLGFCDVKKDKIVVTSILSEQFANVPRLQSRDQITLREEDKVSA
YYAGGLLYATPERAESLL
//
>1vrqA [x.x.x] SARCOSINE OXIDASE ALPHA SUBUNIT
SKPQRLSAAQTAGARINRDEALTLTVDGQQLSAFRGDTVASAMLANGLRSCGNSMYLDRP
RGIFSAGVEEPNALITVGARHQADINESMLPATTVSVTDGLNATLLSGLGVLDPSEDPAY
YDHVHVHTDVLVVGAGPAGLAAAREASRSGARVMLLDERPEAGGTLREASGEQIDGIDAA
QWIDAVTEELAAAEETTHLQRTTVFGSYDANYILAAQRRTVHLDGPSGQGVSRERIWHIR
AKQVVLATAAHERPIVFENNDRPGIMLAGSVRSYLNRFGVRAGSKIAVATTNDSVYPLVS
ELAASGGVVAVIDARQNISAAAAQAVTDGVTVLTGSVVANTEADASGELSAVLVATLDEQ
RNLGEAQRFEADVLAVSGGFNPVVHLHSQRQGKLNWDTSIHAFVPADAVANQHLAGALTG
LLDTASALSTGAATGAAAASAAGFEKIAEVPQALAVPAGETRPVWLVPSLSGDDAVHYKF
HFVDLQRDQTVADVLRATGAGMQSVEHIKRYTSISTANDQGKTSGVAAIGVIAAVLGIEN
PAQIGTTTFRAPYTPVSFAALAGRTRGELLDPARLTAMHPWHLAHGAKFEDVGQWKRPWY
YPQDGESMDEAVYRECKAVRDSVGMLDASTLGKIEIRGKDAAEFLNRMYTNGYTKLKVGM
GRYGVMCKADGMIFDDGVTLRLAEDRFLMHTTTGGAADVLDWLEEWLQTEWPELDVTCTS
VTEQLATVAVVGPRSRDVIAKLASSLDVSNDAFKFMAFQDVTLDSGIEARISRISFSGEL
AFEIAIPAWHGLQVWEDVYAAGQEFNITPYGTETMHVLRAEKGFIIVGQDTDGTVTPQDA
GMEWVVSKLKDFVGKRSFSREDNVREDRKHLVSVLPVDSSLRLAEGAALVAADAVASEGV
TPMEGWVTHAYNSPALGRTFGLALIKNGRNRIGEVLKTPVDGQLVDVQVSDLVLFDPEGS
RRD
//
>1vrqB [x.x.x] SARCOSINE OXIDASE BETA SUBUNIT
ADLLPEHPEFLWNNPEPKKSYDVVIVGGGGHGLATAYYLAKNHGITNVAVLEKGWLAGGN
MARNTTIIRSNYLWDESAGIYEKSLKLWEELPEELEYDFLFSQRGVLNLAHTLGDVRESI
RRVEANKFNGVDAEWLTPEQVKEVCPIINTGDNIRYPVMGATYQPRAGIAKHDHVAWAFA
RKANEMGVDIIQNCEVTGFLKDGEKVTGVKTTRGTILAGKVALAGAGHSSVLAELAGFEL
PIQSHPLQALVSELFEPVHPTVVMSNHIHVYVSQAHKGELVMGAGIDSYNGYGQRGAFHV
IEEQMAAAVELFPIFARAHVLRTWGGIVDTTMDASPIISKTPIQNLYVNCGWGTGGFKGT
PGAGYTLAHTIAHDEPHKLNAPFALERFETGHLIDEHGAAAV
//
>1vrqC [x.x.x] SARCOSINE OXIDASE GAMMA SUBUNIT
QLRRSPAAHLAAAMEAAEVAGERAVTLREVAFTTQLGLRAVPGSTGHAALAAATGVGLPA
AVGEVAGDVSGTAVLWLGPDEFLLAAEENPALLDTLQGALGQEPGQVLDLSANRSVLQLE
GPAAALVLRKSCPADLHPREFGVNRAITTSLANIPVLLWRTGEQSWRILPRASFTEHTVH
WLIDAMSEFSAAEVA
//
>1vrqD [x.x.x] SARCOSINE OXIDASE DELTA SUBUNIT
MMLIECPNCGPRNENEFKYGGEAHVAYPEDPNALSDKEWSRYLFYRGNKKGIFAERWVHS
GGCRKWFNALRDTVSYEFKAVYRAGEARPQL
//
>1vrs_1A [b.1.17] THIOL:DISULFIDE INTERCHANGE PROTEIN DSBD
GLFDAQFVPADQAFAFDFQQNQHDLNLTWQIKDGYYLYRKQIRITPEHAKIADVQLPQGV
WHEDEFYGKSEIYRDRLTLPVTINQASAGATLTVTYQGSADAGFCYPPETKTVPLSEVVA
N
//
>1vrs_1D [c.47.1] THIOL:DISULFIDE INTERCHANGE PROTEIN DSBD
HLNFTQIKTVDELNQALVEAKGKPVMLDLYADWCVASKEFEKYTFSDPQVQKALADTVLL
QANVTANDAQDVALLKHLNVLGLPTILFFDGQGQEHPQARVTGFMDAETFSAHLRDRQ
//
>1vs5F [d.58.14] 30S RIBOSOMAL PROTEIN S6
MRHYEIVFMVHPDQSEQVPGMIERYTAAITGAEGKIHRLEDWGRRQLAYPINKLHKAHYV
LMNVEAPQEVIDELETTFRFNDAVIRSMVMRTKHAVTEAS
//
>1vs5R [a.4.8] 30S RIBOSOMAL PROTEIN S18
EIDYKDIATLKNYITESGKIVPSRITGTRAKYQRQLARAIKRARYLSLLPYTDRH
//
>1vs7C [d.52.3 - d.53.1] 30S RIBOSOMAL PROTEIN S3
GQKVHPNGIRLGIVKPWNSTWFANTKEFADNLDSDFKVRQYLTKELAKASVSRIVIERPA
KSIRVTIHTARPGIVIGKKGEDVEKLRKVVADIAGVPAQINIAEVRKPELDAKLVADSIT
SQLERRVMFRRAMKRAVQNAMRLGAKGIKVEVSGRLGGAEIARTEWYREGRVPLHTLRAD
IDYNTSEAHTTYGVIGVKVWIFKGEI
//
>1vs7J [d.58.15] 30S RIBOSOMAL PROTEIN S10
RIRIRLKAFDHRLIDQATAEIVETAKRTGAQVRGPIPLPTRKERFTVLISPHVNKDARDQ
YEIRTHLRLVDIVEPTEKTVDALMRLDLAAGVDVQISL
//
>1vs8J [c.21.1] 50S RIBOSOMAL PROTEIN L13
MKTFTAKPETVKRDWYVVDATGKTLGRLATELARRLRGKHKAEYTPHVDTGDYIIVLNAD
KVAVTGNKRTDKVYYHHTGHIGGIKQATFEEMIARRPERVIEIAVKGMLPKGPLGRAMFR
KLKVYAGNEHNHAAQQPQVL
//
>1vs8Q [a.144.2] 50S RIBOSOMAL PROTEIN L20
ARVKRGVIARARHKKILKQAKGYYGARSRVYRVAFQAVIKAGQYAYRDRRQRKRQFRQLW
IARINAAARQNGISYSKFINGLKKASVEIDRKILADIAVFDKVAFTALVEKAKAALA
//
>1vs9D [x.x.x]
IPVLSPSGRRDVAADLPAEINPHLLWEVVRWQLAKRRRGTASTKTRGEVAYSGRKIWPQK
HTGRARHGDIGAPIFVGGGVVFGPKPRDYSYTLPKKVRKKGLAMAVADRAREGKLLLVEA
FAGVNGKTKEFLAWAKEAGLDGSESVLLVTGNELVRRAARNLPWVVTLAPEGLNVYDIVR
TERLVMDLDAWEVF
//
>1vs9H [x.x.x]
KTYVPKQVEPRWVLIDAEGKTLGRLATKIATLLRGKHRPDWTPNVAMGDFVVVVNADKIR
VTGKKLEQKIYTRYSGYPGGLKKIPLEKMLATHPERVLEHAVKGMLPKGPLGRRLFKRLK
VYAGPDHPHQAQRPEKL
//
>1vs9J [x.x.x]
MKLSDLRPNPGANKRRKRVGRGPGSGHGKTATRGHKGQKSRSGGLKDPRRFEGGRSTTLM
RLPKRGMQGQVPGEIKRPRYQGVNLKDLARFEGEVTPELLVRAGLLKKGYRLKILGEGEA
KPLKVVAHAFSKSALEKLKAAGGEPVL
//
>1vs9O [x.x.x]
PRAKTGIVRRRRHKKVLKRAKGFWGSRSKQYRNAFQTLLNAATYEYRDRRNKKRDFRRLW
IQRINAGARLHGMNYSTFINGLKRANIDLNRKVLADIAAREPEAFKALVDASRNARQ
//
>1vs9a [x.x.x]
PKMKTHKMAKRRIKITGTGKVMAFKSGKRHQNTGKSGDEIRGKGKGFVLAKAEWARMKLM
LPR
//
>1vyh_5Q (A) [c.23.10] PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB
SNPAAIPHAAEDIQGDDRWMSQHNRFVLDCKDKEPDVLFVGDSMVQLMQQYEIWRELFSP
LHALNFGIGGDTTRHVLWRLKNGELENIKPKVIVVWVGTNNHENTAEEVAGGIEAIVQLI
NTRQPQAKIIVLGLLPRGEKPNPLRQKNAKVNQLLKVSLPKLANVQLLDTDGGFVHSDGA
ISCHDMFDFLHLTGGGYAKICKPLHELIMQLLEETPEE
//
>1vyh_5S (C) [b.69.4] PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB
KEWIPRPPEKYALSGHRSPVTRVIFHPVFSVMVSASEDATIKVWDYETGDFERTLKGHTD
SVQDISFDHSGKLLASCSADMTIKLWDFQGFECIRTMHGHDHNVSSVSIMPNGDHIVSAS
RDKTIKMWEVQTGYCVKTFTGHREWVRMVRPNQDGTLIASCSNDQTVRVWVVATKECKAE
LREHRHVVECISWAPESSYSSISEATGSEGPFLLSGSRDKTIKMWDVSTGMCLMTLVGHD
NWVRGVLFHSGGKFILSCADDKTLRVWDYKNKRCMKTLNAHEHFVTSLDFHKTAPYVVTG
SVDQTVKVWE
//
>1vyt_1A [b.34.2 - c.37.1] CALCIUM CHANNEL BETA-3 SUBUNIT
ESARREVESQAQQQLERAKHKPVAFAVRTNVSYCGVLDEECPVQGSGVNFEAKDFLHIKE
KYSNDWWIGRLVKEGGDIAFIPSPQRLESIRLKQEQKARHVPPYDVVPSMRPVVLVGPSL
KGYEVTDMMQKALFDFLKHRFDGRISITRVTADLSLASIAEVQSEIERIFELAKSLQLVV
LDADTINHPAQLAKTSLAPIIVFVKVSSPKVLQRLIRSRGKSQMKHLTVQMMAYDKLVQC
PPESFDVILDENQLDDACEHLAEYLEVYWRATH
//
>1vyt_1E [j.68.1] VOLTAGE-DEPENDENT L-TYPE CALCIUM CHANNEL
QKLREKQQLEEDLKGYLDWITQAED
//
>1w1i_2D (A) [b.70.3 - c.69.1] DIPEPTIDYL PEPTIDASE IV
SRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEF
GHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWS
PVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSP
NGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSS
VTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWN
CLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFIT
KGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYS
VSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFII
LNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASF
DGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSM
VLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQV
EYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHF
IKQCFSLP
//
>1w1i_2H (E) [c.1.9] ADENOSINE DEAMINASE
TPAFDKPKVELHVHLDGAIKPETILYYGKRRGIALPADTPEELLNIIGMDKPLTLPDFLA
KFDYYMPAIAGCRDAIKRIAYEFVEMKAKDGVVYVEVRYSPHLLANSKVEPIPWNQAEGD
LTPDEVVSLVNQGLQEGERDFGVKVRSILCCMRHQPSWSSEVVELCKKYREQTVVAIDLA
GDETIEGSSLFPGHVQAYAEAVKSGVHRTVHAGEVGSANVVKEAVDTLKTERLGHGYHTL
EDTTLYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRFKNDQVNYSLNTDDPLIFKST
LDTDYQMTKKDMGFTEEEFKRLNINAAKSSFLPEDEKKELLDLLYKAYRMPS
//
>1w1w_1A [c.37.1] STRUCTURAL MAINTENANCE OF CHROMOSOME 1
GRLVGLELSNFKSYRGVTKVGFGESNFTSIIGPNGSGKSNMMDAISFVLGVLKDLIYRGP
QSAYVKAFYQKGNKLVELMRIISRNGDTSYKIDGKTVSYKDYSIFLENENILIKAKNFLV
FQGDVEQIAAQSPVELSRMFTFDYVSDHLDAIYRELTGNASLTKYHATPPLKRFKDMEYL
SGGEKTVAALALLFAINSYQPSPFFVLDEVDAALDITNVQRIAAYIRRHRNPDLQFIVIS
LKNTMFEKSDALVGVYRQQQENSSKIITLDLSNY
//
>1w1w_1B [c.37.1] STRUCTURAL MAINTENANCE OF CHROMOSOME 1
GRLVGLELSNFKSYRGVTKVGFGESNFTSIIGPNGSGKSNMMDAISFVLGVRSLKDLIYR
GPQSAYVKAFYQKGNKLVELMRIISRNGDTSYKIDGKTVSYKDYSIFLENENILIKAKNF
LVFQGDVEQIAAQSPVELSRMFEEVSGSIQYKKEYEELKEKIKILNQFLKIKKKRKELFE
KTFDYVSDHLDAIYRELTGNASLTIEDEDEPFNAGIKYHATPPLKRFKDMEYLSGGEKTV
AALALLFAINSYQPSPFFVLDEVDAALDITNVQRIAAYIRRHRNPDLQFIVISLKNTMFE
KSDALVGVYRQQQENSSKIITLDLSNY
//
>1w1w_1E [a.4.5] SISTER CHROMATID COHESION PROTEIN 1
KAIVQMAKILRKELSEEKEVIFTDVLKSQAKREASRGFFDILSLATEGCIGLSQTEAFGN
IKIDAKPALF
//
>1w1w_1F (E) [a.4.5] SISTER CHROMATID COHESION PROTEIN 1
KAIVQMAKILRKELSEEKEVIFTDVLKSQAKREASRGFFDILSLATEGCIGLSQTEAFGN
IKIDAKPALF
//
>1w2b5 [i.1.1] TRIGGER FACTOR
ETAVKSELVNVAKKVRIDGFRKGKVPMNIVAQRYG
//
>1w2bR [i.1.1] 50S RIBOSOMAL PROTEIN L23P
SWDVIKHPHVTEKAMNDMDFQNKLQFAVDDRASKGEVADAVEEQYDVTVEQVNTQNTMDG
EKKAVVRLSEDDDAQEVASRIGVF
//
>1w2w_1A [c.124.1] 5-METHYLTHIORIBOSE-1-PHOSPHATE ISOMERASE
mSLEAIVFDRSEPENVSVKVLDQLLLPYTTKYVPIHTIDDGYSVIKSmQVRGAPAIAIVG
SLSVLTEVQLIKHNPTSDVATLYSLVNWESTKTVLNKRLDFLLSSRPTAVNLSNSLVEIK
NILKSSSDLKAFDGSLYNYVCELIDEDLANNmKmGDNGAKYLIDVLQKDGFKDEFAVLTI
CNTGSLATSGYGTALGVIRSLWKDSLAKTDK
//
>1w2w_1B [c.124.1] 5-METHYLTHIORIBOSE-1-PHOSPHATE ISOMERASE
CPRmGHVFPLETRPYNQGSRLTAYELVYDKIPSTLITDSSIAYRIRTSPIPIKAAFVGAD
RIVRNGDTANKIGTLQLAVICKQFGIKFFVVAPKTTIDNVTETGDDIIVEERNPEEFKVV
TGTVINPENGSLILNESGEPITGKVGIAPLEINVWNPAFDITPHELIDGIITEEGVFTKN
SSGEFQLESLF
//
>1w36_1B [c.37.1 - c.37.1 - c.52.1] EXODEOXYRIBONUCLEASE V BETA CHAIN
MSDVAETLDPLRLPLQGERLIEASAGTGKTFTIAALYLRLLLGLGGSAAFPRPLTVEELL
VVTFTEAATAELRGRIRSNIHELRIACLRETTDNPLYERLLEEIDDKAQAAQWLLLAERQ
MDEAAVFTIHGFCQRMLNLNAFESGMLFEQQLIEDESLLRYQACADFWRRHCYPLPREIA
QVVFETWKGPQALLRDINRYLQGEAPVIKAPPPDDETLASRHAQIVARIDTVKQQWRDAV
GELDALIESSGIDRRKFNRSNQAKWIDKISAWAEEETNSYQLPESLEKPRHPLFEAIDQL
LAEPLSIRDLVITRALAEIRETVAREKRRRGELGFDDMLSRLDSALRSESGEVLAAAIRT
RFPVAMIDEFQDTDPQQYRIFRRIWHHQPETALLLIGDPKQAIYAFRGADIFTYMKARSE
VHAHYTLDTNWRSAPGMVNSVNKLFSQTDDAFMFREIPFIPVKSAGKNQALRFVFKGETQ
PAMKMWLMEGESCGVGDYQSTMAQVCAAQIRDWLQAGQRGEALLMNGDDARPVRASDISV
LVRSRQEAAQVRDALTLLEIPSVYLSNRDSVFETLEAQEMLWLLQAVMTPERENTLRSAL
ATSMMGLNALDIETLNNDEHAWDVVVEEFDGYRQIWRKRGVMPMLRALMSARNIAENLLA
TAGGERRLTDILHISELLQEAGTQLESEHALVRWLSQHILEPDSNASSQQMRLESDKHLV
QIVTIHKSKGLEYPLVWLPFITNFRVQEQAFYHDRHSFEAVLDLNAAPESVDLAEAERLA
EDLRLLYVALTRSVWHCSLGVAPLVRRRGDKKGDTDVHQSALGRLLQKGEPQDAAGLRTC
IEALCDDDIAWQTAQTGDNQPWQVNDVSTAELNAKTLQRLPGDNWRVTSYSGLQQRGHGI
AQDLMPRLDVDAAGVASVVEEPTLTPHQFPRGASPGTFLHSLFEDLDFTQPVDPNWVREK
LELGGFESQWEPVLTEWITAVLQAPLNETGVSLSQLSARNKQVEMEFYLPISEPLIASQL
DTLIRQFDPLSAGCPPLEFMQVRGMLKGFIDLVFRHEGRYYLLDYKSNWLGEDSSAYTQQ
AMAAAMQAHRYDLQYQLYTLALHRYLRHRIADYDYEHHFGGVIYLFLRGVDKEHPQQGIY
TTRPNAGLIALMDEMFAG
//
>1w36_1C [c.37.1 - c.37.1 - c.52.1] EXODEOXYRIBONUCLEASE V GAMMA CHAIN
MLRVYHSNRLDVLEALMEFIVERERLDDPFEPEMILVQSTGMAQWLQMTLSQKFGIAANI
DFPLPASFIWDMFVRVLPEIPKESAFNKQSMSWKLMTLLPQLLEREDFTLLRHYLTDDSD
KRKLFQLSSKAADLFDQYLVYRPDWLAQWETGHLVEGLGEAQAWQAPLWKALVEYTHQLG
QPRWHRANLYQRFIETLESATTCPPGLPSRVFICGISALPPVYLQALQALGKHIEIHLLF
TNPCRYYWGDIKDPAYLAKLLTRQRRHSFEDRELPLFRDSENAGQLFNSDGEQDVGNPLL
ASWGKLGRDYIYLLSDLESSQELDAFVDVTPDNLLHNIQSDILELENRAVAGVNIEEFSR
SDNKRPLDPLDSSITFHVCHSPQREVEVLHDRLLAMLEEDPTLTPRDIIVMVADIDSYSP
FIQAVFGSAPADRYLPYAISDRRARQSHPVLEAFISLLSLPDSRFVSEDVLALLDVPVLA
ARFDITEEGLRYLRQWVNESGIRWGIDDDNVRELELPATGQHTWRFGLTRMLLGYAMESA
QGEWQSVLPYDESSGLIAELVGHLASLLMQLNIWRRGLAQERPLEEWLPVCRDMLNAFFL
PDAETEAAMTLIEQQWQAIIAEGLGAQYGDAVPLSLLRDELAQRLDQERISQRFLAGPVN
ICTLMPMRSIPFKVVCLLGMNDGVYPRQLAPLGFDLMSQKPKRGDRSRRDDDRYLFLEAL
ISAQQKLYISYIGRSIQDNSERFPSVLVQELIDYIGQSHYLPGDEALNCDESEARVKAHL
TCLHTRMPFDPQNYQPGERQSYAREWLPAASQAGKAHSEFVQPLPFTLPETVPLETLQRF
WAHPVRAFFQMRLQVNFRTEDSEIPDTEPFILEGLSRYQINQQLLNALVEQDDAERLFRR
FRAAGDLPYGAFGEIFWETQCQEMQQLADRVIACRQPGQSMEIDLACNGVQITGWLPQVQ
PDGLLRWRPSLLSVAQGMQLWLEHLVYCASGGNGESRLFLRKDGEWRFPPLAAEQALHYL
SQLIEGYREGMSAPLLVLPESGGAWLKTCYDAQNDAMLDDDSTLQKARTKFLQAYEGNMM
VRGEGDDIWYQRLWRQLTPETMEAIVEQSQRFLLPLFRFNQ
//
>1w36_2F [c.37.1 - c.37.1 - c.52.1] EXODEOXYRIBONUCLEASE V GAMMA CHAIN
MLRVYHSNRLDVLEALMEFIVERERLDDPFEPEMILVQSTGMAQWLQMTLSQKFGIAANI
DFPLPASFIWDMFVRVLPEIPKESAFNKQSMSWKLMTLLPQLLEREDFTLLRHYLTDDSD
KRKLFQLSSKAADLFDQYLVYRPDWLAQWETGHLVEGLGEAQAWQAPLWKALVEYTHQLG
QPRWHRANLYQRFIETLESATTCPPGLPSRVFICGISALPPVYLQALQALGKHIEIHLLF
TNPCRYYWGDVGNPLLASWGKLGRDYIYLLSDLESSQELDAFVDVTPDNLLHNIQSDILE
LENRAVAGVNIEEFSRSDNKRPLDPLDSSITFHVCHSPQREVEVLHDRLLAMLEEDPTLT
PRDIIVMVADIDSYSPFIQAVFGSAPADRYLPYAISDRRARQSHPVLEAFISLLSLPDSR
FVSEDVLALLDVPVLAARFDITEEGLRYLRQWVNESGIRWGIDDDNVRELELPATGQHTW
RFGLTRMLLGYAMESAQGEWQSVLPYDESSGLIAELVGHLASLLMQLNIWRRGLAQERPL
EEWLPVCRDMLNAFFLPDAETEAAMTLIEQQWQAIIAEGLGAQYGDAVPLSLLRDELAQR
LDQERISQRFLAGPVNICTLMPMRSIPFKVVCLLGMNDGVYPRQLAPLGFDLMSQKPKRG
DRSRRDDDRYLFLEALISAQQKLYISYIGRSIQDNSERFPSVLVQELIDYIGQSHYLPGD
EALNCDESEARVKAHLTCLHTRMPFDPQNYQPGERQSYAREWLPAASQAGKAHSEFVQPL
PFTLPETVPLETLQRFWAHPVRAFFQMRLQVNFRTEDSEIPDTEPFILEGLSRYQINQQL
LNALVEQDDAERLFRRFRAAGDLPYGAFGEIFWETQCQEMQQLADRVIACRQPGQSMEID
LACNGVQITGWLPQVQPDGLLRWRPSLLSVAQGMQLWLEHLVYCASGGNGESRLFLRKDG
EWRFPPLAAEQALHYLSQLIEGYREGMSAPLLVLPESGGAWLKTCYDAQNDAMLDDDSTL
QKARTKFLQAYEGNMMVRGEGDDIWYQRLWRQLTPETMEAIVEQSQRFLLPLFRFNQ
//
>1w36_2G (D) [c.37.1 - c.37.1] EXODEOXYRIBONUCLEASE V ALPHA CHAIN
KLQKQLLEAVEHKQLRPLDVQFALTVAGDEHPAVTLAAALLSHDAGEGHVCLPLSRLENN
EASHPLLATCVSEIGELQNWEECLLASQAVSRGDEPTPMILCGDRLYLNRMWCNERTVAR
FFNEVNHAIEVDEALLAQTLDKLFPVSDEINWQKVAAAVALTRRISVISGGPGTGKTTTV
AKLLAALIQMADGERCRIRLAAPTGKAAARLTESLGKALRQLPLTDEQKKRIPEDASTLH
RLLHAGNPLHLDVLVVDEASMIDLPMMSRLIDALPDHARVIFLGDRDQLASVEAGAVLGD
ICAYANAGFTAERARQLSRLTGTHVPAGTGTEAASLRDSLCLLQKSYRFGSDSGIGQLAA
AINRGDKTAVKTVFQQDFTDIEKRLLQSGEDYIAMLEEALAGYGRYLDLLQARAEPDLII
QAFNEYQLLCALREGPFGVAGLNERIEQFMQQKRQPSRLPEHETTWAMTVHKSQGSEFDH
AALILPSQRTPVVTRELVYTAVTRARRRLSLYADERILSAAIATRTERRSGLAALFSS
//
>1w5c_1A [i.5.1] PHOTOSYSTEM Q(B) PROTEIN 1
RESANLWERFCNWVTSTGWFGVIMIPTLLAATICFVIAFIAAPPVDIDGIREPVSGSLLY
GNNIITGAVVPSSNAIGLHFYPIWEAASLDEWLYNGGPYQLIIFHFLLGASCYMGRQWEL
SYRLGMRPWICVAYSAPLASAFAVFLIYPIGQGSFSDGMPLGISGTFNFMIVFQAEHNIL
MHPFHQLGVAGVFGGALFCAMHGSLVTSSEETYNIVAAHGYFGRLIFQYASFNNSRSLHF
FLAAWPVVGVWFTALGISTMAFNLNGFNFNHSVIDAKGNVINTWADIINRANLGMEVMHE
R
//
>1w5c_1B [i.5.1] PHOTOSYSTEM II CORE LIGHT HARVESTING PROTEIN
PGRLIAAHLMHTALVAGWAGSMALYELATFDPSDPVLNPMFVLPFMARLGVTGSWSGWSI
FWSFEGVALAHIVLSGLLFLAACWHWVYWPALDLPKMFGIHLFLAGLLCFGFGAFHLTGL
FGPGMWVSDPYGLTGSVQPDGFNPYNPGGVVAHHIAAGIVGIIAGLFHILVRPPQRLYKA
LRMGNIETVLSSSIAAVFFAAFVVAGTMWYGSATTPIELFGPTRYQWDSSYFQQEINRRV
QASLASGEKLAFYDYIGNNPAMNKGDGIAQAWKGHAVFRNKEGEELFVRRMPAFFESFPV
ILTDKNGVVKADIPFRRAESKYSFEQQGVTVSFYGGELNGQTFTDPPTVKSYARKAIFGE
IFEFTETLNSDGIFRTSPRGWFTFAHAVFALLFFFGHIWHGARTLFRDVFSG
//
>1w5c_1C [i.5.1] PHOTOSYSTEM II CP43 PROTEIN
IFATNRDQESSGFAWWAGNARLINLSGKLLGAHVAHAGLIVFWAGAMTLFELAHFIPEKP
MYEQGLILIPHIATLGWGVGPGGEVVDTFPFFVVGVVHLISSAVLGFGGVYHAIRGPEDW
KDKNKMTTILGFHLIVLGIGALLLVAKAMFFGGLYDTWARVIFGYVSVNNLEDVVGGHIW
IGLICIAGGIWHILTTPFGWARRAFIWSGEAYLSYSLGALSMMGFIATCFVWFNNTVYPS
EFYGPTGPEASQAQAMTFLIRDQKLGANVGSAQGPTGLGKYLETMRFWDFRGPWLEPLRG
PNGLDLNKIKNDIQPWQERRAAEYMTHFVSPRSWLATSHFVLAFFFLVGHLWHAGRARAA
AAGFE
//
>1w5c_1D [i.5.1] PHOTOSYSTEM II REACTION CENTER D2 PROTEIN
MTIAIGRAPAERGWFDILDDWLKRDRFVFVGWSGILLFPCAYLALGGWLTGTTFVTSWYT
HGLASSYLEGCNFLTVAVSTPANSMGHSLLLLWGPEAQGDFTRWCQLGGLWTFIALHGAF
GLIGFMLRQFEIARLVGVRPYNAIAFSAPIAVFVSVFLIYPLGQSSWFFAPSFGVAAIFR
FLLFFQGFHNWTLNPFHMMGVAGVLGGALLCAIHGATVENTLFQDGEGASTFRAFNPTQA
EETYSMVTANRFWSQIFGIAFSNKRWLHFFMLFVPVTGLWMSAIGVVGLALNLRSYDFIS
QEIRAAEDPEFETFYTKNLLLNEGIRAWMAPQDQPHENFVFPEEVLPRGN
//
>1w5c_1E [i.5.1] CYTOCHROME B559 ALPHA SUBUNIT
RPFSDIITSVRYWVIHSITIPALFIAGWLFVSTGLAYDVFGTPRPDSYYAQEQRSIPLAK
QQVETFLEQLK
//
>1w5c_1F [i.5.1] CYTOCHROME B559 BETA SUBUNIT
EPVSYPIFTVRWVAVHTLAVPTIFFLGAIAAMQFIQR
//
>1w5c_1V (T) [i.5.1] CYTOCHROME C-550
ELTPEVLTVPLNSEGKTITLTEKQYLEGKRLFQYACASCHVGGITKTNPSLDLRTETLAL
ATPPRDNIEGLVDYMKNPTTYDGEQEIAEVHPSLRSADIFPKMRNLTEKDLVAIAGHILV
EPKILGDKWGGGKVYY
//
>1w5c_2G (A) [i.5.1] PHOTOSYSTEM Q(B) PROTEIN 1
RESANLWERFCNWVTSTGWFGVIMIPTLLAATICFVIAFIAAPPVDIDGIREPVSGSLLY
GNNIITGAVVPSSNAIGLHFYPIWEAASLDEWLYNGGPYQLIIFHFLLGASCYMGRQWEL
SYRLGMRPWICVAYSAPLASAFAVFLIYPIGQGSFSDGMPLGISGTFNFMIVFQAEHNIL
MHPFHQLGVAGVFGGALFCAMHGSLVTSSEETYNIVAAHGYFGRLIFQYASFNNSRSLHF
FLAAWPVVGVWFTALGISTMAFNLNGFNFNHSVIDAKGNVINTWADIINRANLGMEVMHE
R
//
>1w5c_2J (D) [i.5.1] PHOTOSYSTEM II REACTION CENTER D2 PROTEIN
MTIAIGRAPAERGWFDILDDWLKRDRFVFVGWSGILLFPCAYLALGGWLTGTTFVTSWYT
HGLASSYLEGCNFLTVAVSTPANSMGHSLLLLWGPEAQGDFTRWCQLGGLWTFIALHGAF
GLIGFMLRQFEIARLVGVRPYNAIAFSAPIAVFVSVFLIYPLGQSSWFFAPSFGVAAIFR
FLLFFQGFHNWTLNPFHMMGVAGVLGGALLCAIHGATVENTLFQDGEGASTFRAFNPTQA
EETYSMVTANRFWSQIFGIAFSNKRWLHFFMLFVPVTGLWMSAIGVVGLALNLRSYDFIS
QEIRAAEDPEFETFYTKNLLLNEGIRAWMAPQDQPHENFVFPEEVLPRGN
//
>1w63_1A [i.23.1] ADAPTER-RELATED PROTEIN COMPLEX 1 GAMMA 1
MPAPIRLRELIRTIRTARTQAEEREMIQKECAAIRSSFREEDNTYRCRNVAKLLYMHMLG
YPAHFGQLECLKLIASQKFTDKRIGYLGAMLLLDERQDVHLLMTNCIKNDLNHSTQFVQG
LALCTLGCMGSSEMCRDLAGEVEKLLKTSNSYLRKKAALCAVHVIRKVPELMEMFLPATK
NLLNEKNHGVLHTSVVLLTEMCERSPDMLAHFRKLVPQLVRILKNLIMSGYSPEHDVSGI
SDPFLQVRILRLLRILGRNDDDSSEAMNDILAQVATNTETSKNVGNAILYETVLTIMDIK
SESGLRVLAINILGRFLLNNDKNIRYVALTSLLKTVQTDHNAVQRHRSTIVDCLKDLDVS
IKRRAMELSFALVNGNNIRGMMKELLYFLDSCEPEFKADCASGIFLAAEKYAPSKRWHID
TIMRVLTTAGSYVRDDAVPNLIQLITNSVEMHAYTVQRLYKAILGDYSQQPLVQVAAWCI
GEYGDLLVSGQCEEEEPIQVTEDEVLDILESVLISNMSTSVTRGYALTAIMKLSTRFTCT
VNRIKKVVSIYGSSIDVELQQRAVEYNALFKKYDHMRSALLERMPVMEK
//
>1w63_1B [i.23.1] ADAPTER-RELATED PROTEIN COMPLEX 1 BETA 1 SUBUNIT
TDSKYFTTTKKGEIFELKAELNSDKKEKKKEAVKKVIASMTVGKDVSALFPDVVNCMQTD
NLELKKLVYLYLMNYAKSQPDMAIMAVNTFVKDCEDPNPLIRALAVRTMGCIRVDKITEY
LCEPLRKCLKDEDPYVRKTAAVCVAKLHDINAQMVEDQGFLDTLKDLISDSNPMVVANRV
AALSEIAESHPSSNLLDLKAQSINKLLTALNECTEWAQIFILDCLGNYMPKDDREAQSIC
ERVTPRLSHANSAVVLSAVKVLMKFMDYYATLLKKLAPPLVTLLSAEPEPQYVPLRNINL
IVQKRPEILKHEMKVFFVKYNDPIYVKLEKLDIMIRLASQANIAQVLAELKEYATEVDVD
FVRKAVRAIGRCAIKVEQSAERCVSTLLDLIQTKVNYVVQEAIVVIKDIFRKYPNKYESV
IATLCENLDSDDEPEARAAMIWIVGEYAERSDNADELLESFLDGFHDESTQVQLQLLTAI
VKLFLKKPTETQELVQQVLSLATQDSDNPDLRDRGYIYWRLLSTDPVAAKEVVLAEKPLI
SEETDLIEPTLLDELICYIGTLASVYHKPPNAFVE
//
>1w63_1M [i.23.1] ADAPTOR-RELATED PROTEIN COMPLEX 1, MU 1 SUBUNIT
SASAVYVLDLKGKVLICRNYRGDVDMSEVEHFMPILMEKEEEGMLSPILAHGGVRFMWIK
HNNLYLVATSKKNACVSLVFSFLYKVVQVFSEYFKELEEESIRDNFVIIYELLDELMDFG
YPQTTDSKILQEFITQEGHKLETGVSWRSEGIKYRKNEVFLDVIEAVNLLVSANGNVLRS
EIVGSIKMRVFLSGMPELRLGLNDKVELEDVKFHQCVRLSRFENDRTISFIPPDGEFELM
SYRLNTHVKPLIWIESVIEKHSHSRIEYMVKAKSQFKRRSTANNVEIHIPVPNDADSPKF
KTTVGSVKWVPENSEIVWSVKSFPGGKEYLMRAHFGLKPPISVKFEIPYFTTSGIQVRYL
KIIEKSGYQAIPWVRYITQNGDYQLRTQ
//
>1w63_1S (Q) [i.23.1] ADAPTER-RELATED PROTEIN COMPLEX 1 SIGMA 1A
MMRFMLLFSRQGKLRLQKWYLATSDKERKKMVRELMQVVLARKPKMCSFLEWRDLKVVYK
RYASLYFCCAIEGQDNELITLELIHRYVELLDKYFGSVCELDIIFNFEKAYFILDEFLMG
GDVQDTSKKSVLKAIEQADLLQEEDESP
//
>1w72_1A [d.19.1 - b.1.1] HLA CLASS I HISTOCOMPATIBILITY ANTIGEN
GSHSMRYFFTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQKMEPRAPWIEQEGPEYW
DQETRNMKAHSQTDRANLGTLRGYYNQSEDGSHTIQIMYGCDVGPDGRFLRGYRQDAYDG
KDYIALNEDLRSWTAADMAAQITKRKWEAVHAAEQRRVYLEGRCVDGLRRYLENGKETLQ
RTDPPKTHMTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGT
FQKWAAVVVPSGEEQRYTCHVQHEGLPKPLTLRW
//
>1w72_1H [b.1.1 - b.1.1] HYB3 HEAVY CHAIN
EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWNSGSIGY
ADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARGRGFHYYYYGMDIWGQGTTVTV
SSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQ
SSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK
//
>1w72_1L [b.1.1 - b.1.1] HYB3 LIGHT CHAIN
SYVLTQPPSVSVAPGQTARITCGGNNIGSRSVHWYQQKPGQAPVLVVYDDSDRPSGIPER
FSGSNSGNMATLTISRVEAGDEADYYCQVWDSRTDHWVFGGGTDLTVLGQPKAAPSVTLF
PPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASSYL
SLTPEQWKSHRSYSCQVTHEGSTVEKTVAP
//
>1w72_2I (H) [b.1.1 - b.1.1] HYB3 HEAVY CHAIN
EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWNSGSIGY
ADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARGRGFHYYYYGMDIWGQGTTVTV
SSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQ
SSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK
//
>1w72_2M (L) [b.1.1 - b.1.1] HYB3 LIGHT CHAIN
SYVLTQPPSVSVAPGQTARITCGGNNIGSRSVHWYQQKPGQAPVLVVYDDSDRPSGIPER
FSGSNSGNMATLTISRVEAGDEADYYCQVWDSRTDHWVFGGGTDLTVLGQPKAAPSVTLF
PPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASSYL
SLTPEQWKSHRSYSCQVTHEGSTVEKTVAP
//
>1w7jA [b.34.3 - c.37.1] MYOSIN VA
AASELYTKYARVWIPDPEEVWKSAELLKDYKPGDKVLQLRLEEGKDLEYCLDPKTKELPP
LRNPDILVGENDLTALSYLHEPAVLHNLKVRFIDSKLIYTYCGIVLVAINPYEQLPIYGE
DIINAYSGQNMGDMDPHIFAVAEEAYKQMARDERNQSIIVSGESGAGKTVSAKYAMRYFA
TVSGSASEANVEEKVLASNPIMESIGNAKTTRNDNSSRFGKYIEIGFDKRYRIIGANMRT
YLLEKSRVVFQAEEERNYHIFYQLCASAALPEFKTLRLGNANYFHYTKQGGSPVIDGIDD
AKEMVNTRQACTLLGISDSYQMGIFRILAGILHLGNVEFASRDSDSCAIPPKHDPLTIFC
DLMGVDYEEMAHWLCHRKLATATETYIKPISKLHAINARDALAKHIYANLFNWIVDHVNK
ALHSTVKQHSFIGVLDIYGFETFEINSFEQFCINYANEKLQQQFNMHVFKLEQEEYMKEQ
IPWTLIDFYDNQPCINLIEAKMGVLDLLDEECKMPKGSDDTWAQKLYNTHLNKCALFEKP
RLSNKAFIIKHFADKVEYQCEGFLEKNKDTVYEEQIKVLKSSKKFKLLPELFQKTVGHQF
RNSLHLLMETLNATTPHYVRCIKPNDFKFPFTFDEKRAVQQLRACGVLETIRISAAGFPS
RWTYQEFFSRYRVLMKQKDVLSDRKQTCKNVLEKLILDKDKYQFGKTKIFFRAGQVAYLE
KIRADKLRAACIRIQKTIRGWLMRKKYMRMRR
//
>1w7jB [a.39.1] MYOSIN LIGHT CHAIN 1
EFKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPKSDELKSRRVDFETF
LPMLQAVAKDYLEGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVETVLAGHEDSNGC
INYEAFLKHIL
//
>1w7pA [a.4.5 - a.4.5] VPS22, YPL002C
VNKTILEKQSVELRDQLMVFQERLVEFAKKHNSELQASPEFRSKFMHMCSSIGIDPLSLF
DRDKHLFTVNDFYYEVCLKVIEICRQTKDMNGGVISFQELEKVHFRKLNVGLDDLEKSID
MLKSLECFEIFQIRGKKFLRSVPNELTSDQTKILEICSILGYSSISLLKANLGWEAVRSK
SALDEMVANGLLWIDYQGGAEALYWDPSWITRQ
//
>1w7pC (B) [a.4.5 - a.4.5] VPS25, YJR102C
MSALPPVYSFPPLYTRQPNSLTRRQQISTWIDIISQYCKTKKIWYMSVDGTVINSKNLFN
NEDIQRSVSQVFIDEIWSQMTKEGKCLPIDQSGRRSSNTTTTRYFILWKSLDSWASLILQ
WFEDSGKLNQVITLYELSEGDETVNWEFHRMPESLLYYCLKPLCDRNRATMLKDENDKVI
AI
//
>1w7pD [a.4.5 - a.4.5] VPS36P, YLR417W
LDREKFLNKELFLDEIAREIYEFTLSEFKDLNSDTNYMIITLVDLYAMYNKSMRIGTGLI
SPMEMREACERFEHLGLNELKLVKVNKRILCVTSEKFDVVKEKLVDLIGDNPGSDLLRLT
QILSSNNSKSNWTLGILMEVLQNCVDEGDLLIDKQLSGIYYYKNSYWPSHI
//
>1w7xH [b.47.1] BLOOD COAGULATION FACTOR VIIA
IVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHD
LSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERT
LAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRSPNITEYMFCAGYSDGS
KDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSEPR
PGVLLRAPFP
//
>1w7xL [g.3.11] BLOOD COAGULATION FACTOR VIIA
ICVNENGGCEQYCSDHKRSCRCHEGYSLLADGVSCTPTVEYPCGKIPILEKR
//
>1w85_2J [a.9.1] DIHYDROLIPOYLLYSINE-RESIDUE ACETYLTRANSFERASE
VIAMPSVRKYAREKGVDIGTGKNGRVLKEDIDAF
//
>1w85_2F (B) [c.36.1 - c.48.1] PYRUVATE DEHYDROGENASE E1 COMPONENT, BETA
AQMTMVQAITDALRIELKNDPNVLIFGEDVGVNGGVFRATEGLQAEFGEDRVFDTPLAES
GIGGLAIGLALQGFRPVPEIQFFGFVYEVMDSICGQMARIRYRTGGRYHMPITIRSPFGG
GVHTPELHSDSLEGLVAQQPGLKVVIPSTPYDAKGLLISAIRDNDPVIFLEHLKLYRSFR
QEVPEGEYTIPIGKADIKREGKDITIIAYGAMVHESLKAAAELEKEGISAEVVDLRTVQP
LDIETIIGSVEKTGRAIVVQEAQRQAGIAANVVAEINERAILSLEAPVLRVAAPDTVYPF
AQAESVWLPNFKDVIETAKKVMNF
//
>1w98A [d.144.1] CELL DIVISION PROTEIN KINASE 2
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN
HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH
SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYxHEVVTLWYRAPEILLGCKY
YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS
FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR
//
>1w98B [a.74.1 - a.74.1] G1/S-SPECIFIC CYCLIN E1
SPLPVLSWANREEVWKIMLNKEKTYLRDQHFLEQHPLLQPKMRAILLDWLMEVCEVYKLH
RETFYLAQDFFDRYMATQENVVKTLLQLIGISSLFIAAKLEEIYPPKLHQFAYVTDGACS
GDEILTMELMIMKALKWRLSPLTIVSWLNVYMQVAYLNDLHEVLLPQYPQQIFIQIAELL
DLCVLDVDCLEFPYGILAASALYHFSSSELMQKVSGYQWCDIENCVKWMVPFAMVIRETG
SSKLKHFRGVADEDAHNIQTHRDSLDLLDK
//
>1wa5A [c.37.1] GTP-BINDING NUCLEAR PROTEIN RAN
PQVQFKLVLVGDGGTGKTTFVKRHLTGEFEKKYVATLGVEVHPLVFHTNRGPIKFNVWDT
AGQEKFGGLRDGYYIQAQCAIIMFDVTSRVTYKNVPNWHRDLVRVCENIPIVLCGNKVDI
KDRKVKAKSIVFHRKKNLQYYDISAKSNYNFEKPFLWLARKLIGDPNLEF
//
>1wa5B [a.118.1] IMPORTIN ALPHA SUBUNIT
FVPEYRRTELRRRRDTQQVELRKAKRDEALAKRRNFQELPQMTQQLNSDDMQEQLSATVK
FRQILSREHRPPIDVVIQAGVVPRLVEFMRENQPEMLQLEAAWALTNIASGTSAQTKVVV
DADAVPLFIQLLYTGSVEVKEQAIWALGNVAGDSTDYRDYVLQCNAMEPILGLFNSNKPS
LIRTATWTLSNLCRGKKPQPDWSVVSQALPTLAKLIYSMDTETLVDACWAISYLSDGPQE
AIQAVIDVRIPKRLVELLSHESTLVQTPALRAVGNIVTGNDLQTQVVINAGVLPALRLLL
SSPKENIKKEACWTISNITAGNTEQIQAVIDANLIPPLVKLLEVAEYKTKKEACWAISNA
SSGGLQRPDIIRYLVSQGCIKPLCDLLEIADNRIIEVTLDALENILKMGEADKEARGLNI
NENADFIEKAGGMEKIFNCQQNENDKIYEKAYKIIETYFGEEE
//
>1wa5C [a.118.1] IMPORTIN ALPHA RE-EXPORTER
MSDLETVAKFLAESVIASTAKTSERNLRQLETQDGFGLTLLHVIASTNLPLSTRLAGALF
FKNFIKRKWVDENGNHLLPANNVELIKKEIVPLMISLPNNLQVQIGEAISSIADSDFPDR
WPTLLSDLASRLSNDDMVTNKGVLTVAHSIFKRWRPLFRSDELFLEIKLVLDVFTAPFLN
LLKTVDEQITANEKASLNILFDVLLVLIKLYYDFNCQDIPEFFEDNIQVGMGIFHKYLSY
SNPLLEHASVLIKVKSSIQELVQLYTTRYEDVFGPMINEFIQITWNLLTSISNQPKYDIL
VSKSLSFLTAVTRIPKYFEIFNNESAMNNITEQIILPNVTLREEDVELFEDDPIEYIRRD
LEGTRRRACTDFLKELKEKNEVLVTNIFLAHMKGFVDQYMSNWKFKDLYIYLFTALAING
NITNAGVSSTNNLLNVVDFFTKEIAPDLTSNNIPHIILRVDAIKYIYTFRNQLTKAQLIE
LMPILATFLQTDEYVVYTYAAITIEKILTIRESNTSPAFIFHKEDISNSTEILLKNLIAL
ILKHGSSPEKLAENEFLMRSIFRVLQTSEDSIQPLFPQLLAQFIEIVTIMAKNPSNPRFT
HYTFESIGAILNYTQRQNLPLLVDSMMPTFLTVFSEDIQEFIPYVFQIIAFVVEQSATIP
ESIKPLAQPLLAPNVWELKGNIPAVTRLLKSFIKTDSSIFPDLVPVLGIFQRLIASKAYE
VHGFDLLEHIMLLIDMNRLRPYIKQIAVLLLQRLQNSKTERYVKKLTVFFGLISNKLGSD
FLIHFIDEVQDGLFQQIWGNFIITTLPTIGNLLDRKIALIGVLNMVINGQFFQSKYPTLI
SSTMNSIIETASSQSIANLKNDYVEEISTFGSHFSKLVSISEKPFDPLPEIDVNNGVRLY
VAEALNKYNAISGNTFLNTILPQLTQENQVKLNQLLV
//
>1wcb_1A [b.1.1 - b.1.1] FAB FRAGMENT OF CATALYTIC ANTIBODY 15A9, LIGHT
DIELTQSPAIMAASPGEKVTITCSATSGVNYMHWFQQKPGTSPKLWIYSTSNLASAVPAR
FSGSGSGTSYSLTISRMEAEDAATYYCQQRSTYPFTFGGGTKLELKRADAAPTVSIFPPS
SEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLTL
TKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1wcb_1B [b.1.1 - b.1.1] FAB FRAGMENT OF CATALYTIC ANTIBODY 15A9, HEAVY
EVKLQESGGGLVQPGHSLRLSCATSGFTFTDYYMSWVRQPPGKALEWLGLIRNKANGYTK
EYSASVKGRFTISRDNSQSILYLQMNALRAEDSATYYCVRDKGSYGNYEAWFAYWGQGTT
VTVSSAKTTPPSVYPLAPGSQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVL
QSDLYTLSSSVTVPSSPRPSETVTCNVAHPASSTKVDKKIVPRD
//
>1wdcA [x.x.x] SCALLOP MYOSIN
RDERLSKIISMFQAHIRGYLIRKAYKKLQDQRIGLSVIQRNIRKWLVLRNWQWWKLYSKV
KPLL
//
>1wdcC [a.39.1] SCALLOP MYOSIN
LSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAVGGTHKMGEKS
LPFEEFLPAYEGLMDCEQGTFADYMEAFKTFDREGQGFISGAELRHVLTALGERLSDEDV
DEIIKLTDLQEDLEGNVKYEDFVKKVMAGPYP
//
>1wddC (E) [d.58.9 - c.1.14] RIBULOSE BISPHOSPHATE CARBOXYLASE LARGE CHAIN
GFKAGVKDYKLTYYTPEYETKDTDILAAFRVTPQPGVPPEEAGAAVAAESSTGTWTTVWT
DGLTSLDRYKGRCYHIEPVVGEDNQYIAYVAYPLDLFEEGSVTNMFTSIVGNVFGFKALR
ALRLEDLRIPPTYSKTFQGPPHGIQVERDKLNKYGRPLLGCTIKPKLGLSAKNYGRACYE
CLRGGLDFTxDDENVNSQPFMRWRDRFVFCAEAIYKSQAETGEIKGHYLNATAGTCEEMI
KRAVFARELGVPIVMHDYLTGGFTANTSLAHYCRDNGLLLHIHRAMHAVIDRQKNHGMHF
RVLAKALRMSGGDHIHAGTVVGKLEGEREMTLGFVDLLRDDFIEKDRARGIFFTQDWVSM
PGVIPVASGGIHVWHMPALTEIFGDDSVLQFGGGTLGHPWGNAPGAAANRVALEACVQAR
NEGRDLAREGNEIIRSACKWSPELAAACEIWKAIKFEFEPVDKL
//
>1wddD (S) [d.73.1] RIBULOSE BISPHOSPHATE CARBOXYLASE SMALL CHAIN C
xQVWPIEGIKKFETLSYLPPLTVEDLLKQIEYLLRSKWVPCLEFSKVGFVYRENHRSPGY
YDGRYWTMWKLPMFGCTDATQVLKELEEAKKAYPDAFVRIIGFDNVRQVQLISFIAYKPP
GC
//
>1wdlA [c.14.1 - c.2.1 - a.100.1 - a.100.1] FATTY OXIDATION COMPLEX ALPHA SUBUNIT
MIYEGKAITVTALESGIVELKFDLKGESVNKFNRLTLNELRQAVDAIKADASVKGVIVSS
GKDVFIVGADITEFVENFKLPDAELIAGNLEANKIFSDFEDLNVPTVAAINGIALGGGLE
MCLAADFRVMADSAKIGLPEVKLGIYPGFGGTVRLPRLIGVDNAVEWIASGKENRAEDAL
KVSAVDAVVTADKLGAAALDLIKRAISGELDYKAKRQPKLEKLKLNAIEQMMAFETAKGF
VAGQAGPNYPAPVEAIKTIQKAANFGRDKALEVEAAGFAKLAKTSASNCLIGLFLNDQEL
KKKAKVYDKIAKDVKQAAVLGAGIMGGGIAYQSASKGTPILMKDINEHGIEQGLAEAAKL
LVGRVDKGRMTPAKMAEVLNGIRPTLSYGDFGNVDLVVEAVVENPKVKQAVLAEVENHVR
EDAILASNTSTISISLLAKALKRPENFVGMHFFNPVHMMPLVEVIRGEKSSDLAVATTVA
YAKKMGKNPIVVNDCPGFLVNRVLFPYFGGFAKLVSAGVDFVRIDKVMEKFGWPMGPAYL
MDVVGIDTGHHGRDVMAEGFPDRMKDDRRSAIDALYEAKRLGQKNGKGFYAYEADKKGKQ
KKLVDSSVLEVLKPIVYEQRDVTDEDIINWMMIPLCLETVRCLEDGIVETAAEADMGLVY
GIGFPLFRGGALRYIDSIGVAEFVALADQYAELGALYHPTAKLREMAKNGQSFFG
//
>1wdlC [c.95.1 - c.95.1] 3-KETOACYL-COA THIOLASE
SLNPRDVVIVDFGRTPMGRSKGGMHRNTRAEDMSAHLISKVLERNSKVDPGEVEDVIWGC
VNQTLEQGWNIARMASLMTQIPHTSAAQTVSRLCGSSMSALHTAAQAIMTGNGDVFVVGG
VEHMGHVSMMHGVDPNPHMSLYAAKASGMMGLTAEMLGKMHGISREQQDAFAVRSHQLAH
KATVEGKFKDEIIPMQGYDENGFLKIFDYDETIRPDTTLESLAALKPAFNPKGGTVTAGT
SSQITDGASCMIVMSAQRAKDLGLEPLAVIRSMAVAGVDPAIMGYGPVPATQKALKRAGL
NMADIDFIELNEAFAAQALPVLKDLKVLDKMNEKVNLHGGAIALGHPFGCSGARISGTLL
NVMKQNGGTFGLSTMCIGLGQGIATVFERV
//
>1wdw_3I [c.1.2] TRYPTOPHAN SYNTHASE ALPHA CHAIN
MFKDGSLIPYLTAGDPDKQSTLNFLLALDEYAGAIELGIPFSDPIADGKTIQESHYRALK
NGFKLREAFWIVKEFRRHSSTPIVLMTYYNPIYRAGVRNFLAEAKASGVDGILVVDLPVF
HAKEFTEIAREEGIKTVFLAAPNTPDERLKVIDDMTTGFVYLVSLYGREEIPKTAYDLLR
RAKRICRNKVAVGFGVSKREHVVSLLKEGANGVVVGSALVKIIGEKGREATEFLKKKVEE
LLGI
//
>1wdw_3J (B) [c.79.1] TRYPTOPHAN SYNTHASE BETA CHAIN 1
MWFGEFGGQYVPETLIEPLKELEKAYKRFKDDEEFNRQLNYYLKTWAGRPTPLYYAKRLT
EKIGGAKIYLKREDLVHGGAHKTNNAIGQALLAKFMGKTRLIAETGAGQHGVATAMAGAL
LGMKVDIYMGAEDVERQKMNVFRMKLLGANVIPVNSGSRTLKDAINEALRDWVATFEYTH
YLIGSVVGPHPYPTIVRDFQSVIGREAKAQILEAEGQLPDVIVACVGGGSNAMGIFYPFV
NDKKVKLVGVEAGGKGLESGKHSASLNAGQVGVFHGMLSYFLQDEEGQIKPTHSIAPGLD
YPGVGPEHAYLKKIQRAEYVTVTDEEALKAFHELSRTEGIIPALESAHAVAYAMKLAKEM
SRDEIIIVNLSGRGDKDLDIVLKVS
//
>1we3B (A) [a.129.1 - d.56.1 - c.8.5] CPN60(GROEL)
AKILVFDEAARRALERGVNAVANAVKVTLGPRGRNVVLEKKFGSPTITKDGVTVAKEVEL
EDHLENIGAQLLKEVASKTNDVAGDGTTTATVLAQAIVREGLKNVAAGANPLALKRGIEK
AVEAAVEKIKALAIPVEDRKAIEEVATISANDPEVGKLIADAMEKVGKEGIITVEESKSL
ETELKFVEGYQFDKGYISPYFVTNPETMEAVLEDAFILIVEKKVSNVRELLPILEQVAQT
GKPLLIIAEDVEGEALATLVVNKLRGTLSVAAVKAPGFGDRRKEMLKDIAAVTGGTVISE
ELGFKLENATLSMLGRAERVRITKDETTIVGGKGKKEDIEARINGIKKELETTDSEYARE
KLQERLAKLAGGVAVIRVGAATETELKEKKHRFEDALNATRAAVEEGIVPGGGVTLLRAI
SAVEELIKKLEGDEATGAKIVRRALEEPARQIAENAGYEGSVIVQQILAETKNPRYGFNA
ATGEFVDMVEAGIVDPAKVTRSALQNAASIGALILTTEAVVAEKPEK
//
>1we3P [b.35.1] CPN10(GROES)
VIKPLGDRVVVKRIEEEPKTKGGIVLPDTAKEKPQKGKVIAVGTGRVLENGQRVPLEVKE
GDIVVFAKYGGTEIEIDGEEYVILSERDLLAVLQ
//
>1wejL [b.1.1 - b.1.1] E8 ANTIBODY
DIQMTQSPASLSASVGETVTITCRASGNIHNYLAWYQQKQGKSPQLLVYNAKTLADGVPS
RFSGSGSGTQYSLKINSLQPEDFGSYYCQHFWSTPWTFGGGTKLEIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1wejH [b.1.1 - b.1.1] E8 ANTIBODY
EVQLQQSGAELVKPGASVKLSCTASGFNIKDTYMHWVKQRPEKGLEWIGRIDPASGNTKY
DPKFQDKATITADTSSNTAYLQLSSLTSEDTAVYYCAGYDYGNFDYWGQGTTLTVSSAET
TPPSVYPLAPGTAALKSSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYT
LTSSVTVPSSTWPSQTVTCNVAHPASSTKVDKKIVPRNCGGDC
//
>1wejA (F) [a.3.1] CYTOCHROME C
GDVEKGKKIFVQKCAQCHTVEKGGKHKTGPNLHGLFGRKTGQAPGFTYTDANKNKGITWK
EETLMEYLENPKKYIPGTKMIFAGIKKKTEREDLIAYLKKATNE
//
>1wkwA [d.86.1] EUKARYOTIC TRANSLATION INITIATION FACTOR 4E
EVANPEHYIKHPLQNRWALWFFKNDKSKTWQANLRLISKFDTVEDFWALYNHIQLSSNLM
PGCDYSLFKDGIEPMWEDEKNKRGGRWLITLNKQQRRSDLDRFWLETLLCLIGESFDDYS
DDVCGAVVNVRAKGDKIAIWTTECENREAVTHIGRVYKERLGLPPKIVIGYQSHADTATK
SGSTTKNRFV
//
>1wkwB [x.x.x] EUKARYOTIC TRANSLATION INITIATION FACTOR 4E
PGGTRIIYDRKFLMECRNSP
//
>1wlq_1B [h.1.28] GEMININ
TQEAFDLISKENPSSQYWKEVAEQRRKALYEALKENEKLHKEIEQKDSEIARLRKENKDL
AEVAEHVQYmAEVIERLS
//
>1wlq_1C [a.4.5] CDT1 PROTEIN
KAPAYQRFHALAQPGLPGLVLPYKYQVLVEmFHSmDTIVSmLHNRSETVTFAKVKQGVQE
mmRKRFEERNVGQIKTVYPmSYRFRQECNVPTFKDSIKRSDYQLTIEPLLGQEGATQLTA
TCLLQRRQVFRQNLVERVKEQHKVFLASLNPPmAVPDDQLTRWHPRFNVDEVPDIEPAEL
PQPPV
//
>1wmhA [d.15.2] PROTEIN KINASE C, IOTA TYPE
QVRVKAYYRGDIMITHFEPSISFEGLCNEVRDMCSFDNEQLFTMKWIDEEGDPCTVSSQL
ELEEAFRLYELNKDSELLIHVFP
//
>1wmhB [d.15.2] PARTITIONING DEFECTIVE-6 HOMOLOG ALPHA
SIVEVKSKFDAEFRRFALPRASVSGFQEFSRLLRAVHQIPGLDVLLGYTDAHGDLLPLTN
DDSLHRALASGPPPLRLLVQKR
//
>1wmi_1A [d.298.1] HYPOTHETICAL PROTEIN PHS013
MTYRVKIHKQVVKALQSLPKAHYRRFLEFRDILEYEPVPREKFDVIKLEGTGDLDLYRAR
LGDYRVIYSVNWKDKVIKILKLKPRGRA
//
>1wmi_1B [a.137.13] HYPOTHETICAL PROTEIN PHS014
GDVLKELERLKVEIQRLEAMLMPEERDEDITEEEIAELLELARDEDPENWIDAEELPEPE
D
//
>1wpxA [c.69.1] CARBOXYPEPTIDASE Y
KIKDPKILGIDPNVTQYTGYLDVEDEDKHFFFWTFESRNDPAKDPVILWLNGGPGCSSLT
GLFFELGPSSIGPDLKPIGNPYSWNSNATVIFLDQPVNVGFSYSGSSGVSNTVAAGKDVY
NFLELFFDQFPEYVNKGQDFHIAGESYAGHYIPVFASEILSHKDRNFNLTSVLIGNGLTD
PLTQYNYYEPMACGEGGEPSVLPSEECSAMEDSLERCLGLIESCYDSQSVWSCVPATIYC
NNAQLAPYQRTGRNVYDIRKDCEGGNLCYPTLQDIDDYLNQDYVKEAVGAEVDHYESCNF
DINRNFLFAGDWMKPYHTAVTDLLNQDLPILVYAGDKDFICNWLGNKAWTDVLPWKYDEE
FASQKVRNWTASITDEVAGEVKSYKHFTYLRVFNGGHMVPFDVPENALSMVNEWIHGGFS
L
//
>1wpxB [b.17.1] CARBOXYPEPTIDASE Y INHIBITOR
MNQAIDFAQASIDSYKKHGILEDVIHDTSFQPSGILAVEYSSSAPVAMGNTLPTEKARSK
PQFQFTFNKQMQNAYVPQDDDLFTLVMTDPDAPSKTDHKWSEFCHLVECDLKLLNTEFFA
SEFNTKGSNTLIEYMGPAPPKGSGPHRYVFLLYKQPKGVDSSKFSKIKDRPNWGYGTPAT
GVGKWAKENNLQLVASNFFYAETK
//
>1wq1R [c.37.1] H-RAS
MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAG
QEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDL
AARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH
//
>1wq1G [a.116.1] P120GAP
MPEEEYSEFKELILQKELHVVYALSHVCGQDRTLLASILLRIFLHEKLESLLLCTLNDRE
ISMEDEATTLFRATTLASTLMEQYMKATATQFVHHALKDSILKIMESKQSCELSPSKLEK
NEDVNTNLTHLLNILSELVEKIFMASEILPPTLRYIYGCLQKSVQHKWPTNTTMRTRVVS
GFVFLRLICPAILNPRMFNIISDSPSPIAARTLILVAKSVQNLANLVEFGAKEPYMEGVN
PFIKSNKHRMIMFLDELGNVPELPDTTEHSRTDLSRDLAALHEICVAHSDELRTLSNERG
AQQHVLKKLLAITELLQQKQ
//
>1wqlA [b.33.1 - d.129.3] IRON-SULFUR PROTEIN LARGE SUBUNIT OF CUMENE
NWSDEEIKALVDEEKGLLDPRIFSDQDLYEIELERVFARSWLLLGHEGHIPKAGDYLTTY
MGEDPVIVVRQKDRSIKVFLNQCRHRGMRIERSDFGNAKSFTCTYHGWAYDTAGNLVNVP
YEKEAFCDCGFDKADWGPLQARVDTYKGLIFANWDTEAPDLKTYLSDATPYMDVMLDRTE
AVTQVITGMQKTVIPCNWKFAAEQFCSDMYHAGTMAHLSGVLSSLPPEMDLSQVKLPSSG
NQFRAKWGGHGTGWFNDDFALLQAIMGPKVVDYWTKGPAAERAKERLGKVLPADRMVAQH
MTIFPTCSFLPGINTVRTWHPRGPNEIEVWSFIVVDADAPEDIKEEYRRKNIFTFNQGGT
YEQDDGENWVEVQRGLRGYKARSRPLCAQMGAGVPNKNNPEFPGKTSYVYSEEAARGFYH
HWSRMMSEPSWDTLKS
//
>1wqlB [d.17.4] ETHYLBENZENE DIOXYGENASE SMALL SUBUNIT
DLTKPIEWPEMPVSLELQNAVEQFYYREAQLLDYQNYEAWLALLTQDIQYWMPIRTTHTS
RNKAMEYVPPGGNAHFDETYESMRARIRARVSGLNWTEDPPSRSRHIVSNVIVRETESAG
TLEVSSAFLCYRNRLERMTDIYVGERRDILLRVSDGLGFKIAKRTILLDQSTITANNLSQ
FF
//
>1wr6A [a.7.8] ADP-RIBOSYLATION FACTOR BINDING PROTEIN GGA3
VTKRLHTLEEVNNNVRLLSEmLLHYSQEDSSDGDRELmKELFDQCENKRRTLFKLASETE
DNDNSLGDILQASDNLSRVINSYKTIIEGQ
//
>1wr6E [d.15.1] UBIQUITIN
MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYN
IQKESTLHLVLR
//
>1wr6I [x.x.x]
LHTLEEVNNNVRLLSEmLLHYSQEDSSDGDRELmKELFDQCENKRRTLFKLASETEDNDN
SLGDILQASDNLSRVINSYKTIIEGQVINGLHTLEEVNNNVRLLSEmLLHYSQEDSSDGD
RELmKELFDQCENKRRTLFKLASETEDNDNSLGDILQASDNLSRVINSYKTIIEGQVTLF
KLASETEDNDNSLGDILQASDNLSRVINSYKTIIEGQVITGKTITLEVEPSDTIENVKAK
IQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLR
//
>1wr6O [x.x.x]
LHTLEEVNNNVRLLSEmLLHYSQEDSSDGDRELmKELFDQCENKR
//
>1wr6X [x.x.x]
MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEGRTLSDYNI
QKESTLHLVLRLR
//
>1wr6B [x.x.x]
LHTLEEVNNNVRLLSEmLLHYSQEDSSDGDRELmKELFDQCENKR
//
>1wr6C [x.x.x]
MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEGRTLSDYNI
QKESTLHLVLRLR
//
>1wr6J [x.x.x]
LHTLEEVNNNVRLLSEmLLHYSQEDSSDGDRELmKELFDQCENKRRTLFKLASETEDNDN
SLGDILQASDNLSRVINSYKTIIEGQVINGLHTLEEVNNNVRLLSEmLLHYSQEDSSDGD
RELmKELFDQCENKRRTLFKLASETEDNDNSLGDILQASDNLSRVINSYKTIIEGQVTLF
KLASETEDNDNSLGDILQASDNLSRVINSYKTIIEGQVITGKTITLEVEPSDTIENVKAK
IQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLR
//
>1wr6K [x.x.x]
LHTLEEVNNNVLLSEmLLHYSQEDSSDGDRELmKELFDQCENKRRTLFKLASETEDNDNS
LGDILQASDNLSRVINSYKTIIEGVIGLHTEVNNNVRLLSEmLLHYSQEDSSDGDRELmK
ELFDQCENKRRTLFLASEEDNDNSDILQASDNLSRVINSYKTIIEGQVTLFKLASTEDND
NSLGDILQASDNLRVINSYKTIEGQVTGKTITLEVEPSDTIENVKAIQDKEGIPPDQRLI
FAGKQLEDGRTLSDYNIQKESTLHLVLR
//
>1wr6Q [x.x.x]
LHTLEEVNNNVRLLSEmLLHYSQEDSSDGDRELmKELFDQCENKR
//
>1wr6Z [x.x.x]
MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEGRTLSDYNI
QKESTLHLVLRLR
//
>1wrdA [a.7.8] TARGET OF MYB PROTEIN 1
GPLGSEQIGKLRSELEMVSGNVRVMSEMLTELVPTQAEPADLELLQELNRTCRAMQQRVL
ELIPQIANEQLTEELLIVNDNLNNVFLRHERFERFRTG
//
>1wrdB [d.15.1] UBIQUITIN
MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYN
IQKESTLHLVLRLRGG
//
>1wt5_1A [b.1.1 - b.1.1] ANTI EGFR ANTIBODY FV REGION
QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWMHWVRQAPGQGLEWMGNIYPGSGGTNY
AEKFKNRVTMTRDTSISTAYMELSRLRSDDTAVYYCARSGGPYFFDYWGQGTLVT
//
>1wt5_1C [b.1.1 - b.1.1] ANTI EGFR ANTIBODY FV REGION
DIVMTQSPLSLPVTPGEPASISCRSSQNIVHNNGITYLEWYLQKPGQSPQLLIYKVSDRF
SGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFQGSHIPPTFGQGTKVEI
//
>1wt9A [d.169.1] AGKISACUTACIN A CHAIN
DCSSGWSSYEGHCYKVFKQSKTWTDAESFCTKQVNGGHLVSIESSGEADFVGQLIAQKIK
SAKIHVWIGLRAQNKEKQCSIEWSDGSSISYENWIEEESKKCLGVHIETGFHKWENFYCE
QQDPFVCEA
//
>1wt9B [d.169.1] ANTICOAGULANT PROTEIN-B
DCPSDWSSYEGHCYKPFNEPKNWADAENFCTQQHTGSHLVSFQSTEEADFVVKLAFQTFD
YGIFWMGLSKIWNQCNWQWSNAAMLKYTDWAEESYCVYFKSTNNKWRSITCRMIANFVCE
FQA
//
>1wunL [g.32.1 - g.3.11 - g.3.11] COAGULATION FACTOR VII
ANAFLxxLRPGSLxRxCKxxQCSFxxARxIFKDAxRTKLFWISYSDGDQCASSPCQNGGS
CKDQLQSYICFCLPAFEGRNCETHKDDQLICVNENGGCEQYCSDHTGTKRSCRCHEGYSL
LADGVSCTPTVEYPCGKIPILE
//
>1wunT [b.1.2 - b.1.2] TISSUE FACTOR
TVAAYNLTWKSTNFKTILEWEPKPVNQVYTVQISTKSGDWKSKCFYTTDTECDLTDEIVK
DVKQTYLARVFSYPEPLYENSPEFTPYLETNLGQPTIQSFEQVGTKVNVTVEDERTLVRR
NNTFLSLRDVFGKDLIYTLYYWKSGKKTAKTNTNEFLIDVDKGENYCFSVQAVIPSRTVN
RKSTDSPVECM
//
>1wwwW [g.17.1] PROTEIN (NERVE GROWTH FACTOR)
SSHPIFHRGEFSVCDSVSVWVGDKTTATDIKGKEVMVLGEVNINNSVFKQYFFETKCRDG
CRGIDSKHWNSYCTTTHTFVKALTMDGKQAAWRFIRIDTACVCVLSRKA
//
>1wwwX [b.1.1] PROTEIN (TRKA RECEPTOR)
VSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETV
RHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNP
//
>1wyu_2E (A) [c.67.1] GLYCINE DEHYDROGENASE (DECARBOXYLATING) SUBUNIT
MDYTPHTEEEIREMLRRVGAASLEDLFAHLPKEILSPPIDLPEPLPEWKVLEELRRLAAQ
NLPAHKAFLGGGVRSHHVPPVVQALAARGEFLTAYTPYQPEVSQGVLQATFEYQTMIAEL
AGLEIANASMYDGATALAEGVLLALRETGRMGVLVSQGVHPEYRAVLRAYLEAVGAKLLT
LPLEGGRTPLPEVGEEVGAVVVQNPNFLGALEDLGPFAEAAHGAGALFVAVADPLSLGVL
KPPGAYGADIAVGDGQSLGLPMGFGGPHFGFLATKKAFVRQLPGRLVSETVDVEGRRGFI
LTLQAREQYIRRAKAKSNITTNAQLTALMGAMYLAALGPEGLREVALKSVEMAHKLHALL
LEVPGVRPFTPKPFFNEFALALPKDPEAVRRALAERGFHGATPVPREYGENLALFAATEL
HEEEDLLALREALKEVL
//
>1wyu_2F (B) [c.67.1] GLYCINE DEHYDROGENASE SUBUNIT 2 (P-PROTEIN)
SFPLIFERSRKGRRGLKLVKAVPKAEDLIPKEHLREVPPRLPEVDELTLVRHYTGLSRRQ
VGVDTTFYPLGSCTMKYNPKLHEEAARLFADLHPYQDPRTAQGALRLMWELGEYLKALTG
MDAITLEPAAGAHGELTGILIIRAYHEDRGEGRTRRVVLVPDSAHGSNPATASMAGYQVR
EIPSGPEGEVDLEALKRELGPHVAALMLTNPNTLGLFERRILEISRLCKEAGVQLYYDGA
NLNAIMGWARPGDMGFDVVHLNLHKTFTVPHGGGGPGSGPVGVKAHLAPYLPVPLVERGE
EGFYLDFDRPKSIGRVRSFYGNFLALVRAWAYIRTLGLEGLKKAAALAVLNARYLKELLK
EKGYRVPYDGPSMHEFVAQPPEGFRALDLAKGLLELGFHPPTVYFPLIVKEALMVEPTET
EAKETLEAFAEAMGALLKKPKEWLENAPYSTPVRRLDELRANKHPKLTYFDEG
//
>1wywA [c.18.1] G/T MISMATCH-SPECIFIC THYMINE DNA GLYCOSYLASE
AELLTKTLPDILTFNLDIVIIGINPGLMAAYKGHHYPGPGNHFWKCLFMSGLSEVQLNHM
DDHTLPGKYGIGFTNMVERTTPGSKDLSSKEFREGGRILVQKLQKYQPRIAVFNGKCIYE
IFSKEVFGVKVKNLEFGLQPHKIPDTETLCYVMPSSSARCAQFPRAQDKVHYYIKLKDLR
DQLKGIERNMDVQEVQYTFDLQLAQEDAKKMAVKEE
//
>1wywB [d.15.1] UBIQUITIN-LIKE PROTEIN SMT3C
GEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPK
ELGMEEEDVIEVYQEQTGG
//
>1x2t_1A [d.169.1] COAGULATION FACTOR IX/X-BINDING PROTEIN A CHAIN
DCPSGWSSYEGHCYKPFKLYKTWDDAERFCTEQAKGGHLVSIESAGEADFVAQLVTENIQ
NTKSYVWIGLRVQGKEKQCSSEWSDGSSVSYENWIEAESKTCLGLEKETGFRKWVNIYCG
QQNPFVCEA
//
>1x2t_1B [d.169.1] COAGULATION FACTOR IX/FACTOR X-BINDING PROTEIN B
DCPSDWSSYEGHCYKPFSEPKNWADAENFCTQQHAGGHLVSFQSSEEADFVVKLAFQTFG
HSIFWMGLSNVWNQCNWQWSNAAMLRYKAWAEESYCVYFKSTNNKWRSRACRMMAQFVCE
FQA
//
>1x3wA [d.3.1] PEPTIDE:N-GLYCANASE
NNIDFDSIAKmLLIKYKDFILSKFKKAAPVENIRFQNLVHTNQFAQGVLGQSQHLCTVYD
NPSWHSIVLETLDLDLIYKNVDKEFAKDGHAEGENIYTDYLVKELLRYFKQDFFKWCNKP
DCNHCGQNTSENmTPLGSQGPNGEESKFNCGTVEIYKCNRCGNITRFPRYNDPIKLLETR
KGRCGEWCNLFTLILKSFGLDVRYVWNREDHVWCEYFSNFLNRWVHVDSCEQSFDQPYIY
SINWNKKmSYCIAFGKDGVVDVSKRYILQNELPRDQIKEEDLKFLCQFITKRLRYSLNDD
EIYQLACRDEQEQIELIRGK
//
>1x3wB [a.189.1] UV EXCISION REPAIR PROTEIN RAD23
GSIGLTVEDLLSLRQVVSGNPEALAPLLENISARYPQLREHImANPEVFVSmLLEAV
//
>1x75A [e.11.1] DNA GYRASE SUBUNIT A
TRRTIFELRKARDRAHILEALAVALANIDPIIELIRHAPTPAEAKTALVANPWQLVAAML
EDDAARPEWLEPEFGVRDGLYYLTEQQAQAILDLRLQKLTGLEHEKLLDEYKELLDQIAE
LLRILGS
//
>1x75B [e.11.1] DNA GYRASE SUBUNIT A
TRRTIFELRKARDRAHILEALAVALANIDPIIELIRHAPTPAEAKTALVANPWQLGNVAA
MLEDDAARPEWLEPEFGVRDGLYYLTEQQAQAILDLRLQKLTGLEHEKLLDEYKELLDQI
AELLRILGS
//
>1x75C [b.34.6] CYTOTOXIC PROTEIN CCDB
MQFKVYTYKSRYRLFVDVQSDIIDTPGRRMVIPLASARLLSDKVSRELYPVVHIGDESWR
MMTTDMASVPVSVIGEEVADLSHRENDIKNAINLMFWGI
//
>1x75D [b.34.6] CYTOTOXIC PROTEIN CCDB
MQFKVYTYKRERLFVDVQSDIIDTPGRRMVIPLASARLLSSRELYPVVHIGDESWRMMTT
DMASVPVSVIGEEVADLSHRENDIKNAINLMFWGI
//
>1x79A [a.7.8] ADP-RIBOSYLATION FACTOR BINDING PROTEIN GGA1
ISKRVNAIEEVNNNVKLLTEMVMSHSSSEDLMKELYQRCERMRPTLFRLASDTEDNDEAL
AEILQANDNLTQVINLYKQLVR
//
>1x79B [h.1.27] RAB GTPASE BINDING EFFECTOR PROTEIN 1
ETRDQVKKLQLMLRQANDQLEKTMKDKQELEDFIKQSSEDSSHQISALVLRAQASEILLE
ELQQGLSQAKRDVQEQMAVLMQSREQVSEE
//
>1x7aA (L) [g.3.11 - g.3.11] COAGULATION FACTOR IX, LIGHT CHAIN
QCEPNPCLNGGLCKDDINSYECWCQVGFEGKNCELDATCNIKNGRCKQFCKTGADSKVLC
SCTTGYRLAPDQKSCKPAVPFPCGRVSVSHSPTTLT
//
>1x7aB (C) [b.47.1] COAGULATION FACTOR IXA
IVGGENAKPGQFPWQVLLNGKIDAFCGGSIINEKWVVTAAHCIEPGVKITVVAGEYNTEE
TEPTEQRRNVIRAIPHHSYNATVNKYSHDIALLELDEPLTLNSYVTPICIADKEYTNIFL
KFGSGYVSGWGRVFNRGRSATILQYLKVPLVDRATCLRSTKFTIYSNMFCAGFHEGGKDS
CQGDSGGPHVTEVEGTSFLTGIISWGEECAVKGKYGIYTKVSRYVNWIKEKTKL
//
>1x86_2C (A) [a.87.1 - b.55.1] RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 12
PPNWQQLVSREVLLGLKPCEIKRQEVINELFYTERAHVRTLKVLDQVFYQRVSREGILSP
SELRKIFSNLEDILQLHIGLNEQMKAVRKRNETSVIDQIGEDLLTWFSGPGEEKLKHAAA
TFCSNQPFALEMIKSRQKKDSRFQTFVQDAESNPLCRRLQLKDIIPTQMQRLTKYPLLLD
NIAKYTEWPTEREKVKKAADHCRQILNFVNQAVKEAENKQRLEDYQRRLDTSSLKLSEYP
NVEELRNLDLTKRKMIHEGPLVWKVNRDKTIDLYTLLLEDILVLLQKQDDRLVLRCHSTF
SPVIKLSTVLVRQVATDNKALFVISMSDNGAQIYELVAQTVSEKTVWQDLICRMAASVKE
QS
//
>1x86_2D (B) [c.37.1] TRANSFORMING PROTEIN RHOA
AAIRKKLVIVGDGACGKTCLLIVFSKDQFPEVYVPTVFENYVADIEVDGKQVELALWDTA
GQEDYDRLRPLSYPDTDVILMCFSIDSPDSLENIPEKWTPEVKHFCPNVPIILVGNKKDL
RNDEHTRRELAKMKQEPVKPEEGRDMANRIGAFGYMECSAKTKDGVREVFEMATRAALQA
//
>1x86_3E [a.87.1 - b.55.1] RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 12
PPNWQQLVSREVLLGLKPCEIKRQEVINELFYTERAHVRTLKVLDQVFYQRVSREGILSP
SELRKIFSNLEDILQLHIGLNEQMKAVRKRNETSVIDQIGEDLLTWFSGPGEEKLKHAAA
TFCSNQPFALEMIKSRQKKDSRFQTFVQDAESNPLCRRLQLKDIIPTQMQRLTKYPLLLD
NIAKYTEWPTEREKVKKAADHCRQILNFVNQAVKEAENKQRLEDYQRRLDTVEELRNLDL
TKRKMIHEGPLVWKVNRDKTIDLYTLLLEDILVLLQKQDDRLVSPVIKLSTVLVRQVNKA
LFVISQIYELVAQTVSEKTVWQDLICRMAASVKEQS
//
>1x86_3F [c.37.1] TRANSFORMING PROTEIN RHOA
AIRKKLVIVGDGACGKTCLLIVFSKDQFPEVYVPTVFENYVADIEVDGKQVELALWDTAG
QEDYDRLRPLSYPDTDVILMCFSIDSPDSLENIPEKWTPEVKHFCPNVPIILVGNKKDLR
NDEHTRRELAKMKQEPVKPEEGRDMANRIGAFGYMECSAKTKDGVREVFEMATRAALQA
//
>1x86_4G [a.87.1 - b.55.1] RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 12
PPNWQQLVSREVLLGLKPCEIKRQEVINELFYTERAHVRTLKVLDQVFYQRVSREGILSP
SELRKIFSNLEDILQLHIGLNEQMKAVRKRNETSVIDQIGEDLLTWFSGPGEEKLKHAAA
TFCSNQPFALEMIKSRQKKDSRFQTFVQDAESNPLCRRLQLKDIIPTQMQRLTKYPLLLD
NIAKYTEWPTEREKVKKAADHCRQILNFVNQAVKEAENKQRLEDYQRRLLTKRKMIHEGP
LVWDLYTLLLEDILVLLQKQDDRLVVIKLSTVLVRQVATDNKALFVISQIYELVAQTVSE
KTVWQDLICRMAAS
//
>1x86_4H (F) [c.37.1] TRANSFORMING PROTEIN RHOA
AIRKKLVIVGDGACGKTCLLIVFSKDQFPEVYVPTVFENYVADIEVDGKQVELALWDTAG
QEDYDRLRPLSYPDTDVILMCFSIDSPDSLENIPEKWTPEVKHFCPNVPIILVGNKKDLR
NDEHTRRELAKMKQEPVKPEEGRDMANRIGAFGYMECSAKTKDGVREVFEMATRAALQA
//
>1x9fD [a.1.1] HEMOGLOBIN CHAIN D1
ECLVTESLKVKLQWASAFGHAHERVAFGLELWRDIIDDHPEIKAPFSRVRGDNIYSPEFG
AHSQRVLSGLDITISMLDTPDMLAAQLAHLKVQHVERNLKPEFFDIFLKHLLHVLGDRLG
THFDFGAWHDCVDQIIDGIK
//
>1x9fC [a.1.1] GLOBIN III, EXTRACELLULAR
HEHCCSEEDHRIVQKQWDILWRDTESSKIKIGFGRLLLTKLAKDIPEVNDLFKRVDIEHA
EGPKFSAHALRILNGLDLAINLLDDPPALDAALDHLAHQHEVREGVQKAHFKKFGEILAT
GLPQVLDDYDALAWKSCLKGILTKISSRL
//
>1x9fI (A) [a.1.1] GLOBIN IV, EXTRACELLULAR
DCCSYEDRREIRHIWDDVWSSSFTDRRVAIVRAVFDDLFKHYPTSKALFERVKIDEPESG
EFKSHLVRVANGLKLLINLLDDTLVLQSHLGHLADQHIQRKGVTKEYFRGIGEAFARVLP
QVLSCFNVDAWNRCFHRLVARIAKDLP
//
>1x9fE (A) [a.1.1] GLOBIN IV, EXTRACELLULAR
DCCSYEDRREIRHIWDDVWSSSFTDRRVAIVRAVFDDLFKHYPTSKALFERVKIDEPESG
EFKSHLVRVANGLKLLINLLDDTLVLQSHLGHLADQHIQRKGVTKEYFRGIGEAFARVLP
QVLSCFNVDAWNRCFHRLVARIAKDLP
//
>1x9fJ (B) [a.1.1] GLOBIN II, EXTRACELLULAR
KKQCGVLEGLKVKSEWGRAYGSGHDREAFSQAIWRATFAQVPESRSLFKRVHGDDTSHPA
FIAHADRVLGGLDIAISTLDQPATLKEELDHLQVQHEGRKIPDNYFDAFKTAILHVVAAQ
LGRCYDREAWDACIDHIEDGIKGHH
//
>1x9fL (D) [a.1.1] HEMOGLOBIN CHAIN D1
ECLVTESLKVKLQWASAFGHAHERVAFGLELWRDIIDDHPEIKAPFSRVRGDNIYSPEFG
AHSQRVLSGLDITISMLDTPDMLAAQLAHLKVQHVERNLKPEFFDIFLKHLLHVLGDRLG
THFDFGAWHDCVDQIIDGIK
//
>1x9fK (C) [a.1.1] GLOBIN III, EXTRACELLULAR
HEHCCSEEDHRIVQKQWDILWRDTESSKIKIGFGRLLLTKLAKDIPEVNDLFKRVDIEHA
EGPKFSAHALRILNGLDLAINLLDDPPALDAALDHLAHQHEVREGVQKAHFKKFGEILAT
GLPQVLDDYDALAWKSCLKGILTKISSRL
//
>1xb2A [c.37.1 - b.43.3 - b.44.1] ELONGATION FACTOR TU, MITOCHONDRIAL
PHVNVGTIGHVDHGKTTLTAAITKILAEHVEYSTAARHYAHTDCPGHADYVKNmITGTAP
LDGCILVVAANDGPmPQTREHLLLARQIGVEHVVVYVNKADAVQDSEmVELVELEIRELL
TEFGYKGEETPIIVGSALCALEQRDPELGLKSVQKLLDAVDTYIPVPTRDLEKPFLLPVE
SVYSIPGRGTVVTGTLERGILKKGDECEFLGHSKNIRTVVTGIEmFHKSLDRAEAGDNLG
ALVRGLKREDLRRGLVmAKPGSIQPHQKVEAQVYILTKEEGGRHKPFVSHFmPVmFSLTW
DmACRIILPPGKELAmPGEDLKLTLILRQPmILEKGQRFTLRDGNRTIGTGLVTDTPAmT
EEDKNIKWS
//
>1xb2B [a.5.2 - d.43.1 - d.43.1] ELONGATION FACTOR TS, MITOCHONDRIAL
SASSKELLMKLRRKTGYSFINCKKALETCGGDLKQAESWLHKQAQKEGWSKAARLHGRKT
KEGLIGLLQEGDTTVLVEVNCETDFVSRNLKFQQLVQQVALGTLLHCQNLKDQLSTYSKG
FLNSSELSELPAGPEREGSLKDQLALAIGKLGENMILKRAAWVKVPAGFYVGSYVHGAMH
SPSLHNLVLGKYGALVICETSELKANLADLGRRLGQHVVGMAPLSVGSLDDEPGGEAETK
MLSQPYLLDPSITLGQYVQPHGVSVVDFVRFECGEG
//
>1xcg_1A [a.87.1 - b.55.1] RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 11
QNWQHTVGKDVVAGLTQREIDRQEVINELFVTEASHLRTLRVLDLIFYQRMKKENLMPRE
ELARLFPNLPELIEIHNSWCEAMKKLREEGPIIKEISDLMLARFDGPAREELQQVAAQFC
SYQSIALELIKTKQRKESRFQLFMQEAESHPQCRRLQLRDLIISEMQRLTKYPLLLESII
KHTEGGTSEHEKLCRARDQCREILKYVNEAVKQTENRHRLEGYQKRLDATALERASNPLA
AEFKSLDLTTRKMIHEGPLTWRISKDKTLDLHVLLLEDLLVLLQKQDEKLLLKCTFSPVL
KLNAVLIRSVATDKRAFFIICTSKLGPPQIYELVALTSSDKNTWMELLEEAVRNA
//
>1xcg_1B [c.37.1] TRANSFORMING PROTEIN RHOA
AIRKKLVIVGDGACGKTCLLIVNSKDQFPEVYVPTVFENYVADIEVDGKQVELALWDTAG
QEDYDRLRPLSYPDTDVILMCFSIDSPDSLENIPEKWTPEVKHFCPNVPIILVGNKKDLR
NDEHTRRELAKMKQEPVKPEEGRDMANRIGAFGYMECSAKTKDGVREVFEMATRAALQ
//
>1xcq_3C (A) [b.1.1 - b.1.1] MONOCLONAL ANTIBODY 19D9D6 LIGHT CHAIN
DIVMSQSPSSLAVSAGEKVTMSCKSSQSLLNSRTRKNYLAWYQQKPGQSPKVLIYWASTR
ESGVPDRFTGRGSGTDFTLTISSVQAEDQAVYYCKQAYIPPLTFGAGTKLELKRADAAPT
VSIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYS
MSSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1xcq_3D (B) [b.1.1 - b.1.1] MONOCLONAL ANTIBODY 19D9D6 HEAVY CHAIN
QIQLVQSGPELKKPGETVKISCKASGYTFTDFSMHWVNQAPGKGLNWMGWVNTETGEPTY
ADDFKGRFAFSLETSASTAYLQINSLKNEDTATYFCARFLLRQYFDVWGAGTTVTVSSAK
TTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLY
TLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKIVPR
//
>1xcq_3Q [j.54.1] CAPSID PROTEIN C
STNPKPQRKTKRNTNRRPQDVKFPGGGQIVGGVYLLPRRGPRLG
//
>1xcq_3M [d.15.7] PROTEIN L
EVTIKVNLIFADGKIQTAEFKGTFEEATAEAYRYAALHAKVNGEWTADLEDGGNHMNIKF
AG
//
>1xct_1P [x.x.x] CAPSID PROTEIN C
NRRPQDVKFPGGGQIVGGVYLLPRRGPRLG
//
>1xct_1A [b.1.1 - b.1.1] MONOCLONAL ANTIBODY 19D9D6 LIGHT CHAIN
DIVMSQSPSSLAVSAGEKVTMSCKSSQSLLNSRTRKNYLAWYQQKPGQSPKVLIYWASTR
ESGVPDRFTGRGSGTDFTLTISSVQAEDQAVYYCKQAYIPPLTFGAGTKLELKRADAAPT
VSIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYS
MSSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1xct_1B [b.1.1 - b.1.1] MONOCLONAL ANTIBODY 19D9D6 HEAVY CHAIN
QIQLVQSGPELKKPGETVKISCKASGYTFTDFSMHWVNQAPGKGLNWMGWVNTETGEPTY
ADDFKGRFAFSLETSASTAYLQINSLKNEDTATYFCARFLLRQYFDVWGAGTTVTVSSAK
TTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLY
TLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKIVPR
//
>1xct_2Q [x.x.x] CAPSID PROTEIN C
FPGGGQIVGGVYLLPRRGPRLG
//
>1xct_2C (A) [b.1.1 - b.1.1] MONOCLONAL ANTIBODY 19D9D6 LIGHT CHAIN
DIVMSQSPSSLAVSAGEKVTMSCKSSQSLLNSRTRKNYLAWYQQKPGQSPKVLIYWASTR
ESGVPDRFTGRGSGTDFTLTISSVQAEDQAVYYCKQAYIPPLTFGAGTKLELKRADAAPT
VSIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYS
MSSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1xct_2D (B) [b.1.1 - b.1.1] MONOCLONAL ANTIBODY 19D9D6 HEAVY CHAIN
QIQLVQSGPELKKPGETVKISCKASGYTFTDFSMHWVNQAPGKGLNWMGWVNTETGEPTY
ADDFKGRFAFSLETSASTAYLQINSLKNEDTATYFCARFLLRQYFDVWGAGTTVTVSSAK
TTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLY
TLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKIVPR
//
>1xd2C [a.117.1] SON OF SEVENLESS PROTEIN HOMOLOG 1
QMRLPSADVYRFAEPDSEENIIFEEGIPIIKAGTVIKLIERLTYHMYADPNFVRTFLTTY
RSFCKPQELLSLIIERFEIPEPEPTEADRIAIENGDQPLSAELKRFRKEYIQPVQLRVLN
VCRHWVEHHFYDFERDAYLLQRMEEFIGTVRGKAMKKWVESITKIIQRKKIAHNITFQSS
PPTVEWHISRPGHIETFDLLTLHPIEIARQLTLLESDLYRAVQPSELVGSVWTKEDKEIN
SPNLLKMIRHTTNLTLWFEKCIVETENLEERVAVVSRIIEILQVFQELNNFNGVLEVVSA
MNSSPVYRLDHTFEQIPSRQKKILEEAHELSEDHYKKYLAKLRSINPPCVPFFGIYLTNI
LKTEEGNPEVLKRHGKELINFSKRRKVAEITGEIQQYQNQPYCLRVESDIKRFFENLNPM
GNSMEKEFTDYLFNKSLEIEPRNPKPLPRFPKKYSYPLKSPGVRPSNPR
//
>1xd2B [c.37.1] TRANSFORMING PROTEIN P21/H-RAS-1
MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAG
QEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDL
AARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH
//
>1xd3_1A [d.3.1] UBIQUITIN CARBOXYL-TERMINAL ESTERASE L3
EGQRWLPLEANPEVTNQFLKQLGLHPNWQFVDVYGMDPELLSMVPRPVCAVLLLFPITEK
YEVFRTEEEEKIKSQGQDVTSSVYFMKQTISNACGTIGLIHAIANNKDKMHFESGSTLKK
FLEESVSMSPEERARYLENYDAIRVTHETSAHEGQTEAPSIDEKVDLHFIALVHVDGHLY
ELDGRKPFPINHGETSDETLLEDAIEVCKKFMERDPDELRFNAIALSAA
//
>1xd3_1B [d.15.1] UBC PROTEIN
MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYN
IQKESTLHLVLRLRG
//
>1xdkA [a.123.1] RETINOIC ACID RECEPTOR RXR-ALPHA
ANEDMPVEKILEAELAVEPPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILL
RAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLTELVSKMRDMQ
MDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYASLEAYCKHKYPEQPGRFAKLLLR
LPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLEAP
//
>1xdkB [a.123.1] RETINOIC ACID RECEPTOR, BETA
AELDDLTEKIRKAHQETFPSLCQLGKYTTNSSADHRVRLDLGLWDKFSELATKCIIKIVE
FAKRLPGFTGLTIADQITLLKAACLDILILRICTRYTPEQDTMTFSDGLTLNRTQMHNAG
FGPLTDLVFTFANQLLPLEMDDTETGLLSAICLICGDRQDLEEPTKVDKLQEPLLEALKI
YIRKRRPSKPHMFPKILMKITDLRSISAKGAERVITLKMEIPGSMPPLIQEMLENSEGHE
PLTPS
//
>1xdtA (T) [d.166.1 - f.1.2 - b.2.1] DIPHTHERIA TOXIN
GADDVVDSSKSFVMENFSSYHGTKPGYVDSIQKGIQKPNYDDDWKGFYSTDNKYDAAGYS
VDNENPLSGKAGGVVKVTYPGLTKVLALKVDNAETIKKELGLSLTEPLMEQVGTEEFIKR
FGDGASRVVLSLPFAEGSSSVEYINNWEQAKALSVELEINFETRGKRGQDAMYEYMAQAC
AGSCINLDWDVIRDKTKTKIESLKEHGPIKNKMSESPNKTVSEEKAKQYLEEFHQTALEH
PELSELKTVTGTNPVFAGANYAAWAVNVAQVIDSETADNLEKTTAALSILPGIGSVMGIA
DGAVHHNTEEIVAQSIALSSLMVAQAIPLVGELVDIGFAAYNFVESIINLFQVVHNSYNR
PAYSPGHKTQPFLHDGYAVSWNTVEDSIIRTGFQGESGHDIKITAENTPLPIAGVLLPTI
PGKLDVNKSKTHISVNGRKIRMRCRAIDGDVTFCRPKSPVYVGNGVHANLHVAFHRSSSE
KIHSNEISSDSIGVLGYQKTVDHTKVNSKLSLFFEIKS
//
>1xdtB (R) [g.3.11] HEPARIN-BINDING EPIDERMAL GROWTH FACTOR
PCLRKYKDFCIHGECKYVKELRAPSCICHPGYHGERCHGLS
//
>1xewA (X) [c.37.1] SMC PROTEIN
MPYIEKLELKGFKSYGNKKVVIPFSKGFTAIVGANGSGKSNIGDAILFVLGGLSAKAKYA
EVAIYFNNEDRGFPIDEDEVVIRRRVYPDGRSSYWLNGRRATRSEILDILTAAMISPDGY
NIVLQGDITKFIKMSPLERRLLIDDIS
//
>1xewB (Y) [c.37.1] SMC PROTEIN
VFMRTFEAISRNFSEIFAKLSPGGSARLILENPEDPFSGGLEIEAKPAGKDVKRIEAMSG
GEKALTALAFVFAIQKFKPAPFYLFDEIDAHLDDANVKRVADLIKESSKESQFIVITLRD
VMMANADKIIGVSMGVSKVVSLSLEKAMKILEEIRKKQGW
//
>1xexA [c.37.1] SMC PROTEIN
PYIEKLELKGFKSYGNKKVVIPFSKGFTAIVGANGSGKSNIGDAILFVLGGLSAKAMRAS
RISDLIFAGSKNEPPAKYAEVAIYFNNEDRGFPIDEDEVVIRRRVYPDGRSSYWLNGRRA
TRSEILDILTAAMISPDGYNIVLQGDITKFIKMSPLERRLLIDDIS
//
>1xexB [c.37.1] SMC PROTEIN
KKNVFMRTFEAISRNFSEIFAKLSPGGSARLILENPFSGGLEIEAKPAGKDVKRIEAMSG
GEKALTALAFVFAIQKFKPAPFYLFDQIDAHLDDANVKRVADLIKESSKESQFIVITLRD
VMMANADKIIGVSMRDGVSKVVSLSLEKAMKILEEIRKKQG
//
>1xfw_2B (A) [x.x.x] CALMODULIN-SENSITIVE ADENYLATE CYCLASE
NNLVKTEFTNETLDKIQQTQDLLKKIPKDVLEIYSELGGEIYFTDIDLVEHKELQDLSEE
EKNSMNSRGEKVPFASRFVFEKKRETPKLIINIKDYAINSEQSKEVYYEIGKGISLDIIS
KDKSLDPEFLNLIKSLSDDSDSSDLLFSQKFKEKLELNNKSIDINFIKENLTEFQHAFSL
AFSYYFAPDHRTVLELYAPDMFEYMNKLEKGGFEKISESLKKEGVEKDRIDVLKGEKALK
ASGLVPEHADAFKKIARELNTYILFRPVNKLATNLIKSGVATKGLNVHGKSSDWGPVAGY
IPFDQDLSKKHGQQLAVEKGNLENKKSITEHEGEIGKIPLKLDHLRIEELKENGIILKGK
KEIDNGKKYYLLESNNQVYEFRISDENNEVQYKTKEGKITVLGEKFNWRNIEVMAKNVEG
VLKPLTADYDLFALAPSLTEIKKQIPQKEWDKVVNTPNSLEKQKGVTNLLIKYGIERKPD
STKGTLSNWQKQMLDRLNEAVKYTGYTGGDVVNHGTEQDNEEFPEKDNEIFIINPEGEFI
LTKNWEMTGRFIEKNITGKDYLYYFNRSYNKIAPGNKAYIEWTDPITKAKINTIPTSAEF
IKNLSSIRRSSNVGVYKDSGDKDEFAKKESVKKIAGYLSDYYNSANHIFSQEKKRKISIF
RGIQAYNEIENVLKSKQIAPEYKNYFQYLKERITNQVQLLLTHQKSNIEFKLLYKQLNFT
ENETDNFEVFQKIID
//
>1xfw_2P (O) [a.39.1] CALMODULIN 2
QLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGT
IDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVD
QMIREADIDGDGQVNYEEFVQMMTAK
//
>1xg0A [d.184.1] PHYCOERYTHRIN ALPHA-3 CHAIN
AMDxSAKAPQITIFDHRGCSRAPKESTGGKAGGQDDEMMVKVASTKVTVSESDAAKKLQE
FITFEKGIDGPFTSKN
//
>1xg0C [a.1.1] B-PHYCOERYTHRIN BETA CHAIN
DAFSRVVTADSKAAYVGGADLQALKKFISEGNKRLDSVNSIVSNASCIVSDAVSGMICEN
PSLISPSGxCYTNRRMAACLRDGEIILRYVSYALLSGDASVLEDRCLNGLKETYSSLGVP
ANSNARAVSIMKACAVAFVNNTASQKKLSTPQGDCSGLASEVGGYFDKVTAAIS
//
>1xg2A [b.80.1] PECTINESTERASE 1
IIANAVVAQDGTGDYQTLAEAVAAAPDKSKTRYVIYVKRGTYKENVEVASNKMNLMIVGD
GMYATTITGSLNVVDGSTTFRSATLAAVGQGFILQDICIQNTAGPAKDQAVALRVGADMS
VINRCRIDAYQDTLYAHSQRQFYRDSYVTGTVDFIFGNAAVVFQKCQLVARKPGKYQQNM
VTAQGRTDPNQATGTSIQFCNIIASSDLEPVLKEFPTYLGRPWKEYSRTVVMESYLGGLI
NPAGWAEWDGDFALKTLYYGEFMNNGPGAGTSKRVKWPGYHVITDPAKAMPFTVAKLIQG
GSWLRSTGVAYVDGLYD
//
>1xg2B [x.x.x] PECTINESTERASE INHIBITOR
FENHLISEICPKTRNPSLCLQALESDPRSASKDLKGLGQFSIDIAQASAKQTSKIIASLT
NQATDPKLKGRYETCSENYADAIDSLGQAKQFLTSGDYNSLNIYASAAFDGAGTCEDSFE
GPPNIPTQLHQADLKLEDLCDIVLVISNLLP
//
>1xgy_1M (L) [b.1.1 - b.1.1] K42-41L FAB LIGHT CHAIN
DIVMTQAAFSNPVTLGTSASISCRSSKSLLHSNGITYLYWYLQRPGQSPQLLIYRMSNLA
SGVPDRFSGSGSGTDFALRISRVEAEDVGVYYCGQMLEHPLTFGTGTKLELKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNR
//
>1xgy_1I [b.1.1] K42-41L FAB HEAVY CHAIN
QVQLQQSGPELVRPGASVKISCKASGYTFTDYYINWVKQRPGQGLEWIGWIFPRNGNTKY
NEKFKGKATLTVDKSSSTAFMQLSSLTSEDSAVYFCATTVSYVMDYWGQGTTVTVSSAKT
TPPSVYPLAPGSANSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTLSS
SVTVPSSTWPSETVTCNVAHPASSTKVDKKIVPRD
//
>1xiwA [b.1.1] T-CELL SURFACE GLYCOPROTEIN CD3 EPSILON CHAIN
QTPYKVSISGTTVILTCPQYPGSEILWQHNDKNIGGDEDDKNIGSDEDHLSLKEFSELEQ
SGYYVCYPRGSKPEDANFYLYLRARVCENCM
//
>1xiwB [b.1.1] T-CELL SURFACE GLYCOPROTEIN CD3 DELTA CHAIN
MKIPIEELEDRVFVNCNTSITWVEGTVGTLLSDITRLDLGKRILDPRGIYRCNESTVQVH
YRMCQS
//
>1xiwC [b.1.1] IMMUNOGLOBULIN LIGHT CHAIN VARIABLE REGION
MDIQMTQTTSSLSASLGDRVTISCRASQDIRNYLNWYQQKPDGTVKLLIYYTSRLHSGVP
SKFSGSGSGTDYSLTISNLEQEDIATYFCQQGNTLPWTFAGGTKLEI
//
>1xiwD [b.1.1] IMMUNOGLOBULIN HEAVY CHAIN VARIABLE REGION
EVQLQQSGPELVKPGASMKISCKASGYSFTGYTMNWVKQSHGKNLEWMGLINPYKGVSTY
NQKFKDKATLTVDKSSSTAYMELLSLTSEDSAVYYCARSGYYGDSDWYFDVWGQGTTLTV
FS
//
>1xiwF [b.1.1] T-CELL SURFACE GLYCOPROTEIN CD3 DELTA CHAIN
KIPIEELEDRVFVNCNTSITWVEGTVGTLLSDITRLDLGKRILDPRGIYRCNESTVQVHY
RMC
//
>1xk4_3I (A) [a.39.1] CALGRANULIN A
MLTELEKALNSIIDVYHKYSLIKGNFHAVYRDDLKKLLETESPQYIRKKGADVWFKELDI
NTDGAVNFQEFLILVIKMGVAAHKKSH
//
>1xk4_3K (D) [a.39.1] CALGRANULIN B
KMSQLERNIETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIM
EDLDTNADKQLSFEEFIMLMARLTWASHEKMH
//
>1xkpA [a.243.1] PUTATIVE MEMBRANE-BOUND YOP TARGETING PROTEIN
xQFRGESVQIVSGTLQSIADMAEEVTELSLDxRxLSDSQARVSDVEEQVNQYLSxVPELE
QxQNVSELLSLLSNSPNISLSQLxAYLEGxSEEPSEQFxMLCGLRDALxGRPELAHLSHL
VEQALVSMAEEQGETIVLGARITPEAYRESQSGVNPLQPLRDTYRDAVMGYQGIYAIWSD
LQxRFPNGDIDSVILFLQxALSADLQSQQSGSGRExLGIVISDLQxLxEF
//
>1xkpB [d.198.1] CHAPERONE PROTEIN SYCN
SWIEPIISHFCQDLGVPTSSPLSPLIQLEMAQSGTLQLEQHGATLTLWLARSLAWHRCED
AMVxALTLTAAQxSGALPLRAGWLGESQLVLFVSLDERSLTLPLLHQAFEQLLRLQQEVL
A
//
>1xkpC [d.198.1] CHAPERONE PROTEIN YSCB
QNLLxNLAASLGRxPFVADxQGVYRLTIDxHLVMLAPHGSELVLRTPIDAPMLREGNNVN
VTLLRSLMQQALAWAKRYPQTLVLDDCGQLVLEARLRLQELDTHGLQEVINxQLALLEHL
IPQLTP
//
>1xl3_2B [a.243.1] SECRETION CONTROL PROTEIN
ARVSDVEEQVNQYLSxVPELEQKQNVSELLSLLSNSPNISLSQLxAYLEGxSEEPSEQFx
MLCGLRDALxGRPELAHLSHLVEQALVSMAEEQGETIVLGARITPEAYRESQSGVNPLQP
LRDTYRDAVMGYQGIYAIWSDLQxRFPNGDIDSVILFLQxALSADLQSQQSGSGRExLGI
VISDLQxLxEFGSVSDQVxGFWQFFS
//
>1xl3_2D [a.243.1] PROTEIN TYPE A
AYDLSEFMGDIVALVDxRWAGIHDIEHLANAFSLPTPEIxVRFYQDLxRMFRLFPLGVFS
DEEQRQNLLQMCQNAIDMAIESEEE
//
>1xls_2B (A) [a.123.1] RETINOIC ACID RECEPTOR RXR-ALPHA
NEDMPVERILEAELAVEPKTETYVEANMGLNPSSPNDPVTNICQAADKQLFTLVEWAKRI
PHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIF
DRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYASLEAYCKH
KYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLEAP
//
>1xls_2F (E) [a.123.1] ORPHAN NUCLEAR RECEPTOR NR1I3
NQQQKELVQILLGAHTRHVGPLFDQFVQFRPPAYLFMHHRPFQPRGPVLPLLTHFADINT
FMVQQIIKFTKDLPLFRSLTMEDQISLLKGAAVEILHISLNTTFCLQTENFFCGPLCYKM
EDAVHAGFQYEFLESILHFHKNLKGLHLQEPEYVLMAATALFSPDRPGVTQREEIDQLQE
EMALILNNHIMEQQSRLQSRFLYAKLMGLLADLRSINNAYSYELQRLEELSAMTPLLGEI
CS
//
>1xmgB (A) [a.25.1] METHANE MONOOXYGENASE COMPONENT A ALPHA CHAIN
RAPTSVNAQEVHRWLQSFNWDFKNNRTKYATKYKMANETKEQFKLIAKEYARMEAVKDER
QFGSLQDALTRLNAGVRVHPKWNETMKVVSNFLEVGEYNAIAATGMLWDSAQAAEQKNGY
LAQVLDEIRHTHQCAYVNYYFAKNGQDPAGHNDARRTRTIGPLWKGMKRVFSDGFISGDA
VECSLNLQLVGEACFTNPLIVAVTEWAAANGDEITPTVFLSIETDELRHMANGYQTVVSI
ANDPASAKYLNTDLNNAFWTQQKYFTPVLGMLFEYGSKFKVEPWVKTWDRWVYEDWGGIW
IGRLGKYGVESPRSLKDAKQDAYWAHHDLYLLAYALWPTGFFRLALPDQEEMEWFEANYP
GWYDHYGKIYEEWRARGCEDPSSGFIPLMWFIENNHPIYIDRVSQVPFCPSLAKGASTLR
VHEYNGEMHTFSDQWGERMWLAEPERYECQNIFEQYEGRELSEVIAELHGLRSDGKTLIA
QPHVRGDKLWTLDDIKRLNCVFKNPVKAFN
//
>1xmgF [a.23.3] METHANE MONOOXYGENASE COMPONENT A GAMMA CHAIN
LGIHSNDTRDAWVNKIAQLNTLEKAAEMLKQFRMDHTTPFRNSYELDNDYLWIEAKLEEK
VAVLKARAFNEVDFRHKTAFGEDAKSVLDGTVAKMNAAKDKWEAEKIHIGFRQAYKPPIM
PVNYFLDGERQLGTRLMELRNLNYYDTPLEELRKQRGVRVVHLQSP
//
>1xmoG [a.75.1] 30S RIBOSOMAL PROTEIN S7
ARRRRAEVRQLQPDLVYGDVLVTAFINKIMRDGKKNLAARIFYDACKIIQEKTGQEPLKV
FKQAVENVKPRMEVRSRRVGGANYQVPMEVSPRRQQSLALRWLVQAANQRPERRAAVRIA
HELMDAAEGKGGAVKKKEDVERMAEANRAYAHYRW
//
>1xmoK [c.55.4] 30S RIBOSOMAL PROTEIN S11
KRQVASGRAYIHASYNNTIVTITDPDGNPITWSSGGVIGYKGSRKGTPYAAQLAALDAAK
KAMAYGMQSVDVIVRGTGAGREQAIRALQASGLQVKSIVDDTPVPHNGCRPKKKFRKAS
//
>1xouA [a.231.1] ESPA
DVIDLFNKLGVFQAAILmFAYmYQAQSDLNLTTTVNNSQLEIQQmSNTLNLLTSARSDmQ
SLQYRTISGISL
//
>1xouB [a.231.1] Z5138 GENE PRODUCT
GIVSQTRNKELLDKKIRSEIEAIKKIIAEFDVVKESVNELSEKAKTDPQAAEKLNKLIEG
YTYGEERKLYDSALSKIEKLIETL
//
>1xq5C (A) [a.1.1] HEMOGLOBIN ALPHA-1 CHAIN
SLSSKDKDTVKALWGKIADKAEEIGSDALSRMLAVYPQTKTYFSHWKDLSPGSAPVNKHG
KTIMGGIVDAVASIDDLNAGLLALSELHAFTLRVDPANFKILSHCILVLLAVKFPKDFTP
EVHISYDKFFSALARALAEKYR
//
>1xq5D (B) [a.1.1] HEMOGLOBIN BETA-2 CHAIN
VVWTDFERATIADIFSKLDYEAVGGATLARCLIVYPWTQRYFGNFGNLYNAAAIMGNPMI
AKHGTTILHGLDRAVKNMDNIKATYAELSVLHSEKLHVDPDNFKLLSDCLTIVVAAQLGK
AFSGEVQAAFQKFLSVVVSALGKQYH
//
>1xqs_1A [a.118.1] HSPBP1 PROTEIN
RGEVEQMKSCLRVLSQPMPPTAGEAEQAADQQEREGALELLADLCENMDNAADFCQLSGM
HLLVGRYLEAGAAGLRWRAAQLIGTCSQNVAAIQEQVLGLGALRKLLRLLDRDACDTVRV
KALFAISCLVREQEAGLLQFLRLDGFSVLMRAMQQQVQKLKVKSAFLLQNLLVGHPEHKG
TLCSMGMVQQLVALVRTEHSPFHEHVLGALCSLVTDFPQGVRECREPELGLEELLRHRCQ
LLQQHEEYQEELEFCEKLLQTCFS
//
>1xqs_1C [x.x.x] HEAT SHOCK 70 KDA PROTEIN 1
ERNVLIFDLGGGTFDVSILTIDDGIFEVKATAGDTHLGGEDFDNRLVNHFVEEFKRKHKK
DISQNKRAVRRLRTACERAKRTLSSSTQASLEIDSLFEGIDFYTSITRARFEELCSDLFR
STLEPVEKALRDAKLDKAQIHDLVLVGGSTRIPKVQKLLQDFFNG
//
>1xrsA [c.1.19] D-LYSINE 5,6-AMINOMUTASE ALPHA SUBUNIT
MESKLNLDFNLVEKARAKAKAIAIDTQEFIEKHTTVTVERAVCRLLGIDGVDTDEVPLPN
IVVDHIKENNGLNLGAAMYIANAVLNTGKTPQEIAQAISAGELDLTKLPMKDLFEVKTKA
LSMAKETVEKIKNNRSIRESRFEEYGDKSGPLLYVIVATGNIYEDITQAVAAAKQGADVI
AVIRTTGQSLLDYVPYGATTEGFGGTYATQENFRLMREALDKVGAEVGKYIRLCNYCSGL
CMPEIAAMGAIERLDVMLNDALYGILFRDINMQRTMIDQNFSRIINGFAGVIINTGEDNY
LTTADAFEEAHTVLASQFINEQFALLAGLPEEQMGLGHAFEMDPELKNGFLYELSQAQMA
REIFPKAPLKYMPPTKFMTGNIFKGHIQDALFNMVTIMTNQRIHLLGMLTEALHTPFMSD
RALSIENAQYIFNNMESISEEIQFKEDGLIQKRAGFVLEKANELLEEIEQLGLFDTLEKG
IFGGVKRPKDGGKGLNGVVSKDENYYNPFVELMLNK
//
>1xrsB [d.230.4 - c.23.6] D-LYSINE 5,6-AMINOMUTASE BETA SUBUNIT
KVQLSFTLPLKNNERSAEAAKQIALKMGLEEPSVVMQQSLDEEFTFFVVYGNEILSMEET
DEYIKENIGRKIVVVGASTGTDAHTVGIDAIMNMKGYAGHYGLERYEMIDAYNLGSQVAN
EDFIKKAVELEADVLLVSQTVTQKNVHIQNMTHLIELLEAEGLRDRFVLLCGGPRINNEI
AKELGYDAGFGPGRFADDVATFAVKTLNDRMN
//
>1xt9A [d.3.1] SENTRIN-SPECIFIC PROTEASE 8
DPVVLSYMDSLLRQSDVSLLDPPSWLNDHIIGFAFEYFANSQFHDCSDHVSFISPEVTQF
IKCTSNEIAMFLEPLDLPNKRVVFLAINDNSNQAAGGTHWSLLVYLQDKNSFFHYDSHSR
SNSVHAKQVAEKLEAFLGRKGDKLAFVEEKAPAQQNSYDCGMYVICNTEALCQNFFRQQT
ESLLQLLTPAYITKKRGEWKDLITTLAK
//
>1xt9B [d.15.1] NEDDYLIN
MLIKVKTLTGKEIEIDIEPTDKVERIKERVEEKEGIPPQQQRLIYSGKQMNDEKTAADYK
ILGGSVLHLVLALRGG
//
>1xtcA [d.166.1] CHOLERA TOXIN
NDDKLYRADSRPPDEIKQSGGLMPRGQSEYFDRGTQMNINLYDHARGTQTGFVRHDDGYV
STSISLRSAHLVGQTILSGHSTYYLYVLATAPNMFNVNDVLGAYSPHPDEQEVSALGGIP
YSQIYGWYRVHFGVLDEQLHRNRGYRDRYYSNLDIAPAADGYGLAGFPPEHRAWREEPWI
HHAPPGCGNAPR
//
>1xtcC [d.166.1] CHOLERA TOXIN
SNTCDEKTQSLGVKFLDEYQSKVKRQIFSGYQSDIDTHNRIKDEL
//
>1xtcF (D) [b.40.2] CHOLERA TOXIN
TPQNITDLCAEYHNTQIYTLNDKIFSYTESLAGKREMAIITFKNGAIFQVEVPSSQHIDS
QKKAIERMKDTLRIAYLTEAKVEKLCTWNNKTPHAIAAISMAN
//
>1xtgA [d.92.1] NEUROTOXIN BONT/A
PFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNP
PPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGS
TIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHEVLNLTRNGYG
STQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHQLIHAGHRLYGIAINPNR
VFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDIASTLNKAK
SIVGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVKFFKVL
NRKTFLNFDKAVFKINIVPKVNYTIYDGFNLRNTNLAANFNGQNTEINNMNFTKLKNFTP
LVPR
//
>1xtgB [h.1.15] SYNAPTOSOMAL-ASSOCIATED PROTEIN 25
MDENLEQVSGIIGNLRHMALDMGNEIDTQNRQIDRIMEKADSNKTRIDEANQRATKMLG
//
>1xu1D (A) [b.22.1] TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER
KHSVLHLVPVNITSKADSDVTEVMWQPVLRRGRGLEAQGDIVRVWDTGIYLLYSQVLFHD
VTFTMGQVVSREGQGRRETLFRCIRSMPSDPDRAYNSCYSAGVFHLHQGDIITVKIPRAN
AKLSLSPHGTFLGFVKL
//
>1xu1T [g.24.1] TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY
CRKEQGKFYDHLLRDCISCASICGQHPKQCAYFCENKLR
//
>1xu2S [g.24.1] TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY
GQCSQNEYFDSLLHACIPCQLRCSSNTPPLTCQRYCN
//
>1xu2B (A) [b.22.1] TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER
KHSVLHLVPVNITSKADSDVTEVMWQPVLRRGRGLEAQGDIVRVWDTGIYLLYSQVLFHD
VTFTMGQVVSREGQGRRETLFRCIRSMPSDPDRAYNSCYSAGVFHLHQGDIITVKIPRAN
AKLSLSPHGTFLGFVKL
//
>1xvpC [a.123.1] RETINOIC ACID RECEPTOR RXR-ALPHA
NEDMPVERILEAELAVEPKTETYVEANMGLNPSSPNDPVTNICQAADKQLFTLVEWAKRI
PHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIF
DRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYASLEAYCKH
KYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLEAPHQMT
//
>1xvpD (B) [a.123.1] ORPHAN NUCLEAR RECEPTOR NR1I3
PVQLSKEQEELIRTLLGAHTRHMGTMFEQFVQFRPPAHLFIHHQPLPTLAPVLPLVTHFA
DINTFMVLQVIKFTKDLPVFRSLPIEDQISLLKGAAVEICHIVLNTTFCLQTQNFLCGPL
RYTIEDGARVGFQVEFLELLFHFHGTLRKLQLQEPEYVLLAAMALFSPDRPGVTQRDEID
QLQEEMALTLQSYIKGQQRRPRDRFLYAKLLGLLAELRSINEAYGYQIQHIQGLSAMMPL
LQEICS
//
>1xwd_1A [g.17.1] GLYCOPROTEIN HORMONES ALPHA CHAIN
DVQDCPECTLQENPFFSQPGAPILQCMGCCFSRAYPTPLRSKKTMLVQKNVTSESTCCVA
KSYNRVTVMGGFKVENHTACHCSTCYYHKS
//
>1xwd_1B [g.17.1] FOLLITROPIN BETA CHAIN
CELTNITIAIEKEECRFCISINTTWCAGYCYTRDLVYKDPARPKIQKTCTFKELVYETVR
VPGCAHHADSLYTYPVATQCHCGKCDSDSTDCTVRGLGPSYCSFG
//
>1xwd_1C [c.10.2] FOLLICLE STIMULATING HORMONE RECEPTOR
CHHRICHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEI
SQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPD
VHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDE
LNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKLPT
LE
//
>1xwd_2D [g.17.1] GLYCOPROTEIN HORMONES ALPHA CHAIN
DCPECTLQENPFFSQPGAPILQCMGCCFSRAYPTPLRSKKTMLVQKNVTSESTCCVAKSY
NRVTVMGGFKVENHTACHCSTCYYHKS
//
>1xwd_2F [c.10.2] FOLLICLE STIMULATING HORMONE RECEPTOR
CHHRICHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEI
SQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPD
VHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDE
LNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY
//
>1xwjA [a.24.9 - a.24.9] VINCULIN
MMPVFHTRTIESILEPVAQQISHLVIMHEEGEVDGKAIPDLTAPVSAVQAAVSNLVRVGK
ETVQTTEDQILKRDMPPAFIKVENACTKLVRAAQMLQADPYSVPARDYLIDGSRGILSGT
SDLLLTFDEAEVRKIIRVCKGILEYLTVAEVVETMEDLVTYTKNLGPGMTKMAKMIDERQ
QELTHQEHRVMLVNSMNTVKELLPVLISAMKIFVTTKNTKSQGIEEALKNRNFTVEKMSA
EINEIIRVLQLTS
//
>1xwjB [x.x.x] TALIN
KKELIESARKVSEKVSHVLAALQA
//
>1xx9D [b.16.1] ECOTIN
VQPLEKIAPYPQAEKGMKRQVIQLTPQEDESTLKVELLIGQTLEVDCNLHRLGGKLENKT
LEGWGYDYYVFDKVSSPVSTRMACPDGKKEKKFVTAYLGDAGMLRYNSKLPIVVYTPDNV
DVKYRVWKAEEKIDNAVVR
//
>1xx9B [b.47.1] COAGULATION FACTOR XI
IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG
ILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGYT
DCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACK
GDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV
//
>1xxh_1A [c.37.1 - a.80.1] DNA POLYMERASE III, DELTA SUBUNIT
mIRLYPEQLRAQLNEGLRAAYLLLGNDPLLLQESQDAVRQVAAAQGFEEHHTFSIDPNTD
WNAIFSLCQAmSLFASRQTLLLLLPENGPNAAINEQLLTLTGLLHDDLLLIVRGNKLSKA
QENAAWFTALANRSVQVTCQTPEQAQLPRWVAARAKQLNLELDDAANQVLCYCYEGNLLA
LAQALERLSLLWPDGKLTLPRVEQAVNDAAHFTPFHWVDALLmGKSKRALHILQQLRLEG
SEPVILLRTLQRELLLLVNLKRQSAHTPLRALFDKHRVWQNRRGmmGEALNRLSQTQLRQ
AVQLLTRTELTLKQDYGQSVWAELEGLSLLLCHKPLAD
//
>1xxh_1B [c.37.1 - a.80.1] DNA POLYMERASE III SUBUNIT GAMMA
VLARKWRPQTFADVVGQEHVLTALANGLSLGRIHHAYLFSGTRGVGKTSIARLLAKGLNC
ETGITATPCGVCDNCREIEQGRFVDLIEIDAASRTKVEDTRDLLDNVQYAPARGRFKVYL
IDEVHMLSRHSFNALLKTLEEPPEHVKFLLATTDPQKLPVTILSRCLQFHLKALDVEQIR
HQLEHILNEEHIAHEPRALQLLARAAEGSLRDALSLTDQAIASGDGQVSTQAVSAMLGTL
DDDQALSLVEAMVEANGERVMALINEAAARGIEWEALLVEMLGLLHRIAMVQLSPAALGN
DMAAIELRMRELARTIPPTDIQLYYQTLLIGRKELPYAPDRRMGVEMTLLRALAFHPRMP
LPEP
//
>1xxi_2F (A) [c.37.1 - a.80.1] DNA POLYMERASE III, DELTA SUBUNIT
MIRLYPEQLRAQLNEGLRAAYLLLGNDPLLLQESQDAVRQVAAAQGFEEHHTFSIDPNTD
WNAIFSLCQAMSLFASRQTLLLLLPENGPNAAINEQLLTLTGLLHDDLLLIVRGNKLSKA
QENAAWFTALANRSVQVTCQTPEQAQLPRWVAARAKQLNLELDDAANQVLCYCYEGNLLA
LAQALERLSLLWPDGKLTLPRVEQAVNDAAHFTPFHWVDALLMGKSKRALHILQQLRLEG
SEPVILLRTLQRELLLLVNLKRQSAHTPLRALFDKHRVWQNRRGMMGEALNRLSQTQLRQ
AVQLLTRTELTLKQDYGQSVWAELEGLSLLLCHKPLAD
//
>1xxi_2J (E) [c.37.1 - a.80.1] DNA POLYMERASE III, DELTA PRIME SUBUNIT
MRWYPWLRPDFEKLVASYQAGRGHHALLIQALPGMGDDALIYALSRYLLCQQPQGHKSCG
HCRGCQLMQAGTHPDYYTLAPEKGKNTLGVDAVREVTEKLNEHARLGGAKVVWVTDAALL
TDAAANALLKTLEEPPAETWFFLATREPERLLATLRSRCRLHYLAPPPEQYAVTWLSREV
TMSQDALLAALRLSAGSPGAALALFQGDNWQARETLCQALAYSVPSGDWYSLLAALNHEQ
APARLHWLATLLMDALKRHHGAAQVTNVDVPGLVAELANHLSPSRLQAILGDVCHIREQL
MSVTGINRELLITDLLLRIEHYLQPGVVLPVPHL
//
>1xzpA [d.250.1 - a.24.25 - c.37.1] PROBABLE TRNA MODIFICATION GTPASE TRME
SSVDKLMDTIVAVATPPGKGAIAILRLSGPDSWKIVQKHLRTRSKIVPRKAIHGWIHENG
EDVDEVVVVFYKSPKSYTGEDMVEVMCHGGPLVVKKLLDLFLKSGARMAEPGEFTKRAFL
NGKMDLTSAEAVRDLIEAKSETSLKLSLRNLKGGLRDFVDSLRRELIEVLAEIRVELDYP
DEIETNTGEVVTRLERIKEKLTEELKKADAGILLNRGLRMVIVGKPNVGKSTLLNRLLNE
DRAIVTDIPGTTRDVISEEIVIRGILFRIVDTAGVRSETNDLVERLGIERTLQEIEKADI
VLFVLDASSPLDEEDRKILERIKNKRYLVVINKVDVVEKINEEEIKNKLGTDRHMVKISA
LKGEGLEKLEESIYRETQEIFERGSDSLITNLRQKQLLENVKGHLEDAIKSLKEGMPVDM
ASIDLERALNLLDEVTGRSFREDLLDTIFSNFCVGK
//
>1xzpB [d.250.1] PROBABLE TRNA MODIFICATION GTPASE TRME
HWGSPNSSSVDKLMDTIVAVATPPGKGAIAILRLSGPDSWKIVQKHLRTRSKIVPRKAIH
GWIHENGEDVDEVVVVFYKSPKSYTGEDMVEVMCHGGPLVVKKLLDLFLKSGARMAEPGE
FTKRAFLNGKM
//
>1y01A [a.7.11] ALPHA-HEMOGLOBIN STABILIZING PROTEIN
LLKANKDLISAGLKEFSVLLNQQVFNDALVSEEDMVTVVEDWMNFYINYYRQQVTGEPQE
RDKALQELRQELNTLANPFLAKYRDFLKS
//
>1y01B [a.1.1] HEMOGLOBIN ALPHA CHAIN
LSPADKTNVKAAWGKVGAHAGEYGAEALERMFLSFPTTKTYFPHFDLSHGSAQVKGHGKK
VADALTNAVAHVDMPNALRVDPVNFKLLSHCLLVTLAAHLPAEFTPAVHASLDKFLASVS
TVLTSK
//
>1y14A [a.60.8] DNA-DIRECTED RNA POLYMERASE II 32 KDA
ELIALNLSEARLVIKEALVERRRAFKRSQTREKELESIDVLLEQTTGGNNKDLKNTMQYL
TNFSRFRDQETVGAVIQLLKSTGLHPFEVAQLGSLACDTADEAKTLIPSLNNKISDDELE
RILKELSNLETLY
//
>1y14B [d.230.1 - b.40.4] DNA-DIRECTED RNA POLYMERASE II 19 KDA
MFFIKDLSLNITLHPSFFGPRMKQYLKTKLLEEVEGSCTGKFGYILCVLDYDNIDIQFNV
KYRAVVFKPFKGEVVDGTVVSCSQHGFEVQVGPMKVFVTKHLMPQDLTFNASYQSSEDVI
TIKSRIRVKIEGCISQVSSIHAIGSIKEDYLGAI
//
>1y17A [d.169.1] ANTICOAGULANT PROTEIN A
DCSSSWSSYEGHCYKAFKQSKTWADAESFCTKQVNGGHLVSIESSGEADFVAHLIAQKIK
SAKIHVWIGLRAQNKEKQCSIEWSDGSSISYENWIEEESKKCLGVHKATGFRKWENFYCE
QRDPFVCEA
//
>1y17B [d.169.1] ANTICOAGULANT PROTEIN-B
DCPSDWSSYEGHCYKPFNEPKNWADAENFCTQQHTGSHLVSFQSTEEADFVVKLAFQTFD
YGIFWMGLSKIWNQCNWQWSNAAMLKYTDWAEESYCVYFKSTNNKWRSITCRMIANFVCE
FQA
//
>1y18_2C (L) [b.1.1 - b.1.1] CATALYTIC ANTIBODY 34E4 LIGHT CHAIN
ELVVTQESALTTSPGETVTLTCRSSSGAVTTSNYATWVQEKPDHLFTGLIGGTNKRAPGV
PARFSGSLIGDRAALTITGAQTEDEAIYFCALWNSNHLVFGGGTKLEIKRTVAAPSVFIF
PPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSST
LTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
//
>1y18_2D (H) [b.1.1 - b.1.1] CATALYTIC ANTIBODY 34E4 HEAVY CHAIN
EVKLLESGGGLAQPGGSLKLSCAASGFDFRRYWMTWVRQAPGKGLEWIGDINPDSRTINY
MPSLKDKFIISRDNAKNSLYLQLSRLRSEDSALYYCVRLDFDVYNHYYVLDYWGQGTSVT
VSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVL
QSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC
//
>1y1vA [i.8.1] DNA-DIRECTED RNA POLYMERASE II LARGEST SUBUNIT
VGQQYSSAPLRTVKEVQFGLFSPEEVRAISVAKIRFPETMDETQTRAKIGGLNDPRLGSI
DRNLKCQTCQEGMNECPGHFGHIDLAKPVFHVGFIAKIKKVCECVCMHCGKLLLDEHNEL
MRQALAIKDSKKRFAAIWTLCKTKMVCETDVPSEDDPTQLVSRGGCGNTQPTIRKDGLKL
VGSWKDEPELRVLSTEEILNIFKHISVKDFTSLGFNEVFSRPEWMILTCLPVPPPPVRPS
ISFNESQRGEDDLTFKLADILKANISLETLEHNGAPHHAIEEAESLLQFHVATYMDNDIA
GQPQALQKSGRPVKSIRARLKGKEGRIRGNLMGKRVDFSARTVISGDPNLELDQVGVPKS
IAKTLTYPEVVTPYNIDRLTQLVRNGPNEHPGAKYVIRDSGDRIDLRYSKRAGDIQLQYG
WKVERHIMDNDPVLFNRQPSLHKMSMMAHRVKVIPYSTFRLNLSVTSPYNADFDGDEMNL
HVPQSEETRAELSQLCAVPLQIVSPQSNKPCMGIVQDTLCGIRKLTLRDTFIELDQVLNM
LYWVPDWDGVIPTPAIIKPKPLWSGKQILSVAIPNGIHLQRFDEGTTLLSPKDNGMLIID
GQIIFGVVEKKTVGSSNGGLIHVVTREKGPQVCAKLFGNIQKVVNFWLLHNGFSTGIGDT
IADGPTMREITETIAEAKKKVLDVTKEAQANLLTAKHGMTLRESFEDNVVRFLNEARDKA
GRLAEVNLKDLNNVKQMVMAGSKGSFINIAQMSACVGQQSVEGKRIAFGFVDRTLPHFSK
DDYSPESKGFVENSYLRGLTPQEFFFHAMGGREGLIDTAVKTAETGYIQRRLVKALEDIM
VHYDNTTRNSLGNVIQFIYGEDGMDAAHIEKQSLDTIGGSDAAFEKRYRVDLLNTDHTLD
PSLLESGSEILGDLKLQVLLDEEYKQLVKDRKFLREVFVDGEANWPLPVNIRRIIQNAQQ
TFHIDHTKPSDLTIKDIVLGVKDLQENLLVLRGKNEIIQNAQRDAVTLFCCLLRSRLATR
RVLQEYRLTKQAFDWVLSNIEAQFLRSVVHPGEMVGVLAAQSIGEPATQMTLNTFHFAGV
ASKKVTSGVPRLKEILNVAKNMKTPSLTVYLEPGHAADQEQAKLIRSAIEHTTLKSVTIA
SEIYYDPDPRSTVIPEDEEIIQLHFSLQQSPWLLRLELDRAAMNDKDLTMGQVGERIKQT
FKNDLFVIWSEDNDEKLIIRCRVVAEEDHMLKKIENTMLENITLRGVENIERVVMMKYDR
KVPSPTGEYVKEPEWVLETDGVNLSEVMTVPGIDPTRIYTNSFIDIMEVLGIEAGRAALY
KEVYNVIASDGSYVNYRHMALLVDVMTTQGGLTSVTRHGFNRSNTGALMRCSFEETVEIL
FEAGASAELDDCRGVSENVILGQMAPIGTGAFDVMIDEESLVKYMP
//
>1y1vB [i.8.1] DNA-DIRECTED RNA POLYMERASE II 140 KDA
DESAPITAEDSWAVISAFFREKGLVSQQLDSFNQFVDYTLQDIICEDSTLIISFGKIYVT
KPMVNESDGVTHALYPQEARLRNLTYSSGLFVDVKKKVFIGRLPIMLRSKNCYLSEATES
DLYKLKECPFDMGGYFIINGSEKVLIAQERSAGNIVQVFKKAAPSPISHVAEIRSALEKG
SRFISTLQVKLYGREGSSARTIKATLPYIKQDIPIVIIFRALGIIPDGEILEHICYDVND
WQMLEMLKPCVEDGFVIQDRETALDFIGKEKRIQYAKDILQKEFLPHITQLEGFESRKAF
FLGYMINRLLLCALDRKDQDDRDHFGKKRLDLAGPLLAQLFKTLFKKLTKDIFRYMQRTV
ELAINAKTITSGLKYALATGNWGEQKKAMSSRAGVSQVLNRYTYSSTLSHLRRTNTPIGR
DGKLAKPRQLHNTHWGLVCPAETPEGQACGLVKNLSLMSCISVGTDPMPIITFLSEWGME
PLEDYVPHQSPDATRVFVNGVWHGVHRNPARLMETLRTLRRKGDINPEVSMIRDIREKEL
KIFTDAGRVYRPLFIVEDDESLGHKELKVRKGHIAKLMATEYQDEYTWSSLLNEGLVEYI
DAEEEESILIAMQPEDLEPAEADVDPAKRIRVSHHATTFTHCEIHPSMILGVAASIIPFP
DHNQSPRNTYQSAMGKQAMGVFLTNYNVRMDTMANILYYPQKPLGTTRAMEYLKFRELPA
GQNAIVAIACYSGYNQEDSMIMNQSSIDRGLFRSLFFRSYMDQEKKYGMSITETFEKPQR
TNTLRMKHGTYDKLDDDGLIAPGVRVSGEDVIIGKTTPISSKRDASTPLRSTENGIVDQV
LVTTNQDGLKFVKVRVRTTKIPQIGDKFASRHGQKGTIGITYRREDMPFTAEGIVPDLII
NPHAIPSRMTVAHLIECLLSKVAALSGNEGDASPFTDITVEGISKLLREHGYQSRGFEVM
YNGHTGKKLMAQIFFGPTYYQRLRHMVDDKIHARARGPMQVLTRQPVEGRSRDGGLRFGE
MERDCMIAHGAASFLKERLMEASDAFRVHICGICGLMTVIAKLNHNQFECKGCDNKIDIY
QIHIPYAAKLLFQELMAMNITPRLYTDRSRDF
//
>1y1vS [i.8.1] TRANSCRIPTION ELONGATION FACTOR S-II
PLKQKIEEIAKQNLYNAQGATIERSVTDRFTCGKCKEKKVSYYQLQTRSADEPLTTFCTC
EACGNRWKFS
//
>1y43A [b.29.1] ASPERGILLOPEPSIN II LIGHT CHAIN
EEYSSNWAGAVLIGDGYTKVTGEFTVPSVSAG
//
>1y43B [b.29.1] ASPERGILLOPEPSIN II HEAVY CHAIN
EEYCASAWVGIDGDTCETAILQTGVDFCYEDGQTSYDAWYEWYPDYAYDFSDITISEGDS
IKVTVEATSKSSGSATVENLTTGQSVTHTFSGNVEGDLCETNAEWIVEDFESGDSLVAFA
DFGSVTFTNAEATSGGSTVGPSDATVMDIEQDGSVLTETSVSGDSVTVTYV
//
>1y4h_1A [d.3.1] CYSTEINE PROTEASE
QVQYENTLKNFKIREQQFDNSWCAGFSMAALLNATKNTDTYNAHDIMRTLYPEVSEQDLP
NCATFPNQMIEYGKSQGRDIHYQEGVPSYNQVDQLTKDNVGIMILAQSVSQNPNDPHLGH
ALAVVGNAKINDQEKLIYWNPWDTELSIQDADSSLLHLSFNRDYNWYGSMIGY
//
>1y4h_1C [b.61.2] CYSTEINE PROTEASE INHIBITOR
MYQLQFINLVYDTTKLTHLEQTNINLFIGNWSNHQLQKSICIRHGDDTSHNQYHILFIDT
AHQRIKFSSFDNEEIIYILDYDDTQHILMQTSSKQGIGTSRPIVYERLV
//
>1y4zA [c.81.1 - b.52.2] RESPIRATORY NITRATE REDUCTASE 1 ALPHA CHAIN
SKFLDRFRYFKQKGETFADGHGQLLNTNRDWEDGYRQRWQHDKIVRSTHGVNCTGSCSWK
IYVKNGLVTWETQQTDYPRTRPDLPNHEPRGCPRGASYSWYLYSANRLKYPMMRKRLMKM
WREAKALHSDPVEAWASIIEDADKAKSFKQARGRGGFVRSSWQEVNELIAASNVYTIKNY
GPDRVAGFSPIPAMSMVSYASGARYLSLIGGTCLSFYDWYCDLPPASPQTWGEQTDVPES
ADWYNSSYIIAWGSNVPQTRTPDAHFFTEVRYKGTKTVAVTPDYAEIAKLCDLWLAPKQG
TDAAMALAMGHVMLREFHLDNPSQYFTDYVRRYTDMPMLVMLEERDGYYAAGRMLRAADL
VDALGQENNPEWKTVAFNTNGEMVAPNGSIGFRWGEKGKWNLEQRDGKTGEETELQLSLL
GSQDEIAEVGFPYFGGDGTEHFNKVELENVLLHKLPVKRLQLADGSTALVTTVYDLTLAN
YGLERGLNDVNCATSYDDVKAYTPAWAEQITGVSRSQIIRIAREFADNADKTHGRSMIIV
GAGLNHWYHLDMNYRGLINMLIFCGCVGQSGGGWAHYVGQEKLRPQTGWQPLAFALDWQR
PARHMNSTSYFYNHSSQWRYETVTAEELLSPMADKSRYTGHLIDFNVRAERMGWLPSAPQ
LGTNPLTIAGEAEKAGMNPVDYTVKSLKEGSIRFAAEQPENGKNHPRNLFIWRSNLLGSS
GKGHEFMLKYLLGTEHGIQGKDLGQQGGVKPEEVDWQDNGLEGKLDLVVTLDFRLSSTCL
YSDIILPTATWYEKDDMNTSDMHPFIHPLSAAVDPAWEAKSDWEIYKAIAKKFSEVCVGH
LGKETDIVTLPIQHDSAAELAQPLDVKDWKKGECDLIPGKTAPHIMVVERDYPATYERFT
SIGPLMEKIGNGGKGIAWNTQSEMDLLRKLNYTKAEGPAKGQPMLNTAIDAAEMILTLAP
ETNGQVAVKAWAALSEFTGRDHTHLALNKEDEKIRFRDIQAQPRKIISSPTWSGLEDEHV
SYNAGYTNVHELIPWRTLSGRQQLYQDHQWMRDFGESLLVYRPPIDTRSVKEVIGQKSNG
NQEKALNFLTPHQKWGIHSTYSDNLLMLTLGRGGPVVWLSEADAKDLGIADNDWIEVFNS
NGALTARAVVSQRVPAGMTMMYHAQERIVNLPGSEITQQRGGIHNSVTRITPKPTHMIGG
YAHLAYGFNYYGTVGSNRDEFVVVRKMKNIDWLDGEGNDQVQES
//
>1y4zB [d.58.1] RESPIRATORY NITRATE REDUCTASE 1 BETA CHAIN
MKIRSQVGMVLNLDKCIGCHTCSVTAKNVWTSREGVEYAWFNNVETKPGQGFPTDWENQE
KYKGGWIRKINGKLQPRMGNRAMLLGKIFANPHLPGIDDYYEPFDFDYQNLHTAPEGSKS
QPIARPRSLITGERMAKIEKGPNWEDDLGGEFDKLAKDKNFDNIQKAMYSQFENTFMMYL
PRLCEHCLNPACVATCPSGAIYKREEDGIVLIDQDKCRGWRMCITGCPYKKIYFNWKSGK
SEKCIFCYPRIEAGQPTVCSETCVGRIRYLGVLLYDADAIERAASTENEKDLYQRQLDVF
LDPNDPKVIEQAIKDGIPLSVIEAAQQSPVYKMAMEWKLALPLHPEYRTLPMVWYVPPLS
PIQSAADAGELGSNGILPDVESLRIPVQYLANLLTAGDTKPVLRALKRMLAMRHYKRAET
VDGKVDTRALEEVGLTEAQAQEMYRYLAIANYEDRFVVPSSHRELAREAFPEKNGCGFTF
GDGCHGSDTKFNLFNSRRIDAIDVTSKTE
//
>1y5iB [d.58.1] RESPIRATORY NITRATE REDUCTASE 1 BETA CHAIN
MKIRSQVGMVLNLDKCIGCHTCSVTCKNVWTSREGVEYAWFNNVETKPGQGFPTDWENQE
KYKGGWIRKINGKLQPRMGNRAMLLGKIFANPHLPGIDDYYEPFDFDYQNLHTAPEGSKS
QPIARPRSLITGERMAKIEKGPNWEDDLGGEFDKLAKDKNFDNIQKAMYSQFENTFMMYL
PRLCEHCLNPACVATCPSGAIYKREEDGIVLIDQDKCRGWRMCITGCPYKKIYFNWKSGK
SEKCIFCYPRIEAGQPTVCSETCVGRIRYLGVLLYDADAIERAASTENEKDLYQRQLDVF
LDPNDPKVIEQAIKDGIPLSVIEAAQQSPVYKMAMEWKLALPLHPEYRTLPMVWYVPPLS
PIQSAADAGELGSNGILPDVESLRIPVQYLANLLTAGDTKPVLRALKRMLAMRHYKRAET
VDGKVDTRALEEVGLTEAQAQEMYRYLAIANYEDRFVVPSSHRELAREAFPEKNGCGFTF
GDGCHGSDTKFNLFNSRRIDAIDVTSKTE
//
>1y5iC [f.21.3] RESPIRATORY NITRATE REDUCTASE 1 GAMMA CHAIN
xQFLNMFFFDIYPYIAGAVFLIGSWLRYDYGQYTWRAASSQMLDRKGMNLASNLFHIGIL
GIFVGHFFGMLTLPIEVAQKMAMFAGGASGVLCLIGGVLLLKRRLFSPRVRATTTGADIL
ILSLLVIQCALGLLTIPFSAQHMDGSEMMKLVGWAQSVVTFHGGASQHLDGVAFIFRLHL
VLGMTLFLLFPFSRLIHIWSVPVEYLTRKYQLVRARH
//
>1y6nA (L) [a.26.1] VIRAL INTERLEUKIN-10 HOMOLOG
CDNFPQmLRDLRDAFSRVKTFFQTKDEVDNLLLKESLLEDFKGYLGCQALSEmIQFYLEE
VmPQAENQDPEIKDHVNSLGENLKTLRLRLRRCHRFLPCENKSKAVEQIKNAFNKLQEKG
IYKAmSEFDIFINYIEAYmTIK
//
>1y6nB (R) [b.1.2 - b.1.2] INTERLEUKIN-10 RECEPTOR ALPHA CHAIN
GTELPSPPSVWFEAEFFHHILHWTPIPQQSESTCYEVALLRYGIESWNSISQCSQTLSYD
LTAVTLDLYHSNGYRARVRAVDGSRHSQWTVTNTRFSVDEVTLTVGSVNLEIHNGFILGK
IQLPRPKMAPAQDTYESIFSHFREYEIAIRKVPGQFTFTHKKVKHEQFSLLTSGEVGEFC
VQVKPSVASRSNKGMWSKEECI
//
>1y8pA [a.29.5 - d.122.1] [PYRUVATE DEHYDROGENASE [LIPOAMIDE]] KINASE
VPKQIERYSRFSPSPLSIKQFLDFGRDNACEKTSYMFLRKELPVRLANTMREVNLLPDNL
LNRPSVGLVQSWYMQSFLELLEYENKSPEDPQVLDNFLQVLIKVRNRHNDVVPTMAQGVI
EYKEKFGFDPFISTNIQYFLDRFYTNRISFRMLINQHTLLFGGDTNPVHPKHIGSIDPTC
NVADVVKDAYETAKMLCEQYYLVAPELEVEEFNAKAPDKPIQVVYVPSHLFHMLFELFKN
SMRATVELYEDRKEGYPAVKTLVTLGKEDLSIKISDLGGGVPLRKIDRLFNYMYSTAPRP
LAGFGYGLPISRLYARYFQGDLKLYSMEGVGTDAVIYLKALSSESFERLPVFNKSAWRHY
KTTPEADDWSNPSSEPRDASK
//
>1y8pD (B) [b.84.1] DIHYDROLIPOYLLYSINE-RESIDUE ACETYLTRANSFERASE
SYPPHMQVLLPALSPTMTMGTVQRWEKKVGEKLSEGDLLAEIETDKATIGFEVQEEGYLA
KILVPEGTRDVPLGTPLCIIVEKEADISAFADYTDLK
//
>1y8q_2C [x.x.x] UBIQUITIN-LIKE 1 ACTIVATING ENZYME E1A
GGISEEEAAQYDRQIRLWGLEAQKRLRASRVLLVGLKGLGAEIAKNLILAGVKGLTMLDH
EQVTPEDPGAQFLIRTGSVGRNRAEASLERAQNLNPMVDVKVDTEDIEKKPESFFTQFDA
VCLTCCSRDVIVKVDQICHKNSIKFFTGDVFGYHGYTFANLGEHEFVEETTMVKKKVVFC
PVKEALEVDWSSEKAKAALKRTTSDYFLLQVLLKFRTDKGRDPSSDTYEEDSELLLQIRN
DVLDSLGISPDLLPEDFVRYCFSEMAPVCAVVGGILAQEIVKALSQRDPPHNNFFFFDGM
KGNGIVECLGP
//
>1y8q_2D [x.x.x] UBIQUITIN-LIKE 2 ACTIVATING ENZYME E1B
SRGLPRELAEAVAGGRVLVVGAGGIGCELLKNLVLTGFSHIDLIDLDTIDVSNLNRQFLF
QKKHVGRSKAQVAKESVLQFYPKANIVAYHDSIMNPDYNVEFFRQFILVMNALDNRAARN
HVNRMCLAADVPLIESGTAGYLGQVTTIKKGVTECYECHPKPTQRTFPGATIRNTPSEPI
HCIVWAKYLFNQLFGEEDADQEVSPDRADPEAAWEISTKEWAKSTGYDPVKLFTKLFKDD
IRYLLTMDKLWRKRKPPVPLDWAEVQSQLGLKDQQVLDVKSYARLFSKSIETLRVHLAEK
GDGAELIWDKDDPSAMDFVTSAANLRMHIFSMNMKSRFDIKSMAGNIIPAIATTNAVIAG
LIVLEGLKILSGKIDQCRTIFLNKQPNPRKKLLVPCALDPPNPNCYVCASKPEVTVRLNV
HKVTVLTLQDKIVKEKFAMVAPDVQIEDGKGTILISSEEGETEANNHKKLSEFGIRNGSR
LQADDFLQDYTLLINILHSEDLGKDVEFEVVGDA
//
>1y8r_1B [x.x.x] UBIQUITIN-LIKE 2 ACTIVATING ENZYME E1B
SRGLPRELAEAVAGGRVLVVGAGGIGCELLKNLVLTGFSHIDLIDLDTIDVSNLNRQFLF
QKKHVGRSKAQVAKESVLQFYPKANIVAYHDSIMNPDYNVEFFRQFILVMNALDNRAARN
HVNRMCLAADVPLIESGTAGYLGQVTTIKKGVTECYECHPKPTQRTFPGATIRNTPSEPI
HCIVWAKYLFNQLFGEEDADQEVSPDRADPEAAWETKEWAKSTGYDPVKLFTKLFKDDIR
YLLTMDKLWRKRKPPVPLDWAEVQSQLGLKDQQVLDVKSYARLFSKSIETLRVHLAEKGD
GAELIWDKDDPSAMDFVTSAANLRMHIFSMNMKSRFDIKSMAGNIIPAIATTNAVIAGLI
VLEGLKILSGKIDQCRTIFLNKQPNPRKKLLVPCALDPPNPNCYVCASKPEVTVRLNVHK
VTVLTLQDKIVKEKFAMVAPDVQIEDGKGTILISSEEGETEANNHKKLSEFGIRNGSRLQ
ADDFLQDYTLLINILHSEDLGKDVEFEVVGDA
//
>1y8r_1C [d.15.1] UBIQUITIN-LIKE PROTEIN SMT3C
GDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIAD
NHTPKELGMEEEDVIEVYQEQTGG
//
>1y8xA [d.20.1] UBIQUITIN-CONJUGATING ENZYME E2 M
GSmASAAQLRIQKDINELNLPKTCDISFSDPDDLLNFKLVICPDEGFYKSGKFVFSFKVG
QGYPHDPPKVKCETmVYHPNIDLEGNVCLNILREDWKPVLTINSIIYGLQYLFLEPNPED
PLNKEAAEVLQNNRRLFEQNVQRSmRGGYIGSTYFERCLK
//
>1y8xB [c.111.1] UBIQUITIN-ACTIVATING ENZYME E1C
LPQNIQFSPSAKLQEVLDYLTNSASLQmKSPAITATLEGKNRTLYmQSVTSIEERTRPNL
SKTLKELGLVDGQELAVADVTTPQTVLFKLHF
//
>1y96_1A [x.x.x] GEM-ASSOCIATED PROTEIN 6
MSEWMKKGPLEWQDYIYKEVRVTASEKNEYKGWVLTTDPVSANIVLVNFLEDGSMSVTGI
MGHAVQTVETMNEGDHRVREKLMHLF
//
>1y96_1B [x.x.x] GEM-ASSOCIATED PROTEIN 7
AQESLESQEQRARAALRERYLRSLLAMVGHQVSFTLHEGVRVAAHFGATDLDVANFYVSQ
LQTPIGVQAEALLRCSDIISYTFKP
//
>1ya7C (A) [d.153.1] PROTEASOME ALPHA SUBUNIT
AYDRAITVFSPDGRLFQVEYAREAVKKGSTALGMKFANGVLLISDKKVRSRLIEQNSIEK
IQLIDDYVAAVTSGLVADARVLVDFARISAQQEKVTYGSLVNIENLVKRVADQMQQYTQY
GGVRPYGVSLIFAGIDQIGPRLFDCDPAGTINEYKATAIGSGKDAVVSFLEREYKENLPE
KEAVTLGIKALKSSLEEGEELKAPEIASITVGNKYRIYDQEEVKKFL
//
>1ya7E (A) [d.153.1] PROTEASOME ALPHA SUBUNIT
AYDRAITVFSPDGRLFQVEYAREAVKKGSTALGMKFANGVLLISDKKVRSRLIEQNSIEK
IQLIDDYVAAVTSGLVADARVLVDFARISAQQEKVTYGSLVNIENLVKRVADQMQQYTQY
GGVRPYGVSLIFAGIDQIGPRLFDCDPAGTINEYKATAIGSGKDAVVSFLEREYKENLPE
KEAVTLGIKALKSSLEEGEELKAPEIASITVGNKYRIYDQEEVKKFL
//
>1ya7J (H) [d.153.1] PROTEASOME BETA SUBUNIT
TTTVGITLKDAVIMATERRVTMENFIMHKNGKKLFQIDTYTGMTIAGLVGDAQVLVRYMK
AELELYRLQRRVNMPIEAVATLLSNMLNQVKYMPYMVQLLVGGIDTAPHVFSIDAAGGSV
EDIYASTGSGSPFVYGVLESQYSEKMTVDEGVDLVIRAISAAKQRDSASGGMIDVAVITR
KDGYVQLPTDQIESRIRKLGLIL
//
>1ya7O [a.24.8] PROTEASOME ACTIVATOR PROTEIN PA26
KRAALIQNLRDSYTETSSFAVIEEWAAGTLQEIEGIAKAAAEAHGVIRNSTYGRAQAEKS
PEQLLGVLQRYQDLCHNVYCQAETIRTVIAIRIPEHKEEDNLGVAVQHAVLKIIDELEIK
TLGSGEKSGSGGAPTPIGMYALREYLSARSTVEDKLLGGGSQSPSLLLELRQIDADFMLK
VELATTHLSTMVRAVINAYLLNWKKLIQPRTGSDHMVS
//
>1yagA [c.55.1 - c.55.1] PROTEIN (ACTIN)
EVAALVIDNGSGMCKAGFAGDDAPRAVFPSIVGRPRHQGIMVGMGQKDSYVGDEAQSKRG
ILTLRYPIEHGIVTNWDDMEKIWHHTFYNELRVAPEEHPVLLTEAPMNPKSNREKMTQIM
FETFNVPAFYVSIQAVLSLYSSGRTTGIVLDSGDGVTHVVPIYAGFSLPHAILRIDLAGR
DLTDYLMKILSERGYSFSTTAEREIVRDIKEKLCYVALDFEQEMQTAAQSSSIEKSYELP
DGQVITIGNERFRAPEALFHPSVLGLESAGIDQTTYNSIMKCDVDVRKELYGNIVMSGGT
TMFPGIAERMQKEITALAPSSMKVKIIAPPERKYSVWIGGSILASLTTFQQMWISKQEYD
ESGPSIVHHKCF
//
>1yagG [d.109.1] PROTEIN (GELSOLIN)
MVVEHPEFLKAGKEPGLQIWRVEKFDLVPVPTNLYGDFFTGDAYVILKTVQLRNGNLQYD
LHYWLGNECSQDESGAAAIFTVQLDDYLNGRAVQHREVQGFESATFLGYFKSGLKYKKGG
VASGF
//
>1yc0A [b.47.1] HEPATOCYTE GROWTH FACTOR ACTIVATOR
ACGRRHKKIIGGSSSLPGSHPWLAAIYIGDSFCAGSLVHTCWVVSAAHCFSHSPPRDSVS
VVLGQHFFNRTTDVTQTFGIEKYIPYTLYSVFNPSDHDLVLIRLKKKGDRCATRSQFVQP
ICLPEPGSTFPAGHKCQIAGWGHLDENVSGYSSSLREALVPLVADHKCSSPEVYGADISP
NMLCAGYFDCKSDACQGDSGGPLACEKNGVAYLYGIISWGDGCGRLHKPGVYTRVANYVD
WINDRIR
//
>1yc0I [g.8.1] KUNITZ-TYPE PROTEASE INHIBITOR 1
QHQHQMHQTEDYCLASNKVGRCRGSFPRWYYDPTEQICKSFVYGGCLGNKNNYLREEECI
LACRGV
//
>1ycsA [b.2.5] P53
VPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTR
VRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSV
VVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVRVCA
CPGRDRRTEEE
//
>1ycsB [d.211.1 - b.34.2] 53BP2
PLALLLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNV
NAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTYSDMQTAADKCEEMEEGYTQCSQ
FLYGVQEKMGIMNKGVIYALWDYEPQNDDELPMKEGDCMTIIHREDEDEIEWWWARLNDK
EGYVPRNLLGLYP
//
>1ydiA [a.24.9 - a.24.9] VINCULIN ISOFORM VCL
HHHHHMPVFHTRTIESILEPVAQQISHLVIMHEAIPDLTAPVAAVQAAVSNLVRVGKETV
QTTEDQILKRDMPPAFIKVENACTKLVQAAQMLQSDPYSVPARDYLIDGSRGILSGTSDL
LLTFDEAEVRKIIRVCKGILEYLTVAEVVETMEDLVTYTKNLGPGMTKMAKMIDERQQEL
THQEHRVMLVNSMNTVKELLPVLISAMKIFVTTKNSKNQGIEEALKNRNFTVEKMSAEIN
EIIRVLQLTSWDEDAW
//
>1ydiB [x.x.x] ALPHA-ACTININ 4
VGWEQLLTTIARTINEVENQILTR
//
>1ye9_2J (A) [x.x.x] CATALASE HPII
SENYALTTNQGVRIADDQNSLRAGSRGPTLLEDFILREKITHFDHERIPERIVHARGSAA
HGYFQPYKSLSDITKADFLSDPNKITPVFVRFSTVQGGAGSADTVRDIRGFATKFYTEEG
IFDLVGNNTPIFFIQDAHKFPDFVHAVKPEPHWAIPQGQSAHDTFWDYVSLQPETLHNVM
WAMSDRGIPRSYRTMEGFGIHTFRLINAEGKATFVRFHWKPLA
//
>1ye9_2N (E) [x.x.x] CATALASE HPII
KLTGRDPDFHRRELWEAIEAGDFPEYELGFQLIPEEDEFKFDFDLLDPTKLIPEELVPVQ
RVGKMVLNRNPDNFFAENEQAAFHPGHIVPGLDFTNDPLLQGRLFSYTDTQISRLGGPNF
HEIPINRPTCPYHNFQRDGMHRMGIDTNPANYEPNSINDNWPRETPPGPKRGGFESYQER
VEGNKVRERSPSFGEYYSHPRLFWLSQTPFEQRHIVDGFSFELSKVVRPYIRERVVDQLA
HIDLTLAQAVAKNLGI
//
>1yed_2A (L) [b.1.1 - b.1.1] IGG1 FAB FRAGMENT (D.2.4)
DIVMTQSPLTLSVTIGQPASISCKSSQSLLYSNGKTYLNWLLQRPGQSPKRLIYLVSKLE
SGVPDRFTGSGSGTDFTLKISRVEAADLGVYYCVQGTHFPYTFGGGTKLEILRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1yed_2B (H) [b.1.1 - b.1.1] IGG1 FAB FRAGMENT (D.2.4)
AVKLQQSGPELVRPGTSVKLSCKTSGYIFTSYWIHWLKQSSGQGLEWIARIYPGTGGTYY
NEKFKGKATLTADKSSSTAYMQLSSLKSEDSAVYFCTRWGFTTVRENYYAMDYWGQGTLV
TVSSAKTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAV
LQSDLYTLSSSVTVPSSPRPSETVTCNVAHPASSTKVDKKIVPRDC
//
>1yeeL [b.1.1 - b.1.1] IGG2A FAB FRAGMENT (D2.5)
DIVMTQSPLTLSVTIGQPASISCKSSQSLLYSNGKTYLSWLLQRPGQSPKRLIYLVSKLD
SGVPDRFTGSGSGTDFTLKISRVEAADLGLYYCVQGTHFPYTFGGGTKLEILRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1yeeH [b.1.1 - b.1.1] IGG2A FAB FRAGMENT (D2.5)
EVKLQESGAELVRPGASVKLSCKTSGYIFTSYWIHWVKQRAAAGLEWIARIYPGTGSSYY
NVKFKGKATLTADKSSSTAYMQLSSLKSDDSAVYFCVRWGFIPVREDYVLDYWGQGTLVT
VSSAKTTAPSVYPLAPVCGDTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVL
QSDLYTLSSSVTVTSSTWPSQSITCNVAHPASSTKVDKKIEP
//
>1yewB [x.x.x] PARTICULATE METHANE MONOOXYGENASE, A SUBUNIT
AVRSHAEAVQVSRTIDWMALFVVFFVIVGSYHIHAMLTMGDWDFWSDWKDRRLWVTVTPI
VLVTFPAAVQSYLWERYRLPWGATVCVLGLLLGEWINRYFNFWGWTYFPINFVFPASLVP
GAIILDTVLMLSGSYLFTAIVGAMGWGLIFYPGNWPIIAPLHVPVEYNGMLMSIADIQGY
NYVRTGTPEYIRMVEKGTLRTFGKDVAPVSAFFSAFMSILIYFMWHFIGRWFSNERFL
//
>1yewC [x.x.x] PARTICULATE METHANE MONOOXYGENASE SUBUNIT C2
LLDKKWLTFALAIYTVFYLWVRWYEGVYGWSAGLDSFAPEFETYWMNFLYTEIVLEIVTA
SILWGYLWKTRDRNLAALTPREELRRNFTHLVWLVAYAWAIYWGASYFTEQDGTWHQTIV
RDTDFTPSHIIEFYLSYPIYIITGFAAFIYAKTRLPFFAHTFWFMEELFVAPLHYGFVIF
GWLALAVM
//
>1yewE (A) [x.x.x] PARTICULATE METHANE MONOOXYGENASE, B SUBUNIT
HGEKSQAAFMRMRTIHWYDLSWSKEKVKINETVEIKGKFHVFEGWPETVDEPDVAFLNVG
MPGPVFIRKESYIGGQLVPRSVRLEIGKTYDFRVVLKARRPGDWHVHTMMNVQGGGPIIG
PGKWITVEGSMSEFRNPVTTLTGQTVDLENYNEGNTYFWHAFWFAIGVAWIGYWSRRPIF
IPRLLMVDAGRADELVSATDRKVAMGFLAATILIVVMAMSSANSKYPITIPLQAGTMRGM
KPLELPAPTVSVKVEDATYRVPGRAMRMKLTITNHGNSPIRLGEFYTASVRFLDSDVYKD
TTGYPEDLLAEDGLSVSDNSPLAPGETRTVDVTASDAAWEVYRLSDIIYDPDSRFAGLLF
FFDATGNRQVVQIDAPLIPSFM
//
>1yewI (A) [x.x.x] PARTICULATE METHANE MONOOXYGENASE, B SUBUNIT
HGEKSQAAFMRMRTIHWYDLSWSKEKVKINETVEIKGKFHVFEGWPETVDEPDVAFLNVG
MPGPVFIRKESYIGGQLVPRSVRLEIGKTYDFRVVLKARRPGDWHVHTMMNVQGGGPIIG
PGKWITVEGSMSEFRNPVTTLTGQTVDLENYNEGNTYFWHAFWFAIGVAWIGYWSRRPIF
IPRLLMVDAGRADELVSATDRKVAMGFLAATILIVVMAMSSANSKYPITIPLQAGTMRGM
KPLELPAPTVSVKVEDATYRVPGRAMRMKLTITNHGNSPIRLGEFYTASVRFLDSDVYKD
TTGYPEDLLAEDGLSVSDNSPLAPGETRTVDVTASDAAWEVYRLSDIIYDPDSRFAGLLF
FFDATGNRQVVQIDAPLIPSFM
//
>1yewJ (B) [x.x.x] PARTICULATE METHANE MONOOXYGENASE, A SUBUNIT
AVRSHAEAVQVSRTIDWMALFVVFFVIVGSYHIHAMLTMGDWDFWSDWKDRRLWVTVTPI
VLVTFPAAVQSYLWERYRLPWGATVCVLGLLLGEWINRYFNFWGWTYFPINFVFPASLVP
GAIILDTVLMLSGSYLFTAIVGAMGWGLIFYPGNWPIIAPLHVPVEYNGMLMSIADIQGY
NYVRTGTPEYIRMVEKGTLRTFGKDVAPVSAFFSAFMSILIYFMWHFIGRWFSNERFL
//
>1yewG (C) [x.x.x] PARTICULATE METHANE MONOOXYGENASE SUBUNIT C2
LLDKKWLTFALAIYTVFYLWVRWYEGVYGWSAGLDSFAPEFETYWMNFLYTEIVLEIVTA
SILWGYLWKTRDRNLAALTPREELRRNFTHLVWLVAYAWAIYWGASYFTEQDGTWHQTIV
RDTDFTPSHIIEFYLSYPIYIITGFAAFIYAKTRLPFFAHTFWFMEELFVAPLHYGFVIF
GWLALAVM
//
>1yhnA [c.37.1] RAS-RELATED PROTEIN RAB-7
SRKKVLLKVIILGDSGVGKTSLMNQYVNKKFSNQYKATIGADFLTKEVMVDDRLVTMQIW
DTAGLERFQSLGVAFYRGADCCVLVFDVTAPNTFKTLDSWRDEFLIQASPRDPENFPFVV
LGNKIDLENRQVATKRAQAWCYSKNNIPYFETSAKEAINVEQAFQTIARNALKQETEVEL
YNE
//
>1yhnC (B) [h.1.34] RAB INTERACTING LYSOSOMAL PROTEIN
SREEFEQILQERNELKAKVFLLKEELAYFQRELLTDHRVPSLLLEAMKVAVRKQRKKIKA
KMLGT
//
>1yhuA [a.1.1] HEMOGLOBIN A1 CHAIN
ACAMLERAKVKDEWAKAYGIGAARSKFGDALWRNVFNYAPNARDIFESVNSKDMASPEFK
AHIARVLGGLDRVISMLDNQATLDADLAHLKSQHDPRTIDPVNFVVFRKALIATVAGTFG
VCFDVPAWQGCYNIIAKGITGSDAA
//
>1yhuC [a.1.1] HEMOGLOBIN B1A CHAIN
AANCADAAAAIVQAQWEDVWSAAAAAASRVSAGEEVFAALFKMVPAAKNLFTRVNVADIN
SPEFQGHVVRVMGGLDILINALDDIPTLESMLDHLAGQHAVRDGVTGAGFQLMATVLMES
LPQVVEGFNPDAWASCLAGIAAAISSAL
//
>1yhuD [a.1.1] HEMOGLOBIN B2 CHAIN
AASCTTEDRREMQLMWGNVWSAQFTGRRIAIAQAVFKDLFANVPDAVGLFGAVKGDEVNS
NEFKAHCIRVVNGLDSSIGLLSDPATLNEQLSHLATQHKARSGVTKGGFSAIAQSFLRVM
PQVASCFNPDAWSRCFNRITTGMTEPLPA
//
>1yhuF (B) [a.1.1] GIANT HEMOGLOBINS B CHAIN
DYVCGPLQRLKVKRQWAEAYGSGNSREEFGHFIWSHVFQHSPAARDMFKRVRGDNIHTPA
FRAHATRVLGGLDMCIALLDDEPVLNTQLAHLAKQHETRGVEAAHYDTVNHAVMMGVENV
IGSEVFDQDAWKPCLNVITNGIQG
//
>1yhuJ (B) [a.1.1] GIANT HEMOGLOBINS B CHAIN
DYVCGPLQRLKVKRQWAEAYGSGNSREEFGHFIWSHVFQHSPAARDMFKRVRGDNIHTPA
FRAHATRVLGGLDMCIALLDDEPVLNTQLAHLAKQHETRGVEAAHYDTVNHAVMMGVENV
IGSEVFDQDAWKPCLNVITNGIQG
//
>1yhuH (D) [a.1.1] HEMOGLOBIN B2 CHAIN
AASCTTEDRREMQLMWGNVWSAQFTGRRIAIAQAVFKDLFANVPDAVGLFGAVKGDEVNS
NEFKAHCIRVVNGLDSSIGLLSDPATLNEQLSHLATQHKARSGVTKGGFSAIAQSFLRVM
PQVASCFNPDAWSRCFNRITTGMTEPLPA
//
>1yhuK (C) [a.1.1] HEMOGLOBIN B1A CHAIN
AANCADAAAAIVQAQWEDVWSAAAAAASRVSAGEEVFAALFKMVPAAKNLFTRVNVADIN
SPEFQGHVVRVMGGLDILINALDDIPTLESMLDHLAGQHAVRDGVTGAGFQLMATVLMES
LPQVVEGFNPDAWASCLAGIAAAISSAL
//
>1yhuT (D) [a.1.1] HEMOGLOBIN B2 CHAIN
AASCTTEDRREMQLMWGNVWSAQFTGRRIAIAQAVFKDLFANVPDAVGLFGAVKGDEVNS
NEFKAHCIRVVNGLDSSIGLLSDPATLNEQLSHLATQHKARSGVTKGGFSAIAQSFLRVM
PQVASCFNPDAWSRCFNRITTGMTEPLPA
//
>1yhuQ (A) [a.1.1] HEMOGLOBIN A1 CHAIN
ACAMLERAKVKDEWAKAYGIGAARSKFGDALWRNVFNYAPNARDIFESVNSKDMASPEFK
AHIARVLGGLDRVISMLDNQATLDADLAHLKSQHDPRTIDPVNFVVFRKALIATVAGTFG
VCFDVPAWQGCYNIIAKGITGSDAA
//
>1yi5_4C [b.96.1] ACETYLCHOLINE-BINDING PROTEIN
LDRADILYNIRQTSRPDVIPTQRDRPVAVSVSLKFINILEVNEITNEVDVVFWQQTTWSD
RTLAWNSSHSPDQVSVPISSLWVPDLAAYNAISKPEVLTPQLARVVSDGEVLYMPSIRQR
FSCDVSGVDTESGATCRIKIGSWTHHSREISVDPTSDDSEYFSQYSRFEILDVTQKKNSV
TYSCCPEAYEDVEVSLNFRKKGR
//
>1yi5_4H (F) [g.7.1] LONG NEUROTOXIN 1
IRCFITPDITSKDCPNGHVCYTKTWCDAFCSIRGKRVDLGCAATCPTVKTGVDIQCCSTD
NCNPFPTR
//
>1yjdA (C) [b.1.1] T-CELL-SPECIFIC SURFACE GLYCOPROTEIN CD28
NKILVKQSPMLVAYDNAVNLSCKYSYNLFSREFRASLHKGLDSAVEVCVVYGNYSQQLQV
YSKTGFNCDGKLGNESVTFYLQNLYVNQTDIYFCKIEVMYPPPYLDNEKSNGTIIHVK
//
>1yjdB (L) [b.1.1 - b.1.1] FAB FRAGMENT OF 5.11A1 ANTIBODY LIGHT CHAIN
DIQMNQSPSSLSASLGDTITITCHASQNIYVWLNWYQQKPGNIPKLLIYKASNLHTGVPS
RFSGSGSGTGFTLTISSLQPEDIATYYCQQGQTYPYTFGGGTKLEIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRN
//
>1yjdD (H) [b.1.1] FAB FRAGMENT OF 5.11A1 ANTIBODY HEAVY CHAIN
VQLQQSGPELVKPGTSVRISCEASGYTFTSYYIHWVKQRPGQGLEWIGCIYPGNVNTNYN
EKFKDKATLIVDTSSNTAYMQLSRMTSEDSAVYFCTRSHYGLDWNFDVWGAGTTVTVSSA
KTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDL
YTLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKIV
//
>1yk0A [c.93.1] ATRIAL NATRIURETIC PEPTIDE CLEARANCE RECEPTOR
ALPPQKIEVLVLLPQDDSYLFSLTRVRPAIEYALRSVEGLLPPGTRFQVAYEDSDCGNRA
LFSLVDRVAAARGAKPDLILGPVCEYAAAPVARLASHWDLPMLSAGALAAGFQHKDSEYS
HLTRVAPAYAKMGEMMLALFRHHHWSRAALVYSDDKLERNCYFTLEGVHEVFQEEGLHTS
IYSFDETKDLDLEDIVRNIQASERVVIMCASSDTIRSIMLVAHRHGMTSGDYAFFNIELF
NSSSYGDGSWKRGDKHDFEAKQAYSSLQTVTLLRTVKPEFEKFSMEVKSSVEKQGLNMED
YVNMFVEGFHDAILLYVLALHEVLRAGYSKKDGGKIIQQTWNRTFEGIAGQVSIDANGDR
YGDFSVIAMTDVEAGTQEVIGDYFGKEGRFEMRP
//
>1yk0E [x.x.x] ATRIAL NATRIURETIC FACTOR
SCFGGRMDRIGAQSGLGCNSF
//
>1yk0E [x.x.x] ATRIAL NATRIURETIC FACTOR
SCFGGRMDRIGAQSGLGCNSF
//
>1yk1B (A) [c.93.1] ATRIAL NATRIURETIC PEPTIDE CLEARANCE RECEPTOR
ALPPQKIEVLVLLPQDDSYLFSLTRVRPAIEYALRSVEGLLPPGTRFQVAYEDSDCGNRA
LFSLVDRVAAARGAKPDLILGPVCEYAAAPVARLASHWDLPMLSAGALAAGFQHKDSEYS
HLTRVAPAYAKMGEMMLALFRHHHWSRAALVYSDDKLERNCYFTLEGVHEVFQEEGLHTS
IYSFDETKDLDLEDIVRNIQASERVVIMCASSDTIRSIMLVAHRHGMTSGDYAFFNIELF
NSSSYGDGSWKRGDKHDFEAKQAYSSLQTVTLLRTVKPEFEKFSMEVKSSVEKQGLNMED
YVNMFVEGFHDAILLYVLALHEVLRAGYSKKDGGKIIQQTWNRTFEGIAGQVSIDANGDR
YGDFSVIAMTDVEAGTQEVIGDYFGKEGRFEMRP
//
>1yk1E [x.x.x] NATRIURETIC PEPTIDES B
GCFGRKMDRISSSSGLGCKVL
//
>1yke_2C (A) [a.252.1] RNA POLYMERASE II MEDIATOR COMPLEX PROTEIN MED7
ESTNYQYKIQELRKLLKSLLLNYLELIGVLSINPDMYERKVENIRTILVNIHHLLNEYRP
HQSRESLIMLLEEQLEYKRGEIREIEQVCKQVHDKLTS
//
>1yke_2D [a.252.1] RNA POLYMERASE II HOLOENZYME COMPONENT SRB7
DRLTQLQICLDQMTEQFCATLNYIDKNHGFEVVPPEEFSNTIDELSTDIILKTRQINKLI
DSLPGVDVSAEEQLRKIDMLQKKLVEVEDEKIEAIKKKEKLLRHVDSLIEDFV
//
>1ykkA [b.3.6] PROTOCATECHUATE 3,4-DIOXYGENASE ALPHA CHAIN
PIELLPETPSQTAGPYVHIGLALEAAGNPTRDQEIWNRLAKPDAPGEHILLLGQVYDGNG
HLVRDSFLEVWQADANGEYQDAYNLENAFNSFGRTATTFDAGEWTLHTVKPGVVNNAAGV
PMAPHINISLFARGINIHLHTRLYFDDEAQANAKCPVLNLIEQPQRRETLIAKRCEVDGK
TAYRFDIRIQGEGETVFFDF
//
>1ykkB [b.3.6] PROTOCATECHUATE 3,4-DIOXYGENASE BETA CHAIN
PAQDNSRFVIRDRNWHPKALTPDYKTSIARSPRQALVSIPQSISETTGPNFSHLGFGAHD
HDLLLNFNNGGLPIGERIIVAGRVVDQYGKPVPNTLVEMWQANAGGRCRHKNDRYLAPLD
PNFGGVGRxLTDSDGYYSFRTIKPGPYPWRNGPNDWRPAHIHFGISGPSIATKLITQLYF
EGDPLIPMCPIVKSIANPEAVQQLIAKLDMNNANPMDCLAYRFDIVLRGQRKTHFENC
//
>1yktA [b.47.1] TRYPSIN II
IVGGYTCQENSVPYQVSLNSGYHFCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLEG
NEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLISG
WGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDAGGP
VVCNGELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAAN
//
>1yktB [g.8.1] PANCREATIC TRYPSIN INHIBITOR
RPDFCLEPPYTGPCKARIIRYFYNAKAGLCQTFVYGGCRAKRNNFKSAEDCMRTCG
//
>1yl3J (I) [a.108.1 - d.45.1] 50S RIBOSOMAL PROTEIN L7/L12
MTIDEIIEAIEKLTVSELAELVKKLEDKFGVTAAAPVAVAAAPVAGAAAGAAQEEKTEFD
VVLKSFGQNKIQVIKVVREITGLGLKEAKDLVEKAGSPDAVIKSGVSKEEAEEIKKKLEE
AGAEVELK
//
>1yl3L [d.47.1 - a.4.7] 50S RIBOSOMAL PROTEIN L11
QIKLQLPAGKATPAPPVGPALGQHGVNIMEFCKRFNAETADKAGMILPVVITVYEDKSFT
FIIKTPPASFLLKKAAGIEKGSSEPKRKIVGKVTRKQIEEIAKTKMPDLNANSLEAAMKI
IEGTAKSMGIEVV
//
>1yl3P [d.41.4] 50S RIBOSOMAL PROTEIN L16
SIKPTRREYISGIPGKGIAQFKMGNNTYPAQVENVVEKPVQIRHNALEAARNAANRFVQN
SGKFRIRKFPFHVIREQDGDGMRAPFGKSVGTAARSHGANHDFIAWVNPDPAVEFAWRRA
YMKVTPTVNIDSSPAGNA
//
>1yl3S [d.55.1] 50S RIBOSOMAL PROTEIN L22
EAKAIARYVRISPRKVRLVVDLIRGKSLEEARNILRYTNKRGAYFVAKVLESAAANAVNN
HDLEDRLYVKAAYVDEGPALKRVLPRARGRADIIKKRTSHITVILGEK
//
>1yl3V [b.53.1] 50S GENERAL STRESS PROTEIN CTC (L25)
MELTAKPRTPKQKLDESMIAAVAYNKENNVSFALDRKAFDRAFRQQSTTGLFDITVEGGE
TFPALVKAVQMDKRKRAPIHVDFYMVTYGEPVEVSVPVHTTGRSQGEVQGGLVDIVVHNL
QIVAPGPRRIPQELVVDVTKMNIGDHITAGDIKLPEGCTLAADPELTVVSVLPPRLT
//
>1yl35 [g.41.8] 50S RIBOSOMAL PROTEIN L32
AKHPVPKKKTSKSKRDMRRSHHALTAPNLTECPQCHGKKLSHHICPNCGYYDGRQVLA
//
>1ym0A [b.47.1] FIBRINOTIC ENZYME COMPONENT B
IVGGIEARPYEFPWQVSVRRKSSDSHFCGGSIINDRWVVCAAHCMQGEAPALVSLVVGEH
DSSAASTVRQTHDVDSIFVNENYDPATLENDVSVIKTAVAITFDINVGPICAPDPANDYV
YRKSQCSGWGTINSGGVCCPAVLRYVTLNITTNAFCDAVYTSDTIYDDMICATDNTGMTD
RDSCQGDSGGPLSVKDGSGIFSLVGIVSWGIGCASGYPGVYSRVGFHAGWITDTITNN
//
>1ym0B [x.x.x] FIBRINOTIC ENZYME COMPONENT B
xPPVWYPGGQCGVSQYSDAGDMELPPG
//
>1ymh_1A [b.1.1 - b.1.1] FAB 16D9D6, LIGHT CHAIN
DIVMSQSPSSLAVSAGEKVTMSCKSSQSLLNSRTRKNYLAWYQQKPGQSPKVLIYWASTR
ESGVPDRFTGRGSGTDFTLTISSVQAEDQAVYYCKQAYIPPLTFGAGTKLELKRADAAPT
VSIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYS
MSSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1ymh_1B [b.1.1 - b.1.1] FAB 16D9D6, HEAVY CHAIN
QIQLVQSGPELKKPGETVKISCKASGYTFTDFSMHWVNQAPGKGLNWMGWVNTETGEPTY
ADDFKGRFAFSLETSASTAYLQINSLKNEDTATYFCARFLLRQYFDVWGAGTTVTVSSAK
TTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLY
TLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKIVPR
//
>1ymmB [d.19.1 - b.1.1] HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR BETA
TRPRFLWQPKRECHFFNGTERVRFLDRYFYNQEESVRFDSDVGEFRAVTELGRPDAEYWN
SQKDILEQARAAVDTYCRHNYGVVESFTVQRRVQPKVTVYPSLLVCSVSGFYPGSIEVRW
FLNGQEEKAGMVSTGLIQNGDWTFQTLVMLETVPRSGEVYTCQVEHPSVTSPLTVEWR
//
>1ymmD [b.1.1] T CELL RECEPTOR ALPHA CHAIN
QALSIQEGENATMNCSYKTSINNLQWYRQNSGRGLVHLILIRSNEREKHSGRLRVTLDTS
KKSSSLLITASRAADTASYFCATDTTSGTYKYIFGT
//
>1ymmE [b.1.1 - b.1.1] T-CELL RECEPTOR BETA CHAIN
GAVVSQHPSWVISKSGTSVKIECRSLDFQATTMFWYRQFPKQSLMLMATSNEGSKATYEQ
GVEKDKFLINHASLTLSTLTVTSAHPEDSSFYICSARDLTSGANNEQFFGPGTRLTVLED
LKNVFPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVSTDPQP
LKEQPALNDSRYSLSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVS
AEAWGR
//
>1ynjB [d.74.3 - d.181.1] DNA-DIRECTED RNA POLYMERASE ALPHA CHAIN
SKLKAPVFTATTQGDHYGEFVLEPLERGFGVTLGNPLRRILLSSIPGTAVTSVYIEDVLH
EFSTIPGVKEDVVEIILNLKELVVRFLDPKMASTTLILRAEGPKEVRAGDFTPSADVEIM
NPDLHIATLEEGGKLYMEVRVDRGVGYVPAERHGIKDRINAIPVDAIFSPVRRVAFQVED
TRLGQRTDLDKLTLRIWTDGSVTPLEALNQAVAILKEHLNYFANP
//
>1ynjC [e.29.1] DNA-DIRECTED RNA POLYMERASE BETA CHAIN
MEIKRFGRIREVIPLPPLTEIQVESYKKALQADVPPEKRENVGIQAAFKETFPIEEGDKG
KGGLVLDFLEYRIGDPPFSQDECREKDLTYQAPLYARLQLIHKDTGLIKEDEVFLGHLPL
MTEDGSFIINGADRVIVSQIHRSPGVYFTPDPARPGRYIASIIPLPKRGPWIDLEVEASG
VVTMKVNKRKFPLVLLLRVLGYDQETLVRELSAYGDLVQGLLDEAVLAMRPEEAMVRLFT
LLRPGDPPKKDKALAYLFGLLADPKRYDLGEAGRYKAEEKLGVGLSGRTLVRFEDGEFKD
EVFLPTLRYLFALTAGVPGHEVDDIDHLGNRRIRTVGELMADQFRVGLARLARGVRERMV
MGSPDTLTPAKLVNSRPLEAALREFFSRSQLSQFKDETNPLSSLRHKRRISALGPGGLTR
ERAGFDVRDVHRTHYGRICPVETPEGANIGLITSLAAYARVDALGFIRTPYRRVKNGVVT
EEVVYMTASEEDRYTIAQANTPLEGDRIATDRVVARRRGEPVIVAPEEVEFMDVSPKQVF
SLNTNLIPFLEHDDANRALMGSNMQTQAVPLIRAQAPVVMTGLEERVVRDSLAALYAEED
GEVVKVDGTRIAVRYEDGRLVEHPLRRYARSNQGTAFDQRPRVRVGQRVKKGDLLADGPA
SEEGFLALGQNVLVAIMPFDGYNFEDAIVISEELLKRDFYTSIHIERYEIEARDTKLGPE
RITRDIPHLSEAALRDLDEEGIVRIGAEVKPGDILVGRTSFKGEQEPSPEERLLRSIFGE
KARDVKDTSLRVPPGEGGIVVGRLRLRRGDPGVELKPGVREVVRVFVAQKRKLQVGDKLA
NRHGNKGVVAKILPVEDMPHLPDGTPVDVILNPLGVPSRMNLGQILETHLGLAGYFLGQR
YISPVFDGATEPEIKELLAEAFNLYFGKRQGEGFGVDKREKEVLARAEKLGLVSPGKSPE
EQLKELFDLGKVVLYDGRTGEPFEGPIVVGQMFIMKLYHMVEDKMHARSTGPYSLITQQP
LGGKAQFGGQRFGEMEVWALEAYGAAHTLQEMLTIKSDDIEGRNAAYQAIIKGEDVPEPS
VPESFRVLVKELQALALDVQTLDEKDNPVDIFEG
//
>1ynjD [e.29.1] DNA-DIRECTED RNA POLYMERASE BETA' CHAIN
KEVRKVRIALASPEKIRSWSYGEVEKPETINYRTLKPERDGLFDERIFGPIKDYECACGK
YKRQRFEGKVCERCGVEVTRSIVRRYRMGHIELATPAAHIWFVKDVPSKIGTLLDLSATE
LEQVLYFNKYIVLDPKGAVLDGVPVEKRQLLTDEEYRELRYGKQETYPLPAGVDALVKDG
EEVVKGQELAPGVVSRMDGVALYRFPRRVRVDYLRKERAALRIPLSAWVEKEAYRPGEVL
AELSEPYLFRAEESGVVELKDLAEGHLIYLRQEEEVVARYFLPAGMTPLVVEGEIVEVGQ
PLAEGKGLLRLPRHMTAKEVEAEEEGDSVHLTLFLEWTEPKDYKVAPHMNVIVPEGAKVQ
AGEKIVAAIDPEEEVIAEAEGVVHLHEPASILVVKARVYPFEDDVEVTTGDRVAPGDVLA
DGGKVKSEIYGRVEVDLVRNVVRVVESYDIDARMGAEAIQELLKELDLEKLERELLEEMK
HPSRARRAKARKRLEVVRAFLDSGNRPEWMILEAVPVLPPDLRPMVQVDGGRFATSDLND
LYRRLINRNNRLKKLLAQGAPEIIIRNEKRMLQEAVDAVIDNGRRGSPVTNPGSERPLRS
LTDILSGKQGRFRQNLLGKRVDYSGRSVIVVGPQLKLHQCGLPKRMALELFKPFLLKKME
EKAFAPNVKAARRMLERQRDIKDEVWDALEEVIHGKVVLLNRAPTLHRLGIQAFQPVLVE
GQSIQLHPLVCEAFNADFDGDQMAVHVPLSSFAQAEARIQMLSAHNLLSPASGEPLAKPS
RDIILGLYYITQVRKEKKGAGMAFATPEEALAAYERGEVALNAPIVVAGRETSVGRLKFV
FANPDEALLAVAHGLLDLQDVVTVRYLGRRLETSPGRILFARIVGEAVGDEKVAQELIQM
DVPQEKNSLKDLVYQAFLRLGMEKTARLLDALKYYGFTLSTTSGITIGIDDAVIPEEKQR
YLEEADRKLRQIEQAYEMGFLTDRERYDQVIQLWTETTEKVTQAVFKNFEENYPFNPLYV
MAQSGARGNPQQIRQLCGMRGLMQKPSGETFEVPVRSSFREGLTVLEYFISSHGARKGGA
DTALRTADSGYLTRKLVDVAHEIVVREADCGTTNYISVPLFQMDEVTRTLRLRKRSDIES
GLYGRVLAREVEALGRRLEEGRYLSLEDVHFLIKAAEAGEVREVPVRSPLTCQTRYGVCQ
KCYGYDLSMARPVSIGEAVGVVAAESIGEPGTQLTMRT
//
>1ynjK [a.143.1] DNA-DIRECTED RNA POLYMERASE OMEGA CHAIN
MAEPGIDKLFGMVDSKYRLTVVVAKRAQQLLRHRFKNTVLEPEERPKMRTLEGLYDDPNA
VTWAMKELLTGRLFFGENLVPEDRLQKEMERLYPT
//
>1ynjJ [x.x.x] DNA-DIRECTED RNA POLYMERASE BETA' CHAIN
TQGLPRVIELFEARRPKAKAVISEIDGVVRIEEGEDRLSVFVESEGFSKEYKLPKDARLL
VKDGDYVEAGQPLTRGAIDPHQLLEAKGPEAVERYLVDEIQKVYRAQGVKLHDKHIEIVV
RQMLKYVEVTDPGDSRLLEGQVLEKWDVEALNERLIAEGKVPVAWKPLLMGVTKSALSTK
SWLSAASFQNTTHVLTEAAIAGKKDELIGLKENVILGRLIPAGTGSDFVRFTQVVDQRTL
KAIEEARKE
//
>1ynjE (J) [x.x.x] DNA-DIRECTED RNA POLYMERASE BETA' CHAIN
TQGLPRVIELFEARRPKAKAVISEIDGVVRIEEGEDRLSVFVESEGFSKEYKLPKDARLL
VKDGDYVEAGQPLTRGAIDPHQLLEAKGPEAVERYLVDEIQKVYRAQGVKLHDKHIEIVV
RQMLKYVEVTDPGDSRLLEGQVLEKWDVEALNERLIAEGKVPVAWKPLLMGVTKSALSTK
SWLSAASFQNTTHVLTEAAIAGKKDELIGLKENVILGRLIPAGTGSDFVRFTQVVDQRTL
KAIEEARKE
//
>1ynjH (K) [a.143.1] DNA-DIRECTED RNA POLYMERASE OMEGA CHAIN
MAEPGIDKLFGMVDSKYRLTVVVAKRAQQLLRHRFKNTVLEPEERPKMRTLEGLYDDPNA
VTWAMKELLTGRLFFGENLVPEDRLQKEMERLYPT
//
>1ynlL [b.1.1 - b.1.1] IG GAMMA LIGHT CHAIN
ELVMTQSPLSLPVSLGDQASISCRPSQSLVHSNGNTYLHWYLQKPGQSPKLLIYRVSNRF
SGVPDRFSGSGSGTAFTLKISRVEAEDLGVYFCSQGTHVPYTFGGGTKLELKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1ynlH [b.1.1 - b.1.1] IG GAMMA HEAVY CHAIN
RVQLLESGAELMKPGASVQISCKATGYTFSFYWIEWVKERPGHGLEWIGEILPGSGRTNY
REKFKGKATFTADTSSNTAYMQLSSLTSEDSAVYYCTRGYSSMDYWGQGTSVTVSAAKTT
PPSVYPLAPGCGDTTGSSVTLGCLVKGYFPESVTVTWNSGSLSSSVHTFPALLQSGLYTM
SSSVTVPSSTWPSQTVTCSVAHPASSTTVDKKLEPSGPI
//
>1yntA [b.1.1 - b.1.1] 4F11E12 FAB VARIABLE LIGHT CHAIN REGION
DIQVTQTTSSLSASLGDRVTISCRASQDISNYLNWYQQKPDGTVKLLIYYTSRLHSGVPS
RFSGSGSGTDYSLTISNLEQEDIATYFCQQGNTLPYTFGGGTKLEIKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRNE
//
>1yntB [b.1.1] 4F11E12 FAB VARIABLE HEAVY CHAIN REGION
QVQLQQSGAELVRPGVSVKISCKGSGYTFTDYGMHWVKQSHAKSLEWIGIISTYSGDASY
NQKFKGKATMTVDKSSSTAYMELARLTSEDSAIYYCARSSTWYYFDYWGQGTTLTVSSAK
TTAPSVYPLAPVCGDTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDLY
TLSSSVTVTSSTWPSQSITCNVAHPASSTKVDKKIEPR
//
>1yntE [d.15.7] PROTEIN L
EVTIKVNLIFADGKIQTAEFKGTFEEATAEAYRYADLLAKVNGEYTADLEDGGNHMNIKF
A
//
>1yntF [b.6.2 - b.6.2] MAJOR SURFACE ANTIGEN P30
PLVANQVVTCPDKKSTAAVILTPTENHFTLKCPKTALTEPPTLAYSPNRQICPAGTTSSC
TSKAVTLSSLIPEAEDSWWTGDSASLDTAGIKLTVPIEKFPVTTQTFVVGCIKGDDAQSC
MVTVTVQARASSVVNNVARCSYGADSTLGPVKLSAEGPTTMTLVCGKDGVKVPQDNNQYC
SGTTLTGCNEKSFKDILPKLTENPWQGNASSDKGATLTIKKEAFPAESKSVIIGCTGGSP
EKHHCTVKLEFA
//
>1ypz_2C (A) [d.19.1 - b.1.1] H2-T22 PROTEIN
GSHSLRYFYTAVSRPGLGEPWFIIVGYVDDMQVLRFSSKEETPRMAPWLEQEEADNWEQQ
TRIVTIQGQLSERNLMTLVHFYNKSMDDSHTLQWLQGCDVEPDRHLCLWYNQLAYDSEDL
PTLNENPSSCTVGNSTVPHISQDLKSHCSDLLQKYLEKGKERLLRSDPPKAHVTRHPRPE
GDVTLRCWALGFYPADITLTWQLNGEELTQDMELVETRPAGDGTFQKWAAVVVPLGKEQS
YTCHVYHEGLPEPLILRWGG
//
>1ypz_2D (B) [b.1.1] BETA-2-MICROGLOBULIN
ADPIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFS
KDWSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM
//
>1ypz_3E [b.1.1 - b.1.1] T CELL RECEPTOR DELTA
GDQVEQSPSALSLHEGTDSALRCNFTTTMRSVQWFRQNSRGSLISLFYLASGTKENGRLK
SAFDSKERRYSTLHIRDAQLEDSGTYFCAADTWHISEGYELGTDKLVFGQGTQVTVEPKS
QPPAKPSVFIMKNGTNVACLVKDFYPKEVTISLRSSKKIVEFDPAIVISPSGKYSAVKLG
QYGDSNSVTCSVQHNSETVHSTDFEAA
//
>1ypz_3F [b.1.1 - b.1.1] T-CELL RECEPTOR GAMMA CHAIN
HGKLEQPEISISRPRDETAQISCKVFIESFRSVTIHWYRQKPNQGLEFLLYVLATPTHIF
LDKEYKKMEASKNPSASTSILTIYSLEEEDEAIYYCSYGEGSSGFHKVFAEGTKLIVIPS
DKRLDADISPKPTIFLPSVAETNLHKTGTYLCLLEAFFPDVIRVYWKEKDGNTILDSQEG
DTLKTNDTYMKFSWLTVPERAMGKEHRCIVKHENNKGGADQAIFFPSIKK
//
>1yq3A [c.3.1 - d.168.1 - a.7.3] SUCCINATE DEHYDROGENASE FLAVOPROTEIN SUBUNIT
ISTQYPVVDHEFDAVVVGAGGAGLRAAFGLSEAGFNTACVTKLFPTRSHTVAAQGGINAA
LGNMEDDNWRWHFYDTVKGSDWLGDQDAIHYMTEQAPAAVIELENYGMPFSRTEEGKIYQ
RAFGGQSLQFGKGGQAHRCCCVADRTGHSLLHTLYGRSLRYDTSYFVEYFALDLLMENGE
CRGVIALCIEDGTIHRFRAKNTVIATGGYGRTYFSCTSAHTSTGDGTAMVTRAGLPCQDL
EFVQFHPTGIYGAGCLITEGCRGEGGILINSQGERFMERYAPVAKDLASRDVVSRSMTIE
IREGRGCGPEKDHVYLQLHHLPPQQLATRLPGISETAMIFAGVDVTKEPIPVLPTVHYNM
GGIPTNYKGQVITHVNGEDKVVPGLYACGEAASASVHGANRLGANSLLDLVVFGRACALT
IAETCKPGEPVPSIKPNAGEESVANLDKLRFADGTIRTSEARLNMQKTMQSHAAVFRTGS
ILQEGCEKLSQIYRDLAHLKTFDRGIVWNTDLVETLELQNLMLCALQTIYGAEARKESRG
AHAREDYKLRIDEFDYSKPLQGQQKRPFEEHWRKHTLSYVDVKSGKVTLKYRPVIDRTLN
EEDCSSVPPAIRSY
//
>1yq3B [d.15.4 - a.1.2] SUCCINATE DEHYDROGENASE IP SUBUNIT
AATSRIKKFSIYRWDPDKPGDKPRMQTYEVDLNKCGPMVLDALIKIKNELDSTLTFRRSC
REGICGSCAMNIAGGNTLACTKKIDPDLSKTTKIYPLPHMYVVKDLVPDLSNFYAQYKSI
EPYLKKKDESKQGKEQYLQSIEDRQKLDGLYECILCACCSTSCPSYWWNGDKYLGPAVLM
QAYRWMIDSRDDYTEERLAQLQDPFSLYRCHTIMNCTRTCPKGLNPGKAIAEIKKMMATY
KE
//
>1yq3C [x.x.x] SUCCINATE DEHYDROGENASE CYTOCHROME B, LARGE
ATTAKEEMARFWEKNTKSSRPLSPHISIYKWSLPMAMSITHRGTGVALSLGVSLFSLAAL
LLPEQFPHYVAVVKSLSLSPALIYSAKFALVFPLSYHTWNGIRHLVWDMGKGFKLSQVEQ
SGVVVLILTLLSSAGIAAI
//
>1yq3D [x.x.x] SUCCINATE DEHYDROGENASE CYTOCHROME B, SMALL
SSKAASLHWTSERAVSALLLGLLPAAYLYPGPAVDYSLAAALTLHGHWGLGQVITDYVHG
DTPIKVANTGLYVLSAITFTGLCYFNYYDVGICKAVAMLWSI
//
>1yqvL [b.1.1 - b.1.1] HYHEL-5 ANTIBODY LIGHT CHAIN
MDIVLTQSPAIMSASPGEKVTMTCSASSSVNYMYWYQQKSGTSPKRWIYDTSKLASGVPV
RFSGSGSGTSYSLTISSMETEDAATYYCQQWGRNPTFGGGTKLEIKRADAAPTVSIFPPS
SEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLTL
TKDEYERHNSYTCEATHKTSTSPIVKSFNRN
//
>1yqvY [d.2.1] HEN EGG WHITE LYSOZYME
KVFGRCELAAAMKRHGLDNYRGYSLGNWVCAAKFESNFNTQATNRNTDGSTDYGILQINS
RWWCNDGRTPGSRNLCNIPCSALLSSDITASVNCAKKIVSDGNGMNAWVAWRNRCKGTDV
QAWIRGCRL
//
>1yr4A [x.x.x]
IVGGTDATLGEFPYQLSFQETFIGFSFHFCGASIYNENYAITAGHCVYGDDYENPSGLQI
VAGELDMSVNEGSEQIITVSKIILHENFDYNLLDNDISLLKLSGSLTFNDNVAPIALPEQ
GHTATGDVIVTGWGTTSEGGNTPDVLQKVTVPLVSDEDCRADYGADEILDSMICAGVPEG
GKDSCQGDSGGPLAASDTGSTYLAGIVSWGYGCARPGYPGVYTEVSYHVDWIKANAV
//
>1yr4B [x.x.x]
QECTPGQTKKQDCNTCNCTPTGVWACTRKGCPP
//
>1yrtA [x.x.x] BIFUNCTIONAL HEMOLYSIN-ADENYLATE CYCLASE
AGYANAADRESGIPAAVLDGIKAVAKEKNATLMFRLVNPHSTSLIAEGVATKGLGVHAKS
SDWGLQAGYIPVNPNLSKLFGRAPEVIARADNDVNSSLAHGHTAVDLTLSKERLDYLRQA
GLVTGMADGVVASNHAGYEQFEFRVKETSDGRYAVQYRRKGGDDFEAVKVIGNAAGIPLT
ADIDMFAIMPHLSNFRDSARSSVTSGDSVTDYLARTRRALDRERIDLLWKIARAGARSAV
GTEARRQFRYDGDMNIGVITDFELEVRNALNRRAHAVGAQDVVQHGTEQNNPFPEADEKI
FVVSATGESQMLTRGQLKEYIGQQRGEGYVFYENRAYGVAGKSLFDDGLGA
//
>1yrtB [a.39.1] CALMODULIN
TDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNY
EEFVQMMTA
//
>1yshC [d.79.3] RIBOSOMAL PROTEIN L30
KAKKSGENINNKLQLVMKSGKYTLGYKTVLKTLRSSKGKLIILANNCPPLRKSEIEYYAM
LAKISVHHFHGNNVDLGTACGKYYRVCCLSILDPGDSDIISTTT
//
>1yshE [x.x.x] 40S RIBOSOMAL PROTEIN S13
SVTGSKILRILKAHGLAPEIPEDLYFLIKKAVAIRKHLERNRKDKDSKFRLILVESRIHR
LARYYKRTKKLPPTWKYESTTAST
//
>1ytfB [a.32.1] PROTEIN (TRANSCRIPTION FACTOR IIA - TOA1N
SNAEASRVYEIIVESVVNEVREDFENAGIDEQTLQDLKNIWQKKLT
//
>1ytfC [b.56.1] PROTEIN (TRANSCRIPTION FACTOR IIA - TOA1C
ENLMLCLYDKVTRTKARWKCSLKDGVVTINRNDYTFQKAQVEAEWV
//
>1ytzA (C) [a.39.1] TROPONIN C
TDQQAEARAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIE
EVDEDGSGTIDFEEFLVMMVRQMKEDAKGKSEEELANCFRIFDKNADGFIDIEELGEILR
ATGEHVTEEDIEDLMKDSDKNNDGRIDFDEFLKMMEGVQ
//
>1ytzB (T) [h.1.25] TROPONIN T
SYSSYLAKADQKRGKKQTARETKKKVLAERRKPLNIDHLNEDKLRDKAKELWDWLYQLQT
EKYDFAEQIKRKKYEIVTLRNRIDQAQKHS
//
>1ytzD (I) [h.1.25] TROPONIN I
EEKKRRAATARRQHLKSAMLQLAVTEIEKEAAAKEVEKQNYLAEHSPPLSLPGSMQELQE
LSKKLHAKIDSVDEERYDTEVKLQKTNKELEDLSQKLFDLRGKFKRPPLRRVRMSADAML
RALLGSKHKVNMDLRANLKQV
//
>1yuh_2A (L) [b.1.1 - b.1.1] 88C6/12 FAB (LIGHT CHAIN)
AVVTQESALTTSPGETVTLTCRSSTGAVTTSNYANWVQEKPDRLFTGLIGGTNNRGPGVP
ARFSGSLIGDKAALTITGAQTEDEAIYFCALWYSNHWVFGGGTKLTVLGQPKSSPSVTLF
PPSSEELETNKATLVCTITDFYPGVVTVDWKVDGTPVTEGMETTQPSKQSNNKYMASSYL
TLSARAWERHASYSCQVTHEGHTVEKSLSRA
//
>1yuh_2B (H) [b.1.1 - b.1.1] 88C6/12 FAB (HEAVY CHAIN)
QVQFQQSGAELVKPGASVKLSCKASGYTFTSYLMHWIKQRPGRGLEWIGRIDPNNVVTKF
NEKFKSKATLTVDKPSSTAYMELSSLTSEDSAVYYCARYAYCRPMDYWGQGTTVTVSSAA
TTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGALSSGVHTFPAVLQSDLY
TLSSSVTVPASTWPSGTVTCNVAHPASSTAVDKKIVPR
//
>1yukA [x.x.x] INTEGRIN BETA-2 A CHAIN
QECTKFKVSSCRECIESGPGCTWCQKLNFTGPGDPDSIRCDTRPQLLMRGCAADDIMDPT
SLAETQEQKQLSPQKVTLYLRPGQAAAFNVTFRR
//
>1yukB [x.x.x] INTEGRIN BETA-2 B CHAIN
SRVFLDHNALPDTLKVTYDSFCSNGVTHRNQPRGDCDGVQINVPITFQVKVTATECIQEQ
SFVIRALGFTDIVTVQVLPQCECRCRDQSRDRSLCHGKGFLECGICRCDTGYIGKNCEHH
//
>1yv0A (T) [h.1.25] TROPONIN T, FAST SKELETAL MUSCLE ISOFORMS
LAKADQKRGKKQTARETKKKVLAERRKPLNIDHLNEDKLRDKAKELWDWLYQLQTEKYDF
AEQIKRKKYEIVTLRNRIDQAQKHS
//
>1yv0B (I) [h.1.25] TROPONIN I, FAST SKELETAL MUSCLE
EEKKRRAATARRQHLKSAMLQLAVTEIEKEAAAKEVEKQNYLAEHSPPLSLPGSMQELQE
LSKKLHAKIDSVDEERYDTEVKLQKTNKELEDLSQKLFDLRGKFKRPPLRRVRMSA
//
>1yv0D (C) [a.39.1] TROPONIN C, SKELETAL MUSCLE
TDQQAEARAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIE
EVDEDGSGTIDFEEFLVMMVRQELANCFRIFDKNADGFIDIEELGEILRATGEHVTEEDI
EDLMKDSDKNNDGRIDFDEFLKMMEGVQ
//
>1yvbA [d.3.1] FALCIPAIN 2
QMNYEEVIKKYRGEENFDHAAYDWRLHSGVTPVKDQKNCGSCWAFSSIGSVESQYAIRKN
KLITLSEQELVDCSFKNYGCNGGLINNAFEDMIELGGICPDGDYPYVSDAPNLCNIDRCT
EKYGIKNYLSVPDNKLKEALRFLGPISISVAVSDDFAFYKEGIFDGECGDQLNHAVMLVG
FGMKEIVNPLTKKGEKHYYYIIKNSWGQQWGERGFINIETDESGLMRKCGLGTDAFIPLI
E
//
>1yvbI [d.17.1] CYSTATIN
RLLGAPVPVDENDEGLQRALQFAMAEYNRASNDKYSSRVVRVISAKRQLVSGIKYILQVE
IGRTTCPKSSGDLQSCEFHDEPEMAKYTTCTFVVYSIPWLNQIKLLESKCQ
//
>1yy8_2C (A) [b.1.1 - b.1.1] CETUXIMAB FAB LIGHT CHAIN
DILLTQSPVILSVSPGERVSFSCRASQSIGTNIHWYQQRTNGSPRLLIKYASESISGIPS
RFSGSGSGTDFTLSINSVESEDIADYYCQQNNNWPTTFGAGTKLELKRTVAAPSVFIFPP
SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT
LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGA
//
>1yy8_2D (B) [b.1.1 - b.1.1] CETUXIMAB FAB HEAVY CHAIN
QVQLKQSGPGLVQPSQSLSITCTVSGFSLTNYGVHWVRQSPGKGLEWLGVIWSGGNTDYN
TPFTSRLSINKDNSKSQVFFKMNSLQSNDTAIYYCARALTYYDYEFAYWGQGTLVTVSAA
STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG
LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKS
//
>1yy9A [c.10.2 - g.3.9 - c.10.2 - g.3.9] EPIDERMAL GROWTH FACTOR RECEPTOR
EEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEV
AGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILH
GAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEE
NCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCP
PLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRK
CKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTP
PLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNI
TSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENKCKATGQV
CHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCKLLEGEPREFVENSECIQCHPECLPQ
AMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCT
YGCTGPGLRGCPT
//
>1yy9C [b.1.1 - b.1.1] CETUXIMAB FAB LIGHT CHAIN
DILLTQSPVILSVSPGERVSFSCRASQSIGTNIHWYQQRTNGSPRLLIKYASESISGIPS
RFSGSGSGTDFTLSINSVESEDIADYYCQQNNNWPTTFGAGTKLELKRTVAAPSVFIFPP
SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT
LSKADYEKHKVYACEVTHQGLSSPVTKSFNR
//
>1yy9D [b.1.1 - b.1.1] CETUXIMAB FAB HEAVY CHAIN
QVQLKQSGPGLVQPSQSLSITCTVSGFSLTNYGVHWVRQSPGKGLEWLGVIWSGGNTDYN
TPFTSRLSINKDNSKSQVFFKMNSLQSNDTAIYYCARALTYYDYEFAYWGQGTLVTVSAA
STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG
LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPK
//
>1yyl_3S (M) [k.23.1] CD4M33, SCORPION-TOXIN MIMIC OF CD4
NLHFCQLRCKSLGLLGKCAGSxCACx
//
>1yyl_3P (G) [d.172.1] EXTERIOR MEMBRANE GLYCOPROTEIN(GP120)
EVKLENVTENFNMWKNNMVEQMHEDIISLWDQSLKPCVKLTPLCVGAGSCNTSVITQACP
KVSFEPIPIHYCAPAGFAILKCNDKKFNGTGPCTNVSTVQCTHGIRPVVSTQLLLNGSLA
EEEIVIRSENFTNNAKTIIVQLNESVVINCTGAGHCNLSKTQWENTLEQIAIKLKEQFGN
NKTIIFNPSSGGDPEIVTHSFNCGGEFFYCNSTQLFTWNDRNITLPCRIKQIINMWQEVG
KAMYAPPIRGQIRCSSNITGLLLTRDGGKDTNGTEIFRPGGGDMRDNWRSELYKYKVVKI
E
//
>1yypA [d.131.1 - d.131.1] DNA POLYMERASE PROCESSIVITY FACTOR
EPPTLALRLKPYKTAIQQLRSVIRALKENTTVTFLPTPSLILQTVRSHCVSKITFNSSCL
YITDKSFQPKTINNSTPLLGNFMYLTSSKDLTKFYVQDISDLSAKISMCAPDFNMEFSSA
CVHGQDIVRESENSAVHVDLDFGVVADLLKWIGPTGTVQILVHAGPPAIKFILTNGSELE
FTSNNRVSFHGVKNMRINVQLKNFYQTLLNCAVTKLPCTLRIVTEHDTLLYVASRNGLFA
VENFLTEEP
//
>1yypB [x.x.x] DNA POLYMERASE
RRLHLEPAFLPYSVKAHECC
//
>1z0jA [c.37.1] RAS-RELATED PROTEIN RAB-22A
GSALRELKVCLLGDTGVGKSSIMWRFVEDSFDPNINPTIGASFMTKTVQYQNELHKFLIW
DTAGLERFRALAPMYYRGSAAAIIVYDITKEETFSTLKNWVRELRQHGPPSIVVAIAGNK
CDLTDVREVMERDAKDYADSIHAIFVETSAKNAININELFIEISRRIPS
//
>1z0jB [a.2.19] FYVE-FINGER-CONTAINING RAB5 EFFECTOR PROTEIN
IEEELLLQQIDNIKAYIFDAKQCGRLDEVEVLTENLRELKHTLAKQKGGTD
//
>1z0k_2C [c.37.1] GTP-BINDING PROTEIN
YDFLFKFLVIGNAGTGKSCLLHQFIEKKFKDDSNHTIGVEFGSKIINVGGKYVKLQIWDT
AGLERFRSVTRSYYRGAAGALLVYDITSRETYNALTNWLTDARMLASQNIVIILCGNKKD
LDADREVTFLEASRFAQENELMFLETSALTGEDVEEAFVQCARKILNK
//
>1z0k_2D (B) [a.2.19] FYVE-FINGER-CONTAINING RAB5 EFFECTOR PROTEIN
EGWLPLSGGQGQSEDSDPLLQQIHNITSFIRQAKAAGRMDEVRTLQENLRQLQDEYDQQQ
T
//
>1z2bA [c.32.1 - d.79.2] TUBULIN ALPHA CHAIN
RECISIHVGQAGVQIGNACWELYCLEHGIQPDGQMPDSFNTFFSETGAGKHVPRAVFVDL
EPTVIDEVRTGTYRQLFHPEQLITGKEDAANNYARGHYTIGKEIIDLVLDRIRKLADQCT
GLQGFLVFHSFGGGTGSGFTSLLMERLSVDYGKKSKLEFSIYPAPQVSTAVVEPYNSILT
THTTLEHSDCAFMVDNEAIYDICRRNLDIERPTYTNLNRLIGQIVSSITASLRFDGALNV
DLTEFQTNLVPYPRIHFPLATYAPVISAEKAYHEQLSVAEITNACFEPANQMVKCDPRHG
KYMACCLLYRGDVVPKDVNAAIATIKTKRSIQFVDWCPTGFKVGINYQPPTVVPGGDLAK
VQRAVCMLSNTTAIAEAWARLDHKFDLMYAKRAFVHWYVGEGMEEGEFSEAREDMAALEK
DYEEVGI
//
>1z2bE [a.137.10] RB3 STATHMIN-LIKE DOMAIN 4
ADMEVIELNKCTSGQSFEVILKPPSFDPSLEEIQKKLEAAEERRKYQEAELLKHLAEKRE
HEREVIQKAIEENNNFIKMAKEKLAQKMESNKENREAHLAAMLERLQEKDKHAEEVRKNK
ELKE
//
>1z2c_1A [c.37.1] RHO-RELATED GTP-BINDING PROTEIN RHOC
MAAIRKKLVIVGDGACGKTCLLIVNSKDQFPEVYVPTVFENYIADIEVDGKQVELALWDT
AGQEDYDRLRPLSYPDTDVILMCFSIDSPDSLENIPEKWTPEVKHFCPNVPIILVGNKKD
LRQDEHTRRELAKMKQEPVRSEEGRDMANRISAFGYLECSAKTKEGVREVFEMATRAGL
//
>1z2c_1B [a.118.1] DIAPHANOUS PROTEIN HOMOLOG 1
VLVLFEQMLVDMNLNEEKQQPLREKDIVIKREMVSQYLHTSSSRSAMMYIQELRSGLRDM
HLLSCLESLRVSLNNNPVSWVQTFGAEGLASLLDILKRLHDEKDSRNQHEIIRCLKAFMN
NKFGIKTMLETEEGILLLVRAMDPAVPNMMIDAAKLLSALCILPQPEDMNERVLEAMTER
AEMDEVERFQPLLDGLKSGTSIALKVGCLQLINALITPAEELDFRVHIRSELMRLGLHQV
LQELREIENEDMKVQLCVFDEQGDEDFFDLKGRLDDIRMEMDDFGEVFQIILNTVKDSKA
EPHFLSILQHLLLVRNDYEARPQYYKLIEECVSQIVLHKNGTDPDF
//
>1z3eA [c.47.1] REGULATORY PROTEIN SPX
HMVTLYTSPSCTSCRKARAWLEEHEIPFVERNIFSEPLSIDEIKQILRMTEDGTDEIIST
RSKVFQKLNVNVESMPLQDLYRLINEHPGLLRRPIIIDEKRLQVGYNEDEIRRFLPRKV
//
>1z3eB [a.60.3] DNA-DIRECTED RNA POLYMERASE ALPHA CHAIN
KEKVLEMTIEELDLSVRSYNCLKRAGINTVQELANKTEEDMMKVRNLGRKSLEEVKAKLE
ELGLGLR
//
>1z3g_1L [b.1.1 - b.1.1] 2A8 FAB LIGHT CHAIN
QIVLTQSPAIMSASPGEKVTMTCSASSSVSYMNWYQQKSGTSPKRWIYDTSKLASGVPAH
FRGSGSGTSYSLTISGMEAEDAATYYCQQWSSNPPTFGSGTKLEINRADTAPTVSIFPPS
SEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLTL
TKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC
//
>1z3g_1H [b.1.1] 2A8 FAB HEAVY CHAIN
QLQQPGAELVKPGASVKLSCKASGYTFTSYWMHWVKQRPGQGLEWIGMIHPHSGSTNYNE
KFKSKATLTVDKSSSTAYMQLSSLTSEDSAVYYCARGWDVAYWGQGTLVTVSAAKTTPPS
VYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTLSSS
VTVPSSTWPSETVTCNVAHPASSTKVDKKIVPRD
//
>1z3g_1A [x.x.x] OOKINETE SURFACE PROTEIN PVS25
AVTVDTICKNGQLVQMSNHFKCMCNEGLVHLSENTCEEKNECKKETLGKACGEFGQCIEN
PDPAQVNMYKCGCIEGYTLKEDTCVLDVCQYKNCGESGECIVEYLSEIQSAGCSCAIGKV
PNPEDEKKCTKTGETACQLKCNTDNEVCKNVEGVYKCQCMEGFTFDKEKNVCL
//
>1z56B [x.x.x] LIGASE INTERACTING FACTOR 1
FEMADKLYKDICCVNDSYRNIKESDSSNRNRVEQLARERELLDKLLETRDERTRAMMVTL
LNEKKKKIRELHEILR
//
>1z56C [x.x.x] DNA LIGASE IV
SNIFAGLLFYVLSDYVTEDTGIRITRAELEKTIVEHGGKLIYNVILKRHSIGDVRLISCK
TTTECKALIDRGYDILHPNWVLDCIAYKRLILIEPNYCFNVSQKMRAVAEKRVDCLGDSF
ENDISETKLSSLYKSQLSLPPMGELEIDSEVRRFPLFIEMKIKLFGGKITDQQSLCNLII
IPYTDPILRKDCMNEVHEKIKEQIKASDTIPKIARVVAPEWVDHSINENCQVPEEDF
//
>1z5rD [x.x.x]
GHSYEKYNNWETIEAWTKQVTSENPDLISRTAIGTTFLGNNIYLLKVGK
//
>1z5rF [x.x.x]
GPNKPAIFMDCGFHAREWISHAFCQWFVREAVLTYGYESHMTEFLNDFYVLPVLNIDGYI
YTWTKNRMWRKTRSTNAGTTCIGTDPNRNFDAGWCTTGASTDPCDETYCGSAAESEKETK
ALADFIRNNLSSIKAYLTIHSYSQMILYPYSYDYKLPENNAELNNLAKAAVKELATLYGT
KYTYGPGATTIYPAAGGSDDWAYDQGIKYSFTFELRDKGRYGFILPESQIQATCEETMLA
IKYVTNYVLGHL
//
>1z5sA [d.20.1] UBIQUITIN-CONJUGATING ENZYME E2 I
SGIALSRLAQERKAWRKDHPFGFVAVPTKNPDGTMNLMNWECAIPGKKGTPWEGGLFKLR
MLFKDDYPSSPPKCKFEPPLFHPNVYPSGTVCLSILEEDKDWRPAITIKQILLGIQELLN
EPNIQDPAQAEAYTIYCQNRVEYEKRVRAQAKKFAP
//
>1z5sB [d.15.1] UBIQUITIN-LIKE PROTEIN SMT3C
EYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKE
LGMEEEDVIEVYQEQTGG
//
>1z5sD [x.x.x] RAN-BINDING PROTEIN 2
SLDVLIVYELTPTAEQKALATKLKLPPTFFCYKNRPDYVSEEEEDDEDFETAVKKLNGKL
YLDGS
//
>1z5xU [a.123.1] ULTRASPIRACLE PROTEIN (USP) A HOMOLOGUE OF RXR
VSDICQAADRQLYQLIEWAKHIPHFTELPVEDQVILLKSGWNELLIAGFSHRSMSVKDGI
MLATGLVVHRNCAHQAGVGAIFDRVLTELVAKMREMKMDKTELGCLRSIVLFNPEAKGLK
STQQVENLREKVYAILEEYCRQTYPDQSGRFAKLLLRLPALRSIGLKCLEHLFFFKLVGN
TSIDSFLLSMLES
//
>1z5xE [a.123.1] ECDYSONE RECEPTOR LIGAND BINDING DOMAIN
PITPEQEELIHRLVYFQNEYEHPSPEDIKRIVNAAPEEENVAEERFRHITEITILTVQLI
VEFSKRLPGFDKLIREDQIALLKACSSEVMMFRMARRYDAETDSILFATNQPYTRESYTV
AGMGDTVEDLLRFCRHMCAMKVDNAEYALLTAIVIFSERPSLSEGWKVEKIQEIYIEALK
AYVENRRKPYATTIFAKLLSVLTELRTLGNMNSETCFSLKLKNRKVPSFLEEIWDVV
//
>1z5yD [b.1.17] THIOL:DISULFIDE INTERCHANGE PROTEIN DSBD
RSQFVPADQAFAFDFQQNQHDLNLTWQIKDGYYLYRKQIRITPEHAKIADVQLPQGVWHE
DEFYGKSEIYRDRLTLPVTINQASAGATLTVTYQGSADAGFCYPPETKTVPLSEVVAN
//
>1z5yE [c.47.1] THIOL:DISULFIDE INTERCHANGE PROTEIN DSBE
RLESLDNPGQFYQADVLTQGKPVLLNVWATWCPTSRAEHQYLNQLSAQGIRVVGMNYKDD
RQKAISWLKELGNPYALSLFDGDGMLGLDLGVYGAPETFLIDGNGIIRYRHAGDLNPRVW
EEEIKPLWEKYSKEAA
//
>1z6oA [a.25.1] FERRITIN LIGHT CHAIN
ADTCYNDVALDCGITSNSLALPRCNAVYGEYGSHGNVATELQAYAKLHLERSYDYLLSAA
YFNNYQTNRAGFSKLFKKLSDEAWSKTIDIIKHVTKRGDKMNFDQHSTMKTERKNYTAEN
HELEALAKALDTQKELAERAFYIHREATRNSQHLHDPEIAQYLEEEFIEDHAEKIRTLAG
HTSDLKKFITANNGHDLSLALYVFDEYLQKTV
//
>1z6oM [a.25.1] FERRITIN HEAVY CHAIN
TQCNVNPVQIPKDWITMHRSCRNSMRQQIQMEVGASLQYLAMGAHFSKDVVNRPGFAQLF
FDAASEEREHAMKLIEYLLMRGELTNDVSSLLQVRPPTRSSWKGGVEALEHALSMESDVT
KSIRNVIKACEDDSEFNDYHLVDYLTGDFLEEQYKGQRDLAGKASTLKKLMDRHEALGEF
IFDKKLLGIDV
//
>1z7mB [d.104.1] ATP PHOSPHORIBOSYLTRANSFERASE REGULATORY SUBUNIT
YLLPEESAEMTLNQVKSLRQIEGRLRKLFSLKNYQEVMPPSFEYTQLYTALESNGKTFNQ
EKMFQFIKHEGQSITLRYDFTLPLVRLYSQIKDSTSARYSYFGKIFRKEKRHKGRSTENY
QIGIELFGESADKSELEILSLALQVIEQLGLNKTVFEIGSAKFFQRLCQLADGSTELLTE
LLLKKDLSGLNAFIEKNNFSKELRGLLKEIFITNELSRLENLVTNTKDDVLISSFDQLKE
FSEKLSMIKPIIIDLGMVPKMDYYTDLMFKAYSSAANQPILSGGRYDQLLSNFQEEAFAI
GFCCHMDTILKALERQEL
//
>1z7mG [c.94.1] ATP PHOSPHORIBOSYLTRANSFERASE
MIKIAITKGRIQKQVTKLLENADYDVEPILRELQIKTKDDLQIIFGKPNDVITFLEHGIV
DIGFVGKDTLDENDFDDYYELLYLKIGQCIFALASYPDFSNKNFQRHKRIASKYPRVTKK
YFAQKQEDIEIIKLEGSVELGPVVGLADAIVDIVETGNTLSANGLEVIEKISDISTRMIV
NKSSFKFKKDKIIEMVERLEDAQ
//
>1z7qA [d.153.1] PROTEASOME COMPONENT C7-ALPHA
AGYDRHITIFSPEGRLYQVEYAFKATNQTNINSLAVRGKDCTVVISQKKVPDKLLDPTTV
SYIFCISRTIGMVVNGPIPDARNAALRAKAEAAEFRYKYGYDMPCDVLAKRMANLSQIYT
QRAYMRPLGVILTFVSVDEELGPSIYKTDPAGYYVGYKATATGPKQQEITTNLENHFKKS
KIDHINEESWEKVVEFAITHMIDALGTEFSKNDLEVGVATKDKFFTLSAENIEERLVAIA
EQD
//
>1z7qF [d.153.1] PROTEASOME COMPONENT PRE5
MFRNNYDGDTVTFSPTGRLFQVEYALEAIKQGSVTVGLRSNTHAVLVALKRNADELSSYQ
KKIIKCDEHMGLSLAGLAPDARVLSNYLRQQCNYSSLVFNRKLAVERAGHLLCDKAQKNT
QSYGGRPYGVGLLIIGYDKSGAHLLEFQPSGNVTELYGTAIGARSQGAKTYLERTLDTFI
KIDGNPDELIKAGVEAISQSLRDESLTVDNLSIAIVGKDTPFTIYDGEAVAKYI
//
>1z7qG [d.153.1] PROTEASOME COMPONENT C1
TGYDLSNSVFSPDGRNFQVEYAVKAVENGTTSIGIKCNDGVVFAVEKLITSKLLVPQKNV
KIQVVDRHIGCVYSGLIPDGRHLVNRGREEAASFKKLYKTPIPIPAFADRLGQYVQAHTL
YNSVRPFGVSTIFGGVDKNGAHLYMLEPSGSYWGYKGAATGKGRQSAKAELEKLVDHHPE
GLSAREAVKQAAKIIYLAHEDNKEKDFELEISWCSLSETNGLHKFVKGDLLQEAIDFAQK
EIN
//
>1z7qP (B) [d.153.1] PROTEASOME COMPONENT Y7
TDRYSFSLTTFSPSGKLGQIDYALTAVKQGVTSLGIKATNGVVIATEKKSSSPLAMSETL
SKVSLLTPDIGAVYSGMGPDYRVLVDKSRKVAHTSYKRIYGEYPPTKLLVSEVAKIMQEA
TQSGGVRPFGVSLLIAGHDEFNGFSLYQVDPSGSYFPWKATAIGKGSVAAKTFLEKRWND
ELELEDAIHIALLTLKESVEGEFNGDTIELAIIGDENPDLLGYTGIPTDKGPRFRKLTSQ
EINDRLEAL
//
>1z7qQ (C) [d.153.1] PROTEASOME COMPONENT Y13
SRRYDSRTTIFSPEGRLYQVEYALESISHAGTAIGIMASDGIVLAAERKVTSTLLEQDTS
TEKLYKLNDKIAVAVAGLTADAEILINTARIHAQNYLKTYNEDIPVEILVRRLSDIKQGY
TQHGGLRPFGVSFIYAGYDDRYGYQLYTSNPSGNYTGWKAISVGANTSAAQTLLQMDYKD
DMKVDDAIELALKTLSKTTDSSALTYDRLEFATIRKGANDGEVYQKIFKPQEIKDILVKT
GIT
//
>1z7qS (E) [d.153.1] PROTEASOME COMPONENT PUP2
SEYDRGVSTFSPEGRLFQVEYSLEAIKLGSTAIGIATKEGVVLGVEKRATSPLLESDSIE
KIVEIDRHIGCAMSGLTADARSMIEHARTAAVTHNLYYDEDINVESLTQSVCDLALRFGE
GASGEERLMSRPFGVALLIAGHDADDGYQLFHAEPSGTFYRYNAKAIGSGSEGAQAELLN
EWHSSLTLKEAELLVLKILKQVMEEKLDENNAQLSCITKQDGFKIYDNEKTAELIKELKE
KEAAE
//
>1z7qT (F) [d.153.1] PROTEASOME COMPONENT PRE5
MFRNNYDGDTVTFSPTGRLFQVEYALEAIKQGSVTVGLRSNTHAVLVALKRNADELSSYQ
KKIIKCDEHMGLSLAGLAPDARVLSNYLRQQCNYSSLVFNRKLAVERAGHLLCDKAQKNT
QSYGGRPYGVGLLIIGYDKSGAHLLEFQPSGNVTELYGTAIGARSQGAKTYLERTLDTFI
KIDGNPDELIKAGVEAISQSLRDESLTVDNLSIAIVGKDTPFTIYDGEAVAKYI
//
>1z7qW (I) [d.153.1] PROTEASOME COMPONENT PUP1
TTIVGVKFNNGVVIAADTRSTQGPIVADKNCAKLHRISPKIWCAGAGTAADTEAVTQLIG
SNIELHSLYTSREPRVVSALQMLKQHLFKYQGHIGAYLIVAGVDPTGSHLFSIHAHGSTD
VGYYLSLGSGSLAAMAVLESHWKQDLTKEEAIKLASDAIQAGIWNDLGSGSNVDVCVMEI
GKDAEYLRNYLTPNVREEKQKSYKFPRGTTAVLKESIVNICD
//
>1z7qb (N) [d.153.1] PROTEASOME COMPONENT PRE4
TQQPIVTGTSVISMKYDNGVIIAADNLGSYGSLLRFNGVERLIPVGDNTVVGISGDISDM
QHIERLLKDLVTENAYDNPLADAEEALEPSYIFEYLATVMYQRRSKMNPLWNAIIVAGVQ
SNGDQFLRYVNLLGVTYSSPTLATGFGAHMANPLLRKVVDRESDIPKTTVQVAEEAIVNA
MRVLYYRDARSSRNFSLAIIDKNTGLTFKKNLQVENMKWDFAKDIKGYGTQKI
//
>1z7qg (c) [a.24.8] PROTEASOME ACTIVATOR PROTEIN PA26
PPKRAALIQNLRDSYTETSSFAVIEEWAAGTLQEIEGIAKAAAEAHGVIRNSTYGRAQAE
KSPEQLLGVLQRYQDLCHNVYCQAETIRTVIAIRIPEHKEEDNLGVAVQHAVLKIIDELE
IKTLGSGEKSGSGGAPTPIGMYALREYLSARSTVEDKLLGVDAESGKTKGGGSQSPSLLL
ELRQIDADFMLKVELATTHLSTMVRAVINAYLLNWKKLIQPRTGSDHMVS
//
>1z7qh (c) [a.24.8] PROTEASOME ACTIVATOR PROTEIN PA26
PPKRAALIQNLRDSYTETSSFAVIEEWAAGTLQEIEGIAKAAAEAHGVIRNSTYGRAQAE
KSPEQLLGVLQRYQDLCHNVYCQAETIRTVIAIRIPEHKEEDNLGVAVQHAVLKIIDELE
IKTLGSGEKSGSGGAPTPIGMYALREYLSARSTVEDKLLGVDAESGKTKGGGSQSPSLLL
ELRQIDADFMLKVELATTHLSTMVRAVINAYLLNWKKLIQPRTGSDHMVS
//
>1z7qi (c) [a.24.8] PROTEASOME ACTIVATOR PROTEIN PA26
PPKRAALIQNLRDSYTETSSFAVIEEWAAGTLQEIEGIAKAAAEAHGVIRNSTYGRAQAE
KSPEQLLGVLQRYQDLCHNVYCQAETIRTVIAIRIPEHKEEDNLGVAVQHAVLKIIDELE
IKTLGSGEKSGSGGAPTPIGMYALREYLSARSTVEDKLLGVDAESGKTKGGGSQSPSLLL
ELRQIDADFMLKVELATTHLSTMVRAVINAYLLNWKKLIQPRTGSDHMVS
//
>1z7qk (c) [a.24.8] PROTEASOME ACTIVATOR PROTEIN PA26
PPKRAALIQNLRDSYTETSSFAVIEEWAAGTLQEIEGIAKAAAEAHGVIRNSTYGRAQAE
KSPEQLLGVLQRYQDLCHNVYCQAETIRTVIAIRIPEHKEEDNLGVAVQHAVLKIIDELE
IKTLGSGEKSGSGGAPTPIGMYALREYLSARSTVEDKLLGVDAESGKTKGGGSQSPSLLL
ELRQIDADFMLKVELATTHLSTMVRAVINAYLLNWKKLIQPRTGSDHMVS
//
>1z7qm (c) [a.24.8] PROTEASOME ACTIVATOR PROTEIN PA26
PPKRAALIQNLRDSYTETSSFAVIEEWAAGTLQEIEGIAKAAAEAHGVIRNSTYGRAQAE
KSPEQLLGVLQRYQDLCHNVYCQAETIRTVIAIRIPEHKEEDNLGVAVQHAVLKIIDELE
IKTLGSGEKSGSGGAPTPIGMYALREYLSARSTVEDKLLGVDAESGKTKGGGSQSPSLLL
ELRQIDADFMLKVELATTHLSTMVRAVINAYLLNWKKLIQPRTGSDHMVS
//
>1z7s_21 [b.121.4] HUMAN COXSACKIEVIRUS A21
VSQPPSTQSTEATSGVNSQEVPALTAVETGASGQAIPSDVVETRHVVNYKTRSESCLESF
FGRAACVTILSLTNSSKSGEEKKHFNIWNITYTDTVQLRRKLEFFTYSRFDLEMTFVFTE
NYPSTASGEVRNQVYQIMYIPPGAPRPSSWDDYTWQSSSNPSIFYMYGNAPPRMSIPYVG
IANAYSHFYDGFARVPLEGENTDAGDTFYGLVSINDFGVLAVRAVNRSNPHTIHTSVRVY
MKPKHIRCWCPRPPRAVLYRGEGVDMISSAILPLTKVDSITTF
//
>1z7s_22 [b.121.4] HUMAN COXSACKIEVIRUS A21
ACGYSDRVRQITLGNSTITTQEAANAIVAYGEWPTYINDSEANPVDAPTEPDVSSNRFYT
LESVSWKTTSRGWWWKLPDCLKDMGMFGQNMYYHYLGRSGYTIHVQCNASKFHQGALGVF
LIPEFVMACNTESKTSYVSYINANPGERGGEFTNTYNPSNTDASEGRKFAALDYLLGSGV
LAGNAFVYPHQIINLRTNNSATIVVPYVNSLVIDCMAKHNNWGIVILPLAPLAFAATSSP
QVPITVTIAPMCTEFNGLRNITVPVHQ
//
>1z7s_23 [b.121.4] HUMAN COXSACKIEVIRUS A21
GLPTMNTPGSNQFLTSDDFQSPCALPNFDVTPPIHIPGEVKNMMELAEIDTLIPMNAVDG
KVNTMEMYQIPLNDNLSKAPIFCLSLSPASDKRLSHTMLGEILNYYTHWTGSIRFTFLFC
GSMMATGKLLLSYSPPGAKPPTNRKDAMLGTHIIWDLGLQSSCSMVAPWISNTVYRRCAR
DDFTEGGFITCFYQTRIVVPASTPTSMFMLGFVSACPDFSVRLLKDTPHISQSKLIGRT
//
>1z7s_24 [b.121.4] HUMAN COXSACKIEVIRUS A21
GAQVSTQKTGAHENQNVAANGSTINYTTINYYKDSASNSATRQDLSQDPSKFTEPVKDLM
LKTAPALN
//
>1z7s_21 [b.121.4] HUMAN COXSACKIEVIRUS A21
VSQPPSTQSTEATSGVNSQEVPALTAVETGASGQAIPSDVVETRHVVNYKTRSESCLESF
FGRAACVTILSLTNSSKSGEEKKHFNIWNITYTDTVQLRRKLEFFTYSRFDLEMTFVFTE
NYPSTASGEVRNQVYQIMYIPPGAPRPSSWDDYTWQSSSNPSIFYMYGNAPPRMSIPYVG
IANAYSHFYDGFARVPLEGENTDAGDTFYGLVSINDFGVLAVRAVNRSNPHTIHTSVRVY
MKPKHIRCWCPRPPRAVLYRGEGVDMISSAILPLTKVDSITTF
//
>1z7s_29 (3) [b.121.4] HUMAN COXSACKIEVIRUS A21
GLPTMNTPGSNQFLTSDDFQSPCALPNFDVTPPIHIPGEVKNMMELAEIDTLIPMNAVDG
KVNTMEMYQIPLNDNLSKAPIFCLSLSPASDKRLSHTMLGEILNYYTHWTGSIRFTFLFC
GSMMATGKLLLSYSPPGAKPPTNRKDAMLGTHIIWDLGLQSSCSMVAPWISNTVYRRCAR
DDFTEGGFITCFYQTRIVVPASTPTSMFMLGFVSACPDFSVRLLKDTPHISQSKLIGRT
//
>1z7s_24 [b.121.4] HUMAN COXSACKIEVIRUS A21
GAQVSTQKTGAHENQNVAANGSTINYTTINYYKDSASNSATRQDLSQDPSKFTEPVKDLM
LKTAPALN
//
>1z7x_1X [d.5.1] RIBONUCLEASE I
ESRAKKFQRQHMDSDSSPSSSSTYCNQMMRRRNMTQGRCKPVNTFVHEPLVDVQNVCFQE
KVTCKNGQGNCYKSNSSMHITDCRLTNGSRYPNCAYRTSPKERHIIVACEGSPYVPVHFD
ASVEDS
//
>1z7x_1W [c.10.1] RIBONUCLEASE INHIBITOR
SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL
NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS
DNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNND
INEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD
VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGA
RLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVREL
CQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES
VRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS
//
>1z7z_21 [b.121.4] HUMAN COXSACKIEVIRUS A21
ESFFGRAACVTILSLTNSSKSGEEKKHFNIWNITYTDTVQLRRKLEFFTYSRFDLEMTFV
FTENYPSTASGEVRNQVYQIMYIPPGAPRPSSWDDYTWQSSSNPSIFYMYGNAPPRMSIP
YVGIANAYSHFYDGFARVPLEGENTDAGDTFYGLVSINDFGVLAVRAVNRSNPHTIHTSV
RVYMKPKHIRCWCPRPPRAVLYRGEGVDMISSAI
//
>1z7z_22 [b.121.4] HUMAN COXSACKIEVIRUS A21
SDRVRQITLGNSTITTQEAANAIVAYGEWPTYINDSEANPVDAPTEPDVSSNRFYTLESV
SWKTTSRGWWWKLPDCLKDMGMFGQNMYYHYLGRSGYTIHVQCNASKFHQGALGVFLIPE
FVMACNTESKTSYVSYINANPGERGGEFTNTYNPSNTDASEGRKFAALDYLLGSGVLAGN
AFVYPHQIINLRTNNSATIVVPYVNSLVIDCMAKHNNWGIVILPLAPLAFAATSSPQVPI
TVTIAPMCTEFNGLRNITVPVHQ
//
>1z7z_23 [b.121.4] HUMAN COXSACKIEVIRUS A21
MMELAEIDTLIPMNAVDGKVNTMEMYQIPLNDNLSKAPIFCLSLSPASDKRLSHTMLGEI
LNYYTHWTGSIRFTFLFCGSMMATGKLLLSYSPPGAKPPTNRKDAMLGTHIIWDLGLQSS
CSMVAPWISNTVYRRCARDDFTEGGFITCFYQTRIVVPASTPTSMFMLGFVSACPDFSVR
LLKDTPHISQSK
//
>1z7z_2q (I) [b.1.1 - b.1.1 - b.1.1 - b.1.1 - b.1.1] INTERCELLULAR ADHESION MOLECULE-1
QTSVSPSKVILPRGGSVLVTCSTSCDQPMLLGIETPLPKKELLLPGNNRKVYELSNVQED
SQPMCYSNCPDGQSTAKTFLTVYWTPERVELAPLPSWQPVGKNLTLRCQVEGGAPRANLT
VVLLRGEKELKREPAVGEPAEVTTTVLVRRDHHGANFSCRTELDLRPQGLELFENTSAPY
QLQTFVLPATPPQLVSPRVLEVDTQGTVVCSLDGLFPVSEAQVHLALGDQRLNPTVTYGN
DSFSAKASVSVTAEDEGTQRLTCAVILGNQSQETLQTVTIYSFPAPNVILTKPEVSEGTE
VTVKCEAGPRAQLLLKATPEDNGRSFSCSATLEVAGQLIHKNQTRELRVLYGPRLDERDC
PGNWTWPENSQQTPMCQAWGNPLPELKCLKDGTFPLPIGESVTVTRDLEGTYLCRARSTQ
GEVTREVTVNVLSP
//
>1z7z_2o (4) [x.x.x] 
ESFFGRAACVTILSLTNSSKSGEEKKHFNIWNITYTDTVQLRRKLEFFTYSRFDLEMTFV
FTENYPSTASGEVRNQVYQIMYIPPGAPRPSSWDDYTWQSSSNPSIFYMYGNAPPRMSIP
YVGIANAYSHFYDGFARVPLEGENTDAGDTFYGLVSINDFGVLAVRAVNRSNPHTIHTSV
RVYMKPKHIRCWCPRPPRAVLYRGEGVDMISSAI
//
>1z7z_2q (I) [b.1.1 - b.1.1 - b.1.1 - b.1.1 - b.1.1] INTERCELLULAR ADHESION MOLECULE-1
MMELAEIDTLIPMNAVDGKVNTMEMYQIPLNDNLSKAPIFCLSLSPASDKRLSHTMLGEI
LNYYTHWTGSIRFTFLFCGSMMATGKLLLSYSPPGAKPPTNRKDAMLGTHIIWDLGLQSS
CSMVAPWISNTVYRRCARDDFTEGGFITCFYQTRIVVPASTPTSMFMLGFVSACPDFSVR
LLKDTPHISQSK
//
>1z7z_23 [b.121.4] HUMAN COXSACKIEVIRUS A21
MMELAEIDTLIPMNAVDGKVNTMEMYQIPLNDNLSKAPIFCLSLSPASDKRLSHTMLGEI
LNYYTHWTGSIRFTFLFCGSMMATGKLLLSYSPPGAKPPTNRKDAMLGTHIIWDLGLQSS
CSMVAPWISNTVYRRCARDDFTEGGFITCFYQTRIVVPASTPTSMFMLGFVSACPDFSVR
LLKDTPHISQSK
//
>1z7z_22 [b.121.4] HUMAN COXSACKIEVIRUS A21
SDRVRQITLGNSTITTQEAANAIVAYGEWPTYINDSEANPVDAPTEPDVSSNRFYTLESV
SWKTTSRGWWWKLPDCLKDMGMFGQNMYYHYLGRSGYTIHVQCNASKFHQGALGVFLIPE
FVMACNTESKTSYVSYINANPGERGGEFTNTYNPSNTDASEGRKFAALDYLLGSGVLAGN
AFVYPHQIINLRTNNSATIVVPYVNSLVIDCMAKHNNWGIVILPLAPLAFAATSSPQVPI
TVTIAPMCTEFNGLRNITVPVHQ
//
>1z7z_23 [b.121.4] HUMAN COXSACKIEVIRUS A21
MMELAEIDTLIPMNAVDGKVNTMEMYQIPLNDNLSKAPIFCLSLSPASDKRLSHTMLGEI
LNYYTHWTGSIRFTFLFCGSMMATGKLLLSYSPPGAKPPTNRKDAMLGTHIIWDLGLQSS
CSMVAPWISNTVYRRCARDDFTEGGFITCFYQTRIVVPASTPTSMFMLGFVSACPDFSVR
LLKDTPHISQSK
//
>1z7z_2X (2) [b.121.4] HUMAN COXSACKIEVIRUS A21
SDRVRQITLGNSTITTQEAANAIVAYGEWPTYINDSEANPVDAPTEPDVSSNRFYTLESV
SWKTTSRGWWWKLPDCLKDMGMFGQNMYYHYLGRSGYTIHVQCNASKFHQGALGVFLIPE
FVMACNTESKTSYVSYINANPGERGGEFTNTYNPSNTDASEGRKFAALDYLLGSGVLAGN
AFVYPHQIINLRTNNSATIVVPYVNSLVIDCMAKHNNWGIVILPLAPLAFAATSSPQVPI
TVTIAPMCTEFNGLRNITVPVHQ
//
>1z8u_1A [a.7.11] ALPHA-HEMOGLOBIN STABILIZING PROTEIN
ALLKANKDLISAGLKEFSVLLNQQVFNDALVSEEDMVTVVEDWMNFYINYYRQQVTGEPQ
ERDKALQELRQELNTLANPFLAKYRDFLKS
//
>1z8u_1B [a.1.1] HEMOGLOBIN ALPHA CHAIN
LSPADKTNVKAAWGKVGAHAGEYGAEALERMFLSFPTTKTYFPHFDLSHGSAQVKGHGKK
VADALTNAVAHVDDMPNALSALSDLHAHKLRVDPVNFKLLSHCLLVTLAAHLPAEFTPAV
HASLDKFLASVSTVL
//
>1za3_1B [b.1.1 - b.1.1] FAB-YSD1 HEAVY CHAIN
EVQLVESGGGLVQPGGSLRLSCAASGFSIYSYSIHWVRQAPGKGLEWVASISPYSGYTSY
ADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCSRYSSYYSYYYSSSSYSYAMDYWG
QGTLVTVSSASTKGPSVFPLAPSGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVL
QSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK
//
>1za3_1S [g.24.1 - g.24.1 - g.24.1] TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY
SSPSEGLCPPGHHISEDGRDCISCKYGQDYSTHWNDLLFCLRCTRCDSGEVELSPCTTTR
NTVCQCEEGTFREEDSPEMCRKCRTGCPRGMVKVGDCTPWSDIECV
//
>1za3_2R [g.24.1 - g.24.1 - g.24.1] TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY
SSPSEGLCPPGHHISEDGRDCISCKYGQDYSTHWNDLLFCLRCTRCDSGEVELSPCTTTR
NTVCQCEEGTFREEDSPEMCRKCDCTPWSDI
//
>1za3_2H (B) [b.1.1 - b.1.1] FAB-YSD1 HEAVY CHAIN
EVQLVESGGGLVQPGGSLRLSCAASGFSIYSYSIHWVRQAPGKGLEWVASISPYSGYTSY
ADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCSRYSSYYSYYYSSSSYSYAMDYWG
QGTLVTVSSASTKGPSVFPLAPSGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVL
QSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK
//
>1za3_2L (A) [b.1.1 - b.1.1] FAB-YSD1 LIGHT CHAIN
DIQMTQSPSSLSASVGDRVTITCRASQDVNTAVAWYQQKPGKAPKLLIYAASYLYSGVPS
RFSGSGSGTDFTLTISSLQPEDFATYYCQSSSSPYTFGQGTKVEIKRTVAAPSVFIFPPS
DEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTL
SKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
//
>1za6_2E (A) [b.1.1 - b.1.1] IGG LIGHT CHAIN
DIVMSQSPDSLAVSLGERVTLNCKSSQSLLYSGNQKNYLAWYQQKPGQSPKLLIYWASAR
ESGVPDRFSGSGSGTDFTLTISSVQAEDVAVYYCQQYYSYPLTFGAGTKLELKRTVAAPS
VFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYS
LSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
//
>1za6_2F (B) [b.1.1 - b.1.1 - b.1.1] IGG HEAVY CHAIN
QVQLVQSGAEVVKPGASVKISCKASGYTFTDHAIHWVKQNPGQRLEWIGYFSPGNDDFKY
NERFKGKATLTADTSASTAYVELSSLRSEDTAVYFCTRSLNMAYWGQGTLVTVSSASTKG
PSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSL
SSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCQPREPQVYTLPPSRDELTKNQV
SLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVF
SCSVMHEALHNHYTQKSLSLSPGK
//
>1zanH [b.1.1 - b.1.1] FAB AD11 HEAVY CHAIN
QVQLKESGPGLVQPSQTLSLTCTVSGFSLTNNNVNWVRQATGRGLEWMGGVWAGGATDYN
SALKSRLTITRDTSKSQVFLKMHSLQSEDTATYYCARDGGYSSSTLYAMDAWGQGTTVTV
SSASTTAPSVYPLAPGSMVTLGCLVKGYFPEPVTVTWNSGSLASGVHTFPAVLQSGLYTL
SSSVTVPASPWASEAVTCNVAHPASSTKVDKKIVPR
//
>1zanL [b.1.1 - b.1.1] FAB AD11 LIGHT CHAIN
DIQMTQSPASLSASLGETVTIECRASEDIYNALAWYQQKPGKSPQLLIYNTDTLHTGVPS
RFSGSGSGTQYSLKINSLQSEDVASYFCQHYFGYPRTFGGGTKLELKRADAAPTVSIFPP
SSEQLASGGASVVCLLNNFYPKDISVKWKIDGSERQNGVLDSVTDQDSKDSTYSMSSTLT
LTKAEYESHNSYTCEVTHKTSTSPVVKSFNRGE
//
>1zawA [d.58.62] 50S RIBOSOMAL PROTEIN L10
VmLTRQQKELIVKEmSEIFKKTSLILFADFLGFTVADLTELRSRLREKYGDGARFRVVKN
TLLNLALKNAEYEGYEEFLKGPTAVLYVTEGDPVEAVKIIYNFYKDKKADLSRLKGGFLE
GKKFTAEEVENIAKLPSKEELYAmLVGRVKAPITGLVFALSGILRNLVYVLNAIKEKK
//
>1zawV (U) [a.108.1] 50S RIBOSOMAL PROTEIN L7/L12
mTIDEIIEAIEKLTVSELAELVKKLEDKFG
//
>1zba_21 [b.121.4] COAT PROTEIN VP1
TTTTGESADPVTTTVENYGGDTQVQRRHHTDVGFIMDRFVKINSLSPTHVIDLMQTHKHG
IVGALLRAATYYFSDLEIVVRHDGNLTWVPNGAPEAALSNTSNPTAYNKAPFTRLALPYT
APHRVLATVYDGTNKYSTQLPASFNYGAIQAQAIHELLVRMKRAELYCPRPLLAIKVTSQ
DRYKQKIIAPA
//
>1zba_22 [b.121.4] COAT PROTEIN VP2
DRLLTTRNGHTTSTTQSSVGVTYGYSTEEDHVAGPNTSGLETRVVQAERFFKKFLFDWTT
DKPFGYLTKLELPTDHHGVFGHLVDSYAYMRNGWDVEVSAVGNQFNGGCLLVAMVPEWKA
FDTREKYQLTLFPHQFISPRTNMTAHITVPYLGVNRYDQYKKHKPWTLVVMVLSPLTVSN
TAAPQIKVYANIAPTYVHVAGELPSKE
//
>1zba_24 [b.121.4] COAT PROTEIN VP4
SGNTGSIINNYYMQQYQNSMSTQLGTQNNDWFSKLASSAFTGLFGALLA
//
>1zba_2E (4) [b.121.4] COAT PROTEIN VP4
SGNTGSIINNYYMQQYQNSMSTQLGTQNNDWFSKLASSAFTGLFGALLA
//
>1zba_2J (3) [b.121.4] COAT PROTEIN VP3
GIFPVACADGYGGLVTTDPKTADPVYGKVYNPPKTNYPGRFTNLLDVAEACPTFLRFDDG
KPYVVTRADDTRLLAKFDVSLAAKHMSNTYLSGIAQYYTQYSGTINLHFMFTGSTDSKAR
YMVAYIPPGVETPPDTPEEAAHCIHAEWDTGLNSKFTFSIPYVSAADYAYTASDTAETTN
VQGWVCVYQITHGKAENDTLLVSASAGKDFELRLPIDPRTQTTTTGESADPVTTTVENYG
GDTQVQRRHHTDVGFIMDRFVKINSLSPTHVIDLMQTHKHGIVGALLRAATYYFSDLEIV
VRHDGNLTWVPNGAPEAALSNTSNPTAYNKAPFTRLALPYTAPHRVLATVYDGTNKYSTQ
LPASFNYGAIQAQAIHELLVRMKRAELYCPRPLLAIKVTSQDRYKQKIIAPA
//
>1zba_2O (2) [b.121.4] COAT PROTEIN VP2
DRLLTTRNGHTTSTTQSSVGVTYGYSTEEDHVAGPNTSGLETRVVQAERFFKKFLFDWTT
DKPFGYLTKLELPTDHHGVFGHLVDSYAYMRNGWDVEVSAVGNQFNGGCLLVAMVPEWKA
FDTREKYQLTLFPHQFISPRTNMTAHITVPYLGVNRYDQYKKHKPWTLVVMVLSPLTVSN
TAAPQIKVYANIAPTYVHVAGELPSKE
//
>1zba_2h (3) [b.121.4] COAT PROTEIN VP3
GIFPVACADGYGGLVTTDPKTADPVYGKVYNPPKTNYPGRFTNLLDVAEACPTFLRFDDG
KPYVVTRADDTRLLAKFDVSLAAKHMSNTYLSGIAQYYTQYSGTINLHFMFTGSTDSKAR
YMVAYIPPGVETPPDTPEEAAHCIHAEWDTGLNSKFTFSIPYVSAADYAYTASDTAETTN
VQGWVCVYQITHGKAENDTLLVSASAGKDFELRLPIDPRTQ
//
>1zba_2i (4) [b.121.4] COAT PROTEIN VP4
SGNTGSIINNYYMQQYQNSMSTQLGTQNNDWFSKLASSAFTGLFGALLA
//
>1zba_2L (3) [b.121.4] COAT PROTEIN VP3
GIFPVACADGYGGLVTTDPKTADPVYGKVYNPPKTNYPGRFTNLLDVAEACPTFLRFDDG
KPYVVTRADDTRLLAKFDVSLAAKHMSNTYLSGIAQYYTQYSGTINLHFMFTGSTDSKAR
YMVAYIPPGVETPPDTPEEAAHCIHAEWDTGLNSKFTFSIPYVSAADYAYTASDTAETTN
VQGWVCVYQITHGKAENDTLLVSASAGKDFELRLPIDPRTQ
//
>1zba_2h (3) [b.121.4] COAT PROTEIN VP3
TTTTGESADPVTTTVENYGGDTQVQRRHHTDVGFIMDRFVKINSLSPTHVIDLMQTHKHG
IVGALLRAATYYFSDLEIVVRHDGNLTWVPNGAPEAALSNTSNPTAYNKAPFTRLALPYT
APHRVLATVYDGTNKYSTQLPASFNYGAIQAQAIHELLVRMKRAELYCPRPLLAIKVTSQ
DRYKQKIIAPA
//
>1zba_2i (4) [b.121.4] COAT PROTEIN VP4
DRLLTTRNGHTTSTTQSSVGVTYGYSTEEDHVAGPNTSGLETRVVQAERFFKKFLFDWTT
DKPFGYLTKLELPTDHHGVFGHLVDSYAYMRNGWDVEVSAVGNQFNGGCLLVAMVPEWKA
FDTREKYQLTLFPHQFISPRTNMTAHITVPYLGVNRYDQYKKHKPWTLVVMVLSPLTVSN
TAAPQIKVYANIAPTYVHVAGELPSKE
//
>1zba_2k (4) [b.121.4] COAT PROTEIN VP4
SGNTGSIINNYYMQQYQNSMSTQLGTQNNDWFSKLASSAFTGLFGALLA
//
>1zba_3C (2) [b.121.4] COAT PROTEIN VP2
DRLLTTRNGHTTSTTQSSVGVTYGYSTEEDHVAGPNTSGLETRVVQAERFFKKFLFDWTT
DKPFGYLTKLELPTDHHGVFGHLVDSYAYMRNGWDVEVSAVGNQFNGGCLLVAMVPEWKA
FDTREKYQLTLFPHQFISPRTNMTAHITVPYLGVNRYDQYKKHKPWTLVVMVLSPLTVSN
TAAPQIKVYANIAPTYVHVAGELPSKE
//
>1zba_3i (4) [b.121.4] COAT PROTEIN VP4
SGNTGSIINNYYMQQYQNSMSTQLGTQNNDWFSKLASSAFTGLFGALLA
//
>1zba_4J (3) [b.121.4] COAT PROTEIN VP3
GIFPVACADGYGGLVTTDPKTADPVYGKVYNPPKTNYPGRFTNLLDVAEACPTFLRFDDG
KPYVVTRADDTRLLAKFDVSLAAKHMSNTYLSGIAQYYTQYSGTINLHFMFTGSTDSKAR
YMVAYIPPGVETPPDTPEEAAHCIHAEWDTGLNSKFTFSIPYVSAADYAYTASDTAETTN
VQGWVCVYQITHGKAENDTLLVSASAGKDFELRLPIDPRTQTTTTGESADPVTTTVENYG
GDTQVQRRHHTDVGFIMDRFVKINSLSPTHVIDLMQTHKHGIVGALLRAATYYFSDLEIV
VRHDGNLTWVPNGAPEAALSNTSNPTAYNKAPFTRLALPYTAPHRVLATVYDGTNKYSTQ
LPASFNYGAIQAQAIHELLVRMKRAELYCPRPLLAIKVTSQDRYKQKIIAPA
//
>1zba_4h (1) [b.121.4] COAT PROTEIN VP1
TTTTGESADPVTTTVENYGGDTQVQRRHHTDVGFIMDRFVKINSLSPTHVIDLMQTHKHG
IVGALLRAATYYFSDLEIVVRHDGNLTWVPNGAPEAALSNTSNPTAYNKAPFTRLALPYT
APHRVLATVYDGTNKYSTQLPASFNYGAIQAQAIHELLVRMKRAELYCPRPLLAIKVTSQ
DRYKQKIIAPA
//
>1zbdA [c.37.1] RABPHILIN-3A
SHmFDYmFKILIIGNSSVGKTSFLFRYADDSFTPAFVSTVGIDFKVKTIYRNDKRIKLQI
WDTAGLERYRTITTAYYRGAmGFILmYDITNEESFNAVQDWSTQIKTYSWDNAQVLLVGN
KCDmEDERVVSSERGRQLADHLGFEFFEASAKDNINVKQTFERLVDVICEKmSESLD
//
>1zbdB [g.50.1] RABPHILIN-3A
EELTDEEKEIINRVIARAEKmETmEQERIGRLVDRLETmRKNVAGDGVNRCILCGEQLGm
LGSASVVCEDCKKNVCTKCGVETSNNRPHPVWLCKICLEQREVWKRSGAWFFKGFPKQVL
PQPm
//
>1zbe_23 [b.121.4] COAT PROTEIN VP3
GIFPVACADGYGGLVTTDPKTADPVYGKVYNPPKTNYPGRFTNLLDVAEACPTFLRFDDG
KPYVVTRADDTRLLAKFDVSLAAKHMSNTYLSGIAQYYTQYSGTINLHFMFTGSTDSKAR
YMVAYIPPGVETPPDTPEEAAHCIHAEWDTGLNSKFTFSIPYVSAADYAYTASDTAETTN
VQGWVCVYQITHGKAENDTLLVSASAGKDFELRLPIDPRTQ
//
>1zbe_2B (2) [b.121.4] COAT PROTEIN VP2
DRLLTTRNGHTTSTTQSSVGVTYGYSTEEDHVAGPNTSGLETRVVQAERFFKKFLFDWTT
DKPFGYLTKLELPTDHHGVFGHLVDSYAYMRNGWDVEVSAVGNQFNGGCLLVAMVPEWKA
FDTREKYQLTLFPHQFISPRTNMTAHITVPYLGVNRYDQYKKHKPWTLVVMVLSPLTVSN
TAAPQIKVYANIAPTYVHVAGELPSKE
//
>1zbe_2D (4) [b.121.4] COAT PROTEIN VP4
SGNTGSIINNYYMQQYQNSMSTQLGTQNNDWFSKLASSAFTGLFGALLA
//
>1zbe_2X (4) [b.121.4] COAT PROTEIN VP4
SGNTGSIINNYYMQQYQNSMSTQLGTQNNDWFSKLASSAFTGLFGALLA
//
>1zbe_3B (2) [b.121.4] COAT PROTEIN VP2
DRLLTTRNGHTTSTTQSSVGVTYGYSTEEDHVAGPNTSGLETRVVQAERFFKKFLFDWTT
DKPFGYLTKLELPTDHHGVFGHLVDSYAYMRNGWDVEVSAVGNQFNGGCLLVAMVPEWKA
FDTREKYQLTLFPHQFISPRTNMTAHITVPYLGVNRYDQYKKHKPWTLVVMVLSPLTVSN
TAAPQIKVYANIAPTYVHVAGELPSKE
//
>1zbe_3X (4) [b.121.4] COAT PROTEIN VP4
SGNTGSIINNYYMQQYQNSMSTQLGTQNNDWFSKLASSAFTGLFGALLA
//
>1zbxA [b.34.12] ORIGIN RECOGNITION COMPLEX SUBUNIT 1
AKTLKDLQGWEIITTDEQGNTEHYLKRSSDGIKLGRGDSVVMHNEAAGTYSVYMIQELRL
NTLNNVVELWALTYLRWFEVNPLAHYRQFNPDANILNRPLNYYNKLFSETANKNELYLTA
ELAELQLFNFIRVANVMDGSKWEVLKGNVDPERDFTVRYICEPTGEKFVDINIEDVKAYI
KKVEPREAQEYLKDLTL
//
>1zbxB [x.x.x]
TEEEYVSPRFLVADGFLIDLAEEKPINPKDPRLLTLLKDHQRAMIDQMNLVKWNDFKKYQ
DPIPLKAKTLFKFCKQIKKKFLRGADFKLHTLPMTVLCSCVPILLDDQTVQYLYDDSLE
//
>1zc4A [c.37.1] RAS-RELATED PROTEIN RAL-A
SLALHKVIMVGSGGVGKSALTLQFMYDEFVEDYEPTKADSYRKKVVLDGEEVQIDILDTA
GLEDYAAIRDNYFRSGEGFLCVFSITEMESFAATADFREQILRVKEDENVPFLLVGNKSD
LEDKRQVSVEEAKNRAEQWNVNYVETSAKTRANVDKVFFDLMREIRARKMEDS
//
>1zc4D (B) [b.55.1] EXOCYST COMPLEX PROTEIN EXO84
GQYLVYNGDLVEYEADHMAQLQRVHGFLMNDCLLVATWLPQRRGMYRYNALYPLDRLAVV
NVKDNPPMKDMFKLLMFPESRIFQAENAKIKREWLEVLEETKRALSDKRRREQ
//
>1ze3C [b.1.11 - b.7.2] CHAPERONE PROTEIN FIMC
GVALGATRVIYPAGQKQEQLAVTNNDENSTYLIQSWVENADGVKDGRFIVTPPLFAMKGK
KENTLRILDATNNQLPQDRESLFWMNVKAIPSMDKSKLTENTLQLAIISRIKLYYRPAKL
ALPPDQAAEKLRFRRSANSLTLINPTPYYLTVTELNAGTRVLENALVPPMGESTVKLPSD
AGSNITYRTINDYGALTPKMTGVME
//
>1ze3H [b.2.3] FIMH PROTEIN
TGGCDVSARDVTVTLPDYPGSVPIPLTVYCAKSQNLGYYLSGTTADAGNSIFTNTASFSP
AQGVGVQLTRNGTIIPANNTVSLGAVGTSAVSLGLTANYARTGGQVTAGNVQSIIGVTFV
YQ
//
>1ze3D [b.167.1] OUTER MEMBRANE USHER PROTEIN FIMD
DLYFNPRFLLSRFENGQELPPGTYRVDIYLNNGYMATRDVTFNTGDSEQGIVPCLTRAQL
ASMGLNTASVAGMNLLADDACVPLTTMVQDATAHLDVGQQRLNLTIPQAFMSNRAR
//
>1zeaL [b.1.1 - b.1.1] MONOCLONAL ANTI-CHOLERA TOXIN IGG1 KAPPA
DVLMTQTPLSLPVSLGDQASISCKSSQSIVHSSGNTYFEWYLQKPGQSPKLLIYKVSNRF
SGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCFQGSHIPFTFGSGTKLEIKRADAAPTV
SIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSM
SSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNR
//
>1zeaH [b.1.1 - b.1.1] MONOCLONAL ANTI-CHOLERA TOXIN IGG1 KAPPA
QIQLVQSGPELKTPGETVRISCKASGYTFTTYGMSWVKQTPGKGFKWMGWINTYSGVPTY
ADDFKGRFAFSLETSASTAYLQINNLKNEDTATYFCARRSWYFDVWGTGTTVTVSSAKTT
PPSVYPLAPSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTLSSSVTVP
SSTWPSQTVTCNVAHPASSTKVDKKIVPR
//
>1zglA [d.19.1 - b.1.1] HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR
EHVIIQAEFYLNPDQSGEFMFDFDGDEIFHVDMAKKETVWRLEEFGRFASFEAQGALANI
AVDKANLEIMTKRSNYTPITNVPPEVTVLTNSPVELREPNVLICFIDKFTPPVVNVTWLR
NGKPVTTGVSETVFLPREDHLFRKFHYLPFLPSTEDVYDCRVEHWGLDEPLLKHWEFD
//
>1zglB [d.19.1 - b.1.1] MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DR
GDTRPRFLQQDKYECHFFNGTERVRFLHRDIYNQEEDLRFDSDVGEYRAVTELGRPDAEY
WNSQKDFLEDRRAAVDTYCRHNYGVGESFTVQRRVEPKVTVYPRTNLLVCSVNGFYPGSI
EVRWFNSVVSTGLIQNGDWTFQTLVMLETVPRSGEVYTCQVEHPSVTSPLTVEWR
//
>1zglM [b.1.1 - b.1.1] T CELL RECEPTOR ALPHA CHAIN
DSVTQMEGPVTLSEEAFLTINCTYTATGYPSLFWYVQYPGEGLQLLLKATKADDKGSNKG
FEATYRKETTSFHLEKGSVQVSDSAVYFCALSGGDSSYKLIFGSGTRLLVRPDNPDPVYS
VCLFTDFDSQTNDVYITDKTVLDMRSMDFKSNSAVAWSNSDFACANAFNNSIIPEDTF
//
>1zglP [b.1.1 - b.1.1] T CELL RECEPTOR BETA CHAIN
GGGGGVTQTPRYLIKTRGQQVTLSCSPISGHRSVSWYQQTPGQGLQFLFEYFNETQRNKG
NFPGRFSGRQFSNSRSEMNVSTLELGDSALYLCASSLADRVNTEAFFGQGTRLTVVEDLK
NVFPPEVAVFEPSEAEISHTQATLVCLATGFYPDHVELSWWVNGKEVHSGVSTDPQPLKE
QPALNDSRYSLSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEA
WG
//
>1zglV [b.1.1 - b.1.1] T CELL RECEPTOR BETA CHAIN
GGGGVTQTPRYLIKTRGQQVTLSCSPISGHRSVSWYQQTPGQGLQFLFEYFNETQRNKGN
FPGRFSGRQFSNSRSEMNVSTLELGDSALYLCASSLADRVNTEAFFGQGTRLTVVEDLKN
VFPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVSTDPQPLKE
QPALNDSRYSLSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEA
WG
//
>1zglE [d.19.1 - b.1.1] MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DR
DTRPRFLQQDKYECHFFNGTERVRFLHRDIYNQEEDLRFDSDVGEYRAVTELGRPDAEYW
NSQKDFLEDRRAAVDTYCRHNYGVGESFTVQRRVEPKVTVYPRTNLLVCSVNGFYPGSIE
VRWFRNSQEVVSTGLIQNGDWTFQTLVMLEPRSGEVYTCQVEHPSVTSPLTVEWR
//
>1zglS [b.1.1 - b.1.1] T CELL RECEPTOR ALPHA CHAIN
DSVTQMEGPVTLSEEAFLTINCTYTATGYPSLFWYVQYPGEGLQLLLKATKADDKGSNKG
FEATYRKETTSFHLEKGSVQVSDSAVYFCALSGGDSSYKLIFGSGTRLLVRPQNPDPVYL
RDSLFTFDSQTNSKDDVYITDKTVLDMRSMDFKSNSAVANKSDFANAFNNSPEDTF
//
>1zglT [b.1.1 - b.1.1] T CELL RECEPTOR BETA CHAIN
GGGGGVTQTPRYLIKTRGQQVTLSCSPISGHRSVSWYQQTPGQGLQFLFEYFNETQRNKG
NFPGRFSGRQFSNSRSEMNVSTLELGDSALYLCASSLADRVNTEAFFGQGTRLTVVEDLK
NVFPPEVVFEISHTQATLVCLATGFYPDHVELSWWVNVHSGVSTDPQPLKEQPALNDSRY
SLSSRATWQNPRHFRCQVQFYGLSENDEWTQDRAKPVTQIVSWGAD
//
>1zglJ (A) [d.19.1 - b.1.1] HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR
EHVIIQAEFYLNPDQSGEFMFDFDGDEIFHVDMAKKETVWRLEEFGRFASFEAQGALANI
AVDKANLEIMTKRSNYTPITNVPPEVTVLTNSPVELREPNVLICFIDKFTPPVVNVTWLR
NGKPVTTGVSETVFLPREDHLFRKFHYLPFLPSTEDVYDCRVEHWGLDEPLLKHWEFD
//
>1zglU [b.1.1 - b.1.1] T CELL RECEPTOR ALPHA CHAIN
GDSVTQMEGPVTLSEEAFLTINCTYTATGYPSLFWYVQYPGEGLQLLLKATKADDKGSNK
GFEATYRKETTSFHLEKGSVQVSDSAVYFCALSGGDSSYKLIFGSGTRLLVRPDIQNPDP
VYQLRDSKKSVCLFTDFDSQTNVSQSDVYITDKTVLDMRSMDFKSNSAVAWSNKSDFACA
NAFNNSIIPEDTFFP
//
>1zgxA [x.x.x] GUANYL-SPECIFIC RIBONUCLEASE SA
DVSGTVCLSALPPEATDTLNLIASDGPFPYSQDGVVFQNRESVLPTQSYGYYHEYTVITP
GAR
//
>1zgxB [x.x.x] GUANYL-SPECIFIC RIBONUCLEASE SA
TRGTRRIITGEATQEDYYTGDHYATFSLIDKTC
//
>1zhiA [b.34.12] ORIGIN RECOGNITION COMPLEX SUBUNIT 1
GWEIITTDEQGNIIDGGTEHYLKRSSDGIKLGRGDSVVMHNEAAGTYSVYMIQELRLNTL
NNVVELWALTYLRWFEVNPLAHYRQFNPDANILNRPLNYYNKLFSETANKNELYLTAELA
ELQLFNFIRVANVMDGSKWEVLKGNVDPERDFTVRYICEPTGEKFVDINIEDVKAYIKKV
EPREAQEYLKDLTLP
//
>1zhiB [d.339.1] REGULATORY PROTEIN SIR1
EEYVSPRFLVADGFLIDLAEEKPINPKDPRLLTLLKDHQRAMIDQMNLVKWNDFKKYQDP
IPLKAKTLFKFCKQIKKKFLRGADFKLHTLPTEANLKYEPERMTVLASCVPILLDDQTVQ
YLYDD
//
>1zjdA [b.47.1] CATALYTIC DOMAIN OF COAGULATION FACTOR XI
IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG
ILNQAEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPSKGDR
NVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGG
KDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQA
//
>1zjdB [g.8.1] KUNITZ PROTEASE INHIBITORY DOMAIN OF PROTEASE
EVCSEQAETGPCRAMISRWYFDVTEGKCAPFFYGGCGGNRNNFDTEEYCMAVCGSAI
//
>1zlhA [c.56.5] CARBOXYPEPTIDASE A1
STNTFNYATYHTLDEIYDFMDLLVAEHPQLVSKLQIGRSYEGRPIYVLKFSTGGSNRPAI
WIDLGIHSREWITQATGVWFAKKFTEDYGQDPSFTAILDSMDIFLEIVTNPDGFAFTHSQ
NRLWRKTRSVTSLCVGVDANRNWDAGFGKAGASSSPCSETYHGKYANSEVEVKSIVDFVK
DHGNFKAFLSIHSYSQLLLYPYGYTTQSIPDKTELNQVAKSAVAALKSLYGTSYKYGSII
TTIYQASGGSIDWSYNQGIKYSFTFELRDTGRYGFLLPASQIIPTAQETWLGVLTIMEHT
V
//
>1zlhB [g.9.1 - g.9.1] CARBOXYPEPTIDASE INHIBITOR
NECVSKGFGCLPQSDCPQEARLSYGGCSTVCCDLSKLTGCKGKGGECNPLDRQCKELQAE
SASCGKGQKCCVWL
//
>1zliA [c.56.5] CARBOXYPEPTIDASE B
TGHSYEKYNNWETIEAWTQQVATENPALISRSVIGTTFEGRAIYLLKVGKAGQNKPAIFM
DCGFHAREWISPAFCQWFVREAVRTYGREIQVTELLNKLDFYVLPVLNIDGYIYTWTKSR
FWRKTRSTHTGSSCIGTDPNRNFDAGWCEIGASRNPCDETYCGPAAESEKETKALADFIR
NKLSSIKAYLTIHSYSQMMIYPYSYAYKLGENNAELNALAKATVKELASLHGTKYTYGPG
ATTIYPAAGGSDDWAYDQGIRYSFTFELRDTGRYGFLLPESQIRATCEETFLAIKYVASY
VLEHLY
//
>1zliB [g.9.1 - g.9.1] CARBOXYPEPTIDASE INHIBITOR
NECVSKGFGCLPQSDCPQEARLSYGGCSTVCCDLSKLTGCKGKGGECNPLDRQCKELQAE
SASCGKGQKCCVWL
//
>1zmy_1A [b.1.1] ANTIBODY CABBCII-10:LYS3
VQLVESGGGSVQAGGSLRLSCTASGYTIGPYCMGWFRQAPGGEREAVAAINMGGGITYYA
DSVKGRFTISRDNAKNTVTLQMNSLKPEDTAMYYCAADSTIYASYYECGHGLSTGGYGYD
SWGQGTQVTVSS
//
>1zmy_1L [d.2.1] LYSOZYME C
KVFGRCELAAAMKRHGLDNYRGYSLGNWVCAAKFESNFNTQATNRNTDGSTDYGILQINS
RWWCNDGRTPGSRNLCNIPCSALLSSDITASVNCAKKIVSDGNGMNAWVAWRNRCKGTDV
QAWIRGCRL
//
>1zo1_1I [x.x.x] TRANSLATION INITIATION FACTOR 2
EPRAPVVTIMGHVDHGKTSLLEYIRSTKVASGEAGGITQHIGAYHVETENGMITFLDTPG
HAAFTSMRARGAQATDIVVLVVAADDGVMPQTIEAIQHAKAAQVPVVVAVNKIDKPEADP
DRVKNELSQYGILPEEWGGESQFVHVSAKAGTGIDELLDAILLQAEVLELKAVRKGMASG
AVIESFLDKGRGPVATVLVREGTLHKGDIVLCGFEYGRVRAMRNELGQEVLEAGPSIPVE
ILGLSGVPAAGDEVTVVRDEKKAREVALYRQGKFREVKLARQQKSKLENMFANMTEGEVH
EVNIVLKADVQGSVEAISDSLLKLSTDEVKVKIIGSGVGGITETDATLAAASNAILVGFN
VRADASARKVIEAESLDLRYYSVIYNLIDEVKAAMSGMLSPELKQQIIGLAEVRDVFKSP
KFGAIAGCMVTEGVVKRHNPIRVLRDNVVIYEGELESLRRFKDDVNEVRNGMECGIGVKN
YNDVRTGDVIEVFEIIEIQRT
//
>1zo1_1W [b.40.4] TRANSLATION INITIATION FACTOR 1
AKEKDTIRTEGVVTEALPNATFRVKLDSGPEILAYISGKMRMHYIRILPGDRVVVEITPY
DPTRGRIVYRK
//
>1zoq_1A [b.26.1] INTERFERON REGULATORY FACTOR 3
LVPGEEWEFEVTAFYRGRQVFQQTISCPEGLRLVGSEVGDRTLPGWPVTLPDPGMSLTDR
GVMSYVRHVLSCLGGGLALWRAGQWLWAQRLGHCHTYWAVSEELLPNSGHGPDGEVPKDK
EGGVFDLGPFIVDLITFTEGSGRSPRYALWFCVGESWPQDQPWTKRLVMVKVVPTCLRAL
VEMARVGGASS
//
>1zoq_1C [a.153.1] CREB-BINDING PROTEIN
SALQDLLRTLKSPSSPQQQQQVLNILKSNPQLMAAFIKQRTAKYVAN
//
>1zoyA [c.3.1 - d.168.1 - a.7.3] FAD-BINDING PROTEIN
STQYPVVDHEFDAVVVGAGGAGLRAAFGLSEAGFNTACVTKLFPTRSHTVAAQGGINAAL
GNMEEDNWRWHFYDTVKGSDWLGDQDAIHYMTEQAPASVVELENYGMPFSRTEDGKIYQR
AFGGQSLKFGKGGQAHRCCCVADRTGHSLLHTLYGRSLRYDTSYFVEYFALDLLMENGEC
RGVIALCIEDGSIHRIRARNTVVATGGYGRTYFSCTSAHTSTGDGTAMVTRAGLPCQDLE
FVQFHPTGIYGAGCLITEGCRGEGGILINSQGERFMERYAPVAKDLASRDVVSRSMTLEI
REGRGCGPEKDHVYLQLHHLPPEQLAVRLPGISETAMIFAGVDVTKEPIPVLPTVHYNMG
GIPTNYKGQVLRHVNGQDQVVPGLYACGEAACASVHGANRLGANSLLDLVVFGRACALSI
AESCRPGDKVPSIKPNAGEESVMNLDKLRFANGTIRTSELRLSMQKSMQSHAAVFRVGSV
LQEGCEKILRLYGDLQHLKTFDRGMVWNTDLVETLELQNLMLCALQTIYGAEARKESRGA
HAREDFKERVDEYDYSKPIQGQQKKPFQEHWRKHTLSYVDVKTGKVSLEYRPVIDKTLNE
ADCATVPPAIRSY
//
>1zoyB [d.15.4 - a.1.2] IRON-SULFUR PROTEIN
PRIKKFAIYRWDPDKTGDKPHMQTYEIDLNNCGPMVLDALIKIKNEIDSTLTFRRSCREG
ICGSCAMNINGGNTLACTRRIDTNLDKVSKIYPLPHMYVIKDLVPDLSNFYAQYKSIEPY
LKKKDESQEGKQQYLQSIEEREKLDGLYECILCACCSTSCPSYWWNGDKYLGPAVLMQAY
RWMIDSRDDFTEERLAKLQDPFSLYRCHTIMNCTGTCPKGLNPGKAIAEIKKMMATYKE
//
>1zoyC [x.x.x] LARGE CYTOCHROME BINDING PROTEIN
TTAKEEMERFWNKNLGSNRPLSPHITIYRWSLPMAMSICHRGTGIALSAGVSLFGLSALL
LPGNFESHLELVKSLCLGPTLIYTAKFGIVFPLMYHTWNGIRHLIWDLGKGLTIPQLTQS
GVVVLILTVLSSVGLAAM
//
>1zoyD [x.x.x] SMALL CYTOCHROME BINDING PROTEIN
SSKAASLHWTGERVVSVLLLGLLPAAYLNPCSAMDYSLAAALTLHGHWGIGQVVTDYVRG
DALQKAAKAGLLALSAFTFAGLCYFNYHDVGICKAVAMLWKL
//
>1zp0C [x.x.x] LARGE CYTOCHROME BINDING PROTEIN
TTAKEEMERFWNKNLGSNRPLSPHITIYRWSLPMAMSICHRGTGIALSAGVSLFGLSALL
LPGNFESHLELVKSLCLGPTLIYTAKFGIVFPLMYHTWNGIRHLIWDLGKGLTIPQLTQS
GVVVLILTVLSSVGLAAM
//
>1zp0D [x.x.x] SMALL CYTOCHROME BINDING PROTEIN
SSKAASLHWTGERVVSVLLLGLLPAAYLNPCSAMDYSLAAALTLHGHWGIGQVVTDYVRG
DALQKAAKAGLLALSAFTFAGLCYFNYHDVGICKAVAMLWKL
//
>1zq1B (A) [b.38.3 - c.88.1] GLUTAMYL-TRNA(GLN) AMIDOTRANSFERASE SUBUNIT D
RVDEFLKERNINVGDFVRITKEEDGEEVTYEGYImPPYELSAGDTLVLKLENGYNIGIAL
EKIRRIEVLERAKVKPEVHFEALIEGKPGLPEVTIIGTGGTIASRIDYETGAVYPAFTAE
ELAKALPEIFEVANVKPKLLFNIFSEDmKPKHWVKIAHEVAKALNSGDYGVVVAHGTDTm
GYTAAALSFmLRNLGKPVVLVGAQRSSDRPSSDAAmNLICSVRmATSEVAEVmVVmHGET
GDTYCLAHRGTKVRKmHTSRRDAFRSINDVPIAKIWPNGEIEFLRKDYRKRSDEEVEVDD
KIEEKVALVKVYPGISSEIIDFLVDKGYKGIVIEGTGLGHTPNDIIPSIERAVEEGVAVC
mTSQCIYGRVNLNVYSTGRKLLKAGVIPCEDmLPETAYVKLmWVLGHTQNLEEVRKmmLT
NYAGEITPYTRFDTYLR
//
>1zq1D (C) [d.128.1 - d.74.4 - a.182.1] GLUTAMYL-TRNA(GLN) AMIDOTRANSFERASE SUBUNIT E
TDKFNYEELGLKVGLEIHRQLDTKKLFSPVPSELSDKVEFTFQRRLRPTMSELGEIDPAA
LEEFKKGRVYVYEGNYELTDLVYMDEEPPRGPDREALEVALQIAYLLNAKPVDEVYYMRK
IVIDGSNVSGFQRTAIIATDGKVETPWGAVGIPTICLEEDAARIIERKDKEVIYRLDRLG
IPLIEISTTPDIHHPEQAKVVAKFIGDALRATKKVKRGLGTIRQDLNVSIKGGARIEIKG
VQELDMIPIIIEREVERQLNLLKIRDELRKRGVKPKDIKEEFYDVTDIFENTKSKIIARV
IKKGGKVLAIKLPKFRGLIGREIQPGRRLGTEFADRAKKYVPGIFHIDELPNYGISQEEV
NKVIERLNLSEEDAFVLVAAEEEKAKNALREVIKRAREAIEGVPEETRRALPDGNTEYMR
PLPGKARMYPETDIPPLRIPDDLKKKIKENLPELPQAKVERYVKEYKLDRSLAQTLVDDE
RDELFEELVSMGVKPSLAASILVVVLKG
//
>1zr0_1A [b.47.1] CATIONIC TRYPSIN
IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEG
NEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISG
WGNTKSSGTSYPDVLKCLKAPILSTSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGP
VVCSGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN
//
>1zr0_1B [g.8.1] TISSUE FACTOR PATHWAY INHIBITOR 2
PTGNNAEICLLPLDYGPCRALLLRYYYDRYTQSCRQFLYGGCEGNANNFYTWEACDDACW
RIE
//
>1zrtC [f.21.1 - f.32.1] CYTOCHROME B
SGIPHDHYEPKTGIEKWLHDRLPIVGLVYDTIMIPTPKNLNWWWIWGIVLAFTLVLQIVT
GIVLAMHYTPHVDLAFASVEHIMRDVNGGWAMRYIHANGASLFFLAVYIHIFRGLYYGSY
KAPREITWIVGMVIYLLMMGTAFMGYVLPWGQMSFWGATVITGLFGAIPGIGPSIQAWLL
GGPAVDNATLNRFFSLHYLLPFVIAALVAIHIWAFHTTGNNNPTGVEVRRTSKADAEKDT
LPFWPYFVIKDLFALALVLLGFFAVVAYMPNYLGHPDNYVQANPLSTPAHIVPEWYFLPF
YAILRAFAADVWVVILVDGLTFGIVDAKFFGVIAMFGAIAVMALAPWLDTSKVRSGAYRP
KFRMWFWFLVLDFVVLTWVGAMPTEYPYDWISLIASTYWFAYFLVILPLLGATEKPEPIP
ASIEEDF
//
>1zrtD [x.x.x] CYTOCHROME C1
SNVPDHAFSFEGIFGKYDQAQLRRGFQVYNEVCSACHGMKFVPIRTLADDGGPQLDPTFV
REYAAGLDTIIDKDSGEERDRKETDMFPTRVGDGMGPDLSVMAKARAGFSGPAGSGMNQL
FKGMGGPEYIYNYVIGFEENPECAPEGIDGYYYNKTFQIGPDTCKGVKITHGSWARMPPP
LVDDQVTYEDGTPATVDQMAQDVSAFLMWAAEPKLVARKQMGLVAMVMLGLLSVMLYLTN
KRLWAPYKGHKA
//
>1zrtE [f.23.12 - b.33.1] UBIQUINOL-CYTOCHROME C REDUCTASE IRON-SULFUR
RRDFLYHATAATGVVVTGAAVWPLINQMNASADVKAMASIFVDVSAVEVGTQLTVKWRGK
PVFIRRRDEKDIELARSVPLGALRDTSAENANKPGAEATDENRTLPAFDGTNTGEWLVML
GVCTHLGCVPMGDKSGDFGGWFCPCHGSHYDSAGRIRKGPAPRNLDIPVAAFVDETTIKL
G
//
>1zrtP (C) [f.21.1 - f.32.1] CYTOCHROME B
SGIPHDHYEPKTGIEKWLHDRLPIVGLVYDTIMIPTPKNLNWWWIWGIVLAFTLVLQIVT
GIVLAMHYTPHVDLAFASVEHIMRDVNGGWAMRYIHANGASLFFLAVYIHIFRGLYYGSY
KAPREITWIVGMVIYLLMMGTAFMGYVLPWGQMSFWGATVITGLFGAIPGIGPSIQAWLL
GGPAVDNATLNRFFSLHYLLPFVIAALVAIHIWAFHTTGNNNPTGVEVRRTSKADAEKDT
LPFWPYFVIKDLFALALVLLGFFAVVAYMPNYLGHPDNYVQANPLSTPAHIVPEWYFLPF
YAILRAFAADVWVVILVDGLTFGIVDAKFFGVIAMFGAIAVMALAPWLDTSKVRSGAYRP
KFRMWFWFLVLDFVVLTWVGAMPTEYPYDWISLIASTYWFAYFLVILPLLGATEKPEPIP
ASIEEDF
//
>1zrtR (E) [f.23.12 - b.33.1] UBIQUINOL-CYTOCHROME C REDUCTASE IRON-SULFUR
RRDFLYHATAATGVVVTGAAVWPLINQMNASADVKAMASIFVDVSAVEVGTQLTVKWRGK
PVFIRRRDEKDIELARSVPLGALRDTSAENANKPGAEATDENRTLPAFDGTNTGEWLVML
GVCTHLGCVPMGDKSGDFGGWFCPCHGSHYDSAGRIRKGPAPRNLDIPVAAFVDETTIKL
G
//
>1zrtQ (D) [x.x.x] CYTOCHROME C1
SNVPDHAFSFEGIFGKYDQAQLRRGFQVYNEVCSACHGMKFVPIRTLADDGGPQLDPTFV
REYAAGLDTIIDKDSGEERDRKETDMFPTRVGDGMGPDLSVMAKARAGFSGPAGSGMNQL
FKGMGGPEYIYNYVIGFEENPECAPEGIDGYYYNKTFQIGPDTCKGVKITHGSWARMPPP
LVDDQVTYEDGTPATVDQMAQDVSAFLMWAAEPKLVARKQMGLVAMVMLGLLSVMLYLTN
KRLWAPYKGHKA
//
>1zs8_1A [d.19.1 - b.1.1] HISTOCOMPATIBILITY 2, M REGION LOCUS 10.5
SHWLKTFRIVIMEPGILEPRFIQVSYVDSIQYQGFDSRSGMQPRAAWMKQEPPEYWKNET
EHAMGASLLARRTLIYMVTENNNKKNDYHTLQEVFGCNVAHDGSFLGGHYGLTYYGYDYI
ILNEDLNSWTTEGKVGGKFNSVTEGWRTYLKGECTERFLRCLDLGKETLLRSDAPRTHVT
HKVTVTLRCWALGFYPADITLTWKRDGKNHTQDMELPDTRPAGDGTFQKWAAVVVPFGEE
LRYTCHVHHEGLPGPLTLKWG
//
>1zs8_1B [b.1.1] BETA-2-MICROGLOBULIN
IQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDW
SFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM
//
>1zt1A [d.19.1 - b.1.1] H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, K-K
MGPHSLRYFHTAVSRPGLGKPRFISVGYVDDTQFVRFDSDAENPRYEPRVRWMEQVEPEY
WERNTQIAKGNEQIFRVNLRTALRYYNQSAGGSHTFQRMYGCEVGSDWRLLRGYEQYAYD
GCDYIALNEDLKTWTAADMAALITKHKWEQAGDAERDRAYLEGTCVEWLRRYLQLGNRTD
SPKAHVTRHSRPEDKVTLRCWALGFYPADITLTWQLNGEELTQDMELVETRPAGDGTFQK
WASVVVPLGKEQYYTCHVYHQGLPEPLTLRWEP
//
>1zt1B [b.1.1] BETA-2-MICROGLOBULIN
QKTPQIQVYSRHPPENGKPNILNCYVTQFHPPHIEIQMLKNGKKIPKVEMSDMSFSKDWS
FYILAHTEFTPTETDTYACRVKHDSMAEPKTVYWDRDM
//
>1zt2_1A [d.264.1] DNA PRIMASE SMALL SUBUNIT
TFTLHQGQTNLIKSFFRNYYLNAELELPKDMELREFALQPFGSDTYVRHLSFSSSEELRD
YLVNRNLPLHLFYSSARYQLPSARNMEEKAWMGSDLLFDIDADHLCKLRSIRFCPVCGNA
VVSEKCERDNVETLEYVEMTSECIKRGLEQTRNLVEILEDDFGLKPKVYFSGNRGFHVQV
DCYGNCALLDSDERKEIAEYVMGIGVPGYPGGSENAPGWVGRKNRGINGVTIDEQVTIDV
KRLIRIPNSLHGKSGLIVKRVPNLDDFEFNETLSPFTGYTIFLPYITIETEVLGSIIKLN
RGIPIKIKSSIGIYLHLRNLGEVKAYV
//
>1zt2_1B [a.262.1] DNA PRIMASE LARGE SUBUNIT
LDVKKYPFIKSLDDELKKYGGGITLTDLLLNSTTLIDQAKDRIQKTKSGDELPHYVSYNE
PVLVFYTTLLSLAILNDVKLIRRYAYAEAKQFRSLLHTENEENLLEISKLLDLKINRCDP
IKFYLEKKRRIIQKEFCVHFIDYLKYTKDLKEDWKLSGQILHKGYVYLDKNQLIGLIAES
IKSKIVEMIRPLNLKEIPEKLKSLIER
//
>1zt4A [d.19.1 - b.1.1] T-CELL SURFACE GLYCOPROTEIN CD1D
RLFPLRCLQISSFANSSWTRTDGLAWLGELQTHSWSNDSDTVRSLKPWSQGTFSDQQWET
LQHIFRVYRSSFTRDVKEFAKMLRLSYPLELQVSAGCEVHPGNASNNFFHVAFQGKDILS
FQGTSWEPTQEAPLWVNLAIQVLNQDKWTRETVQWLLNGTCPQFVSGLLESGKSELKKQV
KPKAWLSRGPSPGPGRLLLVCHVSGFYPKPVWVKWMRGEQEQQGTQPGDILPNADETWYL
RATLDVVAGEAAGLSCRVKHSSLEGQDIVLYW
//
>1zt4B [b.1.1] BETA-2-MICROGLOBULIN
MIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKD
WSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM
//
>1ztxE [b.1.18] ENVELOPE PROTEIN
TTYGVCSKAFKFLGTPADTGHGTVVLELQYTGTDGPCKVPISSVASLNDLTPVGRLVTVN
PFVSVATANAKVLIELEPPFGDSYIVVGRGEQQINHHWHKS
//
>1ztxH [b.1.1] HEAVY CHAIN OF E16 ANTIBODY
QVQLQQSGSELMKPGASVQISCKATGYTFSDYWIEWVKQRPGHGLEWIGDILCGTGRTRY
NEKLKAMATFTADTSSNTAFMQLSSLTSEDSAVYYCARSASYGDYADYWGHGTTLTVSSA
KTTPPSVYPLAPGCGDTTGSSVTLGCLVKGYFPESVTVTWNSGSLSSSVHTFPALLQSGL
YTMSSSVTVPSSTWPSQTVTCSVAHPASSTTVDKKLEPS
//
>1ztxL [b.1.1 - b.1.1] LIGHT CHAIN OF E16 ANTIBODY
DIVMTQSHKFMSTSVGDRVSITCKASQDVSTAVAWYQQKPGQSPKLLISWASTRHTGVPD
RFTGSGSGTDYTLTISSVQAEDLALYYCQQHYTTPLTFGAGTKLELKRADAAPTVSIFPP
SSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLT
LTKDEYERHNSYTCEATHKTSTSPIVKSFNRN
//
>1zud3 [c.111.1] ADENYLYLTRANSFERASE THIF
MNDRDFMRYSRQILLDDIALDGQQKLLDSQVLIIGLGGLGTPAALYLAGAGVGTLVLADD
DDVHLSNLQRQILFTTEDIDRPKSQVSQQRLTQLNPDIQLTALQQRLTGEALKDAVARAD
VVLDCTDNMATRQEINAACVALNTPLITASAVGFGGQLMVLTPPWEQGCYRCLWPDNQEP
TAGVVGPVVGVMGTLQALEAIKLLSGIETPAGELRLFDGKSSQWRSLALRRASGCPVCGG
//
>1zud4 [d.15.3] THIS PROTEIN
MQILFNDQAMQCAAGQTVHELLEQLDQRQAGAALAINQQIVPREQWAQHIVQDGDQILLF
QVIAGG
//
>1zunA [c.26.2] SULFATE ADENYLYLTRANSFERASE SUBUNIT 2
LVPRGSHmVDKLTHLKQLEAESIHIIREVAAEFDNPVmLYSIGKDSAVmLHLARKAFFPG
KLPFPVmHVDTRWKFQEmYRFRDQmVEEmGLDLITHINSAKHTDImKTEGLKQALDKHGF
DAAFGGARRDEEKSRAKERVYSFRDSKHRWDPKNQRPELWNVYNGNVNKGESIRVFPLSN
WTELDIWQYIYLEGIPIVPLYFAA
//
>1zunB [c.37.1 - b.43.3 - b.44.1] SULFATE ADENYLATE TRANSFERASE, SUBUNIT
LGQHERKEmLRFLTCGNVDDGKSTLIGRLLHDSKmIGDDLALLVDGLQAITIDVAYRYFS
TAKRKFIIADTPGHEQYTRNmATGASTCDLAIILVDARYGVQTQTRRHSYIASLLGIKHI
VVAINKmDLNGFDERVFESIKADYLKFAEGIAFKPTTmAFVPmSALKGDNVVNKSERSPW
YAGQSLmEILETVEIASDRNYTDLRFPVQYVNRPNLNFRGFAGTLASGIVHKGDEIVVLP
SGKSSRVKSIVTFEGELEQAGPGQAVTLTmEDEIDISRGDLLVHADNVPQVSDAFDAmLV
WmAEEPmLPGKKYDIKRATSYVPGSIASITHRVDVNTLEEGPASSLQLNEIGRVKVSLDA
PIALDGYSSNRTTGAFIVIDRLTNGTVAAGmIIA
//
>1zv5A [b.1.1] IMMUNOGLOBULIN HEAVY CHAIN ANTIBODY VARIABLE
VQLVESGGGSVQAGESLRLSCAASGVTYKNYCIGWFRQAPGKDREGVVFINSDGGITYYA
DSVKGRFTISQDNAKNTVYLQMNSLKPEDTASYYCAAGYRNYGQCATRYWGQGTQVTVS
//
>1zv5L [d.2.1] LYSOZYME C
KVFGRCELAAAMKRHGLDNYRGYSLGNWVCAAKFESNFNTQATNRNTDGSTDYGILQINS
RWWCNDGRTPGSRNLCNIPCSALLSSDITASVNCAKKIVSDGNGMNAWVAWRNRCKGTDV
QAWIRGCRL
//
>1zv8_2G [h.3.3] E2 GLYCOPROTEIN
NQKQIANQFNKAISQIQESLTTTSTALGKLQDVVNQNAQALNTLVKQLSS
//
>1zv8_2H [h.3.3] E2 GLYCOPROTEIN
DISGINASVVNIQKEIDRLNEVAKNLNESLIDLQ
//
>1zvhL [d.2.1] LYSOZYME C
KVFGRCELAAAMKRHGLDNYRGYSLGNWVCAAKFESNFNTQATNRNTDGSTDYGILQINS
RWWCNDGRTPGSRNLCNIPCSALLSSDITASVNCAKKIVSDGMNAWVAWRNRCKGTDVQA
WIRGCRL
//
>1zvhA [b.1.1] IMMUNOGLOBULIN HEAVY CHAIN ANTIBODY VARIABLE
DVQLVESGGGSVQAGGSLRLSCAASGYIASINYLGWFRQAPGKEREGVAAVSPAGGTPYY
ADSVKGRFTVSLDNAENTVYLQMNSLKPEDTALYYCAAARQGWYIPLNSYGYNYWGQGTQ
VTVS
//
>1zvs_2D (A) [d.19.1 - b.1.1] MHC CLASS I ANTIGEN
GSHSMKYFYTSMSRPGRGQPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWVEQEGPEYW
DRETRNMKTETQNAPVNLRTLLRYYNQSEAGSHTLQRMVGCDLGPDGRLLRGYEQYAYDG
KDYIALNEDLRSWTAADVAAQNTQRKWEAADVAESMRAYLEGQCVEWLPRYLEKGKETLQ
RTDPPKTHVTHHPVSDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGT
FQKWAAVVVPSGEEQRYTCHVQHEGLPKPHTLKWEPHH
//
>1zvs_2E (B) [b.1.1] BETA-2-MICROGLOBULIN
IQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDW
SFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM
//
>1zvv_2G [a.35.1 - c.93.1] GLUCOSE-RESISTANCE AMYLASE REGULATOR
MNVTIYDVAREASVSMATVSRVVNGNPNVKPSTRKKVLETIEYRPNAVARGLASKKTTTV
GVIIPDISNIFYAELARGIEDIASMYKYNIILSNSDQNQDKQLHLLNNMLGKQVDGIIFM
SGNVTEEHVEELKKSPVPVVLAASIESTNQIPSVTIDYEQAAFDAVQSLIDSGHKNIAFV
SGTLEEPINHAKKVKGYKRALTESGLPVRDSYIVEGDYTYDSGIEAVEKLLEEDEKPTAI
FVGTDEMALGVIHGAQDRGLNVPNDLEIIGFDNTRLSTMVRPQLTSVVQPMYDIGAVAMR
LLTKYMNKETVDSSIVELPHRIEFRQSTK
//
>1zvv_2J (W) [d.94.1] HPR-LIKE PROTEIN CRH
MVQQKVEVRLKTGLQARPAALFVQEANRFTSDIFLEKDGKKVNAKxIMGLMSLAISTGTE
ITLIAQGEDEQEALEKLAAYVQEE
//
>1zvyA [b.1.1] IMMUNOGLOBULIN HEAVY CHAIN ANTIBODY VARIABLE
VQLVESGGGSVQAGGSLRLSCAASGSTDSIEYMTWFRQAPGKAREGVAALYTHTGNTYYT
DSVKGRFTISQDKAKNMAYLRMDSVKSEDTAIYTCGATRKYVPVRFALDQSSYDYWGQGT
QVTV
//
>1zvyB [d.2.1] LYSOZYME C
KVFGRCELAAAMKRHGLDNYRGYSLGNWVCAAKFESNFNTQATNRNTDGSTDYGILQINS
RWWCNDGRTPGSRNLCNIPCSALLSSDITASVNCAKKIVSDGNGMNAWVAWRNRCKGTDV
QAWIRGCRL
//
>1zvzA [a.24.9 - a.24.9] VINCULIN
MPVFHTRTIESILEPVAQQISHLVIMHEEGEVDGKAIPDLTAPVSAVQAAVSNLVRVGKE
TVQTTEDQILKRDMPPAFIKVENACTKLVRAAQMLQADPYSVPARDYLIDGSRGILSGTS
DLLLTFDEAEVRKIIRVCKGILEYLTVAEVVETMEDLVTYTKNLGPGMTKMAKMIDERQQ
ELTHQEHRVMLVNSMNTVKELLPVLISAMKIFVTTKNTKSQGIEEALKNRNFTVEKMSAE
INEIIRVLQLTSW
//
>1zvzB [x.x.x] TALIN 1
EMVRQARILAQATSDLVNAIKA
//
>1zw2A [a.24.9 - a.24.9] VINCULIN
MPVFHTRTIESILEPVAQQISHLVIMHEEGEVDGKAIPDLTAPVSAVQAAVSNLVRVGKE
TVQTTEDQILKRDMPPAFIKVENACTKLVRAAQMLQADPYSVPARDYLIDGSRGILSGTS
DLLLTFDEAEVRKIIRVCKGILEYLTVAEVVETMEDLVTYTKNLGPGMTKMAKMIDERQQ
ELTHQEHRVMLVNSMNTVKELLPVLISAMKIFVTTKNTKSQGIEEALKNRNFTVEKMSAE
INEIIRVLQLT
//
>1zw2B [x.x.x] TALIN
ILEAAKSIAAATSALVKAASA
//
>1zw3A [a.24.9 - a.24.9] VINCULIN
MPVFHTRTIESILEPVAQQISHLVIMHEEGEVDGKAIPDLTAPVSAVQAAVSNLVRVGKE
TVQTTEDQILKRDMPPAFIKVENACTKLVRAAQMLQADPYSVPARDYLIDGSRGILSGTS
DLLLTFDEAEVRKIIRVCKGILEYLTVAEVVETMEDLVTYTKNLGPGMTKMAKMIDERQQ
ELTHQEHRVMLVNSMNTVKELLPVLISAMKIFVTTKNTKSQGIEEALKNRNFTVEKMSAE
INEIIRVLQLT
//
>1zw3B [x.x.x] TALIN 1
WSVLAGHSRTVSDSIKKLITSMR
//
>1zy8_3F (A) [c.3.1 - c.3.1 - d.87.1] DIHYDROLIPOYL DEHYDROGENASE, MITOCHONDRIAL
ADQPIDADVTVIGSGPGGYVAAIKAAQLGFKTVCIEKNETLGGTCLNVGCIPSKALLNNS
HYYHMAHGKDFASRGIEMSEVRLNLDKMMEQKSTAVKALTGGIAHLFKQNKVVHVNGYGK
ITGKNQVTATKADGGTQVIDTKNILIATGSEVTPFPGITIDEDTIVSSTGALSLKKVPEK
MVVIGAGVIGVELGSVWQRLGADVTAVEFLGHVGGVGIDMEISKNFQRILQKQGFKFKLN
TKVTGATKKSDGKIDVSIEAASGGKAEVITCDVLLVCIGRRPFTKNLGLEELGIELDPRG
RIPVNTRFQTKIPNIYAIGDVVAGPMLAHKAEDEGIICVEGMAGGAVHIDYNCVPSVIYT
HPEVAWVGKSEEQLKEEGIEYKVGKFPFAANSRAKTNADTDGMVKILGQKSTDRVLGAHI
LGPGAGEMVNEAALALEYGASCEDIARVCHAHPTLSEAFREANLAASFGKSINF
//
>1zy8_3M (K) [x.x.x] PYRUVATE DEHYDROGENASE PROTEIN X COMPONENT,
RLSPAARNILEKHSLDASQGTATGPRGIFTKEDALKLVQLKQTGLSPAARNILEKHSLDA
SQGTATPRGFTKEDALKLVQLKQT
//
>1zy8_4H (A) [c.3.1 - c.3.1 - d.87.1] DIHYDROLIPOYL DEHYDROGENASE, MITOCHONDRIAL
ADQPIDADVTVIGSGPGGYVAAIKAAQLGFKTVCIEKNETLGGTCLNVGCIPSKALLNNS
HYYHMAHGKDFASRGIEMSEVRLNLDKMMEQKSTAVKALTGGIAHLFKQNKVVHVNGYGK
ITGKNQVTATKADGGTQVIDTKNILIATGSEVTPFPGITIDEDTIVSSTGALSLKKVPEK
MVVIGAGVIGVELGSVWQRLGADVTAVEFLGHVGGVGIDMEISKNFQRILQKQGFKFKLN
TKVTGATKKSDGKIDVSIEAASGGKAEVITCDVLLVCIGRRPFTKNLGLEELGIELDPRG
RIPVNTRFQTKIPNIYAIGDVVAGPMLAHKAEDEGIICVEGMAGGAVHIDYNCVPSVIYT
HPEVAWVGKSEEQLKEEGIEYKVGKFPFAANSRAKTNADTDGMVKILGQKSTDRVLGAHI
LGPGAGEMVNEAALALEYGASCEDIARVCHAHPTLSEAFREANLAASFGKSINF
//
>1zy8_4N (K) [x.x.x] PYRUVATE DEHYDROGENASE PROTEIN X COMPONENT,
RLSPAARNILEKHSLDASQGTATGPRGIFTKEDALKLVQLKQTGLSPAARNILEKHSLDA
SQGTATGPRGTKEDALKLVQLKQ
//
>1zyr_2N (D) [e.29.1] DNA-DIRECTED RNA POLYMERASE SUBUNIT BETA' CHAIN
KKEVRKVRIALASPEKIRSWSYGEVEKPETINYRTLKPERDGLFDERIFGPIKDYECACG
KYKRQRFEGKVCERCGVEVTKSIVRRYRMGHIELATPAAHIWFVKDVPSKIGTLLDLSAT
ELEQVLYFSKYIVLDPKGAILNGVPVEKRQLLTDEEYRELRYGKQETYPLPPGVDALVKD
GEEVVKGQELAPGVVSRLDGVALYRFPRRVRVEYVKKERAGLRLPLAAWVEKEAYKPGEI
LAELPEPYLFGDKIVAAIDPEEEVIAEAEGVVHLHEPASILVVKARVYPFEDDVEVSTGD
RVAPGDVLADGGKVKSDVYGRVEVDLVRNVVRVVESYDIDARMGAEAIQQLLKELDLEAL
EKELLEEMKHPSRARRAKARKRLEVVRAFLDSGNRPEWMILEAVPVLPPDLRPMVQVDGG
RFATSDLNDLYRRLINRNNRLKKLLAQGAPEIIIRNEKRMLQEAVDALLDNGRRGAPVTN
PGSDRPLRSLTDILSGKQGRFRQNLLGKRVDYSGRSVIVVGPQLKLHQCGLPKRMALELF
KPFLLKKMEEKGIAPNVKAARRMLERQRDIKDEVWDALEEVIHGKVVLLNRAPTLHRLGI
QAFQPVLVEGQSIQLHPLVCEAFNADFDGDQMAVHVPLSSFAQAEARIQMLSAHNLLSPA
SGEPLAKPSRDIILGLYYITQVRKEKKGAGLEFATPEEALAAHERGEVALNAPIKVAGRE
TSVGRLKYVFANPDEALLAVAHGIVDLQDVVTVRYMGKRLETSPGRILFARIVAEAVEDE
KVAWELIQLDVPQEKNSLKDLVYQAFLRLGMEKTARLLDALKYYGFTFSTTSGITIGIDD
AVIPEEKKQYLEEADRKLLQIEQAYEMGFLTDRERYDQILQLWTETTEKVTQAVFKNFEE
NYPFNPLYVMAQSGARGNPQQIRQLCGLRGLMQKPSGETFEVPVRSSFREGLTVLEYFIS
SHGARKGGADTALRTADSGYLTRKLVDVTHEIVVREADCGTTNYISVPLFQPDEVTRSLR
LRKRADIEAGLYGRVLAREVEVLGVRLEEGRYLSMDDVHLLIKAAEAGEIQEVPVRSPLT
CQTRYGVCQKCYGYDLSMARPVSIGEAVGIVAAQSIGEPGTQLTMRTFHTGGVAGAADIT
QGLPRVIELFEARRPKAKAVISEIDGVVRIEETEEKLSVFVESEGFSKEYKLPKEARLLV
KDGDYVEAGQPLTRGAIDPHQLLEAKGPEAVERYLVEEIQKVYRAQGVKLHDKHIEIVVR
QMMKYVEVTDPGDSRLLEGQVLEKWDVEALNERLIAEGKTPVAWKPLLMGVTKSALSTKS
WLSAASFQNTTHVLTEAAIAGKKDELIGLKENVILGRLIPAGTGSDFVRFTQVVDQKTLK
AIEEARKEAVEA
//
>1zyr_2O (E) [a.143.1] DNA-DIRECTED RNA POLYMERASE OMEGA CHAIN
AEPGIDKLFGMVDSKYRLTVVVAKRAQQLLRHGFKNTVLEPEERPKMQTLEGLFDDPNAE
TWAMKELLTGRLVFGENLVPEDRLQKEMERIYPGE
//
>2a06A [d.185.1 - d.185.1] UBIQUINOL-CYTOCHROME-C REDUCTASE COMPLEX CORE
TATYAQALQSVPETQVSQLDNGLRVASEQSSQPTCTVGVWIDAGSRYESEKNNGAGYFVE
HLAFKGTKNRPGNALEKEVESMGAHLNAYSTREHTAYYIKALSKDLPKAVELLADIVQNC
SLEDSQIEKERDVILQELQENDTSMRDVVFNYLHATAFQGTPLAQSVEGPSENVRKLSRA
DLTEYLSRHYKAPRMVLAAAGGLEHRQLLDLAQKHFSGLSGTYDEDAVPTLSPCRFTGSQ
ICHREDGLPLAHVAIAVEGPGWAHPDNVALQVANAIIGHYDCTYGGGAHLSSPLASIAAT
NKLCQSFQTFNICYADTGLLGAHFVCDHMSIDDMMFVLQGQWMRLCTSATESEVLRGKNL
LRNALVSHLDGTTPVCEDIGRSLLTYGRRIPLAEWESRIAEVDARVVREVCSKYFYDQCP
AVAGFGPIEQLPDYNRIRSGMF
//
>2a06B [d.185.1 - d.185.1] UBIQUINOL-CYTOCHROME-C REDUCTASE COMPLEX CORE
EVPPPQDLEFTRLPNGLVIASLENYAPASRIGLFIKAGSRYENSNNLGTSHLLRLASSLT
TKGASSFKITRGIEAVGGKLSVTSTRENMAYTVECLRDDVDILMEFLLNVTTAPEFRRWE
VAALQPQLRIDKAVALQNPQAHVIENLHAAAYRNALANSLYCPDYRIGKVTPVELHDYVQ
NHFTSARMALIGLGVSHPVLKQVAEQFLNIRGGLLSGAKAKYHGGEIREQNGDSLVHAAL
VAESAAIGSAEANAFSVLQHVLGAGPHVKRGSNATSSLYQAVAKGVHQPFDVSAFNASYS
DSGLFGFYTISQAASAGDVIKAAYNQVKTIAQGNLSNPDVQAAKNKLKAGYLMSVESSEG
FLDEVGSQALAAGSYTPPSTVLQQIDAVADADVINAAKKFVSGRKSMAASGNLGHTPFID
EL
//
>2a06D [a.3.1 - f.23.11] CYTOCHROME C1, HEME PROTEIN, MITOCHONDRIAL
SDLELHPPSYPWSHRGLLSSLDHTSIRRGFQVYKQVCSSCHSMDYVAYRHLVGVCYTEDE
AKALAEEVEVQDGPNEDGEMFMRPGKLSDYFPKPYPNPEAARAANNGALPPDLSYIVRAR
HGGEDYVFSLLTGYCEPPTGVSLREGLYFNPYFPGQAIGMAPPIYNEVLEFDDGTPATMS
QVAKDVCTFLRWAAEPEHDHRKRMGLKMLLMMGLLLPLVYAMKRHKWSVLKSRKLAYRPP
K
//
>2a06H [f.28.1] UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX 11 KDA
LVDPLTTVREQCEQLEKCVKARERLELCDERVSSRSQTEEDCTEELLDFLHARDHCVAHK
LFNSLK
//
>2a06J [f.23.14] UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX 7.2 KDA
AFDQGADAIYEHINEGKLWKHIKHKYEK
//
>2a0lA [f.14.1] VOLTAGE-GATED POTASSIUM CHANNEL
HPLVELGVSYAALLSVIVVVVEYTMQLSGEYLVRLYLVDLILVIILWADYAYRAYKSGDP
AGYVKKTLYEIPALVPAGLLALIEGHLAGLGLFRLVRLLRFLRILLIISRGSKFLSAIAD
AADKIRFYHLFGAVMLTVLYGAFAIYIVEYPDPNSSIKSVFDALWWAVVTATTVGYGDVV
PATPIGKVIGIAVMLTGISALTLLIGTVSNMFQK
//
>2a0lC [b.1.1] 33H1 FV FRAGMENT
QIVLTQSPAIMSASLGDRVTMTCTASSSVSSSYLHWYQQKPGSSPKLWIYSTSNLASGVP
ARFSGSGSGTSYSLTISSMEAEDAATYYCHQFHRSLTFGSGTKLE
//
>2a0lD [b.1.1] 33H1 FV FRAGME